{ "schema_version": "1.3", "disclaimer": "Not legal advice: this output is machine-computed from published texts, carries no lawyer's review, and is engineering assistance only.", "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "from_version": "02008R1272-20110419", "to_version": "02008R1272-20131201", "detected_on": "2026-08-13", "in_force": [ "2012-07-31", "2013-06-21" ], "diff_only": false, "summary": { "inserted": 0, "modified": 9, "deleted": 0, "renumbered": 0, "deferred": 0, "touched_units": 9, "unchanged_units": 65, "disputed": 5 }, "counts": { "touched": 9, "substantive": 4, "date_only": 0, "textless": 5, "disputed": 5, "quoted": 0, "unexplained": 6 }, "changes": [ { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AR 14" }, "heading": null, "before": null, "after": null, "previous_location": null, "changed_within": [], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unknown", "reason": null }, "signals": { "structural_diff": { "status": "absent", "detail": "structural_diff", "change_types": [] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 SU", "change_types": [] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": true, "dispute_reason": "textless_metadata_only" }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships marked disputed", "unexplained_kind": "nothing_to_explain" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AR 23" }, "heading": null, "before": null, "after": null, "previous_location": null, "changed_within": [], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unknown", "reason": null }, "signals": { "structural_diff": { "status": "absent", "detail": "structural_diff", "change_types": [] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 J", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": true, "dispute_reason": "textless_metadata_only" }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships marked disputed", "unexplained_kind": "nothing_to_explain" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN I" }, "heading": "CLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES", "before": "\nANNEX I\nCLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES\nThis annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.\n\n\n1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND LABELLING\n\n\n1.0. Definitions\nGas means a substance which:\n\n(i) at 50 oC has a vapour pressure greater than 300 kPa (absolute); or\n\n(ii) is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;\nLiquid means a substance or mixture which:\n\n(i) at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);\n\n(ii) is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and\n\n(iii) which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;\nSolid means a substance or mixture which does not meet the definitions of liquid or gas.\n\n\n1.1. Classification of substances and mixtures\n\n\n1.1.0. Cooperation to meet the requirements in this Regulation\nSuppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.\nSuppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.\nSuppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.\nThe network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.\n\n\n1.1.1. The role and application of expert judgement and weight of evidence determination\n1.1.1.1. Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.\n\n1.1.1.2. The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.\n1.1.1.3. A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.\n1.1.1.4. For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.\n1.1.1.5. For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.\n\n\n1.1.2. Specific concentration limits, M-factors and generic cut-off values\n1.1.2.1. Specific concentration limits or M-factors shall be applied in accordance with Article 10.\n\n\n1.1.2.2. Cut-off values\n1.1.2.2.1. Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).\n\n1.1.2.2.2. The cut-off values referred to in Article 11 shall be the following:\n\n(a) For health and environmental hazards in Parts 3, 4 and 5 of this Annex:\n\n(i) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or\n\n(ii) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or\n\n(iii) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or\n\n(iv) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.\n\n(b) For aquatic environmental hazards in section 4.1 of this Annex:\n\n(i) for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or\n\n(ii) for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.\n\nTable 1.1\nGeneric cut-off values\n\nOr < 1 % where relevant, see 3.2.3.3.1.\nOr < 1 % where relevant, see 3.3.3.3.1.\nOr < 0,1 % where relevant, see 4.1.3.1.\n\nHazard class\nGeneric cut-off values to be taken into account\nAcute Toxicity:\n\n\nCategory 1-3\n0,1 %\n\nCategory 4\n1 %\nSkin corrosion/Irritation\n1 %\nSerious damage to eyes/eye irritation\n1 %\nHazardous to Aquatic Environment\n\n\nAcute Category 1\n0,1 %\n\nChronic Category 1\n0,1 %\n\nChronic Category 2-4\n1 %\n\n\nNote:\nGeneric cut-off values are in weight percentages except for gaseous mixtures for those hazard classes where the generic cut-off values may be best described in volume percentages.\n\n\n\n1.1.3. Bridging principles for the classification of mixtures where test data are not available for the complete mixture\nWhere the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.\n\n\n1.1.3.1. Dilution\nIf a tested mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:\n\nthe new mixture shall be classified as equivalent to the original mixture;\nthe method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;\nin the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).\n\n\n\n1.1.3.2. Batching\nThe hazard category of a tested production batch of a mixture can be assumed to be substantially equivalent to that of another untested production batch of the same commercial product, when produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the untested batch has changed. If the latter occurs, a new evaluation is necessary.\n\n\n\n1.1.3.3. Concentration of highly hazardous mixtures\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a tested mixture is classified in the highest hazard category or sub-category, and the concentration of the components of the tested mixture that are in that category or sub-category is increased, the resulting untested mixture shall be classified in that category or sub-category without additional testing.\n\n\n1.1.3.4. Interpolation within one toxicity category\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures (A, B and C) with identical components, where mixtures A and B have been tested and are in the same hazard category, and where untested mixture C has the same hazardous components as mixture A and B but has concentrations of those hazardous components intermediate to the concentrations in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.\n\n\n\n1.1.3.5. Substantially similar mixtures\nGiven the following:\n\n(a) two mixtures each containing two ingredients:\n\n(i) A + B\n\n(ii) C + B;\n\n(b) the concentration of ingredient B is essentially the same in both mixtures;\n\n(c) the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);\n\n(d) hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.\n\nIf mixture (i) or (ii) is already classified based on test data, then the other mixture shall be assigned the same hazard category.\n\n\n\n1.1.3.6. Review of classification where the composition of a mixture has changed\nThe following variations in initial concentration are defined for the application of Article 15(2)(a):\n\nTable 1.2\nBridging Principle for changes in the composition of a mixture\n\nInitial concentration range of the constituent\nPermitted variation in initial concentration of the constituent\n≤ 2,5 %\n± 30 %\n2,5 < C ≤ 10 %\n± 20 %\n10 < C ≤ 25 %\n± 10 %\n25 < C ≤ 100 %\n± 5 %\n\n\n\n1.1.3.7. Aerosols\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.\n\n\n\n1.2. Labelling\n\n\n1.2.1. General rules for the application of labels required by Article 31\n1.2.1.1.\nHazard pictograms shall be in the shape of a square set at a point.\n1.2.1.2.\nHazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.\n1.2.1.3.\nEach hazard pictogram shall cover at least one fifteenth of the minimum surface area of the label dedicated to the information required by Article 17. The minimum area of each hazard pictogram shall not be less than 1 cm2.\n1.2.1.4.\nThe dimensions of the label and of each pictogram shall be as follows:\n\nTable 1.3\nMinimum dimensions of labels and pictograms\n\nCapacity of the package\nDimensions of the label (in millimetres) for the information required by Article 17\nDimensions of each pictogram (in millimetres)\nNot exceeding 3 litres:\nIf possible, at least 52 × 74\nNot smaller than 10 × 10\nIf possible, at least 16 × 16\nGreater than 3 litres but not exceeding 50 litres:\nAt least 74 × 105\nAt least 23 × 23\nGreater than 50 litres but not exceeding 500 litres:\nAt least 105 × 148\nAt least 32 × 32\nGreater than 500 litres:\nAt least 148 × 210\nAt least 46 × 46\n\n\n\n1.3. Derogations from labelling requirements for special cases\nIn accordance with Article 23 the following derogations shall apply:\n\n\n1.3.1. Transportable gas cylinders\nFor transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:\n\n(a) A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to Gas cylinders — Precautionary labels. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.\n\n\n(b) The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.\n\n\n1.3.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)\n1.3.2.1. If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.\n1.3.2.2. No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).\n1.3.2.3. For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.\n\n\n1.3.3. Aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard\nWith regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.\n\n\n1.3.4. Metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers\n1.3.4.1. Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.\n1.3.4.2. Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.\n\n\n1.3.5. Explosives placed on the market with a view to obtaining an explosive or pyrotechnic effect\nExplosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.\n\n\n1.4. Request for use of an alternative chemical name\n\n\n1.4.1. Requests for use of an alternative chemical name under Article 24 may be granted only where\n\n(I) the substance has not been assigned a Community workplace exposure limit; and\n\n\n(II) the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and\n\n(III) the substance is classified exclusively as one or more of the following hazard categories:\n\n(a) any of the hazard categories referred to in Part 2 of this Annex;\n\n(b) Acute toxicity, Category 4;\n\n(c) Skin corrosion/irritation, Category 2;\n\n(d) Serious eye damage/eye irritation, Category 2;\n\n(e) Specific target organ toxicity — Single exposure, Category 2 or 3;\n\n(f) Specific target organ toxicity — Repeated exposure, Category 2;\n\n(g) Hazardous to the aquatic environment — Chronic, Category 3 or 4.\n\n\n1.4.2. The choice of the chemical name(s) for mixtures intended for the fragrance or perfume industry\nIn the case of substances occurring in nature, a chemical name or chemical names of the type essential oil of … or extract of … may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).\n\n\n1.5. Exemptions from labelling and packaging requirements\n\n\n1.5.1. Exemptions from Article 31 [(Article 29(1))]\n1.5.1.1. Where Article 29(1) applies, the label elements mentioned in Article 17 may be provided in one of the following ways:\n\n(a) in fold-out labels; or\n\n(b) on tie-on tags; or\n\n(c) on an outer packaging.\n1.5.1.2. The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.\n\n\n1.5.2. Exemptions from Article 17 [(Article 29(2)]\n\n\n1.5.2.1. Labelling of packages where the contents do not exceed 125 ml\n1.5.2.1.1. The hazard statements and the precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Oxidising gases of category 1;\n\n2) Gases under pressure;\n\n3) Flammable liquids of category 2 or 3;\n\n4) Flammable solids of category 1 or 2;\n\n\n5) Self-reactive substances or mixtures Types C to F;\n\n6) Self-heating substances or mixtures of category 2;\n\n7) Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;\n\n8) Oxidising liquids of category 2 or 3;\n\n9) Oxidising solids of category 2 or 3;\n\n10) Organic peroxides Types C to F;\n\n11) Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;\n\n12) Skin irritation of category 2;\n\n13) Eye irritation of category 2;\n\n14) Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;\n\n15) Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;\n\n16) Hazardous to the aquatic environment — Acute of category 1;\n\n17) Hazardous to the aquatic environment — Chronic of category 1 or 2.\nThe exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.\n1.5.2.1.2. The precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Flammable gases of category 2;\n\n2) Reproductive toxicity: effects on or via lactation;\n\n3) Hazardous to the aquatic environment — Chronic of category 3 or 4.\n1.5.2.1.3. The pictogram, the signal word, the hazard statement, and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Corrosive to metals.\n\n\n1.5.2.2. Labelling of soluble packaging for single use\nThe label elements required by Article 17 may be omitted from soluble packaging intended for single use where:\n\n(a) The content of each soluble packaging does not exceed a volume of 25 ml;\n\n\n(b) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b), 1.5.2.1.2 (b) or 1.5.2.1.3 (b); and\n\n\n(c) The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.\n1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.\n\n\n\n2. PART 2: PHYSICAL HAZARDS\n\n\n2.1. Explosives\n\n\n2.1.1. Definitions\n2.1.1.1. The class of explosives comprises\n\n(a) explosive substances and mixtures;\n\n(b) explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and\n\n(c) substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n2.1.1.2. For the purposes of this Regulation the following definitions shall apply:\nAn explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.\nA pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.\nAn unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.\nAn explosive article is an article containing one or more explosive substances or mixtures.\nA pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.\nAn intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n\n\n2.1.2. Classification criteria\n2.1.2.1. Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.\n2.1.2.2. Substances, mixtures and articles of this class, which are not classified as an unstable explosive, shall be assigned to one of the following six divisions depending on the type of hazard they present:\n\n(a) Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);\n\n(b) Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;\n\n(c) Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:\n\n(i) combustion of which gives rise to considerable radiant heat; or\n\n\n(ii) which burn one after another, producing minor blast or projection effects or both;\n\n(d) Division 1.4 Substances, mixtures and articles which present no significant hazard:\n\nsubstances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;\n\n(e) Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:\n\nsubstances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;\n\n(f) Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:\n\narticles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.\n2.1.2.3. Explosives, which are not classified as an unstable explosive, shall be classified in one of the six divisions referred to in paragraph 2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to the results of the tests laid down in Table 2.1.1:\n\nTable 2.1.1\nCriteria for explosives\n\nThis comprises substances, mixtures and articles which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n\nCategory\nCriteria\nUnstable explosives or explosives of Divisions 1.1 to 1.6\nFor explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:\nExplosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives shall not be subject to UN Test Series 2.\nSensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\nThermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\nFurther tests are necessary to allocate the correct Division.\n\n2.1.2.4. If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.\n\n\n2.1.3. Hazard Communication\nLabel elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.\nNOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:\n\n(a) the pictogram: exploding bomb;\n\n(b) the signal word: Danger; and\n\n(c) the hazard statement: explosive; mass explosion hazard\nunless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.\n\n\nTable 2.1.2\nLabel elements for explosives\n\nClassification\nUnstable Explosive\nDivision 1.1\nDivision 1.2\nDivision 1.3\nDivision 1.4\nDivision 1.5\nDivision 1.6\nGHS Pictograms\n\n\n\n\n\n\n\nSignal Word\nDanger\nDanger\nDanger\nDanger\nWarning\nDanger\nNo signal word\nHazard Statement\nH200: Unstable Explosive\nH201: Explosive; mass explosion hazard\nH202: Explosive; severe projection hazard\nH203: Explosive; fire, blast or projection hazard\nH204: Fire or projection hazard\nH205: May mass explode in fire\nNo hazard statement\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP210\nP230\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nP210\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nNo precautionary statement\nPrecautionary Statement\nResponse\nP372\nP373\nP380\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nNo precautionary statement\nPrecautionary Statement\nStorage\nP401\nP401\nP401\nP401\nP401\nP401\nNo precautionary statement\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\nP501\nP501\nNo precautionary statement\n\n\n\n2.1.4. Additional Classification Considerations\n2.1.4.1. The classification of substances, mixtures and articles in the explosives hazard class and further allocation to a division is a very complex, three step procedure. Reference to Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria is necessary.\nThe first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE) is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.\nExplosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).\nCertain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.\nThe classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).\n\n\nFigure 2.1.1\nOverall scheme of the procedure for classifying a substance, mixture or article in the class of explosives (Class 1 for transport)\n\n\nSUBSTANCE, MIXTURE OR ARTICLE FOR CLASSIFICATION\nACCEPTANCE PROCEDURE\nCLASSIFY as an UNSTABLE EXPLOSIVE\nREJECT Not an EXPLOSIVE\nCLASSIFY AS AN EXPLOSIVE\nHAZARDOUS DIVISION ASSIGNMENT\nCOMPATIBILITY GROUP ASSIGNMENT\nDIVISION 1.1, 1.2, 1.3, 1.4, 1.5, OR 1.6 COMPATIBILITY GROUP A, B, C, D, E, F, G, H, J, K, L, N or S (*)\nCLASSIFICATION CODE (*)\n(*) see UN Recommendations on the Transport of Dangerous Goods, Model Regulations, 15th rev. ed, sub-section 2.1.2.\n\n\nFigure 2.1.2\nProcedure for provisional acceptance of a substance, mixture or article in the class of explosives (Class 1 for transport)\n\nSUBSTANCE/MIXTURE FOR CLASSIFICATION\nARTICLE FOR CLASSIFICATION\nIs the substance/ mixture manufactured with a view to producing a practical explosive or pyrotechnic effect\nYes\nSubstance/mixture to be considered for this Class\nNo\nTEST SERIES 3\nIs the substance/ mixture a candidate for ammonium nitrate emulsion suspension or gel, intermediate for blasting explosive ANE?\nIs the substance/mixture thermally stable?\nYes\nNo\nNo\nYes\nTEST SERIES 8 Go to figure 2.1.4\nTEST SERIES 1 (*)\nIs the substance/mixture too dangerous in the form in which it was tested?\nNo\nYes\nNo\nIs it an explosive substance/mixture?\nEncapsulate and/or package the substance/mixture\nYes\nTEST SERIES 2\nTEST SERIES 4\nYes\nIs the substance/mixture too insensitive for acceptance into this Class?\nNo\nIs the article, packed article or packaged substance/mixture too dangerous?\nNo\nYes\nNOT AN EXPLOSIVE\nCLASSIFY as an Unstable Explosive\nPROVISIONALLY ACCEPT INTO THIS CLASS (go to figure 2.1.3)\n(*) For classification purposes, start with Test Series 2.\n\n\n\nFigure 2.1.3\nProcedure for assignment to a division in the class of explosives (Class 1 for transport)\n\nARTICLE OR SUBSTANCE PROVISIONALLY ACCEPTED IN THIS CLASS (from 2.1.2)\nNo\nIs the article a candidate for Division 1.6?\nIs the substance a candidate for Division 1.5?\nNo\nPackage the substance\nTEST SERIES 6\nYes\nYes\nIs the result a mass explosion?\nYes\nTEST SERIES 7\nTEST SERIES 5\nNo\nIs it an extremely insensitive article?\nNo\nIs the major hazard that from dangerous projections?\nYes\nYes\nYes\nIs it a very insensitive explosive substance with a mass explosion hazard?\nNo\nNo\nNo\nIs the major hazard radiant heat and/or violent burning but with no dangerous blast or projection hazard?\nWould the hazard hinder fire-fighting in the immediate vicinity?\nYes\nYes\nNo\nNo\nAre there hazardous effects outside the package?\nNo\nIs the substance or article manufactured with the view of producing a practical explosive or pyrotechnic effect?\nYes\nYes\nYes\nIs the product an article excluded by definition? (see 2.1.12 (b))\nNo\nNOT AN EXPLOSIVE\nDIVISION 1.6\nDIVISION 1.5\nDIVISION 1.4 Compatibility group S\nDIVISION 1.4 Compatibility groups other than S\nDIVISION 1.3\nDIVISION 1.2\nDIVISION 1.1\n\n\n\n\nFigure 2.1.4\nProcedure for the classification of ammonium nitrate emulsion, suspension or gel (ANE)\n\nTEST SERIES 8\nTEST 8 (a) Thermal stability test. Is the substance/mixture thermally stable?\nNo\nClassify as unstable explosive\nYes\nTEST 8 (b) ANE Large scale gap test Is the substance/mixture too sensitive to shock to be accepted as an oxidising liquid or an oxidising solid?\nYes\nSubstance/mixture to be considered for classification as an explosive other than as an unstable explosive; If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘no’, the substance/mixture shall be classified in Division 1.1\nNo\nTEST 8 (c) Koenen test Is the substance/mixture too sensitive to the effect of intensive heat under confinement?\nYes\nSubstance/mixture to be considered for classification as an explosive of Division 1.5, proceed with Test Series 5. If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘yes’, the substance/mixture shall be classified in Division 1.5; if the answer is ‘no’ the substance/mixture shall be classified in Division 1.1\nNo\nANE substance/mixture shall be classified as a Category 2 oxidising liquid or a Category 2 oxidising solid (sections 2.13 and 2.14)\n\n\n\n\n2.1.4.2. Screening procedure\nExplosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.\n\n\nNote:\nNeither a series 1 type (a) propagation of detonation test nor a series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g. For organic substances and mixtures of organic substances with a decomposition energy of 800 J/g or more, tests 1 (a) and 2 (a) need not be performed if the outcome of the ballistic mortar Mk.IIId test (F.1), or the ballistic mortar test (F.2) or the BAM Trauzl test (F.3) with initiation by a standard No 8 detonator (see Appendix 1 to the UN RTDG, Manual of Tests and Criteria) is no. In this case, the results of test 1 (a) and 2 (a) are deemed to be -.\n\n2.1.4.3. A substance or mixture shall not be classified as explosive if:\n\n(a) There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or\n\n(b) The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;\nThe oxygen balance is calculated for the chemical reaction:\nCxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O\nUsing the formula:\nOxygen balance = -1600 [2x + (y/2)-z]/molecular weight;\n\n(c) When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or\n\n(d) For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:\n\nless than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;\nless than 30 % by mass, if the oxidising substance is assigned to Category 3.\n\n2.1.4.4. In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.\n\n\n2.2. Flammable gases\n\n\n2.2.1. Definition\nFlammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.\n\n\n2.2.2. Classification criteria\n2.2.2.1. A flammable gas shall be classified in this class in accordance with Table 2.2.1:\n\nTable 2.2.1\nCriteria for flammable gases\n\nCategory\nCriteria\n1\nGases, which at 20 oC and a standard pressure of 101,3 kPa:\n\n(a) are ignitable when in a mixture of 13 % or less by volume in air; or\n\n(b) have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.\n2\nGases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.\n\nNote:\nAerosols shall not be classified as flammable gases; see section 2.3.\n\n\n2.2.3. Hazard Communication\nLabel elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.\n\nTable 2.2.2\nLabel elements for flammable gases\n\nClassification\nCategory 1\nCategory 2\nGHS Pictogram\n\nNo pictogram\nSignal Word\nDanger\nWarning\nHazard Statement\nH220: Extremely flammable gas\nH221: Flammable gas\nPrecautionary Statement\nPrevention\nP210\nP210\nPrecautionary Statement\nResponse\nP377\nP381\nP377\nP381\nPrecautionary Statement\nStorage\nP403\nP403\nPrecautionary Statement\nDisposal\n\n\n\n\n2.2.4. Additional Classification Considerations\n2.2.4.1. Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.\n\n\n2.3. Flammable aerosols\n\n\n2.3.1. Definitions\nAerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.\n\n\n2.3.2. Classification criteria\n2.3.2.1. Aerosols shall be considered for classification as flammable in accordance with 2.3.2.2 if they contain any component which is classified as flammable according to the criteria contained in this Part, i.e.:\n\nLiquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;\nFlammable gases (see 2.2);\nFlammable solids (see 2.7).\n\nNote 1:\nFlammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.\n\nNote 2:\nFlammable aerosols do not fall additionally within the scope of sections 2.2 (flammable gases), 2.6 (flammable liquids) or 2.7 (flammable solids).\n2.3.2.2. A flammable aerosol shall be classified in one of the two categories for this Class on the basis of its components, of its chemical heat of combustion and, if applicable, of the results of the foam test (for foam aerosols) and of the ignition distance test and enclosed space test (for spray aerosols) in accordance with Figure 2.3.1 and the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-sections 31.4, 31.5 and 31.6.\n\n\nFigure 2.3.1\n\nFigure 2.3.1(a) for flammable aerosols\n\nAEROSOL\nDoes it contain ≤ 1% flammable components and does it have a heat of combustion < 20 kJ/g?\nYES\nNOT CLASSIFIED\nNO\nDoes it contain ≥ 85% flammable components and does it have a heat of combustion ≥ 30 kJ/g?\nYES\nCategory 1\nNO\nDanger\nFor spray aerosols, go to decision logic 2.3.1 (b);\nFor foam aerosols, got to decision logic 2.3.1 (c).\n\n\nFigure 2.3.1(b) for spray aerosols\n\nSPRAY AEROSOL\nIn the ignition distance test, does ignition occur at a distance ≥ 75 cm?\nYES\nCategory 1\nNO\nDoes it have a heat of combustion < 20 kJ/g?\nNO\nCategory 2\nYES\nIn the ignition distance test, does ignition occur at a distance ≥ 15 cm?\nYES\nCategory 2\nNO\nIn the enclosed space ignition test; is:\na) the time equivalent ≤ 300 s/m3 or\nb) the deflagration density ≤ 300 g/m3?\nYES\nCategory 2\nNO\nNOT CLASSIFIED\nDanger\nWarning\nWarning\nWarning\n\n\nFigure 2.3.1(c) for foam aerosols\n\nFOAM AEROSOL\nIn the foam test, is: a) the flame height ≥ 20 cm and the flame duration ≥ 2 s; or b) the flame height ≥ 4 cm and the flame duration ≥ 7 s?\nYES\nCategory 1\nNO\nIn the foam test; is the flame height ≥ 4 cm and the flame duration ≥ 2 s?\nYES\nCategory 2\nNO\nNOT CLASSIFIED\nDanger\nWarning\n\n\nNote:\nAerosols not submitted to the flammability classification procedures in this section shall be classified as flammable aerosols, Category 1.\n\n\n\n2.3.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.\n\nTable 2.3.2\nLabel elements for flammable aerosols\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH222: Extremely flammable aerosol\nH223: Flammable aerosol\nPrecautionary Statement\nPrevention\nP210\nP211\nP251\nP210\nP211\nP251\nPrecautionary Statement\nResponse\n\n\nPrecautionary Statement\nStorage\nP410 + P412\nP410 + P412\nPrecautionary Statement\nDisposal\n\n\n\n\n2.3.4. Additional Classification Considerations\n2.3.4.1. The chemical heat of combustion (ΔHc), in kilojoules per gram (kJ/g), is the product of the theoretical heat of combustion (ΔHcomb), and a combustion efficiency, usually less than 1,0 (a typical combustion efficiency is 0,95 or 95 %).\nFor a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:\nΔHc (product)=Σniwi % × ΔHc(i)\nwhere:\n\nΔHc\nchemical heat of combustion (kJ/g);\nwi %\nmass fraction of component i in the product;\nΔHc(i)\nspecific heat of combustion (kJ/g)of component i in the product.\nThe chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).\n\n\n2.4. Oxidising gases\n\n\n2.4.1. Definitions\nOxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.\n\n\n2.4.2. Classification criteria\n2.4.2.1. An oxidising gas shall be classified in a single category for this class in accordance with Table 2.4.1.:\n\nTable 2.4.1\nCriteria for oxidising gases\n\nCategory\nCriteria\n1\nAny gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.\n\nNote:\nGases which cause or contribute to the combustion of other material more than air does mean pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.\n\n\n2.4.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.\n\nTable 2.4.2\nLabel elements for oxidising gases\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH270: May cause or intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP220\nP244\nPrecautionary Statement\nResponse\nP370 + P376\nPrecautionary Statement\nStorage\nP403\nPrecautionary Statement\nDisposal\n\n\n\n2.4.4. Additional Classification Considerations\nTo classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.\n\n\n2.5. Gases under pressure\n\n\n2.5.1. Definition\n2.5.1.1. Gases under pressure are gases which are contained in a receptacle at a pressure of 200 kPa (gauge) or more, or which are liquefied or liquefied and refrigerated.\nThey comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.\n2.5.1.2. The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.\n\n\n\n2.5.2. Classification criteria\nGases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:\n\nTable 2.5.1\nCriteria for gases under pressure\n\nGroup\nCriteria\nCompressed gas\nA gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.\nLiquefied gas\nA gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:\n\n(i) high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and\n\n(ii) low pressure liquefied gas: a gas with a critical temperature above + 65 oC.\nRefrigerated liquefied gas\nA gas which when packaged is made partially liquid because of its low temperature.\nDissolved gas\nA gas which when packaged under pressure is dissolved in a liquid phase solvent.\n\n\n2.5.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.\n\nTable 2.5.2\nLabel elements for gases under pressure\n\nClassification\nCompressed gas\nLiquefied gas\nRefrigerated liquefied gas\nDissolved gas\nGHS Pictograms\n\n\n\n\nSignal Word\nWarning\nWarning\nWarning\nWarning\nHazard Statement\nH280: Contains gas under pressure; may explode if heated\nH280: Contains gas under pressure; may explode if heated\nH281: Contains refrigerated gas; may cause cryogenic burns or injury\nH280: Contains gas under pressure; may explode if heated\nPrecautionary Statement\nPrevention\n\n\nP282\n\nPrecautionary Statement\nResponse\n\n\nP336\nP315\n\nPrecautionary Statement\nStorage\nP410 + P403\nP410 + P403\nP403\nP410 + P403\nPrecautionary Statement\nDisposal\n\n\n\n\n\n\nNote:\nPictogram GHS04 is not required for gases under pressure where pictogram GHS02 or pictogram GHS06 appears.\n\n\n\n2.5.4. Additional Classification Considerations\nFor this group of gases, the following information is required to be known:\n\nthe vapour pressure at 50 oC;\nthe physical state at 20 oC at standard ambient pressure;\nthe critical temperature.\nData can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.\n\n\n2.6. Flammable liquids\n\n\n2.6.1. Definition\nFlammable liquid means a liquid having a flash point of not more than 60 oC.\n\n\n2.6.2. Classification criteria\n2.6.2.1. A flammable liquid shall be classified in one of the three categories for this class in accordance with Table 2.6.1:\n\nTable 2.6.1\nCriteria for flammable liquids\n\nFor the purpose of this Regulation gas oils, diesel and light heating oils having a flash point between ≥ 55 oC and ≤ 75 oC may be regarded as Category 3.\n\nCategory\nCriteria\n1\nFlash point < 23 oC and initial boiling point ≤ 35 oC\n2\nFlash point < 23 oC and initial boiling point > 35 oC\n3\nFlash point ≥ 23 oC and ≤ 60 oC\n\nNote:\nAerosols shall not be classified as flammable liquids; see section 2.3.\n\n\n\n2.6.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.\n\nTable 2.6.2\nLabel elements for flammable liquids\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH224: Extremely flammable liquid and vapour\nH225: Highly flammable liquid and vapour\nH226: Flammable liquid and vapour\nPrecautionary Statement\nPrevention\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nPrecautionary Statement\nResponse\nP303 + P361 + P353\nP370 + P378\nP303 + P361 + P353\nP370 + P378\nP303 + P361 + P353\nP370 + P378\nPrecautionary Statement\nStorage\nP403 + P235\nP403 + P235\nP403 + P235\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.6.4. Additional Classification Considerations\n2.6.4.1. For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.\n2.6.4.2. In the case of mixturesTo date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates. containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 °CIf the calculated flash point is less than 5 °C greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally. greater than the relevant classification criterion (23 °C and 60 °C, respectively) and provided that:\n\n\n(a) the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);\n\n(b) the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit of the mixture;\n\n(c) the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;\n\n(d) the liquid phase is homogeneous.\n2.6.4.3. One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.\n2.6.4.4. Possible test methods for determining the flash point of flammable liquids are listed in Table 2.6.3.\n\nTable 2.6.3\nMethods for determining the flash point of flammable liquids\n\nEuropean standards:\nEN ISO 1516 as amended\nDetermination of flash/no flash — Closed cup equilibrium method\nEN ISO 1523 as amended\nDetermination of flash point — Closed cup equilibrium method\nEN ISO 2719 as amended\nDetermination of flash point — Pensky-Martens closed cup method\nEN ISO 3679 as amended\nDetermination of flash point — Rapid equilibrium closed cup method\nEN ISO 3680 as amended\nDetermination of flash/no flash — Rapid equilibrium closed cup method\nEN ISO 13736 as amended\nPetroleum products and other liquids — Determination of flash point — Abel closed cup method\nNational standards:\nAssociation française de normalisation, AFNOR:\nNF M07-036 as amended\nDétermination du point d'éclair — Vase clos Abel-Pensky\n(identical to DIN 51755)\n\nBritish Standards Institute,\nBS 2000 Part 170 as amended\n(identical to EN ISO 13736)\n\nDeutsches Institut für Normung\nDIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky\n(identical to NF M07-036)\n\n2.6.4.5 Liquids with a flash point of more than 35 °C and not more than 60 °C need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN RTDG, Manual of Tests and Criteria.\n\n\n2.6.4.6. Possible test methods for determining the initial boiling point of flammable liquids are listed in Table 2.6.4.\n\nTable 2.6.4\nMethods for determining the initial boiling point of flammable liquids\n\nOJ L 142, 31.5.2008, p. 1.\n\nEuropean standards:\nEN ISO 3405 as amended\nPetroleum products — Determination of distillation characteristics at atmospheric pressure\nEN ISO 3924 as amended\nPetroleum products — Determination of boiling range distribution — Gas chromatography method\nEN ISO 4626 as amended\nVolatile organic liquids — Determination of boiling range of organic solvents used as raw materials\nRegulation (EC) No 440/2008\nMethod A.2 as described in Part A of the Annex to Regulation (EC) No 440/2008\n\n\n\n2.7. Flammable solids\n\n\n2.7.1. Definition\n2.7.1.1. A flammable solid means a solid which is readily combustible, or may cause or contribute to fire through friction.\nReadily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.\n\n\n2.7.2. Classification criteria\n2.7.2.1. Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.\n2.7.2.2. Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.\n2.7.2.3. A flammable solid shall be classified in one of the two categories for this class using Method N.1 as described in 33.2.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.7.1:\n\nTable 2.7.1\nCriteria for flammable solids\n\nCategory\nCriteria\n1\nBurning rate test\nSubstances and mixtures other than metal powders:\n\n(a) wetted zone does not stop fire and\n\n(b) burning time < 45 seconds or burning rate > 2,2 mm/s\nMetal powders\nburning time ≤ 5 minutes\n2\nBurning rate test\nSubstances and mixtures other than metal powders:\n\n(a) wetted zone stops the fire for at least 4 minutes and\n\n(b) burning time < 45 seconds or burning rate > 2,2 mm/s\nMetal powders\nburning time > 5 minutes and ≤ 10 minutes\n\n\nNote 1:\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\nNote 2:\nAerosols shall not be classified as flammable solids; see section 2.3.\n\n\n\n2.7.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.\n\n\nTable 2.7.2\nLabel elements for flammable solids\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH228: Flammable Solid\nH228: Flammable Solid\nPrecautionary Statement\nPrevention\nP210\nP240\nP241\nP280\nP210\nP240\nP241\nP280\nPrecautionary Statement\nResponse\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\nPrecautionary Statement\nDisposal\n\n\n\n\n2.8. Self-reactive substances and mixtures\n\n\n2.8.1. Definition\n2.8.1.1. Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.\n2.8.1.2. A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.\n\n\n2.8.2. Classification criteria\n2.8.2.1. Any self-reactive substance or mixture shall be considered for classification in this class as a self-reactive substance or mixture unless:\n\n(a) they are explosives, according to the criteria given in 2.1;\n\n(b) they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;\n\n(c) they are organic peroxides, according to the criteria given in 2.15;\n\n(d) their heat of decomposition is less than 300 J/g; or\n\n\n(e) their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3..\n2.8.2.2. Mixtures of oxidising substances, meeting the criteria for classification as oxidising substances, which contain 5 % or more of combustible organic substances and which do not meet the criteria mentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjected to the self-reactive substances classification procedure;\nSuch a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n2.8.2.3. Self-reactive substances and mixtures shall be classified in one of the seven categories of types A to G for this class, according to the following principles:\n\n(a) any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;\n\n(b) any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;\n\n(c) any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;\n\n(d) any self-reactive substance or mixture which in laboratory testing:\n\n(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or\n\n(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or\n\n(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;\nshall be defined as self-reactive substance TYPE D;\n\n(e) any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;\n\n(f) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;\n\n\n(g) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n\n\n2.8.2.4. Criteria for temperature control\nSelf-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.\n\n\n2.8.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.\n\nTable 2.8.1\nLabel elements for self-reactive substances and mixtures\n\nClassification\nType A\nType B\nType C & D\nType E & F\nType G\nGHS Pictograms\n\n\n\n\nThere are no label elements allocated to this hazard category\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement\nH240: Heating may cause an explosion\nH241: Heating may cause a fire or explosion\nH242: Heating may cause a fire\nH242: Heating may cause a fire\nPrecautionary Statement\nPrevention\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nPrecautionary Statement\nResponse\nP370 + P378\nP370 + P380 + P375\nP370 + P378\nP370 + P380 + P375\nP370 + P378\nP370 + P378\n\nPrecautionary Statement\nStorage\nP403 + P235\nP411\nP420\nP403 + P235\nP411\nP420\nP403 + P235\nP411\nP420\nP403 + P235 P411\nP420\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\n\nType G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.\n\n\n2.8.4. Additional Classification Considerations\n2.8.4.1. The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.\n2.8.4.2. The classification procedures for self-reactive substances and mixtures need not be applied if:\n\n(a) There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or\n\n(b) For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\n\n\nFigure 2.8.1\nSelf-reactive substances and mixtures\n\n\nSUBSTANCE/MIXTURE\nBox 1\nTest A\nBox 2\nTest B\n1.1 Yes\nDoes it propogate a detonation?\n1.3 No\n2.1 Yes\nCan it detonate as packaged?\n2.2 No\n1.2 Partial\nBox 3\nTest C\nCan it propogate a deflagration?\n3.1 Yes, rapidly\nBox 4\nTest C\nCan it propogate a deflagration?\n4.1 Yes, rapidly\n3.2 Yes, slowly\n3.3 No\nBox 5\nTest C\nCan it propogate a deflagration?\n5.1 Yes, rapidly\n4.2 Yes, slowly\n4.3 No\nBox 6\nTest D\n5.3 No\n5.2 Yes,\nslowly\n6.2 No\nDoes it deflagrate rapidly in package?\n6.1 Yes\nBox 7\nTest E\nWhat is the effect of heating under confinement?\n7.1 Violent\nBox 8\nTest E\nWhat is the effect of heating under confinement?\n8.1 Violent\n7.2 Medium\n7.3 Low\n7.4 No\nBox 9\nTest E\nWhat is the effect of heating under confinement?\nBox 10\nTest G\n8.2 Medium\n8.3 Low\n8.4 No\n9.3 Low\n9.4 No\nBox 11\n10.2 No\nCan it explode as packaged?\n10.1 Yes\nPackaged in packages of more than 400 kg/450 l or to be considered for exemption?\n11.1 Yes\nBox F\nTest F\nWhat is its explosive power?\n12.3 None\nBox 13\nTest E\n12.1 No low\n12.2 Low\nWhat is effect of heating it under defined confinement?\n11.2 No\n13.1 Low\n13.2 None\nTYPE A\nTYPE B\nTYPE C\nTYPE D\nTYPE E\nTYPE F\nTYPE G\n9.1 violent\n9.2 Medium\n\n\n\n2.9. Pyrophoric liquids\n\n\n2.9.1. Definition\nPyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.\n\n\n2.9.2. Classification criteria\n2.9.2.1. A pyrophoric liquid shall be classified in a single category for this class using test N.3 in Part III, sub-section 33.3.1.5 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to Table 2.9.1:\n\nTable 2.9.1\nCriteria for pyrophoric liquids\n\nCategory\nCriteria\n1\nThe liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min.\n\n\n2.9.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.\n\nTable 2.9.2\nLabel elements for pyrophoric liquids\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH250: Catches fire spontaneously if exposed to air\nPrecautionary Statement\nPrevention\nP210\nP222\nP280\nPrecautionary Statement\nResponse\nP302 + P334\nP370 + P378\nPrecautionary Statement\nStorage\nP422\nPrecautionary Statement\nDisposal\n\n\n\n2.9.4. Additional Classification Considerations\n2.9.4.1. The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).\n\n\n\n2.10. Pyrophoric solids\n\n\n2.10.1. Definition\nPyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.\n\n\n2.10.2. Classification criteria\n2.10.2.1. A pyrophoric solid shall be classified in a single category for this class using test N.2 in Part III, sub-section 33.3.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.10.1:\n\nTable 2.10.1\nCriteria for pyrophoric solids\n\nCategory\nCriteria\n1\nThe solid ignites within 5 minutes of coming into contact with air.\n\nNote\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\n\n2.10.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.\n\nTable 2.10.2\nLabel elements for pyrophoric solids\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH250: Catches fire spontaneously if exposed to air\nPrecautionary Statement\nPrevention\nP210\nP222\nP280\nPrecautionary Statement\nResponse\nP335 + P334\nP370 +P378\nPrecautionary Statement\nStorage\nP422\nPrecautionary Statement\nDisposal\n\n\n\n\n2.10.4. Additional Classification Considerations\n2.10.4.1. The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).\n\n\n2.11. Self-heating substances and mixtures\n\n\n2.11.1. Definition\n2.11.1.1. A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).\n\n2.11.1.2. Self-heating of a substance or a mixture is a process where the gradual reaction of that substance or mixture with oxygen (in the air) generates heat. If the rate of heat production exceeds the rate of heat loss, then the temperature of the substance or mixture will rise which, after an induction time, may lead to self-ignition and combustion.\n\n\n\n2.11.2. Classification criteria\n2.11.2.1. A substance or mixture shall be classified as a self-heating substance or mixture of this class, if in the tests performed in accordance with the test method given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-section 33.3.1.6:\n\n(a) a positive result is obtained using a 25 mm cube sample at 140 oC;\n\n(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;\n\n(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;\n\n(d) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.\n2.11.2.2. A self-heating substance or mixture shall be classified in one of the two categories for this class if, in a test performed in accordance with test method N.4 in Part III, sub-section 33.3.1.6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, the result meets the criteria according to Table 2.11.1:\n\n\nTable 2.11.1\nCriteria for self-heating substances and mixtures\n\nCategory\nCriteria\n1\nA positive result is obtained in a test using a 25 mm sample cube at 140 oC\n2\n\n(a) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or\n\n(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or\n\n(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.\n\nNote\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n2.11.2.3. Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.\n2.11.2.4. Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.\n\n\n2.11.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.\n\nTable 2.11.2\nLabel elements for self-heating substances and mixtures\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH251: Self-heating; may catch fire\nH252: Self-heating in large quantities; may catch fire\nPrecautionary Statement\nPrevention\nP235 + P410\nP280\nP235 + P410\nP280\nPrecautionary Statement\nResponse\n\n\nPrecautionary Statement\nStorage\nP407\nP413\nP420\nP407\nP413\nP420\nPrecautionary Statement\nDisposal\n\n\n\n\n2.11.4. Additional Classification Considerations\n2.11.4.1. For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.\n2.11.4.2. The classification procedure for self-heating substances or mixtures need not be applied if the results of a screening test can be adequately correlated with the classification test and an appropriate safety margin is applied. Examples of screening tests are:\n\n(a) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;\n\n(b) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.\n\n\nFigure 2.11.1.\nSelf-heating substances and mixtures\n\nSUBSTANCE/MIXTURE\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 140°C?\nNO\nNOT CLASSIFIED\nYES\nDoes it undergo dangerous self-heating when tested in a 25 mm sample cube at 140°C?\nYES\nCategory 1\nDanger\nNO\nIs it packaged in more than 3 m3?\nYES\nCategory 2\nWarning\nNO\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 120°C?\nNO\nNOT CLASSIFIED\nYES\nIs it packaged in more than 450 litres volume?\nYES\nCategory 2\nWarning\nNO\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 100°C?\nYES\nCategory 2\nWarning\nNO\nNOT CLASSIFIED\n\n\n\n2.12. Substances and mixtures which in contact with water emit flammable gases\n\n\n2.12.1. Definition\nSubstances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.\n\n\n2.12.2. Classification criteria\n2.12.2.1. A substance or mixture which, in contact with water, emits flammable gases shall be classified in one of the three categories for this class, using test N.5 in Part III, sub-section 33.4.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.12.1:\n\nTable 2.12.1\nCriteria for substances or mixtures which in contact with water emit flammable gases\n\nCategory\nCriteria\n1\nAny substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.\n2\nAny substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.\n3\nAny substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.\n\nNote:\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form.\n2.12.2.2. A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.\n\n\n2.12.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.\n\n\nTable 2.12.2\nLabel elements for substances or mixtures which in contact with water emit flammable gases\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH260: In contact with water releases flammable gases which may ignite spontaneously\nH261: In contact with water releases flammable gases\nH261: In contact with water releases flammable gases\nPrecautionary Statement\nPrevention\nP223\nP231 + P232\nP280\nP223\nP231 + P232\nP280\nP231 + P232\nP280\nPrecautionary Statement\nResponse\nP335 + P334\nP370 + P378\nP335 + P334\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\nP402 + P404\nP402 + P404\nP402 + P404\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.12.4. Additional Classification Considerations\n2.12.4.1. The classification procedure for this class need not be applied if:\n\n(a) the chemical structure of the substance or mixture does not contain metals or metalloids; or\n\n(b) experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or\n\n(c) the substance or mixture is known to be soluble in water to form a stable mixture.\n\n\n2.13. Oxidising liquids\n\n\n2.13.1. Definition\nOxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.\n\n\n2.13.2. Classification criteria\n2.13.2.1. An oxidising liquid shall be classified in one of the three categories for this class using test O.2 in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.13.1:\n\n\nTable 2.13.1\nCriteria for oxidising liquids\n\nCategory\nCriteria\n1\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.\n2\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.\n3\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met.\n\n\n2.13.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.\n\nTable 2.13.2\nLabel elements for oxidising liquids\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH271:May cause fire or explosion; strong oxidiser\nH272: May intensify fire; oxidiser\nH272: May intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP210\nP220\nP221\nP280\nP283\nP210\nP220\nP221\nP280\nP210\nP220\nP221\nP280\nPrecautionary Statement\nResponse\nP306 + P360\nP371 + P380 + P375\nP370 + P378\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.13.4. Additional Classification Considerations\n2.13.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:\n\n(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or\n\n(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.\n2.13.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.\n2.13.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.\n2.13.4.4. In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.\n\n\n2.14. Oxidising solids\n\n\n2.14.1. Definition\nOxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.\n\n\n2.14.2. Classification criteria\n2.14.2.1. An oxidising solid shall be classified in one of the three categories for this class using test O.1 in Part III, sub-section 34.4.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.14.1:\n\nTable 2.14.1\nCriteria for oxidising solids\n\nCategory\nCriteria\n1\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.\n2\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.\n\n3\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.\n\nNote 1\nSome oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the Resistance to detonation test (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.\n\nNote 2\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\n\n2.14.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.\n\nTable 2.14.2\nLabel elements for oxidising solids\n\n\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH271: May cause fire or explosion; strong oxidiser\nH272: May intensify fire; oxidiser\nH272: May intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP210\nP220\nP221\nP280\nP283\nP210\nP220\nP221\nP280\nP210\nP220\nP221\nP280\nPrecautionary Statement\nResponse\nP306 + P360\nP371 + P380 + P375\nP370 + P378\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.14.4. Additional Classification Considerations\n2.14.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:\n\n(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or\n\n(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.\n2.14.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.\n2.14.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.\n\n\n2.15. Organic peroxides\n\n\n2.15.1. Definition\n2.15.1.1. Organic peroxides means liquid or solid organic substances which contain the bivalent -O-O- structure and may be considered derivatives of hydrogen peroxide, where one or both of the hydrogen atoms have been replaced by organic radicals. The term organic peroxide includes organic peroxide mixtures (formulations) containing at least one organic peroxide. Organic peroxides are thermally unstable substances or mixtures, which can undergo exothermic self-accelerating decomposition. In addition, they can have one or more of the following properties:\n\n(i) be liable to explosive decomposition;\n\n(ii) burn rapidly;\n\n(iii) be sensitive to impact or friction;\n\n(iv) react dangerously with other substances.\n2.15.1.2. An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.\n\n\n2.15.2. Classification criteria\n2.15.2.1. Any organic peroxide shall be considered for classification in this class, unless it contains:\n\n(a) not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or\n\n(b) not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.\n\nNote\nThe available oxygen content ( %) of an organic peroxide mixture is given by the formula:\n16×Σnini×cimi\nwhere:\n\nni\nnumber of peroxygen groups per molecule of organic peroxide i;\nci\nconcentration (mass %) of organic peroxide i;\nmi\nmolecular mass of organic peroxide i.\n2.15.2.2. Organic peroxides shall be classified in one of the seven categories of Types A to G for this class, according to the following principles:\n\n(a) any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;\n\n(b) any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;\n\n(c) any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;\n\n(d) any organic peroxide which in laboratory testing:\n\n(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or\n\n(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or\n\n(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;\nshall be defined as organic peroxide TYPE D;\n\n(e) any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;\n\n(f) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;\n\n(g) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3., and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.\n\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n\n\n2.15.2.3. Criteria for temperature control\nThe following organic peroxides need to be subjected to temperature control:\n\n(a) Organic peroxide types B and C with an SADT ≤ 50 C;\n\n(b) Organic peroxide type D showing a medium effect when heated under confinementAs determined by test series E as prescribed in UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II. with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and\n\n(c) Organic peroxide types E and F with an SADT ≤ 45 oC.\nTest methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.\n\n\n2.15.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.\n\nTable 2.15.1\nLabel elements for organic peroxides\n\nClassification\nType A\nType B\nType C & D\nType E & F\nType G\nGHS Pictograms\n\n\n\n\nThere are no label elements allocated to this hazard category\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement\nH240: Heating may cause an explosion\nH241: Heating may cause a fire or explosion\nH242: Heating may cause a fire\nH242: Heating may cause a fire\nPrecautionary Statement\nPrevention\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nPrecautionary Statement\nResponse\n\n\n\n\n\nPrecautionary Statement\nStorage\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\n\nType G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.\n\n\n2.15.4. Additional Classification Considerations\n2.15.4.1. Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.\n2.15.4.2. Mixtures of already classified organic peroxides may be classified as the same type of organic peroxide as that of the most dangerous component. However, as two stable components can form a thermally less stable mixture, the SADT of the mixture shall be determined.\nNote: The sum of the individual parts can be more hazardous than the individual components.\n\n\nFigure 2.15.1\nOrganic Peroxides\n\n\nSUBSTANCE/MIXTURE\nBox 1\nTest A\nBox 2\nTest B\n1.1 Yes\nDoes it propogate a detonation?\n1.3 No\n2.1 Yes\nCan it detonate as packaged?\n2.2 No\n1.2 Partial\nBox 3 Test C\nCan it propogate a detonation?\n3.1 Yes, rapidly\nBox 4 Test C\nCan it propogate a detonation?\nBox 5 Test C\nBox 6 Test D\n3.2 Yes, slowly\n3.3 No\n4.1 Yes rapidly\nCan it propogate a detonation?\n4.2 Yes, slowly\n5.1 Yes, rapidly\n4.3 No\n5.3 No\nDoes it deflagrate rapidly in package?\n6.2 No\nBox 7 Test E\n5.2 Yes, slowly\n6.1 Yes\nWhat is the effect of heating under confinement?\nBox 8 Test E\n7.1 Violent\nWhat is the effect of heating under confinement?\nBox 9 Test E\n7.2 Medium\n8.1 Violent\n7.3 Low\n7.4 No\nWhat is the effect of heating under confinement?\nBox 10 Test G\n9.3 Low\n8.2 Medium\n9.1 Violent\n8.3 Low\n9.4 No\nCan it explode as packaged?\n10.2 No\n8.4 No\n9.2 Medium\nBox 11\nPackaged in packages of more than 400 kg/450 l or to be considered for exemption?\n11.1 Yes\nBox 12 Test F\n11.2 No\nWhat is its explosive power?\n12.3 None\n10.1 Yes\n12.1 Not low\nBox 13 Test E\n12.2 Low\nWhat is the effect of heating it under confinement?\n13.1 Low\n13.2 None\nTYPE A\nTYPE B\nTYPE C\nTYPE D\nTYPE E\nTYPE F\nTYPE G\n\n\n\n2.16. Corrosive to metals\n\n\n2.16.1. Definition\nA substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.\n\n\n2.16.2. Classification criteria\n2.16.2.1. A substance or a mixture which is corrosive to metals is classified in a single category for this class, using the test in Part III, sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.16.1:\n\nTable 2.16.1\nCriteria for substances and mixtures corrosive to metals\n\nCategory\nCriteria\n1\nCorrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.\n\nNote\nWhere an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required.\n\n\n2.16.3. Hazard Communication\nLabel elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.\n\nTable 2.16.2\nLabel elements for substances and mixtures corrosive to metals\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nWarning\nHazard Statement\nH290: May be corrosive to metals\nPrecautionary Statement\nPrevention\nP234\nPrecautionary Statement\nResponse\nP390\nPrecautionary Statement\nStorage\nP406\nPrecautionary Statement\nDisposal\n\n\n\n\n2.16.4. Additional Classification Considerations\n2.16.4.1. The corrosion rate can be measured according to the test method of Part III sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The specimen to be used for the test shall be made of the following materials:\n\n(a) for the purposes of testing steel, steel types\n\nS235JR+CR (1.0037 resp.St 37-2),\nS275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;\n\n(b) for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.\n\n\n\n3. PART 3: HEALTH HAZARDS\n\n\n3.1. Acute toxicity\n\n\n3.1.1. Definitions\n3.1.1.1. Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.\n3.1.1.2. The hazard class Acute Toxicity is differentiated into:\n\nAcute oral toxicity;\nAcute dermal toxicity;\nAcute inhalation toxicity.\n\n\n3.1.2. Criteria for classification of substances as acutely toxic\n\n3.1.2.1. Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.\n\nTable 3.1.1\nAcute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories\n\nGas concentrations are expressed in parts per million per volume (ppmV).\n\nExposure route\nCategory 1\nCategory 2\nCategory 3\nCategory 4\nOral (mg/kg bodyweight)\nATE ≤ 5\n5 < ATE ≤ 50\n50 < ATE ≤ 300\n300 < ATE ≤ 2000\nSee:\nNote (a)\nNote (b)\nDermal (mg/kg bodyweight)\nATE ≤ 50\n50 < ATE ≤ 200\n200 < ATE ≤ 1000\n1000 < ATE ≤ 2000\nSee:\nNote (a)\nNote (b)\nGases (ppmV)\nATE ≤ 100\n100 < ATE ≤ 500\n500 < ATE ≤ 2500\n2500 < ATE ≤ 20000\nsee:\nNote (a)\nNote (b)\nNote (c)\nVapours (mg/l)\nATE ≤ 0,5\n0,5 < ATE ≤ 2,0\n2,0 < ATE ≤ 10,0\n10,0 < ATE ≤ 20,0\nsee:\nNote (a)\nNote (b)\nNote (c)\nNote (d)\nDusts and mists (mg/l)\nATE ≤ 0,05\n0,05 < ATE ≤ 0,5\n0,5 < ATE ≤ 1,0\n1,0 < ATE ≤ 5,0\nsee:\nNote (a)\nNote (b)\nNote (c)\nNotes to Table 3.1.1:\n\n(a) The acute toxicity estimate (ATE) for the classification of a substance is derived using the LD50/LC50 where available.\n\n(b) The acute toxicity estimate (ATE) for the classification of a substance in a mixture is derived using:\n\nthe LD50/LC50 where available,\nthe appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or\nthe appropriate conversion value from Table 3.1.2 that relates to a classification category.\n\n(c) Generic concentration limits for inhalation toxicity in the table are based on 4-hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1-hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.\n\n(d) For some substances the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2500 ppmV), Category 4 (20000 ppmV).\nThe terms dust, mist and vapour are defined as follows:\n\ndust: solid particles of a substance or mixture suspended in a gas (usually air),\nmist: liquid droplets of a substance or mixture suspended in a gas (usually air),\nvapour: the gaseous form of a substance or mixture released from its liquid or solid state.\nDust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.\n\n\n\n3.1.2.2. Specific considerations for classification of substances as acutely toxic\n3.1.2.2.1. The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.\n\n\n3.1.2.3. Specific considerations for classification of substances as acutely toxic by the inhalation route\n3.1.2.3.1. Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.\n\n3.1.2.3.2. Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.\n3.1.2.3.3. In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as corrosive to the respiratory tract (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.\n\n\n3.1.3. Criteria for classification of mixtures as acutely toxic\n3.1.3.1. The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.\n\n3.1.3.2. For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all components and there is no relevant evidence to suggest acute toxicity by multiple routes. When there is relevant evidence of toxicity by multiple routes of exposure, classification is to be conducted for all appropriate routes of exposure. All available information shall be considered. The pictogram and signal word used shall reflect the most severe hazard category and all relevant hazard statements shall be used.\n\n3.1.3.3. In order to make use of all available data for purposes of classifying the hazards of the mixtures, certain assumptions have been made and are applied where appropriate in the tiered approach:\n\n(a) the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).\n\n(b) where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.\n\n\n(c) If the converted acute toxicity point estimates for all components of a mixture are within the same category, then the mixture should be classified in that category.\n\n\n(d) When only range data (or acute toxicity hazard category information) are available for components in a mixture, they may be converted to point estimates in accordance with Table 3.1.2 when calculating the classification of the new mixture using the formulas in sections 3.1.3.6.1 and 3.1.3.6.2.3.\n\n\nFigure 3.1.1\nTiered approach to classification of mixtures for acute toxicity\nTest data on the mixture as a whole\nNo\nYes\nSufficient data available on similar mixtures to estimate classification hazards\nYes\nApply bridging principles outlined in section 1.1.3.\nCLASSIFY\nNo\nAvailable data for all ingredients\nYes\nApply formula in section 3.1.3.6.1\nCLASSIFY\nNo\nOther data available to estimate conversion values for classification\nYes\nApply formula in section 3.1.3.6.1\nCLASSIFY\nNo\nConvey hazards of the known ingredients\n• Apply formula in section 3.1.3.6.1. (unknown ingredients equal or below 10 %)\n• Apply formula in paragraph 3.1.3.6.2.3. (unknown ingredients > 10 %)\nCLASSIFY\n\n\n3.1.3.4. Classification of mixtures where acute toxicity data are available for the complete mixture\n3.1.3.4.1. Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.\n\n\n3.1.3.5. Classification of mixtures where acute toxicity data are available for the complete mixture: bridging principles\n3.1.3.5.1. Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n3.1.3.5.2. If a tested mixture is diluted with a diluent that has an equivalent or lower toxicity classification than the least toxic original components, and which is not expected to affect the toxicity of other components, then the new diluted mixture may be classified as equivalent to the original tested mixture. Alternatively, the formula explained in section 3.1.3.6.1 can be applied.\n\n\n\n3.1.3.6. Classification of mixtures based on ingredients of the mixture (Additivity formula)\n\n\n3.1.3.6.1. Data available for all ingredients\nIn order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:\n\n\n(a) include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;\n\n(b) ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);\n\n\n(c) ignore components if the data available are from a limit dose test (at the upper threshold for Category 4 for the appropriate route of exposure as provided in Table 3.1.1) and do not show acute toxicity.\n\n\nComponents that fall within the scope of this section are considered to be components with a known acute toxicity estimate (ATE). See note (b) to Table 3.1.1 and section 3.1.3.3 for appropriate application of available data to the equation below, and section 3.1.3.6.2.3.\n\nThe ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:\n100ATEmix=ΣnCiATEi\nwhere:\n\nCi\nconcentration of ingredient i ( % w/w or % v/v)\ni\nthe individual ingredient from 1 to n\nn\nthe number of ingredients\nATEi\nAcute Toxicity Estimate of ingredient i.\n\n\n3.1.3.6.2. Classification of mixtures when data are not available for all components\n3.1.3.6.2.1. Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.\nThis includes evaluation of:\n\n(a) extrapolation between oral, dermal and inhalation acute toxicity estimatesWhen mixtures contain components that do not have acute toxicity data for each route of exposure, acute toxicity estimates may be extrapolated from the available data and applied to the appropriate routes (see section 3.1.3.2). However, specific legislation may require testing for a specific route. In those cases, classification shall be performed for that route based upon the legal requirements.. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;\n\n(b) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;\n\n(c) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or\n\n(d) data from closely analogous substances using structure/activity relationships.\nThis approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.\n\n\n3.1.3.6.2.2. In the event that a component without any useable information for classification is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that: × percent of the mixture consists of component(s) of unknown toxicity.\n\n3.1.3.6.2.3. If the total concentration of the ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the total percentage of the unknown ingredient(s) as follows:\n100-Σ C unknown if > 10 %ATEmix=ΣnCiATEi\n\nTable 3.1.2\n\nConversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for use in the formulas for the classification of mixtures\n\n\nExposure routes\nClassification Category or experimentally obtained acute toxicity range estimate\nConverted acute toxicity point estimate\n(see Note 1)\nOral\n(mg/kg bodyweight)\n0 < Category 1 ≤ 5\n5 < Category 2 ≤ 50\n50 < Category 3 ≤ 300\n300 < Category 4 ≤ 2000\n0,5\n5\n100\n500\nDermal\n(mg/kg bodyweight)\n0 < Category 1 ≤ 50\n50 < Category 2 ≤ 200\n200 < Category 3 ≤ 1000\n1000 < Category 4 ≤ 2000\n5\n50\n300\n1100\nGases\n(ppmV)\n0 < Category 1 ≤ 100\n100 < Category 2 ≤ 500\n500 < Category 3 ≤ 2500\n2500 < Category 4 ≤ 20000\n10\n100\n700\n4500\nVapours\n(mg/l)\n0 < Category 1 ≤ 0,5\n0,5 < Category 2 ≤ 2,0\n2,0 < Category 3 ≤ 10,0\n10,0 < Category 4 ≤ 20,0\n0,05\n0,5\n3\n11\nDust/mist\n(mg/l)\n0< Category 1 ≤ 0,05\n0,05 < Category 2 ≤ 0,5\n0,5 < Category 3 ≤ 1,0\n1,0 < Category 4 ≤ 5,0\n0,005\n0,05\n0,5\n1,5\n\nNote 1\nThese values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results.\n\n\n\n3.1.4. Hazard Communication\n3.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.1.3. Without prejudice to Article 27, combined hazard statements may be used in accordance with Annex III.\n\nTable 3.1.3\nAcute toxicity label elements\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nCategory 4\nGHS Pictograms\n\n\n\n\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement:\n\nOral\nH300:\nFatal if swallowed\nH300:\nFatal if swallowed\nH301:\nToxic if swallowed\nH302:\nHarmful if swallowed\n\nDermal\nH310:Fatal in contact with skin\nH310:Fatal in contact with skin\nH311: Toxic in contact with skin\nH312: Harmful in contact with skin\n\nInhalation\n(see Note 1)\nH330:Fatal if inhaled\nH330: Fatal if inhaled\nH331: Toxic if inhaled\nH332: Harmful if inhaled\nPrecautionary Statement Prevention (oral)\nP264\nP270\nP264\nP270\nP264\nP270\nP264\nP270\nPrecautionary Statement Response (oral)\nP301 + P310\nP321\nP330\nP301 + P310\nP321\nP330\nP301 + P310\nP321\nP330\nP301 + P312\nP330\nPrecautionary Statement Storage (oral)\nP405\nP405\nP405\n\nPrecautionary Statement Disposal (oral)\nP501\nP501\nP501\nP501\nPrecautionary Statement Prevention (dermal)\nP262\nP264\nP270\nP280\nP262\nP264\nP270\nP280\nP280\nP280\nPrecautionary Statement Response (dermal)\nP302 + P350\nP310\nP322\nP361\nP363\nP302 + P350\nP310\nP322\nP361\nP363\nP302 + P352\nP312\nP322\nP361\nP363\nP302 + P352\nP312\nP322\nP363\nPrecautionary Statement Storage (dermal)\nP405\nP405\nP405\n\nPrecautionary Statement Disposal (dermal)\nP501\nP501\nP501\nP501\nPrecautionary Statement Prevention (inhalation)\nP260\nP271\nP284\nP260\nP271\nP284\nP261\nP271\nP261\nP271\nPrecautionary Statement Response (inhalation)\nP304 + P340\nP310\nP320\nP304 + P340\nP310\nP320\nP304 + P340\nP311\nP321\nP304 + P340\nP312\nPrecautionary Statement Storage (inhalation)\nP403 + P233\nP405\nP403 + P233\nP405\nP403 + P233\nP405\n\nPrecautionary Statement Disposal (inhalation)\nP501\nP501\nP501\n\nNote 1\nIn addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: corrosive to the respiratory tract — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement corrosive to the respiratory tract.\n\nNote 2\nIn the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity — see advice at 3.1.3.6.2.2.\n\n\n3.2. Skin corrosion/irritation\n\n\n3.2.1. Definitions\n3.2.1.1. Skin Corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test substance for up to 4 hours. Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology shall be considered to evaluate questionable lesions.\nSkin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.\n\n\n3.2.2. Classification criteria for substances\n3.2.2.1. Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.\n3.2.2.2. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n3.2.2.3. If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.\n3.2.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo skin irritation testing.\nAlthough information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.\n3.2.2.5. A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.\n\n\n3.2.2.6. Corrosion\n3.2.2.6.1. On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.\n3.2.2.6.2. Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.\n3.2.2.6.3. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.\n\nTable 3.2.1\nSkin Corrosive category and subcategories\n\n\n\nCorrosive in > 1 of 3 animals\n\nCorrosive subcategories\nExposure\nObservation\nCategory 1: Corrosive\n1A\n≤ 3 minutes\n≤ 1 hour\n1B\n> 3 minutes - ≤ 1 hour\n≤ 14 days\n1C\n> 1 hour - ≤ 4 hours\n≤ 14 days\n\n\n\n3.2.2.7. Irritation\n3.2.2.7.1. Using the results of animal testing a single irritant category (Category 2) is presented in Table 3.2.2. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5. The major criterion for the irritant category is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.\n\nTable 3.2.2\nSkin irritation category\n\nCategory\nCriteria\nCategory 2: Irritant\n(1) Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or\n(2) Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or\n(3) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.\n\n\n3.2.2.8. Comments on responses obtained in skin irritation tests in animals\n3.2.2.8.1. Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.\n3.2.2.8.2. Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.\n\n\n3.2.3. Classification criteria for mixtures\n\n\n3.2.3.1. Classification of mixtures when data are available for the complete mixture\n3.2.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.\n\n3.2.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n\n3.2.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.2.3.2.1. Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n3.2.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.2.3.3.1. In order to make use of all available data for purposes of classifying the skin irritation/corrosion hazards of mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:\nAssumption: the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.\n3.2.3.3.2. In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.\n3.2.3.3.3. Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.\n3.2.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.\n3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.\n\n3.2.3.3.4.3. A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.\n3.2.3.3.5. On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.\n3.2.3.3.6. If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.\n\nTable 3.2.3\nGeneric concentration limits of ingredients classified for skin corrosive/irritant hazard (Category 1 or 2) that trigger classification of the mixture as corrosive/irritant to skin\n\nSum of ingredients classified as:\nConcentration triggering classification of a mixture as:\n\nSkin Corrosive\nSkin Irritant\n\nCategory 1\n(see note below)\nCategory 2\nSkin Corrosive Categories 1A, 1B, 1C\n≥ 5 %\n≥ 1 % but < 5 %\nSkin irritant Category 2\n\n≥ 10 %\n(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2\n\n≥ 10 %\n\nNote\nThe sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.\n\n\nTable 3.2.4\nGeneric concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as corrosive/irritant to skin\n\nIngredient:\nConcentration:\nMixture classified as: Skin\nAcid with pH ≤ 2\n≥ 1 %\nCategory 1\nBase with pH ≥ 11,5\n≥ 1 %\nCategory 1\nOther corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply\n≥ 1 %\nCategory 1\nOther irritant (Category 2) ingredients for which additivity does not apply, including acids and bases\n≥ 3 %\nCategory 2\n\n\n3.2.4. Hazard Communication\n3.2.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.2.5.\n\nTable 3.2.5\nLabel elements for skin corrosion/irritation\n\nClassification\nCategory 1 A/1 B/1 C\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH314: Causes severe skin burns and eye damage\nH315: Causes skin irritation\nPrecautionary Statement\nPrevention\nP260\nP264\nP280\nP264\nP280\nPrecautionary Statement\nResponse\nP301 + P330 + P331\nP303 + P361 + P353\nP363\nP304 + P340\nP310\nP321\nP305 + P351 + P338\nP302 + P352\nP321\nP332 + P313\nP362\nPrecautionary Statement\nStorage\nP405\n\nPrecautionary Statement\nDisposal\nP501\n\n\n\n3.3. Serious eye damage/eye irritation\n\n\n3.3.1. Definitions\n3.3.1.1. Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.\nEye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.\n\n\n3.3.2. Classification criteria for substances\n3.3.2.1. The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.\n3.3.2.2. Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.\n3.3.2.3. Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).\n3.3.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.\n3.3.2.5. A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.\n\n\n3.3.2.6. Irreversible effects on the eye/serious damage to eyes (Category 1)\n3.3.2.6.1. Substances that have the potential to seriously damage the eyes are classified in Category 1 (irreversible effects on the eye). Substances are classified in this hazard category on the basis of the results of animal testing, in accordance with the criteria listed in Table 3.3.1. These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.\n\nTable 3.3.1\nCategory for irreversible eye effects\n\nCategory\nCriteria\nIrreversible effects on the eye\n(Category 1)\nIf, when applied to the eye of an animal, a substance produces:\n\nat least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or\nat least in 2 of 3 tested animals, a positive response of:\n\ncorneal opacity ≥ 3 and/or\niritis > 1,5\ncalculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.\n3.3.2.6.2. The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n\n\n3.3.2.7. Reversible effects on the eye (Category 2)\n3.3.2.7.1. Substances that have the potential to induce reversible eye irritation are classified in Category 2 (irritating to eyes).\n\n\nTable 3.3.2\nCategory for reversible eye effects\n\nCategory\nCriteria\nIrritating to eyes\n(Category 2)\nif, when applied to the eye of an animal, a substance produces:\n\nat least in 2 of 3 tested animals, a positive response of:\n\ncorneal opacity ≥ 1 and/or\niritis ≥ 1, and/or\nconjunctival redness ≥ 2 and/or\nconjunctival oedema (chemosis) ≥ 2\ncalculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days\n3.3.2.7.2. For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.\n\n\n3.3.3. Classification criteria for mixtures\n\n\n3.3.3.1. Classification of mixtures when data are available for the complete mixture\n3.3.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.\n3.3.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n\n3.3.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.3.3.2.1. Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n\n3.3.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.3.3.3.1. In order to make use of all available data for purposes of classifying the eye irritation/serious eye damaging properties of the mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:\nAssumption: The relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.\n3.3.3.3.2. In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.\n3.3.3.3.3. Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.\n3.3.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.\n3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.\n3.3.3.3.4.3. A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.\n3.3.3.3.5. On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.\n\n3.3.3.3.6. If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.\n\nTable 3.3.3\nGeneric concentration limits of ingredients of a mixture classified as Skin corrosive Category 1 and/or eye Category 1 or 2 for effects on the eye that trigger classification of the mixture for effects on the eye (Category 1 or 2)\n\nSum of ingredients classified as:\nConcentration triggering classification of a mixture as:\nIrreversible Eye Effects\nReversible Eye Effects\nCategory 1\nCategory 2\nEye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C\n≥ 3 %\n≥ 1 % but < 3 %\nEye Effects Category 2\n\n≥ 10 %\n(10 × Eye Effects Category 1) + Eye effects Category 2\n\n≥ 10 %\nSkin Corrosive Category 1A, 1B, 1C + Eye effects Category 1\n≥ 3 %\n≥ 1 % but < 3 %\n10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2\n\n≥ 10 %\n\nTable 3.3.4\nGeneric concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as hazardous to the eye\n\nIngredient\nConcentration\nMixture classified as: Eye\nAcid with pH ≤ 2\n≥ 1 %\nCategory 1\nBase with pH ≥ 11,5\n≥ 1 %\nCategory 1\nOther corrosive (Category 1) ingredients for which additivity does not apply\n≥ 1 %\nCategory 1\nOther irritant (Category 2) ingredients for which additivity does not apply, including acids and bases\n≥ 3 %\nCategory 2\n\n\n3.3.4. Hazard Communication\n3.3.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.3.5.\n\n\nTable 3.3.5\nLabel elements for serious eye damage/eye irritation\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH318: Causes serious eye damage\nH319: Causes serious eye irritation\nPrecautionary Statement\nPrevention\nP280\nP264\nP280\nPrecautionary Statement\nResponse\nP305 + P351 + P338\nP310\nP305 + P351 + P338\nP337 + P313\nPrecautionary Statement\nStorage\n\n\nPrecautionary Statement\nDisposal\n\n\n\n\n3.4. Respiratory or skin sensitisation\n\n\n3.4.1. Definitions and general considerations\n3.4.1.1. Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.\n3.4.1.2. Skin sensitiser means a substance that will lead to an allergic response following skin contact.\n3.4.1.3. For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.\n3.4.1.4. For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.\n3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found in Annex II, section 2.8..\n\n3.4.1.6. The hazard class Respiratory or Skin Sensitisation is differentiated into:\n\nRespiratory Sensitisation and;\nSkin Sensitisation.\n\n\n\n3.4.2. Classification criteria for substances\n\n\n3.4.2.1. Respiratory sensitisers\n\n\n3.4.2.1.1. Hazard categories\n3.4.2.1.1.1.\nRespiratory sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.\n3.4.2.1.1.2.\nWhere data are sufficient a refined evaluation according to 3.4.2.1.1.3 shall allow the allocation of respiratory sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other respiratory sensitisers.\n3.4.2.1.1.3.\nEffects seen in either humans or animals will normally justify classification in a weight of evidence approach for respiratory sensitisers. Substances may be allocated to one of the two sub-categories 1A or 1B using a weight of evidence approach in accordance with the criteria given in Table 3.4.1 and on the basis of reliable and good quality evidence from human cases or epidemiological studies and/or observations from appropriate studies in experimental animals.\n3.4.2.1.1.4.\nSubstances shall be classified as respiratory sensitisers in accordance with the criteria in Table 3.4.1:\n\nTable 3.4.1\nHazard category and sub-categories for respiratory sensitisers\n\nAt present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment.\n\nCategory\nCriteria\nCategory 1\nSubstances shall be classified as respiratory sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:\n\n(a) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity; and/or\n\n(b) if there are positive results from an appropriate animal test.\nSub-category 1A:\nSubstances showing a high frequency of occurrence in humans; or a probability of occurrence of a high sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.\nSub-category 1B:\nSubstances showing a low to moderate frequency of occurrence in humans; or a probability of occurrence of a low to moderate sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.\n\n\n\n3.4.2.1.2. Human evidence\n3.4.2.1.2.1.\nEvidence that a substance can lead to specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.\n3.4.2.1.2.2.\nWhen considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:\n\n(a) the size of the population exposed;\n\n(b) the extent of exposure.\nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n3.4.2.1.2.3.\nThe evidence referred to above could be:\n\n(a) clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:\n\n(i) in vivo immunological test (e.g. skin prick test);\n\n(ii) in vitro immunological test (e.g. serological analysis);\n\n(iii) studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;\n\n(iv) a chemical structure related to substances known to cause respiratory hypersensitivity;\n\n(b) data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.\n3.4.2.1.2.4.\nClinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.\n3.4.2.1.2.5.\nThe results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.\n\n\n3.4.2.1.3. Animal studies\n3.4.2.1.3.1.\nData from appropriate animal studiesAt present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment. which may be indicative of the potential of a substance to cause sensitisation by inhalation in humansThe mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers. may include:\n\n\n(a) measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;\n\n(b) specific pulmonary responses in guinea pigs.\n\n\n3.4.2.2. Skin sensitisers\n\n\n3.4.2.2.1. Hazard categories\n3.4.2.2.1.1.\nSkin sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.\n3.4.2.2.1.2.\nWhere data are sufficient a refined evaluation according to section 3.4.2.2.1.3 allows the allocation of skin sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other skin sensitisers.\n3.4.2.2.1.3.\nEffects seen in either humans or animals will normally justify classification in a weight of evidence approach for skin sensitisers as described in section 3.4.2.2.2. Substances may be allocated to one of the two sub-categories 1A or 1B using a weight of evidence approach in accordance with the criteria given in Table 3.4.2 and on the basis of reliable and good quality evidence from human cases or epidemiological studies and/or observations from appropriate studies in experimental animals according to the guidance values provided in sections 3.4.2.2.2.1 and 3.4.2.2.3.2 for sub-category 1A and in sections 3.4.2.2.2.2 and 3.4.2.2.3.3 for sub-category 1B.\n3.4.2.2.1.4.\nSubstances shall be classified as skin sensitisers in accordance with the criteria in Table 3.4.2:\n\nTable 3.4.2\nHazard category and sub-categories for skin sensitisers\n\nCategory\nCriteria\nCategory 1\nSubstances shall be classified as skin sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:\n\n(a) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons; or\n\n(b) if there are positive results from an appropriate animal test (see specific criteria in section 3.4.2.2.4.1).\nSub-category 1A:\nSubstances showing a high frequency of occurrence in humans and/or a high potency in animals can be presumed to have the potential to produce significant sensitisation in humans. Severity of reaction may also be considered.\nSub-category 1B:\nSubstances showing a low to moderate frequency of occurrence in humans and/or a low to moderate potency in animals can be presumed to have the potential to produce sensitisation in humans. Severity of reaction may also be considered.\n\n\n3.4.2.2.2. Human evidence\n3.4.2.2.2.1.\nHuman evidence for sub-category 1A can include:\n\n(a) positive responses at ≤ 500 μg/cm2 (HRIPT, HMT — induction threshold);\n\n\n(b) diagnostic patch test data where there is a relatively high and substantial incidence of reactions in a defined population in relation to relatively low exposure;\n\n(c) other epidemiological evidence where there is a relatively high and substantial incidence of allergic contact dermatitis in relation to relatively low exposure.\n3.4.2.2.2.2.\nHuman evidence for sub-category 1B can include:\n\n(a) positive responses at > 500 μg/cm2 (HRIPT, HMT — induction threshold);\n\n(b) diagnostic patch test data where there is a relatively low but substantial incidence of reactions in a defined population in relation to relatively high exposure;\n\n(c) other epidemiological evidence where there is a relatively low but substantial incidence of allergic contact dermatitis in relation to relatively high exposure.\nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n\n\n3.4.2.2.3. Animal studies\n3.4.2.2.3.1.\nFor Category 1, when an adjuvant type test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant Guinea pig test method a response of at least 15 % of the animals is considered positive. For Category 1, a stimulation index of three or more is considered a positive response in the local lymph node assay. Test methods for skin sensitisation are described in the OECD Guideline 406 (the Guinea Pig Maximisation test and the Buehler guinea pig test) and Guideline 429 (Local Lymph Node Assay). Other methods may be used provided that they are well-validated and scientific justification is given. For example, the mouse ear swelling test (MEST) could be a reliable screening test to detect moderate to strong sensitisers, and could be used as a first stage in the assessment of skin sensitisation potential.\n3.4.2.2.3.2.\nAnimal test results for sub-category 1A can include data with values indicated in Table 3.4.3\n\nTable 3.4.3\nAnimal test results for sub-category 1A\n\nAssay\nCriteria\nLocal lymph node assay\nEC3 value ≤ 2 %\nGuinea pig maximisation test\n≥ 30 % responding at ≤ 0,1 % intradermal induction dose or\n≥ 60 % responding at > 0,1 % to ≤ 1 % intradermal induction dose\nBuehler assay\n≥ 15 % responding at ≤ 0,2 % topical induction dose or\n≥ 60 % responding at > 0,2 % to ≤ 20 % topical induction dose\n3.4.2.2.3.3.\nAnimal test results for sub-category 1B can include data with values indicated in Table 3.4.4 below:\n\n\nTable 3.4.4\nAnimal test results for sub-category 1B\n\nAssay\nCriteria\nLocal lymph node assay\nEC3 value > 2 %\nGuinea pig maximisation test\n≥ 30 % to < 60 % responding at > 0,1 % to ≤ 1 % intradermal induction dose or\n≥ 30 % responding at > 1 % intradermal induction dose\nBuehler assay\n≥ 15 % to < 60 % responding at > 0,2 % to ≤ 20 % topical induction dose or\n≥ 15 % responding at > 20 % topical induction dose\n\n\n3.4.2.2.4. Specific considerations\n3.4.2.2.4.1.\nFor classification of a substance, evidence should include any or all of the following using a weight of evidence approach:\n\n(a) positive data from patch testing, normally obtained in more than one dermatology clinic;\n\n(b) epidemiological studies showing allergic contact dermatitis caused by the substance. Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;\n\n(c) positive data from appropriate animal studies;\n\n(d) positive data from experimental studies in man (see section 1.3.2.4.7);\n\n(e) well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic;\n\n(f) severity of reaction may also be considered.\n3.4.2.2.4.2.\nEvidence from animal studies is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution as the frequency of cases reflect, in addition to the inherent properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data should not normally be used to negate positive results from animal studies. For both animal and human data, consideration should be given to the impact of vehicle.\n3.4.2.2.4.3.\nIf none of the abovementioned conditions are met, the substance need not be classified as a skin sensitiser. However, a combination of two or more indicators of skin sensitisation as listed below may alter the decision. This shall be considered on a case-by-case basis.\n\n(a) Isolated episodes of allergic contact dermatitis;\n\n\n(b) epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;\n\n(c) data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in section 3.4.2.2.3, but which are sufficiently close to the limit to be considered significant;\n\n(d) positive data from non-standard methods;\n\n(e) positive results from close structural analogues.\n\n\n3.4.2.2.4.4. Immunological contact urticaria\nSubstances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration should be given to classifying these substances also as skin sensitisers. Substances which cause immunological contact urticaria without meeting the criteria for respiratory sensitisers should also be considered for classification as skin sensitisers.\nThere is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence which will be similar to that for skin sensitisation.\n\n\n\n3.4.3. Classification criteria for mixtures\n\n\n3.4.3.1. Classification of mixtures when data are available for the complete mixture\n3.4.3.1.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.\n\n\n3.4.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n3.4.3.3. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.5 for solid/liquid and gas respectively.\n3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.5, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.6).\n\n\n\nTable 3.4.5\nGeneric concentration limits of components of a mixture classified as either respiratory sensitisers or skin sensitisers that trigger classification of the mixture\n\nComponent classified as:\nGeneric concentration limits triggering classification of a mixture as:\nRespiratory sensitiser\nCategory 1\nSkin sensitiser\nCategory 1\nSolid/liquid\nGas\nAll physical states\nRespiratory sensitiser\nCategory 1\n≥ 1,0 %\n≥ 0,2 %\n\nRespiratory sensitiser\nSub-category 1A\n≥ 0,1 %\n≥ 0,1 %\n\nRespiratory sensitiser\nSub-category 1B\n≥ 1,0 %\n≥ 0,2 %\n\nSkin sensitiser\nCategory 1\n\n\n≥ 1,0 %\nSkin sensitiser\nSub-category 1A\n\n\n≥ 0,1 %\nSkin sensitiser\nSub-category 1B\n\n\n≥ 1,0 %\n\n\n\nTable 3.4.6\nConcentration limits for elicitation of components of a mixture\n\nComponent classified as:\nConcentration limits for elicitation\nRespiratory sensitiser\nCategory 1\nSkin sensitiser\nCategory 1\nSolid/liquid\nGas\nAll physical states\nRespiratory sensitiser\nCategory 1\n≥ 0,1 % (Note 1)\n≥ 0,1 % (Note 1)\n\nRespiratory sensitiser\nSub-category 1A\n≥ 0,01 % (Note 1)\n≥ 0,01 % (Note 1)\n\nRespiratory sensitiser\nSub-category 1B\n≥ 0,1 % (Note 1)\n≥ 0,1 % (Note 1)\n\nSkin sensitiser\nCategory 1\n\n\n≥ 0,1 % (Note 1)\nSkin sensitiser\nSub-category 1A\n\n\n≥ 0,01 % (Note 1)\nSkin sensitiser\nSub-category 1B\n\n\n≥ 0,1 % (Note 1)\n\nNote 1:\nThis concentration limit for elicitation is used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing a component above this concentration. For sensitising substances with specific concentration limit lower than 0,1 %, the concentration limit for elicitation should be set at one tenth of the specific concentration limit.\n\n\n\n3.4.4. Hazard communication\n\n3.4.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.4.7.\n\nTable 3.4.7\nRespiratory or skin sensitisation label elements\n\nClassification\nRespiratory sensitisation\nSkin sensitisation\nCategory 1 and sub-categories 1A and 1B\nCategory 1 and sub-categories 1A and 1B\nGHS pictograms\n\n\nSignal word\nDanger\nWarning\nHazard statement\nH334: May cause allergy or asthma symptoms or breathing difficulties if inhaled\nH317: May cause an allergic skin reaction\nPrecautionary statement prevention\nP261\nP285\nP261\nP272\nP280\nPrecautionary statement response\nP304 + P341\nP342 + P311\nP302 + P352\nP333 + P313\nP321\nP363\nPrecautionary statement storage\n\n\nPrecautionary statement disposal\nP501\nP501\n\n\n\n3.5. Germ cell mutagenicity\n\n\n3.5.1. Definitions and general considerations\n3.5.1.1. A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term mutation applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term mutagenic and mutagen will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.\n\n3.5.1.2. The more general terms genotoxic and genotoxicity apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.\n\n\n3.5.2. Classification criteria for substances\n3.5.2.1. This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.\n3.5.2.2. For the purpose of classification for germ cell mutagenicity, substances are allocated to one of two categories as shown in Table 3.5.1.\n\nTable 3.5.1\nHazard categories for germ cell mutagens\n\nCategories\nCriteria\nCATEGORY 1:\nSubstances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.\nSubstances known to induce heritable mutations in the germ cells of humans.\nCategory 1A:\nThe classification in Category 1A is based on positive evidence from human epidemiological studies.\nSubstances to be regarded as if they induce heritable mutations in the germ cells of humans.\nCategory 1B:\nThe classification in Category 1B is based on:\n\npositive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or\npositive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or\npositive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.\nCATEGORY 2:\nSubstances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans\nThe classification in Category 2 is based on:\n\npositive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:\n\nsomatic cell mutagenicity tests in vivo, in mammals; or\nother in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.\nNote: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.\n\n\n\n3.5.2.3. Specific considerations for classification of substances as germ cell mutagens\n3.5.2.3.1. To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.\n3.5.2.3.2. The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.\n3.5.2.3.3. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.\n3.5.2.3.4. In vivo heritable germ cell mutagenicity tests, such as:\n\nrodent dominant lethal mutation test;\nmouse heritable translocation assay.\n3.5.2.3.5. In vivo somatic cell mutagenicicty tests, such as:\n\nmammalian bone marrow chromosome aberration test;\nmouse spot test;\nmammalian erythrocyte micronucleus test.\n3.5.2.3.6. Mutagenicity/genotoxicity tests in germ cells, such as:\n\n(a) mutagenicity tests:\n\nmammalian spermatogonial chromosome aberration test;\nspermatid micronucleus assay;\n\n(b) Genotoxicity tests:\n\nsister chromatid exchange analysis in spermatogonia;\nunscheduled DNA synthesis test (UDS) in testicular cells.\n3.5.2.3.7. Genotoxicity tests in somatic cells such as:\n\nliver Unscheduled synthesis test (UDS) in vivo;\nmammalian bone marrow Sister Chromatid Exchanges (SCE);\n3.5.2.3.8. In vitro mutagenicity tests such as:\n\nin vitro mammalian chromosome aberration test;\nin vitro mammalian cell gene mutation test;\nbacterial reverse mutation tests.\n3.5.2.3.9. The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.\n\n\n\n3.5.3. Classification criteria for mixtures\n\n\n3.5.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.5.3.1.1. The mixture shall be classified as a mutagen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 mutagen and is present at or above the appropriate generic concentration limit as shown in Table 3.5.2 for Category 1A, Category 1B and Category 2 respectively.\n\nTable 3.5.2\nGeneric concentration limits of ingredients of a mixture classified as germ cell mutagens that trigger classification of the mixture.\n\n\nConcentration limits triggering classification of a mixture as:\nIngredient classified as:\nCategory 1A mutagen\nCategory 1B mutagen\nCategory 2 mutagen\nCategory 1A mutagen\n≥ 0,1 %\n—\n—\nCategory 1B mutagen\n—\n≥ 0,1 %\n—\nCategory 2 mutagen\n—\n—\n≥ 1,0 %\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\n\n3.5.3.2. Classification of mixtures when data are available for the complete mixture\n3.5.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n3.5.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.5.3.3.1. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.5.4. Hazard communication\n3.5.4.1. Label elements shall be used in accordance with Table 3.5.3, for substances or mixtures meeting the criteria for classification in this hazard class.\n\n\nTable 3.5.3\nLabel elements of germ cell mutagenicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP201\nP202\nP281\nPrecautionary Statement\nResponse\nP308 + P313\nP308 + P313\nPrecautionary Statement\nStorage\nP405\nP405\nPrecautionary Statement\nDisposal\nP501\nP501\n\n\n3.5.5. Additional classification considerations\nIt is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).\n\n\n3.6. Carcinogenicity\n\n\n3.6.1. Definition\n3.6.1.1. Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.\n\n\n3.6.2. Classification criteria for substances\n3.6.2.1. For the purpose of classification for carcinogenicity, substances are allocated to one of two categories based on strength of evidence and additional considerations (weight of evidence). In certain instances, route-specific classification may be warranted, if it can be conclusively proved that no other route of exposure exhibits the hazard.\n\n\nTable 3.6.1\nHazard categories for carcinogens\n\nNote: See 3.6.2.2.4.\n\nCategories\nCriteria\nCATEGORY 1:\nKnown or presumed human carcinogens\nA substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:\nCategory 1A:\nCategory 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or\nCategory 1B:\nCategory 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.\n\nThe classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:\n\nhuman studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or\nanimal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen).\n\nIn addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.\nCATEGORY 2:\nSuspected human carcinogens\nThe placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.\n\n\n3.6.2.2. Specific considerations for classification of substances as carcinogens\n3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.\n\n3.6.2.2.2. Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.\n3.6.2.2.3. Strength of evidence involves the enumeration of tumours in human and animal studies and determination of their level of statistical significance. Sufficient human evidence demonstrates causality between human exposure and the development of cancer, whereas sufficient evidence in animals shows a causal relationship between the substance and an increased incidence of tumours. Limited evidence in humans is demonstrated by a positive association between exposure and cancer, but a causal relationship cannot be stated. Limited evidence in animals is provided when data suggest a carcinogenic effect, but are less than sufficient. The terms sufficient and limited have been used here as they have been defined by the International Agency for Research on Cancer (IARC) and read as follows:\n\n(a) Carcinogenicity in humans\nThe evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:\n\nsufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;\nlimited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.\n\n(b) Carcinogenicity in experimental animals\nCarcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:\n\nsufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;\nlimited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.\n3.6.2.2.4. Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.\n3.6.2.2.5. The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.\n3.6.2.2.6. Some important factors which may be taken into consideration, when assessing the overall level of concern are:\n\n(a) tumour type and background incidence;\n\n(b) multi-site responses;\n\n(c) progression of lesions to malignancy;\n\n(d) reduced tumour latency;\n\n(e) whether responses are in single or both sexes;\n\n(f) whether responses are in a single species or several species;\n\n(g) structural similarity to a substance(s) for which there is good evidence of carcinogenicity;\n\n(h) routes of exposure;\n\n(i) comparison of absorption, distribution, metabolism and excretion between test animals and humans;\n\n(j) the possibility of a confounding effect of excessive toxicity at test doses;\n\n(k) mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.\nMutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.\n\n3.6.2.2.7. A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.\n3.6.2.2.8. The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.\n3.6.2.2.9. It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.\n\n\n3.6.3. Classification criteria for mixtures\n\n\n3.6.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.6.3.1.1. The mixture will be classified as a carcinogen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 carcinogen and is present at or above the appropriate generic concentration limit as shown in Table 3.6.2 for Category 1A, Category 1B and Category 2 respectively.\n\nTable 3.6.2\nGeneric concentration limits of ingredients of a mixture classified as carcinogen that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of a mixture as:\nCategory 1A carcinogen\nCategory 1B carcinogen\nCategory 2 carcinogen\nCategory 1A carcinogen\n≥ 0,1 %\n—\n—\nCategory 1B carcinogen\n—\n≥ 0,1 %\n—\nCategory 2 carcinogen\n—\n—\n≥ 1,0 % [Note 1]\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\nNote 1\nIf a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request.\n\n\n3.6.3.2. Classification of mixtures when data are available for the complete mixture\n3.6.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n\n3.6.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.6.3.3.1. Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.6.4. Hazard Communication\n3.6.4.1. Label elements shall be used in accordance with Table 3.6.3, for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.6.3\nLabel elements for carcinogenicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP201\nP202\nP281\nPrecautionary Statement\nResponse\nP308 + P313\nP308 + P313\nPrecautionary Statement\nStorage\nP405\nP405\nPrecautionary Statement\nDisposal\nP501\nP501\n\n\n3.7. Reproductive toxicity\n\n\n3.7.1. Definitions and general considerations\n3.7.1.1. Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based heritable effects in the offspring is addressed in Germ Cell Mutagenicity (section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.\nIn this classification system, reproductive toxicity is subdivided under two main headings:\n\n(a) adverse effects on sexual function and fertility;\n\n(b) adverse effects on development of the offspring.\nSome reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.\n3.7.1.2. For the purpose of classification the hazard class Reproductive Toxicity is differentiated into:\n\nadverse effects\n\non sexual function and fertility, or\non development;\neffects on or via lactation.\n\n\n3.7.1.3. Adverse effects on sexual function and fertility\nAny effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.\n\n\n3.7.1.4. Adverse effects on development of the offspring\nDevelopmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.\n3.7.1.5. Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.\n\n\n\n3.7.2. Classification criteria for substances\n\n\n3.7.2.1. Hazard categories\n3.7.2.1.1. For the purpose of classification for reproductive toxicity, substances are allocated to one of two categories. Within each category, effects on sexual function and fertility, and on development, are considered separately. In addition, effects on lactation are allocated to a separate hazard category.\n\nTable 3.7.1(a)\nHazard categories for reproductive toxicants\n\nCategories\nCriteria\nCATEGORY 1\nKnown or presumed human reproductive toxicant\nSubstances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).\nCategory 1A\nKnown human reproductive toxicant\nThe classification of a substance in Category 1A is largely based on evidence from humans.\nCategory 1B\nPresumed human reproductive toxicant\nThe classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.\nCATEGORY 2\nSuspected human reproductive toxicant\nSubstances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.\nSuch effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.\n\nTable 3.7.1(b)\nHazard category for lactation effects\n\nEFFECTS ON OR VIA LACTATION\nEffects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:\n\n(a) human evidence indicating a hazard to babies during the lactation period; and/or\n\n(b) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or\n\n(c) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.\n\n\n3.7.2.2. Basis of classification\n3.7.2.2.1. Classification is made on the basis of the appropriate criteria, outlined above, and an assessment of the total weight of evidence (see 1.1.1). Classification as a reproductive toxicant is intended to be used for substances which have an intrinsic, specific property to produce an adverse effect on reproduction and substances shall not be so classified if such an effect is produced solely as a non-specific secondary consequence of other toxic effects.\nThe classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.\n3.7.2.2.2. In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).\n3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.\n\n\n3.7.2.3. Weight of evidence\n3.7.2.3.1. Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).\n3.7.2.3.2. Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.\n3.7.2.3.3. If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.\n3.7.2.3.4. Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.\n\n3.7.2.3.5. If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.\n\n\n3.7.2.4. Maternal toxicity\n3.7.2.4.1. Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.\n3.7.2.4.2. Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.\n3.7.2.4.3. Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.\n3.7.2.4.4. Some of the end points used to assess maternal effects are provided below. Data on these end points, if available, need to be evaluated in light of their statistical or biological significance and dose response relationship.\nMaternal mortality:\nan increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.\nMating index\n(no. animals with seminal plugs or sperm/no. mated × 100)It is recognised that the Mating index and the Fertility index can also be affected by the male.\nFertility index\n(no. animals with implants/no. of matings × 100)\nGestation length\n(if allowed to deliver)\nBody weight and body weight change:\nConsideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.\nFood and water consumption (if relevant):\nThe observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.\nClinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):\nThe observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.\nPost-mortem data:\nIncreased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.\n\n\n3.7.2.5. Animal and experimental data\n3.7.2.5.1. A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).\n3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.\n3.7.2.5.3. Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.\n3.7.2.5.4. Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.\n3.7.2.5.5. It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.\n\n3.7.2.5.6. Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.\n3.7.2.5.7. There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.\n3.7.2.5.8. In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.\n3.7.2.5.9. However, specification of the actual limit dose will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.\n\n\n3.7.3. Classification criteria for mixtures\n\n\n3.7.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.7.3.1.1. The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.\n3.7.3.1.2. The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.\n\nTable 3.7.2\nGeneric concentration limits of ingredients of a mixture classified as reproduction toxicants or for effects on or via lactation that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of a mixture as:\nCategory 1A reproductive toxicant\nCategory 1B reproductive toxicant\nCategory 2 reproductive toxicant\nAdditional category for effects on or via lactation\nCategory 1A reproductive toxicant\n≥ 0,3 %\n[Note 1]\n\n\n\nCategory 1B reproductive toxicant\n\n≥ 0,3 %\n[Note 1]\n\n\nCategory 2 reproductive toxicant\n\n\n≥ 3,0 %\n[Note 1]\n\nAdditional category for effects on or via lactation\n\n\n\n≥ 0,3 %\n[Note 1]\n\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\nNote 1\nIf a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request.\n\n\n3.7.3.2. Classification of mixtures when data are available for the complete mixture\n3.7.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n3.7.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.7.4. Hazard Communication\n3.7.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.7.3\n\n\nTable 3.7.3\nLabel elements for reproductive toxicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nAdditional category for effects on or via lactation\nGHS Pictograms\n\n\nNo pictogram\nSignal Word\nDanger\nWarning\nNo signal word\nHazard Statement\nH360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH362: May cause harm to breast-fed children.\nPrecautionary Statement Prevention\nP201\nP202\nP281\nP201\nP202\nP281\nP201\nP260\nP263\nP264\nP270\nPrecautionary Statement Response\nP308 + P313\nP308 + P313\nP308 + P313\nPrecautionary Statement Storage\nP405\nP405\n\nPrecautionary Statement Disposal\nP501\nP501\n\n\n\n3.8. Specific target organ toxicity — single exposure\n\n\n3.8.1. Definitions and general considerations\n3.8.1.1. Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).\n3.8.1.2. Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.\n3.8.1.3. These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.\n\n3.8.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.\n3.8.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.\n3.8.1.6. Specific target organ toxicity following a repeated exposure is classified as described in Specific target organ toxicity — Repeated exposure (section 3.9) and is therefore excluded from section 3.8. Other specific toxic effects, listed below, are assessed separately and consequently are not included here:\n\n(a) Acute toxicity (section 3.1);\n\n(b) Skin corrosion/irritation (section 3.2);\n\n(c) Serious eye damage/eye irritation (section 3.3);\n\n(d) Respiratory or skin sensitisation (section 3.4);\n\n(e) Germ cell mutagenicity (section 3.5);\n\n(f) Carcinogenicity (section 3.6);\n\n(g) Reproductive toxicity (section 3.7); and\n\n(h) Aspiration toxicity (section 3.10).\n3.8.1.7. The hazard class Specific Target Organ Toxicity — Single Exposure is differentiated into:\n\nSpecific target organ toxicity — single exposure, Category 1 and 2;\nSpecific target organ toxicity — single exposure, Category 3.\nSee Table 3.8.1.\n\nTable 3.8.1\nCategories for specific target organ toxicity-single exposure\n\nNote: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).\n\nCategories\nCriteria\nCategory 1\nSubstances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure\nSubstances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:\n\n(a) reliable and good quality evidence from human cases or epidemiological studies; or\n\n(b) observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.\nCategory 2\nSubstances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure\nSubstances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.\nIn exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).\nCategory 3\nTransient target organ effects\nThis category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.\n\n\n3.8.2. Classification criteria for substances\n\n\n3.8.2.1. Substances of Category 1 and Category 2\n3.8.2.1.1. Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).\n3.8.2.1.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).\n3.8.2.1.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.\n3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.\n3.8.2.1.5. The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.\n3.8.2.1.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of target organ toxicity in Category 2:\n\n(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or\n\n(b) based on the nature and severity of effects.\nDose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.\n\n\n3.8.2.1.7. Effects considered to support classification for Category 1 and 2\n3.8.2.1.7.1. Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.\n3.8.2.1.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.\n3.8.2.1.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:\n\n(a) morbidity resulting from single exposure;\n\n(b) significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);\n\n(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;\n\n(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;\n\n(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;\n\n(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;\n\n\n(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.\n\n\n3.8.2.1.8. Effects considered not to support classification for Category 1 and 2\nIt is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:\n\n(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate significant toxicity;\n\n(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;\n\n(c) changes in organ weights with no evidence of organ dysfunction;\n\n(d) adaptive responses that are not considered toxicologically relevant;\n\n(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.\n\n\n3.8.2.1.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals for Category 1 and 2\n3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.\n3.8.2.1.9.2. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).\n3.8.2.1.9.3. The guidance value (C) ranges for single-dose exposure which has produced a significant non-lethal toxic effect are those applicable to acute toxicity testing, as indicated in Table 3.8.2.\n\n\nTable 3.8.2\nGuidance value ranges for single-dose exposures a\n\n\nGuidance value ranges for:\nRoute of exposure\nUnits\nCategory 1\nCategory 2\nCategory 3\nOral (rat)\nmg/kg body weight\nC ≤ 300\n2000 ≥ C > 300\nGuidance values do not apply b\nDermal (rat or rabbit)\nmg/kg body weight\nC ≤ 1000\n2000 ≥ C > 1000\nInhalation (rat) gas\nppmV/4h\nC ≤ 2500\n20000 ≥ C > 2500\nInhalation (rat) vapour\nmg/l/4h\nC ≤ 10\n20 ≥ C > 10\nInhalation (rat) dust/mist/fume\nmg/l/4h\nC ≤ 1,0\n5,0 ≥ C > 1,0\n\nNote\n\n(a) The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.\n\n(b) Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation.\n\n\n3.8.2.1.10. Other considerations\n3.8.2.1.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.\n3.8.2.1.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.\n3.8.2.1.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.\n\n3.8.2.1.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection\n\n\n3.8.2.2. Substances of Category 3: Transient target organ effects\n\n\n3.8.2.2.1. Criteria for respiratory tract irritation\nThe criteria for classifying substances as Category 3 for respiratory tract irritation are:\n\n(a) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;\n\n(b) subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);\n\n(c) the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of irritation shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;\n\n(d) there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;\n\n(e) this special classification would occur only when more severe organ effects including in the respiratory system are not observed.\n\n\n3.8.2.2.2 Criteria for narcotic effects\nThe criteria for classifying substances as Category 3 for narcotic effects are:\n\n(a) central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;\n\n(b) narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.\n\n\n\n3.8.3. Classification criteria for mixtures\n3.8.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.\n\n\n3.8.3.2. Classification of mixtures when data are available for the complete mixture\n3.8.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.\n\n\n3.8.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.8.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.\n\n\n3.8.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.8.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.\n3.8.3.4.2. These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.\n3.8.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.\n\nTable 3.8.3\nGeneric concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture as Category 1 or 2\n\nIngredient classified as:\nGeneric concentration limits triggering classification of the mixture as:\nCategory 1\nCategory 2\nCategory 1\nSpecific Target Organ Toxicant\nConcentration ≥ 10 %\n1,0 % ≤ concentration < 10 %\nCategory 2\nSpecific Target Organ Toxicant\n\nConcentration ≥ 10 % [(Note 1)]\n\nNote 1\nIf a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.\n3.8.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.\n3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised.Respiratory tract irritation and narcotic effects are to be evaluated separately in accordance with the criteria given in section 3.8.2.2. When conducting classifications for these hazards, the contribution of each component should be considered additive, unless there is evidence that the effects are not additive.\n\n\n3.8.4. Hazard Communication\n3.8.4.1 Label elements shall be used in accordance with Table 3.8.4., for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.8.4\nLabel elements for specific target organ toxicity after single exposure\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nWarning\nWarning\nHazard Statement\nH370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH335: May cause respiratory irritation; or\nH336: May cause drowsiness or dizziness\nPrecautionary Statement Prevention\nP260\nP264\nP270\nP260\nP264\nP270\nP261\nP271\nPrecautionary Statement Response\nP307 + P311\nP321\nP309 + P311\nP304 + P340\nP312\nPrecautionary Statement Storage\nP405\nP405\nP403 + P233\nP405\nPrecautionary Statement Disposal\nP501\nP501\nP501\n\n\n3.9. Specific target organ toxicity — repeated exposure\n\n\n3.9.1. Definitions and general considerations\n3.9.1.1. Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.\n3.9.1.2. Classification for target organ toxicity (repeated exposure) identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.\n3.9.1.3. These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.\n3.9.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.\n3.9.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.\n3.9.1.6. Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.\n\n\n3.9.2. Classification criteria for substances\n3.9.2.1. Substances are classified as specific target organ toxicants following repeated exposure by the use of expert judgement (see 1.1.1), on the basis of the weight of all evidence available, including the use of recommended guidance values which take into account the duration of exposure and the dose/concentration which produced the effect(s), (see 3.9.2.9), and are placed in one of two categories, depending upon the nature and severity of the effect(s) observed (Table 3.9.1).\n\n\nTable 3.9.1\nCategories for specific target organ toxicity-repeated exposure\n\nCategories\nCriteria\nCategory 1\nSubstances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.\nSubstances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:\n\nreliable and good quality evidence from human cases or epidemiological studies; or\nobservations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.\nCategory 2\nSubstances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.\nSubstances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.\nIn exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).\n\nNote\nAttempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).\n3.9.2.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified.\n3.9.2.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.\n3.9.2.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.\n3.9.2.5. The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.\n3.9.2.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of specific target organ toxicity in Category 2:\n\n(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or\n\n(b) based on the nature and severity of effects.\nDose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.\n\n\n3.9.2.7. Effects considered to support classification for specific target organ toxicity following repeated exposure\n3.9.2.7.1. Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.\n3.9.2.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.\n3.9.2.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, haematology, clinical chemistry, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, shall be taken into consideration in the classification process, including but not limited to the following toxic effects in humans and/or animals:\n\n(a) morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;\n\n(b) significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);\n\n\n(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;\n\n(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;\n\n(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;\n\n(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);\n\n(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.\n\n\n3.9.2.8. Effects considered not to support classification for specific target organ toxicity following repeated exposure\n3.9.2.8.1. It is recognised that effects may be seen in humans and/or animals that do not justify classification. Such effects include, but are not limited to:\n\n(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate significant toxicity;\n\n(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;\n\n(c) changes in organ weights with no evidence of organ dysfunction;\n\n(d) adaptive responses that are not considered toxicologically relevant;\n\n(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.\n\n\n3.9.2.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals\n3.9.2.9.1. In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.\n3.9.2.9.2. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.\n3.9.2.9.3. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).\n3.9.2.9.4. The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.\n3.9.2.9.5. The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.\n3.9.2.9.6. Thus classification in Category 1 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur at or below the guidance values (C) as indicated in Table 3.9.2:\n\nTable 3.9.2\nGuidance values to assist in Category 1 classification\n\nRoute of exposure\nUnits\nGuidance values (dose/concentration)\nOral (rat)\nmg/kg body weight/day\nC ≤ 10\nDermal (rat or rabbit)\nmg/kg body weight/day\nC ≤ 20\nInhalation (rat)gas\nppmV/6h/day\nC ≤ 50\nInhalation (rat)vapour\nmg/litre/6h/day\nC ≤ 0,2\nInhalation (rat) dust/mist/fume\nmg/litre/6h/day\nC ≤ 0,02\n3.9.2.9.7. Classification in Category 2 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur within the guidance value ranges as indicated in Table 3.9.3:\n\n\nTable 3.9.3\nGuidance values to assist in Category 2 classification\n\nRoute of Exposure\nUnits\nGuidance Value Ranges:\n(dose/concentration)\nOral (rat)\nmg/kg body weight/day\n10 < C ≤ 100\nDermal (rat or rabbit)\nmg/kg body weight/day\n20 < C ≤ 200\nInhalation (rat) gas\nppmV/6h/day\n50 < C ≤ 250\nInhalation (rat)vapour\nmg/litre/6h/day\n0,2 < C ≤ 1,0\nInhalation (rat) dust/mist/fume\nmg/litre/6h/day\n0,02 < C ≤ 0,2\n3.9.2.9.8. The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.\n3.9.2.9.9. Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.\n\n\n3.9.2.10. Other considerations\n3.9.2.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.\n3.9.2.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.\n\n3.9.2.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.\n3.9.2.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection\n\n\n3.9.3. Classification criteria for mixtures\n3.9.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.\n\n\n3.9.3.2. Classification of mixtures when data are available for the complete mixture\n3.9.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.\n\n\n3.9.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.9.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.\n\n\n3.9.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.9.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, repeat exposure, or both when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as laid out in Table 3.9.4 for Category 1 and 2 respectively.\n\nTable 3.9.4\nGeneric concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of the mixture as:\nCategory 1\nCategory 2\nCategory 1\nSpecific Target Organ Toxicant\nConcentration ≥ 10 %\n1,0 % ≤ concentration < 10 %\nCategory 2\nSpecific Target Organ Toxicant\n\nConcentration ≥ 10 % [(Note 1)]\n\nNote 1\nIf a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.\n3.9.3.4.2. These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.\n3.9.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.\n3.9.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.\n\n\n3.9.4. Hazard Communication\n3.9.4.1. Label elements shall be used in accordance with Table 3.9.5 for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.9.5\nLabel elements for specific target organ toxicity after repeated exposure\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal word\nDanger\nWarning\nHazard Statement\nH372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement Prevention\nP260\nP264\nP270\nP260\nPrecautionary Statement Response\nP314\nP314\nPrecautionary Statement Storage\n\n\nPrecautionary Statement Disposal\nP501\nP501\n\n\n\n3.10. Aspiration hazard\n\n\n3.10.1. Definitions and general considerations\n3.10.1.1. These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.\n3.10.1.2 Aspiration means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.\n3.10.1.3. Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.\n3.10.1.4. Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.\n3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.\n\n\n3.10.1.6. Specific considerations\n3.10.1.6.1. A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.\n3.10.1.6.2. The classification criteria refer to kinematic viscosity. The following provides the conversion between dynamic and kinematic viscosity:\nDynamic viscosity mPa sDensity g/cm3=Kinematic viscosity mm2/s\n\n3.10.1.6.2a Although the definition of aspiration in section 3.10.1.2 includes the entry of solids into the respiratory system, classification according to point (b) in Table 3.10.1 for Category 1 is intended to apply to liquid substances and mixtures only.\n\n\n\n3.10.1.6.3. Classification of aerosol/mist products\nAerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.\n\n\n\n3.10.2. Classification criteria for substances\n\nTable 3.10.1\nHazard category for aspiration toxicity\n\nCategory\nCriteria\nCategory 1\nSubstances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard\nA substance is classified in Category 1:\n\n(a) based on reliable and good quality human evidence\nor\n\n(b) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.\n\nNote:\nSubstances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil.\n\n\n3.10.3. Classification criteria for mixtures\n\n\n3.10.3.1. Classification when data are available for the complete mixture\nA mixture is classified in Category 1 based on reliable and good quality human evidence.\n\n\n3.10.3.2. Classification when data are not available for the complete mixture: bridging principles\n3.10.3.2.1. Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.\n\n\n3.10.3.3. Classification when data are available for all components or only some components of the mixture\n\n\n3.10.3.3.1. Category 1\n3.10.3.3.1.1. A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.\n3.10.3.3.1.2. In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.\n\n\n3.10.4. Hazard Communication\n3.10.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.10.2.\n\n\nTable 3.10.2\nAspiration toxicity label elements\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH304: May be fatal if swallowed and enters airways\nPrecautionary Statement\nPrevention\n\nPrecautionary Statement\nResponse\nP301 + P310\nP331\nPrecautionary Statement\nStorage\nP405\nPrecautionary Statement\nDisposal\nP501\n\n\n\n\n4. PART 4: ENVIRONMENTAL HAZARDS\n\n\n4.1. Hazardous to the aquatic environment\n\n\n4.1.1. Definitions and general considerations\n\n\n4.1.1.1. Definitions\n\n(a) acute aquatic toxicity means the intrinsic property of a substance to be injurious to an aquatic organism in a short-term aquatic exposure to that substance.\n\n(b) acute (short-term) hazard means for classification purposes the hazard of a substance or mixture caused by its acute toxicity to an organism during short-term aquatic exposure to that substance or mixture.\n\n(c) availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (M°) compound can disaggregate from the rest of the compound (molecule).\n\n(d) bioavailability or biological availability means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.\n\n(e) bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).\n\n(f) bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.\n\n(g) chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during aquatic exposures which are determined in relation to the life-cycle of the organism.\n\n(h) degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.\n\n(i) ECx means the effect concentration associated with x% response.\n\n(j) long-term hazard means for classification purposes the hazard of a substance or mixture caused by its chronic toxicity following long-term exposure in the aquatic environment.\n\n(k) no observed effect concentration (NOEC) means the test concentration immediately below the lowest tested concentration with statistically significant adverse effect. The NOEC has no statistically significant adverse effect compared to the control.\n\n\n4.1.1.2. Basic elements\n4.1.1.2.0.\nHazardous to the aquatic environment is differentiated into:\n\nacute aquatic hazard,\nlong-term aquatic hazard.\n4.1.1.2.1.\nThe basic elements used for classification for aquatic environmental hazards are:\n\nacute aquatic toxicity,\n\nchronic aquatic toxicity,\npotential for or actual bioaccumulation, and\ndegradation (biotic or abiotic) for organic chemicals.\n4.1.1.2.2.\nPreferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test methods used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1 of Annex I to Regulation (EC) No 1272/2008.\n\n\n4.1.1.3. Other considerations\n4.1.1.3.1.\nClassification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of acute (short-term) and long-term hazards is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.\n4.1.1.3.2.\nWhile the classification system applies to all substances and mixtures, it is recognised that for special cases (e.g. metals) the European Chemicals Agency has issued guidance.\n\n\n4.1.2. Classification criteria for substances\n4.1.2.1.\nThe system for classification recognises that the intrinsic hazard to aquatic organisms is represented by both the acute and long-term hazard of a substance. For the long-term hazard, separate hazard categories are defined representing a gradation in the level of hazard identified. The lowest of the available toxicity values between and within the different trophic levels (fish, crustacean, algae/aquatic plants) shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.\n4.1.2.2.\nThe core classification system for substances consists of one acute hazard classification category and three long-term hazard classification categories. The acute and the long-term hazard classification categories are applied independently.\n4.1.2.3.\nThe criteria for classification of a substance in category Acute 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the categories Chronic 1 to 3 follow a tiered approach where the first step is to see if available information on chronic toxicity merits long-term hazard classification. In absence of adequate chronic toxicity data, the subsequent step is to combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data) (see figure 4.1.1).\n\n\nFigure 4.1.1\nCategories for substances long-term hazardous to the aquatic environment\nAre there adequate chronic toxicity data available for all three trophic levels?\nYes\nClassify according to the criteria given in Table 4.1.0(b) (i) or 4.1.0(b)(ii) depending on information on rapid degradation\nNo\nAre there adequate chronic toxicity data available for one or two trophic levels?\nYes\nAssess both:\n(a) according to the criteria given in Table 4.1.0(b)(i) or 4.1.0(b)(ii) (depending on information on rapid degradation), and\n(b) (if for the other trophic level(s) adequate acute toxicity data are available) according to the criteria given in Table 4.1.0(b) (iii),\nand classify according to the most stringent outcome\nNo\nAre there adequate acute toxicity data available?\nYes\nClassify according to the criteria given in Table 4.1.0(b) (iii)\n\n4.1.2.4.\nThe system also introduces a safety net classification (referred to as category Chronic 4) for use when the data available do not allow classification under the formal criteria for acute 1 or chronic 1 to 3 but there are nevertheless some grounds for concern (see example in Table 4.1.0).\n4.1.2.5.\nSubstances with acute toxicities below 1 mg/l or chronic toxicities below 0,1 mg/l (if non-rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and section 4.1.3.5.5).\n4.1.2.6.\nThe criteria for classifying and categorising substances as hazardous to the aquatic environment are summarised in Table 4.1.0.\n\nTable 4.1.0\nClassification categories for hazardous to the aquatic environment\n\n(a) Acute (short-term) aquatic hazard\nCategory Acute 1: (Note 1)\n96 hr LC50 (for fish)\n≤ 1 mg/l and/or\n48 hr EC50 (for crustacea)\n≤ 1 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n≤ 1 mg/l. (Note 2)\n(b) Long-term aquatic hazard\n(i) Non-rapidly degradable substances (Note 3) for which there are adequate chronic toxicity data available\nCategory Chronic 1: (Note 1)\nChronic NOEC or ECx (for fish)\n≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n≤0,1 mg/l.\nCategory Chronic 2:\nChronic NOEC or ECx (for fish)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,1 to ≤ 1 mg/l.\n\n(ii) Rapidly degradable substances (Note 3) for which there are adequate chronic toxicity data available\nCategory Chronic 1: (Note 1)\nChronic NOEC or ECx (for fish)\n≤ 0,01 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n≤ 0,01 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n≤ 0,01 mg/l.\nCategory Chronic 2:\nChronic NOEC or ECx (for fish)\n> 0,01 to ≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,01 to ≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,01 to ≤ 0,1 mg/l.\nCategory Chronic 3:\nChronic NOEC or ECx (for fish)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,1 to ≤ 1 mg/l.\n(iii) Substances for which adequate chronic toxicity data are not available\nCategory Chronic 1: (Note 1)\n96 hr LC50 (for fish)\n≤ 1 mg/l and/or\n48 hr EC50 (for crustacea)\n≤ 1 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n≤ 1 mg/l. (Note 2)\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nCategory Chronic 2:\n96 hr LC50 (for fish)\n> 1 to ≤10 mg/l and/or\n48 hr EC50 (for crustacea)\n> 1 to ≤10 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n> 1 to ≤10 mg/l (Note 2)\n\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nCategory Chronic 3:\n96 hr LC50 (for fish)\n> 10 to ≤ 100 mg/l and/or\n48 hr EC50 (for crustacea)\n> 10 to ≤ 100 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n> 10 to ≤ 100 mg/l. (Note 2)\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nSafety net classification\nCategory Chronic 4\nCases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 4), and which are not rapidly degradable in accordance with section 4.1.2.9.5 and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, which will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or other evidence of rapid degradation in the environment than the ones provided by any of the methods listed in section 4.1.2.9.5.\n\n\nNote 1:\nWhen classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate the appropriate M-factor(s) (see Table 4.1.3).\n\nNote 2:\nClassification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.\n\nNote 3:\nWhen no useful data on degradability are available, either experimentally determined or estimated data, the substance should be regarded as not rapidly degradable.\n\nNote 4:\nNo acute toxicity is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity.\n\n\n4.1.2.7. Aquatic toxicity\n4.1.2.7.1.\nAcute aquatic toxicity is normally determined using a fish 96-hour LC50, a crustacea species 48-hour EC50 and/or an algal species 72- or 96-hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).\n4.1.2.7.2.\nFor determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECs or other equivalent ECx (e.g. EC10) shall be used.\n\n\n4.1.2.8. Bioaccumulation\n4.1.2.8.1.\nBioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes. Some relationships can be observed between chronic toxicity and bioaccumulation potential, as toxicity is related to the body burden.\n\n\n4.1.2.9. Rapid degradability of organic substances\n4.1.2.9.1.\nSubstances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.\n4.1.2.9.2.\nOne way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is readily biodegradable. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade rapidly in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of rapid degradability is met.\n4.1.2.9.3.\nMany degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.\n\n4.1.2.9.4.\nThe criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.\n4.1.2.9.5.\nSubstances are considered rapidly degradable in the environment if one of the following criteria holds true:\n\n(a) if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved:\n\n(i) tests based on dissolved organic carbon: 70 %;\n\n(ii) tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.\nThese levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded, unless the substance is identified as an UVCB or as a complex, multi-constituent substance with structurally similar constituents. In this case, and where there is sufficient justification, the 10-day window condition may be waived and the pass level applied at 28 days; or\n\n(b) if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or\n\n(c) if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.\n\n\n4.1.2.10. Inorganic compounds and metals\n4.1.2.10.1.\nFor inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with careSpecific guidance has been issued by the European Chemicals Agency on how these data for such substances may be used in meeting the requirements of the classification criteria..\n\n\n4.1.2.10.2.\nPoorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution. All evidence must be weighed in a classification decision. This would be especially true for metals showing borderline results in the Transformation/Dissolution Protocol.\n\n\n4.1.3. Classification criteria for mixtures\n4.1.3.1.\nThe classification system for mixtures covers all classification categories which are used for substances, i.e. categories Acute 1 and Chronic 1 to 4. In order to make use of all available data for purposes of classifying the aquatic environmental hazards of the mixture, the following is applied where appropriate:\nThe relevant components of a mixture are those which are classified Acute 1or Chronic 1 and present in a concentration of 0,1 % (w/w) or greater, and those which are classified Chronic 2, Chronic 3 or Chronic 4 and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see section 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as Acute 1 or Chronic 1 the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see section 4.1.3.5.5.5.)\n4.1.3.2.\nThe approach for classification of aquatic environmental hazards is tiered, and is dependent upon the type of information available for the mixture itself and for its components. Figure 4.1.2 outlines the process to be followed.\nElements of the tiered approach include:\n\nclassification based on tested mixtures,\nclassification based on bridging principles,\nthe use of summation of classified components and/or an additivity formula.\n\nFigure 4.1.2\nTiered approach to classification of mixtures for acute and long-term aquatic environmental hazards\nAquatic toxicity test data available on the mixture as a whole\nNo\nYes\nCLASSIFY\nfor acute/long-term aquatic hazard (see 4.1.3.3)\nSufficient data available on similar mixtures to estimate hazards\nYes\nApply bridging principles (see 4.1.3.4.)\nCLASSIFY\nfor acute/long-term aquatic hazard\nNo\nEither aquatic toxicity or classification data available for all relevant components\nYes\nApply summation method (see 4.1.3.5.5) using:\n• Percentage of all components classified as ‘Chronic’\n• Percentage of components classified as ‘Acute’\n• Percentage of components with acute or chronic toxicity data: apply additivity formulas (see 4.1.3.5.2) and convert the derived L(E)C50 or EqNOECm to the appropriate ‘Acute’ or ‘Chronic’ category\nCLASSIFY\nfor acute/long-term aquatic hazard\nNo\nUse available hazard data of known components\nApply summation method and/or additivity formula (see 4.1.3.5) and apply 4.1.3.6\nCLASSIFY\nfor acute/long-term aquatic hazard\n\n\n4.1.3.3. Classification of mixtures when toxicity data are available for the complete mixture\n4.1.3.3.1.\nWhen the mixture as a whole has been tested to determine its aquatic toxicity, this information can be used for classifying the mixture according to the criteria that have been agreed for substances. The classification is normally based on the data for fish, crustacea and algae/plants (see sections 4.1.2.7.1 and 4.1.2.7.2). When adequate acute or chronic toxicity data for the mixture as a whole are lacking, bridging principles or summation method should be applied (see sections 4.1.3.4 and 4.1.3.5).\n\n4.1.3.3.2.\nThe long-term hazard classification of mixtures requires additional information on degradability and in certain cases bioaccumulation. Degradability and bioaccumulation tests for mixtures are not used as they are usually difficult to interpret, and such tests may be meaningful only for single substances.\n\n\n4.1.3.3.3. Classification for category Acute 1\n\n(a) When there are adequate acute toxicity test data (LC50 or EC50) available for the mixture as a whole showing L(E)C50 ≤ 1 mg/l:\nClassify mixture as Acute 1 in accordance with point (a) of Table 4.1.0.\n\n(b) When there are acute toxicity test data (LC50(s) or EC50(s)) available for the mixture as a whole showing L(E)C50(s) > 1 mg/l for normally all trophic levels:\nNo need to classify for acute hazard.\n\n\n4.1.3.3.4. Classification for categories Chronic 1, 2 and 3\n\n(a) When there are adequate chronic toxicity data (ECxx or NOEC) available for the mixture as a whole showing ECx or NOEC of the tested mixture ≤ 1mg/l:\n\n(i) Classify the mixture as Chronic 1, 2 or 3 in accordance with point (b)(ii) of Table 4.1.0 as rapidly degradable if the available information allows the conclusion that all relevant components of the mixture are rapidly degradable;\n\n(ii) Classify the mixture as Chronic 1 or 2 in all other cases in accordance with point (b)(i) of Table 4.1.0 as non-rapidly degradable;\n\n(b) When there are adequate chronic toxicity data (ECx or NOEC) available for the mixture as a whole showing ECx(s) or NOEC(s) of the tested mixture > 1 mg/l for normally all trophic levels:\nNo need to classify for long-term hazard in categories Chronic 1, 2 or 3.\n\n\n4.1.3.3.5. Classification for category Chronic 4\nIf there are nevertheless reasons for concern:\nClassify the mixture as Chronic 4 (safety net classification) in accordance with Table 4.1.0.\n\n\n4.1.3.4. Classification of mixtures when toxicity data are not available for the complete mixture: bridging principles\n4.1.3.4.1.\nWhere the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, sections 4.1.3.4.2 and 4.1.3.4.3 shall be used.\n4.1.3.4.2.\nDilution: if a mixture is formed by diluting another tested mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the resulting mixture may be classified as equivalent to the original tested mixture or substance. Alternatively, the method explained in section 4.1.3.5 may be applied.\n4.1.3.4.3.\nIf a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance.\n\n\n4.1.3.5. Classification of mixtures when toxicity data are available for some or all components of the mixture\n4.1.3.5.1.\nThe classification of a mixture is based on summation of the concentration of its classified components. The percentage of components classified as Acute or Chronic is fed straight in to the summation method. Details of the summation method are described in section 4.1.3.5.5.\n4.1.3.5.2.\nMixtures can be made of a combination of both components that are classified (as Acute 1 and/or Chronic 1, 2, 3, 4) and others for which adequate toxicity test data is available. When adequate toxicity data are available for more than one component in the mixture, the combined toxicity of those components is calculated using the following additivity formulas (a) or (b), depending on the nature of the toxicity data:\n\n(a) Based on acute aquatic toxicity:\nΣCiLEC50m = ΣnCiLEC50i\nwhere:\n\nCi\nconcentration of component i (weight percentage);\nL(E)C50i\n(mg/l) LC50 or EC50 for component i;\nη\nnumber of components, and i is running from 1 to n;\nL(E)C50m\nL(E) C50 of the part of the mixture with test data.\nThe calculated toxicity may be used to assign that portion of the mixture an acute hazard category which is then subsequently used in applying the summation method;\n\n(b) Based on chronic aquatic toxicity:\nΣ Ci +Σ CjEqNOECm = ΣnCiNOECi + ΣnCj0,1 × NOECj\nwhere:\n\nCi\nconcentration of component i (weight percentage) covering the rapidly degradable components;\nCj\nconcentration of component j (weight percentage) covering the non- rapidly degradable components;\nNOECi\nNOEC (or other recognised measures for chronic toxicity) for component i covering the rapidly degradable components, in mg/l;\nNOECj\nNOEC (or other recognised measures for chronic toxicity) for component j covering the non-rapidly degradable components, in mg/l;\nn\nnumber of components, and i and j are running from 1 to n;\nEqNOECm\nEquivalent NOEC of the part of the mixture with test data.\n\nThe equivalent toxicity thus reflects the fact that non-rapidly degrading substances are classified one hazard category level more severe than rapidly degrading substances.\nThe calculated equivalent toxicity may be used to assign that portion of the mixture a long-term hazard category, in accordance with the criteria for rapidly degradable substances (point (b)(ii) of Table 4.1.0), which is then subsequently used in applying the summation method.\n4.1.3.5.3.\nWhen applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, crustacean, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute and chronic toxicity is then used to assess whether this part of the mixture shall be classified as Acute 1 and/or Chronic 1, 2 or 3 using the same criteria described for substances.\n4.1.3.5.4.\nIf a mixture is classified in more than one way, the method yielding the more conservative result shall be used.\n\n\n4.1.3.5.5. Summation method\n\n\n4.1.3.5.5.1. Rationale\n4.1.3.5.5.1.1.\nIn case of the substance classification categories Chronic 1 to Chronic 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of any substance classified as Chronic 1, 2 or 3.\n4.1.3.5.5.1.2.\nWhen a mixture contains components classified as Acute 1 or Chronic 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l and/or chronic toxicity is below 0,1 mg/l (if non rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an under-classification of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in section 4.1.3.5.5.5.\n\n\n4.1.3.5.5.2. Classification procedure\n4.1.3.5.5.2.1.\nIn general a more severe classification for mixtures overrides a less severe classification, e.g. a classification with Chronic 1 overrides a classification with Chronic 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic 1. A more severe classification than Chronic 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.\n\n\n\n4.1.3.5.5.3. Classification for category Acute 1\n4.1.3.5.5.3.1.\nFirst all components classified as Acute 1 are considered. If the sum of the concentrations (in %) of these components multiplied by their corresponding M-factors is greater than 25 % the whole mixture is classified as Acute 1.\n4.1.3.5.5.3.2.\nThe classification of mixtures for acute hazards based on this summation of classified components is summarised in Table 4.1.1.\n\nTable 4.1.1\nClassification of a mixture for acute hazards, based on summation of classified components\n\nFor explanation of the M-factor, see 4.1.3.5.5.5.\n\nSum of components classified as:\nMixture is classified as:\nAcute 1 × M ≥ 25 %\nAcute 1\n\n\n4.1.3.5.5.4. Classification for the categories Chronic 1, 2, 3 and 4\n4.1.3.5.5.4.1.\nFirst all components classified as Chronic 1 are considered. If the sum of the concentrations (in %) of these components multiplied by their corresponding M-factors is equal to or greater than 25 %, the mixture is classified as Chronic 1. If the result of the calculation is a classification of the mixture as Chronic 1, the classification procedure is completed.\n4.1.3.5.5.4.2.\nIn cases where the mixture is not classified as Chronic 1, classification of the mixture as Chronic 2 is considered. A mixture is classified as Chronic 2 if 10 times the sum of the concentrations (in %) of all components classified as Chronic 1 multiplied by their corresponding M-factors plus the sum of the concentrations (in %) of all components classified as Chronic 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic 2, the classification process is completed.\n4.1.3.5.5.4.3.\nIn cases where the mixture is not classified either as Chronic 1 or Chronic 2, classification of the mixture as Chronic 3 is considered. A mixture is classified as Chronic 3 if 100 times the sum of the concentrations (in %) of all components classified as Chronic 1 multiplied by their corresponding M-factors plus 10 times the sum of the concentrations (in %) of all components classified with Chronic 2 plus the sum of the concentrations (in %) of all components classified as Chronic 3 is ≥ 25 %.\n4.1.3.5.5.4.4.\nIf the mixture is still not classified in Chronic 1, 2 or 3, classification of the mixture as Chronic 4 shall be considered. A mixture is classified as Chronic 4 if the sum of the concentrations (in %) of components classified as Chronic 1, 2, 3 and 4 is equal to or greater than 25 %.\n4.1.3.5.5.4.5.\nThe classification of mixtures for long-term hazards, based on this summation of the concentrations of classified components, is summarised in Table 4.1.2.\n\n\nTable 4.1.2\nClassification of a mixture for long-term hazards, based on summation of the concentrations of classified components\n\nFor explanation of the M-factor, see 4.1.3.5.5.5.\n\nSum of components classified as:\nMixture is classified as:\nChronic 1 × M ≥ 25 %\nChronic 1\n(M × 10 × Chronic 1) + Chronic 2 ≥ 25 %\nChronic 2\n(M × 100 × Chronic 1) + (10 × Chronic 2) + Chronic 3 ≥ 25 %\nChronic 3\nChronic 1 + Chronic 2 + Chronic 3 + Chronic 4 ≥ 25 %\nChronic 4\n\n\n4.1.3.5.5.5. Mixtures with highly toxic components\n4.1.3.5.5.5.1.\nAcute 1 and Chronic 1 components with toxicities below 1 mg/l and/or chronic toxicities below 0,1 mg/l (if non-rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach. When a mixture contains components classified as Acute or Chronic 1, one of the following shall be applied:\n\nthe tiered approach described in sections 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute 1 and Chronic 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of Acute 1 in the left column of Table 4.1.1 and the concentration of Chronic 1 in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method,\nthe additivity formula (see section 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute and/or chronic toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.\n\nTable 4.1.3\nMultiplying factors for highly toxic components of mixtures\n\nNon-rapidly degradable.\nRapidly degradable.\n\nAcute toxicity\nM factor\nChronic toxicity\nM factor\nL(E)C50 value mg/l\n\nNOEC value mg/l\nNRD components\nRD components\n0,1 < L(E)C50 ≤ 1\n1\n0,01 < NOEC ≤ 0,1\n1\n—\n0,01 < L(E)C50 ≤ 0,1\n10\n0,001 < NOEC ≤ 0,01\n10\n1\n0,001 < L(E)C50 ≤ 0,01\n100\n0,0001 < NOEC ≤ 0,001\n100\n10\n0,0001 < L(E)C50 ≤ 0,001\n1000\n0,00001 < NOEC ≤ 0,0001\n1000\n100\n0,00001 < L(E)C50 ≤ 0,0001\n10000\n0,000001 < NOEC ≤ 0,00001\n10000\n1000\n(continue in factor 10 intervals)\n(continue in factor 10 intervals)\n\n\n4.1.3.6. Classification of mixtures with components without any useable information\n4.1.3.6.1.\nIn the event that no useable information on acute and/or long-term aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that: Contains x % of components with unknown hazards to the aquatic environment.\n\n\n4.1.4. Hazard communication\n4.1.4.1.\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 4.1.4.\n\nTable 4.1.4\nLabel elements for hazardous to the aquatic environment\n\nACUTE AQUATIC HAZARD\n\nAcute 1\nGHS pictogram\n\nSignal word\nWarning\nHazard statement\nH400: Very toxic to aquatic life\nPrecautionary statement prevention\nP273\nPrecautionary statement response\nP391\nPrecautionary statement storage\n\nPrecautionary statement disposal\nP501\n\n\nLONG-TERM AQUATIC HAZARD\n\nChronic 1\nChronic 2\nChronic 3\nChronic 4\nGHS pictograms\n\n\nNo pictogram is used\nNo pictogram is used\nSignal word\nWarning\nNo signal word is used\nNo signal word is used\nNo signal word is used\nHazard statement\nH410: Very toxic to aquatic life with long lasting effects\nH411: Toxic to aquatic life with long lasting effects\nH412: Harmful to aquatic life with long lasting effects\nH413: May cause long lasting harmful effects to aquatic life\nPrecautionary statement prevention\nP273\nP273\nP273\nP273\nPrecautionary statement response\nP391\nP391\n\n\nPrecautionary statement storage\n\n\n\n\nPrecautionary statement disposal\nP501\nP501\nP501\nP501\n\n\n\n\n\n5. PART 5: ADDITIONAL HAZARDS\n\n\n5.1. Hazardous to the ozone layer\n\n\n5.1.1. Definitions and general considerations\n5.1.1.1.\nOzone depleting potential (ODP) is an integrative quantity, distinct for each halocarbon source species, that represents the extent of ozone depletion in the stratosphere expected from the halocarbon on a mass-for-mass basis relative to CFC-11. The formal definition of ODP is the ratio of integrated perturbations to total ozone, for a differential mass emission of a particular compound relative to an equal emission of CFC-11.\nSubstance hazardous to the ozone layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 1005/2009 of the European Parliament and of the Council of 16 September 2009 on substances that deplete the ozone layerOJ L 286, 31.10.2009, p. 1..\n\n\n5.1.2. Classification criteria for substances\n5.1.2.1.\nA substance shall be classified as hazardous to the ozone layer (Category 1) if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.\n\n\n5.1.3. Classification criteria for mixtures\n5.1.3.1.\nMixtures shall be classified as hazardous to the ozone layer (Category 1) on the basis of the individual concentration of the substance(s) contained therein that are also classified as hazardous to the ozone layer (Category 1), in accordance with Table 5.1.\n\nTable 5.1\nGeneric concentration limits for substances (in a mixture), classified as hazardous to the ozone layer (Category 1), that trigger classification of the mixture as hazardous to the ozone layer (Category 1)\n\nClassification of the substance\nClassification of the mixture\nHazardous to the ozone layer (Category 1)\nC ≥ 0,1 %\n\n\n5.1.4. Hazard communication\n5.1.4.1.\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 5.2.\n\nTable 5.2\nLabel elements for hazardous to the ozone layer\n\nSymbol/pictogram\n\nSignal word\nWarning\nHazard statement\nH420: Harms public health and the environment by destroying ozone in the upper atmosphere\nPrecautionary statements\nP502\n", "after": "\nANNEX I\nCLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES\nThis annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.\n\n\n1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND LABELLING\n\n\n1.0. Definitions\nGas means a substance which:\n\n(i) at 50 oC has a vapour pressure greater than 300 kPa (absolute); or\n\n(ii) is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;\nLiquid means a substance or mixture which:\n\n(i) at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);\n\n(ii) is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and\n\n(iii) which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;\nSolid means a substance or mixture which does not meet the definitions of liquid or gas.\n\n\n1.1. Classification of substances and mixtures\n\n\n1.1.0. Cooperation to meet the requirements in this Regulation\nSuppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.\nSuppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.\nSuppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.\nThe network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.\n\n\n1.1.1. The role and application of expert judgement and weight of evidence determination\n1.1.1.1. Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.\n\n1.1.1.2. The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.\n1.1.1.3. A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.\n1.1.1.4. For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.\n1.1.1.5. For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.\n\n\n1.1.2. Specific concentration limits, M-factors and generic cut-off values\n1.1.2.1. Specific concentration limits or M-factors shall be applied in accordance with Article 10.\n\n\n1.1.2.2. Cut-off values\n1.1.2.2.1. Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).\n\n1.1.2.2.2. The cut-off values referred to in Article 11 shall be the following:\n\n(a) For health and environmental hazards in Parts 3, 4 and 5 of this Annex:\n\n(i) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or\n\n(ii) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or\n\n(iii) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or\n\n(iv) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.\n\n(b) For aquatic environmental hazards in section 4.1 of this Annex:\n\n(i) for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or\n\n(ii) for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.\n\nTable 1.1\nGeneric cut-off values\n\nOr < 1 % where relevant, see 3.2.3.3.1.\nOr < 1 % where relevant, see 3.3.3.3.1.\nOr < 0,1 % where relevant, see 4.1.3.1.\n\nHazard class\nGeneric cut-off values to be taken into account\nAcute Toxicity:\n\n\nCategory 1-3\n0,1 %\n\nCategory 4\n1 %\nSkin corrosion/Irritation\n1 %\nSerious damage to eyes/eye irritation\n1 %\nHazardous to Aquatic Environment\n\n\nAcute Category 1\n0,1 %\n\nChronic Category 1\n0,1 %\n\nChronic Category 2-4\n1 %\n\n\nNote:\nGeneric cut-off values are in weight percentages except for gaseous mixtures for those hazard classes where the generic cut-off values may be best described in volume percentages.\n\n\n\n1.1.3. Bridging principles for the classification of mixtures where test data are not available for the complete mixture\nWhere the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.\n\n\n1.1.3.1. Dilution\nIf a tested mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:\n\nthe new mixture shall be classified as equivalent to the original mixture;\nthe method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;\nin the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).\n\n\n\n1.1.3.2. Batching\nThe hazard category of a tested production batch of a mixture can be assumed to be substantially equivalent to that of another untested production batch of the same commercial product, when produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the untested batch has changed. If the latter occurs, a new evaluation is necessary.\n\n\n\n1.1.3.3. Concentration of highly hazardous mixtures\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a tested mixture is classified in the highest hazard category or sub-category, and the concentration of the components of the tested mixture that are in that category or sub-category is increased, the resulting untested mixture shall be classified in that category or sub-category without additional testing.\n\n\n1.1.3.4. Interpolation within one toxicity category\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures (A, B and C) with identical components, where mixtures A and B have been tested and are in the same hazard category, and where untested mixture C has the same hazardous components as mixture A and B but has concentrations of those hazardous components intermediate to the concentrations in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.\n\n\n\n1.1.3.5. Substantially similar mixtures\nGiven the following:\n\n(a) two mixtures each containing two ingredients:\n\n(i) A + B\n\n(ii) C + B;\n\n(b) the concentration of ingredient B is essentially the same in both mixtures;\n\n(c) the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);\n\n(d) hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.\n\nIf mixture (i) or (ii) is already classified based on test data, then the other mixture shall be assigned the same hazard category.\n\n\n\n1.1.3.6. Review of classification where the composition of a mixture has changed\nThe following variations in initial concentration are defined for the application of Article 15(2)(a):\n\nTable 1.2\nBridging Principle for changes in the composition of a mixture\n\nInitial concentration range of the constituent\nPermitted variation in initial concentration of the constituent\n≤ 2,5 %\n± 30 %\n2,5 < C ≤ 10 %\n± 20 %\n10 < C ≤ 25 %\n± 10 %\n25 < C ≤ 100 %\n± 5 %\n\n\n\n1.1.3.7. Aerosols\nIn the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.\n\n\n\n1.2. Labelling\n\n\n1.2.1. General rules for the application of labels required by Article 31\n1.2.1.1.\nHazard pictograms shall be in the shape of a square set at a point.\n1.2.1.2.\nHazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.\n1.2.1.3.\nEach hazard pictogram shall cover at least one fifteenth of the minimum surface area of the label dedicated to the information required by Article 17. The minimum area of each hazard pictogram shall not be less than 1 cm2.\n1.2.1.4.\nThe dimensions of the label and of each pictogram shall be as follows:\n\nTable 1.3\nMinimum dimensions of labels and pictograms\n\nCapacity of the package\nDimensions of the label (in millimetres) for the information required by Article 17\nDimensions of each pictogram (in millimetres)\nNot exceeding 3 litres:\nIf possible, at least 52 × 74\nNot smaller than 10 × 10\nIf possible, at least 16 × 16\nGreater than 3 litres but not exceeding 50 litres:\nAt least 74 × 105\nAt least 23 × 23\nGreater than 50 litres but not exceeding 500 litres:\nAt least 105 × 148\nAt least 32 × 32\nGreater than 500 litres:\nAt least 148 × 210\nAt least 46 × 46\n\n\n\n1.3. Derogations from labelling requirements for special cases\nIn accordance with Article 23 the following derogations shall apply:\n\n\n1.3.1. Transportable gas cylinders\nFor transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:\n\n(a) A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to Gas cylinders — Precautionary labels. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.\n\n\n(b) The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.\n\n\n1.3.2. Gas containers intended for propane, butane or liquefied petroleum gas (LPG)\n1.3.2.1. If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.\n1.3.2.2. No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).\n1.3.2.3. For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.\n\n\n1.3.3. Aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard\nWith regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.\n\n\n1.3.4. Metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers\n1.3.4.1. Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.\n1.3.4.2. Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.\n\n\n1.3.5. Explosives placed on the market with a view to obtaining an explosive or pyrotechnic effect\nExplosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.\n\n\n1.4. Request for use of an alternative chemical name\n\n\n1.4.1. Requests for use of an alternative chemical name under Article 24 may be granted only where\n\n(I) the substance has not been assigned a Community workplace exposure limit; and\n\n\n(II) the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and\n\n(III) the substance is classified exclusively as one or more of the following hazard categories:\n\n(a) any of the hazard categories referred to in Part 2 of this Annex;\n\n(b) Acute toxicity, Category 4;\n\n(c) Skin corrosion/irritation, Category 2;\n\n(d) Serious eye damage/eye irritation, Category 2;\n\n(e) Specific target organ toxicity — Single exposure, Category 2 or 3;\n\n(f) Specific target organ toxicity — Repeated exposure, Category 2;\n\n(g) Hazardous to the aquatic environment — Chronic, Category 3 or 4.\n\n\n1.4.2. The choice of the chemical name(s) for mixtures intended for the fragrance or perfume industry\nIn the case of substances occurring in nature, a chemical name or chemical names of the type essential oil of … or extract of … may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).\n\n\n1.5. Exemptions from labelling and packaging requirements\n\n\n1.5.1. Exemptions from Article 31 [(Article 29(1))]\n1.5.1.1. Where Article 29(1) applies, the label elements mentioned in Article 17 may be provided in one of the following ways:\n\n(a) in fold-out labels; or\n\n(b) on tie-on tags; or\n\n(c) on an outer packaging.\n1.5.1.2. The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.\n\n\n1.5.2. Exemptions from Article 17 [(Article 29(2)]\n\n\n1.5.2.1. Labelling of packages where the contents do not exceed 125 ml\n1.5.2.1.1. The hazard statements and the precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Oxidising gases of category 1;\n\n2) Gases under pressure;\n\n3) Flammable liquids of category 2 or 3;\n\n4) Flammable solids of category 1 or 2;\n\n\n5) Self-reactive substances or mixtures Types C to F;\n\n6) Self-heating substances or mixtures of category 2;\n\n7) Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;\n\n8) Oxidising liquids of category 2 or 3;\n\n9) Oxidising solids of category 2 or 3;\n\n10) Organic peroxides Types C to F;\n\n11) Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;\n\n12) Skin irritation of category 2;\n\n13) Eye irritation of category 2;\n\n14) Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;\n\n15) Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;\n\n16) Hazardous to the aquatic environment — Acute of category 1;\n\n17) Hazardous to the aquatic environment — Chronic of category 1 or 2.\nThe exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.\n1.5.2.1.2. The precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Flammable gases of category 2;\n\n2) Reproductive toxicity: effects on or via lactation;\n\n3) Hazardous to the aquatic environment — Chronic of category 3 or 4.\n1.5.2.1.3. The pictogram, the signal word, the hazard statement, and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:\n\n(a) the contents of the package do not exceed 125 ml; and\n\n(b) the substance or mixture is classified in one or more of the following hazard categories:\n\n1) Corrosive to metals.\n\n\n1.5.2.2. Labelling of soluble packaging for single use\nThe label elements required by Article 17 may be omitted from soluble packaging intended for single use where:\n\n(a) The content of each soluble packaging does not exceed a volume of 25 ml;\n\n\n(b) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b), 1.5.2.1.2 (b) or 1.5.2.1.3 (b); and\n\n\n(c) The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.\n1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.\n\n\n\n2. PART 2: PHYSICAL HAZARDS\n\n\n2.1. Explosives\n\n\n2.1.1. Definitions\n2.1.1.1. The class of explosives comprises\n\n(a) explosive substances and mixtures;\n\n(b) explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and\n\n(c) substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n2.1.1.2. For the purposes of this Regulation the following definitions shall apply:\nAn explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.\nA pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.\nAn unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.\nAn explosive article is an article containing one or more explosive substances or mixtures.\nA pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.\nAn intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n\n\n2.1.2. Classification criteria\n2.1.2.1. Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.\n2.1.2.2. Substances, mixtures and articles of this class, which are not classified as an unstable explosive, shall be assigned to one of the following six divisions depending on the type of hazard they present:\n\n(a) Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);\n\n(b) Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;\n\n(c) Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:\n\n(i) combustion of which gives rise to considerable radiant heat; or\n\n\n(ii) which burn one after another, producing minor blast or projection effects or both;\n\n(d) Division 1.4 Substances, mixtures and articles which present no significant hazard:\n\nsubstances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;\n\n(e) Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:\n\nsubstances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;\n\n(f) Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:\n\narticles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.\n2.1.2.3. Explosives, which are not classified as an unstable explosive, shall be classified in one of the six divisions referred to in paragraph 2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to the results of the tests laid down in Table 2.1.1:\n\nTable 2.1.1\nCriteria for explosives\n\nThis comprises substances, mixtures and articles which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.\n\nCategory\nCriteria\nUnstable explosives or explosives of Divisions 1.1 to 1.6\nFor explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:\nExplosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives shall not be subject to UN Test Series 2.\nSensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\nThermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\nFurther tests are necessary to allocate the correct Division.\n\n2.1.2.4. If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.\n\n\n2.1.3. Hazard Communication\nLabel elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.\nNOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:\n\n(a) the pictogram: exploding bomb;\n\n(b) the signal word: Danger; and\n\n(c) the hazard statement: explosive; mass explosion hazard\nunless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.\n\n\nTable 2.1.2\nLabel elements for explosives\n\nClassification\nUnstable Explosive\nDivision 1.1\nDivision 1.2\nDivision 1.3\nDivision 1.4\nDivision 1.5\nDivision 1.6\nGHS Pictograms\n\n\n\n\n\n\n\nSignal Word\nDanger\nDanger\nDanger\nDanger\nWarning\nDanger\nNo signal word\nHazard Statement\nH200: Unstable Explosive\nH201: Explosive; mass explosion hazard\nH202: Explosive; severe projection hazard\nH203: Explosive; fire, blast or projection hazard\nH204: Fire or projection hazard\nH205: May mass explode in fire\nNo hazard statement\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP210\nP230\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nP210\nP240\nP250\nP280\nP210\nP230\nP240\nP250\nP280\nNo precautionary statement\nPrecautionary Statement\nResponse\nP372\nP373\nP380\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nP370+P380\nP372\nP373\nNo precautionary statement\nPrecautionary Statement\nStorage\nP401\nP401\nP401\nP401\nP401\nP401\nNo precautionary statement\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\nP501\nP501\nNo precautionary statement\n\n\n\n2.1.4. Additional Classification Considerations\n2.1.4.1. The classification of substances, mixtures and articles in the explosives hazard class and further allocation to a division is a very complex, three step procedure. Reference to Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria is necessary.\nThe first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE) is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.\nExplosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).\nCertain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.\nThe classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).\n\n\nFigure 2.1.1\nOverall scheme of the procedure for classifying a substance, mixture or article in the class of explosives (Class 1 for transport)\n\n\nSUBSTANCE, MIXTURE OR ARTICLE FOR CLASSIFICATION\nACCEPTANCE PROCEDURE\nCLASSIFY as an UNSTABLE EXPLOSIVE\nREJECT Not an EXPLOSIVE\nCLASSIFY AS AN EXPLOSIVE\nHAZARDOUS DIVISION ASSIGNMENT\nCOMPATIBILITY GROUP ASSIGNMENT\nDIVISION 1.1, 1.2, 1.3, 1.4, 1.5, OR 1.6 COMPATIBILITY GROUP A, B, C, D, E, F, G, H, J, K, L, N or S (*)\nCLASSIFICATION CODE (*)\n(*) see UN Recommendations on the Transport of Dangerous Goods, Model Regulations, 15th rev. ed, sub-section 2.1.2.\n\n\nFigure 2.1.2\nProcedure for provisional acceptance of a substance, mixture or article in the class of explosives (Class 1 for transport)\n\nSUBSTANCE/MIXTURE FOR CLASSIFICATION\nARTICLE FOR CLASSIFICATION\nIs the substance/ mixture manufactured with a view to producing a practical explosive or pyrotechnic effect\nYes\nSubstance/mixture to be considered for this Class\nNo\nTEST SERIES 3\nIs the substance/ mixture a candidate for ammonium nitrate emulsion suspension or gel, intermediate for blasting explosive ANE?\nIs the substance/mixture thermally stable?\nYes\nNo\nNo\nYes\nTEST SERIES 8 Go to figure 2.1.4\nTEST SERIES 1 (*)\nIs the substance/mixture too dangerous in the form in which it was tested?\nNo\nYes\nNo\nIs it an explosive substance/mixture?\nEncapsulate and/or package the substance/mixture\nYes\nTEST SERIES 2\nTEST SERIES 4\nYes\nIs the substance/mixture too insensitive for acceptance into this Class?\nNo\nIs the article, packed article or packaged substance/mixture too dangerous?\nNo\nYes\nNOT AN EXPLOSIVE\nCLASSIFY as an Unstable Explosive\nPROVISIONALLY ACCEPT INTO THIS CLASS (go to figure 2.1.3)\n(*) For classification purposes, start with Test Series 2.\n\n\n\nFigure 2.1.3\nProcedure for assignment to a division in the class of explosives (Class 1 for transport)\n\nARTICLE OR SUBSTANCE PROVISIONALLY ACCEPTED IN THIS CLASS (from 2.1.2)\nNo\nIs the article a candidate for Division 1.6?\nIs the substance a candidate for Division 1.5?\nNo\nPackage the substance\nTEST SERIES 6\nYes\nYes\nIs the result a mass explosion?\nYes\nTEST SERIES 7\nTEST SERIES 5\nNo\nIs it an extremely insensitive article?\nNo\nIs the major hazard that from dangerous projections?\nYes\nYes\nYes\nIs it a very insensitive explosive substance with a mass explosion hazard?\nNo\nNo\nNo\nIs the major hazard radiant heat and/or violent burning but with no dangerous blast or projection hazard?\nWould the hazard hinder fire-fighting in the immediate vicinity?\nYes\nYes\nNo\nNo\nAre there hazardous effects outside the package?\nNo\nIs the substance or article manufactured with the view of producing a practical explosive or pyrotechnic effect?\nYes\nYes\nYes\nIs the product an article excluded by definition? (see 2.1.12 (b))\nNo\nNOT AN EXPLOSIVE\nDIVISION 1.6\nDIVISION 1.5\nDIVISION 1.4 Compatibility group S\nDIVISION 1.4 Compatibility groups other than S\nDIVISION 1.3\nDIVISION 1.2\nDIVISION 1.1\n\n\n\n\nFigure 2.1.4\nProcedure for the classification of ammonium nitrate emulsion, suspension or gel (ANE)\n\nTEST SERIES 8\nTEST 8 (a) Thermal stability test. Is the substance/mixture thermally stable?\nNo\nClassify as unstable explosive\nYes\nTEST 8 (b) ANE Large scale gap test Is the substance/mixture too sensitive to shock to be accepted as an oxidising liquid or an oxidising solid?\nYes\nSubstance/mixture to be considered for classification as an explosive other than as an unstable explosive; If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘no’, the substance/mixture shall be classified in Division 1.1\nNo\nTEST 8 (c) Koenen test Is the substance/mixture too sensitive to the effect of intensive heat under confinement?\nYes\nSubstance/mixture to be considered for classification as an explosive of Division 1.5, proceed with Test Series 5. If the answer to the question ‘is it a very insensitive explosive substance/mixture with a mass explosion hazard?’ in figure 2.1.3 is ‘yes’, the substance/mixture shall be classified in Division 1.5; if the answer is ‘no’ the substance/mixture shall be classified in Division 1.1\nNo\nANE substance/mixture shall be classified as a Category 2 oxidising liquid or a Category 2 oxidising solid (sections 2.13 and 2.14)\n\n\n\n\n2.1.4.2. Screening procedure\nExplosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.\n\n\nNote:\nNeither a series 1 type (a) propagation of detonation test nor a series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g. For organic substances and mixtures of organic substances with a decomposition energy of 800 J/g or more, tests 1 (a) and 2 (a) need not be performed if the outcome of the ballistic mortar Mk.IIId test (F.1), or the ballistic mortar test (F.2) or the BAM Trauzl test (F.3) with initiation by a standard No 8 detonator (see Appendix 1 to the UN RTDG, Manual of Tests and Criteria) is no. In this case, the results of test 1 (a) and 2 (a) are deemed to be -.\n\n2.1.4.3. A substance or mixture shall not be classified as explosive if:\n\n(a) There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or\n\n(b) The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;\nThe oxygen balance is calculated for the chemical reaction:\nCxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O\nUsing the formula:\nOxygen balance = -1600 [2x + (y/2)-z]/molecular weight;\n\n(c) When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or\n\n(d) For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:\n\nless than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;\nless than 30 % by mass, if the oxidising substance is assigned to Category 3.\n\n2.1.4.4. In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.\n\n\n2.2. Flammable gases\n\n\n2.2.1. Definition\nFlammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.\n\n\n2.2.2. Classification criteria\n2.2.2.1. A flammable gas shall be classified in this class in accordance with Table 2.2.1:\n\nTable 2.2.1\nCriteria for flammable gases\n\nCategory\nCriteria\n1\nGases, which at 20 oC and a standard pressure of 101,3 kPa:\n\n(a) are ignitable when in a mixture of 13 % or less by volume in air; or\n\n(b) have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.\n2\nGases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.\n\nNote:\nAerosols shall not be classified as flammable gases; see section 2.3.\n\n\n2.2.3. Hazard Communication\nLabel elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.\n\nTable 2.2.2\nLabel elements for flammable gases\n\nClassification\nCategory 1\nCategory 2\nGHS Pictogram\n\nNo pictogram\nSignal Word\nDanger\nWarning\nHazard Statement\nH220: Extremely flammable gas\nH221: Flammable gas\nPrecautionary Statement\nPrevention\nP210\nP210\nPrecautionary Statement\nResponse\nP377\nP381\nP377\nP381\nPrecautionary Statement\nStorage\nP403\nP403\nPrecautionary Statement\nDisposal\n\n\n\n\n2.2.4. Additional Classification Considerations\n2.2.4.1. Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.\n\n\n2.3. Flammable aerosols\n\n\n2.3.1. Definitions\nAerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.\n\n\n2.3.2. Classification criteria\n2.3.2.1. Aerosols shall be considered for classification as flammable in accordance with 2.3.2.2 if they contain any component which is classified as flammable according to the criteria contained in this Part, i.e.:\n\nLiquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;\nFlammable gases (see 2.2);\nFlammable solids (see 2.7).\n\nNote 1:\nFlammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.\n\nNote 2:\nFlammable aerosols do not fall additionally within the scope of sections 2.2 (flammable gases), 2.6 (flammable liquids) or 2.7 (flammable solids).\n2.3.2.2. A flammable aerosol shall be classified in one of the two categories for this Class on the basis of its components, of its chemical heat of combustion and, if applicable, of the results of the foam test (for foam aerosols) and of the ignition distance test and enclosed space test (for spray aerosols) in accordance with Figure 2.3.1 and the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-sections 31.4, 31.5 and 31.6.\n\n\nFigure 2.3.1\n\nFigure 2.3.1(a) for flammable aerosols\n\nAEROSOL\nDoes it contain ≤ 1% flammable components and does it have a heat of combustion < 20 kJ/g?\nYES\nNOT CLASSIFIED\nNO\nDoes it contain ≥ 85% flammable components and does it have a heat of combustion ≥ 30 kJ/g?\nYES\nCategory 1\nNO\nDanger\nFor spray aerosols, go to decision logic 2.3.1 (b);\nFor foam aerosols, got to decision logic 2.3.1 (c).\n\n\nFigure 2.3.1(b) for spray aerosols\n\nSPRAY AEROSOL\nIn the ignition distance test, does ignition occur at a distance ≥ 75 cm?\nYES\nCategory 1\nNO\nDoes it have a heat of combustion < 20 kJ/g?\nNO\nCategory 2\nYES\nIn the ignition distance test, does ignition occur at a distance ≥ 15 cm?\nYES\nCategory 2\nNO\nIn the enclosed space ignition test; is:\na) the time equivalent ≤ 300 s/m3 or\nb) the deflagration density ≤ 300 g/m3?\nYES\nCategory 2\nNO\nNOT CLASSIFIED\nDanger\nWarning\nWarning\nWarning\n\n\nFigure 2.3.1(c) for foam aerosols\n\nFOAM AEROSOL\nIn the foam test, is: a) the flame height ≥ 20 cm and the flame duration ≥ 2 s; or b) the flame height ≥ 4 cm and the flame duration ≥ 7 s?\nYES\nCategory 1\nNO\nIn the foam test; is the flame height ≥ 4 cm and the flame duration ≥ 2 s?\nYES\nCategory 2\nNO\nNOT CLASSIFIED\nDanger\nWarning\n\n\nNote:\nAerosols not submitted to the flammability classification procedures in this section shall be classified as flammable aerosols, Category 1.\n\n\n\n2.3.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.\n\nTable 2.3.2\nLabel elements for flammable aerosols\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH222: Extremely flammable aerosol\nH223: Flammable aerosol\nPrecautionary Statement\nPrevention\nP210\nP211\nP251\nP210\nP211\nP251\nPrecautionary Statement\nResponse\n\n\nPrecautionary Statement\nStorage\nP410 + P412\nP410 + P412\nPrecautionary Statement\nDisposal\n\n\n\n\n2.3.4. Additional Classification Considerations\n2.3.4.1. The chemical heat of combustion (ΔHc), in kilojoules per gram (kJ/g), is the product of the theoretical heat of combustion (ΔHcomb), and a combustion efficiency, usually less than 1,0 (a typical combustion efficiency is 0,95 or 95 %).\nFor a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:\nΔHc product\n\nn\niwi %ΔHci\nwhere:\n\nΔHc\nchemical heat of combustion (kJ/g);\nwi %\nmass fraction of component i in the product;\nΔHc(i)\nspecific heat of combustion (kJ/g)of component i in the product.\nThe chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).\n\n\n2.4. Oxidising gases\n\n\n2.4.1. Definitions\nOxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.\n\n\n2.4.2. Classification criteria\n2.4.2.1. An oxidising gas shall be classified in a single category for this class in accordance with Table 2.4.1.:\n\nTable 2.4.1\nCriteria for oxidising gases\n\nCategory\nCriteria\n1\nAny gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.\n\nNote:\nGases which cause or contribute to the combustion of other material more than air does mean pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.\n\n\n2.4.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.\n\nTable 2.4.2\nLabel elements for oxidising gases\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH270: May cause or intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP220\nP244\nPrecautionary Statement\nResponse\nP370 + P376\nPrecautionary Statement\nStorage\nP403\nPrecautionary Statement\nDisposal\n\n\n\n2.4.4. Additional Classification Considerations\nTo classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.\n\n\n2.5. Gases under pressure\n\n\n2.5.1. Definition\n2.5.1.1. Gases under pressure are gases which are contained in a receptacle at a pressure of 200 kPa (gauge) or more, or which are liquefied or liquefied and refrigerated.\nThey comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.\n2.5.1.2. The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.\n\n\n\n2.5.2. Classification criteria\nGases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:\n\nTable 2.5.1\nCriteria for gases under pressure\n\nGroup\nCriteria\nCompressed gas\nA gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.\nLiquefied gas\nA gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:\n\n(i) high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and\n\n(ii) low pressure liquefied gas: a gas with a critical temperature above + 65 oC.\nRefrigerated liquefied gas\nA gas which when packaged is made partially liquid because of its low temperature.\nDissolved gas\nA gas which when packaged under pressure is dissolved in a liquid phase solvent.\n\n\n2.5.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.\n\nTable 2.5.2\nLabel elements for gases under pressure\n\nClassification\nCompressed gas\nLiquefied gas\nRefrigerated liquefied gas\nDissolved gas\nGHS Pictograms\n\n\n\n\nSignal Word\nWarning\nWarning\nWarning\nWarning\nHazard Statement\nH280: Contains gas under pressure; may explode if heated\nH280: Contains gas under pressure; may explode if heated\nH281: Contains refrigerated gas; may cause cryogenic burns or injury\nH280: Contains gas under pressure; may explode if heated\nPrecautionary Statement\nPrevention\n\n\nP282\n\nPrecautionary Statement\nResponse\n\n\nP336\nP315\n\nPrecautionary Statement\nStorage\nP410 + P403\nP410 + P403\nP403\nP410 + P403\nPrecautionary Statement\nDisposal\n\n\n\n\n\n\nNote:\nPictogram GHS04 is not required for gases under pressure where pictogram GHS02 or pictogram GHS06 appears.\n\n\n\n2.5.4. Additional Classification Considerations\nFor this group of gases, the following information is required to be known:\n\nthe vapour pressure at 50 oC;\nthe physical state at 20 oC at standard ambient pressure;\nthe critical temperature.\nData can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.\n\n\n2.6. Flammable liquids\n\n\n2.6.1. Definition\nFlammable liquid means a liquid having a flash point of not more than 60 oC.\n\n\n2.6.2. Classification criteria\n2.6.2.1. A flammable liquid shall be classified in one of the three categories for this class in accordance with Table 2.6.1:\n\nTable 2.6.1\nCriteria for flammable liquids\n\nFor the purpose of this Regulation gas oils, diesel and light heating oils having a flash point between ≥ 55 oC and ≤ 75 oC may be regarded as Category 3.\n\nCategory\nCriteria\n1\nFlash point < 23 oC and initial boiling point ≤ 35 oC\n2\nFlash point < 23 oC and initial boiling point > 35 oC\n3\nFlash point ≥ 23 oC and ≤ 60 oC\n\nNote:\nAerosols shall not be classified as flammable liquids; see section 2.3.\n\n\n\n2.6.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.\n\nTable 2.6.2\nLabel elements for flammable liquids\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH224: Extremely flammable liquid and vapour\nH225: Highly flammable liquid and vapour\nH226: Flammable liquid and vapour\nPrecautionary Statement\nPrevention\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nP210\nP233\nP240\nP241\nP242\nP243\nP280\nPrecautionary Statement\nResponse\nP303 + P361 + P353\nP370 + P378\nP303 + P361 + P353\nP370 + P378\nP303 + P361 + P353\nP370 + P378\nPrecautionary Statement\nStorage\nP403 + P235\nP403 + P235\nP403 + P235\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.6.4. Additional Classification Considerations\n2.6.4.1. For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.\n2.6.4.2. In the case of mixturesTo date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates. containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 °CIf the calculated flash point is less than 5 °C greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally. greater than the relevant classification criterion (23 °C and 60 °C, respectively) and provided that:\n\n\n(a) the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);\n\n(b) the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit of the mixture;\n\n(c) the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;\n\n(d) the liquid phase is homogeneous.\n2.6.4.3. One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.\n2.6.4.4. Possible test methods for determining the flash point of flammable liquids are listed in Table 2.6.3.\n\nTable 2.6.3\nMethods for determining the flash point of flammable liquids\n\nEuropean standards:\nEN ISO 1516 as amended\nDetermination of flash/no flash — Closed cup equilibrium method\nEN ISO 1523 as amended\nDetermination of flash point — Closed cup equilibrium method\nEN ISO 2719 as amended\nDetermination of flash point — Pensky-Martens closed cup method\nEN ISO 3679 as amended\nDetermination of flash point — Rapid equilibrium closed cup method\nEN ISO 3680 as amended\nDetermination of flash/no flash — Rapid equilibrium closed cup method\nEN ISO 13736 as amended\nPetroleum products and other liquids — Determination of flash point — Abel closed cup method\nNational standards:\nAssociation française de normalisation, AFNOR:\nNF M07-036 as amended\nDétermination du point d'éclair — Vase clos Abel-Pensky\n(identical to DIN 51755)\n\nBritish Standards Institute,\nBS 2000 Part 170 as amended\n(identical to EN ISO 13736)\n\nDeutsches Institut für Normung\nDIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky\n(identical to NF M07-036)\n\n2.6.4.5 Liquids with a flash point of more than 35 °C and not more than 60 °C need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN RTDG, Manual of Tests and Criteria.\n\n\n2.6.4.6. Possible test methods for determining the initial boiling point of flammable liquids are listed in Table 2.6.4.\n\nTable 2.6.4\nMethods for determining the initial boiling point of flammable liquids\n\nOJ L 142, 31.5.2008, p. 1.\n\nEuropean standards:\nEN ISO 3405 as amended\nPetroleum products — Determination of distillation characteristics at atmospheric pressure\nEN ISO 3924 as amended\nPetroleum products — Determination of boiling range distribution — Gas chromatography method\nEN ISO 4626 as amended\nVolatile organic liquids — Determination of boiling range of organic solvents used as raw materials\nRegulation (EC) No 440/2008\nMethod A.2 as described in Part A of the Annex to Regulation (EC) No 440/2008\n\n\n\n2.7. Flammable solids\n\n\n2.7.1. Definition\n2.7.1.1. A flammable solid means a solid which is readily combustible, or may cause or contribute to fire through friction.\nReadily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.\n\n\n2.7.2. Classification criteria\n2.7.2.1. Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.\n2.7.2.2. Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.\n2.7.2.3. A flammable solid shall be classified in one of the two categories for this class using Method N.1 as described in 33.2.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.7.1:\n\nTable 2.7.1\nCriteria for flammable solids\n\nCategory\nCriteria\n1\nBurning rate test\nSubstances and mixtures other than metal powders:\n\n(a) wetted zone does not stop fire and\n\n(b) burning time < 45 seconds or burning rate > 2,2 mm/s\nMetal powders\nburning time ≤ 5 minutes\n2\nBurning rate test\nSubstances and mixtures other than metal powders:\n\n(a) wetted zone stops the fire for at least 4 minutes and\n\n(b) burning time < 45 seconds or burning rate > 2,2 mm/s\nMetal powders\nburning time > 5 minutes and ≤ 10 minutes\n\n\nNote 1:\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\nNote 2:\nAerosols shall not be classified as flammable solids; see section 2.3.\n\n\n\n2.7.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.\n\n\nTable 2.7.2\nLabel elements for flammable solids\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH228: Flammable Solid\nH228: Flammable Solid\nPrecautionary Statement\nPrevention\nP210\nP240\nP241\nP280\nP210\nP240\nP241\nP280\nPrecautionary Statement\nResponse\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\nPrecautionary Statement\nDisposal\n\n\n\n\n2.8. Self-reactive substances and mixtures\n\n\n2.8.1. Definition\n2.8.1.1. Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.\n2.8.1.2. A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.\n\n\n2.8.2. Classification criteria\n2.8.2.1. Any self-reactive substance or mixture shall be considered for classification in this class as a self-reactive substance or mixture unless:\n\n(a) they are explosives, according to the criteria given in 2.1;\n\n(b) they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;\n\n(c) they are organic peroxides, according to the criteria given in 2.15;\n\n(d) their heat of decomposition is less than 300 J/g; or\n\n\n(e) their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3..\n2.8.2.2. Mixtures of oxidising substances, meeting the criteria for classification as oxidising substances, which contain 5 % or more of combustible organic substances and which do not meet the criteria mentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjected to the self-reactive substances classification procedure;\nSuch a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n2.8.2.3. Self-reactive substances and mixtures shall be classified in one of the seven categories of types A to G for this class, according to the following principles:\n\n(a) any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;\n\n(b) any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;\n\n(c) any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;\n\n(d) any self-reactive substance or mixture which in laboratory testing:\n\n(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or\n\n(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or\n\n(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;\nshall be defined as self-reactive substance TYPE D;\n\n(e) any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;\n\n(f) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;\n\n\n(g) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n\n\n2.8.2.4. Criteria for temperature control\nSelf-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.\n\n\n2.8.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.\n\nTable 2.8.1\nLabel elements for self-reactive substances and mixtures\n\nClassification\nType A\nType B\nType C & D\nType E & F\nType G\nGHS Pictograms\n\n\n\n\nThere are no label elements allocated to this hazard category\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement\nH240: Heating may cause an explosion\nH241: Heating may cause a fire or explosion\nH242: Heating may cause a fire\nH242: Heating may cause a fire\nPrecautionary Statement\nPrevention\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nPrecautionary Statement\nResponse\nP370 + P378\nP370 + P380 + P375\nP370 + P378\nP370 + P380 + P375\nP370 + P378\nP370 + P378\n\nPrecautionary Statement\nStorage\nP403 + P235\nP411\nP420\nP403 + P235\nP411\nP420\nP403 + P235\nP411\nP420\nP403 + P235 P411\nP420\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\n\nType G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.\n\n\n2.8.4. Additional Classification Considerations\n2.8.4.1. The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.\n2.8.4.2. The classification procedures for self-reactive substances and mixtures need not be applied if:\n\n(a) There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or\n\n(b) For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).\n\n\nFigure 2.8.1\nSelf-reactive substances and mixtures\n\n\nSUBSTANCE/MIXTURE\nBox 1\nTest A\nBox 2\nTest B\n1.1 Yes\nDoes it propogate a detonation?\n1.3 No\n2.1 Yes\nCan it detonate as packaged?\n2.2 No\n1.2 Partial\nBox 3\nTest C\nCan it propogate a deflagration?\n3.1 Yes, rapidly\nBox 4\nTest C\nCan it propogate a deflagration?\n4.1 Yes, rapidly\n3.2 Yes, slowly\n3.3 No\nBox 5\nTest C\nCan it propogate a deflagration?\n5.1 Yes, rapidly\n4.2 Yes, slowly\n4.3 No\nBox 6\nTest D\n5.3 No\n5.2 Yes,\nslowly\n6.2 No\nDoes it deflagrate rapidly in package?\n6.1 Yes\nBox 7\nTest E\nWhat is the effect of heating under confinement?\n7.1 Violent\nBox 8\nTest E\nWhat is the effect of heating under confinement?\n8.1 Violent\n7.2 Medium\n7.3 Low\n7.4 No\nBox 9\nTest E\nWhat is the effect of heating under confinement?\nBox 10\nTest G\n8.2 Medium\n8.3 Low\n8.4 No\n9.3 Low\n9.4 No\nBox 11\n10.2 No\nCan it explode as packaged?\n10.1 Yes\nPackaged in packages of more than 400 kg/450 l or to be considered for exemption?\n11.1 Yes\nBox F\nTest F\nWhat is its explosive power?\n12.3 None\nBox 13\nTest E\n12.1 No low\n12.2 Low\nWhat is effect of heating it under defined confinement?\n11.2 No\n13.1 Low\n13.2 None\nTYPE A\nTYPE B\nTYPE C\nTYPE D\nTYPE E\nTYPE F\nTYPE G\n9.1 violent\n9.2 Medium\n\n\n\n2.9. Pyrophoric liquids\n\n\n2.9.1. Definition\nPyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.\n\n\n2.9.2. Classification criteria\n2.9.2.1. A pyrophoric liquid shall be classified in a single category for this class using test N.3 in Part III, sub-section 33.3.1.5 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to Table 2.9.1:\n\nTable 2.9.1\nCriteria for pyrophoric liquids\n\nCategory\nCriteria\n1\nThe liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min.\n\n\n2.9.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.\n\nTable 2.9.2\nLabel elements for pyrophoric liquids\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH250: Catches fire spontaneously if exposed to air\nPrecautionary Statement\nPrevention\nP210\nP222\nP280\nPrecautionary Statement\nResponse\nP302 + P334\nP370 + P378\nPrecautionary Statement\nStorage\nP422\nPrecautionary Statement\nDisposal\n\n\n\n2.9.4. Additional Classification Considerations\n2.9.4.1. The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).\n\n\n\n2.10. Pyrophoric solids\n\n\n2.10.1. Definition\nPyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.\n\n\n2.10.2. Classification criteria\n2.10.2.1. A pyrophoric solid shall be classified in a single category for this class using test N.2 in Part III, sub-section 33.3.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.10.1:\n\nTable 2.10.1\nCriteria for pyrophoric solids\n\nCategory\nCriteria\n1\nThe solid ignites within 5 minutes of coming into contact with air.\n\nNote\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\n\n2.10.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.\n\nTable 2.10.2\nLabel elements for pyrophoric solids\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH250: Catches fire spontaneously if exposed to air\nPrecautionary Statement\nPrevention\nP210\nP222\nP280\nPrecautionary Statement\nResponse\nP335 + P334\nP370 +P378\nPrecautionary Statement\nStorage\nP422\nPrecautionary Statement\nDisposal\n\n\n\n\n2.10.4. Additional Classification Considerations\n2.10.4.1. The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).\n\n\n2.11. Self-heating substances and mixtures\n\n\n2.11.1. Definition\n2.11.1.1. A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).\n\n2.11.1.2. Self-heating of a substance or a mixture is a process where the gradual reaction of that substance or mixture with oxygen (in the air) generates heat. If the rate of heat production exceeds the rate of heat loss, then the temperature of the substance or mixture will rise which, after an induction time, may lead to self-ignition and combustion.\n\n\n\n2.11.2. Classification criteria\n2.11.2.1. A substance or mixture shall be classified as a self-heating substance or mixture of this class, if in the tests performed in accordance with the test method given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-section 33.3.1.6:\n\n(a) a positive result is obtained using a 25 mm cube sample at 140 oC;\n\n(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;\n\n(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;\n\n(d) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.\n2.11.2.2. A self-heating substance or mixture shall be classified in one of the two categories for this class if, in a test performed in accordance with test method N.4 in Part III, sub-section 33.3.1.6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, the result meets the criteria according to Table 2.11.1:\n\n\nTable 2.11.1\nCriteria for self-heating substances and mixtures\n\nCategory\nCriteria\n1\nA positive result is obtained in a test using a 25 mm sample cube at 140 oC\n2\n\n(a) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or\n\n(b) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or\n\n(c) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.\n\nNote\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n2.11.2.3. Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.\n2.11.2.4. Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.\n\n\n2.11.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.\n\nTable 2.11.2\nLabel elements for self-heating substances and mixtures\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH251: Self-heating; may catch fire\nH252: Self-heating in large quantities; may catch fire\nPrecautionary Statement\nPrevention\nP235 + P410\nP280\nP235 + P410\nP280\nPrecautionary Statement\nResponse\n\n\nPrecautionary Statement\nStorage\nP407\nP413\nP420\nP407\nP413\nP420\nPrecautionary Statement\nDisposal\n\n\n\n\n2.11.4. Additional Classification Considerations\n2.11.4.1. For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.\n2.11.4.2. The classification procedure for self-heating substances or mixtures need not be applied if the results of a screening test can be adequately correlated with the classification test and an appropriate safety margin is applied. Examples of screening tests are:\n\n(a) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;\n\n(b) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.\n\n\nFigure 2.11.1.\nSelf-heating substances and mixtures\n\nSUBSTANCE/MIXTURE\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 140°C?\nNO\nNOT CLASSIFIED\nYES\nDoes it undergo dangerous self-heating when tested in a 25 mm sample cube at 140°C?\nYES\nCategory 1\nDanger\nNO\nIs it packaged in more than 3 m3?\nYES\nCategory 2\nWarning\nNO\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 120°C?\nNO\nNOT CLASSIFIED\nYES\nIs it packaged in more than 450 litres volume?\nYES\nCategory 2\nWarning\nNO\nDoes it undergo dangerous self-heating when tested in a 100 mm sample cube at 100°C?\nYES\nCategory 2\nWarning\nNO\nNOT CLASSIFIED\n\n\n\n2.12. Substances and mixtures which in contact with water emit flammable gases\n\n\n2.12.1. Definition\nSubstances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.\n\n\n2.12.2. Classification criteria\n2.12.2.1. A substance or mixture which, in contact with water, emits flammable gases shall be classified in one of the three categories for this class, using test N.5 in Part III, sub-section 33.4.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.12.1:\n\nTable 2.12.1\nCriteria for substances or mixtures which in contact with water emit flammable gases\n\nCategory\nCriteria\n1\nAny substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.\n2\nAny substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.\n3\nAny substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.\n\nNote:\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form.\n2.12.2.2. A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.\n\n\n2.12.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.\n\n\nTable 2.12.2\nLabel elements for substances or mixtures which in contact with water emit flammable gases\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH260: In contact with water releases flammable gases which may ignite spontaneously\nH261: In contact with water releases flammable gases\nH261: In contact with water releases flammable gases\nPrecautionary Statement\nPrevention\nP223\nP231 + P232\nP280\nP223\nP231 + P232\nP280\nP231 + P232\nP280\nPrecautionary Statement\nResponse\nP335 + P334\nP370 + P378\nP335 + P334\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\nP402 + P404\nP402 + P404\nP402 + P404\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.12.4. Additional Classification Considerations\n2.12.4.1. The classification procedure for this class need not be applied if:\n\n(a) the chemical structure of the substance or mixture does not contain metals or metalloids; or\n\n(b) experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or\n\n(c) the substance or mixture is known to be soluble in water to form a stable mixture.\n\n\n2.13. Oxidising liquids\n\n\n2.13.1. Definition\nOxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.\n\n\n2.13.2. Classification criteria\n2.13.2.1. An oxidising liquid shall be classified in one of the three categories for this class using test O.2 in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.13.1:\n\n\nTable 2.13.1\nCriteria for oxidising liquids\n\nCategory\nCriteria\n1\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.\n2\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.\n3\nAny substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met.\n\n\n2.13.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.\n\nTable 2.13.2\nLabel elements for oxidising liquids\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH271:May cause fire or explosion; strong oxidiser\nH272: May intensify fire; oxidiser\nH272: May intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP210\nP220\nP221\nP280\nP283\nP210\nP220\nP221\nP280\nP210\nP220\nP221\nP280\nPrecautionary Statement\nResponse\nP306 + P360\nP371 + P380 + P375\nP370 + P378\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.13.4. Additional Classification Considerations\n2.13.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:\n\n(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or\n\n(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.\n2.13.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.\n2.13.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.\n2.13.4.4. In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.\n\n\n2.14. Oxidising solids\n\n\n2.14.1. Definition\nOxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.\n\n\n2.14.2. Classification criteria\n2.14.2.1. An oxidising solid shall be classified in one of the three categories for this class using test O.1 in Part III, sub-section 34.4.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.14.1:\n\nTable 2.14.1\nCriteria for oxidising solids\n\nCategory\nCriteria\n1\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.\n2\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.\n\n3\nAny substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.\n\nNote 1\nSome oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the Resistance to detonation test (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.\n\nNote 2\nThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.\n\n\n2.14.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.\n\nTable 2.14.2\nLabel elements for oxidising solids\n\n\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nDanger\nWarning\nHazard Statement\nH271: May cause fire or explosion; strong oxidiser\nH272: May intensify fire; oxidiser\nH272: May intensify fire; oxidiser\nPrecautionary Statement\nPrevention\nP210\nP220\nP221\nP280\nP283\nP210\nP220\nP221\nP280\nP210\nP220\nP221\nP280\nPrecautionary Statement\nResponse\nP306 + P360\nP371 + P380 + P375\nP370 + P378\nP370 + P378\nP370 + P378\nPrecautionary Statement\nStorage\n\n\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\n\n\n2.14.4. Additional Classification Considerations\n2.14.4.1. For organic substances or mixtures the classification procedure for this class shall not apply if:\n\n(a) the substance or mixture does not contain oxygen, fluorine or chlorine; or\n\n(b) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.\n2.14.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.\n2.14.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.\n\n\n2.15. Organic peroxides\n\n\n2.15.1. Definition\n2.15.1.1. Organic peroxides means liquid or solid organic substances which contain the bivalent -O-O- structure and may be considered derivatives of hydrogen peroxide, where one or both of the hydrogen atoms have been replaced by organic radicals. The term organic peroxide includes organic peroxide mixtures (formulations) containing at least one organic peroxide. Organic peroxides are thermally unstable substances or mixtures, which can undergo exothermic self-accelerating decomposition. In addition, they can have one or more of the following properties:\n\n(i) be liable to explosive decomposition;\n\n(ii) burn rapidly;\n\n(iii) be sensitive to impact or friction;\n\n(iv) react dangerously with other substances.\n2.15.1.2. An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.\n\n\n2.15.2. Classification criteria\n2.15.2.1. Any organic peroxide shall be considered for classification in this class, unless it contains:\n\n(a) not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or\n\n(b) not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.\n\nNote\nThe available oxygen content ( %) of an organic peroxide mixture is given by the formula:\n16n\nininjmi\nwhere:\n\nni\nnumber of peroxygen groups per molecule of organic peroxide i;\nci\nconcentration (mass %) of organic peroxide i;\nmi\nmolecular mass of organic peroxide i.\n2.15.2.2. Organic peroxides shall be classified in one of the seven categories of Types A to G for this class, according to the following principles:\n\n(a) any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;\n\n(b) any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;\n\n(c) any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;\n\n(d) any organic peroxide which in laboratory testing:\n\n(i) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or\n\n(ii) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or\n\n(iii) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;\nshall be defined as organic peroxide TYPE D;\n\n(e) any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;\n\n(f) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;\n\n(g) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg packageSee UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3., and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.\n\nWhere the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.\n\n\n2.15.2.3. Criteria for temperature control\nThe following organic peroxides need to be subjected to temperature control:\n\n(a) Organic peroxide types B and C with an SADT ≤ 50 C;\n\n(b) Organic peroxide type D showing a medium effect when heated under confinementAs determined by test series E as prescribed in UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II. with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and\n\n(c) Organic peroxide types E and F with an SADT ≤ 45 oC.\nTest methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.\n\n\n2.15.3. Hazard Communication\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.\n\nTable 2.15.1\nLabel elements for organic peroxides\n\nClassification\nType A\nType B\nType C & D\nType E & F\nType G\nGHS Pictograms\n\n\n\n\nThere are no label elements allocated to this hazard category\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement\nH240: Heating may cause an explosion\nH241: Heating may cause a fire or explosion\nH242: Heating may cause a fire\nH242: Heating may cause a fire\nPrecautionary Statement\nPrevention\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nP210\nP220\nP234\nP280\nPrecautionary Statement\nResponse\n\n\n\n\n\nPrecautionary Statement\nStorage\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\nP411 + P235\nP410\nP420\n\nPrecautionary Statement\nDisposal\nP501\nP501\nP501\nP501\n\nType G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.\n\n\n2.15.4. Additional Classification Considerations\n2.15.4.1. Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.\n2.15.4.2. Mixtures of already classified organic peroxides may be classified as the same type of organic peroxide as that of the most dangerous component. However, as two stable components can form a thermally less stable mixture, the SADT of the mixture shall be determined.\nNote: The sum of the individual parts can be more hazardous than the individual components.\n\n\nFigure 2.15.1\nOrganic Peroxides\n\n\nSUBSTANCE/MIXTURE\nBox 1\nTest A\nBox 2\nTest B\n1.1 Yes\nDoes it propogate a detonation?\n1.3 No\n2.1 Yes\nCan it detonate as packaged?\n2.2 No\n1.2 Partial\nBox 3 Test C\nCan it propogate a detonation?\n3.1 Yes, rapidly\nBox 4 Test C\nCan it propogate a detonation?\nBox 5 Test C\nBox 6 Test D\n3.2 Yes, slowly\n3.3 No\n4.1 Yes rapidly\nCan it propogate a detonation?\n4.2 Yes, slowly\n5.1 Yes, rapidly\n4.3 No\n5.3 No\nDoes it deflagrate rapidly in package?\n6.2 No\nBox 7 Test E\n5.2 Yes, slowly\n6.1 Yes\nWhat is the effect of heating under confinement?\nBox 8 Test E\n7.1 Violent\nWhat is the effect of heating under confinement?\nBox 9 Test E\n7.2 Medium\n8.1 Violent\n7.3 Low\n7.4 No\nWhat is the effect of heating under confinement?\nBox 10 Test G\n9.3 Low\n8.2 Medium\n9.1 Violent\n8.3 Low\n9.4 No\nCan it explode as packaged?\n10.2 No\n8.4 No\n9.2 Medium\nBox 11\nPackaged in packages of more than 400 kg/450 l or to be considered for exemption?\n11.1 Yes\nBox 12 Test F\n11.2 No\nWhat is its explosive power?\n12.3 None\n10.1 Yes\n12.1 Not low\nBox 13 Test E\n12.2 Low\nWhat is the effect of heating it under confinement?\n13.1 Low\n13.2 None\nTYPE A\nTYPE B\nTYPE C\nTYPE D\nTYPE E\nTYPE F\nTYPE G\n\n\n\n2.16. Corrosive to metals\n\n\n2.16.1. Definition\nA substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.\n\n\n2.16.2. Classification criteria\n2.16.2.1. A substance or a mixture which is corrosive to metals is classified in a single category for this class, using the test in Part III, sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.16.1:\n\nTable 2.16.1\nCriteria for substances and mixtures corrosive to metals\n\nCategory\nCriteria\n1\nCorrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.\n\nNote\nWhere an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required.\n\n\n2.16.3. Hazard Communication\nLabel elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.\n\nTable 2.16.2\nLabel elements for substances and mixtures corrosive to metals\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nWarning\nHazard Statement\nH290: May be corrosive to metals\nPrecautionary Statement\nPrevention\nP234\nPrecautionary Statement\nResponse\nP390\nPrecautionary Statement\nStorage\nP406\nPrecautionary Statement\nDisposal\n\n\n\n\n2.16.4. Additional Classification Considerations\n2.16.4.1. The corrosion rate can be measured according to the test method of Part III sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The specimen to be used for the test shall be made of the following materials:\n\n(a) for the purposes of testing steel, steel types\n\nS235JR+CR (1.0037 resp.St 37-2),\nS275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;\n\n(b) for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.\n\n\n\n3. PART 3: HEALTH HAZARDS\n\n\n3.1. Acute toxicity\n\n\n3.1.1. Definitions\n3.1.1.1. Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.\n3.1.1.2. The hazard class Acute Toxicity is differentiated into:\n\nAcute oral toxicity;\nAcute dermal toxicity;\nAcute inhalation toxicity.\n\n\n3.1.2. Criteria for classification of substances as acutely toxic\n\n3.1.2.1. Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.\n\nTable 3.1.1\nAcute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories\n\nGas concentrations are expressed in parts per million per volume (ppmV).\n\nExposure route\nCategory 1\nCategory 2\nCategory 3\nCategory 4\nOral (mg/kg bodyweight)\nATE ≤ 5\n5 < ATE ≤ 50\n50 < ATE ≤ 300\n300 < ATE ≤ 2000\nSee:\nNote (a)\nNote (b)\nDermal (mg/kg bodyweight)\nATE ≤ 50\n50 < ATE ≤ 200\n200 < ATE ≤ 1000\n1000 < ATE ≤ 2000\nSee:\nNote (a)\nNote (b)\nGases (ppmV)\nATE ≤ 100\n100 < ATE ≤ 500\n500 < ATE ≤ 2500\n2500 < ATE ≤ 20000\nsee:\nNote (a)\nNote (b)\nNote (c)\nVapours (mg/l)\nATE ≤ 0,5\n0,5 < ATE ≤ 2,0\n2,0 < ATE ≤ 10,0\n10,0 < ATE ≤ 20,0\nsee:\nNote (a)\nNote (b)\nNote (c)\nNote (d)\nDusts and mists (mg/l)\nATE ≤ 0,05\n0,05 < ATE ≤ 0,5\n0,5 < ATE ≤ 1,0\n1,0 < ATE ≤ 5,0\nsee:\nNote (a)\nNote (b)\nNote (c)\nNotes to Table 3.1.1:\n\n(a) The acute toxicity estimate (ATE) for the classification of a substance is derived using the LD50/LC50 where available.\n\n(b) The acute toxicity estimate (ATE) for the classification of a substance in a mixture is derived using:\n\nthe LD50/LC50 where available,\nthe appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or\nthe appropriate conversion value from Table 3.1.2 that relates to a classification category.\n\n(c) Generic concentration limits for inhalation toxicity in the table are based on 4-hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1-hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.\n\n(d) For some substances the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2500 ppmV), Category 4 (20000 ppmV).\nThe terms dust, mist and vapour are defined as follows:\n\ndust: solid particles of a substance or mixture suspended in a gas (usually air),\nmist: liquid droplets of a substance or mixture suspended in a gas (usually air),\nvapour: the gaseous form of a substance or mixture released from its liquid or solid state.\nDust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.\n\n\n\n3.1.2.2. Specific considerations for classification of substances as acutely toxic\n3.1.2.2.1. The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.\n\n\n3.1.2.3. Specific considerations for classification of substances as acutely toxic by the inhalation route\n3.1.2.3.1. Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.\n\n3.1.2.3.2. Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.\n3.1.2.3.3. In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as corrosive to the respiratory tract (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.\n\n\n3.1.3. Criteria for classification of mixtures as acutely toxic\n3.1.3.1. The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.\n\n3.1.3.2. For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all components and there is no relevant evidence to suggest acute toxicity by multiple routes. When there is relevant evidence of toxicity by multiple routes of exposure, classification is to be conducted for all appropriate routes of exposure. All available information shall be considered. The pictogram and signal word used shall reflect the most severe hazard category and all relevant hazard statements shall be used.\n\n3.1.3.3. In order to make use of all available data for purposes of classifying the hazards of the mixtures, certain assumptions have been made and are applied where appropriate in the tiered approach:\n\n(a) the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).\n\n(b) where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.\n\n\n(c) If the converted acute toxicity point estimates for all components of a mixture are within the same category, then the mixture should be classified in that category.\n\n\n(d) When only range data (or acute toxicity hazard category information) are available for components in a mixture, they may be converted to point estimates in accordance with Table 3.1.2 when calculating the classification of the new mixture using the formulas in sections 3.1.3.6.1 and 3.1.3.6.2.3.\n\n\nFigure 3.1.1\nTiered approach to classification of mixtures for acute toxicity\nTest data on the mixture as a whole\nNo\nYes\nSufficient data available on similar mixtures to estimate classification hazards\nYes\nApply bridging principles outlined in section 1.1.3.\nCLASSIFY\nNo\nAvailable data for all ingredients\nYes\nApply formula in section 3.1.3.6.1\nCLASSIFY\nNo\nOther data available to estimate conversion values for classification\nYes\nApply formula in section 3.1.3.6.1\nCLASSIFY\nNo\nConvey hazards of the known ingredients\n• Apply formula in section 3.1.3.6.1. (unknown ingredients equal or below 10 %)\n• Apply formula in paragraph 3.1.3.6.2.3. (unknown ingredients > 10 %)\nCLASSIFY\n\n\n3.1.3.4. Classification of mixtures where acute toxicity data are available for the complete mixture\n3.1.3.4.1. Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.\n\n\n3.1.3.5. Classification of mixtures where acute toxicity data are available for the complete mixture: bridging principles\n3.1.3.5.1. Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n3.1.3.5.2. If a tested mixture is diluted with a diluent that has an equivalent or lower toxicity classification than the least toxic original components, and which is not expected to affect the toxicity of other components, then the new diluted mixture may be classified as equivalent to the original tested mixture. Alternatively, the formula explained in section 3.1.3.6.1 can be applied.\n\n\n\n3.1.3.6. Classification of mixtures based on ingredients of the mixture (Additivity formula)\n\n\n3.1.3.6.1. Data available for all ingredients\nIn order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:\n\n\n(a) include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;\n\n(b) ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);\n\n\n(c) ignore components if the data available are from a limit dose test (at the upper threshold for Category 4 for the appropriate route of exposure as provided in Table 3.1.1) and do not show acute toxicity.\n\n\nComponents that fall within the scope of this section are considered to be components with a known acute toxicity estimate (ATE). See note (b) to Table 3.1.1 and section 3.1.3.3 for appropriate application of available data to the equation below, and section 3.1.3.6.2.3.\n\nThe ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:\n100ATEmix\n\nnCiATEi\nwhere:\n\nCi\nconcentration of ingredient i ( % w/w or % v/v)\ni\nthe individual ingredient from 1 to n\nn\nthe number of ingredients\nATEi\nAcute Toxicity Estimate of ingredient i.\n\n\n3.1.3.6.2. Classification of mixtures when data are not available for all components\n3.1.3.6.2.1. Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.\nThis includes evaluation of:\n\n(a) extrapolation between oral, dermal and inhalation acute toxicity estimatesWhen mixtures contain components that do not have acute toxicity data for each route of exposure, acute toxicity estimates may be extrapolated from the available data and applied to the appropriate routes (see section 3.1.3.2). However, specific legislation may require testing for a specific route. In those cases, classification shall be performed for that route based upon the legal requirements.. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;\n\n(b) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;\n\n(c) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or\n\n(d) data from closely analogous substances using structure/activity relationships.\nThis approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.\n\n\n3.1.3.6.2.2. In the event that a component without any useable information for classification is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that: × percent of the mixture consists of component(s) of unknown toxicity.\n\n3.1.3.6.2.3. If the total concentration of the ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the total percentage of the unknown ingredient(s) as follows:\n100Cunknown if10%ETAmix\n\nnCiETAi\n\nTable 3.1.2\n\nConversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for use in the formulas for the classification of mixtures\n\n\nExposure routes\nClassification Category or experimentally obtained acute toxicity range estimate\nConverted acute toxicity point estimate\n(see Note 1)\nOral\n(mg/kg bodyweight)\n0 < Category 1 ≤ 5\n5 < Category 2 ≤ 50\n50 < Category 3 ≤ 300\n300 < Category 4 ≤ 2000\n0,5\n5\n100\n500\nDermal\n(mg/kg bodyweight)\n0 < Category 1 ≤ 50\n50 < Category 2 ≤ 200\n200 < Category 3 ≤ 1000\n1000 < Category 4 ≤ 2000\n5\n50\n300\n1100\nGases\n(ppmV)\n0 < Category 1 ≤ 100\n100 < Category 2 ≤ 500\n500 < Category 3 ≤ 2500\n2500 < Category 4 ≤ 20000\n10\n100\n700\n4500\nVapours\n(mg/l)\n0 < Category 1 ≤ 0,5\n0,5 < Category 2 ≤ 2,0\n2,0 < Category 3 ≤ 10,0\n10,0 < Category 4 ≤ 20,0\n0,05\n0,5\n3\n11\nDust/mist\n(mg/l)\n0< Category 1 ≤ 0,05\n0,05 < Category 2 ≤ 0,5\n0,5 < Category 3 ≤ 1,0\n1,0 < Category 4 ≤ 5,0\n0,005\n0,05\n0,5\n1,5\n\nNote 1\nThese values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results.\n\n\n\n3.1.4. Hazard Communication\n3.1.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.1.3. Without prejudice to Article 27, combined hazard statements may be used in accordance with Annex III.\n\nTable 3.1.3\nAcute toxicity label elements\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nCategory 4\nGHS Pictograms\n\n\n\n\nSignal Word\nDanger\nDanger\nDanger\nWarning\nHazard Statement:\n\nOral\nH300:\nFatal if swallowed\nH300:\nFatal if swallowed\nH301:\nToxic if swallowed\nH302:\nHarmful if swallowed\n\nDermal\nH310:Fatal in contact with skin\nH310:Fatal in contact with skin\nH311: Toxic in contact with skin\nH312: Harmful in contact with skin\n\nInhalation\n(see Note 1)\nH330:Fatal if inhaled\nH330: Fatal if inhaled\nH331: Toxic if inhaled\nH332: Harmful if inhaled\nPrecautionary Statement Prevention (oral)\nP264\nP270\nP264\nP270\nP264\nP270\nP264\nP270\nPrecautionary Statement Response (oral)\nP301 + P310\nP321\nP330\nP301 + P310\nP321\nP330\nP301 + P310\nP321\nP330\nP301 + P312\nP330\nPrecautionary Statement Storage (oral)\nP405\nP405\nP405\n\nPrecautionary Statement Disposal (oral)\nP501\nP501\nP501\nP501\nPrecautionary Statement Prevention (dermal)\nP262\nP264\nP270\nP280\nP262\nP264\nP270\nP280\nP280\nP280\nPrecautionary Statement Response (dermal)\nP302 + P350\nP310\nP322\nP361\nP363\nP302 + P350\nP310\nP322\nP361\nP363\nP302 + P352\nP312\nP322\nP361\nP363\nP302 + P352\nP312\nP322\nP363\nPrecautionary Statement Storage (dermal)\nP405\nP405\nP405\n\nPrecautionary Statement Disposal (dermal)\nP501\nP501\nP501\nP501\nPrecautionary Statement Prevention (inhalation)\nP260\nP271\nP284\nP260\nP271\nP284\nP261\nP271\nP261\nP271\nPrecautionary Statement Response (inhalation)\nP304 + P340\nP310\nP320\nP304 + P340\nP310\nP320\nP304 + P340\nP311\nP321\nP304 + P340\nP312\nPrecautionary Statement Storage (inhalation)\nP403 + P233\nP405\nP403 + P233\nP405\nP403 + P233\nP405\n\nPrecautionary Statement Disposal (inhalation)\nP501\nP501\nP501\n\nNote 1\nIn addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: corrosive to the respiratory tract — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement corrosive to the respiratory tract.\n\nNote 2\nIn the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity — see advice at 3.1.3.6.2.2.\n\n\n3.2. Skin corrosion/irritation\n\n\n3.2.1. Definitions\n3.2.1.1. Skin Corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test substance for up to 4 hours. Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology shall be considered to evaluate questionable lesions.\nSkin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.\n\n\n3.2.2. Classification criteria for substances\n3.2.2.1. Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.\n3.2.2.2. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n3.2.2.3. If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.\n3.2.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo skin irritation testing.\nAlthough information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.\n3.2.2.5. A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.\n\n\n3.2.2.6. Corrosion\n3.2.2.6.1. On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.\n3.2.2.6.2. Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.\n3.2.2.6.3. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.\n\nTable 3.2.1\nSkin Corrosive category and subcategories\n\n\n\nCorrosive in > 1 of 3 animals\n\nCorrosive subcategories\nExposure\nObservation\nCategory 1: Corrosive\n1A\n≤ 3 minutes\n≤ 1 hour\n1B\n> 3 minutes - ≤ 1 hour\n≤ 14 days\n1C\n> 1 hour - ≤ 4 hours\n≤ 14 days\n\n\n\n3.2.2.7. Irritation\n3.2.2.7.1. Using the results of animal testing a single irritant category (Category 2) is presented in Table 3.2.2. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5. The major criterion for the irritant category is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.\n\nTable 3.2.2\nSkin irritation category\n\nCategory\nCriteria\nCategory 2: Irritant\n(1) Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or\n(2) Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or\n(3) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.\n\n\n3.2.2.8. Comments on responses obtained in skin irritation tests in animals\n3.2.2.8.1. Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.\n3.2.2.8.2. Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.\n\n\n3.2.3. Classification criteria for mixtures\n\n\n3.2.3.1. Classification of mixtures when data are available for the complete mixture\n3.2.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.\n\n3.2.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n\n3.2.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.2.3.2.1. Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n3.2.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.2.3.3.1. In order to make use of all available data for purposes of classifying the skin irritation/corrosion hazards of mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:\nAssumption: the relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.\n3.2.3.3.2. In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.\n3.2.3.3.3. Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.\n3.2.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.\n3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.\n\n3.2.3.3.4.3. A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.\n3.2.3.3.5. On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.\n3.2.3.3.6. If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.\n\nTable 3.2.3\nGeneric concentration limits of ingredients classified for skin corrosive/irritant hazard (Category 1 or 2) that trigger classification of the mixture as corrosive/irritant to skin\n\nSum of ingredients classified as:\nConcentration triggering classification of a mixture as:\n\nSkin Corrosive\nSkin Irritant\n\nCategory 1\n(see note below)\nCategory 2\nSkin Corrosive Categories 1A, 1B, 1C\n≥ 5 %\n≥ 1 % but < 5 %\nSkin irritant Category 2\n\n≥ 10 %\n(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2\n\n≥ 10 %\n\nNote\nThe sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.\n\n\nTable 3.2.4\nGeneric concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as corrosive/irritant to skin\n\nIngredient:\nConcentration:\nMixture classified as: Skin\nAcid with pH ≤ 2\n≥ 1 %\nCategory 1\nBase with pH ≥ 11,5\n≥ 1 %\nCategory 1\nOther corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply\n≥ 1 %\nCategory 1\nOther irritant (Category 2) ingredients for which additivity does not apply, including acids and bases\n≥ 3 %\nCategory 2\n\n\n3.2.4. Hazard Communication\n3.2.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.2.5.\n\nTable 3.2.5\nLabel elements for skin corrosion/irritation\n\nClassification\nCategory 1 A/1 B/1 C\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH314: Causes severe skin burns and eye damage\nH315: Causes skin irritation\nPrecautionary Statement\nPrevention\nP260\nP264\nP280\nP264\nP280\nPrecautionary Statement\nResponse\nP301 + P330 + P331\nP303 + P361 + P353\nP363\nP304 + P340\nP310\nP321\nP305 + P351 + P338\nP302 + P352\nP321\nP332 + P313\nP362\nPrecautionary Statement\nStorage\nP405\n\nPrecautionary Statement\nDisposal\nP501\n\n\n\n3.3. Serious eye damage/eye irritation\n\n\n3.3.1. Definitions\n3.3.1.1. Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.\nEye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.\n\n\n3.3.2. Classification criteria for substances\n3.3.2.1. The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.\n3.3.2.2. Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.\n3.3.2.3. Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).\n3.3.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.\n3.3.2.5. A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.\n\n\n3.3.2.6. Irreversible effects on the eye/serious damage to eyes (Category 1)\n3.3.2.6.1. Substances that have the potential to seriously damage the eyes are classified in Category 1 (irreversible effects on the eye). Substances are classified in this hazard category on the basis of the results of animal testing, in accordance with the criteria listed in Table 3.3.1. These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.\n\nTable 3.3.1\nCategory for irreversible eye effects\n\nCategory\nCriteria\nIrreversible effects on the eye\n(Category 1)\nIf, when applied to the eye of an animal, a substance produces:\n\nat least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or\nat least in 2 of 3 tested animals, a positive response of:\n\ncorneal opacity ≥ 3 and/or\niritis > 1,5\ncalculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.\n3.3.2.6.2. The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n\n\n3.3.2.7. Reversible effects on the eye (Category 2)\n3.3.2.7.1. Substances that have the potential to induce reversible eye irritation are classified in Category 2 (irritating to eyes).\n\n\nTable 3.3.2\nCategory for reversible eye effects\n\nCategory\nCriteria\nIrritating to eyes\n(Category 2)\nif, when applied to the eye of an animal, a substance produces:\n\nat least in 2 of 3 tested animals, a positive response of:\n\ncorneal opacity ≥ 1 and/or\niritis ≥ 1, and/or\nconjunctival redness ≥ 2 and/or\nconjunctival oedema (chemosis) ≥ 2\ncalculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days\n3.3.2.7.2. For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.\n\n\n3.3.3. Classification criteria for mixtures\n\n\n3.3.3.1. Classification of mixtures when data are available for the complete mixture\n3.3.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.\n3.3.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.\n\n\n3.3.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.3.3.2.1. Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n\n3.3.3.3. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.3.3.3.1. In order to make use of all available data for purposes of classifying the eye irritation/serious eye damaging properties of the mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:\nAssumption: The relevant ingredients of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.\n3.3.3.3.2. In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.\n3.3.3.3.3. Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.\n3.3.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.\n3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.\n3.3.3.3.4.3. A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.\n3.3.3.3.5. On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.\n\n3.3.3.3.6. If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.\n\nTable 3.3.3\nGeneric concentration limits of ingredients of a mixture classified as Skin corrosive Category 1 and/or eye Category 1 or 2 for effects on the eye that trigger classification of the mixture for effects on the eye (Category 1 or 2)\n\nSum of ingredients classified as:\nConcentration triggering classification of a mixture as:\nIrreversible Eye Effects\nReversible Eye Effects\nCategory 1\nCategory 2\nEye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C\n≥ 3 %\n≥ 1 % but < 3 %\nEye Effects Category 2\n\n≥ 10 %\n(10 × Eye Effects Category 1) + Eye effects Category 2\n\n≥ 10 %\nSkin Corrosive Category 1A, 1B, 1C + Eye effects Category 1\n≥ 3 %\n≥ 1 % but < 3 %\n10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2\n\n≥ 10 %\n\nTable 3.3.4\nGeneric concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as hazardous to the eye\n\nIngredient\nConcentration\nMixture classified as: Eye\nAcid with pH ≤ 2\n≥ 1 %\nCategory 1\nBase with pH ≥ 11,5\n≥ 1 %\nCategory 1\nOther corrosive (Category 1) ingredients for which additivity does not apply\n≥ 1 %\nCategory 1\nOther irritant (Category 2) ingredients for which additivity does not apply, including acids and bases\n≥ 3 %\nCategory 2\n\n\n3.3.4. Hazard Communication\n3.3.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.3.5.\n\n\nTable 3.3.5\nLabel elements for serious eye damage/eye irritation\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH318: Causes serious eye damage\nH319: Causes serious eye irritation\nPrecautionary Statement\nPrevention\nP280\nP264\nP280\nPrecautionary Statement\nResponse\nP305 + P351 + P338\nP310\nP305 + P351 + P338\nP337 + P313\nPrecautionary Statement\nStorage\n\n\nPrecautionary Statement\nDisposal\n\n\n\n\n3.4. Respiratory or skin sensitisation\n\n\n3.4.1. Definitions and general considerations\n3.4.1.1. Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.\n3.4.1.2. Skin sensitiser means a substance that will lead to an allergic response following skin contact.\n3.4.1.3. For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.\n3.4.1.4. For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.\n3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found in Annex II, section 2.8..\n\n3.4.1.6. The hazard class Respiratory or Skin Sensitisation is differentiated into:\n\nRespiratory Sensitisation and;\nSkin Sensitisation.\n\n\n\n3.4.2. Classification criteria for substances\n\n\n3.4.2.1. Respiratory sensitisers\n\n\n3.4.2.1.1. Hazard categories\n3.4.2.1.1.1.\nRespiratory sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.\n3.4.2.1.1.2.\nWhere data are sufficient a refined evaluation according to 3.4.2.1.1.3 shall allow the allocation of respiratory sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other respiratory sensitisers.\n3.4.2.1.1.3.\nEffects seen in either humans or animals will normally justify classification in a weight of evidence approach for respiratory sensitisers. Substances may be allocated to one of the two sub-categories 1A or 1B using a weight of evidence approach in accordance with the criteria given in Table 3.4.1 and on the basis of reliable and good quality evidence from human cases or epidemiological studies and/or observations from appropriate studies in experimental animals.\n3.4.2.1.1.4.\nSubstances shall be classified as respiratory sensitisers in accordance with the criteria in Table 3.4.1:\n\nTable 3.4.1\nHazard category and sub-categories for respiratory sensitisers\n\nAt present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment.\n\nCategory\nCriteria\nCategory 1\nSubstances shall be classified as respiratory sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:\n\n(a) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity; and/or\n\n(b) if there are positive results from an appropriate animal test.\nSub-category 1A:\nSubstances showing a high frequency of occurrence in humans; or a probability of occurrence of a high sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.\nSub-category 1B:\nSubstances showing a low to moderate frequency of occurrence in humans; or a probability of occurrence of a low to moderate sensitisation rate in humans based on animal or other tests. Severity of reaction may also be considered.\n\n\n\n3.4.2.1.2. Human evidence\n3.4.2.1.2.1.\nEvidence that a substance can lead to specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.\n3.4.2.1.2.2.\nWhen considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:\n\n(a) the size of the population exposed;\n\n(b) the extent of exposure.\nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n3.4.2.1.2.3.\nThe evidence referred to above could be:\n\n(a) clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:\n\n(i) in vivo immunological test (e.g. skin prick test);\n\n(ii) in vitro immunological test (e.g. serological analysis);\n\n(iii) studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;\n\n(iv) a chemical structure related to substances known to cause respiratory hypersensitivity;\n\n(b) data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.\n3.4.2.1.2.4.\nClinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.\n3.4.2.1.2.5.\nThe results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.\n\n\n3.4.2.1.3. Animal studies\n3.4.2.1.3.1.\nData from appropriate animal studiesAt present, recognised and validated animal models for the testing of respiratory hypersensitivity are not available. Under certain circumstances, data from animal studies may provide valuable information in a weight of evidence assessment. which may be indicative of the potential of a substance to cause sensitisation by inhalation in humansThe mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers. may include:\n\n\n(a) measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;\n\n(b) specific pulmonary responses in guinea pigs.\n\n\n3.4.2.2. Skin sensitisers\n\n\n3.4.2.2.1. Hazard categories\n3.4.2.2.1.1.\nSkin sensitisers shall be classified in Category 1 where data are not sufficient for sub-categorisation.\n3.4.2.2.1.2.\nWhere data are sufficient a refined evaluation according to section 3.4.2.2.1.3 allows the allocation of skin sensitisers into sub-category 1A, strong sensitisers, or sub-category 1B for other skin sensitisers.\n3.4.2.2.1.3.\nEffects seen in either humans or animals will normally justify classification in a weight of evidence approach for skin sensitisers as described in section 3.4.2.2.2. Substances may be allocated to one of the two sub-categories 1A or 1B using a weight of evidence approach in accordance with the criteria given in Table 3.4.2 and on the basis of reliable and good quality evidence from human cases or epidemiological studies and/or observations from appropriate studies in experimental animals according to the guidance values provided in sections 3.4.2.2.2.1 and 3.4.2.2.3.2 for sub-category 1A and in sections 3.4.2.2.2.2 and 3.4.2.2.3.3 for sub-category 1B.\n3.4.2.2.1.4.\nSubstances shall be classified as skin sensitisers in accordance with the criteria in Table 3.4.2:\n\nTable 3.4.2\nHazard category and sub-categories for skin sensitisers\n\nCategory\nCriteria\nCategory 1\nSubstances shall be classified as skin sensitisers (Category 1) where data are not sufficient for sub-categorisation in accordance with the following criteria:\n\n(a) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons; or\n\n(b) if there are positive results from an appropriate animal test (see specific criteria in section 3.4.2.2.4.1).\nSub-category 1A:\nSubstances showing a high frequency of occurrence in humans and/or a high potency in animals can be presumed to have the potential to produce significant sensitisation in humans. Severity of reaction may also be considered.\nSub-category 1B:\nSubstances showing a low to moderate frequency of occurrence in humans and/or a low to moderate potency in animals can be presumed to have the potential to produce sensitisation in humans. Severity of reaction may also be considered.\n\n\n3.4.2.2.2. Human evidence\n3.4.2.2.2.1.\nHuman evidence for sub-category 1A can include:\n\n(a) positive responses at ≤ 500 μg/cm2 (HRIPT, HMT — induction threshold);\n\n\n(b) diagnostic patch test data where there is a relatively high and substantial incidence of reactions in a defined population in relation to relatively low exposure;\n\n(c) other epidemiological evidence where there is a relatively high and substantial incidence of allergic contact dermatitis in relation to relatively low exposure.\n3.4.2.2.2.2.\nHuman evidence for sub-category 1B can include:\n\n(a) positive responses at > 500 μg/cm2 (HRIPT, HMT — induction threshold);\n\n(b) diagnostic patch test data where there is a relatively low but substantial incidence of reactions in a defined population in relation to relatively high exposure;\n\n(c) other epidemiological evidence where there is a relatively low but substantial incidence of allergic contact dermatitis in relation to relatively high exposure.\nThe use of human data is discussed in sections 1.1.1.3, 1.1.1.4 and 1.1.1.5.\n\n\n3.4.2.2.3. Animal studies\n3.4.2.2.3.1.\nFor Category 1, when an adjuvant type test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant Guinea pig test method a response of at least 15 % of the animals is considered positive. For Category 1, a stimulation index of three or more is considered a positive response in the local lymph node assay. Test methods for skin sensitisation are described in the OECD Guideline 406 (the Guinea Pig Maximisation test and the Buehler guinea pig test) and Guideline 429 (Local Lymph Node Assay). Other methods may be used provided that they are well-validated and scientific justification is given. For example, the mouse ear swelling test (MEST) could be a reliable screening test to detect moderate to strong sensitisers, and could be used as a first stage in the assessment of skin sensitisation potential.\n3.4.2.2.3.2.\nAnimal test results for sub-category 1A can include data with values indicated in Table 3.4.3\n\nTable 3.4.3\nAnimal test results for sub-category 1A\n\nAssay\nCriteria\nLocal lymph node assay\nEC3 value ≤ 2 %\nGuinea pig maximisation test\n≥ 30 % responding at ≤ 0,1 % intradermal induction dose or\n≥ 60 % responding at > 0,1 % to ≤ 1 % intradermal induction dose\nBuehler assay\n≥ 15 % responding at ≤ 0,2 % topical induction dose or\n≥ 60 % responding at > 0,2 % to ≤ 20 % topical induction dose\n3.4.2.2.3.3.\nAnimal test results for sub-category 1B can include data with values indicated in Table 3.4.4 below:\n\n\nTable 3.4.4\nAnimal test results for sub-category 1B\n\nAssay\nCriteria\nLocal lymph node assay\nEC3 value > 2 %\nGuinea pig maximisation test\n≥ 30 % to < 60 % responding at > 0,1 % to ≤ 1 % intradermal induction dose or\n≥ 30 % responding at > 1 % intradermal induction dose\nBuehler assay\n≥ 15 % to < 60 % responding at > 0,2 % to ≤ 20 % topical induction dose or\n≥ 15 % responding at > 20 % topical induction dose\n\n\n3.4.2.2.4. Specific considerations\n3.4.2.2.4.1.\nFor classification of a substance, evidence should include any or all of the following using a weight of evidence approach:\n\n(a) positive data from patch testing, normally obtained in more than one dermatology clinic;\n\n(b) epidemiological studies showing allergic contact dermatitis caused by the substance. Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;\n\n(c) positive data from appropriate animal studies;\n\n(d) positive data from experimental studies in man (see section 1.3.2.4.7);\n\n(e) well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic;\n\n(f) severity of reaction may also be considered.\n3.4.2.2.4.2.\nEvidence from animal studies is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution as the frequency of cases reflect, in addition to the inherent properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data should not normally be used to negate positive results from animal studies. For both animal and human data, consideration should be given to the impact of vehicle.\n3.4.2.2.4.3.\nIf none of the abovementioned conditions are met, the substance need not be classified as a skin sensitiser. However, a combination of two or more indicators of skin sensitisation as listed below may alter the decision. This shall be considered on a case-by-case basis.\n\n(a) Isolated episodes of allergic contact dermatitis;\n\n\n(b) epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;\n\n(c) data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in section 3.4.2.2.3, but which are sufficiently close to the limit to be considered significant;\n\n(d) positive data from non-standard methods;\n\n(e) positive results from close structural analogues.\n\n\n3.4.2.2.4.4. Immunological contact urticaria\nSubstances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration should be given to classifying these substances also as skin sensitisers. Substances which cause immunological contact urticaria without meeting the criteria for respiratory sensitisers should also be considered for classification as skin sensitisers.\nThere is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence which will be similar to that for skin sensitisation.\n\n\n\n3.4.3. Classification criteria for mixtures\n\n\n3.4.3.1. Classification of mixtures when data are available for the complete mixture\n3.4.3.1.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.\n\n\n3.4.3.2. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.\n\n\n3.4.3.3. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.5 for solid/liquid and gas respectively.\n3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.5, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.6).\n\n\n\nTable 3.4.5\nGeneric concentration limits of components of a mixture classified as either respiratory sensitisers or skin sensitisers that trigger classification of the mixture\n\nComponent classified as:\nGeneric concentration limits triggering classification of a mixture as:\nRespiratory sensitiser\nCategory 1\nSkin sensitiser\nCategory 1\nSolid/liquid\nGas\nAll physical states\nRespiratory sensitiser\nCategory 1\n≥ 1,0 %\n≥ 0,2 %\n\nRespiratory sensitiser\nSub-category 1A\n≥ 0,1 %\n≥ 0,1 %\n\nRespiratory sensitiser\nSub-category 1B\n≥ 1,0 %\n≥ 0,2 %\n\nSkin sensitiser\nCategory 1\n\n\n≥ 1,0 %\nSkin sensitiser\nSub-category 1A\n\n\n≥ 0,1 %\nSkin sensitiser\nSub-category 1B\n\n\n≥ 1,0 %\n\n\n\nTable 3.4.6\nConcentration limits for elicitation of components of a mixture\n\nComponent classified as:\nConcentration limits for elicitation\nRespiratory sensitiser\nCategory 1\nSkin sensitiser\nCategory 1\nSolid/liquid\nGas\nAll physical states\nRespiratory sensitiser\nCategory 1\n≥ 0,1 % (Note 1)\n≥ 0,1 % (Note 1)\n\nRespiratory sensitiser\nSub-category 1A\n≥ 0,01 % (Note 1)\n≥ 0,01 % (Note 1)\n\nRespiratory sensitiser\nSub-category 1B\n≥ 0,1 % (Note 1)\n≥ 0,1 % (Note 1)\n\nSkin sensitiser\nCategory 1\n\n\n≥ 0,1 % (Note 1)\nSkin sensitiser\nSub-category 1A\n\n\n≥ 0,01 % (Note 1)\nSkin sensitiser\nSub-category 1B\n\n\n≥ 0,1 % (Note 1)\n\nNote 1:\nThis concentration limit for elicitation is used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing a component above this concentration. For sensitising substances with specific concentration limit lower than 0,1 %, the concentration limit for elicitation should be set at one tenth of the specific concentration limit.\n\n\n\n3.4.4. Hazard communication\n\n3.4.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.4.7.\n\nTable 3.4.7\nRespiratory or skin sensitisation label elements\n\nClassification\nRespiratory sensitisation\nSkin sensitisation\nCategory 1 and sub-categories 1A and 1B\nCategory 1 and sub-categories 1A and 1B\nGHS pictograms\n\n\nSignal word\nDanger\nWarning\nHazard statement\nH334: May cause allergy or asthma symptoms or breathing difficulties if inhaled\nH317: May cause an allergic skin reaction\nPrecautionary statement prevention\nP261\nP285\nP261\nP272\nP280\nPrecautionary statement response\nP304 + P341\nP342 + P311\nP302 + P352\nP333 + P313\nP321\nP363\nPrecautionary statement storage\n\n\nPrecautionary statement disposal\nP501\nP501\n\n\n\n3.5. Germ cell mutagenicity\n\n\n3.5.1. Definitions and general considerations\n3.5.1.1. A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term mutation applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term mutagenic and mutagen will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.\n\n3.5.1.2. The more general terms genotoxic and genotoxicity apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.\n\n\n3.5.2. Classification criteria for substances\n3.5.2.1. This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.\n3.5.2.2. For the purpose of classification for germ cell mutagenicity, substances are allocated to one of two categories as shown in Table 3.5.1.\n\nTable 3.5.1\nHazard categories for germ cell mutagens\n\nCategories\nCriteria\nCATEGORY 1:\nSubstances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.\nSubstances known to induce heritable mutations in the germ cells of humans.\nCategory 1A:\nThe classification in Category 1A is based on positive evidence from human epidemiological studies.\nSubstances to be regarded as if they induce heritable mutations in the germ cells of humans.\nCategory 1B:\nThe classification in Category 1B is based on:\n\npositive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or\npositive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or\npositive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.\nCATEGORY 2:\nSubstances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans\nThe classification in Category 2 is based on:\n\npositive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:\n\nsomatic cell mutagenicity tests in vivo, in mammals; or\nother in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.\nNote: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.\n\n\n\n3.5.2.3. Specific considerations for classification of substances as germ cell mutagens\n3.5.2.3.1. To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.\n3.5.2.3.2. The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.\n3.5.2.3.3. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (Test Method Regulation) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.\n3.5.2.3.4. In vivo heritable germ cell mutagenicity tests, such as:\n\nrodent dominant lethal mutation test;\nmouse heritable translocation assay.\n3.5.2.3.5. In vivo somatic cell mutagenicicty tests, such as:\n\nmammalian bone marrow chromosome aberration test;\nmouse spot test;\nmammalian erythrocyte micronucleus test.\n3.5.2.3.6. Mutagenicity/genotoxicity tests in germ cells, such as:\n\n(a) mutagenicity tests:\n\nmammalian spermatogonial chromosome aberration test;\nspermatid micronucleus assay;\n\n(b) Genotoxicity tests:\n\nsister chromatid exchange analysis in spermatogonia;\nunscheduled DNA synthesis test (UDS) in testicular cells.\n3.5.2.3.7. Genotoxicity tests in somatic cells such as:\n\nliver Unscheduled synthesis test (UDS) in vivo;\nmammalian bone marrow Sister Chromatid Exchanges (SCE);\n3.5.2.3.8. In vitro mutagenicity tests such as:\n\nin vitro mammalian chromosome aberration test;\nin vitro mammalian cell gene mutation test;\nbacterial reverse mutation tests.\n3.5.2.3.9. The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.\n\n\n\n3.5.3. Classification criteria for mixtures\n\n\n3.5.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.5.3.1.1. The mixture shall be classified as a mutagen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 mutagen and is present at or above the appropriate generic concentration limit as shown in Table 3.5.2 for Category 1A, Category 1B and Category 2 respectively.\n\nTable 3.5.2\nGeneric concentration limits of ingredients of a mixture classified as germ cell mutagens that trigger classification of the mixture.\n\n\nConcentration limits triggering classification of a mixture as:\nIngredient classified as:\nCategory 1A mutagen\nCategory 1B mutagen\nCategory 2 mutagen\nCategory 1A mutagen\n≥ 0,1 %\n—\n—\nCategory 1B mutagen\n—\n≥ 0,1 %\n—\nCategory 2 mutagen\n—\n—\n≥ 1,0 %\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\n\n3.5.3.2. Classification of mixtures when data are available for the complete mixture\n3.5.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n3.5.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.5.3.3.1. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.5.4. Hazard communication\n3.5.4.1. Label elements shall be used in accordance with Table 3.5.3, for substances or mixtures meeting the criteria for classification in this hazard class.\n\n\nTable 3.5.3\nLabel elements of germ cell mutagenicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP201\nP202\nP281\nPrecautionary Statement\nResponse\nP308 + P313\nP308 + P313\nPrecautionary Statement\nStorage\nP405\nP405\nPrecautionary Statement\nDisposal\nP501\nP501\n\n\n3.5.5. Additional classification considerations\nIt is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).\n\n\n3.6. Carcinogenicity\n\n\n3.6.1. Definition\n3.6.1.1. Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.\n\n\n3.6.2. Classification criteria for substances\n3.6.2.1. For the purpose of classification for carcinogenicity, substances are allocated to one of two categories based on strength of evidence and additional considerations (weight of evidence). In certain instances, route-specific classification may be warranted, if it can be conclusively proved that no other route of exposure exhibits the hazard.\n\n\nTable 3.6.1\nHazard categories for carcinogens\n\nNote: See 3.6.2.2.4.\n\nCategories\nCriteria\nCATEGORY 1:\nKnown or presumed human carcinogens\nA substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:\nCategory 1A:\nCategory 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or\nCategory 1B:\nCategory 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.\n\nThe classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:\n\nhuman studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or\nanimal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen).\n\nIn addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.\nCATEGORY 2:\nSuspected human carcinogens\nThe placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.\n\n\n3.6.2.2. Specific considerations for classification of substances as carcinogens\n3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.\n\n3.6.2.2.2. Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.\n3.6.2.2.3. Strength of evidence involves the enumeration of tumours in human and animal studies and determination of their level of statistical significance. Sufficient human evidence demonstrates causality between human exposure and the development of cancer, whereas sufficient evidence in animals shows a causal relationship between the substance and an increased incidence of tumours. Limited evidence in humans is demonstrated by a positive association between exposure and cancer, but a causal relationship cannot be stated. Limited evidence in animals is provided when data suggest a carcinogenic effect, but are less than sufficient. The terms sufficient and limited have been used here as they have been defined by the International Agency for Research on Cancer (IARC) and read as follows:\n\n(a) Carcinogenicity in humans\nThe evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:\n\nsufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;\nlimited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.\n\n(b) Carcinogenicity in experimental animals\nCarcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:\n\nsufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;\nlimited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.\n3.6.2.2.4. Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.\n3.6.2.2.5. The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.\n3.6.2.2.6. Some important factors which may be taken into consideration, when assessing the overall level of concern are:\n\n(a) tumour type and background incidence;\n\n(b) multi-site responses;\n\n(c) progression of lesions to malignancy;\n\n(d) reduced tumour latency;\n\n(e) whether responses are in single or both sexes;\n\n(f) whether responses are in a single species or several species;\n\n(g) structural similarity to a substance(s) for which there is good evidence of carcinogenicity;\n\n(h) routes of exposure;\n\n(i) comparison of absorption, distribution, metabolism and excretion between test animals and humans;\n\n(j) the possibility of a confounding effect of excessive toxicity at test doses;\n\n(k) mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.\nMutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.\n\n3.6.2.2.7. A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.\n3.6.2.2.8. The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.\n3.6.2.2.9. It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.\n\n\n3.6.3. Classification criteria for mixtures\n\n\n3.6.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.6.3.1.1. The mixture will be classified as a carcinogen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 carcinogen and is present at or above the appropriate generic concentration limit as shown in Table 3.6.2 for Category 1A, Category 1B and Category 2 respectively.\n\nTable 3.6.2\nGeneric concentration limits of ingredients of a mixture classified as carcinogen that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of a mixture as:\nCategory 1A carcinogen\nCategory 1B carcinogen\nCategory 2 carcinogen\nCategory 1A carcinogen\n≥ 0,1 %\n—\n—\nCategory 1B carcinogen\n—\n≥ 0,1 %\n—\nCategory 2 carcinogen\n—\n—\n≥ 1,0 % [Note 1]\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\nNote 1\nIf a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request.\n\n\n3.6.3.2. Classification of mixtures when data are available for the complete mixture\n3.6.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n\n3.6.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.6.3.3.1. Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.6.4. Hazard Communication\n3.6.4.1. Label elements shall be used in accordance with Table 3.6.3, for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.6.3\nLabel elements for carcinogenicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nGHS Pictograms\n\n\nSignal Word\nDanger\nWarning\nHazard Statement\nH350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement\nPrevention\nP201\nP202\nP281\nP201\nP202\nP281\nPrecautionary Statement\nResponse\nP308 + P313\nP308 + P313\nPrecautionary Statement\nStorage\nP405\nP405\nPrecautionary Statement\nDisposal\nP501\nP501\n\n\n3.7. Reproductive toxicity\n\n\n3.7.1. Definitions and general considerations\n3.7.1.1. Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based heritable effects in the offspring is addressed in Germ Cell Mutagenicity (section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.\nIn this classification system, reproductive toxicity is subdivided under two main headings:\n\n(a) adverse effects on sexual function and fertility;\n\n(b) adverse effects on development of the offspring.\nSome reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.\n3.7.1.2. For the purpose of classification the hazard class Reproductive Toxicity is differentiated into:\n\nadverse effects\n\non sexual function and fertility, or\non development;\neffects on or via lactation.\n\n\n3.7.1.3. Adverse effects on sexual function and fertility\nAny effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.\n\n\n3.7.1.4. Adverse effects on development of the offspring\nDevelopmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.\n3.7.1.5. Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.\n\n\n\n3.7.2. Classification criteria for substances\n\n\n3.7.2.1. Hazard categories\n3.7.2.1.1. For the purpose of classification for reproductive toxicity, substances are allocated to one of two categories. Within each category, effects on sexual function and fertility, and on development, are considered separately. In addition, effects on lactation are allocated to a separate hazard category.\n\nTable 3.7.1(a)\nHazard categories for reproductive toxicants\n\nCategories\nCriteria\nCATEGORY 1\nKnown or presumed human reproductive toxicant\nSubstances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).\nCategory 1A\nKnown human reproductive toxicant\nThe classification of a substance in Category 1A is largely based on evidence from humans.\nCategory 1B\nPresumed human reproductive toxicant\nThe classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.\nCATEGORY 2\nSuspected human reproductive toxicant\nSubstances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.\nSuch effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.\n\nTable 3.7.1(b)\nHazard category for lactation effects\n\nEFFECTS ON OR VIA LACTATION\nEffects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:\n\n(a) human evidence indicating a hazard to babies during the lactation period; and/or\n\n(b) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or\n\n(c) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.\n\n\n3.7.2.2. Basis of classification\n3.7.2.2.1. Classification is made on the basis of the appropriate criteria, outlined above, and an assessment of the total weight of evidence (see 1.1.1). Classification as a reproductive toxicant is intended to be used for substances which have an intrinsic, specific property to produce an adverse effect on reproduction and substances shall not be so classified if such an effect is produced solely as a non-specific secondary consequence of other toxic effects.\nThe classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.\n3.7.2.2.2. In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).\n3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.\n\n\n3.7.2.3. Weight of evidence\n3.7.2.3.1. Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).\n3.7.2.3.2. Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.\n3.7.2.3.3. If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.\n3.7.2.3.4. Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.\n\n3.7.2.3.5. If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.\n\n\n3.7.2.4. Maternal toxicity\n3.7.2.4.1. Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.\n3.7.2.4.2. Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.\n3.7.2.4.3. Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.\n3.7.2.4.4. Some of the end points used to assess maternal effects are provided below. Data on these end points, if available, need to be evaluated in light of their statistical or biological significance and dose response relationship.\nMaternal mortality:\nan increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.\nMating index\n(no. animals with seminal plugs or sperm/no. mated × 100)It is recognised that the Mating index and the Fertility index can also be affected by the male.\nFertility index\n(no. animals with implants/no. of matings × 100)\nGestation length\n(if allowed to deliver)\nBody weight and body weight change:\nConsideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.\nFood and water consumption (if relevant):\nThe observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.\nClinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):\nThe observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.\nPost-mortem data:\nIncreased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.\n\n\n3.7.2.5. Animal and experimental data\n3.7.2.5.1. A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).\n3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.\n3.7.2.5.3. Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.\n3.7.2.5.4. Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.\n3.7.2.5.5. It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.\n\n3.7.2.5.6. Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.\n3.7.2.5.7. There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.\n3.7.2.5.8. In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.\n3.7.2.5.9. However, specification of the actual limit dose will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.\n\n\n3.7.3. Classification criteria for mixtures\n\n\n3.7.3.1. Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture\n3.7.3.1.1. The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.\n3.7.3.1.2. The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.\n\nTable 3.7.2\nGeneric concentration limits of ingredients of a mixture classified as reproduction toxicants or for effects on or via lactation that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of a mixture as:\nCategory 1A reproductive toxicant\nCategory 1B reproductive toxicant\nCategory 2 reproductive toxicant\nAdditional category for effects on or via lactation\nCategory 1A reproductive toxicant\n≥ 0,3 %\n[Note 1]\n\n\n\nCategory 1B reproductive toxicant\n\n≥ 0,3 %\n[Note 1]\n\n\nCategory 2 reproductive toxicant\n\n\n≥ 3,0 %\n[Note 1]\n\nAdditional category for effects on or via lactation\n\n\n\n≥ 0,3 %\n[Note 1]\n\n\nNote\nThe concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).\n\nNote 1\nIf a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request.\n\n\n3.7.3.2. Classification of mixtures when data are available for the complete mixture\n3.7.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.\n\n\n3.7.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.\n\n\n3.7.4. Hazard Communication\n3.7.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.7.3\n\n\nTable 3.7.3\nLabel elements for reproductive toxicity\n\nClassification\nCategory 1A or Category 1B\nCategory 2\nAdditional category for effects on or via lactation\nGHS Pictograms\n\n\nNo pictogram\nSignal Word\nDanger\nWarning\nNo signal word\nHazard Statement\nH360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH362: May cause harm to breast-fed children.\nPrecautionary Statement Prevention\nP201\nP202\nP281\nP201\nP202\nP281\nP201\nP260\nP263\nP264\nP270\nPrecautionary Statement Response\nP308 + P313\nP308 + P313\nP308 + P313\nPrecautionary Statement Storage\nP405\nP405\n\nPrecautionary Statement Disposal\nP501\nP501\n\n\n\n3.8. Specific target organ toxicity — single exposure\n\n\n3.8.1. Definitions and general considerations\n3.8.1.1. Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).\n3.8.1.2. Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.\n3.8.1.3. These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.\n\n3.8.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.\n3.8.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.\n3.8.1.6. Specific target organ toxicity following a repeated exposure is classified as described in Specific target organ toxicity — Repeated exposure (section 3.9) and is therefore excluded from section 3.8. Other specific toxic effects, listed below, are assessed separately and consequently are not included here:\n\n(a) Acute toxicity (section 3.1);\n\n(b) Skin corrosion/irritation (section 3.2);\n\n(c) Serious eye damage/eye irritation (section 3.3);\n\n(d) Respiratory or skin sensitisation (section 3.4);\n\n(e) Germ cell mutagenicity (section 3.5);\n\n(f) Carcinogenicity (section 3.6);\n\n(g) Reproductive toxicity (section 3.7); and\n\n(h) Aspiration toxicity (section 3.10).\n3.8.1.7. The hazard class Specific Target Organ Toxicity — Single Exposure is differentiated into:\n\nSpecific target organ toxicity — single exposure, Category 1 and 2;\nSpecific target organ toxicity — single exposure, Category 3.\nSee Table 3.8.1.\n\nTable 3.8.1\nCategories for specific target organ toxicity-single exposure\n\nNote: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).\n\nCategories\nCriteria\nCategory 1\nSubstances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure\nSubstances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:\n\n(a) reliable and good quality evidence from human cases or epidemiological studies; or\n\n(b) observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.\nCategory 2\nSubstances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure\nSubstances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.\nIn exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).\nCategory 3\nTransient target organ effects\nThis category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.\n\n\n3.8.2. Classification criteria for substances\n\n\n3.8.2.1. Substances of Category 1 and Category 2\n3.8.2.1.1. Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).\n3.8.2.1.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).\n3.8.2.1.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.\n3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.\n3.8.2.1.5. The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.\n3.8.2.1.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of target organ toxicity in Category 2:\n\n(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or\n\n(b) based on the nature and severity of effects.\nDose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.\n\n\n3.8.2.1.7. Effects considered to support classification for Category 1 and 2\n3.8.2.1.7.1. Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.\n3.8.2.1.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.\n3.8.2.1.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:\n\n(a) morbidity resulting from single exposure;\n\n(b) significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);\n\n(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;\n\n(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;\n\n(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;\n\n(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;\n\n\n(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.\n\n\n3.8.2.1.8. Effects considered not to support classification for Category 1 and 2\nIt is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:\n\n(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate significant toxicity;\n\n(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;\n\n(c) changes in organ weights with no evidence of organ dysfunction;\n\n(d) adaptive responses that are not considered toxicologically relevant;\n\n(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.\n\n\n3.8.2.1.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals for Category 1 and 2\n3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.\n3.8.2.1.9.2. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).\n3.8.2.1.9.3. The guidance value (C) ranges for single-dose exposure which has produced a significant non-lethal toxic effect are those applicable to acute toxicity testing, as indicated in Table 3.8.2.\n\n\nTable 3.8.2\nGuidance value ranges for single-dose exposures a\n\n\nGuidance value ranges for:\nRoute of exposure\nUnits\nCategory 1\nCategory 2\nCategory 3\nOral (rat)\nmg/kg body weight\nC ≤ 300\n2000 ≥ C > 300\nGuidance values do not apply b\nDermal (rat or rabbit)\nmg/kg body weight\nC ≤ 1000\n2000 ≥ C > 1000\nInhalation (rat) gas\nppmV/4h\nC ≤ 2500\n20000 ≥ C > 2500\nInhalation (rat) vapour\nmg/l/4h\nC ≤ 10\n20 ≥ C > 10\nInhalation (rat) dust/mist/fume\nmg/l/4h\nC ≤ 1,0\n5,0 ≥ C > 1,0\n\nNote\n\n(a) The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.\n\n(b) Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation.\n\n\n3.8.2.1.10. Other considerations\n3.8.2.1.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.\n3.8.2.1.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.\n3.8.2.1.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.\n\n3.8.2.1.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection\n\n\n3.8.2.2. Substances of Category 3: Transient target organ effects\n\n\n3.8.2.2.1. Criteria for respiratory tract irritation\nThe criteria for classifying substances as Category 3 for respiratory tract irritation are:\n\n(a) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;\n\n(b) subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);\n\n(c) the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of irritation shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;\n\n(d) there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;\n\n(e) this special classification would occur only when more severe organ effects including in the respiratory system are not observed.\n\n\n3.8.2.2.2 Criteria for narcotic effects\nThe criteria for classifying substances as Category 3 for narcotic effects are:\n\n(a) central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;\n\n(b) narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.\n\n\n\n3.8.3. Classification criteria for mixtures\n3.8.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.\n\n\n3.8.3.2. Classification of mixtures when data are available for the complete mixture\n3.8.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.\n\n\n3.8.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.8.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.\n\n\n3.8.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.8.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.\n3.8.3.4.2. These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.\n3.8.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.\n\nTable 3.8.3\nGeneric concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture as Category 1 or 2\n\nIngredient classified as:\nGeneric concentration limits triggering classification of the mixture as:\nCategory 1\nCategory 2\nCategory 1\nSpecific Target Organ Toxicant\nConcentration ≥ 10 %\n1,0 % ≤ concentration < 10 %\nCategory 2\nSpecific Target Organ Toxicant\n\nConcentration ≥ 10 % [(Note 1)]\n\nNote 1\nIf a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.\n3.8.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.\n3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised. Respiratory tract irritation and narcotic effects are to be evaluated separately in accordance with the criteria given in section 3.8.2.2. When conducting classifications for these hazards, the contribution of each component should be considered additive, unless there is evidence that the effects are not additive.\n\n\n3.8.4. Hazard Communication\n3.8.4.1 Label elements shall be used in accordance with Table 3.8.4., for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.8.4\nLabel elements for specific target organ toxicity after single exposure\n\nClassification\nCategory 1\nCategory 2\nCategory 3\nGHS Pictograms\n\n\n\nSignal Word\nDanger\nWarning\nWarning\nHazard Statement\nH370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH335: May cause respiratory irritation; or\nH336: May cause drowsiness or dizziness\nPrecautionary Statement Prevention\nP260\nP264\nP270\nP260\nP264\nP270\nP261\nP271\nPrecautionary Statement Response\nP307 + P311\nP321\nP309 + P311\nP304 + P340\nP312\nPrecautionary Statement Storage\nP405\nP405\nP403 + P233\nP405\nPrecautionary Statement Disposal\nP501\nP501\nP501\n\n\n3.9. Specific target organ toxicity — repeated exposure\n\n\n3.9.1. Definitions and general considerations\n3.9.1.1. Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.\n3.9.1.2. Classification for target organ toxicity (repeated exposure) identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.\n3.9.1.3. These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.\n3.9.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.\n3.9.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.\n3.9.1.6. Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.\n\n\n3.9.2. Classification criteria for substances\n3.9.2.1. Substances are classified as specific target organ toxicants following repeated exposure by the use of expert judgement (see 1.1.1), on the basis of the weight of all evidence available, including the use of recommended guidance values which take into account the duration of exposure and the dose/concentration which produced the effect(s), (see 3.9.2.9), and are placed in one of two categories, depending upon the nature and severity of the effect(s) observed (Table 3.9.1).\n\n\nTable 3.9.1\nCategories for specific target organ toxicity-repeated exposure\n\nCategories\nCriteria\nCategory 1\nSubstances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.\nSubstances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:\n\nreliable and good quality evidence from human cases or epidemiological studies; or\nobservations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.\nCategory 2\nSubstances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.\nSubstances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.\nIn exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).\n\nNote\nAttempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).\n3.9.2.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified.\n3.9.2.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.\n3.9.2.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.\n3.9.2.5. The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.\n3.9.2.6. In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of specific target organ toxicity in Category 2:\n\n(a) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or\n\n(b) based on the nature and severity of effects.\nDose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.\n\n\n3.9.2.7. Effects considered to support classification for specific target organ toxicity following repeated exposure\n3.9.2.7.1. Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.\n3.9.2.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.\n3.9.2.7.3. Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, haematology, clinical chemistry, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, shall be taken into consideration in the classification process, including but not limited to the following toxic effects in humans and/or animals:\n\n(a) morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;\n\n(b) significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);\n\n\n(c) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;\n\n(d) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;\n\n(e) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;\n\n(f) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);\n\n(g) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.\n\n\n3.9.2.8. Effects considered not to support classification for specific target organ toxicity following repeated exposure\n3.9.2.8.1. It is recognised that effects may be seen in humans and/or animals that do not justify classification. Such effects include, but are not limited to:\n\n(a) clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate significant toxicity;\n\n(b) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;\n\n(c) changes in organ weights with no evidence of organ dysfunction;\n\n(d) adaptive responses that are not considered toxicologically relevant;\n\n(e) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.\n\n\n3.9.2.9. Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals\n3.9.2.9.1. In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.\n3.9.2.9.2. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration guidance values are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.\n3.9.2.9.3. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).\n3.9.2.9.4. The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.\n3.9.2.9.5. The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.\n3.9.2.9.6. Thus classification in Category 1 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur at or below the guidance values (C) as indicated in Table 3.9.2:\n\nTable 3.9.2\nGuidance values to assist in Category 1 classification\n\nRoute of exposure\nUnits\nGuidance values (dose/concentration)\nOral (rat)\nmg/kg body weight/day\nC ≤ 10\nDermal (rat or rabbit)\nmg/kg body weight/day\nC ≤ 20\nInhalation (rat)gas\nppmV/6h/day\nC ≤ 50\nInhalation (rat)vapour\nmg/litre/6h/day\nC ≤ 0,2\nInhalation (rat) dust/mist/fume\nmg/litre/6h/day\nC ≤ 0,02\n3.9.2.9.7. Classification in Category 2 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur within the guidance value ranges as indicated in Table 3.9.3:\n\n\nTable 3.9.3\nGuidance values to assist in Category 2 classification\n\nRoute of Exposure\nUnits\nGuidance Value Ranges:\n(dose/concentration)\nOral (rat)\nmg/kg body weight/day\n10 < C ≤ 100\nDermal (rat or rabbit)\nmg/kg body weight/day\n20 < C ≤ 200\nInhalation (rat) gas\nppmV/6h/day\n50 < C ≤ 250\nInhalation (rat)vapour\nmg/litre/6h/day\n0,2 < C ≤ 1,0\nInhalation (rat) dust/mist/fume\nmg/litre/6h/day\n0,02 < C ≤ 0,2\n3.9.2.9.8. The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.\n3.9.2.9.9. Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.\n\n\n3.9.2.10. Other considerations\n3.9.2.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.\n3.9.2.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.\n\n3.9.2.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.\n3.9.2.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection\n\n\n3.9.3. Classification criteria for mixtures\n3.9.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.\n\n\n3.9.3.2. Classification of mixtures when data are available for the complete mixture\n3.9.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.\n\n\n3.9.3.3. Classification of mixtures when data are not available for the complete mixture: bridging principles\n3.9.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.\n\n\n3.9.3.4. Classification of mixtures when data are available for all components or only for some components of the mixture\n3.9.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, repeat exposure, or both when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as laid out in Table 3.9.4 for Category 1 and 2 respectively.\n\nTable 3.9.4\nGeneric concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture\n\nIngredient classified as:\nGeneric concentration limits triggering classification of the mixture as:\nCategory 1\nCategory 2\nCategory 1\nSpecific Target Organ Toxicant\nConcentration ≥ 10 %\n1,0 % ≤ concentration < 10 %\nCategory 2\nSpecific Target Organ Toxicant\n\nConcentration ≥ 10 % [(Note 1)]\n\nNote 1\nIf a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.\n3.9.3.4.2. These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.\n3.9.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.\n3.9.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.\n\n\n3.9.4. Hazard Communication\n3.9.4.1. Label elements shall be used in accordance with Table 3.9.5 for substances or mixtures meeting the criteria for classification in this hazard class.\n\nTable 3.9.5\nLabel elements for specific target organ toxicity after repeated exposure\n\nClassification\nCategory 1\nCategory 2\nGHS Pictograms\n\n\nSignal word\nDanger\nWarning\nHazard Statement\nH372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nH373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)\nPrecautionary Statement Prevention\nP260\nP264\nP270\nP260\nPrecautionary Statement Response\nP314\nP314\nPrecautionary Statement Storage\n\n\nPrecautionary Statement Disposal\nP501\nP501\n\n\n\n3.10. Aspiration hazard\n\n\n3.10.1. Definitions and general considerations\n3.10.1.1. These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.\n3.10.1.2 Aspiration means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.\n3.10.1.3. Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.\n3.10.1.4. Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.\n3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.\n\n\n3.10.1.6. Specific considerations\n3.10.1.6.1. A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.\n3.10.1.6.2. The classification criteria refer to kinematic viscosity. The following provides the conversion between dynamic and kinematic viscosity:\nDynamic viscosity mPa sDensity gcm3\n\nKinematic viscosity mm2s\n\n3.10.1.6.2a Although the definition of aspiration in section 3.10.1.2 includes the entry of solids into the respiratory system, classification according to point (b) in Table 3.10.1 for Category 1 is intended to apply to liquid substances and mixtures only.\n\n\n\n3.10.1.6.3. Classification of aerosol/mist products\nAerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.\n\n\n\n3.10.2. Classification criteria for substances\n\nTable 3.10.1\nHazard category for aspiration toxicity\n\nCategory\nCriteria\nCategory 1\nSubstances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard\nA substance is classified in Category 1:\n\n(a) based on reliable and good quality human evidence\nor\n\n(b) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.\n\nNote:\nSubstances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil.\n\n\n3.10.3. Classification criteria for mixtures\n\n\n3.10.3.1. Classification when data are available for the complete mixture\nA mixture is classified in Category 1 based on reliable and good quality human evidence.\n\n\n3.10.3.2. Classification when data are not available for the complete mixture: bridging principles\n3.10.3.2.1. Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.\n\n\n3.10.3.3. Classification when data are available for all components or only some components of the mixture\n\n\n3.10.3.3.1. Category 1\n3.10.3.3.1.1. A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.\n3.10.3.3.1.2. In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.\n\n\n3.10.4. Hazard Communication\n3.10.4.1. Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.10.2.\n\n\nTable 3.10.2\nAspiration toxicity label elements\n\nClassification\nCategory 1\nGHS Pictogram\n\nSignal Word\nDanger\nHazard Statement\nH304: May be fatal if swallowed and enters airways\nPrecautionary Statement\nPrevention\n\nPrecautionary Statement\nResponse\nP301 + P310\nP331\nPrecautionary Statement\nStorage\nP405\nPrecautionary Statement\nDisposal\nP501\n\n\n\n\n4. PART 4: ENVIRONMENTAL HAZARDS\n\n\n4.1. Hazardous to the aquatic environment\n\n\n4.1.1. Definitions and general considerations\n\n\n4.1.1.1. Definitions\n\n(a) acute aquatic toxicity means the intrinsic property of a substance to be injurious to an aquatic organism in a short-term aquatic exposure to that substance.\n\n(b) acute (short-term) hazard means for classification purposes the hazard of a substance or mixture caused by its acute toxicity to an organism during short-term aquatic exposure to that substance or mixture.\n\n(c) availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (M°) compound can disaggregate from the rest of the compound (molecule).\n\n(d) bioavailability or biological availability means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.\n\n(e) bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).\n\n(f) bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.\n\n(g) chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during aquatic exposures which are determined in relation to the life-cycle of the organism.\n\n(h) degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.\n\n(i) ECx means the effect concentration associated with x% response.\n\n(j) long-term hazard means for classification purposes the hazard of a substance or mixture caused by its chronic toxicity following long-term exposure in the aquatic environment.\n\n(k) no observed effect concentration (NOEC) means the test concentration immediately below the lowest tested concentration with statistically significant adverse effect. The NOEC has no statistically significant adverse effect compared to the control.\n\n\n4.1.1.2. Basic elements\n4.1.1.2.0.\nHazardous to the aquatic environment is differentiated into:\n\nacute aquatic hazard,\nlong-term aquatic hazard.\n4.1.1.2.1.\nThe basic elements used for classification for aquatic environmental hazards are:\n\nacute aquatic toxicity,\n\nchronic aquatic toxicity,\npotential for or actual bioaccumulation, and\ndegradation (biotic or abiotic) for organic chemicals.\n4.1.1.2.2.\nPreferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test methods used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1 of Annex I to Regulation (EC) No 1272/2008.\n\n\n4.1.1.3. Other considerations\n4.1.1.3.1.\nClassification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of acute (short-term) and long-term hazards is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.\n4.1.1.3.2.\nWhile the classification system applies to all substances and mixtures, it is recognised that for special cases (e.g. metals) the European Chemicals Agency has issued guidance.\n\n\n4.1.2. Classification criteria for substances\n4.1.2.1.\nThe system for classification recognises that the intrinsic hazard to aquatic organisms is represented by both the acute and long-term hazard of a substance. For the long-term hazard, separate hazard categories are defined representing a gradation in the level of hazard identified. The lowest of the available toxicity values between and within the different trophic levels (fish, crustacean, algae/aquatic plants) shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.\n4.1.2.2.\nThe core classification system for substances consists of one acute hazard classification category and three long-term hazard classification categories. The acute and the long-term hazard classification categories are applied independently.\n4.1.2.3.\nThe criteria for classification of a substance in category Acute 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the categories Chronic 1 to 3 follow a tiered approach where the first step is to see if available information on chronic toxicity merits long-term hazard classification. In absence of adequate chronic toxicity data, the subsequent step is to combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data) (see figure 4.1.1).\n\n\nFigure 4.1.1\nCategories for substances long-term hazardous to the aquatic environment\nAre there adequate chronic toxicity data available for all three trophic levels?\nYes\nClassify according to the criteria given in Table 4.1.0(b) (i) or 4.1.0(b)(ii) depending on information on rapid degradation\nNo\nAre there adequate chronic toxicity data available for one or two trophic levels?\nYes\nAssess both:\n(a) according to the criteria given in Table 4.1.0(b)(i) or 4.1.0(b)(ii) (depending on information on rapid degradation), and\n(b) (if for the other trophic level(s) adequate acute toxicity data are available) according to the criteria given in Table 4.1.0(b) (iii),\nand classify according to the most stringent outcome\nNo\nAre there adequate acute toxicity data available?\nYes\nClassify according to the criteria given in Table 4.1.0(b) (iii)\n\n4.1.2.4.\nThe system also introduces a safety net classification (referred to as category Chronic 4) for use when the data available do not allow classification under the formal criteria for acute 1 or chronic 1 to 3 but there are nevertheless some grounds for concern (see example in Table 4.1.0).\n4.1.2.5.\nSubstances with acute toxicities below 1 mg/l or chronic toxicities below 0,1 mg/l (if non-rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and section 4.1.3.5.5).\n4.1.2.6.\nThe criteria for classifying and categorising substances as hazardous to the aquatic environment are summarised in Table 4.1.0.\n\nTable 4.1.0\nClassification categories for hazardous to the aquatic environment\n\n(a) Acute (short-term) aquatic hazard\nCategory Acute 1: (Note 1)\n96 hr LC50 (for fish)\n≤ 1 mg/l and/or\n48 hr EC50 (for crustacea)\n≤ 1 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n≤ 1 mg/l. (Note 2)\n(b) Long-term aquatic hazard\n(i) Non-rapidly degradable substances (Note 3) for which there are adequate chronic toxicity data available\nCategory Chronic 1: (Note 1)\nChronic NOEC or ECx (for fish)\n≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n≤0,1 mg/l.\nCategory Chronic 2:\nChronic NOEC or ECx (for fish)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,1 to ≤ 1 mg/l.\n\n(ii) Rapidly degradable substances (Note 3) for which there are adequate chronic toxicity data available\nCategory Chronic 1: (Note 1)\nChronic NOEC or ECx (for fish)\n≤ 0,01 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n≤ 0,01 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n≤ 0,01 mg/l.\nCategory Chronic 2:\nChronic NOEC or ECx (for fish)\n> 0,01 to ≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,01 to ≤ 0,1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,01 to ≤ 0,1 mg/l.\nCategory Chronic 3:\nChronic NOEC or ECx (for fish)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for crustacea)\n> 0,1 to ≤ 1 mg/l and/or\nChronic NOEC or ECx (for algae or other aquatic plants)\n> 0,1 to ≤ 1 mg/l.\n(iii) Substances for which adequate chronic toxicity data are not available\nCategory Chronic 1: (Note 1)\n96 hr LC50 (for fish)\n≤ 1 mg/l and/or\n48 hr EC50 (for crustacea)\n≤ 1 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n≤ 1 mg/l. (Note 2)\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nCategory Chronic 2:\n96 hr LC50 (for fish)\n> 1 to ≤10 mg/l and/or\n48 hr EC50 (for crustacea)\n> 1 to ≤10 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n> 1 to ≤10 mg/l (Note 2)\n\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nCategory Chronic 3:\n96 hr LC50 (for fish)\n> 10 to ≤ 100 mg/l and/or\n48 hr EC50 (for crustacea)\n> 10 to ≤ 100 mg/l and/or\n72 or 96 hr ErC50 (for algae or other aquatic plants)\n> 10 to ≤ 100 mg/l. (Note 2)\nand the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow≥ 4). (Note 3).\nSafety net classification\nCategory Chronic 4\nCases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 4), and which are not rapidly degradable in accordance with section 4.1.2.9.5 and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, which will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or other evidence of rapid degradation in the environment than the ones provided by any of the methods listed in section 4.1.2.9.5.\n\n\nNote 1:\nWhen classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate the appropriate M-factor(s) (see Table 4.1.3).\n\nNote 2:\nClassification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.\n\nNote 3:\nWhen no useful data on degradability are available, either experimentally determined or estimated data, the substance should be regarded as not rapidly degradable.\n\nNote 4:\nNo acute toxicity is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity.\n\n\n4.1.2.7. Aquatic toxicity\n4.1.2.7.1.\nAcute aquatic toxicity is normally determined using a fish 96-hour LC50, a crustacea species 48-hour EC50 and/or an algal species 72- or 96-hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).\n4.1.2.7.2.\nFor determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECs or other equivalent ECx (e.g. EC10) shall be used.\n\n\n4.1.2.8. Bioaccumulation\n4.1.2.8.1.\nBioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes. Some relationships can be observed between chronic toxicity and bioaccumulation potential, as toxicity is related to the body burden.\n\n\n4.1.2.9. Rapid degradability of organic substances\n4.1.2.9.1.\nSubstances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.\n4.1.2.9.2.\nOne way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is readily biodegradable. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade rapidly in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of rapid degradability is met.\n4.1.2.9.3.\nMany degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.\n\n4.1.2.9.4.\nThe criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.\n4.1.2.9.5.\nSubstances are considered rapidly degradable in the environment if one of the following criteria holds true:\n\n(a) if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved:\n\n(i) tests based on dissolved organic carbon: 70 %;\n\n(ii) tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.\nThese levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded, unless the substance is identified as an UVCB or as a complex, multi-constituent substance with structurally similar constituents. In this case, and where there is sufficient justification, the 10-day window condition may be waived and the pass level applied at 28 days; or\n\n(b) if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or\n\n(c) if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.\n\n\n4.1.2.10. Inorganic compounds and metals\n4.1.2.10.1.\nFor inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with careSpecific guidance has been issued by the European Chemicals Agency on how these data for such substances may be used in meeting the requirements of the classification criteria..\n4.1.2.10.2.\nPoorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution. All evidence must be weighed in a classification decision. This would be especially true for metals showing borderline results in the Transformation/Dissolution Protocol.\n\n\n4.1.3. Classification criteria for mixtures\n4.1.3.1.\nThe classification system for mixtures covers all classification categories which are used for substances, i.e. categories Acute 1 and Chronic 1 to 4. In order to make use of all available data for purposes of classifying the aquatic environmental hazards of the mixture, the following is applied where appropriate:\nThe relevant components of a mixture are those which are classified Acute 1or Chronic 1 and present in a concentration of 0,1 % (w/w) or greater, and those which are classified Chronic 2, Chronic 3 or Chronic 4 and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see section 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as Acute 1 or Chronic 1 the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see section 4.1.3.5.5.5.)\n4.1.3.2.\nThe approach for classification of aquatic environmental hazards is tiered, and is dependent upon the type of information available for the mixture itself and for its components. Figure 4.1.2 outlines the process to be followed.\nElements of the tiered approach include:\n\nclassification based on tested mixtures,\nclassification based on bridging principles,\nthe use of summation of classified components and/or an additivity formula.\n\nFigure 4.1.2\nTiered approach to classification of mixtures for acute and long-term aquatic environmental hazards\nAquatic toxicity test data available on the mixture as a whole\nNo\nYes\nCLASSIFY\nfor acute/long-term aquatic hazard (see 4.1.3.3)\nSufficient data available on similar mixtures to estimate hazards\nYes\nApply bridging principles (see 4.1.3.4.)\nCLASSIFY\nfor acute/long-term aquatic hazard\nNo\nEither aquatic toxicity or classification data available for all relevant components\nYes\nApply summation method (see 4.1.3.5.5) using:\n• Percentage of all components classified as ‘Chronic’\n• Percentage of components classified as ‘Acute’\n• Percentage of components with acute or chronic toxicity data: apply additivity formulas (see 4.1.3.5.2) and convert the derived L(E)C50 or EqNOECm to the appropriate ‘Acute’ or ‘Chronic’ category\nCLASSIFY\nfor acute/long-term aquatic hazard\nNo\nUse available hazard data of known components\nApply summation method and/or additivity formula (see 4.1.3.5) and apply 4.1.3.6\nCLASSIFY\nfor acute/long-term aquatic hazard\n\n\n4.1.3.3. Classification of mixtures when toxicity data are available for the complete mixture\n4.1.3.3.1.\nWhen the mixture as a whole has been tested to determine its aquatic toxicity, this information can be used for classifying the mixture according to the criteria that have been agreed for substances. The classification is normally based on the data for fish, crustacea and algae/plants (see sections 4.1.2.7.1 and 4.1.2.7.2). When adequate acute or chronic toxicity data for the mixture as a whole are lacking, bridging principles or summation method should be applied (see sections 4.1.3.4 and 4.1.3.5).\n\n4.1.3.3.2.\nThe long-term hazard classification of mixtures requires additional information on degradability and in certain cases bioaccumulation. Degradability and bioaccumulation tests for mixtures are not used as they are usually difficult to interpret, and such tests may be meaningful only for single substances.\n\n\n4.1.3.3.3. Classification for category Acute 1\n\n(a) When there are adequate acute toxicity test data (LC50 or EC50) available for the mixture as a whole showing L(E)C50 ≤ 1 mg/l:\nClassify mixture as Acute 1 in accordance with point (a) of Table 4.1.0.\n\n(b) When there are acute toxicity test data (LC50(s) or EC50(s)) available for the mixture as a whole showing L(E)C50(s) > 1 mg/l for normally all trophic levels:\nNo need to classify for acute hazard.\n\n\n4.1.3.3.4. Classification for categories Chronic 1, 2 and 3\n\n(a) When there are adequate chronic toxicity data (ECxx or NOEC) available for the mixture as a whole showing ECx or NOEC of the tested mixture ≤ 1mg/l:\n\n(i) Classify the mixture as Chronic 1, 2 or 3 in accordance with point (b)(ii) of Table 4.1.0 as rapidly degradable if the available information allows the conclusion that all relevant components of the mixture are rapidly degradable;\n\n(ii) Classify the mixture as Chronic 1 or 2 in all other cases in accordance with point (b)(i) of Table 4.1.0 as non-rapidly degradable;\n\n(b) When there are adequate chronic toxicity data (ECx or NOEC) available for the mixture as a whole showing ECx(s) or NOEC(s) of the tested mixture > 1 mg/l for normally all trophic levels:\nNo need to classify for long-term hazard in categories Chronic 1, 2 or 3.\n\n\n4.1.3.3.5. Classification for category Chronic 4\nIf there are nevertheless reasons for concern:\nClassify the mixture as Chronic 4 (safety net classification) in accordance with Table 4.1.0.\n\n\n4.1.3.4. Classification of mixtures when toxicity data are not available for the complete mixture: bridging principles\n4.1.3.4.1.\nWhere the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, sections 4.1.3.4.2 and 4.1.3.4.3 shall be used.\n4.1.3.4.2.\nDilution: if a mixture is formed by diluting another tested mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the resulting mixture may be classified as equivalent to the original tested mixture or substance. Alternatively, the method explained in section 4.1.3.5 may be applied.\n4.1.3.4.3.\nIf a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance.\n\n\n4.1.3.5. Classification of mixtures when toxicity data are available for some or all components of the mixture\n4.1.3.5.1.\nThe classification of a mixture is based on summation of the concentration of its classified components. The percentage of components classified as Acute or Chronic is fed straight in to the summation method. Details of the summation method are described in section 4.1.3.5.5.\n4.1.3.5.2.\nMixtures can be made of a combination of both components that are classified (as Acute 1 and/or Chronic 1, 2, 3, 4) and others for which adequate toxicity test data is available. When adequate toxicity data are available for more than one component in the mixture, the combined toxicity of those components is calculated using the following additivity formulas (a) or (b), depending on the nature of the toxicity data:\n\n(a) Based on acute aquatic toxicity:\nCiLEC50m\n\nnCiLEC50i\nwhere:\n\nCi\nconcentration of component i (weight percentage);\nL(E)C50i\n(mg/l) LC50 or EC50 for component i;\nη\nnumber of components, and i is running from 1 to n;\nL(E)C50m\nL(E) C50 of the part of the mixture with test data.\nThe calculated toxicity may be used to assign that portion of the mixture an acute hazard category which is then subsequently used in applying the summation method;\n\n(b) Based on chronic aquatic toxicity:\nCiCjEqNOECm\n\nnCiNOECinCj0,1NOECj\nwhere:\n\nCi\nconcentration of component i (weight percentage) covering the rapidly degradable components;\nCj\nconcentration of component j (weight percentage) covering the non- rapidly degradable components;\nNOECi\nNOEC (or other recognised measures for chronic toxicity) for component i covering the rapidly degradable components, in mg/l;\nNOECj\nNOEC (or other recognised measures for chronic toxicity) for component j covering the non-rapidly degradable components, in mg/l;\nn\nnumber of components, and i and j are running from 1 to n;\nEqNOECm\nEquivalent NOEC of the part of the mixture with test data.\n\nThe equivalent toxicity thus reflects the fact that non-rapidly degrading substances are classified one hazard category level more severe than rapidly degrading substances.\nThe calculated equivalent toxicity may be used to assign that portion of the mixture a long-term hazard category, in accordance with the criteria for rapidly degradable substances (point (b)(ii) of Table 4.1.0), which is then subsequently used in applying the summation method.\n4.1.3.5.3.\nWhen applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, crustacean, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute and chronic toxicity is then used to assess whether this part of the mixture shall be classified as Acute 1 and/or Chronic 1, 2 or 3 using the same criteria described for substances.\n4.1.3.5.4.\nIf a mixture is classified in more than one way, the method yielding the more conservative result shall be used.\n\n\n4.1.3.5.5. Summation method\n\n\n4.1.3.5.5.1. Rationale\n4.1.3.5.5.1.1.\nIn case of the substance classification categories Chronic 1 to Chronic 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of any substance classified as Chronic 1, 2 or 3.\n4.1.3.5.5.1.2.\nWhen a mixture contains components classified as Acute 1 or Chronic 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l and/or chronic toxicity is below 0,1 mg/l (if non rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an under-classification of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in section 4.1.3.5.5.5.\n\n\n4.1.3.5.5.2. Classification procedure\n4.1.3.5.5.2.1.\nIn general a more severe classification for mixtures overrides a less severe classification, e.g. a classification with Chronic 1 overrides a classification with Chronic 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic 1. A more severe classification than Chronic 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.\n\n\n\n4.1.3.5.5.3. Classification for category Acute 1\n4.1.3.5.5.3.1.\nFirst all components classified as Acute 1 are considered. If the sum of the concentrations (in %) of these components multiplied by their corresponding M-factors is greater than 25 % the whole mixture is classified as Acute 1.\n4.1.3.5.5.3.2.\nThe classification of mixtures for acute hazards based on this summation of classified components is summarised in Table 4.1.1.\n\nTable 4.1.1\nClassification of a mixture for acute hazards, based on summation of classified components\n\nFor explanation of the M-factor, see 4.1.3.5.5.5.\n\nSum of components classified as:\nMixture is classified as:\nAcute 1 × M ≥ 25 %\nAcute 1\n\n\n4.1.3.5.5.4. Classification for the categories Chronic 1, 2, 3 and 4\n4.1.3.5.5.4.1.\nFirst all components classified as Chronic 1 are considered. If the sum of the concentrations (in %) of these components multiplied by their corresponding M-factors is equal to or greater than 25 %, the mixture is classified as Chronic 1. If the result of the calculation is a classification of the mixture as Chronic 1, the classification procedure is completed.\n4.1.3.5.5.4.2.\nIn cases where the mixture is not classified as Chronic 1, classification of the mixture as Chronic 2 is considered. A mixture is classified as Chronic 2 if 10 times the sum of the concentrations (in %) of all components classified as Chronic 1 multiplied by their corresponding M-factors plus the sum of the concentrations (in %) of all components classified as Chronic 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic 2, the classification process is completed.\n4.1.3.5.5.4.3.\nIn cases where the mixture is not classified either as Chronic 1 or Chronic 2, classification of the mixture as Chronic 3 is considered. A mixture is classified as Chronic 3 if 100 times the sum of the concentrations (in %) of all components classified as Chronic 1 multiplied by their corresponding M-factors plus 10 times the sum of the concentrations (in %) of all components classified with Chronic 2 plus the sum of the concentrations (in %) of all components classified as Chronic 3 is ≥ 25 %.\n4.1.3.5.5.4.4.\nIf the mixture is still not classified in Chronic 1, 2 or 3, classification of the mixture as Chronic 4 shall be considered. A mixture is classified as Chronic 4 if the sum of the concentrations (in %) of components classified as Chronic 1, 2, 3 and 4 is equal to or greater than 25 %.\n4.1.3.5.5.4.5.\nThe classification of mixtures for long-term hazards, based on this summation of the concentrations of classified components, is summarised in Table 4.1.2.\n\n\nTable 4.1.2\nClassification of a mixture for long-term hazards, based on summation of the concentrations of classified components\n\nFor explanation of the M-factor, see 4.1.3.5.5.5.\n\nSum of components classified as:\nMixture is classified as:\nChronic 1 × M ≥ 25 %\nChronic 1\n(M × 10 × Chronic 1) + Chronic 2 ≥ 25 %\nChronic 2\n(M × 100 × Chronic 1) + (10 × Chronic 2) + Chronic 3 ≥ 25 %\nChronic 3\nChronic 1 + Chronic 2 + Chronic 3 + Chronic 4 ≥ 25 %\nChronic 4\n\n\n4.1.3.5.5.5. Mixtures with highly toxic components\n4.1.3.5.5.5.1.\nAcute 1 and Chronic 1 components with toxicities below 1 mg/l and/or chronic toxicities below 0,1 mg/l (if non-rapidly degradable) and 0,01 mg/l (if rapidly degradable) contribute to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach. When a mixture contains components classified as Acute or Chronic 1, one of the following shall be applied:\n\nthe tiered approach described in sections 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute 1 and Chronic 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of Acute 1 in the left column of Table 4.1.1 and the concentration of Chronic 1 in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method,\nthe additivity formula (see section 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute and/or chronic toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.\n\nTable 4.1.3\nMultiplying factors for highly toxic components of mixtures\n\nNon-rapidly degradable.\nRapidly degradable.\n\nAcute toxicity\nM factor\nChronic toxicity\nM factor\nL(E)C50 value mg/l\n\nNOEC value mg/l\nNRD components\nRD components\n0,1 < L(E)C50 ≤ 1\n1\n0,01 < NOEC ≤ 0,1\n1\n—\n0,01 < L(E)C50 ≤ 0,1\n10\n0,001 < NOEC ≤ 0,01\n10\n1\n0,001 < L(E)C50 ≤ 0,01\n100\n0,0001 < NOEC ≤ 0,001\n100\n10\n0,0001 < L(E)C50 ≤ 0,001\n1000\n0,00001 < NOEC ≤ 0,0001\n1000\n100\n0,00001 < L(E)C50 ≤ 0,0001\n10000\n0,000001 < NOEC ≤ 0,00001\n10000\n1000\n(continue in factor 10 intervals)\n(continue in factor 10 intervals)\n\n\n4.1.3.6. Classification of mixtures with components without any useable information\n4.1.3.6.1.\nIn the event that no useable information on acute and/or long-term aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement on the label and in the SDS that: Contains x % of components with unknown hazards to the aquatic environment.\n\n\n4.1.4. Hazard communication\n4.1.4.1.\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 4.1.4.\n\nTable 4.1.4\nLabel elements for hazardous to the aquatic environment\n\nACUTE AQUATIC HAZARD\n\nAcute 1\nGHS pictogram\n\nSignal word\nWarning\nHazard statement\nH400: Very toxic to aquatic life\nPrecautionary statement prevention\nP273\nPrecautionary statement response\nP391\nPrecautionary statement storage\n\nPrecautionary statement disposal\nP501\n\n\nLONG-TERM AQUATIC HAZARD\n\nChronic 1\nChronic 2\nChronic 3\nChronic 4\nGHS pictograms\n\n\nNo pictogram is used\nNo pictogram is used\nSignal word\nWarning\nNo signal word is used\nNo signal word is used\nNo signal word is used\nHazard statement\nH410: Very toxic to aquatic life with long lasting effects\nH411: Toxic to aquatic life with long lasting effects\nH412: Harmful to aquatic life with long lasting effects\nH413: May cause long lasting harmful effects to aquatic life\nPrecautionary statement prevention\nP273\nP273\nP273\nP273\nPrecautionary statement response\nP391\nP391\n\n\nPrecautionary statement storage\n\n\n\n\nPrecautionary statement disposal\nP501\nP501\nP501\nP501\n\n\n\n\n\n5. PART 5: ADDITIONAL HAZARDS\n\n\n5.1. Hazardous to the ozone layer\n\n\n5.1.1. Definitions and general considerations\n5.1.1.1.\nOzone depleting potential (ODP) is an integrative quantity, distinct for each halocarbon source species, that represents the extent of ozone depletion in the stratosphere expected from the halocarbon on a mass-for-mass basis relative to CFC-11. The formal definition of ODP is the ratio of integrated perturbations to total ozone, for a differential mass emission of a particular compound relative to an equal emission of CFC-11.\nSubstance hazardous to the ozone layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 1005/2009 of the European Parliament and of the Council of 16 September 2009 on substances that deplete the ozone layerOJ L 286, 31.10.2009, p. 1..\n\n\n5.1.2. Classification criteria for substances\n5.1.2.1.\nA substance shall be classified as hazardous to the ozone layer (Category 1) if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.\n\n\n5.1.3. Classification criteria for mixtures\n5.1.3.1.\nMixtures shall be classified as hazardous to the ozone layer (Category 1) on the basis of the individual concentration of the substance(s) contained therein that are also classified as hazardous to the ozone layer (Category 1), in accordance with Table 5.1.\n\nTable 5.1\nGeneric concentration limits for substances (in a mixture), classified as hazardous to the ozone layer (Category 1), that trigger classification of the mixture as hazardous to the ozone layer (Category 1)\n\nClassification of the substance\nClassification of the mixture\nHazardous to the ozone layer (Category 1)\nC ≥ 0,1 %\n\n\n5.1.4. Hazard communication\n5.1.4.1.\nLabel elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 5.2.\n\nTable 5.2\nLabel elements for hazardous to the ozone layer\n\nSymbol/pictogram\n\nSignal word\nWarning\nHazard statement\nH420: Harms public health and the environment by destroying ozone in the upper atmosphere\nPrecautionary statements\nP502\n", "previous_location": null, "changed_within": [ "AN I SCT 2 SCT 2.3 SCT 2.3.4", "AN I SCT 2 SCT 2.15 SCT 2.15.2", "AN I SCT 3 SCT 3.1 SCT 3.1.3 SCT 3.1.3.6 SCT 3.1.3.6.1", "AN I SCT 3 SCT 3.1 SCT 3.1.3 SCT 3.1.3.6 SCT 3.1.3.6.2", "AN I SCT 3 SCT 3.8 SCT 3.8.3 SCT 3.8.3.4", "AN I SCT 3 SCT 3.10 SCT 3.10.1 SCT 3.10.1.6", "AN I SCT 4 SCT 4.1 SCT 4.1.3 SCT 4.1.3.5 SCT 4.1.3.5.2 PTA (a)", "AN I SCT 4 SCT 4.1 SCT 4.1.3 SCT 4.1.3.5 SCT 4.1.3.5.2 PTA (b)" ], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unchanged" }, "signals": { "structural_diff": { "status": "observed", "detail": "structural_diff", "change_types": [ "MODIFIED" ] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": false, "dispute_reason": null }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the difference between the two versions lies beyond the characters this stage can show, so no explanation was requested", "unexplained_kind": "" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN II" }, "heading": null, "before": null, "after": null, "previous_location": null, "changed_within": [], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unknown", "reason": null }, "signals": { "structural_diff": { "status": "absent", "detail": "structural_diff", "change_types": [] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": true, "dispute_reason": "textless_metadata_only" }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships marked disputed", "unexplained_kind": "nothing_to_explain" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN III" }, "heading": "LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS", "before": "\nANNEX III\nLIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS\n\n\n1. Part 1: hazard statements\n\nThe hazard statements shall be applied in accordance with Parts 2, 3, 4 and 5 of Annex I.\nIn selecting the hazard statements in accordance with Articles 21 and 27, suppliers may use the combined hazard statements provided for in this Annex.\nIn accordance with Article 27 the following principles of precedence for hazard statements may apply to labelling:\n\n(a) if the hazard statement H410 Very toxic to aquatic life with long lasting effects is assigned, the statement H400 Very toxic to aquatic life may be omitted;\n\n(b) if the statement H314 Causes severe skin burns and eye damage is assigned, the statement H318 Causes serious eye damage may be omitted.\nIn order to indicate the route of administration or exposure the combined hazard statements in Table 1.2 may be used.\n\n\nTable 1.1\nHazard statements for physical hazards\n\n\nThe codification system for GHS hazard statements is still under discussion in the UN Committee of Experts and therefore amendments might be needed.\n\n\nH200\n\nLanguage\n2.1 — Explosives, Unstable explosives\n\nBG\nНестабилен експлозив.\n\nES\nExplosivo inestable.\n\nCS\nNestabilní výbušnina.\n\nDA\nUstabilt eksplosiv.\n\nDE\nInstabil, explosiv.\n\nET\nEbapüsiv lõhkeaine.\n\nEL\nΑσταθή εκρηκτικά.\n\nEN\nUnstable explosives.\n\nFR\nExplosif instable.\n\nGA\nPléascáin éagobhsaí.\n\nIT\nEsplosivo instabile.\n\nLV\nNestabili sprādzienbīstami materiāli.\n\nLT\nNestabilios sprogios medžiagos.\n\nHU\nInstabil robbanóanyagok.\n\nMT\nSplussivi instabbli.\n\nNL\nInstabiele ontplofbare stof.\n\nPL\nMateriały wybuchowe niestabilne.\n\nPT\nExplosivo instável.\n\nRO\nExploziv instabil.\n\nSK\nNestabilné výbušniny.\n\nSL\nNestabilni eksplozivi.\n\nFI\nEpästabiili räjähde.\n\nSV\nInstabilt explosivt.\n\nH201\nLanguage\n2.1 — Explosives, Division 1.1\n\nBG\nЕксплозив; опасност от масова експлозия.\n\nES\nExplosivo; peligro de explosión en masa.\n\nCS\nVýbušnina; nebezpečí masivního výbuchu.\n\nDA\nEksplosiv, masseeksplosionsfare.\n\nDE\nExplosiv, Gefahr der Massenexplosion.\n\nET\nPlahvatusohtlik; massiplahvatusoht.\n\nEL\nΕκρηκτικό· κίνδυνος μαζικής έκρηξης.\n\nEN\nExplosive; mass explosion hazard.\n\nFR\nExplosif; danger d'explosion en masse.\n\nGA\nPléascach; guais mhórphléasctha.\n\nIT\nEsplosivo; pericolo di esplosione di massa.\n\nLV\nSprādzienbīstams; masveida sprādzienbīstamība.\n\nLT\nSprogios medžiagos, kelia masinio sprogimo pavojų.\n\nHU\nRobbanóanyag; teljes tömeg felrobbanásának veszélye.\n\nMT\nSplussiv; periklu li jisplodu kollha f'daqqa.\n\nNL\nOntplofbare stof; gevaar voor massa-explosie.\n\nPL\nMateriał wybuchowy; zagrożenie wybuchem masowym.\n\nPT\nExplosivo; perigo de explosão em massa.\n\nRO\nExploziv; pericol de explozie în masă.\n\nSK\nVýbušnina, nebezpečenstvo rozsiahleho výbuchu.\n\nSL\nEksplozivno; nevarnost eksplozije v masi.\n\nFI\nRäjähde; massaräjähdysvaara.\n\nSV\nExplosivt. Fara för massexplosion.\n\n\nH202\nLanguage\n2.1 — Explosives, Division 1.2\n\nBG\nЕксплозив; сериозна опасност от разпръскване.\n\nES\nExplosivo; grave peligro de proyección.\n\nCS\nVýbušnina; vážné nebezpečí zasažení částicemi.\n\nDA\nEksplosiv, alvorlig fare for udslyngning af fragmenter.\n\nDE\nExplosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.\n\nET\nPlahvatusohtlik; suur laialipaiskumisoht.\n\nEL\nΕκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.\n\nEN\nExplosive, severe projection hazard.\n\nFR\nExplosif; danger sérieux de projection.\n\nGA\nPléascach, guais throm teilgin.\n\nIT\nEsplosivo; grave pericolo di proiezione.\n\nLV\nSprādzienbīstams; augsta izmetes bīstamība.\n\nLT\nSprogios medžiagos, kelia didelį išsvaidymo pavojų.\n\nHU\nRobbanóanyag; kivetés súlyos veszélye.\n\nMT\nSplussiv, periklu serju ta' projezzjoni.\n\nNL\nOntplofbare stof, ernstig gevaar voor scherfwerking.\n\nPL\nMateriał wybuchowy, poważne zagrożenie rozrzutem.\n\nPT\nExplosivo, perigo grave de projecções.\n\nRO\nExploziv; pericol grav de proiectare.\n\nSK\nVýbušnina, závažné nebezpečenstvo rozletenia úlomkov.\n\nSL\nEksplozivno, velika nevarnost za nastanek drobcev.\n\nFI\nRäjähde; vakava sirpalevaara.\n\nSV\nExplosivt. Allvarlig fara för splitter och kaststycken.\n\n\nH203\nLanguage\n2.1 — Explosives, Division 1.3\n\nBG\nЕксплозив; опасност от пожар, взрив или разпръскване.\n\nES\nExplosivo; peligro de incendio, de onda expansiva o de proyección.\n\nCS\nVýbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.\n\nDA\nEksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.\n\nDE\nExplosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.\n\nET\nPlahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.\n\nEL\nΕκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.\n\nEN\nExplosive; fire, blast or projection hazard.\n\nFR\nExplosif; danger d'incendie, d'effet de souffle ou de projection.\n\nGA\nPléascach; guais dóiteáin, phléasctha nó teilgin.\n\nIT\nEsplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.\n\nLV\nSprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.\n\nLT\nSprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.\n\nHU\nRobbanóanyag; tűz, robbanás vagy kivetés veszélye.\n\nMT\nSplussiv; periklu ta' nar, blast jew projezzjoni.\n\nNL\nOntplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.\n\nPL\nMateriał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.\n\nPT\nExplosivo; perigo de incêndio, sopro ou projecções.\n\nRO\nExploziv; pericol de incendiu, detonare sau proiectare.\n\nSK\nVýbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.\n\nSL\nEksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.\n\nFI\nRäjähde; palo-, räjähdys- tai sirpalevaara.\n\nSV\nExplosivt. Fara för brand, tryckvåg eller splitter och kaststycken.\n\n\nH204\nLanguage\n2.1 — Explosives, Division 1.4\n\nBG\nОпасност от пожар или разпръскване.\n\nES\nPeligro de incendio o de proyección.\n\nCS\nNebezpečí požáru nebo zasažení částicemi.\n\nDA\nFare for brand eller udslyngning af fragmenter.\n\nDE\nGefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.\n\nET\nSüttimis- või laialipaiskumisoht.\n\nEL\nΚίνδυνος πυρκαγιάς ή εκτόξευσης.\n\nEN\nFire or projection hazard.\n\nFR\nDanger d'incendie ou de projection.\n\nGA\nGuais dóiteáin nó teilgin.\n\nIT\nPericolo di incendio o di proiezione.\n\nLV\nUguns vai izmetes bīstamība.\n\nLT\nGaisro arba išsvaidymo pavojus.\n\nHU\nTűz vagy kivetés veszélye.\n\nMT\nPeriklu ta' nar jew ta' projezzjoni.\n\nNL\nGevaar voor brand of scherfwerking.\n\nPL\nZagrożenie pożarem lub rozrzutem.\n\nPT\nPerigo de incêndio ou projecções.\n\nRO\nPericol de incendiu sau de proiectare.\n\nSK\nNebezpečenstvo požiaru alebo rozletenia úlomkov.\n\nSL\nNevarnost za nastanek požara ali drobcev.\n\nFI\nPalo- tai sirpalevaara.\n\nSV\nFara för brand eller splitter och kaststycken.\n\nH205\nLanguage\n2.1 — Explosives, Division 1.5\n\nBG\nМоже да предизвика масова експлозия при пожар.\n\nES\nPeligro de explosión en masa en caso de incendio.\n\nCS\nPři požáru může způsobit masivní výbuch.\n\nDA\nFare for masseeksplosion ved brand.\n\nDE\nGefahr der Massenexplosion bei Feuer.\n\nET\nSüttimise korral massiplahvatusoht.\n\nEL\nΚίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.\n\nEN\nMay mass explode in fire.\n\nFR\nDanger d'explosion en masse en cas d'incendie.\n\nGA\nD'fhéadfadh sé go mbeadh mórphléascadh i dtine.\n\nIT\nPericolo di esplosione di massa in caso d'incendio.\n\nLV\nUgunī var masveidā eksplodēt.\n\nLT\nPer gaisrą gali sukelti masinį sprogimą.\n\nHU\nTűz hatására a teljes tömeg felrobbanhat.\n\nMT\nJista' jisplodi f'daqqa fin-nar.\n\nNL\nGevaar voor massa-explosie bij brand.\n\nPL\nMoże wybuchać masowo w przypadku pożaru.\n\nPT\nPerigo de explosão em massa em caso de incêndio.\n\nRO\nPericol de explozie în masă în caz de incendiu.\n\nSK\nNebezpečenstvo rozsiahleho výbuchu pri požiari.\n\nSL\nPri požaru lahko eksplodira v masi.\n\nFI\nKoko massa voi räjähtää tulessa.\n\nSV\nFara för massexplosion vid brand.\n\nH220\nLanguage\n2.2 — Flammable gases, Hazard Category 1\n\nBG\nИзключително запалим газ.\n\nES\nGas extremadamente inflamable.\n\nCS\nExtrémně hořlavý plyn.\n\nDA\nYderst brandfarlig gas.\n\nDE\nExtrem entzündbares Gas.\n\nET\nEriti tuleohtlik gaas.\n\nEL\nΕξαιρετικά εύφλεκτο αέριο.\n\nEN\nExtremely flammable gas.\n\nFR\nGaz extrêmement inflammable.\n\nGA\nGás fíor-inadhainte.\n\nIT\nGas altamente infiammabile.\n\nLV\nĪpaši viegli uzliesmojoša gāze.\n\nLT\nYpač degios dujos.\n\nHU\nRendkívül tűzveszélyes gáz.\n\nMT\nGass li jaqbad malajr ħafna.\n\nNL\nZeer licht ontvlambaar gas.\n\nPL\nSkrajnie łatwopalny gaz.\n\nPT\nGás extremamente inflamável.\n\nRO\nGaz extrem de inflamabil.\n\nSK\nMimoriadne horľavý plyn.\n\nSL\nZelo lahko vnetljiv plin.\n\nFI\nErittäin helposti syttyvä kaasu.\n\nSV\nExtremt brandfarlig gas.\n\nH221\nLanguage\n2.2 — Flammable gases, Hazard Category 2\n\nBG\nЗапалим газ.\n\nES\nGas inflamable.\n\nCS\nHořlavý plyn.\n\nDA\nBrandfarlig gas.\n\nDE\nEntzündbares Gas.\n\nET\nTuleohtlik gaas.\n\nEL\nΕύφλεκτο αέριο.\n\nEN\nFlammable gas.\n\nFR\nGaz inflammable.\n\nGA\nGás inadhainte.\n\nIT\nGas infiammabile.\n\nLV\nUzliesmojoša gāze.\n\nLT\nDegios dujos.\n\nHU\nTűzveszélyes gáz.\n\nMT\nGass li jaqbad.\n\nNL\nOntvlambaar gas.\n\nPL\nGaz łatwopalny.\n\nPT\nGás inflamável.\n\nRO\nGaz inflamabil.\n\nSK\nHorľavý plyn.\n\nSL\nVnetljiv plin.\n\nFI\nSyttyvä kaasu.\n\nSV\nBrandfarlig gas.\n\nH222\nLanguage\n2.3 — Flammable aerosols, Hazard Category 1\n\nBG\nИзключително запалим аерозол.\n\nES\nAerosol extremadamente inflamable.\n\nCS\nExtrémně hořlavý aerosol.\n\nDA\nYderst brandfarlig aerosol.\n\nDE\nExtrem entzündbares Aerosol.\n\nET\nEriti tuleohtlik aerosool.\n\nEL\nΕξαιρετικά εύφλεκτο αερόλυμα.\n\nEN\nExtremely flammable aerosol.\n\nFR\nAérosol extrêmement inflammable.\n\nGA\nAerasól fíor-inadhainte.\n\nIT\nAerosol altamente infiammabile.\n\nLV\nĪpaši viegli uzliesmojošs aerosols.\n\nLT\nYpač degus aerozolis.\n\nHU\nRendkívül tűzveszélyes aeroszol.\n\nMT\nAerosol li jaqbad malajr ħafna.\n\nNL\nZeer licht ontvlambare aerosol.\n\nPL\nSkrajnie łatwopalny aerozol.\n\nPT\nAerossol extremamente inflamável.\n\nRO\nAerosol extrem de inflamabil.\n\nSK\nMimoriadne horľavý aerosól.\n\nSL\nZelo lahko vnetljiv aerosol.\n\nFI\nErittäin helposti syttyvä aerosoli.\n\nSV\nExtremt brandfarlig aerosol.\n\nH223\nLanguage\n2.3 — Flammable aerosols, Hazard Category 2\n\nBG\nЗапалим аерозол.\n\nES\nAerosol inflamable.\n\nCS\nHořlavý aerosol.\n\nDA\nBrandfarlig aerosol.\n\nDE\nEntzündbares Aerosol.\n\nET\nTuleohtlik aerosool.\n\nEL\nΕύφλεκτο αερόλυμα.\n\nEN\nFlammable aerosol.\n\nFR\nAérosol inflammable.\n\nGA\nAerasól inadhainte.\n\nIT\nAerosol infiammabile.\n\nLV\nUzliesmojošs aerosols.\n\nLT\nDegus aerozolis.\n\nHU\nTűzveszélyes aeroszol.\n\nMT\nAerosol li jaqbad.\n\nNL\nOntvlambare aerosol.\n\nPL\nAerozol łatwopalny.\n\nPT\nAerossol inflamável.\n\nRO\nAerosol inflamabil.\n\nSK\nHorľavý aerosól.\n\nSL\nVnetljiv aerosol.\n\nFI\nSyttyvä aerosoli.\n\nSV\nBrandfarlig aerosol.\n\n\nH224\nLanguage\n2.6 — Flammable liquids, Hazard Category 1\n\nBG\nИзключително запалими течност и пари.\n\nES\nLíquido y vapores extremadamente inflamables.\n\nCS\nExtrémně hořlavá kapalina a páry.\n\nDA\nYderst brandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf extrem entzündbar.\n\nET\nEriti tuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί εξαιρετικά εύφλεκτα.\n\nEN\nExtremely flammable liquid and vapour.\n\nFR\nLiquide et vapeurs extrêmement inflammables.\n\nGA\nLeacht fíor-inadhainte agus gal fhíor-inadhainte.\n\nIT\nLiquido e vapori altamente infiammabili.\n\nLV\nĪpaši viegli uzliesmojošs šķidrums un tvaiki.\n\nLT\nYpač degūs skystis ir garai.\n\nHU\nRendkívül tűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu malajr ħafna.\n\nNL\nZeer licht ontvlambare vloeistof en damp.\n\nPL\nSkrajnie łatwopalna ciecz i pary.\n\nPT\nLíquido e vapor extremamente inflamáveis.\n\nRO\nLichid și vapori extrem de inflamabili.\n\nSK\nMimoriadne horľavá kvapalina a pary.\n\nSL\nZelo lahko vnetljiva tekočina in hlapi.\n\nFI\nErittäin helposti syttyvä neste ja höyry.\n\nSV\nExtremt brandfarlig vätska och ånga.\n\nH225\nLanguage\n2.6 — Flammable liquids, Hazard Category 2\n\nBG\nСилно запалими течност и пари.\n\nES\nLíquido y vapores muy inflamables.\n\nCS\nVysoce hořlavá kapalina a páry.\n\nDA\nMeget brandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf leicht entzündbar.\n\nET\nVäga tuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί πολύ εύφλεκτα.\n\nEN\nHighly flammable liquid and vapour.\n\nFR\nLiquide et vapeurs très inflammables.\n\nGA\nLeacht an-inadhainte agus gal an-inadhainte.\n\nIT\nLiquido e vapori facilmente infiammabili.\n\nLV\nViegli uzliesmojošs šķidrums un tvaiki.\n\nLT\nLabai degūs skystis ir garai.\n\nHU\nFokozottan tűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu malajr ħafna.\n\nNL\nLicht ontvlambare vloeistof en damp.\n\nPL\nWysoce łatwopalna ciecz i pary.\n\nPT\nLíquido e vapor facilmente inflamáveis.\n\nRO\nLichid și vapori foarte inflamabili.\n\nSK\nVeľmi horľavá kvapalina a pary.\n\nSL\nLahko vnetljiva tekočina in hlapi.\n\nFI\nHelposti syttyvä neste ja höyry.\n\nSV\nMycket brandfarlig vätska och ånga.\n\nH226\nLanguage\n2.6 — Flammable liquids, Hazard Category 3\n\nBG\nЗапалими течност и пари.\n\nES\nLíquidos y vapores inflamables.\n\nCS\nHořlavá kapalina a páry.\n\nDA\nBrandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf entzündbar.\n\nET\nTuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί εύφλεκτα.\n\nEN\nFlammable liquid and vapour.\n\nFR\nLiquide et vapeurs inflammables.\n\nGA\nLeacht inadhainte agus gal inadhainte.\n\nIT\nLiquido e vapori infiammabili.\n\nLV\nUzliesmojošs šķidrums un tvaiki.\n\nLT\nDegūs skystis ir garai.\n\nHU\nTűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu.\n\nNL\nOntvlambare vloeistof en damp.\n\nPL\nŁatwopalna ciecz i pary.\n\nPT\nLíquido e vapor inflamáveis.\n\nRO\nLichid și vapori inflamabili.\n\nSK\nHorľavá kvapalina a pary.\n\nSL\nVnetljiva tekočina in hlapi.\n\nFI\nSyttyvä neste ja höyry.\n\nSV\nBrandfarlig vätska och ånga.\n\nH228\nLanguage\n2.7 — Flammable solids, Hazard Category 1, 2\n\nBG\nЗапалимо твърдо вещество.\n\nES\nSólido inflamable.\n\nCS\nHořlavá tuhá látka.\n\nDA\nBrandfarligt fast stof.\n\nDE\nEntzündbarer Feststoff.\n\nET\nTuleohtlik tahke aine.\n\nEL\nΕύφλεκτο στερεό.\n\nEN\nFlammable solid.\n\nFR\nMatière solide inflammable.\n\nGA\nSolad inadhainte.\n\nIT\nSolido infiammabile.\n\nLV\nUzliesmojoša cieta viela.\n\nLT\nDegi kietoji medžiaga.\n\nHU\nTűzveszélyes szilárd anyag.\n\nMT\nSolidu li jaqbad.\n\nNL\nOntvlambare vaste stof.\n\nPL\nSubstancja stała łatwopalna.\n\nPT\nSólido inflamável.\n\nRO\nSolid inflamabil.\n\nSK\nHorľavá tuhá látka.\n\nSL\nVnetljiva trdna snov.\n\nFI\nSyttyvä kiinteä aine.\n\nSV\nBrandfarligt fast ämne.\n\nH240\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Type A\n2.1.5 — Organic Peroxides, Type A\n\nBG\nМоже да предизвика експлозия при нагряване.\n\nES\nPeligro de explosión en caso de calentamiento.\n\nCS\nZahřívání může způsobit výbuch.\n\nDA\nEksplosionsfare ved opvarmning.\n\nDE\nErwärmung kann Explosion verursachen.\n\nET\nKuumenemisel võib plahvatada.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει έκρηξη.\n\nEN\nHeating may cause an explosion.\n\nFR\nPeut exploser sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le pléascadh.\n\nIT\nRischio di esplosione per riscaldamento.\n\nLV\nSakaršana var izraisīt eksploziju.\n\nLT\nKaitinant gali sprogti.\n\nHU\nHő hatására robbanhat.\n\nMT\nIt-tisħin jista' jikkawża splużjoni.\n\nNL\nOntploffingsgevaar bij verwarming.\n\nPL\nOgrzanie grozi wybuchem.\n\nPT\nRisco de explosão sob a acção do calor.\n\nRO\nPericol de explozie în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť výbuch.\n\nSL\nSegrevanje lahko povzroči eksplozijo.\n\nFI\nRäjähdysvaarallinen kuumennettaessa.\n\nSV\nExplosivt vid uppvärmning.\n\nH241\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Type B\n2.1.5 — Organic Peroxides, Type B\n\nBG\nМоже да предизвика пожар или експлозия при нагряване.\n\nES\nPeligro de incendio o explosión en caso de calentamiento.\n\nCS\nZahřívání může způsobit požár nebo výbuch.\n\nDA\nBrand- eller eksplosionsfare ved opvarmning.\n\nDE\nErwärmung kann Brand oder Explosion verursachen.\n\nET\nKuumenemisel võib süttida või plahvatada.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.\n\nEN\nHeating may cause a fire or explosion.\n\nFR\nPeut s'enflammer ou exploser sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.\n\nIT\nRischio d'incendio o di esplosione per riscaldamento.\n\nLV\nSakaršana var izraisīt degšanu vai eksploziju.\n\nLT\nKaitinant gali sukelti gaisrą arba sprogti.\n\nHU\nHő hatására meggyulladhat vagy robbanhat.\n\nMT\nIt-tisħin jista' jikkawża nar jew splużjoni.\n\nNL\nBrand- of ontploffingsgevaar bij verwarming.\n\nPL\nOgrzanie może spowodować pożar lub wybuch.\n\nPT\nRisco de explosão ou de incêndio sob a acção do calor.\n\nRO\nPericol de incendiu sau de explozie în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť požiar alebo výbuch.\n\nSL\nSegrevanje lahko povzroči požar ali eksplozijo.\n\nFI\nRäjähdys- tai palovaarallinen kuumennettaessa.\n\nSV\nBrandfarligt eller explosivt vid uppvärmning.\n\n\nH242\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Types C, D, E, F\n2.1.5 — Organic Peroxides, Types C, D, E, F\n\nBG\nМоже да предизвика пожар при нагряване.\n\nES\nPeligro de incendio en caso de calentamiento.\n\nCS\nZahřívání může způsobit požár.\n\nDA\nBrandfare ved opvarmning.\n\nDE\nErwärmung kann Brand verursachen.\n\nET\nKuumenemisel võib süttida.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά.\n\nEN\nHeating may cause a fire.\n\nFR\nPeut s'enflammer sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le dóiteán.\n\nIT\nRischio d'incendio per riscaldamento.\n\nLV\nSakaršana var izraisīt degšanu.\n\nLT\nKaitinant gali sukelti gaisrą.\n\nHU\nHő hatására meggyulladhat.\n\nMT\nIt-tisħin jista' jikkawża nar.\n\nNL\nBrandgevaar bij verwarming.\n\nPL\nOgrzanie może spowodować pożar.\n\nPT\nRisco de incêndio sob a acção do calor.\n\nRO\nPericol de incendiu în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť požiar.\n\nSL\nSegrevanje lahko povzroči požar.\n\nFI\nPalovaarallinen kuumennettaessa.\n\nSV\nBrandfarligt vid uppvärmning.\n\nH250\nLanguage\n2.9 — Pyrophoric Liquids, Hazard Category 1\n2.10 — Pyorphoric Solids, Hazard Category 1\n\nBG\nСамозапалва се при контакт с въздух.\n\nES\nSe inflama espontáneamente en contacto con el aire.\n\nCS\nPři styku se vzduchem se samovolně vznítí.\n\nDA\nSelvantænder ved kontakt med luft.\n\nDE\nEntzündet sich in Berührung mit Luft von selbst.\n\nET\nKokkupuutel õhuga süttib iseenesest.\n\nEL\nΑυταναφλέγεται εάν εκτεθεί στον αέρα.\n\nEN\nCatches fire spontaneously if exposed to air.\n\nFR\nS'enflamme spontanément au contact de l'air.\n\nGA\nTéann trí thine go spontáineach má nochtar don aer.\n\nIT\nSpontaneamente infiammabile all'aria.\n\nLV\nSpontāni aizdegas saskarē ar gaisu.\n\nLT\nVeikiami oro savaime užsidega.\n\nHU\nLevegővel érintkezve önmagától meggyullad.\n\nMT\nJieħu n-nar spontanjament jekk ikun espost għall-arja.\n\nNL\nVat spontaan vlam bij blootstelling aan lucht.\n\nPL\nZapala się samorzutnie w przypadku wystawienia na działanie powietrza.\n\nPT\nRisco de inflamação espontânea em contacto com o ar.\n\nRO\nSe aprinde spontan, în contact cu aerul.\n\nSK\nPri kontakte so vzduchuom sa spontánne vznieti.\n\nSL\nSamodejno se vžge na zraku.\n\nFI\nSyttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.\n\nSV\nSpontanantänder vid kontakt med luft.\n\nH251\nLanguage\n2.11 — Self-Heating Substances and Mixtures, Hazard Category 1\n\nBG\nСамонагряващо се: може да се запали.\n\nES\nSe calienta espontáneamente; puede inflamarse.\n\nCS\nSamovolně se zahřívá: může se vznítit.\n\nDA\nSelvopvarmende, kan selvantænde.\n\nDE\nSelbsterhitzungsfähig; kann in Brand geraten.\n\nET\nIsekuumenev, võib süttida.\n\nEL\nΑυτοθερμαίνεται: μπορεί να αναφλεγεί.\n\nEN\nSelf-heating: may catch fire.\n\nFR\nMatière auto-échauffante; peut s'enflammer.\n\nGA\nFéintéamh: d'fhéadfadh sé dul trí thine.\n\nIT\nAutoriscaldante; può infiammarsi.\n\nLV\nPašsasilstošs; var aizdegties.\n\nLT\nSavaime kaistančios, gali užsidegti.\n\nHU\nÖnmelegedő: meggyulladhat.\n\nMT\nJisħon waħdu: jista' jieħu n-nar.\n\nNL\nVatbaar voor zelfverhitting: kan vlam vatten.\n\nPL\nSubstancja samonagrzewająca się: może się zapalić.\n\nPT\nSusceptível de auto-aquecimento: risco de inflamação.\n\nRO\nSe autoîncălzește, pericol de aprindere.\n\nSK\nSamovoľne sa zahrieva; môže sa vznietiť.\n\nSL\nSamosegrevanje: lahko povzroči požar.\n\nFI\nItsestään kuumeneva; voi syttyä palamaan.\n\nSV\nSjälvupphettande. Kan börja brinna.\n\nH252\nLanguage\n2.11 — Self-Heating Substances and Mixtures, Hazard Category 2\n\nBG\nСамонагряващо се в големи количества; може да се запали.\n\nES\nSe calienta espontáneamente en grandes cantidades; puede inflamarse.\n\nCS\nVe velkém množství se samovolně zahřívá; může se vznítit.\n\nDA\nSelvopvarmende i store mængder, kan selvantænde.\n\nDE\nIn großen Mengen selbsterhitzungsfähig; kann in Brand geraten.\n\nET\nSuurtes kogustes isekuumenev, võib süttida.\n\nEL\nΣε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.\n\nEN\nSelf-heating in large quantities; may catch fire.\n\nFR\nMatière auto-échauffante en grandes quantités; peut s'enflammer.\n\nGA\nFéintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.\n\nIT\nAutoriscaldante in grandi quantità; può infiammarsi.\n\nLV\nLielos apjomos pašsasilstošs; var aizdegties.\n\nLT\nLaikant dideliais kiekiais savaime kaista, gali užsidegti.\n\nHU\nNagy mennyiségben önmelegedő; meggyulladhat.\n\nMT\nJisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.\n\nNL\nIn grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.\n\nPL\nSubstancja samonagrzewająca się w dużych ilościach; może się zapalić.\n\nPT\nSusceptível de auto-aquecimento em grandes quantidades: risco de inflamação.\n\nRO\nSe autoîncălzește, în cantități mari pericol de aprindere.\n\nSK\nVo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.\n\nSL\nSamosegrevanje v velikih količinah; lahko povzroči požar.\n\nFI\nSuurina määrinä itsestään kuumeneva; voi syttyä palamaan.\n\nSV\nSjälvupphettande i stora mängder. Kan börja brinna.\n\n\nH260\nLanguage\n2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1\n\nBG\nПри контакт с вода отделя запалими газове, които могат да се самозапалят.\n\nES\nEn contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.\n\nCS\nPři styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.\n\nDA\nVed kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.\n\nDE\nIn Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.\n\nET\nKokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.\n\nEL\nΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.\n\nEN\nIn contact with water releases flammable gases which may ignite spontaneously.\n\nFR\nDégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.\n\nGA\nI dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.\n\nIT\nA contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.\n\nLV\nNonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.\n\nLT\nKontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.\n\nHU\nVízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.\n\nMT\nMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.\n\nNL\nIn contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.\n\nPL\nW kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.\n\nPT\nEm contacto com a água liberta gases que se podem inflamar espontaneamente.\n\nRO\nÎn contact cu apa degajă gaze inflamabile care se pot aprinde spontan.\n\nSK\nPri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.\n\nSL\nV stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.\n\nFI\nKehittää itsestään syttyviä kaasuja veden kanssa.\n\nSV\nVid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.\n\n\nH261\nLanguage\n2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2\n\nBG\nПри контакт с вода отделя запалими газове.\n\nES\nEn contacto con el agua desprende gases inflamables.\n\nCS\nPři styku s vodou uvolňuje hořlavé plyny.\n\nDA\nVed kontakt med vand udvikles brandfarlige gasser.\n\nDE\nIn Berührung mit Wasser entstehen entzündbare Gase.\n\nET\nKokkupuutel veega eraldab tuleohtlikke gaase.\n\nEL\nΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.\n\nEN\nIn contact with water releases flammable gases.\n\nFR\nDégage au contact de l'eau des gaz inflammables.\n\nGA\nI dteagmháil le huisce scaoiltear gáis inadhainte.\n\nIT\nA contatto con l'acqua libera gas infiammabili.\n\nLV\nNonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.\n\nLT\nKontaktuodami su vandeniu išskiria degias dujas\n\nHU\nVízzel érintkezve tűzveszélyes gázokat bocsát ki.\n\nMT\nMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.\n\nNL\nIn contact met water komen ontvlambare gassen vrij.\n\nPL\nW kontakcie z wodą uwalnia łatwopalne gazy.\n\nPT\nEm contacto com a água liberta gases inflamáveis.\n\nRO\nÎn contact cu apa degajă gaze inflamabile.\n\nSK\nPri kontakte s vodou uvoľňuje horľavé plyny.\n\nSL\nV stiku z vodo se sproščajo vnetljivi plini.\n\nFI\nKehittää syttyviä kaasuja veden kanssa.\n\nSV\nVid kontakt med vatten utvecklas brandfarliga gaser.\n\n\nH270\nLanguage\n2.4 — Oxidising Gases, Hazard Category 1\n\nBG\nМоже да предивзика или усили пожар; окислител.\n\nES\nPuede provocar o agravar un incendio; comburente.\n\nCS\nMůže způsobit nebo zesílit požár; oxidant.\n\nDA\nKan forårsage eller forstærke brand, brandnærende.\n\nDE\nKann Brand verursachen oder verstärken; Oxidationsmittel.\n\nET\nVõib põhjustada süttimise või soodustada põlemist; oksüdeerija.\n\nEL\nΜπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.\n\nEN\nMay cause or intensify fire; oxidiser.\n\nFR\nPeut provoquer ou aggraver un incendie; comburant.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.\n\nIT\nPuò provocare o aggravare un incendio; comburente.\n\nLV\nVar izraisīt vai pastiprināt degšanu, oksidētājs.\n\nLT\nGali sukelti arba padidinti gaisrą, oksidatorius.\n\nHU\nTüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.\n\nMT\nJista' jikkawża jew iżid in-nar; ossidant.\n\nNL\nKan brand veroorzaken of bevorderen; oxiderend.\n\nPL\nMoże spowodować lub intensyfikować pożar; utleniacz.\n\nPT\nPode provocar ou agravar incêndios; comburente.\n\nRO\nPoate provoca sau agrava un incendiu; oxidant.\n\nSK\nMôže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.\n\nSL\nLahko povzroči ali okrepi požar; oksidativna snov.\n\nFI\nAiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.\n\nSV\nKan orsaka eller intensifiera brand. Oxiderande.\n\nH271\nLanguage\n2.13 — Oxidising Liquids, Hazard Category 1\n2.14 — Oxidising Solids, Hazard Category 1\n\nBG\nМоже да предизвика пожар или експлозия; силен окислител.\n\nES\nPuede provocar un incendio o una explosión; muy comburente.\n\nCS\nMůže způsobit požár nebo výbuch; silný oxidant.\n\nDA\nKan forårsage brand eller eksplosion, stærkt brandnærende.\n\nDE\nKann Brand oder Explosion verursachen; starkes Oxidationsmittel.\n\nET\nVõib põhjustada süttimise või plahvatuse; tugev oksüdeerija.\n\nEL\nΜπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.\n\nEN\nMay cause fire or explosion; strong oxidiser.\n\nFR\nPeut provoquer un incendie ou une explosion; comburant puissant.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.\n\nIT\nPuò provocare un incendio o un'esplosione; molto comburente.\n\nLV\nVar izraisīt degšanu vai eksploziju, oksidētājs.\n\nLT\nGali sukelti gaisrą arba sprogimą, stiprus oksidatorius.\n\nHU\nTüzet vagy robbanást okozhat; erősen oxidáló hatású.\n\nMT\nJista' jikkawża nar jew splużjoni; ossidant qawwi.\n\nNL\nKan brand of ontploffingen veroorzaken; sterk oxiderend.\n\nPL\nMoże spowodować pożar lub wybuch; silny utleniacz.\n\nPT\nRisco de incêndio ou de explosão; muito comburente.\n\nRO\nPoate provoca un incendiu sau o explozie; oxidant puternic.\n\nSK\nMôže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.\n\nSL\nLahko povzroči požar ali eksplozijo; močna oksidativna snov.\n\nFI\nAiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.\n\nSV\nKan orsaka brand eller explosion. Starkt oxiderande.\n\nH272\nLanguage\n2.13 — Oxidising Liquids, Hazard Category 2, 3\n2.14 — Oxidising Solids, Hazard Category 2, 3\n\nBG\nМоже да усили пожара; окислител.\n\nES\nPuede agravar un incendio; comburente.\n\nCS\nMůže zesílit požár; oxidant.\n\nDA\nKan forstærke brand, brandnærende.\n\nDE\nKann Brand verstärken; Oxidationsmittel.\n\nET\nVõib soodustada põlemist; oksüdeerija.\n\nEL\nΜπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.\n\nEN\nMay intensify fire; oxidiser.\n\nFR\nPeut aggraver un incendie; comburant.\n\nGA\nD'fhéadfadh sé cur le tine; ocsaídeoir.\n\nIT\nPuò aggravare un incendio; comburente.\n\nLV\nVar pastiprināt degšanu; oksidētājs.\n\nLT\nGali padidinti gaisrą, oksidatorius.\n\nHU\nFokozhatja a tűz intenzitását; oxidáló hatású.\n\nMT\nJista' jżid in-nar; ossidant.\n\nNL\nKan brand bevorderen; oxiderend.\n\nPL\nMoże intensyfikować pożar; utleniacz.\n\nPT\nPode agravar incêndios; comburente.\n\nRO\nPoate agrava un incendiu; oxidant.\n\nSK\nMôže prispieť k rozvoju požiaru; oxidačné činidlo.\n\nSL\nLahko okrepi požar; oksidativna snov.\n\nFI\nVoi edistää tulipaloa; hapettava.\n\nSV\nKan intensifiera brand. Oxiderande.\n\nH280\nLanguage\n2.5 — Gases under pressure:\nCompressed gas\nLiquefied gas\nDissolved gas\n\nBG\nСъдържа газ под налягане; може да експлодира при нагряване.\n\nES\nContiene gas a presión; peligro de explosión en caso de calentamiento.\n\nCS\nObsahuje plyn pod tlakem; při zahřívání může vybuchnout.\n\nDA\nIndeholder gas under tryk, kan eksplodere ved opvarmning.\n\nDE\nEnthält Gas unter Druck; kann bei Erwärmung explodieren.\n\nET\nSisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.\n\nEL\nΠεριέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.\n\nEN\nContains gas under pressure; may explode if heated.\n\nFR\nContient un gaz sous pression; peut exploser sous l'effet de la chaleur.\n\nGA\nGás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.\n\nIT\nContiene gas sotto pressione; può esplodere se riscaldato.\n\nLV\nSatur gāzi zem spiediena; karstumā var eksplodēt.\n\nLT\nTuri slėgio veikiamų dujų, kaitinant gali sprogti.\n\nHU\nNyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.\n\nMT\nFih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.\n\nNL\nBevat gas onder druk; kan ontploffen bij verwarming.\n\nPL\nZawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.\n\nPT\nContém gás sob pressão; risco de explosão sob a acção do calor.\n\nRO\nConține un gaz sub presiune; pericol de explozie în caz de încălzire.\n\nSK\nObsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.\n\nSL\nVsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.\n\nFI\nSisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.\n\nSV\nInnehåller gas under tryck. Kan explodera vid uppvärmning.\n\nH281\nLanguage\n2.5 — Gases under pressure: Refrigerated liquefied gas\n\nBG\nСъдържа охладен газ; може да причини криогенни изгаряния или наранявания.\n\nES\nContiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.\n\nCS\nObsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.\n\nDA\nIndeholder nedkølet gas, kan forårsage kuldeskader.\n\nDE\nEnthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.\n\nET\nSisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.\n\nEL\nΠεριέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.\n\nEN\nContains refrigerated gas; may cause cryogenic burns or injury.\n\nFR\nContient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.\n\nGA\nGás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.\n\nIT\nContiene gas refrigerato; può provocare ustioni o lesioni criogeniche.\n\nLV\nSatur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.\n\nLT\nTuri atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.\n\nHU\nMélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.\n\nMT\nFih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.\n\nNL\nBevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.\n\nPL\nZawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.\n\nPT\nContém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.\n\nRO\nConține un gaz răcit; poate cauza arsuri sau leziuni criogenice.\n\nSK\nObsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.\n\nSL\nVsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.\n\nFI\nSisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.\n\nSV\nInnehåller kyld gas. Kan orsaka svåra köldskador.\n\nH290\nLanguage\n2.16 — Corrosive to metals, Hazard Category 1\n\nBG\nМоже да бъде корозивно за металите.\n\nES\nPuede ser corrosivo para los metales.\n\nCS\nMůže být korozivní pro kovy.\n\nDA\nKan ætse metaller.\n\nDE\nKann gegenüber Metallen korrosiv sein.\n\nET\nVõib söövitada metalle.\n\nEL\nΜπορεί να διαβρώσει μέταλλα.\n\nEN\nMay be corrosive to metals.\n\nFR\nPeut être corrosif pour les métaux.\n\nGA\nD'fhéadfadh sé a bheith creimneach do mhiotail.\n\nIT\nPuò essere corrosivo per i metalli.\n\nLV\nVar kodīgi iedarboties uz metāliem.\n\nLT\nGali ėsdinti metalus.\n\nHU\nFémekre korrozív hatású lehet.\n\nMT\nJista' jkun korrużiv għall-metalli.\n\nNL\nKan bijtend zijn voor metalen.\n\nPL\nMoże powodować korozję metali.\n\nPT\nPode ser corrosivo para os metais.\n\nRO\nPoate fi corosiv pentru metale.\n\nSK\nMôže byť korozívna pre kovy.\n\nSL\nLahko je jedko za kovine.\n\nFI\nVoi syövyttää metalleja.\n\nSV\nKan vara korrosivt för metaller.\n\n\nTable 1.2\nHazard statements for health hazards\n\nH300\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 1, 2\n\nBG\nСмъртоносeн при поглъщане.\n\nES\nMortal en caso de ingestión.\n\nCS\nPři požití může způsobit smrt.\n\nDA\nLivsfarlig ved indtagelse.\n\nDE\nLebensgefahr bei Verschlucken.\n\nET\nAllaneelamisel surmav.\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης.\n\nEN\nFatal if swallowed.\n\nFR\nMortel en cas d'ingestion.\n\nGA\nMarfach má shlogtar.\n\nIT\nLetale se ingerito.\n\nLV\nNorijot iestājas nāve.\n\nLT\nMirtina prarijus.\n\nHU\nLenyelve halálos.\n\nMT\nFatali jekk jinbela’.\n\nNL\nDodelijk bij inslikken.\n\nPL\nPołknięcie grozi śmiercią.\n\nPT\nMortal por ingestão.\n\nRO\nMortal în caz de înghițire.\n\nSK\nSmrteľný po požití.\n\nSL\nSmrtno pri zaužitju.\n\nFI\nTappavaa nieltynä.\n\nSV\nDödligt vid förtäring.\n\nH301\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 3\n\nBG\nТоксичен при поглъщане.\n\nES\nTóxico en caso de ingestión.\n\nCS\nToxický při požití.\n\nDA\nGiftig ved indtagelse.\n\nDE\nGiftig bei Verschlucken.\n\nET\nAllaneelamisel mürgine.\n\nEL\nΤοξικό σε περίπτωση κατάποσης.\n\nEN\nToxic if swallowed.\n\nFR\nToxique en cas d'ingestion.\n\nGA\nTocsaineach má shlogtar.\n\nIT\nTossico se ingerito.\n\nLV\nToksisks, ja norij.\n\nLT\nToksiška prarijus.\n\nHU\nLenyelve mérgező.\n\nMT\nTossiku jekk jinbela’.\n\nNL\nGiftig bij inslikken.\n\nPL\nDziała toksycznie po połknięciu.\n\nPT\nTóxico por ingestão.\n\nRO\nToxic în caz de înghițire.\n\nSK\nToxický po požití.\n\nSL\nStrupeno pri zaužitju.\n\nFI\nMyrkyllistä nieltynä.\n\nSV\nGiftigt vid förtäring.\n\nH302\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 4\n\nBG\nВреден при поглъщане.\n\nES\nNocivo en caso de ingestión.\n\nCS\nZdraví škodlivý při požití.\n\nDA\nFarlig ved indtagelse.\n\nDE\nGesundheitsschädlich bei Verschlucken.\n\nET\nAllaneelamisel kahjulik.\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης.\n\nEN\nHarmful if swallowed.\n\nFR\nNocif en cas d'ingestion.\n\nGA\nDíobhálach má shlogtar.\n\nIT\nNocivo se ingerito.\n\nLV\nKaitīgs, ja norij.\n\nLT\nKenksminga prarijus.\n\nHU\nLenyelve ártalmas.\n\nMT\nJagħmel il-ħsara jekk jinbela’.\n\nNL\nSchadelijk bij inslikken.\n\nPL\nDziała szkodliwie po połknięciu.\n\nPT\nNocivo por ingestão.\n\nRO\nNociv în caz de înghițire.\n\nSK\nŠkodlivý po požití.\n\nSL\nZdravju škodljivo pri zaužitju.\n\nFI\nHaitallista nieltynä.\n\nSV\nSkadligt vid förtäring.\n\nH304\nLanguage\n3.10 — Aspiration hazard, Hazard Category 1\n\nBG\nМоже да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.\n\nES\nPuede ser mortal en caso de ingestión y penetración en las vías respiratorias.\n\nCS\nPři požití a vniknutí do dýchacích cest může způsobit smrt.\n\nDA\nKan være livsfarligt, hvis det indtages og kommer i luftvejene.\n\nDE\nKann bei Verschlucken und Eindringen in die Atemwege tödlich sein.\n\nET\nAllaneelamisel või hingamisteedesse sattumisel võib olla surmav.\n\nEL\nΜπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.\n\nEN\nMay be fatal if swallowed and enters airways.\n\nFR\nPeut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.\n\nGA\nD'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.\n\nHU\nLenyelve és a légutakba kerülve halálos lehet.\n\nIT\nPuò essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.\n\nLV\nVar izraisīt nāvi, ja norij vai iekļūst elpceļos.\n\nLT\nPrarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.\n\nMT\nJista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.\n\nNL\nKan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.\n\nPL\nPołknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.\n\nPT\nPode ser mortal por ingestão e penetração nas vias respiratórias.\n\nRO\nPoate fi mortal în caz de înghițire și de pătrundere în căile respiratorii.\n\nSK\nMôže byť smrteľný po požití a vniknutí do dýchacích ciest.\n\nSL\nPri zaužitju in vstopu v dihalne poti je lahko smrtno.\n\nFI\nVoi olla tappavaa nieltynä ja joutuessaan hengitysteihin.\n\nSV\nKan vara dödligt vid förtäring om det kommer ner i luftvägarna.\n\nH310\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 1, 2\n\nBG\nСмъртоносeн при контакт с кожата.\n\nES\nMortal en contacto con la piel.\n\nCS\nPři styku s kůží může způsobit smrt.\n\nDA\nLivsfarlig ved hudkontakt.\n\nDE\nLebensgefahr bei Hautkontakt.\n\nET\nNahale sattumisel surmav.\n\nEL\nΘανατηφόρο σε επαφή με το δέρμα.\n\nEN\nFatal in contact with skin.\n\nFR\nMortel par contact cutané.\n\nGA\nMarfach i dteagmháil leis an gcraiceann.\n\nHU\nBőrrel érintkezve halálos.\n\nIT\nLetale per contatto con la pelle.\n\nLV\nNonākot saskarē ar ādu, iestājas nāve.\n\nLT\nMirtina susilietus su oda.\n\nMT\nFatali jekk imiss mal-ġilda.\n\nNL\nDodelijk bij contact met de huid.\n\nPL\nGrozi śmiercią w kontacie ze skórą.\n\nPT\nMortal em contacto com a pele.\n\nRO\nMortal în contact cu pielea.\n\nSK\nSmrteľný pri kontakte s pokožkou.\n\nSL\nSmrtno v stiku s kožo.\n\nFI\nTappavaa joutuessaan iholle.\n\nSV\nDödligt vid hudkontakt.\n\nH311\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 3\n\nBG\nТоксичен при контакт с кожата.\n\nES\nTóxico en contacto con la piel.\n\nCS\nToxický při styku s kůží.\n\nDA\nGiftig ved hudkontakt.\n\nDE\nGiftig bei Hautkontakt.\n\nET\nNahale sattumisel mürgine.\n\nEL\nΤοξικό σε επαφή με το δέρμα.\n\nEN\nToxic in contact with skin.\n\nFR\nToxique par contact cutané.\n\nGA\nTocsaineach i dteagmháil leis an gcraiceann.\n\nIT\nTossico per contatto con la pelle.\n\nLV\nToksisks, ja nonāk saskarē ar ādu.\n\nLT\nToksiška susilietus su oda.\n\nHU\nBőrrel érintkezve mérgező.\n\nMT\nTossiku meta jmiss mal-ġilda.\n\nNL\nGiftig bij contact met de huid.\n\nPL\nDziała toksycznie w kontakcie ze skórą.\n\nPT\nTóxico em contacto com a pele.\n\nRO\nToxic în contact cu pielea.\n\nSK\nToxický pri kontakte s pokožkou.\n\nSL\nStrupeno v stiku s kožo.\n\nFI\nMyrkyllistä joutuessaan iholle.\n\nSV\nGiftigt vid hudkontakt.\n\n\nH312\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 4\n\nBG\nВреден при контакт с кожата.\n\nES\nNocivo en contacto con la piel.\n\nCS\nZdraví škodlivý při styku s kůží.\n\nDA\nFarlig ved hudkontakt.\n\nDE\nGesundheitsschädlich bei Hautkontakt.\n\nET\nNahale sattumisel kahjulik.\n\nEL\nΕπιβλαβές σε επαφή με το δέρμα.\n\nEN\nHarmful in contact with skin.\n\nFR\nNocif par contact cutané.\n\nGA\nDíobhálach i dteagmháil leis an gcraiceann.\n\nIT\nNocivo per contatto con la pelle.\n\nLV\nKaitīgs, ja nonāk saskarē ar ādu.\n\nLT\nKenksminga susilietus su oda.\n\nHU\nBőrrel érintkezve ártalmas.\n\nMT\nJagħmel il-ħsara meta jmiss mal-ġilda.\n\nNL\nSchadelijk bij contact met de huid.\n\nPL\nDziała szkodliwie w kontakcie ze skórą.\n\nPT\nNocivo em contacto com a pele.\n\nRO\nNociv în contact cu pielea.\n\nSK\nŠkodlivý pri kontakte s pokožkou.\n\nSL\nZdravju škodljivo v stiku s kožo.\n\nFI\nHaitallista joutuessaan iholle.\n\nSV\nSkadligt vid hudkontakt.\n\nH314\nLanguage\n3.2 — Skin corrosion/irritation, Hazard Category 1A, 1B, 1C\n\nBG\nПричинява тежки изгаряния на кожата и сериозно увреждане на очите.\n\nES\nProvoca quemaduras graves en la piel y lesiones oculares graves.\n\nCS\nZpůsobuje těžké poleptání kůže a poškození očí.\n\nDA\nForårsager svære forbrændinger af huden og øjenskader.\n\nDE\nVerursacht schwere Verätzungen der Haut und schwere Augenschäden.\n\nET\nPõhjustab rasket nahasöövitust ja silmakahjustusi.\n\nEL\nΠροκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.\n\nEN\nCauses severe skin burns and eye damage.\n\nFR\nProvoque des brûlures de la peau et des lésions oculaires graves.\n\nGA\nIna chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.\n\nIT\nProvoca gravi ustioni cutanee e gravi lesioni oculari.\n\nLV\nIzraisa smagus ādas apdegumus un acu bojājumus.\n\nLT\nSmarkiai nudegina odą ir pažeidžia akis.\n\nHU\nSúlyos égési sérülést és szemkárosodást okoz.\n\nMT\nJagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.\n\nNL\nVeroorzaakt ernstige brandwonden en oogletsel.\n\nPL\nPowoduje poważne oparzenia skóry oraz uszkodzenia oczu.\n\nPT\nProvoca queimaduras na pele e lesões oculares graves.\n\nRO\nProvoacă arsuri grave ale pielii și lezarea ochilor.\n\nSK\nSpôsobuje vážne poleptanie kože a poškodenie očí.\n\nSL\nPovzroča hude opekline kože in poškodbe oči.\n\nFI\nVoimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.\n\nSV\nOrsakar allvarliga frätskador på hud och ögon.\n\nH315\nLanguage\n3.2 — Skin corrosion/irritation, Hazard Category 2\n\nBG\nПредизвиква дразнене на кожата.\n\nES\nProvoca irritación cutánea.\n\nCS\nDráždí kůži.\n\nDA\nForårsager hudirritation.\n\nDE\nVerursacht Hautreizungen.\n\nET\nPõhjustab nahaärritust.\n\nEL\nΠροκαλεί ερεθισμό του δέρματος.\n\nEN\nCauses skin irritation.\n\nFR\nProvoque une irritation cutanée.\n\nGA\nIna chúis le greannú craicinn.\n\nIT\nProvoca irritazione cutanea.\n\nLV\nKairina ādu.\n\nLT\nDirgina odą.\n\nHU\nBőrirritáló hatású.\n\nMT\nJagħmel irritazzjoni tal-ġilda.\n\nNL\nVeroorzaakt huidirritatie.\n\nPL\nDziała drażniąco na skórę.\n\nPT\nProvoca irritação cutânea.\n\nRO\nProvoacă iritarea pielii.\n\nSK\nDráždi kožu.\n\nSL\nPovzroča draženje kože.\n\nFI\nÄrsyttää ihoa.\n\nSV\nIrriterar huden.\n\n\nH317\nLanguage\n3.4 — Sensitisation — Skin, hazard category 1, 1A, 1B\n\nBG\nМоже да причини алергична кожна реакция.\n\nES\nPuede provocar una reacción alérgica en la piel.\n\nCS\nMůže vyvolat alergickou kožní reakci.\n\nDA\nKan forårsage allergisk hudreaktion.\n\nDE\nKann allergische Hautreaktionen verursachen.\n\nET\nVõib põhjustada allergilist nahareaktsiooni.\n\nEL\nΜπορεί να προκαλέσει αλλεργική δερματική αντίδραση.\n\nEN\nMay cause an allergic skin reaction.\n\nFR\nPeut provoquer une allergie cutanée.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.\n\nIT\nPuò provocare una reazione allergica cutanea.\n\nLV\nVar izraisīt alerģisku ādas reakciju.\n\nLT\nGali sukelti alerginę odos reakciją.\n\nHU\nAllergiás bőrreakciót válthat ki.\n\nMT\nJista’ jikkawża reazzjoni allerġika tal-ġilda.\n\nNL\nKan een allergische huidreactie veroorzaken.\n\nPL\nMoże powodować reakcję alergiczną skóry.\n\nPT\nPode provocar uma reacção alérgica cutânea.\n\nRO\nPoate provoca o reacție alergică a pielii.\n\nSK\nMôže vyvolať alergickú kožnú reakciu.\n\nSL\nLahko povzroči alergijski odziv kože.\n\nFI\nVoi aiheuttaa allergisen ihoreaktion.\n\nSV\nKan orsaka allergisk hudreaktion.\n\nH318\nLanguage\n3.3 — Serious eye damage/eye irritation, Hazard Category 1\n\nBG\nПредизвиква сериозно увреждане на очите.\n\nES\nProvoca lesiones oculares graves.\n\nCS\nZpůsobuje vážné poškození očí.\n\nDA\nForårsager alvorlig øjenskade.\n\nDE\nVerursacht schwere Augenschäden.\n\nET\nPõhjustab raskeid silmakahjustusi.\n\nEL\nΠροκαλεί σοβαρή οφθαλμική βλάβη.\n\nEN\nCauses serious eye damage.\n\nFR\nProvoque des lésions oculaires graves.\n\nGA\nIna chúis le damáiste tromchúiseach don tsúil.\n\nIT\nProvoca gravi lesioni oculari.\n\nLV\nIzraisa nopietnus acu bojājumus.\n\nLT\nSmarkiai pažeidžia akis.\n\nHU\nSúlyos szemkárosodást okoz.\n\nMT\nJagħmel ħsara serja lill-għajnejn.\n\nNL\nVeroorzaakt ernstig oogletsel.\n\nPL\nPowoduje poważne uszkodzenie oczu.\n\nPT\nProvoca lesões oculares graves.\n\nRO\nProvoacă leziuni oculare grave.\n\nSK\nSpôsobuje vážne poškodenie očí.\n\nSL\nPovzroča hude poškodbe oči.\n\nFI\nVaurioittaa vakavasti silmiä.\n\nSV\nOrsakar allvarliga ögonskador.\n\nH319\nLanguage\n3.3 — Serious eye damage/eye irritation, Hazard Category 2\n\nBG\nПредизвиква сериозно дразнене на очите.\n\nES\nProvoca irritación ocular grave.\n\nCS\nZpůsobuje vážné podráždění očí.\n\nDA\nForårsager alvorlig øjenirritation.\n\nDE\nVerursacht schwere Augenreizung.\n\nET\nPõhjustab tugevat silmade ärritust.\n\nEL\nΠροκαλεί σοβαρό οφθαλμικό ερεθισμό.\n\nEN\nCauses serious eye irritation.\n\nFR\nProvoque une sévère irritation des yeux.\n\nGA\nIna chúis le greannú tromchúiseach don tsúil.\n\nIT\nProvoca grave irritazione oculare.\n\nLV\nIzraisa nopietnu acu kairinājumu.\n\nLT\nSukelia smarkų akių dirginimą.\n\nHU\nSúlyos szemirritációt okoz.\n\nMT\nJagħmel irritazzjoni serja lill-għajnejn.\n\nNL\nVeroorzaakt ernstige oogirritatie.\n\nPL\nDziała drażniąco na oczy.\n\nPT\nProvoca irritação ocular grave.\n\nRO\nProvoacă o iritare gravă a ochilor.\n\nSK\nSpôsobuje vážne podráždenie očí.\n\nSL\nPovzroča hudo draženje oči.\n\nFI\nÄrsyttää voimakkaasti silmiä.\n\nSV\nOrsakar allvarlig ögonirritation.\n\nH330\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 1, 2\n\nBG\nСмъртоносен при вдишване.\n\nES\nMortal en caso de inhalación.\n\nCS\nPři vdechování může způsobit smrt.\n\nDA\nLivsfarlig ved indånding.\n\nDE\nLebensgefahr bei Einatmen.\n\nET\nSissehingamisel surmav.\n\nEL\nΘανατηφόρο σε περίπτωση εισπνοής.\n\nEN\nFatal if inhaled.\n\nFR\nMortel par inhalation.\n\nGA\nMarfach má ionanálaítear.\n\nIT\nLetale se inalato.\n\nLV\nIeelpojot, iestājas nāve.\n\nLT\nMirtina įkvėpus.\n\nHU\nBelélegezve halálos.\n\nMT\nFatali jekk jinxtamm.\n\nNL\nDodelijk bij inademing.\n\nPL\nWdychanie grozi śmiercią.\n\nPT\nMortal por inalação.\n\nRO\nMortal în caz de inhalare.\n\nSK\nSmrteľný pri vdýchnutí.\n\nSL\nSmrtno pri vdihavanju.\n\nFI\nTappavaa hengitettynä.\n\nSV\nDödligt vid inandning.\n\nH331\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 3\n\nBG\nТоксичен при вдишване.\n\nES\nTóxico en caso de inhalación.\n\nCS\nToxický při vdechování.\n\nDA\nGiftig ved indånding.\n\nDE\nGiftig bei Einatmen.\n\nET\nSissehingamisel mürgine.\n\nEL\nΤοξικό σε περίπτωση εισπνοής.\n\nEN\nToxic if inhaled.\n\nFR\nToxique par inhalation.\n\nGA\nTocsaineach má ionanálaítear.\n\nIT\nTossico se inalato.\n\nLV\nToksisks ieelpojot.\n\nLT\nToksiška įkvėpus.\n\nHU\nBelélegezve mérgező.\n\nMT\nTossiku jekk jinxtamm.\n\nNL\nGiftig bij inademing.\n\nPL\nDziała toksycznie w następstwie wdychania.\n\nPT\nTóxico por inalação.\n\nRO\nToxic în caz de inhalare.\n\nSK\nToxický pri vdýchnutí.\n\nSL\nStrupeno pri vdihavanju.\n\nFI\nMyrkyllistä hengitettynä.\n\nSV\nGiftigt vid inandning.\n\n\nH332\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 4\n\nBG\nВреден при вдишване.\n\nES\nNocivo en caso de inhalación.\n\nCS\nZdraví škodlivý při vdechování.\n\nDA\nFarlig ved indånding.\n\nDE\nGesundheitsschädlich bei Einatmen.\n\nET\nSissehingamisel kahjulik.\n\nEL\nΕπιβλαβές σε περίπτωση εισπνοής.\n\nEN\nHarmful if inhaled.\n\nFR\nNocif par inhalation.\n\nGA\nDíobhálach má ionanálaítear.\n\nIT\nNocivo se inalato.\n\nLV\nKaitīgs ieelpojot.\n\nLT\nKenksminga įkvėpus.\n\nHU\nBelélegezve ártalmas.\n\nMT\nJagħmel il-ħsara jekk jinxtamm.\n\nNL\nSchadelijk bij inademing.\n\nPL\nDziała szkodliwie w następstwie wdychania.\n\nPT\nNocivo por inalação.\n\nRO\nNociv în caz de inhalare.\n\nSK\nŠkodlivý pri vdýchnutí.\n\nSL\nZdravju škodljivo pri vdihavanju.\n\nFI\nHaitallista hengitettynä.\n\nSV\nSkadligt vid inandning.\n\nH334\nLanguage\n3.4 — Sensitisation — Respiratory, hazard category 1, 1A, 1B\n\nBG\nМоже да причини алергични или астматични симптоми или затруднения в дишането при вдишване.\n\nES\nPuede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.\n\nCS\nPři vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.\n\nDA\nKan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.\n\nDE\nKann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.\n\nET\nSissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.\n\nEL\nΜπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.\n\nEN\nMay cause allergy or asthma symptoms or breathing difficulties if inhaled.\n\nFR\nPeut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.\n\nIT\nPuò provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.\n\nLV\nJa ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.\n\nLT\nĮkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.\n\nHU\nBelélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.\n\nMT\nJista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.\n\nNL\nKan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.\n\nPL\nMoże powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.\n\nPT\nQuando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.\n\nRO\nPoate provoca simptome de alergie sau astm sau dificultăți de respirație în caz de inhalare.\n\nSK\nPri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.\n\nSL\nLahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.\n\nFI\nVoi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.\n\nSV\nKan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.\n\nH335\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation\n\nBG\nМоже да предизвика дразнене на дихателните пътища.\n\nES\nPuede irritar las vías respiratorias.\n\nCS\nMůže způsobit podráždění dýchacích cest.\n\nDA\nKan forårsage irritation af luftvejene.\n\nDE\nKann die Atemwege reizen.\n\nET\nVõib põhjustada hingamisteede ärritust.\n\nEL\nΜπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.\n\nEN\nMay cause respiratory irritation.\n\nFR\nPeut irriter les voies respiratoires.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le greannú riospráide.\n\nIT\nPuò irritare le vie respiratorie.\n\nLV\nVar izraisīt elpceļu kairinājumu.\n\nLT\nGali dirginti kvėpavimo takus.\n\nHU\nLégúti irritációt okozhat.\n\nMT\nJista’ jikkawża irritazzjoni respiratorja.\n\nNL\nKan irritatie van de luchtwegen veroorzaken.\n\nPL\nMoże powodować podrażnienie dróg oddechowych.\n\nPT\nPode provocar irritação das vias respiratórias.\n\nRO\nPoate provoca iritarea căilor respiratorii.\n\nSK\nMôže spôsobiť podráždenie dýchacích ciest.\n\nSL\nLahko povzroči draženje dihalnih poti.\n\nFI\nSaattaa aiheuttaa hengitysteiden ärsytystä.\n\nSV\nKan orsaka irritation i luftvägarna.\n\nH336\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis\n\nBG\nМоже да предизвика сънливост или световъртеж.\n\nES\nPuede provocar somnolencia o vértigo.\n\nCS\nMůže způsobit ospalost nebo závratě.\n\nDA\nKan forårsage sløvhed eller svimmelhed.\n\nDE\nKann Schläfrigkeit und Benommenheit verursachen.\n\nET\nVõib põhjustada unisust või peapööritust.\n\nEL\nΜπορεί να προκαλέσει υπνηλία ή ζάλη.\n\nEN\nMay cause drowsiness or dizziness.\n\nFR\nPeut provoquer somnolence ou vertiges.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.\n\nIT\nPuò provocare sonnolenza o vertigini.\n\nLV\nVar izraisīt miegainību vai reiboņus.\n\nLT\nGali sukelti mieguistumą arba galvos svaigimą.\n\nHU\nÁlmosságot vagy szédülést okozhat.\n\nMT\nJista’ jikkawża ħedla jew sturdament.\n\nNL\nKan slaperigheid of duizeligheid veroorzaken.\n\nPL\nMoże wywoływać uczucie senności lub zawroty głowy.\n\nPT\nPode provocar sonolência ou vertigens.\n\nRO\nPoate provoca somnolență sau amețeală.\n\nSK\nMôže spôsobiť ospalosť alebo závraty.\n\nSL\nLahko povzroči zaspanost ali omotico.\n\nFI\nSaattaa aiheuttaa uneliaisuutta ja huimausta.\n\nSV\nKan göra att man blir dåsig eller omtöcknad.\n\n\nH340\nLanguage\n3.5 — Germ cell mutagenicity, Hazard Category 1A, 1B\n\nBG\nМоже да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar defectos genéticos .\n\nCS\nMůže vyvolat genetické poškození .\n\nDA\nKan forårsage genetiske defekter .\n\nDE\nKann genetische Defekte verursachen .\n\nET\nVõib põhjustada geneetilisi defekte .\n\nEL\nΜπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nMay cause genetic defects .\n\nFR\nPeut induire des anomalies génétiques .\n\nGA\nD'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha .\n\nIT\nPuò provocare alterazioni genetiche .\n\nLV\nVar izraisīt ģenētiskus bojājumus .\n\nLT\nGali sukelti genetinius defektus .\n\nHU\nGenetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża difetti ġenetiċi .\n\nNL\nKan genetische schade veroorzaken .\n\nPL\nMoże powodować wady genetyczne .\n\nPT\nPode provocar anomalias genéticas .\n\nRO\nPoate provoca anomalii genetice .\n\nSK\nMôže spôsobovať genetické poškodenie .\n\nSL\nLahko povzroči genetske okvare .\n\nFI\nSaattaa aiheuttaa perimävaurioita .\n\nSV\nKan orsaka genetiska defekter .\n\nH341\nLanguage\n3.5 — Germ cell mutagenicity, Hazard Category 2\n\nBG\nПредполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que provoca defectos genéticos .\n\nCS\nPodezření na genetické poškození .\n\nDA\nMistænkt for at forårsage genetiske defekter .\n\nDE\nKann vermutlich genetische Defekte verursachen .\n\nET\nArvatavasti põhjustab geneetilisi defekte .\n\nEL\nΎποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of causing genetic defects .\n\nFR\nSusceptible d'induire des anomalies génétiques .\n\nGA\nCeaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha .\n\nIT\nSospettato di provocare alterazioni genetiche .\n\nLV\nIr aizdomas, ka var izraisīt ģenētiskus bojājumus .\n\nLT\nĮtariama, kad gali sukelti genetinius defektus .\n\nHU\nFeltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jikkawża difetti ġenetiċi .\n\nNL\nVerdacht van het veroorzaken van genetische schade .\n\nPL\nPodejrzewa się, że powoduje wady genetyczne .\n\nPT\nSuspeito de provocar anomalias genéticas .\n\nRO\nSusceptibil de a provoca anomalii genetice < indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.\n\nSK\nPodozrenie, že spôsobuje genetické poškodenie .\n\nSL\nSum povzročitve genetskih okvar .\n\nFI\nEpäillään aiheuttavan perimävaurioita .\n\nSV\nMisstänks kunna orsaka genetiska defekter .\n\nH350\nLanguage\n3.6 — Carcinogenicity, Hazard Category 1A, 1B\n\nBG\nМоже да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar cáncer .\n\nCS\nMůže vyvolat rakovinu .\n\nDA\nKan fremkalde kræft .\n\nDE\nKann Krebs erzeugen .\n\nET\nVõib põhjustada vähktõbe .\n\nEL\nΜπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause cancer .\n\nFR\nPeut provoquer le cancer .\n\nGA\nD'fhéadfadh sé a bheith ina chúis le hailse .\n\nIT\nPuò provocare il cancro.\n\nLV\nVar izraisīt vēzi .\n\nLT\nGali sukelti vėžį .\n\nHU\nRákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża l-kanċer .\n\nNL\nKan kanker veroorzaken \n\nPL\nMoże powodować raka .\n\nPT\nPode provocar cancro .\n\nRO\nPoate provoca cancer .\n\nSK\nMôže spôsobiť rakovinu .\n\nSL\nLahko povzroči raka .\n\nFI\nSaattaa aiheuttaa syöpää .\n\nSV\nKan orsaka cancer .\n\nH351\nLanguage\n3.6 — Carcinogenicity, Hazard Category 2\n\nBG\nПредполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que provoca cáncer .\n\nCS\nPodezření na vyvolání rakoviny .\n\nDA\nMistænkt for at fremkalde kræft .\n\nDE\nKann vermutlich Krebs erzeugen .\n\nET\nArvatavasti põhjustab vähktõbe .\n\nEL\nΎποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of causing cancer .\n\nFR\nSusceptible de provoquer le cancer .\n\nGA\nCeaptar go bhféadfadh sé a bheith ina chúis le hailse .\n\nIT\nSospettato di provocare il cancro .\n\nLV\nIr aizdomas, ka var izraisīt vēzi .\n\nLT\nĮtariama, kad sukelia vėžį .\n\nHU\nFeltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jikkawża l-kanċer .\n\nNL\nVerdacht van het veroorzaken van kanker .\n\nPL\nPodejrzewa się, że powoduje raka .\n\nPT\nSuspeito de provocar cancro .\n\nRO\nSusceptibil de a provoca cancer .\n\nSK\nPodozrenie, že spôsobuje rakovinu .\n\nSL\nSum povzročitve raka .\n\nFI\nEpäillään aiheuttavan syöpää .\n\nSV\nMisstänks kunna orsaka cancer .\n\n\nH360\nLanguage\n3.7 — Reproductive toxicity, Hazard Category 1A, 1B\n\nBG\nМоже да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede perjudicar la fertilidad o dañar al feto .\n\nCS\nMůže poškodit reprodukční schopnost nebo plod v těle matky .\n\nDA\nKan skade forplantningsevnen eller det ufødte barn .\n\nDE\nKann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen .\n\nET\nVõib kahjustada viljakust või loodet .\n\nEL\nΜπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay damage fertility or the unborn child .\n\nFR\nPeut nuire à la fertilité ou au fœtus .\n\nGA\nD'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn .\n\nIT\nPuò nuocere alla fertilità o al feto .\n\nLV\nVar kaitēt auglībai vai nedzimušajam bērnam .\n\nLT\nGali pakenkti vaisingumui arba negimusiam vaikui .\n\nHU\nKárosíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf .\n\nNL\nKan de vruchtbaarheid of het ongeboren kind schaden .\n\nPL\nMoże działać szkodliwie na płodność lub na dziecko w łonie matki .\n\nPT\nPode afectar a fertilidade ou o nascituro .\n\nRO\nPoate dăuna fertilității sau fătului .\n\nSK\nMôže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa .\n\nSL\nLahko škoduje plodnosti ali nerojenemu otroku .\n\nFI\nSaattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä .\n\nSV\nKan skada fertiliteten eller det ofödda barnet .\n\n\nH361\nLanguage\n3.7 — Reproductive toxicity, Hazard Category 2\n\nBG\nПредполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que perjudica la fertilidad o daña al feto .\n\nCS\nPodezření na poškození reprodukční schopnosti nebo plodu v těle matky .\n\nDA\nMistænkt for at skade forplantningsevnen eller det ufødte barn .\n\nDE\nKann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > \n\nET\nArvatavasti kahjustab viljakust või loodet .\n\nEL\nΎποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of damaging fertility or the unborn child .\n\nFR\nSusceptible de nuire à la fertilité ou au fœtus .\n\nGA\nCeaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn .\n\nIT\nSospettato di nuocere alla fertilità o al feto .\n\nLV\nIr aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam .\n\nLT\nĮtariama, kad kenkia vaisingumui arba negimusiam vaikui .\n\nHU\nFeltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf .\n\nNL\nKan mogelijks de vruchtbaarheid of het ongeboren kind schaden .\n\nPL\nPodejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki .\n\nPT\nSuspeito de afectar a fertilidade ou o nascituro .\n\nRO\nSusceptibil de a dăuna fertilității sau fătului .\n\nSK\nPodozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa .\n\nSL\nSum škodljivosti za plodnost ali nerojenega otroka .\n\nFI\nEpäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä .\n\nSV\nMisstänks kunna skada fertiliteten eller det ofödda barnet .\n\nH362\nLanguage\n3.7 — Reproductive toxicity, Additional category, Effects on or via lactation\n\nBG\nМоже да бъде вреден за кърмачета.\n\nES\nPuede perjudicar a los niños alimentados con leche materna.\n\nCS\nMůže poškodit kojence prostřednictvím mateřského mléka.\n\nDA\nKan skade børn, der ammes.\n\nDE\nKann Säuglinge über die Muttermilch schädigen.\n\nET\nVõib kahjustada rinnaga toidetavat last.\n\nEL\nΜπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.\n\nEN\nMay cause harm to breast-fed children.\n\nFR\nPeut être nocif pour les bébés nourris au lait maternel.\n\nGA\nD'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.\n\nIT\nPuò essere nocivo per i lattanti allattati al seno.\n\nLV\nVar radīt kaitējumu ar krūti barotam bērnam.\n\nLT\nGali pakenkti žindomam vaikui.\n\nHU\nA szoptatott gyermeket károsíthatja.\n\nMT\nJista’ jagħmel ħsara lit-tfal imreddgħa.\n\nNL\nKan schadelijk zijn via borstvoeding.\n\nPL\nMoże działać szkodliwie na dzieci karmione piersią.\n\nPT\nPode ser nocivo para as crianças alimentadas com leite materno.\n\nRO\nPoate dăuna copiilor alăptați la sân.\n\nSK\nMôže spôsobiť poškodenie u dojčených detí.\n\nSL\nLahko škoduje dojenim otrokom.\n\nFI\nSaattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.\n\nSV\nKan skada spädbarn som ammas.\n\nH370\nLanguage\n3.8 — Specific target organ toxicity — single exposure, Hazard Category 1\n\nBG\nПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nProvoca daños en los órganos .\n\nCS\nZpůsobuje poškození orgánů .\n\nDA\nForårsager organskader .\n\nDE\nSchädigt die Organe .\n\nET\nKahjustab elundeid .\n\nEL\nΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nCauses damage to organs .\n\nFR\nRisque avéré d'effets graves pour les organes .\n\nGA\nDéanann sé damáiste d'orgáin .\n\nIT\nProvoca danni agli organi .\n\nLV\nRada orgānu bojājumus .\n\nLT\nKenkia organams .\n\nHU\nKárosítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJagħmel ħsara lill-organi .\n\nNL\nVeroorzaakt schade aan organen .\n\nPL\nPowoduje uszkodzenie narządów .\n\nPT\nAfecta os órgãos .\n\nRO\nProvoacă leziuni ale organelor .\n\nSK\nSpôsobuje poškodenie orgánov .\n\nSL\nŠkoduje organom .\n\nFI\nVahingoittaa elimiä .\n\nSV\nOrsakar organskador .\n\nH371\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 2\n\nBG\nМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar daños en los órganos .\n\nCS\nMůže způsobit poškození orgánů .\n\nDA\nKan forårsage organskader .\n\nDE\nKann die Organe schädigen .\n\nET\nVõib kahjustada elundeid .\n\nEL\nΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause damage to organs .\n\nFR\nRisque présumé d'effets graves pour les organes .\n\nGA\nD'fhéadfadh damáiste a dhéanamh d'orgáin .\n\nIT\nPuò provocare danni agli organi .\n\nLV\nVar izraisīt orgānu bojājumus .\n\nLT\nGali pakenkti organams .\n\nHU\nKárosíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża ħsara lill-organi .\n\nNL\nKan schade aan organen veroorzaken .\n\nPL\nMoże powodować uszkodzenie narządów .\n\nPT\nPode afectar os órgãos .\n\nRO\nPoate provoca leziuni ale organelor .\n\nSK\nMôže spôsobiť poškodenie orgánov .\n\nSL\nLahko škoduje organom .\n\nFI\nSaattaa vahingoittaa elimiä .\n\nSV\nKan orsaka organskador .\n\nH372\nLanguage\n3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 1\n\nBG\nПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nProvoca daños en los órganos tras exposiciones prolongadas o repetidas .\n\nCS\nZpůsobuje poškození orgánů při prodloužené nebo opakované expozici .\n\nDA\nForårsager organskader ved længerevarende eller gentagen eksponering .\n\nDE\nSchädigt die Organe bei längerer oder wiederholter Exposition .\n\nET\nKahjustab elundeid pikaajalisel või korduval kokkupuutel .\n\nEL\nΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nCauses damage to organs through prolonged or repeated exposure .\n\nFR\nRisque avéré d'effets graves pour les organes à la suite d'expositions répétées ou d'une exposition prolongée .\n\nGA\nDéanann damáiste d'orgáin trí nochtadh fada nó ilnochtadh .\n\nIT\nProvoca danni agli organi in caso di esposizione prolungata o ripetuta .\n\nLV\nIzraisa orgānu bojājumus ilgstošas vai atkārtotas iedarbības rezultātā .\n\nLT\nKenkia organams , jeigu medžiaga veikia ilgai arba kartotinai .\n\nHU\nIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.\n\nMT\nJikkawża ħsara lill-organi minħabba espożizzjoni fit-tul jew ripetuta .\n\nNL\nVeroorzaakt schade aan organen bij langdurige of herhaalde blootstelling .\n\nPL\nPowoduje uszkodzenie narządów poprzez długotrwałe lub powtarzane narażenie .\n\nPT\nAfecta os órgãos após exposição prolongada ou repetida .\n\nRO\nProvoacă leziuni ale organelor în caz de expunere prelungită sau repetată .\n\nSK\nSpôsobuje poškodenie orgánov pri dlhšej alebo opakovanej expozícii .\n\nSL\nŠkoduje organom pri dolgotrajni ali ponavljajoči se izpostavljenosti .\n\nFI\nVahingoittaa elimiä pitkäaikaisessa tai toistuvassa altistumisessa .\n\nSV\nOrsakar organskador genom lång eller upprepad exponering .\n\nH373\nLanguage\n3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 2\n\nBG\nМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar daños en los órganos tras exposiciones prolongadas o repetidas .\n\nCS\nMůže způsobit poškození orgánů při prodloužené nebo opakované expozici .\n\nDA\nKan forårsage organskader ved længerevarende eller gentagen eksponering .\n\nDE\nKann die Organe schädigen bei längerer oder wiederholter Exposition .\n\nET\nVõib kahjustada elundeid pikaajalisel või korduval kokkupuutel .\n\nEL\nΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause damage to organs through prolonged or repeated exposure .\n\nFR\nRisque présumé d'effets graves pour les organes à la suite d'expositions répétées ou d'une exposition prolongée .\n\nGA\nD'fhéadfadh sé damáiste a dhéanamh d'orgáin trí nochtadh fada nó ilnochtadh .\n\nIT\nPuò provocare danni agli organi in caso di esposizione prolungata o ripetuta .\n\nLV\nVar izraisīt orgānu bojājumus ilgstošas vai atkārtotas iedarbības rezultātā .\n\nLT\nGali pakenkti organams , jeigu medžiaga veikia ilgai arba kartotinai .\n\nHU\nIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.\n\nMT\nJista’ jikkawża ħsara lill-organi minħabba espożizzjoni fit-tul jew ripetuta .\n\nNL\nKan schade aan organen veroorzaken bij langdurige of herhaalde blootstelling .\n\nPL\nMoże powodować uszkodzenie narządów poprzez długotrwałe lub narażenie powtarzane .\n\nPT\nPode afectar os órgãos após exposição prolongada ou repetida .\n\nRO\nPoate provoca leziuni ale organelor în caz de expunere prelungită sau repetată .\n\nSK\nMôže spôsobiť poškodenie orgánov pri dlhšej alebo opakovanej expozícii .\n\nSL\nLahko škoduje organom pri dolgotrajni ali ponavljajoči se izpostavljenosti .\n\nFI\nSaattaa vahingoittaa elimiä pitkäaikaisessa tai toistuvassa altistumisessa \n\nSV\nKan orsaka organskador genom lång eller upprepad exponering .\n\n\nH300\n+\nH310\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане или при контакт с кожата\n\nES\nMortal en caso de ingestión o en contacto con la piel\n\nCS\nPři požití nebo při styku s kůží může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse eller hudkontakt\n\nDE\nLebensgefahr bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nFatal if swallowed or in contact with skin\n\nFR\nMortel par ingestion ou par contact cutané\n\nGA\nÁbhar marfach é seo má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\nIT\nMortale in caso di ingestione o a contatto con la pelle\n\nLV\nVar izraisīt nāvi, ja norīts vai saskaras ar ādu\n\nLT\nMirtina prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve halálos\n\nMT\nFatali jekk tinbela' jew tmiss mal-ġilda\n\nNL\nDodelijk bij inslikken en bij contact met de huid\n\nPL\nGrozi śmiercią po połknięciu lub w kontakcie ze skórą\n\nPT\nMortal por ingestão ou contacto com a pele\n\nRO\nMortal în caz de înghițire sau în contact cu pielea\n\nSK\nPri požití alebo styku s kožou môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju ali v stiku s kožo\n\nFI\nTappavaa nieltynä tai joutuessaan iholle\n\nSV\nDödligt vid förtäring eller vid hudkontakt\n\nH300\n+\nH330\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане или при вдишване\n\nES\nMortal en caso de ingestión o inhalación\n\nCS\nPři požití nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse eller indånding\n\nDE\nLebensgefahr bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nFatal if swallowed or if inhaled\n\nFR\nMortel par ingestion ou par inhalation\n\nGA\nÁbhar marfach é seo má shlogtar nó má ionanálaítear é\n\nIT\nMortale se ingerito o inalato\n\nLV\nVar izraisīt nāvi, ja norīts vai iekļūst elpceļos\n\nLT\nMirtina prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve halálos\n\nMT\nFatali jekk tinbela' jew tittieħed bin-nifs\n\nNL\nDodelijk bij inslikken en bij inademing\n\nPL\nGrozi śmiercią po połknięciu lub w następstwie wdychania\n\nPT\nMortal por ingestão ou inalação\n\nRO\nMortal în caz de înghițire sau inhalare\n\nSK\nPri požití alebo vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju ali vdihavanju\n\nFI\nTappavaa nieltynä tai hengitettynä\n\nSV\nDödligt vid förtäring eller inandning\n\nH310\n+\nH330\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при контакт с кожата или при вдишване\n\nES\nMortal en contacto con la piel o si se inhala\n\nCS\nPři styku s kůží nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved hudkontakt eller indånding\n\nDE\nLebensgefahr bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nFatal in contact with skin or if inhaled\n\nFR\nMortel par contact cutané ou par inhalation\n\nGA\nÁbhar marfach é seo má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nMortale a contatto con la pelle o in caso di inalazione\n\nLV\nVar izraisīt nāvi, ja saskaras ar ādu vai nonāk elpceļos\n\nLT\nMirtina susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve halálos\n\nMT\nFatali f'kuntatt mal-ġilda jew jekk tittieħed bin-nifs\n\nNL\nDodelijk bij contact met de huid en bij inademing\n\nPL\nGrozi śmiercią w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nMortal por contacto com a pele ou inalação\n\nRO\nMortal în contact cu pielea sau prin inhalare\n\nSK\nPri styku s kožou alebo pri vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno v stiku s kožo ali pri vdihavanju\n\nFI\nTappavaa joutuessaan iholle tai hengitettynä\n\nSV\nDödligt vid hudkontakt eller inandning\n\nH300 +\nH310 +\nH330\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане, при контакт с кожата или при вдишване\n\nES\nMortal en caso de ingestión, contacto con la piel o inhalación\n\nCS\nPři požití, při styku s kůží nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse, hudkontakt eller indånding\n\nDE\nLebensgefahr bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nFatal if swallowed, in contact with skin or if inhaled\n\nFR\nMortel par ingestion, par contact cutané ou par inhalation\n\nGA\nÁbhar marfach é seo má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nMortale se ingerito, a contatto con la pelle o se inalato\n\nLV\nVar izraisīt nāvi, ja norīts, saskaras ar ādu vai iekļūst elpceļos\n\nLT\nMirtina prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve halálos\n\nMT\nFatali jekk tinbela', tmiss mal-ġilda jew tittieħed bin-nifs\n\nNL\nDodelijk bij inslikken, bij contact met de huid en bij inademing\n\nPL\nGrozi śmiercią po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nMortal por ingestão, contacto com a pele ou inalação\n\nRO\nMortal în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nPri požití, pri styku s kožou alebo pri vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nTappavaa nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nDödligt vid förtäring, hudkontakt eller inandning\n\n\nH301\n+\nH311\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 3\n\nBG\nТоксичен при поглъщане или при контакт с кожата\n\nES\nTóxico en caso de ingestión o en contacto con la piel\n\nCS\nToxický při požití a při styku s kůží\n\nDA\nGiftig ved indtagelse eller hudkontakt\n\nDE\nGiftig bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nToxic if swallowed or in contact with skin\n\nFR\nToxique par ingestion ou par contact cutané\n\nGA\nÁbhar tocsaineach má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\nIT\nTossico se ingerito o a contatto con la pelle\n\nLV\nToksisks, ja norīts vai saskaras ar ādu\n\nLT\nToksiška prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve mérgező\n\nMT\nTossika jekk tinbela' jew tmiss mal-ġilda\n\nNL\nGiftig bij inslikken en bij contact met de huid\n\nPL\nDziała toksycznie po połknięciu lub w kontakcie ze skórą\n\nPT\nTóxico por ingestão ou contacto com a pele\n\nRO\nToxic în caz de înghițire sau în contact cu pielea\n\nSK\nToxický pri požití a pri styku s kožou\n\nSL\nStrupeno pri zaužitju ali v stiku s kožo\n\nFI\nMyrkyllistä nieltynä tai joutuessaan iholle\n\nSV\nGiftigt vid förtäring eller hudkontakt\n\nH301\n+\nH331\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при поглъщане или при вдишване\n\nES\nTóxico en caso de ingestión o inhalación\n\nCS\nToxický při požití a při vdechování\n\nDA\nGiftig ved indtagelse eller indånding\n\nDE\nGiftig bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nToxic if swallowed or if inhaled\n\nFR\nToxique par ingestion ou par inhalation\n\nGA\nÁbhar tocsaineach má shlogtar nó má ionanálaítear é\n\nIT\nTossico se ingerito o inalato\n\nLV\nToksisks, ja norīts vai iekļūst elpceļos\n\nLT\nToksiška prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve mérgező\n\nMT\nTossika jekk tinbela' jew tittieħed bin-nifs\n\nNL\nGiftig bij inslikken en bij inademing\n\nPL\nDziała toksycznie po połknięciu lub w następstwie wdychania\n\nPT\nTóxico por ingestão ou inalação\n\nRO\nToxic în caz de înghițire sau prin inhalare\n\nSK\nToxický pri požití alebo vdýchnutí\n\nSL\nStrupeno pri zaužitju ali vdihavanju\n\nFI\nMyrkyllistä nieltynä tai hengitettynä\n\nSV\nGiftigt vid förtäring eller inandning\n\nH311\n+\nH331\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при контакт с кожата или при вдишване\n\nES\nTóxico en contacto con la piel o si se inhala\n\nCS\nToxický při styku s kůží a při vdechování\n\nDA\nLivsfarlig ved hudkontakt eller indånding\n\nDE\nGiftig bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nToxic in contact with skin or if inhaled\n\nFR\nToxique par contact cutané ou par inhalation\n\nGA\nÁbhar tocsaineach má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nTossico a contatto con la pelle o se inalato\n\nLV\nToksisks saskarē ar ādu vai ja iekļūst elpceļos\n\nLT\nToksiška susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve mérgező\n\nMT\nTossika jekk tmiss mal-ġilda jew tittieħeb bin-nifs\n\nNL\nGiftig bij contact met de huid en bij inademing\n\nPL\nDziała toksycznie w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nTóxico em contacto com a pele ou por inalação\n\nRO\nToxic în contact cu pielea sau prin inhalare\n\nSK\nToxický pri styku s kožou alebo pri vdýchnutí\n\nSL\nStrupeno v stiku s kožo ali pri vdihavanju\n\nFI\nMyrkyllistä joutuessaan iholle tai hengitettynä\n\nSV\nGiftigt vid hudkontakt eller förtäring\n\nH301 +\nH311 +\nH331\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при поглъщане, при контакт с кожата или при вдишване\n\nES\nTóxico en caso de ingestión, contacto con la piel o inhalación\n\nCS\nToxický při požití, při styku s kůží a při vdechování\n\nDA\nGiftig ved indtagelse, hudkontakt eller indånding\n\nDE\nGiftig bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση κατάποσης\n\nEN\nToxic if swallowed, in contact with skin or if inhaled\n\nFR\nToxique par ingestion, par contact cutané ou par inhalation\n\nGA\nÁbhar tocsaineach má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nTossico se ingerito, a contatto con la pelle o se inalato\n\nLV\nToksisks, ja norīts, saskaras ar ādu vai iekļūst elpceļos\n\nLT\nToksiška prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve mérgező\n\nMT\nTossika jekk tinbela', tmiss mal-ġilda jew tittieħed bin-nifs\n\nNL\nGiftig bij inslikken, bij contact met de huid en bij inademing\n\nPL\nDziała toksycznie po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nTóxico por ingestão, contacto com a pele ou inalação\n\nRO\nToxic în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nToxický pri požití, styku s kožou alebo pri vdýchnutí\n\nSL\nStrupeno pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nMyrkyllistä nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nGiftigt vid förtäring, hudkontakt eller inandning\n\nH302\n+\nH312\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 4\n\nBG\nВреден при поглъщане или при контакт с кожата\n\nES\nNocivo en caso de ingestión o en contacto con la piel\n\nCS\nZdraví škodlivý při požití a při styku s kůží\n\nDA\nLivsfarlig ved indtagelse eller hudkontakt\n\nDE\nGesundheitsschädlich bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nHarmful if swallowed or in contact with skin\n\nFR\nNocif en cas d'ingestion ou de contact cutané\n\nGA\nÁbhar dochrach má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\nIT\nNocivo se ingerito o a contatto con la pelle\n\nLV\nKaitīgs, ja norīts vai saskaras ar ādu\n\nLT\nKenksminga prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve ártalmas\n\nMT\nTagħmel ħsara jekk tinbela' jew jekk tmiss mal-ġilda\n\nNL\nSchadelijk bij inslikken en bij contact met de huid\n\nPL\nDziała szkodliwie po połknięciu lub w kontakcie ze skórą\n\nPT\nNocivo por ingestão ou contacto com a pele\n\nRO\nNociv în caz de înghițire sau în contact cu pielea\n\nSK\nZdraviu škodlivý pri požití alebo pri styku s kožou\n\nSL\nZdravju škodljivo pri zaužitju ali v stiku s kožo\n\nFI\nHaitallista nieltynä tai joutuessaan iholle\n\nSV\nSkadligt vid förtäring eller hudkontakt\n\n\nH302\n+\nH332\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при поглъщане или при вдишване\n\nES\nNocivo en caso de ingestión o inhalación\n\nCS\nZdraví škodlivý při požití a při vdechování\n\nDA\nFarlig ved indtagelse eller indånding\n\nDE\nGesundheitsschädlich bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nHarmful if swallowed or if inhaled\n\nFR\nNocif en cas d'ingestion ou d'inhalation\n\nGA\nÁbhar dochrach má shlogtar nó má ionanálaítear é\n\nIT\nNocivo se ingerito o inalato\n\nLV\nKaitīgs, ja norīts vai iekļūst elpceļos\n\nLT\nKenksminga prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve ártalmas\n\nMT\nTagħmel ħsara jekk tinbela' jew tittieħed bin-nifs\n\nNL\nSchadelijk bij inslikken en bij inademing\n\nPL\nDziała szkodliwie po połknięciu lub w następstwie wdychania\n\nPT\nNocivo por ingestão ou inalação\n\nRO\nNociv în caz de înghițire sau inhalare\n\nSK\nZdraviu škodlivý pri požití alebo vdýchnutí\n\nSL\nZdravju škodljivo pri zaužitju in vdihavanju\n\nFI\nHaitallista nieltynä tai hengitettynä\n\nSV\nSkadligt vid förtäring eller inandning\n\nH312\n+\nH332\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при контакт с кожата или при вдишване\n\nES\nNocivo en contacto con la piel o si se inhala\n\nCS\nZdraví škodlivý při styku s kůží a při vdechování\n\nDA\nFarlig ved hudkontakt eller indånding\n\nDE\nGesundheitsschädlich bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nHarmful in contact with skin or if inhaled\n\nFR\nNocif en cas de contact cutané ou d'inhalation\n\nGA\nÁbhar dochrach má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nNocivo a contatto con la pelle o se inalato\n\nLV\nKaitīgs saskarē ar ādu vai ja iekļūst elpceļos\n\nLT\nKenksminga susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve ártalmas\n\nMT\nTagħmel ħsara jekk tmiss mal-ġilda jew jekk tittieħed bin-nifs\n\nNL\nSchadelijk bij contact met de huid en bij inademing\n\nPL\nDziała szkodliwie w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nNocivo em contacto com a pele ou por inalação\n\nRO\nNociv în contact cu pielea sau prin inhalare\n\nSK\nZdraviu škodlivý pri styku s kožou alebo pri vdýchnutí\n\nSL\nZdravju škodljivo v stiku s kožo in pri vdihavanju\n\nFI\nHaitallista joutuessaan iholle tai hengitettynä\n\nSV\nSkadligt vid hudkontakt eller inandning\n\nH302 +\nH312 +\nH332\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при поглъщане, при контакт с кожата или при вдишване\n\nES\nNocivo en caso de ingestión, contacto con la piel o inhalación\n\nCS\nZdraví škodlivý při požití, při styku s kůží a při vdechování\n\nDA\nFarlig ved indånding, hudkontakt eller indånding\n\nDE\nGesundheitsschädlich bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nHarmful if swallowed, in contact with skin or if inhaled\n\nFR\nNocif en cas d'ingestion, de contact cutané ou d'inhalation\n\nGA\nÁbhar dochrach má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\nIT\nNocivo se ingerito, a contatto con la pelle o se inalato\n\nLV\nKaitīgs, ja norīts, saskaras ar ādu vai nonāk elpceļos\n\nLT\nKenksminga prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve ártalmas\n\nMT\nTagħmel il-ħsara jekk tinbela', tmiss mal-ġilda jew tittiħed bin-nifs\n\nNL\nSchadelijk bij inslikken, bij contact met de huid en bij inademing\n\nPL\nDziała szkodliwie po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nNocivo por ingestão, contacto com a pele ou inalação\n\nRO\nNociv în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nZdraviu škodlivý pri požití, styku s kožou alebo pri vdýchnutí\n\nSL\nZdravju škodljivo pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nHaitallista nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nSkadligt vid förtäring, hudkontakt eller inandning\n\n\nTable 1.3\nHazard statements for environmental hazards\n\nH400\nLanguage\n4.1 — Hazardous to the aquatic environment — AcuteHazard, Category 1\n\nBG\nСилно токсичен за водните организми.\n\nES\nMuy tóxico para los organismos acuáticos.\n\nCS\nVysoce toxický pro vodní organismy.\n\nDA\nMeget giftig for vandlevende organismer.\n\nDE\nSehr giftig für Wasserorganismen.\n\nET\nVäga mürgine veeorganismidele.\n\nEL\nΠολύ τοξικό για τους υδρόβιους οργανισμούς.\n\nEN\nVery toxic to aquatic life.\n\nFR\nTrès toxique pour les organismes aquatiques.\n\nGA\nAn-tocsaineach don saol uisceach.\n\nIT\nMolto tossico per gli organismi acquatici.\n\nLV\nĻoti toksisks ūdens organismiem.\n\nLT\nLabai toksiška vandens organizmams.\n\nHU\nNagyon mérgező a vízi élővilágra.\n\nMT\nTossiku ħafna għall-organiżmi akwatiċi.\n\nNL\nZeer giftig voor in het water levende organismen.\n\nPL\nDziała bardzo toksycznie na organizmy wodne.\n\nPT\nMuito tóxico para os organismos aquáticos.\n\nRO\nFoarte toxic pentru mediul acvatic.\n\nSK\nVeľmi toxický pre vodné organizmy.\n\nSL\nZelo strupeno za vodne organizme.\n\nFI\nErittäin myrkyllistä vesieliöille.\n\nSV\nMycket giftigt för vattenlevande organismer.\n\nH410\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 1\n\nBG\nСилно токсичен за водните организми, с дълготраен ефект.\n\nES\nMuy tóxico para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nVysoce toxický pro vodní organismy, s dlouhodobými účinky.\n\nDA\nMeget giftig med langvarige virkninger for vandlevende organismer.\n\nDE\nSehr giftig für Wasserorganismen mit langfristiger Wirkung.\n\nET\nVäga mürgine veeorganismidele, pikaajaline toime.\n\nEL\nΠολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nVery toxic to aquatic life with long lasting effects.\n\nFR\nTrès toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nAn-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\nIT\nMolto tossico per gli organismi acquatici con effetti di lunga durata.\n\nLV\nĻoti toksisks ūdens organismiem ar ilgstošām sekām.\n\nLT\nLabai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nNagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nTossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nZeer giftig voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nMuito tóxico para os organismos aquáticos com efeitos duradouros.\n\nRO\nFoarte toxic pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nVeľmi toxický pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nZelo strupeno za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nErittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nMycket giftigt för vattenlevande organismer med långtidseffekter.\n\nH411\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 2\n\nBG\nТоксичен за водните организми, с дълготраен ефект.\n\nES\nTóxico para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nToxický pro vodní organismy, s dlouhodobými účinky.\n\nDA\nGiftig for vandlevende organismer, med langvarige virkninger.\n\nDE\nGiftig für Wasserorganismen, mit langfristiger Wirkung.\n\nET\nMürgine veeorganismidele, pikaajaline toime.\n\nEL\nΤοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nToxic to aquatic life with long lasting effects.\n\nFR\nToxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nTocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\nIT\nTossico per gli organismi acquatici con effetti di lunga durata.\n\nLV\nToksisks ūdens organismiem ar ilgstošām sekām.\n\nLT\nToksiška vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nMérgező a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nTossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nGiftig voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała toksycznie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nTóxico para os organismos aquáticos com efeitos duradouros.\n\nRO\nToxic pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nToxický pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nStrupeno za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nMyrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nGiftigt för vattenlevande organismer med långtidseffekter.\n\nH412\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 3\n\nBG\nВреден за водните организми, с дълготраен ефект.\n\nES\nNocivo para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nŠkodlivý pro vodní organismy, s dlouhodobými účinky.\n\nDA\nSkadelig for vandlevende organismer, med langvarige virkninger.\n\nDE\nSchädlich für Wasserorganismen, mit langfristiger Wirkung.\n\nET\nOhtlik veeorganismidele, pikaajaline toime.\n\nEL\nΕπιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nHarmful to aquatic life with long lasting effects.\n\nFR\nNocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nDíobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\nIT\nNocivo per gli organismi acquatici con effetti di lunga durata.\n\nLV\nKaitīgs ūdens organismiem ar ilgstošām sekām.\n\nLT\nKenksminga vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nÁrtalmas a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nJagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nSchadelijk voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała szkodliwie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nNocivo para os organismos aquáticos com efeitos duradouros.\n\nRO\nNociv pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nŠkodlivý pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nŠkodljivo za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nHaitallista vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nSkadliga långtidseffekter för vattenlevande organismer.\n\nH413\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 4\n\nBG\nМоже да причини дълготраен вреден ефект за водните организми.\n\nES\nPuede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nMůže vyvolat dlouhodobé škodlivé účinky pro vodní organismy.\n\nDA\nKan forårsage langvarige skadelige virkninger for vandlevende organismer.\n\nDE\nKann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.\n\nET\nVõib avaldada veeorganismidele pikaajalist kahjulikku toimet.\n\nEL\nΜπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.\n\nEN\nMay cause long lasting harmful effects to aquatic life.\n\nFR\nPeut être nocif à long terme pour les organismes aquatiques.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.\n\nIT\nPuò essere nocivo per gli organismi acquatici con effetti di lunga durata.\n\nLV\nVar radīt ilgstošas kaitīgas sekas ūdens organismiem.\n\nLT\nGali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.\n\nHU\nHosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.\n\nMT\nJista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.\n\nNL\nKan langdurige schadelijke gevolgen voor in het water levende organismen hebben.\n\nPL\nMoże powodować długotrwałe szkodliwe skutki dla organizmów wodnych.\n\nPT\nPode provocar efeitos nocivos duradouros nos organismos aquáticos.\n\nRO\nPoate provoca efecte nocive pe termen lung asupra mediului acvatic.\n\nSK\nMôže mať dlhodobé škodlivé účinky na vodné organizmy.\n\nSL\nLahko ima dolgotrajne škodljive učinke na vodne organizme.\n\nFI\nVoi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.\n\nSV\nKan ge skadliga långtidseffekter på vattenlevande organismer.\n\n\n\nH420\nLanguage\n5.1 – Hazardous to the ozone layer — hazard category 1\n\nBG\nВреди на общественото здраве и на околната среда, като разрушава озона във високите слоеве на атмосферата\n\nES\nCausa daños a la salud pública y el medio ambiente al destruir el ozono en la atmósfera superior\n\nCS\nPoškozuje veřejné zdraví a životní prostředí tím, že ničí ozon ve svrchních vrstvách atmosféry\n\nDA\nSkader folkesundheden og miljøet ved at ødelægge ozon i den øvre atmosfære\n\nDE\nSchädigt die öffentliche Gesundheit und die Umwelt durch Ozonabbau in der äußeren Atmosphäre\n\nET\nKahjustab rahvatervist ja keskkonda, hävitades kõrgatmosfääris asuvat osoonikihti\n\nEL\nΒλάπτει τη δημόσια υγεία και το περιβάλλον καταστρέφοντας το όζον στην ανώτερη ατμόσφαιρα\n\nEN\nHarms public health and the environment by destroying ozone in the upper atmosphere\n\nFR\nNuit à la santé publique et à l'environnement en détruisant l'ozone dans la haute atmosphère\n\nGA\nDéanann an t-ábhar seo díobháil don tsláinte phoiblí agus don chomhshaol trí ózón san atmaisféar uachtarach a scriosadh\n\nIT\nNuoce alla salute pubblica e all'ambiente distruggendo l'ozono dello strato superiore dell'atmosfera\n\nLV\nBīstams sabiedrības veselībai un videi, jo iznīcina ozonu atmosfēras augšējā slānī\n\nLT\nKenkia visuomenės sveikatai ir aplinkai, nes naikina ozono sluoksnį viršutinėje atmosferoje\n\nHU\nKárosítja a közegészséget és a környezetet, mert a légkör felső rétegeiben lebontja az ózont\n\nMT\nTagħmel ħsara lis-saħħa tal-pubbliku u lill-ambjent billi teqred l-ożonu fl-atmosfera ta' fuq\n\nNL\nSchadelijk voor de volksgezondheid en het milieu door afbraak van ozon in de bovenste lagen van de atmosfeer\n\nPL\nSzkodliwe dla zdrowia publicznego i środowiska w związku z niszczącym oddziaływaniem na ozon w górnej warstwie atmosfery\n\nPT\nPrejudica a saúde pública e o ambiente ao destruir o ozono na alta atmosfera\n\nRO\nDăunează sănătății publice și mediului înconjurător prin distrugerea ozonului în atmosfera superioară\n\nSK\nPoškodzuje verejné zdravie a životné prostredie tým, že ničí ozón vo vrchných vrstvách atmosféry\n\nSL\nŠkodljivo za javno zdravje in okolje zaradi uničevanja ozona v zgornji atmosferi\n\nFI\nVahingoittaa kansanterveyttä ja ympäristöä tuhoamalla otsonia ylemmässä ilmakehässä\n\nSV\nSkadar folkhälsan och miljön genom förstöring av ozonet i övre delen av atmosfären\n\n\n\n\n2. Part 2: supplemental hazard information\n\nTable 2.1\nPhysical properties\n\nEUH 001\nLanguage\n\n\nBG\nЕксплозивен в сухо състояние.\n\nES\nExplosivo en estado seco.\n\nCS\nVýbušný v suchém stavu.\n\nDA\nEksplosiv i tør tilstand.\n\nDE\nIn trockenem Zustand explosionsgefährlich.\n\nET\nPlahvatusohtlik kuivana.\n\nEL\nΕκρηκτικό σε ξηρή κατάσταση.\n\nEN\nExplosive when dry.\n\nFR\nExplosif à l'état sec.\n\nGA\nPléascach agus é tirim.\n\nIT\nEsplosivo allo stato secco.\n\nLV\nSprādzienbīstams sausā veidā.\n\nLT\nSausos būsenos gali sprogti.\n\nHU\nSzáraz állapotban robbanásveszélyes.\n\nMT\nJisplodi meta jinxef.\n\nNL\nIn droge toestand ontplofbaar.\n\nPL\nProdukt wybuchowy w stanie suchym.\n\nPT\nExplosivo no estado seco.\n\nRO\nExploziv în stare uscată.\n\nSK\nV suchom stave výbušný.\n\nSL\nEksplozivno v suhem stanju.\n\nFI\nRäjähtävää kuivana.\n\nSV\nExplosivt i torrt tillstånd.\n\nEUH 006\nLanguage\n\n\nBG\nЕксплозивен при или без контакт с въздуха.\n\nES\nExplosivo en contacto o sin contacto con el aire.\n\nCS\nVýbušný za přístupu i bez přístupu vzduchu.\n\nDA\nEksplosiv ved og uden kontakt med luft.\n\nDE\nMit und ohne Luft explosionsfähig.\n\nET\nPlahvatusohtlik õhuga kokkupuutel või kokkupuuteta.\n\nEL\nΕκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.\n\nEN\nExplosive with or without contact with air.\n\nFR\nDanger d'explosion en contact ou sans contact avec l'air.\n\nGA\nPléascach i dteagmháil le haer nó gan é.\n\nIT\nEsplosivo a contatto o senza contatto con l'aria.\n\nLV\nSprādzienbīstams gaisa un bezgaisa vidē.\n\nLT\nGali sprogti ore arba beorėje erdvėje.\n\nHU\nLevegővel érintkezve vagy anélkül is robbanásveszélyes.\n\nMT\nJista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.\n\nNL\nOntplofbaar met en zonder lucht.\n\nPL\nProdukt wybuchowy z dostępem lub bez dostępu powietrza.\n\nPT\nPerigo de explosão com ou sem contacto com o ar.\n\nRO\nExploziv în contact sau fără contactul cu aerul.\n\nSK\nVýbušné pri kontakte alebo bez kontaktu so vzduchom.\n\nSL\nEksplozivno v stiku z zrakom ali brez stika z zrakom.\n\nFI\nRäjähtävää sellaisenaan tai ilman kanssa.\n\nSV\nExplosivt vid eller utan kontakt med luft.\n\nEUH 014\nLanguage\n\n\nBG\nРеагира бурно с вода.\n\nES\nReacciona violentamente con el agua.\n\nCS\nPrudce reaguje s vodou.\n\nDA\nReagerer voldsomt med vand.\n\nDE\nReagiert heftig mit Wasser.\n\nET\nReageerib ägedalt veega.\n\nEL\nΑντιδρά βίαια με νερό.\n\nEN\nReacts violently with water.\n\nFR\nRéagit violemment au contact de l'eau.\n\nGA\nImoibríonn go foirtil le huisce.\n\nIT\nReagisce violentemente con l'acqua.\n\nLV\nAktīvi reaģē ar ūdeni.\n\nLT\nSmarkiai reaguoja su vandeniu.\n\nHU\nVízzel hevesen reagál.\n\nMT\nJirreaġixxi bil-qawwa meta jmiss l-ilma.\n\nNL\nReageert heftig met water.\n\nPL\nReaguje gwałtownie z wodą.\n\nPT\nReage violentamente em contacto com a água.\n\nRO\nReacționează violent în contact cu apa.\n\nSK\nPrudko reaguje s vodou.\n\nSL\nBurno reagira z vodo.\n\nFI\nReagoi voimakkaasti veden kanssa.\n\nSV\nReagerar häftigt med vatten.\n\n\nEUH 018\nLanguage\n\n\nBG\nПри употреба може да се образува запалима/експлозивна паровъздушнa смес.\n\nES\nAl usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.\n\nCS\nPři používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.\n\nDA\nVed brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.\n\nDE\nKann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.\n\nET\nKasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.\n\nEL\nΚατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.\n\nEN\nIn use may form flammable/explosive vapour-air mixture.\n\nFR\nLors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.\n\nGA\nAgus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.\n\nIT\nDurante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.\n\nLV\nIzmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.\n\nLT\nNaudojama gali sudaryti degius (sprogius) garų-oro mišinius.\n\nHU\nA használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.\n\nMT\nMeta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.\n\nNL\nKan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.\n\nPL\nPodczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.\n\nPT\nPode formar mistura vapor-ar explosiva/inflamável durante a utilização.\n\nRO\nÎn timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.\n\nSK\nPri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.\n\nSL\nPri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.\n\nFI\nKäytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.\n\nSV\nVid användning kan brännbara/explosiva ång-luftblandningar bildas.\n\n\nEUH 019\nLanguage\n\n\nBG\nМоже да образува експлозивни пероксиди.\n\nES\nPuede formar peróxidos explosivos.\n\nCS\nMůže vytvářet výbušné peroxidy.\n\nDA\nKan danne eksplosive peroxider.\n\nDE\nKann explosionsfähige Peroxide bilden.\n\nET\nVõib moodustada plahvatusohtlikke peroksiide.\n\nEL\nΜπορεί να σχηματίσει εκρηκτικά υπεροξείδια.\n\nEN\nMay form explosive peroxides.\n\nFR\nPeut former des peroxydes explosifs.\n\nGA\nD'fhéadfadh sé sárocsaídí pléascacha a chruthú.\n\nIT\nPuò formare perossidi esplosivi.\n\nLV\nVar veidot sprādzienbīstamus peroksīdus.\n\nLT\nGali sudaryti sprogius peroksidus.\n\nHU\nRobbanásveszélyes peroxidokat képezhet.\n\nMT\nJista' jifforma perossidi esplussivi.\n\nNL\nKan ontplofbare peroxiden vormen.\n\nPL\nMoże tworzyć wybuchowe nadtlenki.\n\nPT\nPode formar peróxidos explosivos.\n\nRO\nPoate forma peroxizi explozivi.\n\nSK\nMôže vytvárat’ výbušné peroxidy.\n\nSL\nLahko tvori eksplozivne perokside.\n\nFI\nSaattaa muodostaa räjähtäviä peroksideja.\n\nSV\nKan bilda explosiva peroxider.\n\nEUH 044\nLanguage\n\n\nBG\nРиск от експлозия при нагряване в затворено пространство.\n\nES\nRiesgo de explosión al calentarlo en ambiente confinado.\n\nCS\nNebezpečí výbuchu při zahřátí v uzavřeném obalu.\n\nDA\nEksplosionsfarlig ved opvarmning under indeslutning.\n\nDE\nExplosionsgefahr bei Erhitzen unter Einschluss.\n\nET\nPlahvatusohtlik kuumutamisel kinnises mahutis.\n\nEL\nΚίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.\n\nEN\nRisk of explosion if heated under confinement.\n\nFR\nRisque d'explosion si chauffé en ambiance confinée.\n\nGA\nBaol pléasctha arna théamh i limistéar iata.\n\nIT\nRischio di esplosione per riscaldamento in ambiente confinato.\n\nLV\nSprādziena draudi, karsējot slēgtā vidē.\n\nLT\nGali sprogti, jei kaitinama sandariai uždaryta.\n\nHU\nZárt térben hő hatására robbanhat.\n\nMT\nRiskju ta' splużjoni jekk jissaħħan fil-magħluq.\n\nNL\nOntploffingsgevaar bij verwarming in afgesloten toestand.\n\nPL\nZagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.\n\nPT\nRisco de explosão se aquecido em ambiente fechado.\n\nRO\nRisc de explozie, dacă este încălzit în spațiu închis.\n\nSK\nRiziko výbuchu pri zahrievaní v uzavretom priestore.\n\nSL\nNevarnost eksplozije ob segrevanju v zaprtem prostoru.\n\nFI\nRäjähdysvaara kuumennettaessa suljetussa astiassa.\n\nSV\nExplosionsrisk vid uppvärmning i sluten behållare.\n\nTable 2.2\nHealth properties\n\nEUH 029\nLanguage\n\n\nBG\nПри контакт с вода се отделя токсичен газ.\n\nES\nEn contacto con agua libera gases tóxicos.\n\nCS\nUvolňuje toxický plyn při styku s vodou.\n\nDA\nUdvikler giftig gas ved kontakt med vand.\n\nDE\nEntwickelt bei Berührung mit Wasser giftige Gase.\n\nET\nKokkupuutel veega eraldub mürgine gaas.\n\nEL\nΣε επαφή με το νερό ελευθερώνονται τοξικά αέρια.\n\nEN\nContact with water liberates toxic gas.\n\nFR\nAu contact de l'eau, dégage des gaz toxiques.\n\nGA\nI dteagmháil le huisce scaoiltear gás tocsaineach.\n\nIT\nA contatto con l'acqua libera un gas tossico.\n\nLV\nSaskaroties ar ūdeni, izdala toksiskas gāzes.\n\nLT\nKontaktuodama su vandeniu išskiria toksiškas dujas.\n\nHU\nVízzel érintkezve mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku meta jmiss l-ilma.\n\nNL\nVormt giftig gas in contact met water.\n\nPL\nW kontakcie z wodą uwalnia toksyczne gazy.\n\nPT\nEm contacto com a água liberta gases tóxicos.\n\nRO\nÎn contact cu apa, degajă un gaz toxic.\n\nSK\nPri kontakte s vodou uvoľňuje toxický plyn.\n\nSL\nV stiku z vodo se sprošča strupen plin.\n\nFI\nKehittää myrkyllistä kaasua veden kanssa.\n\nSV\nUtvecklar giftig gas vid kontakt med vatten.\n\nEUH 031\nLanguage\n\n\nBG\nПри контакт с киселини се отделя токсичен газ.\n\nES\nEn contacto con ácidos libera gases tóxicos.\n\nCS\nUvolňuje toxický plyn při styku s kyselinami.\n\nDA\nUdvikler giftig gas ved kontakt med syre.\n\nDE\nEntwickelt bei Berührung mit Säure giftige Gase.\n\nET\nKokkupuutel hapetega eraldub mürgine gaas.\n\nEL\nΣε επαφή με οξέα ελευθερώνονται τοξικά αέρια.\n\nEN\nContact with acids liberates toxic gas.\n\nFR\nAu contact d'un acide, dégage un gaz toxique.\n\nGA\nI dteagmháil le haigéid scaoiltear gás tocsaineach.\n\nIT\nA contatto con acidi libera gas tossici.\n\nLV\nSaskaroties ar skābēm, izdala toksiskas gāzes.\n\nLT\nKontaktuodama su rūgštimis išskiria toksiškas dujas.\n\nHU\nSavval érintkezve mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku meta jmiss l-aċidi.\n\nNL\nVormt giftig gas in contact met zuren.\n\nPL\nW kontakcie z kwasami uwalnia toksyczne gazy.\n\nPT\nEm contacto com ácidos liberta gases tóxicos.\n\nRO\nÎn contact cu acizi, degajă un gaz toxic.\n\nSK\nPri kontakte s kyselinami uvoľňuje toxický plyn.\n\nSL\nV stiku s kislinami se sprošča strupen plin.\n\nFI\nKehittää myrkyllistä kaasua hapon kanssa.\n\nSV\nUtvecklar giftig gas vid kontakt med syra.\n\n\nEUH 032\nLanguage\n\n\nBG\nПри контакт с киселини се отделя силно токсичен газ.\n\nES\nEn contacto con ácidos libera gases muy tóxicos.\n\nCS\nUvolňuje vysoce toxický plyn při styku s kyselinami.\n\nDA\nUdvikler meget giftig gas ved kontakt med syre.\n\nDE\nEntwickelt bei Berührung mit Säure sehr giftige Gase.\n\nET\nKokkupuutel hapetega eraldub väga mürgine gaas.\n\nEL\nΣε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.\n\nEN\nContact with acids liberates very toxic gas.\n\nFR\nAu contact d'un acide, dégage un gaz très toxique.\n\nGA\nI dteagmháil le haigéid scaoiltear gás an-tocsaineach.\n\nIT\nA contatto con acidi libera gas molto tossici.\n\nLV\nSaskaroties ar skābēm, izdala ļoti toksiskas gāzes.\n\nLT\nKontaktuodama su rūgštimis išskiria labai toksiškas dujas.\n\nHU\nSavval érintkezve nagyon mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku ħafna meta jmiss l-aċidi.\n\nNL\nVormt zeer giftig gas in contact met zuren.\n\nPL\nW kontakcie z kwasami uwalnia bardzo toksyczne gazy.\n\nPT\nEm contacto com ácidos liberta gases muito tóxicos.\n\nRO\nÎn contact cu acizi, degajă un gaz foarte toxic.\n\nSK\nPri kontakte s kyselinami uvoľňuje veľmi toxický plyn.\n\nSL\nV stiku s kislinami se sprošča zelo strupen plin.\n\nFI\nKehittää erittäin myrkyllistä kaasua hapon kanssa.\n\nSV\nUtvecklar mycket giftig gas vid kontakt med syra.\n\nEUH 066\nLanguage\n\n\nBG\nПовтарящата се експозиция може да предизвика изсушаване или напукване на кожата.\n\nES\nLa exposición repetida puede provocar sequedad o formación de grietas en la piel.\n\nCS\nOpakovaná expozice může způsobit vysušení nebo popraskání kůže.\n\nDA\nGentagen kontakt kan give tør eller revnet hud.\n\nDE\nWiederholter Kontakt kann zu spröder oder rissiger Haut führen.\n\nET\nKorduv kokkupuude võib põhjustada naha kuivust või lõhenemist.\n\nEL\nΠαρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.\n\nEN\nRepeated exposure may cause skin dryness or cracking.\n\nFR\nL'exposition répétée peut provoquer dessèchement ou gerçures de la peau.\n\nGA\nD'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.\n\nIT\nL'esposizione ripetuta può provocare secchezza o screpolature della pelle.\n\nLV\nAtkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.\n\nLT\nPakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.\n\nHU\nIsmétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.\n\nMT\nEspożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.\n\nNL\nHerhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.\n\nPL\nPowtarzające się narażenie może powodować wysuszanie lub pękanie skóry.\n\nPT\nPode provocar pele seca ou gretada, por exposição repetida.\n\nRO\nExpunerea repetată poate provoca uscarea sau crăparea pielii.\n\nSK\nOpakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.\n\nSL\nPonavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.\n\nFI\nToistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.\n\nSV\nUpprepad kontakt kan ge torr hud eller hudsprickor.\n\nEUH 070\nLanguage\n\n\nBG\nТоксично при контакт с очите.\n\nES\nTóxico en contacto con los ojos.\n\nCS\nToxický při styku s očima.\n\nDA\nGiftig ved kontakt med øjnene.\n\nDE\nGiftig bei Berührung mit den Augen.\n\nET\nSilma sattumisel mürgine.\n\nEL\nΤοξικό σε επαφή με τα μάτια.\n\nEN\nToxic by eye contact.\n\nFR\nToxique par contact oculaire.\n\nGA\nTocsaineach trí theagmháil leis an tsúil.\n\nIT\nTossico per contatto oculare.\n\nLV\nToksisks saskarē ar acīm.\n\nLT\nToksiška patekus į akis.\n\nHU\nSzembe kerülve mérgező.\n\nMT\nTossiku meta jmiss ma’ l-għajnejn.\n\nNL\nGiftig bij oogcontact.\n\nPL\nDziała toksycznie w kontakcie z oczami.\n\nPT\nTóxico por contacto com os olhos.\n\nRO\nToxic în caz de contact cu ochii.\n\nSK\nToxické pri kontakte s očami.\n\nSL\nStrupeno ob stiku z očmi.\n\nFI\nMyrkyllistä joutuessaan silmään.\n\nSV\nGiftigt vid kontakt med ögonen.\n\nEUH 071\nLanguage\n\n\nBG\nКорозивен за дихателните пътища.\n\nES\nCorrosivo para las vías respiratorias.\n\nCS\nZpůsobuje poleptání dýchacích cest.\n\nDA\nÆtsende for luftvejene.\n\nDE\nWirkt ätzend auf die Atemwege.\n\nET\nSöövitav hingamisteedele.\n\nEL\nΔιαβρωτικό της αναπνευστικής οδού.\n\nEN\nCorrosive to the respiratory tract.\n\nFR\nCorrosif pour les voies respiratoires.\n\nGA\nCreimneach don chonair riospráide.\n\nIT\nCorrosivo per le vie respiratorie.\n\nLV\nKodīgs elpceļiem.\n\nLT\nĖsdina kvėpavimo takus.\n\nHU\nMaró hatású a légutakra.\n\nMT\nKorrużiv għas-sistema respiratorja.\n\nNL\nBijtend voor de luchtwegen.\n\nPL\nDziała żrąco na drogi oddechowe.\n\nPT\nCorrosivo para as vias respiratórias.\n\nRO\nCorosiv pentru căile respiratorii.\n\nSK\nŽieravé pre dýchacie cesty.\n\nSL\nJedko za dihalne poti.\n\nFI\nHengityselimiä syövyttävää.\n\nSV\nFrätande på luftvägarna.\n\n\nTable 2.3\nEnvironmental properties\n\nEUH 059\nLanguage\nAdditional EU Hazard Class\n\nBG\nОпасно за озоновия слой.\n\nES\nPeligroso para la capa de ozono.\n\nCS\nNebezpečný pro ozonovou vrstvu.\n\nDA\nFarlig for ozonlaget.\n\nDE\nDie Ozonschicht schädigend.\n\nET\nOhtlik osoonikihile.\n\nEL\nΕπικίνδυνο για τη στιβάδα του όζοντος.\n\nEN\nHazardous to the ozone layer.\n\nFR\nDangereux pour la couche d'ozone.\n\nGA\nGuaiseach don chiseal ózóin.\n\nIT\nPericoloso per lo strato di ozono.\n\nLV\nBīstams ozona slānim.\n\nLT\nPavojinga ozono sluoksniui.\n\nHU\nVeszélyes az ózonrétegre.\n\nMT\nPerikoluż għas-saff ta' l-ożonu.\n\nNL\nGevaarlijk voor de ozonlaag.\n\nPL\nStwarza zagrożenie dla warstwy ozonowej.\n\nPT\nPerigoso para a camada de ozono.\n\nRO\nPericulos pentru stratul de ozon.\n\nSK\nNebezpečný pre ozónovú vrstvu.\n\nSL\nNevarno za ozonski plašč.\n\nFI\nVaarallista otsonikerrokselle.\n\nSV\nFarligt för ozonskiktet.\n\n\n\n\n3. Part 3: supplemental label elements/information on certain certain substances and mixtures\n\nEUH 201/ 201A\nLanguage\n\n201\n201A\nBG\nСъдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.\nВнимание! Съдържа олово.\n201\n201A\nES\nContiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.\n¡Atención! Contiene plomo.\n201\n201A\nCS\nObsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.\nPozor! Obsahuje olovo.\n201\n201A\nDA\nIndeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.\nAdvarsel! Indeholder bly.\n201\n201A\nDE\nEnthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.\nAchtung! Enthält Blei.\n201\n201A\nET\nSisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.\nEttevaatust! Sisaldab pliid.\n201\n201A\nEL\nΠεριέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.\nΠροσοχή! Περιέχει μόλυβδο.\n201\n201A\nEN\nContains lead. Should not be used on surfaces liable to be chewed or sucked by children.\nWarning! Contains lead.\n201\n201A\nFR\nContient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.\nAttention! Contient du plomb.\n201\n201A\nGA\nLuaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.\nRabhadh! Luaidhe ann.\n201\n201A\nIT\nContiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.\nAttenzione! Contiene piombo.\n201\n201A\nLV\nSatur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.\nBrīdinājums! Satur svinu.\n201\n201A\nLT\nSudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.\nAtsargiai! Sudėtyje yra švino.\n201\n201A\nHU\nÓlmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.\nFigyelem! Ólmot tartalmaz.\n201\n201A\nMT\nFih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.\nTwissija! Fih iċ-ċomb.\n201\n201A\nNL\nBevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.\nLet op! Bevat lood.\n201\n201A\nPL\nZawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.\nUwaga! Zawiera ołów.\n201\n201A\nPT\nContém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.\nAtenção! Contém chumbo.\n201\n201A\nRO\nConține plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.\nAtenție! Conține plumb.\n201\n201A\nSK\nObsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.\nPozor! Obsahuje olovo.\n201\n201A\nSL\nVsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.\nPozor! Vsebuje svinec.\n201\n201A\nFI\nSisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.\nVaroitus! Sisältää lyijyä.\n201\n201A\nSV\nInnehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.\nVarning! Innehåller bly.\n\nEUH 202\nLanguage\n\n\nBG\nЦианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.\n\nES\nCianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.\n\nCS\nKyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.\n\nDA\nCyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.\n\nDE\nCyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.\n\nET\nTsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.\n\nEL\nΚυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.\n\nEN\nCyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.\n\nFR\nCyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.\n\nGA\nCianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.\n\nIT\nCianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.\n\nLV\nCiānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.\n\nLT\nCianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.\n\nHU\nCianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.\n\nMT\nCyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.\n\nNL\nCyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.\n\nPL\nCyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.\n\nPT\nCianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.\n\nRO\nCianoacrilat. Pericol. Se lipește de piele și ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.\n\nSK\nKyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.\n\nSL\nCianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.\n\nFI\nSyanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.\n\nSV\nCyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.\n\nEUH 203\nLanguage\n\n\nBG\nСъдържа хром (VI). Може да причини алергична реакция.\n\nES\nContiene cromo (VI). Puede provocar una reacción alérgica.\n\nCS\nObsahuje chrom (VI). Může vyvolat alergickou reakci.\n\nDA\nIndeholder krom (VI). Kan udløse allergisk reaktion.\n\nDE\nEnthält Chrom (VI). Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains chromium (VI). May produce an allergic reaction.\n\nFR\nContient du chrome (VI). Peut produire une réaction allergique.\n\nGA\nCróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\nIT\nContiene cromo (VI). Può provocare una reazione allergica.\n\nLV\nSatur hromu (VI). Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.\n\nHU\nKrómot (VI) tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.\n\nNL\nBevat zeswaardig chroom. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém crómio (VI). Pode provocar uma reacção alérgica.\n\nRO\nConține crom (VI). Poate provoca o reacție alergică.\n\nSK\nObsahuje chróm (VI). Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje krom (VI). Lahko povzroči alergijski odziv.\n\nFI\nSisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller krom (VI). Kan orsaka en allergisk reaktion.\n\n\nEUH 204\nLanguage\n\n\nBG\nСъдържа изоцианати. Може да причини алергична реакция.\n\nES\nContiene isocianatos. Puede provocar una reacción alérgica.\n\nCS\nObsahuje isokyanáty. Může vyvolat alergickou reakci.\n\nDA\nIndeholder isocyanater. Kan udløse allergisk reaktion.\n\nDE\nEnthält Isocyanate. Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains isocyanates. May produce an allergic reaction.\n\nFR\nContient des isocyanates. Peut produire une réaction allergique.\n\nGA\nIsicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\nIT\nContiene isocianati. Può provocare una reazione allergica.\n\nLV\nSatur izocianātus. Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra izocianatų. Gali sukelti alerginę reakciją.\n\nHU\nIzocianátokat tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat isocyanaten. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém isocianatos. Pode provocar uma reacção alérgica.\n\nRO\nConține izocianați. Poate provoca o reacție alergică.\n\nSK\nObsahuje izokyanáty. Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje izocianate. Lahko povzroči alergijski odziv.\n\nFI\nSisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller isocyanater. Kan orsaka en allergisk reaktion.\n\n\nEUH 205\nLanguage\n\n\nBG\nСъдържа епоксидни съставки. Може да причини алергична реакция.\n\nES\nContiene componentes epoxídicos. Puede provocar una reacción alérgica.\n\nCS\nObsahuje epoxidové složky. Může vyvolat alergickou reakci.\n\nDA\nIndeholder epoxyforbindelser. Kan udløse allergisk reaktion.\n\nDE\nEnthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains epoxy constituents. May produce an allergic reaction.\n\nFR\nContient des composés époxydiques. Peut produire une réaction allergique.\n\nGA\nComhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\nIT\nContiene componenti epossidici. Può provocare una reazione allergica.\n\nLV\nSatur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.\n\nHU\nEpoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat epoxyverbindingen. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém componentes epoxídicos. Pode provocar uma reacção alérgica.\n\nRO\nConține componenți epoxidici. Poate provoca o reacție alergică.\n\nSK\nObsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.\n\nFI\nSisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller epoxiförening. Kan orsaka en allergisk reaktion.\n\n\nEUH 206\nLanguage\n\n\nBG\nВнимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).\n\nES\n¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).\n\nCS\nPozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).\n\nDA\nAdvarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.\n\nDE\nAchtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.\n\nET\nEttevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).\n\nEL\nΠροσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).\n\nEN\nWarning! Do not use together with other products. May release dangerous gases (chlorine).\n\nFR\nAttention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).\n\nGA\nRabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).\n\nIT\nAttenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).\n\nLV\nBrīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).\n\nLT\nAtsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).\n\nHU\nFigyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.\n\nMT\nTwissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).\n\nNL\nLet op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.\n\nPL\nUwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).\n\nPT\nAtenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).\n\nRO\nAtenție! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).\n\nSK\nPozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).\n\nSL\nPozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).\n\nFI\nVaroitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).\n\nSV\nVarning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).\n\nEUH 207\nLanguage\n\n\nBG\nВнимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.\n\nES\n¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.\n\nCS\nPozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.\n\nDA\nAdvarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.\n\nDE\nAchtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.\n\nET\nEttevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.\n\nEL\nΠροσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.\n\nEN\nWarning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.\n\nFR\nAttention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.\n\nGA\nRabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.\n\nIT\nAttenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.\n\nLV\nBrīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.\n\nLT\nAtsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.\n\nHU\nFigyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.\n\nMT\nTwissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.\n\nNL\nLet op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.\n\nPL\nUwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.\n\nPT\nAtenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.\n\nRO\nAtenție! Conține cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informațiile furnizate de producător. A se respecta instrucțiunile privind siguranța.\n\nSK\nPozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.\n\nSL\nPozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.\n\nFI\nVaroitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.\n\nSV\nVarning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.\n\nEUH 208\nLanguage\n\n\nBG\nСъдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.\n\nES\nContiene . Puede provocar una reacción alérgica.\n\nCS\nObsahuje . Může vyvolat alergickou reakci.\n\nDA\nIndeholder . Kan udløse allergisk reaktion.\n\nDE\nEnthält . Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab . Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains . May produce an allergic reaction.\n\nFR\nContient . Peut produire une réaction allergique.\n\nGA\n ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\nIT\nContiene . Può provocare una reazione allergica.\n\nLV\nSatur . Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra . Gali sukelti alerginę reakciją.\n\nHU\n-t tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih . Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat . Kan een allergische reactie veroorzaken.\n\nPL\nZawiera . Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém . Pode provocar uma reacção alérgica.\n\nRO\nConține . Poate provoca o reacție alergică.\n\nSK\nObsahuje . Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje . Lahko povzroči alergijski odziv.\n\nFI\nSisältää . Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller . Kan orsaka en allergisk reaktion.\n\nEUH 209/ 209A\nLanguage\n\n209\n209A\nBG\nПри употреба може да стане силно запалимо.\nПри употреба може да стане запалимо.\n209\n209A\nES\nPuede inflamarse fácilmente al usarlo\nPuede inflamarse al usarlo.\n209\n209A\nCS\nPři používání se může stát vysoce hořlavým.\nPři používání se může stát hořlavým.\n209\n209A\nDA\nKan blive meget brandfarlig ved brug.\nKan blive brandfarlig ved brug.\n209\n209A\nDE\nKann bei Verwendung leicht entzündbar werden.\nKann bei Verwendung entzündbar werden.\n209\n209A\nET\nKasutamisel võib muutuda väga tuleohtlikuks.\nKasutamisel võib muutuda tuleohtlikuks.\n209\n209A\nEL\nΜπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.\nMπορεί να γίνει εύφλεκτο κατά τη χρήση.\n209\n209A\nEN\nCan become highly flammable in use.\nCan become flammable in use.\n209\n209A\nFR\nPeut devenir facilement inflammable en cours d'utilisation.\nPeut devenir inflammable en cours d'utilisation.\n209\n209A\nGA\nD'fhéadfadh sé éirí an-inadhainte agus é á úsáid.\nD'fhéadfadh sé éirí inadhainte agus é á úsáid.\n209\n209A\nIT\nPuò diventare facilmente infiammabile durante l'uso.\nPuò diventare infiammabile durante l'uso.\n209\n209A\nLV\nLietojot var viegli uzliesmot.\nKļūt uzliesmojošs.\n209\n209A\nLT\nNaudojama gali tapti labai degi.\nNaudojama gali tapti degi.\n209\n209A\nHU\nA használat során fokozottan tűzveszélyessé válhat.\nA használat során tűzveszélyessé válhat.\n209\n209A\nMT\nJista’ jieħu n-nar faċilment meta jintuża.\nJista’ jieħu n-nar meta jintuża.\n209\n209A\nNL\nKan bij gebruik licht ontvlambaar worden.\nKan bij gebruik ontvlambaar worden.\n209\n209A\nPL\nPodczas stosowania może przekształcić się w substancję wysoce łatwopalną.\nPodczas stosowania może przekształcić się w substancję łatwopalną.\n209\n209A\nPT\nPode tornar-se facilmente inflamável durante o uso.\nPode tornar-se inflamável durante o uso.\n209\n209A\nRO\nPoate deveni foarte inflamabil în timpul utilizării.\nPoate deveni inflamabil în timpul utilizării.\n209\n209A\nSK\nPri používaní sa môže stať veľmi horľavou.\nPri používaní sa môže stať horľavou.\n209\n209A\nSL\nMed uporabo utegne postati lahko vnetljivo.\nMed uporabo utegne postati vnetljivo.\n209\n209A\nFI\nVoi muuttua helposti syttyväksi käytössä.\nVoi muuttua syttyväksi käytössä.\n209\n209A\nSV\nKan bli mycket brandfarligt vid användning.\nKan bli brandfarligt vid användning.\n\n\nEUH 210\nLanguage\n\n\nBG\nИнформационен лист за безопасност ще бъде представен при поискване.\n\nES\nPuede solicitarse la ficha de datos de seguridad.\n\nCS\nNa vyžádání je kodispozici bezpečnostní list.\n\nDA\nSikkerhedsdatablad kan på anmodning rekvireres.\n\nDE\nSicherheitsdatenblatt auf Anfrage erhältlich.\n\nET\nOhutuskaart nõudmisel kättesaadav.\n\nEL\nΔελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.\n\nEN\nSafety data sheet available on request.\n\nFR\nFiche de données de sécurité disponible sur demande.\n\nGA\nBileog sonraí sábháilteachta ar fáil arna iarraidh sin.\n\nIT\nScheda dati di sicurezza disponibile su richiesta.\n\nLV\nDrošības datu lapa ir pieejama pēc pieprasījuma.\n\nLT\nSaugos duomenų lapą galima gauti paprašius.\n\nHU\nKérésre biztonsági adatlap kapható.\n\nMT\nIl-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.\n\nNL\nVeiligheidsinformatieblad op verzoek verkrijgbaar.\n\nPL\nKarta charakterystyki dostępna na żądanie.\n\nPT\nFicha de segurança fornecida a pedido.\n\nRO\nFișa cu date de securitate disponibilă la cerere.\n\nSK\nNa požiadanie možno poskytnúť kartu bezpečnostných údajov.\n\nSL\nVarnosti list na voljo na zahtevo.\n\nFI\nKäyttöturvallisuustiedote toimitetaan pyynnöstä.\n\nSV\nSäkerhetsdatablad finns att rekvirera.\n\nEUH 401\nLanguage\n\n\nBG\nЗа да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.\n\nES\nA fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.\n\nCS\nDodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.\n\nDA\nBrugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.\n\nDE\nZur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.\n\nET\nInimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.\n\nEL\nΓια να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.\n\nEN\nTo avoid risks to human health and the environment, comply with the instructions for use.\n\nFR\nRespectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.\n\nGA\nChun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.\n\nIT\nPer evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.\n\nLT\nSiekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.\n\nLV\nLai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.\n\nHU\nAz emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.\n\nMT\nBiex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.\n\nNL\nVolg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.\n\nPL\nW celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.\n\nPT\nPara evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.\n\nRO\nPentru a evita riscurile pentru sănătatea umană și mediu, a se respecta instrucțiunile de utilizare.\n\nSK\nDodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.\n\nSL\nDa bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.\n\nFI\nNoudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.\n\nSV\nFör att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.", "after": "\nANNEX III\nLIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS\n\n\n1. Part 1: hazard statements\n\nThe hazard statements shall be applied in accordance with Parts 2, 3, 4 and 5 of Annex I.\nIn selecting the hazard statements in accordance with Articles 21 and 27, suppliers may use the combined hazard statements provided for in this Annex.\nIn accordance with Article 27 the following principles of precedence for hazard statements may apply to labelling:\n\n(a) if the hazard statement H410 Very toxic to aquatic life with long lasting effects is assigned, the statement H400 Very toxic to aquatic life may be omitted;\n\n(b) if the statement H314 Causes severe skin burns and eye damage is assigned, the statement H318 Causes serious eye damage may be omitted.\nIn order to indicate the route of administration or exposure the combined hazard statements in Table 1.2 may be used.\n\n\nTable 1.1\nHazard statements for physical hazards\n\n\nThe codification system for GHS hazard statements is still under discussion in the UN Committee of Experts and therefore amendments might be needed.\n\n\nH200\n\nLanguage\n2.1 — Explosives, Unstable explosives\n\nBG\nНестабилен експлозив.\n\nES\nExplosivo inestable.\n\nCS\nNestabilní výbušnina.\n\nDA\nUstabilt eksplosiv.\n\nDE\nInstabil, explosiv.\n\nET\nEbapüsiv lõhkeaine.\n\nEL\nΑσταθή εκρηκτικά.\n\nEN\nUnstable explosives.\n\nFR\nExplosif instable.\n\nGA\nPléascáin éagobhsaí.\n\n\nHR\nNestabilni eksplozivi.\n\n\nIT\nEsplosivo instabile.\n\nLV\nNestabili sprādzienbīstami materiāli.\n\nLT\nNestabilios sprogios medžiagos.\n\nHU\nInstabil robbanóanyagok.\n\nMT\nSplussivi instabbli.\n\nNL\nInstabiele ontplofbare stof.\n\nPL\nMateriały wybuchowe niestabilne.\n\nPT\nExplosivo instável.\n\nRO\nExploziv instabil.\n\nSK\nNestabilné výbušniny.\n\nSL\nNestabilni eksplozivi.\n\nFI\nEpästabiili räjähde.\n\nSV\nInstabilt explosivt.\n\nH201\nLanguage\n2.1 — Explosives, Division 1.1\n\nBG\nЕксплозив; опасност от масова експлозия.\n\nES\nExplosivo; peligro de explosión en masa.\n\nCS\nVýbušnina; nebezpečí masivního výbuchu.\n\nDA\nEksplosiv, masseeksplosionsfare.\n\nDE\nExplosiv, Gefahr der Massenexplosion.\n\nET\nPlahvatusohtlik; massiplahvatusoht.\n\nEL\nΕκρηκτικό· κίνδυνος μαζικής έκρηξης.\n\nEN\nExplosive; mass explosion hazard.\n\nFR\nExplosif; danger d'explosion en masse.\n\nGA\nPléascach; guais mhórphléasctha.\n\n\nHR\nEksplozivno; opasnost od eksplozije ogromnih razmjera.\n\n\nIT\nEsplosivo; pericolo di esplosione di massa.\n\nLV\nSprādzienbīstams; masveida sprādzienbīstamība.\n\nLT\nSprogios medžiagos, kelia masinio sprogimo pavojų.\n\nHU\nRobbanóanyag; teljes tömeg felrobbanásának veszélye.\n\nMT\nSplussiv; periklu li jisplodu kollha f'daqqa.\n\nNL\nOntplofbare stof; gevaar voor massa-explosie.\n\nPL\nMateriał wybuchowy; zagrożenie wybuchem masowym.\n\nPT\nExplosivo; perigo de explosão em massa.\n\nRO\nExploziv; pericol de explozie în masă.\n\nSK\nVýbušnina, nebezpečenstvo rozsiahleho výbuchu.\n\nSL\nEksplozivno; nevarnost eksplozije v masi.\n\nFI\nRäjähde; massaräjähdysvaara.\n\nSV\nExplosivt. Fara för massexplosion.\n\nH202\nLanguage\n2.1 — Explosives, Division 1.2\n\nBG\nЕксплозив; сериозна опасност от разпръскване.\n\nES\nExplosivo; grave peligro de proyección.\n\nCS\nVýbušnina; vážné nebezpečí zasažení částicemi.\n\nDA\nEksplosiv, alvorlig fare for udslyngning af fragmenter.\n\nDE\nExplosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.\n\nET\nPlahvatusohtlik; suur laialipaiskumisoht.\n\nEL\nΕκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.\n\nEN\nExplosive, severe projection hazard.\n\nFR\nExplosif; danger sérieux de projection.\n\nGA\nPléascach, guais throm teilgin.\n\n\nHR\nEksplozivno; velika opasnost od rasprskavanja.\n\n\nIT\nEsplosivo; grave pericolo di proiezione.\n\nLV\nSprādzienbīstams; augsta izmetes bīstamība.\n\nLT\nSprogios medžiagos, kelia didelį išsvaidymo pavojų.\n\nHU\nRobbanóanyag; kivetés súlyos veszélye.\n\nMT\nSplussiv, periklu serju ta' projezzjoni.\n\nNL\nOntplofbare stof, ernstig gevaar voor scherfwerking.\n\nPL\nMateriał wybuchowy, poważne zagrożenie rozrzutem.\n\nPT\nExplosivo, perigo grave de projecções.\n\nRO\nExploziv; pericol grav de proiectare.\n\nSK\nVýbušnina, závažné nebezpečenstvo rozletenia úlomkov.\n\nSL\nEksplozivno, velika nevarnost za nastanek drobcev.\n\nFI\nRäjähde; vakava sirpalevaara.\n\nSV\nExplosivt. Allvarlig fara för splitter och kaststycken.\n\nH203\nLanguage\n2.1 — Explosives, Division 1.3\n\nBG\nЕксплозив; опасност от пожар, взрив или разпръскване.\n\nES\nExplosivo; peligro de incendio, de onda expansiva o de proyección.\n\nCS\nVýbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.\n\nDA\nEksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.\n\nDE\nExplosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.\n\nET\nPlahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.\n\nEL\nΕκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.\n\nEN\nExplosive; fire, blast or projection hazard.\n\nFR\nExplosif; danger d'incendie, d'effet de souffle ou de projection.\n\nGA\nPléascach; guais dóiteáin, phléasctha nó teilgin.\n\n\nHR\nEksplozivno; opasnost od vatre, udarnog vala ili rasprskavanja.\n\n\nIT\nEsplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.\n\nLV\nSprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.\n\nLT\nSprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.\n\nHU\nRobbanóanyag; tűz, robbanás vagy kivetés veszélye.\n\nMT\nSplussiv; periklu ta' nar, blast jew projezzjoni.\n\nNL\nOntplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.\n\nPL\nMateriał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.\n\nPT\nExplosivo; perigo de incêndio, sopro ou projecções.\n\nRO\nExploziv; pericol de incendiu, detonare sau proiectare.\n\nSK\nVýbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.\n\nSL\nEksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.\n\nFI\nRäjähde; palo-, räjähdys- tai sirpalevaara.\n\nSV\nExplosivt. Fara för brand, tryckvåg eller splitter och kaststycken.\n\nH204\nLanguage\n2.1 — Explosives, Division 1.4\n\nBG\nОпасност от пожар или разпръскване.\n\nES\nPeligro de incendio o de proyección.\n\nCS\nNebezpečí požáru nebo zasažení částicemi.\n\nDA\nFare for brand eller udslyngning af fragmenter.\n\nDE\nGefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.\n\nET\nSüttimis- või laialipaiskumisoht.\n\nEL\nΚίνδυνος πυρκαγιάς ή εκτόξευσης.\n\nEN\nFire or projection hazard.\n\nFR\nDanger d'incendie ou de projection.\n\nGA\nGuais dóiteáin nó teilgin.\n\n\nHR\nOpasnost od vatre ili rasprskavanja.\n\n\nIT\nPericolo di incendio o di proiezione.\n\nLV\nUguns vai izmetes bīstamība.\n\nLT\nGaisro arba išsvaidymo pavojus.\n\nHU\nTűz vagy kivetés veszélye.\n\nMT\nPeriklu ta' nar jew ta' projezzjoni.\n\nNL\nGevaar voor brand of scherfwerking.\n\nPL\nZagrożenie pożarem lub rozrzutem.\n\nPT\nPerigo de incêndio ou projecções.\n\nRO\nPericol de incendiu sau de proiectare.\n\nSK\nNebezpečenstvo požiaru alebo rozletenia úlomkov.\n\nSL\nNevarnost za nastanek požara ali drobcev.\n\nFI\nPalo- tai sirpalevaara.\n\nSV\nFara för brand eller splitter och kaststycken.\n\nH205\nLanguage\n2.1 — Explosives, Division 1.5\n\nBG\nМоже да предизвика масова експлозия при пожар.\n\nES\nPeligro de explosión en masa en caso de incendio.\n\nCS\nPři požáru může způsobit masivní výbuch.\n\nDA\nFare for masseeksplosion ved brand.\n\nDE\nGefahr der Massenexplosion bei Feuer.\n\nET\nSüttimise korral massiplahvatusoht.\n\nEL\nΚίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.\n\nEN\nMay mass explode in fire.\n\nFR\nDanger d'explosion en masse en cas d'incendie.\n\nGA\nD'fhéadfadh sé go mbeadh mórphléascadh i dtine.\n\n\nHR\nU vatri može izazvati eksploziju ogromnih razmjera.\n\n\nIT\nPericolo di esplosione di massa in caso d'incendio.\n\nLV\nUgunī var masveidā eksplodēt.\n\nLT\nPer gaisrą gali sukelti masinį sprogimą.\n\nHU\nTűz hatására a teljes tömeg felrobbanhat.\n\nMT\nJista' jisplodi f'daqqa fin-nar.\n\nNL\nGevaar voor massa-explosie bij brand.\n\nPL\nMoże wybuchać masowo w przypadku pożaru.\n\nPT\nPerigo de explosão em massa em caso de incêndio.\n\nRO\nPericol de explozie în masă în caz de incendiu.\n\nSK\nNebezpečenstvo rozsiahleho výbuchu pri požiari.\n\nSL\nPri požaru lahko eksplodira v masi.\n\nFI\nKoko massa voi räjähtää tulessa.\n\nSV\nFara för massexplosion vid brand.\n\nH220\nLanguage\n2.2 — Flammable gases, Hazard Category 1\n\nBG\nИзключително запалим газ.\n\nES\nGas extremadamente inflamable.\n\nCS\nExtrémně hořlavý plyn.\n\nDA\nYderst brandfarlig gas.\n\nDE\nExtrem entzündbares Gas.\n\nET\nEriti tuleohtlik gaas.\n\nEL\nΕξαιρετικά εύφλεκτο αέριο.\n\nEN\nExtremely flammable gas.\n\nFR\nGaz extrêmement inflammable.\n\nGA\nGás fíor-inadhainte.\n\n\nHR\nVrlo lako zapaljivi plin.\n\n\nIT\nGas altamente infiammabile.\n\nLV\nĪpaši viegli uzliesmojoša gāze.\n\nLT\nYpač degios dujos.\n\nHU\nRendkívül tűzveszélyes gáz.\n\nMT\nGass li jaqbad malajr ħafna.\n\nNL\nZeer licht ontvlambaar gas.\n\nPL\nSkrajnie łatwopalny gaz.\n\nPT\nGás extremamente inflamável.\n\nRO\nGaz extrem de inflamabil.\n\nSK\nMimoriadne horľavý plyn.\n\nSL\nZelo lahko vnetljiv plin.\n\nFI\nErittäin helposti syttyvä kaasu.\n\nSV\nExtremt brandfarlig gas.\n\nH221\nLanguage\n2.2 — Flammable gases, Hazard Category 2\n\nBG\nЗапалим газ.\n\nES\nGas inflamable.\n\nCS\nHořlavý plyn.\n\nDA\nBrandfarlig gas.\n\nDE\nEntzündbares Gas.\n\nET\nTuleohtlik gaas.\n\nEL\nΕύφλεκτο αέριο.\n\nEN\nFlammable gas.\n\nFR\nGaz inflammable.\n\nGA\nGás inadhainte.\n\n\nHR\nZapaljivi plin.\n\n\nIT\nGas infiammabile.\n\nLV\nUzliesmojoša gāze.\n\nLT\nDegios dujos.\n\nHU\nTűzveszélyes gáz.\n\nMT\nGass li jaqbad.\n\nNL\nOntvlambaar gas.\n\nPL\nGaz łatwopalny.\n\nPT\nGás inflamável.\n\nRO\nGaz inflamabil.\n\nSK\nHorľavý plyn.\n\nSL\nVnetljiv plin.\n\nFI\nSyttyvä kaasu.\n\nSV\nBrandfarlig gas.\n\nH222\nLanguage\n2.3 — Flammable aerosols, Hazard Category 1\n\nBG\nИзключително запалим аерозол.\n\nES\nAerosol extremadamente inflamable.\n\nCS\nExtrémně hořlavý aerosol.\n\nDA\nYderst brandfarlig aerosol.\n\nDE\nExtrem entzündbares Aerosol.\n\nET\nEriti tuleohtlik aerosool.\n\nEL\nΕξαιρετικά εύφλεκτο αερόλυμα.\n\nEN\nExtremely flammable aerosol.\n\nFR\nAérosol extrêmement inflammable.\n\nGA\nAerasól fíor-inadhainte.\n\n\nHR\nVrlo lako zapaljivi aerosol.\n\n\nIT\nAerosol altamente infiammabile.\n\nLV\nĪpaši viegli uzliesmojošs aerosols.\n\nLT\nYpač degus aerozolis.\n\nHU\nRendkívül tűzveszélyes aeroszol.\n\nMT\nAerosol li jaqbad malajr ħafna.\n\nNL\nZeer licht ontvlambare aerosol.\n\nPL\nSkrajnie łatwopalny aerozol.\n\nPT\nAerossol extremamente inflamável.\n\nRO\nAerosol extrem de inflamabil.\n\nSK\nMimoriadne horľavý aerosól.\n\nSL\nZelo lahko vnetljiv aerosol.\n\nFI\nErittäin helposti syttyvä aerosoli.\n\nSV\nExtremt brandfarlig aerosol.\n\nH223\nLanguage\n2.3 — Flammable aerosols, Hazard Category 2\n\nBG\nЗапалим аерозол.\n\nES\nAerosol inflamable.\n\nCS\nHořlavý aerosol.\n\nDA\nBrandfarlig aerosol.\n\nDE\nEntzündbares Aerosol.\n\nET\nTuleohtlik aerosool.\n\nEL\nΕύφλεκτο αερόλυμα.\n\nEN\nFlammable aerosol.\n\nFR\nAérosol inflammable.\n\nGA\nAerasól inadhainte.\n\n\nHR\nZapaljivi aerosol.\n\n\nIT\nAerosol infiammabile.\n\nLV\nUzliesmojošs aerosols.\n\nLT\nDegus aerozolis.\n\nHU\nTűzveszélyes aeroszol.\n\nMT\nAerosol li jaqbad.\n\nNL\nOntvlambare aerosol.\n\nPL\nAerozol łatwopalny.\n\nPT\nAerossol inflamável.\n\nRO\nAerosol inflamabil.\n\nSK\nHorľavý aerosól.\n\nSL\nVnetljiv aerosol.\n\nFI\nSyttyvä aerosoli.\n\nSV\nBrandfarlig aerosol.\n\nH224\nLanguage\n2.6 — Flammable liquids, Hazard Category 1\n\nBG\nИзключително запалими течност и пари.\n\nES\nLíquido y vapores extremadamente inflamables.\n\nCS\nExtrémně hořlavá kapalina a páry.\n\nDA\nYderst brandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf extrem entzündbar.\n\nET\nEriti tuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί εξαιρετικά εύφλεκτα.\n\nEN\nExtremely flammable liquid and vapour.\n\nFR\nLiquide et vapeurs extrêmement inflammables.\n\nGA\nLeacht fíor-inadhainte agus gal fhíor-inadhainte.\n\n\nHR\nVrlo lako zapaljiva tekućina i para.\n\n\nIT\nLiquido e vapori altamente infiammabili.\n\nLV\nĪpaši viegli uzliesmojošs šķidrums un tvaiki.\n\nLT\nYpač degūs skystis ir garai.\n\nHU\nRendkívül tűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu malajr ħafna.\n\nNL\nZeer licht ontvlambare vloeistof en damp.\n\nPL\nSkrajnie łatwopalna ciecz i pary.\n\nPT\nLíquido e vapor extremamente inflamáveis.\n\nRO\nLichid și vapori extrem de inflamabili.\n\nSK\nMimoriadne horľavá kvapalina a pary.\n\nSL\nZelo lahko vnetljiva tekočina in hlapi.\n\nFI\nErittäin helposti syttyvä neste ja höyry.\n\nSV\nExtremt brandfarlig vätska och ånga.\n\nH225\nLanguage\n2.6 — Flammable liquids, Hazard Category 2\n\nBG\nСилно запалими течност и пари.\n\nES\nLíquido y vapores muy inflamables.\n\nCS\nVysoce hořlavá kapalina a páry.\n\nDA\nMeget brandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf leicht entzündbar.\n\nET\nVäga tuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί πολύ εύφλεκτα.\n\nEN\nHighly flammable liquid and vapour.\n\nFR\nLiquide et vapeurs très inflammables.\n\nGA\nLeacht an-inadhainte agus gal an-inadhainte.\n\n\nHR\nLako zapaljiva tekućina i para.\n\n\nIT\nLiquido e vapori facilmente infiammabili.\n\nLV\nViegli uzliesmojošs šķidrums un tvaiki.\n\nLT\nLabai degūs skystis ir garai.\n\nHU\nFokozottan tűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu malajr ħafna.\n\nNL\nLicht ontvlambare vloeistof en damp.\n\nPL\nWysoce łatwopalna ciecz i pary.\n\nPT\nLíquido e vapor facilmente inflamáveis.\n\nRO\nLichid și vapori foarte inflamabili.\n\nSK\nVeľmi horľavá kvapalina a pary.\n\nSL\nLahko vnetljiva tekočina in hlapi.\n\nFI\nHelposti syttyvä neste ja höyry.\n\nSV\nMycket brandfarlig vätska och ånga.\n\nH226\nLanguage\n2.6 — Flammable liquids, Hazard Category 3\n\nBG\nЗапалими течност и пари.\n\nES\nLíquidos y vapores inflamables.\n\nCS\nHořlavá kapalina a páry.\n\nDA\nBrandfarlig væske og damp.\n\nDE\nFlüssigkeit und Dampf entzündbar.\n\nET\nTuleohtlik vedelik ja aur.\n\nEL\nΥγρό και ατμοί εύφλεκτα.\n\nEN\nFlammable liquid and vapour.\n\nFR\nLiquide et vapeurs inflammables.\n\nGA\nLeacht inadhainte agus gal inadhainte.\n\n\nHR\nZapaljiva tekućina i para.\n\n\nIT\nLiquido e vapori infiammabili.\n\nLV\nUzliesmojošs šķidrums un tvaiki.\n\nLT\nDegūs skystis ir garai.\n\nHU\nTűzveszélyes folyadék és gőz.\n\nMT\nLikwidu u fwar li jaqbdu.\n\nNL\nOntvlambare vloeistof en damp.\n\nPL\nŁatwopalna ciecz i pary.\n\nPT\nLíquido e vapor inflamáveis.\n\nRO\nLichid și vapori inflamabili.\n\nSK\nHorľavá kvapalina a pary.\n\nSL\nVnetljiva tekočina in hlapi.\n\nFI\nSyttyvä neste ja höyry.\n\nSV\nBrandfarlig vätska och ånga.\n\nH228\nLanguage\n2.7 — Flammable solids, Hazard Category 1, 2\n\nBG\nЗапалимо твърдо вещество.\n\nES\nSólido inflamable.\n\nCS\nHořlavá tuhá látka.\n\nDA\nBrandfarligt fast stof.\n\nDE\nEntzündbarer Feststoff.\n\nET\nTuleohtlik tahke aine.\n\nEL\nΕύφλεκτο στερεό.\n\nEN\nFlammable solid.\n\nFR\nMatière solide inflammable.\n\nGA\nSolad inadhainte.\n\n\nHR\nZapaljiva krutina.\n\n\nIT\nSolido infiammabile.\n\nLV\nUzliesmojoša cieta viela.\n\nLT\nDegi kietoji medžiaga.\n\nHU\nTűzveszélyes szilárd anyag.\n\nMT\nSolidu li jaqbad.\n\nNL\nOntvlambare vaste stof.\n\nPL\nSubstancja stała łatwopalna.\n\nPT\nSólido inflamável.\n\nRO\nSolid inflamabil.\n\nSK\nHorľavá tuhá látka.\n\nSL\nVnetljiva trdna snov.\n\nFI\nSyttyvä kiinteä aine.\n\nSV\nBrandfarligt fast ämne.\n\n\nH240\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Type A\n2.1.5 — Organic Peroxides, Type A\n\nBG\nМоже да предизвика експлозия при нагряване.\n\nES\nPeligro de explosión en caso de calentamiento.\n\nCS\nZahřívání může způsobit výbuch.\n\nDA\nEksplosionsfare ved opvarmning.\n\nDE\nErwärmung kann Explosion verursachen.\n\nET\nKuumenemisel võib plahvatada.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει έκρηξη.\n\nEN\nHeating may cause an explosion.\n\nFR\nPeut exploser sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le pléascadh.\n\n\nHR\nZagrijavanje može uzrokovati eksploziju.\n\n\nIT\nRischio di esplosione per riscaldamento.\n\nLV\nSakaršana var izraisīt eksploziju.\n\nLT\nKaitinant gali sprogti.\n\nHU\nHő hatására robbanhat.\n\nMT\nIt-tisħin jista' jikkawża splużjoni.\n\nNL\nOntploffingsgevaar bij verwarming.\n\nPL\nOgrzanie grozi wybuchem.\n\nPT\nRisco de explosão sob a acção do calor.\n\nRO\nPericol de explozie în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť výbuch.\n\nSL\nSegrevanje lahko povzroči eksplozijo.\n\nFI\nRäjähdysvaarallinen kuumennettaessa.\n\nSV\nExplosivt vid uppvärmning.\n\nH241\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Type B\n2.1.5 — Organic Peroxides, Type B\n\nBG\nМоже да предизвика пожар или експлозия при нагряване.\n\nES\nPeligro de incendio o explosión en caso de calentamiento.\n\nCS\nZahřívání může způsobit požár nebo výbuch.\n\nDA\nBrand- eller eksplosionsfare ved opvarmning.\n\nDE\nErwärmung kann Brand oder Explosion verursachen.\n\nET\nKuumenemisel võib süttida või plahvatada.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.\n\nEN\nHeating may cause a fire or explosion.\n\nFR\nPeut s'enflammer ou exploser sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.\n\n\nHR\nZagrijavanje može uzrokovati požar ili eksploziju.\n\n\nIT\nRischio d'incendio o di esplosione per riscaldamento.\n\nLV\nSakaršana var izraisīt degšanu vai eksploziju.\n\nLT\nKaitinant gali sukelti gaisrą arba sprogti.\n\nHU\nHő hatására meggyulladhat vagy robbanhat.\n\nMT\nIt-tisħin jista' jikkawża nar jew splużjoni.\n\nNL\nBrand- of ontploffingsgevaar bij verwarming.\n\nPL\nOgrzanie może spowodować pożar lub wybuch.\n\nPT\nRisco de explosão ou de incêndio sob a acção do calor.\n\nRO\nPericol de incendiu sau de explozie în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť požiar alebo výbuch.\n\nSL\nSegrevanje lahko povzroči požar ali eksplozijo.\n\nFI\nRäjähdys- tai palovaarallinen kuumennettaessa.\n\nSV\nBrandfarligt eller explosivt vid uppvärmning.\n\nH242\nLanguage\n2.8 — Self-Reactive Substances and Mixtures, Types C, D, E, F\n2.1.5 — Organic Peroxides, Types C, D, E, F\n\nBG\nМоже да предизвика пожар при нагряване.\n\nES\nPeligro de incendio en caso de calentamiento.\n\nCS\nZahřívání může způsobit požár.\n\nDA\nBrandfare ved opvarmning.\n\nDE\nErwärmung kann Brand verursachen.\n\nET\nKuumenemisel võib süttida.\n\nEL\nΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά.\n\nEN\nHeating may cause a fire.\n\nFR\nPeut s'enflammer sous l'effet de la chaleur.\n\nGA\nD'fhéadfadh téamh a bheith ina chúis le dóiteán.\n\n\nHR\nZagrijavanje može uzrokovati požar.\n\n\nIT\nRischio d'incendio per riscaldamento.\n\nLV\nSakaršana var izraisīt degšanu.\n\nLT\nKaitinant gali sukelti gaisrą.\n\nHU\nHő hatására meggyulladhat.\n\nMT\nIt-tisħin jista' jikkawża nar.\n\nNL\nBrandgevaar bij verwarming.\n\nPL\nOgrzanie może spowodować pożar.\n\nPT\nRisco de incêndio sob a acção do calor.\n\nRO\nPericol de incendiu în caz de încălzire.\n\nSK\nZahrievanie môže spôsobiť požiar.\n\nSL\nSegrevanje lahko povzroči požar.\n\nFI\nPalovaarallinen kuumennettaessa.\n\nSV\nBrandfarligt vid uppvärmning.\n\nH250\nLanguage\n2.9 — Pyrophoric Liquids, Hazard Category 1\n2.10 — Pyorphoric Solids, Hazard Category 1\n\nBG\nСамозапалва се при контакт с въздух.\n\nES\nSe inflama espontáneamente en contacto con el aire.\n\nCS\nPři styku se vzduchem se samovolně vznítí.\n\nDA\nSelvantænder ved kontakt med luft.\n\nDE\nEntzündet sich in Berührung mit Luft von selbst.\n\nET\nKokkupuutel õhuga süttib iseenesest.\n\nEL\nΑυταναφλέγεται εάν εκτεθεί στον αέρα.\n\nEN\nCatches fire spontaneously if exposed to air.\n\nFR\nS'enflamme spontanément au contact de l'air.\n\nGA\nTéann trí thine go spontáineach má nochtar don aer.\n\n\nHR\nSamozapaljivo u dodiru sa zrakom.\n\n\nIT\nSpontaneamente infiammabile all'aria.\n\nLV\nSpontāni aizdegas saskarē ar gaisu.\n\nLT\nVeikiami oro savaime užsidega.\n\nHU\nLevegővel érintkezve önmagától meggyullad.\n\nMT\nJieħu n-nar spontanjament jekk ikun espost għall-arja.\n\nNL\nVat spontaan vlam bij blootstelling aan lucht.\n\nPL\nZapala się samorzutnie w przypadku wystawienia na działanie powietrza.\n\nPT\nRisco de inflamação espontânea em contacto com o ar.\n\nRO\nSe aprinde spontan, în contact cu aerul.\n\nSK\nPri kontakte so vzduchuom sa spontánne vznieti.\n\nSL\nSamodejno se vžge na zraku.\n\nFI\nSyttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.\n\nSV\nSpontanantänder vid kontakt med luft.\n\nH251\nLanguage\n2.11 — Self-Heating Substances and Mixtures, Hazard Category 1\n\nBG\nСамонагряващо се: може да се запали.\n\nES\nSe calienta espontáneamente; puede inflamarse.\n\nCS\nSamovolně se zahřívá: může se vznítit.\n\nDA\nSelvopvarmende, kan selvantænde.\n\nDE\nSelbsterhitzungsfähig; kann in Brand geraten.\n\nET\nIsekuumenev, võib süttida.\n\nEL\nΑυτοθερμαίνεται: μπορεί να αναφλεγεί.\n\nEN\nSelf-heating: may catch fire.\n\nFR\nMatière auto-échauffante; peut s'enflammer.\n\nGA\nFéintéamh: d'fhéadfadh sé dul trí thine.\n\n\nHR\nSamozagrijavanje; može se zapaliti.\n\n\nIT\nAutoriscaldante; può infiammarsi.\n\nLV\nPašsasilstošs; var aizdegties.\n\nLT\nSavaime kaistančios, gali užsidegti.\n\nHU\nÖnmelegedő: meggyulladhat.\n\nMT\nJisħon waħdu: jista' jieħu n-nar.\n\nNL\nVatbaar voor zelfverhitting: kan vlam vatten.\n\nPL\nSubstancja samonagrzewająca się: może się zapalić.\n\nPT\nSusceptível de auto-aquecimento: risco de inflamação.\n\nRO\nSe autoîncălzește, pericol de aprindere.\n\nSK\nSamovoľne sa zahrieva; môže sa vznietiť.\n\nSL\nSamosegrevanje: lahko povzroči požar.\n\nFI\nItsestään kuumeneva; voi syttyä palamaan.\n\nSV\nSjälvupphettande. Kan börja brinna.\n\n\nH252\nLanguage\n2.11 — Self-Heating Substances and Mixtures, Hazard Category 2\n\nBG\nСамонагряващо се в големи количества; може да се запали.\n\nES\nSe calienta espontáneamente en grandes cantidades; puede inflamarse.\n\nCS\nVe velkém množství se samovolně zahřívá; může se vznítit.\n\nDA\nSelvopvarmende i store mængder, kan selvantænde.\n\nDE\nIn großen Mengen selbsterhitzungsfähig; kann in Brand geraten.\n\nET\nSuurtes kogustes isekuumenev, võib süttida.\n\nEL\nΣε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.\n\nEN\nSelf-heating in large quantities; may catch fire.\n\nFR\nMatière auto-échauffante en grandes quantités; peut s'enflammer.\n\nGA\nFéintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.\n\n\nHR\nSamozagrijavanje u velikim količinama; može se zapaliti.\n\n\nIT\nAutoriscaldante in grandi quantità; può infiammarsi.\n\nLV\nLielos apjomos pašsasilstošs; var aizdegties.\n\nLT\nLaikant dideliais kiekiais savaime kaista, gali užsidegti.\n\nHU\nNagy mennyiségben önmelegedő; meggyulladhat.\n\nMT\nJisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.\n\nNL\nIn grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.\n\nPL\nSubstancja samonagrzewająca się w dużych ilościach; może się zapalić.\n\nPT\nSusceptível de auto-aquecimento em grandes quantidades: risco de inflamação.\n\nRO\nSe autoîncălzește, în cantități mari pericol de aprindere.\n\nSK\nVo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.\n\nSL\nSamosegrevanje v velikih količinah; lahko povzroči požar.\n\nFI\nSuurina määrinä itsestään kuumeneva; voi syttyä palamaan.\n\nSV\nSjälvupphettande i stora mängder. Kan börja brinna.\n\n\nH260\nLanguage\n2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1\n\nBG\nПри контакт с вода отделя запалими газове, които могат да се самозапалят.\n\nES\nEn contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.\n\nCS\nPři styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.\n\nDA\nVed kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.\n\nDE\nIn Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.\n\nET\nKokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.\n\nEL\nΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.\n\nEN\nIn contact with water releases flammable gases which may ignite spontaneously.\n\nFR\nDégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.\n\nGA\nI dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.\n\n\nHR\nU dodiru s vodom oslobađa zapaljive plinove koji se mogu spontano zapaliti.\n\n\nIT\nA contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.\n\nLV\nNonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.\n\nLT\nKontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.\n\nHU\nVízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.\n\nMT\nMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.\n\nNL\nIn contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.\n\nPL\nW kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.\n\nPT\nEm contacto com a água liberta gases que se podem inflamar espontaneamente.\n\nRO\nÎn contact cu apa degajă gaze inflamabile care se pot aprinde spontan.\n\nSK\nPri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.\n\nSL\nV stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.\n\nFI\nKehittää itsestään syttyviä kaasuja veden kanssa.\n\nSV\nVid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.\n\n\nH261\nLanguage\n2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2\n\nBG\nПри контакт с вода отделя запалими газове.\n\nES\nEn contacto con el agua desprende gases inflamables.\n\nCS\nPři styku s vodou uvolňuje hořlavé plyny.\n\nDA\nVed kontakt med vand udvikles brandfarlige gasser.\n\nDE\nIn Berührung mit Wasser entstehen entzündbare Gase.\n\nET\nKokkupuutel veega eraldab tuleohtlikke gaase.\n\nEL\nΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.\n\nEN\nIn contact with water releases flammable gases.\n\nFR\nDégage au contact de l'eau des gaz inflammables.\n\nGA\nI dteagmháil le huisce scaoiltear gáis inadhainte.\n\n\nHR\nU dodiru s vodom oslobađa zapaljive plinove.\n\n\nIT\nA contatto con l'acqua libera gas infiammabili.\n\nLV\nNonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.\n\nLT\nKontaktuodami su vandeniu išskiria degias dujas\n\nHU\nVízzel érintkezve tűzveszélyes gázokat bocsát ki.\n\nMT\nMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.\n\nNL\nIn contact met water komen ontvlambare gassen vrij.\n\nPL\nW kontakcie z wodą uwalnia łatwopalne gazy.\n\nPT\nEm contacto com a água liberta gases inflamáveis.\n\nRO\nÎn contact cu apa degajă gaze inflamabile.\n\nSK\nPri kontakte s vodou uvoľňuje horľavé plyny.\n\nSL\nV stiku z vodo se sproščajo vnetljivi plini.\n\nFI\nKehittää syttyviä kaasuja veden kanssa.\n\nSV\nVid kontakt med vatten utvecklas brandfarliga gaser.\n\nH270\nLanguage\n2.4 — Oxidising Gases, Hazard Category 1\n\nBG\nМоже да предивзика или усили пожар; окислител.\n\nES\nPuede provocar o agravar un incendio; comburente.\n\nCS\nMůže způsobit nebo zesílit požár; oxidant.\n\nDA\nKan forårsage eller forstærke brand, brandnærende.\n\nDE\nKann Brand verursachen oder verstärken; Oxidationsmittel.\n\nET\nVõib põhjustada süttimise või soodustada põlemist; oksüdeerija.\n\nEL\nΜπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.\n\nEN\nMay cause or intensify fire; oxidiser.\n\nFR\nPeut provoquer ou aggraver un incendie; comburant.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.\n\n\nHR\nMože uzrokovati ili pojačati požar; oksidans.\n\n\nIT\nPuò provocare o aggravare un incendio; comburente.\n\nLV\nVar izraisīt vai pastiprināt degšanu, oksidētājs.\n\nLT\nGali sukelti arba padidinti gaisrą, oksidatorius.\n\nHU\nTüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.\n\nMT\nJista' jikkawża jew iżid in-nar; ossidant.\n\nNL\nKan brand veroorzaken of bevorderen; oxiderend.\n\nPL\nMoże spowodować lub intensyfikować pożar; utleniacz.\n\nPT\nPode provocar ou agravar incêndios; comburente.\n\nRO\nPoate provoca sau agrava un incendiu; oxidant.\n\nSK\nMôže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.\n\nSL\nLahko povzroči ali okrepi požar; oksidativna snov.\n\nFI\nAiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.\n\nSV\nKan orsaka eller intensifiera brand. Oxiderande.\n\nH271\nLanguage\n2.13 — Oxidising Liquids, Hazard Category 1\n2.14 — Oxidising Solids, Hazard Category 1\n\nBG\nМоже да предизвика пожар или експлозия; силен окислител.\n\nES\nPuede provocar un incendio o una explosión; muy comburente.\n\nCS\nMůže způsobit požár nebo výbuch; silný oxidant.\n\nDA\nKan forårsage brand eller eksplosion, stærkt brandnærende.\n\nDE\nKann Brand oder Explosion verursachen; starkes Oxidationsmittel.\n\nET\nVõib põhjustada süttimise või plahvatuse; tugev oksüdeerija.\n\nEL\nΜπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.\n\nEN\nMay cause fire or explosion; strong oxidiser.\n\nFR\nPeut provoquer un incendie ou une explosion; comburant puissant.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.\n\n\nHR\nMože uzrokovati požar ili eksploziju; jaki oksidans.\n\n\nIT\nPuò provocare un incendio o un'esplosione; molto comburente.\n\nLV\nVar izraisīt degšanu vai eksploziju, oksidētājs.\n\nLT\nGali sukelti gaisrą arba sprogimą, stiprus oksidatorius.\n\nHU\nTüzet vagy robbanást okozhat; erősen oxidáló hatású.\n\nMT\nJista' jikkawża nar jew splużjoni; ossidant qawwi.\n\nNL\nKan brand of ontploffingen veroorzaken; sterk oxiderend.\n\nPL\nMoże spowodować pożar lub wybuch; silny utleniacz.\n\nPT\nRisco de incêndio ou de explosão; muito comburente.\n\nRO\nPoate provoca un incendiu sau o explozie; oxidant puternic.\n\nSK\nMôže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.\n\nSL\nLahko povzroči požar ali eksplozijo; močna oksidativna snov.\n\nFI\nAiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.\n\nSV\nKan orsaka brand eller explosion. Starkt oxiderande.\n\nH272\nLanguage\n2.13 — Oxidising Liquids, Hazard Category 2, 3\n2.14 — Oxidising Solids, Hazard Category 2, 3\n\nBG\nМоже да усили пожара; окислител.\n\nES\nPuede agravar un incendio; comburente.\n\nCS\nMůže zesílit požár; oxidant.\n\nDA\nKan forstærke brand, brandnærende.\n\nDE\nKann Brand verstärken; Oxidationsmittel.\n\nET\nVõib soodustada põlemist; oksüdeerija.\n\nEL\nΜπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.\n\nEN\nMay intensify fire; oxidiser.\n\nFR\nPeut aggraver un incendie; comburant.\n\nGA\nD'fhéadfadh sé cur le tine; ocsaídeoir.\n\n\nHR\nMože pojačati požar; oksidans.\n\n\nIT\nPuò aggravare un incendio; comburente.\n\nLV\nVar pastiprināt degšanu; oksidētājs.\n\nLT\nGali padidinti gaisrą, oksidatorius.\n\nHU\nFokozhatja a tűz intenzitását; oxidáló hatású.\n\nMT\nJista' jżid in-nar; ossidant.\n\nNL\nKan brand bevorderen; oxiderend.\n\nPL\nMoże intensyfikować pożar; utleniacz.\n\nPT\nPode agravar incêndios; comburente.\n\nRO\nPoate agrava un incendiu; oxidant.\n\nSK\nMôže prispieť k rozvoju požiaru; oxidačné činidlo.\n\nSL\nLahko okrepi požar; oksidativna snov.\n\nFI\nVoi edistää tulipaloa; hapettava.\n\nSV\nKan intensifiera brand. Oxiderande.\n\nH280\nLanguage\n2.5 — Gases under pressure:\nCompressed gas\nLiquefied gas\nDissolved gas\n\nBG\nСъдържа газ под налягане; може да експлодира при нагряване.\n\nES\nContiene gas a presión; peligro de explosión en caso de calentamiento.\n\nCS\nObsahuje plyn pod tlakem; při zahřívání může vybuchnout.\n\nDA\nIndeholder gas under tryk, kan eksplodere ved opvarmning.\n\nDE\nEnthält Gas unter Druck; kann bei Erwärmung explodieren.\n\nET\nSisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.\n\nEL\nΠεριέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.\n\nEN\nContains gas under pressure; may explode if heated.\n\nFR\nContient un gaz sous pression; peut exploser sous l'effet de la chaleur.\n\nGA\nGás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.\n\n\nHR\nSadrži stlačeni plin; zagrijavanje može uzrokovati eksploziju.\n\n\nIT\nContiene gas sotto pressione; può esplodere se riscaldato.\n\nLV\nSatur gāzi zem spiediena; karstumā var eksplodēt.\n\nLT\nTuri slėgio veikiamų dujų, kaitinant gali sprogti.\n\nHU\nNyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.\n\nMT\nFih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.\n\nNL\nBevat gas onder druk; kan ontploffen bij verwarming.\n\nPL\nZawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.\n\nPT\nContém gás sob pressão; risco de explosão sob a acção do calor.\n\nRO\nConține un gaz sub presiune; pericol de explozie în caz de încălzire.\n\nSK\nObsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.\n\nSL\nVsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.\n\nFI\nSisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.\n\nSV\nInnehåller gas under tryck. Kan explodera vid uppvärmning.\n\nH281\nLanguage\n2.5 — Gases under pressure: Refrigerated liquefied gas\n\nBG\nСъдържа охладен газ; може да причини криогенни изгаряния или наранявания.\n\nES\nContiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.\n\nCS\nObsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.\n\nDA\nIndeholder nedkølet gas, kan forårsage kuldeskader.\n\nDE\nEnthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.\n\nET\nSisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.\n\nEL\nΠεριέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.\n\nEN\nContains refrigerated gas; may cause cryogenic burns or injury.\n\nFR\nContient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.\n\nGA\nGás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.\n\n\nHR\nSadrži pothlađeni, ukapljeni plin; može uzrokovati kriogene opekline ili ozljede.\n\n\nIT\nContiene gas refrigerato; può provocare ustioni o lesioni criogeniche.\n\nLV\nSatur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.\n\nLT\nTuri atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.\n\nHU\nMélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.\n\nMT\nFih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.\n\nNL\nBevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.\n\nPL\nZawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.\n\nPT\nContém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.\n\nRO\nConține un gaz răcit; poate cauza arsuri sau leziuni criogenice.\n\nSK\nObsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.\n\nSL\nVsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.\n\nFI\nSisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.\n\nSV\nInnehåller kyld gas. Kan orsaka svåra köldskador.\n\nH290\nLanguage\n2.16 — Corrosive to metals, Hazard Category 1\n\nBG\nМоже да бъде корозивно за металите.\n\nES\nPuede ser corrosivo para los metales.\n\nCS\nMůže být korozivní pro kovy.\n\nDA\nKan ætse metaller.\n\nDE\nKann gegenüber Metallen korrosiv sein.\n\nET\nVõib söövitada metalle.\n\nEL\nΜπορεί να διαβρώσει μέταλλα.\n\nEN\nMay be corrosive to metals.\n\nFR\nPeut être corrosif pour les métaux.\n\nGA\nD'fhéadfadh sé a bheith creimneach do mhiotail.\n\n\nHR\nMože nagrizati metale.\n\n\nIT\nPuò essere corrosivo per i metalli.\n\nLV\nVar kodīgi iedarboties uz metāliem.\n\nLT\nGali ėsdinti metalus.\n\nHU\nFémekre korrozív hatású lehet.\n\nMT\nJista' jkun korrużiv għall-metalli.\n\nNL\nKan bijtend zijn voor metalen.\n\nPL\nMoże powodować korozję metali.\n\nPT\nPode ser corrosivo para os metais.\n\nRO\nPoate fi corosiv pentru metale.\n\nSK\nMôže byť korozívna pre kovy.\n\nSL\nLahko je jedko za kovine.\n\nFI\nVoi syövyttää metalleja.\n\nSV\nKan vara korrosivt för metaller.\n\nTable 1.2\nHazard statements for health hazards\n\nH300\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 1, 2\n\nBG\nСмъртоносeн при поглъщане.\n\nES\nMortal en caso de ingestión.\n\nCS\nPři požití může způsobit smrt.\n\nDA\nLivsfarlig ved indtagelse.\n\nDE\nLebensgefahr bei Verschlucken.\n\nET\nAllaneelamisel surmav.\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης.\n\nEN\nFatal if swallowed.\n\nFR\nMortel en cas d'ingestion.\n\nGA\nMarfach má shlogtar.\n\n\nHR\nSmrtonosno ako se proguta.\n\n\nIT\nLetale se ingerito.\n\nLV\nNorijot iestājas nāve.\n\nLT\nMirtina prarijus.\n\nHU\nLenyelve halálos.\n\nMT\nFatali jekk jinbela’.\n\nNL\nDodelijk bij inslikken.\n\nPL\nPołknięcie grozi śmiercią.\n\nPT\nMortal por ingestão.\n\nRO\nMortal în caz de înghițire.\n\nSK\nSmrteľný po požití.\n\nSL\nSmrtno pri zaužitju.\n\nFI\nTappavaa nieltynä.\n\nSV\nDödligt vid förtäring.\n\nH301\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 3\n\nBG\nТоксичен при поглъщане.\n\nES\nTóxico en caso de ingestión.\n\nCS\nToxický při požití.\n\nDA\nGiftig ved indtagelse.\n\nDE\nGiftig bei Verschlucken.\n\nET\nAllaneelamisel mürgine.\n\nEL\nΤοξικό σε περίπτωση κατάποσης.\n\nEN\nToxic if swallowed.\n\nFR\nToxique en cas d'ingestion.\n\nGA\nTocsaineach má shlogtar.\n\n\nHR\nOtrovno ako se proguta.\n\n\nIT\nTossico se ingerito.\n\nLV\nToksisks, ja norij.\n\nLT\nToksiška prarijus.\n\nHU\nLenyelve mérgező.\n\nMT\nTossiku jekk jinbela’.\n\nNL\nGiftig bij inslikken.\n\nPL\nDziała toksycznie po połknięciu.\n\nPT\nTóxico por ingestão.\n\nRO\nToxic în caz de înghițire.\n\nSK\nToxický po požití.\n\nSL\nStrupeno pri zaužitju.\n\nFI\nMyrkyllistä nieltynä.\n\nSV\nGiftigt vid förtäring.\n\n\nH302\nLanguage\n3.1 — Acute toxicity (oral), Hazard Category 4\n\nBG\nВреден при поглъщане.\n\nES\nNocivo en caso de ingestión.\n\nCS\nZdraví škodlivý při požití.\n\nDA\nFarlig ved indtagelse.\n\nDE\nGesundheitsschädlich bei Verschlucken.\n\nET\nAllaneelamisel kahjulik.\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης.\n\nEN\nHarmful if swallowed.\n\nFR\nNocif en cas d'ingestion.\n\nGA\nDíobhálach má shlogtar.\n\n\nHR\nŠtetno ako se proguta.\n\n\nIT\nNocivo se ingerito.\n\nLV\nKaitīgs, ja norij.\n\nLT\nKenksminga prarijus.\n\nHU\nLenyelve ártalmas.\n\nMT\nJagħmel il-ħsara jekk jinbela’.\n\nNL\nSchadelijk bij inslikken.\n\nPL\nDziała szkodliwie po połknięciu.\n\nPT\nNocivo por ingestão.\n\nRO\nNociv în caz de înghițire.\n\nSK\nŠkodlivý po požití.\n\nSL\nZdravju škodljivo pri zaužitju.\n\nFI\nHaitallista nieltynä.\n\nSV\nSkadligt vid förtäring.\n\nH304\nLanguage\n3.10 — Aspiration hazard, Hazard Category 1\n\nBG\nМоже да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.\n\nES\nPuede ser mortal en caso de ingestión y penetración en las vías respiratorias.\n\nCS\nPři požití a vniknutí do dýchacích cest může způsobit smrt.\n\nDA\nKan være livsfarligt, hvis det indtages og kommer i luftvejene.\n\nDE\nKann bei Verschlucken und Eindringen in die Atemwege tödlich sein.\n\nET\nAllaneelamisel või hingamisteedesse sattumisel võib olla surmav.\n\nEL\nΜπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.\n\nEN\nMay be fatal if swallowed and enters airways.\n\nFR\nPeut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.\n\nGA\nD'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.\n\n\n\nHR\nMože biti smrtonosno ako se proguta i uđe u dišni sustav.\n\n\nHU\nLenyelve és a légutakba kerülve halálos lehet.\n\nIT\nPuò essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.\n\nLV\nVar izraisīt nāvi, ja norij vai iekļūst elpceļos.\n\nLT\nPrarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.\n\nMT\nJista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.\n\nNL\nKan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.\n\nPL\nPołknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.\n\nPT\nPode ser mortal por ingestão e penetração nas vias respiratórias.\n\nRO\nPoate fi mortal în caz de înghițire și de pătrundere în căile respiratorii.\n\nSK\nMôže byť smrteľný po požití a vniknutí do dýchacích ciest.\n\nSL\nPri zaužitju in vstopu v dihalne poti je lahko smrtno.\n\nFI\nVoi olla tappavaa nieltynä ja joutuessaan hengitysteihin.\n\nSV\nKan vara dödligt vid förtäring om det kommer ner i luftvägarna.\n\nH310\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 1, 2\n\nBG\nСмъртоносeн при контакт с кожата.\n\nES\nMortal en contacto con la piel.\n\nCS\nPři styku s kůží může způsobit smrt.\n\nDA\nLivsfarlig ved hudkontakt.\n\nDE\nLebensgefahr bei Hautkontakt.\n\nET\nNahale sattumisel surmav.\n\nEL\nΘανατηφόρο σε επαφή με το δέρμα.\n\nEN\nFatal in contact with skin.\n\nFR\nMortel par contact cutané.\n\nGA\nMarfach i dteagmháil leis an gcraiceann.\n\n\nHR\nSmrtonosno u dodiru s kožom.\n\n\nHU\nBőrrel érintkezve halálos.\n\nIT\nLetale per contatto con la pelle.\n\nLV\nNonākot saskarē ar ādu, iestājas nāve.\n\nLT\nMirtina susilietus su oda.\n\nMT\nFatali jekk imiss mal-ġilda.\n\nNL\nDodelijk bij contact met de huid.\n\nPL\nGrozi śmiercią w kontacie ze skórą.\n\nPT\nMortal em contacto com a pele.\n\nRO\nMortal în contact cu pielea.\n\nSK\nSmrteľný pri kontakte s pokožkou.\n\nSL\nSmrtno v stiku s kožo.\n\nFI\nTappavaa joutuessaan iholle.\n\nSV\nDödligt vid hudkontakt.\n\nH311\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 3\n\nBG\nТоксичен при контакт с кожата.\n\nES\nTóxico en contacto con la piel.\n\nCS\nToxický při styku s kůží.\n\nDA\nGiftig ved hudkontakt.\n\nDE\nGiftig bei Hautkontakt.\n\nET\nNahale sattumisel mürgine.\n\nEL\nΤοξικό σε επαφή με το δέρμα.\n\nEN\nToxic in contact with skin.\n\nFR\nToxique par contact cutané.\n\nGA\nTocsaineach i dteagmháil leis an gcraiceann.\n\n\nHR\nOtrovno u dodiru s kožom.\n\n\nIT\nTossico per contatto con la pelle.\n\nLV\nToksisks, ja nonāk saskarē ar ādu.\n\nLT\nToksiška susilietus su oda.\n\nHU\nBőrrel érintkezve mérgező.\n\nMT\nTossiku meta jmiss mal-ġilda.\n\nNL\nGiftig bij contact met de huid.\n\nPL\nDziała toksycznie w kontakcie ze skórą.\n\nPT\nTóxico em contacto com a pele.\n\nRO\nToxic în contact cu pielea.\n\nSK\nToxický pri kontakte s pokožkou.\n\nSL\nStrupeno v stiku s kožo.\n\nFI\nMyrkyllistä joutuessaan iholle.\n\nSV\nGiftigt vid hudkontakt.\n\n\nH312\nLanguage\n3.1 — Acute toxicity (dermal), Hazard Category 4\n\nBG\nВреден при контакт с кожата.\n\nES\nNocivo en contacto con la piel.\n\nCS\nZdraví škodlivý při styku s kůží.\n\nDA\nFarlig ved hudkontakt.\n\nDE\nGesundheitsschädlich bei Hautkontakt.\n\nET\nNahale sattumisel kahjulik.\n\nEL\nΕπιβλαβές σε επαφή με το δέρμα.\n\nEN\nHarmful in contact with skin.\n\nFR\nNocif par contact cutané.\n\nGA\nDíobhálach i dteagmháil leis an gcraiceann.\n\n\nHR\nŠtetno u dodiru s kožom.\n\n\nIT\nNocivo per contatto con la pelle.\n\nLV\nKaitīgs, ja nonāk saskarē ar ādu.\n\nLT\nKenksminga susilietus su oda.\n\nHU\nBőrrel érintkezve ártalmas.\n\nMT\nJagħmel il-ħsara meta jmiss mal-ġilda.\n\nNL\nSchadelijk bij contact met de huid.\n\nPL\nDziała szkodliwie w kontakcie ze skórą.\n\nPT\nNocivo em contacto com a pele.\n\nRO\nNociv în contact cu pielea.\n\nSK\nŠkodlivý pri kontakte s pokožkou.\n\nSL\nZdravju škodljivo v stiku s kožo.\n\nFI\nHaitallista joutuessaan iholle.\n\nSV\nSkadligt vid hudkontakt.\n\nH314\nLanguage\n3.2 — Skin corrosion/irritation, Hazard Category 1A, 1B, 1C\n\nBG\nПричинява тежки изгаряния на кожата и сериозно увреждане на очите.\n\nES\nProvoca quemaduras graves en la piel y lesiones oculares graves.\n\nCS\nZpůsobuje těžké poleptání kůže a poškození očí.\n\nDA\nForårsager svære forbrændinger af huden og øjenskader.\n\nDE\nVerursacht schwere Verätzungen der Haut und schwere Augenschäden.\n\nET\nPõhjustab rasket nahasöövitust ja silmakahjustusi.\n\nEL\nΠροκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.\n\nEN\nCauses severe skin burns and eye damage.\n\nFR\nProvoque des brûlures de la peau et des lésions oculaires graves.\n\nGA\nIna chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.\n\n\nHR\nUzrokuje teške opekline kože i ozljede oka.\n\n\nIT\nProvoca gravi ustioni cutanee e gravi lesioni oculari.\n\nLV\nIzraisa smagus ādas apdegumus un acu bojājumus.\n\nLT\nSmarkiai nudegina odą ir pažeidžia akis.\n\nHU\nSúlyos égési sérülést és szemkárosodást okoz.\n\nMT\nJagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.\n\nNL\nVeroorzaakt ernstige brandwonden en oogletsel.\n\nPL\nPowoduje poważne oparzenia skóry oraz uszkodzenia oczu.\n\nPT\nProvoca queimaduras na pele e lesões oculares graves.\n\nRO\nProvoacă arsuri grave ale pielii și lezarea ochilor.\n\nSK\nSpôsobuje vážne poleptanie kože a poškodenie očí.\n\nSL\nPovzroča hude opekline kože in poškodbe oči.\n\nFI\nVoimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.\n\nSV\nOrsakar allvarliga frätskador på hud och ögon.\n\nH315\nLanguage\n3.2 — Skin corrosion/irritation, Hazard Category 2\n\nBG\nПредизвиква дразнене на кожата.\n\nES\nProvoca irritación cutánea.\n\nCS\nDráždí kůži.\n\nDA\nForårsager hudirritation.\n\nDE\nVerursacht Hautreizungen.\n\nET\nPõhjustab nahaärritust.\n\nEL\nΠροκαλεί ερεθισμό του δέρματος.\n\nEN\nCauses skin irritation.\n\nFR\nProvoque une irritation cutanée.\n\nGA\nIna chúis le greannú craicinn.\n\n\nHR\nNadražuje kožu.\n\n\nIT\nProvoca irritazione cutanea.\n\nLV\nKairina ādu.\n\nLT\nDirgina odą.\n\nHU\nBőrirritáló hatású.\n\nMT\nJagħmel irritazzjoni tal-ġilda.\n\nNL\nVeroorzaakt huidirritatie.\n\nPL\nDziała drażniąco na skórę.\n\nPT\nProvoca irritação cutânea.\n\nRO\nProvoacă iritarea pielii.\n\nSK\nDráždi kožu.\n\nSL\nPovzroča draženje kože.\n\nFI\nÄrsyttää ihoa.\n\nSV\nIrriterar huden.\n\nH317\nLanguage\n3.4 — Sensitisation — Skin, hazard category 1, 1A, 1B\n\nBG\nМоже да причини алергична кожна реакция.\n\nES\nPuede provocar una reacción alérgica en la piel.\n\nCS\nMůže vyvolat alergickou kožní reakci.\n\nDA\nKan forårsage allergisk hudreaktion.\n\nDE\nKann allergische Hautreaktionen verursachen.\n\nET\nVõib põhjustada allergilist nahareaktsiooni.\n\nEL\nΜπορεί να προκαλέσει αλλεργική δερματική αντίδραση.\n\nEN\nMay cause an allergic skin reaction.\n\nFR\nPeut provoquer une allergie cutanée.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.\n\n\nHR\nMože izazvati alergijsku reakciju na koži.\n\n\nIT\nPuò provocare una reazione allergica cutanea.\n\nLV\nVar izraisīt alerģisku ādas reakciju.\n\nLT\nGali sukelti alerginę odos reakciją.\n\nHU\nAllergiás bőrreakciót válthat ki.\n\nMT\nJista’ jikkawża reazzjoni allerġika tal-ġilda.\n\nNL\nKan een allergische huidreactie veroorzaken.\n\nPL\nMoże powodować reakcję alergiczną skóry.\n\nPT\nPode provocar uma reacção alérgica cutânea.\n\nRO\nPoate provoca o reacție alergică a pielii.\n\nSK\nMôže vyvolať alergickú kožnú reakciu.\n\nSL\nLahko povzroči alergijski odziv kože.\n\nFI\nVoi aiheuttaa allergisen ihoreaktion.\n\nSV\nKan orsaka allergisk hudreaktion.\n\nH318\nLanguage\n3.3 — Serious eye damage/eye irritation, Hazard Category 1\n\nBG\nПредизвиква сериозно увреждане на очите.\n\nES\nProvoca lesiones oculares graves.\n\nCS\nZpůsobuje vážné poškození očí.\n\nDA\nForårsager alvorlig øjenskade.\n\nDE\nVerursacht schwere Augenschäden.\n\nET\nPõhjustab raskeid silmakahjustusi.\n\nEL\nΠροκαλεί σοβαρή οφθαλμική βλάβη.\n\nEN\nCauses serious eye damage.\n\nFR\nProvoque des lésions oculaires graves.\n\nGA\nIna chúis le damáiste tromchúiseach don tsúil.\n\n\nHR\nUzrokuje teške ozljede oka.\n\n\nIT\nProvoca gravi lesioni oculari.\n\nLV\nIzraisa nopietnus acu bojājumus.\n\nLT\nSmarkiai pažeidžia akis.\n\nHU\nSúlyos szemkárosodást okoz.\n\nMT\nJagħmel ħsara serja lill-għajnejn.\n\nNL\nVeroorzaakt ernstig oogletsel.\n\nPL\nPowoduje poważne uszkodzenie oczu.\n\nPT\nProvoca lesões oculares graves.\n\nRO\nProvoacă leziuni oculare grave.\n\nSK\nSpôsobuje vážne poškodenie očí.\n\nSL\nPovzroča hude poškodbe oči.\n\nFI\nVaurioittaa vakavasti silmiä.\n\nSV\nOrsakar allvarliga ögonskador.\n\nH319\nLanguage\n3.3 — Serious eye damage/eye irritation, Hazard Category 2\n\nBG\nПредизвиква сериозно дразнене на очите.\n\nES\nProvoca irritación ocular grave.\n\nCS\nZpůsobuje vážné podráždění očí.\n\nDA\nForårsager alvorlig øjenirritation.\n\nDE\nVerursacht schwere Augenreizung.\n\nET\nPõhjustab tugevat silmade ärritust.\n\nEL\nΠροκαλεί σοβαρό οφθαλμικό ερεθισμό.\n\nEN\nCauses serious eye irritation.\n\nFR\nProvoque une sévère irritation des yeux.\n\nGA\nIna chúis le greannú tromchúiseach don tsúil.\n\n\n\nHR\nUzrokuje jako nadraživanje oka.\n\n\nIT\nProvoca grave irritazione oculare.\n\nLV\nIzraisa nopietnu acu kairinājumu.\n\nLT\nSukelia smarkų akių dirginimą.\n\nHU\nSúlyos szemirritációt okoz.\n\nMT\nJagħmel irritazzjoni serja lill-għajnejn.\n\nNL\nVeroorzaakt ernstige oogirritatie.\n\nPL\nDziała drażniąco na oczy.\n\nPT\nProvoca irritação ocular grave.\n\nRO\nProvoacă o iritare gravă a ochilor.\n\nSK\nSpôsobuje vážne podráždenie očí.\n\nSL\nPovzroča hudo draženje oči.\n\nFI\nÄrsyttää voimakkaasti silmiä.\n\nSV\nOrsakar allvarlig ögonirritation.\n\nH330\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 1, 2\n\nBG\nСмъртоносен при вдишване.\n\nES\nMortal en caso de inhalación.\n\nCS\nPři vdechování může způsobit smrt.\n\nDA\nLivsfarlig ved indånding.\n\nDE\nLebensgefahr bei Einatmen.\n\nET\nSissehingamisel surmav.\n\nEL\nΘανατηφόρο σε περίπτωση εισπνοής.\n\nEN\nFatal if inhaled.\n\nFR\nMortel par inhalation.\n\nGA\nMarfach má ionanálaítear.\n\n\nHR\nSmrtonosno ako se udiše.\n\n\nIT\nLetale se inalato.\n\nLV\nIeelpojot, iestājas nāve.\n\nLT\nMirtina įkvėpus.\n\nHU\nBelélegezve halálos.\n\nMT\nFatali jekk jinxtamm.\n\nNL\nDodelijk bij inademing.\n\nPL\nWdychanie grozi śmiercią.\n\nPT\nMortal por inalação.\n\nRO\nMortal în caz de inhalare.\n\nSK\nSmrteľný pri vdýchnutí.\n\nSL\nSmrtno pri vdihavanju.\n\nFI\nTappavaa hengitettynä.\n\nSV\nDödligt vid inandning.\n\nH331\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 3\n\nBG\nТоксичен при вдишване.\n\nES\nTóxico en caso de inhalación.\n\nCS\nToxický při vdechování.\n\nDA\nGiftig ved indånding.\n\nDE\nGiftig bei Einatmen.\n\nET\nSissehingamisel mürgine.\n\nEL\nΤοξικό σε περίπτωση εισπνοής.\n\nEN\nToxic if inhaled.\n\nFR\nToxique par inhalation.\n\nGA\nTocsaineach má ionanálaítear.\n\n\nHR\nOtrovno ako se udiše.\n\n\nIT\nTossico se inalato.\n\nLV\nToksisks ieelpojot.\n\nLT\nToksiška įkvėpus.\n\nHU\nBelélegezve mérgező.\n\nMT\nTossiku jekk jinxtamm.\n\nNL\nGiftig bij inademing.\n\nPL\nDziała toksycznie w następstwie wdychania.\n\nPT\nTóxico por inalação.\n\nRO\nToxic în caz de inhalare.\n\nSK\nToxický pri vdýchnutí.\n\nSL\nStrupeno pri vdihavanju.\n\nFI\nMyrkyllistä hengitettynä.\n\nSV\nGiftigt vid inandning.\n\nH332\nLanguage\n3.1 — Acute toxicity (inhal.), Hazard Category 4\n\nBG\nВреден при вдишване.\n\nES\nNocivo en caso de inhalación.\n\nCS\nZdraví škodlivý při vdechování.\n\nDA\nFarlig ved indånding.\n\nDE\nGesundheitsschädlich bei Einatmen.\n\nET\nSissehingamisel kahjulik.\n\nEL\nΕπιβλαβές σε περίπτωση εισπνοής.\n\nEN\nHarmful if inhaled.\n\nFR\nNocif par inhalation.\n\nGA\nDíobhálach má ionanálaítear.\n\n\nHR\nŠtetno ako se udiše.\n\n\nIT\nNocivo se inalato.\n\nLV\nKaitīgs ieelpojot.\n\nLT\nKenksminga įkvėpus.\n\nHU\nBelélegezve ártalmas.\n\nMT\nJagħmel il-ħsara jekk jinxtamm.\n\nNL\nSchadelijk bij inademing.\n\nPL\nDziała szkodliwie w następstwie wdychania.\n\nPT\nNocivo por inalação.\n\nRO\nNociv în caz de inhalare.\n\nSK\nŠkodlivý pri vdýchnutí.\n\nSL\nZdravju škodljivo pri vdihavanju.\n\nFI\nHaitallista hengitettynä.\n\nSV\nSkadligt vid inandning.\n\nH334\nLanguage\n3.4 — Sensitisation — Respiratory, hazard category 1, 1A, 1B\n\nBG\nМоже да причини алергични или астматични симптоми или затруднения в дишането при вдишване.\n\nES\nPuede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.\n\nCS\nPři vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.\n\nDA\nKan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.\n\nDE\nKann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.\n\nET\nSissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.\n\nEL\nΜπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.\n\nEN\nMay cause allergy or asthma symptoms or breathing difficulties if inhaled.\n\nFR\nPeut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.\n\n\nHR\nAko se udiše može izazvati simptome alergije ili astme ili poteškoće s disanjem.\n\n\nIT\nPuò provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.\n\nLV\nJa ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.\n\nLT\nĮkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.\n\nHU\nBelélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.\n\nMT\nJista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.\n\nNL\nKan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.\n\nPL\nMoże powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.\n\nPT\nQuando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.\n\nRO\nPoate provoca simptome de alergie sau astm sau dificultăți de respirație în caz de inhalare.\n\nSK\nPri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.\n\nSL\nLahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.\n\nFI\nVoi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.\n\nSV\nKan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.\n\nH335\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation\n\nBG\nМоже да предизвика дразнене на дихателните пътища.\n\nES\nPuede irritar las vías respiratorias.\n\nCS\nMůže způsobit podráždění dýchacích cest.\n\nDA\nKan forårsage irritation af luftvejene.\n\nDE\nKann die Atemwege reizen.\n\nET\nVõib põhjustada hingamisteede ärritust.\n\nEL\nΜπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.\n\nEN\nMay cause respiratory irritation.\n\nFR\nPeut irriter les voies respiratoires.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le greannú riospráide.\n\n\nHR\nMože nadražiti dišni sustav.\n\n\nIT\nPuò irritare le vie respiratorie.\n\nLV\nVar izraisīt elpceļu kairinājumu.\n\nLT\nGali dirginti kvėpavimo takus.\n\nHU\nLégúti irritációt okozhat.\n\nMT\nJista’ jikkawża irritazzjoni respiratorja.\n\nNL\nKan irritatie van de luchtwegen veroorzaken.\n\nPL\nMoże powodować podrażnienie dróg oddechowych.\n\nPT\nPode provocar irritação das vias respiratórias.\n\nRO\nPoate provoca iritarea căilor respiratorii.\n\nSK\nMôže spôsobiť podráždenie dýchacích ciest.\n\nSL\nLahko povzroči draženje dihalnih poti.\n\nFI\nSaattaa aiheuttaa hengitysteiden ärsytystä.\n\nSV\nKan orsaka irritation i luftvägarna.\n\nH336\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis\n\nBG\nМоже да предизвика сънливост или световъртеж.\n\nES\nPuede provocar somnolencia o vértigo.\n\nCS\nMůže způsobit ospalost nebo závratě.\n\nDA\nKan forårsage sløvhed eller svimmelhed.\n\nDE\nKann Schläfrigkeit und Benommenheit verursachen.\n\nET\nVõib põhjustada unisust või peapööritust.\n\nEL\nΜπορεί να προκαλέσει υπνηλία ή ζάλη.\n\nEN\nMay cause drowsiness or dizziness.\n\nFR\nPeut provoquer somnolence ou vertiges.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.\n\n\nHR\nMože izazvati pospanost ili vrtoglavicu.\n\n\nIT\nPuò provocare sonnolenza o vertigini.\n\nLV\nVar izraisīt miegainību vai reiboņus.\n\nLT\nGali sukelti mieguistumą arba galvos svaigimą.\n\nHU\nÁlmosságot vagy szédülést okozhat.\n\nMT\nJista’ jikkawża ħedla jew sturdament.\n\nNL\nKan slaperigheid of duizeligheid veroorzaken.\n\nPL\nMoże wywoływać uczucie senności lub zawroty głowy.\n\nPT\nPode provocar sonolência ou vertigens.\n\nRO\nPoate provoca somnolență sau amețeală.\n\nSK\nMôže spôsobiť ospalosť alebo závraty.\n\nSL\nLahko povzroči zaspanost ali omotico.\n\nFI\nSaattaa aiheuttaa uneliaisuutta ja huimausta.\n\nSV\nKan göra att man blir dåsig eller omtöcknad.\n\nH340\nLanguage\n3.5 — Germ cell mutagenicity, Hazard Category 1A, 1B\n\nBG\nМоже да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar defectos genéticos .\n\nCS\nMůže vyvolat genetické poškození .\n\nDA\nKan forårsage genetiske defekter .\n\nDE\nKann genetische Defekte verursachen .\n\nET\nVõib põhjustada geneetilisi defekte .\n\nEL\nΜπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nMay cause genetic defects .\n\nFR\nPeut induire des anomalies génétiques .\n\nGA\nD'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha .\n\n\n\nHR\nMože izazvati genetska oštećenja .\n\n\nIT\nPuò provocare alterazioni genetiche .\n\nLV\nVar izraisīt ģenētiskus bojājumus .\n\nLT\nGali sukelti genetinius defektus .\n\nHU\nGenetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża difetti ġenetiċi .\n\nNL\nKan genetische schade veroorzaken .\n\nPL\nMoże powodować wady genetyczne .\n\nPT\nPode provocar anomalias genéticas .\n\nRO\nPoate provoca anomalii genetice .\n\nSK\nMôže spôsobovať genetické poškodenie .\n\nSL\nLahko povzroči genetske okvare .\n\nFI\nSaattaa aiheuttaa perimävaurioita .\n\nSV\nKan orsaka genetiska defekter .\n\n\nH341\nLanguage\n3.5 — Germ cell mutagenicity, Hazard Category 2\n\nBG\nПредполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que provoca defectos genéticos .\n\nCS\nPodezření na genetické poškození .\n\nDA\nMistænkt for at forårsage genetiske defekter .\n\nDE\nKann vermutlich genetische Defekte verursachen .\n\nET\nArvatavasti põhjustab geneetilisi defekte .\n\nEL\nΎποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of causing genetic defects .\n\nFR\nSusceptible d'induire des anomalies génétiques .\n\nGA\nCeaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha .\n\n\nHR\nSumnja na moguća genetska oštećenja .\n\n\nIT\nSospettato di provocare alterazioni genetiche .\n\nLV\nIr aizdomas, ka var izraisīt ģenētiskus bojājumus .\n\nLT\nĮtariama, kad gali sukelti genetinius defektus .\n\nHU\nFeltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jikkawża difetti ġenetiċi .\n\nNL\nVerdacht van het veroorzaken van genetische schade .\n\nPL\nPodejrzewa się, że powoduje wady genetyczne .\n\nPT\nSuspeito de provocar anomalias genéticas .\n\nRO\nSusceptibil de a provoca anomalii genetice < indicați calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.\n\nSK\nPodozrenie, že spôsobuje genetické poškodenie .\n\nSL\nSum povzročitve genetskih okvar .\n\nFI\nEpäillään aiheuttavan perimävaurioita .\n\nSV\nMisstänks kunna orsaka genetiska defekter .\n\nH350\nLanguage\n3.6 — Carcinogenicity, Hazard Category 1A, 1B\n\nBG\nМоже да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar cáncer .\n\nCS\nMůže vyvolat rakovinu .\n\nDA\nKan fremkalde kræft .\n\nDE\nKann Krebs erzeugen .\n\nET\nVõib põhjustada vähktõbe .\n\nEL\nΜπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause cancer .\n\nFR\nPeut provoquer le cancer .\n\nGA\nD'fhéadfadh sé a bheith ina chúis le hailse .\n\n\nHR\nMože uzrokovati rak .\n\n\nIT\nPuò provocare il cancro.\n\nLV\nVar izraisīt vēzi .\n\nLT\nGali sukelti vėžį .\n\nHU\nRákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża l-kanċer .\n\nNL\nKan kanker veroorzaken \n\nPL\nMoże powodować raka .\n\nPT\nPode provocar cancro .\n\nRO\nPoate provoca cancer .\n\nSK\nMôže spôsobiť rakovinu .\n\nSL\nLahko povzroči raka .\n\nFI\nSaattaa aiheuttaa syöpää .\n\nSV\nKan orsaka cancer .\n\nH351\nLanguage\n3.6 — Carcinogenicity, Hazard Category 2\n\nBG\nПредполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que provoca cáncer .\n\nCS\nPodezření na vyvolání rakoviny .\n\nDA\nMistænkt for at fremkalde kræft .\n\nDE\nKann vermutlich Krebs erzeugen .\n\nET\nArvatavasti põhjustab vähktõbe .\n\nEL\nΎποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of causing cancer .\n\nFR\nSusceptible de provoquer le cancer .\n\nGA\nCeaptar go bhféadfadh sé a bheith ina chúis le hailse .\n\n\nHR\nSumnja na moguće uzrokovanje raka .\n\n\n\nIT\nSospettato di provocare il cancro .\n\nLV\nIr aizdomas, ka var izraisīt vēzi .\n\nLT\nĮtariama, kad sukelia vėžį .\n\nHU\nFeltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jikkawża l-kanċer .\n\nNL\nVerdacht van het veroorzaken van kanker .\n\nPL\nPodejrzewa się, że powoduje raka .\n\nPT\nSuspeito de provocar cancro .\n\nRO\nSusceptibil de a provoca cancer .\n\nSK\nPodozrenie, že spôsobuje rakovinu .\n\nSL\nSum povzročitve raka .\n\nFI\nEpäillään aiheuttavan syöpää .\n\nSV\nMisstänks kunna orsaka cancer .\n\nH360\nLanguage\n3.7 — Reproductive toxicity, Hazard Category 1A, 1B\n\nBG\nМоже да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede perjudicar la fertilidad o dañar al feto .\n\nCS\nMůže poškodit reprodukční schopnost nebo plod v těle matky .\n\nDA\nKan skade forplantningsevnen eller det ufødte barn .\n\nDE\nKann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen .\n\nET\nVõib kahjustada viljakust või loodet .\n\nEL\nΜπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay damage fertility or the unborn child .\n\nFR\nPeut nuire à la fertilité ou au fœtus .\n\nGA\nD'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn .\n\n\nHR\nMože štetno djelovati na plodnost ili naškoditi nerođenom djetetu .\n\n\nIT\nPuò nuocere alla fertilità o al feto .\n\nLV\nVar kaitēt auglībai vai nedzimušajam bērnam .\n\nLT\nGali pakenkti vaisingumui arba negimusiam vaikui .\n\nHU\nKárosíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf .\n\nNL\nKan de vruchtbaarheid of het ongeboren kind schaden .\n\nPL\nMoże działać szkodliwie na płodność lub na dziecko w łonie matki .\n\nPT\nPode afectar a fertilidade ou o nascituro .\n\nRO\nPoate dăuna fertilității sau fătului .\n\nSK\nMôže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa .\n\nSL\nLahko škoduje plodnosti ali nerojenemu otroku .\n\nFI\nSaattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä .\n\nSV\nKan skada fertiliteten eller det ofödda barnet .\n\n\nH361\nLanguage\n3.7 — Reproductive toxicity, Hazard Category 2\n\nBG\nПредполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nSe sospecha que perjudica la fertilidad o daña al feto .\n\nCS\nPodezření na poškození reprodukční schopnosti nebo plodu v těle matky .\n\nDA\nMistænkt for at skade forplantningsevnen eller det ufødte barn .\n\nDE\nKann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > \n\nET\nArvatavasti kahjustab viljakust või loodet .\n\nEL\nΎποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nSuspected of damaging fertility or the unborn child .\n\nFR\nSusceptible de nuire à la fertilité ou au fœtus .\n\nGA\nCeaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn .\n\n\nHR\nSumnja na moguće štetno djelovanje na plodnost ili mogućnost štetnog djelovanja na nerođeno dijete .\n\n\n\nIT\nSospettato di nuocere alla fertilità o al feto .\n\nLV\nIr aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam .\n\nLT\nĮtariama, kad kenkia vaisingumui arba negimusiam vaikui .\n\nHU\nFeltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nSuspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf .\n\nNL\nKan mogelijks de vruchtbaarheid of het ongeboren kind schaden .\n\nPL\nPodejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki .\n\nPT\nSuspeito de afectar a fertilidade ou o nascituro .\n\nRO\nSusceptibil de a dăuna fertilității sau fătului .\n\nSK\nPodozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa .\n\nSL\nSum škodljivosti za plodnost ali nerojenega otroka .\n\nFI\nEpäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä .\n\nSV\nMisstänks kunna skada fertiliteten eller det ofödda barnet .\n\nH362\nLanguage\n3.7 — Reproductive toxicity, Additional category, Effects on or via lactation\n\nBG\nМоже да бъде вреден за кърмачета.\n\nES\nPuede perjudicar a los niños alimentados con leche materna.\n\nCS\nMůže poškodit kojence prostřednictvím mateřského mléka.\n\nDA\nKan skade børn, der ammes.\n\nDE\nKann Säuglinge über die Muttermilch schädigen.\n\nET\nVõib kahjustada rinnaga toidetavat last.\n\nEL\nΜπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.\n\nEN\nMay cause harm to breast-fed children.\n\nFR\nPeut être nocif pour les bébés nourris au lait maternel.\n\nGA\nD'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.\n\n\nHR\nMože štetno djelovati na djecu koja se hrane majčinim mlijekom.\n\n\nIT\nPuò essere nocivo per i lattanti allattati al seno.\n\nLV\nVar radīt kaitējumu ar krūti barotam bērnam.\n\nLT\nGali pakenkti žindomam vaikui.\n\nHU\nA szoptatott gyermeket károsíthatja.\n\nMT\nJista’ jagħmel ħsara lit-tfal imreddgħa.\n\nNL\nKan schadelijk zijn via borstvoeding.\n\nPL\nMoże działać szkodliwie na dzieci karmione piersią.\n\nPT\nPode ser nocivo para as crianças alimentadas com leite materno.\n\nRO\nPoate dăuna copiilor alăptați la sân.\n\nSK\nMôže spôsobiť poškodenie u dojčených detí.\n\nSL\nLahko škoduje dojenim otrokom.\n\nFI\nSaattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.\n\nSV\nKan skada spädbarn som ammas.\n\nH370\nLanguage\n3.8 — Specific target organ toxicity — single exposure, Hazard Category 1\n\nBG\nПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nProvoca daños en los órganos .\n\nCS\nZpůsobuje poškození orgánů .\n\nDA\nForårsager organskader .\n\nDE\nSchädigt die Organe .\n\nET\nKahjustab elundeid .\n\nEL\nΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nCauses damage to organs .\n\nFR\nRisque avéré d'effets graves pour les organes .\n\nGA\nDéanann sé damáiste d'orgáin .\n\n\n\nHR\nUzrokuje oštećenje organa .\n\n\nIT\nProvoca danni agli organi .\n\nLV\nRada orgānu bojājumus .\n\nLT\nKenkia organams .\n\nHU\nKárosítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJagħmel ħsara lill-organi .\n\nNL\nVeroorzaakt schade aan organen .\n\nPL\nPowoduje uszkodzenie narządów .\n\nPT\nAfecta os órgãos .\n\nRO\nProvoacă leziuni ale organelor .\n\nSK\nSpôsobuje poškodenie orgánov .\n\nSL\nŠkoduje organom .\n\nFI\nVahingoittaa elimiä .\n\nSV\nOrsakar organskador .\n\nH371\nLanguage\n3.8 — Specific target organ toxicity — Single exposure, Hazard Category 2\n\nBG\nМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar daños en los órganos .\n\nCS\nMůže způsobit poškození orgánů .\n\nDA\nKan forårsage organskader .\n\nDE\nKann die Organe schädigen .\n\nET\nVõib kahjustada elundeid .\n\nEL\nΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause damage to organs .\n\nFR\nRisque présumé d'effets graves pour les organes .\n\nGA\nD'fhéadfadh damáiste a dhéanamh d'orgáin .\n\n\nHR\nMože uzrokovati oštećenje organa .\n\n\nIT\nPuò provocare danni agli organi .\n\nLV\nVar izraisīt orgānu bojājumus .\n\nLT\nGali pakenkti organams .\n\nHU\nKárosíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.\n\nMT\nJista’ jikkawża ħsara lill-organi .\n\nNL\nKan schade aan organen veroorzaken .\n\nPL\nMoże powodować uszkodzenie narządów .\n\nPT\nPode afectar os órgãos .\n\nRO\nPoate provoca leziuni ale organelor .\n\nSK\nMôže spôsobiť poškodenie orgánov .\n\nSL\nLahko škoduje organom .\n\nFI\nSaattaa vahingoittaa elimiä .\n\nSV\nKan orsaka organskador .\n\nH372\nLanguage\n3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 1\n\nBG\nПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nProvoca daños en los órganos tras exposiciones prolongadas o repetidas .\n\nCS\nZpůsobuje poškození orgánů při prodloužené nebo opakované expozici .\n\nDA\nForårsager organskader ved længerevarende eller gentagen eksponering .\n\nDE\nSchädigt die Organe bei längerer oder wiederholter Exposition .\n\nET\nKahjustab elundeid pikaajalisel või korduval kokkupuutel .\n\nEL\nΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.\n\nEN\nCauses damage to organs through prolonged or repeated exposure .\n\nFR\nRisque avéré d'effets graves pour les organes à la suite d'expositions répétées ou d'une exposition prolongée .\n\nGA\nDéanann damáiste d'orgáin trí nochtadh fada nó ilnochtadh .\n\n\nHR\nUzrokuje oštećenje organa tijekom produljene ili ponavljane izloženosti .\n\n\nIT\nProvoca danni agli organi in caso di esposizione prolungata o ripetuta .\n\nLV\nIzraisa orgānu bojājumus ilgstošas vai atkārtotas iedarbības rezultātā .\n\nLT\nKenkia organams , jeigu medžiaga veikia ilgai arba kartotinai .\n\nHU\nIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.\n\nMT\nJikkawża ħsara lill-organi minħabba espożizzjoni fit-tul jew ripetuta .\n\nNL\nVeroorzaakt schade aan organen bij langdurige of herhaalde blootstelling .\n\nPL\nPowoduje uszkodzenie narządów poprzez długotrwałe lub powtarzane narażenie .\n\nPT\nAfecta os órgãos após exposição prolongada ou repetida .\n\nRO\nProvoacă leziuni ale organelor în caz de expunere prelungită sau repetată .\n\nSK\nSpôsobuje poškodenie orgánov pri dlhšej alebo opakovanej expozícii .\n\nSL\nŠkoduje organom pri dolgotrajni ali ponavljajoči se izpostavljenosti .\n\nFI\nVahingoittaa elimiä pitkäaikaisessa tai toistuvassa altistumisessa .\n\nSV\nOrsakar organskador genom lång eller upprepad exponering .\n\nH373\nLanguage\n3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 2\n\nBG\nМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.\n\nES\nPuede provocar daños en los órganos tras exposiciones prolongadas o repetidas .\n\nCS\nMůže způsobit poškození orgánů při prodloužené nebo opakované expozici .\n\nDA\nKan forårsage organskader ved længerevarende eller gentagen eksponering .\n\nDE\nKann die Organe schädigen bei längerer oder wiederholter Exposition .\n\nET\nVõib kahjustada elundeid pikaajalisel või korduval kokkupuutel .\n\nEL\nΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.\n\nEN\nMay cause damage to organs through prolonged or repeated exposure .\n\nFR\nRisque présumé d'effets graves pour les organes à la suite d'expositions répétées ou d'une exposition prolongée .\n\nGA\nD'fhéadfadh sé damáiste a dhéanamh d'orgáin trí nochtadh fada nó ilnochtadh .\n\n\nHR\nMože uzrokovati oštećenje organa tijekom produljene ili ponavljane izloženosti .\n\n\nIT\nPuò provocare danni agli organi in caso di esposizione prolungata o ripetuta .\n\nLV\nVar izraisīt orgānu bojājumus ilgstošas vai atkārtotas iedarbības rezultātā .\n\nLT\nGali pakenkti organams , jeigu medžiaga veikia ilgai arba kartotinai .\n\nHU\nIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.\n\nMT\nJista’ jikkawża ħsara lill-organi minħabba espożizzjoni fit-tul jew ripetuta .\n\nNL\nKan schade aan organen veroorzaken bij langdurige of herhaalde blootstelling .\n\nPL\nMoże powodować uszkodzenie narządów poprzez długotrwałe lub narażenie powtarzane .\n\nPT\nPode afectar os órgãos após exposição prolongada ou repetida .\n\nRO\nPoate provoca leziuni ale organelor în caz de expunere prelungită sau repetată .\n\nSK\nMôže spôsobiť poškodenie orgánov pri dlhšej alebo opakovanej expozícii .\n\nSL\nLahko škoduje organom pri dolgotrajni ali ponavljajoči se izpostavljenosti .\n\nFI\nSaattaa vahingoittaa elimiä pitkäaikaisessa tai toistuvassa altistumisessa \n\nSV\nKan orsaka organskador genom lång eller upprepad exponering .\n\n\nH300\n+\nH310\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане или при контакт с кожата\n\nES\nMortal en caso de ingestión o en contacto con la piel\n\nCS\nPři požití nebo při styku s kůží může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse eller hudkontakt\n\nDE\nLebensgefahr bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nFatal if swallowed or in contact with skin\n\nFR\nMortel par ingestion ou par contact cutané\n\nGA\nÁbhar marfach é seo má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\n\nHR\nSmrtonosno ako se proguta ili u dodiru s kožom.\n\n\nIT\nMortale in caso di ingestione o a contatto con la pelle\n\nLV\nVar izraisīt nāvi, ja norīts vai saskaras ar ādu\n\nLT\nMirtina prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve halálos\n\nMT\nFatali jekk tinbela' jew tmiss mal-ġilda\n\nNL\nDodelijk bij inslikken en bij contact met de huid\n\nPL\nGrozi śmiercią po połknięciu lub w kontakcie ze skórą\n\nPT\nMortal por ingestão ou contacto com a pele\n\nRO\nMortal în caz de înghițire sau în contact cu pielea\n\nSK\nPri požití alebo styku s kožou môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju ali v stiku s kožo\n\nFI\nTappavaa nieltynä tai joutuessaan iholle\n\nSV\nDödligt vid förtäring eller vid hudkontakt\n\nH300\n+\nH330\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане или при вдишване\n\nES\nMortal en caso de ingestión o inhalación\n\nCS\nPři požití nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse eller indånding\n\nDE\nLebensgefahr bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nFatal if swallowed or if inhaled\n\nFR\nMortel par ingestion ou par inhalation\n\nGA\nÁbhar marfach é seo má shlogtar nó má ionanálaítear é\n\n\nHR\nSmrtonosno ako se proguta ili ako se udiše\n\n\nIT\nMortale se ingerito o inalato\n\nLV\nVar izraisīt nāvi, ja norīts vai iekļūst elpceļos\n\nLT\nMirtina prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve halálos\n\nMT\nFatali jekk tinbela' jew tittieħed bin-nifs\n\nNL\nDodelijk bij inslikken en bij inademing\n\nPL\nGrozi śmiercią po połknięciu lub w następstwie wdychania\n\nPT\nMortal por ingestão ou inalação\n\nRO\nMortal în caz de înghițire sau inhalare\n\nSK\nPri požití alebo vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju ali vdihavanju\n\nFI\nTappavaa nieltynä tai hengitettynä\n\nSV\nDödligt vid förtäring eller inandning\n\nH310\n+\nH330\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при контакт с кожата или при вдишване\n\nES\nMortal en contacto con la piel o si se inhala\n\nCS\nPři styku s kůží nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved hudkontakt eller indånding\n\nDE\nLebensgefahr bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nFatal in contact with skin or if inhaled\n\nFR\nMortel par contact cutané ou par inhalation\n\nGA\nÁbhar marfach é seo má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nSmrtonosno u dodiru s kožom ili ako se udiše\n\n\nIT\nMortale a contatto con la pelle o in caso di inalazione\n\nLV\nVar izraisīt nāvi, ja saskaras ar ādu vai nonāk elpceļos\n\nLT\nMirtina susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve halálos\n\nMT\nFatali f'kuntatt mal-ġilda jew jekk tittieħed bin-nifs\n\nNL\nDodelijk bij contact met de huid en bij inademing\n\nPL\nGrozi śmiercią w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nMortal por contacto com a pele ou inalação\n\nRO\nMortal în contact cu pielea sau prin inhalare\n\nSK\nPri styku s kožou alebo pri vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno v stiku s kožo ali pri vdihavanju\n\nFI\nTappavaa joutuessaan iholle tai hengitettynä\n\nSV\nDödligt vid hudkontakt eller inandning\n\nH300 +\nH310 +\nH330\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 1, 2\n\nBG\nСмъртоносен при поглъщане, при контакт с кожата или при вдишване\n\nES\nMortal en caso de ingestión, contacto con la piel o inhalación\n\nCS\nPři požití, při styku s kůží nebo při vdechování může způsobit smrt\n\nDA\nLivsfarlig ved indtagelse, hudkontakt eller indånding\n\nDE\nLebensgefahr bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel surmav\n\nEL\nΘανατηφόρο σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nFatal if swallowed, in contact with skin or if inhaled\n\nFR\nMortel par ingestion, par contact cutané ou par inhalation\n\nGA\nÁbhar marfach é seo má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nSmrtonosno ako se proguta, u dodiru s kožom ili ako se udiše\n\n\nIT\nMortale se ingerito, a contatto con la pelle o se inalato\n\nLV\nVar izraisīt nāvi, ja norīts, saskaras ar ādu vai iekļūst elpceļos\n\nLT\nMirtina prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve halálos\n\nMT\nFatali jekk tinbela', tmiss mal-ġilda jew tittieħed bin-nifs\n\nNL\nDodelijk bij inslikken, bij contact met de huid en bij inademing\n\nPL\nGrozi śmiercią po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nMortal por ingestão, contacto com a pele ou inalação\n\nRO\nMortal în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nPri požití, pri styku s kožou alebo pri vdýchnutí môže spôsobiť smrť\n\nSL\nSmrtno pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nTappavaa nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nDödligt vid förtäring, hudkontakt eller inandning\n\nH301\n+\nH311\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 3\n\nBG\nТоксичен при поглъщане или при контакт с кожата\n\nES\nTóxico en caso de ingestión o en contacto con la piel\n\nCS\nToxický při požití a při styku s kůží\n\nDA\nGiftig ved indtagelse eller hudkontakt\n\nDE\nGiftig bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nToxic if swallowed or in contact with skin\n\nFR\nToxique par ingestion ou par contact cutané\n\nGA\nÁbhar tocsaineach má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\n\nHR\nOtrovno ako se proguta ili u dodiru s kožom\n\n\nIT\nTossico se ingerito o a contatto con la pelle\n\nLV\nToksisks, ja norīts vai saskaras ar ādu\n\nLT\nToksiška prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve mérgező\n\nMT\nTossika jekk tinbela' jew tmiss mal-ġilda\n\nNL\nGiftig bij inslikken en bij contact met de huid\n\nPL\nDziała toksycznie po połknięciu lub w kontakcie ze skórą\n\nPT\nTóxico por ingestão ou contacto com a pele\n\nRO\nToxic în caz de înghițire sau în contact cu pielea\n\nSK\nToxický pri požití a pri styku s kožou\n\nSL\nStrupeno pri zaužitju ali v stiku s kožo\n\nFI\nMyrkyllistä nieltynä tai joutuessaan iholle\n\nSV\nGiftigt vid förtäring eller hudkontakt\n\nH301\n+\nH331\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при поглъщане или при вдишване\n\nES\nTóxico en caso de ingestión o inhalación\n\nCS\nToxický při požití a při vdechování\n\nDA\nGiftig ved indtagelse eller indånding\n\nDE\nGiftig bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nToxic if swallowed or if inhaled\n\nFR\nToxique par ingestion ou par inhalation\n\nGA\nÁbhar tocsaineach má shlogtar nó má ionanálaítear é\n\n\nHR\nOtrovno ako se proguta ili ako se udiše\n\n\nIT\nTossico se ingerito o inalato\n\nLV\nToksisks, ja norīts vai iekļūst elpceļos\n\nLT\nToksiška prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve mérgező\n\nMT\nTossika jekk tinbela' jew tittieħed bin-nifs\n\nNL\nGiftig bij inslikken en bij inademing\n\nPL\nDziała toksycznie po połknięciu lub w następstwie wdychania\n\nPT\nTóxico por ingestão ou inalação\n\nRO\nToxic în caz de înghițire sau prin inhalare\n\nSK\nToxický pri požití alebo vdýchnutí\n\nSL\nStrupeno pri zaužitju ali vdihavanju\n\nFI\nMyrkyllistä nieltynä tai hengitettynä\n\nSV\nGiftigt vid förtäring eller inandning\n\n\nH311\n+\nH331\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при контакт с кожата или при вдишване\n\nES\nTóxico en contacto con la piel o si se inhala\n\nCS\nToxický při styku s kůží a při vdechování\n\nDA\nLivsfarlig ved hudkontakt eller indånding\n\nDE\nGiftig bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nToxic in contact with skin or if inhaled\n\nFR\nToxique par contact cutané ou par inhalation\n\nGA\nÁbhar tocsaineach má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nOtrovno u dodiru s kožom ili ako se udiše\n\n\nIT\nTossico a contatto con la pelle o se inalato\n\nLV\nToksisks saskarē ar ādu vai ja iekļūst elpceļos\n\nLT\nToksiška susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve mérgező\n\nMT\nTossika jekk tmiss mal-ġilda jew tittieħeb bin-nifs\n\nNL\nGiftig bij contact met de huid en bij inademing\n\nPL\nDziała toksycznie w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nTóxico em contacto com a pele ou por inalação\n\nRO\nToxic în contact cu pielea sau prin inhalare\n\nSK\nToxický pri styku s kožou alebo pri vdýchnutí\n\nSL\nStrupeno v stiku s kožo ali pri vdihavanju\n\nFI\nMyrkyllistä joutuessaan iholle tai hengitettynä\n\nSV\nGiftigt vid hudkontakt eller förtäring\n\nH301 +\nH311 +\nH331\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 3\n\nBG\nТоксичен при поглъщане, при контакт с кожата или при вдишване\n\nES\nTóxico en caso de ingestión, contacto con la piel o inhalación\n\nCS\nToxický při požití, při styku s kůží a při vdechování\n\nDA\nGiftig ved indtagelse, hudkontakt eller indånding\n\nDE\nGiftig bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel mürgine\n\nEL\nΤοξικό σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση κατάποσης\n\nEN\nToxic if swallowed, in contact with skin or if inhaled\n\nFR\nToxique par ingestion, par contact cutané ou par inhalation\n\nGA\nÁbhar tocsaineach má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nOtrovno ako se proguta, u dodiru s kožom ili ako se udiše\n\n\nIT\nTossico se ingerito, a contatto con la pelle o se inalato\n\nLV\nToksisks, ja norīts, saskaras ar ādu vai iekļūst elpceļos\n\nLT\nToksiška prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve mérgező\n\nMT\nTossika jekk tinbela', tmiss mal-ġilda jew tittieħed bin-nifs\n\nNL\nGiftig bij inslikken, bij contact met de huid en bij inademing\n\nPL\nDziała toksycznie po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nTóxico por ingestão, contacto com a pele ou inalação\n\nRO\nToxic în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nToxický pri požití, styku s kožou alebo pri vdýchnutí\n\nSL\nStrupeno pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nMyrkyllistä nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nGiftigt vid förtäring, hudkontakt eller inandning\n\nH302\n+\nH312\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (dermal), hazard category 4\n\nBG\nВреден при поглъщане или при контакт с кожата\n\nES\nNocivo en caso de ingestión o en contacto con la piel\n\nCS\nZdraví škodlivý při požití a při styku s kůží\n\nDA\nLivsfarlig ved indtagelse eller hudkontakt\n\nDE\nGesundheitsschädlich bei Verschlucken oder Hautkontakt\n\nET\nAllaneelamisel või nahale sattumisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης ή σε επαφή με το δέρμα\n\nEN\nHarmful if swallowed or in contact with skin\n\nFR\nNocif en cas d'ingestion ou de contact cutané\n\nGA\nÁbhar dochrach má shlogtar é nó má theagmhaíonn leis an gcraiceann\n\n\nHR\nŠtetno ako se proguta ili u dodiru s kožom\n\n\nIT\nNocivo se ingerito o a contatto con la pelle\n\nLV\nKaitīgs, ja norīts vai saskaras ar ādu\n\nLT\nKenksminga prarijus arba susilietus su oda\n\nHU\nLenyelve vagy bőrrel érintkezve ártalmas\n\nMT\nTagħmel ħsara jekk tinbela' jew jekk tmiss mal-ġilda\n\nNL\nSchadelijk bij inslikken en bij contact met de huid\n\nPL\nDziała szkodliwie po połknięciu lub w kontakcie ze skórą\n\nPT\nNocivo por ingestão ou contacto com a pele\n\nRO\nNociv în caz de înghițire sau în contact cu pielea\n\nSK\nZdraviu škodlivý pri požití alebo pri styku s kožou\n\nSL\nZdravju škodljivo pri zaužitju ali v stiku s kožo\n\nFI\nHaitallista nieltynä tai joutuessaan iholle\n\nSV\nSkadligt vid förtäring eller hudkontakt\n\nH302\n+\nH332\nLanguage\n3.1 — Acute toxicity (oral) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при поглъщане или при вдишване\n\nES\nNocivo en caso de ingestión o inhalación\n\nCS\nZdraví škodlivý při požití a při vdechování\n\nDA\nFarlig ved indtagelse eller indånding\n\nDE\nGesundheitsschädlich bei Verschlucken oder Einatmen\n\nET\nAllaneelamisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης ή σε περίπτωση εισπνοής\n\nEN\nHarmful if swallowed or if inhaled\n\nFR\nNocif en cas d'ingestion ou d'inhalation\n\nGA\nÁbhar dochrach má shlogtar nó má ionanálaítear é\n\n\nHR\nŠtetno ako se proguta ili ako se udiše\n\n\nIT\nNocivo se ingerito o inalato\n\nLV\nKaitīgs, ja norīts vai iekļūst elpceļos\n\nLT\nKenksminga prarijus arba įkvėpus\n\nHU\nLenyelve vagy belélegezve ártalmas\n\nMT\nTagħmel ħsara jekk tinbela' jew tittieħed bin-nifs\n\nNL\nSchadelijk bij inslikken en bij inademing\n\nPL\nDziała szkodliwie po połknięciu lub w następstwie wdychania\n\nPT\nNocivo por ingestão ou inalação\n\nRO\nNociv în caz de înghițire sau inhalare\n\nSK\nZdraviu škodlivý pri požití alebo vdýchnutí\n\nSL\nZdravju škodljivo pri zaužitju in vdihavanju\n\nFI\nHaitallista nieltynä tai hengitettynä\n\nSV\nSkadligt vid förtäring eller inandning\n\nH312\n+\nH332\nLanguage\n3.1 — Acute toxicity (dermal) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при контакт с кожата или при вдишване\n\nES\nNocivo en contacto con la piel o si se inhala\n\nCS\nZdraví škodlivý při styku s kůží a při vdechování\n\nDA\nFarlig ved hudkontakt eller indånding\n\nDE\nGesundheitsschädlich bei Hautkontakt oder Einatmen\n\nET\nNahale sattumisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nHarmful in contact with skin or if inhaled\n\nFR\nNocif en cas de contact cutané ou d'inhalation\n\nGA\nÁbhar dochrach má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nŠtetno u dodiru s kožom ili ako se udiše\n\n\nIT\nNocivo a contatto con la pelle o se inalato\n\nLV\nKaitīgs saskarē ar ādu vai ja iekļūst elpceļos\n\nLT\nKenksminga susilietus su oda arba įkvėpus\n\nHU\nBőrrel érintkezve vagy belélegezve ártalmas\n\nMT\nTagħmel ħsara jekk tmiss mal-ġilda jew jekk tittieħed bin-nifs\n\nNL\nSchadelijk bij contact met de huid en bij inademing\n\nPL\nDziała szkodliwie w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nNocivo em contacto com a pele ou por inalação\n\nRO\nNociv în contact cu pielea sau prin inhalare\n\nSK\nZdraviu škodlivý pri styku s kožou alebo pri vdýchnutí\n\nSL\nZdravju škodljivo v stiku s kožo in pri vdihavanju\n\nFI\nHaitallista joutuessaan iholle tai hengitettynä\n\nSV\nSkadligt vid hudkontakt eller inandning\n\nH302 +\nH312 +\nH332\nLanguage\n3.1 — Acute toxicity (oral), acute toxicity (dermal) and acute toxicity (inhalation), hazard category 4\n\nBG\nВреден при поглъщане, при контакт с кожата или при вдишване\n\nES\nNocivo en caso de ingestión, contacto con la piel o inhalación\n\nCS\nZdraví škodlivý při požití, při styku s kůží a při vdechování\n\nDA\nFarlig ved indånding, hudkontakt eller indånding\n\nDE\nGesundheitsschädlich bei Verschlucken, Hautkontakt oder Einatmen\n\nET\nAllaneelamisel, nahale sattumisel või sissehingamisel kahjulik\n\nEL\nΕπιβλαβές σε περίπτωση κατάποσης, σε επαφή με το δέρμα ή σε περίπτωση εισπνοής\n\nEN\nHarmful if swallowed, in contact with skin or if inhaled\n\nFR\nNocif en cas d'ingestion, de contact cutané ou d'inhalation\n\nGA\nÁbhar dochrach má shlogtar, má theagmhaíonn leis an gcraiceann nó má ionanálaítear é\n\n\nHR\nŠtetno ako se proguta, u dodiru s kožom ili ako se udiše\n\n\nIT\nNocivo se ingerito, a contatto con la pelle o se inalato\n\nLV\nKaitīgs, ja norīts, saskaras ar ādu vai nonāk elpceļos\n\nLT\nKenksminga prarijus, susilietus su oda arba įkvėpus\n\nHU\nLenyelve, bőrrel érintkezve vagy belélegezve ártalmas\n\nMT\nTagħmel il-ħsara jekk tinbela', tmiss mal-ġilda jew tittiħed bin-nifs\n\nNL\nSchadelijk bij inslikken, bij contact met de huid en bij inademing\n\nPL\nDziała szkodliwie po połknięciu, w kontakcie ze skórą lub w następstwie wdychania\n\nPT\nNocivo por ingestão, contacto com a pele ou inalação\n\nRO\nNociv în caz de înghițire, în contact cu pielea sau prin inhalare\n\nSK\nZdraviu škodlivý pri požití, styku s kožou alebo pri vdýchnutí\n\nSL\nZdravju škodljivo pri zaužitju, v stiku s kožo ali pri vdihavanju\n\nFI\nHaitallista nieltynä, joutuessaan iholle tai hengitettynä\n\nSV\nSkadligt vid förtäring, hudkontakt eller inandning\n\n\nTable 1.3\nHazard statements for environmental hazards\n\nH400\nLanguage\n4.1 — Hazardous to the aquatic environment — AcuteHazard, Category 1\n\nBG\nСилно токсичен за водните организми.\n\nES\nMuy tóxico para los organismos acuáticos.\n\nCS\nVysoce toxický pro vodní organismy.\n\nDA\nMeget giftig for vandlevende organismer.\n\nDE\nSehr giftig für Wasserorganismen.\n\nET\nVäga mürgine veeorganismidele.\n\nEL\nΠολύ τοξικό για τους υδρόβιους οργανισμούς.\n\nEN\nVery toxic to aquatic life.\n\nFR\nTrès toxique pour les organismes aquatiques.\n\nGA\nAn-tocsaineach don saol uisceach.\n\n\nHR\nVrlo otrovno za vodeni okoliš.\n\n\nIT\nMolto tossico per gli organismi acquatici.\n\nLV\nĻoti toksisks ūdens organismiem.\n\nLT\nLabai toksiška vandens organizmams.\n\nHU\nNagyon mérgező a vízi élővilágra.\n\nMT\nTossiku ħafna għall-organiżmi akwatiċi.\n\nNL\nZeer giftig voor in het water levende organismen.\n\nPL\nDziała bardzo toksycznie na organizmy wodne.\n\nPT\nMuito tóxico para os organismos aquáticos.\n\nRO\nFoarte toxic pentru mediul acvatic.\n\nSK\nVeľmi toxický pre vodné organizmy.\n\nSL\nZelo strupeno za vodne organizme.\n\nFI\nErittäin myrkyllistä vesieliöille.\n\nSV\nMycket giftigt för vattenlevande organismer.\n\nH410\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 1\n\nBG\nСилно токсичен за водните организми, с дълготраен ефект.\n\nES\nMuy tóxico para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nVysoce toxický pro vodní organismy, s dlouhodobými účinky.\n\nDA\nMeget giftig med langvarige virkninger for vandlevende organismer.\n\nDE\nSehr giftig für Wasserorganismen mit langfristiger Wirkung.\n\nET\nVäga mürgine veeorganismidele, pikaajaline toime.\n\nEL\nΠολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nVery toxic to aquatic life with long lasting effects.\n\nFR\nTrès toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nAn-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\n\nHR\nVrlo otrovno za vodeni okoliš, s dugotrajnim učincima.\n\n\nIT\nMolto tossico per gli organismi acquatici con effetti di lunga durata.\n\nLV\nĻoti toksisks ūdens organismiem ar ilgstošām sekām.\n\nLT\nLabai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nNagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nTossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nZeer giftig voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nMuito tóxico para os organismos aquáticos com efeitos duradouros.\n\nRO\nFoarte toxic pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nVeľmi toxický pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nZelo strupeno za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nErittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nMycket giftigt för vattenlevande organismer med långtidseffekter.\n\nH411\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 2\n\nBG\nТоксичен за водните организми, с дълготраен ефект.\n\nES\nTóxico para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nToxický pro vodní organismy, s dlouhodobými účinky.\n\nDA\nGiftig for vandlevende organismer, med langvarige virkninger.\n\nDE\nGiftig für Wasserorganismen, mit langfristiger Wirkung.\n\nET\nMürgine veeorganismidele, pikaajaline toime.\n\nEL\nΤοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nToxic to aquatic life with long lasting effects.\n\nFR\nToxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nTocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\n\nHR\nOtrovno za vodeni okoliš s dugotrajnim učincima.\n\n\nIT\nTossico per gli organismi acquatici con effetti di lunga durata.\n\nLV\nToksisks ūdens organismiem ar ilgstošām sekām.\n\nLT\nToksiška vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nMérgező a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nTossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nGiftig voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała toksycznie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nTóxico para os organismos aquáticos com efeitos duradouros.\n\nRO\nToxic pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nToxický pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nStrupeno za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nMyrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nGiftigt för vattenlevande organismer med långtidseffekter.\n\nH412\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 3\n\nBG\nВреден за водните организми, с дълготраен ефект.\n\nES\nNocivo para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nŠkodlivý pro vodní organismy, s dlouhodobými účinky.\n\nDA\nSkadelig for vandlevende organismer, med langvarige virkninger.\n\nDE\nSchädlich für Wasserorganismen, mit langfristiger Wirkung.\n\nET\nOhtlik veeorganismidele, pikaajaline toime.\n\nEL\nΕπιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.\n\nEN\nHarmful to aquatic life with long lasting effects.\n\nFR\nNocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.\n\nGA\nDíobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.\n\n\nHR\nŠtetno za vodeni okoliš s dugotrajnim učincima.\n\n\nIT\nNocivo per gli organismi acquatici con effetti di lunga durata.\n\nLV\nKaitīgs ūdens organismiem ar ilgstošām sekām.\n\nLT\nKenksminga vandens organizmams, sukelia ilgalaikius pakitimus.\n\nHU\nÁrtalmas a vízi élővilágra, hosszan tartó károsodást okoz.\n\nMT\nJagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.\n\nNL\nSchadelijk voor in het water levende organismen, met langdurige gevolgen.\n\nPL\nDziała szkodliwie na organizmy wodne, powodując długotrwałe skutki.\n\nPT\nNocivo para os organismos aquáticos com efeitos duradouros.\n\nRO\nNociv pentru mediul acvatic cu efecte pe termen lung.\n\nSK\nŠkodlivý pre vodné organizmy, s dlhodobými účinkami.\n\nSL\nŠkodljivo za vodne organizme, z dolgotrajnimi učinki.\n\nFI\nHaitallista vesieliöille, pitkäaikaisia haittavaikutuksia.\n\nSV\nSkadliga långtidseffekter för vattenlevande organismer.\n\nH413\nLanguage\n4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 4\n\nBG\nМоже да причини дълготраен вреден ефект за водните организми.\n\nES\nPuede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.\n\nCS\nMůže vyvolat dlouhodobé škodlivé účinky pro vodní organismy.\n\nDA\nKan forårsage langvarige skadelige virkninger for vandlevende organismer.\n\nDE\nKann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.\n\nET\nVõib avaldada veeorganismidele pikaajalist kahjulikku toimet.\n\nEL\nΜπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.\n\nEN\nMay cause long lasting harmful effects to aquatic life.\n\nFR\nPeut être nocif à long terme pour les organismes aquatiques.\n\nGA\nD'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.\n\n\nHR\nMože uzrokovati dugotrajne štetne učinke na vodeni okoliš.\n\n\nIT\nPuò essere nocivo per gli organismi acquatici con effetti di lunga durata.\n\nLV\nVar radīt ilgstošas kaitīgas sekas ūdens organismiem.\n\nLT\nGali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.\n\nHU\nHosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.\n\nMT\nJista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.\n\nNL\nKan langdurige schadelijke gevolgen voor in het water levende organismen hebben.\n\nPL\nMoże powodować długotrwałe szkodliwe skutki dla organizmów wodnych.\n\nPT\nPode provocar efeitos nocivos duradouros nos organismos aquáticos.\n\nRO\nPoate provoca efecte nocive pe termen lung asupra mediului acvatic.\n\nSK\nMôže mať dlhodobé škodlivé účinky na vodné organizmy.\n\nSL\nLahko ima dolgotrajne škodljive učinke na vodne organizme.\n\nFI\nVoi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.\n\nSV\nKan ge skadliga långtidseffekter på vattenlevande organismer.\n\n\nH420\nLanguage\n5.1 – Hazardous to the ozone layer — hazard category 1\n\nBG\nВреди на общественото здраве и на околната среда, като разрушава озона във високите слоеве на атмосферата\n\nES\nCausa daños a la salud pública y el medio ambiente al destruir el ozono en la atmósfera superior\n\nCS\nPoškozuje veřejné zdraví a životní prostředí tím, že ničí ozon ve svrchních vrstvách atmosféry\n\nDA\nSkader folkesundheden og miljøet ved at ødelægge ozon i den øvre atmosfære\n\nDE\nSchädigt die öffentliche Gesundheit und die Umwelt durch Ozonabbau in der äußeren Atmosphäre\n\nET\nKahjustab rahvatervist ja keskkonda, hävitades kõrgatmosfääris asuvat osoonikihti\n\nEL\nΒλάπτει τη δημόσια υγεία και το περιβάλλον καταστρέφοντας το όζον στην ανώτερη ατμόσφαιρα\n\nEN\nHarms public health and the environment by destroying ozone in the upper atmosphere\n\nFR\nNuit à la santé publique et à l'environnement en détruisant l'ozone dans la haute atmosphère\n\nGA\nDéanann an t-ábhar seo díobháil don tsláinte phoiblí agus don chomhshaol trí ózón san atmaisféar uachtarach a scriosadh\n\n\n\nHR\nŠtetno za zdravlje ljudi i okoliš zbog uništavanja ozona u višoj atmosferi\n\n\nIT\nNuoce alla salute pubblica e all'ambiente distruggendo l'ozono dello strato superiore dell'atmosfera\n\nLV\nBīstams sabiedrības veselībai un videi, jo iznīcina ozonu atmosfēras augšējā slānī\n\nLT\nKenkia visuomenės sveikatai ir aplinkai, nes naikina ozono sluoksnį viršutinėje atmosferoje\n\nHU\nKárosítja a közegészséget és a környezetet, mert a légkör felső rétegeiben lebontja az ózont\n\nMT\nTagħmel ħsara lis-saħħa tal-pubbliku u lill-ambjent billi teqred l-ożonu fl-atmosfera ta' fuq\n\nNL\nSchadelijk voor de volksgezondheid en het milieu door afbraak van ozon in de bovenste lagen van de atmosfeer\n\nPL\nSzkodliwe dla zdrowia publicznego i środowiska w związku z niszczącym oddziaływaniem na ozon w górnej warstwie atmosfery\n\nPT\nPrejudica a saúde pública e o ambiente ao destruir o ozono na alta atmosfera\n\nRO\nDăunează sănătății publice și mediului înconjurător prin distrugerea ozonului în atmosfera superioară\n\nSK\nPoškodzuje verejné zdravie a životné prostredie tým, že ničí ozón vo vrchných vrstvách atmosféry\n\nSL\nŠkodljivo za javno zdravje in okolje zaradi uničevanja ozona v zgornji atmosferi\n\nFI\nVahingoittaa kansanterveyttä ja ympäristöä tuhoamalla otsonia ylemmässä ilmakehässä\n\nSV\nSkadar folkhälsan och miljön genom förstöring av ozonet i övre delen av atmosfären\n\n\n\n2. Part 2: supplemental hazard information\n\nTable 2.1\nPhysical properties\n\nEUH 001\nLanguage\n\n\nBG\nЕксплозивен в сухо състояние.\n\nES\nExplosivo en estado seco.\n\nCS\nVýbušný v suchém stavu.\n\nDA\nEksplosiv i tør tilstand.\n\nDE\nIn trockenem Zustand explosionsgefährlich.\n\nET\nPlahvatusohtlik kuivana.\n\nEL\nΕκρηκτικό σε ξηρή κατάσταση.\n\nEN\nExplosive when dry.\n\nFR\nExplosif à l'état sec.\n\nGA\nPléascach agus é tirim.\n\n\nHR\nEksplozivno u suhom stanju.\n\n\nIT\nEsplosivo allo stato secco.\n\nLV\nSprādzienbīstams sausā veidā.\n\nLT\nSausos būsenos gali sprogti.\n\nHU\nSzáraz állapotban robbanásveszélyes.\n\nMT\nJisplodi meta jinxef.\n\nNL\nIn droge toestand ontplofbaar.\n\nPL\nProdukt wybuchowy w stanie suchym.\n\nPT\nExplosivo no estado seco.\n\nRO\nExploziv în stare uscată.\n\nSK\nV suchom stave výbušný.\n\nSL\nEksplozivno v suhem stanju.\n\nFI\nRäjähtävää kuivana.\n\nSV\nExplosivt i torrt tillstånd.\n\nEUH 006\nLanguage\n\n\nBG\nЕксплозивен при или без контакт с въздуха.\n\nES\nExplosivo en contacto o sin contacto con el aire.\n\nCS\nVýbušný za přístupu i bez přístupu vzduchu.\n\nDA\nEksplosiv ved og uden kontakt med luft.\n\nDE\nMit und ohne Luft explosionsfähig.\n\nET\nPlahvatusohtlik õhuga kokkupuutel või kokkupuuteta.\n\nEL\nΕκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.\n\nEN\nExplosive with or without contact with air.\n\nFR\nDanger d'explosion en contact ou sans contact avec l'air.\n\nGA\nPléascach i dteagmháil le haer nó gan é.\n\n\nHR\nEksplozivno u dodiru ili bez dodira sa zrakom.\n\n\nIT\nEsplosivo a contatto o senza contatto con l'aria.\n\nLV\nSprādzienbīstams gaisa un bezgaisa vidē.\n\nLT\nGali sprogti ore arba beorėje erdvėje.\n\nHU\nLevegővel érintkezve vagy anélkül is robbanásveszélyes.\n\nMT\nJista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.\n\nNL\nOntplofbaar met en zonder lucht.\n\nPL\nProdukt wybuchowy z dostępem lub bez dostępu powietrza.\n\nPT\nPerigo de explosão com ou sem contacto com o ar.\n\nRO\nExploziv în contact sau fără contactul cu aerul.\n\nSK\nVýbušné pri kontakte alebo bez kontaktu so vzduchom.\n\nSL\nEksplozivno v stiku z zrakom ali brez stika z zrakom.\n\nFI\nRäjähtävää sellaisenaan tai ilman kanssa.\n\nSV\nExplosivt vid eller utan kontakt med luft.\n\nEUH 014\nLanguage\n\n\nBG\nРеагира бурно с вода.\n\nES\nReacciona violentamente con el agua.\n\nCS\nPrudce reaguje s vodou.\n\nDA\nReagerer voldsomt med vand.\n\nDE\nReagiert heftig mit Wasser.\n\nET\nReageerib ägedalt veega.\n\nEL\nΑντιδρά βίαια με νερό.\n\nEN\nReacts violently with water.\n\nFR\nRéagit violemment au contact de l'eau.\n\nGA\nImoibríonn go foirtil le huisce.\n\n\nHR\nBurno reagira s vodom.\n\n\nIT\nReagisce violentemente con l'acqua.\n\nLV\nAktīvi reaģē ar ūdeni.\n\nLT\nSmarkiai reaguoja su vandeniu.\n\nHU\nVízzel hevesen reagál.\n\nMT\nJirreaġixxi bil-qawwa meta jmiss l-ilma.\n\nNL\nReageert heftig met water.\n\nPL\nReaguje gwałtownie z wodą.\n\nPT\nReage violentamente em contacto com a água.\n\nRO\nReacționează violent în contact cu apa.\n\nSK\nPrudko reaguje s vodou.\n\nSL\nBurno reagira z vodo.\n\nFI\nReagoi voimakkaasti veden kanssa.\n\nSV\nReagerar häftigt med vatten.\n\n\nEUH 018\nLanguage\n\n\nBG\nПри употреба може да се образува запалима/експлозивна паровъздушнa смес.\n\nES\nAl usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.\n\nCS\nPři používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.\n\nDA\nVed brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.\n\nDE\nKann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.\n\nET\nKasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.\n\nEL\nΚατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.\n\nEN\nIn use may form flammable/explosive vapour-air mixture.\n\nFR\nLors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.\n\nGA\nAgus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.\n\n\nHR\nPri uporabi može nastati zapaljiva/eksplozivna smjesa para-zrak.\n\n\nIT\nDurante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.\n\nLV\nIzmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.\n\nLT\nNaudojama gali sudaryti degius (sprogius) garų-oro mišinius.\n\nHU\nA használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.\n\nMT\nMeta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.\n\nNL\nKan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.\n\nPL\nPodczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.\n\nPT\nPode formar mistura vapor-ar explosiva/inflamável durante a utilização.\n\nRO\nÎn timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.\n\nSK\nPri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.\n\nSL\nPri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.\n\nFI\nKäytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.\n\nSV\nVid användning kan brännbara/explosiva ång-luftblandningar bildas.\n\n\nEUH 019\nLanguage\n\n\nBG\nМоже да образува експлозивни пероксиди.\n\nES\nPuede formar peróxidos explosivos.\n\nCS\nMůže vytvářet výbušné peroxidy.\n\nDA\nKan danne eksplosive peroxider.\n\nDE\nKann explosionsfähige Peroxide bilden.\n\nET\nVõib moodustada plahvatusohtlikke peroksiide.\n\nEL\nΜπορεί να σχηματίσει εκρηκτικά υπεροξείδια.\n\nEN\nMay form explosive peroxides.\n\nFR\nPeut former des peroxydes explosifs.\n\nGA\nD'fhéadfadh sé sárocsaídí pléascacha a chruthú.\n\n\nHR\nMože stvarati eksplozivne perokside.\n\n\nIT\nPuò formare perossidi esplosivi.\n\nLV\nVar veidot sprādzienbīstamus peroksīdus.\n\nLT\nGali sudaryti sprogius peroksidus.\n\nHU\nRobbanásveszélyes peroxidokat képezhet.\n\nMT\nJista' jifforma perossidi esplussivi.\n\nNL\nKan ontplofbare peroxiden vormen.\n\nPL\nMoże tworzyć wybuchowe nadtlenki.\n\nPT\nPode formar peróxidos explosivos.\n\nRO\nPoate forma peroxizi explozivi.\n\nSK\nMôže vytvárat’ výbušné peroxidy.\n\nSL\nLahko tvori eksplozivne perokside.\n\nFI\nSaattaa muodostaa räjähtäviä peroksideja.\n\nSV\nKan bilda explosiva peroxider.\n\nEUH 044\nLanguage\n\n\nBG\nРиск от експлозия при нагряване в затворено пространство.\n\nES\nRiesgo de explosión al calentarlo en ambiente confinado.\n\nCS\nNebezpečí výbuchu při zahřátí v uzavřeném obalu.\n\nDA\nEksplosionsfarlig ved opvarmning under indeslutning.\n\nDE\nExplosionsgefahr bei Erhitzen unter Einschluss.\n\nET\nPlahvatusohtlik kuumutamisel kinnises mahutis.\n\nEL\nΚίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.\n\nEN\nRisk of explosion if heated under confinement.\n\nFR\nRisque d'explosion si chauffé en ambiance confinée.\n\nGA\nBaol pléasctha arna théamh i limistéar iata.\n\n\nHR\nOpasnost od eksplozije ako se zagrijava u zatvorenom prostoru.\n\n\nIT\nRischio di esplosione per riscaldamento in ambiente confinato.\n\nLV\nSprādziena draudi, karsējot slēgtā vidē.\n\nLT\nGali sprogti, jei kaitinama sandariai uždaryta.\n\nHU\nZárt térben hő hatására robbanhat.\n\nMT\nRiskju ta' splużjoni jekk jissaħħan fil-magħluq.\n\nNL\nOntploffingsgevaar bij verwarming in afgesloten toestand.\n\nPL\nZagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.\n\nPT\nRisco de explosão se aquecido em ambiente fechado.\n\nRO\nRisc de explozie, dacă este încălzit în spațiu închis.\n\nSK\nRiziko výbuchu pri zahrievaní v uzavretom priestore.\n\nSL\nNevarnost eksplozije ob segrevanju v zaprtem prostoru.\n\nFI\nRäjähdysvaara kuumennettaessa suljetussa astiassa.\n\nSV\nExplosionsrisk vid uppvärmning i sluten behållare.\n\nTable 2.2\nHealth properties\n\nEUH 029\nLanguage\n\n\nBG\nПри контакт с вода се отделя токсичен газ.\n\nES\nEn contacto con agua libera gases tóxicos.\n\nCS\nUvolňuje toxický plyn při styku s vodou.\n\nDA\nUdvikler giftig gas ved kontakt med vand.\n\nDE\nEntwickelt bei Berührung mit Wasser giftige Gase.\n\nET\nKokkupuutel veega eraldub mürgine gaas.\n\nEL\nΣε επαφή με το νερό ελευθερώνονται τοξικά αέρια.\n\nEN\nContact with water liberates toxic gas.\n\nFR\nAu contact de l'eau, dégage des gaz toxiques.\n\nGA\nI dteagmháil le huisce scaoiltear gás tocsaineach.\n\n\n\nHR\nU dodiru s vodom oslobađa otrovni plin.\n\n\nIT\nA contatto con l'acqua libera un gas tossico.\n\nLV\nSaskaroties ar ūdeni, izdala toksiskas gāzes.\n\nLT\nKontaktuodama su vandeniu išskiria toksiškas dujas.\n\nHU\nVízzel érintkezve mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku meta jmiss l-ilma.\n\nNL\nVormt giftig gas in contact met water.\n\nPL\nW kontakcie z wodą uwalnia toksyczne gazy.\n\nPT\nEm contacto com a água liberta gases tóxicos.\n\nRO\nÎn contact cu apa, degajă un gaz toxic.\n\nSK\nPri kontakte s vodou uvoľňuje toxický plyn.\n\nSL\nV stiku z vodo se sprošča strupen plin.\n\nFI\nKehittää myrkyllistä kaasua veden kanssa.\n\nSV\nUtvecklar giftig gas vid kontakt med vatten.\n\nEUH 031\nLanguage\n\n\nBG\nПри контакт с киселини се отделя токсичен газ.\n\nES\nEn contacto con ácidos libera gases tóxicos.\n\nCS\nUvolňuje toxický plyn při styku s kyselinami.\n\nDA\nUdvikler giftig gas ved kontakt med syre.\n\nDE\nEntwickelt bei Berührung mit Säure giftige Gase.\n\nET\nKokkupuutel hapetega eraldub mürgine gaas.\n\nEL\nΣε επαφή με οξέα ελευθερώνονται τοξικά αέρια.\n\nEN\nContact with acids liberates toxic gas.\n\nFR\nAu contact d'un acide, dégage un gaz toxique.\n\nGA\nI dteagmháil le haigéid scaoiltear gás tocsaineach.\n\n\nHR\nU dodiru s kiselinama oslobađa otrovni plin.\n\n\nIT\nA contatto con acidi libera gas tossici.\n\nLV\nSaskaroties ar skābēm, izdala toksiskas gāzes.\n\nLT\nKontaktuodama su rūgštimis išskiria toksiškas dujas.\n\nHU\nSavval érintkezve mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku meta jmiss l-aċidi.\n\nNL\nVormt giftig gas in contact met zuren.\n\nPL\nW kontakcie z kwasami uwalnia toksyczne gazy.\n\nPT\nEm contacto com ácidos liberta gases tóxicos.\n\nRO\nÎn contact cu acizi, degajă un gaz toxic.\n\nSK\nPri kontakte s kyselinami uvoľňuje toxický plyn.\n\nSL\nV stiku s kislinami se sprošča strupen plin.\n\nFI\nKehittää myrkyllistä kaasua hapon kanssa.\n\nSV\nUtvecklar giftig gas vid kontakt med syra.\n\nEUH 032\nLanguage\n\n\nBG\nПри контакт с киселини се отделя силно токсичен газ.\n\nES\nEn contacto con ácidos libera gases muy tóxicos.\n\nCS\nUvolňuje vysoce toxický plyn při styku s kyselinami.\n\nDA\nUdvikler meget giftig gas ved kontakt med syre.\n\nDE\nEntwickelt bei Berührung mit Säure sehr giftige Gase.\n\nET\nKokkupuutel hapetega eraldub väga mürgine gaas.\n\nEL\nΣε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.\n\nEN\nContact with acids liberates very toxic gas.\n\nFR\nAu contact d'un acide, dégage un gaz très toxique.\n\nGA\nI dteagmháil le haigéid scaoiltear gás an-tocsaineach.\n\n\nHR\nU dodiru s kiselinama oslobađa vrlo otrovni plin.\n\n\nIT\nA contatto con acidi libera gas molto tossici.\n\nLV\nSaskaroties ar skābēm, izdala ļoti toksiskas gāzes.\n\nLT\nKontaktuodama su rūgštimis išskiria labai toksiškas dujas.\n\nHU\nSavval érintkezve nagyon mérgező gázok képződnek.\n\nMT\nJitfa' gass tossiku ħafna meta jmiss l-aċidi.\n\nNL\nVormt zeer giftig gas in contact met zuren.\n\nPL\nW kontakcie z kwasami uwalnia bardzo toksyczne gazy.\n\nPT\nEm contacto com ácidos liberta gases muito tóxicos.\n\nRO\nÎn contact cu acizi, degajă un gaz foarte toxic.\n\nSK\nPri kontakte s kyselinami uvoľňuje veľmi toxický plyn.\n\nSL\nV stiku s kislinami se sprošča zelo strupen plin.\n\nFI\nKehittää erittäin myrkyllistä kaasua hapon kanssa.\n\nSV\nUtvecklar mycket giftig gas vid kontakt med syra.\n\nEUH 066\nLanguage\n\n\nBG\nПовтарящата се експозиция може да предизвика изсушаване или напукване на кожата.\n\nES\nLa exposición repetida puede provocar sequedad o formación de grietas en la piel.\n\nCS\nOpakovaná expozice může způsobit vysušení nebo popraskání kůže.\n\nDA\nGentagen kontakt kan give tør eller revnet hud.\n\nDE\nWiederholter Kontakt kann zu spröder oder rissiger Haut führen.\n\nET\nKorduv kokkupuude võib põhjustada naha kuivust või lõhenemist.\n\nEL\nΠαρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.\n\nEN\nRepeated exposure may cause skin dryness or cracking.\n\nFR\nL'exposition répétée peut provoquer dessèchement ou gerçures de la peau.\n\nGA\nD'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.\n\n\nHR\nPonavljano izlaganje može prouzročiti sušenje ili pucanje kože.\n\n\nIT\nL'esposizione ripetuta può provocare secchezza o screpolature della pelle.\n\nLV\nAtkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.\n\nLT\nPakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.\n\nHU\nIsmétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.\n\nMT\nEspożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.\n\nNL\nHerhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.\n\nPL\nPowtarzające się narażenie może powodować wysuszanie lub pękanie skóry.\n\nPT\nPode provocar pele seca ou gretada, por exposição repetida.\n\nRO\nExpunerea repetată poate provoca uscarea sau crăparea pielii.\n\nSK\nOpakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.\n\nSL\nPonavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.\n\nFI\nToistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.\n\nSV\nUpprepad kontakt kan ge torr hud eller hudsprickor.\n\nEUH 070\nLanguage\n\n\nBG\nТоксично при контакт с очите.\n\nES\nTóxico en contacto con los ojos.\n\nCS\nToxický při styku s očima.\n\nDA\nGiftig ved kontakt med øjnene.\n\nDE\nGiftig bei Berührung mit den Augen.\n\nET\nSilma sattumisel mürgine.\n\nEL\nΤοξικό σε επαφή με τα μάτια.\n\nEN\nToxic by eye contact.\n\nFR\nToxique par contact oculaire.\n\nGA\nTocsaineach trí theagmháil leis an tsúil.\n\n\nHR\nOtrovno u dodiru s očima.\n\n\nIT\nTossico per contatto oculare.\n\nLV\nToksisks saskarē ar acīm.\n\nLT\nToksiška patekus į akis.\n\nHU\nSzembe kerülve mérgező.\n\nMT\nTossiku meta jmiss ma’ l-għajnejn.\n\nNL\nGiftig bij oogcontact.\n\nPL\nDziała toksycznie w kontakcie z oczami.\n\nPT\nTóxico por contacto com os olhos.\n\nRO\nToxic în caz de contact cu ochii.\n\nSK\nToxické pri kontakte s očami.\n\nSL\nStrupeno ob stiku z očmi.\n\nFI\nMyrkyllistä joutuessaan silmään.\n\nSV\nGiftigt vid kontakt med ögonen.\n\nEUH 071\nLanguage\n\n\nBG\nКорозивен за дихателните пътища.\n\nES\nCorrosivo para las vías respiratorias.\n\nCS\nZpůsobuje poleptání dýchacích cest.\n\nDA\nÆtsende for luftvejene.\n\nDE\nWirkt ätzend auf die Atemwege.\n\nET\nSöövitav hingamisteedele.\n\nEL\nΔιαβρωτικό της αναπνευστικής οδού.\n\nEN\nCorrosive to the respiratory tract.\n\nFR\nCorrosif pour les voies respiratoires.\n\nGA\nCreimneach don chonair riospráide.\n\n\nHR\nNagrizajuće za dišni sustav.\n\n\nIT\nCorrosivo per le vie respiratorie.\n\nLV\nKodīgs elpceļiem.\n\nLT\nĖsdina kvėpavimo takus.\n\nHU\nMaró hatású a légutakra.\n\nMT\nKorrużiv għas-sistema respiratorja.\n\nNL\nBijtend voor de luchtwegen.\n\nPL\nDziała żrąco na drogi oddechowe.\n\nPT\nCorrosivo para as vias respiratórias.\n\nRO\nCorosiv pentru căile respiratorii.\n\nSK\nŽieravé pre dýchacie cesty.\n\nSL\nJedko za dihalne poti.\n\nFI\nHengityselimiä syövyttävää.\n\nSV\nFrätande på luftvägarna.\n\n\nTable 2.3\nEnvironmental properties\n\nEUH 059\nLanguage\nAdditional EU Hazard Class\n\nBG\nОпасно за озоновия слой.\n\nES\nPeligroso para la capa de ozono.\n\nCS\nNebezpečný pro ozonovou vrstvu.\n\nDA\nFarlig for ozonlaget.\n\nDE\nDie Ozonschicht schädigend.\n\nET\nOhtlik osoonikihile.\n\nEL\nΕπικίνδυνο για τη στιβάδα του όζοντος.\n\nEN\nHazardous to the ozone layer.\n\nFR\nDangereux pour la couche d'ozone.\n\nGA\nGuaiseach don chiseal ózóin.\n\nIT\nPericoloso per lo strato di ozono.\n\nLV\nBīstams ozona slānim.\n\nLT\nPavojinga ozono sluoksniui.\n\nHU\nVeszélyes az ózonrétegre.\n\nMT\nPerikoluż għas-saff ta' l-ożonu.\n\nNL\nGevaarlijk voor de ozonlaag.\n\nPL\nStwarza zagrożenie dla warstwy ozonowej.\n\nPT\nPerigoso para a camada de ozono.\n\nRO\nPericulos pentru stratul de ozon.\n\nSK\nNebezpečný pre ozónovú vrstvu.\n\nSL\nNevarno za ozonski plašč.\n\nFI\nVaarallista otsonikerrokselle.\n\nSV\nFarligt för ozonskiktet.\n\n\n\n3. Part 3: supplemental label elements/information on certain certain substances and mixtures\n\nEUH 201/ 201A\nLanguage\n\n201\n201A\nBG\nСъдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.\nВнимание! Съдържа олово.\n201\n201A\nES\nContiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.\n¡Atención! Contiene plomo.\n201\n201A\nCS\nObsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.\nPozor! Obsahuje olovo.\n201\n201A\nDA\nIndeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.\nAdvarsel! Indeholder bly.\n201\n201A\nDE\nEnthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.\nAchtung! Enthält Blei.\n201\n201A\nET\nSisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.\nEttevaatust! Sisaldab pliid.\n201\n201A\nEL\nΠεριέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.\nΠροσοχή! Περιέχει μόλυβδο.\n201\n201A\nEN\nContains lead. Should not be used on surfaces liable to be chewed or sucked by children.\nWarning! Contains lead.\n201\n201A\nFR\nContient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.\nAttention! Contient du plomb.\n201\n201A\nGA\nLuaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.\nRabhadh! Luaidhe ann.\n\n\nHR\nSadrži olovo. Ne smije se koristiti na površinama koje mogu žvakati ili sisati djeca.\nUpozorenje! Sadrži olovo.\n\n201\n201A\nIT\nContiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.\nAttenzione! Contiene piombo.\n201\n201A\nLV\nSatur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.\nBrīdinājums! Satur svinu.\n201\n201A\nLT\nSudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.\nAtsargiai! Sudėtyje yra švino.\n201\n201A\nHU\nÓlmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.\nFigyelem! Ólmot tartalmaz.\n201\n201A\nMT\nFih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.\nTwissija! Fih iċ-ċomb.\n201\n201A\nNL\nBevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.\nLet op! Bevat lood.\n201\n201A\nPL\nZawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.\nUwaga! Zawiera ołów.\n201\n201A\nPT\nContém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.\nAtenção! Contém chumbo.\n201\n201A\nRO\nConține plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.\nAtenție! Conține plumb.\n201\n201A\nSK\nObsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.\nPozor! Obsahuje olovo.\n201\n201A\nSL\nVsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.\nPozor! Vsebuje svinec.\n201\n201A\nFI\nSisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.\nVaroitus! Sisältää lyijyä.\n201\n201A\nSV\nInnehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.\nVarning! Innehåller bly.\n\nEUH 202\nLanguage\n\n\nBG\nЦианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.\n\nES\nCianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.\n\nCS\nKyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.\n\nDA\nCyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.\n\nDE\nCyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.\n\nET\nTsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.\n\nEL\nΚυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.\n\nEN\nCyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.\n\nFR\nCyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.\n\nGA\nCianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.\n\n\nHR\nCianoakrilat. Opasnost. Trenutno lijepi kožu i oči. Čuvati izvan dohvata djece.\n\n\nIT\nCianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.\n\nLV\nCiānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.\n\nLT\nCianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.\n\nHU\nCianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.\n\nMT\nCyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.\n\nNL\nCyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.\n\nPL\nCyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.\n\nPT\nCianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.\n\nRO\nCianoacrilat. Pericol. Se lipește de piele și ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.\n\nSK\nKyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.\n\nSL\nCianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.\n\nFI\nSyanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.\n\nSV\nCyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.\n\nEUH 203\nLanguage\n\n\nBG\nСъдържа хром (VI). Може да причини алергична реакция.\n\nES\nContiene cromo (VI). Puede provocar una reacción alérgica.\n\nCS\nObsahuje chrom (VI). Může vyvolat alergickou reakci.\n\nDA\nIndeholder krom (VI). Kan udløse allergisk reaktion.\n\nDE\nEnthält Chrom (VI). Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains chromium (VI). May produce an allergic reaction.\n\nFR\nContient du chrome (VI). Peut produire une réaction allergique.\n\nGA\nCróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\n\n\nHR\nSadrži krom (VI). Može izazvati alergijsku reakciju.\n\n\nIT\nContiene cromo (VI). Può provocare una reazione allergica.\n\nLV\nSatur hromu (VI). Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.\n\nHU\nKrómot (VI) tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.\n\nNL\nBevat zeswaardig chroom. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém crómio (VI). Pode provocar uma reacção alérgica.\n\nRO\nConține crom (VI). Poate provoca o reacție alergică.\n\nSK\nObsahuje chróm (VI). Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje krom (VI). Lahko povzroči alergijski odziv.\n\nFI\nSisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller krom (VI). Kan orsaka en allergisk reaktion.\n\nEUH 204\nLanguage\n\n\nBG\nСъдържа изоцианати. Може да причини алергична реакция.\n\nES\nContiene isocianatos. Puede provocar una reacción alérgica.\n\nCS\nObsahuje isokyanáty. Může vyvolat alergickou reakci.\n\nDA\nIndeholder isocyanater. Kan udløse allergisk reaktion.\n\nDE\nEnthält Isocyanate. Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains isocyanates. May produce an allergic reaction.\n\nFR\nContient des isocyanates. Peut produire une réaction allergique.\n\nGA\nIsicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\n\nHR\nSadrži izocianate. Može izazvati alergijsku reakciju.\n\n\nIT\nContiene isocianati. Può provocare una reazione allergica.\n\nLV\nSatur izocianātus. Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra izocianatų. Gali sukelti alerginę reakciją.\n\nHU\nIzocianátokat tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat isocyanaten. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém isocianatos. Pode provocar uma reacção alérgica.\n\nRO\nConține izocianați. Poate provoca o reacție alergică.\n\nSK\nObsahuje izokyanáty. Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje izocianate. Lahko povzroči alergijski odziv.\n\nFI\nSisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller isocyanater. Kan orsaka en allergisk reaktion.\n\nEUH 205\nLanguage\n\n\nBG\nСъдържа епоксидни съставки. Може да причини алергична реакция.\n\nES\nContiene componentes epoxídicos. Puede provocar una reacción alérgica.\n\nCS\nObsahuje epoxidové složky. Může vyvolat alergickou reakci.\n\nDA\nIndeholder epoxyforbindelser. Kan udløse allergisk reaktion.\n\nDE\nEnthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains epoxy constituents. May produce an allergic reaction.\n\nFR\nContient des composés époxydiques. Peut produire une réaction allergique.\n\nGA\nComhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\n\nHR\nSadrži epoksidne sastojke. Može izazvati alergijsku reakciju.\n\n\nIT\nContiene componenti epossidici. Può provocare una reazione allergica.\n\nLV\nSatur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.\n\nHU\nEpoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat epoxyverbindingen. Kan een allergische reactie veroorzaken.\n\nPL\nZawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém componentes epoxídicos. Pode provocar uma reacção alérgica.\n\nRO\nConține componenți epoxidici. Poate provoca o reacție alergică.\n\nSK\nObsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.\n\nFI\nSisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller epoxiförening. Kan orsaka en allergisk reaktion.\n\nEUH 206\nLanguage\n\n\nBG\nВнимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).\n\nES\n¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).\n\nCS\nPozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).\n\nDA\nAdvarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.\n\nDE\nAchtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.\n\nET\nEttevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).\n\nEL\nΠροσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).\n\nEN\nWarning! Do not use together with other products. May release dangerous gases (chlorine).\n\nFR\nAttention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).\n\nGA\nRabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).\n\n\nHR\nUpozorenje! Ne koristiti s drugim proizvodima. Mogu se osloboditi opasni plinovi (klor).\n\n\nIT\nAttenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).\n\nLV\nBrīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).\n\nLT\nAtsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).\n\nHU\nFigyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.\n\nMT\nTwissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).\n\nNL\nLet op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.\n\nPL\nUwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).\n\nPT\nAtenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).\n\nRO\nAtenție! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).\n\nSK\nPozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).\n\nSL\nPozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).\n\nFI\nVaroitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).\n\nSV\nVarning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).\n\n\nEUH 207\nLanguage\n\n\nBG\nВнимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.\n\nES\n¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.\n\nCS\nPozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.\n\nDA\nAdvarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.\n\nDE\nAchtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.\n\nET\nEttevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.\n\nEL\nΠροσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.\n\nEN\nWarning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.\n\nFR\nAttention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.\n\nGA\nRabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.\n\n\nHR\nUpozorenje! Sadrži kadmij. Tijekom uporabe stvara se opasni dim. Vidi podatke dostavljene od proizvođača. Postupati prema uputama o mjerama sigurnosti.\n\n\nIT\nAttenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.\n\nLV\nBrīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.\n\nLT\nAtsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.\n\nHU\nFigyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.\n\nMT\nTwissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.\n\nNL\nLet op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.\n\nPL\nUwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.\n\nPT\nAtenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.\n\nRO\nAtenție! Conține cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informațiile furnizate de producător. A se respecta instrucțiunile privind siguranța.\n\nSK\nPozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.\n\nSL\nPozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.\n\nFI\nVaroitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.\n\nSV\nVarning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.\n\nEUH 208\nLanguage\n\n\nBG\nСъдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.\n\nES\nContiene . Puede provocar una reacción alérgica.\n\nCS\nObsahuje . Může vyvolat alergickou reakci.\n\nDA\nIndeholder . Kan udløse allergisk reaktion.\n\nDE\nEnthält . Kann allergische Reaktionen hervorrufen.\n\nET\nSisaldab . Võib esile kutsuda allergilise reaktsiooni.\n\nEL\nΠεριέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.\n\nEN\nContains . May produce an allergic reaction.\n\nFR\nContient . Peut produire une réaction allergique.\n\nGA\n ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.\n\n\nHR\nSadrži . Može izazvati alergijsku reakciju.\n\n\nIT\nContiene . Può provocare una reazione allergica.\n\nLV\nSatur . Var izraisīt alerģisku reakciju.\n\nLT\nSudėtyje yra . Gali sukelti alerginę reakciją.\n\nHU\n-t tartalmaz. Allergiás reakciót válthat ki.\n\nMT\nFih . Jista’ jagħmel reazzjoni allerġika.\n\nNL\nBevat . Kan een allergische reactie veroorzaken.\n\nPL\nZawiera . Może powodować wystąpienie reakcji alergicznej.\n\nPT\nContém . Pode provocar uma reacção alérgica.\n\nRO\nConține . Poate provoca o reacție alergică.\n\nSK\nObsahuje . Môže vyvolať alergickú reakciu.\n\nSL\nVsebuje . Lahko povzroči alergijski odziv.\n\nFI\nSisältää . Voi aiheuttaa allergisen reaktion.\n\nSV\nInnehåller . Kan orsaka en allergisk reaktion.\n\nEUH 209/ 209A\nLanguage\n\n209\n209A\nBG\nПри употреба може да стане силно запалимо.\nПри употреба може да стане запалимо.\n209\n209A\nES\nPuede inflamarse fácilmente al usarlo\nPuede inflamarse al usarlo.\n209\n209A\nCS\nPři používání se může stát vysoce hořlavým.\nPři používání se může stát hořlavým.\n209\n209A\nDA\nKan blive meget brandfarlig ved brug.\nKan blive brandfarlig ved brug.\n209\n209A\nDE\nKann bei Verwendung leicht entzündbar werden.\nKann bei Verwendung entzündbar werden.\n209\n209A\nET\nKasutamisel võib muutuda väga tuleohtlikuks.\nKasutamisel võib muutuda tuleohtlikuks.\n209\n209A\nEL\nΜπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.\nMπορεί να γίνει εύφλεκτο κατά τη χρήση.\n209\n209A\nEN\nCan become highly flammable in use.\nCan become flammable in use.\n209\n209A\nFR\nPeut devenir facilement inflammable en cours d'utilisation.\nPeut devenir inflammable en cours d'utilisation.\n209\n209A\nGA\nD'fhéadfadh sé éirí an-inadhainte agus é á úsáid.\nD'fhéadfadh sé éirí inadhainte agus é á úsáid.\n\n\nHR\nPri uporabi može postati lako zapaljivo.\nPri uporabi može postati zapaljivo.\n\n209\n209A\nIT\nPuò diventare facilmente infiammabile durante l'uso.\nPuò diventare infiammabile durante l'uso.\n209\n209A\nLV\nLietojot var viegli uzliesmot.\nKļūt uzliesmojošs.\n209\n209A\nLT\nNaudojama gali tapti labai degi.\nNaudojama gali tapti degi.\n209\n209A\nHU\nA használat során fokozottan tűzveszélyessé válhat.\nA használat során tűzveszélyessé válhat.\n209\n209A\nMT\nJista’ jieħu n-nar faċilment meta jintuża.\nJista’ jieħu n-nar meta jintuża.\n209\n209A\nNL\nKan bij gebruik licht ontvlambaar worden.\nKan bij gebruik ontvlambaar worden.\n209\n209A\nPL\nPodczas stosowania może przekształcić się w substancję wysoce łatwopalną.\nPodczas stosowania może przekształcić się w substancję łatwopalną.\n209\n209A\nPT\nPode tornar-se facilmente inflamável durante o uso.\nPode tornar-se inflamável durante o uso.\n209\n209A\nRO\nPoate deveni foarte inflamabil în timpul utilizării.\nPoate deveni inflamabil în timpul utilizării.\n209\n209A\nSK\nPri používaní sa môže stať veľmi horľavou.\nPri používaní sa môže stať horľavou.\n209\n209A\nSL\nMed uporabo utegne postati lahko vnetljivo.\nMed uporabo utegne postati vnetljivo.\n209\n209A\nFI\nVoi muuttua helposti syttyväksi käytössä.\nVoi muuttua syttyväksi käytössä.\n209\n209A\nSV\nKan bli mycket brandfarligt vid användning.\nKan bli brandfarligt vid användning.\n\n\nEUH 210\nLanguage\n\n\nBG\nИнформационен лист за безопасност ще бъде представен при поискване.\n\nES\nPuede solicitarse la ficha de datos de seguridad.\n\nCS\nNa vyžádání je kodispozici bezpečnostní list.\n\nDA\nSikkerhedsdatablad kan på anmodning rekvireres.\n\nDE\nSicherheitsdatenblatt auf Anfrage erhältlich.\n\nET\nOhutuskaart nõudmisel kättesaadav.\n\nEL\nΔελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.\n\nEN\nSafety data sheet available on request.\n\nFR\nFiche de données de sécurité disponible sur demande.\n\nGA\nBileog sonraí sábháilteachta ar fáil arna iarraidh sin.\n\n\nHR\nSigurnosno-tehnički list dostupan na zahtjev.\n\n\nIT\nScheda dati di sicurezza disponibile su richiesta.\n\nLV\nDrošības datu lapa ir pieejama pēc pieprasījuma.\n\nLT\nSaugos duomenų lapą galima gauti paprašius.\n\nHU\nKérésre biztonsági adatlap kapható.\n\nMT\nIl-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.\n\nNL\nVeiligheidsinformatieblad op verzoek verkrijgbaar.\n\nPL\nKarta charakterystyki dostępna na żądanie.\n\nPT\nFicha de segurança fornecida a pedido.\n\nRO\nFișa cu date de securitate disponibilă la cerere.\n\nSK\nNa požiadanie možno poskytnúť kartu bezpečnostných údajov.\n\nSL\nVarnosti list na voljo na zahtevo.\n\nFI\nKäyttöturvallisuustiedote toimitetaan pyynnöstä.\n\nSV\nSäkerhetsdatablad finns att rekvirera.\n\nEUH 401\nLanguage\n\n\nBG\nЗа да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.\n\nES\nA fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.\n\nCS\nDodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.\n\nDA\nBrugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.\n\nDE\nZur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.\n\nET\nInimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.\n\nEL\nΓια να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.\n\nEN\nTo avoid risks to human health and the environment, comply with the instructions for use.\n\nFR\nRespectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.\n\nGA\nChun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.\n\n\nHR\nDa bi se izbjegli rizici za zdravlje ljudi i okoliš, treba se pridržavati uputa za uporabu.\n\n\nIT\nPer evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.\n\nLT\nSiekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.\n\nLV\nLai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.\n\nHU\nAz emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.\n\nMT\nBiex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.\n\nNL\nVolg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.\n\nPL\nW celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.\n\nPT\nPara evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.\n\nRO\nPentru a evita riscurile pentru sănătatea umană și mediu, a se respecta instrucțiunile de utilizare.\n\nSK\nDodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.\n\nSL\nDa bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.\n\nFI\nNoudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.\n\nSV\nFör att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.", "previous_location": null, "changed_within": [ "AN III SCT 1", "AN III SCT 2", "AN III SCT 3" ], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null }, { "corpus": "eu", "key": "32013R0517", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unchanged" }, "signals": { "structural_diff": { "status": "observed", "detail": "structural_diff", "change_types": [ "MODIFIED" ] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M; 32013R0517 C", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": false, "dispute_reason": null }, "outcome": "passed", "sentences": [ { "text": "Throughout the tables of hazard statements in sections 1, 2 and 3 of Annex III, a Croatian-language (HR) translation entry has been inserted after each existing GA entry for every hazard statement code shown, where none existed before.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN III" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_III", "label": "Annex III, 02008R1272-20131201" }, { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20110419", "location": "AN III" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20110419#anx_III", "label": "Annex III, 02008R1272-20110419" } ] }, { "text": "The other language versions and the substantive hazard statement content for each code remain the same across both texts as far as shown.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN III" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_III", "label": "Annex III, 02008R1272-20131201" } ] }, { "text": "Because the provided text is truncated partway through the health hazards table, any further changes beyond the point where the text was cut off cannot be described.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN III" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_III", "label": "Annex III, 02008R1272-20131201" } ] } ], "applicability_note": null, "unexplained": "", "unexplained_kind": "" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN IV" }, "heading": "LIST OF PRECAUTIONARY STATEMENTS", "before": "\nANNEX IV\nLIST OF PRECAUTIONARY STATEMENTS\nIn selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.\n\n\n1. Part 1: Criteria for the selection of precautionary statements\n\nTable 6.1\nPrecautionary statements — General\n\nCode\nGeneral precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP101\nIf medical advice is needed, have product container or label at hand.\nas appropriate\n\nConsumer products\nP102\nKeep out of reach of children.\nas appropriate\n\nConsumer products\nP103\nRead label before use.\nas appropriate\n\nConsumer products\n\nTable 6.2\nPrecautionary statements — Prevention\n\nCode\nPrevention precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP201\nObtain special instructions before use.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP202\nDo not handle until all safety precautions have been read and understood.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nP210\nKeep away from heat/sparks/open flames/hot surfaces. — No smoking.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nManufacturer/supplier to specify applicable ignition source(s).\nFlammable gases (section 2.2)\n1, 2\nFlammable aerosols (section 2.3)\n1, 2\nFlammable liquids (section 2.6)\n1, 2, 3\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nOxidising liquids (section 2.13)\n1, 2, 3\n\nSpecify to keep away from heat.\nOxidising solids (section 2.14)\n1, 2, 3\nP211\nDo not spray on an open flame or other ignition source.\nFlammable aerosols (section 2.3)\n1, 2\n\nP220\nKeep/Store away from clothing/…/combustible materials.\nOxidising gases (section 2.4)\n1\n… Manufacturer/supplier to specify incompatible materials.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nOxidising liquids (section 2.13)\n1\n… Manufacturer/supplier to specify incompatible materials.\n\nspecify to keep away from clothing as well as other incompatible materials.\n2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOxidising solids (section 2.14)\n1\n… Manufacturer/supplier to specify incompatible materials.\n\nspecify to keep away from clothing as well as other incompatible materials.\n2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP221\nTake any precaution to avoid mixing with combustibles/…\nOxidising liquids (section 2.13)\n1, 2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOxidising solids (section 2.14)\n1, 2, 3\nP222\nDo not allow contact with air.\nPyrophoric liquids (section 2.9)\n1\n\nPyrophoric solids (section 2.10)\n1\nP223\nKeep away from any possible contact with water, because of violent reaction and possible flash fire.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\n\nP230\nKeep wetted with …\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.5\n… Manufacturer/supplier to specify appropriate material.\n\nif drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).\nP231\nHandle under inert gas.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP232\nProtect from moisture.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP233\nKeep container tightly closed.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\n\nif product is volatile so as to generate hazardous atmosphere.\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP234\nKeep only in original container.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nCorrosive to metals (section 2.16)\n1\nP235\nKeep cool.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSelf-reactive substances and mixtures (Section 2.8)\nTypes A, B, C, D, E, F\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP240\nGround/bond container and receiving equipment.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nif the explosive is electrostatically sensitive.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nif electrostatically sensitive material is for reloading.\nif product is volatile so as to generate hazardous atmosphere.\nFlammable solids (section 2.7)\n1, 2\n\nif electrostatically sensitive material is for reloading.\nP241\nUse explosion-proof electrical/ventilating/lighting/…/equipment.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify other equipment.\nFlammable solids (section 2.7)\n1, 2\n… Manufacturer/supplier to specify other equipment.\n\nif dust clouds can occur.\nP242\nUse only non-sparking tools.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nP243\nTake precautionary measures against static discharge.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nP244\nKeep reduction valves free from grease and oil.\nOxidising gases (section 2.4)\n1\n\nP250\nDo not subject to grinding/shock/…/friction.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n… Manufacturer/supplier to specify applicable rough handling.\nP251\nPressurized container: Do not pierce or burn, even after use.\nFlammable aerosols (section 2.3)\n1, 2\n\nP260\nDo not breathe dust/fume/gas/mist/vapours/spray.\nAcute toxicity — inhalation (section 3.1)\n1, 2\nManufacturer/supplier to specify applicable conditions.\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSpecify do not breathe dusts or mists.\nif inhalable particles of dusts or mists may occur during use.\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP261\nAvoid breathing dust/fume/gas/mist/vapours/spray.\nAcute toxicity — inhalation (section 3.1)\n3, 4\nManufacturer/supplier to specify applicable conditions.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP262\nDo not get in eyes, on skin, or on clothing.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\nP263\nAvoid contact during pregnancy/while nursing.\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP264\nWash … thoroughly after handling.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\nManufacturer/supplier to specify parts of the body to be washed after handling.\nAcute toxicity — dermal (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin irritation (section 3.2)\n2\nEye irritation (section 3.3)\n2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1\nP270\nDo not eat, drink or smoke when using this product.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nAcute toxicity — dermal (section 3.1)\n1, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1\nP271\nUse only outdoors or in a well-ventilated area.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP272\nContaminated work clothing should not be allowed out of the workplace.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP273\nAvoid release to the environment.\nHazardous to the aquatic environment — acute aquatic hazard (section 4.1)\n1\n\nif this is not the intended use.\nHazardous to the aquatic environment — long-term aquatic hazard (section 4.1)\n1, 2, 3, 4\n\n\nHazardous to the ozone layer (section 5.1)\n1\n\n\nP280\nWear protective gloves/protective clothing/eye protection/face protection.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nManufacturer/supplier to specify type of equipment.\n\nSpecify face protection.\nFlammable liquids (section 2.6)\n1, 2, 3\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves and eye/face protection.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves/clothing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves/clothing and eye/face protection.\nSkin irritation (section 3.2)\n2\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nSevere eye damage (section 3.3)\n1\nManufacturer/supplier to specify type of equipment.\n\nSpecify eye/face protection.\nEye irritation (section 3.3)\n2\n\n\nP281\nUse personal protective equipment as required.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nP282\nWear cold insulating gloves/face shield/eye protection.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP283\nWear fire/flame resistant/retardant clothing.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP284\nWear respiratory protection.\nAcute toxicity — inhalation (section 3.1)\n1, 2\nManufacturer/supplier to specify equipment.\n\nP285\nIn case of inadequate ventilation wear respiratory protection.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nManufacturer/supplier to specify equipment.\n\nP231 + P232\nHandle under inert gas. Protect from moisture.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP235 + P410\nKeep cool. Protect from sunlight.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n\n\nTable 6.3\nPrecautionary statements — Response\n\nCode\nResponse precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP301\nIF SWALLOWED:\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nAspiration Hazard (section 3.10)\n1\n\nP302\nIF ON SKIN:\nPyrophoric liquids (section 2.9)\n1\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP303\nIF ON SKIN (or hair):\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP304\nIF INHALED:\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP305\nIF IN EYES:\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP306\nIF ON CLOTHING:\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP307\nIF exposed:\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\nP308\nIF exposed or concerned:\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\n\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP309\nIF exposed or if you feel unwell:\nSpecific target organ toxicity — single exposure (section 3.8)\n2\n\nP310\nImmediately call a POISON CENTER or doctor/physician.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2\nAcute toxicity — inhalation (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSerious eye damage/eye irritation (section 3.3)\n1\nAspiration hazard (section 3.10)\n1\n\nP311\nCall a POISON CENTRE or doctor/physician.\nAcute toxicity — inhalation (section 3.1)\n3\n\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\n\nP312\nCall a POISON CENTER or doctor/physician if you feel unwell.\nAcute toxicity — oral (section 3.1)\n4\n\nAcute toxicity — dermal (section 3.1)\n3, 4\nAcute toxicity — inhalation (section 3.1)\n4\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP313\nGet medical advice/attention.\nSkin irritation (section 3.2)\n2, 3\n\nEye irritation (section 3.3)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP314\nGet medical advice/attention if you feel unwell.\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\n\nP315\nGet immediate medical advice/attention.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP320\nSpecific treatment is urgent (see … on this label).\nAcute toxicity — inhalation (section 3.1)\n1, 2\n… Reference to supplemental first aid instruction.\n\nif immediate administration of antidote is required.\n\nP321\nSpecific treatment (see … on this label).\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\n… Reference to supplemental first aid instruction.\n\n— if immediate administration of antidote is required.\nAcute toxicity — inhalation (section 3.1)\n3\n\n… Reference to supplemental first aid instruction.\n\n— if immediate specific measures are required.\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\n… Reference to supplemental first aid instruction.\n\n— if immediate measures are required.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n… Reference to supplemental first aid instruction.\n\n— manufacturer/supplier may specify a cleansing agent if appropriate.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin irritation (section 3.2)\n2\n\nP322\nSpecific measures (see … on this label).\nAcute toxicity — dermal (section 3.1)\n1, 2\n… Reference to supplemental first aid instruction.\n\nif immediate measures such as specific cleansing agent is advised.\nAcute toxicity — dermal (section 3.1)\n3, 4\n… Reference to supplemental first aid instruction.\n\nif measures such as specific cleansing agent is advised.\nP330\nRinse mouth.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP331\nDo NOT induce vomiting.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nAspiration hazard (section 3.10)\n1\nP332\nIf skin irritation occurs:\nSkin irritation (section 3.2)\n2, 3\n\n\nP333\nIf skin irritation or rash occurs:\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP334\nImmerse in cool water/wrap in wet bandages.\nPyrophoric liquids (section 2.9)\n1\n\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP335\nBrush off loose particles from skin.\nPyrophoric solids (section 2.10)\n1\n\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP336\nThaw frosted parts with lukewarm water. Do not rub affected area.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP337\nIf eye irritation persists:\nEye irritation (section 3.3)\n2\n\nP338\nRemove contact lenses, if present and easy to do. Continue rinsing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP340\nRemove victim to fresh air and keep at rest in a position comfortable for breathing.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP341\nIf breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\n\nP342\nIf experiencing respiratory symptoms:\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP350\nGently wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\nP351\nRinse cautiously with water for several minutes.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\n\nP352\nWash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n3, 4\n\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP353\nRinse skin with water/shower.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP360\nRinse immediately contaminated clothing and skin with plenty of water before removing clothes.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP361\nRemove/Take off immediately all contaminated clothing.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP362\nTake off contaminated clothing and wash before reuse.\nSkin irritation (section 3.2)\n2\n\n\nP363\nWash contaminated clothing before reuse.\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP370\nIn case of fire:\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nOxidising gases (section 2.4)\n1\nFlammable liquids (section 2.6)\n1, 2, 3\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP371\nIn case of major fire and large quantities:\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP372\nExplosion risk in case of fire.\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nexcept if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.\nP373\nDO NOT fight fire when fire reaches explosives.\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nP374\nFight fire with normal precautions from a reasonable distance.\nExplosives (section 2.1)\nDivision 1.4\n\nif explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.\nP375\nFight fire remotely due to the risk of explosion.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\n\nOxidising liquids (section 2.13)\n1\nOxidising solids (section 2.14)\n1\nP376\nStop leak if safe to do so.\nOxidising gases (section 2.4)\n1\n\nP377\nLeaking gas fire:\nDo not extinguish, unless leak can be stopped safely.\nFlammable gases (section 2.2)\n1, 2\n\nP378\nUse … for extinction.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify appropriate media\n\nif water increases risk.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP380\nEvacuate area.\nExplosives (section 2.1)\nUnstable explosives\n\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\nOxidising liquids (section 2.13)\n1\nOxidising solids (section 2.14)\n1\nP381\nEliminate all ignition sources if safe to do so.\nFlammable gases (section 2.2)\n1, 2\n\nP390\nAbsorb spillage to prevent material damage.\nCorrosive to metals (section 2.16)\n1\n\nP391\nCollect spillage.\nHazardous to the aquatic environment – acute aquatic hazard (section 4.1)\n1\n\nHazardous to the aquatic environment – long-term aquatic hazard (section 4.1)\n1, 2\nP301 + P310\nIF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAspiration hazard (section 3.10)\n1\nP301 + P312\nIF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.\nAcute toxicity — oral (section 3.1)\n4\n\nP301 + P330 + P331\nIF SWALLOWED: Rinse mouth. Do NOT induce vomiting.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP302 + P334\nIF ON SKIN: Immerse in cool water/wrap in wet bandages.\nPyrophoric liquids (section 2.9)\n1\n\nP302 + P350\nIF ON SKIN: Gently wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\n\nP302 + P352\nIF ON SKIN: Wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n3, 4\n\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP303 + P361 + P353\nIF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP304 + P340\nIF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP304 + P341\nIF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP305 + P351 + P338\nIF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP306 + P360\nIF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP307 + P311\nIF exposed: Call a POISON CENTER or doctor/physician.\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\nP308 + P313\nIF exposed or concerned: Get medical advice/attention.\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\n\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP309 + P311\nIF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.\nSpecific target organ toxicity — single exposure (section 3.8)\n2\n\nP332 + P313\nIf skin irritation occurs: Get medical advice/attention.\nSkin irritation (section 3.2)\n2\n\n\nP333 + P313\nIf skin irritation or rash occurs: Get medical advice/attention.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP335 + P334\nBrush off loose particles from skin. Immerse in cool water/wrap in wet bandages.\nPyrophoric solids (section 2.10)\n1\n\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP337 + P313\nIf eye irritation persists: Get medical advice/attention.\nEye irritation (section 3.3)\n2\n\n\nP342 + P311\nIf experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP370 + P376\nIn case of fire: Stop leak if safe to do so.\nOxidizing gases (section 2.4)\n1\n\nP370 + P378\nIn case of fire: Use … for extinction.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify appropriate media.\n\nif water increases risk.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP370 + P380\nIn case of fire: Evacuate area.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nP370 + P380 + P375\nIn case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\n\nP371 + P380 + P375\nIn case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\n\nTable 6.4\nPrecautionary statements — Storage\n\nCode\nStorage precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP401\nStore …\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n… in accordance with local/regional/national/international regulations (to be specified).\nP402\nStore in a dry place.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP403\nStore in a well-ventilated place.\nFlammable gases (section 2.2)\n1, 2\n\nif product is volatile so as to generate hazardous atmosphere.\nOxidising gases (section 2.4)\n1\nGases under pressure (section 2.5)\nCompressed gas\nLiquefied gas\nRefrigerated Liquefied gas\nDissolved gas\nFlammable liquids (section 2.6)\n1, 2, 3\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP404\nStore in a closed container.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP405\nStore locked up.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nAspiration hazard (section 3.10)\n1\nP406\nStore in corrosive resistant/… container with a resistant inner liner.\nCorrosive to metals (section 2.16)\n1\n… Manufacturer/supplier to specify other compatible materials.\nP407\nMaintain air gap between stacks/pallets.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n\nP410\nProtect from sunlight.\nFlammable aerosols (section 2.3)\n1, 2\n\nGases under pressure (section 2.5)\nCompressed gas\nLiquefied gas\nDissolved gas\n\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP411\nStore at temperatures not exceeding … oC/…oF.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n… Manufacturer/supplier to specify temperature\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP412\nDo not expose to temperatures exceeding 50 oC/122 oF.\nFlammable aerosols (section 2.3)\n1, 2\n\nP413\nStore bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n… Manufacturer/supplier to specify mass and temperature.\nP420\nStore away from other materials.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP422\nStore contents under …\nPyrophoric liquids (section 2.9)\n1\n… Manufacturer/supplier to specify appropriate liquid or inert gas.\nPyrophoric solids (section 2.10)\n1\nP402 + P404\nStore in a dry place. Store in a closed container.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP403 + P233\nStore in a well-ventilated place. Keep container tightly closed.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\n\nif product is volatile so as to generate hazardous atmosphere.\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP403 + P235\nStore in a well-ventilated place. Keep cool.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nP410 + P403\nProtect from sunlight. Store in a well-ventilated place.\nGases under pressure (section 2.5)\nCompressed gas\n\nLiquefied gas\nDissolved gas\nP410 + P412\nProtect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.\nFlammable aerosols (section 2.3)\n1, 2\n\nP411 + P235\nStore at temperatures not exceeding … oC/…oF. Keep cool.\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\n… Manufacturer/supplier to specify temperature.\n\n\nTable 6.5\nPrecautionary statements — Disposal\n\nCode\nDisposal precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP501\nDispose of contents/container to …\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\n… in accordance with local/regional/national/international regulation (to be specified).\nFlammable liquids (section 2.6)\n1, 2, 3\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nAcute toxicity — inhalation (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\nAspiration hazard (section 3.10)\n1\nHazardous to the aquatic environment — acute aquatic hazard(section 4.1)\n1\nHazardous to the aquatic environment — long-term aquatic hazard (section 4.1)\n1, 2, 3, 4\nP502\nRefer to manufacturer/supplier for information on recovery/recycling\nHazardous to the ozone layer (section 5.1)\n1\n\n\n\n\n\n2. Part 2: precautionary statements\nThe precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.\n\nTable 1.1\nPrecautionary statements — General\n\nP101\nLanguage\n\n\nBG\nПри необходимост от медицинска помощ, носете опаковката или етикета на продукта.\n\nES\nSi se necesita consejo médico, tener a mano el envase o la etiqueta.\n\nCS\nJe-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.\n\nDA\nHvis der er brug for lægehjælp, medbring da beholderen eller etiketten.\n\nDE\nIst ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.\n\nET\nArsti poole pöördudes võtta kaasa toote pakend või etikett.\n\nEL\nΕάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.\n\nEN\nIf medical advice is needed, have product container or label at hand.\n\nFR\nEn cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.\n\nGA\nMás gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.\n\nIT\nIn caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.\n\nLV\nMedicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.\n\nLT\nJei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.\n\nHU\nOrvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.\n\nMT\nJekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.\n\nNL\nBij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.\n\nPL\nW razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.\n\nPT\nSe for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.\n\nRO\nDacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.\n\nSK\nAk je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.\n\nSL\nČe je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.\n\nFI\nJos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.\n\nSV\nHa förpackningen eller etiketten till hands om du måste söka läkarvård.\n\nP102\nLanguage\n\n\nBG\nДа се съхранява извън обсега на деца.\n\nES\nMantener fuera del alcance de los niños.\n\nCS\nUchovávejte mimo dosah dětí.\n\nDA\nOpbevares utilgængeligt for børn.\n\nDE\nDarf nicht in die Hände von Kindern gelangen.\n\nET\nHoida lastele kättesaamatus kohas.\n\nEL\nΜακριά από παιδιά.\n\nEN\nKeep out of reach of children.\n\nFR\nTenir hors de portée des enfants.\n\nGA\nCoimeád as aimsiú leanaí.\n\nIT\nTenere fuori dalla portata dei bambini.\n\nLV\nSargāt no bērniem.\n\nLT\nLaikyti vaikams neprieinamoje vietoje.\n\nHU\nGyermekektől elzárva tartandó.\n\nMT\nŻommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.\n\nNL\nBuiten het bereik van kinderen houden.\n\nPL\nChronić przed dziećmi.\n\nPT\nManter fora do alcance das crianças.\n\nRO\nA nu se lăsa la îndemâna copiilor.\n\nSK\nUchovávajte mimo dosahu detí.\n\nSL\nHraniti zunaj dosega otrok.\n\nFI\nSäilytä lasten ulottumattomissa.\n\nSV\nFörvaras oåtkomligt för barn.\n\n\nP103\nLanguage\n\n\nBG\nПреди употреба прочетете етикета.\n\nES\nLeer la etiqueta antes del uso.\n\nCS\nPřed použitím si přečtěte údaje na štítku.\n\nDA\nLæs etiketten før brug.\n\nDE\nVor Gebrauch Kennzeichnungsetikett lesen.\n\nET\nEnne kasutamist tutvuda etiketil oleva infoga.\n\nEL\nΔιαβάστε την ετικέτα πριν από τη χρήση.\n\nEN\nRead label before use.\n\nFR\nLire l’étiquette avant utilisation.\n\nGA\nLéigh an lipéad roimh úsáid.\n\nIT\nLeggere l’etichetta prima dell’uso.\n\nLV\nPirms izmantošanas izlasīt etiķeti.\n\nLT\nPrieš naudojimą perskaityti etiketę.\n\nHU\nHasználat előtt olvassa el a címkén közölt információkat.\n\nMT\nAqra t-tikketta qabel l-użu.\n\nNL\nAlvorens te gebruiken, het etiket lezen.\n\nPL\nPrzed użyciem przeczytać etykietę.\n\nPT\nLer o rótulo antes da utilização.\n\nRO\nCitiți eticheta înainte de utilizare.\n\nSK\nPred použitím si prečítajte etiketu.\n\nSL\nPred uporabo preberite etiketo.\n\nFI\nLue merkinnät ennen käyttöä.\n\nSV\nLäs etiketten före användning.\n\nTable 1.2\nPrecautionary statements — Prevention\n\nP201\nLanguage\n\n\nBG\nПреди употреба се снабдете със специални инструкции.\n\nES\nPedir instrucciones especiales antes del uso.\n\nCS\nPřed použitím si obstarejte speciální instrukce.\n\nDA\nIndhent særlige anvisninger før brug.\n\nDE\nVor Gebrauch besondere Anweisungen einholen.\n\nET\nEnne kasutamist tutvuda erijuhistega.\n\nEL\nΕφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.\n\nEN\nObtain special instructions before use.\n\nFR\nSe procurer les instructions avant utilisation.\n\nGA\nFaigh treoracha speisialta roimh úsáid.\n\nIT\nProcurarsi istruzioni specifiche prima dell’uso.\n\nLV\nPirms lietošanas saņemt speciālu instruktāžu.\n\nLT\nPrieš naudojimą gauti specialias instrukcijas.\n\nHU\nHasználat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.\n\nMT\nIkseb struzzjonijiet speċjali qabel l-użu.\n\nNL\nAlvorens te gebruiken de speciale aanwijzingen raadplegen.\n\nPL\nPrzed użyciem zapoznać się ze specjalnymi środkami ostrożności.\n\nPT\nPedir instruções específicas antes da utilização.\n\nRO\nProcurați instrucțiuni speciale înainte de utilizare.\n\nSK\nPred použitím sa oboznámte s osobitnými pokynmi.\n\nSL\nPred uporabo pridobiti posebna navodila.\n\nFI\nLue erityisohjeet ennen käyttöä.\n\nSV\nInhämta särskilda instruktioner före användning.\n\nP202\nLanguage\n\n\nBG\nНе използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.\n\nES\nNo manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.\n\nCS\nNepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.\n\nDA\nAnvend ikke produktet, før alle advarsler er læst og forstået.\n\nDE\nVor Gebrauch alle Sicherheitshinweise lesen und verstehen.\n\nET\nMitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.\n\nEL\nΜην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.\n\nEN\nDo not handle until all safety precautions have been read and understood.\n\nFR\nNe pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.\n\nGA\nNá láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.\n\nIT\nNon manipolare prima di avere letto e compreso tutte le avvertenze.\n\nLV\nNeizmantot pirms nav izlasīti un saprasti visi apzīmējumi.\n\nLT\nNenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.\n\nHU\nNe használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.\n\nMT\nTmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.\n\nNL\nPas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft\n\nPL\nNie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.\n\nPT\nNão manuseie o produto antes de ter lido e percebido todas as precauções de segurança.\n\nRO\nA nu se manipula decât după ce au fost citite și înțelese toate măsurile de securitate.\n\nSK\nNepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.\n\nSL\nNe uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.\n\nFI\nLue varoitukset huolellisesti ennen käsittelyä.\n\nSV\nAnvänd inte produkten innan du har läst och förstått säkerhetsanvisningarna\n\nP210\nLanguage\n\n\nBG\nДа се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.\n\nES\nMantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.\n\nCS\nChraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.\n\nDA\nHoldes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.\n\nDE\nVon Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.\n\nET\nHoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.\n\nEL\nΜακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.\n\nEN\nKeep away from heat/sparks/open flames/hot surfaces. — No smoking.\n\nFR\nTenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.\n\nGA\nCoimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.\n\nIT\nTenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.\n\nLV\nNelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.\n\nLT\nLaikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.\n\nHU\nHőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.\n\nMT\nŻomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.\n\nNL\nVerwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.\n\nPL\nPrzechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.\n\nPT\nManter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.\n\nRO\nA se păstra departe de surse de căldură/scântei/flăcări deschise/suprafețe încinse. — Fumatul interzis.\n\nSK\nUchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.\n\nSL\nHraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.\n\nFI\nSuojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.\n\nSV\nFår inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.\n\nP211\nLanguage\n\n\nBG\nДа не се пръска към открит пламък или друг източник на запалване.\n\nES\nNo pulverizar sobre una llama abierta u otra fuente de ignición.\n\nCS\nNestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.\n\nDA\nSpray ikke mod åben ild eller andre antændelseskilder.\n\nDE\nNicht gegen offene Flamme oder andere Zündquelle sprühen.\n\nET\nMitte pihustada leekidesse või muusse süüteallikasse.\n\nEL\nΜην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.\n\nEN\nDo not spray on an open flame or other ignition source.\n\nFR\nNe pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.\n\nGA\nNá spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.\n\nIT\nNon vaporizzare su una fiamma libera o altra fonte di accensione.\n\nLV\nNeizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.\n\nLT\nNepurkšti į atvirą liepsną arba kitus degimo šaltinius.\n\nHU\nTilos nyílt lángra vagy más gyújtóforrásra permetezni.\n\nMT\nTisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.\n\nNL\nNiet in een open vuur of op andere ontstekingsbronnen spuiten.\n\nPL\nNie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.\n\nPT\nNão pulverizar sobre chama aberta ou outra fonte de ignição.\n\nRO\nNu pulverizați deasupra unei flăcări deschise sau unei alte surse de aprindere.\n\nSK\nNestriekajte na otvorený oheň ani iný zdroj zapálenia.\n\nSL\nNe pršiti proti odprtemu ognju ali drugemu viru vžiga.\n\nFI\nEi saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.\n\nSV\nSpreja inte över öppen låga eller andra antändningskällor.\n\nP220\nLanguage\n\n\nBG\nДа се държи/съхранява далеч от облекло/…/горими материали\n\nES\nMantener o almacenar alejado de la ropa/…/materiales combustibles.\n\nCS\nUchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.\n\nDA\nMå ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.\n\nDE\nVon Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.\n\nET\nHoida eemal rõivastest/…/süttivast materjalist.\n\nEL\nΔιατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.\n\nEN\nKeep/Store away from clothing/…/combustible materials.\n\nFR\nTenir/stocker à l’écart des vêtements/…/matières combustibles\n\nGA\nCoimeád/Stóráil glan ar éadaí/…/ábhair indóite.\n\nIT\nTenere/conservare lontano da indumenti/…/materiali combustibili.\n\nLV\nTurēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.\n\nLT\nLaikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.\n\nHU\nRuhától/…/éghető anyagtól távol tartandó/tárolandó.\n\nMT\nŻomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.\n\nNL\nVan kleding/…/brandbare stoffen verwijderd houden/bewaren.\n\nPL\nTrzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.\n\nPT\nManter/guardar afastado de roupa/…/matérias combustíveis.\n\nRO\nA se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.\n\nSK\nUchovávajte/skladujte mimo odevov/…/horľavých materiálov.\n\nSL\nHraniti ločeno od oblačil/…/vnetljivih materialov.\n\nFI\nPidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.\n\nSV\nHålls/förvarad åtskilt från kläder/…/brännbara material.\n\n\nP221\nLanguage\n\n\nBG\nВземете всички предпазни мерки за избягване на смесването с горими материали…\n\nES\nTomar todas las precauciones necesarias para no mezclar con materias combustibles…\n\nCS\nProveďte preventivní opatření proti smíchání s hořlavými materiály…\n\nDA\nUndgå at blande med brændbare materialer…\n\nDE\nMischen mit brennbaren Stoffen/… unbedingt verhindern.\n\nET\nRakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…\n\nEL\nΛάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…\n\nEN\nTake any precaution to avoid mixing with combustibles…\n\nFR\nPrendre toutes précautions pour éviter de mélanger avec des matières combustibles…\n\nGA\nDéan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…\n\nIT\nPrendere ogni precauzione per evitare di miscelare con sostanze combustibili…\n\nLV\nNekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…\n\nLT\nImtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…\n\nHU\nMinden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.\n\nMT\nĦu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…\n\nNL\nVermenging met brandbare stoffen… absoluut vermijden.\n\nPL\nZastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …\n\nPT\nTomar todas as precauções para não misturar com combustíveis…\n\nRO\nLuați toate măsurile de precauție pentru a evita amestecul cu combustibili…\n\nSK\nPrijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…\n\nSL\nPreprečiti mešanje z vnetljivimi snovmi …\n\nFI\nVaro sekoittamasta syttyvien materiaalien… kanssa.\n\nSV\nUndvik att blanda med med brännbara ämnen…\n\n\nP222\nLanguage\n\n\nBG\nНе допускайте конктакт с въздух.\n\nES\nNo dejar que entre en contacto con el aire.\n\nCS\nZabraňte styku se vzduchem.\n\nDA\nUndgå kontakt med luft.\n\nDE\nKontakt mit Luft nicht zulassen.\n\nET\nHoida õhuga kokkupuute eest.\n\nEL\nΝα μην έρθει σε επαφή με τον αέρα.\n\nEN\nDo not allow contact with air.\n\nFR\nNe pas laisser au contact de l’air.\n\nGA\nNá ceadaigh teagmháil le haer.\n\nIT\nEvitare il contatto con l’aria.\n\nLV\nNepieļaut kontaktu ar gaisu.\n\nLT\nSaugoti nuo kontakto su oru.\n\nHU\nNem érintkezhet levegővel.\n\nMT\nTħallix li jkun hemm kuntatt ma' l-arja.\n\nNL\nContact met de lucht vermijden.\n\nPL\nNie dopuszczać do kontaktu z powietrzem.\n\nPT\nNão deixar entrar em contacto com o ar.\n\nRO\nA nu se lăsa în contact cu aerul.\n\nSK\nZabráňte kontaktu so vzduchom.\n\nSL\nPreprečiti stik z zrakom.\n\nFI\nEi saa joutua kosketuksiin ilman kanssa.\n\nSV\nUndvik kontakt med luft.\n\nP223\nLanguage\n\n\nBG\nДа се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.\n\nES\nMantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.\n\nCS\nChraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.\n\nDA\nUndgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.\n\nDE\nKontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.\n\nET\nHoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.\n\nEL\nΑποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.\n\nEN\nKeep away from any possible contact with water, because of violent reaction and possible flash fire.\n\nFR\nÉviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.\n\nGA\nNá ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.\n\nIT\nEvitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.\n\nLV\nNepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.\n\nLT\nSaugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.\n\nHU\nVízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.\n\nMT\nŻomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.\n\nNL\nContact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.\n\nPL\nChronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.\n\nPT\nNão deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.\n\nRO\nA se evita orice contact cu apa, din cauza reacției violente și a riscului de aprindere spontană.\n\nSK\nZabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.\n\nSL\nHraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.\n\nFI\nEi saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.\n\nSV\nUndvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.\n\nP230\nLanguage\n\n\nBG\nДа се държи навлажнен с…\n\nES\nMantener humedecido con…\n\nCS\nUchovávejte ve zvlhčeném stavu…\n\nDA\nHoldes befugtet med…\n\nDE\nFeucht halten mit …\n\nET\nNiisutada …-ga.\n\nEL\nΝα διατηρείται υγρό με …\n\nEN\nKeep wetted with…\n\nFR\nMaintenir humidifié avec…\n\nGA\nCoimeád fliuchta le…\n\nIT\nMantenere umido con…\n\nLV\nVienmēr samitrināt ar …\n\nLT\nLaikyti sudrėkintą (kuo)\n\nHU\n…-val/-vel nedvesítve tartandó.\n\nMT\nŻommu mxarrab bi …\n\nNL\nVochtig houden met…\n\nPL\nPrzechowywać produkt zwilżony…\n\nPT\nManter húmido com…\n\nRO\nA se păstra umezit cu…\n\nSK\nUchovávajte zvlhčené …\n\nSL\nHraniti prepojeno z …\n\nFI\nSäilytä kostutettuna …\n\nSV\nSka hållas fuktigt med…\n\nP231\nLanguage\n\n\nBG\nДа се използва под инертен газ.\n\nES\nManipular en gas inerte.\n\nCS\nManipulace pod inertním plynem.\n\nDA\nHåndteres under inaktiv gas.\n\nDE\nUnter inertem Gas handhaben.\n\nET\nKäidelda inertgaasis.\n\nEL\nΧειρισμός σε αδρανή ατμόσφαιρα.\n\nEN\nHandle under inert gas.\n\nFR\nManipuler sous gaz inerte.\n\nGA\nLáimhsigh faoi thriathghás.\n\nIT\nManipolare in atmosfera di gas inerte.\n\nLV\nRīkoties tikai inertas gāzes apstākļos.\n\nLT\nTvarkyti inertinėse dujose.\n\nHU\nInert gázban használandó.\n\nMT\nImmaniġġja taħt gass inerti.\n\nNL\nOnder inert gas werken.\n\nPL\nUżywać w atmosferze obojętnego gazu.\n\nPT\nManusear em atmosfera de gás inerte.\n\nRO\nA se manipula sub un gaz inert.\n\nSK\nManipulujte v prostredí s inertným plynom.\n\nSL\nHraniti v ustreznem inertnem plinu.\n\nFI\nKäsittele inertissä kaasussa.\n\nSV\nHanteras under inert gas.\n\n\nP232\nLanguage\n\n\nBG\nДа се пази от влага.\n\nES\nProteger de la humedad.\n\nCS\nChraňte před vlhkem.\n\nDA\nBeskyttes mod fugt.\n\nDE\nVor Feuchtigkeit schützen.\n\nET\nHoida niiskuse eest.\n\nEL\nΠροστετέψτε από την υγρασία.\n\nEN\nProtect from moisture.\n\nFR\nProtéger de l’humidité.\n\nGA\nCosain ar thaise.\n\nIT\nProteggere dall’umidità.\n\nLV\nAizsargāt no mitruma.\n\nLT\nSaugoti nuo drėgmės.\n\nHU\nNedvességtől védendő.\n\nMT\nIpproteġi mill-umdità.\n\nNL\nTegen vocht beschermen.\n\nPL\nChronić przed wilgocią.\n\nPT\nManter ao abrigo da humidade.\n\nRO\nA se proteja de umiditate.\n\nSK\nChráňte pred vlhkosťou.\n\nSL\nZaščititi pred vlago.\n\nFI\nSuojaa kosteudelta.\n\nSV\nSkyddas från fukt.\n\nP233\nLanguage\n\n\nBG\nСъдът да се съхранява плътно затворен.\n\nES\nMantener el recipiente herméticamente cerrado.\n\nCS\nUchovávejte obal těsně uzavřený.\n\nDA\nHold beholderen tæt lukket.\n\nDE\nBehälter dicht verschlossen halten.\n\nET\nHoida pakend tihedalt suletuna.\n\nEL\nΝα διατηρείται ο περιέκτης ερμητικά κλειστός.\n\nEN\nKeep container tightly closed.\n\nFR\nMaintenir le récipient fermé de manière étanche.\n\nGA\nCoimeád an coimeádán dúnta go docht.\n\nIT\nTenere il recipiente ben chiuso.\n\nLV\nTvertni stingri noslēgt.\n\nLT\nTalpyklą laikyti sandariai uždarytą.\n\nHU\nAz edény szorosan lezárva tartandó.\n\nMT\nŻomm il-kontenitur magħluq sew.\n\nNL\nIn goed gesloten verpakking bewaren.\n\nPL\nPrzechowywać pojemnik szczelnie zamknięty.\n\nPT\nManter o recipiente bem fechado.\n\nRO\nPăstrați recipientul închis etanș.\n\nSK\nNádobu uchovávajte tesne uzavretú.\n\nSL\nHraniti v tesno zaprti posodi.\n\nFI\nSäilytä tiiviisti suljettuna.\n\nSV\nBehållaren ska vara väl tillsluten.\n\nP234\nLanguage\n\n\nBG\nДа се съхранява само в оригиналната опаковка.\n\nES\nConservar únicamente en el recipiente original.\n\nCS\nUchovávejte pouze v původním obalu.\n\nDA\nOpbevares kun i den originale beholder.\n\nDE\nNur im Originalbehälter aufbewahren.\n\nET\nHoida üksnes originaalpakendis.\n\nEL\nΝα διατηρείται μόνο στον αρχικό περιέκτη.\n\nEN\nKeep only in original container.\n\nFR\nConserver uniquement dans le récipient d’origine.\n\nGA\nCoimeád sa choimeádán bunaidh amháin.\n\nIT\nConservare soltanto nel contenitore originale.\n\nLV\nTurēt tikai oriģinālā iepakojumā.\n\nLT\nLaikyti tik originalioje talpykloje.\n\nHU\nAz eredeti edényben tartandó.\n\nMT\nŻomm biss fil-kontenitur oriġinali.\n\nNL\nUitsluitend in de oorspronkelijke verpakking bewaren.\n\nPL\nPrzechowywać wyłącznie w oryginalnym pojemniku.\n\nPT\nConservar unicamente no recipiente de origem.\n\nRO\nPăstrați numai în recipientul original.\n\nSK\nUchovávajte iba v pôvodnej nádobe.\n\nSL\nHraniti samo v originalni posodi.\n\nFI\nSäilytä alkuperäispakkauksessa.\n\nSV\nFörvaras endast i originalbehållaren.\n\nP235\nLanguage\n\n\nBG\nДа се държи на хладно.\n\nES\nMantener en lugar fresco.\n\nCS\nUchovávejte v chladu.\n\nDA\nOpbevares køligt.\n\nDE\nKühl halten.\n\nET\nHoida jahedas.\n\nEL\nΝα διατηρείται δροσερό.\n\nEN\nKeep cool.\n\nFR\nTenir au frais.\n\nGA\nCoimeád fionnuar é\n\nIT\nConservare in luogo fresco.\n\nLV\nTurēt vēsumā.\n\nLT\nLaikyti vėsioje vietoje.\n\nHU\nHűvös helyen tartandó.\n\nMT\nŻomm frisk.\n\nNL\nKoel bewaren.\n\nPL\nPrzechowywać w chłodnym miejscu.\n\nPT\nConservar em ambiente fresco.\n\nRO\nA se păstra la rece.\n\nSK\nUchovávajte v chlade.\n\nSL\nHraniti na hladnem.\n\nFI\nSäilytä viileässä.\n\nSV\nFörvaras svalt.\n\nP240\nLanguage\n\n\nBG\nЗаземяване/еквипотенциална връзка на съда и приемателното устройство.\n\nES\nConectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.\n\nCS\nUzemněte obal a odběrové zařízení.\n\nDA\nBeholder og modtageudstyr jordforbindes/potentialudlignes.\n\nDE\nBehälter und zu befüllende Anlage erden.\n\nET\nMahuti ja vastuvõtuseade maandada/ühendada.\n\nEL\nΓείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.\n\nEN\nGround/bond container and receiving equipment.\n\nFR\nMise à la terre/liaison équipotentielle du récipient et du matériel de réception.\n\nGA\nNasc an coimeádán agus an trealamh glactha leis an talamh.\n\nIT\nMettere a terra/massa il contenitore e il dispositivo ricevente.\n\nLV\nTvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt\n\nLT\nĮžeminti/įtvirtinti talpyklą ir priėmimo įrangą.\n\nHU\nA tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.\n\nMT\nPoġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.\n\nNL\nOpslag- en opvangreservoir aarden.\n\nPL\nUziemić/połączyć pojemnik i sprzęt odbiorczy.\n\nPT\nLigação à terra/equipotencial do recipiente e do equipamento receptor.\n\nRO\nLegătură la pământ/conexiune echipotențială cu recipientul și cu echipamentul de recepție.\n\nSK\nUzemnite/upevnite nádobu a plniace zariadenie.\n\nSL\nOzemljiti posodo in opremo za sprejem tekočine.\n\nFI\nSäiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.\n\nSV\nJorda/potentialförbind behållare och mottagarutrustning.\n\nP241\nLanguage\n\n\nBG\nИзползвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия\n\nES\nUtilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.\n\nCS\nPoužívejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.\n\nDA\nAnvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.\n\nDE\nExplosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.\n\nET\nKasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.\n\nEL\nΝα χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.\n\nEN\nUse explosion-proof electrical/ventilating/lighting/…/equipment.\n\nFR\nUtiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.\n\nGA\nBain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…\n\nIT\nUtilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.\n\nLV\nIzmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas\n\nLT\nNaudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.\n\nHU\nRobbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.\n\nMT\nUża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.\n\nNL\nExplosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.\n\nPL\nUżywać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.\n\nPT\nUtilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.\n\nRO\nUtilizați echipamente electrice/de ventilare/de iluminat/…/antideflagrante.\n\nSK\nPoužívajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.\n\nSL\nUporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.\n\nFI\nKäytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.\n\nSV\nAnvänd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.\n\nP242\nLanguage\n\n\nBG\nИзползвайте само инструменти, които не предизвикват искри.\n\nES\nUtilizar únicamente herramientas que no produzcan chispas.\n\nCS\nPoužívejte pouze nářadí z nejiskřícího kovu.\n\nDA\nAnvend kun værktøj, som ikke frembringer gnister.\n\nDE\nNur funkenfreies Werkzeug verwenden.\n\nET\nMitte kasutada seadmeid, mis võivad tekitada sädemeid.\n\nEL\nΝα χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.\n\nEN\nUse only non-sparking tools.\n\nFR\nNe pas utiliser d'outils produisant des étincelles.\n\nGA\nBain úsáid as uirlisí neamhspréachta amháin.\n\nIT\nUtilizzare solo utensili antiscintillamento.\n\nLV\nIzmantot instrumentus, kas nerada dzirksteles.\n\nLT\nNaudoti tik kibirkščių nekeliančius įrankius.\n\nHU\nSzikramentes eszközök használandók.\n\nMT\nUża’ biss għodda li ma jtajrux żnied.\n\nNL\nUitsluitend vonkvrij gereedschap gebruiken.\n\nPL\nUżywać wyłącznie nieiskrzących narzędzi.\n\nPT\nUtilizar apenas ferramentas antichispa.\n\nRO\nNu utilizați unelte care produc scântei.\n\nSK\nPoužívajte iba neiskriace prístroje.\n\nSL\nUporabiti le orodje, ki ne povzroča isker.\n\nFI\nKäytä ainoastaan kipinöimättömiä työkaluja.\n\nSV\nAnvänd endast verktyg som inte ger upphov till gnistor.\n\n\nP243\nLanguage\n\n\nBG\nВземете предпазни мерки срещу освобождаване на статично електричество.\n\nES\nTomar medidas de precaución contra descargas electrostáticas.\n\nCS\nProveďte preventivní opatření proti výbojům statické elektřiny.\n\nDA\nTræf foranstaltninger mod statisk elektricitet.\n\nDE\nMaßnahmen gegen elektrostatische Aufladungen treffen.\n\nET\nRakendada ettevaatusabinõusid staatilise elektri vastu.\n\nEL\nΛάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.\n\nEN\nTake precautionary measures against static discharge.\n\nFR\nPrendre des mesures de précaution contre les décharges électrostatiques.\n\nGA\nDéan bearta réamhchúraim in aghaidh díluchtú statach.\n\nIT\nPrendere precauzioni contro le scariche elettrostatiche.\n\nLV\nNodrošināties pret statiskās enerģijas izlādi.\n\nLT\nImtis atsargumo priemonių statinei iškrovai išvengti.\n\nHU\nAz elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.\n\nMT\nĦu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.\n\nNL\nVoorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.\n\nPL\nPrzedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.\n\nPT\nEvitar acumulação de cargas electrostáticas.\n\nRO\nLuați măsuri de precauție împotriva descărcărilor electrostatice.\n\nSK\nUrobte preventívne opatrenia proti výbojom statickej elektriny.\n\nSL\nPreprečiti statično naelektrenje.\n\nFI\nEstä staattisen sähkön aiheuttama kipinöinti.\n\nSV\nVidta åtgärder mot statisk elektricitet.\n\nP244\nLanguage\n\n\nBG\nПочиствайте редуциращите вентили от смазка и масло\n\nES\nMantener las válvulas de reducción limpias de grasa y aceite.\n\nCS\nUdržujte redukční ventily bez maziva a oleje.\n\nDA\nReduktionsventilerne holdes fri for fedt og olie.\n\nDE\nDruckminderer frei von Fett und Öl halten.\n\nET\nHoida reduktsiooniklapid rasvast ja õlist puhtad.\n\nEL\nΝα διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.\n\nEN\nKeep reduction valves free from grease and oil.\n\nFR\nS’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.\n\nGA\nCoimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.\n\nIT\nMantenere le valvole di riduzione libere da grasso e olio.\n\nLV\nTurēt reducēšanās vārstus tīrus no taukiem un eļļas.\n\nLT\nSaugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.\n\nHU\nA nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.\n\nMT\nŻomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.\n\nNL\nReduceerventielen vrij van olie en vet houden.\n\nPL\nChronić zawory redukcyjne przed tłuszczem i olejem.\n\nPT\nManter as válvulas de redução isentas de óleo e massa lubrificantes.\n\nRO\nProtejați supapele reductoare de grăsimi și ulei.\n\nSK\nRedukčné ventily udržiavajte bez mazadiel a oleja.\n\nSL\nPreprečiti stik reducirnih ventilov z mastjo in oljem.\n\nFI\nPidä paineenalennusventtiilit vapaana rasvasta ja öljystä.\n\nSV\nReducerventilerna ska hållas fria från fett och olja.\n\nP250\nLanguage\n\n\nBG\nДа не се подлага на стържене/удар/…/триене\n\nES\nEvitar la abrasión/el choque/…/la fricción.\n\nCS\nNevystavujte obrušování/nárazům/…/tření.\n\nDA\nMå ikke udsættes for slibning/stød/…/gnidning.\n\nDE\nNicht schleifen/stoßen/…/reiben.\n\nET\nHoida kriimustamise/põrutuse/…/hõõrdumise eest.\n\nEL\nΝα αποφεύγεται άλεση/κρούση/…/τριβή.\n\nEN\nDo not subject to grinding/shock/…/friction.\n\nFR\nÉviter les abrasions/les chocs/…/les frottements.\n\nGA\nNá nocht do mheilt/do thurraing/…/do fhrithchuimilt.\n\nIT\nEvitare le abrasioni/gli urti/…/gli attriti.\n\nLV\nNepakļaut drupināšanai/triecienam/…/berzei\n\nLT\nNešlifuoti/netrankyti/…/netrinti.\n\nHU\nTilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.\n\nMT\nTissottoponihomx għal brix/xokk/…/frizzjoni.\n\nNL\nMalen/schokken/…/wrijving vermijden.\n\nPL\nNie poddawać szlifowaniu/wstrząsom/…/tarciu.\n\nPT\nNão submeter a trituração/choque/…/fricção.\n\nRO\nA nu supune la abraziuni/șocuri/…/frecare.\n\nSK\nNevystavujte brúseniu/nárazu/…/treniu.\n\nSL\nNe izpostavljati drgnjenju/udarcem/…/trenju.\n\nFI\nSuojele rasitukselta/iskuilta/…/hankaukselta.\n\nSV\nFår inte utsättas för gnidning/stötar/…/friktion.\n\nP251\nLanguage\n\n\nBG\nСъд под налягане: да не се пробива и изгаря дори след употреба.\n\nES\nRecipiente a presión: no perforar ni quemar, aun después del uso.\n\nCS\nTlakový obal: nepropichujte nebo nespalujte ani po použití.\n\nDA\nBeholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.\n\nDE\nBehälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.\n\nET\nMahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.\n\nEL\nΠεριέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.\n\nEN\nPressurized container: Do not pierce or burn, even after use.\n\nFR\nRécipient sous pression: ne pas perforer, ni brûler, même après usage.\n\nGA\nCoimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.\n\nIT\nRecipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.\n\nLV\nTvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.\n\nLT\nSlėginis indas. Nepradurti ir nedeginti net panaudoto.\n\nHU\nNyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.\n\nMT\nKontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.\n\nNL\nHouder onder druk: ook na gebruik niet doorboren of verbranden.\n\nPL\nPojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.\n\nPT\nRecipiente sob pressão. Não furar nem queimar, mesmo após utilização.\n\nRO\nRecipient sub presiune. Nu perforați sau ardeți, chiar și după utilizare.\n\nSK\nNádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.\n\nSL\nPosoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.\n\nFI\nPainesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.\n\nSV\nTryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.\n\nP260\nLanguage\n\n\nBG\nНе вдишвайте прах/пушек/газ/дим/изпарения/аерозоли\n\nES\nNo respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.\n\nCS\nNevdechujte prach/dým/plyn/mlhu/páry/aerosoly.\n\nDA\nIndånd ikke pulver/røg/gas/tåge/damp/spray.\n\nDE\nStaub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.\n\nET\nTolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.\n\nEL\nΜην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα\n\nEN\nDo not breathe dust/fume/gas/mist/vapours/spray.\n\nFR\nNe pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.\n\nGA\nNá hanálaigh deannach/múch/gás/ceo/gala/sprae.\n\nIT\nNon respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.\n\nLV\nNeieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.\n\nLT\nNeįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.\n\nHU\nA por/füst/gáz/köd/gőzök/permet belélegzése tilos.\n\nMT\nTiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.\n\nNL\nStof/rook/gas/nevel/damp/spuitnevel niet inademen.\n\nPL\nNie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.\n\nPT\nNão respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.\n\nRO\nNu inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.\n\nSK\nNevdychujte prach/dym/plyn/hmlu/pary/aerosóly.\n\nSL\nNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.\n\nFI\nÄlä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.\n\nSV\nInandas inte damm/rök/gaser/dimma/ångor/sprej.\n\nP261\nLanguage\n\n\nBG\nИзбягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли\n\nES\nEvitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.\n\nCS\nZamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.\n\nDA\nUndgå indånding af pulver/røg/gas/tåge/damp/spray.\n\nDE\nEinatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.\n\nET\nVältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.\n\nEL\nAποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.\n\nEN\nAvoid breathing dust/fume/gas/mist/vapours/spray.\n\nFR\nÉviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.\n\nGA\nSeachain deannach/múch/gás/ceo/gala/sprae a análú.\n\nIT\nEvitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.\n\nLV\nIzvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.\n\nLT\nStengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.\n\nHU\nKerülje a por/füst/gáz/köd/gőzök/permet belélegzését.\n\nMT\nEvita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.\n\nNL\nInademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.\n\nPL\nUnikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.\n\nPT\nEvitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.\n\nRO\nEvitați să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.\n\nSK\nZabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.\n\nSL\nNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.\n\nFI\nVältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.\n\nSV\nUndvik att inandas damm/rök/gaser/dimma/ångor/sprej.\n\nP262\nLanguage\n\n\nBG\nДа се избягва контакт с очите, кожата или облеклото.\n\nES\nEvitar el contacto con los ojos, la piel o la ropa.\n\nCS\nZabraňte styku s očima, kůží nebo oděvem.\n\nDA\nMå ikke komme i kontakt med øjne, hud eller tøj.\n\nDE\nNicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.\n\nET\nVältida silma, nahale või rõivastele sattumist.\n\nEL\nΝα μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.\n\nEN\nDo not get in eyes, on skin, or on clothing.\n\nFR\nÉviter tout contact avec les yeux, la peau ou les vêtements.\n\nGA\nNá lig sna súile, ar an gcraiceann, ná ar éadaí.\n\nIT\nEvitare il contatto con gli occhi, la pelle o gli indumenti.\n\nLV\nNepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.\n\nLT\nSaugotis, kad nepatektų į akis, ant odos ar drabužių.\n\nHU\nSzembe, bőrre vagy ruhára nem kerülhet.\n\nMT\nIddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.\n\nNL\nContact met de ogen, de huid of de kleding vermijden.\n\nPL\nNie wprowadzać do oczu, na skórę lub na odzież.\n\nPT\nNão pode entrar em contacto com os olhos, a pele ou a roupa.\n\nRO\nEvitați orice contact cu ochii, pielea sau îmbrăcămintea.\n\nSK\nZabráňte kontaktu s očami, pokožkou alebo odevom.\n\nSL\nPreprečiti stik z očmi, kožo ali oblačili.\n\nFI\nVaro kemikaalin joutumista silmiin, iholle tai vaatteisiin.\n\nSV\nFår inte komma i kontakt med ögonen, huden eller kläderna.\n\n\nP263\nLanguage\n\n\nBG\nДа се избягва контакт по време на бременност/при кърмене.\n\nES\nEvitar el contacto durante el embarazo/la lactancia.\n\nCS\nZabraňte styku během těhotenství/kojení.\n\nDA\nUndgå kontakt under graviditet/amning.\n\nDE\nKontakt während der Schwangerschaft/und der Stillzeit vermeiden.\n\nET\nVältida kokkupuudet raseduse/imetamise ajal.\n\nEL\nAποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.\n\nEN\nAvoid contact during pregnancy/while nursing.\n\nFR\nÉviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.\n\nGA\nSeachain teagmháil le linn toirchis/agus an chíoch á tabhairt.\n\nIT\nEvitare il contatto durante la gravidanza/l’allattamento.\n\nLV\nIzvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.\n\nLT\nVengti kontakto nėštumo metu/maitinant krūtimi.\n\nHU\nA terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.\n\nMT\nEvita l-kuntatt waqt it-tqala/waqt it-treddigħ.\n\nNL\nBij zwangerschap of borstvoeding aanraking vermijden.\n\nPL\nUnikać kontaktu w czasie ciąży/karmienia piersią.\n\nPT\nEvitar o contacto durante a gravidez/o aleitamento.\n\nRO\nEvitați contactul în timpul sarcinii/alăptării.\n\nSK\nZabráňte kontaktu počas tehotenstva a dojčenia.\n\nSL\nPreprečiti stik med nosečnostjo/dojenjem.\n\nFI\nVältä kosketusta raskauden tai imetyksen aikana.\n\nSV\nUndvik kontakt under graviditet eller amning.\n\nP264\nLanguage\n\n\nBG\nДа се измие… старателно след употреба.\n\nES\nLavarse … concienzudamente tras la manipulación.\n\nCS\nPo manipulaci důkladně omyjte …\n\nDA\nVask … grundigt efter brug.\n\nDE\nNach Gebrauch … gründlich waschen.\n\nET\nPärast käitlemist pesta hoolega …\n\nEL\nΠλύνετε … σχολαστικά μετά το χειρισμό.\n\nEN\nWash … thoroughly after handling.\n\nFR\nSe laver … soigneusement après manipulation.\n\nGA\nNigh … go lánchúramach tar éis láimhsithe.\n\nIT\nLavare accuratamente … dopo l’uso.\n\nLV\nPēc izmantošanas … kārtīgi nomazgāt.\n\nLT\nPo naudojimo kruopščiai nuplauti …\n\nHU\nA használatot követően a(z) … -t alaposan meg kell mosni.\n\nMT\nAħsel … sew wara li timmaniġġjah.\n\nNL\nNa het werken met dit product … grondig wassen.\n\nPL\nDokładnie umyć … po użyciu.\n\nPT\nLavar … cuidadosamente após manuseamento.\n\nRO\nSpălați-vă … bine după utilizare.\n\nSK\nPo manipulácii starostlivo umyte…\n\nSL\nPo uporabi temeljito umiti …\n\nFI\nPese … huolellisesti käsittelyn jälkeen.\n\nSV\nTvätta … grundligt efter användning.\n\nP270\nLanguage\n\n\nBG\nДа не се яде, пие или пуши при употреба на продукта.\n\nES\nNo comer, beber ni fumar durante su utilización.\n\nCS\nPři používání tohoto výrobku nejezte, nepijte ani nekuřte.\n\nDA\nDer må ikke spises, drikkes eller ryges under brugen af dette produkt.\n\nDE\nBei Gebrauch nicht essen, trinken oder rauchen.\n\nET\nToote käitlemise ajal mitte süüa, juua ega suitsetada.\n\nEL\nΜην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.\n\nEN\nDo no eat, drink or smoke when using this product.\n\nFR\nNe pas manger, boire ou fumer en manipulant ce produit.\n\nGA\nNá hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.\n\nIT\nNon mangiare, né bere, né fumare durante l’uso.\n\nLV\nNeēst, nedzert un nesmēķēt produkta izmantošanas laikā.\n\nLT\nNaudojant šį produktą, nevalgyti, negerti ir nerūkyti.\n\nHU\nA termék használata közben tilos enni, inni vagy dohányozni.\n\nMT\nTikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.\n\nNL\nNiet eten, drinken of roken tijdens het gebruik van dit product.\n\nPL\nNie jeść, nie pić i nie palić podczas używania produktu.\n\nPT\nNão comer, beber ou fumar durante a utilização deste produto.\n\nRO\nA nu mânca, bea sau fuma în timpul utilizării produsului.\n\nSK\nPri používaní výrobku nejedzte, nepite ani nefajčite.\n\nSL\nNe jesti, piti ali kaditi med uporabo tega izdelka.\n\nFI\nSyöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.\n\nSV\nÄt inte, drick inte och rök inte när du använder produkten.\n\nP271\nLanguage\n\n\nBG\nДа се използва само на открито или на добре проветривомясто.\n\nES\nUtilizar únicamente en exteriores o en un lugar bien ventilado.\n\nCS\nPoužívejte pouze venku nebo v dobře větraných prostorách.\n\nDA\nBrug kun udendørs eller i et rum med god udluftning.\n\nDE\nNur im Freien oder in gut belüfteten Räumen verwenden.\n\nET\nKäidelda üksnes välitingimustes või hästi ventileeritavas kohas.\n\nEL\nΝα χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.\n\nEN\nUse only outdoors or in a well-ventilated area.\n\nFR\nUtiliser seulement en plein air ou dans un endroit bien ventilé.\n\nGA\nÚsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.\n\nIT\nUtilizzare soltanto all’aperto o in luogo ben ventilato.\n\nLV\nIzmantot tikai ārā vai labi vēdināmās telpās.\n\nLT\nNaudoti tik lauke arba gerai vėdinamoje patalpoje.\n\nHU\nKizárólag szabadban vagy jól szellőző helyiségben használható.\n\nMT\nUża biss barra jew f’post ventilat sew.\n\nNL\nAlleen buiten of in een goed geventileerde ruimte gebruiken.\n\nPL\nStosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu\n\nPT\nUtilizar apenas ao ar livre ou em locais bem ventilados.\n\nRO\nA se utiliza numai în aer liber sau în spații bine ventilate.\n\nSK\nPoužívajte iba na voľnom priestranstve alebo v dobre vetranom priestore.\n\nSL\nUporabljati le zunaj ali v dobro prezračevanem prostoru.\n\nFI\nKäytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.\n\nSV\nAnvänds endast utomhus eller i väl ventilerade utrymmen.\n\nP272\nLanguage\n\n\nBG\nДа не се изнася замърсено работно облекло извън работното помещение.\n\nES\nLas prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.\n\nCS\nKontaminovaný pracovní oděv neodnášejte z pracoviště.\n\nDA\nTilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.\n\nDE\nKontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.\n\nET\nSaastunud töörõivaid töökohast mitte välja viia.\n\nEL\nΤα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.\n\nEN\nContaminated work clothing should not be allowed out of the workplace.\n\nFR\nLes vêtements de travail contaminés ne devraient pas sortir du lieu de travail.\n\nGA\nNíor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.\n\nIT\nGli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.\n\nLV\nPiesārņoto darba apģērbu neiznest ārpus darba telpām.\n\nLT\nUžterštų darbo drabužių negalima išnešti iš darbo vietos.\n\nHU\nSzennyezett munkaruhát tilos kivinni a munkahely területéről.\n\nMT\nIlbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.\n\nNL\nVerontreinigde werkkleding mag de werkruimte niet verlaten.\n\nPL\nZanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.\n\nPT\nA roupa de trabalho contaminada não pode sair do local de trabalho.\n\nRO\nNu scoateți îmbrăcămintea de lucru contaminată în afara locului de muncă.\n\nSK\nJe zakázané vyniesť kontaminovaný pracovný odev z pracoviska.\n\nSL\nKontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.\n\nFI\nSaastuneita työvaatteita ei saa viedä työpaikalta.\n\nSV\nNedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.\n\nP273\nLanguage\n\n\nBG\nДа се избягва изпускане в околната среда.\n\nES\nEvitar su liberación al medio ambiente.\n\nCS\nZabraňte uvolnění do životního prostředí.\n\nDA\nUndgå udledning til miljøet.\n\nDE\nFreisetzung in die Umwelt vermeiden.\n\nET\nVältida sattumist keskkonda.\n\nEL\nΝα αποφεύγεται η ελευθέρωση στο περιβάλλον.\n\nEN\nAvoid release to the environment.\n\nFR\nÉviter le rejet dans l’environnement.\n\nGA\nNá scaoiltear amach sa chomhshaol.\n\nIT\nNon disperdere nell’ambiente.\n\nLV\nIzvairīties no izplatīšanas apkārtējā vidē.\n\nLT\nSaugoti, kad nepatektų į aplinką.\n\nHU\nKerülni kell az anyagnak a környezetbe való kijutását.\n\nMT\nEvita r-rilaxx fl-ambjent.\n\nNL\nVoorkom lozing in het milieu.\n\nPL\nUnikać uwolnienia do środowiska.\n\nPT\nEvitar a libertação para o ambiente.\n\nRO\nEvitați dispersarea în mediu.\n\nSK\nZabráňte uvoľneniu do životného prostredia.\n\nSL\nPreprečiti sproščanje v okolje.\n\nFI\nVältettävä päästämistä ympäristöön.\n\nSV\nUndvik utsläpp till miljön.\n\nP280\nLanguage\n\n\nBG\nИзползвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.\n\nES\nLlevar guantes/prendas/gafas/máscara de protección.\n\nCS\nPoužívejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.\n\nDA\nBær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse\n\nDE\nSchutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.\n\nET\nKanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.\n\nEL\nΝα φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.\n\nEN\nWear protective gloves/protective clothing/eye protection/face protection.\n\nFR\nPorter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.\n\nGA\nCaith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.\n\nIT\nIndossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.\n\nLV\nIzmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.\n\nLT\nMūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.\n\nHU\nVédőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.\n\nMT\nIlbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.\n\nNL\nBeschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.\n\nPL\nStosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.\n\nPT\nUsar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.\n\nRO\nPurtați mănuși de protecție/îmbrăcăminte de protecție/echipament de protecție a ochilor/echipament de protecție a feței.\n\nSK\nNoste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.\n\nSL\nNositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.\n\nFI\nKäytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.\n\nSV\nAnvänd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.\n\nP281\nLanguage\n\n\nBG\nИзползвайте предписаните лични предпазни средства.\n\nES\nUtilizar el equipo de protección individual obligatorio.\n\nCS\nPoužívejte požadované osobní ochranné prostředky.\n\nDA\nAnvend de påkrævede personlige værnemidler.\n\nDE\nVorgeschriebene persönliche Schutzausrüstung verwenden.\n\nET\nKasutada vajalikke isikukaitsevahendeid.\n\nEL\nΧρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.\n\nEN\nUse personal protective equipment as required.\n\nFR\nUtiliser l’équipement de protection individuel requis.\n\nGA\nBain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.\n\nIT\nUtilizzare il dispositivo di protezione individuale richiesto.\n\nLV\nIzmantot personisko aizsargaprīkojumu atbilstoši prasībām.\n\nLT\nNaudoti reikalaujamas asmenines apsaugos priemones.\n\nHU\nAz előírt egyéni védőfelszerelés használata kötelező.\n\nMT\nUża’ t-tagħmir personali protettiv kif meħtieġ.\n\nNL\nDe nodige persoonlijke beschermingsuitrusting gebruiken.\n\nPL\nStosować wymagane środki ochrony indywidualnej.\n\nPT\nUsar o equipamento de protecção individual exigido.\n\nRO\nUtilizați echipamentul de protecție individuală conform cerințelor.\n\nSK\nPoužívajte predpísané osobné ochranné prostriedky.\n\nSL\nUporabiti predpisano osebno zaščitno opremo.\n\nFI\nKäytä vaadittuja henkilönsuojaimia.\n\nSV\nAnvänd föreskriven personlig skyddsutrustning.\n\nP282\nLanguage\n\n\nBG\nНосете предпазващи от студ ръкавици/маска за лице/защитни очила.\n\nES\nLlevar guantes que aíslen del frío/gafas/máscara.\n\nCS\nPoužívejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.\n\nDA\nBær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.\n\nDE\nSchutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.\n\nET\nKanda külmakaitsekindaid/kaitsemaski/kaitseprille.\n\nEL\nΦοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.\n\nEN\nWear cold insulating gloves/face shield/eye protection.\n\nFR\nPorter des gants isolants contre le froid/un équipement de protection du visage/des yeux.\n\nGA\nCaith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.\n\nIT\nUtilizzare guanti termici/schermo facciale/Proteggere gli occhi.\n\nLV\nIzmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.\n\nLT\nMūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.\n\nHU\nHidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.\n\nMT\nIlbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.\n\nNL\nKoude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.\n\nPL\nNosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.\n\nPT\nUsar luvas de protecção contra o frio/escudo facial/protecção ocular.\n\nRO\nPurtați mănuși izolante împotriva frigului/echipament de protecție a feței/ochilor.\n\nSK\nPoužívajte termostabilné rukavice/ochranný štít/ochranné okuliare.\n\nSL\nNositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.\n\nFI\nKäytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.\n\nSV\nAnvänd köldisolerande handskar/visir/ögonskydd.\n\nP283\nLanguage\n\n\nBG\nНосете огнеупорно/огнезащитно облекло.\n\nES\nLlevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.\n\nCS\nPoužívejte ohnivzdorný/nehořlavý oděv.\n\nDA\nBær brandbestandig/brandhæmmende beklædning.\n\nDE\nSchwer entflammbare/flammhemmende Kleidung tragen.\n\nET\nKanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.\n\nEL\nΦοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.\n\nEN\nWear fire/flame resistant/retardant clothing.\n\nFR\nPorter des vêtements résistant au feu/aux flammes/ignifuges.\n\nGA\nCaith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.\n\nIT\nIndossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.\n\nLV\nIzmantot aizsargapģērbu pret uguni/liesmām.\n\nLT\nDėvėti ugniai/liepsnai atsparius/antipireninius drabužius.\n\nHU\nTűz-/lángálló/-késleltető ruházat viselése kötelező.\n\nMT\nIlbies ħwejjeġ reżistenti għan-nar/fjammi.\n\nNL\nVuur/vlambestendige/brandwerende kleding dragen.\n\nPL\nNosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.\n\nPT\nUsar vestuário ignífugo/retardador de fogo/chamas.\n\nRO\nPurtați îmbrăcăminte rezistentă la foc/flacără/ignifugă.\n\nSK\nNoste ohňovzdorný odev/odev so zníženou horľavosťou.\n\nSL\nNositi negorljiva oblačila in oblačila, odporna proti ognju.\n\nFI\nKäytä palosuojattua/paloturvallista vaatetusta.\n\nSV\nAnvänd brand-/flamsäkra eller brand-/flamhämmande kläder.\n\nP284\nLanguage\n\n\nBG\nНосете респираторни предпазни средства.\n\nES\nLlevar equipo de protección respiratoria.\n\nCS\nPoužívejte vybavení pro ochranu dýchacích cest.\n\nDA\nAnvend åndedrætsværn.\n\nDE\nAtemschutz tragen.\n\nET\nKanda hingamisteede kaitsevahendeid.\n\nEL\nΦοράτε μέσα ατομικής προστασίας της αναπνοής.\n\nEN\nWear respiratory protection.\n\nFR\nPorter un équipement de protection respiratoire.\n\nGA\nCaith cosaint riospráide.\n\nIT\nUtilizzare un apparecchio respiratorio.\n\nLV\nIzmantot gāzmasku.\n\nLT\nNaudoti kvėpavimo takų apsaugos priemones.\n\nHU\nLégzésvédelem használata kötelező.\n\nMT\nIlbes protezzjoni respiratorja.\n\nNL\nAdembescherming dragen.\n\nPL\nStosować indywidualne środki ochrony dróg oddechowych.\n\nPT\nUsar protecção respiratória.\n\nRO\nPurtați echipament de protecție respiratorie.\n\nSK\nPoužívajte ochranu dýchacích ciest.\n\nSL\nNositi opremo za zaščito dihal.\n\nFI\nKäytä hengityksensuojainta.\n\nSV\nAnvänd andningsskydd.\n\n\nP285\nLanguage\n\n\nBG\nВ случай на лоша вентилация носете респираторни предпазни средства.\n\nES\nEn caso de ventilación insuficiente, llevar equipo de protección respiratoria.\n\nCS\nV případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.\n\nDA\nVed utilstrækkelig udluftning anvendes åndedrætsværn.\n\nDE\nBei unzureichender Belüfung Atemschutz tragen.\n\nET\nEbapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.\n\nEL\nΣε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.\n\nEN\nIn case of inadequate ventilation wear respiratory protection.\n\nFR\nLorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.\n\nGA\nI gcás aerála uireasaigh caith cosaint riospráide.\n\nIT\nIn caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.\n\nLV\nNeatbilstošas ventilācijas gadījumā izmantot gāzmasku.\n\nLT\nEsant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.\n\nHU\nNem megfelelő szellőzés esetén légzésvédelem kötelező.\n\nMT\nF’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.\n\nNL\nBij ontoereikende ventilatie een geschikte adembescherming dragen.\n\nPL\nW przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.\n\nPT\nEm caso de ventilação inadequada, usar protecção respiratória.\n\nRO\nÎn cazul în care ventilarea este insuficientă, purtați echipament de protecție respiratorie.\n\nSK\nV prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.\n\nSL\nOb nezadostnem prezračevanju nositi opremo za zaščito dihal.\n\nFI\nKäytä hengityksensuojainta, jos ilmanvaihto on riittämätön.\n\nSV\nAnvänd andningsskydd vid otillräcklig ventilation.\n\n\nP231 + P232\nLanguage\n\n\nBG\nДа се използва под инертен газ. Да се пази от влага.\n\nES\nManipular en gas inerte. Proteger de la humedad.\n\nCS\nManipulace pod inertním plynem. Chraňte před vlhkem.\n\nDA\nAnvendes under inaktiv gas. Beskyttes mod fugt.\n\nDE\nUnter inertem Gas handhaben. Vor Feuchtigkeit schützen.\n\nET\nKäidelda inertgaasis. Hoida niiskuse eest.\n\nEL\nΧειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.\n\nEN\nHandle under inert gas. Protect from moisture.\n\nFR\nManipuler sous gaz inerte. Protéger de l’humidité.\n\nGA\nLáimhsigh faoi thriathghás. Cosain ó thaise.\n\nIT\nManipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.\n\nLV\nIzmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.\n\nLT\nTvarkyti inertinėse dujose. Saugoti nuo drėgmės.\n\nHU\nInert gázban használandó. Nedvességtől védendő.\n\nMT\nUża’ taħt gass inerti. Ipproteġi mill-umdità.\n\nNL\nOnder inert gas werken. Tegen vocht beschermen.\n\nPL\nUżywać w atmosferze obojętnego gazu Chronić przed wilgocią.\n\nPT\nManusear em atmosfera de gás inerte. Manter ao abrigo da humidade.\n\nRO\nA se manipula sub un gaz inert. A se proteja de umiditate.\n\nSK\nManipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.\n\nSL\nHraniti v ustreznem inertnem plinu. Zaščititi pred vlago.\n\nFI\nKäsittele inertissä kaasussa. Suojaa kosteudelta.\n\nSV\nHanteras under inert gas. Skyddas från fukt.\n\nP235 + P410\nLanguage\n\n\nBG\nДа се държи на хладно. Да се пази от пряка слънчева светлина.\n\nES\nConservar en un lugar fresco. Proteger de la luz del sol.\n\nCS\nUchovávejte v chladu. Chraňte před slunečním zářením.\n\nDA\nOpbevares køligt. Beskyttes mod sollys.\n\nDE\nKühl halten. Vor Sonnenbestrahlung schützen.\n\nET\nHoida jahedas. Hoida päikesevalguse eest.\n\nEL\nΝα διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.\n\nEN\nKeep cool. Protect from sunlight.\n\nFR\nTenir au frais. Protéger du rayonnement solaire.\n\nGA\nCoimeád fionnuar. Cosain ó sholas na gréine.\n\nIT\nTenere in luogo fresco. Proteggere dai raggi solari.\n\nLV\nTurēt vēsumā. Aizsargāt no saules gaismas.\n\nLT\nLaikyti vėsioje vietoje. Saugoti nuo saulės šviesos.\n\nHU\nHűvös helyen tartandó. Napfénytől védendő.\n\nMT\nŻomm frisk. Ipproteġi mir-raġġi tax-xemx.\n\nNL\nKoel bewaren. Tegen zonlicht beschermen.\n\nPL\nPrzechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.\n\nPT\nConservar em ambiente fresco. Manter ao abrigo da luz solar.\n\nRO\nA se păstra la rece. A se proteja de lumina solară.\n\nSK\nUchovávajte v chlade. Chráňte pred slnečným žiarením.\n\nSL\nHraniti na hladnem. Zaščititi pred sončno svetlobo.\n\nFI\nSäilytä viileässä. Suojaa auringonvalolta.\n\nSV\nFörvaras svalt. Skyddas från solljus.\n\nTable 1.3\nPrecautionary statements — Response\n\nP301\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ:\n\nES\nEN CASO DE INGESTIÓN:\n\nCS\nPŘI POŽITÍ:\n\nDA\nI TILFÆLDE AF INDTAGELSE:\n\nDE\nBEI VERSCHLUCKEN:\n\nET\nALLANEELAMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:\n\nEN\nIF SWALLOWED:\n\nFR\nEN CAS D’INGESTION:\n\nGA\nMÁ SHLOGTAR:\n\nIT\nIN CASO DI INGESTIONE:\n\nLV\nNORĪŠANAS GADĪJUMĀ:\n\nLT\nPRARIJUS:\n\nHU\nLENYELÉS ESETÉN:\n\nMT\nJEKK JINBELA’:\n\nNL\nNA INSLIKKEN:\n\nPL\nW PRZYPADKU POŁKNIĘCIA:\n\nPT\nEM CASO DE INGESTÃO:\n\nRO\nÎN CAZ DE ÎNGHIȚIRE:\n\nSK\nPO POŽITÍ:\n\nSL\nPRI ZAUŽITJU:\n\nFI\nJOS KEMIKAALIA ON NIELTY:\n\nSV\nVID FÖRTÄRING:\n\nP302\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА:\n\nES\nEN CASO DE CONTACTO CON LA PIEL:\n\nCS\nPŘI STYKU S KŮŽÍ:\n\nDA\nVED KONTAKT MED HUDEN:\n\nDE\nBEI BERÜHRUNG MIT DER HAUT:\n\nET\nNAHALE SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:\n\nEN\nIF ON SKIN:\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU:\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:\n\nIT\nIN CASO DI CONTATTO CON LA PELLE:\n\nLV\nSASKARĒ AR ĀDU:\n\nLT\nPATEKUS ANT ODOS:\n\nHU\nHA BŐRRE KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MAL-ĠILDA:\n\nNL\nBIJ CONTACT MET DE HUID:\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ:\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE:\n\nRO\nÎN CAZ DE CONTACT CU PIELEA:\n\nSK\nPRI KONTAKTE S POKOŽKOU:\n\nSL\nPRI STIKU S KOŽO:\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE:\n\nSV\nVID HUDKONTAKT:\n\nP303\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА (или косата):\n\nES\nEN CASO DE CONTACTO CON LA PIEL (o el pelo):\n\nCS\nPŘI STYKU S KŮŽÍ (nebo s vlasy):\n\nDA\nVED KONTAKT MED HUDEN (eller håret):\n\nDE\nBEI BERÜHRUNG MIT DER HAUT (oder dem Haar):\n\nET\nNAHALE (või juustele) SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):\n\nEN\nIF ON SKIN (or hair):\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):\n\nIT\nIN CASO DI CONTATTO CON LA PELLE (o con i capelli):\n\nLV\nSASKARĒ AR ĀDU (vai matiem):\n\nLT\nPATEKUS ANT ODOS (arba plaukų):\n\nHU\nHA BŐRRE (vagy hajra) KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):\n\nNL\nBIJ CONTACT MET DE HUID (of het haar):\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):\n\nRO\nÎN CAZ DE CONTACT CU PIELEA (sau părul):\n\nSK\nPRI KONTAKTE S POKOŽKOU (alebo vlasmi):\n\nSL\nPRI STIKU S KOŽO (ali lasmi):\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):\n\nSV\nVID HUDKONTAKT (även håret):\n\nP304\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ:\n\nES\nEN CASO DE INHALACIÓN:\n\nCS\nPŘI VDECHNUTÍ:\n\nDA\nVED INDÅNDING:\n\nDE\nBEI EINATMEN:\n\nET\nSISSEHINGAMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:\n\nEN\nIF INHALED:\n\nFR\nEN CAS D’INHALATION:\n\nGA\nMÁ IONANÁLAÍTEAR:\n\nIT\nIN CASO DI INALAZIONE:\n\nLV\nIEELPOJOT:\n\nLT\nĮKVĖPUS:\n\nHU\nBELÉLEGZÉS ESETÉN:\n\nMT\nJEKK JINĠIBED MAN-NIFS:\n\nNL\nNA INADEMING:\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:\n\nPT\nEM CASO DE INALAÇÃO:\n\nRO\nÎN CAZ DE INHALARE:\n\nSK\nPO VDÝCHNUTÍ:\n\nSL\nPRI VDIHAVANJU:\n\nFI\nJOS KEMIKAALIA ON HENGITETTY:\n\nSV\nVID INANDNING:\n\nP305\nLanguage\n\n\nBG\nПРИ КОНТАКТ С ОЧИТЕ:\n\nES\nEN CASO DE CONTACTO CON LOS OJOS:\n\nCS\nPŘI ZASAŽENÍ OČÍ:\n\nDA\nVED KONTAKT MED ØJNENE:\n\nDE\nBEI KONTAKT MIT DEN AUGEN:\n\nET\nSILMA SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:\n\nEN\nIF IN EYES:\n\nFR\nEN CAS DE CONTACT AVEC LES YEUX:\n\nGA\nI gCÁS TEAGMHÁLA LEIS NA SÚILE:\n\nIT\nIN CASO DI CONTATTO CON GLI OCCHI:\n\nLV\nIEKĻŪSTOT ACĪS:\n\nLT\nPATEKUS Į AKIS:\n\nHU\nSZEMBE KERÜLÉS ESETÉN:\n\nMT\nJEKK JIDĦOL FL-GĦAJNEJN:\n\nNL\nBIJ CONTACT MET DE OGEN:\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO OCZU:\n\nPT\nSE ENTRAR EM CONTACTO COM OS OLHOS:\n\nRO\nÎN CAZ DE CONTACT CU OCHII:\n\nSK\nPO ZASIAHNUTÍ OČÍ:\n\nSL\nPRI STIKU Z OČMI:\n\nFI\nJOS KEMIKAALIA JOUTUU SILMIIN:\n\nSV\nVID KONTAKT MED ÖGONEN:\n\nP306\nLanguage\n\n\nBG\nПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:\n\nES\nEN CASO DE CONTACTO CON LA ROPA:\n\nCS\nPŘI STYKU S ODĚVEM:\n\nDA\nVED KONTAKT MED TØJET:\n\nDE\nBEI KONTAMINIERTER KLEIDUNG:\n\nET\nRÕIVASTELE SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:\n\nEN\nIF ON CLOTHING:\n\nFR\nEN CAS DE CONTACT AVEC LES VÊTEMENTS:\n\nGA\nI gCÁS TEAGMHÁLA LE hÉADAÍ:\n\nIT\nIN CASO DI CONTATTO CON GLI INDUMENTI:\n\nLV\nSASKARĒ AR APĢĒRBU:\n\nLT\nPATEKUS ANT DRABUŽIŲ:\n\nHU\nHA RUHÁRA KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MA' L-ILBIES:\n\nNL\nNA MORSEN OP KLEDING:\n\nPL\nW PRZYPADKU KONTAKTU Z ODZIEŻĄ:\n\nPT\nSE ENTRAR EM CONTACTO COM A ROUPA:\n\nRO\nÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:\n\nSK\nPRI KONTAKTE S ODEVOM:\n\nSL\nPRI STIKU Z OBLAČILI:\n\nFI\nJOS KEMIKAALIA JOUTUU VAATTEISIIN:\n\nSV\nVID KONTAKT MED KLÄDERNA:\n\nP307\nLanguage\n\n\nBG\nПРИ експозиция:\n\nES\nEN CASO DE exposición:\n\nCS\nPŘI expozici:\n\nDA\nVED eksponering:\n\nDE\nBEI Exposition:\n\nET\nKokkupuute korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:\n\nEN\nIF exposed:\n\nFR\nEN CAS d’exposition:\n\nGA\nI gCÁS nochta:\n\nIT\nIN CASO di esposizione:\n\nLV\nJA saskaras:\n\nLT\nEsant sąlyčiui:\n\nHU\nExpozíció esetén:\n\nMT\nJEKK espost:\n\nNL\nNA blootstelling:\n\nPL\nW PRZYPADKU narażenia:\n\nPT\nEM CASO DE exposição:\n\nRO\nÎN CAZ DE expunere:\n\nSK\nPO expozícii:\n\nSL\nPRI izpostavljenosti:\n\nFI\nAltistumisen tapahduttua:\n\nSV\nOm du exponerats:\n\nP308\nLanguage\n\n\nBG\nПРИ явна или предполагаема експозиция:\n\nES\nEN CASO DE exposición manifiesta o presunta:\n\nCS\nPŘI expozici nebo podezření na ni:\n\nDA\nVED eksponering eller mistanke om eksponering:\n\nDE\nBEI Exposition oder falls betroffen\n\nET\nKokkupuute või kokkupuutekahtluse korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:\n\nEN\nIF exposed or concerned:\n\nFR\nEN CAS d’exposition prouvée ou suspectée:\n\nGA\nI gCÁS nochta nó má mheastar a bheith nochtaithe:\n\nIT\nIN CASO di esposizione o di possibile esposizione:\n\nLV\nJa saskaras vai saistīts ar:\n\nLT\nEsant sąlyčiui arba jeigu numanomas sąlytis:\n\nHU\nExpozíció vagy annak gyanúja esetén:\n\nMT\nJEKK espost jew konċernat:\n\nNL\nNA (mogelijke) blootstelling:\n\nPL\nW PRZYPADKU narażenia lub styczności:\n\nPT\nEM CASO DE exposição ou suspeita de exposição:\n\nRO\nÎN CAZ DE expunere sau de posibilă expunere:\n\nSK\nPo expozícii alebo podozrení z nej:\n\nSL\nPRI izpostavljenosti ali sumu izpostavljenosti:\n\nFI\nAltistumisen tapahduttua tai jos epäillään altistumista:\n\nSV\nVid exponering eller misstanke om exponering:\n\nP309\nLanguage\n\n\nBG\nПРИ експозиция или при неразположение:\n\nES\nEN CASO DE exposición o malestar:\n\nCS\nPŘI expozici nebo necítíte-li se dobře:\n\nDA\nVED eksponering eller ubehag:\n\nDE\nBEI Exposition oder Unwohlsein:\n\nET\nKokkupuute või halva enesetunde korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:\n\nEN\nIF exposed or if you feel unwell:\n\nFR\nEN CAS d’exposition ou d'un malaise:\n\nGA\nI gCÁS nochta nó má bhraitear tinn:\n\nIT\nIN CASO di esposizione o di malessere:\n\nLV\nJA saskaras vai ja jums ir slikta pašsajūta:\n\nLT\nEsant sąlyčiui arba blogai pasijutus:\n\nHU\nExpozíció vagy rosszullét esetén:\n\nMT\nJEKK espost jew tħossok ma tiflaħx:\n\nNL\nNA blootstelling of bij onwel voelen:\n\nPL\nW PRZYPADKU narażenia lub złego samopoczucia:\n\nPT\nEM CASO DE exposição ou de indisposição:\n\nRO\nÎN CAZ DE expunere sau dacă nu vă simțiți bine:\n\nSK\nPo expozícii alebo pri zdravotných problémoch.\n\nSL\nPRI izpostavljenosti ali slabem počutju:\n\nFI\nAltistumisen tapahduttua tai jos ilmenee pahoinvointia:\n\nSV\nVid exponering eller obehag:\n\nP310\nLanguage\n\n\nBG\nНезабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.\n\nCS\nOkamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nRing omgående til en GIFTINFORMATION eller en læge.\n\nDE\nSofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nVõtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nImmediately call a POISON CENTER or doctor/physician.\n\nFR\nAppeler immédiatement un CENTRE ANTIPOISON ou un médecin.\n\nGA\nCuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nContattare immediatamente un CENTRO ANTIVELENI o un medico.\n\nLV\nNekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nNedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nAzonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nOnmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nNatychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.\n\nPT\nContacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nOkamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nTakoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nKontakta genast GIFTINFORMATIONSCENTRAL eller läkare.\n\nP311\nLanguage\n\n\nBG\nОбадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.\n\nCS\nVolejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nRing til en GIFTINFORMATION eller en læge.\n\nDE\nGIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nVõtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nCall a POISON CENTER or doctor/physician.\n\nFR\nAppeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nCuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nContattare un CENTRO ANTIVELENI o un medico.\n\nLV\nSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nSkambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nForduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nEen ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nSkontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.\n\nPT\nContacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nVolajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nKontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP312\nLanguage\n\n\nBG\nПри неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.\n\nCS\nNecítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.\n\nDE\nBei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nHalva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.\n\nEN\nCall a POISON CENTER or doctor/physician if you feel unwell.\n\nFR\nAppeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.\n\nGA\nCuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.\n\nIT\nIn caso di malessere, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.\n\nLT\nPasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nRosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.\n\nNL\nBij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nCaso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.\n\nSK\nPri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nOb slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nVid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP313\nLanguage\n\n\nBG\nПотърсете медицински съвет/помощ.\n\nES\nConsultar a un médico.\n\nCS\nVyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg lægehjælp.\n\nDE\nÄrztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nPöörduda arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nGet medical advice/attention.\n\nFR\nConsulter un médecin.\n\nGA\nFaigh comhairle/cúram liachta.\n\nIT\nConsultare un medico.\n\nLV\nLūdziet palīdzību mediķiem.\n\nLT\nKreiptis į gydytoją.\n\nHU\nOrvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib.\n\nNL\nEen arts raadplegen.\n\nPL\nZasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nConsulte um médico.\n\nRO\nConsultați medicul.\n\nSK\nVyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nPoiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu lääkäriin.\n\nSV\nSök läkarhjälp.\n\n\nP314\nLanguage\n\n\nBG\nПри неразположение потърсете медицински съвет/помощ.\n\nES\nConsultar a un médico en caso de malestar.\n\nCS\nNecítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg lægehjælp ved ubehag.\n\nDE\nBei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nHalva enesetunde korral pöörduda arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.\n\nEN\nGet medical advice/attention if you feel unwell.\n\nFR\nConsulter un médecin en cas de malaise.\n\nGA\nFaigh comhairle/cúram liachta má bhraitheann tú tinn.\n\nIT\nIn caso di malessere, consultare un medico.\n\nLV\nLūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.\n\nLT\nPasijutus blogai, kreiptis į gydytoją.\n\nHU\nRosszullét esetén orvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib jekk tħossok ma tiflaħx.\n\nNL\nBij onwel voelen een arts raadplegen.\n\nPL\nW przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de indisposição, consulte um médico.\n\nRO\nConsultați medicul, dacă nu vă simțiți bine.\n\nSK\nAk pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nOb slabem počutju poiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nSök läkarhjälp vid obehag.\n\nP315\nLanguage\n\n\nBG\nНезабавно потърсете медицински съвет/помощ.\n\nES\nConsultar a un médico inmediatamente.\n\nCS\nOkamžitě vyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg omgående lægehjælp.\n\nDE\nSofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nPöörduda viivitamata arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.\n\nEN\nGet immediate medical advice/attention.\n\nFR\nConsulter immédiatement un médecin.\n\nGA\nFaigh comhairle/cúram liachta láithreach.\n\nIT\nConsultare immediatamente un medico.\n\nLV\nNekavējoties lūdziet palīdzību mediķiem.\n\nLT\nNedelsiant kreiptis į gydytoją.\n\nHU\nAzonnal orvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib minnufih.\n\nNL\nOnmiddellijk een arts raadplegen.\n\nPL\nNatychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nConsulte imediatamente um médico.\n\nRO\nConsultați imediat medicul.\n\nSK\nOkamžite vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nTakoj poiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu välittömästi lääkäriin.\n\nSV\nSök omedelbart läkarhjälp.\n\nP320\nLanguage\n\n\nBG\nСпешна нужда от специализирано лечение (вж… на този етикет).\n\nES\nSe necesita urgentemente un tratamiento específico (ver … en esta etiqueta).\n\nCS\nJe nutné odborné ošetření (viz … na tomto štítku).\n\nDA\nSærlig behandling straks påkrævet (se … på denne etiket).\n\nDE\nBesondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab viivitamatut eriravi (vt … käesoleval etiketil).\n\nEL\nΧρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).\n\nEN\nSpecific treatment is urgent (see … on this label).\n\nFR\nUn traitement spécifique est urgent (voir … sur cette étiquette).\n\nGA\nTá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).\n\nIT\nTrattamento specifico urgente (vedere… su questa etichetta).\n\nLV\nSteidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).\n\nLT\nBūtinas skubus specialus gydymas (žr. … šioje etiketėje).\n\nHU\nSürgős szakellátás szükséges (lásd … a címkén).\n\nMT\nTrattament speċifiku hu urġenti (ara … fuq din it-tikketta).\n\nNL\nSpecifieke behandeling dringend vereist (zie … op dit etiket).\n\nPL\nPilnie zastosować określone leczenie (patrz … na etykiecie).\n\nPT\nÉ urgente um tratamento específico (ver … no presente rótulo).\n\nRO\nUn tratament specific este urgent (a se vedea … de pe această etichetă).\n\nSK\nOdborné ošetrenie je naliehavé (pozri … na etikete).\n\nSL\nPosebno zdravljenje je nujno (glejte … na tej etiketi).\n\nFI\nErityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).\n\nSV\nSärskild behandling krävs omedelbart (se … på etiketten).\n\nP321\nLanguage\n\n\nBG\nСпециализирано лечение (вж… на този етикет).\n\nES\nSe necesita un tratamiento específico (ver … en esta etiqueta).\n\nCS\nOdborné ošetření (viz … na tomto štítku).\n\nDA\nSærlig behandling (se … på denne etiket).\n\nDE\nBesondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab eriravi (vt … käesoleval etiketil).\n\nEL\nΧρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).\n\nEN\nSpecific treatment (see … on this label).\n\nFR\nTraitement spécifique (voir … sur cette étiquette).\n\nGA\nCóir liachta ar leith (féach … ar an lipéad seo).\n\nIT\nTrattamento specifico (vedere …su questa etichetta).\n\nLV\nĪpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).\n\nLT\nSpecialus gydymas (žr. … šioje etiketėje).\n\nHU\nSzakellátás (lásd … a címkén).\n\nMT\nTrattament speċifiku (ara … fuq din it-tikketta).\n\nNL\nSpecifieke behandeling vereist (zie … op dit etiket).\n\nPL\nZastosować określone leczenie (patrz … na etykiecie).\n\nPT\nTratamento específico (ver … no presente rótulo).\n\nRO\nTratament specific (a se vedea … de pe această etichetă).\n\nSK\nOdborné ošetrenie (pozri … na etikete).\n\nSL\nPosebno zdravljenje (glejte … na tej etiketi).\n\nFI\nErityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).\n\nSV\nSärskild behandling (se … på etiketten).\n\nP322\nLanguage\n\n\nBG\nСпециални мерки (вж… на този етикет).\n\nES\nSe necesitan medidas específicas (ver … en esta etiqueta).\n\nCS\nSpecifické opatření (viz … na tomto štítku).\n\nDA\nSærlige foranstaltninger (se … på denne etiket).\n\nDE\nGezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab erimeetmeid (vt … käesoleval etiketil).\n\nEL\nΧρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).\n\nEN\nSpecific measures (see … on this label).\n\nFR\nMesures spécifiques (voir … sur cette étiquette).\n\nGA\nBearta ar leith (féach … ar an lipéad seo).\n\nIT\nMisure specifiche (vedere …su questa etichetta).\n\nLV\nĪpaši pasākumi (skat. … uz šīs etiķetes).\n\nLT\nSpecialios priemonės (žr. … šioje etiketėje).\n\nHU\nKülönleges intézkedések (lásd … a címkén).\n\nMT\nMiżuri speċifiċi (ara … fuq din it-tikketta).\n\nNL\nSpecifieke maatregelen (zie … op dit etiket).\n\nPL\nŚrodki szczególne (patrz … na etykiecie).\n\nPT\nMedidas específicas (ver … no presente rótulo).\n\nRO\nMăsuri specifice (a se vedea … de pe această etichetă).\n\nSK\nOsobitné opatrenia (pozri … na etikete).\n\nSL\nPosebni ukrepi (glejte … na tej etiketi).\n\nFI\nErityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).\n\nSV\nSärskilda åtgärder (se … på etiketten).\n\nP330\nLanguage\n\n\nBG\nИзплакнете устата.\n\nES\nEnjuagarse la boca.\n\nCS\nVypláchněte ústa.\n\nDA\nSkyl munden.\n\nDE\nMund ausspülen.\n\nET\nLoputada suud.\n\nEL\nΞεπλύνετε το στόμα.\n\nEN\nRinse mouth.\n\nFR\nRincer la bouche.\n\nGA\nSruthlaítear an béal.\n\nIT\nSciacquare la bocca.\n\nLV\nIzskalot muti.\n\nLT\nIšskalauti burną.\n\nHU\nA szájat ki kell öblíteni.\n\nMT\nLaħlaħ ħalqek.\n\nNL\nDe mond spoelen.\n\nPL\nWypłukać usta.\n\nPT\nEnxaguar a boca.\n\nRO\nClătiți gura.\n\nSK\nVypláchnite ústa.\n\nSL\nIzprati usta.\n\nFI\nHuuhdo suu.\n\nSV\nSkölj munnen.\n\nP331\nLanguage\n\n\nBG\nНЕ предизвиквайте повръщане.\n\nES\nNO provocar el vómito.\n\nCS\nNEVYVOLÁVEJTE zvracení.\n\nDA\nFremkald IKKE opkastning.\n\nDE\nKEIN Erbrechen herbeiführen.\n\nET\nMITTE kutsuda esile oksendamist.\n\nEL\nΜΗΝ προκαλέσετε εμετό.\n\nEN\nDo NOT induce vomiting.\n\nFR\nNE PAS faire vomir.\n\nGA\nNÁ spreagtar urlacan.\n\nIT\nNON provocare il vomito.\n\nLV\nNEIZRAISĪT vemšanu.\n\nLT\nNESKATINTI vėmimo.\n\nHU\nTILOS hánytatni.\n\nMT\nTIPPROVOKAX ir-remettar.\n\nNL\nGEEN braken opwekken.\n\nPL\nNIE wywoływać wymiotów.\n\nPT\nNÃO provocar o vómito.\n\nRO\nNU provocați voma.\n\nSK\nNevyvolávajte zvracanie.\n\nSL\nNE izzvati bruhanja.\n\nFI\nEI saa oksennuttaa.\n\nSV\nFramkalla INTE kräkning.\n\n\nP332\nLanguage\n\n\nBG\nПри поява на кожно дразнене:\n\nES\nEn caso de irritación cutánea:\n\nCS\nPři podráždění kůže:\n\nDA\nVed hudirritation:\n\nDE\nBei Hautreizung:\n\nET\nNahaärrituse korral:\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος:\n\nEN\nIf skin irritation occurs:\n\nFR\nEn cas d’irritation cutanée:\n\nGA\nI gcás greannú craicinn:\n\nIT\nIn caso di irritazione della pelle:\n\nLV\nJa rodas ādas iekaisums:\n\nLT\nJeigu sudirginama oda:\n\nHU\nBőrirritáció esetén:\n\nMT\nJekk ikun hemm irritazzjoni tal-ġilda:\n\nNL\nBij huidirritatie:\n\nPL\nW przypadku wystąpienia podrażnienia skóry:\n\nPT\nEm caso de irritação cutânea:\n\nRO\nÎn caz de iritare a pielii:\n\nSK\nAk sa prejaví podráždenie pokožky:\n\nSL\nČe nastopi draženje kože:\n\nFI\nJos ilmenee ihoärsytystä:\n\nSV\nVid hudirritation:\n\nP333\nLanguage\n\n\nBG\nПри поява на кожно дразнене или обрив на кожата:\n\nES\nEn caso de irritación o erupción cutánea:\n\nCS\nPři podráždění kůže nebo vyrážce:\n\nDA\nVed hudirritation eller udslet:\n\nDE\nBei Hautreizung oder -ausschlag:\n\nET\nNahaärrituse või _obe korral:\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:\n\nEN\nIf skin irritation or rash occurs:\n\nFR\nEn cas d’irritation ou d’éruption cutanée:\n\nGA\nI gcás greannú nó grís craicinn:\n\nIT\nIn caso di irritazione o eruzione della pelle:\n\nLV\nJa rodas ādas iekaisums vai izsitumi:\n\nLT\nJeigu sudirginama oda arba ją išberia.\n\nHU\nBőrirritáció vagy kiütések megjelenése esetén:\n\nMT\nJekk ikun hemm irritazzjoni jew raxx tal-ġilda:\n\nNL\nBij huidirritatie of uitslag:\n\nPL\nW przypadku wystąpienia podrażnienia skóry lub wysypki:\n\nPT\nEm caso de irritação ou erupção cutânea:\n\nRO\nÎn caz de iritare a pielii sau de erupție cutanată:\n\nSK\nAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:\n\nSL\nČe nastopi draženje kože ali se pojavi izpuščaj:\n\nFI\nJos ilmenee ihoärsytystä tai ihottumaa:\n\nSV\nVid hudirritation eller utslag:\n\nP334\nLanguage\n\n\nBG\nПотопете в хладка вода/сложете мокри компреси.\n\nES\nSumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nPonořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nSkyl under koldt vand/anvend våde omslag.\n\nDE\nIn kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nHoida jahedas vees/panna peale niiske kompress.\n\nEL\nΒυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nImmerse in cool water/wrap in wet bandages.\n\nFR\nRincer à l’eau fraîche/poser une compresse humide.\n\nGA\nTum in uisce fionnuar/cuir bréid fliuch air.\n\nIT\nImmergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nIegremdēt vēsā ūdenī/ietīt mitros apsējos.\n\nLT\nĮmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nHideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nDaħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.\n\nNL\nIn koud water onderdompelen/nat verband aanbrengen.\n\nPL\nZanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nMergulhar em água fria/aplicar compressas húmidas.\n\nRO\nIntroduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nPonorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nPotopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nUpota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nSkölj under kallt vatten/använd våta omslag.\n\n\nP335\nLanguage\n\n\nBG\nОтстранете от кожата посипаните частици.\n\nES\nSacudir las partículas que se hayan depositado en la piel.\n\nCS\nVolné částice odstraňte z kůže.\n\nDA\nBørst løse partikler bort fra huden.\n\nDE\nLose Partikel von der Haut abbürsten.\n\nET\nPühkida lahtised osakesed nahalt maha.\n\nEL\nΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.\n\nEN\nBrush off loose particles from skin.\n\nFR\nEnlever avec précaution les particules déposées sur la peau.\n\nGA\nGlan cáithníní scaoilte den chraiceann.\n\nIT\nRimuovere le particelle depositate sulla pelle.\n\nLV\nNoberzt no ādas nepiestiprinātās daļiņas.\n\nLT\nNeprilipusias daleles nuvalyti nuo odos.\n\nHU\nA bőrre lazán tapadó szemcséket óvatosan le kell kefélni.\n\nMT\nFarfar il-frak mhux imwaħħla minn fuq il-ġilda.\n\nNL\nLosse deeltjes van de huid afvegen.\n\nPL\nNie związaną pozostałość strzepnąć ze skóry.\n\nPT\nSacudir da pele as partículas soltas.\n\nRO\nÎndepărtați particulele depuse pe piele.\n\nSK\nZ pokožky oprášte sypké čiastočky.\n\nSL\nS krtačo odstraniti razsute delce s kože.\n\nFI\nPoista irtohiukkaset iholta.\n\nSV\nBorsta bort lösa partiklar från huden.\n\nP336\nLanguage\n\n\nBG\nРазмразете замръзналите части в хладка вода. Не разтривайте засегнатото място.\n\nES\nDescongelar las partes heladas con agua tibia. No frotar la zona afectada.\n\nCS\nOmrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.\n\nDA\nForsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.\n\nDE\nVereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.\n\nET\nSulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.\n\nEL\nΞεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.\n\nEN\nThaw frosted parts with lukewarm water. Do no rub affected area.\n\nFR\nDégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.\n\nGA\nLeáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.\n\nIT\nSgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.\n\nLV\nAtkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.\n\nLT\nPrišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.\n\nHU\nA fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.\n\nMT\nĦoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.\n\nNL\nBevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.\n\nPL\nRozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.\n\nPT\nDerreter as zonas congeladas com água morna. Não friccionar a zona afectada.\n\nRO\nDezghețați părțile degerate cu apă călduță. Nu frecați zona afectată.\n\nSK\nZmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.\n\nSL\nZamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.\n\nFI\nSulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.\n\nSV\nVärm det köldskadade området med ljummet vatten. Gnid inte det skadade området.\n\nP337\nLanguage\n\n\nBG\nПри продължително дразнене на очите:\n\nES\nSi persiste la irritación ocular:\n\nCS\nPřetrvává-li podráždění očí:\n\nDA\nVed vedvarende øjenirritation:\n\nDE\nBei anhaltender Augenreizung:\n\nET\nKui silmade ärritus ei möödu:\n\nEL\nΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:\n\nEN\nIf eye irritation persists:\n\nFR\nSi l’irritation oculaire persiste:\n\nGA\nMá mhaireann an greannú súile:\n\nIT\nSe l’irritazione degli occhi persiste:\n\nLV\nJa acu iekaisums nepāriet:\n\nLT\nJei akių dirginimas nepraeina:\n\nHU\nHa a szemirritáció nem múlik el:\n\nMT\nJekk l-irritazzjoni ta' l-għajnejn tibqa’:\n\nNL\nBij aanhoudende oogirritatie:\n\nPL\nW przypadku utrzymywania się działania drażniącego na oczy:\n\nPT\nCaso a irritação ocular persista:\n\nRO\nDacă iritarea ochilor persistă:\n\nSK\nAk podráždenie očí pretrváva:\n\nSL\nČe draženje oči ne preneha:\n\nFI\nJos silmä-ärsytys jatkuu:\n\nSV\nVid bestående ögonirritation:\n\nP338\nLanguage\n\n\nBG\nСвалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.\n\nES\nQuitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.\n\nCS\nVyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.\n\nDA\nFjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.\n\nDE\nEventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.\n\nET\nEemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.\n\nEL\nΕάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.\n\nEN\nRemove contact lenses, if present and easy to do. Continue rinsing.\n\nFR\nEnlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.\n\nGA\nTóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.\n\nIT\nTogliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.\n\nLV\nIzņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.\n\nLT\nIšimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.\n\nHU\nAdott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.\n\nMT\nNeħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.\n\nNL\nContactlenzen verwijderen, indien mogelijk. Blijven spoelen.\n\nPL\nWyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.\n\nPT\nSe usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.\n\nRO\nScoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.\n\nSK\nAk používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.\n\nSL\nOdstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.\n\nFI\nPoista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.\n\nSV\nTa ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.\n\nP340\nLanguage\n\n\nBG\nИзведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nTransportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPřeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nFlyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nDie betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nToimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΜεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nRemove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nTransporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nTabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\nIT\nTrasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIzvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nIšnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nAz érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nEsponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nHet slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nWyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nRetirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nTransportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.\n\nSK\nPresuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPrenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nSiirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nFlytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen\n\nP341\nLanguage\n\n\nBG\nПри затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nSi respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPři obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVed vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nHingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΕάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIf breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nS'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMás deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\nIT\nSe la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nJa elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nJeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nLégzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.\n\nNL\nBij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEm caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nDacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.\n\nSK\nAk nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP342\nLanguage\n\n\nBG\nПри симптоми на затруднено дишане:\n\nES\nEn caso de síntomas respiratorios:\n\nCS\nPři dýchacích potížích:\n\nDA\nVed luftvejssymptomer:\n\nDE\nBei Symptomen der Atemwege:\n\nET\nHingamisteede probleemide ilmnemise korral:\n\nEL\nΕάν παρουσιάζονται αναπνευστικά συμπτώματα:\n\nEN\nIf experiencing respiratory symptoms:\n\nFR\nEn cas de symptômes respiratoires:\n\nGA\nI gcás siomptóm riospráide:\n\nIT\nIn caso di sintomi respiratori:\n\nLV\nJa rodas elpošanas traucējumu simptomi:\n\nLT\nJeigu pasireiškia respiraciniai simptomai:\n\nHU\nLégzési problémák esetén:\n\nMT\nJekk tkun qed tbati minn sintomi respiratorji:\n\nNL\nBij ademhalingssymptomen:\n\nPL\nW przypadku wystąpienia objawów ze strony układu oddechowego:\n\nPT\nEm caso de sintomas respiratórios:\n\nRO\nÎn caz de simptome respiratorii:\n\nSK\nPri sťaženom dýchaní:\n\nSL\nPri respiratornih simptomih:\n\nFI\nJos ilmenee hengitysoireita:\n\nSV\nVid besvär i luftvägarna:\n\nP350\nLanguage\n\n\nBG\nИзмийте внимателно и обилно със сапун и вода.\n\nES\nLavar suavemente con agua y jabón abundantes.\n\nCS\nJemně omyjte velkým množstvím vody a mýdla.\n\nDA\nVask forsigtigt med rigeligt sæbe og vand.\n\nDE\nBehutsam mit viel Wasser und Seife waschen.\n\nET\nPesta õrnalt rohke vee ja seebiga.\n\nEL\nΠλύνετε απαλά με άφθονο νερό και σαπούνι.\n\nEN\nGently wash with plenty of soap and water.\n\nFR\nLaver avec précaution et abondamment à l’eau et au savon.\n\nGA\nNigh go bog le neart gallúnaí agus uisce.\n\nIT\nLavare delicatamente e abbondantemente con acqua e sapone.\n\nLV\nMaigi izskalot ar lielu daudzumu ziepēm un ūdeni.\n\nLT\nAtsargiai nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nÓvatos lemosás bő szappanos vízzel.\n\nMT\nAħsel bil-mod b’ħafna sapun u ilma.\n\nNL\nVoorzichtig wassen met veel water en zeep.\n\nPL\nDelikatnie umyć dużą ilością wody z mydłem.\n\nPT\nLavar suavemente com sabonete e água abundantes.\n\nRO\nSpălați ușor cu multă apă și săpun.\n\nSK\nOpatrne umyte veľkým množstvom vody a mydla.\n\nSL\nNežno umiti z veliko mila in vode.\n\nFI\nPese varovasti runsaalla vedellä ja saippualla.\n\nSV\nTvätta försiktigt med mycket tvål och vatten.\n\nP351\nLanguage\n\n\nBG\nПромивайте внимателно с вода в продължение на няколко минути.\n\nES\nAclarar cuidadosamente con agua durante varios minutos.\n\nCS\nNěkolik minut opatrně oplachujte vodou.\n\nDA\nSkyl forsigtigt med vand i flere minutter.\n\nDE\nEinige Minuten lang behutsam mit Wasser ausspülen.\n\nET\nLoputada mitme minuti jooksul ettevaatlikult veega.\n\nEL\nΞεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.\n\nEN\nRinse cautiously with water for several minutes.\n\nFR\nRincer avec précaution à l’eau pendant plusieurs minutes.\n\nGA\nSruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.\n\nIT\nSciacquare accuratamente per parecchi minuti.\n\nLV\nUzmanīgi skalot ar ūdeni vairākas minūtes.\n\nLT\nAtsargiai plauti vandeniu kelias minutes.\n\nHU\nÓvatos öblítés vízzel több percen keresztül.\n\nMT\nLaħlaħ b'attenzjoni bl-ilma għal diversi minuti.\n\nNL\nVoorzichtig afspoelen met water gedurende een aantal minuten.\n\nPL\nOstrożnie płukać wodą przez kilka minut.\n\nPT\nEnxaguar cuidadosamente com água durante vários minutos.\n\nRO\nClătiți cu atenție cu apă, timp de mai multe minute.\n\nSK\nOpatrne niekoľko minút oplachujte vodou.\n\nSL\nPrevidno izpirati z vodo nekaj minut.\n\nFI\nHuuhdo huolellisesti vedellä usean minuutin ajan.\n\nSV\nSkölj försiktigt med vatten i flera minuter.\n\nP352\nLanguage\n\n\nBG\nИзмийте обилно със сапун и вода.\n\nES\nLavar con agua y jabón abundantes.\n\nCS\nOmyjte velkým množstvím vody a mýdla.\n\nDA\nVask med rigeligt sæbe og vand.\n\nDE\nMit viel Wasser und Seife waschen.\n\nET\nPesta rohke vee ja seebiga.\n\nEL\nΠλύνετε με άφθονο σαπούνι και νερό.\n\nEN\nWash with plenty of soap and water.\n\nFR\nLaver abondamment à l’eau et au savon.\n\nGA\nNigh le neart gallúnaí agus uisce.\n\nIT\nLavare abbondantemente con acqua e sapone.\n\nLV\nMazgāt ar lielu daudzmu ziepēm un ūdeni.\n\nLT\nPlauti dideliu kiekiu muilo ir vandens.\n\nHU\nLemosás bő szappanos vízzel.\n\nMT\nAħsel b’ħafna sapun u ilma.\n\nNL\nMet veel water en zeep wassen.\n\nPL\nUmyć dużą ilością wody z mydłem.\n\nPT\nLavar com sabonete e água abundantes.\n\nRO\nSpălați cu multă apă și săpun.\n\nSK\nUmyte veľkým množstvom vody a mydla.\n\nSL\nUmiti z veliko mila in vode.\n\nFI\nPese runsaalla vedellä ja saippualla.\n\nSV\nTvätta med mycket tvål och vatten.\n\nP353\nLanguage\n\n\nBG\nОблейте кожата с вода/вземете душ.\n\nES\nAclararse la piel con agua/ducharse.\n\nCS\nOpláchněte kůži vodou/osprchujte.\n\nDA\nSkyl/brus huden med vand.\n\nDE\nHaut mit Wasser abwaschen/duschen.\n\nET\nLoputada nahka veega/loputada duši all.\n\nEL\nΞεπλύνετε την επιδερμίδα με νερό/στο ντους.\n\nEN\nRinse skin with water/shower.\n\nFR\nRincer la peau à l’eau/se doucher.\n\nGA\nSruthlaítear an craiceann le huisce/glac cithfholcadh.\n\nIT\nSciacquare la pelle/fare una doccia.\n\nLV\nNoskalot ādu ar ūdeni/dušā.\n\nLT\nOdą nuplauti vandeniu/čiurkšle.\n\nHU\nA bőrt le kell öblíteni vízzel/zuhanyozás.\n\nMT\nLaħlaħ il-ġilda bl-ilma/bix-xawer.\n\nNL\nHuid met water afspoelen/afdouchen.\n\nPL\nSpłukać skórę pod strumieniem wody/prysznicem.\n\nPT\nEnxaguar a pele com água/tomar um duche.\n\nRO\nClătiți pielea cu apă/faceți duș.\n\nSK\nPokožku opláchnite vodou/sprchou.\n\nSL\nKožo izprati z vodo/prho.\n\nFI\nHuuhdo/suihkuta iho vedellä.\n\nSV\nSkölj huden med vatten/duscha.\n\nP360\nLanguage\n\n\nBG\nНезабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.\n\nES\nAclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.\n\nCS\nKontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.\n\nDA\nSkyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.\n\nDE\nKontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.\n\nET\nSaastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.\n\nEL\nΞεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.\n\nEN\nRinse immediately contaminated clothing and skin with plenty of water before removing clothes.\n\nFR\nRincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.\n\nGA\nSruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.\n\nIT\nSciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.\n\nLV\nNekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.\n\nLT\nPrieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.\n\nHU\nA ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.\n\nMT\nLaħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.\n\nNL\nVerontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.\n\nPL\nNatychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.\n\nPT\nEnxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.\n\nRO\nClătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.\n\nSK\nKontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.\n\nSL\nTakoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.\n\nFI\nHuuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.\n\nSV\nSkölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.\n\nP361\nLanguage\n\n\nBG\nНезабавно свалете цялото замърсено облекло.\n\nES\nQuitarse inmediatamente las prendas contaminadas.\n\nCS\nVeškeré kontaminované části oděvu okamžitě svlékněte.\n\nDA\nTilsmudset tøj tages straks af/fjernes.\n\nDE\nAlle kontaminierten Kleidungsstücke sofort ausziehen.\n\nET\nKõik saastunud rõivad viivitamata seljast võtta.\n\nEL\nΑφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.\n\nEN\nRemove/Take off immediately all contaminated clothing.\n\nFR\nEnlever immédiatement les vêtements contaminés.\n\nGA\nBain díot láithreach na héadaí éillithe go léir.\n\nIT\nTogliersi di dosso immediatamente tutti gli indumenti contaminati.\n\nLV\nNoņemt/Novilkt nekavējoties visu piesārņoto apģērbu.\n\nLT\nNedelsiant nuvilkti/pašalinti visus užterštus drabužius.\n\nHU\nAz összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.\n\nMT\nNeħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.\n\nNL\nVerontreinigde kleding onmiddellijk uittrekken.\n\nPL\nNatychmiast usunąć/zdjąć całą zanieczyszczoną odzież.\n\nPT\nDespir/retirar imediatamente toda a roupa contaminada.\n\nRO\nScoateți imediat toată îmbrăcămintea contaminată.\n\nSK\nIhneď odstráňte/vyzlečte všetky kontaminované časti odevu.\n\nSL\nTakoj odstraniti/sleči vsa kontaminirana oblačila.\n\nFI\nRiisu saastunut vaatetus välittömästi.\n\nSV\nTa omedelbart av alla nedstänkta kläder.\n\n\nP362\nLanguage\n\n\nBG\nСвалете замърсеното облекло и го изперете преди повторна употреба.\n\nES\nQuitarse las prendas contaminadas y lavarlas antes de volver a usarlas.\n\nCS\nKontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.\n\nDA\nForurenet tøj tages af og vaskes, før det bruges igen.\n\nDE\nKontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.\n\nET\nVõtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.\n\nEL\nΒγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.\n\nEN\nTake off contaminated clothing and wash before reuse.\n\nFR\nEnlever les vêtements contaminés et les laver avant réutilisation\n\nGA\nBain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.\n\nIT\nTogliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.\n\nLV\nNovilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.\n\nLT\nNusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.\n\nHU\nA szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.\n\nMT\nInża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.\n\nNL\nVerontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.\n\nPL\nZanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.\n\nPT\nRetirar a roupa contaminada e lavá-la antes de a voltar a usar.\n\nRO\nScoateți îmbrăcămintea contaminată și spălați-o înainte de reutilizare.\n\nSK\nKontaminovaný odev vyzlečte a pred ďalším použitím vyperte.\n\nSL\nSleči kontaminirana oblačila in jih oprati pred ponovno uporabo.\n\nFI\nRiisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.\n\nSV\nNedstänkta kläder tas av och tvättas innan de används igen.\n\n\nP363\nLanguage\n\n\nBG\nИзперете замърсеното облекло преди повторна употреба.\n\nES\nLavar las prendas contaminadas antes de volver a usarlas.\n\nCS\nKontaminovaný oděv před opětovným použitím vyperte.\n\nDA\nTilsmudset tøj skal vaskes, før det kan anvendes igen.\n\nDE\nKontaminierte Kleidung vor erneutem Tragen waschen.\n\nET\nSaastunud rõivad enne järgmist kasutamist pesta.\n\nEL\nΠλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.\n\nEN\nWash contaminated clothing before reuse.\n\nFR\nLaver les vêtements contaminés avant réutilisation.\n\nGA\nNigh éadaí éillithe sula ndéanfar iad a athúsáid.\n\nIT\nLavare gli indumenti contaminati prima di indossarli nuovamente.\n\nLV\nPirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.\n\nLT\nUžterštus drabužius išskalbti prieš vėl juos apsivelkant.\n\nHU\nA szennyezett ruhát újbóli használat előtt ki kell mosni.\n\nMT\nAħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.\n\nNL\nVerontreinigde kleding wassen alvorens deze opnieuw te gebruiken.\n\nPL\nWyprać zanieczyszczoną odzież przed ponownym użyciem.\n\nPT\nLavar a roupa contaminada antes de a voltar a usar.\n\nRO\nSpălați îmbracămintea contaminată, înainte de reutilizare.\n\nSK\nKontaminovaný odev pred ďalším použitím vyperte.\n\nSL\nKontaminirana oblačila oprati pred ponovno uporabo.\n\nFI\nPese saastunut vaatetus ennen uudelleenkäyttöä.\n\nSV\nNedstänkta kläder ska tvättas innan de används igen.\n\nP370\nLanguage\n\n\nBG\nПри пожар:\n\nES\nEn caso de incendio:\n\nCS\nV případě požáru:\n\nDA\nVed brand:\n\nDE\nBei Brand:\n\nET\nTulekahju korral:\n\nEL\nΣε περίπτωση πυρκαγιάς:\n\nEN\nIn case of fire:\n\nFR\nEn cas d’incendie:\n\nGA\nI gcás dóiteáin:\n\nIT\nIn caso di incendio:\n\nLV\nUgunsgrēka gadījumā:\n\nLT\nGaisro atveju:\n\nHU\nTűz esetén:\n\nMT\nF’każ ta' nar:\n\nNL\nIn geval van brand:\n\nPL\nW przypadku pożaru:\n\nPT\nEm caso de incêndio:\n\nRO\nÎn caz de incendiu:\n\nSK\nV prípade požiaru:\n\nSL\nOb požaru:\n\nFI\nTulipalon sattuessa:\n\nSV\nVid brand:\n\nP371\nLanguage\n\n\nBG\nПри голям пожар и значителни количества:\n\nES\nEn caso de incendio importante y en grandes cantidades:\n\nCS\nV případě velkého požáru a velkého množství:\n\nDA\nVed større brand og store mængder:\n\nDE\nBei Großbrand und großen Mengen:\n\nET\nSuure tulekahju korral ning kui on tegemist suurte kogustega:\n\nEL\nΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:\n\nEN\nIn case of major fire and large quantities:\n\nFR\nEn cas d’incendie important et s’il s’agit de grandes quantités:\n\nGA\nI gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:\n\nIT\nIn caso di incendio grave e di quantità rilevanti:\n\nLV\nUgunsgrēka un lielu apjomu gadījumā:\n\nLT\nDidelio gaisro ir didelių kiekių atveju:\n\nHU\nNagyobb tűz és nagy mennyiség esetén:\n\nMT\nF’każ ta' nar kbir u kwantitajiet kbar:\n\nNL\nIn geval van grote brand en grote hoeveelheden:\n\nPL\nW przypadku poważnego pożaru i dużych ilości:\n\nPT\nEm caso de incêndio importante e de grandes quantidades:\n\nRO\nÎn caz de incendiu de proporții și de cantități mari de produs:\n\nSK\nV prípade veľkého požiaru a veľkého množstva:\n\nSL\nOb velikem požaru in velikih količinah:\n\nFI\nJos tulipalo ja ainemäärät ovat suuret:\n\nSV\nVid större brand och stora mängder:\n\nP372\nLanguage\n\n\nBG\nОпасност от експлозия при пожар.\n\nES\nRiesgo de explosión en caso de incendio.\n\nCS\nNebezpečí výbuchu v případě požáru.\n\nDA\nEksplosionsfare ved brand.\n\nDE\nExplosionsgefahr bei Brand.\n\nET\nTulekahju korral plahvatusoht.\n\nEL\nΚίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.\n\nEN\nExplosion risk in case of fire.\n\nFR\nRisque d’explosion en cas d’incendie.\n\nGA\nBaol pléasctha i gcás dóiteáin.\n\nIT\nRischio di esplosione in caso di incendio.\n\nLV\nEksplozijas risks ugunsgrēka gadījumā:\n\nLT\nSprogimo pavojus gaisro atveju.\n\nHU\nTűz esetén robbanásveszély.\n\nMT\nRiskju ta' splużjoni f’każ ta' nar.\n\nNL\nOntploffingsgevaar in geval van brand.\n\nPL\nRyzyko wybuchu w razie pożaru.\n\nPT\nRisco de explosão em caso de incêndio.\n\nRO\nRisc de explozie în caz de incendiu.\n\nSK\nV prípade požiaru hrozí riziko výbuchu.\n\nSL\nNevarnost eksplozije ob požaru.\n\nFI\nTulipalon sattuessa räjähdysvaara.\n\nSV\nExplosionsrisk vid brand.\n\nP373\nLanguage\n\n\nBG\nНЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.\n\nES\nNO luchar contra el incendio cuando el fuego llega a los explosivos.\n\nCS\nPožár NEHASTE, dostane-li se k výbušninám.\n\nDA\nBEKÆMP IKKE branden, hvis denne når eksplosiverne.\n\nDE\nKEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.\n\nET\nKui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.\n\nEL\nΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.\n\nEN\nDO NOT fight fire when fire reaches explosives.\n\nFR\nNE PAS combattre l’incendie lorsque le feu atteint les explosifs.\n\nGA\nNÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.\n\nIT\nNON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.\n\nLV\nNECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.\n\nLT\nNEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.\n\nHU\nTILOS a tűz oltása, ha az robbanóanyagra átterjedt.\n\nMT\nTIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.\n\nNL\nNIET blussen wanneer het vuur de ontplofbare stoffen bereikt.\n\nPL\nNIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe\n\nPT\nSe o fogo atingir os explosivos, NÃO tentar combatê-lo.\n\nRO\nNU încercați să stingeți incendiul atunci când focul a ajuns la explozivi.\n\nSK\nPožiar NEHASTE, ak sa oheň priblížil k výbušninám.\n\nSL\nNE gasiti, ko ogenj doseže eksploziv.\n\nFI\nTulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.\n\nSV\nFörsök INTE bekämpa branden när den når explosiva varor.\n\nP374\nLanguage\n\n\nBG\nГасете пожара с обичайните предпазни мерки от разумно разстояние.\n\nES\nLuchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.\n\nCS\nHaste z přiměřené vzdálenosti a dodržujte běžná opatření.\n\nDA\nTræf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.\n\nDE\nBrandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.\n\nET\nKustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.\n\nEL\nΠροσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.\n\nEN\nFight fire with normal precautions from a reasonable distance.\n\nFR\nCombattre l’incendie à distance en prenant les précautions normales.\n\nGA\nDéan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.\n\nIT\nUtilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.\n\nLV\nDzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.\n\nLT\nGaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.\n\nHU\nTűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.\n\nMT\nItfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.\n\nNL\nMet normale voorzorgen vanaf een redelijke afstand blussen.\n\nPL\nGasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.\n\nPT\nCombater o incêndio tomando as precauções normais e a partir de uma distância razoável.\n\nRO\nStingeți incendiul de la o distanță rezonabilă, luând măsuri normale de precauție.\n\nSK\nPožiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.\n\nSL\nGasiti z običajno previdnostjo in s primerne razdalje.\n\nFI\nSammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.\n\nSV\nBekämpa branden på vanligt sätt på behörigt avstånd.\n\nP375\nLanguage\n\n\nBG\nГасете пожара от разстояние поради опасност от експлозия.\n\nES\nLuchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nKvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nBekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nWegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nPlahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΠροσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nFight fire remotely due to the risk of explosion.\n\nFR\nCombattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nTéigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\nIT\nRischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nDzēst ugunsgrēku no attāluma eksplozijas riska dēļ.\n\nLT\nGaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nA tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nItfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nOp afstand blussen omwille van ontploffingsgevaar.\n\nPL\nZ powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nCombater o incêndio à distância, devido ao risco de explosão.\n\nRO\nStingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nZ dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nGasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nSammuta palo etäältä räjähdysvaaran takia.\n\nSV\nBekämpa branden på avstånd på grund av explosionsrisken.\n\nP376\nLanguage\n\n\nBG\nСпрете теча, ако е безопасно.\n\nES\nDetener la fuga, si no hay peligro en hacerlo.\n\nCS\nZastavte únik, můžete-li tak učinit bez rizika.\n\nDA\nStands lækagen, hvis dette er sikkert.\n\nDE\nUndichtigkeit beseitigen, wenn gefahrlos möglich.\n\nET\nLeke peatada, kui seda on võimalik teha ohutult.\n\nEL\nΣταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.\n\nEN\nStop leak if safe to do so.\n\nFR\nObturer la fuite si cela peut se faire sans danger.\n\nGA\nCuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.\n\nIT\nBloccare la perdita se non c’è pericolo.\n\nLV\nApstādināt noplūdi, ja to var izdarīt drošā veidā.\n\nLT\nSustabdyti nuotėkį, jeigu galima saugiai tai padaryti.\n\nHU\nMeg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.\n\nMT\nWaqqaf it-tnixxija jekk ma jkunx hemm periklu.\n\nNL\nHet lek dichten als dat veilig gedaan kan worden.\n\nPL\nJeżeli jest to bezpieczne zahamować wyciek.\n\nPT\nDeter a fuga se tal puder ser feito em segurança.\n\nRO\nOpriți scurgerea, dacă acest lucru se poate face în siguranță.\n\nSK\nZastavte únik, ak je to bezpečné.\n\nSL\nZaustaviti puščanje, če je varno.\n\nFI\nSulje vuoto, jos sen voi tehdä turvallisesti.\n\nSV\nStoppa läckan om det kan göras på ett säkert sätt.\n\nP377\nLanguage\n\n\nBG\nПожар от изтекъл газ:\nНе гасете освен при възможност за безопасно отстраняване на теча.\n\nES\nFuga de gas en llamas:\nNo apagar, salvo si la fuga puede detenerse sin peligro.\n\nCS\nPožár unikajícího plynu:\nNehaste, nelze-li únik bezpečně zastavit.\n\nDA\nBrand fra udsivende gas:\nSluk ikke, medmindre det er sikkert at stoppe lækagen.\n\nDE\nBrand von ausströmendem Gas:\nNicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.\n\nET\nLekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.\n\nEL\nΔιαρροή φλεγόμενου αερίου:\nΜην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.\n\nEN\nLeaking gas fire:\nDo not extinguish, unless leak can be stopped safely.\n\nFR\nFuite de gaz enflammé:\nNe pas éteindre si la fuite ne peut pas être arrêtée sans danger.\n\nGA\nTine gháis ag sceitheadh:\nNá múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.\n\nIT\nIn caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.\n\nLV\nDegšanas gāzes noplūde:\nNedzēst, ja vien noplūdi var apstādināt drošā veidā.\n\nLT\nDujų nuotėkio sukeltas gaisras:\nNegesinti, nebent nuotėkį būtų galima saugiai sustabdyti.\n\nHU\nÉgő szivárgó gáz:\nCsak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.\n\nMT\nTnixxija ta' gass tan-nar:\nTippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.\n\nNL\nBrand door lekkend gas:\nniet blussen, tenzij het lek veilig gedicht kan worden.\n\nPL\nW przypadku płonięcia wyciekającego gazu:\nNie gasić, jeżeli nie można bezpiecznie zahamować wycieku.\n\nPT\nIncêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.\n\nRO\nIncendiu cauzat de o scurgere de gaz: nu încercați să stingeți, decât dacă scurgerea poate fi oprită în siguranță.\n\nSK\nPožiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.\n\nSL\nPožar zaradi uhajanja plina:\nNe gasiti, če puščanja ni mogoče varno zaustaviti.\n\nFI\nVuotavasta kaasusta johtuva palo:\nEi saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.\n\nSV\nLäckande gas som brinner:\nFörsök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.\n\nP378\nLanguage\n\n\nBG\nИзползвайте … за гасене.\n\nES\nUtilizar … para apagarlo.\n\nCS\nK hašení použijte …\n\nDA\nAnvend … til brandslukning.\n\nDE\n… zum Löschen verwenden.\n\nET\nKustutamiseks kasutada …\n\nEL\nΧρησιμοποιήστε … για την κατάσβεση.\n\nEN\nUse … for extinction.\n\nFR\nUtiliser … pour l’extinction.\n\nGA\nÚsáid … le haghaidh múchta.\n\nIT\nEstinguere con…\n\nLV\nNodzēšanai izmantot…\n\nLT\nGesinimui naudoti …\n\nHU\nAz oltáshoz … használandó.\n\nMT\nUża’ … biex titfi.\n\nNL\nBlussen met …\n\nPL\nUżyć … do gaszenia.\n\nPT\nPara a extinção utilizar …\n\nRO\nUtilizați… pentru stingere.\n\nSK\nNa hasenie použite …\n\nSL\nZa gašenje uporabiti …\n\nFI\nKäytä palon sammuttamiseen …\n\nSV\nSläck branden med …\n\nP380\nLanguage\n\n\nBG\nЕвакуирайте зоната.\n\nES\nEvacuar la zona.\n\nCS\nVykliďte _roctor.\n\nDA\nEvakuer området.\n\nDE\nUmgebung räumen.\n\nET\nAla evakueerida.\n\nEL\nΕκκενώστε την περιοχή.\n\nEN\nEvacuate area.\n\nFR\nÉvacuer la zone.\n\nGA\nAslonnaigh gach duine as an limistéar.\n\nIT\nEvacuare la zona.\n\nLV\nEvakuēt zonu.\n\nLT\nEvakuoti zoną.\n\nHU\nA területet ki kell üríteni.\n\nMT\nEvakwa ż-żona.\n\nNL\nEvacueren.\n\nPL\nEwakuować teren.\n\nPT\nEvacuar a zona.\n\nRO\nEvacuați zona.\n\nSK\nPriestory evakuujte.\n\nSL\nIzprazniti območje.\n\nFI\nEvakuoi alue.\n\nSV\nUtrym området.\n\nP381\nLanguage\n\n\nBG\nПремахнете всички източници на запалване, ако е безопасно.\n\nES\nEliminar todas las fuentes de ignición si no hay peligro en hacerlo.\n\nCS\nOdstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.\n\nDA\nFjern alle antændelseskilder, hvis dette kan gøres sikkert.\n\nDE\nAlle Zündquellen entfernen, wenn gefahrlos möglich.\n\nET\nEemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.\n\nEL\nΑπομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.\n\nEN\nEliminate all ignition sources if safe to do so.\n\nFR\nÉliminer toutes les sources d’ignition si cela est faisable sans danger.\n\nGA\nDíothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.\n\nIT\nEliminare ogni fonte di accensione se non c’è pericolo.\n\nLV\nNovērst visus uzliesmošanas avotus, ja to var izdarīt droši.\n\nLT\nPašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.\n\nHU\nMeg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.\n\nMT\nElimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.\n\nNL\nAlle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.\n\nPL\nWyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.\n\nPT\nEliminar todas as fontes de ignição se tal puder ser feito em segurança.\n\nRO\nEliminați toate sursele de aprindere, dacă acest lucru se poate face în siguranță.\n\nSK\nAk je to bezpečné, odstráňte všetky zdroje zapálenia.\n\nSL\nOdstraniti vse vire vžiga, če je varno.\n\nFI\nPoista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.\n\nSV\nAvlägsna alla antändningskällor om det kan göras på ett säkert sätt.\n\nP390\nLanguage\n\n\nBG\nПопийте разлятото, за да се предотвратят материални вреди.\n\nES\nAbsorber el vertido para que no dañe otros materiales.\n\nCS\nUniklý produkt absorbujte, aby se zabránilo materiálním škodám.\n\nDA\nAbsorber udslip for at undgå materielskade.\n\nDE\nVerschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.\n\nET\nMahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.\n\nEL\nΣκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.\n\nEN\nAbsorb spillage to prevent material damage.\n\nFR\nAbsorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.\n\nGA\nIonsúigh doirteadh chun damáiste d’ábhar a chosc.\n\nIT\nAssorbire la fuoriuscita per evitare danni materiali.\n\nLV\nUzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.\n\nLT\nAbsorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.\n\nHU\nA kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.\n\nMT\nAssorbi t-tixrid biex tipprevjeni ħsara fil-materjal.\n\nNL\nGelekte/gemorste stof opnemen om materiële schade te vermijden.\n\nPL\nUsunąć wyciek, aby zapobiec szkodom materialnym.\n\nPT\nAbsorver o produto derramado a fim de evitar danos materiais.\n\nRO\nAbsorbiți scurgerile de produs, pentru a nu afecta materialele din apropiere.\n\nSK\nAbsorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.\n\nSL\nOdpraviti razlitje, da se prepreči materialna škoda.\n\nFI\nImeytä valumat vahinkojen estämiseksi.\n\nSV\nSug upp spill för att undvika materiella skador.\n\nP391\nLanguage\n\n\nBG\nСъберете разлятото.\n\nES\nRecoger el vertido.\n\nCS\nUniklý produkt seberte.\n\nDA\nUdslip opsamles.\n\nDE\nVerschüttete Mengen aufnehmen.\n\nET\nMahavoolanud toode kokku koguda.\n\nEL\nΜαζέψτε τη χυμένη ποσότητα.\n\nEN\nCollect spillage.\n\nFR\nRecueillir le produit répandu.\n\nGA\nBailigh doirteadh.\n\nIT\nRaccogliere il materiale fuoriuscito.\n\nLV\nSavākt izšļakstīto šķidrumu.\n\nLT\nSurinkti ištekėjusią medžiagą.\n\nHU\nA kiömlött anyagot össze kell gyűjteni.\n\nMT\nIġbor it-tixrid.\n\nNL\nGelekte/gemorste stof opruimen.\n\nPL\nZebrać wyciek.\n\nPT\nRecolher o produto derramado.\n\nRO\nColectați scurgerile de produs.\n\nSK\nZozbierajte uniknutý produkt.\n\nSL\nPrestreči razlito tekočino.\n\nFI\nValumat on kerättävä.\n\nSV\nSamla upp spill.\n\nP301 + P310\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.\n\nDE\nBEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.\n\nGA\nMÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nIN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico\n\nLV\nNORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nPRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: sunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nVID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.\n\nP301 + P312\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.\n\nES\nEN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.\n\nCS\nPŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.\n\nEN\nIF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.\n\nFR\nEN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.\n\nGA\nMÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.\n\nIT\nIN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nNORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.\n\nLT\nPRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.\n\nNL\nNA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.\n\nSK\nPO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nVID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.\n\nP301 + P330 + P331\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.\n\nES\nEN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.\n\nCS\nPŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.\n\nDA\nI TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.\n\nDE\nBEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.\n\nET\nALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.\n\nEN\nIF SWALLOWED: rinse mouth. Do NOT induce vomiting.\n\nFR\nEN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.\n\nGA\nMÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.\n\nIT\nIN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.\n\nLV\nNORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.\n\nLT\nPRARIJUS: išskalauti burną. NESKATINTI vėmimo.\n\nHU\nLENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.\n\nMT\nJEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.\n\nNL\nNA INSLIKKEN: de mond spoelen — GEEN braken opwekken.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.\n\nPT\nEM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: clătiți gura. NU provocați voma.\n\nSK\nPO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.\n\nSL\nPRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.\n\nSV\nVID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.\n\nP302 + P334\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nPŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nVED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.\n\nDE\nBEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nNAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nIF ON SKIN: Immerse in cool water/wrap in wet bandages.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nSASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.\n\nLT\nPATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nHA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nJEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.\n\nNL\nBIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: introduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nPRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nVID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.\n\nP302 + P350\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.\n\nCS\nPŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.\n\nDA\nVED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.\n\nDE\nBEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.\n\nET\nNAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.\n\nEN\nIF ON SKIN: Gently wash with plenty of soap and water.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.\n\nLV\nSASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.\n\nLT\nPATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nHA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.\n\nMT\nJEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.\n\nNL\nBIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: spălați ușor cu multă apă și săpun.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.\n\nSL\nPRI STIKU S KOŽO: nežno umiti z veliko mila in vode.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.\n\nSV\nVID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.\n\nP302 + P352\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.\n\nCS\nPŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.\n\nDA\nVED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.\n\nDE\nBEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.\n\nET\nNAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.\n\nEN\nIF ON SKIN: Wash with plenty of soap and water.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.\n\nLV\nSASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.\n\nLT\nPATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nHA BŐRRE KERÜL: Lemosás bő szappanos vízzel.\n\nMT\nJEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.\n\nNL\nBIJ CONTACT MET DE HUID: met veel water en zeep wassen.\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: spălați cu multă apă și săpun.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.\n\nSL\nPRI STIKU S KOŽO: umiti z veliko mila in vode.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.\n\nSV\nVID HUDKONTAKT: Tvätta med mycket tvål och vatten.\n\nP303 + P361 + P353\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ\n\nES\nEN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.\n\nCS\nPŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.\n\nDA\nVED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.\n\nDE\nBEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.\n\nET\nNAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.\n\nEN\nIF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.\n\nIT\nIN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.\n\nLV\nSASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.\n\nLT\nPATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.\n\nHU\nHA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.\n\nMT\nJEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.\n\nNL\nBIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.\n\nPL\nW PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateți imediat toată îmbrăcămintea contaminată. Clătiți pielea cu apă/faceți duș.\n\nSK\nPRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.\n\nSL\nPRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.\n\nSV\nVID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.\n\nP304 + P340\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nEN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nSISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nEN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\nIT\nIN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nBELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nNA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nÎN CAZ DE INHALARE: transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.\n\nSK\nPO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP304 + P341\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nEN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nSISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nEN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\nIT\nIN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nBELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nNA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nÎN CAZ DE INHALARE: dacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.\n\nSK\nPO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP305 + P351 + P338\nLanguage\n\n\nBG\nПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.\n\nES\nEN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.\n\nCS\nPŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.\n\nDA\nVED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.\n\nDE\nBEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.\n\nET\nSILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.\n\nEN\nIF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.\n\nFR\nEN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.\n\nGA\nI gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.\n\nIT\nIN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.\n\nLV\nSASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.\n\nLT\nPATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.\n\nHU\nSZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.\n\nMT\nJEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.\n\nNL\nBIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.\n\nPT\nSE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.\n\nRO\nÎN CAZ DE CONTACT CU OCHII: clătiți cu atenție cu apă timp de mai multe minute. Scoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.\n\nSK\nPO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.\n\nSL\nPRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.\n\nFI\nJOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.\n\nSV\nVID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.\n\nP306 + P360\nLanguage\n\n\nBG\nПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.\n\nES\nEN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.\n\nCS\nPŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.\n\nDA\nVED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.\n\nDE\nBEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.\n\nET\nRÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.\n\nEN\nIF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.\n\nFR\nEN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.\n\nGA\nI gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.\n\nIT\nIN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.\n\nLV\nSASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.\n\nLT\nPATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.\n\nHU\nHA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.\n\nMT\nJEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.\n\nNL\nNA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.\n\nPL\nW PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.\n\nPT\nSE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.\n\nRO\nÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.\n\nSK\nPRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.\n\nSL\nPRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.\n\nFI\nJOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.\n\nSV\nVID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.\n\nP307 + P311\nLanguage\n\n\nBG\nПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVED eksponering: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nKokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF exposed: Call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nIN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nEsant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nExpozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE expunere: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPo expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nAltistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nOm du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP308 + P313\nLanguage\n\n\nBG\nПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.\n\nES\nEN CASO DE exposición manifiesta o presunta: Consultar a un médico.\n\nCS\nPŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVED eksponering eller mistanke om eksponering: Søg lægehjælp.\n\nDE\nBEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nKokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIF exposed or concerned: Get medical advice/attention.\n\nFR\nEN CAS d’exposition prouvée ou suspectée: consulter un médecin.\n\nGA\nI gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.\n\nIT\nIN CASO di esposizione o di possibile esposizione, consultare un medico.\n\nLV\nJa nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.\n\nLT\nEsant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.\n\nHU\nExpozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.\n\nMT\nJekk espost jew konċernat: Ikkonsulta tabib.\n\nNL\nNA (mogelijke) blootstelling: een arts raadplegen.\n\nPL\nW przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEM CASO DE exposição ou suspeita de exposição: consulte um médico.\n\nRO\nÎN CAZ DE expunere sau de posibilă expunere: consultați medicul.\n\nSK\nPo expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nPRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.\n\nFI\nAltistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.\n\nSV\nVid exponering eller misstanke om exponering Sök läkarhjälp.\n\nP309 + P311\nLanguage\n\n\nBG\nПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nKokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nIN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nEsant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nExpozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE expunere sau dacă nu vă simțiți bine: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPo expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nAltistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.\n\nSV\nVid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\n\nP332 + P313\nLanguage\n\n\nBG\nПри поява на кожно дразнене: Потърсете медицински съвет/помощ.\n\nES\nEn caso de irritación cutánea: Consultar a un médico.\n\nCS\nPři podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed hudirritation: Søg lægehjælp.\n\nDE\nBei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nNahaärrituse korral: pöörduda arsti poole.\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf skin irritation occurs: Get medical advice/attention.\n\nFR\nEn cas d’irritation cutanée: consulter un médecin.\n\nGA\nI gcás greannú craicinn: Faigh comhairle/cúram liachta.\n\nIT\nIn caso di irritazione della pelle: consultare un medico.\n\nLV\nJa rodas ādas iekaisums: lūdziet mediķu palīdzību.\n\nLT\nJeigu sudirginama oda: kreiptis į gydytoją.\n\nHU\nBőrirritáció esetén: orvosi ellátást kell kérni.\n\nMT\nJekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.\n\nNL\nBij huidirritatie: een arts raadplegen.\n\nPL\nW przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de irritação cutânea: consulte um médico.\n\nRO\nÎn caz de iritare a pielii: consultați medicul.\n\nSK\nAk sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos ilmenee ihoärsytystä: Hakeudu lääkäriin.\n\nSV\nVid hudirritation: Sök läkarhjälp.\n\nP333 + P313\nLanguage\n\n\nBG\nПри поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.\n\nES\nEn caso de irritación o erupción cutánea: Consultar a un médico.\n\nCS\nPři podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed hudirritation eller udslet: Søg lægehjælp.\n\nDE\nBei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nNahaärrituse või _obe korral: pöörduda arsti poole.\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf skin irritation or rash occurs: Get medical advice/attention.\n\nFR\nEn cas d’irritation ou d'éruption cutanée: consulter un médecin.\n\nGA\nMá tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.\n\nIT\nIn caso di irritazione o eruzione della pelle: consultare un medico.\n\nLV\nJa rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.\n\nLT\nJeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.\n\nHU\nBőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.\n\nMT\nJekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.\n\nNL\nBij huidirritatie of uitslag: een arts raadplegen.\n\nPL\nW przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de irritação ou erupção cutânea: consulte um médico.\n\nRO\nÎn caz de iritare a pielii sau de erupție cutanată: consultați medicul.\n\nSK\nAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.\n\nSV\nVid hudirritation eller utslag: Sök läkarhjälp.\n\nP335 + P334\nLanguage\n\n\nBG\nОтстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.\n\nES\nSacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nVolné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nBørst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.\n\nDE\nLose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nPühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.\n\nEL\nΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nBrush off loose particles from skin. Immerse in cool water/wrap in wet bandages.\n\nFR\nEnlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.\n\nGA\nScuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.\n\nIT\nRimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nNoberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.\n\nLT\nNeprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nA bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nFarfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.\n\nNL\nLosse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.\n\nPL\nNie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nSacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.\n\nRO\nÎndepărtați particulele depuse pe piele. Introduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nZ pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nS krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nPoista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nBorsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.\n\nP337 + P313\nLanguage\n\n\nBG\nПри продължително дразнене на очите: Потърсете медицински съвет/помощ.\n\nES\nSi persiste la irritación ocular: Consultar a un médico.\n\nCS\nPřetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed vedvarende øjenirritation: Søg lægehjælp.\n\nDE\nBei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nKui silmade ärritus ei möödu: pöörduda arsti poole.\n\nEL\nΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf eye irritation persists: Get medical advice/attention.\n\nFR\nSi l’irritation oculaire persiste: consulter un médecin.\n\nGA\nMá mhaireann an greannú súile: Faigh comhairle/cúram liachta.\n\nIT\nSe l’irritazione degli occhi persiste, consultare un medico.\n\nLV\nJa acu iekaisums nepāriet: lūdziet mediķu palīdzību.\n\nLT\nJei akių dirginimas nepraeina: kreiptis į gydytoją.\n\nHU\nHa a szemirritáció nem múlik el: orvosi ellátást kell kérni.\n\nMT\nJekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.\n\nNL\nBij aanhoudende oogirritatie: een arts raadplegen.\n\nPL\nW przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nCaso a irritação ocular persista: consulte um médico.\n\nRO\nDacă iritarea ochilor persistă: consultați medicul.\n\nSK\nAk podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos silmä-ärsytys jatkuu: Hakeudu lääkäriin.\n\nSV\nVid bestående ögonirritation: Sök läkarhjälp.\n\nP342 + P311\nLanguage\n\n\nBG\nПри симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEn caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPři dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVed luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nHingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΕάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIf experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.\n\nFR\nEn cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\nIT\nIn caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nJeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLégzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nBij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEm caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎn caz de simptome respiratorii: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nVid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP370 + P376\nLanguage\n\n\nBG\nПри пожар: Спрете теча, ако е безопасно.\n\nES\nEn caso de incendio: Detener la fuga, si no hay peligro en hacerlo.\n\nCS\nV případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.\n\nDA\nVed brand: Stands lækagen, hvis dette er sikkert.\n\nDE\nBei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.\n\nET\nTulekahju korral: leke peatada, kui seda on võimalik teha ohutult.\n\nEL\nΣε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.\n\nEN\nIn case of fire: Stop leak if safe to do so.\n\nFR\nEn cas d’incendie: obturer la fuite si cela peut se faire sans danger.\n\nGA\nI gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.\n\nIT\nIn caso di incendio: bloccare la perdita se non c’è pericolo.\n\nLV\nUgunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.\n\nLT\nGaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.\n\nHU\nTűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.\n\nMT\nF’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.\n\nNL\nIn geval van brand: het lek dichten als dat veilig gedaan kan worden.\n\nPL\nW przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.\n\nPT\nEm caso de incêndio: deter a fuga se tal puder ser feito em segurança.\n\nRO\nÎn caz de incendiu: opriți scurgerea, dacă acest lucru se poate face în siguranță.\n\nSK\nV prípade požiaru: ak je to bezpečné, zastavte únik.\n\nSL\nOb požaru: zaustaviti puščanje, če je varno.\n\nFI\nTulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.\n\nSV\nVid brand: Stoppa läckan om det kan göras på ett säkert sätt.\n\nP370 + P378\nLanguage\n\n\nBG\nПри пожар: Използвайте … за гасене.\n\nES\nEn caso de incendio: Utilizar … para apagarlo.\n\nCS\nV případě požáru: K hašení použijte …\n\nDA\nVed brand: Anvend … til brandslukning.\n\nDE\nBei Brand: … zum Löschen verwenden.\n\nET\nTulekahju korral: kasutada kustutamiseks …\n\nEL\nΣε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.\n\nEN\nIn case of fire: Use … for extinction.\n\nFR\nEn cas d’incendie: utiliser … pour l’extinction.\n\nGA\nI gcás dóiteáin: Úsáid … le haghaidh múchta.\n\nIT\nIn caso di incendio: estinguere con…\n\nLV\nUgunsgrēka gadījumā: dzēšanai izmantojiet …\n\nLT\nGaisro atveju: gesinimui naudoti …\n\nHU\nTűz esetén: az oltáshoz …használandó.\n\nMT\nF’każ ta' nar: Uża’ … għat-tifi.\n\nNL\nIn geval van brand: blussen met …\n\nPL\nW przypadku pożaru: Użyć … do gaszenia.\n\nPT\nEm caso de incêndio: para a extinção utilizar …\n\nRO\nÎn caz de incendiu: utilizați… pentru stingere.\n\nSK\nV prípade požiaru: na hasenie použite …\n\nSL\nOb požaru: za gašenje uporabiti …\n\nFI\nTulipalon sattuessa: Käytä palon sammuttamiseen …\n\nSV\nVid brand: Släck branden med …\n\nP370 + P380\nLanguage\n\n\nBG\nПри пожар: Евакуирайте зоната.\n\nES\nEn caso de incendio: Evacuar la zona.\n\nCS\nV případě požáru: Vykliďte prostor.\n\nDA\nVed brand: Evakuer området.\n\nDE\nBei Brand: Umgebung räumen.\n\nET\nTulekahju korral: ala evakueerida.\n\nEL\nΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.\n\nEN\nIn case of fire: Evacuate area.\n\nFR\nEn cas d’incendie: évacuer la zone.\n\nGA\nI gcás dóiteáin: Aslonnaigh gach duine as an limistéar.\n\nIT\nEvacuare la zona in caso di incendio.\n\nLV\nUgunsgrēka gadījumā: evakuēt zonu.\n\nLT\nGaisro atveju: evakuoti zoną.\n\nHU\nTűz esetén: Ki kell üríteni a területet.\n\nMT\nF’każ ta' nar: Evakwa ż-żona.\n\nNL\nIn geval van brand: evacueren.\n\nPL\nW przypadku pożaru: Ewakuować teren.\n\nPT\nEm caso de incêndio: evacuar a zona.\n\nRO\nÎn caz de incendiu: evacuați zona.\n\nSK\nV prípade požiaru: priestory evakuujte.\n\nSL\nOb požaru: izprazniti območje.\n\nFI\nTulipalon sattuessa: Evakuoi alue.\n\nSV\nVid brand: Utrym området.\n\n\nP370 + P380 + P375\nLanguage\n\n\nBG\nПри пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.\n\nES\nEn caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nV případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nVed brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nBei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nTulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nIn case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.\n\nFR\nEn cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nI gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\nIT\nIn caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nUgunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.\n\nLT\nGaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nTűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nF’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nIn geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.\n\nPL\nW przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nEm caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.\n\nRO\nÎn caz de incendiu: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nV prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nOb požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nTulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.\n\nSV\nVid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.\n\nP371 + P380 + P375\nLanguage\n\n\nBG\nПри голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.\n\nES\nEn caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nV případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nVed større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nBei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nSuure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nIn case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.\n\nFR\nEn cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nI gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\nIT\nIn caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nUgunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.\n\nLT\nDidelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nNagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nF’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nIn geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.\n\nPL\nW przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nEm caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.\n\nRO\nÎn caz de incendiu de proporții și de cantități mari de produs: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nV prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nOb velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nJos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.\n\nSV\nVid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.\n\nTable 1.4\nPrecautionary statements — Storage\n\nP401\nLanguage\n\n\nBG\nДа се съхранява…\n\nES\nAlmacenar …\n\nCS\nSkladujte …\n\nDA\nOpbevares …\n\nDE\n… aufbewahren.\n\nET\nHoida …\n\nEL\nΑποθηκεύεται …\n\nEN\nStore …\n\nFR\nStocker …\n\nGA\nStóráil …\n\nIT\nConservare…\n\nLV\nGlabāt…\n\nLT\nLaikyti…\n\nHU\nTárolás: … .\n\nMT\nAħżen …\n\nNL\n… bewaren.\n\nPL\nPrzechowywać …\n\nPT\nArmazenar …\n\nRO\nA se depozita…\n\nSK\nUchovávajte …\n\nSL\nHraniti …\n\nFI\nVarastoi …\n\nSV\nFörvaras …\n\nP402\nLanguage\n\n\nBG\nДа се съхранява на сухо място.\n\nES\nAlmacenar en un lugar seco.\n\nCS\nSkladujte na suchém místě.\n\nDA\nOpbevares et tørt sted.\n\nDE\nAn einem trockenen Ort aufbewahren.\n\nET\nHoida kuivas.\n\nEL\nΑποθηκεύεται σε στεγνό μέρος.\n\nEN\nStore in a dry place.\n\nFR\nStocker dans un endroit sec.\n\nGA\nStóráil in áit thirim.\n\nIT\nConservare in luogo asciutto.\n\nLV\nGlabāt sausā vietā.\n\nLT\nLaikyti sausoje vietoje.\n\nHU\nSzáraz helyen tárolandó.\n\nMT\nAħżen f’post niexef.\n\nNL\nOp een droge plaats bewaren.\n\nPL\nPrzechowywać w suchym miejscu.\n\nPT\nArmazenar em local seco.\n\nRO\nA se depozita într-un loc uscat.\n\nSK\nUchovávajte na suchom mieste.\n\nSL\nHraniti na suhem.\n\nFI\nVarastoi kuivassa paikassa.\n\nSV\nFörvaras torrt.\n\nP403\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място.\n\nES\nAlmacenar en un lugar bien ventilado.\n\nCS\nSkladujte na dobře větraném místě.\n\nDA\nOpbevares på et godt ventileret sted.\n\nDE\nAn einem gut belüfteten Ort aufbewahren.\n\nET\nHoida hästi ventileeritavas kohas.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο.\n\nEN\nStore in a well-ventilated place.\n\nFR\nStocker dans un endroit bien ventilé.\n\nGA\nStóráil in áit dhea-aeráilte.\n\nIT\nConservare in luogo ben ventilato.\n\nLV\nGlabāt labi vēdināmā vietā.\n\nLT\nLaikyti gerai vėdinamoje vietoje.\n\nHU\nJól szellőző helyen tárolandó.\n\nMT\nAħżen f’post b'ventilazzjoni tajba.\n\nNL\nOp een goed geventileerde plaats bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu.\n\nPT\nArmazenar em local bem ventilado.\n\nRO\nA se depozita într-un spațiu bine ventilat.\n\nSK\nUchovávajte na dobre vetranom mieste.\n\nSL\nHraniti na dobro prezračevanem mestu.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto.\n\nSV\nFörvaras på väl ventilerad plats.\n\nP404\nLanguage\n\n\nBG\nДа се съхранява в затворен съд.\n\nES\nAlmacenar en un recipiente cerrado.\n\nCS\nSkladujte v uzavřeném obalu.\n\nDA\nOpbevares i en lukket beholder.\n\nDE\nIn einem geschlossenen Behälter aufbewahren.\n\nET\nHoida suletud mahutis.\n\nEL\nΦυλάσσεται σε κλειστό περιέκτη.\n\nEN\nStore in a closed container.\n\nFR\nStocker dans un récipient fermé.\n\nGA\nStóráil i gcoimeádán iata.\n\nIT\nConservare in un recipiente chiuso.\n\nLV\nGlabāt slēgtā tvertnē.\n\nLT\nLaikyti uždaroje talpykloje.\n\nHU\nZárt edényben tárolandó.\n\nMT\nAħżen f’kontenitur magħluq.\n\nNL\nIn gesloten verpakking bewaren.\n\nPL\nPrzechowywać w zamkniętym pojemniku.\n\nPT\nArmazenar em recipiente fechado.\n\nRO\nA se depozita într-un recipient închis.\n\nSK\nUchovávajte v uzavretej nádobe.\n\nSL\nHraniti v zaprti posodi.\n\nFI\nVarastoi suljettuna.\n\nSV\nFörvaras i sluten behållare.\n\n\nP405\nLanguage\n\n\nBG\nДа се съхранява под ключ.\n\nES\nGuardar bajo llave.\n\nCS\nSkladujte uzamčené.\n\nDA\nOpbevares under lås.\n\nDE\nUnter Verschluss aufbewahren.\n\nET\nHoida lukustatult.\n\nEL\nΦυλάσσεται κλειδωμένο.\n\nEN\nStore locked up.\n\nFR\nGarder sous clef.\n\nGA\nStóráil faoi ghlas.\n\nIT\nConservare sotto chiave.\n\nLV\nGlabāt slēgtā veidā.\n\nLT\nLaikyti užrakintą.\n\nHU\nElzárva tárolandó.\n\nMT\nAħżen f'post imsakkar.\n\nNL\nAchter slot bewaren.\n\nPL\nPrzechowywać pod zamknięciem.\n\nPT\nArmazenar em local fechado à chave.\n\nRO\nA se depozita sub cheie.\n\nSK\nUchovávajte uzamknuté.\n\nSL\nHraniti zaklenjeno.\n\nFI\nVarastoi lukitussa tilassa.\n\nSV\nFörvaras inlåst.\n\nP406\nLanguage\n\n\nBG\nДа се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.\n\nES\nAlmacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.\n\nCS\nSkladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.\n\nDA\nOpbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.\n\nDE\nIn korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.\n\nET\nHoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.\n\nEL\nΑποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.\n\nEN\nStore in corrosive resistant/… container with a resistant inner liner.\n\nFR\nStocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.\n\nGA\nStóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.\n\nIT\nConservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.\n\nLV\nGlabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.\n\nLT\nLaikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.\n\nHU\nSaválló/saválló bélésű … edényben tárolandó.\n\nMT\nAħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.\n\nNL\nIn corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.\n\nPL\nPrzechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.\n\nPT\nArmazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.\n\nRO\nDepozitați într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.\n\nSK\nUchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.\n\nSL\nHraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.\n\nFI\nVarastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.\n\nSV\nFörvaras i korrosionsbeständig/… behållare med beständigt innerhölje.\n\nP407\nLanguage\n\n\nBG\nДа се остави въздушно пространство между купчините/палетите.\n\nES\nDejar una separación entre los bloques/los palés de carga.\n\nCS\nMezi stohy/paletami ponechte vzduchovou mezeru.\n\nDA\nObevares med luftmellemrum mellem stakkene/pallerne.\n\nDE\nLuftspalt zwischen Stapeln/Paletten lassen.\n\nET\nJätta virnade/kaubaaluste vahele õhuvahe.\n\nEL\nΝα υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.\n\nEN\nMaintain air gap between stacks/pallets.\n\nFR\nMaintenir un intervalle d’air entre les piles/palettes.\n\nGA\nCoimeád bearna aeir idir chruacha/phailléid.\n\nIT\nMantenere uno spazio libero tra gli scaffali/i pallet.\n\nLV\nSaglabāt gaisa spraugu starp krāvumiem/paletēm.\n\nLT\nPalikti oro tarpą tarp eilių/palečių.\n\nHU\nA rakatok/raklapok között térközt kell hagyni.\n\nMT\nĦalli l-arja tgħaddi bejn l-imniezel/il-palits.\n\nNL\nRuimte laten tussen stapels/pallets.\n\nPL\nZachować szczelinę powietrzną pomiędzy stosami/paletami.\n\nPT\nRespeitar as distâncias mínimas entre pilhas/paletes.\n\nRO\nPăstrați un spațiu gol între stive/paleți.\n\nSK\nMedzi regálmi/paletami ponechajte vzduchovú medzeru.\n\nSL\nOhraniti zračno režo med skladi/paletami.\n\nFI\nJätä pinojen/kuormalavojen väliin ilmarako.\n\nSV\nSe till att det finns luft mellan staplar/pallar.\n\nP410\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина.\n\nES\nProteger de la luz del sol.\n\nCS\nChraňte před slunečním zářením.\n\nDA\nBeskyttes mod sollys.\n\nDE\nVor Sonnenbestrahlung schützen.\n\nET\nHoida päikesevalguse eest.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες.\n\nEN\nProtect from sunlight.\n\nFR\nProtéger du rayonnement solaire.\n\nGA\nCosain ó sholas na gréine.\n\nIT\nProteggere dai raggi solari.\n\nLV\nAizsargāt no saules gaismas.\n\nLT\nSaugoti nuo saulės šviesos.\n\nHU\nNapfénytől védendő.\n\nMT\nIpproteġi mid-dawl tax-xemx.\n\nNL\nTegen zonlicht beschermen.\n\nPL\nChronić przed światłem słonecznym.\n\nPT\nManter ao abrigo da luz solar.\n\nRO\nA se proteja de lumina solară.\n\nSK\nChráňte pred slnečným žiarením.\n\nSL\nZaščititi pred sončno svetlobo.\n\nFI\nSuojaa auringonvalolta.\n\nSV\nSkyddas från solljus.\n\n\nP411\nLanguage\n\n\nBG\nДа се съхранява при температури, не по-високи от … oC/…oF.\n\nES\nAlmacenar a temperaturas no superiores a … oC/…oF.\n\nCS\nSkladujte při teplotě nepřesahující … oC/…oF.\n\nDA\nOpbevares ved en temperatur, som ikke overstiger … oC/…oF.\n\nDE\nBei Temperaturen von nicht mehr als … oC/…aufbewahren.\n\nET\nHoida temperatuuril mitte üle … oC/… oF.\n\nEL\nΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.\n\nEN\nStore at temperatures not exceeding … oC/…oF.\n\nFR\nStocker à une température ne dépassant pas … oC/… oF.\n\nGA\nStóráil ag teocht nach airde ná … oC/…oF.\n\nIT\nConservare a temperature non superiori a … oC/…oF.\n\nLV\nUzglabāt temperatūrā, kas nepārsniedz … oC/…oF.\n\nLT\nLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje.\n\nHU\nA tárolási hőmérséklet legfeljebb … oC/…oF lehet.\n\nMT\nAħżen f’temperaturi li ma jeċċedux … oC/…oF.\n\nNL\nBij maximaal … oC/…oF bewaren.\n\nPL\nPrzechowywać w temperaturze nieprzekraczającej … oC/…oF.\n\nPT\nArmazenar a uma temperatura não superior a … oC/…oF.\n\nRO\nA se depozita la temperaturi care să nu depășească … oC/…oF.\n\nSK\nUchovávajte pri teplotách do … oC/…oF\n\nSL\nHraniti pri temperaturi do … oC/… oF.\n\nFI\nVarastoi alle … oC/…oF lämpötilassa.\n\nSV\nFörvaras vid högst … oC/…oF.\n\nP412\nLanguage\n\n\nBG\nДа не се излага на температури, по-високи от 50 oC/122oF.\n\nES\nNo exponer a temperaturas superiores a 50 oC/122oF.\n\nCS\nNevystavujte teplotě přesahující 50 oC/122 oF.\n\nDA\nMå ikke udsættes for en temperatur, som overstiger 50 oC/122oF.\n\nDE\nNicht Temperaturen von mehr als 50 oC aussetzen.\n\nET\nMitte hoida temperatuuril üle 50 oC/122 oF.\n\nEL\nΝα μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.\n\nEN\nDo not expose to temperatures exceeding 50 oC/122oF.\n\nFR\nNe pas exposer à une température supérieure à 50 oC/122 oF.\n\nGA\nNá nocht do theocht níos airde ná 50 oC/122oF.\n\nIT\nNon esporre a temperature superiori a 50 oC/122oF.\n\nLV\nNepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.\n\nLT\nNelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.\n\nHU\nNem érheti 50 oC/122oF hőmérsékletet meghaladó hő.\n\nMT\nTesponix għal temperaturi li jeċċedu l-50 oC/122oF.\n\nNL\nNiet blootstellen aan temperaturen boven 50 oC/122oF.\n\nPL\nNie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.\n\nPT\nNão expor a temperaturas superiores a 50 oC/122oF.\n\nRO\nNu expuneți la temperaturi care depășesc 50 oC/122 oF.\n\nSK\nNevystavujte teplotám nad 50 oC/122 oF.\n\nSL\nNe izpostavljati temperaturam nad 50 oC/122 oF.\n\nFI\nEi saa altistaa yli 50 oC/122 oF lämpötiloille.\n\nSV\nFår inte utsättas för temperaturer över 50 oC/122 oF.\n\nP413\nLanguage\n\n\nBG\nПри насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.\n\nES\nAlmacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.\n\nCS\nMnožství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.\n\nDA\nBulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.\n\nDE\nSchüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren\n\nET\nKogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.\n\nEL\nΟι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.\n\nEN\nStore bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.\n\nFR\nStocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.\n\nGA\nStóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.\n\nIT\nConservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.\n\nLV\nLielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.\n\nLT\nDidesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.\n\nHU\nA … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.\n\nMT\nAħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.\n\nNL\nBulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.\n\nPL\nPrzechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.\n\nPT\nArmazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.\n\nRO\nDepozitați cantitățile în vrac mai mari de … kg/… lbs la temperaturi care să nu depășească … oC/…oF.\n\nSK\nVeľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.\n\nSL\nRazsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.\n\nFI\nSäilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.\n\nSV\nBulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.\n\nP420\nLanguage\n\n\nBG\nДа се съхранява на разстояние от други материали.\n\nES\nAlmacenar alejado de otros materiales.\n\nCS\nSkladujte odděleně od ostatních materiálů.\n\nDA\nMå ikke opbevares i nærheden af andre materialer.\n\nDE\nVon anderen Materialien entfernt aufbewahren.\n\nET\nHoida eemal teistest materjalidest.\n\nEL\nΑποθηκεύεται μακριά από άλλα υλικά.\n\nEN\nStore away from other materials.\n\nFR\nStocker à l’écart des autres matières.\n\nGA\nStóráil glan ar ábhair eile.\n\nIT\nConservare lontano da altri materiali.\n\nLV\nGlabāt atsevišķi no citiem materiāliem.\n\nLT\nLaikyti atokiau nuo kitų medžiagų.\n\nHU\nMás anyagoktól távol tárolandó.\n\nMT\nAħżen ‘l bogħod minn materjal ieħor.\n\nNL\nGescheiden van ander materiaal bewaren.\n\nPL\nPrzechowywać z dala od innych materiałów.\n\nPT\nArmazenar afastado de outros materiais.\n\nRO\nDepozitați departe de alte materiale.\n\nSK\nUchovávajte oddelene od iných materiálov.\n\nSL\nHraniti ločeno od drugih materialov.\n\nFI\nVarastoi erillään muista materiaaleista.\n\nSV\nFörvaras åtskilt från andra material.\n\nP422\nLanguage\n\n\nBG\nСъдържанието да се съхранява при…\n\nES\nAlmacenar el contenido en …\n\nCS\nSkladujte pod …\n\nDA\nIndholdet skal opbevares under …\n\nDE\nInhalt in/unter … aufbewahren\n\nET\nHoida sisu …\n\nEL\nΤο περιεχόμενο αποθηκεύεται σε …\n\nEN\nStore contents under …\n\nFR\nStocker le contenu sous …\n\nGA\nStóráil an t-ábhar faoi …\n\nIT\nConservare sotto…\n\nLV\nSaturu uzglabāt zem…\n\nLT\nTurinį laikyti …\n\nHU\nTartalma … -ban/-ben tárolandó.\n\nMT\nAħżen il-kontenut taħt …\n\nNL\nOnder … bewaren.\n\nPL\nZawartość przechowywać w …\n\nPT\nArmazenar o conteúdo em …\n\nRO\nDepozitați conținutul sub …\n\nSK\nObsah uchovávajte v …\n\nSL\nVsebino hraniti v …\n\nFI\nVarastoi sisältö …\n\nSV\nFörvara innehållet i…\n\n\nP402 + P404\nLanguage\n\n\nBG\nДа се съхранява на сухо място. Да се съхранява в затворен съд.\n\nES\nAlmacenar en un lugar seco. Almacenar en un recipiente cerrado.\n\nCS\nSkladujte na suchém místě. Skladujte v uzavřeném obalu.\n\nDA\nOpbevares et tørt sted. Opbevares i en lukket beholder.\n\nDE\nIn einem geschlossenen Behälter an einem trockenen Ort aufbewahren.\n\nET\nHoida kuivas. Hoida suletud mahutis.\n\nEL\nΑποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.\n\nEN\nStore in a dry place. Store in a closed container.\n\nFR\nStocker dans un endroit sec. Stocker dans un récipient fermé.\n\nGA\nStóráil in áit thirim. Stóráil i gcoimeádán iata.\n\nIT\nConservare in luogo asciutto e in recipiente chiuso.\n\nLV\nGlabāt sausā vietā. Glabāt aizvērtā tvertnē.\n\nLT\nLaikyti sausoje vietoje. Laikyti uždaroje talpykloje.\n\nHU\nSzáraz helyen tárolandó. Zárt edényben tárolandó.\n\nMT\nAħżen f’post niexef. Aħżen f’kontenitur magħluq.\n\nNL\nOp een droge plaats bewaren. In gesloten verpakking bewaren.\n\nPL\nPrzechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.\n\nPT\nArmazenar em local seco. Armazenar em recipiente fechado.\n\nRO\nA se depozita într-un loc uscat, într-un recipient închis.\n\nSK\nUchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.\n\nSL\nHraniti na suhem. Hraniti v zaprti posodi.\n\nFI\nVarastoi kuivassa paikassa. Varastoi suljettuna.\n\nSV\nFörvaras torrt. Förvaras i sluten behållare.\n\nP403 + P233\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.\n\nES\nAlmacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.\n\nCS\nSkladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.\n\nDA\nOpbevares på et godt ventileret sted. Hold beholderen tæt lukket.\n\nDE\nBehälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.\n\nET\nHoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.\n\nEN\nStore in a well-ventilated place. Keep container tightly closed.\n\nFR\nStocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.\n\nGA\nStóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.\n\nIT\nTenere il recipiente ben chiuso e in luogo ben ventilato.\n\nLV\nGlabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.\n\nLT\nLaikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.\n\nHU\nJól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.\n\nMT\nAħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.\n\nNL\nOp een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.\n\nPT\nArmazenar em local bem ventilado. Manter o recipiente bem fechado.\n\nRO\nA se depozita într-un spațiu bine ventilat. Păstrați recipientul închis etanș.\n\nSK\nUchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.\n\nSL\nHraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.\n\nSV\nFörvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.\n\nP403 + P235\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място. Да се съхранява на хладно.\n\nES\nAlmacenar en un lugar bien ventilado. Mantener en lugar fresco.\n\nCS\nSkladujte na dobře větraném místě. Uchovávejte v chladu.\n\nDA\nOpbevares på et godt ventileret sted. Opbevares køligt.\n\nDE\nKühl an einem gut belüfteten Ort aufgewahren.\n\nET\nHoida hästi ventileeritavas kohas. Hoida jahedas.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.\n\nEN\nStore in a well-ventilated place. Keep cool.\n\nFR\nStocker dans un endroit bien ventilé. Tenir au frais.\n\nGA\nStóráil in áit dhea-aeráilte. Coimeád fionnuar.\n\nIT\nConservare in luogo fresco e ben ventilato.\n\nLV\nGlabāt labi vēdināmās telpās. Turēt vēsumā.\n\nLT\nLaikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.\n\nHU\nJól szellőző helyen tárolandó. Hűvös helyen tartandó.\n\nMT\nAħżen f'post b'ventilazzjoni tajba. Żomm frisk.\n\nNL\nOp een goed geventileerde plaats bewaren. Koel bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.\n\nPT\nArmazenar em local bem ventilado. Conservar em ambiente fresco.\n\nRO\nA se depozita într-un spațiu bine ventilat. A se păstra la rece.\n\nSK\nUchovávajte na dobre vetranom mieste. Uchovávajte v chlade.\n\nSL\nHraniti na dobro prezračevanem mestu. Hraniti na hladnem.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.\n\nSV\nFörvaras på väl ventilerad plats. Förvaras svalt.\n\nP410 + P403\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.\n\nES\nProteger de la luz del sol. Almacenar en un lugar bien ventilado.\n\nCS\nChraňte před slunečním zářením. Skladujte na dobře větraném místě.\n\nDA\nBeskyttes mod sollys. Opbevares på et godt ventileret sted.\n\nDE\nVor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.\n\nET\nHoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.\n\nEN\nProtect from sunlight. Store in a well-ventilated place.\n\nFR\nProtéger du rayonnement solaire. Stocker dans un endroit bien ventilé.\n\nGA\nCosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.\n\nIT\nProteggere dai raggi solari. Conservare in luogo ben ventilato.\n\nLV\nAizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.\n\nLT\nSaugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.\n\nHU\nNapfénytől védendő. Jól szellőző helyen tárolandó.\n\nMT\nIpproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.\n\nNL\nTegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.\n\nPL\nChronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.\n\nPT\nManter ao abrigo da luz solar. Armazenar em local bem ventilado.\n\nRO\nA se proteja de lumina solară. A se depozita într-un spațiu bine ventilat.\n\nSK\nChráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.\n\nSL\nZaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.\n\nFI\nSuojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.\n\nSV\nSkyddas från solljus. Förvaras på väl ventilerad plats.\n\nP410 + P412\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.\n\nES\nProteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.\n\nCS\nChraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.\n\nDA\nBeskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.\n\nDE\nVor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.\n\nET\nHoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.\n\nEN\nProtect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.\n\nFR\nProtéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.\n\nGA\nCosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.\n\nIT\nProteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.\n\nLV\nAizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.\n\nLT\nSaugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.\n\nHU\nNapfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.\n\nMT\nIpproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.\n\nNL\nTegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.\n\nPL\nChronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.\n\nPT\nManter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.\n\nRO\nA se proteja de lumina solară. Nu expuneți la temperaturi care depășesc 50 oC/122 oF.\n\nSK\nChráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.\n\nSL\nZaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.\n\nFI\nSuojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.\n\nSV\nSkyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.\n\nP411 + P235\nLanguage\n\n\nBG\nДа се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.\n\nES\nAlmacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.\n\nCS\nSkladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.\n\nDA\nOpbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.\n\nDE\nKühl und bei Temperaturen von nicht mehr als … oC aufbewahren.\n\nET\nHoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.\n\nEL\nΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.\n\nEN\nStore at temperatures not exceeding … oC/…oF. Keep cool.\n\nFR\nStocker à une température ne dépassant pas … oC/… oF. Tenir au frais.\n\nGA\nStóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.\n\nIT\nConservare in luogo fresco a temperature non superiori a … oC/…oF.\n\nLV\nGlabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.\n\nLT\nLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.\n\nHU\nA tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.\n\nMT\nAħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.\n\nNL\nBij maximaal … oC/…oF bewaren. Koel bewaren.\n\nPL\nPrzechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.\n\nPT\nArmazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.\n\nRO\nA se depozita la temperaturi care să nu depășească … oC/…oF. A se păstra la rece.\n\nSK\nUchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.\n\nSL\nHraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.\n\nFI\nVarastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.\n\nSV\nFörvaras vid högst … oC/…oF. Förvaras svalt.\n\nTable 1.5\nPrecautionary statements — Disposal\n\nP501\nLanguage\n\n\nBG\nСъдържанието/съдът да се изхвърли в …\n\nES\nEliminar el contenido/el recipiente en …\n\nCS\nOdstraňte obsah/obal …\n\nDA\nIndholdet/beholderen bortskaffes i …\n\nDE\nInhalt/Behälter … zuführen.\n\nET\nSisu/mahuti kõrvaldada …\n\nEL\nΔιάθεση του περιεχομένου/περιέκτη σε …\n\nEN\nDispose of contents/container to …\n\nFR\nÉliminer le contenu/récipient dans …\n\nGA\nDiúscair an t-ábhar/an coimeádán i …\n\nIT\nSmaltire il prodotto/recipiente in …\n\nLV\nAtbrīvoties no satura/tvertnes…\n\nLT\nTurinį/talpyklą išpilti (išmesti) į …\n\nHU\nA tartalom/edény elhelyezése hulladékként: …\n\nMT\nArmi l-kontenut/il-kontenitur fi …\n\nNL\nInhoud/verpakking afvoeren naar …\n\nPL\nZawartość/pojemnik usuwać do …\n\nPT\nEliminar o conteúdo/recipiente em …\n\nRO\nAruncați conținutul/recipientul la …\n\nSK\nZneškodnite obsah/nádobu …\n\nSL\nOdstraniti vsebino/posodo …\n\nFI\nHävitä sisältö/pakkaus …\n\nSV\nInnehållet/behållaren lämnas till…\n\n\nP502\nLanguage\n\n\nBG\nОбърнете се към производителя/доставчика за информация относно възстановяването/рециклирането\n\nES\nPedir información al fabricante o proveedor sobre su recuperación o reciclado\n\nCS\nInformujte se u výrobce nebo dodavatele o regeneraci nebo recyklaci\n\nDA\nIndhent oplysninger om genvinding/genanvendelse hos producenten/leverandøren\n\nDE\nInformationen zur Wiederverwendung/Wiederverwertung beim Hersteller/Lieferanten erfragen\n\nET\nHankida valmistajalt/tarnijalt teavet kemikaali taaskasutamise/ringlussevõtu kohta\n\nEL\nΑπευθυνθείτε στον παραγωγό/προμηθευτή για την ανάκτηση/ανακύκλωση\n\nEN\nRefer to manufacturer/supplier for information on recovery/recycling\n\nFR\nSe reporter au fabricant/fournisseur pour des informations concernant la récupération/le recyclage\n\nGA\nFéach an fhaisnéis ón monaróir/soláthróir maidir le haisghabháil/athchúrsáil\n\nIT\nChiedere informazioni al produttore o fornitore per il recupero/riciclaggio\n\nLV\nInformācija par rekuperāciju/pārstrādi saņemama pie ražotāja/piegādātāja\n\nLT\nKreiptis į gamintoją (tiekėją) informacijai apie šių medžiagų ar preparatų panaudojimą arba perdirbimą gauti\n\nHU\nA gyártó/szállító határozza meg a hasznosításra és újrafeldolgozásra vonatkozó információkat\n\nMT\nIrreferi għall-manifattur/fornitur rigward informazzjoni dwar l-irkupru/riċiklaġġ\n\nNL\nRaadpleeg fabrikant/leverancier voor informatie over terugwinning/recycling\n\nPL\nPrzestrzegać wskazówek producenta lub dostawcy dotyczących odzysku lub wtórnego wykorzystania\n\nPT\nSolicitar ao fabricante/fornecedor informações relativas à recuperação/reciclagem\n\nRO\nAdresați-vă producătorului pentru informații privind recuperarea/reciclarea\n\nSK\nInformujte sa u výrobcu alebo dodávateľa o regenerácii alebo recyklácii\n\nSL\nZa podatke glede obnovitve/reciklaže se obrnite na proizvajalca/dobavitelja\n\nFI\nHanki valmistajalta/toimittajalta tietoja uudelleenkäytöstä/kierrätyksestä\n\nSV\nRådfråga tillverkare/leverantör om återvinning/återanvändning\n", "after": "\nANNEX IV\nLIST OF PRECAUTIONARY STATEMENTS\nIn selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.\n\n\n1. Part 1: Criteria for the selection of precautionary statements\n\nTable 6.1\nPrecautionary statements — General\n\nCode\nGeneral precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP101\nIf medical advice is needed, have product container or label at hand.\nas appropriate\n\nConsumer products\nP102\nKeep out of reach of children.\nas appropriate\n\nConsumer products\nP103\nRead label before use.\nas appropriate\n\nConsumer products\n\nTable 6.2\nPrecautionary statements — Prevention\n\nCode\nPrevention precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP201\nObtain special instructions before use.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP202\nDo not handle until all safety precautions have been read and understood.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nP210\nKeep away from heat/sparks/open flames/hot surfaces. — No smoking.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nManufacturer/supplier to specify applicable ignition source(s).\nFlammable gases (section 2.2)\n1, 2\nFlammable aerosols (section 2.3)\n1, 2\nFlammable liquids (section 2.6)\n1, 2, 3\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nOxidising liquids (section 2.13)\n1, 2, 3\n\nSpecify to keep away from heat.\nOxidising solids (section 2.14)\n1, 2, 3\nP211\nDo not spray on an open flame or other ignition source.\nFlammable aerosols (section 2.3)\n1, 2\n\nP220\nKeep/Store away from clothing/…/combustible materials.\nOxidising gases (section 2.4)\n1\n… Manufacturer/supplier to specify incompatible materials.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nOxidising liquids (section 2.13)\n1\n… Manufacturer/supplier to specify incompatible materials.\n\nspecify to keep away from clothing as well as other incompatible materials.\n2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOxidising solids (section 2.14)\n1\n… Manufacturer/supplier to specify incompatible materials.\n\nspecify to keep away from clothing as well as other incompatible materials.\n2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP221\nTake any precaution to avoid mixing with combustibles/…\nOxidising liquids (section 2.13)\n1, 2, 3\n… Manufacturer/supplier to specify incompatible materials.\nOxidising solids (section 2.14)\n1, 2, 3\nP222\nDo not allow contact with air.\nPyrophoric liquids (section 2.9)\n1\n\nPyrophoric solids (section 2.10)\n1\nP223\nKeep away from any possible contact with water, because of violent reaction and possible flash fire.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\n\nP230\nKeep wetted with …\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.5\n… Manufacturer/supplier to specify appropriate material.\n\nif drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).\nP231\nHandle under inert gas.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP232\nProtect from moisture.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP233\nKeep container tightly closed.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\n\nif product is volatile so as to generate hazardous atmosphere.\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP234\nKeep only in original container.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nCorrosive to metals (section 2.16)\n1\nP235\nKeep cool.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSelf-reactive substances and mixtures (Section 2.8)\nTypes A, B, C, D, E, F\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP240\nGround/bond container and receiving equipment.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nif the explosive is electrostatically sensitive.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nif electrostatically sensitive material is for reloading.\nif product is volatile so as to generate hazardous atmosphere.\nFlammable solids (section 2.7)\n1, 2\n\nif electrostatically sensitive material is for reloading.\nP241\nUse explosion-proof electrical/ventilating/lighting/…/equipment.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify other equipment.\nFlammable solids (section 2.7)\n1, 2\n… Manufacturer/supplier to specify other equipment.\n\nif dust clouds can occur.\nP242\nUse only non-sparking tools.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nP243\nTake precautionary measures against static discharge.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nP244\nKeep reduction valves free from grease and oil.\nOxidising gases (section 2.4)\n1\n\nP250\nDo not subject to grinding/shock/…/friction.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n… Manufacturer/supplier to specify applicable rough handling.\nP251\nPressurized container: Do not pierce or burn, even after use.\nFlammable aerosols (section 2.3)\n1, 2\n\nP260\nDo not breathe dust/fume/gas/mist/vapours/spray.\nAcute toxicity — inhalation (section 3.1)\n1, 2\nManufacturer/supplier to specify applicable conditions.\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSpecify do not breathe dusts or mists.\nif inhalable particles of dusts or mists may occur during use.\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP261\nAvoid breathing dust/fume/gas/mist/vapours/spray.\nAcute toxicity — inhalation (section 3.1)\n3, 4\nManufacturer/supplier to specify applicable conditions.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP262\nDo not get in eyes, on skin, or on clothing.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\nP263\nAvoid contact during pregnancy/while nursing.\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP264\nWash … thoroughly after handling.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\nManufacturer/supplier to specify parts of the body to be washed after handling.\nAcute toxicity — dermal (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin irritation (section 3.2)\n2\nEye irritation (section 3.3)\n2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1\nP270\nDo not eat, drink or smoke when using this product.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nAcute toxicity — dermal (section 3.1)\n1, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1\nP271\nUse only outdoors or in a well-ventilated area.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP272\nContaminated work clothing should not be allowed out of the workplace.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP273\nAvoid release to the environment.\nHazardous to the aquatic environment — acute aquatic hazard (section 4.1)\n1\n\nif this is not the intended use.\nHazardous to the aquatic environment — long-term aquatic hazard (section 4.1)\n1, 2, 3, 4\n\n\nHazardous to the ozone layer (section 5.1)\n1\n\n\nP280\nWear protective gloves/protective clothing/eye protection/face protection.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nManufacturer/supplier to specify type of equipment.\n\nSpecify face protection.\nFlammable liquids (section 2.6)\n1, 2, 3\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves and eye/face protection.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves/clothing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves/clothing and eye/face protection.\nSkin irritation (section 3.2)\n2\nManufacturer/supplier to specify type of equipment.\n\nSpecify protective gloves.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nSevere eye damage (section 3.3)\n1\nManufacturer/supplier to specify type of equipment.\n\nSpecify eye/face protection.\nEye irritation (section 3.3)\n2\n\n\nP281\nUse personal protective equipment as required.\nExplosives (section 2.1)\nUnstable explosive\n\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nP282\nWear cold insulating gloves/face shield/eye protection.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP283\nWear fire/flame resistant/retardant clothing.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP284\nWear respiratory protection.\nAcute toxicity — inhalation (section 3.1)\n1, 2\nManufacturer/supplier to specify equipment.\n\nP285\nIn case of inadequate ventilation wear respiratory protection.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nManufacturer/supplier to specify equipment.\n\nP231 + P232\nHandle under inert gas. Protect from moisture.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP235 + P410\nKeep cool. Protect from sunlight.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n\n\nTable 6.3\nPrecautionary statements — Response\n\nCode\nResponse precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP301\nIF SWALLOWED:\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nAspiration Hazard (section 3.10)\n1\n\nP302\nIF ON SKIN:\nPyrophoric liquids (section 2.9)\n1\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP303\nIF ON SKIN (or hair):\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP304\nIF INHALED:\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP305\nIF IN EYES:\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP306\nIF ON CLOTHING:\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP307\nIF exposed:\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\nP308\nIF exposed or concerned:\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\n\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP309\nIF exposed or if you feel unwell:\nSpecific target organ toxicity — single exposure (section 3.8)\n2\n\nP310\nImmediately call a POISON CENTER or doctor/physician.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2\nAcute toxicity — inhalation (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSerious eye damage/eye irritation (section 3.3)\n1\nAspiration hazard (section 3.10)\n1\n\nP311\nCall a POISON CENTRE or doctor/physician.\nAcute toxicity — inhalation (section 3.1)\n3\n\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\n\nP312\nCall a POISON CENTER or doctor/physician if you feel unwell.\nAcute toxicity — oral (section 3.1)\n4\n\nAcute toxicity — dermal (section 3.1)\n3, 4\nAcute toxicity — inhalation (section 3.1)\n4\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP313\nGet medical advice/attention.\nSkin irritation (section 3.2)\n2, 3\n\nEye irritation (section 3.3)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\n\nP314\nGet medical advice/attention if you feel unwell.\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\n\nP315\nGet immediate medical advice/attention.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP320\nSpecific treatment is urgent (see … on this label).\nAcute toxicity — inhalation (section 3.1)\n1, 2\n… Reference to supplemental first aid instruction.\n\nif immediate administration of antidote is required.\n\nP321\nSpecific treatment (see … on this label).\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\n… Reference to supplemental first aid instruction.\n\n— if immediate administration of antidote is required.\nAcute toxicity — inhalation (section 3.1)\n3\n\n… Reference to supplemental first aid instruction.\n\n— if immediate specific measures are required.\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\n… Reference to supplemental first aid instruction.\n\n— if immediate measures are required.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n… Reference to supplemental first aid instruction.\n\n— manufacturer/supplier may specify a cleansing agent if appropriate.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin irritation (section 3.2)\n2\n\nP322\nSpecific measures (see … on this label).\nAcute toxicity — dermal (section 3.1)\n1, 2\n… Reference to supplemental first aid instruction.\n\nif immediate measures such as specific cleansing agent is advised.\nAcute toxicity — dermal (section 3.1)\n3, 4\n… Reference to supplemental first aid instruction.\n\nif measures such as specific cleansing agent is advised.\nP330\nRinse mouth.\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP331\nDo NOT induce vomiting.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nAspiration hazard (section 3.10)\n1\nP332\nIf skin irritation occurs:\nSkin irritation (section 3.2)\n2, 3\n\n\nP333\nIf skin irritation or rash occurs:\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP334\nImmerse in cool water/wrap in wet bandages.\nPyrophoric liquids (section 2.9)\n1\n\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP335\nBrush off loose particles from skin.\nPyrophoric solids (section 2.10)\n1\n\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP336\nThaw frosted parts with lukewarm water. Do not rub affected area.\nGases under pressure (section 2.5)\nRefrigerated liquefied gas\n\nP337\nIf eye irritation persists:\nEye irritation (section 3.3)\n2\n\nP338\nRemove contact lenses, if present and easy to do. Continue rinsing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP340\nRemove victim to fresh air and keep at rest in a position comfortable for breathing.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP341\nIf breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\n\nP342\nIf experiencing respiratory symptoms:\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP350\nGently wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\nP351\nRinse cautiously with water for several minutes.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\n\nP352\nWash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n3, 4\n\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP353\nRinse skin with water/shower.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP360\nRinse immediately contaminated clothing and skin with plenty of water before removing clothes.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP361\nRemove/Take off immediately all contaminated clothing.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nP362\nTake off contaminated clothing and wash before reuse.\nSkin irritation (section 3.2)\n2\n\n\nP363\nWash contaminated clothing before reuse.\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP370\nIn case of fire:\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nOxidising gases (section 2.4)\n1\nFlammable liquids (section 2.6)\n1, 2, 3\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP371\nIn case of major fire and large quantities:\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP372\nExplosion risk in case of fire.\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nexcept if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.\nP373\nDO NOT fight fire when fire reaches explosives.\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nP374\nFight fire with normal precautions from a reasonable distance.\nExplosives (section 2.1)\nDivision 1.4\n\nif explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.\nP375\nFight fire remotely due to the risk of explosion.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\n\nOxidising liquids (section 2.13)\n1\nOxidising solids (section 2.14)\n1\nP376\nStop leak if safe to do so.\nOxidising gases (section 2.4)\n1\n\nP377\nLeaking gas fire:\nDo not extinguish, unless leak can be stopped safely.\nFlammable gases (section 2.2)\n1, 2\n\nP378\nUse … for extinction.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify appropriate media\n\nif water increases risk.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP380\nEvacuate area.\nExplosives (section 2.1)\nUnstable explosives\n\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\nOxidising liquids (section 2.13)\n1\nOxidising solids (section 2.14)\n1\nP381\nEliminate all ignition sources if safe to do so.\nFlammable gases (section 2.2)\n1, 2\n\nP390\nAbsorb spillage to prevent material damage.\nCorrosive to metals (section 2.16)\n1\n\nP391\nCollect spillage.\nHazardous to the aquatic environment – acute aquatic hazard (section 4.1)\n1\n\nHazardous to the aquatic environment – long-term aquatic hazard (section 4.1)\n1, 2\nP301 + P310\nIF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAspiration hazard (section 3.10)\n1\nP301 + P312\nIF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.\nAcute toxicity — oral (section 3.1)\n4\n\nP301 + P330 + P331\nIF SWALLOWED: Rinse mouth. Do NOT induce vomiting.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP302 + P334\nIF ON SKIN: Immerse in cool water/wrap in wet bandages.\nPyrophoric liquids (section 2.9)\n1\n\nP302 + P350\nIF ON SKIN: Gently wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n1, 2\n\n\nP302 + P352\nIF ON SKIN: Wash with plenty of soap and water.\nAcute toxicity — dermal (section 3.1)\n3, 4\n\nSkin irritation (section 3.2)\n2\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\nP303 + P361 + P353\nIF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nP304 + P340\nIF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3, 4\n\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\n\nP304 + P341\nIF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP305 + P351 + P338\nIF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.\nSkin corrosion (section 3.2)\n1A, 1B, 1C\n\nSerious eye damage/eye irritation (section 3.3)\n1\nEye irritation (section 3.3)\n2\nP306 + P360\nIF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\nP307 + P311\nIF exposed: Call a POISON CENTER or doctor/physician.\nSpecific target organ toxicity — single exposure (section 3.8)\n1\n\nP308 + P313\nIF exposed or concerned: Get medical advice/attention.\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\n\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nReproductive toxicity — effects on or via lactation (section 3.7)\nAdditional category\nP309 + P311\nIF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.\nSpecific target organ toxicity — single exposure (section 3.8)\n2\n\nP332 + P313\nIf skin irritation occurs: Get medical advice/attention.\nSkin irritation (section 3.2)\n2\n\n\nP333 + P313\nIf skin irritation or rash occurs: Get medical advice/attention.\nSkin sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP335 + P334\nBrush off loose particles from skin. Immerse in cool water/wrap in wet bandages.\nPyrophoric solids (section 2.10)\n1\n\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2\nP337 + P313\nIf eye irritation persists: Get medical advice/attention.\nEye irritation (section 3.3)\n2\n\n\nP342 + P311\nIf experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician.\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\n\n\nP370 + P376\nIn case of fire: Stop leak if safe to do so.\nOxidizing gases (section 2.4)\n1\n\nP370 + P378\nIn case of fire: Use … for extinction.\nFlammable liquids (section 2.6)\n1, 2, 3\n… Manufacturer/supplier to specify appropriate media.\n\nif water increases risk.\nFlammable solids (section 2.7)\n1, 2\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nPyrophoric liquids (section 2.9)\n1\nPyrophoric solids (section 2.10)\n1\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nP370 + P380\nIn case of fire: Evacuate area.\nExplosives (section 2.1)\nDivisions 1.1, 1.2, 1.3, 1.4, 1.5\n\nP370 + P380 + P375\nIn case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B\n\nP371 + P380 + P375\nIn case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.\nOxidising liquids (section 2.13)\n1\n\nOxidising solids (section 2.14)\n1\n\nTable 6.4\nPrecautionary statements — Storage\n\nCode\nStorage precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP401\nStore …\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n… in accordance with local/regional/national/international regulations (to be specified).\nP402\nStore in a dry place.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP403\nStore in a well-ventilated place.\nFlammable gases (section 2.2)\n1, 2\n\nif product is volatile so as to generate hazardous atmosphere.\nOxidising gases (section 2.4)\n1\nGases under pressure (section 2.5)\nCompressed gas\nLiquefied gas\nRefrigerated Liquefied gas\nDissolved gas\nFlammable liquids (section 2.6)\n1, 2, 3\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP404\nStore in a closed container.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP405\nStore locked up.\nAcute toxicity — oral (section 3.1)\n1, 2, 3\n\nAcute toxicity — dermal (section 3.1)\n1, 2, 3\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nAspiration hazard (section 3.10)\n1\nP406\nStore in corrosive resistant/… container with a resistant inner liner.\nCorrosive to metals (section 2.16)\n1\n… Manufacturer/supplier to specify other compatible materials.\nP407\nMaintain air gap between stacks/pallets.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n\nP410\nProtect from sunlight.\nFlammable aerosols (section 2.3)\n1, 2\n\nGases under pressure (section 2.5)\nCompressed gas\nLiquefied gas\nDissolved gas\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP411\nStore at temperatures not exceeding … oC/…oF.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n… Manufacturer/supplier to specify temperature\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP412\nDo not expose to temperatures exceeding 50 oC/122 oF.\nFlammable aerosols (section 2.3)\n1, 2\n\nP413\nStore bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF.\nSelf-heating substances and mixtures (section 2.11)\n1, 2\n… Manufacturer/supplier to specify mass and temperature.\nP420\nStore away from other materials.\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\n\nSelf-heating substances and mixtures (section 2.11)\n1, 2\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nP422\nStore contents under …\nPyrophoric liquids (section 2.9)\n1\n… Manufacturer/supplier to specify appropriate liquid or inert gas.\nPyrophoric solids (section 2.10)\n1\nP402 + P404\nStore in a dry place. Store in a closed container.\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\n\nP403 + P233\nStore in a well-ventilated place. Keep container tightly closed.\nAcute toxicity — inhalation (section 3.1)\n1, 2, 3\n\nif product is volatile so as to generate hazardous atmosphere.\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nP403 + P235\nStore in a well-ventilated place. Keep cool.\nFlammable liquids (section 2.6)\n1, 2, 3\n\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nP410 + P403\nProtect from sunlight. Store in a well-ventilated place.\nGases under pressure (section 2.5)\nCompressed gas\n\nLiquefied gas\nDissolved gas\nP410 + P412\nProtect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.\nFlammable aerosols (section 2.3)\n1, 2\n\nP411 + P235\nStore at temperatures not exceeding … oC/…oF. Keep cool.\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\n… Manufacturer/supplier to specify temperature.\n\n\nTable 6.5\nPrecautionary statements — Disposal\n\nCode\nDisposal precautionary statements\nHazard class\nHazard category\nConditions for use\n(1)\n(2)\n(3)\n(4)\n(5)\nP501\nDispose of contents/container to …\nExplosives (section 2.1)\nUnstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5\n\n… in accordance with local/regional/national/international regulation (to be specified).\nFlammable liquids (section 2.6)\n1, 2, 3\nSelf-reactive substances and mixtures (section 2.8)\nTypes A, B, C, D, E, F\nSubstances and mixtures which, in contact with water, emit flammable gases (section 2.12)\n1, 2, 3\nOxidising liquids (section 2.13)\n1, 2, 3\nOxidising solids (section 2.14)\n1, 2, 3\nOrganic peroxides (section 2.15)\nTypes A, B, C, D, E, F\nAcute toxicity — oral (section 3.1)\n1, 2, 3, 4\nAcute toxicity — dermal (section 3.1)\n1, 2, 3, 4\nAcute toxicity — inhalation (section 3.1)\n1, 2\nSkin corrosion (section 3.2)\n1A, 1B, 1C\nRespiratory sensitisation (section 3.4)\n1, 1A, 1B\nSkin sensitisation (section 3.4)\n1, 1A, 1B\nGerm cell mutagenicity (section 3.5)\n1A, 1B, 2\nCarcinogenicity (section 3.6)\n1A, 1B, 2\nReproductive toxicity (section 3.7)\n1A, 1B, 2\nSpecific target organ toxicity — single exposure (section 3.8)\n1, 2\nSpecific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)\n3\nSpecific target organ toxicity — single exposure; narcosis (section 3.8)\n3\nSpecific target organ toxicity — repeated exposure (section 3.9)\n1, 2\nAspiration hazard (section 3.10)\n1\nHazardous to the aquatic environment — acute aquatic hazard(section 4.1)\n1\nHazardous to the aquatic environment — long-term aquatic hazard (section 4.1)\n1, 2, 3, 4\nP502\nRefer to manufacturer/supplier for information on recovery/recycling\nHazardous to the ozone layer (section 5.1)\n1\n\n\n\n\n\n2. Part 2: precautionary statements\nThe precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.\n\nTable 1.1\nPrecautionary statements — General\n\nP101\nLanguage\n\n\nBG\nПри необходимост от медицинска помощ, носете опаковката или етикета на продукта.\n\nES\nSi se necesita consejo médico, tener a mano el envase o la etiqueta.\n\nCS\nJe-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.\n\nDA\nHvis der er brug for lægehjælp, medbring da beholderen eller etiketten.\n\nDE\nIst ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.\n\nET\nArsti poole pöördudes võtta kaasa toote pakend või etikett.\n\nEL\nΕάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.\n\nEN\nIf medical advice is needed, have product container or label at hand.\n\nFR\nEn cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.\n\nGA\nMás gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.\n\n\nHR\nAko je potrebna liječnička pomoć pokazati spremnik ili naljepnicu.\n\n\nIT\nIn caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.\n\nLV\nMedicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.\n\nLT\nJei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.\n\nHU\nOrvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.\n\nMT\nJekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.\n\nNL\nBij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.\n\nPL\nW razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.\n\nPT\nSe for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.\n\nRO\nDacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.\n\nSK\nAk je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.\n\nSL\nČe je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.\n\nFI\nJos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.\n\nSV\nHa förpackningen eller etiketten till hands om du måste söka läkarvård.\n\nP102\nLanguage\n\n\nBG\nДа се съхранява извън обсега на деца.\n\nES\nMantener fuera del alcance de los niños.\n\nCS\nUchovávejte mimo dosah dětí.\n\nDA\nOpbevares utilgængeligt for børn.\n\nDE\nDarf nicht in die Hände von Kindern gelangen.\n\nET\nHoida lastele kättesaamatus kohas.\n\nEL\nΜακριά από παιδιά.\n\nEN\nKeep out of reach of children.\n\nFR\nTenir hors de portée des enfants.\n\nGA\nCoimeád as aimsiú leanaí.\n\n\nHR\nČuvati izvan dohvata djece.\n\n\nIT\nTenere fuori dalla portata dei bambini.\n\nLV\nSargāt no bērniem.\n\nLT\nLaikyti vaikams neprieinamoje vietoje.\n\nHU\nGyermekektől elzárva tartandó.\n\nMT\nŻommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.\n\nNL\nBuiten het bereik van kinderen houden.\n\nPL\nChronić przed dziećmi.\n\nPT\nManter fora do alcance das crianças.\n\nRO\nA nu se lăsa la îndemâna copiilor.\n\nSK\nUchovávajte mimo dosahu detí.\n\nSL\nHraniti zunaj dosega otrok.\n\nFI\nSäilytä lasten ulottumattomissa.\n\nSV\nFörvaras oåtkomligt för barn.\n\nP103\nLanguage\n\n\nBG\nПреди употреба прочетете етикета.\n\nES\nLeer la etiqueta antes del uso.\n\nCS\nPřed použitím si přečtěte údaje na štítku.\n\nDA\nLæs etiketten før brug.\n\nDE\nVor Gebrauch Kennzeichnungsetikett lesen.\n\nET\nEnne kasutamist tutvuda etiketil oleva infoga.\n\nEL\nΔιαβάστε την ετικέτα πριν από τη χρήση.\n\nEN\nRead label before use.\n\nFR\nLire l’étiquette avant utilisation.\n\nGA\nLéigh an lipéad roimh úsáid.\n\n\nHR\nPrije uporabe pročitati naljepnicu.\n\n\nIT\nLeggere l’etichetta prima dell’uso.\n\nLV\nPirms izmantošanas izlasīt etiķeti.\n\nLT\nPrieš naudojimą perskaityti etiketę.\n\nHU\nHasználat előtt olvassa el a címkén közölt információkat.\n\nMT\nAqra t-tikketta qabel l-użu.\n\nNL\nAlvorens te gebruiken, het etiket lezen.\n\nPL\nPrzed użyciem przeczytać etykietę.\n\nPT\nLer o rótulo antes da utilização.\n\nRO\nCitiți eticheta înainte de utilizare.\n\nSK\nPred použitím si prečítajte etiketu.\n\nSL\nPred uporabo preberite etiketo.\n\nFI\nLue merkinnät ennen käyttöä.\n\nSV\nLäs etiketten före användning.\n\nTable 1.2\nPrecautionary statements — Prevention\n\nP201\nLanguage\n\n\nBG\nПреди употреба се снабдете със специални инструкции.\n\nES\nPedir instrucciones especiales antes del uso.\n\nCS\nPřed použitím si obstarejte speciální instrukce.\n\nDA\nIndhent særlige anvisninger før brug.\n\nDE\nVor Gebrauch besondere Anweisungen einholen.\n\nET\nEnne kasutamist tutvuda erijuhistega.\n\nEL\nΕφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.\n\nEN\nObtain special instructions before use.\n\nFR\nSe procurer les instructions avant utilisation.\n\nGA\nFaigh treoracha speisialta roimh úsáid.\n\n\nHR\nPrije uporabe pribaviti posebne upute.\n\n\n\nIT\nProcurarsi istruzioni specifiche prima dell’uso.\n\nLV\nPirms lietošanas saņemt speciālu instruktāžu.\n\nLT\nPrieš naudojimą gauti specialias instrukcijas.\n\nHU\nHasználat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.\n\nMT\nIkseb struzzjonijiet speċjali qabel l-użu.\n\nNL\nAlvorens te gebruiken de speciale aanwijzingen raadplegen.\n\nPL\nPrzed użyciem zapoznać się ze specjalnymi środkami ostrożności.\n\nPT\nPedir instruções específicas antes da utilização.\n\nRO\nProcurați instrucțiuni speciale înainte de utilizare.\n\nSK\nPred použitím sa oboznámte s osobitnými pokynmi.\n\nSL\nPred uporabo pridobiti posebna navodila.\n\nFI\nLue erityisohjeet ennen käyttöä.\n\nSV\nInhämta särskilda instruktioner före användning.\n\nP202\nLanguage\n\n\nBG\nНе използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.\n\nES\nNo manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.\n\nCS\nNepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.\n\nDA\nAnvend ikke produktet, før alle advarsler er læst og forstået.\n\nDE\nVor Gebrauch alle Sicherheitshinweise lesen und verstehen.\n\nET\nMitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.\n\nEL\nΜην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.\n\nEN\nDo not handle until all safety precautions have been read and understood.\n\nFR\nNe pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.\n\nGA\nNá láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.\n\n\nHR\nNe rukovati prije upoznavanja i razumijevanja sigurnosnih mjera predostrožnosti.\n\n\nIT\nNon manipolare prima di avere letto e compreso tutte le avvertenze.\n\nLV\nNeizmantot pirms nav izlasīti un saprasti visi apzīmējumi.\n\nLT\nNenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.\n\nHU\nNe használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.\n\nMT\nTmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.\n\nNL\nPas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft\n\nPL\nNie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.\n\nPT\nNão manuseie o produto antes de ter lido e percebido todas as precauções de segurança.\n\nRO\nA nu se manipula decât după ce au fost citite și înțelese toate măsurile de securitate.\n\nSK\nNepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.\n\nSL\nNe uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.\n\nFI\nLue varoitukset huolellisesti ennen käsittelyä.\n\nSV\nAnvänd inte produkten innan du har läst och förstått säkerhetsanvisningarna\n\nP210\nLanguage\n\n\nBG\nДа се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.\n\nES\nMantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.\n\nCS\nChraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.\n\nDA\nHoldes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.\n\nDE\nVon Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.\n\nET\nHoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.\n\nEL\nΜακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.\n\nEN\nKeep away from heat/sparks/open flames/hot surfaces. — No smoking.\n\nFR\nTenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.\n\nGA\nCoimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.\n\n\nHR\nČuvati odvojeno od topline/iskre/otvorenog plamena/vrućih površina. – Ne pušiti.\n\n\nIT\nTenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.\n\nLV\nNelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.\n\nLT\nLaikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.\n\nHU\nHőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.\n\nMT\nŻomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.\n\nNL\nVerwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.\n\nPL\nPrzechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.\n\nPT\nManter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.\n\nRO\nA se păstra departe de surse de căldură/scântei/flăcări deschise/suprafețe încinse. — Fumatul interzis.\n\nSK\nUchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.\n\nSL\nHraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.\n\nFI\nSuojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.\n\nSV\nFår inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.\n\nP211\nLanguage\n\n\nBG\nДа не се пръска към открит пламък или друг източник на запалване.\n\nES\nNo pulverizar sobre una llama abierta u otra fuente de ignición.\n\nCS\nNestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.\n\nDA\nSpray ikke mod åben ild eller andre antændelseskilder.\n\nDE\nNicht gegen offene Flamme oder andere Zündquelle sprühen.\n\nET\nMitte pihustada leekidesse või muusse süüteallikasse.\n\nEL\nΜην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.\n\nEN\nDo not spray on an open flame or other ignition source.\n\nFR\nNe pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.\n\nGA\nNá spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.\n\n\nHR\nNe prskati u otvoreni plamen ili drugi izvor paljenja.\n\n\nIT\nNon vaporizzare su una fiamma libera o altra fonte di accensione.\n\nLV\nNeizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.\n\nLT\nNepurkšti į atvirą liepsną arba kitus degimo šaltinius.\n\nHU\nTilos nyílt lángra vagy más gyújtóforrásra permetezni.\n\nMT\nTisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.\n\nNL\nNiet in een open vuur of op andere ontstekingsbronnen spuiten.\n\nPL\nNie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.\n\nPT\nNão pulverizar sobre chama aberta ou outra fonte de ignição.\n\nRO\nNu pulverizați deasupra unei flăcări deschise sau unei alte surse de aprindere.\n\nSK\nNestriekajte na otvorený oheň ani iný zdroj zapálenia.\n\nSL\nNe pršiti proti odprtemu ognju ali drugemu viru vžiga.\n\nFI\nEi saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.\n\nSV\nSpreja inte över öppen låga eller andra antändningskällor.\n\nP220\nLanguage\n\n\nBG\nДа се държи/съхранява далеч от облекло/…/горими материали\n\nES\nMantener o almacenar alejado de la ropa/…/materiales combustibles.\n\nCS\nUchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.\n\nDA\nMå ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.\n\nDE\nVon Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.\n\nET\nHoida eemal rõivastest/…/süttivast materjalist.\n\nEL\nΔιατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.\n\nEN\nKeep/Store away from clothing/…/combustible materials.\n\nFR\nTenir/stocker à l’écart des vêtements/…/matières combustibles\n\nGA\nCoimeád/Stóráil glan ar éadaí/…/ábhair indóite.\n\n\nHR\nČuvati/skladištiti odvojeno od odjeće/…/zapaljivih materijala.\n\n\nIT\nTenere/conservare lontano da indumenti/…/materiali combustibili.\n\nLV\nTurēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.\n\nLT\nLaikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.\n\nHU\nRuhától/…/éghető anyagtól távol tartandó/tárolandó.\n\nMT\nŻomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.\n\nNL\nVan kleding/…/brandbare stoffen verwijderd houden/bewaren.\n\nPL\nTrzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.\n\nPT\nManter/guardar afastado de roupa/…/matérias combustíveis.\n\nRO\nA se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.\n\nSK\nUchovávajte/skladujte mimo odevov/…/horľavých materiálov.\n\nSL\nHraniti ločeno od oblačil/…/vnetljivih materialov.\n\nFI\nPidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.\n\nSV\nHålls/förvarad åtskilt från kläder/…/brännbara material.\n\nP221\nLanguage\n\n\nBG\nВземете всички предпазни мерки за избягване на смесването с горими материали…\n\nES\nTomar todas las precauciones necesarias para no mezclar con materias combustibles…\n\nCS\nProveďte preventivní opatření proti smíchání s hořlavými materiály…\n\nDA\nUndgå at blande med brændbare materialer…\n\nDE\nMischen mit brennbaren Stoffen/… unbedingt verhindern.\n\nET\nRakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…\n\nEL\nΛάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…\n\nEN\nTake any precaution to avoid mixing with combustibles…\n\nFR\nPrendre toutes précautions pour éviter de mélanger avec des matières combustibles…\n\nGA\nDéan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…\n\n\nHR\nPoduzeti sve mjere opreza za sprječavanje miješanja sa zapaljivim …\n\n\nIT\nPrendere ogni precauzione per evitare di miscelare con sostanze combustibili…\n\nLV\nNekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…\n\nLT\nImtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…\n\nHU\nMinden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.\n\nMT\nĦu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…\n\nNL\nVermenging met brandbare stoffen… absoluut vermijden.\n\nPL\nZastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …\n\nPT\nTomar todas as precauções para não misturar com combustíveis…\n\nRO\nLuați toate măsurile de precauție pentru a evita amestecul cu combustibili…\n\nSK\nPrijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…\n\nSL\nPreprečiti mešanje z vnetljivimi snovmi …\n\nFI\nVaro sekoittamasta syttyvien materiaalien… kanssa.\n\nSV\nUndvik att blanda med med brännbara ämnen…\n\nP222\nLanguage\n\n\nBG\nНе допускайте конктакт с въздух.\n\nES\nNo dejar que entre en contacto con el aire.\n\nCS\nZabraňte styku se vzduchem.\n\nDA\nUndgå kontakt med luft.\n\nDE\nKontakt mit Luft nicht zulassen.\n\nET\nHoida õhuga kokkupuute eest.\n\nEL\nΝα μην έρθει σε επαφή με τον αέρα.\n\nEN\nDo not allow contact with air.\n\nFR\nNe pas laisser au contact de l’air.\n\nGA\nNá ceadaigh teagmháil le haer.\n\n\nHR\nSpriječiti dodir sa zrakom.\n\n\nIT\nEvitare il contatto con l’aria.\n\nLV\nNepieļaut kontaktu ar gaisu.\n\nLT\nSaugoti nuo kontakto su oru.\n\nHU\nNem érintkezhet levegővel.\n\nMT\nTħallix li jkun hemm kuntatt ma' l-arja.\n\nNL\nContact met de lucht vermijden.\n\nPL\nNie dopuszczać do kontaktu z powietrzem.\n\nPT\nNão deixar entrar em contacto com o ar.\n\nRO\nA nu se lăsa în contact cu aerul.\n\nSK\nZabráňte kontaktu so vzduchom.\n\nSL\nPreprečiti stik z zrakom.\n\nFI\nEi saa joutua kosketuksiin ilman kanssa.\n\nSV\nUndvik kontakt med luft.\n\nP223\nLanguage\n\n\nBG\nДа се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.\n\nES\nMantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.\n\nCS\nChraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.\n\nDA\nUndgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.\n\nDE\nKontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.\n\nET\nHoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.\n\nEL\nΑποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.\n\nEN\nKeep away from any possible contact with water, because of violent reaction and possible flash fire.\n\nFR\nÉviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.\n\nGA\nNá ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.\n\n\nHR\nSpriječiti svaki dodir s vodom zbog burne reakcije i mogućeg zapaljenja.\n\n\nIT\nEvitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.\n\nLV\nNepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.\n\nLT\nSaugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.\n\nHU\nVízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.\n\nMT\nŻomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.\n\nNL\nContact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.\n\nPL\nChronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.\n\nPT\nNão deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.\n\nRO\nA se evita orice contact cu apa, din cauza reacției violente și a riscului de aprindere spontană.\n\nSK\nZabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.\n\nSL\nHraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.\n\nFI\nEi saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.\n\nSV\nUndvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.\n\nP230\nLanguage\n\n\nBG\nДа се държи навлажнен с…\n\nES\nMantener humedecido con…\n\nCS\nUchovávejte ve zvlhčeném stavu…\n\nDA\nHoldes befugtet med…\n\nDE\nFeucht halten mit …\n\nET\nNiisutada …-ga.\n\nEL\nΝα διατηρείται υγρό με …\n\nEN\nKeep wetted with…\n\nFR\nMaintenir humidifié avec…\n\nGA\nCoimeád fliuchta le…\n\n\nHR\nČuvati navlaženo s …\n\n\nIT\nMantenere umido con…\n\nLV\nVienmēr samitrināt ar …\n\nLT\nLaikyti sudrėkintą (kuo)\n\nHU\n…-val/-vel nedvesítve tartandó.\n\nMT\nŻommu mxarrab bi …\n\nNL\nVochtig houden met…\n\nPL\nPrzechowywać produkt zwilżony…\n\nPT\nManter húmido com…\n\nRO\nA se păstra umezit cu…\n\nSK\nUchovávajte zvlhčené …\n\nSL\nHraniti prepojeno z …\n\nFI\nSäilytä kostutettuna …\n\nSV\nSka hållas fuktigt med…\n\nP231\nLanguage\n\n\nBG\nДа се използва под инертен газ.\n\nES\nManipular en gas inerte.\n\nCS\nManipulace pod inertním plynem.\n\nDA\nHåndteres under inaktiv gas.\n\nDE\nUnter inertem Gas handhaben.\n\nET\nKäidelda inertgaasis.\n\nEL\nΧειρισμός σε αδρανή ατμόσφαιρα.\n\nEN\nHandle under inert gas.\n\nFR\nManipuler sous gaz inerte.\n\nGA\nLáimhsigh faoi thriathghás.\n\n\nHR\nRukovati u inertnom plinu.\n\n\nIT\nManipolare in atmosfera di gas inerte.\n\nLV\nRīkoties tikai inertas gāzes apstākļos.\n\nLT\nTvarkyti inertinėse dujose.\n\nHU\nInert gázban használandó.\n\nMT\nImmaniġġja taħt gass inerti.\n\nNL\nOnder inert gas werken.\n\nPL\nUżywać w atmosferze obojętnego gazu.\n\nPT\nManusear em atmosfera de gás inerte.\n\nRO\nA se manipula sub un gaz inert.\n\nSK\nManipulujte v prostredí s inertným plynom.\n\nSL\nHraniti v ustreznem inertnem plinu.\n\nFI\nKäsittele inertissä kaasussa.\n\nSV\nHanteras under inert gas.\n\nP232\nLanguage\n\n\nBG\nДа се пази от влага.\n\nES\nProteger de la humedad.\n\nCS\nChraňte před vlhkem.\n\nDA\nBeskyttes mod fugt.\n\nDE\nVor Feuchtigkeit schützen.\n\nET\nHoida niiskuse eest.\n\nEL\nΠροστετέψτε από την υγρασία.\n\nEN\nProtect from moisture.\n\nFR\nProtéger de l’humidité.\n\nGA\nCosain ar thaise.\n\n\nHR\nZaštititi od vlage.\n\n\nIT\nProteggere dall’umidità.\n\nLV\nAizsargāt no mitruma.\n\nLT\nSaugoti nuo drėgmės.\n\nHU\nNedvességtől védendő.\n\nMT\nIpproteġi mill-umdità.\n\nNL\nTegen vocht beschermen.\n\nPL\nChronić przed wilgocią.\n\nPT\nManter ao abrigo da humidade.\n\nRO\nA se proteja de umiditate.\n\nSK\nChráňte pred vlhkosťou.\n\nSL\nZaščititi pred vlago.\n\nFI\nSuojaa kosteudelta.\n\nSV\nSkyddas från fukt.\n\nP233\nLanguage\n\n\nBG\nСъдът да се съхранява плътно затворен.\n\nES\nMantener el recipiente herméticamente cerrado.\n\nCS\nUchovávejte obal těsně uzavřený.\n\nDA\nHold beholderen tæt lukket.\n\nDE\nBehälter dicht verschlossen halten.\n\nET\nHoida pakend tihedalt suletuna.\n\nEL\nΝα διατηρείται ο περιέκτης ερμητικά κλειστός.\n\nEN\nKeep container tightly closed.\n\nFR\nMaintenir le récipient fermé de manière étanche.\n\nGA\nCoimeád an coimeádán dúnta go docht.\n\n\nHR\nČuvati u dobro zatvorenom spremniku.\n\n\nIT\nTenere il recipiente ben chiuso.\n\nLV\nTvertni stingri noslēgt.\n\nLT\nTalpyklą laikyti sandariai uždarytą.\n\nHU\nAz edény szorosan lezárva tartandó.\n\nMT\nŻomm il-kontenitur magħluq sew.\n\nNL\nIn goed gesloten verpakking bewaren.\n\nPL\nPrzechowywać pojemnik szczelnie zamknięty.\n\nPT\nManter o recipiente bem fechado.\n\nRO\nPăstrați recipientul închis etanș.\n\nSK\nNádobu uchovávajte tesne uzavretú.\n\nSL\nHraniti v tesno zaprti posodi.\n\nFI\nSäilytä tiiviisti suljettuna.\n\nSV\nBehållaren ska vara väl tillsluten.\n\nP234\nLanguage\n\n\nBG\nДа се съхранява само в оригиналната опаковка.\n\nES\nConservar únicamente en el recipiente original.\n\nCS\nUchovávejte pouze v původním obalu.\n\nDA\nOpbevares kun i den originale beholder.\n\nDE\nNur im Originalbehälter aufbewahren.\n\nET\nHoida üksnes originaalpakendis.\n\nEL\nΝα διατηρείται μόνο στον αρχικό περιέκτη.\n\nEN\nKeep only in original container.\n\nFR\nConserver uniquement dans le récipient d’origine.\n\nGA\nCoimeád sa choimeádán bunaidh amháin.\n\n\nHR\nČuvati samo u originalnom spremniku.\n\n\nIT\nConservare soltanto nel contenitore originale.\n\nLV\nTurēt tikai oriģinālā iepakojumā.\n\nLT\nLaikyti tik originalioje talpykloje.\n\nHU\nAz eredeti edényben tartandó.\n\nMT\nŻomm biss fil-kontenitur oriġinali.\n\nNL\nUitsluitend in de oorspronkelijke verpakking bewaren.\n\nPL\nPrzechowywać wyłącznie w oryginalnym pojemniku.\n\nPT\nConservar unicamente no recipiente de origem.\n\nRO\nPăstrați numai în recipientul original.\n\nSK\nUchovávajte iba v pôvodnej nádobe.\n\nSL\nHraniti samo v originalni posodi.\n\nFI\nSäilytä alkuperäispakkauksessa.\n\nSV\nFörvaras endast i originalbehållaren.\n\nP235\nLanguage\n\n\nBG\nДа се държи на хладно.\n\nES\nMantener en lugar fresco.\n\nCS\nUchovávejte v chladu.\n\nDA\nOpbevares køligt.\n\nDE\nKühl halten.\n\nET\nHoida jahedas.\n\nEL\nΝα διατηρείται δροσερό.\n\nEN\nKeep cool.\n\nFR\nTenir au frais.\n\nGA\nCoimeád fionnuar é\n\n\nHR\nOdržavati hladnim.\n\n\nIT\nConservare in luogo fresco.\n\nLV\nTurēt vēsumā.\n\nLT\nLaikyti vėsioje vietoje.\n\nHU\nHűvös helyen tartandó.\n\nMT\nŻomm frisk.\n\nNL\nKoel bewaren.\n\nPL\nPrzechowywać w chłodnym miejscu.\n\nPT\nConservar em ambiente fresco.\n\nRO\nA se păstra la rece.\n\nSK\nUchovávajte v chlade.\n\nSL\nHraniti na hladnem.\n\nFI\nSäilytä viileässä.\n\nSV\nFörvaras svalt.\n\nP240\nLanguage\n\n\nBG\nЗаземяване/еквипотенциална връзка на съда и приемателното устройство.\n\nES\nConectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.\n\nCS\nUzemněte obal a odběrové zařízení.\n\nDA\nBeholder og modtageudstyr jordforbindes/potentialudlignes.\n\nDE\nBehälter und zu befüllende Anlage erden.\n\nET\nMahuti ja vastuvõtuseade maandada/ühendada.\n\nEL\nΓείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.\n\nEN\nGround/bond container and receiving equipment.\n\nFR\nMise à la terre/liaison équipotentielle du récipient et du matériel de réception.\n\nGA\nNasc an coimeádán agus an trealamh glactha leis an talamh.\n\n\nHR\nUzemljiti/učvrstiti spremnik i opremu za prihvat kemikalije.\n\n\nIT\nMettere a terra/massa il contenitore e il dispositivo ricevente.\n\nLV\nTvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt\n\nLT\nĮžeminti/įtvirtinti talpyklą ir priėmimo įrangą.\n\nHU\nA tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.\n\nMT\nPoġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.\n\nNL\nOpslag- en opvangreservoir aarden.\n\nPL\nUziemić/połączyć pojemnik i sprzęt odbiorczy.\n\nPT\nLigação à terra/equipotencial do recipiente e do equipamento receptor.\n\nRO\nLegătură la pământ/conexiune echipotențială cu recipientul și cu echipamentul de recepție.\n\nSK\nUzemnite/upevnite nádobu a plniace zariadenie.\n\nSL\nOzemljiti posodo in opremo za sprejem tekočine.\n\nFI\nSäiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.\n\nSV\nJorda/potentialförbind behållare och mottagarutrustning.\n\nP241\nLanguage\n\n\nBG\nИзползвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия\n\nES\nUtilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.\n\nCS\nPoužívejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.\n\nDA\nAnvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.\n\nDE\nExplosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.\n\nET\nKasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.\n\nEL\nΝα χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.\n\nEN\nUse explosion-proof electrical/ventilating/lighting/…/equipment.\n\nFR\nUtiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.\n\nGA\nBain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…\n\n\nHR\nRabiti električnu/ventilacijsku/rasvjetnu/…/opremu koja neće izazvati eksploziju.\n\n\nIT\nUtilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.\n\nLV\nIzmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas\n\nLT\nNaudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.\n\nHU\nRobbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.\n\nMT\nUża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.\n\nNL\nExplosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.\n\nPL\nUżywać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.\n\nPT\nUtilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.\n\nRO\nUtilizați echipamente electrice/de ventilare/de iluminat/…/antideflagrante.\n\nSK\nPoužívajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.\n\nSL\nUporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.\n\nFI\nKäytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.\n\nSV\nAnvänd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.\n\nP242\nLanguage\n\n\nBG\nИзползвайте само инструменти, които не предизвикват искри.\n\nES\nUtilizar únicamente herramientas que no produzcan chispas.\n\nCS\nPoužívejte pouze nářadí z nejiskřícího kovu.\n\nDA\nAnvend kun værktøj, som ikke frembringer gnister.\n\nDE\nNur funkenfreies Werkzeug verwenden.\n\nET\nMitte kasutada seadmeid, mis võivad tekitada sädemeid.\n\nEL\nΝα χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.\n\nEN\nUse only non-sparking tools.\n\nFR\nNe pas utiliser d'outils produisant des étincelles.\n\nGA\nBain úsáid as uirlisí neamhspréachta amháin.\n\n\nHR\nRabiti samo neiskreći alat.\n\n\nIT\nUtilizzare solo utensili antiscintillamento.\n\nLV\nIzmantot instrumentus, kas nerada dzirksteles.\n\nLT\nNaudoti tik kibirkščių nekeliančius įrankius.\n\nHU\nSzikramentes eszközök használandók.\n\nMT\nUża’ biss għodda li ma jtajrux żnied.\n\nNL\nUitsluitend vonkvrij gereedschap gebruiken.\n\nPL\nUżywać wyłącznie nieiskrzących narzędzi.\n\nPT\nUtilizar apenas ferramentas antichispa.\n\nRO\nNu utilizați unelte care produc scântei.\n\nSK\nPoužívajte iba neiskriace prístroje.\n\nSL\nUporabiti le orodje, ki ne povzroča isker.\n\nFI\nKäytä ainoastaan kipinöimättömiä työkaluja.\n\nSV\nAnvänd endast verktyg som inte ger upphov till gnistor.\n\nP243\nLanguage\n\n\nBG\nВземете предпазни мерки срещу освобождаване на статично електричество.\n\nES\nTomar medidas de precaución contra descargas electrostáticas.\n\nCS\nProveďte preventivní opatření proti výbojům statické elektřiny.\n\nDA\nTræf foranstaltninger mod statisk elektricitet.\n\nDE\nMaßnahmen gegen elektrostatische Aufladungen treffen.\n\nET\nRakendada ettevaatusabinõusid staatilise elektri vastu.\n\nEL\nΛάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.\n\nEN\nTake precautionary measures against static discharge.\n\nFR\nPrendre des mesures de précaution contre les décharges électrostatiques.\n\nGA\nDéan bearta réamhchúraim in aghaidh díluchtú statach.\n\n\n\nHR\nPoduzeti mjere protiv pojave statičkog elektriciteta.\n\n\nIT\nPrendere precauzioni contro le scariche elettrostatiche.\n\nLV\nNodrošināties pret statiskās enerģijas izlādi.\n\nLT\nImtis atsargumo priemonių statinei iškrovai išvengti.\n\nHU\nAz elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.\n\nMT\nĦu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.\n\nNL\nVoorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.\n\nPL\nPrzedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.\n\nPT\nEvitar acumulação de cargas electrostáticas.\n\nRO\nLuați măsuri de precauție împotriva descărcărilor electrostatice.\n\nSK\nUrobte preventívne opatrenia proti výbojom statickej elektriny.\n\nSL\nPreprečiti statično naelektrenje.\n\nFI\nEstä staattisen sähkön aiheuttama kipinöinti.\n\nSV\nVidta åtgärder mot statisk elektricitet.\n\nP244\nLanguage\n\n\nBG\nПочиствайте редуциращите вентили от смазка и масло\n\nES\nMantener las válvulas de reducción limpias de grasa y aceite.\n\nCS\nUdržujte redukční ventily bez maziva a oleje.\n\nDA\nReduktionsventilerne holdes fri for fedt og olie.\n\nDE\nDruckminderer frei von Fett und Öl halten.\n\nET\nHoida reduktsiooniklapid rasvast ja õlist puhtad.\n\nEL\nΝα διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.\n\nEN\nKeep reduction valves free from grease and oil.\n\nFR\nS’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.\n\nGA\nCoimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.\n\n\nHR\nSpriječiti dodir redukcijskih ventila s masti i uljem.\n\n\nIT\nMantenere le valvole di riduzione libere da grasso e olio.\n\nLV\nTurēt reducēšanās vārstus tīrus no taukiem un eļļas.\n\nLT\nSaugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.\n\nHU\nA nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.\n\nMT\nŻomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.\n\nNL\nReduceerventielen vrij van olie en vet houden.\n\nPL\nChronić zawory redukcyjne przed tłuszczem i olejem.\n\nPT\nManter as válvulas de redução isentas de óleo e massa lubrificantes.\n\nRO\nProtejați supapele reductoare de grăsimi și ulei.\n\nSK\nRedukčné ventily udržiavajte bez mazadiel a oleja.\n\nSL\nPreprečiti stik reducirnih ventilov z mastjo in oljem.\n\nFI\nPidä paineenalennusventtiilit vapaana rasvasta ja öljystä.\n\nSV\nReducerventilerna ska hållas fria från fett och olja.\n\nP250\nLanguage\n\n\nBG\nДа не се подлага на стържене/удар/…/триене\n\nES\nEvitar la abrasión/el choque/…/la fricción.\n\nCS\nNevystavujte obrušování/nárazům/…/tření.\n\nDA\nMå ikke udsættes for slibning/stød/…/gnidning.\n\nDE\nNicht schleifen/stoßen/…/reiben.\n\nET\nHoida kriimustamise/põrutuse/…/hõõrdumise eest.\n\nEL\nΝα αποφεύγεται άλεση/κρούση/…/τριβή.\n\nEN\nDo not subject to grinding/shock/…/friction.\n\nFR\nÉviter les abrasions/les chocs/…/les frottements.\n\nGA\nNá nocht do mheilt/do thurraing/…/do fhrithchuimilt.\n\n\nHR\nNe izlagati mrvljenju/udarcima/…/trenju.\n\n\nIT\nEvitare le abrasioni/gli urti/…/gli attriti.\n\nLV\nNepakļaut drupināšanai/triecienam/…/berzei\n\nLT\nNešlifuoti/netrankyti/…/netrinti.\n\nHU\nTilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.\n\nMT\nTissottoponihomx għal brix/xokk/…/frizzjoni.\n\nNL\nMalen/schokken/…/wrijving vermijden.\n\nPL\nNie poddawać szlifowaniu/wstrząsom/…/tarciu.\n\nPT\nNão submeter a trituração/choque/…/fricção.\n\nRO\nA nu supune la abraziuni/șocuri/…/frecare.\n\nSK\nNevystavujte brúseniu/nárazu/…/treniu.\n\nSL\nNe izpostavljati drgnjenju/udarcem/…/trenju.\n\nFI\nSuojele rasitukselta/iskuilta/…/hankaukselta.\n\nSV\nFår inte utsättas för gnidning/stötar/…/friktion.\n\nP251\nLanguage\n\n\nBG\nСъд под налягане: да не се пробива и изгаря дори след употреба.\n\nES\nRecipiente a presión: no perforar ni quemar, aun después del uso.\n\nCS\nTlakový obal: nepropichujte nebo nespalujte ani po použití.\n\nDA\nBeholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.\n\nDE\nBehälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.\n\nET\nMahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.\n\nEL\nΠεριέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.\n\nEN\nPressurized container: Do not pierce or burn, even after use.\n\nFR\nRécipient sous pression: ne pas perforer, ni brûler, même après usage.\n\nGA\nCoimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.\n\n\nHR\nPosuda je pod tlakom: ne bušiti, niti paliti čak niti nakon uporabe.\n\n\nIT\nRecipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.\n\nLV\nTvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.\n\nLT\nSlėginis indas. Nepradurti ir nedeginti net panaudoto.\n\nHU\nNyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.\n\nMT\nKontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.\n\nNL\nHouder onder druk: ook na gebruik niet doorboren of verbranden.\n\nPL\nPojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.\n\nPT\nRecipiente sob pressão. Não furar nem queimar, mesmo após utilização.\n\nRO\nRecipient sub presiune. Nu perforați sau ardeți, chiar și după utilizare.\n\nSK\nNádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.\n\nSL\nPosoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.\n\nFI\nPainesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.\n\nSV\nTryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.\n\nP260\nLanguage\n\n\nBG\nНе вдишвайте прах/пушек/газ/дим/изпарения/аерозоли\n\nES\nNo respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.\n\nCS\nNevdechujte prach/dým/plyn/mlhu/páry/aerosoly.\n\nDA\nIndånd ikke pulver/røg/gas/tåge/damp/spray.\n\nDE\nStaub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.\n\nET\nTolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.\n\nEL\nΜην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα\n\nEN\nDo not breathe dust/fume/gas/mist/vapours/spray.\n\nFR\nNe pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.\n\nGA\nNá hanálaigh deannach/múch/gás/ceo/gala/sprae.\n\n\nHR\nNe udisati prašinu/dim/plin/maglu/pare/aerosol.\n\n\nIT\nNon respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.\n\nLV\nNeieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.\n\nLT\nNeįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.\n\nHU\nA por/füst/gáz/köd/gőzök/permet belélegzése tilos.\n\nMT\nTiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.\n\nNL\nStof/rook/gas/nevel/damp/spuitnevel niet inademen.\n\nPL\nNie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.\n\nPT\nNão respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.\n\nRO\nNu inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.\n\nSK\nNevdychujte prach/dym/plyn/hmlu/pary/aerosóly.\n\nSL\nNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.\n\nFI\nÄlä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.\n\nSV\nInandas inte damm/rök/gaser/dimma/ångor/sprej.\n\nP261\nLanguage\n\n\nBG\nИзбягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли\n\nES\nEvitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.\n\nCS\nZamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.\n\nDA\nUndgå indånding af pulver/røg/gas/tåge/damp/spray.\n\nDE\nEinatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.\n\nET\nVältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.\n\nEL\nAποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.\n\nEN\nAvoid breathing dust/fume/gas/mist/vapours/spray.\n\nFR\nÉviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.\n\nGA\nSeachain deannach/múch/gás/ceo/gala/sprae a análú.\n\n\nHR\nIzbjegavati udisanje prašine/dima/plina/magle/pare/aerosola.\n\n\nIT\nEvitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.\n\nLV\nIzvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.\n\nLT\nStengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.\n\nHU\nKerülje a por/füst/gáz/köd/gőzök/permet belélegzését.\n\nMT\nEvita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.\n\nNL\nInademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.\n\nPL\nUnikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.\n\nPT\nEvitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.\n\nRO\nEvitați să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.\n\nSK\nZabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.\n\nSL\nNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.\n\nFI\nVältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.\n\nSV\nUndvik att inandas damm/rök/gaser/dimma/ångor/sprej.\n\nP262\nLanguage\n\n\nBG\nДа се избягва контакт с очите, кожата или облеклото.\n\nES\nEvitar el contacto con los ojos, la piel o la ropa.\n\nCS\nZabraňte styku s očima, kůží nebo oděvem.\n\nDA\nMå ikke komme i kontakt med øjne, hud eller tøj.\n\nDE\nNicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.\n\nET\nVältida silma, nahale või rõivastele sattumist.\n\nEL\nΝα μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.\n\nEN\nDo not get in eyes, on skin, or on clothing.\n\nFR\nÉviter tout contact avec les yeux, la peau ou les vêtements.\n\nGA\nNá lig sna súile, ar an gcraiceann, ná ar éadaí.\n\n\nHR\nSpriječiti dodir s očima, kožom ili odjećom.\n\n\nIT\nEvitare il contatto con gli occhi, la pelle o gli indumenti.\n\nLV\nNepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.\n\nLT\nSaugotis, kad nepatektų į akis, ant odos ar drabužių.\n\nHU\nSzembe, bőrre vagy ruhára nem kerülhet.\n\nMT\nIddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.\n\nNL\nContact met de ogen, de huid of de kleding vermijden.\n\nPL\nNie wprowadzać do oczu, na skórę lub na odzież.\n\nPT\nNão pode entrar em contacto com os olhos, a pele ou a roupa.\n\nRO\nEvitați orice contact cu ochii, pielea sau îmbrăcămintea.\n\nSK\nZabráňte kontaktu s očami, pokožkou alebo odevom.\n\nSL\nPreprečiti stik z očmi, kožo ali oblačili.\n\nFI\nVaro kemikaalin joutumista silmiin, iholle tai vaatteisiin.\n\nSV\nFår inte komma i kontakt med ögonen, huden eller kläderna.\n\nP263\nLanguage\n\n\nBG\nДа се избягва контакт по време на бременност/при кърмене.\n\nES\nEvitar el contacto durante el embarazo/la lactancia.\n\nCS\nZabraňte styku během těhotenství/kojení.\n\nDA\nUndgå kontakt under graviditet/amning.\n\nDE\nKontakt während der Schwangerschaft/und der Stillzeit vermeiden.\n\nET\nVältida kokkupuudet raseduse/imetamise ajal.\n\nEL\nAποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.\n\nEN\nAvoid contact during pregnancy/while nursing.\n\nFR\nÉviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.\n\nGA\nSeachain teagmháil le linn toirchis/agus an chíoch á tabhairt.\n\n\nHR\nIzbjegavati dodir tijekom trudnoće/dojenja.\n\n\nIT\nEvitare il contatto durante la gravidanza/l’allattamento.\n\nLV\nIzvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.\n\nLT\nVengti kontakto nėštumo metu/maitinant krūtimi.\n\nHU\nA terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.\n\nMT\nEvita l-kuntatt waqt it-tqala/waqt it-treddigħ.\n\nNL\nBij zwangerschap of borstvoeding aanraking vermijden.\n\nPL\nUnikać kontaktu w czasie ciąży/karmienia piersią.\n\nPT\nEvitar o contacto durante a gravidez/o aleitamento.\n\nRO\nEvitați contactul în timpul sarcinii/alăptării.\n\nSK\nZabráňte kontaktu počas tehotenstva a dojčenia.\n\nSL\nPreprečiti stik med nosečnostjo/dojenjem.\n\nFI\nVältä kosketusta raskauden tai imetyksen aikana.\n\nSV\nUndvik kontakt under graviditet eller amning.\n\nP264\nLanguage\n\n\nBG\nДа се измие… старателно след употреба.\n\nES\nLavarse … concienzudamente tras la manipulación.\n\nCS\nPo manipulaci důkladně omyjte …\n\nDA\nVask … grundigt efter brug.\n\nDE\nNach Gebrauch … gründlich waschen.\n\nET\nPärast käitlemist pesta hoolega …\n\nEL\nΠλύνετε … σχολαστικά μετά το χειρισμό.\n\nEN\nWash … thoroughly after handling.\n\nFR\nSe laver … soigneusement après manipulation.\n\nGA\nNigh … go lánchúramach tar éis láimhsithe.\n\n\nHR\nNakon uporabe temeljito oprati …\n\n\nIT\nLavare accuratamente … dopo l’uso.\n\nLV\nPēc izmantošanas … kārtīgi nomazgāt.\n\nLT\nPo naudojimo kruopščiai nuplauti …\n\nHU\nA használatot követően a(z) … -t alaposan meg kell mosni.\n\nMT\nAħsel … sew wara li timmaniġġjah.\n\nNL\nNa het werken met dit product … grondig wassen.\n\nPL\nDokładnie umyć … po użyciu.\n\nPT\nLavar … cuidadosamente após manuseamento.\n\nRO\nSpălați-vă … bine după utilizare.\n\nSK\nPo manipulácii starostlivo umyte…\n\nSL\nPo uporabi temeljito umiti …\n\nFI\nPese … huolellisesti käsittelyn jälkeen.\n\nSV\nTvätta … grundligt efter användning.\n\nP270\nLanguage\n\n\nBG\nДа не се яде, пие или пуши при употреба на продукта.\n\nES\nNo comer, beber ni fumar durante su utilización.\n\nCS\nPři používání tohoto výrobku nejezte, nepijte ani nekuřte.\n\nDA\nDer må ikke spises, drikkes eller ryges under brugen af dette produkt.\n\nDE\nBei Gebrauch nicht essen, trinken oder rauchen.\n\nET\nToote käitlemise ajal mitte süüa, juua ega suitsetada.\n\nEL\nΜην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.\n\nEN\nDo no eat, drink or smoke when using this product.\n\nFR\nNe pas manger, boire ou fumer en manipulant ce produit.\n\nGA\nNá hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.\n\n\nHR\nPri rukovanju proizvodom ne jesti, piti niti pušiti.\n\n\nIT\nNon mangiare, né bere, né fumare durante l’uso.\n\nLV\nNeēst, nedzert un nesmēķēt produkta izmantošanas laikā.\n\nLT\nNaudojant šį produktą, nevalgyti, negerti ir nerūkyti.\n\nHU\nA termék használata közben tilos enni, inni vagy dohányozni.\n\nMT\nTikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.\n\nNL\nNiet eten, drinken of roken tijdens het gebruik van dit product.\n\nPL\nNie jeść, nie pić i nie palić podczas używania produktu.\n\nPT\nNão comer, beber ou fumar durante a utilização deste produto.\n\nRO\nA nu mânca, bea sau fuma în timpul utilizării produsului.\n\nSK\nPri používaní výrobku nejedzte, nepite ani nefajčite.\n\nSL\nNe jesti, piti ali kaditi med uporabo tega izdelka.\n\nFI\nSyöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.\n\nSV\nÄt inte, drick inte och rök inte när du använder produkten.\n\nP271\nLanguage\n\n\nBG\nДа се използва само на открито или на добре проветривомясто.\n\nES\nUtilizar únicamente en exteriores o en un lugar bien ventilado.\n\nCS\nPoužívejte pouze venku nebo v dobře větraných prostorách.\n\nDA\nBrug kun udendørs eller i et rum med god udluftning.\n\nDE\nNur im Freien oder in gut belüfteten Räumen verwenden.\n\nET\nKäidelda üksnes välitingimustes või hästi ventileeritavas kohas.\n\nEL\nΝα χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.\n\nEN\nUse only outdoors or in a well-ventilated area.\n\nFR\nUtiliser seulement en plein air ou dans un endroit bien ventilé.\n\nGA\nÚsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.\n\n\nHR\nRabiti samo na otvorenom ili u dobro prozračenom prostoru.\n\n\nIT\nUtilizzare soltanto all’aperto o in luogo ben ventilato.\n\nLV\nIzmantot tikai ārā vai labi vēdināmās telpās.\n\nLT\nNaudoti tik lauke arba gerai vėdinamoje patalpoje.\n\nHU\nKizárólag szabadban vagy jól szellőző helyiségben használható.\n\nMT\nUża biss barra jew f’post ventilat sew.\n\nNL\nAlleen buiten of in een goed geventileerde ruimte gebruiken.\n\nPL\nStosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu\n\nPT\nUtilizar apenas ao ar livre ou em locais bem ventilados.\n\nRO\nA se utiliza numai în aer liber sau în spații bine ventilate.\n\nSK\nPoužívajte iba na voľnom priestranstve alebo v dobre vetranom priestore.\n\nSL\nUporabljati le zunaj ali v dobro prezračevanem prostoru.\n\nFI\nKäytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.\n\nSV\nAnvänds endast utomhus eller i väl ventilerade utrymmen.\n\nP272\nLanguage\n\n\nBG\nДа не се изнася замърсено работно облекло извън работното помещение.\n\nES\nLas prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.\n\nCS\nKontaminovaný pracovní oděv neodnášejte z pracoviště.\n\nDA\nTilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.\n\nDE\nKontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.\n\nET\nSaastunud töörõivaid töökohast mitte välja viia.\n\nEL\nΤα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.\n\nEN\nContaminated work clothing should not be allowed out of the workplace.\n\nFR\nLes vêtements de travail contaminés ne devraient pas sortir du lieu de travail.\n\nGA\nNíor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.\n\n\nHR\nZagađena radna odjeća ne smije se iznositi izvan radnog prostora.\n\n\nIT\nGli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.\n\nLV\nPiesārņoto darba apģērbu neiznest ārpus darba telpām.\n\nLT\nUžterštų darbo drabužių negalima išnešti iš darbo vietos.\n\nHU\nSzennyezett munkaruhát tilos kivinni a munkahely területéről.\n\nMT\nIlbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.\n\nNL\nVerontreinigde werkkleding mag de werkruimte niet verlaten.\n\nPL\nZanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.\n\nPT\nA roupa de trabalho contaminada não pode sair do local de trabalho.\n\nRO\nNu scoateți îmbrăcămintea de lucru contaminată în afara locului de muncă.\n\nSK\nJe zakázané vyniesť kontaminovaný pracovný odev z pracoviska.\n\nSL\nKontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.\n\nFI\nSaastuneita työvaatteita ei saa viedä työpaikalta.\n\nSV\nNedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.\n\nP273\nLanguage\n\n\nBG\nДа се избягва изпускане в околната среда.\n\nES\nEvitar su liberación al medio ambiente.\n\nCS\nZabraňte uvolnění do životního prostředí.\n\nDA\nUndgå udledning til miljøet.\n\nDE\nFreisetzung in die Umwelt vermeiden.\n\nET\nVältida sattumist keskkonda.\n\nEL\nΝα αποφεύγεται η ελευθέρωση στο περιβάλλον.\n\nEN\nAvoid release to the environment.\n\nFR\nÉviter le rejet dans l’environnement.\n\nGA\nNá scaoiltear amach sa chomhshaol.\n\n\nHR\nIzbjegavati ispuštanje u okoliš.\n\n\nIT\nNon disperdere nell’ambiente.\n\nLV\nIzvairīties no izplatīšanas apkārtējā vidē.\n\nLT\nSaugoti, kad nepatektų į aplinką.\n\nHU\nKerülni kell az anyagnak a környezetbe való kijutását.\n\nMT\nEvita r-rilaxx fl-ambjent.\n\nNL\nVoorkom lozing in het milieu.\n\nPL\nUnikać uwolnienia do środowiska.\n\nPT\nEvitar a libertação para o ambiente.\n\nRO\nEvitați dispersarea în mediu.\n\nSK\nZabráňte uvoľneniu do životného prostredia.\n\nSL\nPreprečiti sproščanje v okolje.\n\nFI\nVältettävä päästämistä ympäristöön.\n\nSV\nUndvik utsläpp till miljön.\n\nP280\nLanguage\n\n\nBG\nИзползвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.\n\nES\nLlevar guantes/prendas/gafas/máscara de protección.\n\nCS\nPoužívejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.\n\nDA\nBær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse\n\nDE\nSchutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.\n\nET\nKanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.\n\nEL\nΝα φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.\n\nEN\nWear protective gloves/protective clothing/eye protection/face protection.\n\nFR\nPorter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.\n\nGA\nCaith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.\n\n\n\nHR\nNositi zaštitne rukavice/zaštitno odijelo/zaštitu za oči/zaštitu za lice.\n\n\nIT\nIndossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.\n\nLV\nIzmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.\n\nLT\nMūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.\n\nHU\nVédőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.\n\nMT\nIlbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.\n\nNL\nBeschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.\n\nPL\nStosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.\n\nPT\nUsar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.\n\nRO\nPurtați mănuși de protecție/îmbrăcăminte de protecție/echipament de protecție a ochilor/echipament de protecție a feței.\n\nSK\nNoste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.\n\nSL\nNositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.\n\nFI\nKäytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.\n\nSV\nAnvänd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.\n\nP281\nLanguage\n\n\nBG\nИзползвайте предписаните лични предпазни средства.\n\nES\nUtilizar el equipo de protección individual obligatorio.\n\nCS\nPoužívejte požadované osobní ochranné prostředky.\n\nDA\nAnvend de påkrævede personlige værnemidler.\n\nDE\nVorgeschriebene persönliche Schutzausrüstung verwenden.\n\nET\nKasutada vajalikke isikukaitsevahendeid.\n\nEL\nΧρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.\n\nEN\nUse personal protective equipment as required.\n\nFR\nUtiliser l’équipement de protection individuel requis.\n\nGA\nBain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.\n\n\nHR\nNositi propisanu osobnu zaštitnu opremu.\n\n\nIT\nUtilizzare il dispositivo di protezione individuale richiesto.\n\nLV\nIzmantot personisko aizsargaprīkojumu atbilstoši prasībām.\n\nLT\nNaudoti reikalaujamas asmenines apsaugos priemones.\n\nHU\nAz előírt egyéni védőfelszerelés használata kötelező.\n\nMT\nUża’ t-tagħmir personali protettiv kif meħtieġ.\n\nNL\nDe nodige persoonlijke beschermingsuitrusting gebruiken.\n\nPL\nStosować wymagane środki ochrony indywidualnej.\n\nPT\nUsar o equipamento de protecção individual exigido.\n\nRO\nUtilizați echipamentul de protecție individuală conform cerințelor.\n\nSK\nPoužívajte predpísané osobné ochranné prostriedky.\n\nSL\nUporabiti predpisano osebno zaščitno opremo.\n\nFI\nKäytä vaadittuja henkilönsuojaimia.\n\nSV\nAnvänd föreskriven personlig skyddsutrustning.\n\nP282\nLanguage\n\n\nBG\nНосете предпазващи от студ ръкавици/маска за лице/защитни очила.\n\nES\nLlevar guantes que aíslen del frío/gafas/máscara.\n\nCS\nPoužívejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.\n\nDA\nBær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.\n\nDE\nSchutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.\n\nET\nKanda külmakaitsekindaid/kaitsemaski/kaitseprille.\n\nEL\nΦοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.\n\nEN\nWear cold insulating gloves/face shield/eye protection.\n\nFR\nPorter des gants isolants contre le froid/un équipement de protection du visage/des yeux.\n\nGA\nCaith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.\n\n\n\nHR\nNositi zaštitne rukavice za hladnoću/zaštitu za lice/zaštitu za oči.\n\n\nIT\nUtilizzare guanti termici/schermo facciale/Proteggere gli occhi.\n\nLV\nIzmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.\n\nLT\nMūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.\n\nHU\nHidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.\n\nMT\nIlbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.\n\nNL\nKoude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.\n\nPL\nNosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.\n\nPT\nUsar luvas de protecção contra o frio/escudo facial/protecção ocular.\n\nRO\nPurtați mănuși izolante împotriva frigului/echipament de protecție a feței/ochilor.\n\nSK\nPoužívajte termostabilné rukavice/ochranný štít/ochranné okuliare.\n\nSL\nNositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.\n\nFI\nKäytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.\n\nSV\nAnvänd köldisolerande handskar/visir/ögonskydd.\n\nP283\nLanguage\n\n\nBG\nНосете огнеупорно/огнезащитно облекло.\n\nES\nLlevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.\n\nCS\nPoužívejte ohnivzdorný/nehořlavý oděv.\n\nDA\nBær brandbestandig/brandhæmmende beklædning.\n\nDE\nSchwer entflammbare/flammhemmende Kleidung tragen.\n\nET\nKanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.\n\nEL\nΦοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.\n\nEN\nWear fire/flame resistant/retardant clothing.\n\nFR\nPorter des vêtements résistant au feu/aux flammes/ignifuges.\n\nGA\nCaith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.\n\n\n\nHR\nNositi otpornu na vatru/nezapaljivu odjeću.\n\n\nIT\nIndossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.\n\nLV\nIzmantot aizsargapģērbu pret uguni/liesmām.\n\nLT\nDėvėti ugniai/liepsnai atsparius/antipireninius drabužius.\n\nHU\nTűz-/lángálló/-késleltető ruházat viselése kötelező.\n\nMT\nIlbies ħwejjeġ reżistenti għan-nar/fjammi.\n\nNL\nVuur/vlambestendige/brandwerende kleding dragen.\n\nPL\nNosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.\n\nPT\nUsar vestuário ignífugo/retardador de fogo/chamas.\n\nRO\nPurtați îmbrăcăminte rezistentă la foc/flacără/ignifugă.\n\nSK\nNoste ohňovzdorný odev/odev so zníženou horľavosťou.\n\nSL\nNositi negorljiva oblačila in oblačila, odporna proti ognju.\n\nFI\nKäytä palosuojattua/paloturvallista vaatetusta.\n\nSV\nAnvänd brand-/flamsäkra eller brand-/flamhämmande kläder.\n\nP284\nLanguage\n\n\nBG\nНосете респираторни предпазни средства.\n\nES\nLlevar equipo de protección respiratoria.\n\nCS\nPoužívejte vybavení pro ochranu dýchacích cest.\n\nDA\nAnvend åndedrætsværn.\n\nDE\nAtemschutz tragen.\n\nET\nKanda hingamisteede kaitsevahendeid.\n\nEL\nΦοράτε μέσα ατομικής προστασίας της αναπνοής.\n\nEN\nWear respiratory protection.\n\nFR\nPorter un équipement de protection respiratoire.\n\nGA\nCaith cosaint riospráide.\n\n\nHR\nNositi sredstva za zaštitu dišnog sustava.\n\n\nIT\nUtilizzare un apparecchio respiratorio.\n\nLV\nIzmantot gāzmasku.\n\nLT\nNaudoti kvėpavimo takų apsaugos priemones.\n\nHU\nLégzésvédelem használata kötelező.\n\nMT\nIlbes protezzjoni respiratorja.\n\nNL\nAdembescherming dragen.\n\nPL\nStosować indywidualne środki ochrony dróg oddechowych.\n\nPT\nUsar protecção respiratória.\n\nRO\nPurtați echipament de protecție respiratorie.\n\nSK\nPoužívajte ochranu dýchacích ciest.\n\nSL\nNositi opremo za zaščito dihal.\n\nFI\nKäytä hengityksensuojainta.\n\nSV\nAnvänd andningsskydd.\n\nP285\nLanguage\n\n\nBG\nВ случай на лоша вентилация носете респираторни предпазни средства.\n\nES\nEn caso de ventilación insuficiente, llevar equipo de protección respiratoria.\n\nCS\nV případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.\n\nDA\nVed utilstrækkelig udluftning anvendes åndedrætsværn.\n\nDE\nBei unzureichender Belüfung Atemschutz tragen.\n\nET\nEbapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.\n\nEL\nΣε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.\n\nEN\nIn case of inadequate ventilation wear respiratory protection.\n\nFR\nLorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.\n\nGA\nI gcás aerála uireasaigh caith cosaint riospráide.\n\n\nHR\nU slučaju nedovoljnog prozračivanja nositi sredstva za zaštitu dišnog sustava.\n\n\nIT\nIn caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.\n\nLV\nNeatbilstošas ventilācijas gadījumā izmantot gāzmasku.\n\nLT\nEsant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.\n\nHU\nNem megfelelő szellőzés esetén légzésvédelem kötelező.\n\nMT\nF’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.\n\nNL\nBij ontoereikende ventilatie een geschikte adembescherming dragen.\n\nPL\nW przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.\n\nPT\nEm caso de ventilação inadequada, usar protecção respiratória.\n\nRO\nÎn cazul în care ventilarea este insuficientă, purtați echipament de protecție respiratorie.\n\nSK\nV prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.\n\nSL\nOb nezadostnem prezračevanju nositi opremo za zaščito dihal.\n\nFI\nKäytä hengityksensuojainta, jos ilmanvaihto on riittämätön.\n\nSV\nAnvänd andningsskydd vid otillräcklig ventilation.\n\nP231 + P232\nLanguage\n\n\nBG\nДа се използва под инертен газ. Да се пази от влага.\n\nES\nManipular en gas inerte. Proteger de la humedad.\n\nCS\nManipulace pod inertním plynem. Chraňte před vlhkem.\n\nDA\nAnvendes under inaktiv gas. Beskyttes mod fugt.\n\nDE\nUnter inertem Gas handhaben. Vor Feuchtigkeit schützen.\n\nET\nKäidelda inertgaasis. Hoida niiskuse eest.\n\nEL\nΧειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.\n\nEN\nHandle under inert gas. Protect from moisture.\n\nFR\nManipuler sous gaz inerte. Protéger de l’humidité.\n\nGA\nLáimhsigh faoi thriathghás. Cosain ó thaise.\n\n\nHR\nRukovati u inertnom plinu. Zaštititi od vlage.\n\n\nIT\nManipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.\n\nLV\nIzmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.\n\nLT\nTvarkyti inertinėse dujose. Saugoti nuo drėgmės.\n\nHU\nInert gázban használandó. Nedvességtől védendő.\n\nMT\nUża’ taħt gass inerti. Ipproteġi mill-umdità.\n\nNL\nOnder inert gas werken. Tegen vocht beschermen.\n\nPL\nUżywać w atmosferze obojętnego gazu Chronić przed wilgocią.\n\nPT\nManusear em atmosfera de gás inerte. Manter ao abrigo da humidade.\n\nRO\nA se manipula sub un gaz inert. A se proteja de umiditate.\n\nSK\nManipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.\n\nSL\nHraniti v ustreznem inertnem plinu. Zaščititi pred vlago.\n\nFI\nKäsittele inertissä kaasussa. Suojaa kosteudelta.\n\nSV\nHanteras under inert gas. Skyddas från fukt.\n\nP235 + P410\nLanguage\n\n\nBG\nДа се държи на хладно. Да се пази от пряка слънчева светлина.\n\nES\nConservar en un lugar fresco. Proteger de la luz del sol.\n\nCS\nUchovávejte v chladu. Chraňte před slunečním zářením.\n\nDA\nOpbevares køligt. Beskyttes mod sollys.\n\nDE\nKühl halten. Vor Sonnenbestrahlung schützen.\n\nET\nHoida jahedas. Hoida päikesevalguse eest.\n\nEL\nΝα διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.\n\nEN\nKeep cool. Protect from sunlight.\n\nFR\nTenir au frais. Protéger du rayonnement solaire.\n\nGA\nCoimeád fionnuar. Cosain ó sholas na gréine.\n\n\nHR\nOdržavati hladnim. Zaštititi od sunčevog svjetla.\n\n\nIT\nTenere in luogo fresco. Proteggere dai raggi solari.\n\nLV\nTurēt vēsumā. Aizsargāt no saules gaismas.\n\nLT\nLaikyti vėsioje vietoje. Saugoti nuo saulės šviesos.\n\nHU\nHűvös helyen tartandó. Napfénytől védendő.\n\nMT\nŻomm frisk. Ipproteġi mir-raġġi tax-xemx.\n\nNL\nKoel bewaren. Tegen zonlicht beschermen.\n\nPL\nPrzechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.\n\nPT\nConservar em ambiente fresco. Manter ao abrigo da luz solar.\n\nRO\nA se păstra la rece. A se proteja de lumina solară.\n\nSK\nUchovávajte v chlade. Chráňte pred slnečným žiarením.\n\nSL\nHraniti na hladnem. Zaščititi pred sončno svetlobo.\n\nFI\nSäilytä viileässä. Suojaa auringonvalolta.\n\nSV\nFörvaras svalt. Skyddas från solljus.\n\nTable 1.3\nPrecautionary statements — Response\n\nP301\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ:\n\nES\nEN CASO DE INGESTIÓN:\n\nCS\nPŘI POŽITÍ:\n\nDA\nI TILFÆLDE AF INDTAGELSE:\n\nDE\nBEI VERSCHLUCKEN:\n\nET\nALLANEELAMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:\n\nEN\nIF SWALLOWED:\n\nFR\nEN CAS D’INGESTION:\n\nGA\nMÁ SHLOGTAR:\n\n\nHR\nAKO SE PROGUTA:\n\n\nIT\nIN CASO DI INGESTIONE:\n\nLV\nNORĪŠANAS GADĪJUMĀ:\n\nLT\nPRARIJUS:\n\nHU\nLENYELÉS ESETÉN:\n\nMT\nJEKK JINBELA’:\n\nNL\nNA INSLIKKEN:\n\nPL\nW PRZYPADKU POŁKNIĘCIA:\n\nPT\nEM CASO DE INGESTÃO:\n\nRO\nÎN CAZ DE ÎNGHIȚIRE:\n\nSK\nPO POŽITÍ:\n\nSL\nPRI ZAUŽITJU:\n\nFI\nJOS KEMIKAALIA ON NIELTY:\n\nSV\nVID FÖRTÄRING:\n\nP302\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА:\n\nES\nEN CASO DE CONTACTO CON LA PIEL:\n\nCS\nPŘI STYKU S KŮŽÍ:\n\nDA\nVED KONTAKT MED HUDEN:\n\nDE\nBEI BERÜHRUNG MIT DER HAUT:\n\nET\nNAHALE SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:\n\nEN\nIF ON SKIN:\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU:\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM:\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE:\n\nLV\nSASKARĒ AR ĀDU:\n\nLT\nPATEKUS ANT ODOS:\n\nHU\nHA BŐRRE KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MAL-ĠILDA:\n\nNL\nBIJ CONTACT MET DE HUID:\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ:\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE:\n\nRO\nÎN CAZ DE CONTACT CU PIELEA:\n\nSK\nPRI KONTAKTE S POKOŽKOU:\n\nSL\nPRI STIKU S KOŽO:\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE:\n\nSV\nVID HUDKONTAKT:\n\nP303\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА (или косата):\n\nES\nEN CASO DE CONTACTO CON LA PIEL (o el pelo):\n\nCS\nPŘI STYKU S KŮŽÍ (nebo s vlasy):\n\nDA\nVED KONTAKT MED HUDEN (eller håret):\n\nDE\nBEI BERÜHRUNG MIT DER HAUT (oder dem Haar):\n\nET\nNAHALE (või juustele) SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):\n\nEN\nIF ON SKIN (or hair):\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM (ili kosom):\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE (o con i capelli):\n\nLV\nSASKARĒ AR ĀDU (vai matiem):\n\nLT\nPATEKUS ANT ODOS (arba plaukų):\n\nHU\nHA BŐRRE (vagy hajra) KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):\n\nNL\nBIJ CONTACT MET DE HUID (of het haar):\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):\n\nRO\nÎN CAZ DE CONTACT CU PIELEA (sau părul):\n\nSK\nPRI KONTAKTE S POKOŽKOU (alebo vlasmi):\n\nSL\nPRI STIKU S KOŽO (ali lasmi):\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):\n\nSV\nVID HUDKONTAKT (även håret):\n\nP304\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ:\n\nES\nEN CASO DE INHALACIÓN:\n\nCS\nPŘI VDECHNUTÍ:\n\nDA\nVED INDÅNDING:\n\nDE\nBEI EINATMEN:\n\nET\nSISSEHINGAMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:\n\nEN\nIF INHALED:\n\nFR\nEN CAS D’INHALATION:\n\nGA\nMÁ IONANÁLAÍTEAR:\n\n\nHR\nAKO SE UDIŠE:\n\n\nIT\nIN CASO DI INALAZIONE:\n\nLV\nIEELPOJOT:\n\nLT\nĮKVĖPUS:\n\nHU\nBELÉLEGZÉS ESETÉN:\n\nMT\nJEKK JINĠIBED MAN-NIFS:\n\nNL\nNA INADEMING:\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:\n\nPT\nEM CASO DE INALAÇÃO:\n\nRO\nÎN CAZ DE INHALARE:\n\nSK\nPO VDÝCHNUTÍ:\n\nSL\nPRI VDIHAVANJU:\n\nFI\nJOS KEMIKAALIA ON HENGITETTY:\n\nSV\nVID INANDNING:\n\nP305\nLanguage\n\n\nBG\nПРИ КОНТАКТ С ОЧИТЕ:\n\nES\nEN CASO DE CONTACTO CON LOS OJOS:\n\nCS\nPŘI ZASAŽENÍ OČÍ:\n\nDA\nVED KONTAKT MED ØJNENE:\n\nDE\nBEI KONTAKT MIT DEN AUGEN:\n\nET\nSILMA SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:\n\nEN\nIF IN EYES:\n\nFR\nEN CAS DE CONTACT AVEC LES YEUX:\n\nGA\nI gCÁS TEAGMHÁLA LEIS NA SÚILE:\n\n\nHR\nU SLUČAJU DODIRA S OČIMA:\n\n\nIT\nIN CASO DI CONTATTO CON GLI OCCHI:\n\nLV\nIEKĻŪSTOT ACĪS:\n\nLT\nPATEKUS Į AKIS:\n\nHU\nSZEMBE KERÜLÉS ESETÉN:\n\nMT\nJEKK JIDĦOL FL-GĦAJNEJN:\n\nNL\nBIJ CONTACT MET DE OGEN:\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO OCZU:\n\nPT\nSE ENTRAR EM CONTACTO COM OS OLHOS:\n\nRO\nÎN CAZ DE CONTACT CU OCHII:\n\nSK\nPO ZASIAHNUTÍ OČÍ:\n\nSL\nPRI STIKU Z OČMI:\n\nFI\nJOS KEMIKAALIA JOUTUU SILMIIN:\n\nSV\nVID KONTAKT MED ÖGONEN:\n\nP306\nLanguage\n\n\nBG\nПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:\n\nES\nEN CASO DE CONTACTO CON LA ROPA:\n\nCS\nPŘI STYKU S ODĚVEM:\n\nDA\nVED KONTAKT MED TØJET:\n\nDE\nBEI KONTAMINIERTER KLEIDUNG:\n\nET\nRÕIVASTELE SATTUMISE KORRAL:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:\n\nEN\nIF ON CLOTHING:\n\nFR\nEN CAS DE CONTACT AVEC LES VÊTEMENTS:\n\nGA\nI gCÁS TEAGMHÁLA LE hÉADAÍ:\n\n\nHR\nU SLUČAJU DODIRA S ODJEĆOM:\n\n\nIT\nIN CASO DI CONTATTO CON GLI INDUMENTI:\n\nLV\nSASKARĒ AR APĢĒRBU:\n\nLT\nPATEKUS ANT DRABUŽIŲ:\n\nHU\nHA RUHÁRA KERÜL:\n\nMT\nF'KAŻ TA' KUNTATT MA' L-ILBIES:\n\nNL\nNA MORSEN OP KLEDING:\n\nPL\nW PRZYPADKU KONTAKTU Z ODZIEŻĄ:\n\nPT\nSE ENTRAR EM CONTACTO COM A ROUPA:\n\nRO\nÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:\n\nSK\nPRI KONTAKTE S ODEVOM:\n\nSL\nPRI STIKU Z OBLAČILI:\n\nFI\nJOS KEMIKAALIA JOUTUU VAATTEISIIN:\n\nSV\nVID KONTAKT MED KLÄDERNA:\n\nP307\nLanguage\n\n\nBG\nПРИ експозиция:\n\nES\nEN CASO DE exposición:\n\nCS\nPŘI expozici:\n\nDA\nVED eksponering:\n\nDE\nBEI Exposition:\n\nET\nKokkupuute korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:\n\nEN\nIF exposed:\n\nFR\nEN CAS d’exposition:\n\nGA\nI gCÁS nochta:\n\n\nHR\nU SLUČAJU izloženosti:\n\n\nIT\nIN CASO di esposizione:\n\nLV\nJA saskaras:\n\nLT\nEsant sąlyčiui:\n\nHU\nExpozíció esetén:\n\nMT\nJEKK espost:\n\nNL\nNA blootstelling:\n\nPL\nW PRZYPADKU narażenia:\n\nPT\nEM CASO DE exposição:\n\nRO\nÎN CAZ DE expunere:\n\nSK\nPO expozícii:\n\nSL\nPRI izpostavljenosti:\n\nFI\nAltistumisen tapahduttua:\n\nSV\nOm du exponerats:\n\nP308\nLanguage\n\n\nBG\nПРИ явна или предполагаема експозиция:\n\nES\nEN CASO DE exposición manifiesta o presunta:\n\nCS\nPŘI expozici nebo podezření na ni:\n\nDA\nVED eksponering eller mistanke om eksponering:\n\nDE\nBEI Exposition oder falls betroffen\n\nET\nKokkupuute või kokkupuutekahtluse korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:\n\nEN\nIF exposed or concerned:\n\nFR\nEN CAS d’exposition prouvée ou suspectée:\n\nGA\nI gCÁS nochta nó má mheastar a bheith nochtaithe:\n\n\nHR\nU SLUČAJU izloženosti ili sumnje na izloženost:\n\n\nIT\nIN CASO di esposizione o di possibile esposizione:\n\nLV\nJa saskaras vai saistīts ar:\n\nLT\nEsant sąlyčiui arba jeigu numanomas sąlytis:\n\nHU\nExpozíció vagy annak gyanúja esetén:\n\nMT\nJEKK espost jew konċernat:\n\nNL\nNA (mogelijke) blootstelling:\n\nPL\nW PRZYPADKU narażenia lub styczności:\n\nPT\nEM CASO DE exposição ou suspeita de exposição:\n\nRO\nÎN CAZ DE expunere sau de posibilă expunere:\n\nSK\nPo expozícii alebo podozrení z nej:\n\nSL\nPRI izpostavljenosti ali sumu izpostavljenosti:\n\nFI\nAltistumisen tapahduttua tai jos epäillään altistumista:\n\nSV\nVid exponering eller misstanke om exponering:\n\n\nP309\nLanguage\n\n\nBG\nПРИ експозиция или при неразположение:\n\nES\nEN CASO DE exposición o malestar:\n\nCS\nPŘI expozici nebo necítíte-li se dobře:\n\nDA\nVED eksponering eller ubehag:\n\nDE\nBEI Exposition oder Unwohlsein:\n\nET\nKokkupuute või halva enesetunde korral:\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:\n\nEN\nIF exposed or if you feel unwell:\n\nFR\nEN CAS d’exposition ou d'un malaise:\n\nGA\nI gCÁS nochta nó má bhraitear tinn:\n\n\nHR\nU SLUČAJU izloženosti ili zdravstvenih tegoba:\n\n\nIT\nIN CASO di esposizione o di malessere:\n\nLV\nJA saskaras vai ja jums ir slikta pašsajūta:\n\nLT\nEsant sąlyčiui arba blogai pasijutus:\n\nHU\nExpozíció vagy rosszullét esetén:\n\nMT\nJEKK espost jew tħossok ma tiflaħx:\n\nNL\nNA blootstelling of bij onwel voelen:\n\nPL\nW PRZYPADKU narażenia lub złego samopoczucia:\n\nPT\nEM CASO DE exposição ou de indisposição:\n\nRO\nÎN CAZ DE expunere sau dacă nu vă simțiți bine:\n\nSK\nPo expozícii alebo pri zdravotných problémoch.\n\nSL\nPRI izpostavljenosti ali slabem počutju:\n\nFI\nAltistumisen tapahduttua tai jos ilmenee pahoinvointia:\n\nSV\nVid exponering eller obehag:\n\nP310\nLanguage\n\n\nBG\nНезабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.\n\nCS\nOkamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nRing omgående til en GIFTINFORMATION eller en læge.\n\nDE\nSofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nVõtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nImmediately call a POISON CENTER or doctor/physician.\n\nFR\nAppeler immédiatement un CENTRE ANTIPOISON ou un médecin.\n\nGA\nCuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nOdmah nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nContattare immediatamente un CENTRO ANTIVELENI o un medico.\n\nLV\nNekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nNedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nAzonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nOnmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nNatychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.\n\nPT\nContacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nOkamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nTakoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nKontakta genast GIFTINFORMATIONSCENTRAL eller läkare.\n\nP311\nLanguage\n\n\nBG\nОбадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.\n\nCS\nVolejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nRing til en GIFTINFORMATION eller en læge.\n\nDE\nGIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nVõtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nCall a POISON CENTER or doctor/physician.\n\nFR\nAppeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nCuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nNazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nContattare un CENTRO ANTIVELENI o un medico.\n\nLV\nSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nSkambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nForduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nEen ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nSkontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.\n\nPT\nContacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nVolajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nKontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP312\nLanguage\n\n\nBG\nПри неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.\n\nCS\nNecítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.\n\nDE\nBei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nHalva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.\n\nEN\nCall a POISON CENTER or doctor/physician if you feel unwell.\n\nFR\nAppeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.\n\nGA\nCuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.\n\n\nHR\nU slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nIn caso di malessere, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.\n\nLT\nPasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nRosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.\n\nNL\nBij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nCaso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nSunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.\n\nSK\nPri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nOb slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nVid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP313\nLanguage\n\n\nBG\nПотърсете медицински съвет/помощ.\n\nES\nConsultar a un médico.\n\nCS\nVyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg lægehjælp.\n\nDE\nÄrztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nPöörduda arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nGet medical advice/attention.\n\nFR\nConsulter un médecin.\n\nGA\nFaigh comhairle/cúram liachta.\n\n\nHR\nZatražiti savjet/pomoć liječnika.\n\n\nIT\nConsultare un medico.\n\nLV\nLūdziet palīdzību mediķiem.\n\nLT\nKreiptis į gydytoją.\n\nHU\nOrvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib.\n\nNL\nEen arts raadplegen.\n\nPL\nZasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nConsulte um médico.\n\nRO\nConsultați medicul.\n\nSK\nVyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nPoiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu lääkäriin.\n\nSV\nSök läkarhjälp.\n\nP314\nLanguage\n\n\nBG\nПри неразположение потърсете медицински съвет/помощ.\n\nES\nConsultar a un médico en caso de malestar.\n\nCS\nNecítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg lægehjælp ved ubehag.\n\nDE\nBei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nHalva enesetunde korral pöörduda arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.\n\nEN\nGet medical advice/attention if you feel unwell.\n\nFR\nConsulter un médecin en cas de malaise.\n\nGA\nFaigh comhairle/cúram liachta má bhraitheann tú tinn.\n\n\nHR\nU slučaju zdravstvenih tegoba zatražiti savjet/pomoć liječnika.\n\n\nIT\nIn caso di malessere, consultare un medico.\n\nLV\nLūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.\n\nLT\nPasijutus blogai, kreiptis į gydytoją.\n\nHU\nRosszullét esetén orvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib jekk tħossok ma tiflaħx.\n\nNL\nBij onwel voelen een arts raadplegen.\n\nPL\nW przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de indisposição, consulte um médico.\n\nRO\nConsultați medicul, dacă nu vă simțiți bine.\n\nSK\nAk pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nOb slabem počutju poiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nSök läkarhjälp vid obehag.\n\nP315\nLanguage\n\n\nBG\nНезабавно потърсете медицински съвет/помощ.\n\nES\nConsultar a un médico inmediatamente.\n\nCS\nOkamžitě vyhledejte lékařskou pomoc/ošetření.\n\nDA\nSøg omgående lægehjælp.\n\nDE\nSofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nPöörduda viivitamata arsti poole.\n\nEL\nΣυμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.\n\nEN\nGet immediate medical advice/attention.\n\nFR\nConsulter immédiatement un médecin.\n\nGA\nFaigh comhairle/cúram liachta láithreach.\n\n\nHR\nHitno zatražiti savjet/pomoć liječnika.\n\n\nIT\nConsultare immediatamente un medico.\n\nLV\nNekavējoties lūdziet palīdzību mediķiem.\n\nLT\nNedelsiant kreiptis į gydytoją.\n\nHU\nAzonnal orvosi ellátást kell kérni.\n\nMT\nIkkonsulta tabib minnufih.\n\nNL\nOnmiddellijk een arts raadplegen.\n\nPL\nNatychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nConsulte imediatamente um médico.\n\nRO\nConsultați imediat medicul.\n\nSK\nOkamžite vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nTakoj poiščite zdravniško pomoč/oskrbo.\n\nFI\nHakeudu välittömästi lääkäriin.\n\nSV\nSök omedelbart läkarhjälp.\n\nP320\nLanguage\n\n\nBG\nСпешна нужда от специализирано лечение (вж… на този етикет).\n\nES\nSe necesita urgentemente un tratamiento específico (ver … en esta etiqueta).\n\nCS\nJe nutné odborné ošetření (viz … na tomto štítku).\n\nDA\nSærlig behandling straks påkrævet (se … på denne etiket).\n\nDE\nBesondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab viivitamatut eriravi (vt … käesoleval etiketil).\n\nEL\nΧρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).\n\nEN\nSpecific treatment is urgent (see … on this label).\n\nFR\nUn traitement spécifique est urgent (voir … sur cette étiquette).\n\nGA\nTá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).\n\n\nHR\nHitno je potrebna posebna liječnička obrada (vidi … na ovoj naljepnici).\n\n\nIT\nTrattamento specifico urgente (vedere… su questa etichetta).\n\nLV\nSteidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).\n\nLT\nBūtinas skubus specialus gydymas (žr. … šioje etiketėje).\n\nHU\nSürgős szakellátás szükséges (lásd … a címkén).\n\nMT\nTrattament speċifiku hu urġenti (ara … fuq din it-tikketta).\n\nNL\nSpecifieke behandeling dringend vereist (zie … op dit etiket).\n\nPL\nPilnie zastosować określone leczenie (patrz … na etykiecie).\n\nPT\nÉ urgente um tratamento específico (ver … no presente rótulo).\n\nRO\nUn tratament specific este urgent (a se vedea … de pe această etichetă).\n\nSK\nOdborné ošetrenie je naliehavé (pozri … na etikete).\n\nSL\nPosebno zdravljenje je nujno (glejte … na tej etiketi).\n\nFI\nErityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).\n\nSV\nSärskild behandling krävs omedelbart (se … på etiketten).\n\nP321\nLanguage\n\n\nBG\nСпециализирано лечение (вж… на този етикет).\n\nES\nSe necesita un tratamiento específico (ver … en esta etiqueta).\n\nCS\nOdborné ošetření (viz … na tomto štítku).\n\nDA\nSærlig behandling (se … på denne etiket).\n\nDE\nBesondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab eriravi (vt … käesoleval etiketil).\n\nEL\nΧρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).\n\nEN\nSpecific treatment (see … on this label).\n\nFR\nTraitement spécifique (voir … sur cette étiquette).\n\nGA\nCóir liachta ar leith (féach … ar an lipéad seo).\n\n\nHR\nPotrebna je posebna liječnička obrada (vidi … na ovoj naljepnici).\n\n\nIT\nTrattamento specifico (vedere …su questa etichetta).\n\nLV\nĪpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).\n\nLT\nSpecialus gydymas (žr. … šioje etiketėje).\n\nHU\nSzakellátás (lásd … a címkén).\n\nMT\nTrattament speċifiku (ara … fuq din it-tikketta).\n\nNL\nSpecifieke behandeling vereist (zie … op dit etiket).\n\nPL\nZastosować określone leczenie (patrz … na etykiecie).\n\nPT\nTratamento específico (ver … no presente rótulo).\n\nRO\nTratament specific (a se vedea … de pe această etichetă).\n\nSK\nOdborné ošetrenie (pozri … na etikete).\n\nSL\nPosebno zdravljenje (glejte … na tej etiketi).\n\nFI\nErityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).\n\nSV\nSärskild behandling (se … på etiketten).\n\n\nP322\nLanguage\n\n\nBG\nСпециални мерки (вж… на този етикет).\n\nES\nSe necesitan medidas específicas (ver … en esta etiqueta).\n\nCS\nSpecifické opatření (viz … na tomto štítku).\n\nDA\nSærlige foranstaltninger (se … på denne etiket).\n\nDE\nGezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).\n\nET\nNõuab erimeetmeid (vt … käesoleval etiketil).\n\nEL\nΧρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).\n\nEN\nSpecific measures (see … on this label).\n\nFR\nMesures spécifiques (voir … sur cette étiquette).\n\nGA\nBearta ar leith (féach … ar an lipéad seo).\n\n\nHR\nPotrebne su posebne mjere (vidi … na ovoj naljepnici).\n\n\nIT\nMisure specifiche (vedere …su questa etichetta).\n\nLV\nĪpaši pasākumi (skat. … uz šīs etiķetes).\n\nLT\nSpecialios priemonės (žr. … šioje etiketėje).\n\nHU\nKülönleges intézkedések (lásd … a címkén).\n\nMT\nMiżuri speċifiċi (ara … fuq din it-tikketta).\n\nNL\nSpecifieke maatregelen (zie … op dit etiket).\n\nPL\nŚrodki szczególne (patrz … na etykiecie).\n\nPT\nMedidas específicas (ver … no presente rótulo).\n\nRO\nMăsuri specifice (a se vedea … de pe această etichetă).\n\nSK\nOsobitné opatrenia (pozri … na etikete).\n\nSL\nPosebni ukrepi (glejte … na tej etiketi).\n\nFI\nErityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).\n\nSV\nSärskilda åtgärder (se … på etiketten).\n\nP330\nLanguage\n\n\nBG\nИзплакнете устата.\n\nES\nEnjuagarse la boca.\n\nCS\nVypláchněte ústa.\n\nDA\nSkyl munden.\n\nDE\nMund ausspülen.\n\nET\nLoputada suud.\n\nEL\nΞεπλύνετε το στόμα.\n\nEN\nRinse mouth.\n\nFR\nRincer la bouche.\n\nGA\nSruthlaítear an béal.\n\n\nHR\nIsprati usta.\n\n\nIT\nSciacquare la bocca.\n\nLV\nIzskalot muti.\n\nLT\nIšskalauti burną.\n\nHU\nA szájat ki kell öblíteni.\n\nMT\nLaħlaħ ħalqek.\n\nNL\nDe mond spoelen.\n\nPL\nWypłukać usta.\n\nPT\nEnxaguar a boca.\n\nRO\nClătiți gura.\n\nSK\nVypláchnite ústa.\n\nSL\nIzprati usta.\n\nFI\nHuuhdo suu.\n\nSV\nSkölj munnen.\n\nP331\nLanguage\n\n\nBG\nНЕ предизвиквайте повръщане.\n\nES\nNO provocar el vómito.\n\nCS\nNEVYVOLÁVEJTE zvracení.\n\nDA\nFremkald IKKE opkastning.\n\nDE\nKEIN Erbrechen herbeiführen.\n\nET\nMITTE kutsuda esile oksendamist.\n\nEL\nΜΗΝ προκαλέσετε εμετό.\n\nEN\nDo NOT induce vomiting.\n\nFR\nNE PAS faire vomir.\n\nGA\nNÁ spreagtar urlacan.\n\n\nHR\nNE izazivati povraćanje.\n\n\nIT\nNON provocare il vomito.\n\nLV\nNEIZRAISĪT vemšanu.\n\nLT\nNESKATINTI vėmimo.\n\nHU\nTILOS hánytatni.\n\nMT\nTIPPROVOKAX ir-remettar.\n\nNL\nGEEN braken opwekken.\n\nPL\nNIE wywoływać wymiotów.\n\nPT\nNÃO provocar o vómito.\n\nRO\nNU provocați voma.\n\nSK\nNevyvolávajte zvracanie.\n\nSL\nNE izzvati bruhanja.\n\nFI\nEI saa oksennuttaa.\n\nSV\nFramkalla INTE kräkning.\n\nP332\nLanguage\n\n\nBG\nПри поява на кожно дразнене:\n\nES\nEn caso de irritación cutánea:\n\nCS\nPři podráždění kůže:\n\nDA\nVed hudirritation:\n\nDE\nBei Hautreizung:\n\nET\nNahaärrituse korral:\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος:\n\nEN\nIf skin irritation occurs:\n\nFR\nEn cas d’irritation cutanée:\n\nGA\nI gcás greannú craicinn:\n\n\nHR\nU slučaju nadražaja kože:\n\n\nIT\nIn caso di irritazione della pelle:\n\nLV\nJa rodas ādas iekaisums:\n\nLT\nJeigu sudirginama oda:\n\nHU\nBőrirritáció esetén:\n\nMT\nJekk ikun hemm irritazzjoni tal-ġilda:\n\nNL\nBij huidirritatie:\n\nPL\nW przypadku wystąpienia podrażnienia skóry:\n\nPT\nEm caso de irritação cutânea:\n\nRO\nÎn caz de iritare a pielii:\n\nSK\nAk sa prejaví podráždenie pokožky:\n\nSL\nČe nastopi draženje kože:\n\nFI\nJos ilmenee ihoärsytystä:\n\nSV\nVid hudirritation:\n\nP333\nLanguage\n\n\nBG\nПри поява на кожно дразнене или обрив на кожата:\n\nES\nEn caso de irritación o erupción cutánea:\n\nCS\nPři podráždění kůže nebo vyrážce:\n\nDA\nVed hudirritation eller udslet:\n\nDE\nBei Hautreizung oder -ausschlag:\n\nET\nNahaärrituse või _obe korral:\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:\n\nEN\nIf skin irritation or rash occurs:\n\nFR\nEn cas d’irritation ou d’éruption cutanée:\n\nGA\nI gcás greannú nó grís craicinn:\n\n\nHR\nU slučaju nadražaja ili osipa na koži:\n\n\nIT\nIn caso di irritazione o eruzione della pelle:\n\nLV\nJa rodas ādas iekaisums vai izsitumi:\n\nLT\nJeigu sudirginama oda arba ją išberia.\n\nHU\nBőrirritáció vagy kiütések megjelenése esetén:\n\nMT\nJekk ikun hemm irritazzjoni jew raxx tal-ġilda:\n\nNL\nBij huidirritatie of uitslag:\n\nPL\nW przypadku wystąpienia podrażnienia skóry lub wysypki:\n\nPT\nEm caso de irritação ou erupção cutânea:\n\nRO\nÎn caz de iritare a pielii sau de erupție cutanată:\n\nSK\nAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:\n\nSL\nČe nastopi draženje kože ali se pojavi izpuščaj:\n\nFI\nJos ilmenee ihoärsytystä tai ihottumaa:\n\nSV\nVid hudirritation eller utslag:\n\nP334\nLanguage\n\n\nBG\nПотопете в хладка вода/сложете мокри компреси.\n\nES\nSumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nPonořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nSkyl under koldt vand/anvend våde omslag.\n\nDE\nIn kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nHoida jahedas vees/panna peale niiske kompress.\n\nEL\nΒυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nImmerse in cool water/wrap in wet bandages.\n\nFR\nRincer à l’eau fraîche/poser une compresse humide.\n\nGA\nTum in uisce fionnuar/cuir bréid fliuch air.\n\n\nHR\nUroniti u hladnu vodu/omotati vlažnim zavojem.\n\n\nIT\nImmergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nIegremdēt vēsā ūdenī/ietīt mitros apsējos.\n\nLT\nĮmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nHideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nDaħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.\n\nNL\nIn koud water onderdompelen/nat verband aanbrengen.\n\nPL\nZanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nMergulhar em água fria/aplicar compressas húmidas.\n\nRO\nIntroduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nPonorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nPotopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nUpota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nSkölj under kallt vatten/använd våta omslag.\n\nP335\nLanguage\n\n\nBG\nОтстранете от кожата посипаните частици.\n\nES\nSacudir las partículas que se hayan depositado en la piel.\n\nCS\nVolné částice odstraňte z kůže.\n\nDA\nBørst løse partikler bort fra huden.\n\nDE\nLose Partikel von der Haut abbürsten.\n\nET\nPühkida lahtised osakesed nahalt maha.\n\nEL\nΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.\n\nEN\nBrush off loose particles from skin.\n\nFR\nEnlever avec précaution les particules déposées sur la peau.\n\nGA\nGlan cáithníní scaoilte den chraiceann.\n\n\nHR\nIzmesti zaostale čestice s kože.\n\n\nIT\nRimuovere le particelle depositate sulla pelle.\n\nLV\nNoberzt no ādas nepiestiprinātās daļiņas.\n\nLT\nNeprilipusias daleles nuvalyti nuo odos.\n\nHU\nA bőrre lazán tapadó szemcséket óvatosan le kell kefélni.\n\nMT\nFarfar il-frak mhux imwaħħla minn fuq il-ġilda.\n\nNL\nLosse deeltjes van de huid afvegen.\n\nPL\nNie związaną pozostałość strzepnąć ze skóry.\n\nPT\nSacudir da pele as partículas soltas.\n\nRO\nÎndepărtați particulele depuse pe piele.\n\nSK\nZ pokožky oprášte sypké čiastočky.\n\nSL\nS krtačo odstraniti razsute delce s kože.\n\nFI\nPoista irtohiukkaset iholta.\n\nSV\nBorsta bort lösa partiklar från huden.\n\nP336\nLanguage\n\n\nBG\nРазмразете замръзналите части в хладка вода. Не разтривайте засегнатото място.\n\nES\nDescongelar las partes heladas con agua tibia. No frotar la zona afectada.\n\nCS\nOmrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.\n\nDA\nForsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.\n\nDE\nVereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.\n\nET\nSulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.\n\nEL\nΞεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.\n\nEN\nThaw frosted parts with lukewarm water. Do no rub affected area.\n\nFR\nDégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.\n\nGA\nLeáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.\n\n\nHR\nZamrznute dijelove odmrznuti mlakom vodom. Ne trljati oštećeno mjesto.\n\n\nIT\nSgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.\n\nLV\nAtkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.\n\nLT\nPrišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.\n\nHU\nA fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.\n\nMT\nĦoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.\n\nNL\nBevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.\n\nPL\nRozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.\n\nPT\nDerreter as zonas congeladas com água morna. Não friccionar a zona afectada.\n\nRO\nDezghețați părțile degerate cu apă călduță. Nu frecați zona afectată.\n\nSK\nZmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.\n\nSL\nZamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.\n\nFI\nSulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.\n\nSV\nVärm det köldskadade området med ljummet vatten. Gnid inte det skadade området.\n\nP337\nLanguage\n\n\nBG\nПри продължително дразнене на очите:\n\nES\nSi persiste la irritación ocular:\n\nCS\nPřetrvává-li podráždění očí:\n\nDA\nVed vedvarende øjenirritation:\n\nDE\nBei anhaltender Augenreizung:\n\nET\nKui silmade ärritus ei möödu:\n\nEL\nΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:\n\nEN\nIf eye irritation persists:\n\nFR\nSi l’irritation oculaire persiste:\n\nGA\nMá mhaireann an greannú súile:\n\n\nHR\nAko nadražaj oka ne prestaje:\n\n\nIT\nSe l’irritazione degli occhi persiste:\n\nLV\nJa acu iekaisums nepāriet:\n\nLT\nJei akių dirginimas nepraeina:\n\nHU\nHa a szemirritáció nem múlik el:\n\nMT\nJekk l-irritazzjoni ta' l-għajnejn tibqa’:\n\nNL\nBij aanhoudende oogirritatie:\n\nPL\nW przypadku utrzymywania się działania drażniącego na oczy:\n\nPT\nCaso a irritação ocular persista:\n\nRO\nDacă iritarea ochilor persistă:\n\nSK\nAk podráždenie očí pretrváva:\n\nSL\nČe draženje oči ne preneha:\n\nFI\nJos silmä-ärsytys jatkuu:\n\nSV\nVid bestående ögonirritation:\n\nP338\nLanguage\n\n\nBG\nСвалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.\n\nES\nQuitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.\n\nCS\nVyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.\n\nDA\nFjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.\n\nDE\nEventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.\n\nET\nEemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.\n\nEL\nΕάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.\n\nEN\nRemove contact lenses, if present and easy to do. Continue rinsing.\n\nFR\nEnlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.\n\nGA\nTóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.\n\n\nHR\nUkloniti kontaktne leće ukoliko ih nosite i ako se one lako uklanjaju. Nastaviti ispiranje.\n\n\nIT\nTogliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.\n\nLV\nIzņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.\n\nLT\nIšimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.\n\nHU\nAdott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.\n\nMT\nNeħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.\n\nNL\nContactlenzen verwijderen, indien mogelijk. Blijven spoelen.\n\nPL\nWyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.\n\nPT\nSe usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.\n\nRO\nScoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.\n\nSK\nAk používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.\n\nSL\nOdstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.\n\nFI\nPoista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.\n\nSV\nTa ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.\n\n\nP340\nLanguage\n\n\nBG\nИзведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nTransportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPřeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nFlyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nDie betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nToimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΜεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nRemove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nTransporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nTabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\n\nHR\nPremjestiti unesrećenog na svježi zrak, umiriti ga i postaviti u položaj koji olakšava disanje.\n\n\nIT\nTrasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIzvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nIšnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nAz érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nEsponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nHet slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nWyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nRetirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nTransportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.\n\nSK\nPresuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPrenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nSiirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nFlytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen\n\nP341\nLanguage\n\n\nBG\nПри затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nSi respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPři obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVed vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nHingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΕάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIf breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nS'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMás deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\n\nHR\nU slučaju otežanog disanja premjestiti unesrećenog na svježi zrak, umiriti ga i postaviti u položaj koji olakšava disanje.\n\n\nIT\nSe la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nJa elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nJeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nLégzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.\n\nNL\nBij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEm caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nDacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus într-o poziție confortabilă pentru respirație.\n\nSK\nAk nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP342\nLanguage\n\n\nBG\nПри симптоми на затруднено дишане:\n\nES\nEn caso de síntomas respiratorios:\n\nCS\nPři dýchacích potížích:\n\nDA\nVed luftvejssymptomer:\n\nDE\nBei Symptomen der Atemwege:\n\nET\nHingamisteede probleemide ilmnemise korral:\n\nEL\nΕάν παρουσιάζονται αναπνευστικά συμπτώματα:\n\nEN\nIf experiencing respiratory symptoms:\n\nFR\nEn cas de symptômes respiratoires:\n\nGA\nI gcás siomptóm riospráide:\n\n\n\nHR\nPri otežanom disanju:\n\n\nIT\nIn caso di sintomi respiratori:\n\nLV\nJa rodas elpošanas traucējumu simptomi:\n\nLT\nJeigu pasireiškia respiraciniai simptomai:\n\nHU\nLégzési problémák esetén:\n\nMT\nJekk tkun qed tbati minn sintomi respiratorji:\n\nNL\nBij ademhalingssymptomen:\n\nPL\nW przypadku wystąpienia objawów ze strony układu oddechowego:\n\nPT\nEm caso de sintomas respiratórios:\n\nRO\nÎn caz de simptome respiratorii:\n\nSK\nPri sťaženom dýchaní:\n\nSL\nPri respiratornih simptomih:\n\nFI\nJos ilmenee hengitysoireita:\n\nSV\nVid besvär i luftvägarna:\n\nP350\nLanguage\n\n\nBG\nИзмийте внимателно и обилно със сапун и вода.\n\nES\nLavar suavemente con agua y jabón abundantes.\n\nCS\nJemně omyjte velkým množstvím vody a mýdla.\n\nDA\nVask forsigtigt med rigeligt sæbe og vand.\n\nDE\nBehutsam mit viel Wasser und Seife waschen.\n\nET\nPesta õrnalt rohke vee ja seebiga.\n\nEL\nΠλύνετε απαλά με άφθονο νερό και σαπούνι.\n\nEN\nGently wash with plenty of soap and water.\n\nFR\nLaver avec précaution et abondamment à l’eau et au savon.\n\nGA\nNigh go bog le neart gallúnaí agus uisce.\n\n\nHR\nNježno oprati velikom količinom sapuna i vode.\n\n\nIT\nLavare delicatamente e abbondantemente con acqua e sapone.\n\nLV\nMaigi izskalot ar lielu daudzumu ziepēm un ūdeni.\n\nLT\nAtsargiai nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nÓvatos lemosás bő szappanos vízzel.\n\nMT\nAħsel bil-mod b’ħafna sapun u ilma.\n\nNL\nVoorzichtig wassen met veel water en zeep.\n\nPL\nDelikatnie umyć dużą ilością wody z mydłem.\n\nPT\nLavar suavemente com sabonete e água abundantes.\n\nRO\nSpălați ușor cu multă apă și săpun.\n\nSK\nOpatrne umyte veľkým množstvom vody a mydla.\n\nSL\nNežno umiti z veliko mila in vode.\n\nFI\nPese varovasti runsaalla vedellä ja saippualla.\n\nSV\nTvätta försiktigt med mycket tvål och vatten.\n\nP351\nLanguage\n\n\nBG\nПромивайте внимателно с вода в продължение на няколко минути.\n\nES\nAclarar cuidadosamente con agua durante varios minutos.\n\nCS\nNěkolik minut opatrně oplachujte vodou.\n\nDA\nSkyl forsigtigt med vand i flere minutter.\n\nDE\nEinige Minuten lang behutsam mit Wasser ausspülen.\n\nET\nLoputada mitme minuti jooksul ettevaatlikult veega.\n\nEL\nΞεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.\n\nEN\nRinse cautiously with water for several minutes.\n\nFR\nRincer avec précaution à l’eau pendant plusieurs minutes.\n\nGA\nSruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.\n\n\nHR\nOprezno ispirati vodom nekoliko minuta.\n\n\nIT\nSciacquare accuratamente per parecchi minuti.\n\nLV\nUzmanīgi skalot ar ūdeni vairākas minūtes.\n\nLT\nAtsargiai plauti vandeniu kelias minutes.\n\nHU\nÓvatos öblítés vízzel több percen keresztül.\n\nMT\nLaħlaħ b'attenzjoni bl-ilma għal diversi minuti.\n\nNL\nVoorzichtig afspoelen met water gedurende een aantal minuten.\n\nPL\nOstrożnie płukać wodą przez kilka minut.\n\nPT\nEnxaguar cuidadosamente com água durante vários minutos.\n\nRO\nClătiți cu atenție cu apă, timp de mai multe minute.\n\nSK\nOpatrne niekoľko minút oplachujte vodou.\n\nSL\nPrevidno izpirati z vodo nekaj minut.\n\nFI\nHuuhdo huolellisesti vedellä usean minuutin ajan.\n\nSV\nSkölj försiktigt med vatten i flera minuter.\n\n\nP352\nLanguage\n\n\nBG\nИзмийте обилно със сапун и вода.\n\nES\nLavar con agua y jabón abundantes.\n\nCS\nOmyjte velkým množstvím vody a mýdla.\n\nDA\nVask med rigeligt sæbe og vand.\n\nDE\nMit viel Wasser und Seife waschen.\n\nET\nPesta rohke vee ja seebiga.\n\nEL\nΠλύνετε με άφθονο σαπούνι και νερό.\n\nEN\nWash with plenty of soap and water.\n\nFR\nLaver abondamment à l’eau et au savon.\n\nGA\nNigh le neart gallúnaí agus uisce.\n\n\nHR\nOprati velikom količinom sapuna i vode.\n\n\nIT\nLavare abbondantemente con acqua e sapone.\n\nLV\nMazgāt ar lielu daudzmu ziepēm un ūdeni.\n\nLT\nPlauti dideliu kiekiu muilo ir vandens.\n\nHU\nLemosás bő szappanos vízzel.\n\nMT\nAħsel b’ħafna sapun u ilma.\n\nNL\nMet veel water en zeep wassen.\n\nPL\nUmyć dużą ilością wody z mydłem.\n\nPT\nLavar com sabonete e água abundantes.\n\nRO\nSpălați cu multă apă și săpun.\n\nSK\nUmyte veľkým množstvom vody a mydla.\n\nSL\nUmiti z veliko mila in vode.\n\nFI\nPese runsaalla vedellä ja saippualla.\n\nSV\nTvätta med mycket tvål och vatten.\n\nP353\nLanguage\n\n\nBG\nОблейте кожата с вода/вземете душ.\n\nES\nAclararse la piel con agua/ducharse.\n\nCS\nOpláchněte kůži vodou/osprchujte.\n\nDA\nSkyl/brus huden med vand.\n\nDE\nHaut mit Wasser abwaschen/duschen.\n\nET\nLoputada nahka veega/loputada duši all.\n\nEL\nΞεπλύνετε την επιδερμίδα με νερό/στο ντους.\n\nEN\nRinse skin with water/shower.\n\nFR\nRincer la peau à l’eau/se doucher.\n\nGA\nSruthlaítear an craiceann le huisce/glac cithfholcadh.\n\n\nHR\nIsprati kožu vodom/tuširanjem.\n\n\n\nIT\nSciacquare la pelle/fare una doccia.\n\nLV\nNoskalot ādu ar ūdeni/dušā.\n\nLT\nOdą nuplauti vandeniu/čiurkšle.\n\nHU\nA bőrt le kell öblíteni vízzel/zuhanyozás.\n\nMT\nLaħlaħ il-ġilda bl-ilma/bix-xawer.\n\nNL\nHuid met water afspoelen/afdouchen.\n\nPL\nSpłukać skórę pod strumieniem wody/prysznicem.\n\nPT\nEnxaguar a pele com água/tomar um duche.\n\nRO\nClătiți pielea cu apă/faceți duș.\n\nSK\nPokožku opláchnite vodou/sprchou.\n\nSL\nKožo izprati z vodo/prho.\n\nFI\nHuuhdo/suihkuta iho vedellä.\n\nSV\nSkölj huden med vatten/duscha.\n\nP360\nLanguage\n\n\nBG\nНезабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.\n\nES\nAclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.\n\nCS\nKontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.\n\nDA\nSkyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.\n\nDE\nKontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.\n\nET\nSaastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.\n\nEL\nΞεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.\n\nEN\nRinse immediately contaminated clothing and skin with plenty of water before removing clothes.\n\nFR\nRincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.\n\nGA\nSruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.\n\n\nHR\nOdmah isprati zagađenu odjeću i kožu velikom količinom vode prije uklanjanja odjeće.\n\n\n\nIT\nSciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.\n\nLV\nNekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.\n\nLT\nPrieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.\n\nHU\nA ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.\n\nMT\nLaħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.\n\nNL\nVerontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.\n\nPL\nNatychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.\n\nPT\nEnxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.\n\nRO\nClătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.\n\nSK\nKontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.\n\nSL\nTakoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.\n\nFI\nHuuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.\n\nSV\nSkölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.\n\nP361\nLanguage\n\n\nBG\nНезабавно свалете цялото замърсено облекло.\n\nES\nQuitarse inmediatamente las prendas contaminadas.\n\nCS\nVeškeré kontaminované části oděvu okamžitě svlékněte.\n\nDA\nTilsmudset tøj tages straks af/fjernes.\n\nDE\nAlle kontaminierten Kleidungsstücke sofort ausziehen.\n\nET\nKõik saastunud rõivad viivitamata seljast võtta.\n\nEL\nΑφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.\n\nEN\nRemove/Take off immediately all contaminated clothing.\n\nFR\nEnlever immédiatement les vêtements contaminés.\n\nGA\nBain díot láithreach na héadaí éillithe go léir.\n\n\nHR\nOdmah ukloniti/skinuti svu zagađenu odjeću.\n\n\n\nIT\nTogliersi di dosso immediatamente tutti gli indumenti contaminati.\n\nLV\nNoņemt/Novilkt nekavējoties visu piesārņoto apģērbu.\n\nLT\nNedelsiant nuvilkti/pašalinti visus užterštus drabužius.\n\nHU\nAz összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.\n\nMT\nNeħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.\n\nNL\nVerontreinigde kleding onmiddellijk uittrekken.\n\nPL\nNatychmiast usunąć/zdjąć całą zanieczyszczoną odzież.\n\nPT\nDespir/retirar imediatamente toda a roupa contaminada.\n\nRO\nScoateți imediat toată îmbrăcămintea contaminată.\n\nSK\nIhneď odstráňte/vyzlečte všetky kontaminované časti odevu.\n\nSL\nTakoj odstraniti/sleči vsa kontaminirana oblačila.\n\nFI\nRiisu saastunut vaatetus välittömästi.\n\nSV\nTa omedelbart av alla nedstänkta kläder.\n\nP362\nLanguage\n\n\nBG\nСвалете замърсеното облекло и го изперете преди повторна употреба.\n\nES\nQuitarse las prendas contaminadas y lavarlas antes de volver a usarlas.\n\nCS\nKontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.\n\nDA\nForurenet tøj tages af og vaskes, før det bruges igen.\n\nDE\nKontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.\n\nET\nVõtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.\n\nEL\nΒγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.\n\nEN\nTake off contaminated clothing and wash before reuse.\n\nFR\nEnlever les vêtements contaminés et les laver avant réutilisation\n\nGA\nBain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.\n\n\nHR\nSkinuti zagađenu odjeću i oprati prije ponovne uporabe.\n\n\nIT\nTogliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.\n\nLV\nNovilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.\n\nLT\nNusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.\n\nHU\nA szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.\n\nMT\nInża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.\n\nNL\nVerontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.\n\nPL\nZanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.\n\nPT\nRetirar a roupa contaminada e lavá-la antes de a voltar a usar.\n\nRO\nScoateți îmbrăcămintea contaminată și spălați-o înainte de reutilizare.\n\nSK\nKontaminovaný odev vyzlečte a pred ďalším použitím vyperte.\n\nSL\nSleči kontaminirana oblačila in jih oprati pred ponovno uporabo.\n\nFI\nRiisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.\n\nSV\nNedstänkta kläder tas av och tvättas innan de används igen.\n\nP363\nLanguage\n\n\nBG\nИзперете замърсеното облекло преди повторна употреба.\n\nES\nLavar las prendas contaminadas antes de volver a usarlas.\n\nCS\nKontaminovaný oděv před opětovným použitím vyperte.\n\nDA\nTilsmudset tøj skal vaskes, før det kan anvendes igen.\n\nDE\nKontaminierte Kleidung vor erneutem Tragen waschen.\n\nET\nSaastunud rõivad enne järgmist kasutamist pesta.\n\nEL\nΠλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.\n\nEN\nWash contaminated clothing before reuse.\n\nFR\nLaver les vêtements contaminés avant réutilisation.\n\nGA\nNigh éadaí éillithe sula ndéanfar iad a athúsáid.\n\n\nHR\nOprati zagađenu odjeću prije ponovne uporabe.\n\n\nIT\nLavare gli indumenti contaminati prima di indossarli nuovamente.\n\nLV\nPirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.\n\nLT\nUžterštus drabužius išskalbti prieš vėl juos apsivelkant.\n\nHU\nA szennyezett ruhát újbóli használat előtt ki kell mosni.\n\nMT\nAħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.\n\nNL\nVerontreinigde kleding wassen alvorens deze opnieuw te gebruiken.\n\nPL\nWyprać zanieczyszczoną odzież przed ponownym użyciem.\n\nPT\nLavar a roupa contaminada antes de a voltar a usar.\n\nRO\nSpălați îmbracămintea contaminată, înainte de reutilizare.\n\nSK\nKontaminovaný odev pred ďalším použitím vyperte.\n\nSL\nKontaminirana oblačila oprati pred ponovno uporabo.\n\nFI\nPese saastunut vaatetus ennen uudelleenkäyttöä.\n\nSV\nNedstänkta kläder ska tvättas innan de används igen.\n\nP370\nLanguage\n\n\nBG\nПри пожар:\n\nES\nEn caso de incendio:\n\nCS\nV případě požáru:\n\nDA\nVed brand:\n\nDE\nBei Brand:\n\nET\nTulekahju korral:\n\nEL\nΣε περίπτωση πυρκαγιάς:\n\nEN\nIn case of fire:\n\nFR\nEn cas d’incendie:\n\nGA\nI gcás dóiteáin:\n\n\nHR\nU slučaju požara:\n\n\nIT\nIn caso di incendio:\n\nLV\nUgunsgrēka gadījumā:\n\nLT\nGaisro atveju:\n\nHU\nTűz esetén:\n\nMT\nF’każ ta' nar:\n\nNL\nIn geval van brand:\n\nPL\nW przypadku pożaru:\n\nPT\nEm caso de incêndio:\n\nRO\nÎn caz de incendiu:\n\nSK\nV prípade požiaru:\n\nSL\nOb požaru:\n\nFI\nTulipalon sattuessa:\n\nSV\nVid brand:\n\nP371\nLanguage\n\n\nBG\nПри голям пожар и значителни количества:\n\nES\nEn caso de incendio importante y en grandes cantidades:\n\nCS\nV případě velkého požáru a velkého množství:\n\nDA\nVed større brand og store mængder:\n\nDE\nBei Großbrand und großen Mengen:\n\nET\nSuure tulekahju korral ning kui on tegemist suurte kogustega:\n\nEL\nΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:\n\nEN\nIn case of major fire and large quantities:\n\nFR\nEn cas d’incendie important et s’il s’agit de grandes quantités:\n\nGA\nI gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:\n\n\nHR\nU slučaju velikog požara i velikih količina:\n\n\nIT\nIn caso di incendio grave e di quantità rilevanti:\n\nLV\nUgunsgrēka un lielu apjomu gadījumā:\n\nLT\nDidelio gaisro ir didelių kiekių atveju:\n\nHU\nNagyobb tűz és nagy mennyiség esetén:\n\nMT\nF’każ ta' nar kbir u kwantitajiet kbar:\n\nNL\nIn geval van grote brand en grote hoeveelheden:\n\nPL\nW przypadku poważnego pożaru i dużych ilości:\n\nPT\nEm caso de incêndio importante e de grandes quantidades:\n\nRO\nÎn caz de incendiu de proporții și de cantități mari de produs:\n\nSK\nV prípade veľkého požiaru a veľkého množstva:\n\nSL\nOb velikem požaru in velikih količinah:\n\nFI\nJos tulipalo ja ainemäärät ovat suuret:\n\nSV\nVid större brand och stora mängder:\n\nP372\nLanguage\n\n\nBG\nОпасност от експлозия при пожар.\n\nES\nRiesgo de explosión en caso de incendio.\n\nCS\nNebezpečí výbuchu v případě požáru.\n\nDA\nEksplosionsfare ved brand.\n\nDE\nExplosionsgefahr bei Brand.\n\nET\nTulekahju korral plahvatusoht.\n\nEL\nΚίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.\n\nEN\nExplosion risk in case of fire.\n\nFR\nRisque d’explosion en cas d’incendie.\n\nGA\nBaol pléasctha i gcás dóiteáin.\n\n\nHR\nOpasnost od eksplozije u slučaju požara.\n\n\nIT\nRischio di esplosione in caso di incendio.\n\nLV\nEksplozijas risks ugunsgrēka gadījumā:\n\nLT\nSprogimo pavojus gaisro atveju.\n\nHU\nTűz esetén robbanásveszély.\n\nMT\nRiskju ta' splużjoni f’każ ta' nar.\n\nNL\nOntploffingsgevaar in geval van brand.\n\nPL\nRyzyko wybuchu w razie pożaru.\n\nPT\nRisco de explosão em caso de incêndio.\n\nRO\nRisc de explozie în caz de incendiu.\n\nSK\nV prípade požiaru hrozí riziko výbuchu.\n\nSL\nNevarnost eksplozije ob požaru.\n\nFI\nTulipalon sattuessa räjähdysvaara.\n\nSV\nExplosionsrisk vid brand.\n\nP373\nLanguage\n\n\nBG\nНЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.\n\nES\nNO luchar contra el incendio cuando el fuego llega a los explosivos.\n\nCS\nPožár NEHASTE, dostane-li se k výbušninám.\n\nDA\nBEKÆMP IKKE branden, hvis denne når eksplosiverne.\n\nDE\nKEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.\n\nET\nKui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.\n\nEL\nΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.\n\nEN\nDO NOT fight fire when fire reaches explosives.\n\nFR\nNE PAS combattre l’incendie lorsque le feu atteint les explosifs.\n\nGA\nNÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.\n\n\n\nHR\nNE gasiti vatru kada plamen može zahvatiti eksplozive.\n\n\nIT\nNON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.\n\nLV\nNECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.\n\nLT\nNEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.\n\nHU\nTILOS a tűz oltása, ha az robbanóanyagra átterjedt.\n\nMT\nTIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.\n\nNL\nNIET blussen wanneer het vuur de ontplofbare stoffen bereikt.\n\nPL\nNIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe\n\nPT\nSe o fogo atingir os explosivos, NÃO tentar combatê-lo.\n\nRO\nNU încercați să stingeți incendiul atunci când focul a ajuns la explozivi.\n\nSK\nPožiar NEHASTE, ak sa oheň priblížil k výbušninám.\n\nSL\nNE gasiti, ko ogenj doseže eksploziv.\n\nFI\nTulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.\n\nSV\nFörsök INTE bekämpa branden när den når explosiva varor.\n\nP374\nLanguage\n\n\nBG\nГасете пожара с обичайните предпазни мерки от разумно разстояние.\n\nES\nLuchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.\n\nCS\nHaste z přiměřené vzdálenosti a dodržujte běžná opatření.\n\nDA\nTræf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.\n\nDE\nBrandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.\n\nET\nKustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.\n\nEL\nΠροσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.\n\nEN\nFight fire with normal precautions from a reasonable distance.\n\nFR\nCombattre l’incendie à distance en prenant les précautions normales.\n\nGA\nDéan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.\n\n\nHR\nGasiti vatru uz odgovarajući oprez s primjerene udaljenosti.\n\n\nIT\nUtilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.\n\nLV\nDzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.\n\nLT\nGaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.\n\nHU\nTűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.\n\nMT\nItfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.\n\nNL\nMet normale voorzorgen vanaf een redelijke afstand blussen.\n\nPL\nGasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.\n\nPT\nCombater o incêndio tomando as precauções normais e a partir de uma distância razoável.\n\nRO\nStingeți incendiul de la o distanță rezonabilă, luând măsuri normale de precauție.\n\nSK\nPožiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.\n\nSL\nGasiti z običajno previdnostjo in s primerne razdalje.\n\nFI\nSammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.\n\nSV\nBekämpa branden på vanligt sätt på behörigt avstånd.\n\nP375\nLanguage\n\n\nBG\nГасете пожара от разстояние поради опасност от експлозия.\n\nES\nLuchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nKvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nBekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nWegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nPlahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΠροσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nFight fire remotely due to the risk of explosion.\n\nFR\nCombattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nTéigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\n\nHR\nGasiti s veće udaljenosti zbog opasnosti od eksplozije.\n\n\nIT\nRischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nDzēst ugunsgrēku no attāluma eksplozijas riska dēļ.\n\nLT\nGaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nA tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nItfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nOp afstand blussen omwille van ontploffingsgevaar.\n\nPL\nZ powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nCombater o incêndio à distância, devido ao risco de explosão.\n\nRO\nStingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nZ dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nGasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nSammuta palo etäältä räjähdysvaaran takia.\n\nSV\nBekämpa branden på avstånd på grund av explosionsrisken.\n\nP376\nLanguage\n\n\nBG\nСпрете теча, ако е безопасно.\n\nES\nDetener la fuga, si no hay peligro en hacerlo.\n\nCS\nZastavte únik, můžete-li tak učinit bez rizika.\n\nDA\nStands lækagen, hvis dette er sikkert.\n\nDE\nUndichtigkeit beseitigen, wenn gefahrlos möglich.\n\nET\nLeke peatada, kui seda on võimalik teha ohutult.\n\nEL\nΣταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.\n\nEN\nStop leak if safe to do so.\n\nFR\nObturer la fuite si cela peut se faire sans danger.\n\nGA\nCuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.\n\n\n\nHR\nAko je sigurno, zaustaviti istjecanje.\n\n\nIT\nBloccare la perdita se non c’è pericolo.\n\nLV\nApstādināt noplūdi, ja to var izdarīt drošā veidā.\n\nLT\nSustabdyti nuotėkį, jeigu galima saugiai tai padaryti.\n\nHU\nMeg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.\n\nMT\nWaqqaf it-tnixxija jekk ma jkunx hemm periklu.\n\nNL\nHet lek dichten als dat veilig gedaan kan worden.\n\nPL\nJeżeli jest to bezpieczne zahamować wyciek.\n\nPT\nDeter a fuga se tal puder ser feito em segurança.\n\nRO\nOpriți scurgerea, dacă acest lucru se poate face în siguranță.\n\nSK\nZastavte únik, ak je to bezpečné.\n\nSL\nZaustaviti puščanje, če je varno.\n\nFI\nSulje vuoto, jos sen voi tehdä turvallisesti.\n\nSV\nStoppa läckan om det kan göras på ett säkert sätt.\n\nP377\nLanguage\n\n\nBG\nПожар от изтекъл газ:\nНе гасете освен при възможност за безопасно отстраняване на теча.\n\nES\nFuga de gas en llamas:\nNo apagar, salvo si la fuga puede detenerse sin peligro.\n\nCS\nPožár unikajícího plynu:\nNehaste, nelze-li únik bezpečně zastavit.\n\nDA\nBrand fra udsivende gas:\nSluk ikke, medmindre det er sikkert at stoppe lækagen.\n\nDE\nBrand von ausströmendem Gas:\nNicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.\n\nET\nLekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.\n\nEL\nΔιαρροή φλεγόμενου αερίου:\nΜην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.\n\nEN\nLeaking gas fire:\nDo not extinguish, unless leak can be stopped safely.\n\nFR\nFuite de gaz enflammé:\nNe pas éteindre si la fuite ne peut pas être arrêtée sans danger.\n\nGA\nTine gháis ag sceitheadh:\nNá múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.\n\n\nHR\nPožar zbog istjecanja plina:\nne gasiti ako nije moguće sa sigurnošću zaustaviti istjecanje.\n\n\nIT\nIn caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.\n\nLV\nDegšanas gāzes noplūde:\nNedzēst, ja vien noplūdi var apstādināt drošā veidā.\n\nLT\nDujų nuotėkio sukeltas gaisras:\nNegesinti, nebent nuotėkį būtų galima saugiai sustabdyti.\n\nHU\nÉgő szivárgó gáz:\nCsak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.\n\nMT\nTnixxija ta' gass tan-nar:\nTippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.\n\nNL\nBrand door lekkend gas:\nniet blussen, tenzij het lek veilig gedicht kan worden.\n\nPL\nW przypadku płonięcia wyciekającego gazu:\nNie gasić, jeżeli nie można bezpiecznie zahamować wycieku.\n\nPT\nIncêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.\n\nRO\nIncendiu cauzat de o scurgere de gaz: nu încercați să stingeți, decât dacă scurgerea poate fi oprită în siguranță.\n\nSK\nPožiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.\n\nSL\nPožar zaradi uhajanja plina:\nNe gasiti, če puščanja ni mogoče varno zaustaviti.\n\nFI\nVuotavasta kaasusta johtuva palo:\nEi saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.\n\nSV\nLäckande gas som brinner:\nFörsök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.\n\nP378\nLanguage\n\n\nBG\nИзползвайте … за гасене.\n\nES\nUtilizar … para apagarlo.\n\nCS\nK hašení použijte …\n\nDA\nAnvend … til brandslukning.\n\nDE\n… zum Löschen verwenden.\n\nET\nKustutamiseks kasutada …\n\nEL\nΧρησιμοποιήστε … για την κατάσβεση.\n\nEN\nUse … for extinction.\n\nFR\nUtiliser … pour l’extinction.\n\nGA\nÚsáid … le haghaidh múchta.\n\n\nHR\nZa gašenje rabiti …\n\n\nIT\nEstinguere con…\n\nLV\nNodzēšanai izmantot…\n\nLT\nGesinimui naudoti …\n\nHU\nAz oltáshoz … használandó.\n\nMT\nUża’ … biex titfi.\n\nNL\nBlussen met …\n\nPL\nUżyć … do gaszenia.\n\nPT\nPara a extinção utilizar …\n\nRO\nUtilizați… pentru stingere.\n\nSK\nNa hasenie použite …\n\nSL\nZa gašenje uporabiti …\n\nFI\nKäytä palon sammuttamiseen …\n\nSV\nSläck branden med …\n\nP380\nLanguage\n\n\nBG\nЕвакуирайте зоната.\n\nES\nEvacuar la zona.\n\nCS\nVykliďte _roctor.\n\nDA\nEvakuer området.\n\nDE\nUmgebung räumen.\n\nET\nAla evakueerida.\n\nEL\nΕκκενώστε την περιοχή.\n\nEN\nEvacuate area.\n\nFR\nÉvacuer la zone.\n\nGA\nAslonnaigh gach duine as an limistéar.\n\n\nHR\nEvakuirati područje.\n\n\nIT\nEvacuare la zona.\n\nLV\nEvakuēt zonu.\n\nLT\nEvakuoti zoną.\n\nHU\nA területet ki kell üríteni.\n\nMT\nEvakwa ż-żona.\n\nNL\nEvacueren.\n\nPL\nEwakuować teren.\n\nPT\nEvacuar a zona.\n\nRO\nEvacuați zona.\n\nSK\nPriestory evakuujte.\n\nSL\nIzprazniti območje.\n\nFI\nEvakuoi alue.\n\nSV\nUtrym området.\n\nP381\nLanguage\n\n\nBG\nПремахнете всички източници на запалване, ако е безопасно.\n\nES\nEliminar todas las fuentes de ignición si no hay peligro en hacerlo.\n\nCS\nOdstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.\n\nDA\nFjern alle antændelseskilder, hvis dette kan gøres sikkert.\n\nDE\nAlle Zündquellen entfernen, wenn gefahrlos möglich.\n\nET\nEemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.\n\nEL\nΑπομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.\n\nEN\nEliminate all ignition sources if safe to do so.\n\nFR\nÉliminer toutes les sources d’ignition si cela est faisable sans danger.\n\nGA\nDíothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.\n\n\nHR\nUkloniti sve izvore paljenja ukoliko je to moguće sigurno učiniti.\n\n\nIT\nEliminare ogni fonte di accensione se non c’è pericolo.\n\nLV\nNovērst visus uzliesmošanas avotus, ja to var izdarīt droši.\n\nLT\nPašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.\n\nHU\nMeg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.\n\nMT\nElimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.\n\nNL\nAlle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.\n\nPL\nWyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.\n\nPT\nEliminar todas as fontes de ignição se tal puder ser feito em segurança.\n\nRO\nEliminați toate sursele de aprindere, dacă acest lucru se poate face în siguranță.\n\nSK\nAk je to bezpečné, odstráňte všetky zdroje zapálenia.\n\nSL\nOdstraniti vse vire vžiga, če je varno.\n\nFI\nPoista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.\n\nSV\nAvlägsna alla antändningskällor om det kan göras på ett säkert sätt.\n\nP390\nLanguage\n\n\nBG\nПопийте разлятото, за да се предотвратят материални вреди.\n\nES\nAbsorber el vertido para que no dañe otros materiales.\n\nCS\nUniklý produkt absorbujte, aby se zabránilo materiálním škodám.\n\nDA\nAbsorber udslip for at undgå materielskade.\n\nDE\nVerschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.\n\nET\nMahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.\n\nEL\nΣκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.\n\nEN\nAbsorb spillage to prevent material damage.\n\nFR\nAbsorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.\n\nGA\nIonsúigh doirteadh chun damáiste d’ábhar a chosc.\n\n\nHR\nApsorbirati proliveno kako bi se spriječila materijalna šteta.\n\n\nIT\nAssorbire la fuoriuscita per evitare danni materiali.\n\nLV\nUzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.\n\nLT\nAbsorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.\n\nHU\nA kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.\n\nMT\nAssorbi t-tixrid biex tipprevjeni ħsara fil-materjal.\n\nNL\nGelekte/gemorste stof opnemen om materiële schade te vermijden.\n\nPL\nUsunąć wyciek, aby zapobiec szkodom materialnym.\n\nPT\nAbsorver o produto derramado a fim de evitar danos materiais.\n\nRO\nAbsorbiți scurgerile de produs, pentru a nu afecta materialele din apropiere.\n\nSK\nAbsorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.\n\nSL\nOdpraviti razlitje, da se prepreči materialna škoda.\n\nFI\nImeytä valumat vahinkojen estämiseksi.\n\nSV\nSug upp spill för att undvika materiella skador.\n\nP391\nLanguage\n\n\nBG\nСъберете разлятото.\n\nES\nRecoger el vertido.\n\nCS\nUniklý produkt seberte.\n\nDA\nUdslip opsamles.\n\nDE\nVerschüttete Mengen aufnehmen.\n\nET\nMahavoolanud toode kokku koguda.\n\nEL\nΜαζέψτε τη χυμένη ποσότητα.\n\nEN\nCollect spillage.\n\nFR\nRecueillir le produit répandu.\n\nGA\nBailigh doirteadh.\n\n\nHR\nSakupiti proliveno/rasuto.\n\n\nIT\nRaccogliere il materiale fuoriuscito.\n\nLV\nSavākt izšļakstīto šķidrumu.\n\nLT\nSurinkti ištekėjusią medžiagą.\n\nHU\nA kiömlött anyagot össze kell gyűjteni.\n\nMT\nIġbor it-tixrid.\n\nNL\nGelekte/gemorste stof opruimen.\n\nPL\nZebrać wyciek.\n\nPT\nRecolher o produto derramado.\n\nRO\nColectați scurgerile de produs.\n\nSK\nZozbierajte uniknutý produkt.\n\nSL\nPrestreči razlito tekočino.\n\nFI\nValumat on kerättävä.\n\nSV\nSamla upp spill.\n\nP301 + P310\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.\n\nDE\nBEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.\n\nGA\nMÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nAKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nIN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico\n\nLV\nNORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nPRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: sunați imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nVID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.\n\nP301 + P312\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.\n\nES\nEN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.\n\nCS\nPŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nI TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.\n\nEN\nIF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.\n\nFR\nEN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.\n\nGA\nMÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.\n\n\nHR\nAKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nIN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nNORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.\n\nLT\nPRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.\n\nNL\nNA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simțiți bine.\n\nSK\nPO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.\n\nSV\nVID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.\n\nP301 + P330 + P331\nLanguage\n\n\nBG\nПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.\n\nES\nEN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.\n\nCS\nPŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.\n\nDA\nI TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.\n\nDE\nBEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.\n\nET\nALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.\n\nEN\nIF SWALLOWED: rinse mouth. Do NOT induce vomiting.\n\nFR\nEN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.\n\nGA\nMÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.\n\n\nHR\nAKO SE PROGUTA: isprati usta. NE izazivati povraćanje.\n\n\nIT\nIN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.\n\nLV\nNORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.\n\nLT\nPRARIJUS: išskalauti burną. NESKATINTI vėmimo.\n\nHU\nLENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.\n\nMT\nJEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.\n\nNL\nNA INSLIKKEN: de mond spoelen — GEEN braken opwekken.\n\nPL\nW PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.\n\nPT\nEM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.\n\nRO\nÎN CAZ DE ÎNGHIȚIRE: clătiți gura. NU provocați voma.\n\nSK\nPO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.\n\nSL\nPRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.\n\nFI\nJOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.\n\nSV\nVID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.\n\nP302 + P334\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nPŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nVED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.\n\nDE\nBEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nNAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nIF ON SKIN: Immerse in cool water/wrap in wet bandages.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM: uroniti u hladnu vodu/omotati vlažnim zavojem.\n\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nSASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.\n\nLT\nPATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nHA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nJEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.\n\nNL\nBIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: introduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nPRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nVID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.\n\nP302 + P350\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.\n\nCS\nPŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.\n\nDA\nVED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.\n\nDE\nBEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.\n\nET\nNAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.\n\nEN\nIF ON SKIN: Gently wash with plenty of soap and water.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM: nježno oprati velikom količinom sapuna i vode.\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.\n\nLV\nSASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.\n\nLT\nPATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nHA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.\n\nMT\nJEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.\n\nNL\nBIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: spălați ușor cu multă apă și săpun.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.\n\nSL\nPRI STIKU S KOŽO: nežno umiti z veliko mila in vode.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.\n\nSV\nVID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.\n\nP302 + P352\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.\n\nES\nEN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.\n\nCS\nPŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.\n\nDA\nVED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.\n\nDE\nBEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.\n\nET\nNAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.\n\nEN\nIF ON SKIN: Wash with plenty of soap and water.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM: oprati velikom količinom sapuna i vode.\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.\n\nLV\nSASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.\n\nLT\nPATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.\n\nHU\nHA BŐRRE KERÜL: Lemosás bő szappanos vízzel.\n\nMT\nJEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.\n\nNL\nBIJ CONTACT MET DE HUID: met veel water en zeep wassen.\n\nPL\nW PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA: spălați cu multă apă și săpun.\n\nSK\nPRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.\n\nSL\nPRI STIKU S KOŽO: umiti z veliko mila in vode.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.\n\nSV\nVID HUDKONTAKT: Tvätta med mycket tvål och vatten.\n\nP303 + P361 + P353\nLanguage\n\n\nBG\nПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ\n\nES\nEN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.\n\nCS\nPŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.\n\nDA\nVED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.\n\nDE\nBEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.\n\nET\nNAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.\n\nEN\nIF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.\n\nFR\nEN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.\n\nGA\nI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.\n\n\nHR\nU SLUČAJU DODIRA S KOŽOM (ili kosom): odmah ukloniti/skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.\n\n\nIT\nIN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.\n\nLV\nSASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.\n\nLT\nPATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.\n\nHU\nHA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.\n\nMT\nJEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.\n\nNL\nBIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.\n\nPL\nW PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.\n\nPT\nSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.\n\nRO\nÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateți imediat toată îmbrăcămintea contaminată. Clătiți pielea cu apă/faceți duș.\n\nSK\nPRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.\n\nSL\nPRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.\n\nFI\nJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.\n\nSV\nVID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.\n\nP304 + P340\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nEN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nSISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nEN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\n\nHR\nAKO SE UDIŠE: premjestiti unesrećenog na svježi zrak, umiriti ga i postaviti u položaj koji olakšava disanje.\n\n\nIT\nIN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nBELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nNA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nÎN CAZ DE INHALARE: transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.\n\nSK\nPO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP304 + P341\nLanguage\n\n\nBG\nПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.\n\nES\nEN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.\n\nCS\nPŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.\n\nDA\nVED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.\n\nDE\nBEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.\n\nET\nSISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.\n\nEN\nIF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.\n\nFR\nEN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.\n\nGA\nMÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.\n\n\nHR\nAKO SE UDIŠE: u slučaju otežanog disanja premjestiti unesrećenog na svježi zrak, umiriti ga i postaviti u položaj koji olakšava disanje.\n\n\nIT\nIN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.\n\nLV\nIEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.\n\nLT\nĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.\n\nHU\nBELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.\n\nMT\nJEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.\n\nNL\nNA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.\n\nPT\nEM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.\n\nRO\nÎN CAZ DE INHALARE: dacă respirația este dificilă, transportați victima la aer liber și mențineți-o în stare de repaus, într-o poziție confortabilă pentru respirație.\n\nSK\nPO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.\n\nSL\nPRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.\n\nFI\nJOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.\n\nSV\nVID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.\n\nP305 + P351 + P338\nLanguage\n\n\nBG\nПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.\n\nES\nEN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.\n\nCS\nPŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.\n\nDA\nVED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.\n\nDE\nBEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.\n\nET\nSILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.\n\nEN\nIF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.\n\nFR\nEN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.\n\nGA\nI gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.\n\n\n\nHR\nU SLUČAJU DODIRA S OČIMA: oprezno ispirati vodom nekoliko minuta. Ukloniti kontaktne leće ukoliko ih nosite i ako se one lako uklanjaju. Nastaviti ispiranje.\n\n\nIT\nIN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.\n\nLV\nSASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.\n\nLT\nPATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.\n\nHU\nSZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.\n\nMT\nJEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.\n\nNL\nBIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.\n\nPL\nW PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.\n\nPT\nSE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.\n\nRO\nÎN CAZ DE CONTACT CU OCHII: clătiți cu atenție cu apă timp de mai multe minute. Scoateți lentilele de contact, dacă este cazul și dacă acest lucru se poate face cu ușurință. Continuați să clătiți.\n\nSK\nPO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.\n\nSL\nPRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.\n\nFI\nJOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.\n\nSV\nVID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.\n\n\nP306 + P360\nLanguage\n\n\nBG\nПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.\n\nES\nEN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.\n\nCS\nPŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.\n\nDA\nVED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.\n\nDE\nBEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.\n\nET\nRÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.\n\nEN\nIF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.\n\nFR\nEN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.\n\nGA\nI gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.\n\n\nHR\nU SLUČAJU DODIRA S ODJEĆOM: odmah isprati zagađenu odjeću i kožu velikom količinom vode prije uklanjanja odjeće.\n\n\nIT\nIN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.\n\nLV\nSASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.\n\nLT\nPATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.\n\nHU\nHA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.\n\nMT\nJEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.\n\nNL\nNA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.\n\nPL\nW PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.\n\nPT\nSE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.\n\nRO\nÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiți imediat îmbrăcămintea contaminată și pielea cu multă apă, înainte de scoaterea îmbrăcămintei.\n\nSK\nPRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.\n\nSL\nPRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.\n\nFI\nJOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.\n\nSV\nVID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.\n\nP307 + P311\nLanguage\n\n\nBG\nПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVED eksponering: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nKokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF exposed: Call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nU SLUČAJU izloženosti: nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\n\nIT\nIN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nEsant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nExpozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE expunere: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPo expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nAltistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nOm du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP308 + P313\nLanguage\n\n\nBG\nПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.\n\nES\nEN CASO DE exposición manifiesta o presunta: Consultar a un médico.\n\nCS\nPŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVED eksponering eller mistanke om eksponering: Søg lægehjælp.\n\nDE\nBEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nKokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIF exposed or concerned: Get medical advice/attention.\n\nFR\nEN CAS d’exposition prouvée ou suspectée: consulter un médecin.\n\nGA\nI gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.\n\n\n\nHR\nU SLUČAJU izloženosti ili sumnje na izloženost: zatražiti savjet/pomoć liječnika.\n\n\nIT\nIN CASO di esposizione o di possibile esposizione, consultare un medico.\n\nLV\nJa nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.\n\nLT\nEsant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.\n\nHU\nExpozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.\n\nMT\nJekk espost jew konċernat: Ikkonsulta tabib.\n\nNL\nNA (mogelijke) blootstelling: een arts raadplegen.\n\nPL\nW przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEM CASO DE exposição ou suspeita de exposição: consulte um médico.\n\nRO\nÎN CAZ DE expunere sau de posibilă expunere: consultați medicul.\n\nSK\nPo expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nPRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.\n\nFI\nAltistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.\n\nSV\nVid exponering eller misstanke om exponering Sök läkarhjälp.\n\nP309 + P311\nLanguage\n\n\nBG\nПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nKokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.\n\nFR\nEN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nU SLUČAJU izloženosti ili zdravstvenih tegoba: nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nIN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nEsant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nExpozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nNA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎN CAZ DE expunere sau dacă nu vă simțiți bine: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPo expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nAltistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.\n\nSV\nVid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP332 + P313\nLanguage\n\n\nBG\nПри поява на кожно дразнене: Потърсете медицински съвет/помощ.\n\nES\nEn caso de irritación cutánea: Consultar a un médico.\n\nCS\nPři podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed hudirritation: Søg lægehjælp.\n\nDE\nBei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nNahaärrituse korral: pöörduda arsti poole.\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf skin irritation occurs: Get medical advice/attention.\n\nFR\nEn cas d’irritation cutanée: consulter un médecin.\n\nGA\nI gcás greannú craicinn: Faigh comhairle/cúram liachta.\n\n\nHR\nU slučaju nadražaja kože: zatražiti savjet/pomoć liječnika.\n\n\nIT\nIn caso di irritazione della pelle: consultare un medico.\n\nLV\nJa rodas ādas iekaisums: lūdziet mediķu palīdzību.\n\nLT\nJeigu sudirginama oda: kreiptis į gydytoją.\n\nHU\nBőrirritáció esetén: orvosi ellátást kell kérni.\n\nMT\nJekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.\n\nNL\nBij huidirritatie: een arts raadplegen.\n\nPL\nW przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de irritação cutânea: consulte um médico.\n\nRO\nÎn caz de iritare a pielii: consultați medicul.\n\nSK\nAk sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos ilmenee ihoärsytystä: Hakeudu lääkäriin.\n\nSV\nVid hudirritation: Sök läkarhjälp.\n\nP333 + P313\nLanguage\n\n\nBG\nПри поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.\n\nES\nEn caso de irritación o erupción cutánea: Consultar a un médico.\n\nCS\nPři podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed hudirritation eller udslet: Søg lægehjælp.\n\nDE\nBei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nNahaärrituse või _obe korral: pöörduda arsti poole.\n\nEL\nΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf skin irritation or rash occurs: Get medical advice/attention.\n\nFR\nEn cas d’irritation ou d'éruption cutanée: consulter un médecin.\n\nGA\nMá tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.\n\n\nHR\nU slučaju nadražaja ili osipa na koži: zatražiti savjet/pomoć liječnika.\n\n\nIT\nIn caso di irritazione o eruzione della pelle: consultare un medico.\n\nLV\nJa rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.\n\nLT\nJeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.\n\nHU\nBőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.\n\nMT\nJekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.\n\nNL\nBij huidirritatie of uitslag: een arts raadplegen.\n\nPL\nW przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nEm caso de irritação ou erupção cutânea: consulte um médico.\n\nRO\nÎn caz de iritare a pielii sau de erupție cutanată: consultați medicul.\n\nSK\nAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.\n\nSV\nVid hudirritation eller utslag: Sök läkarhjälp.\n\nP335 + P334\nLanguage\n\n\nBG\nОтстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.\n\nES\nSacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.\n\nCS\nVolné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.\n\nDA\nBørst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.\n\nDE\nLose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.\n\nET\nPühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.\n\nEL\nΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.\n\nEN\nBrush off loose particles from skin. Immerse in cool water/wrap in wet bandages.\n\nFR\nEnlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.\n\nGA\nScuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.\n\n\nHR\nIzmesti zaostale čestice s kože. Uroniti u hladnu vodu/omotati vlažnim zavojem.\n\n\nIT\nRimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.\n\nLV\nNoberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.\n\nLT\nNeprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.\n\nHU\nA bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.\n\nMT\nFarfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.\n\nNL\nLosse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.\n\nPL\nNie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.\n\nPT\nSacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.\n\nRO\nÎndepărtați particulele depuse pe piele. Introduceți în apă rece/acoperiți cu o compresă umedă.\n\nSK\nZ pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.\n\nSL\nS krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.\n\nFI\nPoista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.\n\nSV\nBorsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.\n\n\nP337 + P313\nLanguage\n\n\nBG\nПри продължително дразнене на очите: Потърсете медицински съвет/помощ.\n\nES\nSi persiste la irritación ocular: Consultar a un médico.\n\nCS\nPřetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.\n\nDA\nVed vedvarende øjenirritation: Søg lægehjælp.\n\nDE\nBei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.\n\nET\nKui silmade ärritus ei möödu: pöörduda arsti poole.\n\nEL\nΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.\n\nEN\nIf eye irritation persists: Get medical advice/attention.\n\nFR\nSi l’irritation oculaire persiste: consulter un médecin.\n\nGA\nMá mhaireann an greannú súile: Faigh comhairle/cúram liachta.\n\n\nHR\nAko nadražaj oka ne prestaje: zatražiti savjet/pomoć liječnika.\n\n\nIT\nSe l’irritazione degli occhi persiste, consultare un medico.\n\nLV\nJa acu iekaisums nepāriet: lūdziet mediķu palīdzību.\n\nLT\nJei akių dirginimas nepraeina: kreiptis į gydytoją.\n\nHU\nHa a szemirritáció nem múlik el: orvosi ellátást kell kérni.\n\nMT\nJekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.\n\nNL\nBij aanhoudende oogirritatie: een arts raadplegen.\n\nPL\nW przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.\n\nPT\nCaso a irritação ocular persista: consulte um médico.\n\nRO\nDacă iritarea ochilor persistă: consultați medicul.\n\nSK\nAk podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.\n\nSL\nČe draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.\n\nFI\nJos silmä-ärsytys jatkuu: Hakeudu lääkäriin.\n\nSV\nVid bestående ögonirritation: Sök läkarhjälp.\n\n\nP342 + P311\nLanguage\n\n\nBG\nПри симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.\n\nES\nEn caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.\n\nCS\nPři dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.\n\nDA\nVed luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.\n\nDE\nBei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.\n\nET\nHingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.\n\nEL\nΕάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.\n\nEN\nIf experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.\n\nFR\nEn cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.\n\nGA\nI gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.\n\n\nHR\nPri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA ili liječnika.\n\n\nIT\nIn caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.\n\nLV\nJa rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.\n\nLT\nJeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.\n\nHU\nLégzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.\n\nMT\nJekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.\n\nNL\nBij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.\n\nPL\nW przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.\n\nPT\nEm caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.\n\nRO\nÎn caz de simptome respiratorii: sunați la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.\n\nSK\nPri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.\n\nSL\nPri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.\n\nFI\nJos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.\n\nSV\nVid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.\n\nP370 + P376\nLanguage\n\n\nBG\nПри пожар: Спрете теча, ако е безопасно.\n\nES\nEn caso de incendio: Detener la fuga, si no hay peligro en hacerlo.\n\nCS\nV případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.\n\nDA\nVed brand: Stands lækagen, hvis dette er sikkert.\n\nDE\nBei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.\n\nET\nTulekahju korral: leke peatada, kui seda on võimalik teha ohutult.\n\nEL\nΣε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.\n\nEN\nIn case of fire: Stop leak if safe to do so.\n\nFR\nEn cas d’incendie: obturer la fuite si cela peut se faire sans danger.\n\nGA\nI gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.\n\n\nHR\nU slučaju požara: ako je sigurno, zaustaviti istjecanje.\n\n\nIT\nIn caso di incendio: bloccare la perdita se non c’è pericolo.\n\nLV\nUgunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.\n\nLT\nGaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.\n\nHU\nTűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.\n\nMT\nF’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.\n\nNL\nIn geval van brand: het lek dichten als dat veilig gedaan kan worden.\n\nPL\nW przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.\n\nPT\nEm caso de incêndio: deter a fuga se tal puder ser feito em segurança.\n\nRO\nÎn caz de incendiu: opriți scurgerea, dacă acest lucru se poate face în siguranță.\n\nSK\nV prípade požiaru: ak je to bezpečné, zastavte únik.\n\nSL\nOb požaru: zaustaviti puščanje, če je varno.\n\nFI\nTulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.\n\nSV\nVid brand: Stoppa läckan om det kan göras på ett säkert sätt.\n\nP370 + P378\nLanguage\n\n\nBG\nПри пожар: Използвайте … за гасене.\n\nES\nEn caso de incendio: Utilizar … para apagarlo.\n\nCS\nV případě požáru: K hašení použijte …\n\nDA\nVed brand: Anvend … til brandslukning.\n\nDE\nBei Brand: … zum Löschen verwenden.\n\nET\nTulekahju korral: kasutada kustutamiseks …\n\nEL\nΣε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.\n\nEN\nIn case of fire: Use … for extinction.\n\nFR\nEn cas d’incendie: utiliser … pour l’extinction.\n\nGA\nI gcás dóiteáin: Úsáid … le haghaidh múchta.\n\n\nHR\nU slučaju požara: za gašenje rabiti …\n\n\nIT\nIn caso di incendio: estinguere con…\n\nLV\nUgunsgrēka gadījumā: dzēšanai izmantojiet …\n\nLT\nGaisro atveju: gesinimui naudoti …\n\nHU\nTűz esetén: az oltáshoz …használandó.\n\nMT\nF’każ ta' nar: Uża’ … għat-tifi.\n\nNL\nIn geval van brand: blussen met …\n\nPL\nW przypadku pożaru: Użyć … do gaszenia.\n\nPT\nEm caso de incêndio: para a extinção utilizar …\n\nRO\nÎn caz de incendiu: utilizați… pentru stingere.\n\nSK\nV prípade požiaru: na hasenie použite …\n\nSL\nOb požaru: za gašenje uporabiti …\n\nFI\nTulipalon sattuessa: Käytä palon sammuttamiseen …\n\nSV\nVid brand: Släck branden med …\n\nP370 + P380\nLanguage\n\n\nBG\nПри пожар: Евакуирайте зоната.\n\nES\nEn caso de incendio: Evacuar la zona.\n\nCS\nV případě požáru: Vykliďte prostor.\n\nDA\nVed brand: Evakuer området.\n\nDE\nBei Brand: Umgebung räumen.\n\nET\nTulekahju korral: ala evakueerida.\n\nEL\nΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.\n\nEN\nIn case of fire: Evacuate area.\n\nFR\nEn cas d’incendie: évacuer la zone.\n\nGA\nI gcás dóiteáin: Aslonnaigh gach duine as an limistéar.\n\n\nHR\nU slučaju požara: evakuirati područje.\n\n\nIT\nEvacuare la zona in caso di incendio.\n\nLV\nUgunsgrēka gadījumā: evakuēt zonu.\n\nLT\nGaisro atveju: evakuoti zoną.\n\nHU\nTűz esetén: Ki kell üríteni a területet.\n\nMT\nF’każ ta' nar: Evakwa ż-żona.\n\nNL\nIn geval van brand: evacueren.\n\nPL\nW przypadku pożaru: Ewakuować teren.\n\nPT\nEm caso de incêndio: evacuar a zona.\n\nRO\nÎn caz de incendiu: evacuați zona.\n\nSK\nV prípade požiaru: priestory evakuujte.\n\nSL\nOb požaru: izprazniti območje.\n\nFI\nTulipalon sattuessa: Evakuoi alue.\n\nSV\nVid brand: Utrym området.\n\nP370 + P380 + P375\nLanguage\n\n\nBG\nПри пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.\n\nES\nEn caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nV případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nVed brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nBei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nTulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nIn case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.\n\nFR\nEn cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nI gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\n\nHR\nU slučaju požara: evakuirati područje. Gasiti s veće udaljenosti zbog opasnosti od eksplozije.\n\n\nIT\nIn caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nUgunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.\n\nLT\nGaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nTűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nF’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nIn geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.\n\nPL\nW przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nEm caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.\n\nRO\nÎn caz de incendiu: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nV prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nOb požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nTulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.\n\nSV\nVid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.\n\n\nP371 + P380 + P375\nLanguage\n\n\nBG\nПри голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.\n\nES\nEn caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.\n\nCS\nV případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.\n\nDA\nVed større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.\n\nDE\nBei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.\n\nET\nSuure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.\n\nEL\nΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.\n\nEN\nIn case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.\n\nFR\nEn cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.\n\nGA\nI gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.\n\n\nHR\nU slučaju velikog požara i velikih količina: evakuirati područje. Gasiti s veće udaljenosti zbog opasnosti od eksplozije.\n\n\nIT\nIn caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.\n\nLV\nUgunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.\n\nLT\nDidelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.\n\nHU\nNagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.\n\nMT\nF’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.\n\nNL\nIn geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.\n\nPL\nW przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.\n\nPT\nEm caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.\n\nRO\nÎn caz de incendiu de proporții și de cantități mari de produs: evacuați zona. Stingeți incendiul de la distanță din cauza pericolului de explozie.\n\nSK\nV prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.\n\nSL\nOb velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.\n\nFI\nJos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.\n\nSV\nVid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.\n\nTable 1.4\nPrecautionary statements — Storage\n\nP401\nLanguage\n\n\nBG\nДа се съхранява…\n\nES\nAlmacenar …\n\nCS\nSkladujte …\n\nDA\nOpbevares …\n\nDE\n… aufbewahren.\n\nET\nHoida …\n\nEL\nΑποθηκεύεται …\n\nEN\nStore …\n\nFR\nStocker …\n\nGA\nStóráil …\n\n\nHR\nSkladištiti …\n\n\nIT\nConservare…\n\nLV\nGlabāt…\n\nLT\nLaikyti…\n\nHU\nTárolás: … .\n\nMT\nAħżen …\n\nNL\n… bewaren.\n\nPL\nPrzechowywać …\n\nPT\nArmazenar …\n\nRO\nA se depozita…\n\nSK\nUchovávajte …\n\nSL\nHraniti …\n\nFI\nVarastoi …\n\nSV\nFörvaras …\n\nP402\nLanguage\n\n\nBG\nДа се съхранява на сухо място.\n\nES\nAlmacenar en un lugar seco.\n\nCS\nSkladujte na suchém místě.\n\nDA\nOpbevares et tørt sted.\n\nDE\nAn einem trockenen Ort aufbewahren.\n\nET\nHoida kuivas.\n\nEL\nΑποθηκεύεται σε στεγνό μέρος.\n\nEN\nStore in a dry place.\n\nFR\nStocker dans un endroit sec.\n\nGA\nStóráil in áit thirim.\n\n\nHR\nSkladištiti na suhom mjestu.\n\n\nIT\nConservare in luogo asciutto.\n\nLV\nGlabāt sausā vietā.\n\nLT\nLaikyti sausoje vietoje.\n\nHU\nSzáraz helyen tárolandó.\n\nMT\nAħżen f’post niexef.\n\nNL\nOp een droge plaats bewaren.\n\nPL\nPrzechowywać w suchym miejscu.\n\nPT\nArmazenar em local seco.\n\nRO\nA se depozita într-un loc uscat.\n\nSK\nUchovávajte na suchom mieste.\n\nSL\nHraniti na suhem.\n\nFI\nVarastoi kuivassa paikassa.\n\nSV\nFörvaras torrt.\n\nP403\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място.\n\nES\nAlmacenar en un lugar bien ventilado.\n\nCS\nSkladujte na dobře větraném místě.\n\nDA\nOpbevares på et godt ventileret sted.\n\nDE\nAn einem gut belüfteten Ort aufbewahren.\n\nET\nHoida hästi ventileeritavas kohas.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο.\n\nEN\nStore in a well-ventilated place.\n\nFR\nStocker dans un endroit bien ventilé.\n\nGA\nStóráil in áit dhea-aeráilte.\n\n\nHR\nSkladištiti na dobro prozračenom mjestu.\n\n\nIT\nConservare in luogo ben ventilato.\n\nLV\nGlabāt labi vēdināmā vietā.\n\nLT\nLaikyti gerai vėdinamoje vietoje.\n\nHU\nJól szellőző helyen tárolandó.\n\nMT\nAħżen f’post b'ventilazzjoni tajba.\n\nNL\nOp een goed geventileerde plaats bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu.\n\nPT\nArmazenar em local bem ventilado.\n\nRO\nA se depozita într-un spațiu bine ventilat.\n\nSK\nUchovávajte na dobre vetranom mieste.\n\nSL\nHraniti na dobro prezračevanem mestu.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto.\n\nSV\nFörvaras på väl ventilerad plats.\n\nP404\nLanguage\n\n\nBG\nДа се съхранява в затворен съд.\n\nES\nAlmacenar en un recipiente cerrado.\n\nCS\nSkladujte v uzavřeném obalu.\n\nDA\nOpbevares i en lukket beholder.\n\nDE\nIn einem geschlossenen Behälter aufbewahren.\n\nET\nHoida suletud mahutis.\n\nEL\nΦυλάσσεται σε κλειστό περιέκτη.\n\nEN\nStore in a closed container.\n\nFR\nStocker dans un récipient fermé.\n\nGA\nStóráil i gcoimeádán iata.\n\n\nHR\nSkladištiti u zatvorenom spremniku.\n\n\nIT\nConservare in un recipiente chiuso.\n\nLV\nGlabāt slēgtā tvertnē.\n\nLT\nLaikyti uždaroje talpykloje.\n\nHU\nZárt edényben tárolandó.\n\nMT\nAħżen f’kontenitur magħluq.\n\nNL\nIn gesloten verpakking bewaren.\n\nPL\nPrzechowywać w zamkniętym pojemniku.\n\nPT\nArmazenar em recipiente fechado.\n\nRO\nA se depozita într-un recipient închis.\n\nSK\nUchovávajte v uzavretej nádobe.\n\nSL\nHraniti v zaprti posodi.\n\nFI\nVarastoi suljettuna.\n\nSV\nFörvaras i sluten behållare.\n\nP405\nLanguage\n\n\nBG\nДа се съхранява под ключ.\n\nES\nGuardar bajo llave.\n\nCS\nSkladujte uzamčené.\n\nDA\nOpbevares under lås.\n\nDE\nUnter Verschluss aufbewahren.\n\nET\nHoida lukustatult.\n\nEL\nΦυλάσσεται κλειδωμένο.\n\nEN\nStore locked up.\n\nFR\nGarder sous clef.\n\nGA\nStóráil faoi ghlas.\n\n\nHR\nSkladištiti pod ključem.\n\n\nIT\nConservare sotto chiave.\n\nLV\nGlabāt slēgtā veidā.\n\nLT\nLaikyti užrakintą.\n\nHU\nElzárva tárolandó.\n\nMT\nAħżen f'post imsakkar.\n\nNL\nAchter slot bewaren.\n\nPL\nPrzechowywać pod zamknięciem.\n\nPT\nArmazenar em local fechado à chave.\n\nRO\nA se depozita sub cheie.\n\nSK\nUchovávajte uzamknuté.\n\nSL\nHraniti zaklenjeno.\n\nFI\nVarastoi lukitussa tilassa.\n\nSV\nFörvaras inlåst.\n\n\nP406\nLanguage\n\n\nBG\nДа се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.\n\nES\nAlmacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.\n\nCS\nSkladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.\n\nDA\nOpbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.\n\nDE\nIn korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.\n\nET\nHoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.\n\nEL\nΑποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.\n\nEN\nStore in corrosive resistant/… container with a resistant inner liner.\n\nFR\nStocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.\n\nGA\nStóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.\n\n\nHR\nSkladištiti u spremniku otpornom na nagrizanje/… spremniku s otpornom unutarnjom oblogom.\n\n\nIT\nConservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.\n\nLV\nGlabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.\n\nLT\nLaikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.\n\nHU\nSaválló/saválló bélésű … edényben tárolandó.\n\nMT\nAħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.\n\nNL\nIn corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.\n\nPL\nPrzechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.\n\nPT\nArmazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.\n\nRO\nDepozitați într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.\n\nSK\nUchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.\n\nSL\nHraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.\n\nFI\nVarastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.\n\nSV\nFörvaras i korrosionsbeständig/… behållare med beständigt innerhölje.\n\nP407\nLanguage\n\n\nBG\nДа се остави въздушно пространство между купчините/палетите.\n\nES\nDejar una separación entre los bloques/los palés de carga.\n\nCS\nMezi stohy/paletami ponechte vzduchovou mezeru.\n\nDA\nObevares med luftmellemrum mellem stakkene/pallerne.\n\nDE\nLuftspalt zwischen Stapeln/Paletten lassen.\n\nET\nJätta virnade/kaubaaluste vahele õhuvahe.\n\nEL\nΝα υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.\n\nEN\nMaintain air gap between stacks/pallets.\n\nFR\nMaintenir un intervalle d’air entre les piles/palettes.\n\nGA\nCoimeád bearna aeir idir chruacha/phailléid.\n\n\nHR\nOsigurati razmak između polica/paleta.\n\n\nIT\nMantenere uno spazio libero tra gli scaffali/i pallet.\n\nLV\nSaglabāt gaisa spraugu starp krāvumiem/paletēm.\n\nLT\nPalikti oro tarpą tarp eilių/palečių.\n\nHU\nA rakatok/raklapok között térközt kell hagyni.\n\nMT\nĦalli l-arja tgħaddi bejn l-imniezel/il-palits.\n\nNL\nRuimte laten tussen stapels/pallets.\n\nPL\nZachować szczelinę powietrzną pomiędzy stosami/paletami.\n\nPT\nRespeitar as distâncias mínimas entre pilhas/paletes.\n\nRO\nPăstrați un spațiu gol între stive/paleți.\n\nSK\nMedzi regálmi/paletami ponechajte vzduchovú medzeru.\n\nSL\nOhraniti zračno režo med skladi/paletami.\n\nFI\nJätä pinojen/kuormalavojen väliin ilmarako.\n\nSV\nSe till att det finns luft mellan staplar/pallar.\n\nP410\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина.\n\nES\nProteger de la luz del sol.\n\nCS\nChraňte před slunečním zářením.\n\nDA\nBeskyttes mod sollys.\n\nDE\nVor Sonnenbestrahlung schützen.\n\nET\nHoida päikesevalguse eest.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες.\n\nEN\nProtect from sunlight.\n\nFR\nProtéger du rayonnement solaire.\n\nGA\nCosain ó sholas na gréine.\n\n\nHR\nZaštititi od sunčevog svjetla.\n\n\nIT\nProteggere dai raggi solari.\n\nLV\nAizsargāt no saules gaismas.\n\nLT\nSaugoti nuo saulės šviesos.\n\nHU\nNapfénytől védendő.\n\nMT\nIpproteġi mid-dawl tax-xemx.\n\nNL\nTegen zonlicht beschermen.\n\nPL\nChronić przed światłem słonecznym.\n\nPT\nManter ao abrigo da luz solar.\n\nRO\nA se proteja de lumina solară.\n\nSK\nChráňte pred slnečným žiarením.\n\nSL\nZaščititi pred sončno svetlobo.\n\nFI\nSuojaa auringonvalolta.\n\nSV\nSkyddas från solljus.\n\nP411\nLanguage\n\n\nBG\nДа се съхранява при температури, не по-високи от … oC/…oF.\n\nES\nAlmacenar a temperaturas no superiores a … oC/…oF.\n\nCS\nSkladujte při teplotě nepřesahující … oC/…oF.\n\nDA\nOpbevares ved en temperatur, som ikke overstiger … oC/…oF.\n\nDE\nBei Temperaturen von nicht mehr als … oC/…aufbewahren.\n\nET\nHoida temperatuuril mitte üle … oC/… oF.\n\nEL\nΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.\n\nEN\nStore at temperatures not exceeding … oC/…oF.\n\nFR\nStocker à une température ne dépassant pas … oC/… oF.\n\nGA\nStóráil ag teocht nach airde ná … oC/…oF.\n\n\n\nHR\nSkladištiti na temperaturi koja ne prelazi …oC/…oF.\n\n\nIT\nConservare a temperature non superiori a … oC/…oF.\n\nLV\nUzglabāt temperatūrā, kas nepārsniedz … oC/…oF.\n\nLT\nLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje.\n\nHU\nA tárolási hőmérséklet legfeljebb … oC/…oF lehet.\n\nMT\nAħżen f’temperaturi li ma jeċċedux … oC/…oF.\n\nNL\nBij maximaal … oC/…oF bewaren.\n\nPL\nPrzechowywać w temperaturze nieprzekraczającej … oC/…oF.\n\nPT\nArmazenar a uma temperatura não superior a … oC/…oF.\n\nRO\nA se depozita la temperaturi care să nu depășească … oC/…oF.\n\nSK\nUchovávajte pri teplotách do … oC/…oF\n\nSL\nHraniti pri temperaturi do … oC/… oF.\n\nFI\nVarastoi alle … oC/…oF lämpötilassa.\n\nSV\nFörvaras vid högst … oC/…oF.\n\nP412\nLanguage\n\n\nBG\nДа не се излага на температури, по-високи от 50 oC/122oF.\n\nES\nNo exponer a temperaturas superiores a 50 oC/122oF.\n\nCS\nNevystavujte teplotě přesahující 50 oC/122 oF.\n\nDA\nMå ikke udsættes for en temperatur, som overstiger 50 oC/122oF.\n\nDE\nNicht Temperaturen von mehr als 50 oC aussetzen.\n\nET\nMitte hoida temperatuuril üle 50 oC/122 oF.\n\nEL\nΝα μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.\n\nEN\nDo not expose to temperatures exceeding 50 oC/122oF.\n\nFR\nNe pas exposer à une température supérieure à 50 oC/122 oF.\n\nGA\nNá nocht do theocht níos airde ná 50 oC/122oF.\n\n\nHR\nNe izlagati temperaturi višoj od 50 oC/122 oF.\n\n\nIT\nNon esporre a temperature superiori a 50 oC/122oF.\n\nLV\nNepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.\n\nLT\nNelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.\n\nHU\nNem érheti 50 oC/122oF hőmérsékletet meghaladó hő.\n\nMT\nTesponix għal temperaturi li jeċċedu l-50 oC/122oF.\n\nNL\nNiet blootstellen aan temperaturen boven 50 oC/122oF.\n\nPL\nNie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.\n\nPT\nNão expor a temperaturas superiores a 50 oC/122oF.\n\nRO\nNu expuneți la temperaturi care depășesc 50 oC/122 oF.\n\nSK\nNevystavujte teplotám nad 50 oC/122 oF.\n\nSL\nNe izpostavljati temperaturam nad 50 oC/122 oF.\n\nFI\nEi saa altistaa yli 50 oC/122 oF lämpötiloille.\n\nSV\nFår inte utsättas för temperaturer över 50 oC/122 oF.\n\nP413\nLanguage\n\n\nBG\nПри насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.\n\nES\nAlmacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.\n\nCS\nMnožství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.\n\nDA\nBulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.\n\nDE\nSchüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren\n\nET\nKogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.\n\nEL\nΟι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.\n\nEN\nStore bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.\n\nFR\nStocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.\n\nGA\nStóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.\n\n\nHR\nSkladištiti količine veće od … kg/ … lbs na temperaturi koja ne prelazi … oC/… oF.\n\n\n\nIT\nConservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.\n\nLV\nLielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.\n\nLT\nDidesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.\n\nHU\nA … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.\n\nMT\nAħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.\n\nNL\nBulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.\n\nPL\nPrzechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.\n\nPT\nArmazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.\n\nRO\nDepozitați cantitățile în vrac mai mari de … kg/… lbs la temperaturi care să nu depășească … oC/…oF.\n\nSK\nVeľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.\n\nSL\nRazsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.\n\nFI\nSäilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.\n\nSV\nBulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.\n\nP420\nLanguage\n\n\nBG\nДа се съхранява на разстояние от други материали.\n\nES\nAlmacenar alejado de otros materiales.\n\nCS\nSkladujte odděleně od ostatních materiálů.\n\nDA\nMå ikke opbevares i nærheden af andre materialer.\n\nDE\nVon anderen Materialien entfernt aufbewahren.\n\nET\nHoida eemal teistest materjalidest.\n\nEL\nΑποθηκεύεται μακριά από άλλα υλικά.\n\nEN\nStore away from other materials.\n\nFR\nStocker à l’écart des autres matières.\n\nGA\nStóráil glan ar ábhair eile.\n\n\nHR\nSkladištiti odvojeno od drugih materijala.\n\n\n\nIT\nConservare lontano da altri materiali.\n\nLV\nGlabāt atsevišķi no citiem materiāliem.\n\nLT\nLaikyti atokiau nuo kitų medžiagų.\n\nHU\nMás anyagoktól távol tárolandó.\n\nMT\nAħżen ‘l bogħod minn materjal ieħor.\n\nNL\nGescheiden van ander materiaal bewaren.\n\nPL\nPrzechowywać z dala od innych materiałów.\n\nPT\nArmazenar afastado de outros materiais.\n\nRO\nDepozitați departe de alte materiale.\n\nSK\nUchovávajte oddelene od iných materiálov.\n\nSL\nHraniti ločeno od drugih materialov.\n\nFI\nVarastoi erillään muista materiaaleista.\n\nSV\nFörvaras åtskilt från andra material.\n\nP422\nLanguage\n\n\nBG\nСъдържанието да се съхранява при…\n\nES\nAlmacenar el contenido en …\n\nCS\nSkladujte pod …\n\nDA\nIndholdet skal opbevares under …\n\nDE\nInhalt in/unter … aufbewahren\n\nET\nHoida sisu …\n\nEL\nΤο περιεχόμενο αποθηκεύεται σε …\n\nEN\nStore contents under …\n\nFR\nStocker le contenu sous …\n\nGA\nStóráil an t-ábhar faoi …\n\n\nHR\nSkladištiti uz ove uvjete …\n\n\nIT\nConservare sotto…\n\nLV\nSaturu uzglabāt zem…\n\nLT\nTurinį laikyti …\n\nHU\nTartalma … -ban/-ben tárolandó.\n\nMT\nAħżen il-kontenut taħt …\n\nNL\nOnder … bewaren.\n\nPL\nZawartość przechowywać w …\n\nPT\nArmazenar o conteúdo em …\n\nRO\nDepozitați conținutul sub …\n\nSK\nObsah uchovávajte v …\n\nSL\nVsebino hraniti v …\n\nFI\nVarastoi sisältö …\n\nSV\nFörvara innehållet i…\n\n\nP402 + P404\nLanguage\n\n\nBG\nДа се съхранява на сухо място. Да се съхранява в затворен съд.\n\nES\nAlmacenar en un lugar seco. Almacenar en un recipiente cerrado.\n\nCS\nSkladujte na suchém místě. Skladujte v uzavřeném obalu.\n\nDA\nOpbevares et tørt sted. Opbevares i en lukket beholder.\n\nDE\nIn einem geschlossenen Behälter an einem trockenen Ort aufbewahren.\n\nET\nHoida kuivas. Hoida suletud mahutis.\n\nEL\nΑποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.\n\nEN\nStore in a dry place. Store in a closed container.\n\nFR\nStocker dans un endroit sec. Stocker dans un récipient fermé.\n\nGA\nStóráil in áit thirim. Stóráil i gcoimeádán iata.\n\n\nHR\nSkladištiti na suhom mjestu. Skladištiti u zatvorenom spremniku.\n\n\nIT\nConservare in luogo asciutto e in recipiente chiuso.\n\nLV\nGlabāt sausā vietā. Glabāt aizvērtā tvertnē.\n\nLT\nLaikyti sausoje vietoje. Laikyti uždaroje talpykloje.\n\nHU\nSzáraz helyen tárolandó. Zárt edényben tárolandó.\n\nMT\nAħżen f’post niexef. Aħżen f’kontenitur magħluq.\n\nNL\nOp een droge plaats bewaren. In gesloten verpakking bewaren.\n\nPL\nPrzechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.\n\nPT\nArmazenar em local seco. Armazenar em recipiente fechado.\n\nRO\nA se depozita într-un loc uscat, într-un recipient închis.\n\nSK\nUchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.\n\nSL\nHraniti na suhem. Hraniti v zaprti posodi.\n\nFI\nVarastoi kuivassa paikassa. Varastoi suljettuna.\n\nSV\nFörvaras torrt. Förvaras i sluten behållare.\n\nP403 + P233\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.\n\nES\nAlmacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.\n\nCS\nSkladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.\n\nDA\nOpbevares på et godt ventileret sted. Hold beholderen tæt lukket.\n\nDE\nBehälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.\n\nET\nHoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.\n\nEN\nStore in a well-ventilated place. Keep container tightly closed.\n\nFR\nStocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.\n\nGA\nStóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.\n\n\nHR\nSkladištiti na dobro prozračenom mjestu. Čuvati u dobro zatvorenom spremniku.\n\n\nIT\nTenere il recipiente ben chiuso e in luogo ben ventilato.\n\nLV\nGlabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.\n\nLT\nLaikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.\n\nHU\nJól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.\n\nMT\nAħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.\n\nNL\nOp een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.\n\nPT\nArmazenar em local bem ventilado. Manter o recipiente bem fechado.\n\nRO\nA se depozita într-un spațiu bine ventilat. Păstrați recipientul închis etanș.\n\nSK\nUchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.\n\nSL\nHraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.\n\nSV\nFörvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.\n\n\nP403 + P235\nLanguage\n\n\nBG\nДа се съхранява на добре проветриво място. Да се съхранява на хладно.\n\nES\nAlmacenar en un lugar bien ventilado. Mantener en lugar fresco.\n\nCS\nSkladujte na dobře větraném místě. Uchovávejte v chladu.\n\nDA\nOpbevares på et godt ventileret sted. Opbevares køligt.\n\nDE\nKühl an einem gut belüfteten Ort aufgewahren.\n\nET\nHoida hästi ventileeritavas kohas. Hoida jahedas.\n\nEL\nΑποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.\n\nEN\nStore in a well-ventilated place. Keep cool.\n\nFR\nStocker dans un endroit bien ventilé. Tenir au frais.\n\nGA\nStóráil in áit dhea-aeráilte. Coimeád fionnuar.\n\n\nHR\nSkladištiti na dobro prozračenom mjestu. Održavati hladnim.\n\n\nIT\nConservare in luogo fresco e ben ventilato.\n\nLV\nGlabāt labi vēdināmās telpās. Turēt vēsumā.\n\nLT\nLaikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.\n\nHU\nJól szellőző helyen tárolandó. Hűvös helyen tartandó.\n\nMT\nAħżen f'post b'ventilazzjoni tajba. Żomm frisk.\n\nNL\nOp een goed geventileerde plaats bewaren. Koel bewaren.\n\nPL\nPrzechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.\n\nPT\nArmazenar em local bem ventilado. Conservar em ambiente fresco.\n\nRO\nA se depozita într-un spațiu bine ventilat. A se păstra la rece.\n\nSK\nUchovávajte na dobre vetranom mieste. Uchovávajte v chlade.\n\nSL\nHraniti na dobro prezračevanem mestu. Hraniti na hladnem.\n\nFI\nVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.\n\nSV\nFörvaras på väl ventilerad plats. Förvaras svalt.\n\n\nP410 + P403\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.\n\nES\nProteger de la luz del sol. Almacenar en un lugar bien ventilado.\n\nCS\nChraňte před slunečním zářením. Skladujte na dobře větraném místě.\n\nDA\nBeskyttes mod sollys. Opbevares på et godt ventileret sted.\n\nDE\nVor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.\n\nET\nHoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.\n\nEN\nProtect from sunlight. Store in a well-ventilated place.\n\nFR\nProtéger du rayonnement solaire. Stocker dans un endroit bien ventilé.\n\nGA\nCosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.\n\n\nHR\nZaštititi od sunčevog svjetla. Skladištiti na dobro prozračenom mjestu.\n\n\nIT\nProteggere dai raggi solari. Conservare in luogo ben ventilato.\n\nLV\nAizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.\n\nLT\nSaugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.\n\nHU\nNapfénytől védendő. Jól szellőző helyen tárolandó.\n\nMT\nIpproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.\n\nNL\nTegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.\n\nPL\nChronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.\n\nPT\nManter ao abrigo da luz solar. Armazenar em local bem ventilado.\n\nRO\nA se proteja de lumina solară. A se depozita într-un spațiu bine ventilat.\n\nSK\nChráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.\n\nSL\nZaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.\n\nFI\nSuojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.\n\nSV\nSkyddas från solljus. Förvaras på väl ventilerad plats.\n\n\nP410 + P412\nLanguage\n\n\nBG\nДа се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.\n\nES\nProteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.\n\nCS\nChraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.\n\nDA\nBeskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.\n\nDE\nVor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.\n\nET\nHoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.\n\nEL\nΝα προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.\n\nEN\nProtect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.\n\nFR\nProtéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.\n\nGA\nCosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.\n\n\nHR\nZaštititi od sunčevog svjetla. Ne izlagati temperaturi višoj od 50 oC/122 oF.\n\n\nIT\nProteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.\n\nLV\nAizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.\n\nLT\nSaugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.\n\nHU\nNapfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.\n\nMT\nIpproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.\n\nNL\nTegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.\n\nPL\nChronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.\n\nPT\nManter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.\n\nRO\nA se proteja de lumina solară. Nu expuneți la temperaturi care depășesc 50 oC/122 oF.\n\nSK\nChráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.\n\nSL\nZaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.\n\nFI\nSuojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.\n\nSV\nSkyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.\n\n\nP411 + P235\nLanguage\n\n\nBG\nДа се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.\n\nES\nAlmacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.\n\nCS\nSkladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.\n\nDA\nOpbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.\n\nDE\nKühl und bei Temperaturen von nicht mehr als … oC aufbewahren.\n\nET\nHoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.\n\nEL\nΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.\n\nEN\nStore at temperatures not exceeding … oC/…oF. Keep cool.\n\nFR\nStocker à une température ne dépassant pas … oC/… oF. Tenir au frais.\n\nGA\nStóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.\n\n\nHR\nSkladištiti na temperaturi koja ne prelazi … oC/… oF. Održavati hladnim.\n\n\nIT\nConservare in luogo fresco a temperature non superiori a … oC/…oF.\n\nLV\nGlabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.\n\nLT\nLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.\n\nHU\nA tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.\n\nMT\nAħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.\n\nNL\nBij maximaal … oC/…oF bewaren. Koel bewaren.\n\nPL\nPrzechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.\n\nPT\nArmazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.\n\nRO\nA se depozita la temperaturi care să nu depășească … oC/…oF. A se păstra la rece.\n\nSK\nUchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.\n\nSL\nHraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.\n\nFI\nVarastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.\n\nSV\nFörvaras vid högst … oC/…oF. Förvaras svalt.\n\n\nTable 1.5\nPrecautionary statements — Disposal\n\nP501\nLanguage\n\n\nBG\nСъдържанието/съдът да се изхвърли в …\n\nES\nEliminar el contenido/el recipiente en …\n\nCS\nOdstraňte obsah/obal …\n\nDA\nIndholdet/beholderen bortskaffes i …\n\nDE\nInhalt/Behälter … zuführen.\n\nET\nSisu/mahuti kõrvaldada …\n\nEL\nΔιάθεση του περιεχομένου/περιέκτη σε …\n\nEN\nDispose of contents/container to …\n\nFR\nÉliminer le contenu/récipient dans …\n\nGA\nDiúscair an t-ábhar/an coimeádán i …\n\n\nHR\nOdložiti sadržaj/spremnik u/na …\n\n\nIT\nSmaltire il prodotto/recipiente in …\n\nLV\nAtbrīvoties no satura/tvertnes…\n\nLT\nTurinį/talpyklą išpilti (išmesti) į …\n\nHU\nA tartalom/edény elhelyezése hulladékként: …\n\nMT\nArmi l-kontenut/il-kontenitur fi …\n\nNL\nInhoud/verpakking afvoeren naar …\n\nPL\nZawartość/pojemnik usuwać do …\n\nPT\nEliminar o conteúdo/recipiente em …\n\nRO\nAruncați conținutul/recipientul la …\n\nSK\nZneškodnite obsah/nádobu …\n\nSL\nOdstraniti vsebino/posodo …\n\nFI\nHävitä sisältö/pakkaus …\n\nSV\nInnehållet/behållaren lämnas till…\n\n\nP502\nLanguage\n\n\nBG\nОбърнете се към производителя/доставчика за информация относно възстановяването/рециклирането\n\nES\nPedir información al fabricante o proveedor sobre su recuperación o reciclado\n\nCS\nInformujte se u výrobce nebo dodavatele o regeneraci nebo recyklaci\n\nDA\nIndhent oplysninger om genvinding/genanvendelse hos producenten/leverandøren\n\nDE\nInformationen zur Wiederverwendung/Wiederverwertung beim Hersteller/Lieferanten erfragen\n\nET\nHankida valmistajalt/tarnijalt teavet kemikaali taaskasutamise/ringlussevõtu kohta\n\nEL\nΑπευθυνθείτε στον παραγωγό/προμηθευτή για την ανάκτηση/ανακύκλωση\n\nEN\nRefer to manufacturer/supplier for information on recovery/recycling\n\nFR\nSe reporter au fabricant/fournisseur pour des informations concernant la récupération/le recyclage\n\nGA\nFéach an fhaisnéis ón monaróir/soláthróir maidir le haisghabháil/athchúrsáil\n\n\nHR\nPogledajte proizvođača/dobavljača zatražiti podatke o recikliranju/preradi\n\n\nIT\nChiedere informazioni al produttore o fornitore per il recupero/riciclaggio\n\nLV\nInformācija par rekuperāciju/pārstrādi saņemama pie ražotāja/piegādātāja\n\nLT\nKreiptis į gamintoją (tiekėją) informacijai apie šių medžiagų ar preparatų panaudojimą arba perdirbimą gauti\n\nHU\nA gyártó/szállító határozza meg a hasznosításra és újrafeldolgozásra vonatkozó információkat\n\nMT\nIrreferi għall-manifattur/fornitur rigward informazzjoni dwar l-irkupru/riċiklaġġ\n\nNL\nRaadpleeg fabrikant/leverancier voor informatie over terugwinning/recycling\n\nPL\nPrzestrzegać wskazówek producenta lub dostawcy dotyczących odzysku lub wtórnego wykorzystania\n\nPT\nSolicitar ao fabricante/fornecedor informações relativas à recuperação/reciclagem\n\nRO\nAdresați-vă producătorului pentru informații privind recuperarea/reciclarea\n\nSK\nInformujte sa u výrobcu alebo dodávateľa o regenerácii alebo recyklácii\n\nSL\nZa podatke glede obnovitve/reciklaže se obrnite na proizvajalca/dobavitelja\n\nFI\nHanki valmistajalta/toimittajalta tietoja uudelleenkäytöstä/kierrätyksestä\n\nSV\nRådfråga tillverkare/leverantör om återvinning/återanvändning\n", "previous_location": null, "changed_within": [ "AN IV SCT 2" ], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null }, { "corpus": "eu", "key": "32013R0517", "display_name": null }, { "corpus": "eu", "key": "32013R0944", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unchanged" }, "signals": { "structural_diff": { "status": "observed", "detail": "structural_diff", "change_types": [ "MODIFIED" ] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M; 32013R0517 C; 32013R0944 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": false, "dispute_reason": null }, "outcome": "passed", "sentences": [ { "text": "The table of translated precautionary statements in Part 2 of Annex IV has additional Croatian-language (HR) entries inserted for statements such as P101, P102, P103, P201 and P202, alongside the existing language versions.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN IV" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_IV", "label": "Annex IV, 02008R1272-20131201" } ] }, { "text": "Both versions being shown are truncated before the full extent of the added or changed Croatian entries can be seen, so only the portion visible before the cut can be described.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20110419", "location": "AN IV" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20110419#anx_IV", "label": "Annex IV, 02008R1272-20110419" }, { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN IV" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_IV", "label": "Annex IV, 02008R1272-20131201" } ] } ], "applicability_note": null, "unexplained": "", "unexplained_kind": "" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN V" }, "heading": null, "before": null, "after": null, "previous_location": null, "changed_within": [], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unknown", "reason": null }, "signals": { "structural_diff": { "status": "absent", "detail": "structural_diff", "change_types": [] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": true, "dispute_reason": "textless_metadata_only" }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships marked disputed", "unexplained_kind": "nothing_to_explain" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN VI" }, "heading": "Harmonised classification and labelling for certain hazardous substances", "before": "\nANNEX VI\nHarmonised classification and labelling for certain hazardous substances\nPart 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.\nPart 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.\nPart 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.\n\n\n1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED CLASSIFICATIONS AND LABELLING\n\n\n1.1. Information listed for each entry\n\n\n1.1.1. Numbering of entries and identification of a substance\n\n\n1.1.1.1. Index numbers\nEntries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled Index No.\n\n\n1.1.1.2. EC numbers\nThe EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS)\nOJ C 146A, 15.6.1990.. The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of No-longer-polymers (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled EC No.\n\n\n1.1.1.3. CAS number\nThe Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled CAS No.\n\n\n\n1.1.1.4. International Chemical Identification\nWherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of No-longer-polymers are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.\nImpurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.\nSome substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.\nWhere specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.\nWithout prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.\nCertain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: (containing ≥ xx % impurity). The reference in brackets is then to be considered as a part of the name, and must be included on the label.\n\n\n1.1.1.5. Entries for groups of substances\nA number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.\nIn some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase except those specified elsewhere in this Annex.\nIn some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.\nEntries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.\nEC or CAS numbers are not usually included for entries which comprise more than four individual substances.\n\n\n\n1.1.2. Information related to the classification and labelling of each entry in Table 3.1\n\n\n1.1.2.1. Classification codes\n\n\n1.1.2.1.1. Hazard class and category codes\nThe classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.\nThe Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.\n\nTable 1.1\n\nsee Note U in 1.1.3.\n\nHazard Class\nHazard Class and Category Code\nExplosive\nUnst. Expl.\nExpl. 1.1\nExpl. 1.2\nExpl. 1.3\nExpl. 1.4\nExpl. 1.5\nExpl. 1.6\nFlammable gas\nFlam. Gas 1\nFlam. Gas 2\nFlammable aerosol\nFlam. Aerosol 1\nFlam. Aerosol 2\nOxidising gas\nOx. Gas 1\nGases under pressure\nPress. Gas\n\nFlammable liquid\nFlam. Liq. 1\nFlam. Liq. 2\nFlam. Liq. 3\nFlammable solid\nFlam. Sol. 1\nFlam. Sol. 2\nSelf-reactive substance or mixture\nSelf-react. A\nSelf-react. B\nSelf-react. CD\nSelf-react. EF\nSelf-react. G\nPyrophoric liquid\nPyr. Liq. 1\nPyrophoric solid\nPyr. Sol. 1\nSelf-heating substance or mixture\nSelf-heat. 1\nSelf-heat. 2\nSubstance or mixture which in contact with water emits flammable gas\nWater-react. 1\nWater-react. 2\nWater-react. 3\nOxidising liquid\nOx. Liq. 1\nOx. Liq. 2\nOx. Liq. 3\nOxidising solid\nOx. Sol. 1\nOx. Sol. 2\nOx. Sol. 3\nOrganic peroxide\nOrg. Perox. A\nOrg. Perox. B\nOrg. Perox. CD\nOrg. Perox. EF\nOrg. Perox. G\nSubstance or mixture corrosive to metals\nMet. Corr. 1\nAcute toxicity\nAcute Tox. 1\nAcute Tox. 2\nAcute Tox. 3\nAcute Tox. 4\nSkin corrosion/irritation\nSkin Corr. 1A\nSkin Corr. 1B\nSkin Corr. 1C\nSkin Irrit. 2\nSerious eye damage/eye irritation\nEye Dam. 1\nEye Irrit. 2\nRespiratory/skin sensitization\nResp. Sens. 1, 1A, 1B\nSkin. Sens. 1, 1A, 1B\nGerm cell mutagenicity\nMuta. 1A\nMuta. 1B\nMuta. 2\nCarcinogenicity\nCarc. 1A\nCarc. 1B\nCarc. 2\nReproductive toxicity\nRepr. 1A\nRepr. 1B\nRepr. 2\nLact.\nSpecific target organ toxicity — single exposure\nSTOT SE 1\nSTOT SE 2\nSTOT SE 3\nSpecific target organ toxicity — repeated exposure\nSTOT RE 1\nSTOT RE 2\nAspiration hazard\nAsp. Tox. 1\nHazardous to the aquatic environment\nAquatic Acute 1\nAquatic Chronic 1\nAquatic Chronic 2\nAquatic Chronic 3\nAquatic Chronic 4\nHazardous for the ozone layer\nOzone 1\n\n\n1.1.2.1.2. Hazard statement codes\nThe hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:\n\nH350i\nMay cause cancer by inhalation.\nH360F\nMay damage fertility.\nH360D\nMay damage the unborn child.\nH361f\nSuspected of damaging fertility.\nH361d\nSuspected of damaging the unborn child.\nH360FD\nMay damage fertility. May damage the unborn child.\nH361fd\nSuspected of damaging fertility. Suspected of damaging the unborn child.\nH360Fd\nMay damage fertility. Suspected of damaging the unborn child.\nH360Df\nMay damage the unborn child. Suspected of damaging fertility.\n\n\n1.1.2.2. Labelling codes\nIn the labelling column, the following elements are listed:\n\n(i) the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;\n\n(ii) the signal word code Dgr for Dangeror Wng for Warning, in accordance with the precedence rule in Article 20(3);\n\n(iii) the hazard statement codes as specified in Annex III, in accordance with the classification;\n\n(iv) the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.\n\n\n1.1.2.3. Specific concentration limits and M-factors\nSpecific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.\nUnless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.\n\nIn case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in Table 3.1 in the same column as the specific concentration limits. In case an M-factor for Aquatic Acute 1 and an M-factor for Aquatic Chronic 1 have been harmonised, each M-factor shall be listed in the same line as its corresponding differentiation. Where a single M-factor is given in Table 3.1 and the substance is classified as Aquatic Acute 1 and Aquatic Chronic 1, this M-factor shall be used by the manufacturer, importer or downstream user for the classification of a mixture containing this substance for acute and long-term aquatic hazards using the summation method. Where no M-factor is given in Table 3.1, M-factor(s) based on available data for the substance shall be set by the manufacturer, importer or downstream user. For the setting and use of M-factors, see section 4.1.3.5.5.5 of Annex I.\n\n\n\n\n1.1.3. Notes assigned to an entry\nThe note(s) assigned to an entry are listed in the column entitled Notes. The meaning of the notes is as follows:\n\n\n1.1.3.1. Notes relating to the identification, classification and labelling of substances\n\nNote A:\nWithout prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.\nIn Part 3, use is sometimes made of a general description such as ... compounds or ... salts. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.\n\nNote B:\nSome substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.\nIn Part 3 entries with Note B have a general designation of the following type: nitric acid … %.\nIn this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.\n\nNote C:\nSome organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.\nIn this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.\n\nNote D:\nCertain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.\nHowever, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words non-stabilised.\n\nNote E (Table 3.2):\nSubstances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word Also.\n\nNote F:\nThis substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.\n\n\nNote G:\nThis substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.\n\n\nNote H (Table 3.1):\nThe classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.\nThe final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.\n\nNote H (Table 3.2):\nThe classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.\n\n\nNote J:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.\n\nNote K:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote L:\nThe classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote M:\nThe classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.\n\nNote N:\nThe classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote P:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).\nWhen the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.\nThis note applies only to certain complex oil-derived substances in Part 3.\n\nNote Q:\nThe classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:\n\n\na short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or\na short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or\nan appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or\nabsence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.\n\nNote R:\nThe classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.\n\nNote S:\nThis substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).\nThis substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).\n\nNote T:\nThis substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.\n\nNote U (Table 3.1):\nWhen put on the market gases have to be classified as Gases under pressure, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.\n\n\n1.1.3.2. Notes relating to the classification and labelling of mixtures\n\nNote 1:\nThe concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.\n\nNote 2:\nThe concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.\n\nNote 3:\nThe concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.\n\nNote 5:\nThe concentration limits for gaseous mixtures are expressed as volume per volume percentage.\n\n\nNote 7:\nAlloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.\n\n\n1.1.4. Information related to the classification and labelling of each entry in Table 3.2\n\n\n1.1.4.1. Classification codes\nThe classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;\nThe abbreviation for each of the categories of danger is shown below:\n\nexplosive: E\noxidising: O\nextremely flammable: F+\nhighly flammable: F\nflammable: R10\nvery toxic: T+\nToxic: T\nharmful: Xn\ncorrosive: C\nirritant: Xi\nsensitising: R42 and/or R43\ncarcinogenic: Carc. Cat. (1, 2 or 3)\nmutagenic: Muta. Cat. (1, 2 or 3)\ntoxic for reproduction: Repr. Cat. (1, 2 or 3)\ndangerous for the environment: N or R52 and/or R53;\n\n\n1.1.4.2. Labelling codes\n\n(i) the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);\n\n(ii) the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;\n\n(iii) the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.\n\nNote that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.\nS1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.\nS2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.\nSafety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.\n\n\n1.1.4.3. Specific Concentration Limits\nThe concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.\nUnless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.\nWhere no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.\n\n\n\n1.1.4.4. Non-conformity with Table 3.1 for physical hazards\nIt is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.\nUntil these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference in Table 3.2.\n\n\n\n1.2. Classifications and hazard statements in table 3.1 arising from translation of classifications listed in Annex i to directive 67/548/EEC\n\n\n1.2.1. Minimum classification\nFor certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:\n\nthe manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;\nthe minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.\nMinimum classification for a category is indicated by the reference * in the column Classification in Table 3.1.\n\nThe reference * can also be found in the column Specific concentration Limits and M-factors where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be translated into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.\n\n\n1.2.2. Route of exposure cannot be excluded\nFor certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.\nThese hazard statements are indicated by the reference ** in Table 3.1.\n\n\n1.2.3. Hazard statements for reproductive toxicity\nHazard statements H360 and H361 indicate a general concern for effects on both fertility and development: May damage/Suspected of damaging fertility or the unborn child. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.\nIn order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.\nThese hazard statements are indicated by the reference *** in Table 3.1.\n\n\n1.2.4. Correct classification for physical hazards could not be established\nFor some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.\nThe entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.\n\n\n2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION AND LABELLING\nThis Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.\nThe relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.\n\nFor all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.\nA dossier for harmonised classification and labelling shall contain the following:\n\nProposal\nThe proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.\nJustification for the proposed harmonised classification and labelling\nA comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.\nJustification for other effects at Community level\nFor other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.\n\n\n3. PART 3: HARMONISED CLASSIFICATION AND LABELLING TABLES\n\nTable 3.1: List of harmonised classification and labelling of hazardous substances.\nTable 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC.\n\n\n\nTable 3.1\nList of harmonised classification and labelling of hazardous substances\n\nIndex No\nInternational Chemical Identification\nEC No\nCAS No\nClassification\nLabelling\nSpecific Conc. Limits, M-factors\nNotes\nHazard Class and Category Code(s)\nHazard statement Code(s)\nPictogram, Signal Word Code(s)\nHazard statement Code(s)\nSuppl. Hazard statement Code(s)\n\n\n001-001-00-9\nhydrogen\n215-605-7\n1333-74-0\nFlam. Gas 1\nPress. Gas\nH220\nGHS02\nGHS04\nDgr\nH220\n\n\nU\n\n\n001-002-00-4\naluminium lithium hydride\n240-877-9\n16853-85-3\nWater-react. 1\nSkin Corr. 1A\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\n\n\n\n\n001-003-00-X\nsodium hydride\n231-587-3\n7646-69-7\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\n\n001-004-00-5\ncalcium hydride\n232-189-2\n7789-78-8\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\n\n003-001-00-4\nlithium\n231-102-5\n7439-93-2\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n003-002-00-X\nn-hexyllithium\n404-950-0\n21369-64-2\nWater-react. 1\nPyr. Sol. 1\nSkin Corr. 1A\nH260\nH250\nH314\nGHS02\nGHS05\nDgr\nH260\nH250\nH314\nEUH014\n\n\n\n\n003-003-00-5\n(2-methylpropyl)lithium;\nisobutyllithium\n440-620-2\n920-36-5\nWater-react. 1\nPyr. Liq. 1\nSkin Corr. 1A\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH260\nH250\nH314\nH336\nH400\nH410\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH260\nH250\nH314\nH336\nH410\nEUH014\n\n\n\n\n004-001-00-7\nberyllium\n231-150-7\n7440-41-7\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nGHS06\nGHS08\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\n\n\n\n004-002-00-2\nberyllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex\n—\n—\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nH411\n\n\nA\n004-003-00-8\nberyllium oxide\n215-133-1\n1304-56-9\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nGHS06\nGHS08\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\n\n\n\n\n005-001-00-X\nboron trifluoride\n231-569-5\n7637-07-2\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH314\nEUH014\n\nU\n005-002-00-5\nboron trichloride\n233-658-4\n10294-34-5\nPress. Gas\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1B\nH330\nH300\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH300\nH314\nEUH014\n\nU\n005-003-00-0\nboron tribromide\n233-657-9\n10294-33-4\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH300\nH314\nEUH014\n\n\n005-004-00-6\ntrialkylboranes, solid\n—\n—\nPyr. Sol. 1\nSkin Corr. 1B\nH250\nH314\nGHS02\nGHS05\nDgr\nH250\nH314\n\n\nA\n005-004-01-3\ntrialkylboranes, liquid\n—\n—\nPyr. Liq. 1\nSkin Corr. 1B\nH250\nH314\nGHS02\nGHS05\nDgr\nH250\nH314\n\n\nA\n005-005-00-1\ntrimethyl borate\n204-468-9\n121-43-7\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH312\nGHS02\nGHS07\nWng\nH226\nH312\n\n\n\n\n\n005-006-00-7\ndibutyltin hydrogen borate\n401-040-5\n75113-37-0\nRepr. 1B\nMuta. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH360FD\nH341\nH372\nH312\nH302\nH318\nH317\nH410\n\n\n\n\n\n\n\n005-007-00-2\nboric acid; [1]\nboric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]\n233-139-2 [1]\n234-343-4 [2]\n10043-35-3 [1]\n11113-50-1 [2]\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 5,5 %\n\n\n005-008-00-8\ndiboron trioxide;\nboric oxide\n215-125-8\n1303-86-2\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 3,1 %\n\n\n005-009-00-3\ntetrabutylammonium butyltriphenylborate\n418-080-4\n120307-06-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n005-010-00-9\nN,N-dimethylanilinium tetrakis(pentafluorophenyl)borate\n422-050-6\n118612-00-3\nCarc. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH351\nH302\nH315\nH318\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH302\nH315\nH318\n\n\n\n\n\n005-011-00-4\ndisodium tetraborate, anhydrous;\nboric acid, disodium salt; [1]\ntetraboron disodium heptaoxide, hydrate; [2]\northoboric acid, sodium salt [3]\n215-540-4 [1]\n235-541-3 [2]\n237-560-2 [3]\n1330-43-4 [1]\n12267-73-1 [2]\n13840-56-7 [3]\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 4,5 %\n\n\n005-011-01-1\ndisodium tetraborate decahydrate;\nborax decahydrate\n215-540-4\n1303-96-4\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 8,5 %\n\n\n005-011-02-9\ndisodium tetraborate pentahydrate;\nborax pentahydrate\n215-540-4\n12179-04-3\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 6,5 %\n\n\n\n005-012-00-X\ndiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate\n418-070-1\n141714-54-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n\n005-013-00-5\ndiethylmethoxyborane\n425-380-9\n7397-46-8\nPyr. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 4\nH250\nH332\nH312\nH302\nH373**\nH314\nH317\nH413\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH250\nH332\nH312\nH302\nH373**\nH314\nH317\nH413\n\n\n\n\n005-014-00-0\n4-formylphenylboronic acid\n438-670-5\n87199-17-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n005-015-00-6\n1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n414-380-4\n140681-55-6\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n005-016-00-1\ntetrabutylammonium butyl tris-(4-tert-butylphenyl)borate\n431-370-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n005-017-00-7\nsodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n231-556-4 [2]\n15120-21-5 [1]\n7632-04-4 [2]\nOxid. Sol. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH302\nH335\nH318\nGHS03\nGHS05\nGHS08\nGHS07\nDgr\nH272\nH360Df\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n\n005-017-01-4\nsodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n231-556-4 [2]\n15120-21-5 [1]\n7632-04-4 [2]\nOxid. Sol. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH331\nH302\nH335\nH318\nGHS03\nGHS06\nGHS05\nGHS08\nDgr\nH272\nH360Df\nH331\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n\n005-018-00-2\nperboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\nRepr. 1B\nSTOT SE 3\nEye Dam. 1\nH360Df\nH335\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH360Df\nH335\nH318\n\nRepr. 1B; H360 Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %\n\n\n005-018-01-X\nperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH360Df\nH332\nH335\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH360Df\nH332\nH335\nH318\n\nRepr. 1B; H360 Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %\n\n\n005-019-00-8\nperboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]\n11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]\nOxid. Sol. 3\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH302\nH335\nH318\nGHS03\nGHS05\nGHS08\nGHS07\nDgr\nH272\nH360Df\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n\n005-019-01-5\nperboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]\n11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]\nOxid. Sol. 3\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH331\nH302\nH335\nH318\nGHS03\nGHS06\nGHS05\nGHS08\nDgr\nH272\nH360Df\nH331\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n\n\n006-001-00-2\ncarbon monoxide\n211-128-3\n630-08-0\nFlam. Gas 1\nPress. Gas\nRepr. 1A\nAcute Tox. 3 *\nSTOT RE 1\nH220\nH360D ***\nH331\nH372 **\nGHS02\nGHS04\nGHS06\nGHS08\nDgr\nH220\nH360D ***\nH331\nH372 **\n\n\nU\n006-002-00-8\nphosgene;\ncarbonyl chloride\n200-870-3\n75-44-5\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nH330\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH314\n\n\nU\n006-003-00-3\ncarbon disulphide\n200-843-6\n75-15-0\nFlam. Liq. 2\nRepr. 2\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nH225\nH361fd\nH372 **\nH319\nH315\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH361fd\nH372 **\nH319\nH315\n\nRepr. 2; H361fd: C ≥ 1 %\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤C < 1 %\n\n006-004-00-9\ncalcium carbide\n200-848-3\n75-20-7\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\nT\n006-005-00-4\nthiram (ISO);\ntetramethylthiuram disulphide\n205-286-2\n137-26-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH373 **\nH319\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH332\nH302\nH373 **\nH319\nH315\nH317\nH410\n\nM = 10\n\n006-006-00-X\nhydrogen cyanide;\nhydrocyanic acid\n200-821-6\n74-90-8\nFlam. Liq. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH224\nH330\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH224\nH330\nH410\n\n\n\n006-006-01-7\nhydrogen cyanide … %;\nhydrocyanic acid … %\n200-821-6\n74-90-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\n\nB\n\n\n006-007-00-5\nsalts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\nEUH032\n\nA\n\n006-008-00-0\nantu (ISO);\n1-(1-naphthyl)-2-thiourea\n201-706-3\n86-88-4\nAcute Tox. 2 *\nCarc. 2\nH300\nH351\nGHS06\nGHS08\nDgr\nH300\nH351\n\n\n\n006-009-00-6\n1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;\nisolan\n204-318-2\n119-38-0\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n006-010-00-1\n5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;\ndimetan\n204-525-8\n122-15-6\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n\n\n\n006-011-00-7\ncarbaryl (ISO);\n1-naphthyl methylcarbamate\n200-555-0\n63-25-2\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH351\nH332\nH302\nH400\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH302\nH400\n\nM=100\n\n\n006-012-00-2\nziram (ISO);\nzinc bis dimethyldithiocarbamate\n205-288-3\n137-30-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH373 **\nH335\nH318\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH330\nH302\nH373 **\nH335\nH318\nH317\nH410\n\nM = 100\n\n006-013-00-8\nmetam-sodium (ISO);\nsodium methyldithiocarbamate\n205-293-0\n137-42-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\nEUH031\n\n\n006-014-00-3\nnabam (ISO);\ndisodium ethylenebis(N,N'-dithiocarbamate)\n205-547-0\n142-59-6\nAcute Tox. 4 *\nSTOT SE 3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH335\nH317\nH410\nGHS07\nGHS09\nWng\nH302\nH335\nH317\nH410\n\n\n\n\n\n006-015-00-9\ndiuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea\n206-354-4\n330-54-1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH373\nH410\n\nM=10\n\n\n\n006-016-00-4\npropoxur (ISO);\n2-isopropyloxyphenyl N-methylcarbamate;\n2-isopropoxyphenyl methylcarbamate\n204-043-8\n114-26-1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-017-00-X\naldicarb (ISO);\n2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime\n204-123-2\n116-06-3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH410\n\n\n\n006-018-00-5\naminocarb (ISO);\n4-dimethylamino-3-tolyl methylcarbamate\n217-990-7\n2032-59-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n006-019-00-0\ndi-allate (ISO);\nS-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate\n218-961-1\n2303-16-4\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n006-020-00-6\nbarban (ISO);\n4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate\n202-930-4\n101-27-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n006-021-00-1\nlinuron (ISO);\n3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea\n206-356-5\n330-55-2\nRepr. 1B\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH351\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360Df\nH351\nH302\nH373 **\nH410\n\n\n\n006-022-00-7\ndecarbofuran (ISO);\n2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate\n—\n1563-67-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n006-023-00-2\nmercaptodimethur (ISO);\nmethiocarb (ISO);\n3,5-dimethyl-4-methylthiophenyl N-methylcarbamate\n217-991-2\n2032-65-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-024-00-8\nproxan-sodium (ISO);\nsodium O-isopropyldithiocarbonate\n205-443-5\n140-93-2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 2\nH302\nH315\nH411\nGHS07\nGHS09\nWng\nH302\nH315\nH411\n\n\n\n006-025-00-3\nallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;\nbioallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]\nS-bioallethrin;\n(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]\nesbiothrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]\n209-542-4 [1]\n249-013-5 [2]-[3]\n584-79-2 [1]\n28434-00-6 [2]\n84030-86-4 [3]\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\n\nC\n006-026-00-9\ncarbofuran (ISO);\n2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate\n216-353-0\n1563-66-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\n\n006-028-00-X\ndinobuton (ISO);\n2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate\n213-546-1\n973-21-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-029-00-5\ndioxacarb (ISO);\n2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate\n230-253-4\n6988-21-2\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n006-030-00-0\nEPTC (ISO);\nS-ethyl dipropylthiocarbamate\n212-073-8\n759-94-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-031-00-6\nformetanate (ISO);\n3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate\n244-879-0\n22259-30-9\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH317\nH410\n\n\n\n006-032-00-1\nmonolinuron (ISO);\n3-(4-chlorophenyl)-1-methoxy-1-methylurea\n217-129-5\n1746-81-2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH410\n\n\n\n006-033-00-7\nmetoxuron (ISO);\n3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea\n243-433-2\n19937-59-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n006-034-00-2\npebulate (ISO);\nN-butyl-N-ethyl-S-propylthiocarbamate\n214-215-4\n1114-71-2\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-035-00-8\npirimicarb (ISO);\n5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate\n245-430-1\n23103-98-2\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-036-00-3\nbenzthiazuron (ISO);\n1-benzothiazol-2-yl-3-methylurea\n217-685-9\n1929-88-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-037-00-9\npromecarb (ISO);\n3-isopropyl-5-methylphenyl N-methylcarbamate\n220-113-0\n2631-37-0\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-038-00-4\nsulfallate (ISO);\n2-chloroallyl N,N-dimethyldithiocarbamate\n202-388-9\n95-06-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n006-039-00-X\ntri-allate (ISO);\nS-2,3,3-trichloroallyl diisopropylthiocarbamate\n218-962-7\n2303-17-5\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n006-040-00-5\n3-methylpyrazol-5-yl-dimethylcarbamate;\nmonometilan\n—\n2532-43-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n006-041-00-0\ndimethylcarbamoyl chloride\n201-208-6\n79-44-7\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH350\nH331\nH302\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH350\nH331\nH302\nH319\nH335\nH315\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n006-042-00-6\nmonuron (ISO);\n3-(4-chlorophenyl)-1,1-dimethylurea\n205-766-1\n150-68-5\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n006-043-00-1\n3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;\nmonuron-TCA\n—\n140-41-0\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH319\nH315\nH410\n\n\n\n006-044-00-7\nisoproturon (ISO);\n3-(4-isopropylphenyl)-1,1-dimethylurea\n251-835-4\n34123-59-6\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\nM = 10\n\n\n\n006-045-00-2\nmethomyl (ISO);\n1-(methylthio)ethylideneamino N-methylcarbamate\n240-815-0\n16752-77-5\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH410\n\nM=100\n\n\n\n006-046-00-8\nbendiocarb (ISO);\n2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate\n245-216-8\n22781-23-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH410\n\n\n\n006-047-00-3\nbufencarb (ISO);\nreaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate\n—\n8065-36-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n006-048-00-9\nethiofencarb (ISO);\n2-(ethylthiomethyl)phenyl N-methylcarbamate\n249-981-9\n29973-13-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-049-00-4\ndixanthogen;\nO,O-diethyl dithiobis(thioformate)\n207-944-4\n502-55-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-050-00-X\n1,1-dimethyl-3-phenyluronium trichloroacetate;\nfenuron-TCA\n—\n4482-55-7\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n006-051-00-5\nferbam (ISO);\niron tris(dimethyldithiocarbamate)\n238-484-2\n14484-64-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\n\n\n006-052-00-0\nformetanate hydrochloride;\n3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate\n245-656-0\n23422-53-9\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH317\nH410\n\n\n\n006-053-00-6\nisoprocarb (ISO);\n2-isopropylphenyl N-methylcarbamate\n220-114-6\n2631-40-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-054-00-1\nmexacarbate (ISO);\n3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate\n206-249-3\n315-18-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n006-055-00-7\nxylylcarb (ISO);\n3,4-dimethylphenyl N-methylcarbamate;\n3,4-xylyl methylcarbamate;\nMPMC\n219-364-9\n2425-10-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-056-00-2\nmetolcarb (ISO);\nm-tolyl methylcarbamate;\nMTMC\n214-446-0\n1129-41-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-057-00-8\nnitrapyrin (ISO);\n2-chloro-6-trichloromethylpyridine\n217-682-2\n1929-82-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-058-00-3\nnoruron (ISO);\n1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea\n—\n2163-79-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-059-00-9\noxamyl (ISO);\nN',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;\n245-445-3\n23135-22-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH330\nH300\nH312\nH411\nGHS06\nGHS09\nDgr\nH330\nH300\nH312\nH411\n\n\n\n006-060-00-4\noxycarboxin (ISO);\n2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide\n226-066-2\n5259-88-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n006-061-00-X\nS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;\nprothiocarb hydrochloride\n243-193-9\n19622-19-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-062-00-5\nmethyl 3,4-dichlorophenylcarbanilate;\nSWEP.\n—\n1918-18-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-063-00-0\nthiobencarb (ISO);\nS-4-chlorobenzyl diethylthiocarbamate\n248-924-5\n28249-77-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-064-00-6\nthiofanox (ISO);\n3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime\n254-346-4\n39196-18-4\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n006-065-00-1\n3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;\ntriamid\n—\n15271-41-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH300\nH311\nH411\nGHS06\nGHS09\nDgr\nH300\nH311\nH411\n\n\n\n006-066-00-7\nvernolate (ISO);\nS-propyl dipropylthiocarbamate\n217-681-7\n1929-77-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-067-00-2\nXMC;\n3,5-xylyl methylcarbamate\n—\n2655-14-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-068-00-8\ndiazomethane\n206-382-7\n334-88-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n006-069-00-3\nthiophanate-methyl (ISO);\n1,2-di-(3-methoxycarbonyl-2-thioureido)benzene\n245-740-7\n23564-05-8\nMuta. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH332\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH332\nH317\nH410\n\n\n\n006-070-00-9\nfurmecyclox (ISO);\nN-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide\n262-302-0\n60568-05-0\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n006-071-00-4\ncyclooct-4-en-1-yl methyl carbonate\n401-620-8\n87731-18-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n006-072-00-X\nprosulfocarb (ISO);\nS-benzyl N,N-dipropylthiocarbamate\n401-730-6\n52888-80-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n006-073-00-5\n3-(dimethylamino)propylurea\n401-950-2\n31506-43-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n006-074-00-0\n2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate\n402-440-2\n2094-99-7\nAcute Tox. 2 *\nSkin Corr. 1B\nSTOT RE 2 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH314\nH373 **\nH334\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH330\nH314\nH373 **\nH334\nH317\nH410\n\n\n\n\n\n006-076-00-1\nmancozeb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt\n—\n8018-01-7\nRepr. 2\nSkin Sens. 1\nAquatic Acute 1\nH361d***\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH317\nH400\n\nM=10\n\n\n006-077-00-7\nmaneb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric)\n235-654-8\n12427-38-2\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d***\nH332\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH332\nH319\nH317\nH410\n\nM=10\n\n\n006-078-00-2\nzineb (ISO);\nzinc ethylenebis(dithiocarbamate) (polymeric)\n235-180-1\n12122-67-7\nSTOT SE 3\nSkin Sens. 1\nH335\nH317\nGHS07\nWng\nH335\nH317\n\n\n\n006-079-00-8\ndisulfiram;\ntetraethylthiuramdisulfide\n202-607-8\n97-77-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n006-080-00-3\ntetramethylthiuram monosulphide\n202-605-7\n97-74-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n006-081-00-9\nzinc bis(dibutyldithiocarbamate)\n205-232-8\n136-23-2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH410\n\n\n\n006-082-00-4\nzinc bis(diethyldithiocarbamate)\n238-270-9\n14324-55-1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH317\nH410\n\n\n\n006-083-00-X\nbutocarboxim (ISO);\n3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime\n252-139-3\n34681-10-2\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH331\nH311\nH301\nH319\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH226\nH331\nH311\nH301\nH319\nH410\n\n\n\n\n\n\n006-084-00-5\ncarbosulfan (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate\n259-565-9\n55285-14-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH317\nH410\n\n\n\n\n006-085-00-0\nfenobucarb (ISO);\n2-butylphenyl methylcarbamate\n223-188-8\n3766-81-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-086-00-6\nethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;\nfenoxycarb\n276-696-7\n72490-01-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n006-087-00-1\nfurathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate\n265-974-3\n65907-30-4\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH373**\nH319\nH315\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH301\nH373\nH319\nH315\nH317\nH410\n\nM=100\n\n\n006-088-00-7\nbenfuracarb (ISO);\nethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate\n—\n82560-54-1\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH331\nH302\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361f***\nH331\nH302\nH410\n\n\n\n\n\n\n006-089-00-2\nchlorine dioxide\n233-162-8\n10049-04-4\nOx. Gas 1\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1\nH270\nH330\nH314\nH400\nGHS03\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH270\nH330\nH314\nH400\nEUH006\nM = 1000\nU\n006-089-01-X\nchlorine dioxide . . . %\n233-162-8\n10049-04-4\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH314\nH400\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 0,3 % ≤ C < 10 %\nSTOT SE 3; H335: C ≥ 3 %\nM = 10\nB\n\n006-090-00-8\n2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate\n408-010-0\n88558-41-2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH332\nH318\nH412\nGHS05\nGHS07\nDgr\nH332\nH318\nH412\n\n\n\n\n\n006-091-00-3\npropineb (ISO);\npolymeric zinc propylenebis(dithiocarbamate)\n—\n9016-72-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nH332\nH373**\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH332\nH373**\nH317\nH400\n\n\n\n\n006-092-00-9\ntert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate\n425-420-5\n98737-29-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n006-093-00-4\n2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)\n427-180-7\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n006-094-00-X\nO-isobutyl-N-ethoxy carbonylthiocarbamate\n434-350-4\n103122-66-3\nFlam. Liq. 3\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH226\nH350\nH340\nH302\nH373**\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH350\nH340\nH302\nH373**\nH317\nH411\n\n\n\n\n006-095-00-5\nfosetyl-aluminium (ISO);\naluminium triethyl triphosphonate\n254-320-2\n39148-24-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n006-096-00-0\nchlorpropham (ISO);\nisopropyl 3-chlorocarbanilate\n202-925-7\n101-21-3\nCarc. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH351\nH373**\nH411\nGHS08\nGHS09\nWng\nH351\nH373**\nH411\n\n\n\n\n006-097-00-6\n1-phenyl-3-(p-toluenesulfonyl)urea\n424-620-1\n13909-63-2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n006-098-00-1\ntert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate\n429-170-8\n134575-17-0\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgrg\nH302\nH373**\nH318\nH317\n\n\n\n\n006-099-00-7\nN-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;\n3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate\n520-2\n232938-43-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n006-101-00-6\nreaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];\nN-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;\nN,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]\n423-070-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n006-102-00-1\nO-hexyl-N-ethoxycarbonylthiocarbamate\n432-750-3\n—\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH340\nH302\nH373**\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH340\nH302\nH373**\nH317\nH411\n\n\n\n\n006-103-00-7\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea\n445-760-8\n—\nEye Dam. 1\nResp. Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH334\nH400\nH410\nGHS05\nGHS08\nGHS09\nDgr\nH318\nH334\nH410\n\nM=100\n\n\n007-001-00-5\nammonia, anhydrous\n231-635-3\n7664-41-7\nFlam. Gas 2\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH221\nH331\nH314\nH400\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH221\nH331\nH314\nH400\n\n\nU\n007-001-01-2\nammonia ….%\n215-647-6\n1336-21-6\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\nB\n\n\n007-002-00-0\nnitrogen dioxide; [1]\ndinitrogen tetraoxide [2]\n233-272-6 [1]\n234-126-4 [2]\n10102-44-0 [1]\n10544-72-6 [2]\nPress. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1B\nH270\nH330\nH314\nGHS04\nGHS03\nGHS06\nGHS05\nDgr\nH270\nH330\nH314\n\n*\nSTOT SE 3; H335: C ≥ 0,5 %\n5\n\n007-003-00-6\nchlormequat chloride (ISO);\n2-chloroethyltrimethylammonium chloride\n213-666-4\n999-81-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n007-004-00-1\nnitric acid … %\n231-714-2\n7697-37-2\nOx. Liq. 3\nSkin Corr. 1A\nH272\nH314\nGHS03\nGHS05\nDgr\nH272\nH314\n\nSkin Corr. 1A; H314: C ≥ 20 %\nSkin Corr. 1B; H314: 5 % ≤ C < 20 %\nOx. Liq. 3; H272: C ≥ 65 %\nB\n007-006-00-2\nethyl nitrite\n203-722-6\n109-95-5\nFlam. Gas 1\nPress. Gas\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH220\nH332\nH312\nH302\nGHS02\nGHS04\nGHS07\nDgr\nH220\nH332\nH312\nH302\n\n\nU\n\n\n007-007-00-8\nethyl nitrate\n210-903-3\n625-58-1\nUnst. Expl\nH200\nGHS01\nDgr\nH200\n\n\n\n\n007-008-00-3\nhydrazine\n206-114-9\n302-01-2\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 3 % ≤ C < 10 %\n\n007-009-00-9\ndicyclohexylammonium nitrite\n221-515-9\n3129-91-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n*\n\n007-010-00-4\nsodium nitrite\n231-555-9\n7632-00-0\nOx. Sol. 3\nAcute Tox. 3 *\nAquatic Acute 1\nH272\nH301\nH400\nGHS03\nGHS06\nGHS09\nDgr\nH272\nH301\nH400\n\n*\n\n007-011-00-X\npotassium nitrite\n231-832-4\n7758-09-0\nOx. Sol. 2\nAcute Tox. 3 *\nAquatic Acute 1\nH272\nH301\nH400\nGHS03\nGHS06\nGHS09\nDgr\nH272\nH301\nH400\n\n*\n\n007-012-00-5\nN,N-dimethylhydrazine\n200-316-0\n57-14-7\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH225\nH350\nH331\nH301\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH331\nH301\nH314\nH411\n\n\n\n007-013-00-0\n1,2-dimethylhydrazine\n—\n540-73-8\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n007-014-00-6\nsalts of hydrazine\n—\n—\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH331\nH311\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH317\nH410\n\n\nA\n007-015-00-1\nO-ethylhydroxylamine\n402-030-3\n624-86-2\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH225\nH331\nH311\nH301\nH372 **\nH319\nH317\nH400\nGHS02\nGHS06\nGHS08\nGHS09\nDgr\nH225\nH331\nH311\nH301\nH372 **\nH319\nH317\nH400\n\n\n\n007-016-00-7\nbutyl nitrite\n208-862-1\n544-16-1\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nH225\nH331\nH301\nGHS02\nGHS06\nDgr\nH225\nH331\nH301\n\n\n\n007-017-00-2\nisobutyl nitrite\n208-819-7\n542-56-3\nFlam. Liq. 2\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH350\nH341\nH332\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH350\nH341\nH332\nH302\n\n\n\n007-018-00-8\nsec-butyl nitrite\n213-104-8\n924-43-6\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-019-00-3\ntert-butyl nitrite\n208-757-0\n540-80-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-020-00-9\npentyl nitrite; [1]\namyl nitrite, mixed isomers [2]\n207-332-7 [1]\n203-770-8 [2]\n463-04-7 [1]\n110-46-3 [2]\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-021-00-4\nhydrazobenzene;\n1,2-diphenylhydrazine\n204-563-5\n122-66-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n007-022-00-X\nhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)\n405-030-1\n—\nCarc. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH302\nH314\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH302\nH314\nH317\nH412\n\n\n\n007-023-00-5\nsodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate\n405-510-0\n—\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n007-024-00-0\n2-(decylthio)ethylammonium chloride\n405-640-8\n36362-09-1\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH315\nH318\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH315\nH318\nH410\n\n\n\n007-025-00-6\n(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride\n406-090-1\n81880-96-8\nMuta. 2\nAcute Tox. 3 *\nSTOT RE 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH301\nH372 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH301\nH372 **\nH317\nH410\n\n\n\n007-026-00-1\noxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide\n413-230-5\n122035-71-6\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n007-027-00-7\n1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane\n420-190-2\n771478-66-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n\n\n007-028-00-2\nhydroxylammonium nitrate\n236-691-2\n13465-08-2\nExpl. 1.1 ****\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH201\nH351\nH311\nH302\nH373**\nH319\nH315\nH317\nH400\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH351\nH311\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\n\n\n007-029-00-8\ndiethyldimethylammonium hydroxide\n419-400-5\n95500-19-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n\n008-001-00-8\noxygen\n231-956-9\n7782-44-7\nOx. Gas 1\nPress. Gas\nH270\nGHS03\nGHS04\nDgr\nH270\n\n\nU\n008-003-00-9\nhydrogen peroxide solution … %\n231-765-0\n7722-84-1\nOx. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH271\nH332\nH302\nH314\nGHS03\nGHS05\nGHS07\nDgr\nH271\nH332\nH302\nH314\n\nOx. Liq. 1; H271: C ≥ 70 %****\nOx. Liq. 2; H272: 50 % ≤ C < 70 % ****\n*\nSkin Corr. 1A; H314: C ≥ 70 %\nSkin Corr. 1B; H314: 50 % ≤ C < 70 %\nSkin Irrit. 2; H315: 35 % ≤ C < 50 %\nEye Dam. 1; H318: 8 % ≤ C < 50 %\nEye Irrit. 2; H319: 5 % ≤ C < 8 %\nSTOT SE 3; H335; C ≥ 35 %\nB\n\n\n009-001-00-0\nfluorine\n231-954-8\n7782-41-4\nPress. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH270\nH330\nH314\nGHS04\nGHS03\nGHS06\nGHS05\nDgr\nH270\nH330\nH314\n\n\n\n\n\n009-002-00-6\nhydrogen fluoride\n231-634-8\n7664-39-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH310\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH310\nH300\nH314\n\n\n\n009-003-00-1\nhydrofluoric acid … %\n231-634-8\n7664-39-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH310\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH310\nH300\nH314\n\nSkin Corr. 1A; H314: C ≥ 7 %\nSkin Corr. 1B; H314: 1 % ≤ C < 7 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\nB\n009-004-00-7\nsodium fluoride\n231-667-8\n7681-49-4\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH319\nH315\nGHS06\nDgr\nH301\nH319\nH315\nEUH032\n\n\n009-005-00-2\npotassium fluoride\n232-151-5\n7789-23-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n009-006-00-8\nammonium fluoride\n235-185-9\n12125-01-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n009-007-00-3\nsodium bifluoride;\nsodium hydrogen difluoride\n215-608-3\n1333-83-1\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-008-00-9\npotassium bifluoride;\npotassium hydrogen difluoride\n232-156-2\n7789-29-9\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-009-00-4\nammonium bifluoride;\nammonium hydrogen difluoride\n215-676-4\n1341-49-7\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-010-00-X\nfluoroboric acid ... %\n240-898-3\n16872-11-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n009-011-00-5\nfluorosilicic acid ... %\n241-034-8\n16961-83-4\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\nB\n009-012-00-0\nalkali fluorosilicates(Na); [1]\nalkali fluorosilicates(K); [2]\nalkali fluorosilicates(NH4) [3]\n240-934-8 [1]\n240-896-2 [2]\n240-968-3 [3]\n16893-85-9 [1]\n16871-90-2 [2]\n16919-19-0 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n*\nA\n009-013-00-6\nfluorosilicates, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n*\nA\n009-014-00-1\nlead hexafluorosilicate\n247-278-1\n25808-74-6\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n009-015-00-7\nsulphuryl difluoride\n220-281-5\n2699-79-8\nPress. Gas\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH373 **\nH400\nGHS04\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH373 **\nH400\n\n\nU\n009-016-00-2\ntrisodium hexafluoroaluminate;\ncryolite\n237-410-6\n239-148-8\n13775-53-6\n15096-52-3\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH372 **\nH332\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH332\nH302\nH411\n\n\nC\n009-017-00-8\npotassium mu-fluoro-bis(triethylaluminium)\n400-040-2\n12091-08-6\nFlam. Sol. 1\nWater-react. 1\nSkin Corr. 1A\nAcute Tox. 4 *\nH228\nH270\nH314\nH332\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH270\nH314\nH332\nEUH014\n\nT\n009-018-00-3\nmagnesium hexafluorosilicate\n241-022-2\n16949-65-8\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n*\n\n011-001-00-0\nsodium\n231-132-9\n7440-23-5\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n011-002-00-6\nsodium hydroxide;\ncaustic soda\n215-185-5\n1310-73-2\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 5 %\nSkin Corr. 1B; H314: 2 % ≤ C < 5 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 2 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\n\n011-003-00-1\nsodium peroxide\n215-209-4\n1313-60-6\nOx. Sol. 1\nSkin Corr. 1A\nH271\nH314\nGHS03\nGHS05\nDgr\nH271\nH314\n\n\n\n011-004-00-7\nsodium azide\n247-852-1\n26628-22-8\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH400\nH410\nEUH032\n\n\n011-005-00-2\nsodium carbonate\n207-838-8\n497-19-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n011-006-00-8\nsodium cyanate\n213-030-6\n917-61-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n011-007-00-3\npropoxycarbazone-sodium\n—\n181274-15-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 10\n\n012-001-00-3\nmagnesium powder (pyrophoric)\n231-104-6\n7439-95-4\nWater-react. 1\nPyr. Sol. 1\nH260\nH250\nGHS02\nDgr\nH260\nH250\n\n\nT\n012-002-00-9\nmagnesium, powder or turnings\n231-104-6\n—\nFlam. Sol. 1\nWater-react. 2\nSelf-heat. 1\nH228\nH261\nH252\nGHS02\nDgr\nH228\nH261\nH252\n\n\nT\n012-003-00-4\nmagnesium alkyls\n—\n—\nPyr. Liq. 1\nWater-react. 1\nSkin Corr. 1B\nH250\nH260\nH314\nGHS02\nGHS05\nDgr\nH250\nH260\nH314\nEUH014\n\nA\n\n\n012-004-00-X\naluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate\n422-150-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n013-001-00-6\naluminium powder (pyrophoric)\n231-072-3\n7429-90-5\nWater-react. 2\nPyr. Sol. 1\nH261\nH250\nGHS02\nDgr\nH261\nH250\n\n\nT\n\n\n013-002-00-1\naluminium powder (stabilised)\n231-072-3\n7429-90-5\nWater-react. 2\nFlam. Sol. 1\nH261\nH228\nGHS02\nDgr\nH261\nH228\n\n\nT\n\n013-003-00-7\naluminium chloride, anhydrous\n231-208-1\n7446-70-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n013-004-00-2\naluminium alkyls\n—\n—\nPyr. Liq. 1\nWater-react. 1\nSkin Corr. 1B\nH250\nH260\nH314\nGHS02\nGHS05\nDgr\nH250\nH260\nH314\nEUH014\n\nA\n013-005-00-8\ndiethyl(ethyldimethylsilanolato)aluminium\n401-160-8\n55426-95-4\nWater-react. 1\nPyr. Liq. 1\nSkin Corr. 1A\nH260\nH250\nH314\nGHS02\nGHS05\nDgr\nH260\nH250\nH314\nEUH014\n\n\n013-006-00-3\n(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised\n402-370-2\n—\nFlam. Liq. 3\nEye Dam. 1\nH226\nH318\nGHS02\nGHS05\nDgr\nH226\nH318\n\n\n\n013-007-00-9\npoly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)\n403-430-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n013-008-00-4\ndi-n-octylaluminium iodide\n408-190-0\n7585-14-0\nPyr. Liq. 1\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH250\nH314\nH400\nH410\nGHS02\nGHS05\nGHS09\nDgr\nH250\nH314\nH410\nEUH014\n\n\n013-009-00-X\nsodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5\n418-720-2\n—\nFlam. Sol. 1\nWater-react. 1\nPyr. Sol. 1\nAcute Tox. 4 *\nSkin Corr. 1A\nH228\nH260\nH250\nH332\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH260\nH250\nH332\nH314\nEUH014\n\nT\n\n\n013-010-00-5\nhydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)\n430-650-4\n151841-65-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n014-001-00-9\ntrichlorosilane\n233-042-5\n10025-78-2\nFlam. Liq. 1\nPyr. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH224\nH250\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH224\nH250\nH332\nH302\nH314\nEUH014\nEUH029\n*\nSTOT SE 3; H335: C ≥ 1 %\nT\n014-002-00-4\nsilicon tetrachloride\n233-054-0\n10026-04-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\nEUH014\n\n\n014-003-00-X\ndimethyldichlorosilane\n200-901-0\n75-78-5\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\n\n\n\n014-004-00-5\ntrichloro(methyl)silane;\nmethyltrichlorosilane\n200-902-6\n75-79-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\nEUH014\nSkin Irrit. 2; H315: C ≥ 1 %\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n014-005-00-0\ntetraethyl silicate;\nethyl silicate\n201-083-8\n78-10-4\nFlam. Liq. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH226\nH332\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH332\nH319\nH335\n\n\n\n014-006-00-6\nbis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride\n401-380-4\n—\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n014-007-00-1\ntriethoxyisobutylsilane\n402-810-3\n17980-47-1\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n014-008-00-7\n(chloromethyl)bis(4-fluorophenyl)methylsilane\n401-200-4\n85491-26-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-009-00-2\nisobutylisopropyldimethoxysilane\n402-580-4\n111439-76-0\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Irrit. 2\nH226\nH332\nH315\nGHS02\nGHS07\nWng\nH226\nH332\nH315\n\n\n\n014-010-00-8\ndisodium metasilicate\n229-912-9\n6834-92-0\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\n\n\n014-011-00-3\ncyclohexyldimethoxymethylsilane\n402-140-1\n17865-32-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n014-012-00-9\nbis(3-(trimethoxysilyl)propyl)amine\n403-480-3\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n014-013-00-4\nα-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)\n404-920-7\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH312\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH411\n\n\n\n014-014-00-X\netacelasil (ISO);\n6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane\n253-704-7\n37894-46-5\nRepr. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nH360D ***\nH302\nH373 **\nGHS08\nGHS07\nDgr\nH360D ***\nH302\nH373 **\n\n\n\n014-015-00-5\nα-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))\n406-420-4\n69430-40-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n014-016-00-0\nreaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;\n1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane\n406-490-6\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-017-00-6\nflusilazole (ISO);\nbis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane\n—\n85509-19-9\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360D ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D ***\nH302\nH411\n\n\n\n014-018-00-1\noctamethylcyclotetrasiloxane\n209-136-7\n556-67-2\nRepr. 2\nAquatic Chronic 4\nH361f ***\nH413\nGHS08\nWng\nH361f ***\nH413\n\n\n\n014-019-00-7\nreaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;\n1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole\n403-250-2\n—\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360D ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D ***\nH302\nH411\n\n\n\n014-020-00-2\nbis(1,1-dimethyl-2-propynyloxy)dimethylsilane\n414-960-7\n53863-99-3\nAcute Tox. 4 *\nH332\nGHS07\nWng\nH332\n\n\n\n014-021-00-8\ntris(isopropenyloxy)phenyl silane\n411-340-8\n52301-18-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH400\nH410\n\n\n\n014-022-00-3\nreaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)\n401-530-9\n—\nFlam. Sol. 1\nSTOT SE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH228\nH370 **\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH370 **\nH332\nH312\nH302\n\n\nT\n014-023-00-9\nα, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole\n408-160-7\n125613-45-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-024-00-4\n1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene\n412-620-2\n121626-74-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-025-00-X\n4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine\n411-400-3\n102089-33-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH302\nH373 **\nH315\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH315\nH318\nH412\n\n\n\n014-026-00-5\ndichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane\n407-180-3\n770722-36-6\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n014-027-00-0\nchloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane\n410-270-5\n770722-46-8\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n014-028-00-6\nα-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)\n415-290-8\n193159-06-7\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n014-029-00-1\nO,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]\n421-870-1\n156145-66-3\nRepr. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nH361f ***\nH302\nH373 **\nGHS08\nGHS07\nWng\nH361f ***\nH302\nH373 **\n\n\n\n014-030-00-7\n[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium\n422-060-0\n137390-08-0\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n014-031-00-2\nbis(1-methylethyl)-dimethoxysilane\n421-540-7\n18230-61-0\nFlam. Liq. 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH315\nH317\nH412\nGHS02\nGHS07\nWng\nH226\nH315\nH317\nH412\n\n\n\n014-032-00-8\ndicyclopentyldimethoxysilane\n404-370-8\n126990-35-0\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n\n\n014-033-00-3\n2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica\n419-030-4\n125804-20-8\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\n\n\n\n\n014-034-00-9\n3-hexylheptamethyltrisiloxane\n428-700-5\n1873-90-1\nAcute Tox. 4 *\nAquatic Chronic 4\nH332\nH413\nGHS07\nWng\nH332\nH413\n\n\n\n\n014-035-00-4\n2-(3,4-epoxycyclohexyl)ethyltriethoxy silane\n425-050-4\n10217-34-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n014-036-00-X\n(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane\n405-020-7\n105024-66-6\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360F***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360F***\nH410\n\nM=1000\n\n\n014-037-00-5\n2-butanone-O,O',O''-(phenylsilylidyne)trioxime\n433-360-6\n34036-80-1\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373**\nH317\nH412\nGHS08\nGHS07\nWng\nH373**\nH317\nH412\n\n\n\n\n014-038-00-0\nS-(3-(triethoxysilyl)propyl) octanethioate\n436-690-9\n220727-26-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n014-039-00-6\n(2,3-dimethylbut-2-yl)-trimethoxysilane\n439-360-2\n142877-45-0\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n014-041-00-7\nN,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane\n445-890-5\n201290-01-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n014-042-00-2\nreaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-010-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n014-043-00-8\nreaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)\n432-200-2\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n014-044-00-3\n3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane\n433-050-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n014-045-00-9\nmagnesium sodium fluoride silicate\n442-650-1\n—\nSTOT RE 2 *\nH373**\nGHS08\nWng\nH373**\n\n\n\n\n015-001-00-1\nwhite phosphorus\n231-768-7\n12185-10-3\nPyr. Sol. 1\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1A\nAquatic Acute 1\nH250\nH330\nH300\nH314\nH400\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH250\nH330\nH300\nH314\nH400\n\n\n\n015-002-00-7\nred phosphorus\n231-768-7\n7723-14-0\nFlam. Sol. 1\nAquatic Chronic 3\nH228\nH412\nGHS02\nDgr\nH228\nH412\n\n\n\n\n\n015-003-00-2\ncalcium phosphide;\ntricalcium diphosphide\n215-142-0\n1305-99-3\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nM=100\n\n\n015-004-00-8\naluminium phosphide\n244-088-0\n20859-73-8\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nEUH032\nM=100\n\n\n015-005-00-3\nmagnesium phosphide;\ntrimagnesium diphosphide\n235-023-7\n12057-74-8\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nM=100\n\n\n015-006-00-9\ntrizinc diphosphide;\nzinc phosphide\n215-244-5\n1314-84-7\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH260\nH300\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH410\nEUH029\nEUH032\nM=100\nT\n\n015-007-00-4\nphosphorus trichloride\n231-749-3\n7719-12-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nSTOT RE 2 *\nSkin Corr. 1A\nH330\nH300\nH373 **\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH300\nH373 **\nH314\nEUH014\nEUH029\n\n\n015-008-00-X\nphosphorus pentachloride\n233-060-3\n10026-13-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nH330\nH302\nH373 **\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH302\nH373 **\nH314\nEUH014\nEUH029\n\n\n015-009-00-5\nphosphoryl trichloride\n233-046-7\n10025-87-3\nAcute Tox. 2 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1A\nH330\nH372 **\nH302\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH372 **\nH302\nH314\nEUH014\nEUH029\n\n\n015-010-00-0\nphosphorus pentoxide\n215-236-1\n1314-56-3\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n015-011-00-6\nphosphoric acid ... %, orthophosphoric acid ... %\n231-633-2\n7664-38-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n015-012-00-1\ntetraphosphorus trisulphide;\nphosphorus sesquisulphid\n215-245-0\n1314-85-8\nFlam. Sol. 2\nWater-react. 1\nAcute Tox. 4 *\nAquatic Acute 1\nH228\nH260\nH302\nH400\nGHS02\nGHS07\nGHS09\nDgr\nH228\nH260\nH302\nH400\n\n\nT\n015-013-00-7\ntriethyl phosphate\n201-114-5\n78-40-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-014-00-2\ntributyl phosphate\n204-800-2\n126-73-8\nCarc. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nH351\nH302\nH315\nGHS08\nGHS07\nWng\nH351\nH302\nH315\n\n\n\n015-015-00-8\ntricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\ntritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\n201-103-5\n78-30-8\nSTOT SE 1\nAquatic Chronic 2\nH370 **\nH411\nGHS08\nGHS09\nDgr\nH370 **\nH411\n\nSTOT SE 1; H370: C ≥ 1 %\nSTOT SE 2; H371: 0,2 % ≤ C < 1 %\nC\n015-016-00-3\ntricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\ntritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\n201-105-6\n78-32-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH302\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH411\n\n*\nC\n\n\n015-019-00-X\ndichlorvos (ISO);\n2,2-dichlorovinyl dimethyl phosphate\n200-547-7\n62-73-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nH330\nH311\nH301\nH317\nH400\nGHS06\nGHS09\nDgr\nH330\nH311\nH301\nH317\nH400\n\nM=1000\n\n\n015-020-00-5\nmevinphos (ISO);\n2-methoxycarbonyl-1-methylvinyl dimethyl phosphate\n232-095-1\n7786-34-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 10000\n\n015-021-00-0\ntrichlorfon (ISO);\ndimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate\n200-149-3\n52-68-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH400\nH410\n\nM = 1000\n\n015-022-00-6\nphosphamidon (ISO);\n2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate\n236-116-5\n13171-21-6\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH300\nH311\nH410\n\n\n\n015-023-00-1\npyrazoxon;\ndiethyl 3-methylpyrazol-5-yl phosphate\n—\n108-34-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n015-024-00-7\ntriamiphos (ISO);\n5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide\n—\n1031-47-6\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-025-00-2\nTEPP (ISO);\ntetraethyl pyrophosphate\n203-495-3\n107-49-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-026-00-8\nschradan (ISO);\noctamethylpyrophosphoramide\n205-801-0\n152-16-9\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-027-00-3\nsulfotep (ISO);\nO,O,O,O-tetraethyl dithiopyrophosphate\n222-995-2\n3689-24-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n015-028-00-9\ndemeton-O (ISO);\nO,O-diethyl-O-2-ethylthioethyl phosphorothioate\n206-053-8\n298-03-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-029-00-4\ndemeton-S (ISO);\ndiethyl-S-2-ethylthioethyl phosphorothioate\n204-801-8\n126-75-0\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-030-00-X\ndemeton-O-methyl (ISO);\nO-2-ethylthioethyl O,O-dimethyl phosphorothioate\n212-758-1\n867-27-6\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n015-031-00-5\ndemeton-S-methyl (ISO);\nS-2-ethylthioethyl dimethyl phosphorothioate\n213-052-6\n919-86-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH311\nH301\nH411\n\n\n\n015-032-00-0\nprothoate (ISO);\nO,O-diethyl isopropylcarbamoylmethyl phosphorodithioate\n218-893-2\n2275-18-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 3\nH310\nH300\nH412\nGHS06\nDgr\nH310\nH300\nH412\n\n\n\n015-033-00-6\nphorate (ISO);\nO,O-diethyl ethylthiomethyl phosphorodithioate\n206-052-2\n298-02-2\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n015-034-00-1\nparathion (ISO);\nO,O-diethyl O-4-nitrophenyl phosphorothioate\n200-271-7\n56-38-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH300\nH311\nH372 **\nH410\n\nM = 100\n\n015-035-00-7\nparathion — methyl (ISO);\nO,O-dimethyl O-4-nitrophenyl phosphorothioate\n206-050-1\n298-00-0\nFlam. Liq. 3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH330\nH300\nH311\nH373 **\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS09\nDgr\nH226\nH330\nH300\nH311\nH373 **\nH410\n\nM = 100\n\n015-036-00-2\nO-ethyl O-4-nitrophenyl phenylphosphonothioate;\nEPN\n218-276-8\n2104-64-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-037-00-8\nphenkapton (ISO);\nS-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate\n218-892-7\n2275-14-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n015-038-00-3\ncoumaphos (ISO);\nO-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate\n200-285-3\n56-72-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n015-039-00-9\nazinphos-methyl (ISO);\nO,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n201-676-1\n86-50-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH317\nH410\n\n\n\n015-040-00-4\ndiazinon (ISO);\nO,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate\n206-373-8\n333-41-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH400\nH410\n\n\n\n\n\n\n015-041-00-X\nmalathion (ISO);\n1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;\n[containing ≤ 0,03 % isomalathion]\n204-497-7\n121-75-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=1000\n\n\n015-042-00-5\nchlorthion\nO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate\n207-902-5\n500-28-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\nM = 100\n\n015-043-00-0\nphosnichlor (ISO);\nO-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate\n—\n5826-76-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n015-044-00-6\ncarbophenothion (ISO);\n4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate\n212-324-1\n786-19-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n015-045-00-1\nmecarbam (ISO);\nN-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate\n219-993-9\n2595-54-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH400\nH410\n\n\n\n015-046-00-7\noxydemeton-methyl;\nS-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate\n206-110-7\n301-12-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nH311\nH301\nH400\nGHS06\nGHS09\nDgr\nH311\nH301\nH400\n\n\n\n015-047-00-2\nethion (ISO);\nO,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);\ndiethion\n209-242-3\n563-12-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\nM = 10000\n\n\n\n015-048-00-8\nfenthion (ISO);\nO,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate\n200-231-9\n55-38-9\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH312\nH302\nH372**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH312\nH302\nH372**\nH410\n\nM=100\n\n\n015-049-00-3\nendothion (ISO);\nS-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate\n220-472-3\n2778-04-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n015-050-00-9\nthiometon (ISO);\nS-2-ethylthioethyl O,O-dimethyl phosphorodithioate\n211-362-6\n640-15-3\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n015-051-00-4\ndimethoate (ISO);\nO,O-dimethyl methylcarbamoylmethyl phosphorodithioate\n200-480-3\n60-51-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-052-00-X\nfenchlorphos (ISO);\nO,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate\n206-082-6\n299-84-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-053-00-5\nmenazon (ISO);\nS-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate\n201-123-4\n78-57-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n015-054-00-0\nfenitrothion (ISO);\nO,O-dimethyl O-4-nitro-m-tolyl phosphorothioate\n204-524-2\n122-14-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-055-00-6\nnaled (ISO);\n1,2-dibromo-2,2-dichloroethyl dimethyl phosphate\n206-098-3\n300-76-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nH312\nH302\nH319\nH315\nH400\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH400\n\nM = 1000\n\n\n\n015-056-00-1\nazinphos-ethyl (ISO);\nO,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n220-147-6\n2642-71-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM=100\n\n\n015-057-00-7\nformothion (ISO);\nN-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n219-818-6\n2540-82-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-058-00-2\nmorphothion (ISO);\nO,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate\n205-628-0\n144-41-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n015-059-00-8\nvamidothion (ISO);\nO,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate\n218-894-8\n2275-23-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nH301\nH312\nH400\nGHS06\nGHS09\nDgr\nH301\nH312\nH400\n\n\n\n015-060-00-3\ndisulfoton (ISO);\nO,O-diethyl 2-ethylthioethyl phosphorodithioate\n206-054-3\n298-04-4\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-061-00-9\ndimefox (ISO);\ntetramethylphosphorodiamidic fluoride\n204-076-8\n115-26-4\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-062-00-4\nmipafox (ISO);\nN,N'- di-isopropylphosphorodiamidic fluoride\n206-742-3\n371-86-8\nSTOT SE 1\nH370 **\nGHS08\nDgr\nH370 **\n\n\n\n015-063-00-X\ndioxathion (ISO);\n1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)\n201-107-7\n78-34-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH410\n\nM = 1000\n\n015-064-00-5\nbromophos-ethyl (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate\n225-399-0\n4824-78-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n015-065-00-0\nS-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate\n—\n2703-37-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH411\n\n\n\n015-066-00-6\nomethoate (ISO);\nO,O-dimethyl S-methylcarbamoylmethyl phosphorothioate\n214-197-8\n1113-02-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nH301\nH312\nH400\nGHS06\nGHS09\nDgr\nH301\nH312\nH400\n\n\n\n\n\n015-067-00-1\nphosalone (ISO);\nS-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate\n218-996-2\n2310-17-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH332\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH410\n\nM=1000\n\n\n015-068-00-7\ndichlofenthion (ISO);\nO—2,4-dichlorophenyl O,O-diethyl phosphorothioate\n202-564-5\n97-17-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH400\nH410\n\n\n\n015-069-00-2\nmethidathion (ISO);\n2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate\n213-449-4\n950-37-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n015-070-00-8\ncyanthoate (ISO);\nS-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate\n223-099-4\n3734-95-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-071-00-3\nchlorfenvinphos (ISO);\n2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate\n207-432-0\n470-90-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-072-00-9\nmonocrotophos (ISO);\ndimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate\n230-042-7\n6923-22-4\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH330\nH300\nH311\nH410\n\n\n\n015-073-00-4\ndicrotophos (ISO);\n(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate\n205-494-3\n141-66-2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-074-00-X\ncrufomate (ISO);\n4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate\n206-083-1\n299-86-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-075-00-5\nS-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate\n—\n2635-50-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n015-076-00-0\npotasan;\nO,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate\n—\n299-45-6\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\nM = 1000\n\n015-077-00-6\n2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate\n—\n7076-53-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n015-078-00-1\ndemeton-S-methylsulphon (ISO);\nS-2-ethylsulphonylethyl dimethyl phosphorothioate\n241-109-5\n17040-19-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH301\nH312\nH411\nGHS06\nGHS09\nDgr\nH301\nH312\nH411\n\n\n\n015-079-00-7\nacephate (ISO);\nO,S-dimethyl acetylphosphoramidothioate\n250-241-2\n30560-19-1\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-080-00-2\namidithion (ISO);\n2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n—\n919-76-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-081-00-8\nO,O,O',O'-tetrapropyl dithiopyrophosphate\n221-817-0\n3244-90-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-082-00-3\nazothoate (ISO);\nO-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate\n227-419-3\n5834-96-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n015-083-00-9\nbensulide (ISO);\nO,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate\n212-010-4\n741-58-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-084-00-4\nchlorpyrifos (ISO);\nO,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n220-864-4\n2921-88-2\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH400\nH410\n\nM = 10000\n\n015-085-00-X\nchlorphonium chloride (ISO);\ntributyl (2,4-dichlorobenzyl) phosphonium chloride\n204-105-4\n115-78-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH312\nH319\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH315\n\n\n\n015-086-00-5\ncoumithoate (ISO);\nO,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate\n—\n572-48-5\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n015-087-00-0\ncyanophos (ISO);\nO-4-cyanophenyl O,O-dimethyl phosphorothioate\n220-130-3\n2636-26-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-088-00-6\ndialifos (ISO);\n2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate\n233-689-3\n10311-84-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH400\nH410\n\n\n\n015-089-00-1\nethoate-methyl (ISO);\nethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n204-121-1\n116-01-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-090-00-7\nfensulfothion (ISO);\nO,O-diethyl O-4-methylsulfinylphenyl phosphorothioate\n204-114-3\n115-90-2\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-091-00-2\nfonofos (ISO);\nO-ethyl phenyl ethylphosphonodithioate\n213-408-0\n944-22-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-092-00-8\nphosacetim (ISO);\nO,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate\n223-874-7\n4104-14-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-093-00-3\nleptophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate\n244-472-8\n21609-90-5\nAcute Tox. 3 *\nSTOT SE 1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH370 **\nH312\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH370 **\nH312\nH410\n\n\n\n015-094-00-9\nmephosfolan (ISO);\ndiethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate\n213-447-3\n950-10-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH310\nH300\nH411\n\n\n\n015-095-00-4\nmethamidophos (ISO);\nO,S-dimethyl phosphoramidothioate\n233-606-0\n10265-92-6\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nH330\nH300\nH311\nH400\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH400\n\n\n\n015-096-00-X\noxydisulfoton (ISO);\nO,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate\n219-679-1\n2497-07-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM = 10\n\n015-097-00-5\nphenthoate (ISO);\nethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate\n219-997-0\n2597-03-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\nM = 100\n\n015-098-00-0\ntrichloronate (ISO);\nO-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate\n206-326-1\n327-98-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-099-00-6\npirimiphos-ethyl (ISO);\nO,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate\n245-704-0\n23505-41-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n\n\n015-100-00-X\nphoxim (ISO);\nα-(diethoxyphosphinothioylimino) phenylacetonitrile\n238-887-3\n14816-18-3\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f***\nH302\nH317\nH410\n\nM=1000\n\n\n\n015-101-00-5\nphosmet (ISO);\nO,O-dimethyl phthalimidomethyl S-phosphorodithioate\n211-987-4\n732-11-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\nM = 100\n\n\n\n015-102-00-0\ntris(2-chloroethyl)phosphate\n204-118-5\n115-96-8\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360F***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360F***\nH302\nH411\n\n\n\n\n015-103-00-6\nphosphorus tribromide\n232-178-2\n7789-60-8\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n015-104-00-1\ndiphosphorus pentasulphide;\nphosphorus pentasulphide\n215-242-4\n1314-80-3\nFlam. Sol. 1\nWater-react. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH228\nH260\nH332\nH302\nH400\nGHS02\nGHS07\nGHS09\nDgr\nH228\nH260\nH332\nH302\nH400\nEUH029\n\nT\n015-105-00-7\ntriphenyl phosphite\n202-908-4\n101-02-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Irrit. 2; H319: C ≥ 5 %\n\n015-106-00-2\nhexamethylphosphoric triamide;\nhexamethylphosphoramide\n211-653-8\n680-31-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n015-107-00-8\nethoprophos (ISO);\nethyl-S,S-dipropyl phosphorodithioate\n236-152-1\n13194-48-4\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH301\nH317\nH410\n\n\n\n015-108-00-3\nbromophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate\n218-277-3\n2104-96-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 100\n\n015-109-00-9\ncrotoxyphos (ISO);\n1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate\n231-720-5\n7700-17-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 10\n\n015-110-00-4\ncyanofenphos (ISO);\nO-4-cyanophenyl O-ethyl phenylphosphonothioate\n—\n13067-93-1\nAcute Tox. 3 *\nSTOT SE 1\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH301\nH370 **\nH312\nH319\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH370 **\nH312\nH319\nH411\n\n\n\n015-111-00-X\nphosfolan (ISO);\ndiethyl 1,3-dithiolan-2-ylidenephosphoramidate\n213-423-2\n947-02-4\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-112-00-5\nthionazin (ISO);\nO,O-diethyl O-pyrazin-2-yl phosphorothioate;\n206-049-6\n297-97-2\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n\n\n015-113-00-0\ntolclofos-methyl (ISO);\nO-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate\n260-515-3\n57018-04-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n\n\n015-114-00-6\nchlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate\n246-538-1\n24934-91-6\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH317\nH410\n\nM=10\n\n\n015-115-00-1\nchlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]\n244-663-6\n21923-23-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM=1000\n\n\n015-116-00-7\ndemephion-O (ISO);\nO,O-dimethyl O-2-methylthioethyl phosphorothioate\n211-666-9\n682-80-4\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-117-00-2\ndemephion-S (ISO);\nO,O-dimethyl S-2-methylthioethyl phosphorothioate\n219-971-9\n2587-90-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-118-00-8\ndemeton\n—\n8065-48-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-119-00-3\ndimethyl 4-(methylthio)phenyl phosphate\n—\n3254-63-5\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-120-00-9\nditalimfos (ISO);\nO,O-diethyl phthalimidophosphonothioate\n225-875-8\n5131-24-8\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n015-121-00-4\nedifenphos (ISO);\nO-ethyl S,S-diphenyl phosphorodithioate\n241-178-1\n17109-49-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH317\nH410\n\n\n\n015-122-00-X\netrimfos (ISO);\nO-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate\n253-855-9\n38260-54-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 10\n\n015-123-00-5\nfenamiphos (ISO);\nethyl-4-methylthio-m-tolyl isopropyl phosphoramidate\n244-848-1\n22224-92-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM = 100\n\n015-124-00-0\nfosthietan (ISO);\ndiethyl 1,3-dithietan-2-ylidenephosphoramidate\n244-437-7\n21548-32-3\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-125-00-6\nglyphosine (ISO);\nN,N-bis(phosphonomethyl)glycine\n219-468-4\n2439-99-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n015-126-00-1\nheptenophos (ISO);\n7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate\n245-737-0\n23560-59-0\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\nM = 100\n\n015-127-00-7\niprobenfos(ISO);\nS-benzyl diisopropyl phosphorothioate\n247-449-0\n26087-47-8\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n015-128-00-2\nIPSP;\nS-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate\n—\n5827-05-4\nAcute Tox. 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH301\nH410\n\nM = 100\n\n015-129-00-8\nisofenphos (ISO);\nO-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate\n246-814-1\n25311-71-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 100\n\n015-130-00-3\nisothioate (ISO);\nS-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;\n—\n36614-38-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n015-131-00-9\nisoxathion (ISO);\nO,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate\n242-624-8\n18854-01-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n015-132-00-4\nS-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;\nmethylcarbophenothione\n—\n953-17-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 1000\n\n015-133-00-X\npiperophos (ISO);\nS-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate\n—\n24151-93-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 10\n\n015-134-00-5\npirimiphos-methyl (ISO);\nO-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate\n249-528-5\n29232-93-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-135-00-0\nprofenofos (ISO)\nO-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;\n255-255-2\n41198-08-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\nM = 1000\n\n015-136-00-6\ntrans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;\nisopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;\npropetamphos (ISO)\n250-517-2\n31218-83-4\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\nM = 100\n\n015-137-00-1\npyrazophos (ISO);\nO,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate\n236-656-1\n13457-18-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\n\n\n015-138-00-7\nquinalphos (ISO);\nO,O-diethyl-O-quinoxalin-2-yl phosphorothioate\n237-031-6\n13593-03-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\nM = 1000\n\n015-139-00-2\nterbufos (ISO);\nS-tert-butylthiomethyl O,O-diethylphosphorodithioate;\n235-963-8\n13071-79-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n\n\n015-140-00-8\ntriazophos (ISO);\nO,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate\n245-986-5\n24017-47-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH410\n\nM=100\n\n\n015-141-00-3\nethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers\n400-520-1\n—\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH410\n\n\n\n015-142-00-9\nbutyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate\n401-100-0\n—\nFlam. Liq. 2\nEye Irrit. 2\nAquatic Chronic 2\nH225\nH319\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH319\nH411\n\n\nT\n015-143-00-4\nreaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,\nreaction mass of isomers\n401-740-0\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-144-00-X\nreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate\n402-090-0\n87025-52-3\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n015-145-00-5\nreaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate\n401-520-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-146-00-0\nS-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate\n401-850-9\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-147-00-6\nreaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)\n400-930-0\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n015-148-00-1\n2-(diphosphonomethyl)succinic acid\n403-070-4\n51395-42-7\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n015-149-00-7\nreaction mass of: hexyldioctylphosphineoxide;\ndihexyloctylphosphineoxide;\ntrioctylphosphineoxide\n403-470-9\n—\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n015-150-00-2\n(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide\n404-940-6\n86608-70-0\nAcute Tox. 4 *\nEye Dam. 1\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH318\nH373 **\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH318\nH373 **\nH412\n\n\n\n015-151-00-8\ntris(isopropyl/tert-butylphenyl) phosphate\n405-010-2\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n015-152-00-3\ndioxabenzofos (ISO);\n2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide\n223-292-3\n3811-49-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 1\nAquatic Chronic 2\nH311\nH301\nH370 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH311\nH301\nH370 **\nH411\n\n\n\n015-153-00-9\nisazofos (ISO);\nO-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate\n255-863-8\n42509-80-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH311\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH311\nH301\nH373 **\nH317\nH410\n\n\n\n015-154-00-4\n2-chloroethylphosphonic acid;\nethephon\n240-718-3\n16672-87-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH332\nH312\nH314\nH412\nGHS05\nGHS07\nDgr\nH332\nH312\nH314\nH412\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n015-155-00-X\nglufosinate ammonium (ISO);\nammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate\n278-636-5\n77182-82-2\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH360Fd\nH332\nH312\nH302\nH373**\nGHS08\nGHS07\nDgr\nH360Fd\nH332\nH312\nH302\nH373**\n\n\n\n\n015-156-00-5\nmethyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]\nmethacrifos (ISO);\nmethyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]\n250-366-9 [1]-[2]\n30864-28-9 [1]\n62610-77-9 [2]\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n015-157-00-0\nphosphonic acid; [1]\nphosphorous acid [2]\n237-066-7 [1]\n233-663-1\n[2]\n13598-36-2 [1]\n10294-56-1 [2]\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n015-158-00-6\n(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)\n402-340-9\n32760-80-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n015-159-00-1\nhydroxyphosphonoacetic acid\n405-710-8\n23783-26-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH373 **\nH314\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH314\nH317\n\n\n\n015-160-00-7\nvanadyl pyrophosphate\n406-260-5\n58834-75-6\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n015-161-00-2\ndivanadyl pyrophosphate\n407-130-0\n65232-89-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n015-162-00-8\nvanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped\n407-350-7\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH332\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH373 **\nH318\nH411\n\n\n\n015-163-00-3\nbis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide\n412-010-6\n145052-34-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n015-164-00-9\ncalcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate\n400-480-5\n36669-85-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n015-165-00-4\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate\n404-986-7\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n015-166-00-X\n3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n410-290-4\n80693-00-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n015-167-00-5\n3-(hydroxyphenylphosphinyl)propanoic acid\n411-200-6\n14657-64-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n015-168-00-0\nfosthiazate (ISO);\n(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate\n—\n98886-44-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH317\nH410\nEUH070\n\n\n015-169-00-6\ntributyltetradecylphosphonium tetrafluoroborate\n413-520-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n015-170-00-1\nreaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;\n1-octane-N,N,N-trimethylammonium di-octylphosphate;\n1-octane-N,N,N-trimethylammonium octylphosphate\n407-490-9\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n015-171-00-7\nO,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate\n406-940-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n015-172-00-2\nreaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;\nisotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate\n406-240-6\n—\nFlam. Liq. 3\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH314\nH411\nGHS02\nGHS05\nGHS09\nDgr\nH226\nH314\nH411\n\n\n\n015-173-00-8\nmethyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate\n414-080-3\n117291-73-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-174-00-3\n1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine\n411-370-1\n82857-68-9\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Chronic 2\nH301\nH318\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH411\n\n\n\n015-175-00-9\ntert-butyl (triphenylphosphoranylidene) acetate\n412-880-7\n35000-38-5\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH373 **\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH319\nH317\nH411\n\n\n\n015-176-00-4\nP,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine\n413-430-2\n116163-96-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-177-00-X\n((4-phenylbutyl)hydroxyphosphoryl)acetic acid\n412-170-7\n83623-61-4\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH373 **\nH318\nH317\nGHS08\nGHS05\nDgr\nH373 **\nH318\nH317\n\n\n\n015-178-00-5\n(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate\n418-570-8\n25383-07-7\nRepr. 2\nAquatic Chronic 2\nH361f ***\nH411\nGHS08\nGHS09\nWng\nH361f ***\nH411\n\n\n\n015-179-00-0\nUVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine\n422-720-8\n166242-53-1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH351\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n015-180-00-6\n[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt\n415-820-8\n137590-32-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n015-181-00-1\nphosphine\n232-260-8\n7803-51-2\nFlam. Gas 1\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1\nH220\nH330\nH314\nH400\nGHS02\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH220\nH330\nH314\nH400\n\n\nU\n\n\n015-182-00-7\ntetraisopropyldichloromethylenebisphosphonate\n430-630-5\n10596-22-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS06\nWng\nH302\nH319\nH317\n\n\n\n\n015-183-00-2\n(1-hydroxydodecylidene)diphosphonic acid\n425-230-2\n16610-63-2\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n\n\n015-184-00-8\nSalts of glyphosate, with the exception of those specified elsewhere in this Annex\n—\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\nA\n015-186-00-9\nchlorpyrifos-methyl (ISO)\nO,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n227-011-5\n5598-13-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM = 10000\n\n015-187-00-4\nreaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;\ntrisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide\n417-540-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n\n015-188-00-X\n(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate\n425-220-8\n5945-33-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n015-189-00-5\nphenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide\n423-340-5\n162881-26-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n\n015-190-00-0\nbis(2,4-dicumylphenyl) neopentyl diphosphite;\n3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n421-920-2\n154862-43-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n015-191-00-6\ndodecyldiphenyl phosphate\n431-760-5\n27460-02-2\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n015-192-00-1\ntetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate\n432-770-2\n139189-30-3\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n015-193-00-7\ntriphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)\n442-960-7\n332350-93-3\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH400\nH410\nGHS05\nGHS06\nGHS09\nDgr\nH301\nH318\nH410\n\n\n\n\n015-194-00-2\ntetrabutyl-phosphonium nonafluoro-butane-1-sulfonate\n444-440-5\n220689-12-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n015-195-00-8\nreaction mass of: potassium o-toluenephosphonate;\npotassium m-toluenephosphonate;\npotassium p-toluenephosphonate\n433-860-4\n—\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n\n015-196-00-3\nreaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\ndiethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\nmethyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate\n435-960-3\n—\nCarc. 1B\nMuta. 1B\nSkin Sens. 1\nH350\nH340\nH317\nGHS08\nGHS07\nDgr\nH350\nH340\nH317\n\n\n\n\n015-197-00-9\nbis(2,4,4-trimethylpentyl)dithiophosphonic acid\n420-160-9\n107667-02-7\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH331\nH302\nH314\nH411\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH226\nH331\nH302\nH314\nH411\n\n\n\n\n015-198-00-4\n(4-phenylbutyl)phosphinic acid\n420-450-5\n86552-32-1\nCarc. 2\nEye Dam. 1\nH351\nH318\nGHS05\nGHS08\nDgr\nH351\nH318\n\n\n\n\n\n016-001-00-4\nhydrogen sulphide\n231-977-3\n7783-06-4\nFlam. Gas 1\nPress. Gas\nAcute Tox. 2 *\nAquatic Acute 1\nH220\nH330\nH400\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH330\nH400\n\n\nU\n016-002-00-X\nbarium sulphide\n244-214-4\n21109-95-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH332\nH302\nH400\nGHS07\nGHS09\nWng\nH332\nH302\nH400\nEUH031\n\n\n016-003-00-5\nbarium polysulphides\n256-814-3\n50864-67-0\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-004-00-0\ncalcium sulphide\n243-873-5\n20548-54-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-005-00-6\ncalcium polysulphides\n215-709-2\n1344-81-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-006-00-1\ndipotassium sulphide;\npotassium sulphide\n215-197-0\n1312-73-8\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\n\n\n016-007-00-7\npotassium polysulphides\n253-390-1\n37199-66-9\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\n\n\n016-008-00-2\nammonium polysulphides\n232-989-1\n9080-17-5\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\nEUH031: C ≥ 1 %\n\n\n\n016-009-00-8\ndisodium sulfide;\nsodium sulfide\n215-211-5\n1313-82-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH311\nH302\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH302\nH314\nH400\n\n\n\n\n016-010-00-3\nsodium polysulphides\n215-686-9\n1344-08-7\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH314\nH400\nEUH031\n\n\n016-011-00-9\nsulphur dioxide\n231-195-2\n7446-09-5\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1B\nH331\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH331\nH314\n\n*\nU5\n016-012-00-4\ndisulphur dichloride;\nsulfur monochloride\n233-036-2\n10025-67-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH301\nH332\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH332\nH314\nH400\nEUH014\nEUH029\nSTOT SE 3; H335: C ≥ 1 %\n\n016-013-00-X\nsulphur dichloride\n234-129-0\n10545-99-0\nSkin Corr. 1B\nSTOT SE 3\nAquatic Acute 1\nH314\nH335\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH335\nH400\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n016-014-00-5\nsulphur tetrachloride\n—\n13451-08-6\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n016-015-00-0\nthionyl dichloride;\nthionyl chloride\n231-748-8\n7719-09-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH332\nH302\nH314\nGHS05\nGHS07\nDgr\nH332\nH302\nH314\nEUH014\nEUH029\nSTOT SE 3; H335: C ≥ 1 %\n\n016-016-00-6\nsulphuryl chloride\n232-245-6\n7791-25-5\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n016-017-00-1\nchlorosulphonic acid\n232-234-6\n7790-94-5\nSkin Corr. 1A\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n016-018-00-7\nfluorosulphonic acid\n232-149-4\n7789-21-1\nAcute Tox. 4 *\nSkin Corr. 1A\nH332\nH314\nGHS05\nGHS07\nDgr\nH332\nH314\n\n\n\n016-019-00-2\noleum ... % SO3\n—\n—\nSkin Corr. 1A\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\nB\n016-020-00-8\nsulphuric acid ... %\n231-639-5\n7664-93-9\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 15 %\nSkin Irrit. 2; H315: 5 % ≤ C < 15 %\nEye Irrit. 2; H319: 5 % ≤ C < 15 %\nB\n016-021-00-3\nmethanethiol;\nmethyl mercaptan\n200-822-1\n74-93-1\nFlam. Gas. 1\nPress. Gas\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH220\nH331\nH400\nH410\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH331\nH410\n\n\nU\n016-022-00-9\nethanethiol;\nethyl mercaptan\n200-837-3\n75-08-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH225\nH332\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH332\nH410\n\n\n\n016-023-00-4\ndimethyl sulphate\n201-058-1\n77-78-1\nCarc. 1B\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH350\nH341\nH330\nH301\nH314\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH350\nH341\nH330\nH301\nH314\nH317\n\nCarc. 1B; H350: C ≥ 0,01 %\nMuta. 2; H341: C ≥ 0,01 %\nSTOT SE 3; H335: C ≥ 5 %\n\n016-024-00-X\ndimexano(ISO);\nbis(methoxythiocarbonyl) disulphide\n215-993-8\n1468-37-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n016-025-00-5\ndisul (ISO);\n2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;\n2,4-DES\n205-259-5\n149-26-8\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\n\n\n\n016-026-00-0\nsulphamidic acid;\nsulphamic acid;\nsulfamic acid\n226-218-8\n5329-14-6\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n016-027-00-6\ndiethyl sulphate\n200-589-6\n64-67-5\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH350\nH340\nH332\nH312\nH302\nH314\nGHS05\nGHS08\nGHS07\nDgr\nH350\nH340\nH332\nH312\nH302\nH314\n\n\n\n016-028-00-1\nsodium dithionite;\nsodium hydrosulphite\n231-890-0\n7775-14-6\nSelf-heat. 1\nAcute Tox. 4 *\nH251\nH302\nGHS02\nGHS07\nDgr\nH251\nH302\nEUH031\n\n\n016-029-00-7\np-toluenesulphonic acid, containing more than 5 % H2SO4\n—\n—\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\n\n016-030-00-2\np-toluenesulphonic acid (containing a maximum of 5 % H2SO4)\n203-180-0\n104-15-4\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 20 %\n\n016-031-00-8\ntetrahydrothiophene-1,1-dioxide;\nsulpholane\n204-783-1\n126-33-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n016-032-00-3\n1,3-propanesultone;\n1,2-oxathiolane 2,2-dioxide\n214-317-9\n1120-71-4\nCarc. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH350\nH312\nH302\nGHS08\nGHS07\nDgr\nH350\nH312\nH302\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n016-033-00-9\ndimethylsulfamoylchloride\n236-412-4\n13360-57-1\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH350\nH330\nH312\nH302\nH314\nGHS06\nGHS05\nGHS08\nDgr\nH350\nH330\nH312\nH302\nH314\n\n\n\n016-034-00-4\ntetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)\n400-010-9\n81898-60-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-035-00-X\npentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate\n400-120-7\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n016-036-00-5\ntetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate\n400-130-1\n—\nResp. Sens. 1\nAquatic Chronic 2\nH334\nH411\nGHS08\nGHS09\nDgr\nH334\nH411\n\n\n\n016-037-00-0\ndisodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate\n400-350-8\n85153-93-1\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-038-00-6\ndisodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate\n400-380-1\n86393-35-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-039-00-1\ntetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate\n400-430-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-040-00-7\nreaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate\n400-570-4\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n016-041-00-2\ncalcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate\n400-710-4\n—\nAcute Tox. 4 *\nH332\nGHS07\nWng\nH332\n\n\n\n016-042-00-8\ntetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate\n400-790-0\n85665-97-0\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n016-043-00-3\ndilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate\n401-010-1\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-044-00-9\ndisodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate\n401-320-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n016-045-00-4\nlithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate\n401-560-2\n108624-00-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-046-00-X\nsodium hydrogensulphate\n231-665-7\n7681-38-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n016-047-00-5\nhexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate\n401-650-1\n85665-96-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-048-00-0\nsodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate\n401-870-8\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-049-00-6\ncalcium octadecylxylenesulphonate\n402-040-8\n—\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n016-050-00-1\npotassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat\n402-150-6\n—\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n016-051-00-7\ntrisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate\n402-170-5\n106359-91-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-052-00-2\nbenzyltributylammonium 4-hydroxynaphthalene-1-sulphonate\n402-240-5\n102561-46-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH411\nGHS07\nGHS09\nWng\nH332\nH411\n\n\n\n016-053-00-8\n(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate\n402-460-1\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n016-054-00-3\nsodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate\n400-030-8\n—\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Sens. 1\nH331\nH372 **\nH302\nH319\nH335\nH317\nGHS06\nGHS08\nDgr\nH331\nH372 **\nH302\nH319\nH335\nH317\n\n\n\n016-055-00-9\ntetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)\n400-510-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n016-056-00-4\npotassium hydrogensulphate\n231-594-1\n7646-93-7\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\n\n\n016-057-00-X\nstyrene-4-sulfonyl chloride\n404-770-2\n2633-67-2\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n016-058-00-5\nthionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine\n404-820-3\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH317\nH412\nGHS07\nWng\nH315\nH317\nH412\n\n\n\n016-059-00-0\nN,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride\n405-300-9\n17339-60-5\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH317\nH410\n\n\n\n016-060-00-6\ndiammonium peroxodisulphate;\nammonium persulphate\n231-786-5\n7727-54-0\nOx. Sol. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH272\nH302\nH319\nH335\nH315\nH334\nH317\nGHS03\nGHS08\nGHS07\nDgr\nH272\nH302\nH319\nH335\nH315\nH334\nH317\n\n\n\n016-061-00-1\ndipotassium peroxodisulphate;\npotassium persulphate\n231-781-8\n7727-21-1\nOx. Sol. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH272\nH302\nH319\nH335\nH315\nH334\nH317\nGHS03\nGHS08\nGHS07\nDgr\nH272\nH302\nH319\nH335\nH315\nH334\nH317\n\n\n\n016-062-00-7\nbensultap (ISO);\n1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane\n—\n17606-31-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n016-063-00-2\nsodium metabisulphite\n231-673-0\n7681-57-4\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\nEUH031\n\n\n016-064-00-8\nsodium hydrogensulphite . . . %;\nsodium bisulphite . . . %\n231-548-0\n7631-90-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\nEUH031\n\nB\n016-065-00-3\nsodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate\n400-100-8\n84057-97-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n016-066-00-9\ntetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)\n404-070-7\n116912-62-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n016-067-00-4\n(4-methylphenyl)mesitylene sulfonate\n407-530-5\n67811-06-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-068-00-X\nsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate\n407-720-8\n155160-86-4\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-069-00-5\n3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid\n407-990-7\n141915-64-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-070-00-0\n4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone\n408-220-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-071-00-6\ntrisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate\n410-130-3\n136248-03-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-072-00-1\n3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide\n411-520-6\n112195-27-4\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n016-073-00-7\ntetrakis(phenylmethyl)thioperoxydi(carbothioamide)\n404-310-0\n10591-85-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-074-00-2\n6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene\n405-410-7\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n016-075-00-8\n2,2'-diallyl-4,4'-sulfonyldiphenol\n411-570-9\n41481-66-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-076-00-3\n2,3-bis((2-mercaptoethyl)thio)-1-propanethiol\n411-290-7\n131538-00-6\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH410\n\n\n\n016-077-00-9\n2-chloro-p-toluenesulfochloride\n412-890-1\n42413-03-6\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH314\nH317\nH412\n\n\n\n016-078-00-4\n4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide\n413-300-5\n56187-04-3\nAquatic Chronic 4\nH413\n—\n\n\n\n\n016-079-00-X\nN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide\n412-920-3\n16695-22-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n016-080-00-5\nsodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate\n412-320-1\n31361-99-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-081-00-0\nhexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide\n418-350-1\n—\nMuta. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH302\nH319\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH319\nH317\nH411\n\n\n\n016-082-00-6\nethoxysulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea\n—\n126801-58-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n016-083-00-1\nacibenzolar-S-methyl;\nbenzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester\n420-050-0\n135158-54-2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH410\n\n\n\n\n\n016-084-00-7\nprosulfuron (ISO);\n1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea\n—\n94125-34-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=100\n\n\n016-085-00-2\nflazasulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea\n—\n104040-78-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n016-086-00-8\ntetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n402-590-9\n109125-56-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n016-087-00-3\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;\npropylene carbonate\n403-490-8\n104558-95-4\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH317\nH410\n\n\n\n016-088-00-9\n4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid\n407-280-7\n71297-11-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n016-089-00-4\nreaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene\n413-840-1\n—\nSelf-react. C ****\nAquatic Chronic 4\nH242\nH413\nGHS02\nDgr\nH242\nH413\n\n\n\n016-090-00-X\n4-methyl-N-(methylsulfonyl)benzenesulfonamide\n415-040-8\n14653-91-9\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH302\nH335\nH318\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\n\n\n\n016-091-00-5\nC12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate\n414-110-5\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n\n016-092-00-0\nreaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol\n427-050-1\n—\nRepr. 1A\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH361f\nH315\nH317\nH410\n\n\n\n\n\n016-093-00-6\nreaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);\n4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)\n414-770-4\n140698-96-0\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n\n\n016-094-00-1\nsulfur\n231-722-6\n7704-34-9\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n016-095-00-7\nreaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);\nReaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)\n417-980-4\n—\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n016-096-00-2\nthifensulfuron-methyl (ISO);\nmethyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate\n—\n79277-27-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n016-097-00-8\n1-amino-2-methyl-2-propanethiol hydrochloride\n434-480-1\n32047-53-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH412\n\n\n\n\n\n\n017-001-00-7\nchlorine\n231-959-5\n7782-50-5\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH331\nH319\nH335\nH315\nH400\nGHS06\nGHS09\nDgr\nH331\nH319\nH335\nH315\nH400\n\nM=100\n\n\n017-002-00-2\nhydrogen chloride\n231-595-7\n7647-01-0\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1A\nH331\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH331\nH314\n\n\nU5\n017-002-01-X\nhydrochloric acid ... %\n231-595-7\n—\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 10 %\nB\n017-003-00-8\nbarium chlorate\n236-760-7\n13477-00-4\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH332\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH332\nH302\nH411\n\n\n\n017-004-00-3\npotassium chlorate\n223-289-7\n3811-04-9\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH332\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH332\nH302\nH411\n\n\n\n017-005-00-9\nsodium chlorate\n231-887-4\n7775-09-9\nOx. Sol. 1\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH302\nH411\n\n\n\n017-006-00-4\nperchloric acid ... %\n231-512-4\n7601-90-3\nOx. Liq. 1\nSkin Corr. 1A\nH271\nH314\nGHS03\nGHS05\nDgr\nH271\nH314\n\nSkin Corr. 1A; H314: C ≥ 50 %\nSkin Corr. 1B; H314: 10 % ≤ C < 50 %\nSkin Irrit. 2; H315: 1 % ≤ C < 10 %\nEye Irrit. 2; H319: 1 % ≤ C < 10 %\nOx. Liq. 1; H271: C > 50 %:\nOx. Liq. 2; H272: C ≤ 50 %:\nB\n017-007-00-X\nbarium perchlorate\n236-710-4\n13465-95-7\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nH271\nH332\nH302\nGHS03\nGHS07\nDgr\nH271\nH332\nH302\n\n\n\n017-008-00-5\npotassium perchlorate\n231-912-9\n7778-74-7\nOx. Sol. 1\nAcute Tox. 4 *\nH271\nH302\nGHS03\nGHS07\nDgr\nH271\nH302\n\n\n\n\n\n017-009-00-0\nammonium perchlorate\n232-235-1\n7790-98-9\nExpl. 1.1\nOx. Sol. 1\nH201\nH271\nGHS01\nDgr\nH201\nH271\n\n\nT\n\n\n017-010-00-6\nsodium perchlorate\n231-511-9\n7601-89-0\nOx. Sol. 1\nAcute Tox. 4 *\nH271\nH302\nGHS03\nGHS07\nDgr\nH271\nH302\n\n\n\n017-011-00-1\nsodium hypochlorite, solution ... % Cl active\n231-668-3\n7681-52-9\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\nEUH031: C ≥ 5 %\nB\n\n\n017-012-00-7\ncalcium hypochlorite\n231-908-7\n7778-54-3\nOx. Sol. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH272\nH302\nH314\nH400\nGHS03\nGHS05\nGHS07\nGHS09\nDgr\nH272\nH302\nH314\nH400\nEUH031\nSkin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H; 315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 3 %\nSTOT SE 3; H335: C ≥ 3 %\nM=10\nT\n\n017-013-00-2\ncalcium chloride\n233-140-8\n10043-52-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n017-014-00-8\nammonium chloride\n235-186-4\n12125-02-9\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n017-015-00-3\n(2-(aminomethyl)phenyl)acetylchloride hydrochloride\n417-410-4\n61807-67-8\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n017-016-00-9\nmethyltriphenylphosphonium chloride\n418-400-2\n1031-15-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH411\n\n\n\n017-017-00-4\n(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride\n426-210-6\n120086-58-0\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n017-018-00-X\nN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride\n405-660-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n017-019-00-5\n(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride\n415-110-8\n54417-53-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n017-020-00-0\nethyl propoxy aluminium chloride\n421-790-7\n13014-29-4\nWater-react. 1\nSkin Corr. 1A\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n017-021-00-6\nbehenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride\n423-420-1\n136920-10-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n\n017-023-00-7\n[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides\n425-520-9\n197179-61-6\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n019-001-00-2\npotassium\n231-119-8\n7440-09-7\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n019-002-00-8\npotassium hydroxide;\ncaustic potash\n215-181-3\n1310-58-3\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\nSkin Corr. 1A; H314: C ≥ 5 %\nSkin Corr. 1B; H314: 2 % ≤ C < 5 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 2 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\n\n020-001-00-X\ncalcium\n231-179-5\n7440-70-2\nWater-react. 2\nH261\nGHS02\nDgr\nH261\n\n\n\n020-002-00-5\ncalcium cyanide\n209-740-0\n592-01-8\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH410\nEUH032\n\n\n020-003-00-0\nreaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;\ntri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;\npoly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]\n420-470-4\n—\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n022-001-00-5\ntitanium tetrachloride\n231-441-9\n7550-45-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\nEUH014\n\n\n022-002-00-0\ntitanium(4+) oxalate\n403-260-7\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n022-003-00-6\nbis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium\n412-000-1\n125051-32-3\nFlam. Sol. 1\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH228\nH361f ***\nH373 **\nH411\nGHS02\nGHS08\nGHS09\nDgr\nH228\nH361f ***\nH373 **\nH411\n\n\nT\n\n\n022-004-00-1\npotassium titanium oxide (K2Ti6O13)\n432-240-0\n12056-51-8\nCarc. 2\nH351\nGHS08\nDgr\nH351\n\n\n\n\n022-005-00-7\n[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium\n419-840-8\n169104-71-6\nFlam. Sol. 1****\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 4\nH228\nH314\nH317\nH413\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH314\nH317\nH413\n\n\n\n\n023-001-00-8\ndivanadium pentaoxide;\nvanadium pentoxide\n215-239-8\n1314-62-1\nMuta. 2\nRepr. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nAquatic Chronic 2\nH341\nH361d ***\nH372 **\nH332\nH302\nH335\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH361d ***\nH372 **\nH332\nH302\nH335\nH411\n\n\n\n024-001-00-0\nchromium (VI) trioxide\n215-607-8\n1333-82-0\nOx. Sol. 1\nCarc. 1A\nMuta. 1B\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1A\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350\nH340\nH361f ***\nH330\nH311\nH301\nH372 **\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH271\nH350\nH340\nH361f ***\nH330\nH311\nH301\nH372 **\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 1 %\n\n024-002-00-6\npotassium dichromate\n231-906-6\n7778-50-9\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n3\n024-003-00-1\nammonium dichromate\n232-143-1\n7789-09-5\nOx. Sol. 2 ****\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\nG3\n\n\n024-004-00-7\nsodium dichromate\n234-190-3\n10588-01-9\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH410\n\nResp. Sens. 1; H334: C ≥ 0,2 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n\n024-004-01-4\nsodium dichromate, dihydrate\n234-190-3\n7789-12-0\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\n3\n\n024-005-00-2\nchromyl dichloride;\nchromic oxychloride\n239-056-8\n14977-61-8\nOx. Liq. 1\nCarc. 1B\nMuta. 1B\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350i\nH340\nH314\nH317\nH400\nH410\nGHS03\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH271\nH350i\nH340\nH314\nH317\nH410\n\nSkin Corr. 1A; H314: C ≥ 10 %\nSkin Corr. 1B; H314: 5 % ≤ C < 10 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 5 %\nSTOT SE 3; H335: 0,5 % ≤ C < 5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\nT3\n024-006-00-8\npotassium chromate\n232-140-5\n7789-00-6\nCarc. 1B\nMuta. 1B\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH340\nH319\nH335\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH340\nH319\nH335\nH315\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,5 %\n3\n024-007-00-3\nzinc chromates including zinc potassium chromate\n—\n—\nCarc. 1A\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH410\n\n\nA\n024-008-00-9\ncalcium chromate\n237-366-8\n13765-19-0\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n024-009-00-4\nstrontium chromate\n232-142-6\n7789-06-2\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH400\nH410\n\n\n\n024-010-00-X\ndichromium tris(chromate);\nchromium III chromate;\nchromic chromate\n246-356-2\n24613-89-6\nOx. Sol. 1\nCarc. 1B\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350\nH314\nH317\nH400\nH410\nGHS03\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH271\nH350\nH314\nH317\nH410\n\n\nT\n024-011-00-5\nammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)\n400-110-2\n109125-51-1\nSelf-react. C ****\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH400\nH410\nGHS02\nGHS09\nDgr\nH242\nH410\n\n\n\n024-012-00-0\ntrisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)\n400-810-8\n—\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n024-013-00-6\ntrisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)\n402-500-8\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n024-014-00-1\ntrisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)\n402-870-0\n93952-24-0\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n024-015-00-7\ndisodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)\n404-930-1\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH332\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH318\nH411\n\n\n\n024-016-00-2\ntetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)\n405-110-6\n88377-66-6\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n024-017-00-8\nChromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex\n—\n—\nCarc. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH317\nH410\n\n\nA\n024-018-00-3\nsodium chromate\n231-889-5\n7775-11-3\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\n3\n024-019-00-9\nMain component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);\nby-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);\nby-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-230-1\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n024-020-00-4\ntrisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)\n418-220-4\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n\n024-021-00-X\npotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)\n425-830-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n025-001-00-3\nmanganese dioxide\n215-202-6\n1313-13-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n025-002-00-9\npotassium permanganate\n231-760-3\n7722-64-7\nOx. Sol. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH410\n\n\n\n025-003-00-4\nmanganese sulphate\n232-089-9\n7785-87-7\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n025-004-00-X\nbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate\n411-760-1\n116633-53-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n025-005-00-5\nreaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);\ntetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);\npentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)\n417-660-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n026-001-00-6\n(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate\n407-840-0\n100011-37-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n026-002-00-1\n(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate\n407-880-9\n117549-13-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n026-003-00-7\niron (II) sulfate\n231-753-5\n7720-78-7\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n\n026-003-01-4\niron (II) sulfate (1:1) heptahydrate;\nsulfuric acid, iron(II) salt (1:1), heptahydrate;\nferrous sulfate heptahydrate\n231-753-5\n7782-63-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\nSkin Irrit. 2; H315: C ≥ 25 %\n\n\n026-004-00-2\npotassium ferrite\n430-010-4\n12160-44-0\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n\n027-001-00-9\ncobalt\n231-158-0\n7440-48-4\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 4\nH334\nH317\nH413\nGHS08\nDgr\nH334\nH317\nH413\n\n\n\n\n\n027-002-00-4\ncobalt oxide\n215-154-6\n1307-96-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=10\n\n\n027-003-00-X\ncobalt sulfide\n215-273-3\n1317-42-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n027-004-00-5\ncobalt dichloride\n231-589-4\n7646-79-9\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM=10\n1\n\n027-005-00-0\ncobalt sulfate\n233-334-2\n10124-43-3\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM=10\n1\n\n\n\n027-006-00-6\ncobalt acetate\n200-755-8\n71-48-7\nCarc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH334\nH317\nH400\nH410\nGHS08\nGHS09\nDgr\nH350i\nH341\nH360F***\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM=10\n1\n\n027-007-00-1\nzinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex\n425-240-7\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n027-008-00-7\ncomplex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,225 % phlegmatiser]\n211-745-8\n693-21-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 3\nH201\nH330\nH310\nH300\nH373 **\nH412\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH330\nH310\nH300\nH373 **\nH412\n\n\n\n603-034-00-X\nglycerol trinitrate;\nnitroglycerine\n200-240-8\n55-63-0\nUnst. Expl.\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH200\nH330\nH310\nH300\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH200\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n603-034-01-7\nglycerol trinitrate;\nnitroglycerine;\n[>40 % phlegmatiser]\n200-240-8\n55-63-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n603-035-00-5\npentaerythritol tetranitrate; pentaerythrite tetranitrate;\nP.E.T.N.\n201-084-3\n78-11-5\nUnst. Expl.\nH200\nGHS01\nDgr\nH200\n\n\n\n603-035-01-2\npentaerythritol tetranitrate; pentaerythrite tetranitrate;\nP.E.T.N.;\n[>20 % phlegmatiser]\n201-084-3\n78-11-5\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\nT\n603-036-00-0\nmannitol hexanitrate;\nnitromannite\n239-924-6\n15825-70-4\nUnst. Expl.\nH200\nGHS01\nDgr\nH200\n\n\n\n603-036-01-8\nmannitol hexanitrate;\nnitromannite;\n[>40 % phlegmatiser]\n239-924-6\n15825-70-4\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\n\n\n\n603-037-00-6\ncellulose nitrate;\nnitrocellulose\n—\n—\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\nT\n\n\n603-038-00-1\nallyl glycidyl ether;\nallyl 2,3-epoxypropyl ether;\nprop-2-en-1-yl 2,3-epoxypropyl ether\n203-442-4\n106-92-3\nFlam. Liq. 3\nCarc. 2\nMuta. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH351\nH341\nH361f ***\nH332\nH302\nH335\nH315\nH318\nH317\nH412\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH351\nH341\nH361f ***\nH332\nH302\nH335\nH315\nH318\nH317\nH412\n\n\n\n603-039-00-7\nbutyl glycidyl ether;\nbutyl 2,3-epoxypropyl ether\n219-376-4\n2426-08-6\nFlam. Liq. 3\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH351\nH341\nH332\nH302\nH335\nH317\nH412\nGHS02\nGHS08\nGHS07\nWng\nH226\nH351\nH341\nH332\nH302\nH335\nH317\nH412\n\n\n\n603-040-00-2\nsodium methanolate;\nsodium methoxide; [1]\npotassium methanolate;\npotassium methoxide; [2]\nlithium methanolate;\nlithium methoxide [3]\n204-699-5 [1]\n212-736-1 [2]\n212-737-7 [3]\n124-41-4 [1]\n865-33-8 [2]\n865-34-9 [3]\nSelf-heat 1\nSkin Corr. 1B\nH251\nH314\nGHS02\nGHS05\nDgr\nH251\nH314\nEUH014\n\nT\n603-041-00-8\npotassium ethanolate;\npotassium ethoxide; [1]\nsodium ethanolate;\nsodium ethoxide [2]\n213-029-0 [1]\n205-487-5 [2]\n917-58-8 [1]\n141-52-6 [2]\nSelf-heat 1\nSkin Corr. 1B\nH251\nH314\nGHS02\nGHS05\nDgr\nH251\nH314\nEUH014\n\nT\n603-042-00-3\naluminium-tri-isopropoxide\n209-090-8\n555-31-7\nFlam. Sol. 1\nH228\nGHS02\nDgr\nH228\n\n\nT\n603-043-00-9\ntriarimol (ISO);\n2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol\n—\n26766-27-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-044-00-4\ndicofol (ISO);\n2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol\n204-082-0\n115-32-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH315\nH317\nH410\n\n\n\n603-045-00-X\ndiisopropyl ether; [1]\ndipropyl ether [2]\n203-560-6 [1]\n203-869-6 [2]\n108-20-3 [1]\n111-43-3 [2]\nFlam. Liq. 2\nSTOT SE 3\nH225\nH336\nGHS02\nGHS07\nDgr\nH225\nH336\nEUH019\nEUH066\n\nC\n\n\n603-046-00-5\nbis(chloromethyl) ether;\noxybis(chloromethane)\n208-832-8\n542-88-1\nFlam. Liq. 2\nCarc. 1A\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nH225\nH350\nH330\nH311\nH302\nGHS02\nGHS06\nGHS08\nDgr\nH225\nH350\nH330\nH311\nH302\n\nCarc. 1A; H350: C ≥ 0,001 %\n\n\n603-047-00-0\n2-dimethylaminoethanol;\nN,N-dimethylethanolamine\n203-542-8\n108-01-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-048-00-6\n2-diethylaminoethanol;\nN,N-diethylethanolamine\n202-845-2\n100-37-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07 GHS09\nDgr\nH226\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-049-00-1\nchlorfenethol (ISO);\n1,1-bis (4-chlorophenyl) ethanol\n201-246-3\n80-06-8\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n603-050-00-7\n1-(2-butoxypropoxy)propan-2-ol\n246-011-6\n24083-03-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n603-051-00-2\n2-ethylbutan-1-ol\n202-621-4\n97-95-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n603-052-00-8\n3-butoxypropan-2-ol;\npropylene glycol monobutyl ether\n225-878-4\n5131-66-8\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-053-00-3\n2-methylpentane-2,4-diol\n203-489-0\n107-41-5\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-054-00-9\ndi-n-butyl ether;\ndibutyl ether\n205-575-3\n142-96-1\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH226\nH319\nH335\nH315\nH412\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH412\n\nSTOT SE 3; H335: C ≥ 10 %\n\n603-055-00-4\npropylene oxide;\n1,2-epoxypropane;\nmethyloxirane\n200-879-2\n75-56-9\nFlam. Liq. 1\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH224\nH350\nH340\nH332\nH312\nH302\nH319\nH335\nH315\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH350\nH340\nH332\nH312\nH302\nH319\nH335\nH315\n\n\n\n603-056-00-X\n[(p-tolyloxy)methyl]oxirane; [1]\n[(m-tolyloxy)methyl]oxirane; [2]\n2,3-epoxypropyl o-tolyl ether; [3]\n[(tolyloxy)methyl]oxirane;\ncresyl glycidyl ether [4]\n218-574-8 [1]\n218-575-3 [2]\n218-645-3 [3]\n247-711-4 [4]\n2186-24-5 [1]\n2186-25-6 [2]\n2210-79-9 [3]\n26447-14-3 [4]\nMuta. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH315\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH315\nH317\nH411\n\n\nC\n603-057-00-5\nbenzyl alcohol\n202-859-9\n100-51-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n603-058-00-0\n1,3-propylene oxide\n207-964-3\n503-30-0\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH312\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\n\n\n\n603-059-00-6\nhexan-1-ol\n203-852-3\n111-27-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-060-00-1\n2,2'-bioxirane;\n1,2:3,4-diepoxybutane\n215-979-1\n1464-53-5\nCarc. 1B\nMuta. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH350\nH340\nH330\nH311\nH301\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH350\nH340\nH330\nH311\nH301\nH314\n\n\n\n603-061-00-7\ntetrahydro-2-furylmethanol;\ntetrahydrofurfuryl alcohol\n202-625-6\n97-99-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-062-00-2\ntetrahydrofuran-2,5-diyldimethanol\n203-239-0\n104-80-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n603-063-00-8\n2,3-epoxypropan-1-ol;\nglycidol;\noxiranemethanol\n209-128-3\n556-52-5\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH319\nH335\nH315\n\n\n\n\n\n603-064-00-3\n1-methoxy-2-propanol;\nmonopropylene glycol methyl ether\n203-539-1\n107-98-2\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\n\n\n\n\n603-065-00-9\nresorcinol diglycidyl ether;\n1,3-bis(2,3-epoxypropoxy)benzene\n202-987-5\n101-90-6\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH351\nH341\nH312\nH302\nH319\nH315\nH317\nH412\nGHS08\nGHS07\nWng\nH351\nH341\nH312\nH302\nH319\nH315\nH317\nH412\n\n\n\n\n\n\n603-066-00-4\n1,2-epoxy-4-epoxyethylcyclohexane;\n4-vinylcyclohexene diepoxide\n203-437-7\n106-87-6\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH351\nH331\nH311\nH301\nGHS06\nGHS08\nDgr\nH351\nH331\nH311\nH301\n\n*\n\n\n603-067-00-X\nphenyl glycidyl ether;\n2,3-epoxypropyl phenyl ether;\n1,2-epoxy-3-phenoxypropane\n204-557-2\n122-60-1\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH341\nH332\nH335\nH315\nH317\nH412\nGHS08\nGHS07\nDgr\nH350\nH341\nH332\nH335\nH315\nH317\nH412\n\n\n\n603-068-00-5\n2,3-epoxypropyl-2-ethylcyclohexyl ether;\nethylcyclohexylglycidyl ether\n—\n130014-35-6\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n603-069-00-0\n2,4,6-tris(dimethylaminomethyl)phenol\n202-013-9\n90-72-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n603-070-00-6\n2-amino-2-methylpropanol\n204-709-8\n124-68-5\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n603-071-00-1\n2,2'-iminodiethanol;\ndiethanolamine\n203-868-0\n111-42-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH373 **\nH315\nH318\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH315\nH318\n\n\n\n603-072-00-7\n1,4-bis(2,3 epoxypropoxy)butane;\nbutanedioldiglycidyl ether\n219-371-7\n2425-79-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH312\nH319\nH315\nH317\nGHS07\nWng\nH332\nH312\nH319\nH315\nH317\n\n\n\n603-073-00-2\nbis-[4-(2,3-epoxipropoxi)phenyl]propane\n216-823-5\n1675-54-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n603-074-00-8\nreaction product: bisphenol-A-(epichlorhydrin);\nepoxy resin (number average molecular weight ≤ 700)\n500-033-5\n25068-38-6\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH411\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n603-075-00-3\nchlormethyl methyl ether;\nchlorodimethyl ether\n203-480-1\n107-30-2\nFlam. Liq. 2\nCarc. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH350\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH350\nH332\nH312\nH302\n\n\n\n603-076-00-9\nbut-2-yne-1,4-diol;\n2-butyne-1,4-diol\n203-788-6\n110-65-6\nSkin Corr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nH314\nH331\nH301\nH312\nH373 **\nH317\nGHS06\nGHS05\nGHS08\nDgr\nH314\nH331\nH301\nH312\nH373 **\nH317\n\nSkin Corr. 1B; H314: C ≥ 50 %\nSkin Irrit. 2; H315: 25 % ≤ C < 50 %\nEye Irrit. 2; H319: 25 % ≤ C < 50 %\nD\n603-077-00-4\n1-dimethylaminopropan-2-ol;\ndimepranol (INN)\n203-556-4\n108-16-7\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH302\nH314\n\n\n\n603-078-00-X\nprop-2-yn-1-ol;\npropargyl alcohol\n203-471-2\n107-19-7\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH331\nH311\nH301\nH314\nH411\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH226\nH331\nH311\nH301\nH314\nH411\n\n\n\n603-079-00-5\n2,2'-(methylimino)diethanol;\nN-methyldiethanolamine\n203-312-7\n105-59-9\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-080-00-0\n2-methylaminoethanol;\nN-methylethanolamine;\nN-methyl-2-ethanolamine;\nN-methyl-2-amino ethanol;\n2-(methylamino)ethanol\n203-710-0\n109-83-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05 GHS07\nDgr\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-081-00-6\n2,2'-thiodiethanol;\nthiodiglycol\n203-874-3\n111-48-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-082-00-1\n1-aminopropan-2-ol;\nisopropanolamine\n201-162-7\n78-96-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n603-083-00-7\n1,1'-iminodipropan-2-ol;\ndi-isopropanolamine\n203-820-9\n110-97-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-084-00-2\nstyrene oxide;\n(epoxyethyl)benzene;\nphenyloxirane\n202-476-7\n96-09-3\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nH350\nH312\nH319\nGHS08\nGHS07\nDgr\nH350\nH312\nH319\n\n\n\n\n\n603-085-00-8\nbronopol (INN);\n2-bromo-2-nitropropane-1,3-diol\n200-143-0\n52-51-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH312\nH302\nH335\nH315\nH318\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH335\nH315\nH318\nH400\n\nM=10\n\n\n603-086-00-3\nethirimol (ISO);\n5-butyl-2-ethylamino-6-methylpyrimidin-4-ol\n245-949-3\n23947-60-6\nAcute Tox. 4 *\nH312\nGHS07\nWng\nH312\n\n\n\n603-087-00-9\n2-ethylhexane-1,3-diol;\noctylene glycol;\nethoexadiol\n202-377-9\n94-96-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-088-00-4\n2-(octylthio)ethanol;\n2-hydroxyethyl octyl sulphide\n222-598-4\n3547-33-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-089-00-X\n7,7-dimethyl-3-oxa-6-azaoctan-1-ol\n400-390-6\n—\nSkin Corr. 1A\nAcute Tox. 4 *\nH314\nH302\nGHS05\nGHS07\nDgr\nH314\nH302\n\n\n\n603-090-00-5\n2-(2-bromoethoxy)anisole\n402-010-4\n4463-59-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-091-00-0\nexo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol\n402-470-6\n87172-89-2\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n603-092-00-6\n2-methyl-4-phenylpentanol\n402-770-7\n92585-24-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n603-093-00-1\ncinmethylin (ISO);\nexo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane\n402-410-9\n87818-31-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH411\nGHS07\nGHS09\nDgr\nH332\nH411\n\n\n\n603-094-00-7\n1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane\n241-536-7\n17557-23-2\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n603-095-00-2\n2-(propyloxy)ethanol;\nEGPE\n220-548-6\n2807-30-9\nAcute Tox. 4 *\nEye Irrit. 2\nH312\nH319\nGHS07\nWng\nH312\nH319\n\n\n\n603-096-00-8\n2-(2-butoxyethoxy)ethanol;\ndiethylene glycol monobutyl ether\n203-961-6\n112-34-5\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-097-00-3\n1,1',1''-nitrilotripropan-2-ol;\ntriisopropanolamine\n204-528-4\n122-20-3\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n603-098-00-9\n2-phenoxyethanol\n204-589-7\n122-99-6\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n603-099-00-4\n3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride\n403-440-5\n93633-79-5\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-100-00-8\n1,2-dimethoxypropane\n404-630-0\n7778-85-0\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH019\n\n\n603-101-00-3\ntetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)\n405-040-6\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-102-00-9\n1,2-epoxybutane\n203-438-2\n106-88-7\nFlam. Liq. 2\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH225\nH351\nH332\nH312\nH302\nH319\nH335\nH315\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH351\nH332\nH312\nH302\nH319\nH335\nH315\nH412\n\n\n\n603-103-00-4\noxirane, mono[(C12-14-alkyloxy)methyl] derivs.\n271-846-8\n68609-97-2\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n603-104-00-X\nfenarimol (ISO);\n2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol\n262-095-7\n60168-88-9\nRepr. 2\nLact.\nAquatic Chronic 2\nH361fd\nH362\nH411\nGHS08 GHS09\nWng\nH361fd\nH362\nH411\n\n\n\n603-105-00-5\nfuran\n203-727-3\n110-00-9\nFlam. Liq. 1\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Chronic 3\nH224\nH350\nH341\nH332\nH302\nH373 **\nH315\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH350\nH341\nH332\nH302\nH373 **\nH315\nH412\nEUH019\n\n\n603-106-00-0\n2-methoxypropanol\n216-455-5\n1589-47-5\nFlam. Liq. 3\nRepr. 1B\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH226\nH360D ***\nH335\nH315\nH318\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH360D ***\nH335\nH315\nH318\n\n\n\n603-107-00-6\n2-(2-methoxyethoxy)ethanol;\ndiethylene glycol monomethyl ether\n203-906-6\n111-77-3\nRepr. 2\nH361d ***\nGHS08\nWng\nH361d ***\n\n\n\n603-108-00-1\n2-methylpropan-1-ol;\niso-butanol\n201-148-0\n78-83-1\nFlam. Liq. 3\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSTOT SE 3\nH226\nH335\nH315\nH318\nH336\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH335\nH315\nH318\nH336\n\n\n\n\n\n603-109-00-7\nreaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;\n1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane\n425-340-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-110-00-2\nreaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;\ntrans-2-isobutyl-5-methyl 1,3-dioxane\n426-130-1\n166301-21-9\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n603-111-00-8\nreaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;\n1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane\n426-530-6\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n603-112-00-3\ncyclopentyl 2-phenylethyl ether\n428-340-9\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n603-113-00-9\n6-glycidyloxynapht-1-yl oxymethyloxirane\n429-960-2\n27610-48-6\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH341\nH312\nH315\nH317\nH412\nGHS08\nGHS07\nWng\nH341\nH312\nH315\nH317\nH412\n\n\n\n\n603-114-00-4\n9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene\n430-830-2\n26912-64-1\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n603-115-00-X\nreaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-580-0\n—\nSTOT RE 2 *\nAquatic Chronic 4\nH373**\nH413\nGHS08\nWng\nH373**\nH413\n\n\n\n\n603-116-00-5\n(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride\n424-740-2\n138271-16-6\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n603-117-00-0\npropan-2-ol;\nisopropyl alcohol;\nisopropanol\n200-661-7\n67-63-0\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\n\n\n\n603-118-00-6\n6-dimethylaminohexan-1-ol\n404-680-3\n1862-07-3\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH412\n\n\n\n603-119-00-1\n1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)\n405-840-5\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n603-120-00-7\n2-methyl-5-phenylpentanol\n405-890-8\n25634-93-9\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-121-00-2\n4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone\n406-057-1\n114565-66-1\nCarc. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH317\nH413\n\n\n\n603-122-00-8\nsodium 2-ethylhexanolate\n406-150-7\n38411-13-1\nFlam. Sol. 1\nSkin Corr. 1B\nAquatic Chronic 3\nH228\nH314\nH412\nGHS02\nGHS05\nDgr\nH228\nH314\nH412\n\n\nT\n603-123-00-3\n4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol\n406-330-5\n122760-84-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n603-124-00-9\n1,4-bis[2-(vinyloxy)ethoxy]benzene\n406-900-3\n84563-49-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-125-00-4\n2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol\n407-850-5\n89544-40-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-126-00-X\n2-((4-methyl-2-nitrophenyl)amino)ethanol\n408-090-7\n100418-33-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n\n603-127-00-5\nbutan-2-ol; [1]\n(S)-butan-2-ol; [2]\n(R)-butan-2-ol; [3]\n(±)-butan-2-ol [4]\n201-158-5 [1]\n224-168-1 [2]\n238-967-8 [3]\n240-029-8 [4]\n78-92-2 [1]\n4221-99-2 [2]\n14898-79-4 [3]\n15892-23-6 [4]\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSTOT SE 3\nH226\nH319\nH335\nH336\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH336\n\n\nC\n\n603-128-00-0\n2-(phenylmethoxy)naphthalene\n405-490-3\n613-62-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-129-00-6\n1-tert-butoxypropan-2-ol\n406-180-0\n57018-52-7\nFlam. Liq. 3\nEye Dam. 1\nH226\nH318\nGHS02\nGHS05\nDgr\nH226\nH318\n\n\n\n603-130-00-1\nreaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)\n406-325-8\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-131-00-7\nreaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;\n1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)\n407-290-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-132-00-2\n2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane\n408-200-3\n63187-91-7\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n603-133-00-8\nreaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;\n3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)\n408-240-1\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-134-00-3\nreaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.\n410-450-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-135-00-9\nbis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium\n410-500-4\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n603-136-00-4\n3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol\n410-910-3\n104226-19-9\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n603-137-00-X\nreaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;\n1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol\n411-130-6\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-138-00-5\n3-(2,2-dimethyl-3-hydroxypropyl)toluene;\n(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol\n403-140-4\n103694-68-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-139-00-0\nbis(2-methoxyethyl) ether\n203-924-4\n111-96-6\nFlam. Liq. 3\nRepr. 1B\nH226\nH360FD\nGHS02\nGHS08\nDgr\nH226\nH360FD\nEUH019\n\n\n603-140-00-6\n2,2' -oxybisethanol;\ndiethylene glycol\n203-872-2\n111-46-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-141-00-1\nreaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;\ndodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane\n413-780-6\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-142-00-7\n2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane\n407-360-1\n116230-20-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH373 **\nH315\nH318\nGHS06\nGHS08\nGHS05\nDgr\nH312\nH302\nH373 **\nH315\nH318\n\n\n\n603-143-00-2\nR—2,3-epoxy-1-propanol\n404-660-4\n57044-25-4\nSelf-react. C ****\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH242\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH314\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH242\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH314\n\n\n\n603-144-00-8\nreaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;\n6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol\n413-530-6\n111850-00-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n603-145-00-3\n2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane\n406-970-5\n129228-11-1\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n603-146-00-9\n2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol\n406-080-7\n83016-70-0\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH412\n\n\n\n603-147-00-4\n(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine\n406-030-4\n105812-81-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-148-00-X\n1,4-bis[(vinyloxy)methyl]cyclohexane\n413-370-7\n17351-75-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07 GHS09\nWng\nH317\nH411\n\n\n\n603-149-00-5\nreaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane\n407-640-3\n63767-86-2\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH315\nH411\nGHS07 GHS09\nWng\nH319\nH315\nH411\n\n\n\n603-150-00-0\n(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol\n411-580-3\n107898-54-4\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n603-151-00-6\n(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol\n413-570-4\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-152-00-1\n2-(4-tert-butylphenyl)ethanol\n410-020-5\n5406-86-0\nRepr. 2\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH361f ***\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH361f ***\nH373 **\nH318\nH411\n\n\n\n603-153-00-7\n3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol\n410-010-0\n104333-00-8\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-154-00-2\n1-[(2-tert-butyl)cyclohexyloxy]-2-butanol\n412-300-2\n139504-68-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n603-155-00-8\nReaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane\n410-560-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-156-00-3\n2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane\n411-210-0\n89544-48-9\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n603-157-00-9\n6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol\n411-450-6\n143747-72-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-158-00-4\nreaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene\n412-460-3\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07 GHS09\nWng\nH315\nH411\n\n\n\n603-159-00-X\n2-cyclododecylpropan-1-ol\n411-410-8\n118562-73-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-160-00-5\n1,2-diethoxypropane\n412-180-1\n10221-57-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH019\n\n\n603-161-00-0\n1,3-diethoxypropane\n413-140-6\n3459-83-4\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n603-162-00-6\nα[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]\n413-420-8\n144736-29-8\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n603-163-00-1\n2-phenyl-1,3-propanediol\n411-810-2\n1570-95-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-164-00-7\n2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole\n412-420-5\n133909-99-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-165-00-2\nreaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol\n417-470-1\n—\nMuta. 2\nSkin Sens. 1\nH341\nH317\nGHS08\nGHS07\nWng\nH341\nH317\n\n\n\n603-166-00-8\nR-1-chloro-2,3-epoxypropane\n424-280-2\n51594-55-9\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH226\nH350\nH331\nH311\nH301\nH314\nH317\n\n\n\n603-167-00-3\n3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol\n407-920-5\n6390-69-8\nAquatic Chronic 4\nH413\nGHS05\nDgr\nH413\n\n\n\n603-168-00-9\n3-(2-ethylhexyloxy)propane-1,2-diol\n408-080-2\n70445-33-9\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n603-169-00-4\n(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine\n415-550-0\n109887-53-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-170-00-X\nreaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;\n2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;\n2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol\n415-990-3\n67739-11-1\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n603-171-00-5\n5-thiazolylmethanol\n414-780-9\n38585-74-9\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n603-172-00-0\nmono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate\n415-180-1\n773058-82-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-173-00-6\n4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane\n421-750-9\n57280-22-5\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n603-174-00-1\n4-cyclohexyl-2-methyl-2-butanol\n420-630-3\n83926-73-2\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n603-175-00-7\n2-(2-hexyloxyethoxy)ethanol;\nDEGHE;\ndiethylene glycol monohexyl ether;\n3,6-dioxa-1-dodecanol;\nhexyl carbitol;\n3,6-dioxadodecan-1-ol\n203-988-3\n112-59-4\nAcute Tox. 4 *\nEye Dam. 1\nH312\nH318\nGHS05\nGHS07\nDgr\nH312\nH318\n\n\n\n603-176-00-2\n1,2-bis(2-methoxyethoxy)ethane;\nTEGDME;\ntriethylene glycol dimethyl ether;\ntriglyme\n203-977-3\n112-49-2\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\nEUH019\n\n\n603-177-00-8\n1-ethoxypropan-2-ol;\n2PG1EE;\n1-ethoxy-2-propanol;\npropylene glycol monoethyl ether; [1]\n2-ethoxy-1-methylethyl acetate;\n2PG1EEA [2]\n216-374-5 [1]\n259-370-9 [2]\n1569-02-4 [1]\n54839-24-6 [2]\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\n\n\n\n603-178-00-3\n2-hexyloxyethanol;\nethylene glycol monohexyl ether;\nn-hexylglycol\n203-951-1\n112-25-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n603-179-00-9\nergocalciferol (ISO);\nVitamin D2\n200-014-9\n50-14-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nH330\nH311\nH301\nH372 **\nGHS06\nGHS08\nDgr\nH330\nH311\nH301\nH372 **\n\n\n\n603-180-00-4\ncolecalciferol;\nVitamin D3\n200-673-2\n67-97-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nH330\nH311\nH301\nH372 **\nGHS06\nGHS08\nDgr\nH330\nH311\nH301\nH372 **\n\n\n\n603-181-00-X\ntert-butyl methyl ether;\nMTBE;\n2-methoxy-2-methylpropane\n216-653-1\n1634-04-4\nFlam. Liq. 2\nSkin Irrit. 2\nH225\nH315\nGHS02\nGHS07\nDgr\nH225\nH315\n\n\n\n\n\n603-182-00-5\nreaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide\n428-630-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n603-183-00-0\n2-[2-(2-butoxyethoxy)ethoxy]ethanol;\nTEGBE;\ntriethylene glycol monobutyl ether;\nbutoxytriethylene glycol\n205-592-6\n143-22-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\nEye Dam. 1; H318: C ≥ 30 %\nEye Irrit. 2; H319: 20 % ≤ C < 30 %\n\n603-184-00-6\n2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol\n416-380-1\n146925-83-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-185-00-1\n2,4-dichloro-3-ethyl-6-nitrophenol\n420-740-1\n99817-36-4\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n603-186-00-7\ntrans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol\n419-050-3\n79944-37-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n603-187-00-2\n2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride\n419-360-9\n163661-77-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n603-188-00-8\nreaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;\n7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene\n426-970-9\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-189-00-3\nreaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol\n405-250-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n603-190-00-9\n8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane\n424-030-2\n62406-73-9\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n603-191-00-4\n2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol\n419-740-4\n137658-79-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n603-192-00-X\n(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol\n423-240-1\n125474-34-2\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n\n603-193-00-5\ndisodium 9,10-anthracenedioxide\n426-030-8\n46492-07-3\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n\n603-194-00-0\n2-(2-aminoethylamino)ethanol;\n(AEEA)\n203-867-5\n111-41-1\nRepr. 1B\nSkin Corr. 1B\nSkin Sens. 1\nH360Fd\nH361\nH314\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH360Fd\nH361\nH314\nH317\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n603-195-00-6\n2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol\n430-810-3\n154825-62-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-196-00-1\n2-(7-ethyl-1H-indol-3-yl)ethanol\n431-020-1\n41340-36-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n603-197-00-7\ntebuconazole (ISO);\n1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol\n403-640-2\n107534-96-3\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH361d ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH411\n\n\n\n603-199-00-8\netoxazol (ISO);\n(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole\n—\n153233-91-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 100\n\n\n\n\n603-200-00-1\n1-pentanol; [1]\n3-pentanol [2]\n200-752-1 [1]\n209-526-7 [2]\n71-41-0 [1]\n584-02-1 [2]\nFlam. Liq. 3\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nH226\nH332\nH335\nH315\nGHS02\nGHS07\nWng\nH226\nH332\nH335\nH315\n\n\n\n\n603-201-00-7\n(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol\n416-120-5\n—\nSkin Irrit. 2\nAquatic Chronic 4\nH315\nH413\nGHS07\nWng\nH315\nH413\n\n\n\n\n603-202-00-2\n4,4,5,5,5-pentafluoropentan-1-ol\n421-360-9\n148043-73-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n603-203-00-8\n(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane\n427-580-1\n—\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n603-204-00-3\nreaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;\n2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane\n428-110-8\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-205-00-9\n(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride\n426-200-1\n172015-79-1\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH372**\nH302\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH372**\nH302\nH318\nH317\nH412\n\n\n\n\n603-206-00-4\n2,2-dichloro-1,3-benzodioxol\n426-850-6\n2032-75-9\nFlam. Liq. 3\nSkin Corr. 1A\nAcute Tox. 4 *\nSkin Sens. 1\nH226\nH314\nH302\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH314\nH302\nH317\nEUH014\n\n\n\n603-207-00-X\n2-isobutyl-2-isopropyl-1,3-dimethoxypropane\n430-800-9\n129228-21-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n603-208-00-5\n1,2-diethoxyethane\n211-076-1\n629-14-1\nFlam. Liq. 2\nRepr. 1A\nEye Irrit. 2\nH225\nH360Df\nH319\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH360Df\nH319\nEUH019\n\n\n\n603-209-00-0\nspinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);\nreaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]\nspinosyn A; [2]\nspinosyn D [3]\n- [1]\n- [2]\n- [3]\n- [1]\n131929-60-7 [2]\n131929-63-0 [3]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n\n603-210-00-6\n2,4-diethyl-1,5-pentanediol\n429-310-8\n57987-55-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n603-211-00-1\n2,3-epoxypropyltrimethylammonium chloride … %;\nglycidyl trimethylammonium chloride … %\n221-221-0\n3033-77-0\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH341\nH361f***\nH312\nH302\nH373**\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH350\nH341\nH361f***\nH312\nH302\nH373**\nH318\nH317\nH412\n\n\nB\n\n603-212-00-7\n1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;\ngalaxolide;\n(HHCB)\n214-946-9\n1222-05-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-213-00-2\n2-methoxy-2-methylbutane;\ntert-amyl methyl ether\n213-611-4\n994-05-8\nFlam. Liq. 2\nAcute Tox. 4 *\nSTOT SE 3\nH225\nH302\nH336\nGHS02\nGHS07\nDgr\nH225\nH302\nH336\n\n\n\n\n603-214-00-8\n1,1-diisopropoxycyclohexane\n413-740-8\n1132-95-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n\n603-215-00-3\n1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n418-330-2\n162241-33-0\nExpl. 1.1****\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS01\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n603-216-00-9\ncis-1-amino-2,3-dihydro-1H-inden-2-ol\n422-660-2\n7480-35-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n603-217-00-4\n2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite\n423-560-1\n161717-32-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n603-220-00-0\n1-{]benzyl[}2-(2-methoxyphenoxy)ethyl{]amino[}-3-(9H-carbazol-4-yloxy)propan-2-ol\n432-890-5\n72955-94-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-221-00-6\n1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;\n[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]\n433-580-2\n214353-17-0\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n\n603-221-01-3\n1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;\n[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]\n433-580-2\n214353-17-0\nCarc. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH350\nH302\nH314\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH314\nH411\n\n\n\n\n603-222-00-1\n(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane\n433-820-6\n118058-74-5\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n603-223-00-7\n2-cyclopentylidene cyclopentanol;\n1,1'-bi(cyclopentyliden)-2-ol\n434-270-1\n6261-30-9\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n603-224-00-2\n3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane\n435-790-1\n297730-93-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-225-00-8\nerythromycin A9-oxime (E);\n(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)\n437-070-0\n13127-18-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n603-226-00-3\n4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol\n444-500-0\n1440-00-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-227-00-9\nα-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);\nreaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate\n445-060-2\n203574-04-3\n****\nAquatic Acute 1\nAquatic Chronic 1\n****\nH400\nH410\n****\nGHS09\nWng\n****\nH410\n\n\n\n\n603-228-00-4\n(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;\n6-fluoro-2-(2-oxiranyl)chromane\n419-620-1\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n603-229-00-X\nsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate\n420-800-7\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n\n603-230-00-5\n2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan\n440-030-5\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 4\nH315\nH318\nH413\nGHS05\nDgr\nH315\nH318\nH413\n\n\n\n\n603-231-00-0\n(S)-1,1-diphenyl-1,2-propanediol\n443-220-6\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-232-00-6\n3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane\n444-420-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-233-00-1\nreaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;\n4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;\n1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;\n1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;\n(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;\n(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol\n444-430-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n603-234-00-7\n(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene\n444-480-3\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n604-001-00-2\nphenol;\ncarbolic acid;\nmonohydroxybenzene;\nphenylalcohol\n203-632-7\n108-95-2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Corr. 1B\nH341\nH331\nH311\nH301\nH373 **\nH314\nGHS06\nGHS08 GHS05\nDgr\nH341\nH331\nH311\nH301\nH373 **\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 3 %\nSkin Irrit. 2; H315: 1 % ≤ C < 3 %\nEye Irrit. 2; H319: 1 % ≤ C < 3 %\n\n604-002-00-8\npentachlorophenol\n201-778-6\n87-86-5\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH410\n\n\n\n604-003-00-3\nsodium pentachlorophenolate; [1]\npotassium pentachlorophenolate [2]\n205-025-2 [1]\n231-911-3 [2]\n131-52-2 [1]\n7778-73-6 [2]\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH410\n\n\n\n604-004-00-9\nm-cresol; [1]\no-cresol; [2]\np-cresol; [3]\nmix-cresol [4]\n203-577-9 [1]\n202-423-8 [2]\n203-398-6 [3]\n215-293-2 [4]\n108-39-4 [1]\n95-48-7 [2]\n106-44-5 [3]\n1319-77-3 [4]\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH311\nH301\nH314\n\n*\nC\n\n\n604-005-00-4\n1,4-dihydroxybenzene;\nhydroquinone;\nquinol\n204-617-8\n123-31-9\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH302\nH318\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH341\nH302\nH318\nH317\nH400\n\nM=10\n\n\n604-006-00-X\n3,4-xylenol; [1]\n2,5-xylenol; [2]\n2,4-xylenol; [3]\n2,3-xylenol; [4]\n2,6-xylenol; [5]\nxylenol; [6]\n2,4(or 2,5)-xylenol [7]\n202-439-5 [1]\n202-461-5 [2]\n203-321-6 [3]\n208-395-3 [4]\n209-400-1 [5]\n215-089-3 [6]\n276-245-4 [7]\n95-65-8 [1]\n95-87-4 [2]\n105-67-9 [3]\n526-75-0 [4]\n576-26-1 [5]\n1300-71-6 [6]\n71975-58-1 [7]\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH311\nH301\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH301\nH314\nH411\n\n\nC\n604-007-00-5\n2-naphthol\n205-182-7\n135-19-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH332\nH302\nH400\nGHS07\nGHS09\nWng\nH332\nH302\nH400\n\n\n\n604-008-00-0\n2-chlorophenol; [1]\n4-chlorophenol; [2]\n3-chlorophenol; [3]\nchlorophenol [4]\n202-433-2 [1]\n203-402-6 [2]\n203-582-6 [3]\n246-691-4 [4]\n95-57-8 [1]\n106-48-9 [2]\n108-43-0 [3]\n25167-80-0 [4]\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH312\nH302\nH411\nGHS07 GHS09\nWng\nH332\nH312\nH302\nH411\n\n\nC\n604-009-00-6\npyrogallol;\n1,2,3-trihydroxybenzene\n201-762-9\n87-66-1\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH341\nH332\nH312\nH302\nH412\nGHS08\nGHS07\nWng\nH341\nH332\nH312\nH302\nH412\n\n*\n\n604-010-00-1\nresorcinol;\n1,3-benzenediol\n203-585-2\n108-46-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nH302\nH319\nH315\nH400\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH400\n\n*\n\n604-011-00-7\n2,4-dichlorophenol\n204-429-6\n120-83-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH311\nH302\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH302\nH314\nH411\n\n\n\n604-012-00-2\n4-chloro-o-cresol;\n4-chloro-2-methyl phenol\n216-381-3\n1570-64-5\nAcute Tox. 3 *\nSkin Corr. 1A\nAquatic Acute 1\nH331\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 1 %\n\n604-013-00-8\n2,3,4,6-tetrachlorophenol\n200-402-8\n58-90-2\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH315\nH410\n\n*\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n604-014-00-3\nchlorocresol;\n4-chloro-m-cresol;\n4-chloro-3-methylphenol\n200-431-6\n59-50-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH312\nH302\nH318\nH317\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH318\nH317\nH400\n\n*\n\n604-015-00-9\n2,2'-methylenebis-(3,4,6-trichlorophenol);\nhexachlorophene\n200-733-8\n70-30-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n*\n\n604-016-00-4\n1,2-dihydroxybenzene;\npyrocatechol\n204-427-5\n120-80-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH312\nH302\nH319\nH315\nGHS07\nWng\nH312\nH302\nH319\nH315\n\n\n\n604-017-00-X\n2,4,5-trichlorophenol\n202-467-8\n95-95-4\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n*\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n604-018-00-5\n2,4,6-trichlorophenol\n201-795-9\n88-06-2\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH315\nH410\n\n\n\n604-019-00-0\ndichlorophen (ISO)\n202-567-1\n97-23-4\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n604-020-00-6\n2-phenylphenol (ISO)\nbiphenyl-2-ol;\n2-hydroxybiphenyl;\n201-993-5\n90-43-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\n\n\n\n604-021-00-1\nsodium 2-biphenylate;\n2-phenylphenol, sodium salt\n205-055-6\n132-27-4\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH302\nH335\nH315\nH318\nH400\nGHS05\nGHS07\nGHS09\nWng\nH302\nH335\nH315\nH318\nH400\n\n\n\n604-022-00-7\n2,2-dimethyl-1,3-benzodioxol-4-ol\n400-900-7\n22961-82-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n604-023-00-2\n2,4-dichloro-3-ethylphenol\n401-060-4\n—\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n604-024-00-8\n4,4-isobutylethylidenediphenol\n401-720-1\n6807-17-6\nRepr. 1B\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360F ***\nH319\nH400\nH410\nGHS08\nGHS09\nDgr\nH360F ***\nH319\nH410\n\n\n\n604-025-00-3\n2,5-bis(1,1-dimethylbutyl)hydroquinone\n400-220-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-026-00-9\n2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)\n400-270-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-027-00-4\n2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone\n400-530-6\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n604-028-00-X\n4-amino-3-fluorophenol\n402-230-0\n399-95-1\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH411\n\n\n\n604-029-00-5\n1-naphtol\n201-969-4\n90-15-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH335\nH315\nH318\nGHS05\nGHS07\nDgr\nH312\nH302\nH335\nH315\nH318\n\n\n\n\n\n604-030-00-0\nbisphenol A;\n4,4'-isopropylidenediphenol\n201-245-8\n80-05-7\nRepr. 2\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nH361f***\nH335\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH361f\nH335\nH318\nH317\n\n\n\n\n604-031-00-6\nguaiacol\n201-964-7\n90-05-1\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n604-032-00-1\nthymol\n201-944-8\n89-83-8\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n604-033-00-7\nisobutyl but-3-enoate\n401-170-2\n24342-03-8\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n604-034-00-2\n4,4'-thiodi-o-cresol\n403-330-7\n24197-34-0\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n604-035-00-8\n4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol\n404-160-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n604-036-00-3\n4,4'-oxybis(ethylenethio)diphenol\n404-590-4\n90884-29-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n604-037-00-9\n3,5-xylenol;\n3,5-dimethylphenol\n203-606-5\n108-68-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH311\nH301\nH314\n\n\n\n604-038-00-4\n4-chloro-3,5-dimethylphenol; [1]\nchloroxylenol [2]\n201-793-8 [1]\n215-316-6 [2]\n88-04-0 [1]\n1321-23-9 [2]\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH302\nH319\nH315\nH317\nGHS07\nWng\nH302\nH319\nH315\nH317\n\n\n\n604-039-00-X\nethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;\nfenoxaprop-ethyl\n266-362-9\n66441-23-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n604-040-00-5\nfomesafen (ISO);\n5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide\n276-439-9\n72178-02-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n604-041-00-0\nacifluorfen (ISO);\n5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]\nsodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;\nacifluorfen-sodium [2]\n256-634-5 [1]\n263-560-7 [2]\n50594-66-6 [1]\n62476-59-9 [2]\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\n\n604-042-00-6\n4-nitrosophenol\n203-251-6\n104-91-6\nMuta. 2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH341\nH302\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH341\nH302\nH318\nH411\n\n\n\n604-043-00-1\nmonobenzone;\n4-hydroxyphenyl benzyl ether;\nhydroquinone monobenzyl ether\n203-083-3\n103-16-2\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n604-044-00-7\nmequinol;\n4-methoxyphenol;\nhydroquinone monomethyl ether\n205-769-8\n150-76-5\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS07\nWng\nH302\nH319\nH317\n\n\n\n604-045-00-2\n2,3,5-trimethylhydroquinone\n211-838-3\n700-13-0\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH335\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH335\nH315\nH318\nH317\nH410\n\n\n\n604-046-00-8\n4-(4-isopropoxyphenylsulfonyl)phenol\n405-520-5\n95235-30-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-047-00-3\n4-(4-tolyloxy)biphenyl\n405-730-7\n51601-57-1\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n604-048-00-9\n4,4',4''-(ethan-1,1,1-triyl)triphenol\n405-800-7\n27955-94-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-049-00-4\n4-4'-methylenebis(oxyethylenethio)diphenol\n407-480-4\n93589-69-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-051-00-5\n3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol\n401-110-5\n87113-78-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n604-052-00-0\n2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)\n403-800-1\n103597-45-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n604-053-00-6\n2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol\n410-760-9\n157661-93-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n604-054-00-1\nreaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;\n4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol\n412-020-0\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n604-055-00-7\n2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane\n413-900-7\n85954-11-6\nCarc. 2\nSkin Sens. 1\nH351\nH317\nGHS08\nGHS07\nWng\nH351\nH317\n\n\n\n\n604-056-00-2\n2-(2-hydroxy-3,5-dinitroanilino)ethanol\n412-520-9\n99610-72-7\nFlam. Sol. 2\nRepr. 2\nAcute Tox. 4 *\nH228\nH361f ***\nH302\nGHS02\nGHS07\nGHS08\nDgr\nH228\nH361f ***\nH302\n\n\n\n604-057-00-8\nreaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;\nisomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;\nisomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6\n401-680-5\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-058-00-3\n1,2-bis(3-methylphenoxy)ethane\n402-730-9\n54914-85-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n604-059-00-9\n2-n-hexadecylhydroquinone\n406-400-5\n—\nSTOT RE 2 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH373 **\nH315\nH317\nH413\nGHS08\nGHS07\nWng\nH373 **\nH315\nH317\nH413\n\n\n\n604-060-00-4\n9,9-bis(4-hydroxyphenyl)fluorene\n406-950-6\n3236-71-3\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n604-061-00-X\nreaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;\n1-ethyldodecyl;\n1-propylundecyl;\n1-butyldecyl;\n1-pentylnonyl;\n1-hexyloctyl\n407-740-7\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH317\nH412\nGHS07\nWng\nH315\nH317\nH412\n\n\n\n604-062-00-5\n2,4-dimethyl-6-(1-methyl-pentadecyl)phenol\n411-220-5\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n604-063-00-0\n5,6-dihydroxyindole\n412-130-9\n3131-52-0\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05 GHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n604-064-00-6\n2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol\n411-380-6\n147315-50-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n604-065-00-1\n4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)\n407-460-5\n111850-25-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-066-00-7\nreaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);\n2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;\n2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol\n414-550-8\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n604-067-00-2\nreaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];\nformaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);\nformaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)\n414-520-4\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n604-068-00-8\n(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride\n415-170-5\n90274-24-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nH332\nH302\nH317\nGHS07\nWng\nH332\nH302\nH317\n\n\n\n604-069-00-3\n2-(1-methylpropyl)-4-tert-butylphenol\n421-740-4\n51390-14-8\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n604-070-00-9\ntriclosan;\n2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;\n5-chloro-2-(2,4-dichlorophenoxy)phenol\n222-182-2\n3380-34-5\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\nM = 100\n\n\n\n604-071-00-4\n4,4'-(1-{]4-[}1-(4-hydroxyphenyl)-1-methylethyl{]phenyl[}ethylidene)diphenol\n425-600-3\n110726-28-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-072-00-X\n1,2-bis(phenoxymethyl)benzene\n428-620-0\n10403-74-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-073-00-5\n(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol\n428-010-4\n82413-20-5\nCarc. 2\nRepr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH360F***\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360F***\nH317\nH410\n\n\n\n\n604-074-00-0\ntetrabromobisphenol-A;\n2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol\n201-236-9\n79-94-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-075-00-6\n4-(1,1,3,3-tetramethylbutyl)phenol;\n4-tert-octylphenol\n205-426-2\n140-66-9\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\nM=10\n\n\n604-076-00-1\nphenolphthalein\n201-004-7\n77-09-8\nCarc. 1B\nMuta. 2\nRepr. 2\nH350\nH341\nH361f***\nGHS08\nDgr\nH350\nH341\nH361f***\n\nCarc. 1A; H350: C ≥ 1 %\n\n\n604-077-00-7\n2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol\n419-750-9\n98809-58-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-079-00-8\n4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol\n428-970-4\n13595-25-0\nRepr. 2\nSkin Sens. 1\nAquatic Chronic 2\nH361f***\nH317\nH411\nGHS08\nGHS09\nWng\nH361f***\nH317\nH411\n\n\n\n\n604-080-00-3\n4-fluoro-3-trifluoromethylphenol\n432-560-0\n61721-07-1\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Chronic 2\nH332\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH314\nH317\nH411\n\n\n\n\n604-081-00-9\n1,1-bis(4-hydroxyphenyl)-1-phenylethane\n433-130-5\n1571-75-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-082-00-4\n2-chloro-6-fluoro-phenol\n433-890-8\n2040-90-6\nMuta. 1B\nRepr. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH340\nH361f***\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH340\nH361f***\nH302\nH314\nH317\nH411\n\n\n\n\n604-083-00-X\n4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol\n439-270-3\n260408-02-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-084-00-5\n1-ethoxy-2,3-difluorobenzene\n441-000-4\n121219-07-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n604-087-00-1\nreaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;\n1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;\n1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol\n433-640-8\n—\nPyr. Sol. 1\nAquatic Chronic 4\nH250\nH413\nGHS02\nDgr\nH250\nH413\nEUH044\n\n\n\n604-089-00-2\n2-methyl-5-tert-butylthiophenol\n444-970-7\n—\nFlam. Liq. 3\nRepr. 2\nSTOT RE 2 *\nAsp. Tox. 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH361d***\nH373**\nH304\nH319\nH315\nH317\nH336\nH400\nH410\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH361d***\nH373**\nH304\nH319\nH315\nH317\nH336\nH410\n\n\n\n\n\n605-001-00-5\nformaldehyde ...%\n200-001-8\n50-00-0\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH351\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH351\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Corr. 1B; H314: C ≥25 %\nSkin Irrit. 2; H315: 5 % ≤ C < 25 %\nEye Irrit. 2; H319: 5 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 5 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nB D\n605-002-00-0\n1,3,5-trioxan;\ntrioxymethylene\n203-812-5\n110-88-3\nFlam. Sol. 1\nRepr. 2\nSTOT SE 3\nH228\nH361d ***\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH361d ***\nH335\n\n\nT\n605-003-00-6\nacetaldehyde;\nethanal\n200-836-8\n75-07-0\nFlam. Liq. 1\nCarc. 2\nEye Irrit. 2\nSTOT SE 3\nH224\nH351\nH319\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH351\nH319\nH335\n\n\n\n\n\n605-004-00-1\n2,4,6-trimethyl-1,3,5-trioxane;\nparaldehyde\n204-639-8\n123-63-7\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n605-005-00-7\n2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;\nmetaldehyde\n203-600-2\n108-62-3\nFlam. Sol. 2\nAcute Tox. 4 *\nH228\nH302\nGHS02\nGHS07\nDgr\nH228\nH302\n\n\n\n\n\n605-006-00-2\nbutyraldehyde\n204-646-6\n123-72-8\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-007-00-8\n1,1-dimethoxyethane;\ndimethyl acetal\n208-589-8\n534-15-6\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-008-00-3\nacrylaldehyde;\nacrolein;\nprop-2-enal\n203-453-4\n107-02-8\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH225\nH330\nH311\nH301\nH314\nH400\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH225\nH330\nH311\nH301\nH314\nH400\n\n\nD\n605-009-00-9\ncrotonaldehyde;\n2-butenal; [1]\n(E)-2-butenal;\n(E)-crotonaldehyde [2]\n224-030-0 [1]\n204-647-1 [2]\n4170-30-3 [1]\n123-73-9 [2]\nFlam. Liq. 2\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH225\nH341\nH330\nH311\nH301\nH373 **\nH335\nH315\nH318\nH400\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH341\nH330\nH311\nH301\nH373 **\nH335\nH315\nH318\nH400\n\n\n\n\n\n605-010-00-4\n2-furaldehyde\n202-627-7\n98-01-1\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH351\nH331\nH301\nH312\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH351\nH331\nH301\nH312\nH319\nH335\nH315\n\n\n\n\n\n605-011-00-X\n2-chlorobenzaldehyde;\no-chlorobenzaldehyde\n201-956-3\n89-98-5\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n605-012-00-5\nbenzaldehyde\n202-860-4\n100-52-7\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n605-013-00-0\nchloralose (INN);\n(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;\nglucochloralose;\nanhydroglucochloral\n240-016-7\n15879-93-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n605-014-00-6\nchloral hydrate;\n2,2,2-trichloroethane-1,1-diol\n206-117-5\n302-17-0\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH319\nH315\nGHS06\nDgr\nH301\nH319\nH315\n\n\n\n605-015-00-1\n1,1-diethoxyethane;\nacetal\n203-310-6\n105-57-7\nFlam. Liq. 2\nEye Irrit. 2\nSkin Irrit. 2\nH225\nH319\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH315\n\n\n\n605-016-00-7\nglyoxal...%;\nethandial...%\n203-474-9\n107-22-2\nMuta. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH341\nH332\nH319\nH315\nH317\nGHS07\nGHS08\nWng\nH341\nH332\nH319\nH315\nH317\n\n*\nB\n605-017-00-2\n1,3-dioxolane\n211-463-5\n646-06-0\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-018-00-8\npropanal;\npropionaldehyde\n204-623-0\n123-38-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\n\n\n\n605-019-00-3\ncitral\n226-394-6\n5392-40-5\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n605-020-00-9\nsafrole;\n5-allyl-1,3-benzodioxole\n202-345-4\n94-59-7\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nH350\nH341\nH302\nGHS08\nGHS07\nDgr\nH350\nH341\nH302\n\n\n\n605-021-00-4\nformaldehyde, reaction products with butylphenol\n294-145-9\n91673-30-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n605-022-00-X\nglutaral;\nglutaraldehyde;\n1,5-pentanedial\n203-856-5\n111-30-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nH331\nH301\nH314\nH334\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH301\nH314\nH334\nH317\nH400\n\n*\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 10 %\nEye Dam. ; H318: 2 % ≤ C < 10 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\nSTOT SE; H335: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n\n\n\n605-023-00-5\n5-chloro-2-(4-chlorophenoxy)phenol\n429-290-0\n3380-30-1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n605-024-00-0\n2-bromo-5-hydroxy-4-methoxybenzaldehyde\n426-540-0\n2973-59-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n605-025-00-6\nchloroacetaldehyde\n203-472-8\n107-20-0\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH351\nH330\nH311\nH301\nH314\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\n\n605-026-00-1\n2,5,7,7-tetramethyloctanal\n405-690-0\n114119-97-0\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07 GHS09\nWng\nH315\nH317\nH411\n\n\n\n605-027-00-7\nreaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;\n3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde\n410-480-7\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n605-028-00-2\nβ-methyl-3-(1-methylethyl)-benzenepropanal\n412-050-4\n125109-85-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n605-029-00-8\n2-cyclohexylpropanal\n412-270-0\n2109-22-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n605-030-00-3\n1-(p-methoxyphenyl)acetaldehyde oxime\n411-510-1\n3353-51-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n605-031-00-9\nreaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;\nwater(Including free water and water in hydrated 2,2-dimethoxyethanal)]\n421-890-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n605-032-00-4\n3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal\n425-370-4\n93957-50-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n605-033-00-X\nreaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;\n3,7,11-trimethyl-trans-6,10-dodecadienal\n425-910-9\n32480-08-3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n605-034-00-5\nreaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;\n(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;\n(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde\n429-860-9\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n605-035-00-0\n(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal\n426-330-9\n177964-68-0\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH319\nH317\nH413\nGHS07\nWng\nH319\nH317\nH413\n\n\n\n\n605-036-00-6\n2-bromomalonaldehyde\n430-470-6\n2065-75-0\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n605-037-00-1\ntrans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;\n3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde\n421-800-1\n120578-03-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n605-038-00-7\n3-methyl-5-phenylpentan-1-al\n433-900-0\n55066-49-4\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH315\nH317\nH411\n\n\n\n\n605-039-00-2\n3,4-dihydroxy-5-nitrobenzaldehyde\n441-810-8\n116313-85-0\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n606-001-00-8\nacetone;\npropan-2-one;\npropanone\n200-662-2\n67-64-1\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n606-002-00-3\nbutanone;\nethyl methyl ketone\n201-159-0\n78-93-3\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n606-003-00-9\nheptan-3-one;\nbutyl ethyl ketone\n203-388-1\n106-35-4\nFlam. Liq. 3\nAcute Tox. 4 *\nEye Irrit. 2\nH226\nH332\nH319\nGHS02\nGHS07\nWng\nH226\nH332\nH319\n\n\n\n606-004-00-4\n4-methylpentan-2-one;\nisobutyl methyl ketone\n203-550-1\n108-10-1\nFlam. Liq. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH225\nH332\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH332\nH319\nH335\nEUH066\n\n\n606-005-00-X\n2,6-dimethylheptan-4-one;\ndi-isobutyl ketone\n203-620-1\n108-83-8\nFlam. Liq. 3\nSTOT SE 3\nH226\nH335\nGHS02\nGHS07\nWng\nH226\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n606-006-00-5\npentan-3-one;\ndiethyl ketone\n202-490-3\n96-22-0\nFlam. Liq. 2\nSTOT SE 3\nSTOT SE 3\nH225\nH335\nH336\nGHS02\nGHS07\nDgr\nH225\nH335\nH336\nEUH066\n\n\n606-007-00-0\n3-methylbutan-2-one;\nmethyl isopropyl ketone\n209-264-3\n563-80-4\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n606-009-00-1\n4-methylpent-3-en-2-one;\nmesityl oxide\n205-502-5\n141-79-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n*\n\n606-010-00-7\ncyclohexanone\n203-631-1\n108-94-1\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-011-00-2\n2-methylcyclohexanone\n209-513-6\n583-60-8\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-012-00-8\n3,5,5-trimethylcyclohex-2-enone;\nisophorone\n201-126-0\n78-59-1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH351\nH312\nH302\nH319\nH335\nGHS08\nGHS07\nWng\nH351\nH312\nH302\nH319\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n\n606-013-00-3\np-benzoquinone;\nquinone\n203-405-2\n106-51-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH331\nH301\nH319\nH335\nH315\nH400\nGHS06\nGHS09\nDgr\nH331\nH301\nH319\nH335\nH315\nH400\n\nM=10\n\n\n606-014-00-9\nchlorophacinone (ISO);\n2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione\n223-003-0\n3691-35-8\nAcute Tox. 1\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH331\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH310\nH300\nH331\nH372 **\nH410\n\n\n\n606-016-00-X\npindone (ISO);\n2-pivaloylindan-1,3-dione\n201-462-8\n83-26-1\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH372 **\nH410\n\n\n\n606-017-00-5\ndiketene;\ndiketen\n211-617-1\n674-82-8\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\nD\n606-018-00-0\ndichlone (ISO);\n2,3-dichloro-1,4-naphthoquinone\n204-210-5\n117-80-6\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n\n\n606-019-00-6\nchlordecone (ISO);\nperchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;\ndecachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one\n205-601-3\n143-50-0\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH311\nH301\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH311\nH301\nH410\n\n\n\n606-020-00-1\n5-methylheptan-3-one\n208-793-7\n541-85-5\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH319\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n\n606-021-00-7\nN-methyl-2-pyrrolidone;\n1-methyl-2-pyrrolidone\n212-828-1\n872-50-4\nRepr. 1B\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH360D***\nH319\nH335\nH315\nGHS08\nGHS07\nDgr\nH360D***\nH319\nH335\nH315\n\nRepr. 1B; H360D: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 10 %\n\n\n606-022-00-2\n1-phenyl-3-pyrazolidone\n202-155-1\n92-43-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-023-00-8\n4-methoxy-4-methylpentan-2-one\n203-512-4\n107-70-0\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-024-00-3\nheptan-2-one;\nmethyl amyl ketone\n203-767-1\n110-43-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH302\n\n\n\n606-025-00-9\ncyclopentanone\n204-435-9\n120-92-3\nFlam. Liq. 3\nEye Irrit. 2\nSkin Irrit. 2\nH226\nH319\nH315\nGHS02\nGHS07\nWng\nH226\nH319\nH315\n\n\n\n606-026-00-4\n5-methylhexan-2-one;\nisoamyl methyl ketone\n203-737-8\n110-12-3\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-027-00-X\nheptan-4-one;\ndi-n-propyl ketone\n204-608-9\n123-19-3\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-028-00-5\n2,4-dimethylpentan-3-one;\ndi-isopropyl ketone\n209-294-7\n565-80-0\nFlam. Liq. 2\nAcute Tox. 4 *\nH225\nH332\nGHS02\nGHS07\nDgr\nH225\nH332\n\n\n\n606-029-00-0\npentane-2,4-dione;\nacetylacetone\n204-634-0\n123-54-6\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH302\nGHS02\nGHS07\nWng\nH226\nH302\n\n\n\n606-030-00-6\nhexan-2-one;\nmethyl butyl ketone;\nbutyl methyl ketone;\nmethyl-n-butyl ketone\n209-731-1\n591-78-6\nFlam. Liq. 3\nRepr. 2\nSTOT RE 1\nSTOT SE 3\nH226\nH361f ***\nH372 **\nH336\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH361f ***\nH372 **\nH336\n\n\n\n606-031-00-1\n3-propanolide;\n1,3-propiolactone\n200-340-1\n57-57-8\nCarc. 1B\nAcute Tox. 2 *\nEye Irrit. 2\nSkin Irrit. 2\nH350\nH330\nH319\nH315\nGHS06\nGHS08\nDgr\nH350\nH330\nH319\nH315\n\n\n\n606-032-00-7\nhexachloroacetone\n204-129-5\n116-16-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-033-00-2\n2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;\nmethazole\n243-761-6\n20354-26-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH312\nH302\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH411\n\n\n\n\n\n606-034-00-8\nmetribuzin (ISO);\n4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;\n4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one\n244-209-7\n21087-64-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n606-035-00-3\nchloridazon (ISO);\n5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;\npyrazon\n216-920-2\n1698-60-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n606-036-00-9\nquinomethionate;\nchinomethionat (ISO);\n6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one\n219-455-3\n2439-01-2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH332\nH312\nH302\nH373 **\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH332\nH312\nH302\nH373 **\nH319\nH317\nH410\n\n\n\n606-037-00-4\ntriadimefon (ISO);\n1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone\n256-103-8\n43121-43-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n606-038-00-X\ndiphacinone (ISO);\n2-diphenylacetylindan-1,3-dione\n201-434-5\n82-66-6\nAcute Tox. 2 *\nSTOT RE 1\nH300\nH372 **\nGHS06\nGHS08\nDgr\nH300\nH372 **\n\n\n\n606-039-00-5\n5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one\n400-680-2\n—\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH410\n\n\n\n606-040-00-0\n(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride\n401-840-4\n55845-90-4\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n606-041-00-6\n2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one\n400-600-6\n71868-10-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-042-00-1\nacetophenone\n202-708-7\n98-86-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n606-043-00-7\n2,4-di-tert-butylcyclohexanone\n405-340-7\n13019-04-0\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n606-044-00-2\n2,4,6-trimethylbenzophenone\n403-150-9\n954-16-5\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n606-045-00-8\noxadiazon (ISO);\n3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one\n243-215-7\n19666-30-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-046-00-3\nreaction mass of cis- and trans-cyclohexadec-8-en-1-one\n401-700-2\n3100-36-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-047-00-9\n2-benzyl-2-dimethylamino-4-morpholinobutyrophenone\n404-360-3\n119313-12-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-048-00-4\n2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one\n406-480-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n606-049-00-X\n4-(trans-4-propylcyclohexyl)acetophenone\n406-700-6\n78531-61-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n606-050-00-5\n6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione\n412-480-2\n72453-58-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-051-00-0\n4-pentylcyclohexanone\n406-670-4\n61203-83-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-052-00-6\n4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone\n410-410-5\n54574-82-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n606-053-00-1\nflurtamone (ISO);\n(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one\n—\n96525-23-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-054-00-7\nisoxaflutole (ISO);\n5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone\n—\n141112-29-0\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH361d ***\nH410\n\n\n\n606-055-00-2\n1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone\n411-180-9\n92836-10-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n606-056-00-8\n4-chloro-3',4'-dimethoxybenzophenone\n404-610-1\n116412-83-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-057-00-3\n4-propylcyclohexanone\n406-810-4\n40649-36-3\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n606-058-00-9\n4'-fluoro-2,2-dimethoxyacetophenone\n407-500-1\n21983-80-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n606-059-00-4\n2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride\n412-390-3\n86386-75-6\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n606-060-00-X\nreaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;\ncis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane\n412-950-7\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-061-00-5\n(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone\n423-290-4\n66938-41-8\nMuta. 2\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH400\nH410\nGHS08\nGHS09\nWng\nH341\nH410\n\n\n\n606-062-00-0\ntetrahydrothiopyran-3-carboxaldehyde\n407-330-8\n61571-06-0\nRepr. 1B\nEye Dam. 1\nAquatic Chronic 3\nH360D ***\nH318\nH412\nGHS08\nGHS05\nDgr\nH360D ***\nH318\nH412\n\n\n\n606-063-00-6\n(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal\n410-980-5\n112704-51-5\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n606-064-00-1\npregn-5-ene-3,20-dione bis(ethylene ketal)\n407-450-0\n7093-55-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n606-065-00-7\n1-(4-morpholinophenyl)butan-1-one\n413-790-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-066-00-2\n(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone\n410-440-9\n164058-20-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-067-00-8\nreaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;\n1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;\n1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;\n1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone\n414-870-8\n96792-67-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-068-00-3\n2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al\n415-770-7\n1638-05-7\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH317\nH412\nGHS08\nGHS07\nWng\nH373 **\nH317\nH412\n\n\n\n606-069-00-9\nspiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]\n415-460-1\n154171-76-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-070-00-4\nbutroxydim (ISO);\n5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one\n414-790-3\n138164-12-2\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361fd\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361fd\nH302\nH315\nH410\n\n\n\n606-071-00-X\n17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one\n421-050-3\n13258-43-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-072-00-5\n3-acetyl-1-phenyl-pyrrolidine-2,4-dione\n421-600-2\n719-86-8\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n606-073-00-0\n4,4'-bis(dimethylamino)benzophenone;\nMichler's ketone\n202-027-5\n90-94-8\nCarc. 1B\nMuta. 2\nEye Dam. 1\nH350\nH341\nH318\nGHS08\nGHS05\nDgr\nH350\nH341\nH318\n\n\n\n\n\n606-074-00-6\nreaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;\n(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene\n425-570-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n606-075-00-1\n1-benzyl-5-ethoxyimidazolidine-2,4-dione\n417-340-4\n65855-02-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n606-076-00-7\n1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione\n418-630-3\n136465-99-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n606-077-00-2\n(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone\n418-650-2\n104872-06-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-078-00-8\n1-octylazepin-2-one\n420-040-6\n59227-88-2\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n606-079-00-3\n2-n-butyl-benzo[d]isothiazol-3-one\n420-590-7\n4299-07-4\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n606-080-00-9\nReaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene\n417-100-9\n—\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n\n606-081-00-4\n(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one\n419-790-7\n4229-69-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n606-082-00-X\nreaction mass of: butan-2-one oxime;\nsyn-O,O'-di(butan-2-one oxime)diethoxysilane\n406-930-7\n\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 3\nH372 **\nH317\nH412\nGHS08\nGHS07\nDgr\nH372 **\nH317\nH412\n\n\n\n606-083-00-5\n2-chloro-5-sec-hexadecylhydroquinone\n407-750-1\n137193-60-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH315\nH317\nH412\nGHS07\nWng\nH319\nH315\nH317\nH412\n\n\n\n606-084-00-0\n1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione\n414-540-3\n484-33-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-085-00-6\n(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one\n418-530-1\n79200-56-9\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n606-086-00-1\n1-(3,3-dimethylcyclohexyl)pent-4-en-1-one\n422-330-8\n56973-87-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-087-00-7\n6-ethyl-5-fluoro-4(3H)-pyrimidone\n422-460-5\n137234-87-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n606-088-00-2\n2,4,4,7-tetramethyl-6-octen-3-one\n422-520-0\n74338-72-0\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n606-089-00-8\nreaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;\n1,4-diamino-2,3-bis-phenoxyanthraquinone\n423-220-2\n12223-77-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n606-090-00-3\n1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone\n430-920-1\n73096-98-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n\n606-091-00-9\n6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one\n421-320-0\n118289-55-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-092-00-4\nreaction mass of: (E)-oxacyclohexadec-12-en-2-one;\n(E)-oxacyclohexadec-13-en-2-one;\na) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one\n422-320-3\n\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n606-093-00-X\n5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one\n414-470-3\n95885-13-5\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n606-094-00-5\nN-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one\n417-460-7\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-095-00-0\n(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one\n421-830-3\n49805-30-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n606-096-00-6\n3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one\n424-170-4\n130603-71-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n606-097-00-1\n2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone\n424-210-0\n23911-85-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-098-00-7\n1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione\n431-220-9\n158574-65-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-099-00-2\n5-methoxy-4'-(trifluoromethyl)valerophenone\n425-000-1\n61718-80-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-100-00-6\n2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one\n425-150-8\n94723-86-1\nRepr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH360F***\nH302\nH317\nH412\nGHS08\nGHS07\nDgr\nH360F***\nH302\nH317\nH412\n\n\n\n\n606-101-00-1\nreaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;\n1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;\n1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;\n1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;\n1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;\n1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione\n426-050-7\n165038-51-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n606-102-00-7\n4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone\n431-490-8\n79876-59-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-103-00-2\n1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone\n426-460-6\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n606-104-00-8\n1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone\n426-830-7\n78531-59-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-105-00-3\n3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione\n431-500-0\n226065-73-2\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-106-00-9\n1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone\n427-320-7\n83626-30-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-107-00-4\n8-azaspiro[4.5]decane-7,9-dione\n427-770-4\n1075-89-4\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n\n606-108-00-X\n1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone\n436-710-6\n756-13-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n606-109-00-5\n2-(4-methyl-3-pentenyl)anthraquinone\n428-320-1\n71308-16-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 4\nH302\nH317\nH314\nGHS07\nWng\nH302\nH317\nH314\n\n\n\n\n606-110-00-0\n5-ethoxy-5H-furan-2-one\n428-330-4\n2833-30-9\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nH314\nH312\nH302\nH373**\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH314\nH312\nH302\nH373**\nH317\n\n\n\n\n606-111-00-6\n5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one\n428-410-9\n67014-36-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n606-112-00-1\n(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one\n428-690-2\n1668-86-6\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH412\nGHS07\nWng\nH302\nH319\nH412\n\n\n\n\n606-113-00-7\n1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one\n429-040-0\n272460-97-6\nEye Dam. 1\nAquatic Chronic 4\nH318\nH314\nGHS05\nDgr\nH318\nH314\n\n\n\n\n606-114-00-2\n4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone\n429-150-9\n67887-47-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-115-00-8\nprofoxydim (ISO);\n2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{]butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one\n—\n139001-49-3\nCarc. 2\nRepr. 2\nSkin Sens. 1\nH351\nH361d\nH317\nGHS08\nGHS07\nWng\nH351\nH361d\nH317\n\n\n\n\n606-116-00-3\ntepraloxydim (ISO);\n(RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one\n—\n149979-41-9\nCarc. 2\nRepr. 2\nH351\nH361fd\nGHS08\nWng\nH351\nH361fd\n\n\n\n\n606-117-00-9\n2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one\n429-460-4\n7078-98-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-118-00-4\nN-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine\n429-640-2\n52870-46-9\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n\n606-119-00-X\n(E)-3-methyl-5-cyclopentadecen-1-one\n429-900-5\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n606-120-00-5\n2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one\n430-170-5\n114625-74-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n606-121-00-0\n(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)\n430-460-1\n133636-82-5\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n606-122-00-6\n3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one\n430-820-8\n114341-88-7\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH302\nH373**\nH315\nH318\nH317\nH410\n\n\n\n\n606-123-00-1\n4-hexadecyl-1-phenylpyrazolidin-3-one\n430-840-7\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-124-00-7\n1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione\n421-080-7\n161462-35-7\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n606-125-00-2\n1-benzylimidazolidine-2,4-dione\n421-340-1\n6777-05-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n606-126-00-8\n1,4-bis(2,3-dihydroxypropylamino)anthraquinone\n421-470-7\n99788-75-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-128-00-9\n2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione\n422-650-8\n148935-94-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-129-00-4\n5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;\n(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one\n423-090-7\n156732-13-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-130-00-X\n4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone\n423-860-2\n56309-94-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n606-131-00-5\ncyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione\n427-230-8\n5571-36-8\nRepr. 1B\nSTOT RE 2 *\nAquatic Chronic 2\nH360F***\nH373**\nH411\nGHS08\nGHS09\nDgr\nH360F***\nH373**\nH411\n\n\n\n\n606-132-00-0\n(6β)-6,19-epoxyandrost-4-ene-3,17-dione\n433-490-3\n6563-83-3\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n606-134-00-1\nandrosta-1,4,9(11)-triene-3,17-dione\n433-560-3\n15375-21-0\nRepr. 2\nH361f***\nGHS08\nWng\nH361f***\n\n\n\n\n606-135-00-7\ncyclohexadecanone\n438-930-8\n2550-52-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-136-00-2\n(3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone\n444-350-6\n133413-70-4\nEye Irrit. 2\nAquatic Chronic 4\nH319\nH413\nGHS07\nWng\nH319\nH413\n\n\n\n\n606-137-00-8\ntrans-7,7'-dimethyl-(4H, 4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione\n444-750-0\n211387-26-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-138-00-3\n(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone\n444-800-1\n141645-23-0\nFlam. Liq. 3\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH302\nH373**\nH315\nH318\nH317\nH400\nH410\nGHS02\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH302\nH373**\nH315\nH318\nH317\nH410\n\nM=10\n\n\n606-139-00-9\n(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one\n444-830-5\n124379-29-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-140-00-4\n2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one\n444-860-9\n474510-57-1\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n606-141-00-X\nsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate\n418-410-7\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n606-142-00-5\nreaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;\n(1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;\n(1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one\n434-290-9\n—\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n607-001-00-0\nformic acid ... %\n200-579-1\n64-18-6\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 90 %\nSkin Corr. 1B; H314: 10 % ≤ C < 90 %\nSkin Irrit. 2; H315: 2 % ≤ C < 10 %\nEye Irrit. 2; H319: 2 % ≤ C < 10 %\nB\n607-002-00-6\nacetic acid ... %\n200-580-7\n64-19-7\nFlam. Liq. 3\nSkin Corr. 1A\nH226\nH314\nGHS02\nGHS05\nDgr\nH226\nH314\n\nSkin Corr. 1A; H314: C ≥ 90 %\nSkin Corr. 1B; H314: 25 % ≤ C < 90 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n\n\n607-003-00-1\nchloroacetic acid\n201-178-4\n79-11-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH331\nH311\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n607-004-00-7\nTCA (ISO);\ntrichloroacetic acid\n200-927-2\n76-03-9\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 1 %\n\n607-005-00-2\nTCA-sodium (ISO);\nsodium trichloroacetate\n211-479-2\n650-51-1\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH335\nH410\n\n\n\n607-006-00-8\noxalic acid\n205-634-3\n144-62-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n*\n\n\n\n607-007-00-3\nsalts of oxalic acid with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n*\nA\n\n607-008-00-9\nacetic anhydride\n203-564-8\n108-24-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH302\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 5 % ≤ C < 25 %\nEye Dam. 1; H318: 5 % ≤ C < 25 %\nEye Irrit. 2; H319: 1 % ≤ C < 5 %\nSTOT SE 3; H335: C ≥ 5 %\n\n607-009-00-4\nphthalic anhydride\n201-607-5\n85-44-9\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH302\nH335\nH315\nH318\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH335\nH315\nH318\nH334\nH317\n\n\n\n607-010-00-X\npropionic anhydride\n204-638-2\n123-62-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\n\n607-011-00-5\nacetyl chloride\n200-865-6\n75-36-5\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\nEUH014\n\n\n\n\n607-012-00-0\nbenzoyl chloride\n202-710-8\n98-88-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH332\nH312\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH332\nH312\nH302\nH314\nH317\n\n\n\n\n607-013-00-6\ndimethyl carbonate\n210-478-4\n616-38-6\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-014-00-1\nmethyl formate\n203-481-7\n107-31-3\nFlam. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH224\nH332\nH302\nH319\nH335\nGHS02\nGHS07\nDgr\nH224\nH332\nH302\nH319\nH335\n\n\n\n607-015-00-7\nethyl formate\n203-721-0\n109-94-4\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH225\nH332\nH302\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\nH319\nH335\n\n\n\n607-016-00-2\npropyl formate; [1]\nisopropyl formate [2]\n203-798-0 [1]\n210-901-2 [2]\n110-74-7 [1]\n625-55-8 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSTOT SE 3\nH225\nH319\nH335\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH336\n\n\nC\n607-017-00-8\nbutyl formate; [1]\ntert-butyl formate; [2]\nisobutyl formate [3]\n209-772-5 [1]\n212-105-0 [2]\n208-818-1 [3]\n592-84-7 [1]\n762-75-4 [2]\n542-55-2 [3]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\n\n\nC\n607-018-00-3\nisopentyl formate; [1]\n2-methylbutyl formate [2]\n203-769-2 [1]\n252-343-2 [2]\n110-45-2 [1]\n35073-27-9 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\n\n\nC\n607-019-00-9\nmethyl chloroformate\n201-187-3\n79-22-1\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH330\nH312\nH302\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH330\nH312\nH302\nH314\n\n\n\n607-020-00-4\nethyl chloroformate\n208-778-5\n541-41-3\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH330\nH302\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH330\nH302\nH314\n\n\n\n607-021-00-X\nmethyl acetate\n201-185-2\n79-20-9\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n607-022-00-5\nethyl acetate\n205-500-4\n141-78-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n607-023-00-0\nvinyl acetate\n203-545-4\n108-05-4\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\nD\n607-024-00-6\npropyl acetate; [1]\nisopropyl acetate [2]\n203-686-1 [1]\n203-561-1 [2]\n109-60-4 [1]\n108-21-4 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\nC\n607-025-00-1\nn-butyl acetate\n204-658-1\n123-86-4\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\nEUH066\n\n\n607-026-00-7\nsec-butyl acetate; [1]\nisobutyl acetate; [2]\ntert-butyl acetate [3]\n203-300-1 [1]\n203-745-1 [2]\n208-760-7 [3]\n105-46-4 [1]\n110-19-0 [2]\n540-88-5 [3]\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH066\n\nC\n607-027-00-2\nmethyl propionate\n209-060-4\n554-12-1\nFlam. Liq. 2\nAcute Tox. 4 *\nH225\nH332\nGHS02\nGHS07\nDgr\nH225\nH332\n\n\n\n607-028-00-8\nethyl propionate\n203-291-4\n105-37-3\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-029-00-3\nn-butyl propionate; [1]\nsec-butyl propionate; [2]\niso-butyl propionate [3]\n209-669-5 [1]\n- [2]\n208-746-0 [3]\n590-01-2 [1]\n591-34-4 [2]\n540-42-1 [3]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-030-00-9\npropyl propionate\n203-389-7\n106-36-5\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n607-031-00-4\nbutyl butyrate\n203-656-8\n109-21-7\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-032-00-X\nethyl acrylate\n205-438-8\n140-88-5\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\n\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Irrit. 2; H319: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 5 %\nD\n607-033-00-5\nn-butyl methacrylate\n202-615-1\n97-88-1\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH317\n\n\nD\n607-034-00-0\nmethyl acrylate;\nmethyl propenoate\n202-500-6\n96-33-3\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\n\n\nD\n607-035-00-6\nmethyl methacrylate;\nmethyl 2-methylprop-2-enoate;\nmethyl 2-methylpropenoate\n201-297-1\n80-62-6\nFlam. Liq. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH335\nH315\nH317\n\n\nD\n607-036-00-1\n2-methoxyethyl acetate;\nmethylglycol acetate\n203-772-9\n110-49-6\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH360FD\nH332\nH312\nH302\nGHS08\nGHS07\nDgr\nH360FD\nH332\nH312\nH302\n\n\n\n\n\n607-037-00-7\n2-ethoxyethyl acetate;\nethylglycol acetate\n203-839-2\n111-15-9\nFlam. Liq. 3\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH360FD\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH360FD\nH332\nH312\nH302\n\n\n\n\n607-038-00-2\n2-butoxyethyl acetate;\nbutylglycol acetate\n203-933-3\n112-07-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nGHS07\nWng\nH332\nH312\n\n\n\n607-039-00-8\n2,4-D (ISO);\n2,4-dichlorophenoxyacetic acid\n202-361-1\n94-75-7\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH335\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\nH317\nH412\n\n\n\n607-040-00-3\nsalts of 2,4-D\n—\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\nA\n607-041-00-9\n2,4,5-T (ISO);\n2,4,5-trichlorophenoxy acetic acid\n202-273-3\n93-76-5\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH410\n\n\n\n607-042-00-4\nsalts and esters of 2,4,5-T;\nsalts and esters of 2,4,5-trichlorophenoxy acetic acid\n—\n—\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH410\n\n\nA\n607-043-00-X\ndicamba (ISO);\n2,5-dichloro-6-methoxybenzoic acid;\n3,6-dichloro-2-methoxybenzoic acid\n217-635-6\n1918-00-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n607-044-00-5\n3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]\npotassium 3,6-dichloro-o-anisate [2]\n218-951-7 [1]\n233-002-7 [2]\n2300-66-5 [1]\n10007-85-9 [2]\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n607-045-00-0\ndichlorprop (ISO);\n2-(2,4-dichlorophenoxy) propionic acid\n204-390-5\n120-36-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH312\nH302\nH315\nH318\n\n\n\n607-046-00-6\nsalts of dichlorprop\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\nA\n607-047-00-1\nfenoprop (ISO);\n2-(2,4,5-trichlorophenoxy)propionic acid\n202-271-2\n93-72-1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-048-00-7\nsalts of fenoprop;\nsalts of 2-(2,4,5-trichlorophenoxy)propionic acid\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n607-049-00-2\nmecoprop (ISO);\n2-(4-chloro-o-tolyloxy) propionic acid;\n(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]\n2-(4-chloro-2-methylphenoxy)propionic acid [2]\n230-386-8 [1]\n202-264-4 [2]\n7085-19-0 [1]\n708519-0 [2]\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\nM=100\n\n607-050-00-8\nsalts of mecoprop\n—\n—\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\nA\n\n\n607-051-00-3\nMCPA (ISO);\n4-chloro-o-tolyloxyacetic acid\n202-360-6\n94-74-6\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\n\n\n607-052-00-9\nsalts and esters of MCPA\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n\n\n607-053-00-4\nMCPB (ISO);\n4-(4-chloro-o-tolyloxy) butyric acid\n202-365-3\n94-81-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-054-00-X\nsalts and esters of MCPB\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n607-055-00-5\nendothal-sodium (ISO);\ndisodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate\n204-959-8\n129-67-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH301\nH312\nH319\nH335\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH335\nH315\n\n\n\n607-056-00-0\nwarfarin (ISO); [1]\n(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]\n(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]\n201-377-6 [1]\n226-907-3 [2]\n226-908-9 [3]\n81-81-2 [1]\n5543-57-7 [2]\n5543-58-8 [3]\nRepr. 1A\nSTOT RE 1\nAquatic Chronic 3\nH360D ***\nH372 **\nH412\nGHS08\nDgr\nH360D ***\nH372 **\nH412\n\n\n\n607-057-00-6\ncoumachlor (ISO);\n3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin\n201-378-1\n81-82-3\nSTOT RE 2 *\nAquatic Chronic 3\nH373 **\nH412\nGHS08\nWng\nH373 **\nH412\n\n\n\n607-058-00-1\ncoumafuryl (ISO);\nfumarin;\n(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;\n4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin\n204-195-5\n117-52-2\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 3\nH301\nH372 **\nH412\nGHS06\nGHS08\nDgr\nH301\nH372 **\nH412\n\n\n\n607-059-00-7\ncoumatetralyl;\n4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin\n227-424-0\n5836-29-3\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Chronic 3\nH310\nH300\nH372 **\nH412\nGHS06\nGHS08\nDgr\nH310\nH300\nH372 **\nH412\n\n\n\n607-060-00-2\ndicoumarol;\n4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)\n200-632-9\n66-76-2\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Chronic 2\nH372 **\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH302\nH411\n\n\n\n607-061-00-8\nacrylic acid;\nprop-2-enoic acid\n201-177-9\n79-10-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH226\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH332\nH312\nH302\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 1 %\nD\n607-062-00-3\nn-butyl acrylate\n205-480-7\n141-32-2\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH317\n\n\nD\n607-063-00-9\nisobutyric acid\n201-195-7\n79-31-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n607-064-00-4\nbenzyl chloroformate\n207-925-0\n501-53-1\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n607-065-00-X\nbromoacetic acid\n201-175-8\n79-08-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nH331\nH311\nH301\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH317\nH400\n\n\n\n\n\n607-066-00-5\ndichloroacetic acid\n201-207-0\n79-43-6\nSkin Corr. 1A\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\n\n\n607-067-00-0\ndichloroacetyl chloride\n201-199-9\n79-36-7\nSkin Corr. 1A\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\n\n\n607-068-00-6\niodoacetic acid\n200-590-1\n64-69-7\nAcute Tox. 3 *\nSkin Corr. 1A\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n\n\n607-069-00-1\nethyl bromoacetate\n203-290-9\n105-36-2\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n607-070-00-7\nethyl chloroacetate\n203-294-0\n105-39-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nH331\nH311\nH301\nH400\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH400\n\n\n\n607-071-00-2\nethyl methacrylate\n202-597-5\n97-63-2\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\nH317\n\n\nD\n607-072-00-8\n2-hydroxyethyl acrylate\n212-454-9\n818-61-1\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nH311\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH314\nH317\nH400\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-073-00-3\n4-CPA (ISO);\n4-chlorophenoxyacetic acid\n204-581-3\n122-88-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-074-00-9\nchlorfenac(ISO);\n2,3,6-trichlorophenylacetic acid\n201-599-3\n85-34-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-075-00-4\nchlorfenprop-methyl;\nmethyl 2-chloro-3-(4-chlorophenyl)propionate\n238-413-5\n14437-17-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n607-076-00-X\ndodine(ISO);\ndodecylguanidinium acetate\n219-459-5\n2439-10-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n\n\n607-077-00-5\nerbon (ISO);\n2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate\n—\n136-25-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-078-00-0\nfluenetil (ISO);\n2-fluoroethyl biphenyl-4-ylacetate\n—\n4301-50-2\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n607-079-00-6\nkelevan (ISO);\nethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;\nethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate\n—\n4234-79-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH311\nH302\nH411\nGHS06\nGHS09\nDgr\nH311\nH302\nH411\n\n\n\n607-080-00-1\nchloroacetyl chloride\n201-171-6\n79-04-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1A\nAquatic Acute 1\nH331\nH311\nH301\nH372 **\nH314\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH372 **\nH314\nH400\nEUH014\nEUH029\n\n\n607-081-00-7\nfluoroacetic acid\n205-631-7\n144-49-0\nAcute Tox. 2 *\nAquatic Acute 1\nH300\nH400\nGHS06\nGHS09\nDgr\nH300\nH400\n\n\n\n607-082-00-2\nfluoroacetates, soluble\n—\n—\nAcute Tox. 2 *\nAquatic Acute 1\nH300\nH400\nGHS06\nGHS09\nDgr\nH300\nH400\n\n\nA\n607-083-00-8\n2,4-DB (ISO);\n4-(2,4-dichlorophenoxy)butyric acid\n202-366-9\n94-82-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-084-00-3\nsalts of 2,4-DB\n—\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\nA\n\n\n607-085-00-9\nbenzyl benzoate\n204-402-9\n120-51-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n607-086-00-4\ndiallyl phthalate\n205-016-3\n131-17-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-088-00-5\nmethacrylic acid;\n2-methylpropenoic acid\n201-204-4\n79-41-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\nD\n607-089-00-0\npropionic acid ... %\n201-176-3\n79-09-4\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H319: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 10 %\nB\n607-090-00-6\nthioglycolic acid\n200-677-4\n68-11-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH331\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\n\n*\n\n607-091-00-1\ntrifluoroacetic acid . . . %\n200-929-3\n76-05-1\nAcute Tox. 4 *\nH332\nGHS05\nH332\n\n*\nB\n\n\n\n\nSkin Corr. 1A\nAquatic Chronic 3\nH314\nH412\nGHS07\nDgr\nH314\nH412\n\n\n\n607-092-00-7\nmethyl lactate; [1]\nmethyl (±)-lactate; [2]\nmethyl (R)-lactate; [3]\nmethyl (S)-(-)-lactate [4]\n208-930-0 [1]\n218-449-8 [2]\n241-420-6 [3]\n248-704-9 [4]\n547-64-8 [1]\n2155-30-8 [2]\n17392-83-5 [3]\n27871-49-4 [4]\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH319\nH335\n\n\nC\n607-093-00-2\npropionyl chloride\n201-170-0\n79-03-8\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\nEUH014\n\nB D\n607-094-00-8\nperacetic acid . . . %\n201-186-8\n79-21-0\nFlam. Liq. 3\nOrg. Perox. D ****\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH226\nH242\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH242\nH332\nH312\nH302\nH314\nH400\n\n*\nSTOT SE 3; H335: C ≥ 1 %\nB D\n\n\n607-095-00-3\nmaleic acid\n203-742-5\n110-16-7\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH302\nH319\nH335\nH315\nH317\nGHS07\nWng\nH302\nH319\nH335\nH315\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n\n607-096-00-9\nmaleic anhydride\n203-571-6\n108-31-6\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH302\nH314\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH314\nH334\nH317\n\n\n\n607-097-00-4\nbenzene-1,2,4-tricarboxylic acid 1,2-anhydride;\ntrimellitic anhydride\n209-008-0\n552-30-7\nSTOT SE 3\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH335\nH318\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH335\nH318\nH334\nH317\n\n\n\n607-098-00-X\nbenzene-1,2:4,5-tetracarboxylic dianhydride;\nbenzene-1,2:4,5-tetracarboxylic dianhydride;\npyromellitic dianhydride\n201-898-9\n89-32-7\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\n\n607-099-00-5\n1,2,3,6-tetrahydrophthalic anhydride; [1]\ncis-1,2,3,6-tetrahydrophthalic anhydride; [2]\n3,4,5,6-tetrahydrophthalic anhydride; [3]\ntetrahydrophthalic anhydride [4]\n201-605-4 [1]\n213-308-7 [2]\n219-374-3 [3]\n247-570-9 [4]\n85-43-8 [1]\n935-79-5 [2]\n2426-02-0 [3]\n26266-63-7 [4]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH334\nH317\nH412\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\nH412\n\n\nC\n607-100-00-9\nbenzophenone-3,3',4,4'-tetracarboxylic dianhydride;\n4,4'-carbonyldi(phthalic anhydride)\n219-348-1\n2421-28-5\nEye Irrit. 2\nSTOT SE 3\nH319\nH335\nGHS07\nWng\nH319\nH335\n\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-101-00-4\n1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride\n204-077-3\n115-27-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSkin Irrit. 2; H315: C ≥ 1 %\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-102-00-X\ncyclohexane-1,2-dicarboxylic anhydride; [1]\ncis-cyclohexane-1,2-dicarboxylic anhydride; [2]\ntrans-cyclohexane-1,2-dicarboxylic anhydride [3]\n201-604-9 [1]\n236-086-3 [2]\n238-009-9 [3]\n85-42-7 [1]\n13149-00-3 [2]\n14166-21-3 [3]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n\n\n607-103-00-5\nsuccinic anhydride\n203-570-0\n108-30-5\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH302\nH319\nH335\nGHS07\nWng\nH302\nH319\nH335\n\n*\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n\n\n607-104-00-0\ncyclopentane-1,2,3,4-tetracarboxylic dianhydride\n227-964-7\n6053-68-5\nEye Irrit. 2\nSTOT SE 3\nH319\nH335\nGHS07\nWng\nH319\nH335\n\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-105-00-6\n8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]\n1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]\n(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]\n204-957-7 [1]\n212-557-9 [2]\n220-384-5 [3]\n129-64-6 [1]\n826-62-0 [2]\n2746-19-2 [3]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-106-00-1\n8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride\n—\n123748-85-6\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH302\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH302\nH319\nH335\nH315\nH334\n\nSTOT SE 3; H335: C ≥ 10 %\nC\n607-107-00-7\n2-ethylhexyl acrylate\n203-080-7\n103-11-7\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH335\nH315\nH317\nGHS07\nWng\nH335\nH315\nH317\n\n\nD\n607-108-00-2\n2-hydroxy-1-methylethylacrylate; [1]\n2-hydroxypropylacrylate; [2]\nacrylic acid, monoester with propane-1,2-diol [3]\n220-852-9 [1]\n213-663-8 [2]\n247-118-0 [3]\n2918-23-2 [1]\n999-61-1 [2]\n25584-83-2 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nC D\n607-109-00-8\nhexamethylene diacrylate;\nhexane-1,6-diol diacrylate\n235-921-9\n13048-33-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-110-00-3\npentaerythritol triacrylate\n222-540-8\n3524-68-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-111-00-9\n2,2-bis(acryloyloxymethyl)butyl acrylate;\ntrimethylolpropane triacrylate\n239-701-3\n15625-89-5\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-112-00-4\n2,2-dimethyltrimethylene diacrylate;\nneopentyl glycol diacrylate\n218-741-5\n2223-82-7\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH311\nH319\nH315\nH317\nGHS06\nDgr\nH311\nH319\nH315\nH317\n\n*\nD\n607-113-00-X\nisobutyl methacrylate\n202-613-0\n97-86-9\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH226\nH319\nH335\nH315\nH317\nH400\nGHS02\nGHS07\nGHS09\nWng\nH226\nH319\nH335\nH315\nH317\nH400\n\n\nD\n607-114-00-5\nethylene dimethacrylate\n202-617-2\n97-90-5\nSTOT SE 3\nSkin Sens. 1\nH335\nH317\nGHS07\nWng\nH335\nH317\n\nSTOT SE 3; H335: C ≥ 10 %\nD\n607-115-00-0\nisobutyl acrylate\n203-417-8\n106-63-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH332\nH312\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH315\nH317\n\n\nD\n607-116-00-6\ncyclohexyl acrylate\n221-319-3\n3066-71-5\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH335\nH315\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\nD\n607-117-00-1\n2,3-epoxypropyl acrylate;\nglycidyl acrylate\n203-440-3\n106-90-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-118-00-7\n1-methyltrimethylene diacrylate;\n1,3-butylene glycol diacrylate\n243-105-9\n19485-03-1\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\n\n\nD\n607-119-00-2\ntetramethylene diacrylate;\n1,4-butyleneglycol diacrylate\n213-979-6\n1070-70-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\n\n\nD\n607-120-00-8\n2,2'-oxydiethyl diacrylate;\ndiethylene glycol diacrylate\n223-791-6\n4074-88-8\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH311\nH319\nH315\nH317\nGHS06\nDgr\nH311\nH319\nH315\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-121-00-3\n8,9,10-trinorborn-2-yl acrylate\n—\n10027-06-2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nH312\nH315\nH317\nGHS07\nWng\nH312\nH315\nH317\n\n\nD\n607-122-00-9\npentaerythritol tetraacrylate\n225-644-1\n4986-89-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-123-00-4\n2,3-epoxypropyl methacrylate;\nglycidyl methacrylate\n203-441-9\n106-91-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH312\nH302\nH319\nH315\nH317\nGHS07\nWng\nH332\nH312\nH302\nH319\nH315\nH317\n\n\nD\n607-124-00-X\n2-hydroxyethyl methacrylate\n212-782-2\n868-77-9\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-125-00-5\n2-hydroxypropyl methacrylate; [1]\n3-hydroxypropyl methacrylate [2]\n213-090-3 [1]\n220-426-2 [2]\n923-26-2 [1]\n2761-09-3 [2]\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\nC D\n607-126-00-0\n2,2'-(ethylenedioxy)diethyl diacrylate;\ntriethylene glycol diacrylate\n216-853-9\n1680-21-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-127-00-6\n2-diethylaminoethyl methacrylate\n203-275-7\n105-16-8\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH319\nH315\nH317\nGHS07\nWng\nH332\nH319\nH315\nH317\n\n\nD\n607-128-00-1\n2-tert-butylaminoethyl methacrylate\n223-228-4\n3775-90-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-129-00-7\nethyl lactate;\nethyl DL-lactate; [1]\nethyl (S)-2-hydroxypropionate;\nethyl L-lactate;\nethyl-(S)-lactate [2]\n202-598-0 [1]\n211-694-1 [2]\n97-64-3 [1]\n687-47-8 [2]\nFlam. Liq. 3\nSTOT SE 3\nEye Dam. 1\nH226\nH335\nH318\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH335\nH318\n\n\nC\n607-130-00-2\npentyl acetate; [1]\nisopentyl acetate; [2]\n1-methylbutyl acetate; [3]\n2-methylbutyl acetat; [4]\n2(or 3)-methylbutyl acetate [5]\n211-047-3 [1]\n204-662-3 [2]\n210-946-8 [3]\n210-843-8 [4]\n282-263-3 [5]\n628-63-7 [1]\n123-92-2 [2]\n626-38-0 [3]\n624-41-9 [4]\n84145-37-9 [5]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\nEUH066\n\nC\n607-131-00-8\nisopentyl propionate; [1]\npentyl propionate; [2]\n2-methylbutyl propionate [3]\n203-322-1 [1]\n210-852-7 [2]\n219-449-0 [3]\n105-68-0 [1]\n624-54-4 [2]\n2438-20-2 [3]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-132-00-3\n2-dimethylaminoethyl methacrylate\n220-688-8\n2867-47-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH312\nH302\nH319\nH315\nH317\nGHS07\nWng\nH312\nH302\nH319\nH315\nH317\n\n\nD\n607-133-00-9\nmonoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\nA\n607-134-00-4\nmonoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\nA\n607-135-00-X\nbutyric acid\n203-532-3\n107-92-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-136-00-5\nbutyryl chloride\n205-498-5\n141-75-3\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\n\n\n\n607-137-00-0\nmethyl acetoacetate\n203-299-8\n105-45-3\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-138-00-6\nbutyl chloroformate;\nchloroformic acid butyl ester\n209-750-5\n592-34-7\nFlam. Liq. 3\nAcute Tox. 3 *\nSkin Corr. 1B\nH226\nH331\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH226\nH331\nH314\n\n\n\n607-139-00-1\n2-chloropropionic acid\n209-952-3\n598-78-7\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n607-140-00-7\nisobutyryl chloride\n201-194-1\n79-30-1\nFlam. Liq. 2\nSkin Corr. 1A\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\n\n\n\n607-141-00-2\noxydiethylene bis(chloroformate)\n203-430-9\n106-75-2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH411\n\n\n\n\n\n607-142-00-8\npropyl chloroformate;\nchloroformic acid propylester;\nn-propyl chloroformate\n203-687-7\n109-61-5\nFlam. Liq. 2\nAcute Tox. 3 *\nSkin Corr. 1B\nH225\nH331\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH331\nH314\n\n\n\n\n607-143-00-3\nvaleric acid\n203-677-2\n109-52-4\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n607-144-00-9\nadipic acid\n204-673-3\n124-04-9\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-145-00-4\nmethanesulphonic acid\n200-898-6\n75-75-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-146-00-X\nfumaric acid\n203-743-0\n110-17-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-147-00-5\noxalic acid diethylester;\ndiethyl oxalate\n202-464-1\n95-92-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n607-148-00-0\nguanidinium chloride;\nguanadine hydrochloride\n200-002-3\n50-01-1\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n607-149-00-6\nurethane (INN);\nethyl carbamate\n200-123-1\n51-79-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n607-150-00-1\nendothal (ISO);\n7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid\n205-660-5\n145-73-3\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH301\nH312\nH319\nH335\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH335\nH315\n\n\n\n607-151-00-7\npropargite (ISO);\n2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite\n219-006-1\n2312-35-8\nCarc. 2\nAcute Tox. 3 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH331\nH315\nH318\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH331\nH315\nH318\nH410\n\nM = 10\n\n607-152-00-2\n2,3,6-TBA (ISO);\n2,3,6-trichlorobenzoic acid\n200-026-4\n50-31-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-153-00-8\nbenazolin (ISO);\n4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid\n223-297-0\n3813-05-6\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n607-154-00-3\nethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;\nbenzoylprop-ethyl (ISO)\n244-845-5\n22212-55-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-155-00-9\n3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;\nblasticidin-s\n—\n2079-00-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n607-156-00-4\nchlorfenson (ISO);\n4-chlorophenyl 4-chlorobenzenesulfonate\n201-270-4\n80-33-1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-157-00-X\n3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;\ndifenacoum\n259-978-4\n56073-07-5\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH300\nH372 **\nH410\n\n\n\n607-158-00-5\nsodium salt of chloroacetic acid;\nsodium chloroacetate\n223-498-3\n3926-62-3\nAcute Tox. 3 *\nSkin Irrit. 2\nAquatic Acute 1\nH301\nH315\nH400\nGHS06\nGHS09\nDgr\nH301\nH315\nH400\n\n\n\n607-159-00-0\nchlorobenzilate (ISO);\nethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;\nethyl 4,4'-dichlorobenzilate\n208-110-2\n510-15-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-160-00-6\nisobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;\nclofop-isobutyl (ISO)\n—\n51337-71-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-161-00-1\ndiethanolamine salt of 4-CPA\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n607-162-00-7\ndalapon;\n2,2-dichloropropionic acid; [1]\ndalapon-sodium;\nsodium 2,2-dichloropropionate [2]\n200-923-0 [1]\n204-828-5 [2]\n75-99-0 [1]\n127-20-8 [2]\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n607-163-00-2\n3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;\ndehydracetic acid\n208-293-9\n520-45-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-164-00-8\nsodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;\nsodium dehydracetate\n224-580-1\n4418-26-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-165-00-3\ndiclofop-methyl (ISO)\nmethyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;\nmethyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;\n257-141-8\n51338-27-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-166-00-9\nmedinoterb acetate (ISO);\n6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate\n219-634-6\n2487-01-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n607-167-00-4\nsodium 3-chloroacrylate\n—\n4312-97-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n607-168-00-X\ndipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;\npropylisome\n—\n83-59-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH302\nH410\n\n\n\n607-169-00-5\nsodium fluoroacetate\n200-548-2\n62-74-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH330\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH400\n\n\n\n607-170-00-0\nbis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;\nthiocyclam-oxalate\n250-859-2\n31895-22-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n607-172-00-1\n4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;\nbrodifacoum\n259-980-5\n56073-10-0\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH310\nH300\nH372 **\nH410\n\n\n\n607-173-00-7\ndimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate\n400-460-6\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-174-00-2\nreaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate\n400-580-9\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-175-00-8\nmethyl 2-(2-nitrobenzylidene)acetoacetate\n400-650-9\n39562-27-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-176-00-3\nreaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)\n400-830-7\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n607-177-00-9\ntribenuron-methyl (ISO);\n2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester;\nmethyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate\n401-190-1\n101200-48-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=100\n\n\n\n607-178-00-4\nmethyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate\n401-340-6\n83055-99-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-179-00-X\n(benzothiazol-2-ylthio)succinic acid\n401-450-4\n95154-01-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-180-00-5\npotassium 2-hydroxycarbazole-1-carboxylate\n401-630-2\n96566-70-0\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Chronic 3\nH302\nH319\nH335\nH412\nGHS07\nWng\nH302\nH319\nH335\nH412\n\n\n\n607-181-00-0\n3,5-dichloro-2,4-difluorobenzoyl fluoride\n401-800-6\n101513-70-6\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH331\nH314\nH302\nH317\nH412\nGHS06\nGHS05\nDgr\nH331\nH314\nH302\nH317\nH412\nEUH029\n\n\n607-182-00-6\nmethyl 3-sulphamoyl-2-thenoate\n402-050-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-183-00-1\nzinc 2-hydroxy-5-C13-18alkylbenzoate\n402-280-3\n—\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH411\n\n\n\n607-184-00-7\nS-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate\n402-290-8\n85702-90-5\nFlam. Liq. 3\nResp. Sens. 1\nSkin Sens. 1\nH226\nH334\nH317\nGHS02\nGHS08\nDgr\nH226\nH334\nH317\n\n\n\n607-185-00-2\nethyl trans-3-dimethylaminoacrylate\n402-650-4\n1117-37-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-186-00-8\nquinclorac (ISO);\n3,7-dichloroquinoline-8-carboxylic acid\n402-780-1\n84087-01-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-187-00-3\nbis(2,2,6,6-tetramethyl-4-piperidyl) succinate\n402-940-0\n62782-03-0\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n607-188-00-9\nhydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate\n402-970-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n607-189-00-4\ntrimethylenediaminetetraacetic acid\n400-400-9\n1939-36-2\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n607-190-00-X\nmethyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)\n401-890-7\n77402-03-0\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nH350\nH340\nH302\nH319\nGHS08\nGHS07\nDgr\nH350\nH340\nH302\nH319\n\n\n\n607-191-00-5\nisobutyl 3,4-epoxybutyrate\n401-920-9\n100181-71-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-192-00-0\ndisodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate\n402-360-8\n92511-22-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-194-00-1\npropylene carbonate\n203-572-1\n108-32-7\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n\n607-195-00-7\n2-methoxy-1-methylethyl acetate\n203-603-9\n108-65-6\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n607-196-00-2\nheptanoic acid\n203-838-7\n111-14-8\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-197-00-8\nnonanoic acid\n203-931-2\n112-05-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-198-00-3\npropyl 3,4,5-trihydroxybenzoate\n204-498-2\n121-79-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n607-199-00-9\noctyl 3,4,5-trihydroxybenzoate\n213-853-0\n1034-01-1\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n607-200-00-2\ndodecyl 3,4,5-trihydroxybenzoate\n214-620-6\n1166-52-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-201-00-8\nthiocarbonyl chloride\n207-341-6\n463-71-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH331\nH302\nH319\nH335\nH315\nGHS06\nDgr\nH331\nH302\nH319\nH335\nH315\n\n\n\n607-203-00-9\n2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate\n279-452-8\n80387-97-9\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH360D ***\nH317\nH412\nGHS08\nGHS07\nDgr\nH360D ***\nH317\nH412\n\n\n\n607-204-00-4\n(chlorophenyl)(chlorotolyl)methane, mixed isomers\n400-140-6\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-205-00-X\nmethyl chloroacetate\n202-501-1\n96-34-4\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH226\nH331\nH301\nH335\nH315\nH318\nGHS02\nGHS06\nGHS05\nDgr\nH226\nH331\nH301\nH335\nH315\nH318\n\n\n\n607-206-00-5\nisopropyl chloroacetate\n203-301-7\n105-48-6\nFlam. Liq. 3\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH226\nH301\nH319\nH335\nH315\nGHS02\nGHS06\nDgr\nH226\nH301\nH319\nH335\nH315\n\n\n\n607-207-00-0\nhaloxyfop-etotyl (ISO);\n2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;\nhaloxyfop-(2-ethoxyethyl)\n402-560-5\n87237-48-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-208-00-6\n4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers\n403-000-2\n91853-67-7\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-209-00-1\nreaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate\n403-030-6\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-210-00-7\nmethyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)\n403-230-3\n77402-05-2\nCarc. 1B\nMuta. 1B\nSkin Corr. 1B\nSkin Sens. 1\nH350\nH340\nH314\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH340\nH314\nH317\n\n\n\n607-211-00-2\nmethyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate\n403-270-1\n6386-39-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-212-00-8\npoly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate\n403-300-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n607-213-00-3\nethyl 3,3-bis(tert-pentylperoxy)butyrate\n403-320-2\n67567-23-1\nOrg. Perox. D****\nFlam. Liq. 3\nAquatic Chronic 2\nH242\nH226\nH411\nGHS02\nGHS09\nDgr\nH242\nH226\nH411\n\n\n\n\n607-214-00-9\nN,N-hydrazinodiacetic acid\n403-510-5\n19247-05-3\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH373 **\nH317\nH412\nGHS06\nGHS08\nDgr\nH301\nH373 **\nH317\nH412\n\n\n\n607-215-00-4\n3-(3-tert-butyl-4-hydroxyphenyl)propionic acid\n403-920-4\n107551-67-7\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n\n607-216-00-X\nglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine\n403-950-8\n—\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH330\nH302\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH302\nH314\nH400\n\n\n\n\n\n607-217-00-5\n2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate\n403-960-2\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-218-00-0\ndichlorprop-P (ISO);\n(+)-R-2-(2,4-dichlorophenoxy)propionic acid\n403-980-1\n15165-67-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-219-00-6\nbis(2-ethylhexyl) dithiodiacetate\n404-510-8\n62268-47-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n607-221-00-7\n6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid\n404-550-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-222-00-2\n6-(2,3-dimethylmaleimido)hexyl methacrylate\n404-870-6\n63740-41-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-223-00-8\ntransfluthrin (ISO);\n2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate\n405-060-5\n118712-89-3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-224-00-3\nmethyl 2-(3-nitrobenzylidene)acetoacetate\n405-270-7\n39562-17-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-225-00-9\n3-azidosulfonylbenzoic acid\n405-310-3\n15980-11-7\nSelf-React. C ****\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH241\nH373 **\nH318\nH317\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH241\nH373 **\nH318\nH317\n\n\n\n607-226-00-4\nreaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate\n405-360-6\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\nH412\n\n\n\n607-227-00-X\npotassium 2-amino-2-methylpropionate octahydrate\n405-560-3\n120447-91-8\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n607-228-00-5\nbis(2-methoxyethyl) phthalate\n204-212-6\n117-82-8\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\n\n\n607-229-00-0\ndiethylcarbamoyl chloride\n201-798-5\n88-10-8\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH351\nH332\nH302\nH319\nH335\nH315\nGHS08\nGHS07\nWng\nH351\nH332\nH302\nH319\nH335\nH315\n\n\n\n607-230-00-6\n2-ethylhexanoic acid\n205-743-6\n149-57-5\nRepr. 2\nH361d ***\nGHS08\nWng\nH361d ***\n\n\n\n\n\n607-231-00-1\nclopyralid (ISO);\n3,6-dichloropyridine-2-carboxylic acid\n216-935-4\n1702-17-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-232-00-7\npyridate (ISO);\nO-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate\n259-686-7\n55512-33-9\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-233-00-2\nhexyl acrylate\n219-698-5\n2499-95-8\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH335\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH411\n\n\n\n607-234-00-8\nflurenol (ISO);\n9-hydroxy-9H-fluorene-9-carboxylic acid\n207-397-1\n467-69-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-235-00-3\nmecrilate;\nmethyl 2-cyanoacrylate\n205-275-2\n137-05-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-236-00-9\nethyl 2-cyanoacrylate\n230-391-5\n7085-85-0\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-237-00-4\nbenzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;\nflurazole\n276-942-3\n72850-64-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-238-00-X\ntau-fluvalinate (ISO);\ncyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate\n—\n102851-06-9\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-239-00-5\nfenpropathrin (ISO);\nα-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate\n254-485-0\n39515-41-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH312\nH410\n\n\n\n607-240-00-0\ncis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]\n1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]\n1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]\ntetrahydromethylphthalic anhydride; [4]\n1,2,3,6-tetrahydromethylphthalic anhydride; [5]\ntetrahydro-4-methylphthalic anhydride; [6]\n2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]\n216-906-6 [1]\n222-323-8 [2]\n226-247-6 [3]\n234-290-7 [4]\n247-830-1 [5]\n251-823-9 [6]\n255-853-3 [7]\n1694-82-2 [1]\n3425-89-6 [2]\n5333-84-6 [3]\n11070-44-3 [4]\n26590-20-5 [5]\n34090-76-1 [6]\n42498-58-8 [7]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-241-00-6\nhexahydro-4-methylphthalic anhydride; [1]\nhexahydromethylphthalic anhydride; [2]\nhexahydro-1-methylphthalic anhydride; [3]\nhexahydro-3-methylphthalic anhydride [4]\n243-072-0 [1]\n247-094-1 [2]\n256-356-4 [3]\n260-566-1 [4]\n19438-60-9 [1]\n25550-51-0 [2]\n48122-14-1 [3]\n57110-29-9 [4]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-242-00-1\ntetrachlorophthalic anhydride\n204-171-4\n117-08-8\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH334\nH317\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH318\nH334\nH317\nH410\n\n\n\n607-243-00-7\nsodium 3,6-dichloro-o-anisate; [1]\n3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]\n3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]\n217-846-3 [1]\n246-590-5 [2]\n258-527-9 [3]\n1982-69-0 [1]\n25059-78-3 [2]\n53404-28-7 [3]\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-244-00-2\nisooctyl acrylate\n249-707-8\n29590-42-9\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n\n607-245-00-8\ntert-butyl acrylate\n216-768-7\n1663-39-4\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH332\nH312\nH302\nH335\nH315\nH317\nH411\nGHS02\nGHS07\nGHS09\nWng\nH225\nH332\nH312\nH302\nH335\nH315\nH317\nH411\n\n\nD\n\n607-246-00-3\nallyl methacrylate;\n2-methyl-2-propenoic acid 2-propenyl ester\n202-473-0\n96-05-9\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH226\nH331\nH312\nH302\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH226\nH331\nH312\nH302\nH400\n\n\n\n607-247-00-9\ndodecyl methacrylate\n205-570-6\n142-90-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-248-00-4\nnaptalam-sodium (ISO);\nsodium N-naphth-1-ylphthalamate\n205-073-4\n132-67-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-249-00-X\n(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate\n256-032-2\n42978-66-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH335\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-250-00-5\n4H-3,1-benzoxazine-2,4(1H)-dione\n204-255-0\n118-48-9\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n607-251-00-0\n2-methoxypropyl acetate\n274-724-2\n70657-70-4\nFlam. Liq. 3\nRepr. 1B\nSTOT SE 3\nH226\nH360D ***\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH360D ***\nH335\n\n\n\n\n\n607-252-00-6\nlambda-cyhalothrin (ISO);\nreaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)\n415-130-7\n91465-08-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH312\nH410\n\nM=10000\n\n\n607-253-00-1\ncyfluthrin (ISO);\nα-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n269-855-7\n68359-37-5\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH331\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH331\nH410\n\nM=1000\n\n\n607-254-00-7\nα-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;\nbeta-cyfluthrin\n269-855-7\n68359-37-5\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\n\n607-255-00-2\nfluroxypyr (ISO);\n4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid\n—\n69377-81-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-256-00-8\nazoxystrobin (ISO);\nmethyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate\n—\n131860-33-8\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH410\n\n\n\n607-257-00-3\nisopropyl propionate\n211-300-8\n637-78-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-258-00-9\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate\n403-990-6\n70950-45-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-259-00-4\nmethyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate\n404-130-2\n105560-93-8\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-260-00-X\nethyl 2-(3-nitrobenzylidene)acetoacetate\n404-490-0\n39562-16-8\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-261-00-5\niso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate\n404-800-4\n118832-72-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-262-00-0\n7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid\n405-050-0\n86393-33-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n607-263-00-6\npotassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate\n405-680-6\n—\nSelf-heat. 2 ****\nAquatic Chronic 2\nH252\nH411\nGHS02\nGHS09\nWng\nH252\nH411\n\n\n\n607-264-00-1\n2-chloro-4-(methylsulfonyl)benzoic acid\n406-520-8\n53250-83-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-265-00-7\nethyl-2-chloro-2,2-diphenylacetate\n406-580-5\n52460-86-3\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n607-266-00-2\nreaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];\n3,5-di-tert-butyl-salicylic acid\n406-890-0\n130296-87-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-267-00-8\ntert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate\n407-620-4\n33610-13-8\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH334\nH317\nH412\nGHS08\nDgr\nH334\nH317\nH412\n\n\n\n607-268-00-3\n2-methylpropyl (R)-2-hydroxypropanoate\n407-770-0\n61597-96-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-269-00-9\n(R)-2-(4-hydroxyphenoxy)propanoic acid\n407-960-3\n94050-90-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-270-00-4\n3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane\n410-730-5\n90498-90-1\nAcute Tox. 4 *\nH312\nGHS07\nWng\nH312\n\n\n\n607-271-00-X\n2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane\n417-420-9\n156324-82-2\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n607-272-00-5\nfluroxypyr-meptyl (ISO);\nmethylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]\nfluroxypyr-butometyl (ISO);\n2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]\n279-752-9 [1]\n- [2]\n81406-37-3 [1]\n154486-27-8 [2]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-273-00-0\nammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate\n404-520-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-274-00-6\n2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate\n405-350-1\n54527-73-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-275-00-1\nsodium benzoyloxybenzene-4-sulfonate\n405-450-5\n66531-87-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-276-00-7\nbis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex\n405-635-0\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-277-00-2\nreaction mass of: 2-(hexylthio)ethylamine hydrochloride;\nsodium propionate\n405-720-2\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n607-278-00-8\nreaction mass of isomers of: sodium phenethylnaphthalenesulfonate;\nsodium naphthylethylbenzenesulfonate\n405-760-0\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-279-00-3\nreaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);\nn-octadecylaminodiethyl hydrogen maleate hydrogenphthalate\n405-960-8\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-280-00-9\nsodium 4-chloro-1-hydroxybutane-1-sulfonate\n406-190-5\n54322-20-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS07\nWng\nH302\nH319\nH317\n\n\n\n607-281-00-4\nreaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates\n407-000-3\n127519-17-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-282-00-X\n2-acetoxymethyl-4-benzyloxybut-1-yl acetate\n407-140-5\n131266-10-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-283-00-5\nE-ethyl-4-oxo-4-phenylcrotonate\n408-040-4\n15121-89-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH317\nH410\n\n\n\n607-284-00-0\nreaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);\nlithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)\n410-040-4\n136213-76-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-285-00-6\nreaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;\nsodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;\npotassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate\n410-065-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\n\n\n\n\n607-286-00-1\nreaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate\n410-070-8\n141880-36-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-287-00-7\nO'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate\n410-140-8\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-288-00-2\ntetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively\n410-160-7\n148732-74-5\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n607-289-00-8\n3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid\n410-370-9\n105488-33-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-290-00-3\nreaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;\nammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate\n410-540-2\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-291-00-9\ndodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate\n410-630-1\n104051-92-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-292-00-4\nreaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;\n[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid\n410-640-6\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-293-00-X\nreaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;\nN-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate\n410-650-0\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n607-294-00-5\nsodium 2-benzoyloxy-1-hydroxyethane-sulfonate\n410-680-4\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-295-00-0\nreaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;\nhexasodium phosphonobutane-1,2,3,4-tetracarboxylate\n410-800-5\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-296-00-6\nreaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid\n410-830-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-297-00-1\n(E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)\n410-960-6\n92761-26-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-298-00-7\n2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate\n411-010-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-299-00-2\nmethyl 3-(acetylthio)-2-methyl-propanoate\n411-040-7\n97101-46-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-300-00-6\ntrisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25\n411-430-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-301-00-1\nreaction mass of: dodecanoic acid;\npoly(1-7)lactate esters of dodecanoic acid\n411-860-5\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-302-00-7\nreaction mass of: tetradecanoic acid;\npoly(1-7)lactate esters of tetradecanoic acid\n411-910-6\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n607-303-00-2\n1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid\n413-760-7\n93107-30-3\nRepr. 2\nAquatic Chronic 3\nH361f ***\nH412\nGHS08\nWng\nH361f ***\nH412\n\n\n\n607-304-00-8\nfluazifop-butyl (ISO);\nbutyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate\n274-125-6\n69806-50-4\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D ***\nH410\n\n\n\n607-305-00-3\nfluazifop-P-butyl (ISO);\nbutyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate\n—\n79241-46-6\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH361d ***\nH410\n\n\n\n607-306-00-9\nchlozolinate (ISO);\nethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate\n282-714-4\n84332-86-5\nCarc. 2\nAquatic Chronic 2\nH351\nH411\nGHS08\nGHS09\nWng\nH351\nH411\n\n\n\n607-307-00-4\nvinclozolin (ISO);\nN-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione\n256-599-6\n50471-44-8\nCarc. 2\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH360FD\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360FD\nH317\nH411\n\n\n\n607-308-00-X\nesters of 2,4-D\n—\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\nA\n607-309-00-5\ncarfentrazone-ethyl (ISO);\nethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate\n—\n128639-02-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-310-00-0\nkresoxim-methyl (ISO);\nmethyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate\n—\n143390-89-0\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n607-311-00-6\nbenazolin-ethyl;\nethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate\n246-591-0\n25059-80-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-312-00-1\nmethoxyacetic acid\n210-894-6\n625-45-6\nRepr. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nH360FD\nH302\nH314\nGHS08\nGHS05\nGHS07\nDgr\nH360FD\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n607-313-00-7\nneodecanoyl chloride\n254-875-0\n40292-82-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH330\nH302\nH314\nGHS06\nGHS06\nDgr\nH330\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n607-314-00-2\nethofumesate (ISO);\n(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate\n247-525-3\n26225-79-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-315-00-8\nglyphosate (ISO);\nN-(phosphonomethyl)glycine\n213-997-4\n1071-83-6\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-316-00-3\nglyphosate-trimesium;\nglyphosate-trimethylsulfonium\n—\n81591-81-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07 GHS09\nWng\nH302\nH411\n\n\n\n607-317-00-9\nbis(2-ethylhexyl) phthalate;\ndi-(2-ethylhexyl) phthalate;\nDEHP\n204-211-0\n117-81-7\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\n\n\n607-318-00-4\ndibutyl phthalate;\nDBP\n201-557-4\n84-74-2\nRepr. 1B\nAquatic Acute 1\nH360Df\nH400\nGHS08\nGHS09\nDgr\nH360Df\nH400\n\n\n\n\n\n\n607-319-00-X\ndeltamethrin (ISO);\n(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-256-6\n52918-63-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\nM=1000000\n\n\n607-320-00-5\nbis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate\n413-930-0\n130066-57-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-321-00-0\n(S)-methyl-2-chloropropionate\n412-470-8\n73246-45-4\nFlam. Liq. 3\nSTOT RE 2 *\nEye Irrit. 2\nH226\nH373 **\nH319\nGHS02\nGHS08\nWng\nH226\nH373 **\nH319\n\n\n\n607-322-00-6\n4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid\n413-120-7\n107144-30-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-323-00-1\n2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate\n413-850-6\n123968-25-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-324-00-7\nreaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;\ndihydrogenated alkyl (C14-C18)amine\n413-800-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-325-00-2\n(S)-2-chloropropionic acid\n411-150-5\n29617-66-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n607-326-00-8\nreaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;\nisobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate\n410-720-0\n141847-13-4\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-327-00-3\n2-(2-iodoethyl)-1,3-propanediol diacetate\n411-780-0\n127047-77-2\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-328-00-9\nmethyl 4-bromomethyl-3-methoxybenzoate\n410-310-1\n70264-94-7\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-329-00-4\nreaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;\nsodium 2-octadecenyl-amino-1,4-butandioate\n411-250-9\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-330-00-X\n(S)-2,3-dihydro-1H-indole-2-carboxylic acid\n410-860-2\n79815-20-6\nRepr. 2\nSTOT RE 2 *\nSkin Sens. 1\nH361f ***\nH373 **\nH317\nGHS08\nGHS07\nWng\nH361f ***\nH373 **\nH317\n\n\n\n607-331-00-5\nreaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;\n1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane\n406-750-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-332-00-0\ncyclopentyl chloroformate\n411-460-0\n50715-28-1\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH226\nH331\nH302\nH373 **\nH318\nH317\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH226\nH331\nH302\nH373 **\nH318\nH317\n\n\n\n607-333-00-6\nreaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;\ntetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate\n405-670-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH410\n\n\n\n607-334-00-1\nethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate\n405-880-3\n100501-62-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-335-00-7\nmethyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate\n406-250-0\n72619-32-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-336-00-2\n4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate\n406-560-6\n122760-85-4\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n607-337-00-8\ndi-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate\n406-052-4\n125078-60-6\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH226\nH302\nH315\nH318\nH411\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH302\nH315\nH318\nH411\n\n\n\n607-338-00-3\n2-methylpropyl 2-hydroxy-2-methylbut-3-enoate\n406-235-9\n72531-53-4\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n607-339-00-9\n2,3,4,5-tetrachlorobenzoylchloride\n406-760-3\n42221-52-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n607-340-00-4\n1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate\n406-990-4\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-341-00-X\n(9S)-9-amino-9-deoxyerythromycin\n406-790-7\n26116-56-3\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n607-342-00-5\n4-chlorobutyl veratrate\n410-950-1\n69788-75-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-343-00-0\n4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)\n407-410-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-344-00-6\nreaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;\nN-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;\n3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate\n407-810-7\n—\nSTOT RE 2 *\nH373 **\nGHS08\nWng\nH373 **\n\n\n\n607-345-00-1\npotassium 2-(2,4-dichlorophenoxy)-(R)-propionate\n413-580-9\n113963-87-4\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-346-00-7\n3-icosyl-4-henicosylidene-2-oxetanone\n401-210-9\n83708-14-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-347-00-2\nsodium (R)-2-(2,4-dichlorophenoxy)propionate\n413-340-3\n119299-10-4\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-348-00-8\nmagnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)\n413-360-2\n—\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-349-00-3\nmono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate\n411-270-8\n—\nAquatic Chronic 3\nH412\n\nH412\n\n\n\n607-350-00-9\nbis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane\n412-060-9\n136210-32-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-351-00-4\nmethyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate\n407-550-4\n69184-17-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-352-00-X\n4,4'-oxydiphthalic anhydride\n412-830-4\n1823-59-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-353-00-5\nreaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;\nethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate\n407-520-0\n80657-64-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-354-00-0\nethyl 2-cyclohexylpropionate\n412-280-5\n2511-00-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-355-00-6\np-tolyl 4-chlorobenzoate\n411-530-0\n15024-10-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-356-00-1\nethyl trans-2,2,6-trimethylcyclohexanecarboxylate\n412-540-8\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-357-00-7\nreaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;\ncis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran\n412-450-9\n131766-73-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-358-00-2\n(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate\n412-670-5\n54275-93-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n607-359-00-8\n(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate\n412-800-0\n76109-32-5\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n607-360-00-3\nsodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate\n411-680-7\n133167-77-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-361-00-9\nmethyl (R)-2-(4-hydroxyphenoxy)propionate\n411-950-4\n96562-58-2\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-362-00-4\nreaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate\n413-500-2\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH315\nH318\nH411\nGHS05\nGHS09\nDgr\nH315\nH318\nH411\n\n\n\n607-363-00-X\nmethyl-3-methoxyacrylate\n412-900-4\n5788-17-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-364-00-5\n3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione\n413-330-9\n134724-55-3\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n607-365-00-0\n2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride\n410-620-7\n119154-86-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n607-366-00-6\n3,5-dimethylbenzoyl chloride\n413-010-9\n6613-44-1\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n607-367-00-1\npotassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate\n411-640-9\n153352-59-1\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-368-00-7\n1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole\n411-650-3\n110895-43-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\n\n\n607-369-00-2\nreaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;\ncis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid\n411-660-8\n147027-04-1\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-370-00-8\n2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol\n412-210-3\n41620-33-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-371-00-3\n3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate\n413-410-3\n88150-62-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-372-00-9\nethoxylated bis phenol A di-(norbornene carboxylate)\n412-410-0\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-373-00-4\n(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate\n414-200-4\n119738-06-6\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH360Df\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH360Df\nH302\nH373 **\nH410\n\n\n\n607-374-00-X\n5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride\n417-220-1\n37441-29-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-375-00-5\nreaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;\ntrans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin\n421-960-0\n90035-08-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH372 **\nH410\n\n\n\n607-376-00-0\nbenzyl 2,4-dibromobutanoate\n420-710-8\n23085-60-1\nRepr. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH315\nH317\nH410\n\n\n\n607-377-00-6\ntrans-4-cyclohexyl-L-proline monohydrochloride\n419-160-1\n90657-55-9\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH361f ***\nH302\nH315\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH361f ***\nH302\nH315\nH318\nH317\n\n\n\n607-378-00-1\nammonium (Z)-α-methoxyimino-2-furylacetate\n405-990-1\n97148-39-5\nFlam. Sol. 2\nH228\nGHS02\nDgr\nH228\n\n\nT\n607-379-00-7\nreaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;\nsodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;\nsodium [bis(2-hydroxyethyl)amino]methylsulfonate;\nN,N-bis(2-hydroxyethyl)stearamide\n401-230-8\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-380-00-2\nreaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;\nammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;\nammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate\n407-320-3\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n607-381-00-8\nreaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid\n413-710-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-382-00-3\n2-((4-amino-2-nitrophenyl)amino)benzoic acid\n411-260-3\n117907-43-4\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-383-00-9\nreaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;\n2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate\n415-430-8\n86403-32-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n607-384-00-4\nreaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;\nC15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;\nC13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate\n413-750-2\n171090-93-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-385-00-X\nCopolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate\n414-590-6\n125229-74-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-386-00-5\nreaction mass of: tetradecanoic acid (42,5- 47,5 %);\npoly(1-7)lactate esters of tetradecanoic acid (52,5- 57,5 %)\n412-580-6\n174591-51-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-387-00-0\nreaction mass of: dodecanoic acid (35-40 %);\npoly(1-7)lactate esters of dodecanoic acid (60-65 %)\n412-590-0\n58856-63-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-388-00-6\n4-ethylamino-3-nitrobenzoic acid\n412-090-2\n2788-74-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n607-389-00-1\ntrisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate\n414-130-4\n119710-96-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-390-00-7\n1,2,3,4-tetrahydro-6-nitro-quinoxaline\n414-270-6\n41959-35-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-391-00-2\ndimethylcyclopropane-1,1-dicarboxylate\n414-240-2\n6914-71-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-392-00-8\n2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate\n414-260-1\n88938-37-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-393-00-3\n3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid\n415-750-8\n106447-44-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-394-00-9\n5-methylpyrazine-2-carboxylic acid\n413-260-9\n5521-55-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-395-00-4\nreaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;\nsodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate\n410-230-7\n—\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n607-396-00-X\nbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate\n414-840-4\n147783-69-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n607-397-00-5\nreaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);\nCa phenates (branched C10-14 and C18-30 alkylated);\nCa sulfurised phenates (branched C10-14 and C18-30 alkylated)\n415-930-6\n—\nRepr. 2\nSkin Sens. 1\nH361f***\nH317\nGHS08\nGHS07\nWng\nH361f***\nH317\n\n\n\n\n607-398-00-0\nethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate\n414-820-5\n125630-94-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-399-00-6\n2,2-dimethyl 3-methyl-3-butenyl propanoate\n415-610-6\n104468-21-5\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n607-400-00-X\nmethyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate\n414-400-1\n32750-89-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-401-00-5\nethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate\n414-450-4\n88805-65-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n607-402-00-0\nmethyl N-(phenoxycarbonyl)-L-valinate\n414-500-5\n153441-77-1\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-403-00-6\nreaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;\nisopropyl alcohol\n414-810-0\n—\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH318\nH410\n\n\n\n607-404-00-1\nreaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;\ndi-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;\ndi-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;\n(Z)-3,7-dimethyl-2,6-octadienyl butandioate;\n((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid\n415-190-4\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-405-00-7\n2-hexyldecyl-p-hydroxybenzoate\n415-380-7\n148348-12-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-406-00-2\npotassium 2,5-dichlorobenzoate\n415-700-5\n184637-62-5\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n607-407-00-8\nethyl 2-carboxy-3-(2-thienyl)propionate\n415-680-8\n143468-96-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n607-408-00-3\npotassium N-(4-fluorophenyl)glycinate\n415-710-1\n184637-63-6\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH318\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH373 **\nH318\nH317\nH412\n\n\n\n607-409-00-9\nreaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;\ninert biomass from Aspergillus terreus\n415-840-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-410-00-4\nmono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate\n415-880-5\n779343-34-9\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-411-00-X\noxiranemethanol, 4-methylbenzene-sulfonate, (S)-\n417-210-7\n70987-78-9\nCarc. 1B\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH350\nH341\nH318\nH317\nH411\n\n\n\n607-412-00-5\nethyl 2-(1-cyanocyclohexyl)acetate\n415-970-4\n133481-10-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373 **\nH412\nGHS08\nGHS07\nWng\nH302\nH373 **\nH412\n\n\n\n607-413-00-0\ntrans-4-phenyl-L-proline\n416-020-1\n96314-26-0\nRepr. 2\nSkin Sens. 1\nH361f ***\nH317\nGHS08\nGHS07\nWng\nH361f ***\nH317\n\n\n\n607-414-00-6\ntris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate\n402-070-1\n88122-99-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-415-00-1\npoly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride)\n419-590-1\n—\nFlam. Sol. 1\nSkin Sens. 1\nH228\nH317\nGHS02\nGHS07\nDgr\nH228\nH317\n\n\nT\n607-416-00-7\n4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide\n420-730-7\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n607-417-00-2\n3-chloropropyl chloroformiate\n425-770-9\n628-11-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH331\nH302\nH373**\nH315\nH318\nH317\nGHS06\nGHS05\nGHS08\nDgr\nH331\nH302\nH373**\nH315\nH318\nH317\n\n\n\n\n607-418-00-8\n2-ethylhexyl 4-aminobenzoate\n420-170-3\n26218-04-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-419-00-3\n(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid\n422-240-9\n166596-68-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-420-00-9\n2,2-bis(hydroxymethyl)butanoic acid\n424-090-1\n10097-02-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-421-00-4\ncypermethrin cis/trans +/- 40/60;\n(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n52315-07-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH335\nH410\n\n\n\n\n\n607-422-00-X\nα-cypermethrin (ISO);\nracemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;\n(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n67375-30-8\nAcute Tox. 3 *\nSTOT RE 2 *\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373**\nH335\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373**\nH335\nH410\n\nM=1000\n\n\n607-423-00-5\nesters of mecoprop and of mecoprop-P\n—\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\nA\n607-424-00-0\ntrifloxystrobin (ISO);\n(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester\n—\n141517-21-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-425-00-6\nmetalaxyl (ISO);\nmethyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate\n260-979-7\n57837-19-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n607-426-00-1\n1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]\nn-pentyl-isopentylphthalate; [2]\ndi-n-pentyl phthalate; [3]\ndiisopentylphthalate [4]\n284-032-2 [1]\n- [2]\n205-017-9 [3]\n210-088-4 [4]\n84777-06-0 [1]\n- [2]\n131-18-0 [3]\n605-50-5 [4]\nRepr. 1B\nAquatic Acute 1\nH360FD\nH400\nGHS08\nGHS09\nDgr\nH360FD\nH400\n\n\n\n607-427-00-7\nbromoxynil heptanoate (ISO);\n2,6-dibromo-4-cyanophenyl heptanoate\n260-300-4\n56634-95-8\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH332\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH332\nH302\nH317\nH410\n\n\n\n\n\n607-428-00-2\ntetrasodium ethylene diamine tetraacetate\n200-573-9\n64-02-8\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n607-429-00-8\nedetic acid;\n(EDTA)\n200-449-4\n60-00-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-430-00-3\nBBP;\nbenzyl butyl phthalate e\n201-622-7\n85-68-7\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH400\nH410\nGHS08\nGHS09\nDgr\nH360Df\nH410\n\n\n\n607-431-00-9\nprallethrin (ISO);\nETOC;\n2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n245-387-9\n23031-36-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\n\n\n607-432-00-4\nS-metolachlor;\nreaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]\n- [1]\n- [2]\n87392-12-9 [1]\n178961-20-1 [2]\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-433-00-X\ncypermethrin cis/trans +/- 80/20;\n(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n52315-07-8\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH335\nH315\nH317\nH410\n\n\n\n607-434-00-5\nmecoprop-P [1] and its salts;\n(R)-2-(4-chloro-2-methylphenoxy)propionic acid\n240-539-0\n16484-77-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n607-435-00-0\n2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate\n416-810-6\n111969-64-3\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH318\nH411\n\n\n\n607-436-00-6\n2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate\n417-350-9\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-437-00-1\n3-(4-aminophenyl)-2-cyano-2-propenoic acid\n417-480-6\n252977-62-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-438-00-7\nmethyl-2-[(aminosulfonyl)methyl]benzoate\n419-010-5\n112941-26-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n607-439-00-2\nmethyl tetrahydro-2-furancarboxylate\n420-670-1\n37443-42-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-440-00-8\nmethyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate\n421-220-7\n144740-59-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-441-00-3\n3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid\n421-490-6\n167684-63-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-442-00-9\nbenzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate\n416-050-5\n87460-09-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-443-00-4\nbis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate\n416-140-4\n145650-60-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-444-00-X\nreaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;\ntrans-1,4-dimethylcyclohexyl dibenzoate\n416-230-3\n35541-81-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-445-00-5\nIron (III) tris(4-methylbenzenesulfonate)\n420-960-8\n77214-82-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-446-00-0\nmethyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate\n416-240-8\n155522-12-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-447-00-6\nsodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate\n416-370-5\n156738-27-1\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-448-00-1\n2,3,5,6-tetrafluorobenzoic acid\n416-800-1\n652-18-6\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n607-449-00-7\nreaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];\n4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]\n417-080-1\n—\nSelf-react. D ****\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH317\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH317\nH410\n\n\n\n607-450-00-2\n2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate\n419-040-9\n89604-92-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-451-00-8\n4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt\n417-640-5\n161935-19-9\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-453-00-9\n4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)\n418-100-1\n172964-15-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-454-00-4\nreaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;\ncis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid\n418-170-3\n116193-72-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-455-00-X\n1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt\n419-520-8\n172890-93-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-456-00-5\n3-amino-4-chlorobenzoic acid, hexadecyl ester\n419-700-6\n143269-74-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-457-00-0\ntetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)\n420-350-1\n172277-97-3\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-458-00-6\nreaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;\n2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;\n2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]\n420-850-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-459-00-1\nisopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate\n418-930-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-460-00-7\n3-tridecyloxy-propyl-ammonium 9-octadecenoate\n418-990-1\n778577-53-0\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH319\nH315\nH410\n\n\n\n607-461-00-2\nreaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;\npentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate\n421-160-1\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-462-00-8\nreaction mass of: 1-hexyl acetate;\n2-methyl-1-pentyl acetate;\n3-methyl-1-pentyl acetate;\n4-methyl-1-pentyl acetate;\nother mixed linear and branched C6-alkyl acetates\n421-230-1\n88230-35-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-463-00-3\n3-(phenothiazin-10-yl)propionic acid\n421-260-5\n362-03-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-464-00-9\nreaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;\n5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid\n421-280-4\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-465-00-4\ntris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate\n421-440-3\n778583-04-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-466-00-X\nreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;\nphenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;\nphenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate\n421-480-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-467-00-5\n1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate\n419-430-9\n56533-00-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH314\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH314\nH410\n\n\n\n607-468-00-0\nreaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ndisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ntrisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ntetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate\n419-450-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-469-00-6\ndisodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate\n419-460-2\n120029-06-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-470-00-1\npotassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n414-100-0\n154336-20-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n\n607-471-00-7\n1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane\n429-280-6\n151900-44-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n607-472-00-2\nammonium iron(III) trimethylenediaminetetraacetate hemihydrate\n400-660-3\n111687-36-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n\n607-473-00-8\npentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid\n426-590-3\n187412-41-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-474-00-3\n(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid\n410-430-4\n117573-89-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-475-00-9\nreaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;\ntetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)\n412-940-2\n148878-18-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-476-00-4\ntrisodium N,N-bis(carboxymethyl)-β-alanine\n414-070-9\n129050-62-0\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n\n\n607-477-00-X\n(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt\n426-740-8\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-478-00-5\ntetramethylammonium hydrogen phthalate\n416-900-5\n79723-02-7\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH400\n\n\n\n607-479-00-0\nhexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate\n418-550-9\n168689-49-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-480-00-6\n1,2-benzenedicarboxylic acid;\ndi-C7-11-branched and linear alkylesters\n271-084-6\n68515-42-4\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\n\n\n\n\n607-481-00-1\nreaction mass of: trihexyl citrate;\ndihexyloctyl citrate;\ndioctylhexyl citrate;\ndihexyldecyl citrate\n430-290-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-482-00-7\nN-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride\n430-360-8\n84793-24-8\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-483-00-2\n1,2-benzenedicarboxylic acid;\ndi-C6-8-branched alkylesters, C7-rich\n276-158-1\n71888-89-6\nRepr. 1B\nH360D***\nGHS08\nDgr\nH360D***\n\n\n\n\n607-484-00-8\nethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate\n430-480-0\n221452-67-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-485-00-3\n(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate\n430-510-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-486-00-9\npotassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate\n402-110-8\n110081-40-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-487-00-4\nreaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;\ntrisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate\n402-660-9\n—\nRepr. 1B\nAquatic Chronic 3\nH360D ***\nH412\nGHS08\nDgr\nH360D ***\nH412\n\n\n\n607-488-00-X\nethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate\n414-210-9\n147379-38-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-489-00-5\nreaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;\n2-ethylhexyl epoxyoleate;\n2-ethylhexyl diepoxylinoleate;\n2-ethylhexyl triepoxylinolenate\n414-890-7\n71302-79-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-490-00-0\nN-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate\n415-060-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n\n\n607-491-00-6\nreaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);\ntriester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)\n427-140-9\n—\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n\n607-492-00-1\n2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate\n415-490-5\n141773-73-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-493-00-7\nmethyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate\n415-670-3\n78850-37-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-494-00-2\nbis(2-ethylhexyl)octylphosphonate\n417-170-0\n52894-02-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-495-00-8\nsodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate\n417-550-6\n168151-92-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-496-00-3\n2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite\n418-310-3\n126050-54-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-497-00-9\ncerium oxide isostearate\n419-760-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-498-00-4\n(E)-3,7-dimethyl-2,6-octadienylhexadecanoate\n421-370-3\n3681-73-0\nSkin Irrit. 2\nAquatic Chronic 4\nH315\nH413\nGHS07\nWng\nH315\nH413\n\n\n\n607-499-00-X\nbis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)\n421-660-1\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n607-500-00-3\ncalcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate\n421-670-4\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-501-00-9\nreaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives\n421-820-9\n192268-65-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-502-00-4\n(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate\n422-200-0\n178277-55-9\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH314\nH302\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH411\n\n\n\n607-503-00-X\n2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane\n422-210-5\n68957-94-8\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n\n\n\n607-504-00-5\ndiammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate\n422-670-7\n—\nRepr. 1A\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH361f\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361f\nH301\nH373**\nH410\n\n\n\n\n607-505-00-0\npentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate\n422-930-1\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-506-00-6\nreaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;\ndisodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate\n422-970-8\n\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-507-00-1\npotassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate\n422-980-2\n187026-95-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-508-00-7\ndisodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]\n423-110-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n\n607-509-00-2\n2-phenoxyethyl 4-aminobenzoate\n430-880-5\n88938-23-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-510-00-8\n(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide\n427-200-4\n76646-91-8\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n\n607-511-00-3\nreaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;\n4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid\n423-750-4\n—\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n\n\n607-512-00-9\ntrisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate\n423-970-0\n182926-43-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-513-00-4\nreaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;\n5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;\n5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid\n423-200-3\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n\n607-514-00-X\npotassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate\n427-240-2\n134841-35-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-515-00-5\nreaction mass of: disodium hexyldiphenyl ether disulphonate;\ndisodium dihexyldiphenyl ether disulphonate\n429-650-7\n147732-60-3\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n607-516-00-0\nN,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine\n429-670-6\n105996-54-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-517-00-6\n(S)-α-(acetylthio)benzenepropanoic acid\n430-300-0\n76932-17-7\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n\n607-518-00-1\n3-oxoandrost-4-ene-17-β-carboxylic acid\n414-990-0\n302-97-6\nRepr. 1A\nAquatic Chronic 4\nH361f\nH413\nGHS08\nDgr\nH361f\nH413\n\n\n\n\n607-519-00-7\npoly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]\n427-280-0\n176429-27-9\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH335\nH315\nH318\nH410\n\n\n\n\n607-520-00-2\nreaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;\ndisodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate\n427-740-0\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-521-00-8\ntetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate\n429-270-1\n136210-30-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-522-00-3\nsodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate\n429-720-7\n184246-86-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-523-00-9\nreaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6', 13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6', 3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate\n430-200-7\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-524-00-4\ntall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters\n430-310-5\n—\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n\n607-525-00-X\n(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid\n431-520-1\n64485-90-1\nFlam. Sol. 1****\nCarc. 2\nAquatic Chronic 3\nH228\nH351\nH412\nGHS02\nGHS08\nDgr\nH228\nH351\nH412\n\n\n\n\n607-526-00-5\ncartap (ISO);\n1,3-bis(carbamoylthio)-2-(dimethylamino)propane\n—\n15263-53-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-527-00-0\nreaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate\n423-180-6\n—\nSTOT RE 2 *\nH373 **\nGHS08\nWng\nH373 **\n\n\n\n\n\n607-528-00-6\n(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid\n430-900-2\n192725-50-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-529-00-1\nbenzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate\n426-070-6\n67299-45-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-530-00-7\nreaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate\n406-040-9\n125643-61-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-531-00-2\nmethyl 3-amino-4,6-dibromo-2-methyl-benzoate\n425-190-6\n119916-05-1\nSTOT RE 2 *\nAquatic Chronic 2\nH373**\nH411\nGHS08\nGHS09\nWng\nH373**\nH411\n\n\n\n\n607-532-00-8\n(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt\n425-510-4\n167944-94-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-533-00-3\npentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n414-910-4\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-534-00-9\nethyl 2-(3-benzoylphenyl)propanoate\n414-920-9\n60658-04-0\nAcute Tox. 3 *\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH372**\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH372**\nH317\nH411\n\n\n\n\n607-535-00-4\npotassium 4-iodo-2-sulfonato-benzoic acid\n426-620-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-536-00-X\n(2,6-xylyloxy) acetic acid\n430-910-7\n13335-71-2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n607-537-00-5\nisopropylammonium 2-(3-benzoylphenyl)propionate\n417-970-1\n—\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH372**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH312\nH372**\nH318\nH410\n\n\n\n\n607-539-00-6\npropyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate\n431-000-2\n198705-81-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-540-00-1\n1-(mercaptomethyl)cyclopropylacetic acid\n420-240-3\n162515-68-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH312\nH302\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH312\nH302\nH317\nH411\n\n\n\n\n607-541-00-7\n[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)\n421-940-1\n28698-31-9\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n607-542-00-2\nmethyl 2-(4-butanesulfonamidophenoxy)tetradecanoate\n422-110-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-543-00-8\npoly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]\n427-480-8\n176429-22-4\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH335\nH315\nH318\nH410\n\n\n\n\n607-544-00-3\nethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate\n427-490-2\n158585-86-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-545-00-9\n1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate\n424-070-0\n94346-09-5\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-546-00-4\nreaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]methoxycarbonylmethylamino[}acetate;\nmethyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]ethoxycarbonylmethylamino[}acetate\n424-290-7\n188070-47-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-547-00-X\n18-methylnonadecyl 2,2 -dimethylpropanoate\n424-370-1\n125496-22-2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n\n607-548-00-5\n1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate\n431-010-7\n154486-26-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-549-00-0\nmethyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate\n424-430-7\n125778-19-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-550-00-6\n2-amino-4-bromo-5-chlorobenzoic acid\n424-700-4\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH410\nGHS05\nDgr\nH318\nH410\n\n\n\n\n607-551-00-1\ntetrabutylammonium 2-amino-6-iodopurinate\n424-710-9\n156126-48-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH373**\nH315\nH318\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH312\nH302\nH373**\nH315\nH318\nH317\nH411\n\n\n\n\n607-552-00-7\nhexadecyl 3-amino-4-isopropoxybenzoate\n424-830-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-553-00-2\n7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt\n424-850-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-554-00-8\n2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid\n424-870-1\n27624-67-5\nExpl. 1.1\nEye Dam. 1\nAquatic Chronic 3\nH201\nH318\nH412\nGHS01\nGHS05\nDgr\nH201\nH318\nH412\n\n\n\n\n607-555-00-3\n1,1,3,3-tetramethylbutylperoxypivalate\n424-980-8\n22288-41-1\nFlam. Liq. 2\nOrg. Perox. D\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH242\nH315\nH317\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH242\nH315\nH317\nH411\n\n\n\n\n607-556-00-9\n2-acetoxymethylene-4-acetylphenylacetate\n425-160-2\n24085-06-1\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS05 GHS08 GHS07 GHS09 Dgr\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n607-557-00-4\nsalt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid\n425-210-3\n169939-84-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-558-00-X\n2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate\n425-250-1\n147027-10-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-559-00-5\ncoconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid\n425-400-6\n179986-09-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-560-00-0\n(R,S)-2-butyloctanedioic acid\n431-210-4\n50905-10-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-561-00-6\nsodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate\n425-460-3\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-562-00-1\nreaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;\n(2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate\n425-530-3\n98769-75-6\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-563-00-7\n5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid\n431-250-2\n171850-30-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-564-00-2\n1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate\n425-730-0\n51178-75-7\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-565-00-8\n3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate\n425-820-1\n88150-42-9\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH373**\nH318\nH410\n\n\n\n\n607-566-00-3\nreaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;\nbis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate\n426-140-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-567-00-9\npotassium 3-iodo-6-methylbenzenesulfonate\n426-300-5\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-568-00-4\npotassium 2-chloro-3-(benzyloxy)propionate\n426-350-8\n138666-92-9\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\n\n\n\n\n607-569-00-X\nreaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;\nsodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate\n426-470-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-570-00-5\nsodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate\n426-520-1\n71420-85-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-571-00-0\n2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate\n431-400-7\n57374-49-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-572-00-6\ndiethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate\n426-790-0\n162208-27-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH312\nH302\nH373**\nH317\nH410\n\n\n\n\n607-573-00-1\nreaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;\ndisodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate\n426-840-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-574-00-7\n[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate\n426-890-4\n77341-67-4\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-575-00-2\n4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt\n426-900-7\n—\nSTOT SE 3\nAquatic Chronic 3\nH335\nH412\nGHS07\nWng\nH335\nH412\n\n\n\n\n607-576-00-8\nbranched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate\n427-030-0\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-577-00-3\n(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate\n427-100-0\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n607-578-00-9\nethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate\n427-110-5\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 4\nH302\nH373**\nH413\nGHS08\nGHS07\nWng\nH302\nH373**\nH413\n\n\n\n\n607-579-00-4\ndiethyl[(p-ethoxyanilino)methylene]malonate\n431-430-0\n103976-28-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n607-580-00-X\nethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate\n422-360-1\n100491-29-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-581-00-5\nethyl 2-ethoxy-4-carboxymethylbenzoate\n427-630-2\n99469-99-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-582-00-0\nreaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;\ntetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate\n427-650-1\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-583-00-6\n4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid\n427-680-5\n188907-52-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n607-584-00-1\ntrisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate\n427-710-7\n215612-56-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n607-585-00-7\nstrontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate\n427-930-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-586-00-2\ndodecyl 3-amino-4-chlorobenzoate\n428-020-9\n6195-20-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-587-00-8\nethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate\n428-030-3\n67914-69-6\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n607-588-00-3\nreaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;\nbis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate\n428-050-2\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-589-00-9\ntetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate\n428-070-1\n91788-83-9\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH372**\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH372**\nH302\nH410\n\n\n\n\n607-590-00-4\nhexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate\n428-140-1\n210706-50-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-591-00-X\nreaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ndisodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate\n428-400-4\n—\nEye Dam.\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-592-00-5\ndi(C9-11-alkyl) cyclohexane-1,4-dicarboxylate\n428-870-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-593-00-0\n4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate\n429-000-2\n159235-16-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-594-00-6\nethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate\n429-020-1\n204254-96-6\nSTOT RE 2 *\nSkin Sens. 1\nH373**\nH317\nGHS08\nGHS07\nWng\nH373**\nH317\n\n\n\n\n607-595-00-1\nN-amidino-N-methylglycine-2-oxopropionate\n429-120-5\n208535-04-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-596-00-7\nethyl 2-(4-phenoxyphenyl)lactate\n429-220-9\n132584-17-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-597-00-2\ntetrasodium 4,4'-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2'-disulfonate\n429-230-3\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-598-00-8\ntrisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate\n429-240-8\n212652-59-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-599-00-3\n1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate\n431-610-9\n68860-54-8\nOrg. Perox. D\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH317\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH317\nH410\n\n\n\n\n607-600-00-7\n(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate\n431-700-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-601-00-2\n1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate\n429-370-5\n220410-74-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-602-00-8\nethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate\n429-680-0\n122665-86-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-603-00-3\nlithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate\n429-730-1\n193562-37-7\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-604-00-9\nguanidinium benzoate\n429-820-0\n26739-54-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-605-00-4\nmethyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate\n429-890-2\n144550-06-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-606-00-X\n(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid\n430-100-3\n86978-24-7\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-607-00-5\nreaction mass of: calcium bis(C10-14 branched alkyl salicylate);\ncalcium bis(C18-30-alkyl salicylate);\ncalcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;\ncalcium bis (C10-14 branched alkyl phenolate);\ncalcium bis (C18-30-alkyl phenolate);\ncalcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;\nC10-14 branched alkyl phenol;\nC18-30-alkyl phenol\n430-180-1\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-608-00-0\npentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate\n430-210-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-609-00-6\nethyl (3R)-4-cyano-3-hydroxybutanoate\n430-220-6\n141942-85-0\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-610-00-1\ntrisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate\n430-280-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-611-00-7\nmethyl 3-amino-2,2,3-trimethylbutyrate\n431-720-7\n90886-53-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 3\nH314\nH302\nH412\nGHS05\nGHS07\nDgr\nH314\nH302\nH412\n\n\n\n\n607-612-00-2\nreaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;\nammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate\n432-190-1\n182176-52-9\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nH302\nH373**\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\n\n\n\n\n607-613-00-8\nreaction mass of: succinic acid;\nmonopersuccinic acid;\ndipersuccinic acid;\nmonomethyl ester of succinic acid;\nmonomethyl ester of persuccinic acid;\ndimethyl succinate;\nglutaric acid;\nmonoperglutaric acid;\ndiperglutaric acid;\nmonomethyl ester of glutaric acid;\nmonomethyl ester of perglutaric acid;\ndimethyl glutarate;\nadipic acid;\nmonoperadipic acid;\ndiperadipic acid;\nmonomethyl ester of adipic acid;\nmonomethyl ester of peradipic acid;\ndimethyl adipate;\nhydrogen peroxide;\nmethanol;\nwater\n432-790-1\n—\nMuta. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH341\nH314\nH332\nH312\nH302\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH314\nH332\nH312\nH302\n\n\n\n\n607-614-00-3\n2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid\n426-480-5\n63562-33-4\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-615-00-9\nreaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance\n431-120-5\n—\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH331\nH302\nH319\nH317\nGHS06\nDgr\nH331\nH302\nH319\nH317\n\n\n\n\n607-616-00-4\n2,4-dichloro-5-fluorobenzoylchloride\n428-390-1\n86393-34-2\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH335\nH315\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH335\nH315\nH318\nH317\nH412\n\n\n\n\n607-617-00-X\nbis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate\n430-700-5\n10138-36-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-618-00-5\nmenadione sodium bisulfite;\n2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt\n204-987-0\n130-37-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n\n607-619-00-0\nmenadione nicotinamide bisulfite;\n1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)\n277-543-7\n73581-79-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n\n607-620-00-6\ntrisodium nitrilotriacetate\n225-768-6\n5064-31-3\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nH351\nH302\nH319\nGHS08\nGHS07\nWng\nH351\nH302\nH319\n\nCarc. 2; H351: C ≥ 5 %\n\n\n607-621-00-1\nmilbemectin (ISO);\n[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\nM=100\n\n\n607-622-00-7\n2-ethylhexyl-2-ethylhexanoate\n231-057-1\n7425-14-1\nRepr. 2\nH361d***\nGHS08\nWng\nH361d***\n\n\n\n\n607-623-00-2\ndiisobutyl phthalate\n201-553-2\n84-69-5\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\nRepr. 1B; H360Df: C ≥ 25 %\nRepr. 2; H361f: 5 % ≤ C < 25 %\n\n\n607-624-00-8\nperfluorooctane sulfonic acid;\nheptadecafluorooctane-1-sulfonic acid; [1]\npotassium perfluorooctanesulfonate;\npotassium heptadecafluorooctane-1-sulfonate; [2]\ndiethanolamine perfluorooctane sulfonate; [3]\nammonium perfluorooctane sulfonate;\nammonium heptadecafluorooctanesulfonate; [4]\nlithium perfluorooctane sulfonate;\nlithium heptadecafluorooctanesulfonate [5]\n217-179-8 [1]\n220-527-1 [2]\n274-460-8 [3]\n249-415-0 [4]\n249-644-6 [5]\n1763-23-1 [1]\n2795-39-3 [2]\n70225-14-8 [3]\n29081-56-9 [4]\n29457-72-5 [5]\nCarc. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nLact.\nAquatic Chronic 2\nH351\nH360D***\nH372**\nH332\nH302\nH362\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D***\nH372**\nH332\nH302\nH362\nH411\n\n\n\n\n607-625-00-3\nclodinafop-propargyl (ISO)\n—\n105512-06-9\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,001 %\nM=1\n\n\n607-626-00-9\nethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate\n401-290-5\n103112-35-2\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n\n607-627-00-4\n[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate\n416-360-0\n162221-28-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-628-00-X\n4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine\n419-240-6\n171054-89-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-629-00-5\n[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid\n419-270-1\n123599-82-6\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-630-00-0\nacrylic acid, 3-(trimethoxysilyl)propyl ester\n419-560-6\n4369-14-6\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH332\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH332\nH314\nH317\nH412\n\n\n\n\n607-631-00-6\nreaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;\n(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate\n442-300-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-632-00-1\nN-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide\n420-210-1\n111244-14-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-633-00-7\ntrisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate\n440-480-2\n341026-59-3\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-634-00-2\n(S)-(–)-2-acetoxypropionylchloride;\n(1S)-2-chloro-1-methyl-2-oxoethyl acetate\n420-610-4\n36394-75-9\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n\n607-635-00-8\ntrisodium N-(3-propionato)-l-aspartate\n422-090-4\n172737-80-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-636-00-3\n1-bromo-2-methylpropyl propionate\n422-900-6\n158894-67-8\nFlam. Liq. 3\nCarc. 2\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH351\nH314\nH317\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH351\nH314\nH317\n\n\n\n\n607-637-00-9\ndisodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[}naphthalene-2-sulfonate\n423-730-5\n250688-43-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-638-00-4\n2-hydroxybenzoic acid 2-butyloctyl ester\n431-090-3\n190085-41-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-639-00-X\n2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate\n431-770-1\n216698-07-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-641-00-0\n2-(formylamino)-3-thiophenecarboxylic acid;\n2-formamido-3-thiophenecarboxylic acid\n431-930-9\n43028-69-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n607-642-00-6\n3,6,9-trithiaundecamethylene-1,11-dimethacrylate\n432-210-7\n141631-22-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-643-00-1\ndimethyl (2S)-2-hydroxysuccinate\n432-310-0\n617-55-0\nFlam. Liq. 3\nEye Dam. 1\nSkin Sens. 1\nH226\nH318\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH318\nH317\n\n\n\n\n607-644-00-7\nmethyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate\n432-350-9\n81752-87-6\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n607-645-00-2\ntetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate\n432-550-6\n243858-01-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-646-00-8\nd-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;\ntert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate\n432-960-5\n124655-09-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-647-00-3\n5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane\n433-530-1\n143446-73-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nH302\nH317\nH400\nGHS07\nGHS09\nWng\nH302\nH317\nH400\n\n\n\n\n607-649-00-4\n[3-(chlorocarbonyl)-2-methylphenyl]acetate\n433-690-0\n167678-46-8\nSkin Corr. 1A\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n\n607-650-00-X\n2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate\n433-910-5\n145153-52-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-651-00-5\nsodium 2-(nonanoyloxy)benzenesulfonate\n434-360-9\n91125-43-8\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-652-00-0\nethyl N2-dodecanoyl-l-argininate hydrochloride\n434-630-6\n60372-77-2\nEye Dam. 1\nAquatic Acute 1\nH318\nH400\nGHS05\nGHS09\nDgr\nH318\nH400\n\n\n\n\n607-653-00-6\ntetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate\n434-840-8\n225786-91-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-654-00-1\n(S)-3-hydroxy-γ-butyrolactone\n434-990-4\n7331-52-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-655-00-7\nethyl 6,8-dichlorooctanoate\n435-080-1\n1070-64-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-656-00-2\nsodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid\n435-350-7\n141250-43-3\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-657-00-8\npentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate\n436-920-8\n172399-10-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-658-00-3\n3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt\n440-770-9\n371921-63-0\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-659-00-9\npentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid\n442-030-0\n321912-47-4\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-660-00-4\n2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{]phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt\n442-230-8\n321679-52-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-661-00-X\n1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate\n442-850-9\n114772-40-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-662-00-5\nmethyl 2-(acetylamino)-3-chloropropionate\n442-860-3\n87333-22-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-663-00-0\nbis(2-ethylhexyl) naphthalene-2,6-dicarboxylate\n442-980-6\n127474-91-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-664-00-6\nmethyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate\n443-120-2\n393509-79-0\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n607-665-00-1\ntrans-methyl-2-ethyl-but-2-enoate\n443-150-6\n101226-85-1\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n607-666-00-7\n(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid\n443-560-5\n88784-33-2\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-667-00-2\nchloro-1-ethylcyclohexyl carbonate\n444-950-8\n99464-83-2\nMuta. 2\nSkin Sens. 1\nH341\nH317\nGHS08\nGHS07\nWng\nH341\nH317\n\n\n\n\n607-668-00-8\ntrans-2-isopropyl-5-carboxy-1,3-dioxane\n445-770-2\n42031-28-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-669-00-3\nmethyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate\n445-990-9\n376588-17-9\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-670-00-9\ndibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;\n(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate\n448-700-9\n500791-70-8\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH373**\nH318\nH317\nH410\n\nM=10\n\n\n607-671-00-4\ndiethyl 1,4-cyclohexanedicarboxylate\n417-310-0\n72903-27-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-672-00-X\nreaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;\n1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;\nx-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate\n419-000-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-673-00-5\n1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate\n419-570-0\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n607-675-00-6\nreaction mass of: cis-9-octadecenedioic acid;\ncis-9-cis-12-octadecadienedioic acid;\nhexadecanedioic acid;\noctadecanedioic acid\n422-260-8\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n607-676-00-1\nreaction mass of: 2-methylnonanedioic acid;\n2,4-dimethyl-4-methoxycarbonylundecanedioic acid;\n2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;\n8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid\n423-670-1\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-677-00-7\n2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate\n424-660-8\n—\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH373**\nH318\nH317\n\n\n\n\n607-678-00-2\nreaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;\nethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate\n427-090-8\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-679-00-8\nreaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate);\n3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate);\n3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate)\n431-440-5\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n607-680-00-3\ntert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{]pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate\n432-810-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-681-00-9\nreaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;\n9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;\ndihexadecyl 9-nonyl-10-octylnonadecandioate;\n1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate;\ndioctadecyl 9-nonyl-10-octylnonadecandioate\n432-910-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-682-00-4\ncomplex reaction mass of Chinese gum rosin post reacted with acrylic acid\n434-230-1\n144413-22-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-683-00-X\nreaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\nmethyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)\n435-450-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-684-00-5\nalkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts\n435-660-2\n243662-67-1\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n\n607-685-00-0\nammonium 2-cocoyloxyethanesulfonate\n441-050-7\n—\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n\n607-686-00-6\n6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)\n441-550-5\n—\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n\n607-687-00-1\nreaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %)\n442-800-6\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-688-00-7\n(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride\n444-320-2\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-689-00-2\nreaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers);\nmethyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers)\n444-920-4\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-690-00-8\ndimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate\n432-860-1\n255387-46-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-691-00-3\nmagnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear\n448-690-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-692-00-9\nzinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear\n446-470-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-693-00-4\nhexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate\n443-860-6\n302776-68-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-694-00-X\nethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate\n443-870-0\n163520-33-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n607-696-00-0\npentyl formate\n211-340-6\n638-49-3\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nDgr\nH226\nH319\nH335\n\n\nC\n607-697-00-6\ntert-butyl propionate\n—\n20487-40-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\nC\n608-001-00-3\nacetonitrile;\ncyanomethane\n200-835-2\n75-05-8\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH225\nH332\nH312\nH302\nH319\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\n\n\n\n608-002-00-9\ntrichloroacetonitrile\n208-885-7\n545-06-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH331\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH411\n\n\n\n608-003-00-4\nacrylonitrile\n203-466-5\n107-13-1\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH350\nH331\nH311\nH301\nH335\nH315\nH318\nH317\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH331\nH311\nH301\nH335\nH315\nH318\nH317\nH411\n\n*\nD\n608-004-00-X\n2-hydroxy-2-methylpropionitrile;\n2-cyanopropan-2-ol;\nacetone cyanohydrin\n200-909-4\n75-86-5\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\n\n\n\n\n608-005-00-5\nn-butyronitrile\n203-700-6\n109-74-0\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH225\nH331\nH311\nH301\nGHS02\nGHS06\nDgr\nH225\nH331\nH311\nH301\n\n\n\n\n608-006-00-0\nbromoxynil (ISO)\n3,5-dibromo-4-hydroxybenzonitrile;\nbromoxynil phenol\n216-882-7\n1689-84-5\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH330\nH301\nH317\nH410\n\nM = 10\n\n608-007-00-6\nioxynil (ISO)\n4-hydroxy-3,5-diiodobenzonitrile\n216-881-1\n1689-83-4\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH410\n\nM = 10\n\n608-008-00-1\nchloroacetonitrile\n203-467-0\n107-14-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH331\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH411\n\n\n\n608-009-00-7\nmalononitrile\n203-703-2\n109-77-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n608-010-00-2\nmethacrylonitrile;\n2-methyl-2-propene nitrile\n204-817-5\n126-98-7\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nH225\nH331\nH311\nH301\nH317\nGHS02\nGHS06\nDgr\nH225\nH331\nH311\nH301\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n\n\n608-011-00-8\noxalonitrile;\ncyanogen\n207-306-5\n460-19-5\nPress. Gas\nFlam. Gas 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH220\nH331\nH400\nH410\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH331\nH410\n\n\n\n\n608-012-00-3\nbenzonitrile\n202-855-7\n100-47-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n608-013-00-9\n2-chlorobenzonitrile\n212-836-5\n873-32-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH312\nH302\nH319\nGHS07\nWng\nH312\nH302\nH319\n\n\n\n\n\n608-014-00-4\nchlorothalonil (ISO);\ntetrachloroisophthalonitrile\n217-588-1\n1897-45-6\nCarc. 2\nAcute Tox. 2 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH335\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH351\nH330\nH335\nH318\nH317\nH410\n\nM=10\n\n\n\n608-015-00-X\ndichlobenil (ISO);\n2,6-dichlorobenzonitrile\n214-787-5\n1194-65-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH411\nGHS07\nGHS09\nWng\nH312\nH411\n\n\n\n608-016-00-5\n1,4-Dicyano-2,3,5,6-tetra-chloro-benzene\n401-550-8\n1897-41-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n608-017-00-0\nbromoxynil octanoate (ISO);\n2,6-dibromo-4-cyanophenyl octanoate\n216-885-3\n1689-99-2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH302\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH302\nH317\nH410\n\nM = 10\n\n608-018-00-6\nioxynil octanoate (ISO);\n4-cyano-2,6-diiodophenyl octanoate\n223-375-4\n3861-47-0\nRepr. 2\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH301\nH319\nH317\nH410\n\nM = 10\n\n608-019-00-1\n2,2'-dimethyl-2,2'-azodipropiononitrile;\nADZN\n201-132-3\n78-67-1\nSelf-react. C\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH242\nH332\nH302\nH412\nGHS02\nGHS07\nDgr\nH242\nH332\nH302\nH412\n\n\nT\n\n\n608-020-00-7\ndiphenoxymethylenecyanamide\n427-300-8\n79463-77-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n608-021-00-2\n3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile\n403-710-2\n76823-93-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n608-022-00-8\n3,7-dimethyloctanenitrile\n403-620-3\n40188-41-8\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n608-023-00-3\nfenbuconazole (ISO);\n4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile\n406-140-2\n114369-43-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-024-00-9\n2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile\n407-650-8\n97460-76-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-025-00-4\n2-nitro-4,5-bis(benzyloxy)phenylacetonitrile\n410-970-0\n117568-27-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-026-00-X\n3-cyano-3,5,5-trimethylcyclohexanone\n411-490-4\n7027-11-4\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH373 **\nH317\nH412\nGHS08\nGHS07\nWng\nH302\nH373 **\nH317\nH412\n\n\n\n608-027-00-5\nreaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;\n3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;\n3-(3-ethylphenyl)-2,2-dimethylpropanenitrile\n412-660-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n608-028-00-0\n4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate\n413-510-7\n147374-67-2\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n608-029-00-6\n1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile\n411-990-2\n68612-94-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n608-030-00-1\nN-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide\n412-340-0\n147741-93-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-031-00-7\n2-benzyl-2-methyl-3-butenitrile\n407-870-4\n97384-48-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n608-032-00-2\nacetamiprid (ISO);\n(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine\n—\n135410-20-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n608-033-00-8\nN-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide\n407-970-8\n75511-91-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n608-034-00-3\nchlorfenapyr (ISO);\n4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile\n—\n122453-73-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\nM=100\n\n\n608-035-00-9\n(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile\n419-290-9\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n608-036-00-4\n3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile\n419-060-8\n79026-02-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-037-00-X\nreaction mass of: (E)-2,12-tridecadiennitrile;\n(E)-3,12-tridecadiennitrile;\n(Z)-3,12-tridecadiennitrile\n422-190-8\n\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-038-00-5\n2,2,4-trimethyl-4-phenyl-butane-nitrile\n422-580-8\n75490-39-0\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n608-039-00-0\n2-phenylhexanenitrile\n423-460-8\n3508-98-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n608-040-00-6\n4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)\n423-490-1\n130755-46-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-041-00-1\n4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile\n423-500-4\n138401-24-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n608-042-00-7\n(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide\n421-810-4\n194602-27-2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n\n608-043-00-2\n3-(cis-3-hexenyloxy)propanenitril\n415-220-6\n142653-61-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\n\n\n\n\n\n608-044-00-8\n2-cyclohexylidene-2-phenylacetonitrile\n423-740-1\n10461-98-0\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n608-046-00-9\n5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile\n425-310-7\n77889-90-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n608-047-00-4\n2-piperidin-1-yl-benzonitrile\n427-330-1\n72752-52-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n608-048-00-X\n1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile\n427-450-4\n152630-47-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373**\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH411\n\n\n\n\n608-049-00-5\n2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile\n429-180-2\n157362-53-3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n608-050-00-0\nreaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;\n5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile\n429-760-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n608-051-00-6\n(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-760-2\n219861-18-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-052-00-1\n(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-770-7\n128173-52-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-053-00-7\n(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-780-1\n103146-25-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-054-00-2\n(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate\n430-790-6\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n\n608-055-00-8\nfipronil (ISO);\n5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile\n—\n120068-37-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH372**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH372**\nH410\n\nM=10\n\n\n608-056-00-3\nN-methyl-N-cyanomethylmorpholiniummethylsulfate\n429-340-1\n—\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n608-057-00-9\n4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate\n431-200-1\n208538-34-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n608-059-00-X\n5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile\n421-240-6\n120068-79-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n608-060-00-5\n5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile\n421-300-1\n138564-59-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n608-062-00-6\n2-fluoro-4-hydroxybenzonitrile\n422-810-7\n82380-18-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n608-063-00-1\n(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile\n441-070-6\n61826-76-4\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n\n608-064-00-7\ncyanomethyltrimethylammoniummethylsulfate\n433-720-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n608-065-00-2\nsalts of bromoxynil with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH330\nH301\nH317\nH410\n\nM = 10\nA\n608-066-00-8\nsalts of ioxynil with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH410\n\nM = 10\nA\n609-001-00-6\n1-nitropropane\n203-544-9\n108-03-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n*\n\n609-002-00-1\n2-nitropropane\n201-209-1\n79-46-9\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH350\nH332\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH350\nH332\nH302\n\n\n\n609-003-00-7\nnitrobenzene\n202-716-0\n98-95-3\nCarc. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 2\nH351\nH361f ***\nH331\nH311\nH301\nH372 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH361f ***\nH331\nH311\nH301\nH372 **\nH411\n\n\n\n609-004-00-2\ndinitrobenzene; [1]\n1,4-dinitrobenzene; [2]\n1,3-dinitrobenzene; [3]\n1,2-dinitrobenzene [4]\n246-673-6 [1]\n202-833-7 [2]\n202-776-8 [3]\n208-431-8 [4]\n25154-54-5 [1]\n100-25-4 [2]\n99-65-0 [3]\n528-29-0 [4]\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH410\n\n\n\n\n\n609-005-00-8\n1,3,5-trinitrobenzene\n202-752-7\n99-35-4\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH330\nH310\nH300\nH373**\nH400\nH410\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH410\n\n\n\n\n\n609-006-00-3\n4-nitrotoluene\n202-808-0\n99-99-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n\n\n609-007-00-9\n2,4-dinitrotoluene; [1]\ndinitrotoluene [2]\n204-450-0 [1]\n246-836-1 [2]\n121-14-2 [1]\n25321-14-6 [2]\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH361f***\nH331\nH311\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH331\nH311\nH301\nH373**\nH410\n\n\n\n\n609-008-00-4\n2,4,6-trinitrotoluene;\nTNT\n204-289-6\n118-96-7\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH201\nH331\nH311\nH301\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n\n\n609-009-00-X\n2,4,6-trinitrophenol;\npicric acid\n201-865-9\n88-89-1\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH201\nH331\nH311\nH301\nGHS01\nGHS06\nDgr\nH201\nH331\nH311\nH301\n\n\n\n\n\n609-010-00-5\nsalts of picric acid\n—\n—\nUnst. Expl\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH201\nH331\nH311\nH301\nGHS01\nGHS06\nDgr\nH201\nH331\nH311\nH301\n\n\nT\n609-011-00-0\n2,4,6-trinitroanisole\n—\n606-35-9\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH201\nH332\nH312\nH302\nH411\nGHS01\nGHS07\nGHS09\nWng\nH201\nH332\nH312\nH302\nH411\n\n\n\n609-012-00-6\n2,4,6-trinitro-m-cresol\n210-027-1\n602-99-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nWng\nH201\nH332\nH312\nH302\n\n\n\n609-013-00-1\n2,4,6-trinitro-m-xylene\n211-187-5\n632-92-8\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH201\nH332\nH312\nH302\nH373 **\nGHS01\nGHS08\nGHS07\nWng\nH201\nH332\nH312\nH302\nH373 **\n\n\n\n609-015-00-2\n4-nitrophenol;\np-nitrophenol\n202-811-7\n100-02-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH332\nH312\nH302\nH373 **\nGHS08\nGHS07\nWng\nH332\nH312\nH302\nH373 **\n\n\n\n609-016-00-8\ndinitrophenol (reaction mass of isomers); [1]\n2,4(or 2,6)-dinitrophenol [2]\n247-096-2 [1]\n275-732-9 [2]\n25550-58-7 [1]\n71629-74-8 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n\n\n\n609-018-00-9\n2,4,6-trinitroresorcinol;\nstyphnic acid\n201-436-6\n82-71-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\n\n\n\n\n609-019-00-4\nlead 2,4,6-trinitro-m-phenylene dioxide;\nlead 2,4,6-trinitroresorcinoxide;\nlead styphnate\n239-290-0\n15245-44-0\nUnst. Expl\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH200\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH200\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n609-019-01-1\nlead 2,4,6-trinitro-m-phenylene dioxide;\nlead 2,4,6-trinitroresorcinoxide;\nlead styphnate (≥ 20 % phlegmatiser)\n239-290-0\n15245-44-0\nExpl. 1.1\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n609-020-00-X\nDNOC (ISO);\n4,6-dinitro-o-cresol\n208-601-1\n534-52-1\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH330\nH310\nH300\nH315\nH318\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH341\nH330\nH310\nH300\nH315\nH318\nH317\nH410\nEUH044\n\n\n609-021-00-5\nsodium salt of DNOC;\nsodium 4,6-dinitro-o-cresolate; [1]\npotassium salt of DNOC;\npotassium 4,6-dinitro-o-cresolate [2]\n219-007-7 [1]\n- [2]\n2312-76-7 [1]\n5787-96-2 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n609-022-00-0\nammonium salt of DNOC;\nammonium 4,6-dinitro-o-tolyl oxide\n221-037-0\n2980-64-5\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH410\n\n\n\n\n\n609-023-00-6\ndinocap (ISO);\n(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which octyl is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups\n254-408-0\n39300-45-3\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH332\nH302\nH373**\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D***\nH332\nH302\nH373**\nH315\nH317\nH410\n\nM=100\n\n\n609-024-00-1\nbinapacryl (ISO);\n2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate\n207-612-9\n485-31-4\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH312\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D ***\nH312\nH302\nH410\n\n\n\n609-025-00-7\ndinoseb(ISO);\n6-sec-butyl-2,4-dinitrophenol\n201-861-7\n88-85-7\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH311\nH301\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360Df\nH311\nH301\nH319\nH410\nEUH044\n\n\n609-026-00-2\nsalts and esters of dinoseb, with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH311\nH301\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360Df\nH311\nH301\nH319\nH410\nEUH044\n\nA\n609-027-00-8\ndinocton;\nreaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate\n—\n63919-26-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n609-028-00-3\ndinex (ISO);\n2-cyclohexyl-4,6-dinitrophenol\n205-042-5\n131-89-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n609-029-00-9\nsalts and esters of dinex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\nA\n609-030-00-4\ndinoterb (ISO);\n2-tert-butyl-4,6-dinitrophenol\n215-813-8\n1420-07-1\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360D ***\nH300\nH311\nH410\nEUH044\n\n\n609-031-00-X\nsalts and esters of dinoterb\n—\n—\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360D ***\nH300\nH311\nH410\n\n\nA\n609-032-00-5\nbromofenoxim (ISO);\n3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime\n236-129-6\n13181-17-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n609-033-00-0\ndinosam (ISO);\n2-(1-methylbutyl)-4,6-dinitrophenol\n—\n4097-36-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n609-034-00-6\nsalts and esters of dinosam\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\nA\n609-035-00-1\nnitroethane\n201-188-9\n79-24-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH302\n\n*\n\n609-036-00-7\nnitromethane\n200-876-6\n75-52-5\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH302\nGHS02\nGHS07\nWng\nH226\nH302\n\n*\n\n609-037-00-2\n5-nitroacenaphthene\n210-025-0\n602-87-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n609-038-00-8\n2-nitronaphthalene\n209-474-5\n581-89-5\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n609-039-00-3\n4-nitrobiphenyl\n202-204-7\n92-93-3\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n609-040-00-9\nnitrofen (ISO);\n2,4-dichlorophenyl 4-nitrophenyl ether\n217-406-0\n1836-75-5\nCarc. 1B\nRepr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH360D ***\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH360D ***\nH302\nH410\n\n\n\n609-041-00-4\n2,4-dinitrophenol\n200-087-7\n51-28-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH311\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH400\n\n\n\n609-042-00-X\npendimethalin (ISO);\nN-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine\n254-938-2\n40487-42-1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-043-00-5\nquintozene (ISO);\npentachloronitrobenzene\n201-435-0\n82-68-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-044-00-0\ntecnazene (ISO);\n1,2,4,5-tetrachloro-3-nitrobenzene\n204-178-2\n117-18-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n609-045-00-6\nreaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;\ndinocton-6\n—\n8069-76-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n\n609-046-00-1\ntrifluralin (ISO) (containing < 0,5 ppm NPDA);\nα, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);\n2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);\nN,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA)\n216-428-8\n1582-09-8\nCarc. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH317\nH410\n\nM=10\n\n\n609-047-00-7\n2-nitroanisole\n202-052-1\n91-23-6\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n609-048-00-2\nsodium 3-nitrobenzenesulphonate\n204-857-3\n127-68-4\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n609-049-00-8\n2,6-dinitrotoluene\n210-106-0\n606-20-2\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\n\n\n\n609-050-00-3\n2,3-dinitrotoluene\n210-013-5\n602-01-7\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n609-051-00-9\n3,4-dinitrotoluene\n210-222-1\n610-39-9\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-052-00-4\n3,5-dinitrotoluene\n210-566-2\n618-85-9\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\n\n\n\n609-053-00-X\nhydrazine-trinitromethane\n414-850-9\n—\nExpl. 1.1 ****\nSelf-react. A\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nH201\nH240\nH350\nH331\nH301\nH317\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH240\nH350\nH331\nH301\nH317\n\n\n\n609-054-00-5\n2,3-dinitrophenol; [1]\n2,5-dinitrophenol; [2]\n2,6-dinitrophenol; [3]\n3,4-dinitrophenol; [4]\nsalts of dinitrophenol [5]\n200-628-7 [1]\n206-348-1 [2]\n209-357-9 [3]\n209-415-3 [4]\n- [5]\n66-56-8 [1]\n329-71-5 [2]\n573-56-8 [3]\n577-71-9 [4]\n- [5]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-055-00-0\n2,5-dinitrotoluene\n210-581-4\n619-15-8\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-056-00-6\n2,2-dibromo-2-nitroethanol\n412-380-9\n69094-18-4\nExpl. 1.1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH351\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS01\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH201\nH351\nH302\nH373 **\nH314\nH317\nH410\n\n*\nSTOT SE 3; H335: C ≥ 1 %\nT\n609-057-00-1\n3-chloro-2,4-difluoronitrobenzene\n411-980-8\n3847-58-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n609-058-00-7\n2-nitro-2-phenyl-1,3-propanediol\n410-360-4\n5428-02-4\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH312\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH312\nH302\nH317\nH411\nEUH070\n\n\n609-059-00-2\n2-chloro-6-(ethylamino)-4-nitrophenol\n411-440-1\n131657-78-8\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n609-060-00-8\n4-[(3-hydroxypropyl)amino]-3-nitrophenol\n406-305-9\n92952-81-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n609-061-00-3\n(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime\n406-100-4\n94097-88-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-062-00-9\n2-bromo-2-nitropropanol\n407-030-7\n24403-04-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH311\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n609-063-00-4\n2-[(4-chloro-2-nitrophenyl)amino]ethanol\n413-280-8\n59320-13-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n609-064-00-X\nmesotrione(ISO);\n2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione\n—\n104206-82-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n609-065-00-5\n2-nitrotoluene\n201-853-3\n88-72-2\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH340\nH361f ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH340\nH361f ***\nH302\nH411\n\n\n\n609-066-00-0\nlithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n418-870-9\n154212-58-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 2 **\nH332\nH312\nH302\nH371 **\nGHS08\nGHS07\nDgr\nH332\nH312\nH302\nH371 **\n\n\n\n609-067-00-6\nsodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine\n416-280-6\n156769-97-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n609-068-00-1\nmusk xylene;\n5-tert-butyl-2,4,6-trinitro-m-xylene\n201-329-4\n81-15-2\nExpl. 1.1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH351\nH400\nH410\nGHS01\nGHS08\nGHS09\nWng\nH201\nH351\nH410\n\n\nT\n\n\n609-069-00-7\nmusk ketone;\n3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;\n4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone\n201-328-9\n81-14-1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n\n609-070-00-2\n1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene\n415-580-4\n130841-23-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n609-071-00-8\nreaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;\n2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol\n423-520-3\n156137-33-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n609-072-00-3\n4-mesyl-2-nitrotoluene\n430-550-0\n1671-49-4\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH361f***\nH302\nH317\nH412\nGHS08\nGHS07\nDgr\nH361f***\nH302\nH317\nH412\n\n\n\n\n609-073-00-9\nlithium potassium sodium N,N''-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N'-(2-aminoethyl)piperazine\n427-850-9\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n610-001-00-3\ntrichloronitromethane;\nchloropicrin\n200-930-9\n76-06-2\nAcute Tox. 2 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH330\nH302\nH319\nH335\nH315\nGHS06\nDgr\nH330\nH302\nH319\nH335\nH315\n\n\n\n610-002-00-9\n1,1-dichloro-1-nitroethane\n209-854-0\n594-72-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n610-003-00-4\nchlorodinitrobenzene\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\nC\n610-004-00-X\n2-chloro-1,3,5-trinitrobenzene\n201-864-3\n88-88-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH330\nH310\nH300\nH400\nH410\nGHS01\nGHS06\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH410\n\n\n\n610-005-00-5\n1-chloro-4-nitrobenzene\n202-809-6\n100-00-5\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH351\nH341\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n610-006-00-0\nchloronitroanilines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH411\n\n\nA C\n610-007-00-6\n1-chloro-1-nitropropane\n209-990-0\n600-25-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n*\n\n610-008-00-1\n2,6-dichloro-4-nitroanisole\n403-350-6\n17742-69-7\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n610-009-00-7\n2-chloro-4-nitroaniline\n204-502-2\n121-87-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n610-010-00-2\n2-bromo-1-(2-furyl)-2-nitroethylene\n406-110-9\n35950-52-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n611-001-00-6\nazobenzene\n203-102-5\n103-33-3\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH332\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH332\nH302\nH373 **\nH410\n\n\n\n611-002-00-1\nazoxybenzene\n207-802-1\n495-48-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n611-003-00-7\nfenaminosulf (ISO);\nsodium 4-dimethylaminobenzenediazosulphonate\n205-419-4\n140-56-7\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH301\nH312\nH412\nGHS06\nDgr\nH301\nH312\nH412\n\n\n\n611-004-00-2\nmethyl-ONN-azoxymethyl acetate;\nmethyl azoxy methyl acetate\n209-765-7\n592-62-1\nCarc. 1B\nRepr. 1B\nH350\nH360D ***\nGHS08\nDgr\nH350\nH360D ***\n\n\n\n611-005-00-8\ndisodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);\nCI Direct Brown 95\n240-221-1\n16071-86-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-006-00-3\n4-o-tolylazo-o-toluidine;\n4-amino-2',3-dimethylazobenzene;\nfast garnet GBC base;\nAAT;\no-aminoazotoluene\n202-591-2\n97-56-3\nCarc. 1B\nSkin Sens. 1\nH350\nH317\nGHS08\nDgr\nH350\nH317\n\n\n\n611-007-00-9\ntricyclazole (ISO);\n5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;\n255-559-5\n41814-78-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n611-008-00-4\n4-aminoazobenzene;\n4-phenylazoaniline\n200-453-6\n60-09-3\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n611-009-00-X\nsodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)\n401-220-3\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH412\nGHS07\nWng\nH332\nH412\n\n\n\n611-010-00-5\n2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide\n403-010-7\n106359-94-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n611-011-00-0\nN,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate\n403-340-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDg\nH318\nH411\n\n\n\n611-012-00-6\nreaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate\n403-410-1\n114565-65-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-013-00-1\ntrilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate\n403-650-7\n117409-78-6\nExpl. 1.3 ****\nAquatic Chronic 2\nH203\nH411\nGHS01\nGHS09\nDgr\nH203\nH411\n\n\n\n611-014-00-7\n(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide\n404-250-5\n115099-55-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-015-00-2\ntetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate\n404-320-5\n116889-78-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-016-00-8\nreaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride\n404-540-1\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-017-00-3\n2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide\n404-910-2\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-018-00-9\ntetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate\n405-130-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-019-00-4\ntetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate\n405-150-4\n106028-58-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-020-00-X\ntetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate\n405-170-3\n116340-05-7\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH317\nH412\nGHS06\nDgr\nH301\nH317\nH412\n\n\n\n611-021-00-5\n2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate\n405-480-9\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Chronic 4\nH302\nH373 **\nH315\nH413\nGHS08\nGHS07\nWng\nH302\nH373 **\nH315\nH413\n\n\n\n611-022-00-0\n4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate\n404-980-4\n—\nSelf-react. C\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH331\nH301\nH312\nH373 **\nH318\nH317\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH242\nH331\nH301\nH312\nH373 **\nH318\nH317\nH410\n\n\nT\n611-023-00-6\ndisodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate\n404-600-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-024-00-1\nBenzidine based azo dyes;\n4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA\n611-025-00-7\ndisodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;\nC.I. Direct Black 38\n217-710-3\n1937-37-7\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n611-026-00-2\ntetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];\nC.I. Direct Blue 6\n220-012-1\n2602-46-2\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n611-027-00-8\ndisodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);\nC.I. Direct Red 28\n209-358-4\n573-58-0\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n\n\n611-028-00-3\nC,C'-azodi(formamide)\n204-650-8\n123-77-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n\n\n611-029-00-9\no-dianisidine based azo dyes;\n4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA H\n611-030-00-4\no-tolidine based dyes;\n4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA H\n611-031-00-X\n4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;\nC.I. Basic Red 9\n209-321-2\n569-61-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-032-00-5\n1,4,5,8-tetraaminoanthraquinone;\nC.I. Disperse Blue 1\n219-603-7\n2475-45-8\nCarc. 1B\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH350\nH315\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH315\nH318\nH317\n\n\n\n611-033-00-0\nhexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)\n400-020-3\n82027-60-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-034-00-6\nN-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide\n402-430-8\n105076-77-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n611-035-00-1\ntetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate\n403-660-1\n107246-80-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-036-00-7\n2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate\n405-440-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-037-00-2\n3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate\n406-055-0\n124584-00-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n611-038-00-8\ntrisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate\n406-820-9\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n611-039-00-3\n7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid\n407-050-6\n117715-57-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-040-00-9\n3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid\n407-670-7\n115099-58-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-041-00-4\n2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide\n407-680-1\n98809-11-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n611-042-00-X\ntrisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate\n411-770-6\n136213-71-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-043-00-5\nreaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;\ntrisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;\ntrisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)\n402-850-1\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-044-00-0\nreaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);\ntert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);\ntert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)\n403-720-7\n117527-94-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-045-00-6\n2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene\n404-830-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-046-00-1\n4,4'-diamino-2-methylazobenzene\n407-590-2\n43151-99-1\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH410\n\n\n\n611-047-00-7\nreaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;\n2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)\n407-890-3\n111381-11-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-048-00-2\nreaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;\n2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)\n407-900-6\n111381-12-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-049-00-8\nreaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)\n408-000-6\n118658-98-3\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH317\nH412\nGHS08\nWng\nH373 **\nH317\nH412\n\n\n\n\n\n\n611-050-00-3\nreaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;\npentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;\npentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;\ntetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;\ntetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate\n415-350-3\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-051-00-9\n2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride\n411-110-7\n136213-74-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-052-00-4\nmonosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex\n400-720-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-053-00-X\n2,2'-azobis[2-methylpropionamidine] dihydrochloride\n221-070-0\n2997-92-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n611-055-00-0\nC.I. Disperse Yellow 3;\nN-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide\n220-600-8\n2832-40-8\nCarc. 2\nSkin Sens. 1\nH351\nH317\nGHS08\nGHS07\nWng\nH351\nH317\n\n\n\n611-056-00-6\nC.I. Solvent Yellow 14;\n1-phenylazo-2-naphthol\n212-668-2\n842-07-9\nCarc. 2\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH341\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH341\nH317\nH413\n\n\n\n611-057-00-1\n6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile\n400-340-3\n85136-74-9\nCarc. 1B\nAquatic Chronic 4\nH350\nH413\nGHS08\nWng\nH350\nH413\n\n\n\n611-058-00-7\n(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate\n402-060-7\n108225-03-2\nCarc. 1B\nEye Dam. 1\nAquatic Chronic 2\nH350\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH350\nH318\nH411\n\n\n\n611-059-00-2\noctasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate\n412-960-1\n148878-21-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n611-060-00-8\nreaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;\nammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;\n5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid\n413-180-4\n187285-15-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-061-00-3\ndisodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate\n412-530-3\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-062-00-9\noctasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate\n413-550-5\n—\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n611-063-00-4\ntrisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)\n413-590-3\n164058-22-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-064-00-X\n4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol\n410-600-8\n124719-26-2\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH315\nH410\n\n\n\n611-065-00-5\n4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol\n410-610-2\n111850-24-9\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH319\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH319\nH315\nH317\nH410\n\n\n\n611-066-00-0\ntetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate\n411-540-5\n130201-57-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n\n\n611-067-00-6\nreaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;\nbis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate\n406-910-8\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n611-068-00-1\ntetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate\n400-690-7\n85665-98-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-069-00-7\nN,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline\n413-380-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-070-00-2\nreaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);\ntrisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)\n405-665-4\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n611-071-00-8\ntris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate\n406-073-9\n131013-81-5\nAcute Tox. 3 *\nAquatic Chronic 3\nH301\nH412\nGHS06\nDgr\nH301\nH412\n\n\n\n611-072-00-3\n2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride\n407-010-8\n118208-02-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n611-073-00-9\ndimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate\n407-310-9\n122630-55-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-074-00-4\nreaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);\nsodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)\n407-100-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-075-00-X\nreaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;\ntris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)\n406-000-0\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-076-00-5\n3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole\n406-280-4\n117584-16-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-077-00-0\ndilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)\n407-230-4\n126637-70-5\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n611-078-00-6\n(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate\n407-240-9\n159604-94-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-079-00-1\ndisodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate\n410-390-8\n147703-64-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-080-00-7\nsodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate\n410-150-2\n147703-65-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-081-00-2\ntetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)\n411-470-5\n141048-13-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n611-082-00-8\nreaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);\npentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)\n407-570-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-083-00-3\nreaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;\n2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)\n411-560-4\n—\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH317\nH411\n\n\n\n\n\n611-084-00-9\nreaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;\nN-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide\n412-550-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n611-085-00-4\nreaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine\n411-880-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-086-00-X\nmonolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate\n411-360-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-087-00-5\nreaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;\n3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)\n411-710-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-088-00-0\nreaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;\ntrilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate\n411-890-9\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n611-089-00-6\n2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate\n411-100-2\n136213-73-5\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH317\nH410\n\n\n\n611-090-00-1\n2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate\n413-290-2\n93672-52-7\nSelf-react. C\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH242\nH302\nH318\nH317\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH302\nH318\nH317\nH412\n\n\nT\n611-091-00-7\nsodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate\n413-470-0\n134595-59-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-092-00-2\ntert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate\n413-210-6\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-093-00-8\nsodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate\n410-770-3\n146177-84-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-094-00-3\nreaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;\n2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)\n411-600-0\n143145-93-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-095-00-9\nhexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide\n412-240-7\n89797-03-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-096-00-4\nmethyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate\n413-040-2\n149850-30-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-097-00-X\nreaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)\n414-150-3\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-098-00-5\ntetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate\n405-950-3\n131013-83-7\nAcute Tox. 3 *\nAquatic Chronic 3\nH301\nH412\nGHS06\nDgr\nH301\nH412\n\n\n\n611-099-00-0\n(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride\n401-500-5\n118658-99-4\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n611-100-00-4\npotassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate\n403-810-6\n140876-13-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-101-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide\n405-200-5\n104366-25-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n611-102-00-5\nreaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[}benzendiazoniumchlorid;\ndisodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{]phenylsulfonylamino[}benzen-diazoniumchlorid\n424-500-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n\n611-103-00-0\ntrisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)\n407-110-1\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n611-104-00-6\nreaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);\ntrisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);\ntrisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);\ntrisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);\ndisodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate\n406-870-1\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-105-00-1\nsodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate\n407-800-2\n136213-75-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-106-00-7\nhexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate\n410-180-6\n157627-99-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-107-00-2\npotassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate\n412-490-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-108-00-8\ndisodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate\n413-600-6\n6527-62-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-109-00-3\nreaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)\n407-710-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-110-00-9\ntetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene\n408-210-8\n124605-82-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-111-00-4\ndisodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)\n414-230-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-112-00-X\ntetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate\n413-070-6\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-113-00-5\nlithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)\n414-280-0\n149626-00-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-114-00-0\nlithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)\n414-250-7\n149564-66-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n611-115-00-6\ntrilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)\n414-290-5\n149564-65-8\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n611-116-00-1\nreaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate\n414-620-8\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-117-00-7\n1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt\n415-100-3\n149850-29-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-118-00-2\nsodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt\n413-990-8\n\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-119-00-8\ntetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate\n415-400-4\n148878-22-2\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-120-00-3\n5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt\n418-340-7\n157707-94-3\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-121-00-9\nmain component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;\nmain component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol\n417-280-9\n30785-74-1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n611-122-00-4\nhexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel\n417-250-5\n151436-99-6\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-123-00-X\n3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate\n424-310-4\n178452-66-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-124-00-5\nreaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;\npentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;\ntetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate\n424-320-9\n\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-125-00-0\nreaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;\nDisodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex\n423-940-7\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-126-00-6\n2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride\n424-120-1\n174514-06-8\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n611-127-00-1\npentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate\n423-790-2\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\nG\n611-128-00-7\nN,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt\n419-500-9\n171599-85-2\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-129-00-2\nreaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;\n5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid\n418-230-9\n163879-69-4\nExpl. 1.3 ****\nRepr. 2\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH203\nH361f ***\nH373 **\nH317\nH411\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH203\nH361f ***\nH373 **\nH317\nH411\n\n\n\n\n\n611-130-00-8\ntetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate\n418-520-5\n183130-96-3\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-131-00-3\n2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one\n420-580-2\n151798-26-4\nRepr. 1B\nAquatic Chronic 4\nH360D ***\nH413\nGHS08\nDgr\nH360D ***\nH413\n\n\n\n611-132-00-9\npentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-210-2\n178452-71-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-133-00-4\nProduct by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt\n419-260-5\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-134-00-X\ntrisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex\n423-770-3\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-135-00-5\nreaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt\n424-250-9\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-136-00-0\n2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate\n424-260-3\n—\nRepr. 2\nEye Dam. 1\nAquatic Chronic 2\nH361f ***\nH318\nH411\nGHS05\nGHS08\nGHS09\nDgr\nH361f ***\nH318\nH411\n\n\n\n611-137-00-6\n6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole\n419-870-1\n159038-16-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-138-00-1\n2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole\n415-910-7\n152828-25-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n611-139-00-7\nreaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride\n424-510-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n611-140-00-2\nazafenidin (ISO);\n2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one\n—\n68049-83-2\nRepr. 1B\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH373 **\nH400\nH410\nGHS08\nGHS09\nDgr\nH360Df\nH373 **\nH410\n\nM = 1000\n\n\n\n611-141-00-8\n5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt\n414-410-6\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-142-00-3\nproduct-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;\nsodium chloride\n425-740-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-143-00-9\nreaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);\ntrisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)\n428-260-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-144-00-4\nreaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;\n7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;\n7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;\n7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt\n429-070-4\n214362-06-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-145-00-X\nreaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate;\n3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt\n429-440-5\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-146-00-5\nreaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;\npentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;\npentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;\nhexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate\n430-070-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-147-00-0\nsodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate\n430-090-0\n205764-96-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-148-00-6\nreaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;\n2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;\n3-(2,6-dichloro-4-nitrophenylazo)carbazol\n429-590-1\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n611-149-00-1\n2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate\n427-570-7\n193486-83-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-150-00-7\ntetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate\n440-460-3\n—\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-151-00-2\nchrysoidine;\n4-(phenylazo)benzene-1,3-diamine\n207-803-7\n495-54-5\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH315\nH410\n\n\n\n\n611-152-00-8\nchrysoidine monohydrochloride;\n4-phenylazophenylene-1,3-diamine monohydrochloride; [1]\nchrysoidine monoacetate;\n4-(phenylazo)benzene-1,3-diamine monoacetate; [2]\nchrysoidine acetate;\n4-(phenylazo)benzene-1,3-diamine acetate; [3]\nchrysoidine-p-dodecylbenzenesulfonate;\ndodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]\nchrysoidine dihydrochloride;\n4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]\nchrysoidine sulfate;\nbis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]\n208-545-8 [1]\n278-290-5 [2]\n279-116-0 [3]\n264-409-8 [4]\n281-549-5 [5]\n282-432-1 [6]\n532-82-1 [1]\n75660-25-2 [2]\n79234-33-6 [3]\n63681-54-9 [4]\n83968-67-6 [5]\n84196-22-5 [6]\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH302\nH315\nH318\nH410\n\n\n\n\n611-153-00-3\nchrysoidine C10-14-alkyl derivatives;\nbenzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]\nchrysoidine compound with dibutylnaphthalene sulfonic acid;\ndibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]\n286-946-7 [1]\n304-236-8 [2]\n85407-90-5 [1]\n94247-67-3 [2]\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH341\nH302\nH315\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH302\nH315\nH318\n\n\n\n\n611-154-00-9\ntrisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate\n403-670-6\n92408-46-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-155-00-4\n4,4'-oxybis(benzenesulfonylazide)\n431-850-4\n7456-68-0\nExpl. 1.1****\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH373**\nH400\nH410\nGHS01\nGHS08\nGHS09\nDgr\nH201\nH373**\nH410\n\n\n\n\n611-156-00-X\ntriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate\n432-270-4\n221354-37-6\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH361f***\nH373**\nH411\nGHS08\nGHS09\nWng\nH361f***\nH373**\nH411\n\n\n\n\n611-157-00-5\nbenzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;\npotassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate\n432-590-4\n243869-48-9\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-158-00-0\nreaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride\n421-520-8\n—\n****\nAquatic Chronic 4\n****\nH413\n****\n****\nH413\n\n\n\n\n611-159-00-6\ndisodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate\n421-880-6\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-160-00-1\nreaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;\n1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;\nreaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);\nreaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)\n422-760-6\n—\n****\nAquatic Chronic 4\n****\nH413\n****\n****\nH413\n\n\n\n\n611-161-00-7\ntrisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)\n423-100-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-162-00-2\n2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)\n429-600-4\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n611-163-00-8\n2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate\n429-610-9\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n611-164-00-3\nreaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;\n2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);\n2,2'-dimethyl-2,2'-azoheptanenitrile;\n2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);\n2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)\n429-710-2\n—\nSelf React D\nAcute Tox. 4 *\nAquatic Chronic 2\nH242\nH302\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH302\nH411\n\n\n\n\n611-165-00-9\nreaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate\n431-830-5\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-166-00-4\nreaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate\n432-100-9\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-167-00-X\nsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)\n435-240-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-168-00-5\nreaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;\n3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid\n435-440-6\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-169-00-0\nsodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate\n435-800-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-170-00-6\nreaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);\ndisodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)\n435-880-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-171-00-1\nreaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;\ntrisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate\n436-890-6\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-172-00-7\nreaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;\ndiammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate\n438-310-7\n—\nSelf-react. C****\nRepr. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH242\nH361f***\nH302\nH373**\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH242\nH361f***\nH302\nH373**\nH412\n\n\n\n\n611-173-00-2\nreaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;\n3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt\n440-510-4\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-174-00-8\nreaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;\n3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt\n442-290-5\n457624-86-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-175-00-3\nreaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntrisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ndisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate\n444-050-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-176-00-9\n2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate\n444-250-2\n—\nSelf-react. C****\nAquatic Chronic 2\nH242\nH411\nGHS02\nGHS09\nDgr\nH242\nH411\n\n\n\n\n611-177-00-4\nreaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);\ntetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);\ntrisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)\n444-290-0\n508202-43-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n611-178-00-X\nreaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate\n445-280-9\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n611-179-00-5\nreaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;\n2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate\n450-010-8\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-180-00-0\niron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts\n417-850-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-001-00-9\nmono-methylamine; [1]\ndi-methylamine; [2]\ntri-methylamine [3]\n200-820-0 [1]\n204-697-4 [2]\n200-875-0 [3]\n74-89-5 [1]\n124-40-3 [2]\n75-50-3 [3]\nFlam. Gas 1\nPress. Gas\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH220\nH332\nH335\nH315\nH318\nGHS02\nGHS04\nGHS05\nGHS07\nDgr\nH220\nH332\nH335\nH315\nH318\n\n*\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Dam. 1; H318: C ≥ 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 5 %\nSTOT SE 3; H335: C ≥ 5 %\nU5\n612-001-01-6\nmono-methylamine ... %; [1]\ndi-methylamine ... %; [2]\ntri-methylamine ... % [3]\n200-820-0 [1]\n204-697-4 [2]\n200-875-0 [3]\n74-89-5 [1]\n124-40-3 [2]\n75-50-3 [3]\nFlam. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH224\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH224\nH332\nH302\nH314\n\n*\nSTOT SE 3; H335: C ≥ 5 %\nB\n612-002-00-4\nethylamine\n200-834-7\n75-04-7\nFlam. Gas 1\nPress. Gas\nEye Irrit. 2\nSTOT SE 3\nH220\nH319\nH335\nGHS02\nGHS04\nGHS07\nDgr\nH220\nH319\nH335\n\n\nU\n612-003-00-X\ndiethylamine\n203-716-3\n109-89-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-004-00-5\ntriethylamine\n204-469-4\n121-44-8\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-005-00-0\nbutylamine\n203-699-2\n109-73-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-006-00-6\nethylenediamine;\n1,2-diaminoethane\n203-468-6\n107-15-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH226\nH312\nH302\nH314\nH334\nH317\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\nH334\nH317\n\n\n\n612-007-00-1\n2-aminopropane;\nisopropylamine\n200-860-9\n75-31-0\nFlam. Liq. 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH224\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH224\nH319\nH335\nH315\n\n\n\n612-008-00-7\naniline\n200-539-3\n62-53-3\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\n\n*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤ C < 1 %\n\n612-009-00-2\nsalts of aniline\n—\n—\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\n\n*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤ C < 1 %\nA\n612-010-00-8\nchloroanilines (with exception of those specified elsewhere in this Annex)\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\nC\n612-011-00-3\n4-nitrosoaniline\n211-535-6\n659-49-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-012-00-9\no-nitroaniline; [1]\nm-nitroaniline; [2]\np-nitroaniline [3]\n201-855-4 [1]\n202-729-1 [2]\n202-810-1 [3]\n88-74-4 [1]\n99-09-2 [2]\n100-01-6 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n\nC\n612-013-00-4\n3-aminobenzene sulphonic acid;\nmetanilic acid\n204-473-6\n121-47-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-014-00-X\nsulphanilic acid;\n4-aminobenzenesulphonic acid\n204-482-5\n121-57-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n612-015-00-5\nN-methylaniline\n202-870-9\n100-61-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n612-016-00-0\nN,N-dimethylaniline\n204-493-5\n121-69-7\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH351\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH311\nH301\nH411\n\n\n\n\n\n\n612-017-00-6\nN-methyl-N-2,4,6-tetranitroaniline;\ntetryl\n207-531-9\n479-45-8\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2\nH201\nH331\nH311\nH301\nH373**\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH331\nH311\nH301\nH373**\n\n\n\n\n612-018-00-1\nbis(2,4,6-trinitrophenyl)amine;\nhexyl\n205-037-8\n131-73-7\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373**\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH411\n\n\n\n\n612-019-00-7\ndipicrylamine, ammonium salt\n220-639-0\n2844-92-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373**\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH411\n\n\n\n\n612-020-00-2\n1-naphthylamine\n205-138-7\n134-32-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n612-022-00-3\n2-naphthylamine\n202-080-4\n91-59-8\nCarc. 1A\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\nCarc. 1A; H350: C ≥ 0,01 %\n\n612-023-00-9\nphenylhydrazine; [1]\nphenylhydrazinium chloride; [2]\nphenylhydrazine hydrochloride; [3]\nphenylhydrazinium sulphate (2:1) [4]\n202-873-5 [1]\n200-444-7 [2]\n248-259-0 [3]\n257-622-2 [4]\n100-63-0 [1]\n59-88-1 [2]\n27140-08-5 [3]\n52033-74-6 [4]\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH350\nH341\nH331\nH311\nH301\nH372 **\nH319\nH315\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH331\nH311\nH301\nH372 **\nH319\nH315\nH317\nH400\n\n\n\n612-024-00-4\nm-toluidine;\n3-aminotoluene\n203-583-1\n108-44-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH311\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH400\n\n\n\n612-025-00-X\nnitrotoluidines, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\nC\n612-026-00-5\ndiphenylamine\n204-539-4\n122-39-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n612-027-00-0\nxylidines with the exception of those specified elsewhere in this Annex;\ndimethyl anilines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\nC\n612-028-00-6\np-phenylenediamine\n203-404-7\n106-50-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-029-00-1\nbenzene-1,4-diamine dihydrochloride;\np-phenylenediamine dihydrochloride\n210-834-9\n624-18-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-030-00-7\n2-methyl-p-phenylenediamine sulphate [1]\n210-431-8 [1]\n228-871-4 [2]\n615-50-9 [1]\n6369-59-1 [2]\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH332\nH312\nH317\nH411\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH411\n\n\n\n612-031-00-2\nN,N-dimethylbenzene-1,3-diamine; [1]\n4-amino-N,N-dimethylaniline;\n3-amino-N,N'-dimethylaniline [2]\n220-623-3 [1]\n202-807-5 [2]\n2836-04-6 [1]\n99-98-9 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\nC\n612-032-00-8\nN,N,N',N'-tetramethyl-p-phenylenediamine\n202-831-6\n100-22-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-033-00-3\n2-aminophenol\n202-431-1\n95-55-6\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH341\nH332\nH302\nGHS08\nGHS07\nWng\nH341\nH332\nH302\n\n\n\n\n\n612-034-00-9\n2-amino-4,6-dinitrophenol;\npicramic acid\n202-544-6\n96-91-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH201\nH332\nH312\nH302\nH412\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\nH412\n\n\n\n\n612-034-01-6\n2-amino-4,6-dinitrophenol;\npicramic acid;\n[≥ 20 % water]\n202-544-6\n96-91-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\n\n\nG\n612-035-00-4\n2-methoxyaniline;\no-anisidine\n201-963-1\n90-04-0\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH350\nH341\nH331\nH311\nH301\nGHS06\nGHS08\nDgr\nH350\nH341\nH331\nH311\nH301\n\n\n\n612-036-00-X\n3,3'-dimethoxybenzidine;\no-dianisidine\n204-355-4\n119-90-4\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-037-00-5\nsalts of 3,3'-dimethoxybenzidine;\nsalts of o-dianisidine\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\nA\n612-038-00-0\n2-nitro-p-anisidine;\n4-methoxy-2-nitroaniline\n202-547-2\n96-96-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 3\nH330\nH310\nH300\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH330\nH310\nH300\nH373 **\nH412\n\n\n\n612-039-00-6\n2-ethoxyaniline;\no-phenetidine\n202-356-4\n94-70-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH311\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\n\n\n\n612-040-00-1\n2,4-dinitroaniline\n202-553-5\n97-02-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n612-041-00-7\n4,4'-bi-o-toluidine\n204-358-0\n119-93-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\n\n612-042-00-2\nbenzidine;\n1,1'-biphenyl-4,4'-diamine;\n4,4'-diaminobiphenyl;\nbiphenyl-4,4'-ylenediamine\n202-199-1\n92-87-5\nCarc. 1A\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\nCarc. 1A; H350: C ≥ 0,01 %\n\n612-043-00-8\nN,N'-dimethylbenzidine\n—\n2810-74-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n\n\n612-044-00-3\nN,N'-diacetylbenzidine\n210-338-2\n613-35-4\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH350\nH341\nH332\nH312\nH302\nGHS08\nGHS07\nDgr\nH350\nH341\nH332\nH312\nH302\n\n\n\n\n612-046-00-4\nallylamine\n203-463-9\n107-11-9\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH225\nH331\nH311\nH301\nH411\nGHS02\nGHS06\nGHS09\nDgr\nH225\nH331\nH311\nH301\nH411\n\n\n\n612-047-00-X\nbenzylamine\n202-854-1\n100-46-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n612-048-00-5\ndipropylamine\n205-565-9\n142-84-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-049-00-0\ndi-n-butylamine; [1]\ndi-sec-butylamine [2]\n203-921-8 [1]\n210-937-9 [2]\n111-92-2 [1]\n626-23-3 [2]\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n\n\n\n\n\n612-050-00-6\ncyclohexylamine\n203-629-0\n108-91-8\nFlam. Liq. 3\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH361f***\nH312\nH302\nH314\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH361f***\nH312\nH302\nH314\n\n\n\n\n612-051-00-1\n4,4'-diaminodiphenylmethane;\n4,4'-methylenedianiline\n202-974-4\n101-77-9\nCarc. 1B\nMuta. 2\nSTOT SE 1\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH370 **\nH373 **\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH370 **\nH373 **\nH317\nH411\n\n\n\n612-052-00-7\n(S)-sec-butylamine;\n(S)-2-aminobutane; [1]\n(R)-sec-butylamine;\n(R)-2-aminobutane; [2]\nsec-butylamine;\n2-aminobutane [3]\n208-164-7 [1]\n236-232-6 [2]\n237-732-7 [3]\n513-49-5 [1]\n13250-12-9 [2]\n13952-84-6 [3]\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH225\nH332\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH225\nH332\nH302\nH314\nH400\n\n\nC\n612-053-00-2\nN-ethylaniline\n203-135-5\n103-69-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH311\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\n\n\n\n612-054-00-8\nN,N-diethylaniline\n202-088-8\n91-66-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n*\n\n612-055-00-3\nN-methyl-o-toluidine; [1]\nN-methyl-m-toluidine; [2]\nN-methyl-p-toluidine [3]\n210-260-9 [1]\n211-795-0 [2]\n210-769-6 [3]\n611-21-2 [1]\n696-44-6 [2]\n623-08-5 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n\nC\n612-056-00-9\nN,N-dimethyl-p-toluidine; [1]\nN,N-dimethyl-m-toluidine; [2]\nN,N-dimethyl-o-toluidine [3]\n202-805-4 [1]\n204-495-6 [2]\n210-199-8 [3]\n99-97-8 [1]\n121-72-2 [2]\n609-72-3 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n*\nC\n\n\n612-057-00-4\npiperazine;\n[solid]\n203-808-3\n110-85-0\nRepr. 2\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH361fd\nH314\nH334\nH317\nGHS05\nGHS08\nDgr\nH361fd\nH314\nH334\nH317\n\n\n\n\n\n\n612-057-01-1\npiperazine;\n[liquid]\n203-808-3\n110-85-0\nRepr. 2\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH361fd\nH314\nH334\nH317\nGHS05\nGHS08\nDgr\nH361fd\nH314\nH334\nH317\n\n\n\n\n\n612-058-00-X\n2,2'-iminodiethylamine;\ndiethylenetriamine\n203-865-4\n111-40-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\n\n\n\n612-059-00-5\n3,6-diazaoctanethylenediamin;\ntriethylenetetramine\n203-950-6\n112-24-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\nH412\n\n\n\n612-060-00-0\n3,6,9-triazaundecamethylenediamine;\ntetraethylenepentamine\n203-986-2\n112-57-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH411\n\n\n\n612-061-00-6\n3-aminopropyldimethylamine;\nN,N-dimethyl-1,3-diaminopropane\n203-680-9\n109-55-7\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH302\nH314\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH302\nH314\nH317\n\n\n\n612-062-00-1\n3-aminopropyldiethylamine;\nN,N-diethyl-1,3-diaminopropane\n203-236-4\n104-78-9\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH312\nH302\nH314\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\nH317\n\n\n\n612-063-00-7\n3,3'-iminodi(propylamine);\ndipropylenetriamine\n200-261-2\n56-18-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nH330\nH311\nH302\nH314\nH317\nGHS06\nGHS05\nDgr\nH330\nH311\nH302\nH314\nH317\n\n\n\n612-064-00-2\n3,6,9,12-tetra-azatetradecamethylenediamine;\npentacthylenehexamine\n223-775-9\n4067-16-7\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n612-065-00-8\npolyethlyenepolyamines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n612-066-00-3\ndicyclohexylamine\n202-980-7\n101-83-7\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n612-067-00-9\n3-aminomethyl-3,5,5-trimethylcyclohexylamine\n220-666-8\n2855-13-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\nH412\n\n\n\n612-068-00-4\n3,3'-dichlorobenzidine;\n3,3'-dichlorobiphenyl-4,4'-ylenediamine\n202-109-0\n91-94-1\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH312\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH312\nH317\nH410\n\n\n\n612-069-00-X\nsalts of 3,3'-dichlorobenzidine;\nsalts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH312\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH312\nH317\nH410\n\n\nA\n612-070-00-5\nsalts of benzidine\n208-519-6\n208-520-1\n244-236-4\n252-984-8\n531-85-1\n531-86-2\n21136-70-9\n36341-27-2\nCarc. 1A\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\nA\n612-071-00-0\nsalts of 2-naphthylamine\n209-030-0\n210-313-6\n553-00-4\n612-52-2\nCarc. 1A\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\nA\n612-072-00-6\nbiphenyl-4-ylamine;\nxenylamine;\n4-aminobiphenyl\n202-177-1\n92-67-1\nCarc. 1A\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-073-00-1\nsalts of biphenyl-4-ylamine;\nsalts of xenylamine;\nsalts of 4-aminobiphenyl\n—\n—\nCarc. 1A\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\nA\n612-074-00-7\nbenzyldimethylamine\n203-149-1\n103-83-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH226\nH332\nH312\nH302\nH314\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH314\nH412\n\n\n\n612-075-00-2\n2-aminoethyldimethylamine;\n2-dimethylaminoethylamine\n203-541-2\n108-00-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH312\nH302\nH314\n\n\n\n\n\n612-076-00-8\nethyldimethylamine\n209-940-8\n598-56-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\n\n\n\n\n612-077-00-3\ndimethylnitrosoamine;\nN-nitrosodimethylamine\n200-549-8\n62-75-9\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 2\nH350\nH330\nH301\nH372 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH330\nH301\nH372 **\nH411\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n612-078-00-9\n2,2'-dichloro-4,4'-methylenedianiline;\n4,4'-methylene bis(2-chloroaniline)\n202-918-9\n101-14-4\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n612-079-00-4\nsalts of 2,2'-dichloro-4,4'-methylenedianiline;\nsalts of 4,4'-methylenebis(2-chloroaniline)\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\nA\n612-080-00-X\n4-amino-N,N-diethylaniline;\nN,N-diethyl-p-phenylendiamine\n202-214-1\n93-05-0\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n\n\n612-081-00-5\nsalts of 4,4'-bi-o-toluidine;\nsalts of 3,3'-dimethylbenzidine;\nsalts of o-tolidine\n210-322-5\n265-294-7\n277-985-0\n612-82-8\n64969-36-4\n74753-18-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\nA\n612-082-00-0\nthiourea;\nthiocarbamide\n200-543-5\n62-56-6\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH361d ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361d ***\nH302\nH411\n\n\n\n\n\n\n612-083-00-6\n1-methyl-3-nitro-1-nitrosoguanidine\n200-730-1\n70-25-7\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH350\nH332\nH319\nH315\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH332\nH319\nH315\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n\n612-084-00-1\ndapsone;\n4,4'-diamino diphenyl sulfone\n201-248-4\n80-08-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n612-085-00-7\n4,4'-methylenedi-o-toluidine\n212-658-8\n838-88-0\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH410\n\n\n\n612-086-00-2\namitraz (ISO);\nN,N-bis(2,4-xylyliminomethyl) methylamine\n251-375-4\n33089-61-1\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\nM = 10\n\n612-087-00-8\nguazatine (ISO)\n\n108173-90-6\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH312\nH302\nH335\nH315\nH318\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH312\nH302\nH335\nH315\nH318\nH410\n\n\n\n612-088-00-3\nsimazine (ISO);\n6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine\n204-535-2\n122-34-9\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n612-089-00-9\n1,5-naphthylenediamine\n218-817-8\n2243-62-1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n612-090-00-4\n2,2'-(nitrosoimino)bisethanol\n214-237-4\n1116-54-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n612-091-00-X\no-toluidine;\n2-aminotoluene\n202-429-0\n95-53-4\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nH350\nH331\nH301\nH319\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH301\nH319\nH400\n\n\n\n612-092-00-5\nN,N'-(2,2-dimethylpropylidene)hexamethylenediamine\n401-660-6\n1000-78-8\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n612-093-00-0\n3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline\n401-790-3\n104147-32-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n\n612-094-00-6\n4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride\n402-190-4\n113674-95-6\nSTOT RE 1\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH372**\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH372**\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n\n612-095-00-1\nbenzyl-2-hydroxydodecyldimethylammonium benzoate\n402-610-6\n113694-52-3\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH410\n\n\n\n612-096-00-7\n4,4'-carbonimidoylbis[N,N-dimethylaniline]\n207-762-5\n492-80-8\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH351\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH411\n\n\n\n612-097-00-2\nsalts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]\n—\n—\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH351\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH411\n\n\nA\n\n\n612-098-00-8\nnitrosodipropylamine\n210-698-0\n621-64-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n\n612-099-00-3\n4-methyl-m-phenylenediamine;\n2,4-toluenediamine\n202-453-1\n95-80-7\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH317\nH411\n\n\n\n\n\n612-100-00-7\npropylenediamine\n201-155-9\n78-90-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH226\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\n\n\n\n\n\n612-101-00-2\nmethenamine;\nhexamethylenetetramine\n202-905-8\n100-97-0\nFlam. Sol. 2\nSkin Sens. 1\nH228\nH317\nGHS02\nGHS07\nWng\nH228\nH317\n\n\n\n\n612-102-00-8\nN,N-bis(3-aminopropyl)methylamine\n203-336-8\n105-83-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH331\nH311\nH302\nH314\nGHS06\nGHS05\nDgr\nH331\nH311\nH302\nH314\n\n\n\n612-103-00-3\nN,N,N',N'-tetramethylethylenediamine\n203-744-6\n110-18-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\n\n\n612-104-00-9\nhexamethylenediamine\n204-679-6\n124-09-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Corr. 1B\nH312\nH302\nH335\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH335\nH314\n\n\n\n612-105-00-4\n2-piperazin-1-ylethylamine\n205-411-0\n140-31-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\nH412\n\n\n\n612-106-00-X\n2,6-diethylaniline\n209-445-7\n579-66-8\nAcute Tox. 4 *\nH302\n—\nH302\n\n\n\n612-107-00-5\n1-phenylethylamine; [1]\nDL-α-methylbenzylamine [2]\n202-706-6 [1]\n210-545-8 [2]\n98-84-0 [1]\n618-36-0 [2]\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n612-108-00-0\n3-aminopropyltriethoxysilane\n213-048-4\n919-30-2\nAcute Tox. 4 *\nSkin Corr. 1B\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n612-109-00-6\nbis(2-dimethylaminoethyl)(methyl)amine\n221-201-1\n3030-47-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH311\nH302\nH314\nGHS06\nGHS05\nDgr\nH311\nH302\nH314\n\n\n\n612-110-00-1\n2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)\n229-962-1\n6864-37-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Chronic 2\nH331\nH311\nH302\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH302\nH314\nH411\n\n\n\n612-111-00-7\n2-methyl-m-phenylenediamine;\n2,6-toluenediamine\n212-513-9\n823-40-5\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH312\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH312\nH302\nH317\nH411\n\n\n\n612-112-00-2\np-anisidine;\n4-methoxyaniline\n203-254-2\n104-94-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nH330\nH310\nH300\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH400\n\n\n\n612-113-00-8\n6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine\n403-240-8\n106264-79-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-114-00-3\nR,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate\n404-390-7\n—\nFlam. Sol. 1\nSkin Sens. 1\nAquatic Chronic 3\nH228\nH317\nH412\nGHS02\nGHS07\nWng\nH228\nH317\nH412\n\n\n\n612-115-00-9\ndimethyldioctadecylammonium hydrogen sulfate\n404-050-8\n123312-54-9\nEye Irrit. 2\nAquatic Chronic 4\nH319\nH413\nGHS07\nWng\nH319\nH413\n\n\n\n612-116-00-4\nC8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate\n404-690-8\n68132-19-4\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH314\nH317\nH410\n\n\n\n612-117-00-X\nC12-14-tert-alkylamine, methylphosphonic acid salt\n404-750-3\n119415-07-5\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n612-118-00-5\nA reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;\n(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide\n405-080-4\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-119-00-0\nbenzyldimethyloctadecylammonium 3-nitrobenzenesulfonate\n405-330-2\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n612-120-00-6\naclonifen (ISO);\n2-chloro-6-nitro-3-phenoxyaniline\n277-704-1\n74070-46-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n612-121-00-1\namines, polyethylenepoly-;\nHEPA\n268-626-9\n68131-73-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n\n\n612-122-00-7\nhydroxylamine … %\n[> 55 % in aqueous solution]\n232-259-2\n7803-49-8\nUnst. Expl.\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH200\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\nGHS01\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH200\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\n\n\nB\n\n\n\n\n612-122-01-4\nhydroxylamine …% [≤ 55 % in aqueous solution]\n232-259-2\n7803-49-8\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\n\n\nB\n\n\n\n612-123-00-2\nhydroxylammonium chloride;\nhydroxylamine hydrochloride; [1]\nbis(hydroxylammonium) sulfate;\nhydroxylamine sulfate (2:1) [2]\n226-798-2 [1]\n233-118-8 [2]\n5470-11-1 [1]\n10039-54-0 [2]\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH290\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nWng\nH290\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\n\n\n612-124-00-8\nN,N,N-trimethylanilinium chloride\n205-319-0\n138-24-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n612-125-00-3\n2-methyl-p-phenylenediamine;\n2,5-toluenediamine\n202-442-1\n95-70-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH332\nH312\nH317\nH411\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH411\n\n\n\n612-126-00-9\ntoluene-2,4-diammonium sulphate;\n4-methyl-m-phenylenediamine sulfate\n265-697-8\n65321-67-7\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH301\nH312\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH301\nH312\nH319\nH317\nH411\n\n\n\n612-127-00-4\n3-aminophenol\n209-711-2\n591-27-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH302\nH411\nGHS07\nGHS09\nWng\nH332\nH302\nH411\n\n\n\n612-128-00-X\n4-aminophenol\n204-616-2\n123-30-8\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH332\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH332\nH302\nH410\n\n\n\n612-129-00-5\ndiisopropylamine\n203-558-5\n108-18-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n612-130-00-0\n2,6-diamino-3,5-diethyltoluene;\n4,6-diethyl-2-methyl-1,3-benzenediamine; [1]\n2,4-diamino-3,5-diethyltoluene;\n2,4-diethyl-6-methyl-1,3-benzenediamine; [2]\ndiethylmethylbenzenediamine [3]\n218-255-3 [1]\n218-256-9 [2]\n270-877-4 [3]\n2095-01-4 [1]\n2095-02-5 [2]\n68479-98-1 [3]\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH319\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH312\nH302\nH373 **\nH319\nH410\n\n\nC\n612-131-00-6\ndidecyldimethylammonium chloride\n230-525-2\n7173-51-5\nAcute Tox. 4 *\nSkin Corr. 1B\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n612-132-00-1\nN,N'-diphenyl-p-phenylenediamine;\nN,N'-diphenyl-1,4-benzenediamine\n200-806-4\n74-31-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n612-133-00-7\n(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;\n4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate\n247-162-0\n25646-77-9\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH410\n\n\n\n612-134-00-2\nN-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;\n4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate\n247-161-5\n25646-71-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-135-00-8\nN-2-naphthylaniline;\nN-phenyl-2-naphthylamine\n205-223-9\n135-88-6\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH319\nH315\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH319\nH315\nH317\nH411\n\n\n\n612-136-00-3\nN-isopropyl-N'-phenyl-p-phenylenediamine\n202-969-7\n101-72-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n612-137-00-9\n4-chloroaniline\n203-401-0\n106-47-8\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH331\nH311\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH317\nH410\n\n\n\n612-138-00-4\nfuralaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate\n260-875-1\n57646-30-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n612-139-00-X\nmefenacet (ISO);\n2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide\n277-328-8\n73250-68-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-140-00-5\nquaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides\n264-151-6\n63449-41-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH312\nH302\nH314\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH400\n\n\n\n612-141-00-0\n4,4'-methylenebis(2-ethylaniline);\n4,4'-methylenebis(2-ethylbenzeneamine)\n243-420-1\n19900-65-3\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n612-142-00-6\nbiphenyl-2-ylamine\n201-990-9\n90-41-5\nCarc. 2\nAcute Tox. 4 *\nAquatic Chronic 3\nH351\nH302\nH412\nGHS08\nGHS07\nWng\nH351\nH302\nH412\n\n\n\n612-143-00-1\nN5,N5-diethyltoluene-2,5-diamine monohydrochloride;\n4-diethylamino-2-methylaniline monohydrochloride\n218-130-3\n2051-79-8\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH317\nH410\n\n\n\n612-144-00-7\nflumetralin (ISO);\nN-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine\n—\n62924-70-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH410\n\n\n\n612-145-00-2\no-phenylenediamine\n202-430-6\n95-54-5\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH410\n\n\n\n612-146-00-8\no-phenylenediamine dihydrochloride\n210-418-7\n615-28-1\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH410\n\n\n\n612-147-00-3\nm-phenylenediamine\n203-584-7\n108-45-2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-148-00-9\nm-phenylenediamine dihydrochloride\n208-790-0\n541-69-5\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-149-00-4\n1,3-diphenylguanidine\n203-002-1\n102-06-7\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH361f ***\nH302\nH319\nH335\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH302\nH319\nH335\nH315\nH411\n\n\n\n612-150-00-X\nspiroxamine (ISO);\n8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine\n—\n118134-30-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH315\nH317\nH410\n\n\n\n\n\n\n612-151-00-5\nmethyl-phenylene diamine;\ndiaminotoluene;\n[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]\n—\n—\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH319\nH317\nH411\n\n\n\n\n612-152-00-0\nN,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine\n406-610-7\n62478-82-4\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Chronic 3\nH226\nH332\nH302\nH373 **\nH314\nH412\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH332\nH302\nH373 **\nH314\nH412\n\n\n\n612-153-00-6\n4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride\n407-020-2\n132885-85-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n612-154-00-1\n6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]\n410-890-6\n95235-29-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-155-00-7\n2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene\n411-730-8\n93071-94-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-156-00-2\nreaction mass of: trihexadecylmethylammonium chloride;\ndihexadecyldimethylammonium chloride\n405-620-9\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-157-00-8\n(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride\n410-780-8\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373 **\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH318\nH317\nH411\n\n\n\n612-158-00-3\nreaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;\n4-dodecylsalicylaldoxime\n410-820-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-159-00-9\nReaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid\n410-880-1\n—\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n612-160-00-4\np-toluidine;\n4-aminotoluene; [1]\ntoluidinium chloride; [2]\ntoluidine sulphate (1:1) [3]\n203-403-1 [1]\n208-740-8 [2]\n208-741-3 [3]\n106-49-0 [1]\n540-23-8 [2]\n540-25-0 [3]\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH351\nH331\nH311\nH301\nH319\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH311\nH301\nH319\nH317\nH400\n\n\n\n612-161-00-X\n2,6-xylidine;\n2,6-dimethylaniline\n201-758-7\n87-62-7\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH351\nH332\nH312\nH302\nH335\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH312\nH302\nH335\nH315\nH411\n\n\n\n612-162-00-5\ndimethyldioctadecylammonium chloride;\nDODMAC\n203-508-2\n107-64-2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-163-00-0\nmetalaxyl-M (ISO);\nmefenoxam;\n(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester\n—\n70630-17-0\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n612-164-00-6\n2-butyl-2-ethyl-1,5-diaminopentane\n412-700-7\n137605-95-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH373 **\nH314\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH312\nH302\nH373 **\nH314\nH317\nH412\n\n\n\n612-165-00-1\nN,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine\n413-810-8\n65181-78-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-166-00-7\nreaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);\ntrans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)\n411-830-1\n114765-88-7\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n612-167-00-2\n5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride\n410-490-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373 **\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH318\nH317\nH411\n\n\n\n612-168-00-8\n3,5-dichloro-2,6-difluoropyrdine-4-amine\n220-630-1\n2840-00-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH302\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH411\n\n\n\n\n\n612-169-00-3\nbis(N-methyl-N-phenylhydrazine)sulfate\n423-170-1\n618-26-8\nFlam. Liq. 2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH225\nH372**\nH302\nH318\nH317\nH400\nH410\nGHS02\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH225\nH372**\nH302\nH318\nH317\nH410\n\n\n\n\n612-170-00-9\n4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime\n405-260-2\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-171-00-4\nN,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane\n410-060-3\n130728-76-6\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH317\nH411\nGHS08\nGHS09\nWng\nH341\nH317\nH411\n\n\n\n612-172-00-X\n4,4'-methylenebis(N,N'-dimethylcyclohexanamine\n412-840-9\n13474-64-1\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Chronic 3\nH302\nH373 **\nH314\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH314\nH412\n\n\n\n612-173-00-5\nlithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate\n411-140-0\n125328-86-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n612-174-00-0\n4,4-dimethoxybutylamine\n407-690-6\n19060-15-2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH412\n\n\n\n612-175-00-6\n2-(O-aminooxy)ethylamine dihydrochloride\n412-310-7\n37866-45-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n612-176-00-1\npolymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine\n410-570-6\n143747-73-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n612-177-00-7\n2-naphthylamino-6-sulfomethylamide\n412-120-4\n104295-55-8\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n612-178-00-2\n1,4,7,10-tetraazacyclododecane disulfate\n412-080-8\n112193-77-8\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nAquatic Chronic 3\nH302\nH335\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\nH412\n\n\n\n612-179-00-8\n1-(2-propenyl)pyridinium chloride\n412-740-5\n25965-81-5\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n612-180-00-3\n3-aminobenzylamine\n412-230-2\n4403-70-7\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n612-181-00-9\n2-phenylthioaniline\n413-030-8\n1134-94-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n612-182-00-4\n1-ethyl-1-methylmorpholinium bromide\n418-210-1\n65756-41-4\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n612-183-00-X\n1-ethyl-1-methylpyrrolidinium bromide\n418-200-5\n69227-51-6\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n612-184-00-5\n6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one\n403-830-5\n89331-94-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n612-185-00-0\n1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide\n407-400-8\n59493-72-0\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-186-00-6\nbis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate\n406-770-8\n149057-64-7\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH373 **\nH318\nH317\nH410\n\n\n\n612-187-00-1\n2,3,4-trifluoroaniline\n407-170-9\n3862-73-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH373 **\nH315\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH315\nH318\nH411\n\n\n\n612-188-00-7\n4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)\n407-560-9\n107934-68-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-189-00-2\n4-amino-2-(aminomethyl)phenol dihydrochloride\n412-510-4\n135043-64-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-190-00-8\n4,4'-methylenebis(2-isopropyl-6-methylaniline)\n415-150-6\n16298-38-7\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n612-191-00-3\npolymer of allylamine hydrochloride\n415-050-2\n71550-12-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n612-192-00-9\n2-isopropyl-4-(N-methyl)aminomethylthiazole\n414-800-6\n154212-60-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH411\n\n\n\n612-193-00-4\n3-methylaminomethylphenylamine\n414-570-7\n18759-96-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n612-194-00-X\n2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride\n414-670-0\n141890-30-4\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n612-195-00-5\nbis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate\n415-210-1\n160236-81-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH410\n\n\n\n612-196-00-0\n4-chloro-o-toluidine; [1]\n4-chloro-o-toluidine hydrochloride [2]\n202-441-6 [1]\n221-627-8 [2]\n95-69-2 [1]\n3165-93-3 [2]\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH331\nH311\nH301\nH410\n\n\n\n612-197-00-6\n2,4,5-trimethylaniline; [1]\n2,4,5-trimethylaniline hydrochloride [2]\n205-282-0 [1] - [2]\n137-17-7 [1]\n21436-97-5 [2]\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH411\n\n\n\n612-198-00-1\n4,4'-thiodianiline and its salts\n205-370-9\n139-65-1\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\n\n612-199-00-7\n4,4'-oxydianiline and its salts;\np-aminophenyl ether\n202-977-0\n101-80-4\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH340\nH361f ***\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH340\nH361f ***\nH331\nH311\nH301\nH411\n\n\n\n612-200-00-0\n2,4-diaminoanisole;\n4-methoxy-m-phenylenediamine; [1]\n2,4-diaminoanisole sulphate [2]\n210-406-1 [1]\n254-323-9 [2]\n615-05-4 [1]\n39156-41-7 [2]\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH341\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH302\nH411\n\n\n\n612-201-00-6\nN,N,N',N'-tetramethyl-4,4'-methylendianiline\n202-959-2\n101-61-1\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n612-202-00-1\n3,4-dichloroaniline\n202-448-4\n95-76-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH318\nH317\nH410\n\n\n\n\n\n612-203-00-7\nC8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %)\n417-360-3\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nH312\nH302\nH315\nGHS07\nWng\nH312\nH302\nH315\n\n\n\n\n612-204-00-2\nC.I. Basic Violet 3;\n4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride\n208-953-6\n548-62-9\nCarc. 2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH351\nH302\nH318\nH410\n\n\n\n612-205-00-8\nC.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5)\n208-953-6\n548-62-9\nCarc. 1B\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH350\nH302\nH318\nH410\n\n\n\n612-206-00-3\nfamoxadone (ISO);\n3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione\n—\n131807-57-3\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n612-207-00-9\n4-ethoxyaniline;\np-phenetidine\n205-855-5\n156-43-4\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH341\nH332\nH312\nH302\nH319\nH317\nGHS08\nGHS07\nWng\nH341\nH332\nH312\nH302\nH319\nH317\n\n\n\n\n\n612-208-00-4\nN-methylbenzene-1,2-diammonium hydrogen phosphate\n424-460-0\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n612-209-00-X\n6-methoxy-m-toluidine;\np-cresidine\n204-419-1\n120-71-8\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-210-00-5\n5-nitro-o-toluidine; [1]\n5-nitro-o-toluidine hydrochloride [2]\n202-765-8 [1]\n256-960-8 [2]\n99-55-8 [1]\n51085-52-0 [2]\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 3\nH351\nH331\nH311\nH301\nH412\nGHS06\nGHS08\nDgr\nH351\nH331\nH311\nH301\nH412\n\n\n\n612-211-00-0\nN-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide\n416-470-9\n170292-97-4\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n612-212-00-6\n2,6-dichloro-4-trifluoromethylaniline\n416-430-0\n24279-39-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH315\nH317\nH410\n\n\n\n612-213-00-1\nisobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine\n419-850-2\n148348-13-4\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n612-214-00-7\n4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine\n421-390-2\n89114-90-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-215-00-2\n3-chloro-2-(isopropylthio)aniline\n421-700-6\n179104-32-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n\n612-216-00-8\n1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt\n425-870-2\n19450-38-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n612-217-00-3\n1-methoxy-2-propylamine\n422-550-4\n37143-54-7\nFlam. Liq. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 3\nH225\nH314\nH302\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH314\nH302\nH412\n\n\n\n\n\n612-219-00-4\n(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride\n402-200-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-220-00-X\nN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine\n431-060-1\n153719-38-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n612-221-00-5\n2-amino-4-(trifluoromethyl)benzenethiol hydrochloride\n429-560-8\n4274-38-8\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nH314\nH332\nH312\nH302\nH373**\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH314\nH332\nH312\nH302\nH373**\nH317\nH400\n\n\n\n\n612-222-00-0\ncis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine\n425-080-8\n104860-26-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373**\nH318\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH312\nH302\nH373**\nH318\nH410\n\n\n\n\n612-223-00-6\nN-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine\n425-300-2\n186450-73-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n612-224-00-1\nN2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine\n426-150-0\n121246-28-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n612-225-00-7\n1,4,7,10-tetraazacyclododecane\n425-450-9\n294-90-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH312\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH312\nH302\nH410\n\n\n\n\n612-226-00-2\n3-(2'-phenoxyethoxy)propylamine\n427-870-8\n6903-18-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH302\nH315\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH412\n\n\n\n\n612-227-00-8\nbenzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride\n428-290-8\n120606-08-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n\n612-228-00-3\nreaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine\n414-340-6\n—\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH332\nH312\nH302\nH371\nH318\nH317\nH412\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH371\nH318\nH317\nH412\n\n\n\n\n612-229-00-9\nmepanipyrim;\n4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine\n—\n110235-47-7\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n\n612-230-00-4\nN,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide\n431-530-4\n—\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n612-231-00-X\n3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride\n427-370-1\n164288-56-6\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n612-232-00-5\nreaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;\ntriisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid\n430-410-9\n186148-38-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-237-00-2\nhydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]\n233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]\n10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]\nExpl. 1.1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\nHS01\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\nT\n\n612-238-00-8\n(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%\n222-048-3\n3327-22-8\nCarc. 2\nAquatic Chronic 3\nH351\nH412\nGHS08\nWng\nH351\nH412\n\n\nB\n\n612-239-00-3\nbiphenyl-3,3', 4,4'-tetrayltetraamine;\ndiaminobenzidine\n202-110-6\n91-95-2\nCarc. 1B\nMuta. 2\nH350\nH341\nGHS08\nDgr\nH350\nH341\n\n\n\n\n612-240-00-9\npyrimethanil (ISO);\nN-(4,6-dimethylpyrimidin-2-yl)aniline\n—\n53112-28-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-241-00-4\npiperazine hydrochloride; [1]\npiperazine dihydrochloride; [2]\npiperazine phosphate [3]\n228-042-7 [1]\n205-551-2 [2]\n217-775-8 [3]\n6094-40-2 [1]\n142-64-3 [2]\n1951-97-9 [3]\nRepr. 2\nEye Irrit. 2\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH361fd\nH319\nH315\nH334\nH317\nH412\nGHS08\nDgr\nH361fd\nH319\nH315\nH334\nH317\nH412\n\n\n\n\n612-242-00-X\ncyprodinil (ISO);\n4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine\n—\n121552-61-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n612-243-00-5\n(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate\n420-560-3\n79617-97-3\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\nM=10\n\n\n612-244-00-0\n3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride\n421-310-6\n87691-88-1\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH302\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f***\nH302\nH319\nH317\nH410\n\n\n\n\n612-245-00-6\n2-ethylphenylhydrazine hydrochloride\n421-460-2\n19398-06-2\nCarc. 2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH372**\nH302\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH372**\nH302\nH318\nH317\nH410\n\nM=10\n\n\n612-246-00-1\n(2-chloroethyl)(3-hydroxypropyl)ammonium chloride\n429-740-6\n40722-80-3\nCarc. 1B\nMuta. 1B\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH340\nH373**\nH317\nH412\nGHS08\nGHS07\nDgr\nH350\nH340\nH373**\nH317\nH412\n\n\n\n\n612-247-00-7\nN-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide\n423-530-8\n152828-23-4\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Chronic 3\nH372**\nH302\nH412\nGHS08\nGHS07\nDgr\nH372**\nH302\nH412\n\n\n\n\n612-248-00-2\nreaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)\n439-540-0\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n\n612-249-00-8\n4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride\n425-030-5\n159939-85-2\nRepr. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH361f***\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH361f***\nH302\nH314\nH317\nH411\n\n\n\n\n612-250-00-3\nchloro-N,N-dimethylformiminium chloride\n425-970-6\n3724-43-4\nRepr. 1B\nAcute Tox. 4 *\nSkin Corr. 1A\nH360D***\nH302\nH314\nGHS05\nGHS08\nGHS07\nDgr\nH360D***\nH302\nH314\nEUH014\n\n\n\n612-251-00-9\ncis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride\n426-020-3\n51229-78-8\nFlam. Sol. 2\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH228\nH361d***\nH302\nH315\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nWng\nH228\nH361d***\nH302\nH315\nH317\nH411\n\n\n\n\n612-252-00-4\nimidacloprid (ISO);\n1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine\n428-040-8\n138261-41-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n612-253-00-X\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing < 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-253-01-7\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing ≥ 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nRepr. 1B\nAquatic Chronic 3\nH360D***\nH412\nGHS08\nDgr\nH360D***\nH412\n\n\n\n\n612-254-00-5\nreaction products of diisopropanolamine with formaldehyde (1:4)\n432-440-8\n220444-73-5\nCarc. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH302\nH314\nH317\nH411\n\n\n\n\n612-255-00-0\n1-(3-methoxypropyl)-4-piperidinamine\n431-950-8\n179474-79-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH312\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH412\n\n\n\n\n612-256-00-6\nbenzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate\n427-470-3\n137864-22-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n612-257-00-1\ntripropylammonium dihydrogenphosphate\n433-700-3\n35687-90-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n612-259-00-2\nN-ethyl-3-trimethoxysilyl-2-methyl-propanamine\n437-720-3\n227085-51-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n612-261-00-3\n3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline\n441-190-9\n121451-05-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=10\n\n\n612-265-00-5\nbis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate\n444-360-0\n191617-13-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-266-00-0\n3-chloro-4-(3-fluorobenzyloxy)aniline\n445-590-4\n202197-26-0\nMuta. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH373**\nH410\n\n\n\n\n612-267-00-6\nbis(hydrogenated tallow C16-18-alkyl)hydroxylamine\n418-370-0\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n612-269-00-7\nreaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;\n1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;\nreaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;\nN-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline\n420-720-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n612-270-00-2\n(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride\n433-010-2\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n612-271-00-8\nreaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;\nethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate\n434-970-5\n160987-57-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n612-272-00-3\nammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate\n435-210-5\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-273-00-9\nalkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride\n435-650-8\n—\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n\n612-274-00-4\n(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate\n445-750-3\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n612-275-00-X\nfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil\n447-880-6\n206565-89-1\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\nM=10\n\n\n612-276-00-5\n1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts\n451-430-4\n500717-36-2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n612-277-00-0\nreaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;\n4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium\n451-440-9\n586372-44-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n612-278-00-6\nethidium bromide;\n3,8-diamino-1-ethyl-6-phenylphenantridinium bromide\n214-984-6\n1239-45-8\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nH341\nH330\nH302\nGHS06\nGHS08\nDgr\nH341\nH330\nH302\n\n\n\n\n612-279-00-1\n(R, S)-2-amino-3,3-dimethylbutane amide\n447-860-7\n144177-62-8\nRepr. 2\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH361f***\nH373**\nH319\nH315\nH317\nGHS08\nGHS07\nWng\nH361f***\nH373**\nH319\nH315\nH317\n\n\n\n\n612-280-00-7\n3-amino-9-ethyl carbazole;\n9-ethylcarbazol-3-ylamine\n205-057-7\n132-32-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n613-001-00-1\nethyleneimine;\naziridine\n205-793-9\n151-56-4\nFlam. Liq. 2\nCarc. 1B\nMuta. 1B\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Chronic 2\nH225\nH350\nH340\nH330\nH310\nH300\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH340\nH330\nH310\nH300\nH314\nH411\n\n\nD\n613-002-00-7\npyridine\n203-809-9\n110-86-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH312\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\n\n*\n\n\n\n613-003-00-2\n1,2,3,4-tetranitrocarbazole\n—\n6202-15-9\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\n\n\n\n\n613-004-00-8\ncrimidine (ISO);\n2-chloro-6-methylpyrimidin-4-yldimethylamine\n208-622-6\n535-89-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n613-007-00-4\ndesmetryne (ISO);\n6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine\n213-800-1\n1014-69-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n613-008-00-X\ndazomet (ISO);\ntetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione\n208-576-7\n533-74-4\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-009-00-5\n2,4,6-trichloro-1,3,5-triazine;\ncyanuric chloride\n203-614-9\n108-77-0\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH330\nH302\nH314\nH317\nGHS06\nGHS05\nDgr\nH330\nH302\nH314\nH317\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n613-010-00-0\nametryn (ISO);\n2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine\n212-634-7\n834-12-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=100\n\n\n613-011-00-6\namitrole (ISO);\n1,2,4-triazol-3-ylamine\n200-521-5\n61-82-5\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH361d ***\nH373 **\nH411\nGHS08\nGHS09\nWng\nH361d ***\nH373 **\nH411\n\n\n\n613-012-00-1\nbentazone (ISO);\n3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide\n246-585-8\n25057-89-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH319\nH317\nH412\nGHS07\nWng\nH302\nH319\nH317\nH412\n\n\n\n613-013-00-7\ncyanazine (ISO);\n2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile\n244-544-9\n21725-46-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-014-00-2\nethoxyquin(ISO);\n6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline\n202-075-7\n91-53-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-015-00-8\nfenazaflor (ISO);\nphenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate\n238-134-9\n14255-88-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n613-016-00-3\nfuberidazole(ISO);\n2-(2-furyl)benzimidazole\n223-404-0\n3878-19-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-017-00-9\nbis (8-hydroxyquinolinium) sulphate\n205-137-1\n134-31-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-018-00-4\nmorfamquat (ISO);\n1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion\n—\n7411-47-4\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH335\nH315\nH412\nGHS07\nWng\nH302\nH319\nH335\nH315\nH412\n\n\n\n613-019-00-X\nthioquinox(ISO);\n2-thio-1,3-dithiolo(4,5,b)quinoxaline\n202-272-8\n93-75-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-020-00-5\ntridemorph (ISO);\n2,6-dimethyl-4-tridecylmorpholine\n246-347-3\n24602-86-6\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH332\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D ***\nH332\nH302\nH315\nH410\n\n\n\n613-021-00-0\ndithianon (ISO);\n5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile\n222-098-6\n3347-22-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-022-00-6\npyrethrins including cinerins, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n613-023-00-1\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;\npyrethrin I\n204-455-8\n121-21-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\n\n613-024-00-7\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\npyrethrin II\n204-462-6\n121-29-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\n\n613-025-00-2\ncinerin I;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n246-948-0\n25402-06-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-026-00-8\ncinerin II;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate\n204-454-2\n121-20-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-027-00-3\npiperidine\n203-813-0\n110-89-4\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH225\nH331\nH311\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH331\nH311\nH314\n\n*\n\n613-028-00-9\nmorpholine\n203-815-1\n110-91-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDg\nH226\nH332\nH312\nH302\nH314\n\n\n\n613-029-00-4\ndichloro-1,3,5-triazinetrione;\ndichloroisocyanuric acid\n220-487-5\n2782-57-2\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n\nT\n\n\n613-030-00-X\ntroclosene potassium; [1]\ntroclosene sodium [2]\n218-828-8 [1]\n220-767-7 [2]\n2244-21-5 [1]\n2893-78-9 [2]\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n*\nSTOT SE 3; H335: C ≥ 10 %\nEUH031: C ≥ 10 %\nG\n\n613-030-01-7\ntroclosene sodium, dihydrate\n220-767-7\n51580-86-0\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH410\nEUH031\n\n\n613-031-00-5\nsymclosene;\ntrichloroisocyanuric acid;\ntrichloro-1,3,5-triazinetrion\n201-782-8\n87-90-1\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n\n\n613-032-00-0\nmethyl-2,3,5,6-tetrachloro-4-pyridylsulphone;\n2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine\n236-035-5\n13108-52-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH312\nH302\nH319\nH317\nGHS07\nWng\nH312\nH302\nH319\nH317\n\n\n\n613-033-00-6\n2-methylaziridine;\npropyleneimine\n200-878-7\n75-55-8\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nEye Dam. 1\nAquatic Chronic 2\nH225\nH350\nH330\nH310\nH300\nH318\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH330\nH310\nH300\nH318\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n613-034-00-1\n1,2-dimethylimidazole\n217-101-2\n1739-84-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\n\n\n\n613-035-00-7\n1-methylimidazole\n210-484-7\n616-47-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n613-036-00-2\n2-methylpyridine;\n2-picoline\n203-643-7\n109-06-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH226\nH332\nH312\nH302\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\nH319\nH335\n\n\n\n613-037-00-8\n4-methylpyridine;\n4-picoline\n203-626-4\n108-89-4\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH226\nH311\nH332\nH302\nH319\nH335\nH315\nGHS02\nGHS06\nDgr\nH226\nH311\nH332\nH302\nH319\nH335\nH315\n\n\n\n613-038-00-3\n6-phenyl-1,3,5-triazine-2,4-diyldiamine;\n6-phenyl-1,3,5-triazine-2,4-diamine;\nbenzoguanamine\n202-095-6\n91-76-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-039-00-9\nethylene thiourea;\nimidazolidine-2-thione;\n2-imidazoline-2-thiol\n202-506-9\n96-45-7\nRepr. 1B\nAcute Tox. 4 *\nH360D ***\nH302\nGHS08\nGHS07\nDgr\nH360D ***\nH302\n\n\n\n613-040-00-4\nazaconazole (ISO);\n1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole\n262-102-3\n60207-31-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-041-00-X\nmorpholine-4-carbonyl chloride\n239-213-0\n15159-40-7\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nH351\nH319\nH315\nGHS08\nWng\nH351\nH319\nH315\nEUH014\n\n\n613-042-00-5\nimazalil (ISO);\n1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole\n252-615-0\n35554-44-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH410\n\n\n\n613-043-00-0\nimazalil sulphate (ISO) powder;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n613-043-01-8\nimazalil sulphate (ISO), aqueous solution;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nWng\nH302\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 50 %\nSkin Irrit. 2; H315: 30 % ≤ C < 50 %\nEye Dam. 1; H318: 15 % ≤ C < 50 %\nEye Irrit. 2; H319: 5 % ≤ C < 15 %\n\n\n\n613-044-00-6\ncaptan (ISO);\n1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide\n205-087-0\n133-06-2\nCarc. 2\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH331\nH318\nH317\nH400\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH351\nH331\nH318\nH317\nH400\n\nM=10\n\n\n613-045-00-1\nfolpet (ISO);\nN-(trichloromethylthio)phthalimide\n205-088-6\n133-07-3\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH351\nH332\nH319\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH319\nH317\nH400\n\nM=10\n\n\n\n613-046-00-7\ncaptafol (ISO);\n1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide\n219-363-3\n2425-06-1\nCarc. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH317\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH317\nH410\n\n\n\n613-047-00-2\n1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;\ndimetilan (ISO)\n211-420-0\n644-64-4\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n613-048-00-8\ncarbendazim (ISO);\nmethyl benzimidazol-2-ylcarbamate\n234-232-0\n10605-21-7\nMuta. 1B\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH340\nH360FD\nH400\nH410\nGHS08\nGHS09\nDgr\nH340\nH360FD\nH410\n\n\n\n613-049-00-3\nbenomyl (ISO);\nmethyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate\n241-775-7\n17804-35-2\nMuta. 1B\nRepr. 1B\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH340\nH360FD\nH335\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH340\nH360FD\nH335\nH315\nH317\nH410\n\nM = 10\n\n613-050-00-9\ncarbadox (INN);\nmethyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;\n2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide\n229-879-0\n6804-07-5\nFlam. Sol. 1\nCarc. 1B\nAcute Tox. 4 *\nH228\nH350\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH350\nH302\n\n\nT\n613-051-00-4\nmolinate (ISO);\nS-ethyl 1-perhydroazepinecarbothioate;\nS-ethyl perhydroazepine-1-carbothioate\n218-661-0\n2212-67-1\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361f ***\nH332\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361f ***\nH332\nH302\nH373 **\nH317\nH410\n\nM = 100\n\n613-052-00-X\ntrifenmorph (ISO);\n4-tritylmorpholine\n215-812-2\n1420-06-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-053-00-5\nanilazine (ISO);\n2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline\n202-910-5\n101-05-3\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n613-054-00-0\nthiabendazol (ISO);\n2-(thiazole-4-yl)benzimidazole\n205-725-8\n148-79-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-056-00-1\n1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;\ndifenzoquat methyl sulfate\n256-152-5\n43222-48-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS09\nWng\nH302\nH410\n\n\n\n613-057-00-7\ndodemorph (ISO);\n4-cyclododecyl-2,6-dimethylmorpholine\n216-474-9\n1593-77-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH411\n\n\n\n613-058-00-2\npermethrin (ISO);\nm-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-067-9\n52645-53-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH317\nH410\n\nM = 1000\n\n613-059-00-8\nprofluralin (ISO);\nN-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine\n247-656-6\n26399-36-0\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n\n\n613-060-00-3\nresmethrin (ISO);\n5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate\n233-940-7\n10453-86-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=1000\n\n\n613-061-00-9\n6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;\nryania\n239-732-2\n15662-33-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n613-062-00-4\nsabadilla (ISO);\nveratrine\n—\n8051-02-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\n\n\n613-063-00-X\nsecbumeton (ISO);\n2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n247-554-1\n26259-45-0\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-064-00-5\n5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;\nsesamex\n—\n51-14-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-065-00-0\nsimetryn (ISO);\n2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine\n213-801-7\n1014-70-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-066-00-6\nterbumeton (ISO);\n2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n251-637-8\n33693-04-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-067-00-1\npropazine(ISO);\n2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine\n205-359-9\n139-40-2\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n613-068-00-7\natrazine (ISO);\n2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine\n217-617-8\n1912-24-9\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH317\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH317\nH410\n\n\n\n613-069-00-2\nε-caprolactam\n203-313-2\n105-60-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH332\nH302\nH319\nH335\nH315\nGHS07\nWng\nH332\nH302\nH319\nH335\nH315\n\n\n\n613-070-00-8\npropylenethiourea\n—\n2122-19-2\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 3\nH361d ***\nH302\nH412\nGHS08\nGHS07\nWng\nH361d ***\nH302\nH412\n\n\n\n613-071-00-3\n2-fluoro-5-trifluoromethylpyridine\n400-290-2\n69045-82-5\nFlam. Liq. 3\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH317\nH412\nGHS02\nGHS07\nWng\nH226\nH317\nH412\n\n\n\n613-072-00-9\nN,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine\n401-280-0\n91273-04-0\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n613-073-00-4\nN,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine\n401-410-6\n10357-99-0\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n613-074-00-X\n3-(3-methylpent-3-yl)isoxazol-5-ylamine\n401-460-9\n82560-06-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Chronic 3\nH331\nH301\nH318\nH412\nGHS06\nGHS05\nDgr\nH331\nH301\nH318\nH412\n\n\n\n613-075-00-5\n1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione\n401-570-7\n89415-87-2\nOx. Sol. 1 ****\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nH271\nH331\nH314\nH302\nH317\nH400\nGHS03\nGHS06\nGHS05\nGHS09\nDgr\nH271\nH331\nH314\nH302\nH317\nH400\n\n\n\n613-076-00-0\n3-chloro-5-trifluoromethyl-2-pyridylamine\n401-670-0\n79456-26-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-077-00-6\nreaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine\n401-940-8\n—\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH302\nH319\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH411\n\n\n\n613-078-00-1\nN,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine\n401-990-0\n106990-43-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-079-00-7\n4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers\n402-520-7\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH315\nH317\nH410\n\n\n\n613-080-00-2\n3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione\n402-540-6\n105254-85-1\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n613-081-00-8\n1-butyl-2-methylpyridinium bromide\n402-680-8\n26576-84-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-082-00-3\n2-methyl-1-pentylpyridinium bromide\n402-690-2\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH312\nH302\nH412\nGHS07\nWng\nH312\nH302\nH412\n\n\n\n613-083-00-9\n2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate\n402-120-2\n—\nSkin Corr. 1B\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH373 **\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH373 **\nH317\nH410\n\n\n\n613-084-00-4\n2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate\n402-490-5\n106359-93-7\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n613-085-00-X\nreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione\n401-970-1\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-086-00-5\ncaffeine\n200-362-1\n58-08-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-087-00-0\ntetrahydrothiophene\n203-728-9\n110-01-0\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH225\nH332\nH312\nH302\nH319\nH315\nH412\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH315\nH412\n\n\n\n613-088-00-6\n1,2-benzisothiazol-3(2H)-one;\n1,2-benzisothiazolin-3-one\n220-120-9\n2634-33-5\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH302\nH315\nH318\nH317\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH317\nH400\n\nSkin Sens. 1; H317: C ≥ 0,05 %\n\n613-089-00-1\ndiquat dibromide; [1]\ndiquat dichloride; [2]\n6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]\n201-579-4 [1]\n223-714-6 [2]\n301-467-6 [3]\n85-00-7 [1]\n4032-26-2 [2]\n94021-76-8 [3]\nAcute Tox. 2 *\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH372 **\nH302\nH319\nH335\nH315\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH372 **\nH302\nH319\nH335\nH315\nH317\nH410\n\n\n\n613-090-00-7\nparaquat dichloride;\n1,1-dimethyl-4,4'-bipyridinium dichloride; [1]\nparaquat dimethylsulfate;\n1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]\n217-615-7 [1]\n218-196-3 [2]\n1910-42-5 [1]\n2074-50-2 [2]\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH311\nH301\nH372 **\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH311\nH301\nH372 **\nH319\nH335\nH315\nH410\n\n\n\n613-091-00-2\nmorfamquat dichloride; [1]\nmorfamquat sulfate [2]\n225-062-8 [1]\n[2]\n4636-83-3 [1]\n29873-36-7 [2]\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH335\nH315\nH412\nGHS07\nWng\nH302\nH319\nH335\nH315\nH412\n\n\n\n613-092-00-8\n1,10-phenanthroline\n200-629-2\n66-71-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n613-093-00-3\nhexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n400-050-7\n85153-92-0\nResp. Sens. 1\nSkin Sens. 1\nH334\nH317\nGHS08\nDgr\nH334\nH317\n\n\n\n613-094-00-9\n4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine\n401-360-5\n5248-39-5\nAcute Tox. 4 *\nSTOT RE 2 *\nH302\nH373 **\nGHS08\nGHS07\nWng\nH302\nH373 **\n\n\n\n613-095-00-4\nsodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate\n403-080-9\n92484-48-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-096-00-X\n2-amino-6-ethoxy-4-methylamino-1,3,5-triazine\n403-580-7\n62096-63-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-097-00-5\n7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid\n403-690-5\n111298-82-9\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH334\nH317\nH412\nGHS08\nDgr\nH334\nH317\nH412\n\n\n\n613-098-00-0\nN-(n-octyl)-2-pyrrolidone\n403-700-8\n2687-94-7\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n613-099-00-6\n1-dodecyl-2-pyrrolidone\n403-730-1\n2687-96-9\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n613-100-00-X\n2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione\n404-230-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n613-101-00-5\nN—tert-pentyl-2-benzothiazolesulfenamide\n404-380-2\n110799-28-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-102-00-0\ndimethomorph (ISO);\n4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine\n404-200-2\n110488-70-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-103-00-6\nsodium 5-n-butylbenzotriazole\n404-450-2\n118685-34-0\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH411\n\n\n\n613-104-00-1\n5-tert-butyl-3-isoxazolylamine hydrochloride\n404-840-2\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH373 **\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH318\nH412\n\n\n\n613-105-00-7\nhexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)\n405-160-9\n124537-30-0\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH317\nH412\nGHS06\nDgr\nH301\nH317\nH412\n\n\n\n613-106-00-2\ntetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate\n405-240-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n613-107-00-8\nhexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate\n405-280-1\n76508-02-6\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n613-108-00-3\nbenzothiazole-2-thiol\n205-736-8\n149-30-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-109-00-9\nbis(piperidinothiocarbonyl) disulphide\n202-328-1\n94-37-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH335\nH315\nH317\nGHS07\nWng\nH319\nH335\nH315\nH317\n\n\n\n613-110-00-4\ndimepiperate (ISO);\nS-(1-methyl-1-phenylethyl) piperidine-1-carbothioate\n262-784-2\n61432-55-1\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n613-111-00-X\n1,2,4-triazole\n206-022-9\n288-88-0\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nH361d ***\nH302\nH319\nGHS08\nGHS07\nWng\nH361d ***\nH302\nH319\n\n\n\n613-112-00-5\nocthilinone (ISO);\n2-octyl-2H-isothiazol-3-one\n247-761-7\n26530-20-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH302\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH302\nH314\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,05 %\n\n613-113-00-0\n2-(morpholinothio)benzothiazole\n203-052-4\n102-77-2\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH411\n\n\n\n613-114-00-6\n2,2',2\"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;\n1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine\n225-208-0\n4719-04-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n613-115-00-1\nhymexazol (ISO);\n3-hydroxy-5-methylisoxazole\n233-000-6\n10004-44-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n\n613-116-00-7\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nAcute Tox. 2 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH330\nH372**\nH319\nH335\nH315\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH372**\nH319\nH335\nH315\nH317\nH400\n\nM=10\n\n\n\n\n613-116-01-4\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH319\nH335\nH315\nH317\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH400\n\nM=10\n\n\n613-117-00-2\ndiniconazole (ISO);\n(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;\n(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol\n—\n76714-88-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-118-00-8\nflubenzimine (ISO);\nN-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline\n253-703-1\n37893-02-0\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n613-119-00-3\n(benzothiazol-2-ylthio)methyl thiocyanate;\nTCMTB\n244-445-0\n21564-17-0\nAcute Tox. 2 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH319\nH315\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH302\nH319\nH315\nH317\nH410\n\n\n\n\n\n613-120-00-9\nbioresmethrin (ISO);\n(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate\n249-014-0\n28434-01-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n613-121-00-4\nchlorsulfuron (ISO);\n2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide\n265-268-5\n64902-72-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-122-00-X\ndiclobutrazole (ISO);\n(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;\n(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol\n—\n75736-33-3\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n613-123-00-5\n5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;\netem\n251-684-4\n33813-20-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-124-00-0\nfenpropimorph (ISO);\ncis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine\n266-719-9\n67564-91-4\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 2\nH361d ***\nH302\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH315\nH411\n\n\n\n613-125-00-6\nhexythiazox(ISO);\ntrans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide\n—\n78587-05-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-126-00-1\nimazapyr (ISO);\n2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate\n—\n81334-34-1\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n613-127-00-7\n1,1-dimethylpiperidinium chloride;\nmepiquat chloride\n246-147-6\n24307-26-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-128-00-2\nprochloraz (ISO);\nN-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide\n266-994-5\n67747-09-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-129-00-8\nmetamitron (ISO);\n4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one\n255-349-3\n41394-05-2\nAcute Tox. 4 *\nAquatic Acute 1\nH302\nH400\nGHS07\nGHS09\nWng\nH302\nH400\n\n\n\n613-131-00-9\npyroquilon (ISO);\n1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one\n—\n57369-32-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-132-00-4\nhexazinone (ISO);\n3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione\n257-074-4\n51235-04-2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-133-00-X\netridiazole (ISO);\n5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole\n219-991-8\n2593-15-9\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH331\nH312\nH302\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH312\nH302\nH410\n\n\n\n613-134-00-5\nmyclobutanil(ISO);\n2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile\n—\n88671-89-0\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH361d ***\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH319\nH411\n\n\n\n613-135-00-0\ndi(benzothiazol-2-yl) disulphide\n204-424-9\n120-78-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\nEUH031\n\n\n613-136-00-6\nN-cyclohexylbenzothiazole-2-sulphenamide\n202-411-2\n95-33-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-137-00-1\nmethabenzthiazuron (ISO);\n1-(1,3-benzothiazol-2-yl)1,3-dimethylurea\n242-505-0\n18691-97-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-138-00-7\nquinoxyfen (ISO);\n5,7-dichloro-4-(4-fluorophenoxy)quinoline\n—\n124495-18-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n\n613-139-00-2\nmetsulfuron-methyl (ISO);\n2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid\n—\n74223-64-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n613-140-00-8\ncycloheximide (ISO);\n4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione\n200-636-0\n66-81-9\nMuta. 2\nRepr. 1B\nAcute Tox. 2 *\nAquatic Chronic 2\nH341\nH360D ***\nH300\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH360D ***\nH300\nH411\n\n\n\n613-141-00-3\n1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone\n401-470-3\n93686-63-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-142-00-9\ntrans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate\n405-860-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-143-00-4\n1-(3-phenylpropyl)-2-methylpyridinium bromide\n405-930-4\n10551-42-5\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH412\nGHS07\nWng\nH302\nH319\nH412\n\n\n\n613-144-00-X\nreaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate\n406-460-2\n125139-08-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-145-00-5\n(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate\n406-960-0\n77497-97-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-146-00-0\nN-ethyl-N-methylpiperidinium iodide\n407-780-5\n4186-71-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n613-147-00-6\n4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine\n407-940-4\n111681-72-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-148-00-1\ntetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane\n411-240-4\n143683-23-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-149-00-7\npyridaben (ISO);\n2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one\n405-700-3\n96489-71-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\n\n\n613-150-00-2\n2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione\n406-295-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-151-00-8\n1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine\n406-360-9\n104218-44-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-152-00-3\nphenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate\n406-600-2\n89392-03-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-153-00-9\n2,3,5-trichloropyridine\n407-270-2\n16063-70-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-154-00-4\n2-amino-4-chloro-6-methoxypyrimidine\n410-050-9\n5734-64-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-155-00-X\n5-chloro-2,3-difluoropyridine\n410-090-7\n89402-43-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAquatic Chronic 3\nH226\nH302\nH412\nGHS02\nGHS07\nWng\nH226\nH302\nH412\n\n\n\n613-156-00-5\n2-butyl-4-chloro-5-formylimidazole\n410-260-0\n83857-96-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-157-00-0\n2,4-diamino-5-methoxymethylpyrimidine\n410-330-0\n54236-98-5\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nH302\nH373 **\nH319\nGHS08\nGHS07\nWng\nH302\nH373 **\nH319\n\n\n\n613-158-00-6\n2,3-dichloro-5-trifluoromethyl-pyridine\n410-340-5\n69045-84-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH332\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH317\nH411\n\n\n\n613-159-00-1\nfenazaquin (ISO);\n4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline\n410-580-0\n120928-09-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH332\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH332\nH410\n\n\n\n613-160-00-7\n(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide\n411-000-9\n125224-62-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n613-161-00-2\n2,4-diamino-6-hydroxymethylpteridinehydrobromide\n430-620-0\n76145-91-0\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373**\nH317\nH412\nGHS08\nGHS07\nWng\nH373**\nH317\nH412\n\n\n\n\n613-162-00-8\n(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide\n423-260-0\n100988-63-4\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH317\nH411\n\n\n\n\n\n\n613-163-00-3\nazimsulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea\n—\n120162-55-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n613-164-00-9\nflufenacet (ISO);\nN-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide\n—\n142459-58-3\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\nM=100\n\n\n613-165-00-4\nflupyrsulfuron-methyl-sodium (ISO);\nmethyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt\n—\n144740-54-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=100\n\n\n613-166-00-X\nflumioxazin (ISO);\nN-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide\n—\n103361-09-7\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D***\nH410\n\nM=1000\n\n\n613-167-00-5\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)\n—\n55965-84-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 0,6 %\nSkin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %\nEye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %\nSkin Sens. 1; H317: C ≥ 0,0015 %\n\n613-168-00-0\n1-vinyl-2-pyrrolidone\n201-800-4\n88-12-0\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nEye Dam. 1\nH351\nH332\nH312\nH302\nH373 **\nH335\nH318\nGHS06\nGHS05\nGHS09\nDgr\nH351\nH332\nH312\nH302\nH373 **\nH335\nH318\n\n\nD\n\n\n\n613-169-00-6\n9-vinylcarbazole\n216-055-0\n1484-13-5\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH312\nH302\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH312\nH302\nH315\nH317\nH410\n\nM=100\n\n\n613-170-00-1\n2,2-ethylmethylthiazolidine\n404-500-3\n694-64-4\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-171-00-7\nhexaconazole (ISO);\n(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol\n413-050-7\n79983-71-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n613-172-00-2\n5-chloro-1,3-dihydro-2H-indol-2-one\n412-200-9\n17630-75-0\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH361f ***\nH302\nH317\nH412\nGHS08\nGHS07\nWng\nH361f ***\nH302\nH317\nH412\n\n\n\n613-173-00-8\nfluquinconazole (ISO);\n3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one\n411-960-9\n136426-54-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH372 **\nH312\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH301\nH372 **\nH312\nH315\nH410\n\n\n\n\n\n\n613-174-00-3\ntetraconazole (ISO);\n(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether\n407-760-6\n112281-77-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH302\nH411\nGHS07\nGHS09\nWng\nH332\nH302\nH411\n\n\n\n\n613-175-00-9\nepoxiconazole(ISO);\n(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane\n406-850-2\n133855-98-8\nCarc. 2\nRepr. 2\nAquatic Chronic 2\nH351\nH361fd\nH411\nGHS08\nGHS09\nWng\nH351\nH361fd\nH411\n\n\n\n613-176-00-4\n2-methyl-2-azabicyclo[2.2.1]heptane\n404-810-9\n4524-95-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nH226\nH312\nH302\nH373 **\nH314\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH373 **\nH314\n\n\n\n613-177-00-X\n8-amino-7-methylquinoline\n412-760-4\n5470-82-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH317\nH411\n\n\n\n613-178-00-5\n4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine\n410-470-2\n137796-06-6\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\nSTOT SE 3; H335: C ≥ 5 %\n\n613-179-00-0\nlithium 3-oxo-1,2(2H)-benzisothiazol-2-ide\n411-690-1\n111337-53-2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH411\n\n\n\n613-180-00-6\nN-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide\n407-430-1\n3741-80-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-181-00-1\n5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone\n405-090-9\n67485-29-4\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH372 **\nH302\nH319\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH302\nH319\nH410\n\n\n\n613-182-00-7\n1-(1-naphthylmethyl)quinolinium chloride\n406-220-7\n65322-65-8\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH351\nH341\nH302\nH315\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH341\nH302\nH315\nH318\nH412\n\n\n\n613-183-00-2\nreaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;\n5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one\n413-640-4\n—\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n613-184-00-8\nnitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate\n413-670-8\n—\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n613-185-00-3\n2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one\n407-630-9\n82633-79-2\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n613-186-00-9\n(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate\n408-050-9\n76855-69-1\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH317\nH411\n\n\n\n\n\n613-187-00-4\n5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene\n410-530-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-188-00-X\n1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone\n411-500-7\n116256-11-2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-189-00-5\n1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane\n414-030-0\n52667-88-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-190-00-0\ndisodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate\n414-040-5\n149530-93-8\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n613-191-00-6\n3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine\n421-150-7\n143860-04-2\nRepr. 1B\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360F ***\nH314\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH360F ***\nH314\nH410\n\n\n\n\n\n\n613-192-00-1\n3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane\n426-750-2\n151860-15-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-193-00-7\npentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate\n414-930-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-194-00-2\n6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt\n418-000-8\n163062-28-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-195-00-8\n2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)\n418-280-1\n18600-59-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n613-196-00-3\n5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt\n418-380-5\n168113-78-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-197-00-9\nreaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;\n2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;\n[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;\n[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine\n420-390-1\n187547-46-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n613-198-00-4\n2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine\n415-500-8\n145963-84-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n613-199-00-X\nreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;\nreaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione\n421-550-1\n—\nCarc. 1B\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH360D ***\nH317\nH412\nGHS08\nDgr\nH350\nH360D ***\nH317\nH412\n\n\n\n613-200-00-3\nReaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts\n420-980-7\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-201-00-9\n(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole\n422-390-5\n143322-57-0\nRepr. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH372 **\nH332\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH361f ***\nH372 **\nH332\nH302\nH317\nH410\nEUH070\n\n\n613-202-00-4\npymetrozine (ISO);\n(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one\n—\n123312-89-0\nCarc. 2\nAquatic Chronic 3\nH351\nH412\nGHS08\nWng\nH351\nH412\n\n\n\n\n\n613-203-00-X\npyraflufen-ethyl (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]\npyraflufen (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]\n- [1]\n- [2]\n129630-19-9 [1]\n129630-17-7 [2]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n613-204-00-5\noxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;\n5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one\n254-637-6\n39807-15-3\nRepr. 1A\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Fd\nH373**\nH400\nH410\nGHS08\nGHS09\nDgr\nH360Fd\nH373**\nH410\n\nM=1000\n\n\n613-205-00-0\npropiconazole(ISO);\n(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole\n262-104-4\n60207-90-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n613-206-00-6\nfenamidone (ISO);\n(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one\n—\n161326-34-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-208-00-7\nimazamox (ISO);\n(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid\n—\n114311-32-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-209-00-2\ncis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride\n417-430-3\n63645-17-0\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH373 **\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH411\n\n\n\n613-210-00-8\n2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane\n417-650-1\n88128-57-8\nSTOT RE 2 *\nAquatic Chronic 3\nH373 **\nH412\nGHS08\nWng\nH373 **\nH412\n\n\n\n613-211-00-3\nN-methyl-4-(p-formylstyryl)pyridinium methylsulfate\n418-240-3\n74401-04-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-212-00-9\n4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)\n418-320-8\n133467-41-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-213-00-4\ncis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline\n416-040-0\n120807-02-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-214-00-X\nN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide\n416-260-7\n147613-95-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-215-00-5\n2-chloromethyl-3,4-dimethoxypyridinium chloride\n416-440-5\n72830-09-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH373 **\nH315\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH315\nH318\nH317\nH411\n\n\n\n613-216-00-0\n6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole\n416-490-8\n162208-01-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-217-00-6\n4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine\n416-770-1\n73754-27-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-218-00-1\n6-hydroxyindole\n417-020-4\n2380-86-1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-219-00-7\n7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole\n417-140-7\n79185-77-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n613-220-00-2\ntrans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide\n417-290-3\n147086-81-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-221-00-8\n2-chloro-5-methyl-pyridine\n418-050-0\n18368-64-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 3\nH312\nH302\nH315\nH412\nGHS07\nWng\nH312\nH302\nH315\nH412\n\n\n\n613-222-00-3\n4-(1-oxo-2-propenyl)-morpholine\n418-140-1\n5117-12-4\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373 **\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH318\nH317\n\n\n\n613-223-00-9\nN-isopropyl-3-(4-fluorophenyl)-1H-indole\n418-790-4\n93957-49-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-224-00-4\n2,5-dimercaptomethyl-1,4-dithiane\n419-770-8\n136122-15-1\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n613-225-00-X\nreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;\n2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.\n421-290-9\n—\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n613-226-00-5\n1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride\n420-950-3\n163831-67-2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n613-227-00-0\n(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-600-2\n99199-90-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-228-00-6\n(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-630-6\n793669-26-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n613-229-00-1\n1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine\n411-930-5\n106917-31-1\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n\n\n613-230-00-7\nflorasulam (ISO);\n2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];\npyrimidine-2-sulfonanilide\n—\n145701-23-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n613-231-00-2\n2,6-diamino-3-((pyridine-3-yl)azo)pyridine\n421-430-9\n28365-08-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373**\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH411\n\n\n\n\n613-232-00-8\n3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide\n431-030-6\n163269-30-5\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH373**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH331\nH373**\nH318\nH410\n\n\n\n\n613-233-00-3\n4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane\n423-230-7\n56552-15-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n\n613-234-00-9\nimidazo[1,2-b]pyridazin hydrochloride\n431-510-5\n18087-70-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n613-235-00-4\n2,3-dihydro-2,2-dimethyl-1H-perimidine\n424-060-6\n6364-17-6\nAcute Tox. 4*\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\n\n\n\n613-236-00-X\n2-chloro-3-trifluoromethylpyridine\n424-520-6\n65753-47-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1B\nAquatic Chronic 3\nH311\nH301\nH372**\nH314\nH412\nGHS06\nGHS05\nGHS08\nDgr\nH311\nH301\nH372**\nH314\nH412\n\n\n\n\n613-237-00-5\n6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine\n424-950-4\n133949-92-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-238-00-0\nsodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate\n430-890-1\n81992-66-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n613-239-00-6\n2-[3-(methylamino)propyl]-1H-benzimidazole\n425-760-4\n64137-52-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n613-241-00-7\n3-(2H-tetrazol-5-yl)pyridine\n426-810-8\n3250-74-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-242-00-2\nreaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts\n426-860-0\n191877-09-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-243-00-8\n4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)\n427-350-0\n182235-14-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-244-00-3\n5,7-dichloro-4-hydroxyquinoline\n427-420-0\n21873-52-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-245-00-9\n2-fluoro-6-trifluoromethylpyridine\n428-100-3\n94239-04-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH226\nH332\nH302\nH412\nGHS02\nGHS07\nWng\nH226\nH332\nH302\nH412\n\n\n\n\n613-246-00-4\n2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine\n428-200-7\n103577-66-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-247-00-X\n3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole\n428-910-7\n107786-36-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-248-00-5\n3,4-dimethyl-1H-pyrazole\n429-130-1\n2820-37-3\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-249-00-0\n1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate\n429-300-3\n155601-30-2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n\n613-250-00-6\nreaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;\nmethyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;\n2-isopropyl-N-hydroxyethyl 1,3-oxazolidine\n429-990-6\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n613-251-00-1\n(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole\n430-560-5\n180637-89-2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\n\n\n\n\n613-253-00-2\n2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;\nreaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)\n430-580-4\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\nEUH019\n\n\n\n613-254-00-8\nforchlorfenuron (ISO);\n1-(2-chloro-4-pyridyl)-3-phenylurea\n—\n68157-60-8\nCarc. 2\nAquatic Chronic 2\nH351\nH411\nGHS08\nGHS09\nWng\nH351\nH411\n\n\n\n\n613-255-00-3\nreaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)\n424-270-8\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-256-00-9\n3'5'-anhydro thymidine\n425-810-5\n38313-48-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-257-00-4\n2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate\n426-400-9\n170222-39-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n613-258-00-X\nreaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;\n4-chloro-5-methylbenzotriazole sodium salt;\n5-chloro-4-methylbenzotriazole sodium salt\n427-730-6\n202420-04-0\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n\n613-259-00-5\nreaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;\n[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate\n428-790-6\n72963-72-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n613-260-00-0\n(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin\n430-730-9\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n613-261-00-6\npyrazole-1-carboxamidine monohydrochloride\n429-520-1\n4023-02-3\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH373**\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\nH412\n\n\n\n\n613-262-00-1\ndisodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene\n427-310-2\n180850-95-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-263-00-7\nmonosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate\n429-570-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-266-00-3\n2-chloro-5-chloromethylthiazole\n429-830-5\n105827-91-6\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH311\nH314\nH302\nH317\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH314\nH302\nH317\nH411\n\n\n\n\n613-267-00-9\nthiamethoxam (ISO);\n3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine\n428-650-4\n153719-23-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n613-268-00-4\n(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine\n425-930-8\n151213-39-7\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH314\nH332\nH302\nH373**\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH314\nH332\nH302\nH373**\nH411\n\n\n\n\n613-269-00-X\n2-thiazolidinylidenecyanamide\n427-720-1\n26364-65-8\nAcute Tox. 4*\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n613-270-00-5\n5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide\n428-150-6\n113171-13-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-271-00-0\ntritosulfuron (ISO) (containing ≤ 0,02 % AMTT);\n1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)\n—\n142469-14-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n613-272-00-6\npyraclostrobin (ISO);\nmethyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate\n—\n—\nAcute Tox. 3 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH315\nH410\n\nM=100\n\n\n613-273-00-1\ntetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine\n427-600-9\n192439-46-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-274-00-7\n2,6-dichloro-1-fluoropyridiniumtetrafluoroborate\n427-400-1\n140623-89-8\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH317\nH410\n\n\n\n\n613-275-00-2\n3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride\n424-530-0\n93076-03-0\nAcute Tox. 3 *\nSTOT SE 2\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH371**\nH373**\nH318\nH317\nH411\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH371\nH373**\nH318\nH317\nH411\n\n\n\n\n613-276-00-8\n1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one\n426-110-2\n98377-35-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-277-00-3\n(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one\n427-070-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-278-00-9\n(3-aminophenyl)pyridin-3-ylmethanone\n428-230-0\n79568-06-2\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n613-279-00-4\n2-ethyl-2,3-dihydro-2-methyl-1H-perimidine\n424-380-6\n43057-68-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n613-280-00-X\ntetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;\ndimethyl propyleneurea\n230-625-6\n7226-23-5\nRepr. 2\nAcute Tox. 4 *\nEye Dam. 1\nH361f***\nH302\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH361f***\nH302\nH318\n\n\n\n\n613-281-00-5\nquinoline\n202-051-6\n91-22-5\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH350\nH341\nH312\nH302\nH319\nH315\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH312\nH302\nH319\nH315\nH411\n\n\n\n\n613-282-00-0\ntriticonazole (ISO);\n(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol\n—\n131983-72-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-283-00-6\nketoconazole;\n1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone\n265-667-4\n65277-42-1\nRepr. 1B\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360F***\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360F***\nH301\nH373**\nH410\n\n\n\n\n613-284-00-1\nmetconazole (ISO);\n(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol\n—\n125116-23-6\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH361d***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH302\nH411\n\n\n\n\n613-285-00-7\n1-hydroxybenzotriazole, anhydrous; [1]\n1-hydroxybenzotriazole, monohydrated [2]\n219-989-7 [1]\n219-989-7 [2]\n2592-95-2 [1]\n123333-53-9 [2]\nExpl. 1.3\nH203\nGHS01\nDgr\nH203\n\n\n\n\n613-286-00-2\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]\n418-260-2\n183196-57-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-286-01-X\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]\n418-260-2\n183196-57-8\nRepr. 1B\nSkin Sens. 1\nH360D***\nH317\nGHS08\nGHS07\nDgr\nH360D***\nH317\n\n\n\n\n613-287-00-8\n1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole\n419-540-7\n160194-26-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n613-288-00-3\n1,3-bis(dimethylcarbamoyl)-imidazolium chloride\n420-930-4\n135756-61-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-289-00-9\n3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole\n432-020-4\n142623-48-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-290-00-4\n4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride\n432-470-1\n189012-93-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n613-291-00-X\n2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one\n434-820-9\n106461-41-0\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n613-292-00-5\nN,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine\n435-010-8\n26157-73-3\nMuta. 2\nAquatic Chronic 3\nH341\nH412\nGHS08\nWng\nH341\nH412\n\n\n\n\n613-293-00-0\n2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester\n448-050-6\n444065-11-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-294-00-6\n2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester\n448-260-8\n379268-96-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-295-00-1\n11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride\n448-720-8\n363138-44-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-296-00-7\npentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate\n418-270-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-297-00-2\n5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole\n420-820-6\n—\nFlam. Liq. 3\nAcute Tox. 4 *\nAquatic Chronic 2\nH226\nH302\nH411\nGHS02\nGHS07\nGHS09\nWng\nH226\nH302\nH411\n\n\n\n\n613-298-00-8\nbis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate\n421-560-6\n—\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH373**\nH318\nH411\nGHS05\nGHS08\nGHS09\nDgr\nH373**\nH318\nH411\n\n\n\n\n613-299-00-3\nmain component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt\n422-610-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-300-00-7\n1-imidazol-1-yl-octadecan-2-ol\n434-120-3\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n613-301-00-2\ndimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate\n443-910-7\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-302-00-8\ndisodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate\n432-980-4\n243858-60-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-303-00-3\n2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine\n429-800-1\n95737-68-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-304-00-9\n5,6-dihydroxy-2,3-dihydro-1H-indolium bromide\n421-170-6\n138937-28-7\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n613-305-00-4\n2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole\n448-630-9\n3147-77-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-306-00-X\n(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate\n433-520-5\n82911-69-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n613-307-00-5\nclothianidin (ISO);\n3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine\n—\n210880-92-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n613-308-00-0\n2-amino-5-methylthiazole\n423-800-5\n7305-71-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n613-309-00-6\n1-methyl-3-phenyl-1-piperazine\n431-180-2\n5271-27-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH312\nH302\nH315\nH318\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH315\nH318\nH412\n\n\n\n\n613-310-00-1\n(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride\n432-360-3\n105813-13-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n613-311-00-7\nmethyl-5-nitrophenyl-guanidine\n435-500-1\n152460-07-6\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH319\nH317\nH412\nGHS07\nWng\nH302\nH319\nH317\nH412\n\n\n\n\n613-312-00-2\n2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride\n420-200-5\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n613-313-00-8\n2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione\n442-780-9\n173838-67-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-314-00-3\n4-decyloxazolidin-2-one;\n4-decyl-1,3-oxazolidin-2-one\n443-770-7\n7693-82-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-315-00-9\ntetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate\n430-390-1\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH412\nGHS07\nWng\nH332\nH412\n\n\n\n\n613-316-00-4\ntrimethylopropane tri(3-aziridinylpropanoate);\n(TAZ)\n257-765-0\n52234-82-9\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nH341\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH318\nH317\n\n\nH\n\n614-001-00-4\nnicotine (ISO);\n3-(N-methyl-2-pyrrolidinyl)pyridine\n200-193-3\n54-11-5\nAcute Tox. 1\nAcute Tox. 3 *\nAquatic Chronic 2\nH310\nH301\nH411\nGHS06\nGHS09\nDgr\nH310\nH301\nH411\n\n\n\n614-002-00-X\nsalts of nicotine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH411\n\n\nA\n614-003-00-5\nstrychnine\n200-319-7\n57-24-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n614-004-00-0\nsalts of strychnine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\nA\n\n\n614-005-00-6\ncolchicine\n200-598-5\n64-86-8\nMuta. 1B\nAcute Tox. 2 *\nH340\nH300\nGHS06\nGHS08\nDgr\nH340\nH300\n\n\n\n\n614-006-00-1\nbrucine;\n2,3-dimethoxystrychnine\n206-614-7\n357-57-3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Chronic 3\nH330\nH300\nH412\nGHS06\nDgr\nH330\nH300\nH412\n\n\n\n614-007-00-7\nbrucine sulphate; [1]\nbrucine nitrate; [2]\nstrychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]\nstrychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]\n225-432-9 [1]\n227-317-9 [2]\n269-439-5 [3]\n269-710-8 [4]\n4845-99-2 [1]\n5786-97-0 [2]\n68239-26-9 [3]\n68310-42-9 [4]\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Chronic 3\nH330\nH300\nH412\nGHS06\nDgr\nH330\nH300\nH412\n\n\nA\n614-008-00-2\naconitine\n206-121-7\n302-27-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-009-00-8\nsalts of aconitine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-010-00-3\natropine\n200-104-8\n51-55-8\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-011-00-9\nsalts of atropine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-012-00-4\nhyoscyamine\n202-933-0\n101-31-5\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-013-00-X\nsalts of hyoscyamine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-014-00-5\nhyoscine\n200-090-3\n51-34-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n614-015-00-0\nsalts of hyoscine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\nA\n614-016-00-6\npilocarpine\n202-128-4\n92-13-7\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-017-00-1\nsalts of pilocarpine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-018-00-7\npapaverine\n200-397-2\n58-74-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n614-019-00-2\nsalts of papaverine\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n614-020-00-8\nphysostigmine\n200-332-8\n57-47-6\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-021-00-3\nsalts of physostigmine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-022-00-9\ndigitoxin\n200-760-5\n71-63-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-023-00-4\nephedrine\n206-080-5\n299-42-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n614-024-00-X\nsalts of ephedrine\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n614-025-00-5\nouabain\n211-139-3\n630-60-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-026-00-0\nstrophantin-K\n234-239-9\n11005-63-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-027-00-6\nbufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;\nred squill;\nscilliroside\n208-077-4\n507-60-8\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n614-028-00-1\nreaction mass of: 2-ethylhexyl mono-D-glucopyranoside;\n2-ethylhexyl di-D-glucopyranoside\n414-420-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n614-029-00-7\nconstitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside\n419-640-0\n68784-14-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n615-001-00-7\nmethyl isocyanate\n210-866-3\n624-83-9\nFlam. Liq. 2\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nResp. Sens. 1\nSkin Sens. 1\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH225\nH361d***\nH330\nH311\nH301\nH334\nH317\nH335\nH315\nH318\nGHS02\nGHS06\nGHS05\nGHS08\nDgr\nH225\nH361d***\nH330\nH311\nH301\nH334\nH317\nH335\nH315\nH318\n\n\n\n\n615-002-00-2\nmethyl isothiocyanate\n209-132-5\n556-61-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH301\nH314\nH317\nH410\n\n\n\n615-003-00-8\nthiocyanic acid\n207-337-4\n463-56-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\nEUH032\n\n\n\n\n\n615-004-00-3\nsalts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\nEUH032\n\nA\n\n615-005-00-9\n4,4'-methylenediphenyl diisocyanate;\ndiphenylmethane-4,4'-diisocyanate; [1]\n2,2'-methylenediphenyl diisocyanate;\ndiphenylmethane-2,2'-diisocyanate; [2]\no-(p-isocyanatobenzyl)phenyl isocyanate;\ndiphenylmethane-2,4'-diisocyanate; [3]\nmethylenediphenyl diisocyanate [4]\n202-966-0 [1]\n219-799-4 [2]\n227-534-9 [3]\n247-714-0 [4]\n101-68-8 [1]\n2536-05-2 [2]\n5873-54-1 [3]\n26447-40-5 [4]\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH351\nH332\nH373**\nH319\nH335\nH315\nH334\nH317\nGHS08\nGHS07\nDgr\nH351\nH332\nH373**\nH319\nH335\nH315\nH334\nH317\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\nResp. Sens. 1; H334: C ≥ 0,1 %\nSTOT SE 3; H335: C ≥ 5 %\nC2\n\n615-006-00-4\n2-methyl-m-phenylene diisocyanate;\ntoluene-2,4-di-isocyanate; [1]\n4-methyl-m-phenylene diisocyanate;\ntoluene-2,6-di-isocyanate; [2]\nm-tolylidene diisocyanate;\ntoluene-diisocyanate [3]\n202-039-0 [1]\n209-544-5 [2]\n247-722-4 [3]\n91-08-7 [1]\n584-84-9 [2]\n26471-62-5 [3]\nCarc. 2\nAcute Tox. 2 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH351\nH330\nH319\nH335\nH315\nH334\nH317\nH412\nGHS06\nGHS08\nDgr\nH351\nH330\nH319\nH335\nH315\nH334\nH317\nH412\n\nResp. Sens. 1; H334: C ≥ 0,1 %\nC\n615-007-00-X\n1,5-naphthylene diisocyanate\n221-641-4\n3173-72-6\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nAquatic Chronic 3\nH332\nH319\nH335\nH315\nH334\nH412\nGHS08\nGHS07\nDgr\nH332\nH319\nH335\nH315\nH334\nH412\n\n\n\n615-008-00-5\n3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;\nisophorone di-isocyanate\n223-861-6\n4098-71-9\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 2\nH331\nH319\nH335\nH315\nH334\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\nH411\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens.1; H317: C ≥ 0,5 %\n2\n615-009-00-0\n4,4'-methylenedi(cyclohexyl isocyanate);\ndicyclohexylmethane-4,4'-di-isocyanate\n225-863-2\n5124-30-1\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH331\nH319\nH335\nH315\nH334\nH317\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n2\n615-010-00-6\n2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]\n2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]\n241-001-8 [1]\n239-714-4 [2]\n16938-22-0 [1]\n15646-96-5 [2]\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH331\nH319\nH335\nH315\nH334\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\nC2\n615-011-00-1\nhexamethylene-di-isocyanate\n212-485-8\n822-06-0\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH331\nH319\nH335\nH315\nH334\nH317\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n2\n615-012-00-7\n4-isocyanatosulphonyltoluene;\ntosyl isocyanate\n223-810-8\n4083-64-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\nEUH014\nEye Irrit.; H319: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n615-013-00-2\ncyanamide;\ncarbanonitril\n206-992-3\n420-04-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH301\nH312\nH319\nH315\nH317\nGHS06\nDgr\nH301\nH312\nH319\nH315\nH317\n\n\n\n615-014-00-8\ntris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate\n—\n7276-58-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n615-015-00-3\n1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;\nisobornyl thiocyanoacetate\n204-081-5\n115-31-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n615-016-00-9\npotassium cyanate\n209-676-3\n590-28-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n615-017-00-4\ncalcium cyanamide\n205-861-8\n156-62-7\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH302\nH335\nH318\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\n\n\n\n615-018-00-X\n2-(2-butoxyethoxy)ethyl thiocyanate\n203-985-7\n112-56-1\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nH226\nH311\nH301\nGHS02\nGHS06\nDgr\nH226\nH311\nH301\n\n\n\n615-019-00-5\ndicyclohexylcarbodiimide\n208-704-1\n538-75-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH311\nH302\nH318\nH317\nGHS06\nGHS05\nDgr\nH311\nH302\nH318\nH317\n\n\n\n615-020-00-0\nmethylene dithiocyanate\n228-652-3\n6317-18-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nH330\nH301\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH301\nH314\nH317\nH400\n\n\n\n615-021-00-6\n1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;\nTGIC\n219-514-3\n2451-62-9\nMuta. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH340\nH331\nH301\nH373 **\nH318\nH317\nH412\nGHS06\nGHS08\nGHS05\nDgr\nH340\nH331\nH301\nH373 **\nH318\nH317\nH412\n\n\n\n\n\n615-022-00-1\nmethyl 3-isocyanatosulfonyl-2-thiophene-carboxylate\n410-550-7\n79277-18-2\nSTOT RE 2 *\nResp. Sens. 1\nSkin Sens. 1\nH373**\nH334\nH317\nGHS08\nDgr\nH373**\nH334\nH317\nEUH014\n\n\n\n\n615-023-00-7\n2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;\n(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate\n410-900-9\n83056-32-0\nFlam. Liq. 3\nMuta. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nResp. Sens. 1\nH226\nH341\nH332\nH373 **\nH318\nH334\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH341\nH332\nH373 **\nH318\nH334\nEUH014\n\n\n615-024-00-2\n2-phenylethylisocyanate\n413-080-0\n1943-82-4\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 2\nH331\nH302\nH314\nH334\nH317\nH411\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH302\nH314\nH334\nH317\nH411\n\n\n\n615-025-00-8\n4,4'-ethylidenediphenyl dicyanate\n405-740-1\n47073-92-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH373 **\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH373 **\nH318\nH410\n\n\n\n615-026-00-3\n4,4'-methylenebis(2,6-dimethylphenyl cyanate)\n405-790-4\n101657-77-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n615-028-00-4\nethyl 2-(isocyanatosulfonyl)benzoate\n410-220-2\n77375-79-2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH334\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH334\nH317\nEUH014\n\n\n\n\n615-029-00-X\n2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane\n411-280-2\n—\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH330\nH302\nH314\nH334\nH317\nH412\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH302\nH314\nH334\nH317\nH412\n\n\n\n\n\n615-030-00-5\nalkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\n\n\nA\n\n615-031-00-0\nthallium thiocyanate\n222-571-7\n3535-84-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2\nAquatic Chronic 2\nH330\nH300\nH312\nH373**\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH300\nH312\nH373**\nH411\n\n\n\n\n615-032-00-6\nmetal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n\n\n\n615-033-00-1\nreaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)\n430-980-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-034-00-7\nreaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)\n430-750-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-035-00-2\nreaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)\n430-930-6\n122886-55-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-036-00-8\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)\n430-940-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-037-00-3\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)\n430-950-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-038-00-9\nreaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)\n430-960-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-039-00-4\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)\n430-970-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-044-00-1\n4-chlorophenylisocyanate\n203-176-9\n104-12-1\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH335\nH315\nH318\nH334\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH330\nH302\nH335\nH315\nH318\nH334\nH410\n\n\n\n\n615-045-00-7\n4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)\n420-530-1\n—\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 4\nH334\nH317\nH413\nGHS08\nDgr\nH334\nH317\nH413\n\n\n\n\n616-001-00-X\nN,N-dimethylformamide;\ndimethyl formamide\n200-679-5\n68-12-2\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH360D ***\nH332\nH312\nH319\nGHS08\nGHS07\nDgr\nH360D ***\nH332\nH312\nH319\n\n\n\n616-002-00-5\n2-fluoroacetamide\n211-363-1\n640-19-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n616-003-00-0\nacrylamide;\nprop-2-enamide\n201-173-7\n79-06-1\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH350\nH340\nH361f ***\nH301\nH372 **\nH332\nH312\nH319\nH315\nH317\nGHS06\nGHS08\nDgr\nH350\nH340\nH361f ***\nH301\nH372 **\nH332\nH312\nH319\nH315\nH317\n\n\nD\n616-004-00-6\nallidochlor (ISO);\nN,N-diallylchloroacetamide\n202-270-7\n93-71-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH312\nH302\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH411\n\n\n\n616-005-00-1\nchlorthiamid (ISO);\n2,6-dichloro (thiobenzamide)\n217-637-7\n1918-13-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n616-006-00-7\ndichlofluanid (ISO);\nN-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide\n214-118-7\n1085-98-9\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH332\nH319\nH317\nH400\nGHS07\nGHS09\nWng\nH332\nH319\nH317\nH400\n\nM=10\n\n\n616-007-00-2\ndiphenamid (ISO);\nN,N-dimethyl-2,2-diphenylacetamide\n213-482-4\n957-51-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-008-00-8\npropachlor (ISO);\n2-chloro-N-isopropylacetanilide;\nα-chloro-N-isopropylacetanilide\n217-638-2\n1918-16-7\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH317\nH410\n\n\n\n\n\n616-009-00-3\npropanil (ISO);\n3', 4'-dichloropropionanilide\n211-914-6\n709-98-8\nAcute Tox. 4 *\nAquatic Acute 1\nH302\nH400\nGHS07\nGHS09\nWng\nH302\nH400\n\nM=10\n\n\n616-010-00-9\ntosylchloramide sodium\n204-854-7\n127-65-1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nH302\nH314\nH334\nGHS08\nGHS05\nGHS07\nDg\nH302\nH314\nH334\nEUH031\n\n\n616-011-00-4\nN,N-dimethylacetamide\n204-826-4\n127-19-5\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH360D ***\nH332\nH312\nGHS08\nGHS07\nDgr\nH360D ***\nH332\nH312\n\nRepr. 1B; H360D: C ≥ 5 %\n\n616-012-00-X\nN-(dichlorofluoromethylthio)phthalimide;\nN-(fluorodichloromethylthio)phthalimide\n211-952-3\n719-96-0\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n616-013-00-5\nbutyraldehyde oxime\n203-792-8\n110-69-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nH311\nH302\nH319\nGHS06\nDgr\nH311\nH302\nH319\n\n\n\n616-014-00-0\n2-butanone oxime;\nethyl methyl ketoxime;\nethyl methyl ketone oxime\n202-496-6\n96-29-7\nCarc. 2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH351\nH312\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH312\nH318\nH317\n\n\n\n616-015-00-6\nalachlor (ISO);\n2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide\n240-110-8\n15972-60-8\nCarc. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH317\nH410\n\nM=10\n\n616-016-00-1\n1-(3,4-dichlorophenylimino) thiosemicarbazide\n—\n5836-73-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n616-017-00-7\ncartap hydrochloride\n239-309-2\n15263-52-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n616-018-00-2\nN,N-diethyl-m-toluamide;\ndeet\n205-149-7\n134-62-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH315\nH412\nGHS07\nWng\nH302\nH319\nH315\nH412\n\n\n\n616-019-00-8\nperfluidone (ISO);\n1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;\n253-718-3\n37924-13-3\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n616-020-00-3\ntebuthiuron (ISO);\n1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n251-793-7\n34014-18-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n616-021-00-9\nthiazafluron (ISO);\n1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea\n246-901-4\n25366-23-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n616-022-00-4\nacetamide\n200-473-5\n60-35-5\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n616-023-00-X\nN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide\n401-980-6\n—\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n616-024-00-5\n2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide\n402-260-4\n54942-74-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-025-00-0\nvalinamide\n402-840-7\n20108-78-5\nRepr. 2\nEye Irrit. 2\nSkin Sens. 1\nH361f ***\nH319\nH317\nGHS08\nWng\nH361f ***\nH319\nH317\n\n\n\n616-026-00-6\nthioacetamide\n200-541-4\n62-55-5\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH350\nH302\nH319\nH315\nH412\nGHS08\nGHS07\nDgr\nH350\nH302\nH319\nH315\nH412\n\n\n\n616-027-00-1\ntris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate\n403-760-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-028-00-7\nN-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n403-790-9\n108673-51-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-029-00-2\nN,N'-ethylenebis(vinylsulfonylacetamide)\n404-790-1\n66710-66-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n616-030-00-8\nethidimuron (ISO);\n1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n250-010-6\n30043-49-3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-031-00-3\ndimethachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;\n256-625-6\n50563-36-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-032-00-9\ndiflufenican (ISO);\nN-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide\n—\n83164-33-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-033-00-4\ncyprofuram (ISO);\nN-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide\n274-050-9\n69581-33-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n616-034-00-X\npyracarbolid; (ISO);\n3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide\n246-419-4\n24691-76-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-035-00-5\ncymoxanil (ISO);\n2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide\n261-043-0\n57966-95-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-036-00-0\n2-chloracetamide\n201-174-2\n79-07-2\nRepr. 2\nAcute Tox. 3 *\nSkin Sens. 1\nH361f ***\nH301\nH317\nGHS06\nGHS08\nDgr\nH361f ***\nH301\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n616-037-00-6\nacetochlor (ISO);\n2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide\n251-899-3\n34256-82-1\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH335\nH315\nH317\nH410\n\n\n\n616-038-00-1\n(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride\n406-010-5\n88918-84-7\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n616-039-00-7\n3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide\n406-200-8\n117827-06-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-040-00-2\npotassium N-(4-toluenesulfonyl)-4-toluenesulfonamide\n406-650-5\n97888-41-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n616-041-00-8\n3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide\n406-840-8\n101664-25-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-042-00-3\nN-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide\n407-070-5\n142859-67-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-043-00-9\nisoxaben (ISO);\nN-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide\n407-190-8\n82558-50-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-044-00-4\nN-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide\n402-510-2\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-045-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide\n405-190-2\n122371-93-1\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-046-00-5\nN-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n406-390-2\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-047-00-0\nreaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;\n2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide\n406-640-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-048-00-6\n3'-trifluoromethylisobutyranilide\n406-740-4\n1939-27-1\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n616-049-00-1\n2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide\n408-150-2\n99141-89-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-050-00-7\nlufenuron (ISO);\nN-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide\n410-690-9\n103055-07-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-051-00-2\nreaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;\n2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene\n411-070-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-052-00-8\nformamide\n200-842-0\n75-12-7\nRepr. 1B\nH360D ***\nGHS08\nDgr\nH360D ***\n\n\n\n616-053-00-3\nN-methylacetamide\n201-182-6\n79-16-3\nRepr. 1B\nH360D ***\nGHS08\nDgr\nH360D ***\n\n\n\n616-054-00-9\niprodione (ISO);\n3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide\n253-178-9\n36734-19-7\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n616-055-00-4\npropyzamide (ISO);\n3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide\n245-951-4\n23950-58-5\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n616-056-00-X\nN-methylformamide\n204-624-6\n123-39-7\nRepr. 1B\nAcute Tox. 4 *\nH360D ***\nH312\nGHS08\nGHS07\nDg\nH360D ***\nH312\n\n\n\n616-057-00-5\nreaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nN-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nmethacrylamide;\n2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;\nN-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide\n412-790-8\n—\nCarc. 1B\nMuta. 2\nSTOT RE 2 *\nH350\nH341\nH373 **\nGHS08\nDgr\nH350\nH341\nH373 **\n\n\n\n616-058-00-0\n1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene\n412-570-1\n119462-56-5\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH373 **\nH318\nH317\nH410\n\n\n\n616-059-00-6\n4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide\n412-650-6\n121487-83-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-060-00-1\nCondensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)\n413-770-1\n—\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n616-061-00-7\nN,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide\n413-610-0\n124172-53-8\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n616-062-00-2\nN-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide\n411-590-8\n70693-57-1\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n616-063-00-8\n3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione\n411-920-0\n106917-30-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH373 **\nH314\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH302\nH373 **\nH314\nH410\n\n\n\n616-064-00-3\nN—tert-butyl-3-methylpicolinamide\n406-720-5\n32998-95-1\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-065-00-9\n3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea\n411-970-3\n79881-89-3\nAcute Tox. 4 *\nSTOT RE 2 *\nH302\nH373 **\nGHS08\nGHS07\nWng\nH302\nH373 **\n\n\n\n616-066-00-4\n5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone\n405-100-1\n115662-06-1\nRepr. 2\nH361f ***\nGHS08\nWng\nH361f ***\n\n\n\n616-067-00-X\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate\n407-300-4\n92683-20-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-068-00-5\npotassium 4-(11-methacrylamidoundecanamido)benzenesulfonate\n406-500-9\n174393-75-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-069-00-0\n1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide\n406-210-2\n110560-22-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-070-00-6\nreaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;\n3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-530-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-071-00-1\nreaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;\nbis(N-octadecyl-N'-phenyleneureido)methylene;\nbis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)\n406-550-1\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-072-00-7\n1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine\n407-120-6\n55612-11-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-073-00-2\n4'-ethoxy-2-benzimidazoleanilide\n407-600-5\n120187-29-3\nMuta. 2\nAquatic Chronic 4\nH341\nH413\nGHS08\nWng\nH341\nH413\n\n\n\n616-074-00-8\nN-butyl-2-(4-morpholinylcarbonyl)benzamide\n407-730-2\n104958-67-0\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n616-075-00-3\nD, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)\n408-120-9\n65197-96-8\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n616-076-00-9\ntebufenozide (ISO);\nN-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide\n412-850-3\n112410-23-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-077-00-4\nreaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;\npotassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate\n411-310-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n616-078-00-X\n2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide\n411-330-3\n104541-33-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-079-00-5\n1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate\n411-700-4\n140921-24-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-080-00-0\n4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)\n411-850-0\n119018-29-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-081-00-6\n5-bromo-8-naphtholactam\n413-480-5\n24856-00-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-082-00-1\nN-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide\n413-200-1\n129604-78-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-083-00-7\n[2-[(4-nitrophenyl)amino]ethyl]urea\n410-700-1\n27080-42-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n616-084-00-2\n2,4-bis[N'-(4-methylphenyl)ureido]toluene\n411-790-5\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-085-00-8\n3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione\n412-190-6\n168900-02-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-086-00-3\n2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene\n412-250-1\n102387-48-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-087-00-9\nreaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;\n7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate\n412-260-6\n52658-19-2\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH317\nH411\n\n\n\n616-088-00-4\n2-aminosulfonyl-N,N-dimethylnicotinamide\n413-440-7\n112006-75-4\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n616-089-00-X\n5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran\n415-360-8\n41107-56-6\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n616-090-00-5\n1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride\n415-660-9\n70918-74-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n616-091-00-0\n1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione\n423-400-0\n59653-74-6\nMuta. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH340\nH331\nH302\nH373 **\nH318\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH340\nH331\nH302\nH373 **\nH318\nH317\n\n\n\n616-092-00-6\nPolymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide\n404-035-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-093-00-1\nReaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride\n406-620-1\n129217-90-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-094-00-7\n3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-370-3\n58890-25-8\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-095-00-2\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-690-3\n43136-14-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-096-00-8\nN-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide\n408-110-4\n110483-07-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-097-00-3\nN,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide\n411-840-6\n83372-55-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-098-00-9\n1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide\n411-750-7\n119126-15-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-099-00-4\n2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide\n414-170-2\n135937-20-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-100-00-8\n1,3-dimethyl-1,3-bis(trimethylsilyl)urea\n414-180-7\n10218-17-4\nAcute Tox. 4 *\nSkin Irrit. 2\nH302\nH315\nGHS07\nWng\nH302\nH315\n\n\n\n616-101-00-3\n(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide\n414-600-9\n149182-72-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-102-00-9\nreaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);\n1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;\n1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]\n415-870-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-103-00-4\n(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide\n415-030-3\n120298-38-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-104-00-X\nbenalaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate\n275-728-7\n71626-11-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-105-00-5\nchlorotoluron (ISO);\n3-(3-chloro-p-tolyl)-1,1-dimethylurea\n239-592-2\n15545-48-9\nCarc. 2\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH361d ***\nH410\n\n\n\n616-106-00-0\nphenmedipham (ISO);\nmethyl 3-(3-methylcarbaniloyloxy)carbanilate\n237-199-0\n13684-63-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n616-107-00-6\ncinidon ethyl (ISO);\nethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate\n—\n142891-20-1\nCarc. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH317\nH410\n\n\n\n\n616-108-00-1\niodosulfuron-methyl-sodium;\nsodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide\n—\n144550-36-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-109-00-7\nsulfosulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea\n—\n141776-32-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-110-00-2\ncyclanilide (ISO);\n1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid\n419-150-7\n113136-77-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n616-111-00-8\nfenhexamid (ISO);\nN-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid\n422-530-5\n126833-17-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-112-00-3\noxasulfuron (ISO);\noxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate\n—\n144651-06-9\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n616-113-00-9\ndesmedipham (ISO);\nethyl 3-phenylcarbamoyloxyphenylcarbamate\n237-198-5\n13684-56-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n616-114-00-4\ndodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-\n418-010-2\n136897-58-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-115-00-X\nN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide\n416-150-9\n136450-06-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-116-00-5\nN-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate\n416-790-9\n143052-96-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-117-00-0\nN-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide\n416-860-9\n777891-21-1\nRepr. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH317\nH400\nH410\nGHS08\nGHS09\nWng\nH361f ***\nH317\nH410\n\n\n\n616-118-00-6\nN-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride\n417-950-0\n65797-42-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-119-00-1\n2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide\n418-060-5\n118020-93-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-120-00-7\nreaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-2-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-3-methyl-phenyl)-benzamide\n420-600-1\n—\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n616-121-00-2\n2,4-dihydroxy-N-(2-methoxyphenyl)benzamide\n419-090-1\n129205-19-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n616-122-00-8\nmethylneodecanamide\n414-460-9\n105726-67-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n616-123-00-3\nN-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide\n414-740-0\n96141-86-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n616-124-00-9\nlithium bis(trifluoromethylsulfonyl)imide\n415-300-0\n90076-65-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Chronic 3\nH311\nH301\nH373**\nH314\nH412\nGHS06\nGHS05\nGHS08\nDgr\nH311\nH301\nH373**\nH314\nH412\n\n\n\n\n616-125-00-4\n3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide\n415-730-9\n151338-11-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\n410\n\n\n\n\n\n616-126-00-X\n1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide\n423-960-6\n139756-01-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n616-127-00-5\nreaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);\n12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;\nN,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n430-050-2\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-128-00-0\nN-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide\n417-530-7\n123590-00-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-129-00-6\nN,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide\n419-710-0\n42774-15-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n616-130-00-1\nN-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide\n421-780-2\n150919-56-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n616-131-00-7\n1-aminocyclopentanecarboxamide\n422-950-9\n17193-28-1\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nH372**\nH302\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH372**\nH302\nH318\n\n\n\n\n616-132-00-2\nN-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide\n423-250-6\n130016-98-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-133-00-8\nN-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide\n423-990-1\n149118-66-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n616-134-00-3\n3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide\n401-820-5\n793710-14-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-135-00-9\n(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide\n430-230-0\n136522-17-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n616-136-00-4\nreaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)\n430-380-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n616-137-00-X\n4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane\n401-130-4\n71526-07-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-138-00-5\nbenzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide\n431-600-4\n112226-61-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-139-00-0\n(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide\n420-380-5\n136465-81-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n616-140-00-6\nN,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]\n429-380-1\n133336-92-2\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-141-00-1\nzoxamide (ISO);\n(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide\n—\n156052-68-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n616-142-00-7\n1,3-Bis(vinylsulfonylacetamido)propane\n428-350-3\n93629-90-4\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH341\nH318\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH341\nH318\nH317\nH412\n\n\n\n616-143-00-2\nN,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide\n422-560-9\n149591-38-8\nRepr. 2\nEye Irrit. 2\nAquatic Chronic 4\nH361f ***\nH319\nH413\nGHS08\nWng\nH361f ***\nH319\nH413\n\n\n\n\n\n616-144-00-8\n3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-130-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-145-00-3\npethoxamide (ISO);\n2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide\n—\n106700-29-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=100\n\n\n616-146-00-9\nN-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide\n431-330-7\n142776-95-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-147-00-4\n1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide\n424-160-1\n139481-22-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n616-148-00-X\nN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide\n424-550-1\n84245-12-5\nCarc. 1B\nMuta. 1B\nRepr. 1B\nH350\nH340\nH360FD\nGHS08\nDgr\nH350\nH340\nH360FD\n\n\n\n\n616-150-00-0\n(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride\n425-260-6\n—\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH373**\nH318\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH373**\nH318\nH317\nH411\n\n\n\n\n616-151-00-6\nN-(2-amino-4,6-dichloropyrimidin-5-yl)formamide\n425-650-6\n171887-03-9\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n616-152-00-1\n4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide\n425-850-3\n125971-96-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-153-00-7\n4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide\n425-860-8\n125971-57-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-154-00-2\n3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-110-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-155-00-8\nN,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide\n431-040-0\n104560-40-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-156-00-3\n6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide\n430-500-8\n204277-61-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-157-00-9\n3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride\n427-780-9\n114565-70-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n\n616-158-00-4\nN-[4-cyano-3-trifluoromethylphenyl]methacrylamide\n427-880-2\n90357-53-2\nSTOT RE 2 *\nAquatic Chronic 2\nH373**\nH411\nGHS08\nGHS09\nWng\nH373**\nH411\n\n\n\n\n616-160-00-5\n2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]\n429-090-3\n61551-69-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n616-161-00-0\n2,4-dichloro-5-hydroxyacetanilide\n429-110-0\n67669-19-6\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n616-162-00-6\nisostearic acid monoisopropanolamide\n431-540-9\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n616-163-00-1\n4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]\n430-350-3\n192463-88-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-164-00-7\ndimoxystrobin (ISO);\n(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide\n—\n149961-52-4\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361d***\nH332\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361d***\nH332\nH410\n\nM=10\n\n\n616-165-00-2\nbeflubutamid (ISO);\n(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide\n—\n113614-08-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=100\n\n\n616-166-00-8\ncyazofamid (ISO);\n4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide\n—\n120116-88-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n\n616-167-00-3\nN,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide\n418-290-6\n168612-06-4\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n\n616-168-00-9\n1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium\n418-440-0\n136997-71-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n616-169-00-4\n4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one\n420-220-4\n92771-56-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-170-00-X\n(2R)-2-amino-2-phenylacetamide\n420-370-0\n6485-67-2\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n\n616-171-00-5\n2-(para-chlorophenyl)glycineamide\n420-830-0\n102333-75-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n616-172-00-0\nN-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;\n(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl\n423-840-3\n14691-89-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n616-174-00-1\n2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride\n424-560-4\n151257-01-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n616-175-00-7\n2-(2-hexyldecyloxy)benzamide\n431-230-3\n202483-62-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-176-00-2\n3-N,N-bis(methoxyethyl)aminoacetanilide\n432-530-7\n24294-01-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n616-177-00-8\n(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;\nN-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide\n432-970-1\n217324-98-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-178-00-3\nN-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide\n434-500-9\n52583-35-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-179-00-9\n2-chloro-N-(4-methylphenyl)acetamide\n435-170-9\n16634-82-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n616-180-00-4\nN,N-(dimethylamino)thioacetamide hydrochloride\n435-470-1\n27366-72-9\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D***\nH410\n\n\n\n\n616-181-00-X\n4'-methyldodecane-1-sulfonanilide\n435-490-9\n17417-32-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-182-00-5\nN'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide\n435-860-1\n214417-91-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-183-00-0\nN-dodecyl-4-methoxybenzamide\n442-340-6\n1854-15-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-184-00-6\n3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide\n442-560-2\n105043-55-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-186-00-7\nN,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)\n443-010-4\n53641-10-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n616-188-00-8\n2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide\n443-980-9\n221215-20-9\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-189-00-3\nN-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide\n444-780-4\n452962-97-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-190-00-9\nN-decyl-4-nitrobenzamide\n445-880-0\n64026-19-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-191-00-4\n2-ethyl-N-methyl-N-(3-methylphenyl)butanamide\n446-190-2\n406488-30-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH317\nH411\n\n\n\n\n616-192-00-X\n2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide\n448-060-0\n727678-39-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-193-00-5\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide\n449-940-7\n368450-39-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-194-00-0\n2,2-diethoxy-N,N-dimethylacetamide\n449-950-1\n34640-92-1\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n616-196-00-1\ndisodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide\n419-990-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-197-00-7\nreaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;\nN-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide\n422-500-1\n—\nSTOT RE 2 *\nH373**\nGHS08\nWng\nH373**\n\n\n\n\n616-198-00-2\n1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene\n423-300-7\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-200-00-1\nreaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);\n12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;\nN,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n432-430-3\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-201-00-7\n12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine\n432-840-2\n220926-97-6\nAcute Tox. 4 *\nAquatic Chronic 4\nH332\nH413\nGHS07\nWng\nH332\nH413\n\n\n\n\n616-202-00-2\nreaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide\n434-330-5\n—\nCarc. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH317\nH413\n\n\n\n\n616-203-00-8\nreaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide\n442-280-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-204-00-3\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]\n451-060-3\n122886-55-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n617-001-00-2\ndi-tert-butyl peroxide\n203-733-6\n110-05-4\nOrg. Perox. E\nFlam. Liq. 2\nH242\nH225\nGHS02\nDgr\nH242\nH225\n\n\n\n617-002-00-8\nα, α-dimethylbenzyl hydroperoxide;\ncumene hydroperoxide\n201-254-7\n80-15-9\nOrg. Perox. E\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Chronic 2\nH242\nH331\nH312\nH302\nH373 **\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH242\nH331\nH312\nH302\nH373 **\nH314\nH411\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Dam. 1; H318: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 1 % ≤ C < 3 %\nSTOT SE 3; H335: C < 10 %\n\n617-003-00-3\ndilauroyl peroxide\n203-326-3\n105-74-8\nOrg. Perox. D\nH242\nGHS02\nDgr\nH242\n\n\n\n617-004-00-9\n1,2,3,4-tetrahydro-1-naphthyl hydroperoxide\n212-230-0\n771-29-9\nOrg. Perox. D\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH302\nH314\nH400\nH410\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH302\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n\n617-006-00-X\nbis(α, α-dimethylbenzyl) peroxide\n201-279-3\n80-43-3\nOrg. Perox. F\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH242\nH319\nH315\nH411\nGHS02\nGHS07\nGHS09\nWng\nH242\nH319\nH315\nH411\n\n\n\n617-007-00-5\ntert-butyl α, α-dimethylbenzyl peroxide\n222-389-8\n3457-61-2\nOrg. Perox. E Skin Irrit. 2\nAquatic Chronic 2\nH242\nH315\nH411\nGHS02\nGHS07\nGHS09\nWng\nH242\nH315\nH411\n\n\n\n\n\n617-008-00-0\ndibenzoyl peroxide;\nbenzoyl peroxide\n202-327-6\n94-36-0\nOrg. Perox. B\nEye Irrit. 2\nSkin Sens. 1\nH214\nH319\nH317\nGHS01\nGHS02\nGHS07\nDgr\nH214\nH319\nH317\n\n\n\n\n617-010-00-1\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nOrg. Perox. A\nSkin Corr. 1B\nAcute Tox. 4 *\nH242\nH314\nH302\nGHS01\nGHS05\nGHS07\nDgr\nH242\nH314\nH302\n\nSTOT SE 3; H335: C ≥ 5 %\nC\n\n\n617-010-01-9\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n[≤ 91 % solution]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nOrg. Perox. C\nAcute Tox. 4 *\nSkin Corr. 1B\nH242\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\nC T\n617-012-00-2\n8-p-menthyl hydroperoxide;\np-menthane hydroperoxide\n201-281-4\n80-47-7\nOrg. Perox. D\nSkin Corr. 1B\nAcute Tox. 4 *\nH242\nH314\nH332\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH314\nH332\n\nSTOT SE 3; H335: C ≥ 5 %\n\n617-013-00-8\nO,O-tert-butyl O-docosyl monoperoxyoxalate\n404-300-6\n116753-76-5\nOrg. Perox. C ****\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH400\nH410\nGHS02\nGHS09\nDgr\nH242\nH410\n\n\n\n617-014-00-3\n6-(nonylamino)-6-oxo-peroxyhexanoic acid\n406-680-9\n104788-63-8\nOrg. Perox. C ****\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH242\nH318\nH317\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH318\nH317\nH400\n\n\n\n617-015-00-9\nbis(4-methylbenzoyl)peroxide\n407-950-9\n895-85-2\nOrg. Perox. B ****\nAquatic Acute 1\nAquatic Chronic 1\nH241\nH400\nH410\nGHS01\nGHS02\nGHS09\nDgr\nH241\nH410\n\n\n\n617-016-00-4\n3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate\n413-910-1\n—\nOrg. Perox. C ****\nFlam. Liq. 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH226\nH315\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH226\nH315\nH410\n\n\n\n\n\n\n617-017-00-X\nreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;\n2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene\n412-140-3\n32144-25-5\nOrg. Perox. D\nAquatic Chronic 4\nH242\nH413\nGHS02\nDgr\nH242\nH413\n\n\nT\n\n617-018-00-5\nreaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;\n1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight\n410-840-3\n71566-50-2\nOrg. Perox. C ****\nAquatic Chronic 2\nH242\nH411\nGHS02\nGHS09\nDgr\nH242\nH411\n\n\nT\n617-019-00-0\n6-(phthalimido)peroxyhexanoic acid\n410-850-8\n128275-31-0\nOrg. Perox. D\nEye Dam. 1\nAquatic Acute 1\nH242\nH318\nH400\nGHS02\nGHS05\nGHS09\nDgDgr\nH242\nH318\nH400\n\n\nT\n617-020-00-6\n1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)\n420-060-5\n117663-11-3\nFlam. Liq. 3\nOrg. Perox. D ****\nAquatic Chronic 2\nH226\nH242\nH411\nGHS02\nGHS09\nDgr\nH226\nH242\nH411\n\n\n\n\n\n617-021-00-1\nmethylethylketone peroxide trimer\n429-320-2\n—\nOrg. Perox. B****\nAsp. Tox. 1\nSkin Irrit. 2\nSkin Sens. 1\nH241\nH304\nH315\nH317\nGHS01\nGHS02\nGHS08\nGHS07\nDgr\nH241\nH304\nH315\nH317\n\n\n\n\n617-022-00-7\nreaction mass of: 1,2-dimethylpropylidene dihydroperoxide;\ndimethyl 1,2-benzenedicarboxylate\n442-480-8\n—\nOrg. Perox. C\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH242\nH302\nH314\nH317\nH411\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH302\nH314\nH317\nH411\n\n\n\n\n647-001-00-8\nglucosidase, β-\n232-589-7\n9001-22-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-002-00-3\ncellulase\n232-734-4\n9012-54-8\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-003-00-9\ncellobiohydrolase, exo-\n253-465-9\n37329-65-0\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-004-00-4\ncellulases with the exception of those specified elsewhere in this Annex\n—\n—\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\nA\n647-005-00-X\nbromelain, juice\n232-572-4\n9001-00-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-006-00-5\nficin\n232-599-1\n9001-33-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-007-00-0\npapain\n232-627-2\n9001-73-4\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-008-00-6\npepsin A\n232-629-3\n9001-75-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-009-00-1\nrennin\n232-645-0\n9001-98-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-010-00-7\ntrypsin\n232-650-8\n9002-07-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-011-00-2\nchymotrypsin\n232-671-2\n9004-07-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-012-00-8\nsubtilisin\n232-752-2\n9014-01-1\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nH335\nH315\nH318\nH334\nGHS08\nGHS05 GHS07\nDgr\nH335\nH315\nH318\nH334\n\n\n\n647-013-00-3\nproteinase, microbial neutral\n232-966-6\n9068-59-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-014-00-9\nproteases with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-015-00-4\namylase, α-\n232-565-6\n9000-90-2\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-016-00-X\namylases with the exception of those specified elsewhere in this Annex\n—\n—\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n\n\n647-017-00-5\nlaccase\n420-150-4\n80498-15-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n\n648-001-00-0\nDistillates (coal tar), benzole fraction;\nLight Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]\n283-482-7\n84650-02-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-002-00-6\nTar oils, brown-coal;\nLight Oil;\n[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]\n302-674-4\n94114-40-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-003-00-1\nBenzol forerunnings (coal);\nLight Oil Redistillate, low boiling;\n[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]\n266-023-5\n65996-88-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-004-00-7\nDistillates (coal tar), benzole fraction, BTX-rich;\nLight Oil Redistillate, low boiling;\n[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]\n309-984-9\n101896-26-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-005-00-2\nAromatic hydrocarbons, C6-10, C8-rich;\nLight Oil Redistillate, low boiling\n292-697-5\n90989-41-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-006-00-8\nSolvent naphtha (coal), light;\nLight Oil Redistillate, low boiling\n287-498-5\n85536-17-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-007-00-3\nSolvent naphtha (coal), xylene-styrene cut;\nLight Oil Redistillate, intermediate boiling\n287-502-5\n85536-20-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-008-00-9\nSolvent naphtha (coal), coumarone-styrene contg.;\nLight Oil Redistillate, intermediate boiling\n287-500-4\n85536-19-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-009-00-4\nNaphtha (coal), distn. residues;\nLight Oil Redistillate, high boiling;\n[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]\n292-636-2\n90641-12-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-010-00-X\nAromatic hydrocarbons, C8;\nLight Oil Redistillate, high boiling\n292-694-9\n90989-38-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-012-00-0\nAromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;\nLight Oil Redistillate, high boiling;\n[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]\n295-281-1\n91995-20-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-013-00-6\nAromatic hydrocarbons, C9-12, benzene distn.;\nLight Oil Redistillate, high boiling\n295-551-9\n92062-36-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-014-00-1\nExtract residues (coal), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]\n295-323-9\n91995-61-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-015-00-7\nExtract residues (coal tar), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]\n309-868-8\n101316-63-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-016-00-2\nExtract residues (coal), benzole fraction acid;\nLight Oil Extract Residues, low boiling;\n[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]\n298-725-2\n93821-38-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-017-00-8\nExtract residues (coal), light oil alk., distn. overheads;\nLight Oil Extract Residues, low boiling;\n[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]\n292-625-2\n90641-02-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-018-00-3\nExtract residues (coal), light oil alk., acid ext., indene fraction;\nLight Oil Extract Residues, intermediate boiling\n309-867-2\n101316-62-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-019-00-9\nExtract residues (coal), light oil alk., indene naphtha fraction;\nLight Oil Extract Residues, high boiling;\n[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]\n292-626-8\n90641-03-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-020-00-4\nSolvent naphtha (coal);\nLight Oil Extract Residues, high boiling;\n[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]\n266-013-0\n65996-79-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-021-00-X\nDistillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]\n309-971-8\n101794-90-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-022-00-5\nDistillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;\n[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]\n292-609-5\n90640-87-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-023-00-0\nDistillates (coal tar), light oils; Carbolic Oil;\n[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]\n283-483-2\n84650-03-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-024-00-6\nTar oils, coal;\nCarbolic Oil;\n[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]\n266-016-7\n65996-82-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-026-00-7\nExtract residues (coal), light oil alk., acid ext.;\nCarbolic Oil Extract Residue;\n[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]\n292-624-7\n90641-01-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-027-00-2\nExtract residues (coal), tar oil alk.;\nCarbolic Oil Extract Residue;\n[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]\n266-021-4\n65996-87-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-028-00-8\nExtract oils (coal), light oil;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-622-6\n90640-99-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-029-00-3\nPyridine, alkyl derivs.;\nCrude Tar Bases;\n[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]\n269-929-9\n68391-11-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-030-00-9\nTar bases, coal, picoline fraction;\nDistillate Bases;\n[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]\n295-548-2\n92062-33-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-031-00-4\nTar bases, coal, lutidine fraction;\nDistillate Bases\n293-766-2\n91082-52-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-032-00-X\nExtract oils (coal), tar base, collidine fraction;\nDistillate Bases;\n[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]\n273-077-3\n68937-63-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-033-00-5\nTar bases, coal, collidine fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]\n295-543-5\n92062-28-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-034-00-0\nTar bases, coal, aniline fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]\n295-541-4\n92062-27-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-035-00-6\nTar bases, coal, toluidine fraction;\nDistillate Bases\n293-767-8\n91082-53-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-036-00-1\nDistillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;\nRedistillates;\n[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]\n295-292-1\n91995-31-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-037-00-7\nDistillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]\n295-295-8\n91995-35-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-038-00-2\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;\nRedistillates;\n[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]\n295-329-1\n91995-66-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-039-00-8\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]\n310-170-0\n122070-79-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-040-00-3\nExtract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;\nRedistillates;\n[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]\n310-171-6\n122070-80-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n\n648-041-00-9\nAbsorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]\n309-851-5\n101316-45-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-042-00-4\nDistillates (coal tar), upper, fluorene-rich;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]\n284-900-0\n84989-11-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-043-00-X\nCreosote oil, acenaphthene fraction, acenaphthene-free;\nWash Oil Redistillate;\n[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]\n292-606-9\n90640-85-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-044-00-5\nDistillates (coal tar), heavy oils;\nHeavy Anthracene Oil;\n[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]\n292-607-4\n90640-86-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-045-00-0\nDistillates (coal tar), upper;\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]\n266-026-1\n65996-91-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-046-00-6\nAnthracene oil, acid ext.;\nAnthracene Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]\n295-274-3\n91995-14-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-047-00-1\nDistillates (coal tar);\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]\n266-027-7\n65996-92-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-048-00-7\nDistillates (coal tar), pitch, heavy oils;\nHeavy Anthracene Oil;\n[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]\n295-312-9\n91995-51-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-049-00-2\nDistillates (coal tar), pitch;\nHeavy Anthracene Oil;\n[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]\n309-855-7\n101316-49-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-050-00-8\nDistillates (coal tar), heavy oils, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]\n295-304-5\n91995-42-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-051-00-3\nDistillates (coal tar), pitch, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]\n295-313-4\n91995-52-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-052-00-9\nParaffin waxes (coal), brown-coal high-temp. tar, carbon-treated;\nCoal Tar Extract;\n[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-296-6\n97926-76-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-053-00-4\nParaffin waxes (coal), brown-coal high-temp tar, clay-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-297-1\n97926-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-054-00-X\nPitch;\nPitch\n263-072-4\n61789-60-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-055-00-5\nPitch, coal tar, high-temp.;\nPitch;\n[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n266-028-2\n65996-93-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-056-00-0\nPitch, coal tar, high-temp., heat-treated;\nPitch;\n[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n310-162-7\n121575-60-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-057-00-6\nPitch, coal tar, high-temp., secondary;\nPitch Redistillate;\n[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]\n302-650-3\n94114-13-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-058-00-1\nResidues (coal tar), pitch distn.;\nPitch Redistillate;\n[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]\n295-507-9\n92061-94-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-059-00-7\nTar, coal, high-temp., distn. and storage residues;\nCoal Tar Solids Residue;\n[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]\n295-535-1\n92062-20-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-060-00-2\nTar, coal, storage residues;\nCoal Tar Solids Residue;\n[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]\n293-764-1\n91082-50-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-061-00-8\nTar, coal, high-temp., residues;\nCoal Tar Solids Residue;\n[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]\n309-726-5\n100684-51-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-062-00-3\nTar, coal, high-temp., high-solids;\nCoal Tar Solids Residue;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]\n273-615-7\n68990-61-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-063-00-9\nWaste solids, coal-tar pitch coking;\nCoal Tar Solids Residue;\n[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]\n295-549-8\n92062-34-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-064-00-4\nExtract residues (coal), brown;\nCoal Tar Extract;\n[The residue from extraction of dried coal.]\n294-285-0\n91697-23-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-065-00-X\nParaffin waxes (coal), brown-coal-high-temp. tar;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-454-1\n92045-71-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-066-00-5\nParaffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-455-7\n92045-72-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-067-00-0\nParaffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-298-7\n97926-78-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-068-00-6\nTar, coal, low-temp., distn. residues;\nTar Oil, intermediate boiling;\n[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]\n309-887-1\n101316-85-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-069-00-1\nPitch, coal tar, low-temp;\nPitch Residue;\n[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-651-4\n90669-57-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-070-00-7\nPitch, coal tar, low-temp., oxidized;\nPitch Residue, oxidised;\n[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-654-0\n90669-59-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-071-00-2\nPitch, coal tar, low-temp., heat-treated;\nPitch Residue, oxidised;\nPitch Residue, heat-treated;\n[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]\n292-653-5\n90669-58-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-072-00-8\nDistillates (coal-petroleum), condensed-ring arom;\nDistillates;\n[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]\n269-159-3\n68188-48-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-073-00-3\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-956-6\n101794-74-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-074-00-9\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-957-1\n101794-75-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-075-00-4\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-958-7\n101794-76-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-076-00-X\nPitch, coal tar-petroleum;\nPitch Residues;\n[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]\n269-109-0\n68187-57-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-077-00-5\nPhenanthrene, distn. residues;\nHeavy Anthracene Oil Redistillate;\n[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]\n310-169-5\n122070-78-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-078-00-0\nDistillates (coal tar), upper, fluorene-free;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]\n284-899-7\n84989-10-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-079-00-6\nAnthracene oil;\nAnthracene oil;\n[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]\n292-602-7\n90640-80-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n\n648-080-00-1\nResidues (coal tar), creosote oil distn.;\nWash Oil Redistillate;\n[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]\n295-506-3\n92061-93-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-081-00-7\nTar, coal;\nCoal tar;\n[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]\n232-361-7\n8007-45-2\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-082-00-2\nTar, coal, high-temp.;\nCoal tar;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]\n266-024-0\n65996-89-6\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-083-00-8\nTar, coal, low-temp.;\nCoal oil;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]\n266-025-6\n65996-90-9\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-084-00-3\nDistillates (coal), coke-oven light oil, naphthalene cut;\nNaphthalene Oil;\n[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]\n285-076-5\n85029-51-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-085-00-9\nDistillates (coal tar), naphthalene oils;\nNaphthalene Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]\n283-484-8\n84650-04-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-086-00-4\nDistillates (coal tar), naphthalene oils, naphthalene-low;\nNaphthalene Oil Redistillate;\n[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]\n284-898-1\n84989-09-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-087-00-X\nDistillates (coal tar), naphthalene oil crystn. mother liquor;\nNaphthalene Oil Redistillate;\n[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]\n295-310-8\n91995-49-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-088-00-5\nExtract residues (coal), naphthalene oil, alk.;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]\n310-166-9\n121620-47-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-089-00-0\nExtract residues (coal), naphthalene oil, alk., naphthalene-low;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-167-4\n121620-48-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-090-00-6\nDistillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;\nNaphthalene Oil Extract Residue;\n[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]\n292-612-1\n90640-90-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-091-00-1\nExtract residues (coal), naphthalene oil alk., distn. overheads;\nNaphthalene Oil Extract Residue;\n[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]\n292-627-3\n90641-04-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-092-00-7\nDistillates (coal tar), naphthalene oils, methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]\n309-985-4\n101896-27-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-093-00-2\nDistillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]\n309-972-3\n101794-91-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-094-00-8\nDistillates (coal tar), naphthalene oils, acid exts.;\nMethylnaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]\n295-309-2\n91995-48-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-095-00-3\nExtract residues (coal), naphthalene oil alk., distn. residues;\nMethylnaphthalene Oil Extract Residue;\n[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]\n292-628-9\n90641-05-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-096-00-9\nExtract oils (coal), acidic, tar-base free;\nMethylnaphthalene Oil Extract Residue;\n[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]\n284-901-6\n84989-12-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-097-00-4\nDistillates (coal tar), benzole fraction, distn. residues;\nWash Oil;\n[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-165-3\n121620-46-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-098-00-X\nCreosote oil, acenaphthene fraction;\nWash Oil;\n[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]\n292-605-3\n90640-84-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-099-00-5\nCreosote oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]\n263-047-8\n61789-28-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-100-00-9\nCreosote oil, high-boiling distillate;\nWash Oil;\n[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]\n274-565-9\n70321-79-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-101-00-4\nCreosote;\n[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]\n232-287-5\n8001-58-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-102-00-X\nExtract residues (coal), creosote oil acid;\nWash Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]\n310-189-4\n122384-77-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-103-00-5\nAnthracene oil, anthracene paste;\nAnthracene Oil Fraction;\n[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]\n292-603-2\n90640-81-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-104-00-0\nAnthracene oil, anthracene-low;\nAnthracene Oil Fraction;\n[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]\n292-604-8\n90640-82-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-105-00-6\nResidues (coal tar), anthracene oil distn.;\nAnthracene Oil Fraction;\n[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]\n295-505-8\n92061-92-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-106-00-1\nAnthracene oil, anthracene paste, anthracene fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-275-9\n91995-15-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-107-00-7\nAnthracene oil, anthracene paste, carbazole fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-276-4\n91995-16-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-108-00-2\nAnthracene oil, anthracene paste, distn. lights;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]\n295-278-5\n91995-17-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-109-00-8\nTar oils, coal, low-temp.;\nTar Oil, high boiling;\n[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]\n309-889-2\n101316-87-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-110-00-3\nExtract residues (coal), low temp. coal atar alk.;\n[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]\n310-191-5\n122384-78-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-111-00-9\nPhenols, ammonia liquor ext.;\nAlkaline Extract;\n[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]\n284-881-9\n84988-93-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-112-00-4\nDistillates (coal tar), light oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-610-0\n90640-88-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-113-00-X\nExtracts, coal tar oil alk.;\nAlkaline Extract;\n[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n266-017-2\n65996-83-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-114-00-5\nDistillates (coal tar), naphthalene oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-611-6\n90640-89-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-115-00-0\nExtract residues (coal), tar oil alk., carbonated, limed;\nCrude Phenols;\n[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]\n292-629-4\n90641-06-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-116-00-6\nTar acids, coal, crude;\nCrude Phenols;\n[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]\n266-019-3\n65996-85-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-117-00-1\nTar acids, brown-coal, crude;\nCrude Phenols;\n[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]\n309-888-7\n101316-86-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-118-00-7\nTar acids, brown-coal gasification;\nCrude Phenols;\n[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]\n295-536-7\n92062-22-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-119-00-2\nTar acids, distn. residues;\nDistillate Phenols;\n[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]\n306-251-5\n96690-55-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-120-00-8\nTar acids, methylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-892-9\n84989-04-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-121-00-3\nTar acids, polyalkylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]\n284-893-4\n84989-05-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-122-00-9\nTar acids, xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-895-5\n84989-06-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-123-00-4\nTar acids, ethylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-891-3\n84989-03-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-124-00-X\nTar acids, 3,5-xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]\n284-896-0\n84989-07-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-125-00-5\nTar acids, residues, distillates, first-cut;\nDistillate Phenols;\n[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]\n270-713-1\n68477-23-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-126-00-0\nTar acids, cresylic, residues;\nDistillate Phenols;\n[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]\n271-418-0\n68555-24-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-127-00-6\nPhenols, C9-11;\nDistillate Phenols\n293-435-2\n91079-47-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-128-00-1\nTar acids, cresylic;\nDistillate Phenols;\n[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]\n295-540-9\n92062-26-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-129-00-7\nTar acids, brown-coal, C2-alkylphenol fraction;\nDistillate Phenols;\n[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]\n302-662-9\n94114-29-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-130-00-2\nExtract oils (coal), naphthalene oils;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-623-1\n90641-00-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-131-00-8\nTar bases, quinoline derivs.;\nDistillate Bases\n271-020-7\n68513-87-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-132-00-3\nTar bases, coal, quinoline derivs. fraction;\nDistillate Bases\n274-560-1\n70321-67-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-133-00-9\nTar bases, coal, distn. residues;\nDistillate Bases;\n[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]\n295-544-0\n92062-29-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-134-00-4\nHydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]\n309-745-9\n100801-63-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-135-00-X\nHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]\n309-748-5\n100801-65-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-136-00-5\nHydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]\n309-749-0\n100801-66-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-137-00-0\nExtract residues (coal), tar oil alk., naphthalene distn. residues;\nNaphthalene Oil Extract Residue;\n[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]\n277-567-8\n73665-18-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-138-00-6\nCreosote oil, low-boiling distillate;\nWash Oil;\n[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]\n274-566-4\n70321-80-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-139-00-1\nTar acids, cresylic, sodium salts, caustic solns.;\nAlkaline Extract\n272-361-4\n68815-21-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-140-00-7\nExtract oils (coal), tar base;\nAcid Extract;\n[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]\n266-020-9\n65996-86-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-141-00-2\nTar bases, coal, crude;\nCrude Tar Bases;\n[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]\n266-018-8\n65996-84-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-142-00-8\nResidues (coal), liq. solvent extn.;\n[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]\n302-681-2\n94114-46-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-143-00-3\nCoal liquids, liq. solvent extn. soln.;\n[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]\n302-682-8\n94114-47-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-144-00-9\nCoal liquids, liq. solvent extn.;\n[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]\n302-683-3\n94114-48-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-145-00-4\nTar brown-coal;\n[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]\n309-885-0\n101316-83-0\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-146-00-X\nTar, brown-coal, low-temp.;\n[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]\n309-886-6\n101316-84-1\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-147-00-5\nLight oil (coal), coke-oven;\nCrude benzole;\n[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]\n266-012-5\n65996-78-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-148-00-0\nDistillates (coal), liq. solvent extn., primary;\n[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]\n302-688-0\n94114-52-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-149-00-6\nDistillates (coal), solvent extn., hydrocracked;\n[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-689-6\n94114-53-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-150-00-1\nNaphtha (coal), solvent extn., hydrocracked;\n[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-690-1\n94114-54-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-151-00-7\nGasoline, coal solvent extn., hydrocracked naphtha;\n[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]\n302-691-7\n94114-55-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-152-00-2\nDistillates (coal), solvent extn., hydrocracked middle;\n[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]\n302-692-2\n94114-56-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-153-00-8\nDistillates (coal), solvent extn., hydrocracked hydrogenated middle;\n[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]\n302-693-8\n94114-57-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-154-00-3\nFuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;\n[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]\n302-694-3\n94114-58-6\nCarc. 2\nH351\nGHS08\nWng\nH350\n\n\nH\n648-155-00-9\nFuels, diesel, coal solvent extn., hydrocracked hydrogenated;\n[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]\n302-695-9\n94114-59-7\nCarc. 2\nH351\nGHS08\nWng\nH350\n\n\nH\n\n\n648-156-00-4\nLight oil (coal), semi-coking process;\nFresh oil;\n[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]\n292-635-7\n90641-11-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n\n649-001-00-3\nExtracts (petroleum), light naphthenic distillate solvent\n265-102-1\n64742-03-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-002-00-9\nExtracts (petroleum), heavy paraffinic distillate solvent\n265-103-7\n64742-04-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-003-00-4\nExtracts (petroleum), light paraffinic distillate solvent\n265-104-2\n64742-05-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-004-00-X\nExtracts (petroleum), heavy naphthenic distillate solvent\n265-111-0\n64742-11-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-005-00-5\nExtracts (petroleum), light vacuum gas oil solvent\n295-341-7\n91995-78-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-006-00-0\nhydrocarbons C26-55, arom-rich\n307-753-7\n97722-04-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-007-00-6\nfatty acids, tall-oil, reaction products with iminodiethanol and boric acid\n400-160-5\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n649-008-00-1\nResidues (petroleum), atm. tower;\nHeavy Fuel oil;\n[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-045-2\n64741-45-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-009-00-7\nGas oils (petroleum), heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n265-058-3\n64741-57-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-010-00-2\nDistillates (petroleum), heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-063-0\n64741-61-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-011-00-8\nClarified oils (petroleum), catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-064-6\n64741-62-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-012-00-3\nResidues (petroleum), hydrocracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]\n265-076-1\n64741-75-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-013-00-9\nResidues (petroleum), thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-081-9\n64741-80-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-014-00-4\nDistillates (petroleum), heavy thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-082-4\n64741-81-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-015-00-X\nGas oils (petroleum), hydrotreated vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-162-9\n64742-59-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-016-00-5\nResidues (petroleum), hydrodesulfurized atmospheric tower;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-181-2\n64742-78-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-017-00-0\nGas oils (petroleum), hydrodesulfurized heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-189-6\n64742-86-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-018-00-6\nResidues (petroleum), steam-cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-193-8\n64742-90-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-019-00-1\nResidues (petroleum), atmospheric;\nHeavy Fuel oil;\n[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-777-3\n68333-22-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-020-00-7\nClarified oils (petroleum), hydrodesulfurized catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-782-0\n68333-26-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-021-00-2\nDistillates (petroleum), hydrodesulfurized intermediate catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n269-783-6\n68333-27-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-022-00-8\nDistillates (petroleum), hydrodesulfurized heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n269-784-1\n68333-28-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-023-00-3\nFuel oil, residues-straight-run gas oils, high-sulfur;\nHeavy Fuel oil\n270-674-0\n68476-32-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-024-00-9\nFuel oil, residual;\nHeavy Fuel oil;\n[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]\n270-675-6\n68476-33-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-025-00-4\nResidues (petroleum), catalytic reformer fractionator residue distn.;\nHeavy Fuel oil;\n[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]\n270-792-2\n68478-13-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-026-00-X\nResidues (petroleum), heavy coker gas oil and vacuum gas oil;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-796-4\n68478-17-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-027-00-5\nResidues (petroleum), heavy coker and light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-983-0\n68512-61-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-028-00-0\nResidues (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-984-6\n68512-62-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-029-00-6\nResidues (petroleum), steam-cracked light;\nHeavy Fuel oil;\n[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]\n271-013-9\n68513-69-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-030-00-1\nFuel oil, No 6;\nHeavy Fuel oil;\n[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]\n271-384-7\n68553-00-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-031-00-7\nResidues (petroleum), topping plant, low-sulfur;\nHeavy Fuel oil;\n[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]\n271-763-7\n68607-30-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-032-00-2\nGas oils (petroleum), heavy atmospheric;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]\n272-184-2\n68783-08-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-033-00-8\nResidues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;\nHeavy Fuel oil;\n[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]\n272-187-9\n68783-13-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-034-00-3\nDistillates (petroleum), petroleum residues vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]\n273-263-4\n68955-27-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-035-00-9\nResidues (petroleum), steam-cracked, resinous;\nHeavy Fuel oil;\n[A complex residuum from the distillation of steam-cracked petroleum residues.]\n273-272-3\n68955-36-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-036-00-4\nDistillates (petroleum), intermediate vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-683-0\n70592-76-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-037-00-X\nDistillates (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]\n274-684-6\n70592-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-038-00-5\nDistillates (petroleum), vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-685-1\n70592-78-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-039-00-0\nGas oils (petroleum), hydrodesulfurized coker heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n285-555-9\n85117-03-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-040-00-6\nResidues (petroleum), steam-cracked, distillates;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]\n292-657-7\n90669-75-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-041-00-1\nResidues (petroleum), vacuum, light;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]\n292-658-2\n90669-76-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-042-00-7\nFuel oil, heavy, high-sulfur;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n295-396-7\n92045-14-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-043-00-2\nResidues (petroleum), catalytic cracking;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]\n295-511-0\n92061-97-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-044-00-8\nDistillates (petroleum), intermediate catalytic cracked, thermally degraded;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]\n295-990-6\n92201-59-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-045-00-3\nResidual oils (petroleum);\nHeavy Fuel oil;\n[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]\n298-754-0\n93821-66-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-046-00-9\nResidues, steam cracked, thermally treated;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]\n308-733-0\n98219-64-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-047-00-4\nDistillates (petroleum), hydrodesulfurized full-range middle;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]\n309-863-0\n101316-57-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-048-00-X\nResidues (petroleum), catalytic reformer fractionator;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]\n265-069-3\n64741-67-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-049-00-5\nPetroleum;\nCrude oil;\n[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]\n232-298-5\n8002-05-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-050-00-0\nDistillates (petroleum), light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]\n265-051-5\n64741-50-0\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-051-00-6\nDistillates (petroleum), heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]\n265-052-0\n64741-51-1\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-052-00-1\nDistillates (petroleum), light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-053-6\n64741-52-2\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-053-00-7\nDistillates (petroleum), heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-054-1\n64741-53-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-054-00-2\nDistillates (petroleum), acid-treated heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-117-3\n64742-18-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-055-00-8\nDistillates (petroleum), acid-treated light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-118-9\n64742-19-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-056-00-3\nDistillates (petroleum), acid-treated heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-119-4\n64742-20-7\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-057-00-9\nDistillates (petroleum), acid-treated light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-121-5\n64742-21-8\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-058-00-4\nDistillates (petroleum), chemically neutralized heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]\n265-127-8\n64742-27-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-059-00-X\nDistillates (petroleum), chemically neutralized light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-128-3\n64742-28-5\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-060-00-5\nDistillates (petroleum), chemically neutralized heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-135-1\n64742-34-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-061-00-0\nDistillates (petroleum), chemically neutralized light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-136-7\n64742-35-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n649-062-00-6\nGases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]\n270-755-0\n68477-73-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-063-00-1\nGases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-756-6\n68477-74-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-064-00-7\nGases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]\n270-757-1\n68477-75-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-065-00-2\nGases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]\n270-758-7\n68477-76-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-066-00-8\nGases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]\n270-760-8\n68477-79-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-067-00-3\nGases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]\n270-765-5\n68477-83-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-068-00-9\nGases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-767-6\n68477-85-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-069-00-4\nGases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]\n270-768-1\n68477-86-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-070-00-X\nGases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-769-7\n68477-87-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-071-00-5\nGases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]\n270-772-3\n68477-90-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-072-00-0\nGases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-773-9\n68477-91-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-073-00-6\nGases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]\n270-777-0\n68477-94-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-074-00-1\nGases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-778-6\n68477-95-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-075-00-7\nGases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas\n270-782-8\n68477-99-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-076-00-2\nTail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-802-5\n68478-21-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-077-00-8\nTail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-803-0\n68478-22-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-078-00-3\nTail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]\n270-804-6\n68478-24-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-079-00-9\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-806-7\n68478-26-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-080-00-4\nTail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]\n270-813-5\n68478-32-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-081-00-X\nTail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]\n270-814-0\n68478-33-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-082-00-5\nTail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-815-6\n68478-34-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-083-00-0\nHydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]\n270-990-9\n68512-91-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-084-00-6\nGases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-000-8\n68513-15-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-085-00-1\nGases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]\n271-001-3\n68513-16-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-086-00-7\nGases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-002-9\n68513-17-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-087-00-2\nResidues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27,8 °C (11 °F to 82 °F).]\n271-010-2\n68513-66-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-088-00-8\nHydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]\n271-032-2\n68514-31-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-089-00-3\nHydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]\n271-038-5\n68514-36-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-090-00-9\nHydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]\n271-259-7\n68527-16-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-091-00-4\nHydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas\n271-261-8\n68527-19-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-092-00-X\nGases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n271-624-0\n68602-83-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-093-00-5\nHydrocarbons, C2-4;\nPetroleum gas\n271-734-9\n68606-25-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-094-00-0\nHydrocarbons, C3;\nPetroleum gas\n271-735-4\n68606-26-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-095-00-6\nGases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n271-737-5\n68606-27-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-096-00-1\nGases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]\n271-742-2\n68606-34-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-097-00-7\nGases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-183-7\n68783-07-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-098-00-2\nGases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n272-203-4\n68783-64-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-099-00-8\nGases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]\n272-205-5\n68783-65-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-100-00-1\nGases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-871-7\n68918-99-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-101-00-7\nGases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-872-2\n68919-00-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-102-00-2\nGases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-878-5\n68919-05-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-103-00-8\nGases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-879-0\n68919-06-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-104-00-3\nGases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]\n272-882-7\n68919-09-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-105-00-9\nGases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]\n272-893-7\n68919-20-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-106-00-4\nGases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-883-2\n68919-10-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-107-00-X\nGases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-169-3\n68952-76-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-108-00-5\nTail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-170-9\n68952-77-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-109-00-0\nTail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-175-6\n68952-81-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-110-00-6\nTail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-176-1\n68952-82-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-111-00-1\nGases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]\n273-265-5\n68955-28-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-112-00-7\nGases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n273-270-2\n68955-34-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-113-00-2\nHydrocarbons, C4;\nPetroleum gas\n289-339-5\n87741-01-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-114-00-8\nAlkanes, C1-4, C3-rich;\nPetroleum gas\n292-456-4\n90622-55-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-115-00-3\nGases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]\n295-404-9\n92045-22-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-116-00-9\nHydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]\n295-405-4\n92045-23-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-117-00-4\nPetroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]\n295-463-0\n92045-80-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKSU\n\n649-118-00-X\nHydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas\n306-004-1\n95465-89-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-119-00-5\nRaffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas\n307-769-4\n97722-19-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-120-00-0\nGases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]\n270-746-1\n68477-65-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-121-00-6\nGases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]\n270-747-7\n68477-66-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-122-00-1\nGases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]\n270-748-2\n68477-67-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-123-00-7\nGases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-749-8\n68477-68-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-124-00-2\nGases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-759-2\n68477-77-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-125-00-8\nGases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-761-3\n68477-80-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-126-00-3\nGases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]\n270-762-9\n68477-81-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-127-00-9\nGases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas\n270-763-4\n68477-82-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-128-00-4\nGases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]\n270-766-0\n68477-84-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-129-00-X\nGases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-774-4\n68477-92-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-130-00-5\nGases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]\n270-776-5\n68477-93-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-131-00-0\nGases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]\n270-779-1\n68477-96-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-132-00-6\nGases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]\n270-780-7\n68477-97-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-133-00-1\nGases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-781-2\n68477-98-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-134-00-7\nGases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n270-783-3\n68478-00-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-135-00-2\nGases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-784-9\n68478-01-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-136-00-8\nGases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-785-4\n68478-02-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-137-00-3\nGases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n270-787-5\n68478-03-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-138-00-9\nGases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-788-0\n68478-04-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-139-00-4\nGases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-789-6\n68478-05-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-140-00-X\nTail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-805-1\n68478-25-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-141-00-5\nTail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-807-2\n68478-27-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-142-00-0\nTail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-808-8\n68478-28-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-143-00-6\nTail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-809-3\n68478-29-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-144-00-1\nTail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-810-9\n68478-30-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-145-00-7\nGases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]\n270-999-8\n68513-14-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-146-00-2\nGases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-003-4\n68513-18-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-147-00-8\nGases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-005-5\n68513-19-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-148-00-3\nGases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]\n271-258-1\n68527-15-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-149-00-9\nGases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]\n271-623-5\n68602-82-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-150-00-4\nGases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n271-625-6\n68602-84-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-151-00-X\nPetroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-750-6\n68607-11-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-152-00-5\nGases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-182-1\n68783-06-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-153-00-0\nGases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-338-9\n68814-67-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-154-00-6\nGases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n272-343-6\n68814-90-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-155-00-1\nGases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]\n272-775-5\n68911-58-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-156-00-7\nGases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n272-776-0\n68911-59-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-157-00-2\nGases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]\n272-873-8\n68919-01-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-158-00-8\nGases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-874-3\n68919-02-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-159-00-3\nGases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]\n272-875-9\n68919-03-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-160-00-9\nGases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-876-4\n68919-04-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-161-00-4\nGases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]\n272-880-6\n68919-07-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-162-00-X\nGases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-881-1\n68919-08-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-163-00-5\nGases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-884-8\n68919-11-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-164-00-0\nGases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]\n272-885-3\n68919-12-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-165-00-6\nTail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]\n273-173-5\n68952-79-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-166-00-1\nTail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n273-174-0\n68952-80-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-167-00-7\nGases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-269-7\n68955-33-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-168-00-2\nGases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-563-5\n68989-88-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-169-00-8\nGases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n295-397-2\n92045-15-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-170-00-3\nGases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n295-398-8\n92045-16-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-171-00-9\nGases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n295-399-3\n92045-17-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-172-00-4\nGases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n295-400-7\n92045-18-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-173-00-X\nGases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]\n295-401-2\n92045-19-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-174-00-5\nGases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n295-402-8\n92045-20-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n\n649-175-00-0\nFoots oil (petroleum), acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-225-7\n93924-31-3\nFlam. Gas 1\nPress. Gas\nCarc. 1B\nH220\nH350\nH340\nGHS02\nGHS04\nGHS08\nDgr\nH220\nH350\nH340\n\n\nH K U\n649-176-00-6\nFoots oil (petroleum), clay-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-226-2\n93924-32-4\nFlam. Gas 1\nPress. Gas\nCarc. 1B\nH220\nH350\nH340\nGHS02\nGHS04\nGHS08\nDgr\nH220\nH350\nH340\n\n\nH K U\n\n\n\n649-177-00-1\nGases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]\n268-629-5\n68131-75-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-178-00-7\nTail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-617-2\n68307-98-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-179-00-2\nTail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-618-8\n68307-99-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-180-00-8\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-619-3\n68308-00-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-181-00-3\nTail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-620-9\n68308-01-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-182-00-9\nTail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-630-3\n68308-10-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-183-00-4\nTail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-623-5\n68308-03-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-184-00-X\nTail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-624-0\n68308-04-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-185-00-5\nTail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-625-6\n68308-05-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-186-00-0\nTail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-626-1\n68308-06-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-187-00-6\nTail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-627-7\n68308-07-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-188-00-1\nTail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-629-8\n68308-09-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-189-00-7\nTail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-631-9\n68308-11-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-190-00-2\nTail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-632-4\n68308-12-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-191-00-8\nGases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]\n270-071-2\n68409-99-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-193-00-9\nAlkanes, C1-2;\nPetroleum gas\n270-651-5\n68475-57-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-194-00-4\nAlkanes, C2-3;\nPetroleum gas\n270-652-0\n68475-58-1\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-195-00-X\nAlkanes, C3-4;\npetroleum gas\n270-653-6\n68475-59-2\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-196-00-5\nAlkanes, C4-5;\nPetroleum gas\n270-654-1\n68475-60-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-197-00-0\nFuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]\n270-667-2\n68476-26-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-198-00-6\nFuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]\n270-670-9\n68476-29-9\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-199-00-1\nHydrocarbons, C3-4;\nPetroleum gas\n270-681-9\n68476-40-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-200-00-5\nHydrocarbons, C4-5;\nPetroleum gas\n270-682-4\n68476-42-6\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-201-00-0\nHydrocarbons, C2-4, C3-rich;\nPetroleum gas\n270-689-2\n68476-49-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-202-00-6\nPetroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-704-2\n68476-85-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKSU\n\n649-203-00-1\nPetroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-705-8\n68476-86-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKSU\n\n649-204-00-7\ngases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]\n270-724-1\n68477-33-8\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-205-00-2\nDistillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]\n270-726-2\n68477-35-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-206-00-8\nGases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-750-3\n68477-69-0\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-207-00-3\nGases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]\n270-751-9\n68477-70-3\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-208-00-9\nGases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-752-4\n68477-71-4\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-209-00-4\nGases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-754-5\n68477-72-5\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-210-00-X\nTail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-628-2\n68308-08-7\nPress. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nHKU\n\n649-211-00-5\nFoots oil (petroleum), carbon-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-126-0\n97862-76-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-212-00-0\nDistillates (petroleum), sweetened middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-088-7\n64741-86-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-213-00-6\nGas oils (petroleum), solvent-refined;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-092-9\n64741-90-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-214-00-1\nDistillates (petroleum), solvent-refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-093-4\n64741-91-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-215-00-7\nGas oils (petroleum), acid-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-112-6\n64742-12-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-216-00-2\nDistillates (petroleum), acid-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-113-1\n64742-13-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-217-00-8\nDistillates (petroleum), acid-treated light;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-114-7\n64742-14-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-218-00-3\nGas oils (petroleum), chemically neutralized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-129-9\n64742-29-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-219-00-9\nDistillates (petroleum), chemically neutralized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-130-4\n64742-30-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-220-00-4\nDistillates (petroleum), clay-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-139-3\n64742-38-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-221-00-X\nDistillates (petroleum), hydrotreated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-148-2\n64742-46-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-222-00-5\nGas oils (petroleum), hydrodesulfurized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-182-8\n64742-79-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-223-00-0\nDistillates (petroleum), hydrodesulfurized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-183-3\n64742-80-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-224-00-6\nFuels, diesel;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]\n269-822-7\n68334-30-5\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH N\n649-225-00-1\nFuel oil, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]\n270-671-4\n68476-30-2\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-226-00-7\nFuel oil, No 4;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]\n270-673-5\n68476-31-3\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-227-00-2\nFuels, diesel, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]\n270-676-1\n68476-34-6\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-228-00-8\nDistillates (petroleum), catalytic reformer fractionator residue, high-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]\n270-719-4\n68477-29-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-229-00-3\nDistillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]\n270-721-5\n68477-30-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-230-00-9\nDistillates (petroleum), catalytic reformer fractionator residue, low-boiling;\nGasoil — unspecified;\n[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]\n270-722-0\n68477-31-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-231-00-4\nDistillates (petroleum), highly refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]\n292-615-8\n90640-93-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-232-00-X\nDistillates (petroleum) catalytic reformer, heavy arom. conc.;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n295-294-2\n91995-34-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-233-00-5\nGas oils, paraffinic;\nGasoil — unspecified;\n[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]\n300-227-8\n93924-33-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-234-00-0\nNaphtha (petroleum), solvent-refined hydrodesulfurized heavy;\nGasoil — unspecified\n307-035-3\n97488-96-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-235-00-6\nHydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-659-6\n97675-85-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-236-00-1\nHydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-660-1\n97675-86-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-237-00-7\nHydrocarbons, C11-17, solvent-extd. light naphthenic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n307-757-9\n97722-08-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-238-00-2\nGas oils, hydrotreated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]\n308-128-1\n97862-78-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-239-00-8\nDistillates (petroleum), carbon-treated light paraffinic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]\n309-667-5\n100683-97-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-240-00-3\nDistillates (petroleum), intermediate paraffinic, carbon-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-668-0\n100683-98-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-241-00-9\nDistillates (petroleum), intermediate paraffinic, clay-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-669-6\n100683-99-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-242-00-4\nAlkanes, C12-26-branched and linear\n292-454-3\n90622-53-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-243-00-X\nLubricating greases;\nGrease;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]\n278-011-7\n74869-21-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-244-00-5\nSlack wax (petroleum);\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n265-165-5\n64742-61-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-245-00-0\nSlack wax (petroleum), acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n292-659-8\n90669-77-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-246-00-6\nSlack wax (petroleum), clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]\n292-660-3\n90669-78-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-247-00-1\nSlack wax (petroleum), hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n295-523-6\n92062-09-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-248-00-7\nSlack wax (petroleum), low-melting;\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-524-1\n92062-10-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-249-00-2\nSlack wax (petroleum), low-melting, hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-525-7\n92062-11-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-250-00-8\nSlack wax (petroleum), low-melting, carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-155-9\n97863-04-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-251-00-3\nSlack wax (petroleum), low-melting, clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-156-4\n97863-05-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-252-00-9\nSlack wax (petroleum), low-melting, silicic acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-158-5\n97863-06-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-253-00-4\nSlack wax (petroleum), carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]\n309-723-9\n100684-49-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-254-00-X\nPetrolatum;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n232-373-2\n8009-03-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-255-00-5\nPetrolatum (petroleum), oxidized;\nPetrolatum;\n[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]\n265-206-7\n64743-01-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-256-00-0\nPetrolatum (petroleum), alumina-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n285-098-5\n85029-74-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-257-00-6\nPetrolatum (petroleum), hydrotreated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]\n295-459-9\n92045-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-258-00-1\nPetrolatum (petroleum), carbon-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-149-6\n97862-97-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-259-00-7\nPetrolatum (petroleum), silicic acid-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-150-1\n97862-98-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-260-00-2\nPetrolatum (petroleum), clay-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]\n309-706-6\n100684-33-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n\n\n649-261-00-8\nGasoline, natural;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]\n232-349-1\n8006-61-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-262-00-3\nNaphtha;\nLow boiling point naphtha;\n[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n232-443-2\n8030-30-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-263-00-9\nLigroine;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]\n232-453-7\n8032-32-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-264-00-4\nNaphtha (petroleum), heavy straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-041-0\n64741-41-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-265-00-X\nNaphtha (petroleum), full-range straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]\n265-042-6\n64741-42-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-266-00-5\nNaphtha (petroleum), light straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-046-8\n64741-46-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-267-00-0\nSolvent naphtha (petroleum), light aliph.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]\n265-192-2\n64742-89-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-268-00-6\nDistillates (petroleum), straight-run light;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]\n270-077-5\n68410-05-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-269-00-1\nGasoline, vapor-recovery;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C (– 4 °F to 384 °F).]\n271-025-4\n68514-15-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-270-00-7\nGasoline, straight-run, topping-plant;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]\n271-727-0\n68606-11-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-271-00-2\nNaphtha (petroleum), unsweetened;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]\n272-186-3\n68783-12-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-272-00-8\nDistillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]\n272-931-2\n68921-08-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-273-00-3\nNaphtha (petroleum), heavy straight run, arom.-contg.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n309-945-6\n101631-20-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-274-00-9\nNaphtha (petroleum), full-range alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]\n265-066-7\n64741-64-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-275-00-4\nNaphtha (petroleum), heavy alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]\n265-067-2\n64741-65-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-276-00-X\nNaphtha (petroleum), light alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]\n265-068-8\n64741-66-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-277-00-5\nNaphtha (petroleum), isomerization;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]\n265-073-5\n64741-70-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-278-00-0\nNaphtha (petroleum), solvent-refined light;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n265-086-6\n64741-84-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-279-00-6\nNaphtha (petroleum), solvent-refined heavy;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-095-5\n64741-92-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-280-00-1\nRaffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]\n270-088-5\n68410-71-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-281-00-7\nRaffinates (petroleum), reformer, Lurgi unit-sepd.;\nLow boiling point modified naphtha;\n[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]\n270-349-3\n68425-35-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-282-00-2\nNaphtha (petroleum), full-range alkylate, butane-contg.;\nLow boiling point modified naphta;\n[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]\n271-267-0\n68527-27-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-283-00-8\nDistillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]\n295-315-5\n91995-53-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-284-00-3\nNaphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-430-0\n92045-49-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-285-00-9\nHydrocarbons, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]\n295-436-3\n92045-55-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-286-00-4\nNaphtha (petroleum), isomerization, C6-fraction;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]\n295-440-5\n92045-58-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-287-00-X\nHydrocarbons, C6-7, naphtha-cracking, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]\n295-446-8\n92045-64-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-288-00-5\nHydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]\n309-871-4\n101316-67-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-289-00-0\nNaphtha (petroleum), heavy catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-055-7\n64741-54-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-290-00-6\nNaphtha (petroleum), light catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-056-2\n64741-55-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-291-00-1\nHydrocarbons, C3-11, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]\n270-686-6\n68476-46-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-292-00-7\nNaphtha (petroleum), catalytic cracked light distd.;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-185-8\n68783-09-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-293-00-2\nDistillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;\nLow boiling point cat-cracked naphtha.;\n[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]\n295-311-3\n91995-50-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-294-00-8\nNaphtha (petroleum), heavy catalytic cracked, sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]\n295-431-6\n92045-50-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-295-00-3\nNaphtha (petroleum), light catalytic cracked sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-441-0\n92045-59-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-296-00-9\nHydrocarbons, C8-12, catalytic-cracking, chem. neutralized;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n295-794-0\n92128-94-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-297-00-4\nHydrocarbons, C8-12, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]\n309-974-4\n101794-97-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-298-00-X\nHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;\nLow boiling point cat-cracked naphtha\n309-987-5\n101896-28-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-299-00-5\nNaphtha (petroleum), light catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n265-065-1\n64741-63-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-300-00-9\nNaphtha (petroleum), heavy catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-070-9\n64741-68-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-301-00-4\nDistillates (petroleum), catalytic reformed depentanizer;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]\n270-660-4\n68475-79-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-302-00-X\nHydrocarbons, C2-6, C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha\n270-687-1\n68476-47-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-303-00-5\nResidues (petroleum), C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha;\n[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n270-794-3\n68478-15-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-304-00-0\nNaphtha (petroleum), light catalytic reformed, arom.-free;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]\n270-993-5\n68513-03-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-305-00-6\nDistillates (petroleum), catalytic reformed straight-run naphtha overheads;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-008-1\n68513-63-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-306-00-1\nPetroleum products, hydrofiner-powerformer reformates;\nLow boiling point cat-reformed naphtha;\n[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]\n271-058-4\n68514-79-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-307-00-7\nNaphtha (petroleum), full-range reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n272-895-8\n68919-37-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-308-00-2\nNaphtha (petroleum), catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n273-271-8\n68955-35-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-309-00-8\nDistillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]\n285-509-8\n85116-58-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-310-00-3\nAromatic hydrocarbons, C8, catalytic reforming-derived;\nLow boiling point cat-reformed naphtha\n295-279-0\n91995-18-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-311-00-9\nAromatic hydrocarbons, C7-12, C8-rich;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]\n297-401-8\n93571-75-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-312-00-4\nGasoline, C5-11, high-octane stabilised reformed;\nLow boiling point cat-reformed naphtha;\n[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]\n297-458-9\n93572-29-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-313-00-X\nHydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]\n297-465-7\n93572-35-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-314-00-5\nHydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]\n297-466-2\n93572-36-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n\n649-315-00-0\nFoots oil (petroleum), silicic acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-127-6\n97862-77-6\nCarc. 1B\nH350\nH304\nGHS08\nDgr\nH350\nH304\n\n\nH L\n\n\n649-316-00-6\nNaphtha (petroleum), light thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]\n265-075-6\n64741-74-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-317-00-1\nNaphtha (petroleum), heavy thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]\n265-085-0\n64741-83-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-318-00-7\nDistillates (petroleum), heavy arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]\n267-563-4\n67891-79-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-319-00-2\nDistillates (petroleum), light arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]\n267-565-5\n67891-80-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-320-00-8\nDistillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]\n270-344-6\n68425-29-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-321-00-3\nAromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]\n270-658-3\n68475-70-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-322-00-9\nDistillates (petroleum), thermal cracked naphtha and gas oil;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]\n271-631-9\n68603-00-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-323-00-4\nDistillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]\n271-632-4\n68603-01-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-324-00-X\nDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]\n271-634-5\n68603-03-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-325-00-5\nDistillates (petroleum), light thermal cracked, debutanized arom.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]\n273-266-0\n68955-29-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-326-00-0\nNaphtha (petroleum), light thermal cracked, sweetened;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]\n295-447-3\n92045-65-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-327-00-6\nNaphtha (petroleum), hydrotreated heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-150-3\n64742-48-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-328-00-1\nNaphtha (petroleum), hydrotreated light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-151-9\n64742-49-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-329-00-7\nNaphtha (petroleum), hydrodesulfurized light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-178-6\n64742-73-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-330-00-2\nNaphtha (petroleum), hydrodesulfurized heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-185-4\n64742-82-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-331-00-8\nDistillates (petroleum), hydrotreated middle, intermediate boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]\n270-092-7\n68410-96-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-332-00-3\nDistillates (petroleum), light distillate hydrotreating process, low-boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]\n270-093-2\n68410-97-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-333-00-9\nDistillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]\n270-094-8\n68410-98-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-334-00-4\nSolvent naphtha (petroleum), light arom., hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n270-988-8\n68512-78-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-335-00-X\nNaphtha (petroleum), hydrodesulfurized thermal cracked light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]\n285-511-9\n85116-60-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-336-00-5\nNaphtha (petroleum), hydrotreated light, cycloalkane-contg.;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n285-512-4\n85116-61-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-337-00-0\nNaphtha (petroleum), heavy steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha\n295-432-1\n92045-51-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-338-00-6\nNaphtha (petroleum), hydrodesulfurized full-range;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]\n295-433-7\n92045-52-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-339-00-1\nNaphtha (petroleum), hydrotreated light steam-cracked;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n295-438-4\n92045-57-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-340-00-7\nHydrocarbons, C4-12, naphtha-cracking, hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]\n295-443-1\n92045-61-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-341-00-2\nSolvent naphtha (petroleum), hydrotreated light naphthenic;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]\n295-529-9\n92062-15-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-342-00-8\nNaphtha (petroleum), light steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]\n296-942-7\n93165-55-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-343-00-3\nHydrocarbons, C6-11, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-852-0\n93763-33-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-344-00-9\nHydrocarbons, C9-12, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-853-6\n93763-34-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-345-00-4\nStoddard solvent;\nLow boiling point naphtha - unspecified;\n[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]\n232-489-3\n8052-41-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-346-00-X\nNatural gas condensates (petroleum);\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]\n265-047-3\n64741-47-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-347-00-5\nNatural gas (petroleum), raw liq. mix;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]\n265-048-9\n64741-48-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-348-00-0\nNaphtha (petroleum), light hydrocracked;\nLow boiling naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-071-4\n64741-69-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-349-00-6\nNaphtha (petroleum), heavy hydrocracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]\n265-079-8\n64741-78-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-350-00-1\nNaphtha (petroleum), sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]\n265-089-2\n64741-87-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-351-00-7\nNaphtha (petroleum), acid-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-115-2\n64742-15-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-352-00-2\nNaphtha (petroleum), chemically neutralized heavy;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-122-0\n64742-22-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-353-00-8\nNaphtha (petroleum), chemically neutralized light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-123-6\n64742-23-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-354-00-3\nNaphtha (petroleum), catalytic dewaxed;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n265-170-2\n64742-66-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-355-00-9\nNaphtha (petroleum), light steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]\n265-187-5\n64742-83-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-356-00-4\nSolvent naphtha (petroleum), light arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n265-199-0\n64742-95-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-357-00-X\nAromatic hydrocarbons, C6-10, acid-treated, neutralized;\nLow boiling point naphtha - unspecified\n268-618-5\n68131-49-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-358-00-5\nDistillates (petroleum), C3-5, 2-methyl-2-butene-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]\n270-725-7\n68477-34-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-359-00-0\nDistillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-735-1\n68477-50-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-360-00-6\nDistillates (petroleum), steam-cracked, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-736-7\n68477-53-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-361-00-1\nDistillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;\nLow boiling point naphtha - unspecified\n270-738-8\n68477-55-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-362-00-7\nExtracts (petroleum), cold-acid, C4-6;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n270-741-4\n68477-61-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-363-00-2\nDistillates (petroleum), depentanizer overheads;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-771-8\n68477-89-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-364-00-8\nResidues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-791-7\n68478-12-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\n\n\n\nH P\n\n649-365-00-3\nResidual oils (petroleum), deisobutanizer tower;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-795-9\n68478-16-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-366-00-9\nNaphtha (petroleum), full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]\n270-991-4\n68513-02-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-367-00-4\nNaphtha (petroleum), steam-cracked middle arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]\n271-138-9\n68516-20-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-368-00-X\nNaphtha (petroleum), clay-treated full-range straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]\n271-262-3\n68527-21-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-369-00-5\nNaphtha (petroleum), clay-treated light straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]\n271-263-9\n68527-22-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-370-00-0\nNaphtha (petroleum), light steam-cracked arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]\n271-264-4\n68527-23-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-371-00-6\nNaphtha (petroleum), light steam-cracked, debenzenized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]\n271-266-5\n68527-26-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-372-00-1\nNaphtha (petroleum), arom.-contg.;\nLow boiling point naphtha - unspecified\n271-635-0\n68603-08-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-373-00-7\nGasoline, pyrolysis, debutanizer bottoms;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]\n271-726-5\n68606-10-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-374-00-2\nNaphtha (petroleum), light, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]\n272-206-0\n68783-66-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-375-00-8\nNatural gas condensates;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]\n272-896-3\n68919-39-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-376-00-3\nDistillates (petroleum), naphtha unifiner stripper;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n272-932-8\n68921-09-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-377-00-9\nNaphtha (petroleum), catalytic reformed light, arom.-free fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]\n285-510-3\n85116-59-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-378-00-4\nGasoline;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]\n289-220-8\n86290-81-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-379-00-X\nAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;\nLow boiling point naphtha - unspecified\n292-698-0\n90989-42-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-380-00-5\nHydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]\n295-298-4\n91995-38-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-381-00-0\nDistillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n295-302-4\n91995-41-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-382-00-6\nExtracts (petroleum), catalytic reformed light naphtha solvent;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n295-331-2\n91995-68-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-383-00-1\nNaphtha (petroleum), hydrodesulfurized light, dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]\n295-434-2\n92045-53-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-384-00-7\nNaphtha (petroleum), light, C5-rich, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]\n295-442-6\n92045-60-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-385-00-2\nHydrocarbons, C8-11, naphtha-cracking, toluene cut;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]\n295-444-7\n92045-62-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-386-00-8\nHydrocarbons, C4-11, naphtha-cracking, arom.-free;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]\n295-445-2\n92045-63-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-387-00-3\nNaphtha (petroleum), light heat-soaked, steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]\n296-028-8\n92201-97-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-388-00-9\nDistillates (petroleum), C6-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]\n296-903-4\n93165-19-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-389-00-4\nGasoline, pyrolysis, hydrogenated;\nLow boiling point naphtha-unspecified;\n[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]\n302-639-3\n94114-03-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-390-00-X\nDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n305-750-5\n95009-23-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-391-00-5\nExtracts (petroleum) heavy naphtha solvent, clay-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]\n308-261-5\n97926-43-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-392-00-0\nNaphtha (petroleum), light steam-cracked, debenzenized, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]\n308-713-1\n98219-46-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-393-00-6\nNaphtha (petroleum), light steam-cracked, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]\n308-714-7\n98219-47-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-394-00-1\nDistillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]\n309-862-5\n101316-56-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-395-00-7\nHydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]\n309-870-9\n101316-66-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-396-00-2\nNaphtha (petroleum), hydrodesulfurised full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]\n309-879-8\n101316-76-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-397-00-8\nNaphtha (petroleum), sweetened light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]\n309-976-5\n101795-01-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-398-00-3\nHydrocarbons, C3-6, C5-rich, steam-cracked naphtha;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]\n310-012-0\n102110-14-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-399-00-9\nHydrocarbons, C5-rich, dicyclopentadiene-contg.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]\n310-013-6\n102110-15-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-400-00-2\nResidues (petroleum), steam-cracked light, arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]\n310-057-6\n102110-55-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-401-00-8\nHydrocarbons, C≥5, C5-6-rich;\nLow boiling point naphtha - unspecified\n270-690-8\n68476-50-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-402-00-3\nHydrocarbons, C5-rich;\nLow boiling point naphtha - unspecified\n270-695-5\n68476-55-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-403-00-9\nAromatic hydrocarbons, C8-10;\nLow boiling point naphtha - unspecified\n292-695-4\n90989-39-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-404-00-4\nKerosine (petroleum);\nStraight run kerosine;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]\n232-366-4\n8008-20-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-405-00-X\nSolvent naphtha (petroleum), medium aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]\n265-191-7\n64742-88-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-406-00-5\nSolvent naphtha (petroleum) heavy aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]\n265-200-4\n64742-96-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-407-00-0\nKerosine (petroleum), straight-run wide-cut;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]\n295-418-5\n92045-37-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-408-00-6\nDistillates (petroleum), steam-cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]\n265-194-3\n64742-91-2\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-409-00-1\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]\n270-728-3\n68477-39-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-410-00-7\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]\n270-729-9\n68477-40-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-411-00-2\nDistillates (petroleum), steam-cracked, C8-12 fraction;\nCracked kerosine;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n270-737-2\n68477-54-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-412-00-8\nKerosine (petroleum), hydrodesulfurized thermal cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]\n285-507-7\n85116-55-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-413-00-3\nAromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]\n292-621-0\n90640-98-5\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-414-00-9\nNaphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]\n292-637-8\n90641-13-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-415-00-4\nDistillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]\n309-866-7\n101316-61-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-416-00-X\nDistillates (petroleum), catalytic cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-938-8\n101631-13-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-417-00-5\nSolvent naphtha (petroleum), hydrocracked heavy arom.;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]\n309-881-9\n101316-80-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-418-00-0\nDistillates (petroleum), steam-cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-940-9\n101631-15-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-419-00-6\nDistillates (petroleum), alkylate;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]\n265-074-0\n64741-73-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-420-00-1\nExtracts (petroleum), heavy naphtha solvent;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]\n265-099-7\n64741-98-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-421-00-7\nDistillates (petroleum), chemically neutralized light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-132-5\n64742-31-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-422-00-2\nDistillates (petroleum), hydrotreated light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-149-8\n64742-47-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-423-00-8\nKerosine (petroleum), hydrodesulfurized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-184-9\n64742-81-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-424-00-3\nSolvent naphtha (petroleum), heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]\n265-198-5\n64742-94-5\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-425-00-9\nNaphtha (petroleum), heavy coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]\n269-778-9\n68333-23-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-426-00-4\nNaphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]\n285-508-2\n85116-57-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-427-00-X\nKerosine (petroleum), sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]\n294-799-5\n91770-15-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-428-00-5\nKerosine (petroleum), solvent-refined sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]\n295-416-4\n92045-36-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-429-00-0\nHydrocarbons, C9-16, hydrotreated, dearomatized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-854-1\n93763-35-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-430-00-6\nKerosine (petroleum), solvent-refined hydrodesulfurized;\nKerosine — unspecified\n307-033-2\n97488-94-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-431-00-1\nDistillates (petroleum), hydrodesulfurized full-range middle coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]\n309-864-6\n101316-58-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-432-00-7\nSolvent naphtha (petroleum), hydrodesulfurized heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]\n309-882-4\n101316-81-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-433-00-2\nSolvent naphtha (petroleum), hydrodesulfurized medium;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]\n309-884-5\n101316-82-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-434-00-8\nKerosine (petroleum), hydrotreated;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]\n309-944-0\n101631-19-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-435-00-3\nDistillates (petroleum), light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n265-060-4\n64741-59-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-436-00-9\nDistillates (petroleum), intermediate catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n265-062-5\n64741-60-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-437-00-4\nDistillates (petroleum), light hydrocracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]\n265-078-2\n64741-77-1\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-438-00-X\nDistillates (petroleum), light thermal cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]\n265-084-5\n64741-82-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-439-00-5\nDistillates (petroleum), hydrodesulfurized light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n269-781-5\n68333-25-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-440-00-0\nDistillates (petroleum), light steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]\n270-662-5\n68475-80-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-441-00-6\nDistillates (petroleum), cracked steam-cracked petroleum distillates;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]\n270-727-8\n68477-38-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-442-00-1\nGas oils (petroleum), steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]\n271-260-2\n68527-18-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-443-00-7\nDistillates (petroleum), hydrodesulfurized thermal cracked middle;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n285-505-6\n85116-53-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-444-00-2\nGas oils (petroleum), thermal-cracked, hydrodesulfurized;\nCracked gasoil\n295-411-7\n92045-29-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-445-00-8\nResidues (petroleum), hydrogenated steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]\n295-514-7\n92062-00-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-446-00-3\nResidues (petroleum), steam-cracked naphtha distn.;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]\n295-517-3\n92062-04-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-447-00-9\nDistillates (petroleum), light catalytic cracked, thermally degraded;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]\n295-991-1\n92201-60-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-448-00-4\nResidues (petroleum), steam-cracked heat-soaked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]\n297-905-8\n93763-85-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-449-00-X\nHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]\n307-662-2\n97675-88-2\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-450-00-5\nGas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]\n308-278-8\n97926-59-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-451-00-0\nDistillates (petroleum), hydrodesulfurized middle coker;\nCracked gasoil;\n[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]\n309-865-1\n101316-59-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-452-00-6\nDistillates (petroleum), heavy steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]\n309-939-3\n101631-14-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-453-00-1\nDistillates (petroleum), heavy hydrocracked;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]\n265-077-7\n64741-76-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-454-00-7\nDistillates (petroleum), solvent-refined heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-090-8\n64741-88-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-455-00-2\nDistillates (petroleum), solvent-refined light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-091-3\n64741-89-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-456-00-8\nResidual oils (petroleum), solvent deasphalted;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-096-0\n64741-95-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-457-00-3\nDistillates (petroleum), solvent-refined heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]\n265-097-6\n64741-96-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-458-00-9\nDistillates (petroleum), solvent-refined light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-098-1\n64741-97-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-459-00-4\nResidual oils (petroleum,) solvent-refined;\nBaseoil — unspecified;\n[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-101-6\n64742-01-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-460-00-X\nDistillates (petroleum), clay-treated paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-137-2\n64742-36-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-461-00-5\nDistillates (petroleum), clay-treated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-138-8\n64742-37-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-462-00-0\nResidual oils (petroleum), clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-143-5\n64742-41-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-463-00-6\nDistillates (petroleum), clay-treated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-146-1\n64742-44-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-464-00-1\nDistillates (petroleum), clay-treated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-147-7\n64742-45-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-465-00-7\nDistillates (petroleum), hydrotreated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-155-0\n64742-52-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-466-00-2\nDistillates (petroleum), hydrotreated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-156-6\n64742-53-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-467-00-8\nDistillates (petroleum), hydrotreated heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-157-1\n64742-54-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-468-00-3\nDistillates (petroleum), hydrotreated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-158-7\n64742-55-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-469-00-9\nDistillates (petroleum), solvent-dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-159-2\n64742-56-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-470-00-4\nResidual oils (petroleum), hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-160-8\n64742-57-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-471-00-X\nResidual oils (petroleum), solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-166-0\n64742-62-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-472-00-5\nDistillates (petroleum), solvent-dewaxed heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-167-6\n64742-63-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-473-00-0\nDistillates (petroleum), solvent-dewaxed light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-168-1\n64742-64-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-474-00-6\nDistillates (petroleum), solvent-dewaxed heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-169-7\n64742-65-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-475-00-1\nNaphthenic oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-172-3\n64742-68-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-476-00-7\nNaphthenic oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-173-9\n64742-69-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-477-00-2\nParaffin oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-174-4\n64742-70-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-478-00-8\nParaffin oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-176-5\n64742-71-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-479-00-3\nNaphthenic oils (petroleum), complex dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-179-1\n64742-75-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-480-00-9\nNaphthenic oils (petroleum), complex dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-180-7\n64742-76-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-481-00-4\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-736-3\n72623-85-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-482-00-X\nLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]\n276-737-9\n72623-86-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-483-00-5\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-738-4\n72623-87-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-484-00-0\nLubricating oils;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]\n278-012-2\n74869-22-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-485-00-6\nDistillates (petroleum), complex dewaxed heavy paraffinci;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-613-7\n90640-91-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-486-00-1\nDistillates (petroleum), complex dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-614-2\n90640-92-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-487-00-7\nDistillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-616-3\n90640-94-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-488-00-2\nHydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-617-9\n90640-95-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-489-00-8\nDistillates (petroleum), solvent dewaxed light paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-618-4\n90640-96-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-490-00-3\nDistillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-620-5\n90640-97-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-491-00-9\nResidual oils (petroleum), hydrotreated solvent dewaxed;\nBaseoil — unspecified\n292-656-1\n90669-74-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-492-00-4\nResidual oils (petroleum), catalytic dewaxed;\nBaseoil — unspecified\n294-843-3\n91770-57-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-493-00-X\nDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]\n295-300-3\n91995-39-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-494-00-5\nDistillates (petroleum), dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]\n295-301-9\n91995-40-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-495-00-0\nDistillates (petroleum), hydrocracked solvent-refined, dewaxed;\nBaseoil — unspecified;\n[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]\n295-306-6\n91995-45-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-496-00-6\nDistillates (petroleum), solvent-refined light naphthenic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]\n295-316-0\n91995-54-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-497-00-1\nLubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;\nBaseoil — unspecified\n295-423-2\n92045-42-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-498-00-7\nLubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;\nBaseoil — unspecified\n295-424-8\n92045-43-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-499-00-2\nResidual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]\n295-499-7\n92061-86-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-500-00-6\nParaffin oils (petroleum), solvent-refined dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]\n295-810-6\n92129-09-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-501-00-1\nLubricating oils (petroleum), base oils, paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]\n297-474-6\n93572-43-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-502-00-7\nHydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;\nBaseoil — unspecified\n297-857-8\n93763-38-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-503-00-2\nHydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;\nBaseoil — unspecified\n300-257-1\n93924-61-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-504-00-8\nDistillates (petroleum), solvent-refined hydrotreated heavy;\nhydrogenated;\nBaseoil — unspecified\n305-588-5\n94733-08-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-505-00-3\nDistillates (petroleum), solvent-refined hydrocracked light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]\n305-589-0\n94733-09-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-506-00-9\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-594-8\n94733-15-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-507-00-4\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-595-3\n94733-16-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-508-00-X\nHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-971-7\n95371-04-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-509-00-5\nHydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-972-2\n95371-05-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-510-00-0\nHydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;\nBaseoil — unspecified\n305-974-3\n95371-07-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-511-00-6\nHydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;\nBaseoil — unspecified\n305-975-9\n95371-08-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-512-00-1\nDistillates (petroleum), hydrocracked solvent-refined light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]\n307-010-7\n97488-73-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-513-00-7\nDistillates (petroleum), solvent-refined hydrogenated heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]\n307-011-2\n97488-74-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-514-00-2\nLubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;\nBaseoil — unspecified\n307-034-8\n97488-95-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-515-00-8\nHydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]\n307-661-7\n97675-87-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-516-00-3\nHydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]\n307-755-8\n97722-06-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-517-00-9\nHydrocarbons, C13-27, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).]\n307-758-4\n97722-09-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-518-00-4\nHydrocarbons, C14-29, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]\n307-760-5\n97722-10-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-519-00-X\nHydrocarbons, C27-42, dearomatized;\nBaseoil — unspecified\n308-131-8\n97862-81-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-520-00-5\nHydrocarbons, C17-30, hydrotreated distillates, distn. lights;\nBaseoil — unspecified\n308-132-3\n97862-82-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-521-00-0\nHydrocarbons, C27-45, naphthenic vacuum distn.;\nBaseoil — unspecified\n308-133-9\n97862-83-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-522-00-6\nHydrocarbons, C27-45, dearomatized;\nBaseoil — unspecified\n308-287-7\n97926-68-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-523-00-1\nHydrocarbons, C20-58, hydrotreated;\nBaseoil — unspecified\n308-289-8\n97926-70-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-524-00-7\nHydrocarbons, C27-42, naphthenic;\nBaseoil — unspecified\n308-290-3\n97926-71-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-525-00-2\nResidual oils (petroleum), carbon-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]\n309-710-8\n100684-37-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-526-00-8\nResidual oils (petroleum), clay-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]\n309-711-3\n100684-38-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-527-00-3\nLubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]\n309-874-0\n101316-69-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-528-00-9\nLubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]\n309-875-6\n101316-70-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-529-00-4\nLubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]\n309-876-1\n101316-71-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-530-00-X\nLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]\n309-877-7\n101316-72-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-531-00-5\nExtracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;\nDistillate aromatic extract (treated);\n[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]\n272-175-3\n68783-00-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-532-00-0\nExtracts (petroleum), solvent-refined heavy paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n272-180-0\n68783-04-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-533-00-6\nExtracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]\n272-342-0\n68814-89-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-534-00-1\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]\n292-631-5\n90641-07-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-535-00-7\nExtracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).\n292-632-0\n90641-08-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-536-00-2\nExtracts (petroleum), light paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]\n292-633-6\n90641-09-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-537-00-8\nExtracts (petroleum), hydrotreated light paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n295-335-4\n91995-73-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-538-00-3\nExtracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n295-338-0\n91995-75-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-539-00-9\nExtracts (petroleum), light paraffinic distillate solvent, acid-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n295-339-6\n91995-76-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-540-00-4\nExtracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]\n295-340-1\n91995-77-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-541-00-X\nExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n295-342-2\n91995-79-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-542-00-5\nExtracts (petroleum), heavy paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]\n296-437-1\n92704-08-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-543-00-0\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-827-4\n93763-10-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-544-00-6\nExtracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-829-5\n93763-11-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-545-00-1\nExtracts (petroleum), light paraffinic distillate solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-672-2\n100684-02-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-546-00-7\nExtracts (petroleum), light paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-673-8\n100684-03-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-547-00-2\nExtracts (petroleum), light vacuum, gas oil solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-674-3\n100684-04-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-548-00-8\nExtracts (petroleum), light vacuum gas oil solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-675-9\n100684-05-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-549-00-3\nFoots oil (petroleum);\nFoots oil;\n[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n265-171-8\n64742-67-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-550-00-9\nFoots oil (petroleum), hydrotreated;\nFoots oil\n295-394-6\n92045-12-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n650-002-00-6\nturpentine, oil\n232-350-7\n8006-64-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAsp. Tox. 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH226\nH332\nH312\nH302\nH304\nH319\nH315\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH332\nH312\nH302\nH304\nH319\nH315\nH317\nH411\n\n\n\n650-003-00-1\nfenson (ISO);\n4-chlorophenyl benzenesulphonate;\n201-274-6\n80-38-6\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH302\nH319\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH411\n\n\n\n650-004-00-7\nnorbormide (ISO);\n5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide\n213-589-6\n991-42-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n650-005-00-2\n(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone\n201-501-9\n83-79-4\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH335\nH315\nH410\n\n\n\n650-006-00-8\nbenquinox (ISO);\np-benzoquinone 1-benzoylhydrazone 4-oxime\n207-807-9\n495-73-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n650-007-00-3\nchlordimeform (ISO);\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine\n228-200-5\n6164-98-3\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH312\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH312\nH302\nH410\n\n\n\n650-008-00-9\ndrazoxolon (ISO);\n4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone\n227-197-8\n5707-69-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n650-009-00-4\nchlordimeform hydrochloride;\nN'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride\n243-269-1\n19750-95-9\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n650-010-00-X\nbenzyl violet 4B;\nα-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate\n216-901-9\n1694-09-3\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n650-012-00-0\nerionite\n—\n12510-42-8\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\n\n650-013-00-6\nasbestos\n—\n—\n—\n—\n—\n—\n—\n12001-28-4\n132207-32-0\n12172-73-5\n77536-66-4\n77536-68-6\n77536-67-5\n12001-29-5\nCarc. 1A\nSTOT RE 1\nH350\nH372 **\nGHS08\nDgr\nH350\nH372 **\n\n\n\n650-014-00-1\ndiethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate\n401-770-4\n—\nSkin Corr. 1B\nAcute Tox. 4 *\nH314\nH302\nGHS05\nGHS07\nDgr\nH314\nH302\n\n\n\n650-015-00-7\nrosin;\ncolophony\n232-475-7\n232-484-6\n277-299-1\n8050-09-7\n8052-10-6\n73138-82-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n650-016-00-2\nMineral wool, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]\n—\n—\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nAQR\n\n650-017-00-8\nRefractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]\n—\n—\nCarc. 1B\nH350i\nGHS08\nDgr\nH350i\n\n\nAR\n\n650-018-00-3\nReaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid\n406-230-1\n—\nFlam. Liq. 3\nCarc. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH351\nH314\nH332\nH317\nH400\nH410\nGHS02\nGHS08\nGHS05 GHS07\nGHS09\nDgr\nH226\nH351\nH314\nH332\nH317\nH410\n\n\n\n650-031-00-4\nbis(4-hydroxy-N-methylanilinium) sulphate\n200-237-1\n55-55-0\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n650-032-00-X\ncyproconazole (ISO);\n(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol\n—\n94361-06-5\nRepr. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH302\nH400\nH410\nGHS08\nGHS07 GHS09\nWng\nH361d ***\nH302\nH410\n\n\n\n\n\n650-033-00-5\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;\nesfenvalerate\n—\n66230-04-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH317\nH410\n\n\n\n\n650-041-00-9\ntriasulfuron (ISO);\n1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea\n—\n82097-50-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n650-042-00-4\nreaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates\n417-450-2\n—\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH315\nH317\nH412\nGHS07\nWng\nH319\nH315\nH317\nH412\n\n\n\n650-043-00-X\nreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate\n420-310-3\n—\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n650-044-00-5\nmixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin\n420-480-9\n158570-99-1\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n650-045-00-0\nreaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate\n417-110-3\n—\nFlam. Liq. 2\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH225\nH315\nH318\nH411\nGHS02\nGHS05\nGHS09\nDgr\nH225\nH315\nH318\nH411\n\n\n\n650-046-00-6\ndi(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates\n416-180-2\n12222-04-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n650-047-00-1\ndibenzylphenylsulfonium hexafluoroantimonate\n417-760-8\n134164-24-2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH302\nH318\nH317\nH411\nGHS08\nGHS05 GHS07\nGHS09\nDgr\nH372 **\nH302\nH318\nH317\nH411\n\n\n\n650-048-00-7\nreaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid\n420-070-1\n—\nOrg. Perox. D ****\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH242\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05 GHS07\nGHS09\nDgr\nH242\nH332\nH312\nH302\nH314\nH400\n\n\n\n650-049-00-2\n2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl\n417-960-5\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05 GHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n650-050-00-8\nreaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;\n1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;\n1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers\n423-600-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n650-055-00-5\nsilver sodium zirconium hydrogenphosphate\n422-570-3\n155925-27-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\nTable 3.2\nThe list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC\n\nIndex No\nInternational Chemical Identification\nEC No\nCAS No\nClassification\nLabelling\nConcentration Limits\nNotes\n001-001-00-9\nhydrogen\n215-605-7\n1333-74-0\nF+; R12\nF+\nR: 12\nS: (2-)9-16-33\n\n\n\n\n001-002-00-4\naluminium lithium hydride\n240-877-9\n16853-85-3\nF; R15\nC; R35\nF; C\nR: 15-35\nS: (1/2-)7/8-26-36/37/39-43-45\n\n\n\n001-003-00-X\nsodium hydride\n231-587-3\n7646-69-7\nF; R15\nF\nR: 15\nS: (2-)7/8-24/25-43\n\n\n001-004-00-5\ncalcium hydride\n232-189-2\n7789-78-8\nF; R15\nF\nR: 15\nS: (2-)7/8-24/25-43\n\n\n003-001-00-4\nlithium\n231-102-5\n7439-93-2\nF; R15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)8-43-45\n\n\n003-002-00-X\nn-hexyllithium\n404-950-0\n21369-64-2\nF; R15-17\nR14\nC; R35\nF; C\nR: 14/15-17-35\nS: (1/2-)6-16-26-30-36/37/39-43-45\n\n\n\n\n003-003-00-5\n(2-methylpropyl)lithium;\nisobutyllithium\n440-620-2\n920-36-5\nF; R15-17\nR14\nC; R35\nR67\nN; R50-53\nF; C; N\nR: 14/15-17-35-67-50/53\nS: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61\n\n\n\n\n004-001-00-7\nberyllium\n231-150-7\n7440-41-7\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nT+\nR: 49-25-26-36/37/38-43-48/23\nS: 53-45\n\nE\n004-002-00-2\nberyllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex\n—\n—\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nN; R51-53\nT+; N\nR: 49-25-26-36/37/38-43-48/23-51/53\nS: 53-45-61\n\nAE\n004-003-00-8\nberyllium oxide\n215-133-1\n1304-56-9\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nT+\nR: 49-25-26-36/37/38-43-48/23\nS: 53-45\n\nE\n005-001-00-X\nboron trifluoride\n231-569-5\n7637-07-2\nR14\nT+; R26\nC; R35\nT+; C\nR: 14-26-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-002-00-5\nboron trichloride\n233-658-4\n10294-34-5\nR14\nT+; R26/28\nC; R34\nT+\nR: 14-26/28-34\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-003-00-0\nboron tribromide\n233-657-9\n10294-33-4\nR14\nT+; R26/28\nC; R35\nT+; C\nR: 14-26/28-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-004-00-6\ntrialkylboranes\n—\n—\nF; R17\nC; R34\nF; C\nR: 17-34\nS: (1/2-)7-23-26-36/37/39-43-45\n\nA\n005-005-00-1\ntrimethyl borate\n204-468-9\n121-43-7\nR10\nXn; R21\nXn\nR: 10-21\nS: (2-)23-25\n\n\n\n\n\n005-006-00-7\ndibutyltin hydrogen borate\n401-040-5\n75113-37-0\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60-61\nT; R48/25\nXn; R21/22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 60-61-21/22-41-43-48/25-68-50/53\nS: 53-45-60-61\n\nE\n\n\n\n005-007-00-2\nboric acid; [1]\nboric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]\n233-139-2 [1]\n234-343-4 [2]\n10043-35-3 [1]\n11113-50-1 [2]\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 5,5 %\n\n\n005-008-00-8\ndiboron trioxide;\nboric oxide\n215-125-8\n1303-86-2\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 3,1 %\n\n\n005-009-00-3\ntetrabutylammonium butyltriphenylborate\n418-080-4\n120307-06-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-56-61\n\n\n005-010-00-9\nN,N-dimethylanilinium tetrakis(pentafluorophenyl)borate\n422-050-6\n118612-00-3\nCarc. Cat. 3; R40\nXn; R22\nXi; R38-41\nXn\nR: 22-38-40-41\nS: (2-)22-26-36/37/39\n\n\n\n\n005-011-00-4\ndisodium tetraborate, anhydrous;\nboric acid, disodium salt; [1]\ntetraboron disodium heptaoxide, hydrate; [2]\northoboric acid, sodium salt [3]\n215-540-4 [1]\n235-541-3 [2]\n237-560-2 [3]\n1330-43-4 [1]\n12267-73-1 [2]\n13840-56-7 [3]\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 4,5 %\n\n\n005-011-01-1\ndisodium tetraborate decahydrate;\nborax decahydrate\n215-540-4\n1303-96-4\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 8,5 %\n\n\n005-011-02-9\ndisodium tetraborate pentahydrate;\nborax pentahydrate\n215-540-4\n12179-04-3\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 6,5 %\n\n\n005-012-00-X\ndiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate\n418-070-1\n141714-54-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n005-013-00-5\ndiethylmethoxyborane\n425-380-9\n7397-46-8\nF; R17\nXn; R20/21/22-48/22\nC; R34\nR43\nR53\nF; C\nR: 17-20/21/22-34-43-48/22-53\nS: (1/2-)6-26-36/37/39-43-45-61\n\n\n\n005-014-00-0\n4-formylphenylboronic acid\n438-670-5\n87199-17-5\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n005-015-00-6\n1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n414-380-4\n140681-55-6\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)21-26-36/37/39-61\n\n\n\n005-016-00-1\ntetrabutylammonium butyl tris-(4-tert-butylphenyl)borate\n431-370-5\n-\nR53\nR: 53\nS: 61\n\n\n\n005-017-00-7\nsodium perborate; [1]\nperboric acid, sodium salt; [2]\nperboric acid, sodium salt, monohydrate; [3]\nsodium peroxometaborate; [4]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [5]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n234-390-0 [3]\n231-556-4 [4]\n231-556-4 [5]\n15120-21-5 [1]\n11138-47-9 [2]\n12040-72-1 [3]\n7632-04-4 [4]\n10332-33-9 [5]\nO; R8\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXn; R22\nXi; R37-41\nO; T\nR: 61-8-22-37-41-62\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 6,5 %\nRepr. Cat. 3; R62: C ≥ 9 %\nXi; R41: C ≥ 22 %\nXi; R36: 14 % ≤ C < 22 %\nE\n\n005-017-01-4\nsodium perborate; [1]\nperboric acid, sodium salt; [2]\nperboric acid, sodium salt, monohydrate; [3]\nsodium peroxometaborate; [4]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [5]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n234-390-0 [3]\n231-556-4 [4]\n231-556-4 [5]\n15120-21-5 [1]\n11138-47-9 [2]\n12040-72-1 [3]\n7632-04-4 [4]\n10332-33-9 [5]\n-\nO; R8\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nT; R23\nXn; R22\nXi; R37-41\nO; T\nR: 61-8-22-23-37-41-62\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 6,5 %\nRepr. Cat. 3; R62: C ≥ 9 %\nXi; R41: C ≥ 22 %\nXi; R36: 14 % ≤ C < 22 %\nE\n\n005-018-00-2\nperboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\n-\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXi; R37-41\nT\nR: 61-37-41-62\nS: 53-45-47\nRepr. Cat. 2; R61: C ≥ 10 %\nRepr. Cat. 3; R62: C ≥ 14 %\nXi; R41: C ≥ 36 %\nXi; R36: 22 % ≤ C < 36 %\n\n\n005-018-01-X\nperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\n-\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXn; R20\nXi; R37-41\nT\nR: 61-20-37-41-62\nS: 53-45-47\nRepr. Cat. 2; R61: C ≥ 10 %\nRepr. Cat. 3; R62: C ≥ 14 %\nXi; R41: C ≥ 36 %\nXi; R36: 22 % ≤ C < 36 %\nE\n\n006-001-00-2\ncarbon monoxide\n211-128-3\n630-08-0\nF+; R12\nRepr. Cat. 1; R61\nT; R23-48/23\nF+; T\nR: 61-12-23-48/23\nS: 53-45\n\nE\n006-002-00-8\nphosgene;\ncarbonyl chloride\n200-870-3\n75-44-5\nT+; R26\nC; R34\nT+\nR: 26-34\nS: (1/2-)9-26-36/37/39-45\n\n\n006-003-00-3\ncarbon disulphide\n200-843-6\n75-15-0\nF; R11\nRepr. Cat. 3; R62-63\nT; R48/23\nXi; R36/38\nF; T\nR: 11-36/38-48/23-62-63\nS: (1/2-)16-33-36/37-45\nRepr. Cat. 3; R62-63: C ≥ 1 %\nT; R48/23: C ≥ 1 %\nXn; R48/20: 0,2 % ≤ C < 1 %\n\n006-004-00-9\ncalcium carbide\n200-848-3\n75-20-7\nF; R15\nF\nR: 15\nS: (2-)8-43\n\n\n006-005-00-4\nthiram (ISO);\ntetramethylthiuram disulphide\n205-286-2\n137-26-8\nXn; R20/22-48/22\nXi; R36/38\nR43\nN; R50-53\nXn; N\nR: 20/22-36/38-43-48/22-50/53\nS: (2-)26-36/37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n006-006-00-X\nhydrogen cyanide;\nhydrocyanic acid\n200-821-6\n74-90-8\nF+; R12\nT+; R26\nN; R50-53\nF+; T+; N\nR: 12-26-50/53\nS: (1/2-)7/9-16-36/37-38-45-60-61\n\n\n006-006-01-7\nhydrogen cyanide ...%;\nhydrocyanic acid ...%\n200-821-6\n74-90-8\nT+; R26/27/28\nN; R50-53\nT+; N\nR: 26/27/28-50/53\nS: (1/2-)7/9-36/37-38-45-60-61\n\nB\n\n\n006-007-00-5\nsalts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex\n—\n—\nT+; R26/27/28\nR32\nN; R50-53\nT+; N\nR: 26/27/28-32-50/53\nS: (1/2-)7-28-29-45-60-61\n\nA\n\n\n006-008-00-0\nantu (ISO);\n1-(1-naphthyl)-2-thiourea\n201-706-3\n86-88-4\nT+; R28\nCarc. Cat. 3; R40\nT+\nR: 28-40\nS: (1/2-)25-36/37-45\n\n\n006-009-00-6\n1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;\nisolan\n204-318-2\n119-38-0\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37/39-45\n\n\n006-010-00-1\n5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;\ndimetan\n204-525-8\n122-15-6\nT; R25\nT\nR: 25\nS: (1/2-)36/37-45\n\n\n\n\n006-011-00-7\ncarbaryl (ISO);\n1-naphthyl methylcarbamate\n200-555-0\n63-25-2\nCarc. Cat. 3; R40\nXn; R20/22\nN; R50\nXn; N\nR: 20/22-40-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 0,25 %\n\n\n006-012-00-2\nziram (ISO);\nzinc bis dimethyldithiocarbamate\n205-288-3\n137-30-4\nT+; R26\nXn; R22-48/22\nXi; R37-41\nR43\nN; R50-53\nT+; N\nR: 22-26-37-41-43-48/22-50/53\nS: (1/2-)22-26-28-36/37/39-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n006-013-00-8\nmetam-sodium (ISO);\nsodium methyldithiocarbamate\n205-293-0\n137-42-8\nXn; R22\nR31\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-31-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n006-014-00-3\nnabam (ISO);\ndisodium ethylenebis(N,N'-dithiocarbamate)\n205-547-0\n142-59-6\nXn; R22\nXi; R37\nR43\nN; R50-53\nXn; N\nR: 22-37-43-50/53\nS: (2-)8-24/25-46-60-61\n\n\n\n\n\n006-015-00-9\ndiuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea\n206-354-4\n330-54-1\nCarc. Cat. 3; R40\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-40-48/22-50/53\nS: (2-)13-36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n006-016-00-4\npropoxur (ISO);\n2-isopropyloxyphenyl N-methylcarbamate;\n2-isopropoxyphenyl methylcarbamate\n204-043-8\n114-26-1\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\n\n\n006-017-00-X\naldicarb (ISO);\n2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime\n204-123-2\n116-06-3\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n006-018-00-5\naminocarb (ISO);\n4-dimethylamino-3-tolyl methylcarbamate\n217-990-7\n2032-59-9\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n006-019-00-0\ndi-allate (ISO);\nS-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate\n218-961-1\n2303-16-4\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)25-36/37-60-61\n\n\n006-020-00-6\nbarban (ISO);\n4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate\n202-930-4\n101-27-9\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-36/37-60-61\n\n\n006-021-00-1\nlinuron (ISO);\n3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea\n206-356-5\n330-55-2\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nCarc. Cat. 3; R40\nXn; R22-48/22\nN; R50-53\nT; N\nR: 61-22-40-48/22-62-50/53\nS: 53-45-60-61\n\nE\n006-022-00-7\ndecarbofuran (ISO);\n2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate\n—\n1563-67-3\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-36/37-45\n\n\n006-023-00-2\nmercaptodimethur (ISO);\nmethiocarb (ISO);\n3,5-dimethyl-4-methylthiophenyl N-methylcarbamate\n217-991-2\n2032-65-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-37-45-60-61\n\n\n006-024-00-8\nproxan-sodium (ISO);\nsodium O-isopropyldithiocarbonate\n205-443-5\n140-93-2\nXn; R22\nXi; R38\nN; R51-53\nXn; N\nR: 22-38-51/53\nS: (2-)13-61\n\n\n006-025-00-3\nallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;\nbioallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]\nS-bioallethrin;\n(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]\nesbiothrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]\n209-542-4 [1]\n249-013-5 [2]\n- [3]\n584-79-2 [1]\n28434-00-6 [2]\n84030-86-4 [3]\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53\nS: (2-)36-60-61\n\nC\n006-026-00-9\ncarbofuran (ISO);\n2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate\n216-353-0\n1563-66-2\nT+; R26/28\nN; R50-53\nT+; N\nR: 26/28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n006-028-00-X\ndinobuton (ISO);\n2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate\n213-546-1\n973-21-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\n\n\n006-029-00-5\ndioxacarb (ISO);\n2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate\n230-253-4\n6988-21-2\nT; R25\nN; R51-53\nT; N\nR: 25-51/53\nS: (1/2-)37-45-61\n\n\n006-030-00-0\nEPTC (ISO);\nS-ethyl dipropylthiocarbamate\n212-073-8\n759-94-4\nXn; R22\nXn\nR: 22\nS: (2-)23\n\n\n006-031-00-6\nformetanate (ISO);\n3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate\n244-879-0\n22259-30-9\nT+; R26/28\nR43\nN; R50-53\nT+; N\nR: 26/28-43-50/53\nS: (1/2-)24-28-37/39-45-60-61\n\n\n006-032-00-1\nmonolinuron (ISO);\n3-(4-chlorophenyl)-1-methoxy-1-methylurea\n217-129-5\n1746-81-2\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)22-60-61\n\n\n006-033-00-7\nmetoxuron (ISO);\n3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea\n243-433-2\n19937-59-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n006-034-00-2\npebulate (ISO);\nN-butyl-N-ethyl-S-propylthiocarbamate\n214-215-4\n1114-71-2\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)23-61\n\n\n006-035-00-8\npirimicarb (ISO);\n5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate\n245-430-1\n23103-98-2\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-37-45-60-61\n\n\n006-036-00-3\nbenzthiazuron (ISO);\n1-benzothiazol-2-yl-3-methylurea\n217-685-9\n1929-88-0\nXn; R22\nXn\nR: 22\nS: (2-)24/25\n\n\n006-037-00-9\npromecarb (ISO);\n3-isopropyl-5-methylphenyl N-methylcarbamate\n220-113-0\n2631-37-0\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)24-37-45-60-61\n\n\n006-038-00-4\nsulfallate (ISO);\n2-chloroallyl N,N-dimethyldithiocarbamate\n202-388-9\n95-06-7\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n006-039-00-X\ntri-allate (ISO);\nS-2,3,3-trichloroallyl diisopropylthiocarbamate\n218-962-7\n2303-17-5\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)24-37-60-61\n\n\n006-040-00-5\n3-methylpyrazol-5-yl-dimethylcarbamate;\nmonometilan\n—\n2532-43-6\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n006-041-00-0\ndimethylcarbamoyl chloride\n201-208-6\n79-44-7\nCarc. Cat. 2; R45\nT; R23\nXn; R22\nXi; R36/37/38\nT\nR: 45-22-23-36/37/38\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,001 %\nE\n006-042-00-6\nmonuron (ISO);\n3-(4-chlorophenyl)-1,1-dimethylurea\n205-766-1\n150-68-5\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)36/37-60-61\n\n\n006-043-00-1\n3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;\nmonuron-TCA\n—\n140-41-0\nXi; R36/38\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 36/38-40-50/53\nS: (2-)36/37-60-61\n\n\n006-044-00-7\nisoproturon (ISO);\n3-(4-isopropylphenyl)-1,1-dimethylurea\n251-835-4\n34123-59-6\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n\n006-045-00-2\nmethomyl (ISO);\n1-(methylthio)ethylideneamino N-methylcarbamate\n240-815-0\n16752-77-5\nT+; R28\nN; R50-53\nT+; N\nR: 28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n006-046-00-8\nbendiocarb (ISO);\n2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate\n245-216-8\n22781-23-3\nT; R23/25\nXn; R21\nN; R50-53\nT; N\nR: 21-23/25-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n006-047-00-3\nbufencarb (ISO);\nreaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate\n—\n8065-36-9\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n006-048-00-9\nethiofencarb (ISO);\n2-(ethylthiomethyl)phenyl N-methylcarbamate\n249-981-9\n29973-13-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-049-00-4\ndixanthogen;\nO,O-diethyl dithiobis(thioformate)\n207-944-4\n502-55-6\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n006-050-00-X\n1,1-dimethyl-3-phenyluronium trichloroacetate;\nfenuron-TCA\n—\n4482-55-7\nXi; R38\nN; R50-53\nXi; N\nR: 38-50/53\nS: (2-)60-61\n\n\n006-051-00-5\nferbam (ISO);\niron tris(dimethyldithiocarbamate)\n238-484-2\n14484-64-1\nXi; R36/37/38\nN; R50-53\nXi; N\nR: 36/37/38-50/53\nS: (2-)60-61\n\n\n006-052-00-0\nformetanate hydrochloride;\n3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate\n245-656-0\n23422-53-9\nT+; R26/28\nR43\nN; R50-53\nT+; N\nR: 26/28-43-50/53\nS: (1/2-)24-28-37/39-45-60-61\n\n\n006-053-00-6\nisoprocarb (ISO);\n2-isopropylphenyl N-methylcarbamate\n220-114-6\n2631-40-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-054-00-1\nmexacarbate (ISO);\n3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate\n206-249-3\n315-18-4\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n006-055-00-7\nxylylcarb (ISO);\n3,4-dimethylphenyl N-methylcarbamate;\n3,4-xylyl methylcarbamate;\nMPMC\n219-364-9\n2425-10-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-056-00-2\nmetolcarb (ISO);\nm-tolyl methylcarbamate;\nMTMC\n214-446-0\n1129-41-5\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-057-00-8\nnitrapyrin (ISO);\n2-chloro-6-trichloromethylpyridine\n217-682-2\n1929-82-4\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)24-61\n\n\n006-058-00-3\nnoruron (ISO);\n1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea\n—\n2163-79-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-059-00-9\noxamyl (ISO);\nN',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;\n245-445-3\n23135-22-0\nT+; R26/28\nXn; R21\nN; R51-53\nT+; N\nR: 21-26/28-51/53\nS: (1/2-)36/37-45-61\n\n\n006-060-00-4\noxycarboxin (ISO);\n2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide\n226-066-2\n5259-88-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n006-061-00-X\nS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;\nprothiocarb hydrochloride\n243-193-9\n19622-19-6\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-062-00-5\nmethyl 3,4-dichlorophenylcarbanilate;\nSWEP.\n—\n1918-18-9\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-063-00-0\nthiobencarb (ISO);\nS-4-chlorobenzyl diethylthiocarbamate;\n248-924-5\n28249-77-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-064-00-6\nthiofanox (ISO);\n3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime;\n254-346-4\n39196-18-4\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)27-36/37-45-60-61\n\n\n006-065-00-1\n3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;\ntriamid\n—\n15271-41-7\nT+; R28\nT; R24\nN; R51-53\nT+; N\nR: 24-28-51/53\nS: (1/2-)28-36/37-45-61\n\n\n006-066-00-7\nvernolate (ISO);\nS-propyl dipropylthiocarbamate;\n217-681-7\n1929-77-7\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-067-00-2\nXMC;\n3,5-xylyl methylcarbamate\n—\n2655-14-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-068-00-8\ndiazomethane\n206-382-7\n334-88-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\n\n006-069-00-3\nthiophanate-methyl (ISO);\n1,2-di-(3-methoxycarbonyl-2-thioureido)benzene\n245-740-7\n23564-05-8\nMuta. Cat. 3; R68\nXn; R20\nR43\nN; R50-53\nXn; N\nR: 20-43-50/53-68\nS: (2-)36/37-46-60-61\n\n\n006-070-00-9\nfurmecyclox (ISO);\nN-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide;\n262-302-0\n60568-05-0\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n006-071-00-4\ncyclooct-4-en-1-yl methyl carbonate\n401-620-8\n87731-18-8\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n006-072-00-X\nprosulfocarb(ISO);\nS-benzyl N,N-dipropylthiocarbamate;\n401-730-6\n52888-80-9\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n006-073-00-5\n3-(dimethylamino)propylurea\n401-950-2\n31506-43-1\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n006-074-00-0\n2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate\n402-440-2\n2094-99-7\nT+; R26\nC; R34\nXn; R48/20\nR42/43\nN; R50-53\nT+; N\nR: 26-34-42/43-48/20-50/53\nS: (1/2-)7-15-28-36/37/39-38-45-60-61\n\n\n\n\n006-076-00-1\nmancozeb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt\n—\n8018-01-7\nRepr. Cat. 3; R63\nR43\nN; R50\nXn; N\nR: 43-63-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n006-077-00-7\nmaneb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric)\n235-654-8\n12427-38-2\nRepr. Cat. 3; R63\nXn; R20\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 20-36-43-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n006-078-00-2\nzineb (ISO);\nzinc ethylenebis(dithiocarbamate) (polymeric)\n235-180-1\n12122-67-7\nXi; R37\nR43\nXi\nR: 37-43\nS: (2-)8-24/25-46\n\n\n006-079-00-8\ndisulfiram;\ntetraethylthiuramdisulfide\n202-607-8\n97-77-8\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)24-37-60-61\n\n\n006-080-00-3\ntetramethylthiuram monosulphide\n202-605-7\n97-74-5\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-26-37-61\n\n\n006-081-00-9\nzinc bis(dibutyldithiocarbamate)\n205-232-8\n136-23-2\nXi; R36/37/38\nR43\nN; R50-53\nXi; N\nR: 36/37/38-43-50/53\nS: (2-)24-37-60-61\n\n\n006-082-00-4\nzinc bis(diethyldithiocarbamate)\n238-270-9\n14324-55-1\nXn; R22\nXi; R36/37/38\nR43\nN; R50-53\nXn; N\nR: 22-36/37/38-43-50/53\nS: (2-)24-37-60-61\n\n\n006-083-00-X\nbutocarboxim (ISO);\n3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime\n252-139-3\n34681-10-2\nR10\nT; R23/24/25\nXi; R36\nN; R50-53\nT; N\nR: 10-23/24/25-36-50/53\nS: (1/2-)36/37-45-60-61\n\n\n\n\n006-084-00-5\ncarbosulfan (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate\n259-565-9\n55285-14-8\nT+; R26\nT; R25\nR43\nN; R50-53\nT+; N\nR: 25-26-43-50/53\nS: (1/2-)28-36/37-38-45-63-60-61\n\n\n\n\n006-085-00-0\nfenobucarb (ISO);\n2-butylphenyl methylcarbamate;\n223-188-8\n3766-81-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-086-00-6\nethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;\nfenoxycarb\n276-696-7\n72490-01-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n006-087-00-1\nfurathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate\n265-974-3\n65907-30-4\nT+; R26\nT; R25\nXn; R48/22\nXi; R36/38\nR43\nN; R50-53\nT+; N\nR: 25-26-36/38-43-48/22-50/53\nS: (1/2-)28-36/37-38-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n006-088-00-7\nbenfuracarb (ISO);\nethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate\n—\n82560-54-1\nRepr. Cat. 3; R62\nT; R23\nXn; R22\nN; R50-53\nT; N\nR: 22-23-62-50/53\nS: (1/2-)36/37-45-60-61\n\n\n\n\n006-089-00-2\nchlorine dioxide\n233-162-8\n10049-04-4\nO; R8\nR6\nT+; R26\nC; R34\nN; R50\nO; T+; N\nR: 6-8-26-34-50\nS: (1/2-)23-26-28-36/37/39-38-45-61\nN; R50: C ≥ 0,02 %\n5\n006-089-01-X\nchlorine dioxide … %\n233-162-8\n10049-04-4\nT; R25\nC; R34\nN; R50\nT; N\nR: 25-34-50\nS: (1/2-)23-26-28-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 3 % ≤ C < 10 %\nXi; R36: 0,3 % ≤ C < 3 %\nN; R50: C ≥ 3 %\nB\n\n006-090-00-8\n2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate\n408-010-0\n88558-41-2\nXn; R20\nXi; R41\nR52-53\nXn\nR: 20-41-52/53\nS: (2-)22-26-39-61\n\n\n\n\n006-091-00-3\npropineb (ISO);\npolymeric zinc propylenebis(dithiocarbamate)\n-\n9016-72-2\nXn; R20-48/20/22\nR43\nN; R50\nXn; N\nR: 20-43-48/20/22-50\nS: (1/2-)24-37-46-61\n\n\n\n006-092-00-9\ntert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate\n425-420-5\n98737-29-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n006-093-00-4\n2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)\n427-180-7\n-\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)15-22-29-36/37-60-61\n\n\n\n006-094-00-X\nO-isobutyl-N-ethoxy carbonylthiocarbamate\n434-350-4\n103122-66-3\nR10\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R22-48/22\nR43\nN; R51-53\nT; N\nR: 45-46-10-22-43-48/22-51/53\nS: 53-45-61\n\nE\n\n006-095-00-5\nfosetyl-aluminium (ISO);\naluminium triethyl triphosphonate\n254-320-2\n39148-24-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39-46\n\n\n\n006-096-00-0\nchlorpropham (ISO);\nisopropyl 3-chlorocarbanilate\n202-925-7\n101-21-3\nCarc. Cat. 3; R40\nXn; R48/22\nN; R51-53\nXn; N\nR: 40-48/22-51/53\nS: (2-)36/37-61\n\n\n\n006-097-00-6\n1-phenyl-3-(p-toluenesulfonyl)urea\n424-620-1\n13909-63-2\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n006-098-00-1\ntert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate\n429-170-8\n134575-17-0\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)22-26-36/37/39\n\n\n\n006-099-00-7\nN-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;\n3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate\n432-520-2\n232938-43-1\nN; R51-53\nN\nR: 51/53\nS: 22-61\n\n\n\n006-101-00-6\nreaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];\nN-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;\nN,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]\n423-070-8\n-\nR53\nR: 53\nS: 61\n\n\n\n006-102-00-1\nO-hexyl-N-ethoxycarbonylthiocarbamate\n432-750-3\n-\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R22-48/22\nR43\nN; R51-53\nT; N\nR: 45-46-22-43-48/22-51/53\nS: 53-45-61\n\nE\n\n006-103-00-7\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea\n445-760-8\n-\nXi; R41\nR42\nN; R50-53\nXn; N\nR: 41-42-50/53\nS: (2-)22-26-39-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n007-001-00-5\nammonia, anhydrous\n231-635-3\n7664-41-7\nR10\nT; R23\nC; R34\nN; R50\nT; N\nR: 10-23-34-50\nS: (1/2-)9-16-26-36/37/39-45-61\n\n\n007-001-01-2\nammonia ....%\n215-647-6\n1336-21-6\nC; R34\nN; R50\nC; N\nR: 34-50\nS: (1/2-)26-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nB\n\n\n007-002-00-0\nnitrogen dioxide; [1]\ndinitrogen tetraoxide [2]\n233-272-6 [1]\n234-126-4 [2]\n10102-44-0 [1]\n10544-72-6 [2]\nO; R8\nT+; R26\nC; R34\nO; T+\nR: 8-26-34\nS: (1/2-)9-26-28-36/37/39-45\nT+; R26: C ≥ 10 %\nT; R23: 1 % ≤ C < 10 %\nXn; R20: 0,1 % ≤ C < 1 %\n5\n\n\n007-003-00-6\nchlormequat chloride (ISO);\n2-chloroethyltrimethylammonium chloride\n213-666-4\n999-81-5\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n007-004-00-1\nnitric acid ... %\n231-714-2\n7697-37-2\nO; R8\nC; R35\nO; C\nR: 8-35\nS: (1/2-)23-26-36-45\nC; R35: C ≥ 20 %\nC; R34: 5 % ≤ C < 20 %\nFootnote:\nO; R8: C ≥ 70 %\nB\n007-006-00-2\nethyl nitrite\n203-722-6\n109-95-5\nE; R2\nXn; R20/21/22\nE; Xn\nR: 2-20/21/22\nS: (2-)\n\n\n\n\n007-007-00-8\nethyl nitrate\n210-903-3\n625-58-1\nE; R3\nE\nR: 3\nS: (2-)23-24/25\n\n\n\n007-008-00-3\nhydrazine\n206-114-9\n302-01-2\nR10\nCarc. Cat. 2; R45\nT; R23/24/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 45-10-23/24/25-34-43-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/38: 3 % ≤ C < 10 %\nE\n007-009-00-9\ndicyclohexylammonium nitrite\n221-515-9\n3129-91-7\nXn; R20/22\nXn\nR: 20/22\nS: (2-)15-41\nXn; R20/22: C ≥ 10 %\n\n007-010-00-4\nsodium nitrite\n231-555-9\n7632-00-0\nO; R8\nT; R25\nN; R50\nO; T; N\nR: 8-25-50\nS: (1/2-)45-61\nT; R25: C ≥ 5 %\nXn; R22: 1 % ≤ C < 5 %\n\n007-011-00-X\npotassium nitrite\n231-832-4\n7758-09-0\nO; R8\nT; R25\nN; R50\nO; T; N\nR: 8-25-50\nS: (1/2-)45-61\nT; R25: C ≥ 5 %\nXn; R22: 1 % ≤ C < 5 %\n\n007-012-00-5\nN,N-dimethylhydrazine\n200-316-0\n57-14-7\nF; R11\nCarc. Cat. 2; R45\nT; R23/25\nC; R34\nN; R51-53\nF; T; N\nR: 45-11-23/25-34-51/53\nS: 53-45-61\n\nE\n007-013-00-0\n1,2-dimethylhydrazine\n—\n540-73-8\nCarc. Cat. 2; R45\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-23/24/25-51/53\nS: 53-45-61\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n007-014-00-6\nsalts of hydrazine\n—\n—\nCarc. Cat. 2; R45\nT; R23/24/25\nR43\nN; R50-53\nT; N\nR: 45-23/24/25-43-50/53\nS: 53-45-60-61\n\nAE\n007-015-00-1\nO-ethylhydroxylamine\n402-030-3\n624-86-2\nF; R11\nT; R23/24/25-48/23\nXi; R36\nR43\nN; R50\nF; T; N\nR: 11-23/24/25-36-43-48/23-50\nS: (1/2-)16-26-36/37/39-45-60-61\n\n\n007-016-00-7\nbutyl nitrite\n208-862-1\n544-16-1\nF; R11\nT; R23/25\nF; T\nR: 11-23/25\nS: (1/2-)16-24-45\n\n\n007-017-00-2\nisobutyl nitrite\n208-819-7\n542-56-3\nF; R11\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R20/22\nF; T\nR: 11-20/22-45-68\nS: 53-45\n\nE\n007-018-00-8\nsec-butyl nitrite\n213-104-8\n924-43-6\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-019-00-3\ntert-butyl nitrite\n208-757-0\n540-80-7\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-020-00-9\npentyl nitrite; [1]\namyl nitrite, mixed isomers [2]\n207-332-7 [1]\n203-770-8 [2]\n463-04-7 [1]\n110-46-3 [2]\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-021-00-4\nhydrazobenzene;\n1,2-diphenylhydrazine\n204-563-5\n122-66-7\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n007-022-00-X\nhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)\n405-030-1\n—\nCarc. Cat. 2; R45\nXn; R22\nC; R34\nR43\nR52-53\nT\nR: 45-22-34-43-52/53\nS: 53-45-61\n\nE\n007-023-00-5\nsodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate\n405-510-0\n—\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)24-37\n\n\n007-024-00-0\n2-(decylthio)ethylammonium chloride\n405-640-8\n36362-09-1\nXn; R48/22\nXi; R38-41\nN; R50-53\nXn; N\nR: 38-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n007-025-00-6\n(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride\n406-090-1\n81880-96-8\nMuta. Cat. 3; R68\nT; R25-48/25\nR43\nN; R50-53\nT; N\nR: 25-43-48/25-68-50/53\nS: (1/2-)22-36/37/39-45-60-61\n\n\n007-026-00-1\noxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide\n413-230-5\n122035-71-6\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)8-22-24-26-30-37/39\n\n\n007-027-00-7\n1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane\n420-190-2\n771478-66-1\nC; R34\nXn; R21/22-48/21\nR43\nN; R50-53\nC; N\nR: 21/22-34-43-48/21-50/53\nS: (1/2-)7-26-36/37/39-45-60-61\n\n\n\n\n\n007-028-00-2\nhydroxylammonium nitrate\n236-691-2\n13465-08-2\nE; R2\nCarc. Cat. 3; R40\nT; R24\nXn; R22-48/22\nXi; R36/38\nR43\nN; R50\nE; T; N\nR: 2-22-24-36/38-40-43-48/22-50\nS: (1/2-)26-36/37-45-61\n\n\n\n007-029-00-8\ndiethyldimethylammonium hydroxide\n419-400-5\n95500-19-9\nXn; R21/22\nC; R35\nC\nR: 21/22-35\nS: (1/2-)26-36/37/39-45\n\n\n\n008-001-00-8\noxygen\n231-956-9\n7782-44-7\nO; R8\nO\nR: 8\nS: (2-)17\n\n\n008-003-00-9\nhydrogen peroxide solution ... %\n231-765-0\n7722-84-1\nR5\nO; R8\nC; R35\nXn; R20/22\nO; C\nR: 5-8-20/22-35\nS: (1/2-)17-26-28-36/37/39-45\nXn; R20: C ≥ 50 %\nXn; R22: C ≥ 8 %\nC; R35: C ≥ 70 %\nC; R34: 50 % ≤ C < 70 %\nXi; R37/38: 35 % ≤ C < 50 %\nXi; R41: 8 % ≤ C < 50 %\nXi; R36: 5 % ≤ C < 8 %\nFootnote:\nO; R8: C ≥ 50 %\nR5: C ≥ 70 %\nB\n\n\n009-001-00-0\nfluorine\n231-954-8\n7782-41-4\nO; R8\nT+; R26\nC; R35\nO; T+; C\nR: 8-26-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n\n\n009-002-00-6\nhydrogen fluoride\n231-634-8\n7664-39-3\nT+; R26/27/28\nC; R35\nT+; C\nR: 26/27/28-35\nS: (1/2-)7/9-26-36/37/39-45\n\n\n009-003-00-1\nhydrofluoric acid ... %\n231-634-8\n7664-39-3\nT+; R26/27/28\nC; R35\nT+; C\nR: 26/27/28-35\nS: (1/2-)7/9-26-36/37-45\nC; R35: C ≥ 7 %\nC; R34: 1 % ≤ C < 7 %\nXi; R36: 0,1 % ≤ C < 1 %\nB\n009-004-00-7\nsodium fluoride\n231-667-8\n7681-49-4\nT; R25\nXi; R36/38\nR32\nT\nR: 25-32-36/38\nS: (1/2-)22-36-45\n\n\n009-005-00-2\npotassium fluoride\n232-151-5\n7789-23-3\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\n\n\n009-006-00-8\nammonium fluoride\n235-185-9\n12125-01-8\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\n\n\n009-007-00-3\nsodium bifluoride;\nsodium hydrogen difluoride\n215-608-3\n1333-83-1\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-008-00-9\npotassium bifluoride;\npotassium hydrogen difluoride\n232-156-2\n7789-29-9\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-009-00-4\nammonium bifluoride;\nammonium hydrogen difluoride\n215-676-4\n1341-49-7\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-010-00-X\nfluoroboric acid ... %\n240-898-3\n16872-11-0\nC; R34\nC\nR: 34\nS: (1/2-)26-27-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\nB\n009-011-00-5\nfluorosilicic acid ... %\n241-034-8\n16961-83-4\nC; R34\nC\nR: 34\nS: (1/2-)26-27-45\n\nB\n009-012-00-0\nalkali fluorosilicates(Na); [1]\nalkali fluorosilicates(K); [2]\nalkali fluorosilicates(NH4) [3]\n240-934-8 [1]\n240-896-2 [2]\n240-968-3 [3]\n16893-85-9 [1]\n16871-90-2 [2]\n16919-19-0 [3]\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\nT; R23/24/25: C ≥ 10 %\nXn; R20/21/22: 1 % ≤ C < 10 %\nA\n009-013-00-6\nfluorosilicates, with the exception of those specified elsewhere in this annex\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)13-24/25\nXn; R22: C ≥ 10 %\nA\n009-014-00-1\nlead hexafluorosilicate\n247-278-1\n25808-74-6\nRepr. Cat. 1; R61\nRepr. Cat. 3; R62\nXn; R20/22\nR33\nN; R50-53\nT; N\nR: 61-62-20/22-33-50/53\nS: 53-45-60-61\n\nE1\n009-015-00-7\nsulphuryl difluoride\n220-281-5\n2699-79-8\nT; R23\nXn; R48/20\nN; R50\nT; N\nR: 23-48/20-50\nS: (1/2-)45-63-60-61\n\n\n009-016-00-2\ntrisodium hexafluoroaluminate;\ncryolite\n237-410-6\n239-148-8\n13775-53-6\n15096-52-3\nT; R48/23/25\nXn; R20/22\nN; R51-53\nT; N\nR: 20/22-48/23/25-51/53\nS: (1/2-)22-37-45-61\n\nC\n009-017-00-8\npotassium mu-fluoro-bis(triethylaluminium)\n400-040-2\n12091-08-6\nF; R11-14/15\nC; R35\nXn; R20\nF; C\nR: 11-14/15-20-35\nS: (1/2-)16-30-36/39-43-45\n\n\n009-018-00-3\nmagnesium hexafluorosilicate\n241-022-2\n16949-65-8\nT; R25\nT\nR: 25\nS: (1/2-)24/25-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\n\n011-001-00-0\nsodium\n231-132-9\n7440-23-5\nF; 15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)5-8-43-45\n\n\n011-002-00-6\nsodium hydroxide;\ncaustic soda\n215-185-5\n1310-73-2\nC; R35\nC\nR: 35\nS: (1/2-)26-37/39-45\nC; R35: C ≥ 5 %\nC; R34: 2 % ≤ C < 5 %\nXi; R36/38: 0,5 % ≤ C < 2 %\n\n011-003-00-1\nsodium peroxide\n215-209-4\n1313-60-6\nO; R8\nC; R35\nO; C\nR: 8-35\nS: (1/2-)8-27-39-45\n\n\n011-004-00-7\nsodium azide\n247-852-1\n26628-22-8\nT+; R28\nR32\nN; R50-53\nT+; N\nR: 28-32-50/53\nS: (1/2-)28-45-60-61\n\n\n011-005-00-2\nsodium carbonate\n207-838-8\n497-19-8\nXi; R36\nXi\nR: 36\nS: (2-)22-26\n\n\n011-006-00-8\nsodium cyanate\n213-030-6\n917-61-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)24/25-61\n\n\n011-007-00-3\npropoxycarbazone-sodium\n—\n181274-15-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n012-001-00-3\nmagnesium powder (pyrophoric)\n231-104-6\n7439-95-4\nF; R15-17\nF\nR: 15-17\nS: (2-)7/8-43\n\n\n012-002-00-9\nmagnesium, powder or turnings\n231-104-6\n—\nF; R11-15\nF\nR: 11-15\nS: (2-)7/8-43\n\n\n012-003-00-4\nmagnesium alkyls\n—\n—\nR14\nF; R17\nC; R34\nF; C\nR: 14-17-34\nS: (1/2-)16-43-45\n\nA\n\n\n012-004-00-X\naluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate\n422-150-1\n-\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n013-001-00-6\naluminium powder (pyrophoric)\n231-072-3\n7429-90-5\nF; R15-17\nF\nR: 15-17\nS: (2-)7/8-43\n\n\n\n\n013-002-00-1\naluminium powder (stabilised)\n231-072-3\n7429-90-5\nF; R11-15\nF\nR: 11-15\nS: (2-)7/8-43\n\nT\n\n013-003-00-7\naluminium chloride, anhydrous\n231-208-1\n7446-70-0\nC; R34\nC\nR: 34\nS: (1/2-)7/8-28-45\n\n\n013-004-00-2\naluminium alkyls\n—\n—\nR14\nF; R17\nC; R34\nF; C\nR: 14-17-34\nS: (1/2-)16-43-45\n\nA\n013-005-00-8\ndiethyl(ethyldimethylsilanolato)aluminium\n401-160-8\n55426-95-4\nF; R 15-17\nR14\nC; R35\nF; C\nR: 14/15-17-35\nS: (1/2-)6-16-30-36/39-43-45\n\n\n013-006-00-3\n(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised\n402-370-2\n—\nR10\nXi; R41\nXi\nR: 10-41\nS: (2-)26-39\n\n\n013-007-00-9\npoly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)\n403-430-0\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n013-008-00-4\ndi-n-octylaluminium iodide\n408-190-0\n7585-14-0\nR14\nF; R17\nC; R34\nN; R50-53\nF; C; N\nR: 14-17-34-50/53\nS: (1/2-)6-16-26-36/37/39-43-45-60-61\n\n\n013-009-00-X\nsodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5\n418-720-2\n—\nF; R11-15-17\nR14\nXn; R20\nC; R35\nF; C\nR: 11-14/15-17-20-35\nS: (1/2-)6-16-26-30-36/37/39-43-45\n\n\n\n\n013-010-00-5\nhydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide)\n430-650-4\n151841-65-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n014-001-00-9\ntrichlorosilane\n233-042-5\n10025-78-2\nF+; R12\nR14\nF; R17\nXn; R20/22\nR29\nC; R35\nF+; C\nR: 12-14-17-20/22-29-35\nS: (2-)7/9-16-26-36/37/39-43-45\nXn; R20/22: C ≥ 10 %\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n014-002-00-4\nsilicon tetrachloride\n233-054-0\n10026-04-7\nR14\nXi; R36/37/38\nXi\nR: 14-36/37/38\nS: (2-)7/8-26\n\n\n014-003-00-X\ndimethyldichlorosilane\n200-901-0\n75-78-5\nF; R11\nXi; R36/37/38\nF; Xi\nR: 11-36/37/38\nS: (2-)\n\n\n014-004-00-5\ntrichloro(methyl)silane;\nmethyltrichlorosilane\n200-902-6\n75-79-6\nR14\nF; R11\nXi; R36/37/38\nF; Xi\nR: 11-14-36/37/38\nS: (2-)26-39\nXi; R36/37/38: C ≥ 1 %\n\n014-005-00-0\ntetraethyl silicate;\nethyl silicate\n201-083-8\n78-10-4\nR10\nXn; R20\nXi; R36/37\nXn\nR: 10-20-36/37\nS: (2-)\n\n\n014-006-00-6\nbis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride\n401-380-4\n—\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n014-007-00-1\ntriethoxyisobutylsilane\n402-810-3\n17980-47-1\nXi; R38\nXi\nR: 38\nS: (2-)24\n\n\n014-008-00-7\n(chloromethyl)bis(4-fluorophenyl)methylsilane\n401-200-4\n85491-26-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-009-00-2\nisobutylisopropyldimethoxysilane\n402-580-4\n111439-76-0\nR10\nXn; R20\nXi; R38\nXn\nR: 10-20-38\nS: (2-)25-26-36/37\n\n\n014-010-00-8\ndisodium metasilicate\n229-912-9\n6834-92-0\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)13-24/25-36/37/39-45\n\n\n014-011-00-3\ncyclohexyldimethoxymethylsilane\n402-140-1\n17865-32-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)24-61\n\n\n014-012-00-9\nbis(3-(trimethoxysilyl)propyl)amine\n403-480-3\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)24-26-39-61\n\n\n014-013-00-4\nα-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)\n404-920-7\n—\nXn; R21/22\nC; R34\nN; R51-53\nC; N\nR: 21/22-34-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n014-014-00-X\netacelasil (ISO);\n6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane;\n253-704-7\n37894-46-5\nRepr. Cat. 2; R61\nXn; R22-48/22\nT\nR: 61-22-48/22\nS: 53-45\n\nE\n014-015-00-5\nα-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))\n406-420-4\n69430-40-6\nR53\nR: 53\nS: 61\n\n\n014-016-00-0\nreaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;\n1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane\n406-490-6\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-017-00-6\nflusilazole (ISO);\nbis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane\n—\n85509-19-9\nCarc. Cat. 3; R40\nRepr. Cat. 2; R61\nXn; R22\nN; R51-53\nT; N\nR: 61-22-40-51/53\nS: 53-45-61\n\nE\n014-018-00-1\noctamethylcyclotetrasiloxane\n209-136-7\n556-67-2\nRepr. Cat. 3; R62\nR53\nXn\nR: 53-62\nS: (2-)36/37-46-51-61\n\n\n014-019-00-7\nreaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;\n1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole\n403-250-2\n—\nCarc. Cat. 3; R40\nRepr. Cat. 2; R61\nXn; R22\nN; R51-53\nT; N\nR: 61-22-40-51/53\nS: 53-45-61\n\nE\n014-020-00-2\nbis(1,1-dimethyl-2-propynyloxy)dimethylsilane\n414-960-7\n53863-99-3\nXn; R20\nXn\nR: 20\nS: (2)\n\n\n014-021-00-8\ntris(isopropenyloxy)phenyl silane\n411-340-8\n52301-18-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n014-022-00-3\nreaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)\n401-530-9\n—\nF; R11\nT; R39/23/24/25\nXn; R20/21/22\nF; T\nR: 11-20/21/22-39/23/24/25\nS: (1/2-)16-29-36/37-45\n\n\n014-023-00-9\nα, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole\n408-160-7\n125613-45-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-024-00-4\n1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene\n412-620-2\n121626-74-2\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-025-00-X\n4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine\n411-400-3\n102089-33-8\nXn; R22-48/21\nXi; R38-41\nR52-53\nXn\nR: 22-38-41-48/21-52/53\nS: (2-)26-36/37/39-61\n\n\n014-026-00-5\ndichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane\n407-180-3\n770722-36-6\nC; R35\nC\nR: 35\nS: (1/2-)26-36/37/39-45\n\n\n014-027-00-0\nchloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane\n410-270-5\n770722-46-8\nC; R35\nC\nR: 35\nS: (1/2-)8-26-28-36/37/39-45\n\n\n014-028-00-6\nα-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)\n415-290-8\n193159-06-7\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n014-029-00-1\nO,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]\n421-870-1\n156145-66-3\nRepr. Cat. 3; R62\nXn; R22-48/22\nXn\nR: 22-48/22-62\nS: (2-)36/37\n\n\n014-030-00-7\n[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium\n422-060-0\n137390-08-0\nT+; R28\nT+\nR: 28\nS: (1/2-)6-22-28-36/37-45\n\n\n014-031-00-2\nbis(1-methylethyl)-dimethoxysilane\n421-540-7\n18230-61-0\nR10\nXi; R38\nR43\nR52-53\nXi\nR: 10-38-43-52/53\nS: (2-)24-37-61\n\n\n014-032-00-8\ndicyclopentyldimethoxysilane\n404-370-8\n126990-35-0\nXi; R38-41\nN; R50-53\nXi; N\nR: 38-41-50/53\nS: (2-)26-37/39-60-61\n\n\n\n\n014-033-00-3\n2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica\n419-030-4\n125804-20-8\nF; R11\nXi; R36\nR67\nF; Xi\nR: 11-36-67\nS: (2-)16-26\n\n\n\n014-034-00-9\n3-hexylheptamethyltrisiloxane\n428-700-5\n1873-90-1\nXn; R20\nR53\nXn\nR: 20-53\nS: (2-)61\n\n\n\n014-035-00-4\n2-(3,4-epoxycyclohexyl)ethyltriethoxy silane\n425-050-4\n10217-34-2\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n014-036-00-X\n(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane\n405-020-7\n105024-66-6\nRepr. Cat.2; R60\nN; R50-53\nT; N\nR: 60-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n014-037-00-5\n2-butanone-O, O', O''-(phenylsilylidyne)trioxime\n433-360-6\n34036-80-1\nXn; R48/22\nR43\nR52-53\nXn\nR: 43-48/22-52/53\nS: (2-)36/37-61\n\n\n\n014-038-00-0\nS-(3-(triethoxysilyl)propyl) octanethioate\n436-690-9\n220727-26-4\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n014-039-00-6\n(2,3-dimethylbut-2-yl)-trimethoxysilane\n439-360-2\n142877-45-0\nXi; R38-41\nR52-53\nXi\nR: 38-41-52/53\nS: (2-)26-37/39-61\n\n\n\n014-041-00-7\nN,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane\n445-890-5\n201290-01-9\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\n\n\n\n014-042-00-2\nreaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-010-0\n-\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n014-043-00-8\nreaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)\n432-200-2\n-\nF; R11\nXi; R37/38-41\nR52-53\nF; Xi\nR: 11-37/38-41-52/53\nS: (2-)6-26-36/39-61\n\n\n\n014-044-00-3\n3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane\n433-050-0\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n014-045-00-9\nmagnesium sodium fluoride silicate\n442-650-1\n-\nXn; R48/20\nXn\nR: 48/20\nS: (2-)22-36\n\n\n\n015-001-00-1\nwhite phosphorus\n231-768-7\n12185-10-3\nF; R17\nT+; R26/28\nC; R35\nN; R50\nF; T+; C; N\nR: 17-26/28-35-50\nS: (1/2-)5-26-38-45-61\n\n\n015-002-00-7\nred phosphorus\n231-768-7\n7723-14-0\nF; R11\nR16\nR52-53\nF\nR: 11-16-52/53\nS: (2-)7-43-61\n\n\n\n\n015-003-00-2\ncalcium phosphide;\ntricalcium diphosphide\n215-142-0\n1305-99-3\nF; R15\nT+; R28\nR29\nN; R50\nF; T+; N\nR: 15/29-28-50\nS: (1/2-)22-28-36/37-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-004-00-8\naluminium phosphide\n244-088-0\n20859-73-8\nF; R15\nT+; R28\nR29\nR32\nN; R50\nF; T+; N\nR: 15/29-28-32-50\nS: (1/2-)3/9/14-28-30-36/37-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-005-00-3\nmagnesium phosphide;\ntrimagnesium diphosphide\n235-023-7\n12057-74-8\nF; R15\nT+; R28\nR29\nN; R50\nF; T+; N\nR: 15/29-28-50\nS: (1/2-)22-28-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-006-00-9\ntrizinc diphosphide;\nzinc phosphide\n215-244-5\n1314-84-7\nF; R15\nT+; R28\nR29\nR32\nN; R50-53\nF; T+; N\nR: 15/29-28-32-50/53\nS: (1/2-)28-30-36/37-43-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\nT\n\n015-007-00-4\nphosphorus trichloride\n231-749-3\n7719-12-2\nR14\nT+; R26/28\nXn; R48/20\nC; R35\nR29\nT+; C\nR: 14-26/28-35-48/20\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-008-00-X\nphosphorus pentachloride\n233-060-3\n10026-13-8\nR14\nT+; R26\nXn; R22-48/20\nC; R34\nR29\nT+\nR: 14-22-26-34-48/20\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-009-00-5\nphosphoryl trichloride\n233-046-7\n10025-87-3\nR14\nT+; R26\nT; R48/23\nXn; R22\nC; R35\nR29\nT+; C\nR: 14-22-26-35-48/23\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-010-00-0\nphosphorus pentoxide\n215-236-1\n1314-56-3\nC; R35\nC\nR: 35\nS: (1/2-)22-26-45\n\n\n015-011-00-6\nphosphoric acid ... %, orthophosphoric acid ... %\n231-633-2\n7664-38-2\nC; R34\nC\nR: 34\nS: (1/2-)26-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\nB\n015-012-00-1\ntetraphosphorus trisulphide;\nphosphorus sesquisulphid\n215-245-0\n1314-85-8\nF; R11\nXn; R22\nN; R50\nF; Xn; N\nR: 11-22-50\nS: (2-)7-16-24/25-61\n\n\n015-013-00-7\ntriethyl phosphate\n201-114-5\n78-40-0\nXn; R22\nXn\nR: 22\nS: (2-)25\n\n\n015-014-00-2\ntributyl phosphate\n204-800-2\n126-73-8\nCarc. Cat. 3; R40\nXn; R22\nXi; R38\nXn\nR: 22-38-40\nS: (2-)36/37-46\n\n\n015-015-00-8\ntricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\ntritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\n201-103-5\n78-30-8\nT; R39/23/24/25\nN; R51-53\nT; N\nR: 39/23/24/25-51/53\nS: (1/2-)20/21-28-45-61\nT; R39/23/24/25: C ≥ 1 %\nXn; R68/20/21/22: 0,2 % ≤ C < 1 %\nC\n015-016-00-3\ntricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\ntritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\n201-105-6\n78-32-0\nXn; R21/22\nN; R51-53\nXn; N\nR: 21/22-51/53\nS: (2-)28-61\nXn; R21/22: C ≥ 5 %\nC\n\n\n015-019-00-X\ndichlorvos (ISO);\n2,2-dichlorovinyl dimethyl phosphate\n200-547-7\n62-73-7\nT+; R26\nT; R24/25\nR43\nN; R50\nT+; N\nR: 24/25-26-43-50\nS: (1/2-)28-36/37-45-61\nN; R50: C ≥ 0,025 %\n\n\n015-020-00-5\nmevinphos (ISO);\n2-methoxycarbonyl-1-methylvinyl dimethyl phosphate\n232-095-1\n7786-34-7\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-021-00-0\ntrichlorfon (ISO);\ndimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate\n200-149-3\n52-68-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-022-00-6\nphosphamidon (ISO);\n2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate\n236-116-5\n13171-21-6\nT+; R28\nT; R24\nMuta. Cat. 3; R68\nN; R50-53\nT+; N\nR: 24-28-50/53-68\nS: (1/2-)23-36/37-45-60-61\n\n\n015-023-00-1\npyrazoxon;\ndiethyl 3-methylpyrazol-5-yl phosphate\n—\n108-34-9\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)13-28-45\n\n\n015-024-00-7\ntriamiphos (ISO);\n5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide\n—\n1031-47-6\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)22-28-36/37-45\n\n\n015-025-00-2\nTEPP (ISO);\ntetraethyl pyrophosphate\n203-495-3\n107-49-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)36/37/39-38-45-61\n\n\n015-026-00-8\nschradan (ISO);\noctamethylpyrophosphoramide\n205-801-0\n152-16-9\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37-38-45\n\n\n015-027-00-3\nsulfotep (ISO);\nO,O,O,O-tetraethyl dithiopyrophosphate\n222-995-2\n3689-24-5\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-028-00-9\ndemeton-O (ISO);\nO,O-diethyl-O-2-ethylthioethyl phosphorothioate\n206-053-8\n298-03-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-029-00-4\ndemeton-S (ISO);\ndiethyl-S-2-ethylthioethyl phosphorothioate\n204-801-8\n126-75-0\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-030-00-X\ndemeton-O-methyl (ISO);\nO-2-ethylthioethyl O,O-dimethyl phosphorothioate\n212-758-1\n867-27-6\nT; R25\nT\nR: 25\nS: (1/2-)24-36/37-45\n\n\n015-031-00-5\ndemeton-S-methyl (ISO);\nS-2-ethylthioethyl dimethyl phosphorothioate\n213-052-6\n919-86-8\nT; R24/25\nN; R51-53\nT; N\nR: 24/25-51/53\nS: (1/2-)28-36/37-45-61\n\n\n015-032-00-0\nprothoate (ISO);\nO,O-diethyl isopropylcarbamoylmethyl phosphorodithioate\n218-893-2\n2275-18-5\nT+; R27/28\nR52-53\nT+\nR: 27/28-52/53\nS: (1/2-)28-36/37-45-61\n\n\n015-033-00-6\nphorate (ISO);\nO,O-diethyl ethylthiomethyl phosphorodithioate\n206-052-2\n298-02-2\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-034-00-1\nparathion (ISO);\nO,O-diethyl O-4-nitrophenyl phosphorothioate\n200-271-7\n56-38-2\nT+; R26/28\nT; R24-48/25\nN; R50-53\nT+; N\nR: 24-26/28-48/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-035-00-7\nparathion — methyl (ISO);\nO,O-dimethyl O-4-nitrophenyl phosphorothioate\n206-050-1\n298-00-0\nR5\nR10\nT+; R26/28\nT; R24\nXn; R48/22\nN; R50-53\nT+; N\nR: 5-10-24-26/28-48/22-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-036-00-2\nO-ethyl O-4-nitrophenyl phenylphosphonothioate;\nEPN\n218-276-8\n2104-64-5\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n015-037-00-8\nphenkapton (ISO);\nS-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate\n218-892-7\n2275-14-1\nT; R23/24/25\nN; R50-53\nT; N\nR: 23/24/25-50/53\nS: (1/2-)13-45-60-61\n\n\n015-038-00-3\ncoumaphos (ISO);\nO-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate\n200-285-3\n56-72-4\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-039-00-9\nazinphos-methyl (ISO);\nO,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n201-676-1\n86-50-0\nT+; R26/28\nT; R24\nR43\nN; R50-53\nT+; N\nR: 24-26/28-43-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-040-00-4\ndiazinon (ISO);\nO,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate\n206-373-8\n333-41-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24/25-60-61\n\n\n\n\n015-041-00-X\nmalathion (ISO);\n1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;\n[containing ≤ 0,03 % isomalathion]\n204-497-7\n121-75-5\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-042-00-5\nchlorthion\nO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate\n207-902-5\n500-28-7\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-043-00-0\nphosnichlor (ISO);\nO-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate\n—\n5826-76-6\nXn; R20/21/22\nXn\nR: 20/21/22\nS: (2-)13\n\n\n015-044-00-6\ncarbophenothion (ISO);\n4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate\n212-324-1\n786-19-6\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-045-00-1\nmecarbam (ISO);\nN-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate\n219-993-9\n2595-54-2\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n015-046-00-7\noxydemeton-methyl;\nS-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate\n206-110-7\n301-12-2\nT; R24/25\nN; R50\nT; N\nR: 24/25-50\nS: (1/2-)23-36/37-45-61\n\n\n015-047-00-2\nethion (ISO);\nO,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);\ndiethion\n209-242-3\n563-12-2\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)25-36/37-45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n\n\n015-048-00-8\nfenthion (ISO);\nO,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate\n200-231-9\n55-38-9\nMuta. Cat. 3; R68\nT; R23-48/25\nXn; R21/22\nN; R50-53\nT; N\nR: 21/22-23-48/25-68-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-049-00-3\nendothion (ISO);\nS-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate\n220-472-3\n2778-04-3\nT; R24/25\nT\nR: 24/25\nS: (1/2-)36/37-45\n\n\n015-050-00-9\nthiometon (ISO);\nS-2-ethylthioethyl O,O-dimethyl phosphorodithioate\n211-362-6\n640-15-3\nT; R25\nXn; R21\nT\nR: 21-25\nS: (1/2-)36/37-45\n\n\n015-051-00-4\ndimethoate (ISO);\nO,O-dimethyl methylcarbamoylmethyl phosphorodithioate\n200-480-3\n60-51-5\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-052-00-X\nfenchlorphos (ISO);\nO,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate\n206-082-6\n299-84-3\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)25-36/37-60-61\n\n\n015-053-00-5\nmenazon (ISO);\nS-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate\n201-123-4\n78-57-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n015-054-00-0\nfenitrothion (ISO);\nO,O-dimethyl O-4-nitro-m-tolyl phosphorothioate\n204-524-2\n122-14-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-055-00-6\nnaled (ISO);\n1,2-dibromo-2,2-dichloroethyl dimethyl phosphate\n206-098-3\n300-76-5\nXn; R21/22\nXi; R36/38\nN; R50\nXn; N\nR: 21/22-36/38-50\nS: (2-)36/37-61\nN; R50: C ≥ 0,025 %\n\n\n\n015-056-00-1\nazinphos-ethyl (ISO);\nO,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n220-147-6\n2642-71-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-057-00-7\nformothion (ISO);\nN-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n219-818-6\n2540-82-1\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-058-00-2\nmorphothion (ISO);\nO,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate\n205-628-0\n144-41-2\nT; R23/24/25\nN; R50-53\nT; N\nR: 23/24/25-50/53\nS: (1/2-)13-45-60-61\n\n\n015-059-00-8\nvamidothion (ISO);\nO,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate\n218-894-8\n2275-23-2\nT; R25\nXn; R21\nN; R50\nT; N\nR: 21-25-50\nS: (1/2-)36/37-45-61\n\n\n015-060-00-3\ndisulfoton (ISO);\nO,O-diethyl 2-ethylthioethyl phosphorodithioate\n206-054-3\n298-04-4\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-061-00-9\ndimefox (ISO);\ntetramethylphosphorodiamidic fluoride\n204-076-8\n115-26-4\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)23-28-36/37-38-45\n\n\n015-062-00-4\nmipafox (ISO);\nN,N'- di-isopropylphosphorodiamidic fluoride\n206-742-3\n371-86-8\nT+; R39/26/27/28\nT+\nR: 39/26/27/28\nS: (1/2-)13-45\n\n\n015-063-00-X\ndioxathion (ISO);\n1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)\n201-107-7\n78-34-2\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-064-00-5\nbromophos-ethyl (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate\n225-399-0\n4824-78-6\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-065-00-0\nS-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate\n—\n2703-37-9\nT+; R26/27/28\nN; R51-53\nT+; N\nR: 26/27/28-51/53\nS: (1/2-)13-28-45-61\n\n\n015-066-00-6\nomethoate (ISO);\nO,O-dimethyl S-methylcarbamoylmethyl phosphorothioate\n214-197-8\n1113-02-6\nT; R25\nXn; R21\nN; R50\nT; N\nR: 21-25-50\nS: (1/2-)23-36/37-45-61\n\n\n\n\n015-067-00-1\nphosalone (ISO);\nS-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate\n218-996-2\n2310-17-0\nT; R25\nXn; R20/21\nR43\nN; R50-53\nT; N\nR: 20/21-25-43-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-068-00-7\ndichlofenthion (ISO);\nO-,4-dichlorophenyl O,O-diethyl phosphorothioate\n202-564-5\n97-17-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-069-00-2\nmethidathion (ISO);\n2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate\n213-449-4\n950-37-8\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)22-28-36/37-45-60-61\n\n\n015-070-00-8\ncyanthoate (ISO);\nS-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate\n223-099-4\n3734-95-0\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)36/37-45\n\n\n015-071-00-3\nchlorfenvinphos (ISO);\n2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate\n207-432-0\n470-90-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-072-00-9\nmonocrotophos (ISO);\ndimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate\n230-042-7\n6923-22-4\nMuta. Cat. 3; R68\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53-68\nS: (1/2-)36/37-45-60-61\n\n\n015-073-00-4\ndicrotophos (ISO);\n(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate\n205-494-3\n141-66-2\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-074-00-X\ncrufomate (ISO);\n4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate\n206-083-1\n299-86-5\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-075-00-5\nS-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate\n—\n2635-50-9\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n015-076-00-0\npotasan;\nO,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate\n—\n299-45-6\nT+; R26/27/28\nN; R50-53\nT+; N\nR: 26/27/28-50/53\nS: (1/2-)13-28-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-077-00-6\n2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate\n—\n7076-53-1\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n015-078-00-1\ndemeton-S-methylsulphon (ISO);\nS-2-ethylsulphonylethyl dimethyl phosphorothioate\n241-109-5\n17040-19-6\nT; R25\nXn; R21\nN; R51-53\nT; N\nR: 21-25-51/53\nS: (1/2-)22-28-36/37-45-61\n\n\n015-079-00-7\nacephate (ISO);\nO,S-dimethyl acetylphosphoramidothioate\n250-241-2\n30560-19-1\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n015-080-00-2\namidithion (ISO);\n2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n—\n919-76-6\nXn; R22\nXn\nR: 22\nS: (2-)24-36\n\n\n015-081-00-8\nO,O,O',O'-tetrapropyl dithiopyrophosphate\n221-817-0\n3244-90-4\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-082-00-3\nazothoate (ISO);\nO-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate\n227-419-3\n5834-96-8\nXn; R20/22\nXn\nR: 20/22\nS: (2-)13\n\n\n015-083-00-9\nbensulide (ISO);\nO,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate\n212-010-4\n741-58-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24-36-60-61\n\n\n015-084-00-4\nchlorpyrifos (ISO);\nO,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n220-864-4\n2921-88-2\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-085-00-X\nchlorphonium chloride (ISO);\ntributyl (2,4-dichlorobenzyl) phosphonium chloride\n204-105-4\n115-78-6\nT; R25\nXn; R21\nXi; R36/38\nT\nR: 21-25-36/38\nS: (1/2-)36/37/39-45\n\n\n015-086-00-5\ncoumithoate (ISO);\nO,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate\n—\n572-48-5\nT; R25\nT\nR: 25\nS: (1/2-)28-36/37-45\n\n\n015-087-00-0\ncyanophos (ISO);\nO-4-cyanophenyl O,O-dimethyl phosphorothioate\n220-130-3\n2636-26-2\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-088-00-6\ndialifos (ISO);\n2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate\n233-689-3\n10311-84-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-089-00-1\nethoate-methyl (ISO);\nethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n204-121-1\n116-01-8\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-090-00-7\nfensulfothion (ISO);\nO,O-diethyl O-4-methylsulfinylphenyl phosphorothioate\n204-114-3\n115-90-2\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\n\n\n015-091-00-2\nfonofos (ISO);\nO-ethyl phenyl ethylphosphonodithioate\n213-408-0\n944-22-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-092-00-8\nphosacetim (ISO);\nO,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate\n223-874-7\n4104-14-7\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-093-00-3\nleptophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate\n244-472-8\n21609-90-5\nT; R25-39/25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-39/25-50/53\nS: (1/2-)25-36/37/39-45-60-61\n\n\n015-094-00-9\nmephosfolan (ISO);\ndiethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate\n213-447-3\n950-10-7\nT+; R27/28\nN; R51-53\nT+; N\nR: 27/28-51/53\nS: (1/2-)36/37/39-45-61\n\n\n015-095-00-4\nmethamidophos (ISO);\nO,S-dimethyl phosphoramidothioate\n233-606-0\n10265-92-6\nT+; R26/28\nT; R24\nN; R50\nT+; N\nR: 24-26/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-096-00-X\noxydisulfoton (ISO);\nO, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate\n219-679-1\n2497-07-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-097-00-5\nphenthoate (ISO);\nethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate\n219-997-0\n2597-03-7\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)22-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-098-00-0\ntrichloronate (ISO);\nO-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate\n206-326-1\n327-98-0\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)23-28-36/37-45-60-61\n\n\n015-099-00-6\npirimiphos-ethyl (ISO);\nO,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate\n245-704-0\n23505-41-1\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)23-36/37-45-60-61\n\n\n\n\n015-100-00-X\nphoxim (ISO);\nα-(diethoxyphosphinothioylimino) phenylacetonitrile\n238-887-3\n14816-18-3\nRepr. Cat. 3; R62\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-62-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-101-00-5\nphosmet (ISO);\nO,O-dimethyl phthalimidomethyl S-phosphorodithioate\n211-987-4\n732-11-6\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)22-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n\n\n015-102-00-0\ntris(2-chloroethyl)phosphate\n204-118-5\n115-96-8\nCarc. Cat. 3; R40\nRepr. Cat. 2; R60\nXn; R22\nN; R51-53\nT; N\nR: 60-22-40-51/53\nS: 53-45-61\n\nE\n\n015-103-00-6\nphosphorus tribromide\n232-178-2\n7789-60-8\nR14\nC; R34\nXi; R37\nC\nR: 14-34-37\nS: (1/2-)26-45\n\n\n015-104-00-1\ndiphosphorus pentasulphide;\nphosphorus pentasulphide\n215-242-4\n1314-80-3\nF; R11\nR29\nXn; R20/22\nN; R50\nF; Xn; N\nR: 11-20/22-29-50\nS: (2-)61\n\n\n015-105-00-7\ntriphenyl phosphite\n202-908-4\n101-02-0\nXi; R36/38\nN; R50-53\nXi; N\nR: 36/38-50/53\nS: (2-)28-60-61\nXi; R36/38: C ≥ 5 %\n\n015-106-00-2\nhexamethylphosphoric triamide;\nhexamethylphosphoramide\n211-653-8\n680-31-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,01 %\n\n015-107-00-8\nethoprophos (ISO);\nethyl-S,S-dipropyl phosphorodithioate\n236-152-1\n13194-48-4\nT+; R26/27\nT; R25\nR43\nN; R50-53\nT+; N\nR: 25-26/27-43-50/53\nS: (1/2-)27/28-36/37/39-45-60-61\n\n\n015-108-00-3\nbromophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate\n218-277-3\n2104-96-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-) 46-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-109-00-9\ncrotoxyphos (ISO);\n1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate\n231-720-5\n7700-17-6\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-110-00-4\ncyanofenphos (ISO);\nO-4-cyanophenyl O-ethyl phenylphosphonothioate\n—\n13067-93-1\nT; R25-39/25\nXn; R21\nXi; R36\nN; R51-53\nT; N\nR: 21-25-36-39/25-51/53\nS: (1/2-)36/37-45-61\n\n\n015-111-00-X\nphosfolan (ISO);\ndiethyl 1,3-dithiolan-2-ylidenephosphoramidate\n213-423-2\n947-02-4\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-112-00-5\nthionazin (ISO);\nO,O-diethyl O-pyrazin-2-yl phosphorothioate;\n206-049-6\n297-97-2\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37/39-38-45\n\n\n\n\n015-113-00-0\ntolclofos-methyl (ISO);\nO-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate\n260-515-3\n57018-04-9\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n\n015-114-00-6\nchlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate\n246-538-1\n24934-91-6\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)27-28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n015-115-00-1\nchlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]\n244-663-6\n21923-23-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-116-00-7\ndemephion-O (ISO);\nO,O-dimethyl O-2-methylthioethyl phosphorothioate\n211-666-9\n682-80-4\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)28-36/37-45\n\n\n015-117-00-2\ndemephion-S (ISO);\nO,O-dimethyl S-2-methylthioethyl phosphorothioate\n219-971-9\n2587-90-8\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)28-36/37-45\n\n\n015-118-00-8\ndemeton\n—\n8065-48-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-119-00-3\ndimethyl 4-(methylthio)phenyl phosphate\n—\n3254-63-5\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-120-00-9\nditalimfos (ISO);\nO,O-diethyl phthalimidophosphonothioate;\n225-875-8\n5131-24-8\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)36/37\n\n\n015-121-00-4\nedifenphos (ISO);\nO-ethyl S,S-diphenyl phosphorodithioate\n241-178-1\n17109-49-8\nT; R23/25\nXn; R21\nR43\nN; R50-53\nT; N\nR: 21-23/25-43-50/53\nS: (1/2-)36/37-45-60-61\n\n\n015-122-00-X\netrimfos (ISO);\nO-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate;\n253-855-9\n38260-54-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-123-00-5\nfenamiphos (ISO);\nethyl-4-methylthio-m-tolyl isopropyl phosphoramidate\n244-848-1\n22224-92-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-124-00-0\nfosthietan (ISO);\ndiethyl 1,3-dithietan-2-ylidenephosphoramidate;\n244-437-7\n21548-32-3\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37-45\n\n\n015-125-00-6\nglyphosine (ISO);\nN,N-bis(phosphonomethyl)glycine\n219-468-4\n2439-99-8\nXi; R41\nXi\nR: 41\nS: (2-)26\n\n\n015-126-00-1\nheptenophos (ISO);\n7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate\n245-737-0\n23560-59-0\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)23-28-37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-127-00-7\niprobenfos (ISO);\nS-benzyl diisopropyl phosphorothioate\n247-449-0\n26087-47-8\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n015-128-00-2\nIPSP;\nS-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate\n—\n5827-05-4\nT+; R27\nT; R25\nN; R50-53\nT+; N\nR: 25-27-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-129-00-8\nisofenphos (ISO);\nO-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate\n246-814-1\n25311-71-1\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-130-00-3\nisothioate (ISO)\nS-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;\n—\n36614-38-7\nT; R24/25\nT\nR: 24/25\nS: (1/2-)28-36/37-45\n\n\n015-131-00-9\nisoxathion (ISO);\nO,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate\n242-624-8\n18854-01-8\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-132-00-4\nS-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;\nmethylcarbophenothione\n—\n953-17-3\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-133-00-X\npiperophos (ISO);\nS-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate\n—\n24151-93-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-134-00-5\npirimiphos-methyl (ISO);\nO-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate\n249-528-5\n29232-93-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-135-00-0\nprofenofos (ISO);\nO-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate\n255-255-2\n41198-08-7\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-136-00-6\ntrans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;\nisopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;\npropetamphos (ISO)\n250-517-2\n31218-83-4\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-137-00-1\npyrazophos (ISO);\nO,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate\n236-656-1\n13457-18-6\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53\nS: (2-)36/37-46-60-61\n\n\n015-138-00-7\nquinalphos (ISO);\nO,O-diethyl-O-quinoxalin-2-yl phosphorothioate\n237-031-6\n13593-03-8\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)22-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-139-00-2\nterbufos (ISO)\nS-tert-butylthiomethyl O,O-diethylphosphorodithioate;\n235-963-8\n13071-79-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n\n015-140-00-8\ntriazophos (ISO);\nO,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate\n245-986-5\n24017-47-8\nT; R23/25\nXn; R21\nN; R50-53\nT; N\nR: 21-23/25-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-141-00-3\nethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers\n400-520-1\n—\nC; R34\nXn; R22\nN; R50-53\nC; N\nR: 22-34-50/53\nS: (1/2-)24/25-26-28-39-45-60-61\n\n\n015-142-00-9\nbutyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate\n401-100-0\n—\nF; R11\nXi; R36\nN; R51-53\nF; Xi; N\nR: 11-36-51/53\nS: (2-)7/9-16-26-43-61\n\n\n015-143-00-4\nreaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers\n401-740-0\n—\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n015-144-00-X\nreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate\n402-090-0\n87025-52-3\nC; R34\nC\nR: 34\nS: (1/2-)26-36/37/39-45\n\n\n015-145-00-5\nreaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate\n401-520-4\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-146-00-0\nS-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate\n401-850-9\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-147-00-6\nreaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)\n400-930-0\n—\nXi; R38-41\nN; R51-53\nR43\nXi; N\nR: 38-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n015-148-00-1\n2-(diphosphonomethyl)succinic acid\n403-070-4\n51395-42-7\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)26-36/37/39-45\n\n\n015-149-00-7\nreaction mass of: hexyldioctylphosphineoxide;\ndihexyloctylphosphineoxide;\ntrioctylphosphineoxide\n403-470-9\n—\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n015-150-00-2\n(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide\n404-940-6\n86608-70-0\nXn; R22\nXi; R41\nR33\nR52-53\nXn\nR: 22-33-41-52/53\nS: (2-)22-26-39-61\n\n\n015-151-00-8\ntris(isopropyl/tert-butylphenyl) phosphate\n405-010-2\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n015-152-00-3\ndioxabenzofos (ISO);\n2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide;\n223-292-3\n3811-49-2\nT; R24/25-39/25\nN; R51-53\nT; N\nR: 24/25-39/25-51/53\nS: (1/2-)36/37-38-45-61\n\n\n015-153-00-9\nisazofos (ISO);\nO-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate;\n255-863-8\n42509-80-8\nT+; R26\nT; R24/25\nXn; R48/20\nR43\nN; R50-53\nT+; N\nR: 24/25-26-43-48/20-50/53\nS: (1/2-)28-36/37-38-45-59-61\n\n\n015-154-00-4\n2-chloroethylphosphonic acid;\nethephon\n240-718-3\n16672-87-0\nXn; R20/21\nC; R34\nR52-53\nC\nR: 20/21-34-52/53\nS: (1/2-)26-28-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n\n\n015-155-00-X\nglufosinate ammonium (ISO);\nammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate\n278-636-5\n77182-82-2\nRepr. Cat. 2; R60\nRepr. Cat. 3; R63\nXn; R20/21/22-48/20/22\nT\nR: 60-20/21/22-48/20/22-63\nS: 53-45\n\nE\n\n015-156-00-5\nmethyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]\nmethacrifos (ISO);\nmethyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]\n250-366-9 [1]\n- [2]\n30864-28-9 [1]\n62610-77-9 [2]\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-60-61\n\n\n015-157-00-0\nphosphonic acid; [1]\nphosphorous acid [2]\n237-066-7 [1]\n233-663-1 [2]\n13598-36-2 [1]\n10294-56-1 [2]\nXn; R22\nC; R35\nC\nR: 22-35\nS: (1/2-)26-36/37/39-45\n\n\n015-158-00-6\n(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)\n402-340-9\n32760-80-8\nR52-53\nR: 52/53\nS: 61\n\n\n015-159-00-1\nhydroxyphosphonoacetic acid\n405-710-8\n23783-26-8\nXn; R22-48/22\nC; R34\nR43\nC\nR: 22-34-43-48/22\nS: (1/2-)22-26-36/37/39-45\n\n\n015-160-00-7\nvanadyl pyrophosphate\n406-260-5\n58834-75-6\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n015-161-00-2\ndivanadyl pyrophosphate\n407-130-0\n65232-89-5\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n015-162-00-8\nvanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped\n407-350-7\n—\nXn; R20-48/22\nXi; R41\nN; R51-53\nXn; N\nR: 20-41-48/22-51/53\nS: (2-)22-26-36/39-61\n\n\n015-163-00-3\nbis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide\n412-010-6\n145052-34-2\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n015-164-00-9\ncalcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate\n400-480-5\n36669-85-9\nR52-53\nR: 52/53\nS: 61\n\n\n015-165-00-4\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate\n404-986-7\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)15-26-39-60-61\n\n\n015-166-00-X\n3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n410-290-4\n80693-00-1\nR53\nR: 53\nS: 61\n\n\n015-167-00-5\n3-(hydroxyphenylphosphinyl)propanoic acid\n411-200-6\n14657-64-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n015-168-00-0\nfosthiazate (ISO);\n(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate\n—\n98886-44-3\nT; R23/25-39\nXn; R21\nXi; R41\nR43\nN; R50-53\nT; N\nR: 21-23/25-39-41-43-50/53\nS: (1/2-)53-45-25-26-39-60-61\n\n\n015-169-00-6\ntributyltetradecylphosphonium tetrafluoroborate\n413-520-1\n—\nXn; R22-48/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-48/22-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n015-170-00-1\nreaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;\n1-octane-N,N,N-trimethylammonium di-octylphosphate;\n1-octane-N,N,N-trimethylammonium octylphosphate\n407-490-9\n—\nXn; R21/22\nC; R34\nC\nR: 21/22-34\nS: (1/2-)26-36/37/39-45\n\n\n015-171-00-7\nO,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate\n406-940-1\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n015-172-00-2\nreaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;\nisotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate\n406-240-6\n—\nR10\nC; R34\nN; R51-53\nC; N\nR: 10-34-51/53\nS: (1/2-)23-26-28-36/37/39-45-61\n\n\n015-173-00-8\nmethyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate\n414-080-3\n117291-73-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)23-36-60-61\n\n\n015-174-00-3\n1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine\n411-370-1\n82857-68-9\nT; R25\nXi; R41\nN; R51-53\nT; N\nR: 25-41-51/53\nS: (1/2-)26-37/39-41-45-61\n\n\n015-175-00-9\ntert-butyl (triphenylphosphoranylidene) acetate\n412-880-7\n35000-38-5\nT; R25\nXn; R48/22\nXi; R36\nR43\nN; R51-53\nT; N\nR: 25-36-43-48/22-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n015-176-00-4\nP,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine\n413-430-2\n116163-96-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-177-00-X\n((4-phenylbutyl)hydroxyphosphoryl)acetic acid\n412-170-7\n83623-61-4\nXn; R48/22\nXi; R41\nR43\nXn\nR: 41-43-48/22\nS: (2-)22-26-36/37/39\n\n\n015-178-00-5\n(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate\n418-570-8\n25383-07-7\nRepr. Cat. 3; R62\nN; R51-53\nXn; N\nR: 62-51/53\nS: (2-)22-36/37-61\n\n\n015-179-00-0\nUVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine\n422-720-8\n166242-53-1\nCarc. Cat. 3; R40\nXn; R22-48/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-40-43-48/22-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n015-180-00-6\n[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt\n415-820-8\n137590-32-0\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n015-181-00-1\nphosphine\n232-260-8\n7803-51-2\nF+; R12\nR17\nT+; R26\nC; R34\nN; R50\nF+; T+; N\nR: 12-17-26-34-50\nS: (1/2-)28-36/37-45-61-63\n\n\n\n\n015-182-00-7\ntetraisopropyldichloromethylenebisphosphonate\n430-630-5\n10596-22-2\nXn; R22\nXi; R36\nR43\nXn\nR: 22-36-43\nS: (2-)24-26-37\n\n\n\n015-183-00-2\n(1-hydroxydodecylidene)diphosphonic acid\n425-230-2\n16610-63-2\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n015-184-00-8\nSalts of glyphosate, with the exception of those specified elsewhere in this Annex\n—\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\nA\n015-186-00-9\nchlorpyrifos-methyl (ISO),\nO, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n227-011-5\n5598-13-0\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-187-00-4\nreaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;\ntrisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide\n417-540-1\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)26-39-61\n\n\n\n\n015-188-00-X\n(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate\n425-220-8\n5945-33-5\nR53\nR: 53\nS: 61\n\n\n\n015-189-00-5\nphenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide\n423-340-5\n162881-26-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n\n\n015-190-00-0\nbis(2,4-dicumylphenyl) neopentyl diphosphite;\n3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n421-920-2\n154862-43-8\nR53\nR: 53\nS: 61\n\n\n\n015-191-00-6\ndodecyldiphenyl phosphate\n431-760-5\n27460-02-2\nXi; R38\nR52-53\nXi\nR: 38-52/53\nS: (2-)37-61\n\n\n\n015-192-00-1\ntetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate\n432-770-2\n139189-30-3\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n015-193-00-7\ntriphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)\n442-960-7\n332350-93-3\nT; R25\nXi; R41\nN; R50-53\nT; N\nR: 25-41-50/53\nS: (1/2-)26-39-45-60-61\n\n\n\n015-194-00-2\ntetrabutyl-phosphonium nonafluoro-butane-1-sulfonate\n444-440-5\n220689-12-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n\n015-195-00-8\nreaction mass of: potassium o-toluenephosphonate;\npotassium m-toluenephosphonate;\npotassium p-toluenephosphonate\n433-860-4\n-\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n\n015-196-00-3\nreaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\ndiethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\nmethyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate\n435-960-3\n-\nCarc. Cat.2; R45\nMuta. Cat.2; R46\nR43\nT\nR: 45-46-43\nS: 53-45\n\n\n\n015-197-00-9\nbis(2,4,4-trimethylpentyl)dithiophosphonic acid\n420-160-9\n107667-02-7\nR10\nT; R23\nXn; R22\nC; R34\nN; R51-53\nT; N\nR: 10-22-23-34-51/53\nS: (1/2-)9-26-36/37/39-45-61\n\n\n\n015-198-00-4\n(4-phenylbutyl)phosphinic acid\n420-450-5\n86552-32-1\nCarc. Cat.3; R40\nXi; R41\nXn\nR: 40-41\nS: (2-)23-26-36/37/39\n\n\n\n\n016-001-00-4\nhydrogen sulphide\n231-977-3\n7783-06-4\nF+; R12\nT+; R26\nN; R50\nF+; T+; N\nR: 12-26-50\nS: (1/2-)9-16-36-38-45-61\n\n\n016-002-00-X\nbarium sulphide\n244-214-4\n21109-95-5\nR31\nXn; R20/22\nN; R50\nXn; N\nR: 20/22-31-50\nS: (2-)28-61\n\n\n016-003-00-5\nbarium polysulphides\n256-814-3\n50864-67-0\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-004-00-0\ncalcium sulphide\n243-873-5\n20548-54-3\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-005-00-6\ncalcium polysulphides\n215-709-2\n1344-81-6\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-006-00-1\ndipotassium sulphide;\npotassium sulphide\n215-197-0\n1312-73-8\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\n\n\n016-007-00-7\npotassium polysulphides\n253-390-1\n37199-66-9\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\n\n\n016-008-00-2\nammonium polysulphides\n232-989-1\n9080-17-5\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\nC; R34: C ≥ 5 %\nXi; R36/38: 1 % ≤ C < 5 %\nR31: C ≥ 1 %\n\n\n\n016-009-00-8\ndisodium sulfide;\nsodium sulfide\n215-211-5\n1313-82-2\nT; R24\nXn; R22\nC; R34\nR31\nN; R50\nT; C; N\nR: 22-24-31-34-50\nS: (1/2-)26-36/37/39-45-61\n\n\n\n\n016-010-00-3\nsodium polysulphides\n215-686-9\n1344-08-7\nT; R25\nR31\nC; R34\nN; R50\nT; N\nR: 25-31-34-50\nS: (1/2-)26-36/37/39-45-61\n\n\n016-011-00-9\nsulphur dioxide\n231-195-2\n7446-09-5\nT; R23\nC; R34\nT\nR: 23-34\nS: (1/2-)9-26-36/37/39-45\nT; R23: C ≥ 20 %\nXn; R20: 5 % ≤ C < 20 %\n5\n016-012-00-4\ndisulphur dichloride;\nsulfur monochloride\n233-036-2\n10025-67-9\nR14\nT; R25\nXn; R20\nR29\nC; R35\nN; R50\nT; C; N\nR: 14-20-25-29-35-50\nS: (1/2-)26-36/37/39-45-61\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n016-013-00-X\nsulphur dichloride\n234-129-0\n10545-99-0\nR14\nC; R34\nXi; R37\nN; R50\nC; N\nR: 14-34-37-50\nS: (1/2-)26-45-61\n\n\n016-014-00-5\nsulphur tetrachloride\n—\n13451-08-6\nR14\nC; R34\nN; R50\nC; N\nR: 14-34-50\nS: (1/2-)26-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n016-015-00-0\nthionyl dichloride;\nthionyl chloride\n231-748-8\n7719-09-7\nR14\nXn; R20/22\nR29\nC; R35\nC\nR: 14-20/22-29-35\nS: (1/2-)26-36/37/39-45\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n016-016-00-6\nsulphuryl chloride\n232-245-6\n7791-25-5\nR14\nC; R34\nXi; R37\nC\nR: 14-34-37\nS: (1/2-)26-45\n\n\n016-017-00-1\nchlorosulphonic acid\n232-234-6\n7790-94-5\nR14\nC; R35\nXi; R37\nC\nR: 14-35-37\nS: (1/2-)26-45\n\n\n016-018-00-7\nfluorosulphonic acid\n232-149-4\n7789-21-1\nXn; R20\nC; R35\nC\nR: 20-35\nS: (1/2-)26-45\n\n\n016-019-00-2\noleum ... % SO3\n—\n—\nR14\nC; R35\nXi; R37\nC\nR: 14-35-37\nS: (1/2-)26-30-45\n\nB\n016-020-00-8\nsulphuric acid ... %\n231-639-5\n7664-93-9\nC; R35\nC\nR: 35\nS: (1/2-)26-30-45\nC; R35: C ≥ 15 %\nXi; R36/38: 5 % ≤ C < 15 %\nB\n016-021-00-3\nmethanethiol;\nmethyl mercaptan\n200-822-1\n74-93-1\nF+; R12\nT; R23\nN; R50-53\nF+; T; N\nR: 12-23-50/53\nS: (2-)16-25-60-61\n\n\n016-022-00-9\nethanethiol;\nethyl mercaptan\n200-837-3\n75-08-1\nF; R11\nXn; R20\nN; R50-53\nF; Xn; N\nR: 11-20-50/53\nS: (2-)16-25-60-61\n\n\n016-023-00-4\ndimethyl sulphate\n201-058-1\n77-78-1\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT+; R26\nT; R25\nC; R34\nR43\nT+\nR: 45-25-26-34-43-68\nS: 53-45\nCar. Cat. 2; R45: C ≥ 0,01 %\nMuta. Cat. 3, R68: C ≥ 0,01 %\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nE\n016-024-00-X\ndimexano (ISO);\nbis(methoxythiocarbonyl) disulphide\n215-993-8\n1468-37-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n016-025-00-5\ndisul (ISO);\n2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;\n2,4-DES\n205-259-5\n149-26-8\nXn; R22\nXi; R38-41\nXn\nR: 22-38-41\nS: (2-)26\n\n\n016-026-00-0\nsulphamidic acid;\nsulphamic acid;\nsulfamic acid\n226-218-8\n5329-14-6\nXi; R36/38\nR52-53\nXi\nR: 36/38-52/53\nS: (2-)26-28-61\n\n\n016-027-00-6\ndiethyl sulphate\n200-589-6\n64-67-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R20/21/22\nC; R34\nT\nR: 45-46-20/21/22-34\nS: 53-45\n\nE\n016-028-00-1\nsodium dithionite;\nsodium hydrosulphite\n231-890-0\n7775-14-6\nR7\nR31\nXn; R22\nXn\nR: 7-22-31\nS: (2-)7/8-26-28-43\n\n\n016-029-00-7\np-toluenesulphonic acid, containing more than 5 % H2SO4\n—\n—\nC; R34\nC\nR: 34\nS: (1/2-)26-37/39-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\n\n016-030-00-2\np-toluenesulphonic acid (containing a maximum of 5 % H2SO4)\n203-180-0\n104-15-4\nXi; R36/37/38\nXi\nR: 36/37/38\nS: (2-)26-37\n\n\n016-031-00-8\ntetrahydrothiophene-1,1-dioxide;\nsulpholane\n204-783-1\n126-33-0\nXn; R22\nXn\nR: 22\nS: (2-)25\n\n\n016-032-00-3\n1,3-propanesultone;\n1,2-oxathiolane 2,2-dioxide\n214-317-9\n1120-71-4\nCarc. Cat. 2; R45\nXn; R21/22\nT\nR: 45-21/22\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n016-033-00-9\ndimethylsulfamoylchloride\n236-412-4\n13360-57-1\nCarc. Cat. 2; R45\nT+; R26\nXn; R21/22\nC; R34\nT+\nR: 45-21/22-26-34\nS: 53-45\n\nE\n016-034-00-4\ntetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)\n400-010-9\n81898-60-4\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-035-00-X\npentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate\n400-120-7\n—\nXi; R36\nXi\nR: 36\nS: (2-)22-26\n\n\n016-036-00-5\ntetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate\n400-130-1\n—\nR42\nN; R51-53\nXn; N\nR: 42-51/53\nS: (2-)22-61\n\n\n016-037-00-0\ndisodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate\n400-350-8\n85153-93-1\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n016-038-00-6\ndisodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate\n400-380-1\n86393-35-3\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-039-00-1\ntetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate\n400-430-2\n—\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-040-00-7\nreaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate\n400-570-4\n—\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n016-041-00-2\ncalcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate\n400-710-4\n—\nXn; R20\nXn\nR: 20\nS: (2-)\n\n\n016-042-00-8\ntetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate\n400-790-0\n85665-97-0\nXi; R36/38\nR43\nXi\nR: 36/38-43\nS: (2-)22-24/25-37\n\n\n016-043-00-3\ndilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate\n401-010-1\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n016-044-00-9\ndisodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate\n401-320-7\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n016-045-00-4\nlithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate\n401-560-2\n108624-00-6\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-046-00-X\nsodium hydrogensulphate\n231-665-7\n7681-38-1\nXi; R41\nXi\nR: 41\nS: (2-)24-26\n\n\n016-047-00-5\nhexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate\n401-650-1\n85665-96-9\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-048-00-0\nsodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate\n401-870-8\n—\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-61\n\n\n016-049-00-6\ncalcium octadecylxylenesulphonate\n402-040-8\n—\nC; R34\nN; R51-53\nC; N\nR: 34-51/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n016-050-00-1\npotassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat\n402-150-6\n—\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)22-24-26-37\n\n\n016-051-00-7\ntrisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate\n402-170-5\n106359-91-5\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-052-00-2\nbenzyltributylammonium 4-hydroxynaphthalene-1-sulphonate\n402-240-5\n102561-46-6\nXn; R20\nN; R51-53\nXn; N\nR: 20-51/53\nS: (2-)22-61\n\n\n016-053-00-8\n(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate\n402-460-1\n—\nXi; R38\nR43\nR53\nXi\nR: 38-43-53\nS: (2-)24-37-61\n\n\n016-054-00-3\nsodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate\n400-030-8\n—\nT; R23-48/23\nXn; R22\nXi; R36/37\nR43\nT\nR: 22-23-36/37-43-48/23\nS: (1/2-)22-24-36-45\n\n\n016-055-00-9\ntetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)\n400-510-7\n—\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)22-24-26-37/39\n\n\n016-056-00-4\npotassium hydrogensulphate\n231-594-1\n7646-93-7\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)26-36/37/39-45\n\n\n016-057-00-X\nstyrene-4-sulfonyl chloride\n404-770-2\n2633-67-2\nXi; R38-41\nR43\nXi\nR: 38-41-43\nS: (2-)24-26-37/39\n\n\n016-058-00-5\nthionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine\n404-820-3\n—\nXi; R38\nR43\nR52-53\nXi\nR: 38-43-52/53\nS: (2-)36/37-61\n\n\n016-059-00-0\nN,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride\n405-300-9\n17339-60-5\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-50/53\nS: (2-)26-36/37-60-61\n\n\n016-060-00-6\ndiammonium peroxodisulphate;\nammonium persulphate\n231-786-5\n7727-54-0\nO; R8\nXn; R22\nXi; R36/37/38\nR42/43\nO; Xn\nR: 8-22-36/37/38-42/43\nS: (2-)22-24-26-37\n\n\n016-061-00-1\ndipotassium peroxodisulphate;\npotassium persulphate\n231-781-8\n7727-21-1\nO; R8\nXn; R22\nXi; R36/37/38\nR42/43\nO; Xn\nR: 8-22-36/37/38-42/43\nS: (2-)22-24-26-37\n\n\n016-062-00-7\nbensultap (ISO);\n1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane\n—\n17606-31-4\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n016-063-00-2\nsodium metabisulphite\n231-673-0\n7681-57-4\nXn; R22\nXi; R41\nR31\nXn\nR: 22-31-41\nS: (2-)26-39-46\n\n\n016-064-00-8\nsodium hydrogensulphite … %;\nsodium bisulphite … %\n231-548-0\n7631-90-5\nXn; R22\nR31\nXn\nR: 22-31\nS: (2-)25-46\n\nB\n016-065-00-3\nsodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate\n400-100-8\n84057-97-6\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n016-066-00-9\ntetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)\n404-070-7\n116912-62-0\nR52-53\nR: 52/53\nS: 61\n\n\n016-067-00-4\n(4-methylphenyl)mesitylene sulfonate\n407-530-5\n67811-06-7\nR53\nR: 53\nS: 61\n\n\n016-068-00-X\nsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate\n407-720-8\n155160-86-4\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-069-00-5\n3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid\n407-990-7\n141915-64-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-070-00-0\n4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone\n408-220-2\n—\nR53\nR: 53\nS: 61\n\n\n016-071-00-6\ntrisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate\n410-130-3\n136248-03-8\nR43\nXi\nR: - 43\nS: (2-)22-24-37\n\n\n016-072-00-1\n3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide\n411-520-6\n112195-27-4\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n016-073-00-7\ntetrakis(phenylmethyl)thioperoxydi(carbothioamide)\n404-310-0\n10591-85-2\nR53\nR: 53\nS: 61\n\n\n016-074-00-2\n6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene\n405-410-7\n—\nXi; R38-41\nR43\nN; R51-53\nXi; N\nR: 38-41-43-51/53\nS: (2-)26-36/37/39-61\n\n\n016-075-00-8\n2,2'-diallyl-4,4'-sulfonyldiphenol\n411-570-9\n41481-66-7\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-076-00-3\n2,3-bis((2-mercaptoethyl)thio)-1-propanethiol\n411-290-7\n131538-00-6\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)23-24/25-36-60-61\n\n\n016-077-00-9\n2-chloro-p-toluenesulfochloride\n412-890-1\n42413-03-6\nC; R34\nR43\nR52-53\nC\nR: 34-43-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n016-078-00-4\n4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide\n413-300-5\n56187-04-3\nR53\nR: 53\nS: 61\n\n\n016-079-00-X\nN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide\n412-920-3\n16695-22-0\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n016-080-00-5\nsodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate\n412-320-1\n31361-99-6\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n016-081-00-0\nhexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide\n418-350-1\n—\nMuta. Cat. 3; R68\nXn; R22\nXi; R36\nR43\nN; R51-53\nXn; N\nR: 22-36-43-68-51/53\nS: (2-)26-36/37-61\n\n\n016-082-00-6\nethoxysulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea\n—\n126801-58-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n016-083-00-1\nacibenzolar-S-methyl;\nbenzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester\n420-050-0\n135158-54-2\nXi; R36/37/38\nR43\nN; R50-53\nXi; N\nR: 36/37/38-43-50/53\nS: (2-)24/25-37-46-59-60-61\n\n\n\n\n016-084-00-7\nprosulfuron (ISO);\n1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea\n—\n94125-34-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n016-085-00-2\nflazasulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea\n—\n104040-78-0\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n016-086-00-8\ntetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n402-590-9\n109125-56-6\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n016-087-00-3\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;\npropylene carbonate\n403-490-8\n104558-95-4\nXi; R36\nR43\nN; R50-53\nXi; N\nR: 36-43-50/53\nS: (2-)24-26-37-60-61\n\n\n016-088-00-9\n4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid\n407-280-7\n71297-11-5\nR52-53\nR: 52/53\nS: 61\n\n\n016-089-00-4\nreaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene\n413-840-1\n—\nE; R2\nF; R11\nR53\nE\nR: 2-11-53\nS: (2-)33-35-40-61\n\n\n016-090-00-X\n4-methyl-N-(methylsulfonyl)benzenesulfonamide\n415-040-8\n14653-91-9\nXn; R22\nXi; R37-41\nXn\nR: 22-37-41\nS: (2-)26-39\n\n\n016-091-00-5\nC12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate\n414-110-5\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n\n016-092-00-0\nreaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol\n427-050-1\n-\nRepr. Cat. 3; R62\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 38-43-62-50/53\nS: (2-)36/37-60-61\n\n\n\n016-093-00-6\nreaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);\n4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)\n414-770-4\n140698-96-0\nF; R11\nCarc. Cat. 3; R40\nF; Xn\nR: 11-40\nS: (2-)7-36/37\n\n\n\n\n016-094-00-1\nsulfur\n231-722-6\n7704-34-9\nXi; R38\nXi\nR: 38\nS: (2-)46\n\n\n\n016-095-00-7\nreaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);\nReaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)\n417-980-4\n—\nF; R11\nCarc. Cat. 3; R40\nF; Xn\nR: 11-40\nS: (2-)7-36/37\n\n\n016-096-00-2\nthifensulfuron-methyl (ISO);\nmethyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate\n—\n79277-27-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n016-097-00-8\n1-amino-2-methyl-2-propanethiol hydrochloride\n434-480-1\n32047-53-3\nXn; R22\nC; R34\nR43\nR52-53\nC\nR: 22-34-43-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n\n\n017-001-00-7\nchlorine\n231-959-5\n7782-50-5\nT; R23\nXi; R36/37/38\nN; R50\nT; N\nR: 23-36/37/38-50\nS: (1/2-)9-45-61\nN; R50: C ≥ 0,25 %\n\n\n017-002-00-2\nhydrogen chloride\n231-595-7\n7647-01-0\nT; R23\nC; R35\nT; C\nR: 23-35\nS: (1/2-)9-26-36/37/39-45\n\n5\n017-002-01-X\nhydrochloric acid ... %\n231-595-7\n—\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)26-45\nC; R34-37: C ≥ 25 %\nXi; R36/37/38: 10 % ≤ C < 25 %\nB\n017-003-00-8\nbarium chlorate\n236-760-7\n13477-00-4\nO; R9\nXn; R20/22\nN; R51-53\nO; Xn; N\nR: 9-20/22-51/53\nS: (2-)13-27-61\n\n\n017-004-00-3\npotassium chlorate\n223-289-7\n3811-04-9\nO; R9\nXn; R20/22\nN; R51-53\nO; Xn; N\nR: 9-20/22-51/53\nS: (2-)13-16-27-61\n\n\n017-005-00-9\nsodium chlorate\n231-887-4\n7775-09-9\nO; R9\nXn; R22\nN; R51-53\nO; Xn; N\nR: 9-22-51/53\nS: (2-)13-17-46-61\n\n\n017-006-00-4\nperchloric acid ... %\n231-512-4\n7601-90-3\nR5\nO; R8\nC; R35\nO; C\nR: 5-8-35\nS: (1/2-)23-26-36-45\nC; R35: C ≥ 50 %\nC; R34: 10 % ≤ C < 50 %\nXi; R36/38: 1 % ≤ C < 10 %\nFootnote\nO; R5-8: C > 50 %\nB\n017-007-00-X\nbarium perchlorate\n236-710-4\n13465-95-7\nO; R9\nXn; R20/22\nO; Xn\nR: 9-20/22\nS: (2-)27\n\n\n017-008-00-5\npotassium perchlorate\n231-912-9\n7778-74-7\nO; R9\nXn; R22\nO; Xn\nR: 9-22\nS: (2-)13-22-27\n\n\n\n\n017-009-00-0\nammonium perchlorate;\n[containing ≥ 80 % of 0-30 μm particles]\n232-235-1\n7790-98-9\nE; R3\nO; R9\nE\nR: 3-9\nS: (2-)14-16-36/37\n\nT\n\n\n\n017-009-01-8\nammonium perchlorate;\n[containing < 80 % of 0-30 μm particles]\n232-235-1\n7790-98-9\nE; R2\nO; R9\nE\nR: 2-9\nS: (2-)14-16-36/37\n\nT\n\n017-010-00-6\nsodium perchlorate\n231-511-9\n7601-89-0\nO; R9\nXn; R22\nO; Xn\nR: 9-22\nS: (2-)13-22-27\n\n\n017-011-00-1\nsodium hypochlorite, solution ... % Cl active\n231-668-3\n7681-52-9\nC; R34\nR31\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)28-45-50-61\nR31: C ≥ 5 %\nB\n\n\n\n017-012-00-7\ncalcium hypochlorite\n231-908-7\n7778-54-3\nO; R8\nC; R34\nXn; R22\nR31\nN; R50\nO; C; N\nR: 8-22-31-34-50\nS: (1/2-)26-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R37/38-41: 3 % ≤ C < 10 %\nXi; R36: 0,5 % ≤ C < 3 %\nN; R50: C ≥ 2,5 %\n\n\n017-013-00-2\ncalcium chloride\n233-140-8\n10043-52-4\nXi; R36\nXi\nR: 36\nS: (2-)22-24\n\n\n017-014-00-8\nammonium chloride\n235-186-4\n12125-02-9\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22\n\n\n017-015-00-3\n(2-(aminomethyl)phenyl)acetylchloride hydrochloride\n417-410-4\n61807-67-8\nXn; R22\nC; R35\nR43\nC\nR: 22-35-43\nS: (1/2-)26-36/37/39-45\n\n\n017-016-00-9\nmethyltriphenylphosphonium chloride\n418-400-2\n1031-15-8\nXn; R21/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-51/53\nS: (2-)22-26-36/37/39-61\n\n\n017-017-00-4\n(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride\n426-210-6\n120086-58-0\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (2-)26-36/37/39-45-60-61\n\n\n017-018-00-X\nN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride\n405-660-7\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n017-019-00-5\n(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride\n415-110-8\n54417-53-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n017-020-00-0\nethyl propoxy aluminium chloride\n421-790-7\n13014-29-4\nF; R15\nR 14\nC; R35\nF; C\nR: 14/15-35\nS: (1/2-)16-23-26-30-36/37/39-43-45\n\n\n017-021-00-6\nbehenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride\n423-420-1\n136920-10-0\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)26-36/37/39-60-61\n\n\n\n\n017-023-00-7\n[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides\n425-520-9\n197179-61-6\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n019-001-00-2\npotassium\n231-119-8\n7440-09-7\nF; R15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)5-8-45\n\n\n019-002-00-8\npotassium hydroxide;\ncaustic potash\n215-181-3\n1310-58-3\nXn; R22\nC; R35\nC\nR: 22-35\nS: (1/2-)26-36/37/39-45\nC; R35: C ≥ 5 %\nC; R34: 2 % ≤ C < 5 %\nXi; R36/38: 0.5 % ≤ C < 2 %\n\n020-001-00-X\ncalcium\n231-179-5\n7440-70-2\nF; R15\nF\nR: 15\nS: (2-)8-24/25-43\n\n\n020-002-00-5\ncalcium cyanide\n209-740-0\n592-01-8\nT+; R28\nR32\nN; R50-53\nT+; N\nR: 28-32-50/53\nS: (1/2-)7/8-23-36/37-45-60-61\n\n\n020-003-00-0\nreaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;\ntri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;\npoly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]\n420-470-4\n—\nXi; R36/38\nR43\nXi\nR: 36/38-43\nS: (2-)24-26-37\n\n\n022-001-00-5\ntitanium tetrachloride\n231-441-9\n7550-45-0\nR14\nC; R34\nC\nR: 14-34\nS: (1/2-)7/8-26-36/37/39-45\n\n\n022-002-00-0\ntitanium(4+) oxalate\n403-260-7\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n022-003-00-6\nbis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium\n412-000-1\n125051-32-3\nF; R11\nRepr. Cat. 3; R62\nXn; R48/22\nN; R51-53\nF; Xn; N\nR: 11-48/22-62-51/53\nS: (2-)7-22-33-36/37-61\n\n\n\n\n022-004-00-1\npotassium titanium oxide (K2Ti6O13)\n432-240-0\n12056-51-8\nCarc. Cat.3; R40\nXn\nR: 40\nS: (2-)22-36/37\n\n\n\n022-005-00-7\n[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium\n419-840-8\n169104-71-6\nF; R11\nC; R34\nR43\nR53\nF; C\nR: 11-34-43-53\nS: (1/2-)6-9-16-26-36/37/39-45-61\n\n\n\n023-001-00-8\ndivanadium pentaoxide;\nvanadium pentoxide\n215-239-8\n1314-62-1\nMuta. Cat. 3; R68\nRepr. Cat. 3; R63\nT; R48/23\nXn; R20/22\nXi; R37\nN; R51-53\nT; N\nR: 20/22-37-48/23-51/53-63-68\nS: (1/2-)36/37-38-45-61\n\n\n024-001-00-0\nchromium (VI) trioxide\n215-607-8\n1333-82-0\nO; R9\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT+; R26\nT; R24/25-48/23\nC; R35\nR42/43\nN; R50-53\nO; T+; N\nR: 45-46-9-24/25-26-35-42/43-48/23-62-50/53\nS: 53-45-60-61\nC: R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\nE\n024-002-00-6\npotassium dichromate\n231-906-6\n7778-50-9\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N; O\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %:\nXi; R36/37/38: 5 % ≤ C < 10 %\nE3\n024-003-00-1\nammonium dichromate\n232-143-1\n7789-09-5\nE; R2\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nE; T+; N\nR: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE3\n\n\n024-004-00-7\nsodium dichromate\n234-190-3\n10588-01-9\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nO; T+; N\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 25 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE\n\n\n\n024-004-01-4\nsodium dichromate, dihydrate\n234-190-3\n7789-12-0\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N; O\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE3\n\n024-005-00-2\nchromyl dichloride;\nchromic oxychloride\n239-056-8\n14977-61-8\nO; R8\nCarc. Cat. 2; R49\nMuta. Cat. 2; R46\nC; R35\nR43\nN; R50-53\nO; T; C; N\nR: 49-46-8-35-43-50/53\nS: 53-45-60-61\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 0,5 % ≤ C < 5 %\nR43: C ≥ 0,5 %\n3\n024-006-00-8\npotassium chromate\n232-140-5\n7789-00-6\nCarc. Cat. 2; R49\nMuta. Cat. 2; R46\nXi; R36/37/38\nR43\nN; R50-53\nT; N\nR: 49-46-36/37/38-43-50/53\nS: 53-45-60-61\nR43: C ≥ 0,5 %\n3\n024-007-00-3\nzinc chromates including zinc potassium chromate\n—\n—\nCarc. Cat. 1; R45\nXn; R22\nR43\nN; R50-53\nT; N\nR: 45-22-43-50/53\nS: 53-45-60-61\n\nAE\n024-008-00-9\ncalcium chromate\n237-366-8\n13765-19-0\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n024-009-00-4\nstrontium chromate\n232-142-6\n7789-06-2\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n024-010-00-X\ndichromium tris(chromate);\nchromium III chromate;\nchromic chromate\n246-356-2\n24613-89-6\nO; R8\nCarc. Cat. 2; R45\nC; R35\nR43\nN; R50-53\nO; T; C; N\nR: 45-8-35-43-50/53\nS: 53-45-60-61\n\n\n024-011-00-5\nammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)\n400-110-2\n109125-51-1\nF; R11\nN; R50-53\nF; N\nR: 11-50/53\nS: (2-)33-60-61\n\n\n024-012-00-0\ntrisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)\n400-810-8\n—\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)22-36/37\n\n\n024-013-00-6\ntrisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)\n402-500-8\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)26-39-61\n\n\n024-014-00-1\ntrisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)\n402-870-0\n93952-24-0\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n024-015-00-7\ndisodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)\n404-930-1\n—\nXn; R20\nXi; R41\nN; R51-53\nXn; N\nR: 20-41-51/53\nS: (2-)26-39-61\n\n\n024-016-00-2\ntetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)\n405-110-6\n88377-66-6\nXn; R48/22\nR53\nXn\nR: 48/22-53\nS: (2-)22-36-61\n\n\n024-017-00-8\nChromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex\n—\n—\nCarc. Cat. 2; R49\nR43\nN; R50-53\nT; N\nR: 49-43-50/53\nS: 53-45-60-61\n\nA\n024-018-00-3\nsodium chromate\n231-889-5\n7775-11-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N\nR: 45-46-60-61-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nR42/43: C ≥ 0,2 %\nE3\n024-019-00-9\nMain component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);\nby-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);\nby-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-230-1\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n024-020-00-4\ntrisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)\n418-220-4\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n\n\n024-021-00-X\npotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)\n425-830-4\n-\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n025-001-00-3\nmanganese dioxide\n215-202-6\n1313-13-9\nXn; R20/22\nXn\nR: 20/22\nS: (2-)25\n\n\n025-002-00-9\npotassium permanganate\n231-760-3\n7722-64-7\nO; R8\nXn; R22\nN; R50-53\nO; Xn; N\nR: 8-22-50/53\nS: (2-)60-61\n\n\n025-003-00-4\nmanganese sulphate\n232-089-9\n7785-87-7\nXn; R48/20/22\nN; R51-53\nXn; N\nR: 48/20/22-51/53\nS: (2-)22-61\n\n\n025-004-00-X\nbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate\n411-760-1\n116633-53-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n025-005-00-5\nreaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);\ntetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);\npentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)\n417-660-4\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n026-001-00-6\n(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate\n407-840-0\n100011-37-8\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n026-002-00-1\n(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate\n407-880-9\n117549-13-0\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)26-61\n\n\n\n\n026-003-00-7\niron (II) sulfate\n231-753-5\n7720-78-7\nXn; R22\nXi; R36/38\nXn\nR: 22-36/38\nS: (2-)46\n\n\n\n026-003-01-4\niron (II) sulfate (1:1) heptahydrate;\nsulfuric acid, iron(II) salt (1:1), heptahydrate;\nferrous sulfate heptahydrate\n231-753-5\n7782-63-0\nXn; R22\nXi; R36/38\nXn\nR: 22-36/38\nS: (2-)46\nXi; R38: C ≥ 25 %\n\n\n026-004-00-2\npotassium ferrite\n430-010-4\n12160-44-0\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)22-26-36/37/39-40-45\n\n\n\n\n027-001-00-9\ncobalt\n231-158-0\n7440-48-4\nR42/43\nR53\nXn\nR: 42/43-53\nS: (2-)22-24-37-61\n\n\n\n\n027-002-00-4\ncobalt oxide\n215-154-6\n1307-96-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n027-003-00-X\ncobalt sulfide\n215-273-3\n1317-42-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n027-004-00-5\ncobalt dichloride\n231-589-4\n7646-79-9\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nXn; R22\nR42/43\nN; R50-53\nT; N\nR: 49-60-22-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\nE1\n\n027-005-00-0\ncobalt sulfate\n233-334-2\n10124-43-3\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nXn; R22\nR42/43\nN; R50-53\nT; N\nR: 49-60-22-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\nE1\n\n\n\n\n027-006-00-6\ncobalt acetate\n200-755-8\n71-48-7\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53\nT; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n1\n\n027-007-00-1\nzinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex\n425-240-7\n-\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)22-26-39-61\n\n\n\n027-008-00-7\ncomplex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 55 % in aqueous solution]\n232-259-2\n7803-49-8\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R37/38-41\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-37/38-40-41-43-48/22-50\nS: (2-)26-36/37/39-61\n\nB\n\n\n\n612-122-01-4\nhydroxylamine …% [≤ 55 % in aqueous solution]\n232-259-2\n7803-49-8\nR5\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R37/38-41\nR43\nN; R50\nXn; N\nR: 5-21/22-37/38-40-41-43-48/22-50\nS: (2-)26-36/37/39-46-61\n\nB\n\n\n\n612-123-00-2\nhydroxylammonium chloride;\nhydroxylamine hydrochloride; [1]\nbis(hydroxylammonium) sulfate;\nhydroxylamine sulfate (2:1) [2]\n226-798-2 [1]\n233-118-8 [2]\n5470-11-1 [1]\n10039-54-0 [2]\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R36/38\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-36/38-40-43-48/22-50\nS: (2-)36/37-61\n\n\n\n612-124-00-8\nN,N,N-trimethylanilinium chloride\n205-319-0\n138-24-9\nT; R24/25\nT\nR: 24/25\nS: (1/2-)25-39-45-53\n\n\n612-125-00-3\n2-methyl-p-phenylenediamine;\n2,5-toluenediamine\n202-442-1\n95-70-5\nT; R25\nXn; R20/21\nR43\nN; R51-53\nT; N\nR: 20/21-25-43-51/53\nS: (1/2-)24-37-45-61\n\n\n612-126-00-9\ntoluene-2,4-diammonium sulphate;\n4-methyl-m-phenylenediamine sulfate\n265-697-8\n65321-67-7\nCarc. Cat. 2; R45\nT; R25\nXn; R21\nXi; R36\nR43\nN; R51-53\nT; N\nR: 45-21-25-36-43-51/53\nS: 53-45-61\n\nE\n612-127-00-4\n3-aminophenol\n209-711-2\n591-27-5\nXn; R20/22\nN; R51-53\nXn; N\nR: 20/22-51/53\nS: (2-)28-61\n\n\n612-128-00-X\n4-aminophenol\n204-616-2\n123-30-8\nMuta. Cat. 3; R68\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53-68\nS: (2-)28-36/37-60-61\n\n\n612-129-00-5\ndiisopropylamine\n203-558-5\n108-18-9\nF; R11\nXn; R20/22\nC; R34\nF; C\nR: 11-20/22-34\nS: (1/2-)16-26-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n612-130-00-0\n2,6-diamino-3,5-diethyltoluene;\n4,6-diethyl-2-methyl-1,3-benzenediamine; [1]\n2,4-diamino-3,5-diethyltoluene;\n2,4-diethyl-6-methyl-1,3-benzenediamine; [2]\ndiethylmethylbenzenediamine [3]\n218-255-3 [1]\n218-256-9 [2]\n270-877-4 [3]\n2095-01-4 [1]\n2095-02-5 [2]\n68479-98-1 [3]\nXn; R21/22-48/22\nXi; R36\nN; R50-53\nXn; N\nR: 21/22-36-48/22-50/53\nS: (2-)26-28-36/37/39-60-61\n\nC\n612-131-00-6\ndidecyldimethylammonium chloride\n230-525-2\n7173-51-5\nXn; R22\nC; R34\nC\nR: 22-34\nS: (2-)26-36/37/39-45\n\n\n612-132-00-1\nN,N'-diphenyl-p-phenylenediamine;\nN,N'-diphenyl-1,4-benzenediamine\n200-806-4\n74-31-7\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n612-133-00-7\n(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;\n4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate\n247-162-0\n25646-77-9\nT; R25\nXn; R48/22\nR43\nN; R50-53\nT; N\nR: 25-43-48/22-50/53\nS: (1/2-)24-37-45-60-61\n\n\n612-134-00-2\nN-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;\n4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate\n247-161-5\n25646-71-3\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n612-135-00-8\nN-2-naphthylaniline;\nN-phenyl-2-naphthylamine\n205-223-9\n135-88-6\nCarc. Cat. 3; R40\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 36/38-40-43-51/53\nS: (2-)26-36/37-61\n\n\n612-136-00-3\nN-isopropyl-N'-phenyl-p-phenylenediamine\n202-969-7\n101-72-4\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nR43: C ≥ 0,1 %\n\n612-137-00-9\n4-chloroaniline\n203-401-0\n106-47-8\nCarc. Cat. 2; R45\nT; R23/24/25\nR43\nN; R50-53\nT; N\nR: 45-23/24/25-43-50/53\nS: 53-45-60-61\n\nE\n612-138-00-4\nfuralaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate\n260-875-1\n57646-30-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)36/37/39-61\n\n\n612-139-00-X\nmefenacet (ISO);\n2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide\n277-328-8\n73250-68-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-140-00-5\nquaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides\n264-151-6\n63449-41-2\nXn; R21/22\nC; R34\nN; R50\nC; N\nR: 21/22-34-50\nS: (2-)36/37/39-45-61\n\n\n612-141-00-0\n4,4'-methylenebis(2-ethylaniline);\n4,4'-methylenebis(2-ethylbenzeneamine)\n243-420-1\n19900-65-3\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)36/37-60-61\n\n\n612-142-00-6\nbiphenyl-2-ylamine\n201-990-9\n90-41-5\nCarc. Cat. 3; R40\nXn; R22\nR52-53\nXn\nR: 22-40-52/53\nS: (2-)36/37-61\n\n\n612-143-00-1\nN5,N5-diethyltoluene-2,5-diamine monohydrochloride;\n4-diethylamino-2-methylaniline monohydrochloride\n218-130-3\n2051-79-8\nT; R25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 25-36-43-50/53\nS: (1/2-)24-26-37-45-60-61\n\n\n612-144-00-7\nflumetralin (ISO);\nN-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine\n—\n62924-70-3\nXi; R36/38\nR43\nN; R50-53\nXi; N\nR: 36/38-43-50/53\nS: (2-)36/37-60-61\n\n\n612-145-00-2\no-phenylenediamine\n202-430-6\n95-54-5\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nT; R25\nXn; R20/21\nXi; R36\nR43\nN; R50-53\nT; N\nR: 20/21-25-36-40-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-146-00-8\no-phenylenediamine dihydrochloride\n210-418-7\n615-28-1\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nT; R25\nXn; R20/21\nXi; R36\nR43\nN; R50-53\nT; N\nR: 20/21-25-36-40-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-147-00-3\nm-phenylenediamine\n203-584-7\n108-45-2\nMuta. Cat. 3; R68\nT; R23/24/25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 23/24/25-36-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-148-00-9\nm-phenylenediamine dihydrochloride\n208-790-0\n541-69-5\nMuta. Cat. 3; R68\nT; R23/24/25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 23/24/25-36-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-149-00-4\n1,3-diphenylguanidine\n203-002-1\n102-06-7\nRepr. Cat. 3; R62\nXn; R22\nXi; R36/37/38\nN; R51-53\nXn; N\nR: 22-36/37/38-51/53-62\nS: (2-)26-36/37/39-61\n\n\n612-150-00-X\nspiroxamine (ISO);\n8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine\n—\n118134-30-8\nXn; R20/21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 20/21/22-38-43-50/53\nS: (2-)36/37/39-46-60-61\n\n\n\n\n612-151-00-5\nmethyl-phenylene diamine;\ndiaminotoluene;\n[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]\n—\n—\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nRepr. Cat. 3; R62\nT; R25\nXn; R21-48/22\nXi; R36\nR43\nN; R51-53\nT; N\nR: 45-21-25-36-43-48/22-62-68-51/53\nS: 53-45-61\n\nE\n\n612-152-00-0\nN,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine\n406-610-7\n62478-82-4\nR10\nXn; R20/22-48/20\nC; R35\nR52-53\nC\nR: 10-20/22-35-48/20-52/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n612-153-00-6\n4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride\n407-020-2\n132885-85-9\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-24-37-61\n\n\n612-154-00-1\n6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]\n410-890-6\n95235-29-3\nR53\nR: 53\nS: 61\n\n\n612-155-00-7\n2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene\n411-730-8\n93071-94-4\nR53\nR: 53\nS: 61\n\n\n612-156-00-2\nreaction mass of: trihexadecylmethylammonium chloride;\ndihexadecyldimethylammonium chloride\n405-620-9\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n612-157-00-8\n(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride\n410-780-8\n—\nXn; R22-48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-158-00-3\nreaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;\n4-dodecylsalicylaldoxime\n410-820-4\n—\nR53\nR: 53\nS: 61\n\n\n612-159-00-9\nReaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid\n410-880-1\n—\nXn; R22\nC; R34\nN; R50-53\nC; N\nR: 22-34-50/53\nS: (1/2-)23-26-36/37/39-45-60-61\n\n\n612-160-00-4\np-toluidine;\n4-aminotoluene; [1]\ntoluidinium chloride; [2]\ntoluidine sulphate (1:1) [3]\n203-403-1 [1]\n208-740-8 [2]\n208-741-3 [3]\n106-49-0 [1]\n540-23-8 [2]\n540-25-0 [3]\nCarc. Cat. 3; R40\nT; R23/24/25\nXi; R36\nR43\nN; R50\nT; N\nR: 23/24/25-36-40-43-50\nS: (1/2-)28-36/37-45-61\n\n\n612-161-00-X\n2,6-xylidine;\n2,6-dimethylaniline\n201-758-7\n87-62-7\nCarc. Cat. 3; R40\nXn; R20/21/22\nXi; R37/38\nN; R51-53\nXn; N\nR: 20/21/22-37/38-40-51/53\nS: (2-)23-25-36/37-61\n\n\n612-162-00-5\ndimethyldioctadecylammonium chloride;\nDODMAC\n203-508-2\n107-64-2\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)24-26-39-46-60-61\n\n\n612-163-00-0\nmetalaxyl-M (ISO);\nmefenoxam;\n(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester\n—\n70630-17-0\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)26-39-46\n\n\n612-164-00-6\n2-butyl-2-ethyl-1,5-diaminopentane\n412-700-7\n137605-95-9\nXn; R21/22-48/22\nC; R34\nR43\nR52-53\nC\nR: 21/22-34-43-48/22-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-165-00-1\nN,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine\n413-810-8\n65181-78-4\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-166-00-7\nreaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);\ntrans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)\n411-830-1\n114765-88-7\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n612-167-00-2\n5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride\n410-490-1\n—\nXn; R22-48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-168-00-8\n3,5-dichloro-2,6-difluoropyrdine-4-amine\n220-630-1\n2840-00-8\nXn; R21/22\nN; R51-53\nXn; N\nR: 21/22-51/53\nS: (2-)36/37-61\n\n\n\n\n612-169-00-3\nbis(N-methyl-N-phenylhydrazine)sulfate\n423-170-1\n618-26-8\nF; R11\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R50-53\nF; T; N\nR: 11-22-41-43-48/25-50/53\nS: (1/2-)22-26-33-36/37/39-45-60-61\n\n\n\n\n612-170-00-9\n4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime\n405-260-2\n—\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n612-171-00-4\nN,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane\n410-060-3\n130728-76-6\nMuta. Cat. 3; R68\nR43\nN; R51-53\nXn; N\nR: 43-68-51/53\nS: (2-)36/37-61\n\n\n612-172-00-X\n4,4'-methylenebis(N,N'-dimethylcyclohexanamine\n412-840-9\n13474-64-1\nXn; R22-48/22\nC; R35\nR52-53\nC\nR: 22-35-48/22-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-173-00-5\nlithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate\n411-140-0\n125328-86-1\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-174-00-0\n4,4-dimethoxybutylamine\n407-690-6\n19060-15-2\nXn; R22\nC; R34\nR43\nR52-53\nC\nR: 22-34-43-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-175-00-6\n2-(O-aminooxy)ethylamine dihydrochloride\n412-310-7\n37866-45-8\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n612-176-00-1\nPolymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine\n410-570-6\n143747-73-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n612-177-00-7\n2-naphthylamino-6-sulfomethylamide\n412-120-4\n104295-55-8\nXn; R48/22\nR43\nN; R51-53\nXn; N\nR: 43-48/22-51/53\nS: (2-)22-36/37-61\n\n\n612-178-00-2\n1,4,7,10-tetraazacyclododecane disulfate\n412-080-8\n112193-77-8\nXn; R22\nXi; R37-41\nR52-53\nXn\nR: 22-37-41-52/53\nS: (2-)26-36/37/39-61\n\n\n612-179-00-8\n1-(2-propenyl)pyridinium chloride\n412-740-5\n25965-81-5\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\n\n\n612-180-00-3\n3-aminobenzylamine\n412-230-2\n4403-70-7\nXn; R22\nC; R34\nN; R51-53\nC; N\nR: 22-34-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n612-181-00-9\n2-phenylthioaniline\n413-030-8\n1134-94-7\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n612-182-00-4\n1-ethyl-1-methylmorpholinium bromide\n418-210-1\n65756-41-4\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)36/37\n\n\n612-183-00-X\n1-ethyl-1-methylpyrrolidinium bromide\n418-200-5\n69227-51-6\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)36/37\n\n\n612-184-00-5\n6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one\n403-830-5\n89331-94-2\nR52-53\nR: 52/53\nS: 61\n\n\n612-185-00-0\n1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide\n407-400-8\n59493-72-0\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n612-186-00-6\nbis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate\n406-770-8\n149057-64-7\nXn; R48/22\nXi; R41\nR43\nN; R50-53\nXn; N\nR: 41-43-48/22-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n612-187-00-1\n2,3,4-trifluoroaniline\n407-170-9\n3862-73-5\nXn; R21/22-48/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-48/22-51/53\nS: (2-)23-26-36/37/39-61\n\n\n612-188-00-7\n4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)\n407-560-9\n107934-68-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-189-00-2\n4-amino-2-(aminomethyl)phenol dihydrochloride\n412-510-4\n135043-64-0\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n612-190-00-8\n4,4'-methylenebis(2-isopropyl-6-methylaniline)\n415-150-6\n16298-38-7\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36-61\n\n\n612-191-00-3\nPolymer of allylamine hydrochloride\n415-050-2\n71550-12-4\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)36/37\n\n\n612-192-00-9\n2-isopropyl-4-(N-methyl)aminomethylthiazole\n414-800-6\n154212-60-9\nXn; R21/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-51/53\nS: (2-)26-36/37/39-61\n\n\n612-193-00-4\n3-methylaminomethylphenylamine\n414-570-7\n18759-96-1\nXn; R21/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 21/22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n612-194-00-X\n2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride\n414-670-0\n141890-30-4\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)26-39-60-61\n\n\n612-195-00-5\nbis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate\n415-210-1\n160236-81-7\nXn; R20/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-50/53\nS: (2-)26-36/39-60-61\n\n\n612-196-00-0\n4-chloro-o-toluidine; [1]\n4-chloro-o-toluidine hydrochloride [2]\n202-441-6 [1]\n221-627-8 [2]\n95-69-2 [1]\n3165-93-3 [2]\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT; R23/24/25\nN; R50-53\nT; N\nR: 45-23/24/25-68-50/53\nS: 53-45-60-61\n\nE\n612-197-00-6\n2,4,5-trimethylaniline; [1]\n2,4,5-trimethylaniline hydrochloride [2]\n205-282-0 [1]\n[2]\n137-17-7 [1]\n21436-97-5 [2]\nCarc. Cat. 2; R45\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-23/24/25-51/53\nS: 53-45-61\n\nE\n612-198-00-1\n4,4'-thiodianiline and its salts\n205-370-9\n139-65-1\nCarc. Cat. 2; R45\nXn; R22\nN; R51-53\nT; N\nR: 45-22-51/53\nS: 53-45-61\n\nE\n612-199-00-7\n4,4'-oxydianiline and its salts;\np-aminophenyl ether\n202-977-0\n101-80-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-46-23/24/25-62-51/53\nS: 53-45-61\n\nE\n612-200-00-0\n2,4-diaminoanisole;\n4-methoxy-m-phenylenediamine; [1]\n2,4-diaminoanisole sulphate [2]\n210-406-1 [1]\n254-323-9 [2]\n615-05-4 [1]\n39156-41-7 [2]\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R22\nN; R51-53\nT; N\nR: 45-22-68-51/53\nS: 53-45-61\n\nE\n612-201-00-6\nN,N,N',N'-tetramethyl-4,4'-methylendianiline\n202-959-2\n101-61-1\nCarc. Cat. 2; R45\nN; R50-53\nT; N\nR: 45-50/53\nS: 53-45-60-61\n\n\n612-202-00-1\n3,4-dichloroaniline\n202-448-4\n95-76-1\nT; R23/24/25\nXi; R41\nR43\nN; R50-53\nT; N\nR: 23/24/25-41-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n\n612-203-00-7\nC8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: <3 %)\n417-360-3\n-\nXn; R21/22\nXi; R38\nXn\nR: 21/22-38\nS: (2-)25-36/37\n\n\n\n612-204-00-2\nC.I. Basic Violet 3;\n4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride\n208-953-6\n548-62-9\nCarc. Cat. 3; R40\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-40-41-50/53\nS: (2-)26-36/37/39-46-60-61\n\n\n612-205-00-8\nC.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5)\n208-953-6\n548-62-9\nCarc. Cat. 2; R45\nXn; R22\nXi; R41\nN; R50-53\nT; N\nR: 45-22-41-50/53\nS: 53-45-60-61\n\nE\n612-206-00-3\nfamoxadone (ISO);\n3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione\n—\n131807-57-3\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)46-60-61\n\n\n612-207-00-9\n4-ethoxyaniline;\np-phenetidine\n205-855-5\n156-43-4\nMuta. Cat. 3; R68\nXn; R20/21/22\nXi; R36\nR43\nXn\nR: 20/21/22-36-43-68\nS: (2-)36/37-46\n\n\n\n\n612-208-00-4\nN-methylbenzene-1,2-diammonium hydrogen phosphate\n424-460-0\n-\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)22-25-36/37-61\n\n\n\n612-209-00-X\n6-methoxy-m-toluidine;\np-cresidine\n204-419-1\n120-71-8\nCarc. Cat. 2; R45\nXn; R22\nT\nR: 45-22\nS: 53-45\n\nE\n612-210-00-5\n5-nitro-o-toluidine; [1]\n5-nitro-o-toluidine hydrochloride [2]\n202-765-8 [1]\n256-960-8 [2]\n99-55-8 [1]\n51085-52-0 [2]\nCarc. Cat. 3; R40\nT; R23/24/25\nR52-53\nT\nR: 23/24/25-40-52/53\nS: (1/2-)36/37-45-61\n\n\n612-211-00-0\nN-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide\n416-470-9\n170292-97-4\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n612-212-00-6\n2,6-dichloro-4-trifluoromethylaniline\n416-430-0\n24279-39-8\nXn; R20/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 20/22-38-43-50/53\nS: (2-)24-37-60-61\n\n\n612-213-00-1\nisobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine\n419-850-2\n148348-13-4\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n612-214-00-7\n4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine\n421-390-2\n89114-90-9\nR53\nR: 53\nS: 61\n\n\n612-215-00-2\n3-chloro-2-(isopropylthio)aniline\n421-700-6\n179104-32-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n\n\n612-216-00-8\n1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt\n425-870-2\n19450-38-5\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n612-217-00-3\n1-methoxy-2-propylamine\n422-550-4\n37143-54-7\nF; R11\nC; R34\nXn; R22\nR52-53\nF; C\nR: 11-22-34-52/53\nS: (1/2-)9-26-36/37/39-45-61\n\n\n\n\n612-219-00-4\n(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride\n402-200-7\n-\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-220-00-X\nN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine\n431-060-1\n153719-38-1\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-24-37-61\n\n\n\n612-221-00-5\n2-amino-4-(trifluoromethyl)benzenethiol hydrochloride\n429-560-8\n4274-38-8\nC; R34\nXn; R20/21/22-48/22\nR43\nN; R50\nC; N\nR: 20/21/22-34-43-48/22-50\nS: (1/2-)26-36/37/39-45-61\n\n\n\n612-222-00-0\ncis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine\n425-080-8\n104860-26-6\nXn; R21/22-48/22\nXi; R41\nN; R50-53\nXn; N\nR: 21/22-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n\n612-223-00-6\nN-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine\n425-300-2\n186450-73-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n\n612-224-00-1\nN2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine\n426-150-0\n121246-28-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n612-225-00-7\n1,4,7,10-tetraazacyclododecane\n425-450-9\n294-90-6\nC; R34\nXn; R21/22\nN; R50-53\nC; N\nR: 21/22-34-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\n\n\n\n612-226-00-2\n3-(2'-phenoxyethoxy)propylamine\n427-870-8\n6903-18-0\nXn; R22\nXi; R38-41\nR52-53\nXn\nR: 22-38-41-52/53\nS: (2-)23-26-37/39-61\n\n\n\n612-227-00-8\nbenzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride\n428-290-8\n120606-08-8\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)22-26-39-60-61\n\n\n\n612-228-00-3\nreaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine\n414-340-6\n-\nR10\nXn; R20/21/22-68/20/21/22\nXi; R41\nR43\nR52-53\nXn\nR: 10-20/21/22-41-43-68/20/21/22-52/53\nS: (2-)26-36/37/39-61\n\n\n\n612-229-00-9\nmepanipyrim;\n4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine\n-\n110235-47-7\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-46-60-61\n\n\n\n612-230-00-4\nN,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide\n431-530-4\n-\nC; R35\nR43\nN; R50-53\nC; N\nR: 35-43-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n\n612-231-00-X\n3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride\n427-370-1\n164288-56-6\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n612-232-00-5\nreaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;\ntriisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid\n430-410-9\n186148-38-9\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-237-00-2\nhydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]\n233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]\n10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R36/38\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-36/38-40-43-48/22-50\nS: (2-)36/37-61\n\nT\n\n612-238-00-8\n(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%\n222-048-3\n3327-22-8\nCarc. Cat. 3, R40\nR52-53\nXn\nR: 40-52/53\nS: 36/37-61\n\nB\n\n612-239-00-3\nbiphenyl-3,3', 4,4'-tetrayltetraamine;\ndiaminobenzidine\n202-110-6\n91-95-2\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT\nR: 45-68\nS: 53-45\n\n\n\n612-240-00-9\npyrimethanil (ISO);\nN-(4,6-dimethylpyrimidin-2-yl)aniline\n-\n53112-28-0\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n612-241-00-4\npiperazine hydrochloride; [1]\npiperazine dihydrochloride; [2]\npiperazine phosphate [3]\n228-042-7 [1]\n205-551-2 [2]\n217-775-8 [3]\n6094-40-2 [1]\n142-64-3 [2]\n1951-97-9 [3]\nRepr. Cat. 3; R62-63\nXi; R36/38\nR42/43\nR52-53\nXn\nR: 36/38-42/43-62-63-52/53\nS: (1/2-)22-36/37-45-63-61\n\n\n\n612-242-00-X\ncyprodinil (ISO);\n4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine\n-\n121552-61-2\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-243-00-5\n(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate\n420-560-3\n79617-97-3\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-244-00-0\n3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride\n421-310-6\n87691-88-1\nRepr. Cat. 3; R62\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-62-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n\n612-245-00-6\n2-ethylphenylhydrazine hydrochloride\n421-460-2\n19398-06-2\nCarc. Cat. 3; R40\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 22-40-41-43-48/25-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-246-00-1\n(2-chloroethyl)(3-hydroxypropyl)ammonium chloride\n429-740-6\n40722-80-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R48/22\nR43\nR52-53\nT\nR: 45-46-43-48/22-52/53\nS: 53-45-61\n\nE\n\n612-247-00-7\nN-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide\n423-530-8\n152828-23-4\nT; R48/25\nXn; R22\nR52-53\nT\nR: 22-48/25-52/53\nS: (1/2-)22-36-45-61\n\n\n\n612-248-00-2\nreaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)\n439-540-0\n-\nXi; R38\nR43\nR53\nXi\nR: 38-43-53\nS: (2-)24-37-61\n\n\n\n612-249-00-8\n4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride\n425-030-5\n159939-85-2\nRepr. Cat. 3; R62\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-62-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n612-250-00-3\nchloro-N,N-dimethylformiminium chloride\n425-970-6\n3724-43-4\nR14\nRepr. Cat. 2; R61\nXn; R22\nC; R35\nT; C\nR: 61-14-22-35\nS: 53-45\n\nE\n\n612-251-00-9\ncis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride\n426-020-3\n51229-78-8\nF; R11\nRepr. Cat. 3; R63\nXn; R22\nXi; R38\nR43\nN; R51-53\nF; Xn; N\nR: 11-22-38-43-63-51/53\nS: (2-)7-22-33-36/37-61\n\n\n\n612-252-00-4\nimidacloprid (ISO);\n1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine\n428-040-8\n138261-41-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-57-60-61\n\n\n\n612-253-00-X\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing < 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nR52-53\nR: R52/53\nS: 61\n\n\n\n612-253-01-7\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing ≥ 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nRepr. Cat. 2; R61\nR52-53\nT\nR: 61-52/53\nS: 53-45-61\n\n\n\n612-254-00-5\nreaction products of diisopropanolamine with formaldehyde (1:4)\n432-440-8\n220444-73-5\nCarc. Cat. 3; R40\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-40-43-51/53\nS: (1/2-)13-25-26-36/37/39-45-61\n\n\n\n612-255-00-0\n1-(3-methoxypropyl)-4-piperidinamine\n431-950-8\n179474-79-4\nXn; R21/22\nC; R34\nR52-53\nC\nR: 21/22-34-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n612-256-00-6\nbenzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate\n427-470-3\n137864-22-3\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)36/37\n\n\n\n612-257-00-1\ntripropylammonium dihydrogenphosphate\n433-700-3\n35687-90-2\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n\n612-259-00-2\nN-ethyl-3-trimethoxysilyl-2-methyl-propanamine\n437-720-3\n227085-51-0\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n612-261-00-3\n3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline\n441-190-9\n121451-05-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-265-00-5\nbis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate\n444-360-0\n191617-13-7\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-266-00-0\n3-chloro-4-(3-fluorobenzyloxy)aniline\n445-590-4\n202197-26-0\nMuta. Cat. 3; R68\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-68-50/53\nS: (2-)22-36/37-60-61\n\n\n\n612-267-00-6\nbis(hydrogenated tallow C16-18-alkyl)hydroxylamine\n418-370-0\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)36/37-61\n\n\n\n612-269-00-7\nreaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;\n1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;\nreaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;\nN-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline\n420-720-2\n-\nR53\nR: 53\nS: 22-61\n\n\n\n612-270-00-2\n(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride\n433-010-2\n-\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-36/37-61\n\n\n\n612-271-00-8\nreaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;\nethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate\n434-970-5\n160987-57-5\nR53\nR: 53\nS: 61\n\n\n\n612-272-00-3\nammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate\n435-210-5\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n612-273-00-9\nalkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride\n435-650-8\n-\nXn; R22\nC; R35\nN; R50-53\nC; N\nR: 22-35-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n612-274-00-4\n(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate\n445-750-3\n-\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)22-24-26-37/39-61\n\n\n\n612-275-00-X\nfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil\n447-880-6\n206565-89-1\nXi; R38-41\nR43\nN; R50-53\nXi; N\nR: 38-41-43-50/53\nS: (2-)23-26-36/37/39-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-276-00-5\n1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts\n451-430-4\n500717-36-2\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)22-24-26-36/37/39-61\n\n\n\n612-277-00-0\nreaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;\n4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium\n451-440-9\n586372-44-3\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n612-278-00-6\nethidium bromide;\n3,8-diamino-1-ethyl-6-phenylphenantridinium bromide\n214-984-6\n1239-45-8\nMuta. Cat. 3; R68\nT+; R26\nXn; R22\nT+\nR: 22-26-68\nS: (1/2-)28-36/37-45-63\n\n\n\n612-279-00-1\n(R, S)-2-amino-3,3-dimethylbutane amide\n447-860-7\n144177-62-8\nRepr. Cat. 3; R62\nXn; R48/22\nXi; R36/38\nR43\nXn\nR: 36/38-43-48/22-62\nS: (2-)22-26-36/37\n\n\n\n612-280-00-7\n3-amino-9-ethyl carbazole;\n9-ethylcarbazol-3-ylamine\n205-057-7\n132-32-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n613-001-00-1\nethyleneimine;\naziridine\n205-793-9\n151-56-4\nF; R11\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT+; R26/27/28\nC; R34\nN; R51-53\nF; T+; N\nR: 45-46-11-26/27/28-34-51/53\nS: 53-45-61\n\nD E\n613-002-00-7\npyridine\n203-809-9\n110-86-1\nF; R11\nXn; R20/21/22\nF; Xn\nR: 11-20/21/22\nS: (2-)26-28\nXn; R20/21/22: C ≥ 5 %\n\n\n\n613-003-00-2\n1,2,3,4-tetranitrocarbazole\n—\n6202-15-9\nE; R2\nXn; R20/21/22\nE; Xn\nR: 2-20/21/22\nS: (2-)35-36/37\n\n\n\n613-004-00-8\ncrimidine (ISO);\n2-chloro-6-methylpyrimidin-4-yldimethylamine\n208-622-6\n535-89-7\nT+; R28\nT+\nR: 28\nS: (1/2-)36/37-45\n\n\n613-007-00-4\ndesmetryne (ISO);\n6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine\n213-800-1\n1014-69-3\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n613-008-00-X\ndazomet (ISO);\ntetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione\n208-576-7\n533-74-4\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)15-22-24-60-61\n\n\n613-009-00-5\n2,4,6-trichloro-1,3,5-triazine;\ncyanuric chloride\n203-614-9\n108-77-0\nR14\nT+; R26\nXn; R22\nC; R34\nR43\nT+;\nR: 14-22-26-34-43\nS: (1/2-)26-28-36/37/39-45-46-63\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n\n\n613-010-00-0\nametryn (ISO);\n2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine\n212-634-7\n834-12-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)36-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n\n613-011-00-6\namitrole (ISO);\n1,2,4-triazol-3-ylamine\n200-521-5\n61-82-5\nRepr. Cat. 3; R63\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-63-51/53\nS: (2-)13-36/37-61\n\n\n613-012-00-1\nbentazone (ISO);\n3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide\n246-585-8\n25057-89-0\nXn; R22\nXi; R36\nR43\nR52-53\nXn\nR: 22-36-43-52/53\nS: (2-)24-37-61\n\n\n613-013-00-7\ncyanazine (ISO);\n2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile\n244-544-9\n21725-46-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)37-60-61\n\n\n613-014-00-2\nethoxyquin (ISO);\n6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline\n202-075-7\n91-53-2\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n613-015-00-8\nfenazaflor (ISO);\nphenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate\n238-134-9\n14255-88-0\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n613-016-00-3\nfuberidazole (ISO);\n2-(2-furyl)benzimidazole\n223-404-0\n3878-19-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-60-61\n\n\n613-017-00-9\nbis (8-hydroxyquinolinium) sulphate\n205-137-1\n134-31-6\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n613-018-00-4\nmorfamquat (ISO);\n1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion\n—\n7411-47-4\nXn; R22\nXi; R36/37/38\nR52-53\nXn\nR: 22-36/37/38-52/53\nS: (2-)22-36-61\n\n\n613-019-00-X\nthioquinox (ISO);\n2-thio-1,3-dithiolo(4,5,b)quinoxaline\n202-272-8\n93-75-4\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n613-020-00-5\ntridemorph (ISO);\n2,6-dimethyl-4-tridecylmorpholine\n246-347-3\n24602-86-6\nRepr. Cat. 2; R61\nXn; R20/22\nXi; R38\nN; R50-53\nT; N\nR: 61-20/22-38-50/53\nS: 53-45-60-61\n\nE\n613-021-00-0\ndithianon (ISO);\n5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile\n222-098-6\n3347-22-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24-60-61\n\n\n613-022-00-6\npyrethrins including cinerins, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\nA\n613-023-00-1\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;\npyrethrin I\n204-455-8\n121-21-1\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\n\n613-024-00-7\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\npyrethrin II\n204-462-6\n121-29-9\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\n\n613-025-00-2\ncinerin I;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n246-948-0\n25402-06-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-026-00-8\ncinerin II;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate\n204-454-2\n121-20-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-027-00-3\npiperidine\n203-813-0\n110-89-4\nF; R11\nT; R23/24\nC; R34\nF; T\nR: 11-23/24-34\nS: (1/2-)16-26-27-45\nT; R23/24: C ≥ 5 %\nXn; R20/21: 1 % ≤ C < 5 %\nC; R34: C ≥ 5 %\nXi: R36/38: 1 % ≤ C < 5 %\n\n613-028-00-9\nmorpholine\n203-815-1\n110-91-8\nR10\nXn; R20/21/22\nC; R34\nC\nR: 10-20/21/22-34\nS: (1/2-)23-36-45\nC; R34: C ≥ 10 %\nXi; R36/38: 1 % ≤ C < 10 %\n\n613-029-00-4\ndichloro-1,3,5-triazinetrione;\ndichloroisocyanuric acid\n220-487-5\n2782-57-2\nO; R8\nXn; R22\nR31\nXi; R36/37\nN; R50-53\nO; Xn; N\nR: 8-22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n\n\n613-030-00-X\ntroclosene potassium; [1]\ntroclosene sodium [2]\n218-828-8 [1]\n220-767-7 [2]\n2244-21-5 [1]\n2893-78-9 [2]\nE; R2\nO; R8\nXn; R22\nXi; R36/37\nR31\nN; R50-53\nE; Xn; N\nR: 2-8-22-31-36/37-50/53\nS: (2-)8-26-41-45-60-61\nXn; R22: C ≥ 10 %\nXi; R36/37: C ≥ 10 %\nR31: C ≥ 10 %\nT\n\n613-030-01-7\ntroclosene sodium, dihydrate\n220-767-7\n51580-86-0\nXn; R22\nR31\nXi; R36/37\nN; R50-53\nXn; N\nR: 22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n613-031-00-5\nsymclosene;\ntrichloroisocyanuric acid;\ntrichloro-1,3,5-triazinetrion\n201-782-8\n87-90-1\nO; R8\nXn; R22\nXi; R36/37\nR31\nN; R50-53\nO; Xn; N\nR: 8-22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n613-032-00-0\nmethyl-2,3,5,6-tetrachloro-4-pyridylsulphone;\n2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine\n236-035-5\n13108-52-6\nXn; R21/22\nXi; R36\nR43\nXn\nR: 21/22-36-43\nS: (2-)26-28\n\n\n613-033-00-6\n2-methylaziridine;\npropyleneimine\n200-878-7\n75-55-8\nF; R11\nCarc. Cat. 2; R45\nT+; R26/27/28\nXi; R41\nN; R51-53\nF; T+; N\nR: 45-11-26/27/28-41-51/53\nS: 53-45-61\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n613-034-00-1\n1,2-dimethylimidazole\n217-101-2\n1739-84-0\nXn; R22\nXi; R38-41\nXn\nR: 22-38-41\nS: (2-)24-26\n\n\n613-035-00-7\n1-methylimidazole\n210-484-7\n616-47-7\nXn; R21/22\nC; R34\nC\nR: 21/22-34\nS: (1/2-)26-36-45\n\n\n613-036-00-2\n2-methylpyridine;\n2-picoline\n203-643-7\n109-06-8\nR10\nXn; R20/21/22\nXi; R36/37\nXn\nR: 10-20/21/22-36/37\nS: (2-)26-36\n\n\n613-037-00-8\n4-methylpyridine;\n4-picoline\n203-626-4\n108-89-4\nR10\nT; R24\nXn; R20/22\nXi; R36/37/38\nT\nR: 10-20/22-24-36/37/38\nS: (1/2-)26-36-45\n\n\n613-038-00-3\n6-phenyl-1,3,5-triazine-2,4-diyldiamine;\n6-phenyl-1,3,5-triazine-2,4-diamine;\nbenzoguanamine\n202-095-6\n91-76-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-039-00-9\nethylene thiourea;\nimidazolidine-2-thione;\n2-imidazoline-2-thiol\n202-506-9\n96-45-7\nRepr. Cat. 2; R61\nXn; R22\nT\nR: 61-22\nS: 53-45\n\nE\n613-040-00-4\nazaconazole (ISO);\n1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole\n262-102-3\n60207-31-0\nXn; R22\nXn\nR: 22\nS: (2-)46\n\n\n613-041-00-X\nmorpholine-4-carbonyl chloride\n239-213-0\n15159-40-7\nR14\nCarc. Cat. 3; R40\nXi; R36/38\nXn\nR: 14-36/38-40\nS: (2-)26-30-36-38\n\n\n613-042-00-5\nimazalil (ISO);\n1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole\n252-615-0\n35554-44-0\nXn; R20/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-50/53\nS: (2-)26-39-60-61\n\n\n613-043-00-0\nimazalil sulphate (ISO) powder;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24/25-37-46-60-61\n\n\n613-043-01-8\nimazalil sulphate (ISO), aqueous solution;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (2-)26-36/37/39-45-60-61\nC; R34: C ≥ 50 %\nXi; R38: 30 % ≤ C < 50 %\nXi; R41: 15 % ≤ C < 50 %\nXi; R36: 5 % ≤ C < 15 %\n\n\n\n613-044-00-6\ncaptan (ISO);\n1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide\n205-087-0\n133-06-2\nCarc. Cat. 3; R40\nT; R23\nXi; R41\nR43\nN; R50\nT; N\nR: 23-40-41-43-50\nS: (1/2-)26-29-36/37/39-45-61\nN; R50: C ≥ 2,5 %\n\n\n613-045-00-1\nfolpet (ISO);\nN-(trichloromethylthio)phthalimide\n205-088-6\n133-07-3\nCarc. Cat. 3; R40\nXn; R20\nXi; R36\nR43\nN; R50\nXn; N\nR: 20-36-40-43-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n613-046-00-7\ncaptafol (ISO);\n1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide\n219-363-3\n2425-06-1\nCarc. Cat. 2; R45\nR43\nN; R50-53\nT; N\nR: 45-43-50/53\nS: 53-45-60-61\n\n\n613-047-00-2\n1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;\ndimetilan (ISO)\n211-420-0\n644-64-4\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n613-048-00-8\ncarbendazim (ISO);\nmethyl benzimidazol-2-ylcarbamate\n234-232-0\n10605-21-7\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nN; R50-53\nT; N\nR: 46-60-61-50/53\nS: 53-45-60-61\n\n\n613-049-00-3\nbenomyl (ISO);\nmethyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate\n241-775-7\n17804-35-2\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nXi; R37/38\nR43\nN; R50-53\nT; N\nR: 46-60-61-37/38-43-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n613-050-00-9\ncarbadox (INN);\nmethyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;\n2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide\n229-879-0\n6804-07-5\nF; R11\nCarc. Cat. 2; R45\nXn; R22\nF; T\nR: 45-11-22\nS: 53-45\n\nE\n613-051-00-4\nmolinate (ISO);\nS-ethyl 1-perhydroazepinecarbothioate;\nS-ethyl perhydroazepine-1-carbothioate\n218-661-0\n2212-67-1\nCarc. Cat. 3; R40\nRepr. Cat. 3; R62\nXn; R20/2248/22\nR43\nN; R50-53\nXn; N\nR: 20/22-40-43-48/22-62-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n613-052-00-X\ntrifenmorph (ISO);\n4-tritylmorpholine\n215-812-2\n1420-06-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-053-00-5\nanilazine (ISO);\n2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline\n202-910-5\n101-05-3\nXi; R36/38\nN; R50-53\nXi; N\nR: 36/38-50/53\nS: (2-)22-60-61\n\n\n613-054-00-0\nthiabendazol (ISO);\n2-(thiazole-4-yl)benzimidazole\n205-725-8\n148-79-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-056-00-1\n1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;\ndifenzoquat methyl sulfate\n256-152-5\n43222-48-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-057-00-7\ndodemorph (ISO);\n4-cyclododecyl-2,6-dimethylmorpholine\n216-474-9\n1593-77-7\nXi; R36/37/38\nN; R51-53\nXi; N\nR: 36/37/38-51/53\nS: (2-)26-61\n\n\n613-058-00-2\npermethrin (ISO);\nm-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-067-9\n52645-53-1\nXn; R20/22\nR43\nN; R50-53\nXn; N\nR: 20/22-43-50/53\nS: (2-)13-24-36/37/39-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n613-059-00-8\nprofluralin (ISO);\nN-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine\n247-656-6\n26399-36-0\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)60-61\n\n\n\n\n613-060-00-3\nresmethrin (ISO);\n5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate\n233-940-7\n10453-86-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-061-00-9\n6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;\nryania\n239-732-2\n15662-33-6\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n613-062-00-4\nsabadilla (ISO);\nveratrine\n—\n8051-02-3\nXi; R36/37/38\nXi\nR: 36/37/38\nS: (2-)36/37/39\n\n\n613-063-00-X\nsecbumeton (ISO);\n2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n247-554-1\n26259-45-0\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)60-61\n\n\n613-064-00-5\n5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;\nsesamex\n—\n51-14-9\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-065-00-0\nsimetryn (ISO);\n2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine\n213-801-7\n1014-70-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-066-00-6\nterbumeton (ISO);\n2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n251-637-8\n33693-04-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-067-00-1\npropazine (ISO);\n2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine\n205-359-9\n139-40-2\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n613-068-00-7\natrazine (ISO);\n2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine\n217-617-8\n1912-24-9\nXn; R48/22\nR43\nN; R50-53\nXn; N\nR: 43-48/22-50/53\nS: (2-)36/37-60-61\n\n\n613-069-00-2\nε-caprolactam\n203-313-2\n105-60-2\nXn; R20/22\nXi; R36/37/38\nXn\nR: 20/22-36/37/38\nS: (2-)\n\n\n613-070-00-8\npropylenethiourea\n—\n2122-19-2\nRepr. Cat. 3; R63\nXn; R22\nR52-53\nXn\nR: 22-52/53-63\nS: (2-)36/37-46-61\n\n\n613-071-00-3\n2-fluoro-5-trifluoromethylpyridine\n400-290-2\n69045-82-5\nR10\nR43\nR52-53\nXi\nR: 10-43-52/53\nS: (2-)24-37-61\n\n\n613-072-00-9\nN,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine\n401-280-0\n91273-04-0\nC; R34\nR43\nN; R51-53\nC; N\nR: 34-43-51/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n613-073-00-4\nN,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine\n401-410-6\n10357-99-0\nXn; R48/22\nR43\nN; R51-53\nXn; N\nR: 43-48/22-51/53\nS: (2-)24-37-61\n\n\n613-074-00-X\n3-(3-methylpent-3-yl)isoxazol-5-ylamine\n401-460-9\n82560-06-3\nT; R23/25\nXi; R41\nR52-53\nT\nR: 23/25-41-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n613-075-00-5\n1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione\n401-570-7\n89415-87-2\nO; R8\nT; R23\nC; R34\nXn; R22\nR43\nN; R50\nO; T; N\nR: 8-22-23-34-43-50\nS: (1/2-)8-26-36/37/39-45-61\n\n\n613-076-00-0\n3-chloro-5-trifluoromethyl-2-pyridylamine\n401-670-0\n79456-26-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-077-00-6\nreaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine\n401-940-8\n—\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53\nS: (2-)22-26-61\n\n\n613-078-00-1\nN,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine\n401-990-0\n106990-43-6\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n613-079-00-7\n4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers\n402-520-7\n—\nXn; R21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 21/22-38-43-50/53\nS: (2-)36/37-60-61\n\n\n613-080-00-2\n3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione\n402-540-6\n105254-85-1\nC; R34\nR43\nN; R50-53\nC; N\nR: 34-43-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n613-081-00-8\n1-butyl-2-methylpyridinium bromide\n402-680-8\n26576-84-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-082-00-3\n2-methyl-1-pentylpyridinium bromide\n402-690-2\n—\nXn; R21/22\nR52-53\nXn\nR: 21/22-52/53\nS: (2-)36/37-61\n\n\n613-083-00-9\n2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate\n402-120-2\n—\nC; R34\nXn; R48/22\nR43\nN; R50-53\nC; N\nR: 34-43-48/22-50/53\nS: (1/2-)24-26-28-37/39-45-60-61\n\n\n613-084-00-4\n2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate\n402-490-5\n106359-93-7\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)26-60-61\n\n\n613-085-00-X\nreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione\n401-970-1\n—\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-086-00-5\ncaffeine\n200-362-1\n58-08-2\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-087-00-0\ntetrahydrothiophene\n203-728-9\n110-01-0\nF; R11\nXn; R20/21/22\nXi; R36/38\nR52-53\nF; Xn\nR: 11-20/21/22-36/38-52/53\nS: (2-)16-23-36/37-61\n\n\n613-088-00-6\n1,2-benzisothiazol-3(2H)-one;\n1,2-benzisothiazolin-3-one\n220-120-9\n2634-33-5\nXn; R22\nXi; R38-41\nR43\nN; R50\nXn; N\nR: 22-38-41-43-50\nS: (2-)24-26-37/39-61\nR43: C ≥ 0,05 %\n\n613-089-00-1\ndiquat dibromide; [1]\ndiquat dichloride; [2]\n6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]\n201-579-4 [1]\n223-714-6 [2]\n301-467-6 [3]\n85-00-7 [1]\n4032-26-2 [2]\n94021-76-8 [3]\nT+; R26\nT; R48/25\nXn; R22\nXi; R36/37/38\nR43\nN; R50-53\nT+; N\nR: 22-26-36/37/38-43-48/25-50/53\nS: (1/2-)28-36/37/39-45-60-61\n\n\n613-090-00-7\nparaquat dichloride;\n1,1-dimethyl-4,4'-bipyridinium dichloride; [1]\nparaquat dimethylsulfate;\n1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]\n217-615-7 [1]\n218-196-3 [2]\n1910-42-5 [1]\n2074-50-2 [2]\nT+; R26\nT; R24/25-48/25\nXi; R36/37/38\nN; R50-53\nT+; N\nR: 24/25-26-36/37/38-48/25-50/53\nS: (1/2-)22-28-36/37/39-45-60-61\n\n\n613-091-00-2\nmorfamquat dichloride; [1]\nmorfamquat sulfate [2]\n225-062-8 [1]\n[2]\n4636-83-3 [1]\n29873-36-7 [2]\nXn; R22\nXi; R36/37/38\nR52-53\nXn\nR: 22-36/37/38-52/53\nS: (2-)22-36-61\n\n\n613-092-00-8\n1,10-phenanthroline\n200-629-2\n66-71-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)45-60-61\n\n\n613-093-00-3\nhexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n400-050-7\n85153-92-0\nR42/43\nXn\nR: 42/43\nS: (2-)22-24-37\n\n\n613-094-00-9\n4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine\n401-360-5\n5248-39-5\nXn; R22-48/22\nXn\nR: 22-48/22\nS: (2-)22-36\n\n\n613-095-00-4\nsodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate\n403-080-9\n92484-48-5\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-096-00-X\n2-amino-6-ethoxy-4-methylamino-1,3,5-triazine\n403-580-7\n62096-63-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-097-00-5\n7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid\n403-690-5\n111298-82-9\nR42/43\nR52-53\nXn\nR: 42/43-52/53\nS: (2-)22-24-37-61\n\n\n613-098-00-0\nN-(n-octyl)-2-pyrrolidone\n403-700-8\n2687-94-7\nC; R34\nN; R51-53\nC; N\nR: 34-51/53\nS: (1/2-)23-26-36/37/39-45\n\n\n613-099-00-6\n1-dodecyl-2-pyrrolidone\n403-730-1\n2687-96-9\nC; R34\nR43\nN; R50-53\nC; N\nR: 34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n613-100-00-X\n2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione\n404-230-6\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n613-101-00-5\nN-tert-pentyl-2-benzothiazolesulfenamide\n404-380-2\n110799-28-5\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)36/37-61\n\n\n613-102-00-0\ndimethomorph (ISO);\n4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine\n404-200-2\n110488-70-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-103-00-6\nsodium 5-n-butylbenzotriazole\n404-450-2\n118685-34-0\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n613-104-00-1\n5-tert-butyl-3-isoxazolylamine hydrochloride\n404-840-2\n—\nXn; R22-48/22\nXi; R41\nR52-53\nXn\nR: 22-41-48/22-52/53\nS: (2-)26-36/39-61\n\n\n613-105-00-7\nhexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)\n405-160-9\n124537-30-0\nT; R25\nR43\nR52-53\nT\nR: 25-43-52/53\nS: (1/2-)24-37-45-61\n\n\n613-106-00-2\ntetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate\n405-240-3\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n613-107-00-8\nhexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate\n405-280-1\n76508-02-6\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n613-108-00-3\nbenzothiazole-2-thiol\n205-736-8\n149-30-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-109-00-9\nbis(piperidinothiocarbonyl) disulphide\n202-328-1\n94-37-1\nXi; R36/37/38\nR43\nXi\nR: 36/37/38-43\nS: (2-)24-26-37\n\n\n613-110-00-4\ndimepiperate (ISO);\nS-(1-methyl-1-phenylethyl) piperidine-1-carbothioate\n262-784-2\n61432-55-1\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n613-111-00-X\n1,2,4-triazole\n206-022-9\n288-88-0\nRepr. Cat. 3; R63\nXn; R22\nXi; R36\nXn\nR: 22-36-63\nS: (2-)36/37\n\n\n613-112-00-5\nocthilinone (ISO);\n2-octyl-2H-isothiazol-3-one\n247-761-7\n26530-20-1\nT; R23/24\nXn; R22\nC; R34\nR43\nN; R50-53\nT; N\nR: 22-23/24-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\nR43: C ≥ 0,05 %\n\n613-113-00-0\n2-(morpholinothio)benzothiazole\n203-052-4\n102-77-2\nXi; R36/38\nR43\nN; R51-53\nXi; N\nR: 36/38-43-51/53\nS: (2-)24-26-37-61\n\n\n613-114-00-6\n2,2',2\"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;\n1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine\n225-208-0\n4719-04-4\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\nR43: C ≥ 0,1 %\n\n613-115-00-1\nhymexazol (ISO);\n3-hydroxy-5-methylisoxazole\n233-000-6\n10004-44-1\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)26-39-61\n\n\n\n\n613-116-00-7\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nT+; R26\nT; R48/23\nXi; R36/37/38\nR43\nN; R50\nT+; N\nR: 26-36/37/38-43-48/23-50\nS: (1/2-)28-36/37/39-45-63-61\nN; R50: C ≥ 2,5 %\n\n\n\n\n613-116-01-4\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nXi; R36/37/38\nR43\nN; R50\nXi; N\nR: 36/37/38-43-50\nS: (2-)25-36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n\n613-117-00-2\ndiniconazole (ISO);\n(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;\n(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol\n—\n76714-88-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-118-00-8\nflubenzimine (ISO);\nN-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline;\n253-703-1\n37893-02-0\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)26-60-61\n\n\n613-119-00-3\n(benzothiazol-2-ylthio)methyl thiocyanate;\nTCMTB\n244-445-0\n21564-17-0\nT+; R26\nXn; R22\nXi; R36/38\nR43\nN; R50-53\nT+; N\nR: 22-26-36/38-43-50/53\nS: (1/2-)28-36/37-38-45-60-61\n\n\n\n\n613-120-00-9\nbioresmethrin (ISO);\n(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate\n249-014-0\n28434-01-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-121-00-4\nchlorsulfuron (ISO);\n2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide;\n265-268-5\n64902-72-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-122-00-X\ndiclobutrazole (ISO);\n(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;\n(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol\n—\n75736-33-3\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n613-123-00-5\n5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;\netem\n251-684-4\n33813-20-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-124-00-0\nfenpropimorph (ISO);\ncis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine\n266-719-9\n67564-91-4\nRepr. Cat. 3; R63\nXn; R22\nXi; R38\nN; R51-53\nXn; N\nR: 22-38-63-51/53\nS: (2-)36/37-46-61\n\n\n613-125-00-6\nhexythiazox (ISO);\ntrans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide\n—\n78587-05-0\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-126-00-1\nimazapyr (ISO);\n2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate\n—\n81334-34-1\nXi; R36\nR52-53\nXi\nR: 36-52/53\nS: (2-)26-61\n\n\n613-127-00-7\n1,1-dimethylpiperidinium chloride;\nmepiquat chloride\n246-147-6\n24307-26-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-128-00-2\nprochloraz (ISO);\nN-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide;\n266-994-5\n67747-09-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-129-00-8\nmetamitron (ISO);\n4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one\n255-349-3\n41394-05-2\nXn; R22\nN; R50\nXn; N\nR: 22-50\nS: (2-)61\n\n\n613-131-00-9\npyroquilon (ISO);\n1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one\n—\n57369-32-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-132-00-4\nhexazinone (ISO);\n3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione;\n257-074-4\n51235-04-2\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)60-61\n\n\n613-133-00-X\netridiazole (ISO);\n5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole\n219-991-8\n2593-15-9\nCarc. Cat. 3; R40\nT; R23\nXn; R21/22\nN; R50-53\nT; N\nR: 21/22-23-40-50/53\nS: (1/2-)36/37-38-45-60-61\n\n\n613-134-00-5\nmyclobutanil (ISO);\n2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile\n—\n88671-89-0\nRepr. Cat. 3; R63\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53-63\nS: (2-)36/37-46-61\n\n\n613-135-00-0\ndi(benzothiazol-2-yl) disulphide\n204-424-9\n120-78-5\nR31\nR43\nN; R50-53\nXi; N\nR: 31-43-50/53\nS: (2-)36/37-60-61\n\n\n613-136-00-6\nN-cyclohexylbenzothiazole-2-sulphenamide\n202-411-2\n95-33-0\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-137-00-1\nmethabenzthiazuron (ISO);\n1-(1,3-benzothiazol-2-yl)1,3-dimethylurea\n242-505-0\n18691-97-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-138-00-7\nquinoxyfen (ISO);\n5,7-dichloro-4-(4-fluorophenoxy)quinoline\n—\n124495-18-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\n\n\n\n\n613-139-00-2\nmetsulfuron-methyl (ISO);\n2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid\n—\n74223-64-6\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-140-00-8\ncycloheximide (ISO);\n4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione\n200-636-0\n66-81-9\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT+; R28\nN; R51-53\nT+; N\nR: 61-28-51/53-68\nS: 53-45-61\n\nE\n613-141-00-3\n1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone\n401-470-3\n93686-63-6\nR53\nR: 53\nS: 61\n\n\n613-142-00-9\ntrans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate\n405-860-4\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n613-143-00-4\n1-(3-phenylpropyl)-2-methylpyridinium bromide\n405-930-4\n10551-42-5\nXn; R22\nXi; R36\nR52-53\nXn\nR: 22-36-52/53\nS: (2-)26-36/37-61\n\n\n613-144-00-X\nReaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate\n406-460-2\n125139-08-4\nR52-53\nR: 52/53\nS: 61\n\n\n613-145-00-5\n(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate\n406-960-0\n77497-97-3\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-146-00-0\nN-ethyl-N-methylpiperidinium iodide\n407-780-5\n4186-71-4\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)22-61\n\n\n613-147-00-6\n4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine\n407-940-4\n111681-72-2\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-148-00-1\ntetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane\n411-240-4\n143683-23-2\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24/25-37-61\n\n\n613-149-00-7\npyridaben (ISO);\n2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one\n405-700-3\n96489-71-3\nT; R23/25\nN; R50-53\nT; N\nR: 23/25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n613-150-00-2\n2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione\n406-295-6\n—\nR53\nR: 53\nS: 61\n\n\n613-151-00-8\n1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine\n406-360-9\n104218-44-2\nR53\nR: 53\nS: 61\n\n\n613-152-00-3\nphenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate\n406-600-2\n89392-03-0\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n613-153-00-9\n2,3,5-trichloropyridine\n407-270-2\n16063-70-0\nR52-53\nR: 52/53\nS: 61\n\n\n613-154-00-4\n2-amino-4-chloro-6-methoxypyrimidine\n410-050-9\n5734-64-5\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n613-155-00-X\n5-chloro-2,3-difluoropyridine\n410-090-7\n89402-43-7\nR10\nXn; R22\nR52-53\nXn\nR: 10-22-52/53\nS: (2-)23-36-61\n\n\n613-156-00-5\n2-butyl-4-chloro-5-formylimidazole\n410-260-0\n83857-96-9\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n613-157-00-0\n2,4-diamino-5-methoxymethylpyrimidine\n410-330-0\n54236-98-5\nXn; R22-48/22\nXi; R36\nXn\nR: 22-36-48/22\nS: (2-)22-26-36\n\n\n613-158-00-6\n2,3-dichloro-5-trifluoromethyl-pyridine\n410-340-5\n69045-84-7\nXn; R20/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 20/22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-159-00-1\nfenazaquin (ISO);\n4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline\n410-580-0\n120928-09-8\nT; R25\nXn; R20\nN; R50-53\nT; N\nR: 20-25-50/53\nS: (1/2-)37-45-60-61\n\n\n613-160-00-7\n(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide\n411-000-9\n125224-62-6\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n\n\n613-161-00-2\n2,4-diamino-6-hydroxymethylpteridinehydrobromide\n430-620-0\n76145-91-0\nXn; R48/22\nR43\nR52-53\nXn\nR: 43-48/22-52/53\nS: (2-)22-36/37-61\n\n\n\n613-162-00-8\n(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide\n423-260-0\n100988-63-4\nMuta. Cat. 3; R68\nR43\nN; R51-53\nXn; N\nR: 43-68-51/53\nS: (2-)36/37-61\n\n\n\n\n\n613-163-00-3\nazimsulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea\n—\n120162-55-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-164-00-9\nflufenacet (ISO);\nN-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide\n—\n142459-58-3\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)13-24-37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-165-00-4\nflupyrsulfuron-methyl-sodium (ISO);\nmethyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt\n—\n144740-54-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-166-00-X\nflumioxazin (ISO);\nN-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide\n—\n103361-09-7\nRepr. Cat. 2; R61\nN; R50-53\nT; N\nR: 61-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n\n613-167-00-5\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)\n—\n55965-84-9\nT; R23/24/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 23/24/25-34-43-50/53\nS: (2-)26-28-36/37/39-45-60-61\nC; R34: C ≥ 0,6 %\nXi; R36/38: 0,06 % ≤ C < 0,6 %\nR43: C ≥ 0,0015 %\n\n613-168-00-0\n1-vinyl-2-pyrrolidone\n201-800-4\n88-12-0\nCarc. Cat. 3; R40\nXn; R20/21/22-48/20\nXi; R37-41\nXn\nR: 20/21/22-37-40-41-48/20\nS: (2-)26-36/37/39\n\nD\n\n\n613-169-00-6\n9-vinylcarbazole\n216-055-0\n1484-13-5\nMuta. Cat. 3; R68\nXn; R21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 21/22-38-43-68-50/53\nS: (2-)22-23-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-170-00-1\n2,2-ethylmethylthiazolidine\n404-500-3\n694-64-4\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-171-00-7\nhexaconazole (ISO);\n(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol\n413-050-7\n79983-71-4\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n613-172-00-2\n5-chloro-1,3-dihydro-2H-indol-2-one\n412-200-9\n17630-75-0\nRepr. Cat. 3; R62\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-62-52/53\nS: (2-)22-36/37-61\n\n\n613-173-00-8\nfluquinconazole (ISO);\n3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one\n411-960-9\n136426-54-5\nT; R23/25-48/25\nXn; R21\nXi; R38\nN; R50-53\nT; N\nR: 21-23/25-38-48/25-50/53\nS: (1/2-)36/37/39-38-45-60-61\n\n\n\n\n\n613-174-00-3\ntetraconazole (ISO);\n(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether\n407-760-6\n112281-77-3\nXn; R20/22\nN; R51-53\nXn; N\nR: 20/22-51/53\nS: (2-)36-61\n\n\n\n613-175-00-9\nepoxiconazole (ISO);\n(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane\n406-850-2\n133855-98-8\nCarc. Cat. 3; R40\nRepr. Cat. 3; R62\nRepr. Cat. 3; R63\nN; R51-53\nXn; N\nR: 40-62-63-51/53\nS: (2-)36/37-46-61\n\n\n613-176-00-4\n2-methyl-2-azabicyclo[2.2.1]heptane\n404-810-9\n4524-95-2\nR10\nXn; R21/22-48/20\nC; R34\nC\nR: 10-21/22-34-48/20\nS: (1/2-)16-26-36/37/39-45\n\n\n613-177-00-X\n8-amino-7-methylquinoline\n412-760-4\n5470-82-6\nXn; R21/22\nR43\nN; R51-53\nXn; N\nR: 21/22-43-51/53\nS: (2-)36/37-61\n\n\n613-178-00-5\n4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine\n410-470-2\n137796-06-6\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)7/8-26-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n613-179-00-0\nlithium 3-oxo-1,2(2H)-benzisothiazol-2-ide\n411-690-1\n111337-53-2\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n613-180-00-6\nN-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide\n407-430-1\n3741-80-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-181-00-1\n5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone\n405-090-9\n67485-29-4\nT; R48/25\nXn; R22\nXi; R36\nN; R50-53\nT; N\nR: 22-36-48/25-50/53\nS: (1/2-)22-26-36/37-45-60-61\n\n\n613-182-00-7\n1-(1-naphthylmethyl)quinolinium chloride\n406-220-7\n65322-65-8\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nXn; R22\nXi; R38-41\nR52-53\nXn\nR: 22-38-40-41-52/53-68\nS: (2-)22-26-36/37/39-61\n\n\n613-183-00-2\nreaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;\n5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one\n413-640-4\n—\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)36-60-61\n\n\n613-184-00-8\nnitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate\n413-670-8\n—\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)24-26-37\n\n\n613-185-00-3\n2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one\n407-630-9\n82633-79-2\nT; R25\nXi; R41\nR43\nN; R50-53\nT; N\nR: 25-41-43-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\n\n\n613-186-00-9\n(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate\n408-050-9\n76855-69-1\nXi; R36\nR43\nN; R51-53\nXi; N\nR: 36-43-51/53\nS: (2-)24-26-37-61\n\n\n\n\n613-187-00-4\n5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene\n410-530-8\n-\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-188-00-X\n1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone\n411-500-7\n116256-11-2\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)22-24-26-37/39-61\n\n\n613-189-00-5\n1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane\n414-030-0\n52667-88-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-190-00-0\ndisodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate\n414-040-5\n149530-93-8\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)22-24-37\n\n\n613-191-00-6\n3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine\n421-150-7\n143860-04-2\nRepr. Cat. 2; R60\nC; R34\nN; R50-53\nT; N\nR: 60-34-50/53\nS: 53-45-60-61\n\n\n\n\n613-192-00-1\n3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane\n426-750-2\n151860-15-0\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n613-193-00-7\npentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate\n414-930-3\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-194-00-2\n6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt\n418-000-8\n163062-28-0\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n613-195-00-8\n2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)\n418-280-1\n18600-59-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n613-196-00-3\n5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt\n418-380-5\n168113-78-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-197-00-9\nreaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;\n2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;\n[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;\n[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine\n420-390-1\n187547-46-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n\n613-198-00-4\n2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine\n415-500-8\n145963-84-4\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n613-199-00-X\nreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;\nreaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione\n421-550-1\n—\nCarc. Cat. 2; R45\nRepr. Cat. 2; R61\nR43\nR52-53\nT\nR: 45-61-43-52/53\nS: 53-45-61\n\n\n613-200-00-3\nReaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts\n420-980-7\n—\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n613-201-00-9\n(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole\n422-390-5\n143322-57-0\nRepr. Cat. 3; R62\nT; R39-48/25\nXn; R20/22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 20/22-39-41-43-48/25-62-50/53\nS: (1/2-)53-45-60-61\n\n\n613-202-00-4\npymetrozine (ISO);\n(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one\n—\n123312-89-0\nCarc. Cat. 3; R40\nR52-53\nXn\nR: 40-52/53\nS: (2-)36/37-61\n\n\n\n\n\n613-203-00-X\npyraflufen-ethyl (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]\npyraflufen (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]\n- [1]\n- [2]\n129630-19-9 [1]\n129630-17-7 [2]\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-204-00-5\noxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;\n5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one\n254-637-6\n39807-15-3\nRepr. Cat. 3; R63\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-205-00-0\npropiconazole (ISO);\n(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole\n262-104-4\n60207-90-1\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-46-60-61\n\n\n613-206-00-6\nfenamidone (ISO);\n(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one\n—\n161326-34-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-208-00-7\nimazamox (ISO);\n(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid\n—\n114311-32-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-209-00-2\ncis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride\n417-430-3\n63645-17-0\nT; R25\nXn; R48/22\nR43\nN; R51-53\nT; N\nR: 25-43-48/22-51/53\nS: (1/2-)22-36/37-45-61\n\n\n613-210-00-8\n2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane\n417-650-1\n88128-57-8\nXn; R48/22\nR52-53\nXn\nR: 48/22-52/53\nS: (2-)23-25-36-61\n\n\n613-211-00-3\nN-methyl-4-(p-formylstyryl)pyridinium methylsulfate\n418-240-3\n74401-04-0\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n613-212-00-9\n4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)\n418-320-8\n133467-41-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-60-61\n\n\n613-213-00-4\ncis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline\n416-040-0\n120807-02-5\nR52-53\nR: 52/53\nS: 61\n\n\n613-214-00-X\nN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide\n416-260-7\n147613-95-4\nR53\nR: 53\nS: 61\n\n\n613-215-00-5\n2-chloromethyl-3,4-dimethoxypyridinium chloride\n416-440-5\n72830-09-2\nXn; R21/22-48/22\nXi; R38-41\nR43\nN; R51-53\nXn; N\nR: 21/22-38-41-43-48/22-51/53\nS: (2-)26-36/37/39-61\n\n\n613-216-00-0\n6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole\n416-490-8\n162208-01-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-217-00-6\n4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine\n416-770-1\n73754-27-5\nR53\nR: 53\nS: 61\n\n\n613-218-00-1\n6-hydroxyindole\n417-020-4\n2380-86-1\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-219-00-7\n7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole\n417-140-7\n79185-77-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n613-220-00-2\ntrans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide\n417-290-3\n147086-81-5\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n613-221-00-8\n2-chloro-5-methyl-pyridine\n418-050-0\n18368-64-4\nXn; R21/22\nXi; R38\nR52-53\nXn\nR: 21/22-38-52/53\nS: (2-)23-25-36/37-61\n\n\n613-222-00-3\n4-(1-oxo-2-propenyl)-morpholine\n418-140-1\n5117-12-4\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)23-26-36/37/39\n\n\n613-223-00-9\nN-isopropyl-3-(4-fluorophenyl)-1H-indole\n418-790-4\n93957-49-4\nR53\nR: 53\nS: 61\n\n\n613-224-00-4\n2,5-dimercaptomethyl-1,4-dithiane\n419-770-8\n136122-15-1\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n613-225-00-X\nreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;\n2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.\n421-290-9\n—\nXn; R48/22\nR53\nXn\nR: 48/22-53\nS: (2-)22-36-61\n\n\n613-226-00-5\n1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride\n420-950-3\n163831-67-2\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n613-227-00-0\n(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-600-2\n99199-90-3\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-28-36/37-61\n\n\n613-228-00-6\n(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-630-6\n793669-26-8\nN; R51-53\nN\nR: 51/53\nS: 24-61\n\n\n\n\n613-229-00-1\n1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine\n411-930-5\n106917-31-1\nXi; R38\nR43\nN; R50-53\nXi; N\nR: 38-43-50/53\nS: (2-)24-37-60-61\n\n\n\n613-230-00-7\nflorasulam (ISO);\n2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];\npyrimidine-2-sulfonanilide\n—\n145701-23-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n613-231-00-2\n2,6-diamino-3-((pyridine-3-yl)azo)pyridine\n421-430-9\n28365-08-4\nXn; R22-48/22\nN; R51-53\nXn; N\nR: 22-48/22-51/53\nS: (2-)22-36-61\n\n\n\n613-232-00-8\n3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide\n431-030-6\n163269-30-5\nT; R23\nXn; R48/22\nXi; R41\nN; R50-53\nT; N\nR: 23-41-48/22-50/53\nS: (1/2-)26-36/39-45-57-60-61\n\n\n\n613-233-00-3\n4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane\n423-230-7\n56552-15-9\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n\n613-234-00-9\nimidazo[1,2-b]pyridazin hydrochloride\n431-510-5\n18087-70-2\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)26\n\n\n\n613-235-00-4\n2,3-dihydro-2,2-dimethyl-1H-perimidine\n424-060-6\n6364-17-6\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)28-36/37-60-61\n\n\n\n613-236-00-X\n2-chloro-3-trifluoromethylpyridine\n424-520-6\n65753-47-1\nT; R24/25-48/25\nC; R34\nR52-53\nT\nR: 24/25-34-48/25-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n\n613-237-00-5\n6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine\n424-950-4\n133949-92-5\nR53\nR: 53\nS: 61\n\n\n\n613-238-00-0\nsodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate\n430-890-1\n81992-66-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)22-24-37-60-61\n\n\n\n613-239-00-6\n2-[3-(methylamino)propyl]-1H-benzimidazole\n425-760-4\n64137-52-6\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n\n613-241-00-7\n3-(2H-tetrazol-5-yl)pyridine\n426-810-8\n3250-74-6\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-242-00-2\nreaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts\n426-860-0\n191877-09-5\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-243-00-8\n4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)\n427-350-0\n182235-14-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-244-00-3\n5,7-dichloro-4-hydroxyquinoline\n427-420-0\n21873-52-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-245-00-9\n2-fluoro-6-trifluoromethylpyridine\n428-100-3\n94239-04-0\nR10\nXn; R20/22\nR52-53\nXn\nR: 10-20/22-52/53\nS: (2-)16-61\n\n\n\n613-246-00-4\n2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine\n428-200-7\n103577-66-8\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-247-00-X\n3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole\n428-910-7\n107786-36-7\nR53\nR: 53\nS: 61\n\n\n\n613-248-00-5\n3,4-dimethyl-1H-pyrazole\n429-130-1\n2820-37-3\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)26-39-61\n\n\n\n613-249-00-0\n1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate\n429-300-3\n155601-30-2\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n\n613-250-00-6\nreaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;\nmethyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;\n2-isopropyl-N-hydroxyethyl 1,3-oxazolidine\n429-990-6\n-\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n\n613-251-00-1\n(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole\n430-560-5\n180637-89-2\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)26-36/37/39\n\n\n\n613-253-00-2\n2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;\nreaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)\n430-580-4\n-\nR19\nXi; R38\nN; R51-53\nXi; N\nR: 19-38-51/53\nS: (2-)37-61\n\n\n\n613-254-00-8\nforchlorfenuron (ISO);\n1-(2-chloro-4-pyridyl)-3-phenylurea\n-\n68157-60-8\nCarc. Cat. 3; R40\nN; R51-53\nXn; N\nR: 40-51/53\nS: (2-)36/37-46-61\n\n\n\n613-255-00-3\nreaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)\n424-270-8\n-\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n613-256-00-9\n3'5'-anhydro thymidine\n425-810-5\n38313-48-3\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-257-00-4\n2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate\n426-400-9\n170222-39-6\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n613-258-00-X\nreaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;\n4-chloro-5-methylbenzotriazole sodium salt;\n5-chloro-4-methylbenzotriazole sodium salt\n427-730-6\n202420-04-0\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n\n613-259-00-5\nreaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;\n[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate\n428-790-6\n72963-72-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n\n613-260-00-0\n(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin\n430-730-9\n-\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)22-26-39-60-61\n\n\n\n613-261-00-6\npyrazole-1-carboxamidine monohydrochloride\n429-520-1\n4023-02-3\nXn; R22-48/22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-48/22-52/53\nS: (2-)22-26-36/37/39-61\n\n\n\n613-262-00-1\ndisodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene\n427-310-2\n180850-95-7\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n613-263-00-7\nmonosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate\n429-570-2\n-\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-266-00-3\n2-chloro-5-chloromethylthiazole\n429-830-5\n105827-91-6\nT; R24\nC; R34\nXn; R22\nR43\nN; R51-53\nT; N\nR: 22-24-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n613-267-00-9\nthiamethoxam (ISO);\n3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine\n428-650-4\n153719-23-4\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-268-00-4\n(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine\n425-930-8\n151213-39-7\nC; R34\nXn; R20/22-48/22\nN; R51-53\nC; N\nR: 20/22-34-48/22-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n613-269-00-X\n2-thiazolidinylidenecyanamide\n427-720-1\n26364-65-8\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n613-270-00-5\n5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide\n428-150-6\n113171-13-4\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-271-00-0\ntritosulfuron (ISO) (containing ≤ 0,02 % AMTT);\n1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)\n-\n142469-14-5\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-272-00-6\npyraclostrobin (ISO);\nmethyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate\n-\n-\nT; R23\nXi; R38\nN; R50-53\nT; N\nR: 23-38-50/53\nS: (1/2-)45-60-61-63\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-273-00-1\ntetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine\n427-600-9\n192439-46-6\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-274-00-7\n2,6-dichloro-1-fluoropyridiniumtetrafluoroborate\n427-400-1\n140623-89-8\nC; R34\nXn; R22\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n613-275-00-2\n3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride\n424-530-0\n93076-03-0\nT; R25\nXn; R68/21-48/22\nXi; R41\nR43\nN; R51-53\nT; N\nR: 25-41-43-48/22-68/21-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n613-276-00-8\n1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one\n426-110-2\n98377-35-6\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24/25-37-61\n\n\n\n613-277-00-3\n(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one\n427-070-9\n-\nR53\nR: 53\nS: 61\n\n\n\n613-278-00-9\n(3-aminophenyl)pyridin-3-ylmethanone\n428-230-0\n79568-06-2\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-279-00-4\n2-ethyl-2,3-dihydro-2-methyl-1H-perimidine\n424-380-6\n43057-68-7\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)36/37-60-61\n\n\n\n613-280-00-X\ntetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;\ndimethyl propyleneurea\n230-625-6\n7226-23-5\nRepr. Cat. 3; R62\nXn; R22\nXi; R41\nXn\nR: 22-41-62\nS: 26-36/37/39\n\n\n\n613-281-00-5\nquinoline\n202-051-6\n91-22-5\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R21/22\nXi; R36/38\nN; R51-53\nT; N\nR: 45-21/22-36/38-68-51/53\nS: 53-45-61\n\nE\n\n613-282-00-0\ntriticonazole (ISO);\n(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol\n-\n131983-72-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-283-00-6\nketoconazole;\n1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone\n265-667-4\n65277-42-1\nRepr. Cat. 2; R60\nT; R25\nXn; R48/22\nN; R50-53\nT; N\nR: 60-25-48/22-50/53\nS: 53-45-60-61\n\nE\n\n613-284-00-1\nmetconazole (ISO);\n(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol\n-\n125116-23-6\nRepr. Cat. 3; R63\nXn; R22\nN; R51-53\nXn; N\nR: 22-63-51/53\nS: (2-)36/37-46-61\n\n\n\n613-285-00-7\n1-hydroxybenzotriazole, anhydrous; [1]\n1-hydroxybenzotriazole, monohydrated [2]\n219-989-7 [1]\n219-989-7 [2]\n2592-95-2 [1]\n123333-53-9 [2]\nE; R2\nE\nR: 2\nS: 16-35\n\n\n\n613-286-00-2\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]\n418-260-2\n183196-57-8\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-286-01-X\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]\n418-260-2\n183196-57-8\nRepr. Cat. 2; R61\nR43\nT\nR: 61-43\nS: 53-45\n\n\n\n613-287-00-8\n1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole\n419-540-7\n160194-26-3\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n\n613-288-00-3\n1,3-bis(dimethylcarbamoyl)-imidazolium chloride\n420-930-4\n135756-61-5\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-37/39-61\n\n\n\n613-289-00-9\n3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole\n432-020-4\n142623-48-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n613-290-00-4\n4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride\n432-470-1\n189012-93-9\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)24-26-37/39-60-61\n\n\n\n613-291-00-X\n2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one\n434-820-9\n106461-41-0\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-292-00-5\nN,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine\n435-010-8\n26157-73-3\nMuta. Cat. 3; R68\nR52-53\nXn\nR: 68-52/53\nS: (2-)36/37-61\n\n\n\n613-293-00-0\n2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester\n448-050-6\n444065-11-6\nR53\nR: 53\nS: 61\n\n\n\n613-294-00-6\n2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester\n448-260-8\n379268-96-9\nR53\nR: 53\nS: 61\n\n\n\n613-295-00-1\n11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride\n448-720-8\n363138-44-7\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n\n613-296-00-7\npentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate\n418-270-7\n-\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-47-61\n\n\n\n613-297-00-2\n5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole\n420-820-6\n-\nR10\nXn; R22\nN; R51-53\nXn; N\nR: 10-22-51/53\nS: (2-)16-61\n\n\n\n613-298-00-8\nbis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate\n421-560-6\n-\nXn; R48/22\nXi; R41\nN; R51-53\nXn; N\nR: 41-48/22-51/53\nS: (2-)22-26-36/39-61\n\n\n\n613-299-00-3\nmain component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt\n422-610-1\n-\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-300-00-7\n1-imidazol-1-yl-octadecan-2-ol\n434-120-3\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n613-301-00-2\ndimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate\n443-910-7\n-\nR53\nR: 53\nS: 61\n\n\n\n613-302-00-8\ndisodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate\n432-980-4\n243858-60-8\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-303-00-3\n2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine\n429-800-1\n95737-68-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n613-304-00-9\n5,6-dihydroxy-2,3-dihydro-1H-indolium bromide\n421-170-6\n138937-28-7\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)22-26-39\n\n\n\n613-305-00-4\n2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole\n448-630-9\n3147-77-1\nR53\nR: 53\nS: 61\n\n\n\n613-306-00-X\n(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate\n433-520-5\n82911-69-1\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n\n613-307-00-5\nclothianidin (ISO);\n3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine\n-\n210880-92-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-308-00-0\n2-amino-5-methylthiazole\n423-800-5\n7305-71-7\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-309-00-6\n1-methyl-3-phenyl-1-piperazine\n431-180-2\n5271-27-2\nXn; R21/22\nXi; R38-41\nR52-53\nXn\nR: 21/22-38-41-52/53\nS: (2-)26-36/37/39-61\n\n\n\n613-310-00-1\n(–)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride\n432-360-3\n105813-13-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n\n613-311-00-7\nmethyl-5-nitrophenyl-guanidine\n435-500-1\n152460-07-6\nXn; R22\nXi; R36\nR43\nR52-53\nXn\nR: 22-36-43-52/53\nS: (2-)22-24-26-37-61\n\n\n\n613-312-00-2\n2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride\n420-200-5\n-\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)22-26-36/37/39-61\n\n\n\n613-313-00-8\n2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione\n442-780-9\n173838-67-0\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-314-00-3\n4-decyloxazolidin-2-one;\n4-decyl-1,3-oxazolidin-2-one\n443-770-7\n7693-82-5\nN; R50-53\nN\nR: 50/53\nS: 22-24-60-61\n\n\n\n613-315-00-9\ntetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate\n430-390-1\n-\nXn; R20\nR52-53\nXn\nR: 20-52/53\nS: (2-)25-61\n\n\n\n613-316-00-4\ntrimethylopropane tri(3-aziridinylpropanoate);\n(TAZ)\n257-765-0\n52234-82-9\nMuta. Cat. 3; R68\nXi; R41\nR43\nXn\nR: 41-43-68\nS: 26-36/37/39-42\n\nH\n\n\n614-001-00-4\nnicotine (ISO);\n3-(N-methyl-2-pyrrolidinyl)pyridine\n200-193-3\n54-11-5\nT+; R27\nT; R25\nN; R51-53\nT+; N\nR: 25-27-51/53\nS: (1/2-)36/37-45-61\n\n\n614-002-00-X\nsalts of nicotine\n—\n—\nT+; R26/27/28\nN; R51-53\nT+; N\nR: 26/27/28-51/53\nS: (1/2-)13-28-45-61\n\nA\n614-003-00-5\nstrychnine\n200-319-7\n57-24-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n614-004-00-0\nsalts of strychnine\n—\n—\nT+; R26/28\nN; R50-53\nT+; N\nR: 26/28-50/53\nS: (1/2-)13-28-45-60-61\n\nA\n\n\n614-005-00-6\ncolchicine\n200-598-5\n64-86-8\nMuta. Cat. 2; R46\nT+; R28\nT+\nR: 46-28\nS: 53-45\n\nE\n\n614-006-00-1\nbrucine;\n2,3-dimethoxystrychnine\n206-614-7\n357-57-3\nT+; R26/28\nR52-53\nT+\nR: 26/28-52/53\nS: (1/2-)13-45-61\n\n\n614-007-00-7\nbrucine sulphate; [1]\nbrucine nitrate; [2]\nStrychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]\nStrychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]\n225-432-9 [1]\n227-317-9 [2]\n269-439-5 [3]\n269-710-8 [4]\n4845-99-2 [1]\n5786-97-0 [2]\n68239-26-9 [3]\n68310-42-9 [4]\nT+; R26/28\nR52-53\nT+\nR: 26/28-52/53\nS: (1/2-)13-45-61\n\nA\n614-008-00-2\naconitine\n206-121-7\n302-27-2\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\n\n614-009-00-8\nsalts of aconitine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\nA\n614-010-00-3\natropine\n200-104-8\n51-55-8\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-011-00-9\nsalts of atropine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-012-00-4\nhyoscyamine\n202-933-0\n101-31-5\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\n\n614-013-00-X\nsalts of hyoscyamine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\nA\n614-014-00-5\nhyoscine\n200-090-3\n51-34-3\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)25-45\n\n\n614-015-00-0\nsalts of hyoscine\n—\n—\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)25-45\n\nA\n614-016-00-6\npilocarpine\n202-128-4\n92-13-7\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-017-00-1\nsalts of pilocarpine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-018-00-7\npapaverine\n200-397-2\n58-74-2\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n614-019-00-2\nsalts of papaverine\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)22\n\nA\n614-020-00-8\nphysostigmine\n200-332-8\n57-47-6\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-021-00-3\nsalts of physostigmine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-022-00-9\ndigitoxin\n200-760-5\n71-63-6\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-023-00-4\nephedrine\n206-080-5\n299-42-3\nXn; R22\nXn\nR: 22\nS: (2-)22-25\n\n\n614-024-00-X\nsalts of ephedrine\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)22-25\n\nA\n614-025-00-5\nouabain\n211-139-3\n630-60-4\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-026-00-0\nstrophantin-K\n234-239-9\n11005-63-3\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-027-00-6\nbufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;\nred squill;\nscilliroside\n208-077-4\n507-60-8\nT+; R28\nT+\nR: 28\nS: (1/2-)36/37-45\n\n\n614-028-00-1\nreaction mass of: 2-ethylhexyl mono-D-glucopyranoside;\n2-ethylhexyl di-D-glucopyranoside\n414-420-0\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n614-029-00-7\nconstitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside\n419-640-0\n68784-14-5\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n\n\n615-001-00-7\nmethyl isocyanate\n210-866-3\n624-83-9\nF; R11\nRepr. Cat. 3; R63\nT+; R26\nT; R24/25\nR42/43\nXi; R37/38-41\nF; T+\nR: 11-24/25-26-37/38-41-42/43-63\nS: (1/2-)16-26-27/28-36/37/39-45-63\n\n\n\n615-002-00-2\nmethyl isothiocyanate\n209-132-5\n556-61-6\nT; R23/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 23/25-34-43-50/53\nS: (1/2-)36/37-38-45-60-61\n\n\n615-003-00-8\nthiocyanic acid\n207-337-4\n463-56-9\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-61\n\n\n\n\n615-004-00-3\nsalts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-36/37-46-61\n\nA\n\n615-005-00-9\n4,4'-methylenediphenyl diisocyanate;\ndiphenylmethane-4,4'-diisocyanate; [1]\n2,2'-methylenediphenyl diisocyanate;\ndiphenylmethane-2,2'-diisocyanate; [2]\no-(p-isocyanatobenzyl)phenyl isocyanate;\ndiphenylmethane-2,4'-diisocyanate; [3]\nmethylenediphenyl diisocyanate [4]\n202-966-0 [1]\n219-799-4 [2]\n227-534-9 [3]\n247-714-0 [4]\n101-68-8 [1]\n2536-05-2 [2]\n5873-54-1 [3]\n26447-40-5 [4]\nCarc. Cat. 3; R40\nXn; R20-48/20\nXi; R36/37/38\nR42/43\nXn\nR: 20-36/37/38-40-42/43-48/20\nS: (1/2-)23-36/37-45\nXi; R36/37/38: C ≥ 5 %\nR42: C ≥ 0,1 %\nC2\n\n\n615-006-00-4\n2-methyl-m-phenylene diisocyanate;\ntoluene-2,4-di-isocyanate; [1]\n4-methyl-m-phenylene diisocyanate;\ntoluene-2,6-di-isocyanate; [2]\nm-tolylidene diisocyanate;\ntoluene-diisocyanate [3]\n202-039-0 [1]\n209-544-5 [2]\n247-722-4 [3]\n91-08-7 [1]\n584-84-9 [2]\n26471-62-5 [3]\nCarc. Cat. 3; R40\nT+; R26\nXi; R36/37/38\nR42/43\nR52-53\nT+\nR: 26-36/37/38-40-42/43-52/53\nS: (1/2-)23-36/37-45-61\nR42: C ≥ 0,1 %\nC2\n615-007-00-X\n1,5-naphthylene diisocyanate\n221-641-4\n3173-72-6\nXn; R20\nXi; R36/37/38\nR42\nR52-53\nXn\nR: 20-36/37/38-42-52/53\nS: (2-)26-28-38-45-61\n\n\n615-008-00-5\n3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;\nisophorone di-isocyanate\n223-861-6\n4098-71-9\nT; R23\nXi; R36/37/38\nR42/43\nN; R51-53\nT; N\nR: 23-36/37/38-42/43-51/53\nS: (1/2-)26-28-38-45-61\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-009-00-0\n4,4'-methylenedi(cyclohexyl isocyanate);\ndicyclohexylmethane-4,4'-di-isocyanate\n225-863-2\n5124-30-1\nT; R23\nXi; R36/37/38\nR42/43\nT\nR: 23-36/37/38-42/43\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-010-00-6\n2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]\n2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]\n241-001-8 [1]\n239-714-4 [2]\n16938-22-0 [1]\n15646-96-5 [2]\nT; R23\nXi; R36/37/38\nR42\nT\nR: 23-36/37/38-42\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42: C ≥ 0,5 %\nC2\n615-011-00-1\nhexamethylene-di-isocyanate\n212-485-8\n822-06-0\nT; R23\nXi; R36/37/38\nR42/43\nT\nR: 23-36/37/38-42/43\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-012-00-7\n4-isocyanatosulphonyltoluene;\ntosyl isocyanate\n223-810-8\n4083-64-1\nR14\nXi; R36/37/38\nR42\nXn\nR: 14-36/37/38-42\nS: (2-)26-28-30\nXi; R36/37/38: C ≥ 5 %\n\n615-013-00-2\ncyanamide;\ncarbanonitril\n206-992-3\n420-04-2\nT; R25\nXn; R21\nXi; R36/38\nR43\nT\nR: 21-25-36/38-43\nS: (1/2-)3-22-36/37-45\n\n\n615-014-00-8\ntris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate\n—\n7276-58-6\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n615-015-00-3\n1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;\nisobornyl thiocyanoacetate\n204-081-5\n115-31-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24/25-60-61\n\n\n615-016-00-9\npotassium cyanate\n209-676-3\n590-28-3\nXn; R22\nXn\nR: 22\nS: (2-)24/25\n\n\n615-017-00-4\ncalcium cyanamide\n205-861-8\n156-62-7\nXn; R22\nXi; R37-41\nXn\nR: 22-37-41\nS: (2-)22-26-36/37/39\n\n\n615-018-00-X\n2-(2-butoxyethoxy)ethyl thiocyanate\n203-985-7\n112-56-1\nR10\nT; R24/25\nT\nR: 10-24/25\nS: (1/2-)13-36/37-45\n\n\n615-019-00-5\ndicyclohexylcarbodiimide\n208-704-1\n538-75-0\nT; R24\nXn; R22\nXi; R41\nR43\nT\nR: 22-24-41-43\nS: (1/2-)24-26-37/39-45\n\n\n615-020-00-0\nmethylene dithiocyanate\n228-652-3\n6317-18-6\nT+; R26\nT; R25\nC; R34\nR43\nN; R50\nT+; N\nR: 25-26-34-43-50\nS: (1/2-)26-28-36/37/39-45-61\n\n\n615-021-00-6\n1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;\nTGIC\n219-514-3\n2451-62-9\nMuta. Cat. 2; R46\nT; R23/25\nXn; R48/22\nXi; R41\nR43\nR52-53\nT\nR: 46-23/25-41-43-48/22-52/53\nS: 53-45-61\n\nE\n\n\n615-022-00-1\nmethyl 3-isocyanatosulfonyl-2-thiophene-carboxylate\n410-550-7\n79277-18-2\nR14\nXn; R48/22\nR42/43\nXn\nR: 14-42/43-48/22\nS: (2-)22-30-35-36/37-45\n\n\n\n615-023-00-7\n2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;\n(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate\n410-900-9\n83056-32-0\nR10\nR14\nMuta. Cat. 3; R68\nXn; R20-48/22\nXi; R41\nR42\nXn\nR: 10-14-20-41-42-48/22-68\nS: (2-)23-26-36/37/39\n\n\n615-024-00-2\n2-phenylethylisocyanate\n413-080-0\n1943-82-4\nT; R23\nXn; R22\nC; R35\nR42/43\nN; R51-53\nT; C; N\nR: 22-23-35-42/43-51/53\nS: (1/2-)23-26-36/37/39-43-45-61\n\n\n615-025-00-8\n4,4'-ethylidenediphenyl dicyanate\n405-740-1\n47073-92-7\nXn; R20/22-48/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n615-026-00-3\n4,4'-methylenebis(2,6-dimethylphenyl cyanate)\n405-790-4\n101657-77-6\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n\n\n\n615-028-00-4\nethyl 2-(isocyanatosulfonyl)benzoate\n410-220-2\n77375-79-2\nR14\nXn; R22-48/22\nXi; R41\nR42/43\nXn\nR: 14-22-41-42/43-48/22\nS: (2-)8-23-26-30-35-36/37/39\n\n\n\n615-029-00-X\n2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane\n411-280-2\n—\nT+; R26\nXn; R22\nC; R34\nR42/43\nR52-53\nT+\nR: 22-26-34-42/43-52/53\nS: (1/2-)23-26-28-36/37/39-45-61\n\n\n\n\n615-030-00-5\nalkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-36/37-46-61\n\nA\n\n615-031-00-0\nthallium thiocyanate\n222-571-7\n3535-84-0\nT+; R26/28\nXn; R21\nR32\nR33\nN; R51-53\nT+; N\nR: 21-26/28-32-33-51/53\nS: (1/2-)13-28-36/37-45-61\n\n\n\n615-032-00-6\nmetal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nN; R50-53\nXn; N\nR: 20/21/22-32-50/53\nS: (2-)13-36/37-46-60-61\n\nA\n\n\n\n615-033-00-1\nreaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)\n430-980-9\n-\nR53\nR: 53\nS: 61\n\n\n\n615-034-00-7\nreaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)\n430-750-8\n-\nR53\nR: 53\nS: 61\n\n\n\n615-035-00-2\nreaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)\n430-930-6\n122886-55-9\nR53\nR: 53\nS: 61\n\n\n\n615-036-00-8\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)\n430-940-0\n-\nR53\nR: 53\nS: 61\n\n\n\n615-037-00-3\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)\n430-950-5\n-\nR53\nR: 53\nS: 61\n\n\n\n615-038-00-9\nreaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)\n430-960-1\n-\nR53\nR: 53\nS: 61\n\n\n\n615-039-00-4\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)\n430-970-4\n-\nR53\nR: 53\nS: 61\n\n\n\n615-044-00-1\n4-chlorophenylisocyanate\n203-176-9\n104-12-1\nT+; R26\nXn; R22\nXi; R37/38-41\nR42\nN; R50-53\nT+; N\nR: 22-26-37/38-41-42-50/53\nS: (1/2-)26-28-36/37/39-45-63-60-61\n\n\n\n615-045-00-7\n4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)\n420-530-1\n-\nR42/43\nR53\nXn\nR: 42/43-53\nS: (2-)23-24-37-45-61\n\n\n\n616-001-00-X\nN,N-dimethylformamide;\ndimethyl formamide\n200-679-5\n68-12-2\nRepr. Cat. 2; R61\nXn; R20/21\nXi; R36\nT\nR: 61-20/21-36\nS: 53-45\n\nE\n616-002-00-5\n2-fluoroacetamide\n211-363-1\n640-19-7\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)36/37-45\n\n\n616-003-00-0\nacrylamide;\nprop-2-enamide\n201-173-7\n79-06-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT; R25-48/23/24/25\nXn; R20/21\nXi; R36/38\nR43\nT\nR: 45-46-20/21-25-36/38-43-48/23/24/25-62\nS: 53-45\n\nDE\n616-004-00-6\nallidochlor (ISO);\nN,N-diallylchloroacetamide\n202-270-7\n93-71-0\nXn; R21/22\nXi; R36/38\nN; R51-53\nXn; N\nR: 21/22-36/38-51/53\nS: (2-)26-28-36/37/39-61\n\n\n616-005-00-1\nchlorthiamid (ISO);\n2,6-dichloro (thiobenzamide)\n217-637-7\n1918-13-4\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n\n\n616-006-00-7\ndichlofluanid (ISO);\nN-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide\n214-118-7\n1085-98-9\nXn; R20\nXi; R36\nR43\nN; R50\nXn; N\nR: 20-36-43-50\nS: (2-)24-37-61\nN; R50: C ≥ 2,5 %\n\n\n616-007-00-2\ndiphenamid (ISO);\nN,N-dimethyl-2,2-diphenylacetamide\n213-482-4\n957-51-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n616-008-00-8\npropachlor (ISO);\n2-chloro-N-isopropylacetanilide;\nα-chloro-N-isopropylacetanilide\n217-638-2\n1918-16-7\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n616-009-00-3\npropanil (ISO);\n3', 4'-dichloropropionanilide\n211-914-6\n709-98-8\nXn; R22\nN; R50\nXn; N\nR: 22-50\nS: (2-)22-61\nN; R50: C ≥ 2,5 %\n\n\n\n616-010-00-9\ntosylchloramide sodium\n204-854-7\n127-65-1\nXn; R22\nR31\nC; R34\nR42\nC\nR: 22-31-34-42\nS: (1/2-)7-22-26-36/37/39-45\n\n\n616-011-00-4\nN,N-dimethylacetamide\n204-826-4\n127-19-5\nRepr. Cat. 2; R61\nXn; R20/21\nT\nR: 61-20/21\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 5 %\nE\n616-012-00-X\nN-(dichlorofluoromethylthio)phthalimide;\nN-(fluorodichloromethylthio)phthalimide\n211-952-3\n719-96-0\nXi; R38\nXi\nR: 38\nS: (2-)28\n\n\n616-013-00-5\nbutyraldehyde oxime\n203-792-8\n110-69-0\nT; R24\nXn; R22\nXi; R36\nT\nR: 22-24-36\nS: (1/2-)23-36-45\n\n\n616-014-00-0\n2-butanone oxime;\nethyl methyl ketoxime;\nethyl methyl ketone oxime\n202-496-6\n96-29-7\nCarc. Cat. 3; R40\nXn; R21\nXi; R41\nR43\nXn\nR: 21-40-41-43\nS: (2-)13-23-26-36/37/39\n\n\n616-015-00-6\nalachlor (ISO);\n2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide\n240-110-8\n15972-60-8\nCarc. Cat. 3; R40\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-40-43-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,2,5 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n616-016-00-1\n1-(3,4-dichlorophenylimino) thiosemicarbazide\n—\n5836-73-7\nT+; R28\nT+\nR: 28\nS: (1/2-)22-36/37-45\n\n\n616-017-00-7\ncartap hydrochloride\n239-309-2\n15263-52-2\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n616-018-00-2\nN,N-diethyl-m-toluamide;\ndeet\n205-149-7\n134-62-3\nXn; R22\nXi; R36/38\nR52-53\nXn\nR: 22-36/38-52/53\nS: (2-)61\n\n\n616-019-00-8\nperfluidone (ISO);\n1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide\n253-718-3\n37924-13-3\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)\n\n\n616-020-00-3\ntebuthiuron (ISO);\n1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n251-793-7\n34014-18-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)37-60-61\n\n\n616-021-00-9\nthiazafluron (ISO);\n1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea\n246-901-4\n25366-23-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n616-022-00-4\nacetamide\n200-473-5\n60-35-5\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\n\n616-023-00-X\nN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide\n401-980-6\n—\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)24-37\n\n\n616-024-00-5\n2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide\n402-260-4\n54942-74-4\nR53\nR: 53\nS: 61\n\n\n616-025-00-0\nvalinamide\n402-840-7\n20108-78-5\nRepr. Cat. 3; R62\nXi; R36\nR43\nXn\nR: 36-43-62\nS: (2-)26-36/37\n\n\n616-026-00-6\nthioacetamide\n200-541-4\n62-55-5\nCarc. Cat. 2; R45\nXn; R22\nXi; R36/38\nR52-53\nT\nR: 45-22-36/38-52/53\nS: 53-45-61\n\nE\n616-027-00-1\ntris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate\n403-760-5\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-028-00-7\nN-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n403-790-9\n108673-51-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-029-00-2\nN,N'-ethylenebis(vinylsulfonylacetamide)\n404-790-1\n66710-66-5\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)24-26-37/39\n\n\n616-030-00-8\nethidimuron (ISO);\n1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n250-010-6\n30043-49-3\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-031-00-3\ndimethachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide\n256-625-6\n50563-36-5\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n616-032-00-9\ndiflufenican (ISO);\nN-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide\n—\n83164-33-4\nR52-53\nR: 52/53\nS: 61\n\n\n616-033-00-4\ncyprofuram (ISO);\nN-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide\n274-050-9\n69581-33-5\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)36/37-60-61\n\n\n616-034-00-X\npyracarbolid (ISO);\n3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide\n246-419-4\n24691-76-7\nR52-53\nR: 52/53\nS: 61\n\n\n616-035-00-5\ncymoxanil (ISO);\n2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide\n261-043-0\n57966-95-7\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-60-61\n\n\n616-036-00-0\n2-chloracetamide\n201-174-2\n79-07-2\nRepr. Cat. 3; R62\nT; R25\nR43\nT\nR: 25-43-62\nS: (1/2-)22-36/37-45\nR43: C ≥ 0,1 %\n\n616-037-00-6\nacetochlor (ISO);\n2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide\n251-899-3\n34256-82-1\nXn; R20\nXi; R37/38\nR43\nN; R50-53\nXn; N\nR: 20-37/38-43-50/53\nS: (2-)36/37-60-61\n\n\n616-038-00-1\n(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride\n406-010-5\n88918-84-7\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n616-039-00-7\n3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide\n406-200-8\n117827-06-2\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-040-00-2\npotassium N-(4-toluenesulfonyl)-4-toluenesulfonamide\n406-650-5\n97888-41-0\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n616-041-00-8\n3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide\n406-840-8\n101664-25-9\nR53\nR: 53\nS: 61\n\n\n616-042-00-3\nN-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide\n407-070-5\n142859-67-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n616-043-00-9\nisoxaben (ISO);\nN-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide\n407-190-8\n82558-50-7\nR53\nR: 53\nS: 61\n\n\n616-044-00-4\nN-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide\n402-510-2\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-045-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide\n405-190-2\n122371-93-1\nR43\nR53\nXi\nR: 43-53\nS: 2-22-24-37-61\n\n\n616-046-00-5\nN-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n406-390-2\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-047-00-0\nreaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;\n2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide\n406-640-0\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-048-00-6\n3'-trifluoromethylisobutyranilide\n406-740-4\n1939-27-1\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)22-36-61\n\n\n616-049-00-1\n2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide\n408-150-2\n99141-89-6\nR53\nR: 53\nS: 61\n\n\n616-050-00-7\nlufenuron (ISO);\nN-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide\n410-690-9\n103055-07-8\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-051-00-2\nreaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;\n2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene\n411-070-0\n—\nR53\nR: 53\nS: 61\n\n\n616-052-00-8\nformamide\n200-842-0\n75-12-7\nRepr. Cat. 2; R61\nT\nR: 61\nS: 53-45\n\n\n616-053-00-3\nN-methylacetamide\n201-182-6\n79-16-3\nRepr. Cat. 2; R61\nT\nR: 61\nS: 53-45\n\n\n616-054-00-9\niprodione (ISO);\n3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide\n253-178-9\n36734-19-7\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n616-055-00-4\npropyzamide (ISO);\n3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide\n245-951-4\n23950-58-5\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n616-056-00-X\nN-methylformamide\n204-624-6\n123-39-7\nRepr. Cat. 2; R61\nXn; R21\nT\nR: 61-21\nS: 53-45\n\nE\n616-057-00-5\nreaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nN-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nmethacrylamide;\n2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;\nN-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide\n412-790-8\n—\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R48/22\nT\nR: 45-48/22\nS: 53-45\n\nE\n616-058-00-0\n1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene\n412-570-1\n119462-56-5\nXn; R48/22\nXi; R41\nR43\nN; R50-53\nXn; N\nR: 41-43-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n616-059-00-6\n4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide\n412-650-6\n121487-83-0\nR53\nR: 53\nS: 61\n\n\n616-060-00-1\nCondensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)\n413-770-1\n—\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n616-061-00-7\nN,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide\n413-610-0\n124172-53-8\nXi; R36\nR52-53\nXi\nR: 36-52/53\nS: (2-)26-61\n\n\n616-062-00-2\nN-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide\n411-590-8\n70693-57-1\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n616-063-00-8\n3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione\n411-920-0\n106917-30-0\nT; R23\nXn; R22-48/22\nC; R35\nN; R50-53\nT; C; N\nR: 22-23-35-48/22-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n616-064-00-3\nN-tert-butyl-3-methylpicolinamide\n406-720-5\n32998-95-1\nR52-53\nR: 52/53\nS: 61\n\n\n616-065-00-9\n3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea\n411-970-3\n79881-89-3\nXn; R22-48/22\nXn\nR: 22-48/22\nS: (2-)22-36\n\n\n616-066-00-4\n5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone\n405-100-1\n115662-06-1\nRepr. Cat. 3; R62\nXn\nR: 62\nS: (2-)22-36/37\n\n\n616-067-00-X\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate\n407-300-4\n92683-20-0\nR53\nR: 53\nS: 61\n\n\n616-068-00-5\npotassium 4-(11-methacrylamidoundecanamido)benzenesulfonate\n406-500-9\n174393-75-0\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n616-069-00-0\n1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide\n406-210-2\n110560-22-0\nR53\nR: 53\nS: 61\n\n\n616-070-00-6\nreaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;\n3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-530-2\n—\nR53\nR: 53\nS: 22-61\n\n\n616-071-00-1\nreaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;\nbis(N-octadecyl-N'-phenyleneureido)methylene;\nbis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)\n406-550-1\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n616-072-00-7\n1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine\n407-120-6\n55612-11-8\nR53\nR: 53\nS: 61\n\n\n616-073-00-2\n4'-ethoxy-2-benzimidazoleanilide\n407-600-5\n120187-29-3\nMuta. Cat. 3; R68\nR53\nXn\nR: 68-53\nS: (2-)22-36/37-61\n\n\n616-074-00-8\nN-butyl-2-(4-morpholinylcarbonyl)benzamide\n407-730-2\n104958-67-0\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n616-075-00-3\nD,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)\n408-120-9\n65197-96-8\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)26-39-46\n\n\n616-076-00-9\ntebufenozide (ISO);\nN-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide\n412-850-3\n112410-23-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-077-00-4\nreaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;\npotassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate\n411-310-4\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n616-078-00-X\n2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide\n411-330-3\n104541-33-5\nR53\nR: 53\nS: 61\n\n\n616-079-00-5\n1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate\n411-700-4\n140921-24-0\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-080-00-0\n4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)\n411-850-0\n119018-29-0\nR52-53\nR: 52/53\nS: 61\n\n\n616-081-00-6\n5-bromo-8-naphtholactam\n413-480-5\n24856-00-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n616-082-00-1\nN-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide\n413-200-1\n129604-78-0\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-083-00-7\n[2-[(4-nitrophenyl)amino]ethyl]urea\n410-700-1\n27080-42-8\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n616-084-00-2\n2,4-bis[N'-(4-methylphenyl)ureido]toluene\n411-790-5\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-085-00-8\n3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione\n412-190-6\n168900-02-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-086-00-3\n2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene\n412-250-1\n102387-48-4\nR53\nR: 53\nS: 61\n\n\n616-087-00-9\nreaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;\n7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate\n412-260-6\n52658-19-2\nXi; R36\nR43\nN; R51-53\nXi; N\nR: 36-43-51/53\nS: (2-)26-36/37-61\n\n\n616-088-00-4\n2-aminosulfonyl-N,N-dimethylnicotinamide\n413-440-7\n112006-75-4\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n616-089-00-X\n5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran\n415-360-8\n41107-56-6\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)22-36/37\n\n\n616-090-00-5\n1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride\n415-660-9\n70918-74-0\nT; R23/24/25\nXn; R48/22\nN; R51-53\nT; N\nR: 23/24/25-48/22-51/53\nS: 53-45-61\n\n\n616-091-00-0\n1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione\n423-400-0\n59653-74-6\nMuta. Cat. 2; R46\nT; R23\nXn; R22-48/22\nXi; R41\nR43\nT\nR: 46-22-23-41-43-48/22\nS: 53-45\n\nE\n616-092-00-6\nPolymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide\n404-035-6\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-093-00-1\nReaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride\n406-620-1\n129217-90-9\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n616-094-00-7\n3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-370-3\n58890-25-8\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-095-00-2\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-690-3\n43136-14-7\nR53\nR: 53\nS: 61\n\n\n616-096-00-8\nN-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide\n408-110-4\n110483-07-3\nR53\nR: 53\nS: 61\n\n\n616-097-00-3\nN,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide\n411-840-6\n83372-55-8\nR53\nR: 53\nS: 61\n\n\n616-098-00-9\n1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide\n411-750-7\n119126-15-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-099-00-4\n2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide\n414-170-2\n135937-20-1\nR53\nR: 53\nS: 61\n\n\n616-100-00-8\n1,3-dimethyl-1,3-bis(trimethylsilyl)urea\n414-180-7\n10218-17-4\nXn; R22\nXi; R38\nXn\nR: 22-38\nS: (2-)36/37\n\n\n616-101-00-3\n(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide\n414-600-9\n149182-72-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n616-102-00-9\nreaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);\n1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;\n1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]\n415-870-0\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)36/37-61\n\n\n616-103-00-4\n(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide\n415-030-3\n120298-38-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-104-00-X\nbenalaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate\n275-728-7\n71626-11-4\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-105-00-5\nchlorotoluron (ISO);\n3-(3-chloro-p-tolyl)-1,1-dimethylurea\n239-592-2\n15545-48-9\nCarc. Cat. 3; R40\nRepr. Cat. 3; R63\nN; R50-53\nXn; N\nR: 40-63-50/53\nS: (2-)26-36/37-46-60-61\n\n\n616-106-00-0\nphenmedipham (ISO);\nmethyl 3-(3-methylcarbaniloyloxy)carbanilate\n237-199-0\n13684-63-4\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n616-107-00-6\ncinidon ethyl (ISO);\nethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate\n-\n142891-20-1\nCarc. Cat. 3; R40\nR43\nN; R50-53\nXn; N\nR: 40-43-50/53\nS: (2-)24-37-46-60-61\n\n\n\n\n616-108-00-1\niodosulfuron-methyl-sodium;\nsodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide\n—\n144550-36-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-109-00-7\nsulfosulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea\n—\n141776-32-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-110-00-2\ncyclanilide (ISO);\n1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid\n419-150-7\n113136-77-9\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n616-111-00-8\nfenhexamid (ISO);\nN-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid\n422-530-5\n126833-17-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-112-00-3\noxasulfuron (ISO);\noxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate\n—\n144651-06-9\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)46-60-61\n\n\n616-113-00-9\ndesmedipham (ISO);\nethyl 3-phenylcarbamoyloxyphenylcarbamate\n237-198-5\n13684-56-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n616-114-00-4\ndodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-\n418-010-2\n136897-58-0\nR53\nR: 53\nS: 22-61\n\n\n616-115-00-X\nN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide\n416-150-9\n136450-06-1\nR53\nR: 53\nS: 61\n\n\n616-116-00-5\nN-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate\n416-790-9\n143052-96-4\nR53\nR: 53\nS: 61\n\n\n616-117-00-0\nN-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide\n416-860-9\n777891-21-1\nRepr. Cat. 3; R62\nR43\nN; R50-53\nXn; N\nR: 43-62-50/53\nS: (2-)22-36/37-60-61\n\n\n616-118-00-6\nN-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride\n417-950-0\n65797-42-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n616-119-00-1\n2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide\n418-060-5\n118020-93-2\nR53\nR: 53\nS: 61\n\n\n616-120-00-7\nreaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-2-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-3-methyl-phenyl)-benzamide\n420-600-1\n—\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36/37-61\n\n\n616-121-00-2\n2,4-dihydroxy-N-(2-methoxyphenyl)benzamide\n419-090-1\n129205-19-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n\n616-122-00-8\nmethylneodecanamide\n414-460-9\n105726-67-8\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n\n616-123-00-3\nN-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide\n414-740-0\n96141-86-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n\n616-124-00-9\nlithium bis(trifluoromethylsulfonyl)imide\n415-300-0\n90076-65-6\nT; R24/25\nXn; R48/22\nC; R34\nR52-53\nT\nR: 24/25-34-48/22-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n616-125-00-4\n3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide\n415-730-9\n151338-11-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n616-126-00-X\n1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide\n423-960-6\n139756-01-7\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36/37-61\n\n\n\n616-127-00-5\nreaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);\n12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;\nN,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n430-050-2\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n616-128-00-0\nN-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide\n417-530-7\n123590-00-1\nR53\nR: 53\nS: 61\n\n\n616-129-00-6\nN,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide\n419-710-0\n42774-15-2\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22-25-26\n\n\n616-130-00-1\nN-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide\n421-780-2\n150919-56-5\nR53\nR: 53\nS: 61\n\n\n\n\n616-131-00-7\n1-aminocyclopentanecarboxamide\n422-950-9\n17193-28-1\nT; R48/25\nXn; R22\nXi; R41\nT\nR: 22-41-48/25\nS: (1/2-)22-26-36/39-45\n\n\n\n\n616-132-00-2\nN-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide\n423-250-6\n130016-98-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-133-00-8\nN-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide\n423-990-1\n149118-66-1\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)22-26-39-60-61\n\n\n616-134-00-3\n3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide\n401-820-5\n793710-14-2\nR52-53\nR: 52/53\nS: 61\n\n\n616-135-00-9\n(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide\n430-230-0\n136522-17-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n\n\n616-136-00-4\nreaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)\n430-380-7\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n616-137-00-X\n4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane\n401-130-4\n71526-07-3\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-138-00-5\nbenzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide\n431-600-4\n112226-61-6\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-139-00-0\n(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide\n420-380-5\n136465-81-1\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n\n616-140-00-6\nN,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]\n429-380-1\n133336-92-2\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-141-00-1\nzoxamide (ISO);\n(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide\n-\n156052-68-5\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-142-00-7\n1,3-Bis(vinylsulfonylacetamido)propane\n428-350-3\n93629-90-4\nMuta. Cat. 3; R68\nXi; R41\nR43\nR52-53\nXn\nR: 41-43-68-52/53\nS: (2-)22-26-36/37/39-61\n\n\n616-143-00-2\nN,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide\n422-560-9\n149591-38-8\nRepr. Cat. 3; R62\nXi; R36\nR53\nXn\nR: 36-62-53\nS: (2-)26-36/37-61\n\n\n\n\n616-144-00-8\n3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-130-1\n-\nR53\nR: 53\nS: 61\n\n\n\n616-145-00-3\npethoxamide (ISO);\n2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide\n-\n106700-29-2\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 0, 25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n616-146-00-9\nN-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide\n431-330-7\n142776-95-2\nR53\nR: 53\nS: 22-61\n\n\n\n616-147-00-4\n1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide\n424-160-1\n139481-22-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n\n616-148-00-X\nN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide\n424-550-1\n84245-12-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT\nR: 45-46-60-61\nS: 53-45\n\n\n\n616-150-00-0\n(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride\n425-260-6\n-\nXn; R48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n\n616-151-00-6\nN-(2-amino-4,6-dichloropyrimidin-5-yl)formamide\n425-650-6\n171887-03-9\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n\n616-152-00-1\n4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide\n425-850-3\n125971-96-2\nR53\nR: 53\nS: 61\n\n\n\n616-153-00-7\n4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide\n425-860-8\n125971-57-5\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n\n616-154-00-2\n3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-110-0\n-\nR53\nR: 53\nS: 61\n\n\n\n616-155-00-8\nN,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide\n431-040-0\n104560-40-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-156-00-3\n6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide\n430-500-8\n204277-61-2\nR53\nR: 53\nS: 61\n\n\n\n616-157-00-9\n3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride\n427-780-9\n114565-70-7\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)26-39-60-61\n\n\n\n616-158-00-4\nN-[4-cyano-3-trifluoromethylphenyl]methacrylamide\n427-880-2\n90357-53-2\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36-61\n\n\n\n616-160-00-5\n2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]\n429-090-3\n61551-69-7\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)12-15-24-37-61\n\n\n\n616-161-00-0\n2,4-dichloro-5-hydroxyacetanilide\n429-110-0\n67669-19-6\nR52-53\nR: 52/53\nS: 61\n\n\n\n616-162-00-6\nisostearic acid monoisopropanolamide\n431-540-9\n-\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n\n616-163-00-1\n4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]\n430-350-3\n192463-88-0\nR53\nR: 53\nS: 61\n\n\n\n616-164-00-7\ndimoxystrobin (ISO);\n(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide\n-\n149961-52-4\nCarc. Cat. 3; R40\nRepr. Cat. 3; R63\nXn; R20\nN; R50-53\nXn; N\nR: 20-40-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-165-00-2\nbeflubutamid (ISO);\n(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide\n-\n113614-08-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n616-166-00-8\ncyazofamid (ISO);\n4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide\n-\n120116-88-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-167-00-3\nN,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide\n418-290-6\n168612-06-4\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)24-26-37\n\n\n\n616-168-00-9\n1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium\n418-440-0\n136997-71-2\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n\n616-169-00-4\n4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one\n420-220-4\n92771-56-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-170-00-X\n(2R)-2-amino-2-phenylacetamide\n420-370-0\n6485-67-2\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)22-26-36/37\n\n\n\n616-171-00-5\n2-(para-chlorophenyl)glycineamide\n420-830-0\n102333-75-5\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)24-26-37/39\n\n\n\n616-172-00-0\nN-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;\n(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl\n423-840-3\n14691-89-5\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n\n616-174-00-1\n2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride\n424-560-4\n151257-01-1\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22-26\n\n\n\n616-175-00-7\n2-(2-hexyldecyloxy)benzamide\n431-230-3\n202483-62-3\nR53\nR: 53\nS: 61\n\n\n\n616-176-00-2\n3-N,N-bis(methoxyethyl)aminoacetanilide\n432-530-7\n24294-01-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-24-61\n\n\n\n616-177-00-8\n(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;\nN-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide\n432-970-1\n217324-98-6\nR53\nR: 53\nS: 61\n\n\n\n616-178-00-3\nN-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide\n434-500-9\n52583-35-4\nR53\nR: 53\nS: 22-61\n\n\n\n616-179-00-9\n2-chloro-N-(4-methylphenyl)acetamide\n435-170-9\n16634-82-5\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n\n616-180-00-4\nN,N-(dimethylamino)thioacetamide hydrochloride\n435-470-1\n27366-72-9\nRepr. Cat. 2; R61\nN; R50-53\nT; N\nR: 61-50/53\nS: 53-45-60-61\n\n\n\n616-181-00-X\n4'-methyldodecane-1-sulfonanilide\n435-490-9\n17417-32-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-182-00-5\nN'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide\n435-860-1\n214417-91-1\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-183-00-0\nN-dodecyl-4-methoxybenzamide\n442-340-6\n1854-15-5\nR53\nR: 53\nS: 61\n\n\n\n616-184-00-6\n3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide\n442-560-2\n105043-55-8\nR53\nR: 53\nS: 61\n\n\n\n616-186-00-7\nN,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)\n443-010-4\n53641-10-4\nR52-53\nR: 52/53\nS: 61\n\n\n\n616-188-00-8\n2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide\n443-980-9\n221215-20-9\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-189-00-3\nN-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide\n444-780-4\n452962-97-9\nR53\nR: 53\nS: 61\n\n\n\n616-190-00-9\nN-decyl-4-nitrobenzamide\n445-880-0\n64026-19-3\nR53\nR: 53\nS: 61\n\n\n\n616-191-00-4\n2-ethyl-N-methyl-N-(3-methylphenyl)butanamide\n446-190-2\n406488-30-0\nXn; R22\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 22-36/38-43-51/53\nS: (2-)24-26-37-61\n\n\n\n616-192-00-X\n2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide\n448-060-0\n727678-39-9\nR53\nR: 53\nS: 61\n\n\n\n616-193-00-5\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide\n449-940-7\n368450-39-9\nR53\nR: 53\nS: 61\n\n\n\n616-194-00-0\n2,2-diethoxy-N,N-dimethylacetamide\n449-950-1\n34640-92-1\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n\n616-196-00-1\ndisodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide\n419-990-4\n-\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-197-00-7\nreaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;\nN-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide\n422-500-1\n-\nXn; R48/22\nXn\nR: 48/22\nS: (2-)22-36\n\n\n\n616-198-00-2\n1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene\n423-300-7\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-200-00-1\nreaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);\n12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;\nN,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n432-430-3\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-201-00-7\n12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine\n432-840-2\n220926-97-6\nXn; R20\nR53\nXn\nR: 20-53\nS: (2-)22-61\n\n\n\n616-202-00-2\nreaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide\n434-330-5\n-\nCarc. Cat. 3; R40\nR43\nR53\nXn\nR: 40-43-53\nS: (2-)36/37-61\n\n\n\n616-203-00-8\nreaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide\n442-280-0\n-\nR53\nR: 53\nS: 61\n\n\n\n616-204-00-3\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]\n451-060-3\n122886-55-9\nR53\nR: 53\nS: 61\n\n\n\n617-001-00-2\ndi-tert-butyl peroxide\n203-733-6\n110-05-4\nO; R7\nF; R11\nO; F\nR: 7-11\nS: (2-)3/7-14-16-36/37/39\n\n\n617-002-00-8\nα,α-dimethylbenzyl hydroperoxide;\ncumene hydroperoxide\n201-254-7\n80-15-9\nO; R7\nT; R23\nXn; R21/22-48/20/22\nC; R34\nN; R51-53\nO; T; N\nR: 7-21/22-23-34-48/20/22-51/53\nS: (1/2-)3/7-14-36/37/39-45-50-61\nC; R34: C ≥ 10 %\nXi; R37/38-41: 3 % ≤ C < 10 %\nXi; R36/37: 1 % ≤ C < 3 %\n\n617-003-00-3\ndilauroyl peroxide\n203-326-3\n105-74-8\nO; R7\nO\nR: 7\nS: (2-)3/7-14-36/37/39\n\n\n617-004-00-9\n1,2,3,4-tetrahydro-1-naphthyl hydroperoxide\n212-230-0\n771-29-9\nO; R7\nXn; R22\nC; R34\nN; R50-53\nO; C; N\nR: 7-22-34-50/53\nS: (1/2-)3/7-14-26-36/37/39-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n617-006-00-X\nbis(α,α-dimethylbenzyl) peroxide\n201-279-3\n80-43-3\nO; R7\nXi; R36/38\nN; R51-53\nO; Xi; N\nR: 7-36/38-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n617-007-00-5\ntert-butyl α,α-dimethylbenzyl peroxide\n222-389-8\n3457-61-2\nO; R7\nXi; R38\nN; R51-53\nO; Xi; N\nR: 7-38-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n\n\n617-008-00-0\ndibenzoyl peroxide;\nbenzoyl peroxide\n202-327-6\n94-36-0\nE; R3\nO; R7\nXi; R36\nR43\nE; Xi\nR: 3-7-36-43\nS: (2-)3/7-14-36/37/39\n\n\n\n617-010-00-1\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nE; R3\nO; R7\nC; R34\nXn; R22\nE; C\nR: 3-7-22-34\nS: (1/2-)3/7-14-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nC\n\n617-012-00-2\n8-p-menthyl hydroperoxide;\np-menthane hydroperoxide\n201-281-4\n80-47-7\nO; R7\nC; R34\nXn; R20\nO; C\nR: 7-20-34\nS: (1/2-)3/7-14-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n617-013-00-8\nO,O-tert-butyl O-docosyl monoperoxyoxalate\n404-300-6\n116753-76-5\nO; R7\nN; R50-53\nO; N\nR: 7-50/53\nS: (2-)7-14-36/37/39-47-60-61\n\n\n617-014-00-3\n6-(nonylamino)-6-oxo-peroxyhexanoic acid\n406-680-9\n104788-63-8\nO; R7\nXi; R41\nR43\nN; R50\nO; Xi; N\nR: 7-41-43-50\nS: (2-)3/7-14-26-36/37/39-61\n\n\n617-015-00-9\nbis(4-methylbenzoyl)peroxide\n407-950-9\n895-85-2\nE; R2\nO; R7\nN; R50-53\nE; N\nR: 2-7-50/53\nS: (2-)7-14-36/37/39-47-60-61\n\n\n617-016-00-4\n3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate\n413-910-1\n—\nO; R7\nR10\nXi; R38\nN; R50-53\nO; Xi; N\nR: 7-10-38-50/53\nS: (2-)7/47-14-36/37/39-60-61\n\n\n\n\n617-017-00-X\nreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;\n2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene\n412-140-3\n32144-25-5\nE; R2\nO; R7\nR53\nE\nR: 2-7-53\nS: (2-)3/7-14-36/37/39-61\n\nT\n\n617-018-00-5\nreaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;\n1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight\n410-840-3\n71566-50-2\nO; R7\nN; R51-53\nO; N\nR: 7-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n617-019-00-0\n6-(phthalimido)peroxyhexanoic acid\n410-850-8\n128275-31-0\nO; R7\nXi; R41\nN; R50\nO; Xi; N\nR: 7-41-50\nS: (2-)3/7-14-26-36/37/39-61\n\n\n617-020-00-6\n1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)\n420-060-5\n117663-11-3\nR10\nO; R7\nN; R51-53\nO; N\nR: 7-10-51/53\nS: (2-)7-14-36/37/39-47-61\n\n\n\n\n617-021-00-1\nmethylethylketone peroxide trimer\n429-320-2\n-\nE; R2\nO; R7\nXn; R65\nXi; R38\nR43\nE; Xn\nR: 2-7-38-43-65\nS: (2-)3/7-14-23-36/37/39-62\n\n\n\n617-022-00-7\nreaction mass of: 1,2-dimethylpropylidene dihydroperoxide;\ndimethyl 1,2-benzenedicarboxylate\n442-480-8\n-\nO; R7\nXn; R22\nC; R34\nR43\nN; R51-53\nO; C; N\nR: 7-22-34-43-51/53\nS: (1/2-)3/7-14-26-36/37/39-45-50-61\n\n\n\n647-001-00-8\nglucosidase, β-\n232-589-7\n9001-22-3\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-002-00-3\ncellulase\n232-734-4\n9012-54-8\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-003-00-9\ncellobiohydrolase, exo-\n253-465-9\n37329-65-0\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-004-00-4\ncellulases with the exception of those specified elsewhere in this Annex\n—\n—\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\nA\n647-005-00-X\nbromelain, juice\n232-572-4\n9001-00-7\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-006-00-5\nficin\n232-599-1\n9001-33-6\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-007-00-0\npapain\n232-627-2\n9001-73-4\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-008-00-6\npepsin A\n232-629-3\n9001-75-6\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-009-00-1\nrennin\n232-645-0\n9001-98-3\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-010-00-7\ntrypsin\n232-650-8\n9002-07-7\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-011-00-2\nchymotrypsin\n232-671-2\n9004-07-3\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-012-00-8\nsubtilisin\n232-752-2\n9014-01-1\nXi; R37/38-41\nR42\nXn\nR: 37/38-41-42\nS: (2-)22-24-26-36/37/39\n\n\n647-013-00-3\nproteinase, microbial neutral\n232-966-6\n9068-59-1\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-014-00-9\nproteases with the exception of those specified elsewhere in this Annex\n—\n—\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-015-00-4\namylase, α-\n232-565-6\n9000-90-2\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-016-00-X\namylases with the exception of those specified elsewhere in this Annex\n—\n—\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n\n\n647-017-00-5\nlaccase\n420-150-4\n80498-15-3\nR42\nXn\nR: 42\nS: (2-)23-45\n\n\n\n\n648-001-00-0\nDistillates (coal tar), benzole fraction;\nLight Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]\n283-482-7\n84650-02-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-002-00-6\nTar oils, brown-coal;\nLight Oil;\n[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]\n302-674-4\n94114-40-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-003-00-1\nBenzol forerunnings (coal);\nLight Oil Redistillate, low boiling;\n[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]\n266-023-5\n65996-88-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-004-00-7\nDistillates (coal tar), benzole fraction, BTX-rich;\nLight Oil Redistillate, low boiling;\n[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]\n309-984-9\n101896-26-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-005-00-2\nAromatic hydrocarbons, C6-10, C8-rich;\nLight Oil Redistillate, low boiling\n292-697-5\n90989-41-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-006-00-8\nSolvent naphtha (coal), light;\nLight Oil Redistillate, low boiling\n287-498-5\n85536-17-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-007-00-3\nSolvent naphtha (coal), xylene-styrene cut;\nLight Oil Redistillate, intermediate boiling\n287-502-5\n85536-20-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-008-00-9\nSolvent naphtha (coal), coumarone-styrene contg.;\nLight Oil Redistillate, intermediate boiling\n287-500-4\n85536-19-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-009-00-4\nNaphtha (coal), distn. residues;\nLight Oil Redistillate, high boiling;\n[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]\n292-636-2\n90641-12-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-010-00-X\nAromatic hydrocarbons, C8;\nLight Oil Redistillate, high boiling\n292-694-9\n90989-38-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-012-00-0\nAromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;\nLight Oil Redistillate, high boiling;\n[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]\n295-281-1\n91995-20-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-013-00-6\nAromatic hydrocarbons, C9-12, benzene distn.;\nLight Oil Redistillate, high boiling\n295-551-9\n92062-36-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-014-00-1\nExtract residues (coal), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]\n295-323-9\n91995-61-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-015-00-7\nExtract residues (coal tar), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]\n309-868-8\n101316-63-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-016-00-2\nExtract residues (coal), benzole fraction acid;\nLight Oil Extract Residues, low boiling;\n[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]\n298-725-2\n93821-38-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-017-00-8\nExtract residues (coal), light oil alk., distn. overheads;\nLight Oil Extract Residues, low boiling;\n[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]\n292-625-2\n90641-02-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-018-00-3\nExtract residues (coal), light oil alk., acid ext., indene fraction;\nLight Oil Extract Residues, intermediate boiling\n309-867-2\n101316-62-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-019-00-9\nExtract residues (coal), light oil alk., indene naphtha fraction;\nLight Oil Extract Residues, high boiling;\n[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]\n292-626-8\n90641-03-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-020-00-4\nSolvent naphtha (coal);\nLight Oil Extract Residues, high boiling;\n[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]\n266-013-0\n65996-79-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-021-00-X\nDistillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]\n309-971-8\n101794-90-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-022-00-5\nDistillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;\n[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]\n292-609-5\n90640-87-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-023-00-0\nDistillates (coal tar), light oils; Carbolic Oil;\n[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]\n283-483-2\n84650-03-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-024-00-6\nTar oils, coal;\nCarbolic Oil;\n[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]\n266-016-7\n65996-82-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-026-00-7\nExtract residues (coal), light oil alk., acid ext.;\nCarbolic Oil Extract Residue;\n[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]\n292-624-7\n90641-01-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-027-00-2\nExtract residues (coal), tar oil alk.;\nCarbolic Oil Extract Residue;\n[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]\n266-021-4\n65996-87-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-028-00-8\nExtract oils (coal), light oil;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-622-6\n90640-99-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-029-00-3\nPyridine, alkyl derivs.;\nCrude Tar Bases;\n[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]\n269-929-9\n68391-11-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-030-00-9\nTar bases, coal, picoline fraction;\nDistillate Bases;\n[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]\n295-548-2\n92062-33-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-031-00-4\nTar bases, coal, lutidine fraction;\nDistillate Bases\n293-766-2\n91082-52-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-032-00-X\nExtract oils (coal), tar base, collidine fraction;\nDistillate Bases;\n[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]\n273-077-3\n68937-63-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-033-00-5\nTar bases, coal, collidine fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]\n295-543-5\n92062-28-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-034-00-0\nTar bases, coal, aniline fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]\n295-541-4\n92062-27-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-035-00-6\nTar bases, coal, toluidine fraction;\nDistillate Bases\n293-767-8\n91082-53-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-036-00-1\nDistillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;\nRedistillates;\n[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]\n295-292-1\n91995-31-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-037-00-7\nDistillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]\n295-295-8\n91995-35-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-038-00-2\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;\nRedistillates;\n[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]\n295-329-1\n91995-66-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-039-00-8\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]\n310-170-0\n122070-79-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-040-00-3\nExtract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;\nRedistillates;\n[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]\n310-171-6\n122070-80-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-041-00-9\nAbsorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]\n309-851-5\n101316-45-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-042-00-4\nDistillates (coal tar), upper, fluorene-rich;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]\n284-900-0\n84989-11-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-043-00-X\nCreosote oil, acenaphthene fraction, acenaphthene-free;\nWash Oil Redistillate;\n[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]\n292-606-9\n90640-85-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-044-00-5\nDistillates (coal tar), heavy oils;\nHeavy Anthracene Oil;\n[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]\n292-607-4\n90640-86-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n648-045-00-0\nDistillates (coal tar), upper;\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]\n266-026-1\n65996-91-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-046-00-6\nAnthracene oil, acid ext.;\nAnthracene Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]\n295-274-3\n91995-14-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-047-00-1\nDistillates (coal tar);\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]\n266-027-7\n65996-92-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-048-00-7\nDistillates (coal tar), pitch, heavy oils;\nHeavy Anthracene Oil;\n[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]\n295-312-9\n91995-51-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-049-00-2\nDistillates (coal tar), pitch;\nHeavy Anthracene Oil;\n[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]\n309-855-7\n101316-49-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-050-00-8\nDistillates (coal tar), heavy oils, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]\n295-304-5\n91995-42-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-051-00-3\nDistillates (coal tar), pitch, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]\n295-313-4\n91995-52-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-052-00-9\nParaffin waxes (coal), brown-coal high-temp. tar, carbon-treated;\nCoal Tar Extract;\n[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-296-6\n97926-76-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-053-00-4\nParaffin waxes (coal), brown-coal high-temp tar, clay-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-297-1\n97926-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-054-00-X\nPitch;\nPitch\n263-072-4\n61789-60-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-055-00-5\nPitch, coal tar, high-temp.;\nPitch;\n[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n266-028-2\n65996-93-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n648-056-00-0\nPitch, coal tar, high-temp., heat-treated;\nPitch;\n[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n310-162-7\n121575-60-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-057-00-6\nPitch, coal tar, high-temp., secondary;\nPitch Redistillate;\n[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]\n302-650-3\n94114-13-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-058-00-1\nResidues (coal tar), pitch distn.;\nPitch Redistillate;\n[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]\n295-507-9\n92061-94-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-059-00-7\nTar, coal, high-temp., distn. and storage residues;\nCoal Tar Solids Residue;\n[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]\n295-535-1\n92062-20-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-060-00-2\nTar, coal, storage residues;\nCoal Tar Solids Residue;\n[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]\n293-764-1\n91082-50-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-061-00-8\nTar, coal, high-temp., residues;\nCoal Tar Solids Residue;\n[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]\n309-726-5\n100684-51-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-062-00-3\nTar, coal, high-temp., high-solids;\nCoal Tar Solids Residue;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]\n273-615-7\n68990-61-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-063-00-9\nWaste solids, coal-tar pitch coking;\nCoal Tar Solids Residue;\n[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]\n295-549-8\n92062-34-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-064-00-4\nExtract residues (coal), brown;\nCoal Tar Extract;\n[The residue from extraction of dried coal.]\n294-285-0\n91697-23-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-065-00-X\nParaffin waxes (coal), brown-coal-high-temp. tar;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-454-1\n92045-71-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-066-00-5\nParaffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-455-7\n92045-72-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-067-00-0\nParaffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-298-7\n97926-78-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-068-00-6\nTar, coal, low-temp., distn. residues;\nTar Oil, intermediate boiling;\n[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]\n309-887-1\n101316-85-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-069-00-1\nPitch, coal tar, low-temp;\nPitch Residue;\n[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-651-4\n90669-57-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-070-00-7\nPitch, coal tar, low-temp., oxidized;\nPitch Residue, oxidised;\n[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-654-0\n90669-59-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-071-00-2\nPitch, coal tar, low-temp., heat-treated;\nPitch Residue, oxidised;\nPitch Residue, heat-treated;\n[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]\n292-653-5\n90669-58-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-072-00-8\nDistillates (coal-petroleum), condensed-ring arom;\nDistillates;\n[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]\n269-159-3\n68188-48-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-073-00-3\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-956-6\n101794-74-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-074-00-9\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-957-1\n101794-75-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-075-00-4\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-958-7\n101794-76-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-076-00-X\nPitch, coal tar-petroleum;\nPitch Residues;\n[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]\n269-109-0\n68187-57-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-077-00-5\nPhenanthrene, distn. residues;\nHeavy Anthracene Oil Redistillate;\n[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]\n310-169-5\n122070-78-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-078-00-0\nDistillates (coal tar), upper, fluorene-free;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]\n284-899-7\n84989-10-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-079-00-6\nAnthracene oil;\nAnthracene oil;\n[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]\n292-602-7\n90640-80-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-080-00-1\nResidues (coal tar), creosote oil distn.;\nWash Oil Redistillate;\n[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]\n295-506-3\n92061-93-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-081-00-7\nTar, coal;\nCoal tar;\n[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]\n232-361-7\n8007-45-2\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-082-00-2\nTar, coal, high-temp.;\nCoal tar;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]\n266-024-0\n65996-89-6\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-083-00-8\nTar, coal, low-temp.;\nCoal oil;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]\n266-025-6\n65996-90-9\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n\n648-084-00-3\nDistillates (coal), coke-oven light oil, naphthalene cut;\nNaphthalene Oil;\n[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]\n285-076-5\n85029-51-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-085-00-9\nDistillates (coal tar), naphthalene oils;\nNaphthalene Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]\n283-484-8\n84650-04-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-086-00-4\nDistillates (coal tar), naphthalene oils, naphthalene-low;\nNaphthalene Oil Redistillate;\n[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]\n284-898-1\n84989-09-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-087-00-X\nDistillates (coal tar), naphthalene oil crystn. mother liquor;\nNaphthalene Oil Redistillate;\n[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]\n295-310-8\n91995-49-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-088-00-5\nExtract residues (coal), naphthalene oil, alk.;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]\n310-166-9\n121620-47-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-089-00-0\nExtract residues (coal), naphthalene oil, alk., naphthalene-low;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-167-4\n121620-48-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-090-00-6\nDistillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;\nNaphthalene Oil Extract Residue;\n[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]\n292-612-1\n90640-90-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-091-00-1\nExtract residues (coal), naphthalene oil alk., distn. overheads;\nNaphthalene Oil Extract Residue;\n[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]\n292-627-3\n90641-04-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-092-00-7\nDistillates (coal tar), naphthalene oils, methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]\n309-985-4\n101896-27-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-093-00-2\nDistillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]\n309-972-3\n101794-91-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-094-00-8\nDistillates (coal tar), naphthalene oils, acid exts.;\nMethylnaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]\n295-309-2\n91995-48-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-095-00-3\nExtract residues (coal), naphthalene oil alk., distn. residues;\nMethylnaphthalene Oil Extract Residue;\n[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]\n292-628-9\n90641-05-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-096-00-9\nExtract oils (coal), acidic, tar-base free;\nMethylnaphthalene Oil Extract Residue;\n[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]\n284-901-6\n84989-12-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-097-00-4\nDistillates (coal tar), benzole fraction, distn. residues;\nWash Oil;\n[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-165-3\n121620-46-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-098-00-X\nCreosote oil, acenaphthene fraction;\nWash Oil;\n[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]\n292-605-3\n90640-84-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-099-00-5\nCreosote oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]\n263-047-8\n61789-28-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-100-00-9\nCreosote oil, high-boiling distillate;\nWash Oil;\n[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]\n274-565-9\n70321-79-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-101-00-4\nCreosote;\n[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]\n232-287-5\n8001-58-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-102-00-X\nExtract residues (coal), creosote oil acid;\nWash Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]\n310-189-4\n122384-77-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-103-00-5\nAnthracene oil, anthracene paste;\nAnthracene Oil Fraction;\n[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]\n292-603-2\n90640-81-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-104-00-0\nAnthracene oil, anthracene-low;\nAnthracene Oil Fraction;\n[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]\n292-604-8\n90640-82-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-105-00-6\nResidues (coal tar), anthracene oil distn.;\nAnthracene Oil Fraction;\n[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]\n295-505-8\n92061-92-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-106-00-1\nAnthracene oil, anthracene paste, anthracene fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-275-9\n91995-15-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-107-00-7\nAnthracene oil, anthracene paste, carbazole fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-276-4\n91995-16-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-108-00-2\nAnthracene oil, anthracene paste, distn. lights;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]\n295-278-5\n91995-17-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-109-00-8\nTar oils, coal, low-temp.;\nTar Oil, high boiling;\n[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]\n309-889-2\n101316-87-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-110-00-3\nExtract residues (coal), low temp. coal atar alk.;\n[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]\n310-191-5\n122384-78-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-111-00-9\nPhenols, ammonia liquor ext.;\nAlkaline Extract;\n[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]\n284-881-9\n84988-93-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-112-00-4\nDistillates (coal tar), light oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-610-0\n90640-88-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-113-00-X\nExtracts, coal tar oil alk.;\nAlkaline Extract;\n[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n266-017-2\n65996-83-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-114-00-5\nDistillates (coal tar), naphthalene oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-611-6\n90640-89-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-115-00-0\nExtract residues (coal), tar oil alk., carbonated, limed;\nCrude Phenols;\n[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]\n292-629-4\n90641-06-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-116-00-6\nTar acids, coal, crude;\nCrude Phenols;\n[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]\n266-019-3\n65996-85-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-117-00-1\nTar acids, brown-coal, crude;\nCrude Phenols;\n[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]\n309-888-7\n101316-86-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-118-00-7\nTar acids, brown-coal gasification;\nCrude Phenols;\n[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]\n295-536-7\n92062-22-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-119-00-2\nTar acids, distn. residues;\nDistillate Phenols;\n[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]\n306-251-5\n96690-55-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-120-00-8\nTar acids, methylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-892-9\n84989-04-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-121-00-3\nTar acids, polyalkylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]\n284-893-4\n84989-05-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-122-00-9\nTar acids, xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-895-5\n84989-06-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-123-00-4\nTar acids, ethylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-891-3\n84989-03-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-124-00-X\nTar acids, 3,5-xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]\n284-896-0\n84989-07-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-125-00-5\nTar acids, residues, distillates, first-cut;\nDistillate Phenols;\n[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]\n270-713-1\n68477-23-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-126-00-0\nTar acids, cresylic, residues;\nDistillate Phenols;\n[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]\n271-418-0\n68555-24-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-127-00-6\nPhenols, C9-11;\nDistillate Phenols\n293-435-2\n91079-47-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-128-00-1\nTar acids, cresylic;\nDistillate Phenols;\n[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]\n295-540-9\n92062-26-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-129-00-7\nTar acids, brown-coal, C2-alkylphenol fraction;\nDistillate Phenols;\n[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]\n302-662-9\n94114-29-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-130-00-2\nExtract oils (coal), naphthalene oils;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-623-1\n90641-00-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-131-00-8\nTar bases, quinoline derivs.;\nDistillate Bases\n271-020-7\n68513-87-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-132-00-3\nTar bases, coal, quinoline derivs. fraction;\nDistillate Bases\n274-560-1\n70321-67-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-133-00-9\nTar bases, coal, distn. residues;\nDistillate Bases;\n[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]\n295-544-0\n92062-29-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-134-00-4\nHydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]\n309-745-9\n100801-63-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-135-00-X\nHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]\n309-748-5\n100801-65-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-136-00-5\nHydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]\n309-749-0\n100801-66-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-137-00-0\nExtract residues (coal), tar oil alk., naphthalene distn. residues;\nNaphthalene Oil Extract Residue;\n[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]\n277-567-8\n73665-18-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-138-00-6\nCreosote oil, low-boiling distillate;\nWash Oil;\n[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]\n274-566-4\n70321-80-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-139-00-1\nTar acids, cresylic, sodium salts, caustic solns.;\nAlkaline Extract\n272-361-4\n68815-21-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-140-00-7\nExtract oils (coal), tar base;\nAcid Extract;\n[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]\n266-020-9\n65996-86-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-141-00-2\nTar bases, coal, crude;\nCrude Tar Bases;\n[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]\n266-018-8\n65996-84-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-142-00-8\nResidues (coal), liq. solvent extn.;\n[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]\n302-681-2\n94114-46-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-143-00-3\nCoal liquids, liq. solvent extn. soln.;\n[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]\n302-682-8\n94114-47-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-144-00-9\nCoal liquids, liq. solvent extn.;\n[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]\n302-683-3\n94114-48-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-145-00-4\nTar brown-coal;\n[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]\n309-885-0\n101316-83-0\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-146-00-X\nTar, brown-coal, low-temp.;\n[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]\n309-886-6\n101316-84-1\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-147-00-5\nLight oil (coal), coke-oven;\nCrude benzole;\n[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]\n266-012-5\n65996-78-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-148-00-0\nDistillates (coal), liq. solvent extn., primary;\n[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]\n302-688-0\n94114-52-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-149-00-6\nDistillates (coal), solvent extn., hydrocracked;\n[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-689-6\n94114-53-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-150-00-1\nNaphtha (coal), solvent extn., hydrocracked;\n[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-690-1\n94114-54-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-151-00-7\nGasoline, coal solvent extn., hydrocracked naphtha;\n[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]\n302-691-7\n94114-55-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-152-00-2\nDistillates (coal), solvent extn., hydrocracked middle;\n[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]\n302-692-2\n94114-56-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-153-00-8\nDistillates (coal), solvent extn., hydrocracked hydrogenated middle;\n[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]\n302-693-8\n94114-57-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n\n648-154-00-3\nFuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;\n[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]\n302-694-3\n94114-58-6\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n648-155-00-9\nFuels, diesel, coal solvent extn., hydrocracked hydrogenated;\n[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]\n302-695-9\n94114-59-7\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n\n\n648-156-00-4\nLight oil (coal), semi-coking process;\nFresh oil;\n[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]\n292-635-7\n90641-11-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n\n649-001-00-3\nExtracts (petroleum), light naphthenic distillate solvent\n265-102-1\n64742-03-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-002-00-9\nExtracts (petroleum), heavy paraffinic distillate solvent\n265-103-7\n64742-04-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-003-00-4\nExtracts (petroleum), light paraffinic distillate solvent\n265-104-2\n64742-05-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-004-00-X\nExtracts (petroleum), heavy naphthenic distillate solvent\n265-111-0\n64742-11-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-005-00-5\nExtracts (petroleum), light vacuum gas oil solvent\n295-341-7\n91995-78-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-006-00-0\nhydrocarbons C26-55, arom-rich\n307-753-7\n97722-04-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-007-00-6\nfatty acids, tall-oil, reaction products with iminodiethanol and boric acid\n400-160-5\n—\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)28-37-61\n\n\n649-008-00-1\nResidues (petroleum), atm. tower;\nHeavy Fuel oil;\n[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-045-2\n64741-45-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-009-00-7\nGas oils (petroleum), heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n265-058-3\n64741-57-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-010-00-2\nDistillates (petroleum), heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-063-0\n64741-61-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-011-00-8\nClarified oils (petroleum), catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-064-6\n64741-62-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-012-00-3\nResidues (petroleum), hydrocracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]\n265-076-1\n64741-75-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-013-00-9\nResidues (petroleum), thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-081-9\n64741-80-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-014-00-4\nDistillates (petroleum), heavy thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-082-4\n64741-81-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-015-00-X\nGas oils (petroleum), hydrotreated vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-162-9\n64742-59-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-016-00-5\nResidues (petroleum), hydrodesulfurized atmospheric tower;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-181-2\n64742-78-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-017-00-0\nGas oils (petroleum), hydrodesulfurized heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-189-6\n64742-86-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-018-00-6\nResidues (petroleum), steam-cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-193-8\n64742-90-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-019-00-1\nResidues (petroleum), atmospheric;\nHeavy Fuel oil;\n[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-777-3\n68333-22-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-020-00-7\nClarified oils (petroleum), hydrodesulfurized catalytic cracked;\nHeavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-782-0\n68333-26-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-021-00-2\nDistillates (petroleum), hydrodesulfurized intermediate catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n269-783-6\n68333-27-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-022-00-8\nDistillates (petroleum), hydrodesulfurized heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n269-784-1\n68333-28-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-023-00-3\nFuel oil, residues-straight-run gas oils, high-sulfur;\nHeavy Fuel oil\n270-674-0\n68476-32-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-024-00-9\nFuel oil, residual;\nHeavy Fuel oil;\n[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]\n270-675-6\n68476-33-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-025-00-4\nResidues (petroleum), catalytic reformer fractionator residue distn.;\nHeavy Fuel oil;\n[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]\n270-792-2\n68478-13-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-026-00-X\nResidues (petroleum), heavy coker gas oil and vacuum gas oil;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-796-4\n68478-17-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-027-00-5\nResidues (petroleum), heavy coker and light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-983-0\n68512-61-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-028-00-0\nResidues (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-984-6\n68512-62-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-029-00-6\nResidues (petroleum), steam-cracked light;\nHeavy Fuel oil;\n[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]\n271-013-9\n68513-69-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-030-00-1\nFuel oil, No 6;\nHeavy Fuel oil;\n[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]\n271-384-7\n68553-00-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-031-00-7\nResidues (petroleum), topping plant, low-sulfur;\nHeavy Fuel oil;\n[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]\n271-763-7\n68607-30-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-032-00-2\nGas oils (petroleum), heavy atmospheric;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]\n272-184-2\n68783-08-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-033-00-8\nResidues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;\nHeavy Fuel oil;\n[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]\n272-187-9\n68783-13-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-034-00-3\nDistillates (petroleum), petroleum residues vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]\n273-263-4\n68955-27-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-035-00-9\nResidues (petroleum), steam-cracked, resinous;\nHeavy Fuel oil;\n[A complex residuum from the distillation of steam-cracked petroleum residues.]\n273-272-3\n68955-36-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-036-00-4\nDistillates (petroleum), intermediate vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-683-0\n70592-76-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-037-00-X\nDistillates (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]\n274-684-6\n70592-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-038-00-5\nDistillates (petroleum), vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-685-1\n70592-78-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-039-00-0\nGas oils (petroleum), hydrodesulfurized coker heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n285-555-9\n85117-03-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-040-00-6\nResidues (petroleum), steam-cracked, distillates;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]\n292-657-7\n90669-75-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-041-00-1\nResidues (petroleum), vacuum, light;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]\n292-658-2\n90669-76-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-042-00-7\nFuel oil, heavy, high-sulfur;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n295-396-7\n92045-14-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-043-00-2\nResidues (petroleum), catalytic cracking;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]\n295-511-0\n92061-97-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-044-00-8\nDistillates (petroleum), intermediate catalytic cracked, thermally degraded;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]\n295-990-6\n92201-59-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-045-00-3\nResidual oils (petroleum);\nHeavy Fuel oil;\n[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]\n298-754-0\n93821-66-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-046-00-9\nResidues, steam cracked, thermally treated;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]\n308-733-0\n98219-64-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-047-00-4\nDistillates (petroleum), hydrodesulfurized full-range middle;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]\n309-863-0\n101316-57-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-048-00-X\nResidues (petroleum), catalytic reformer fractionator;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]\n265-069-3\n64741-67-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-049-00-5\nPetroleum;\nCrude oil;\n[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]\n232-298-5\n8002-05-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-050-00-0\nDistillates (petroleum), light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]\n265-051-5\n64741-50-0\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-051-00-6\nDistillates (petroleum), heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]\n265-052-0\n64741-51-1\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-052-00-1\nDistillates (petroleum), light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-053-6\n64741-52-2\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-053-00-7\nDistillates (petroleum), heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-054-1\n64741-53-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-054-00-2\nDistillates (petroleum), acid-treated heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-117-3\n64742-18-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-055-00-8\nDistillates (petroleum), acid-treated light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-118-9\n64742-19-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-056-00-3\nDistillates (petroleum), acid-treated heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-119-4\n64742-20-7\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-057-00-9\nDistillates (petroleum), acid-treated light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-121-5\n64742-21-8\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-058-00-4\nDistillates (petroleum), chemically neutralized heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]\n265-127-8\n64742-27-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-059-00-X\nDistillates (petroleum), chemically neutralized light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-128-3\n64742-28-5\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-060-00-5\nDistillates (petroleum), chemically neutralized heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-135-1\n64742-34-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-061-00-0\nDistillates (petroleum), chemically neutralized light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-136-7\n64742-35-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n649-062-00-6\nGases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]\n270-755-0\n68477-73-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-063-00-1\nGases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-756-6\n68477-74-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-064-00-7\nGases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]\n270-757-1\n68477-75-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-065-00-2\nGases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]\n270-758-7\n68477-76-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-066-00-8\nGases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]\n270-760-8\n68477-79-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-067-00-3\nGases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]\n270-765-5\n68477-83-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-068-00-9\nGases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-767-6\n68477-85-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-069-00-4\nGases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]\n270-768-1\n68477-86-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-070-00-X\nGases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-769-7\n68477-87-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-071-00-5\nGases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]\n270-772-3\n68477-90-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-072-00-0\nGases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-773-9\n68477-91-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-073-00-6\nGases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]\n270-777-0\n68477-94-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-074-00-1\nGases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-778-6\n68477-95-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-075-00-7\nGases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas\n270-782-8\n68477-99-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-076-00-2\nTail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-802-5\n68478-21-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-077-00-8\nTail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-803-0\n68478-22-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-078-00-3\nTail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]\n270-804-6\n68478-24-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-079-00-9\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-806-7\n68478-26-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-080-00-4\nTail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]\n270-813-5\n68478-32-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-081-00-X\nTail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]\n270-814-0\n68478-33-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-082-00-5\nTail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-815-6\n68478-34-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-083-00-0\nHydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]\n270-990-9\n68512-91-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-084-00-6\nGases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-000-8\n68513-15-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-085-00-1\nGases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]\n271-001-3\n68513-16-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-086-00-7\nGases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-002-9\n68513-17-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-087-00-2\nResidues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27.8 °C (11 °F to 82 °F).]\n271-010-2\n68513-66-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-088-00-8\nHydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]\n271-032-2\n68514-31-8\nF+; R12\nCarc. Cat 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-089-00-3\nHydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]\n271-038-5\n68514-36-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-090-00-9\nHydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]\n271-259-7\n68527-16-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-091-00-4\nHydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas\n271-261-8\n68527-19-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-092-00-X\nGases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n271-624-0\n68602-83-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-093-00-5\nHydrocarbons, C2-4;\nPetroleum gas\n271-734-9\n68606-25-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-094-00-0\nHydrocarbons, C3;\nPetroleum gas\n271-735-4\n68606-26-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-095-00-6\nGases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n271-737-5\n68606-27-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-096-00-1\nGases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]\n271-742-2\n68606-34-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-097-00-7\nGases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-183-7\n68783-07-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-098-00-2\nGases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n272-203-4\n68783-64-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-099-00-8\nGases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]\n272-205-5\n68783-65-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-100-00-1\nGases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-871-7\n68918-99-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-101-00-7\nGases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-872-2\n68919-00-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-102-00-2\nGases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-878-5\n68919-05-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-103-00-8\nGases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-879-0\n68919-06-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-104-00-3\nGases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]\n272-882-7\n68919-09-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-105-00-9\nGases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]\n272-893-7\n68919-20-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-106-00-4\nGases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-883-2\n68919-10-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-107-00-X\nGases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-169-3\n68952-76-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-108-00-5\nTail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-170-9\n68952-77-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-109-00-0\nTail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-175-6\n68952-81-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-110-00-6\nTail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-176-1\n68952-82-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-111-00-1\nGases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]\n273-265-5\n68955-28-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-112-00-7\nGases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n273-270-2\n68955-34-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-113-00-2\nHydrocarbons, C4;\nPetroleum gas\n289-339-5\n87741-01-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-114-00-8\nAlkanes, C1-4, C3-rich;\nPetroleum gas\n292-456-4\n90622-55-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-115-00-3\nGases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]\n295-404-9\n92045-22-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-116-00-9\nHydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]\n295-405-4\n92045-23-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-117-00-4\nPetroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]\n295-463-0\n92045-80-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-118-00-X\nHydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas\n306-004-1\n95465-89-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-119-00-5\nRaffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas\n307-769-4\n97722-19-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-120-00-0\nGases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]\n270-746-1\n68477-65-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-121-00-6\nGases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]\n270-747-7\n68477-66-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-122-00-1\nGases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]\n270-748-2\n68477-67-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-123-00-7\nGases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-749-8\n68477-68-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-124-00-2\nGases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-759-2\n68477-77-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-125-00-8\nGases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-761-3\n68477-80-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-126-00-3\nGases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]\n270-762-9\n68477-81-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-127-00-9\nGases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas\n270-763-4\n68477-82-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-128-00-4\nGases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]\n270-766-0\n68477-84-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-129-00-X\nGases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-774-4\n68477-92-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-130-00-5\nGases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]\n270-776-5\n68477-93-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-131-00-0\nGases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]\n270-779-1\n68477-96-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-132-00-6\nGases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]\n270-780-7\n68477-97-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-133-00-1\nGases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-781-2\n68477-98-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-134-00-7\nGases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n270-783-3\n68478-00-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-135-00-2\nGases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-784-9\n68478-01-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-136-00-8\nGases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-785-4\n68478-02-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-137-00-3\nGases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n270-787-5\n68478-03-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-138-00-9\nGases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-788-0\n68478-04-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-139-00-4\nGases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-789-6\n68478-05-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-140-00-X\nTail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-805-1\n68478-25-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-141-00-5\nTail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-807-2\n68478-27-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-142-00-0\nTail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-808-8\n68478-28-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-143-00-6\nTail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-809-3\n68478-29-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-144-00-1\nTail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-810-9\n68478-30-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-145-00-7\nGases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]\n270-999-8\n68513-14-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-146-00-2\nGases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-003-4\n68513-18-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-147-00-8\nGases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-005-5\n68513-19-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-148-00-3\nGases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]\n271-258-1\n68527-15-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-149-00-9\nGases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]\n271-623-5\n68602-82-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-150-00-4\nGases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n271-625-6\n68602-84-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-151-00-X\nPetroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-750-6\n68607-11-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-152-00-5\nGases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-182-1\n68783-06-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-153-00-0\nGases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-338-9\n68814-67-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-154-00-6\nGases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n272-343-6\n68814-90-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-155-00-1\nGases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]\n272-775-5\n68911-58-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-156-00-7\nGases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n272-776-0\n68911-59-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-157-00-2\nGases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]\n272-873-8\n68919-01-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-158-00-8\nGases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-874-3\n68919-02-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-159-00-3\nGases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]\n272-875-9\n68919-03-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-160-00-9\nGases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-876-4\n68919-04-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-161-00-4\nGases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]\n272-880-6\n68919-07-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-162-00-X\nGases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-881-1\n68919-08-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-163-00-5\nGases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-884-8\n68919-11-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-164-00-0\nGases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]\n272-885-3\n68919-12-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-165-00-6\nTail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]\n273-173-5\n68952-79-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-166-00-1\nTail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n273-174-0\n68952-80-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-167-00-7\nGases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-269-7\n68955-33-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-168-00-2\nGases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-563-5\n68989-88-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-169-00-8\nGases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n295-397-2\n92045-15-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-170-00-3\nGases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n295-398-8\n92045-16-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-171-00-9\nGases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n295-399-3\n92045-17-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-172-00-4\nGases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n295-400-7\n92045-18-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-173-00-X\nGases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]\n295-401-2\n92045-19-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-174-00-5\nGases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n295-402-8\n92045-20-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-175-00-0\nFoots oil (petroleum), acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-225-7\n93924-31-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-176-00-6\nFoots oil (petroleum), clay-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-226-2\n93924-32-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n\n\n649-177-00-1\nGases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]\n268-629-5\n68131-75-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-178-00-7\nTail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-617-2\n68307-98-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-179-00-2\nTail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-618-8\n68307-99-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-180-00-8\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-619-3\n68308-00-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-181-00-3\nTail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-620-9\n68308-01-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-182-00-9\nTail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-630-3\n68308-10-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-183-00-4\nTail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-623-5\n68308-03-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-184-00-X\nTail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-624-0\n68308-04-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-185-00-5\nTail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-625-6\n68308-05-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-186-00-0\nTail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-626-1\n68308-06-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-187-00-6\nTail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-627-7\n68308-07-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-188-00-1\nTail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-629-8\n68308-09-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-189-00-7\nTail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-631-9\n68308-11-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-190-00-2\nTail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-632-4\n68308-12-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-191-00-8\nGases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]\n270-071-2\n68409-99-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-193-00-9\nAlkanes, C1-2;\nPetroleum gas\n270-651-5\n68475-57-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-194-00-4\nAlkanes, C2-3;\nPetroleum gas\n270-652-0\n68475-58-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-195-00-X\nAlkanes, C3-4;\npetroleum gas\n270-653-6\n68475-59-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-196-00-5\nAlkanes, C4-5;\nPetroleum gas\n270-654-1\n68475-60-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-197-00-0\nFuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]\n270-667-2\n68476-26-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-198-00-6\nFuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]\n270-670-9\n68476-29-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-199-00-1\nHydrocarbons, C3-4;\nPetroleum gas\n270-681-9\n68476-40-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-200-00-5\nHydrocarbons, C4-5;\nPetroleum gas\n270-682-4\n68476-42-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-201-00-0\nHydrocarbons, C2-4, C3-rich;\nPetroleum gas\n270-689-2\n68476-49-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-202-00-6\nPetroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-704-2\n68476-85-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-203-00-1\nPetroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-705-8\n68476-86-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-204-00-7\ngases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]\n270-724-1\n68477-33-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-205-00-2\nDistillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]\n270-726-2\n68477-35-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-206-00-8\nGases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-750-3\n68477-69-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-207-00-3\nGases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]\n270-751-9\n68477-70-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-208-00-9\nGases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-752-4\n68477-71-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-209-00-4\nGases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-754-5\n68477-72-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-210-00-X\nTail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-628-2\n68308-08-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-211-00-5\nFoots oil (petroleum), carbon-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-126-0\n97862-76-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-212-00-0\nDistillates (petroleum), sweetened middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-088-7\n64741-86-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-213-00-6\nGas oils (petroleum), solvent-refined;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-092-9\n64741-90-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-214-00-1\nDistillates (petroleum), solvent-refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-093-4\n64741-91-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-215-00-7\nGas oils (petroleum), acid-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-112-6\n64742-12-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-216-00-2\nDistillates (petroleum), acid-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-113-1\n64742-13-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-217-00-8\nDistillates (petroleum), acid-treated light;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-114-7\n64742-14-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-218-00-3\nGas oils (petroleum), chemically neutralized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-129-9\n64742-29-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-219-00-9\nDistillates (petroleum), chemically neutralized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-130-4\n64742-30-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-220-00-4\nDistillates (petroleum), clay-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-139-3\n64742-38-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-221-00-X\nDistillates (petroleum), hydrotreated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-148-2\n64742-46-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-222-00-5\nGas oils (petroleum), hydrodesulfurized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-182-8\n64742-79-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-223-00-0\nDistillates (petroleum), hydrodesulfurized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-183-3\n64742-80-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-224-00-6\nFuels, diesel;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]\n269-822-7\n68334-30-5\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH N\n649-225-00-1\nFuel oil, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]\n270-671-4\n68476-30-2\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-226-00-7\nFuel oil, No 4;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]\n270-673-5\n68476-31-3\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-227-00-2\nFuels, diesel, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]\n270-676-1\n68476-34-6\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-228-00-8\nDistillates (petroleum), catalytic reformer fractionator residue, high-boiling;\nGasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]\n270-719-4\n68477-29-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-229-00-3\nDistillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]\n270-721-5\n68477-30-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-230-00-9\nDistillates (petroleum), catalytic reformer fractionator residue, low-boiling;\nGasoil — unspecified;\n[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]\n270-722-0\n68477-31-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-231-00-4\nDistillates (petroleum), highly refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]\n292-615-8\n90640-93-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-232-00-X\nDistillates (petroleum) catalytic reformer, heavy arom. conc.;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n295-294-2\n91995-34-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-233-00-5\nGas oils, paraffinic;\nGasoil — unspecified;\n[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]\n300-227-8\n93924-33-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-234-00-0\nNaphtha (petroleum), solvent-refined hydrodesulfurized heavy;\nGasoil — unspecified\n307-035-3\n97488-96-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-235-00-6\nHydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-659-6\n97675-85-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-236-00-1\nHydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-660-1\n97675-86-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-237-00-7\nHydrocarbons, C11-17, solvent-extd. light naphthenic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n307-757-9\n97722-08-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-238-00-2\nGas oils, hydrotreated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]\n308-128-1\n97862-78-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-239-00-8\nDistillates (petroleum), carbon-treated light paraffinic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]\n309-667-5\n100683-97-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-240-00-3\nDistillates (petroleum), intermediate paraffinic, carbon-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-668-0\n100683-98-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-241-00-9\nDistillates (petroleum), intermediate paraffinic, clay-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-669-6\n100683-99-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-242-00-4\nAlkanes, C12-26-branched and linear\n292-454-3\n90622-53-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-243-00-X\nLubricating greases;\nGrease;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]\n278-011-7\n74869-21-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-244-00-5\nSlack wax (petroleum);\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n265-165-5\n64742-61-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-245-00-0\nSlack wax (petroleum), acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n292-659-8\n90669-77-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-246-00-6\nSlack wax (petroleum), clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]\n292-660-3\n90669-78-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-247-00-1\nSlack wax (petroleum), hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n295-523-6\n92062-09-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-248-00-7\nSlack wax (petroleum), low-melting;\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-524-1\n92062-10-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-249-00-2\nSlack wax (petroleum), low-melting, hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-525-7\n92062-11-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-250-00-8\nSlack wax (petroleum), low-melting, carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-155-9\n97863-04-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-251-00-3\nSlack wax (petroleum), low-melting, clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-156-4\n97863-05-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-252-00-9\nSlack wax (petroleum), low-melting, silicic acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-158-5\n97863-06-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-253-00-4\nSlack wax (petroleum), carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]\n309-723-9\n100684-49-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-254-00-X\nPetrolatum;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n232-373-2\n8009-03-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-255-00-5\nPetrolatum (petroleum), oxidized;\nPetrolatum;\n[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]\n265-206-7\n64743-01-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-256-00-0\nPetrolatum (petroleum), alumina-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n285-098-5\n85029-74-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-257-00-6\nPetrolatum (petroleum), hydrotreated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]\n295-459-9\n92045-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-258-00-1\nPetrolatum (petroleum), carbon-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-149-6\n97862-97-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-259-00-7\nPetrolatum (petroleum), silicic acid-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-150-1\n97862-98-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-260-00-2\nPetrolatum (petroleum), clay-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]\n309-706-6\n100684-33-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n\n\n649-261-00-8\nGasoline, natural;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]\n232-349-1\n8006-61-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-262-00-3\nNaphtha;\nLow boiling point naphtha;\n[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n232-443-2\n8030-30-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-263-00-9\nLigroine;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]\n232-453-7\n8032-32-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-264-00-4\nNaphtha (petroleum), heavy straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-041-0\n64741-41-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-265-00-X\nNaphtha (petroleum), full-range straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]\n265-042-6\n64741-42-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-266-00-5\nNaphtha (petroleum), light straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-046-8\n64741-46-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-267-00-0\nSolvent naphtha (petroleum), light aliph.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]\n265-192-2\n64742-89-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-268-00-6\nDistillates (petroleum), straight-run light;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]\n270-077-5\n68410-05-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-269-00-1\nGasoline, vapor-recovery;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C(-4 °F to 384 °F).]\n271-025-4\n68514-15-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-270-00-7\nGasoline, straight-run, topping-plant;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]\n271-727-0\n68606-11-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-271-00-2\nNaphtha (petroleum), unsweetened;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]\n272-186-3\n68783-12-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-272-00-8\nDistillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]\n272-931-2\n68921-08-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-273-00-3\nNaphtha (petroleum), heavy straight run, arom.-contg.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n309-945-6\n101631-20-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-274-00-9\nNaphtha (petroleum), full-range alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]\n265-066-7\n64741-64-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-275-00-4\nNaphtha (petroleum), heavy alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]\n265-067-2\n64741-65-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-276-00-X\nNaphtha (petroleum), light alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]\n265-068-8\n64741-66-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-277-00-5\nNaphtha (petroleum), isomerization;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]\n265-073-5\n64741-70-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-278-00-0\nNaphtha (petroleum), solvent-refined light;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n265-086-6\n64741-84-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-279-00-6\nNaphtha (petroleum), solvent-refined heavy;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-095-5\n64741-92-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-280-00-1\nRaffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]\n270-088-5\n68410-71-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-281-00-7\nRaffinates (petroleum), reformer, Lurgi unit-sepd.;\nLow boiling point modified naphtha;\n[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]\n270-349-3\n68425-35-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-282-00-2\nNaphtha (petroleum), full-range alkylate, butane-contg.;\nLow boiling point modified naphta;\n[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]\n271-267-0\n68527-27-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-283-00-8\nDistillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]\n295-315-5\n91995-53-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-284-00-3\nNaphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-430-0\n92045-49-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-285-00-9\nHydrocarbons, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]\n295-436-3\n92045-55-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-286-00-4\nNaphtha (petroleum), isomerization, C6-fraction;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]\n295-440-5\n92045-58-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-287-00-X\nHydrocarbons, C6-7, naphtha-cracking, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]\n295-446-8\n92045-64-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-288-00-5\nHydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]\n309-871-4\n101316-67-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-289-00-0\nNaphtha (petroleum), heavy catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-055-7\n64741-54-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-290-00-6\nNaphtha (petroleum), light catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-056-2\n64741-55-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-291-00-1\nHydrocarbons, C3-11, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]\n270-686-6\n68476-46-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-292-00-7\nNaphtha (petroleum), catalytic cracked light distd.;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-185-8\n68783-09-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-293-00-2\nDistillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;\nLow boiling point cat-cracked naphtha.;\n[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]\n295-311-3\n91995-50-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-294-00-8\nNaphtha (petroleum), heavy catalytic cracked, sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]\n295-431-6\n92045-50-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-295-00-3\nNaphtha (petroleum), light catalytic cracked sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-441-0\n92045-59-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-296-00-9\nHydrocarbons, C8-12, catalytic-cracking, chem. neutralized;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n295-794-0\n92128-94-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-297-00-4\nHydrocarbons, C8-12, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]\n309-974-4\n101794-97-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-298-00-X\nHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;\nLow boiling point cat-cracked naphtha\n309-987-5\n101896-28-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-299-00-5\nNaphtha (petroleum), light catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n265-065-1\n64741-63-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-300-00-9\nNaphtha (petroleum), heavy catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-070-9\n64741-68-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-301-00-4\nDistillates (petroleum), catalytic reformed depentanizer;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]\n270-660-4\n68475-79-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-302-00-X\nHydrocarbons, C2-6, C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha\n270-687-1\n68476-47-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-303-00-5\nResidues (petroleum), C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha;\n[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n270-794-3\n68478-15-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-304-00-0\nNaphtha (petroleum), light catalytic reformed, arom.-free;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]\n270-993-5\n68513-03-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-305-00-6\nDistillates (petroleum), catalytic reformed straight-run naphtha overheads;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-008-1\n68513-63-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-306-00-1\nPetroleum products, hydrofiner-powerformer reformates;\nLow boiling point cat-reformed naphtha;\n[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]\n271-058-4\n68514-79-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-307-00-7\nNaphtha (petroleum), full-range reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n272-895-8\n68919-37-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-308-00-2\nNaphtha (petroleum), catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n273-271-8\n68955-35-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-309-00-8\nDistillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]\n285-509-8\n85116-58-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-310-00-3\nAromatic hydrocarbons, C8, catalytic reforming-derived;\nLow boiling point cat-reformed naphtha\n295-279-0\n91995-18-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-311-00-9\nAromatic hydrocarbons, C7-12, C8-rich;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]\n297-401-8\n93571-75-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-312-00-4\nGasoline, C5-11, high-octane stabilised reformed;\nLow boiling point cat-reformed naphtha;\n[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]\n297-458-9\n93572-29-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-313-00-X\nHydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]\n297-465-7\n93572-35-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-314-00-5\nHydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]\n297-466-2\n93572-36-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-315-00-0\nFoots oil (petroleum), silicic acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-127-6\n97862-77-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n\n\n649-316-00-6\nNaphtha (petroleum), light thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]\n265-075-6\n64741-74-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-317-00-1\nNaphtha (petroleum), heavy thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]\n265-085-0\n64741-83-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-318-00-7\nDistillates (petroleum), heavy arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]\n267-563-4\n67891-79-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-319-00-2\nDistillates (petroleum), light arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]\n267-565-5\n67891-80-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-320-00-8\nDistillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]\n270-344-6\n68425-29-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-321-00-3\nAromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]\n270-658-3\n68475-70-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-322-00-9\nDistillates (petroleum), thermal cracked naphtha and gas oil;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]\n271-631-9\n68603-00-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-323-00-4\nDistillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]\n271-632-4\n68603-01-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-324-00-X\nDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]\n271-634-5\n68603-03-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-325-00-5\nDistillates (petroleum), light thermal cracked, debutanized arom.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]\n273-266-0\n68955-29-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-326-00-0\nNaphtha (petroleum), light thermal cracked, sweetened;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]\n295-447-3\n92045-65-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-327-00-6\nNaphtha (petroleum), hydrotreated heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-150-3\n64742-48-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-328-00-1\nNaphtha (petroleum), hydrotreated light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-151-9\n64742-49-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-329-00-7\nNaphtha (petroleum), hydrodesulfurized light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-178-6\n64742-73-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-330-00-2\nNaphtha (petroleum), hydrodesulfurized heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-185-4\n64742-82-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-331-00-8\nDistillates (petroleum), hydrotreated middle, intermediate boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]\n270-092-7\n68410-96-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-332-00-3\nDistillates (petroleum), light distillate hydrotreating process, low-boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]\n270-093-2\n68410-97-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-333-00-9\nDistillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]\n270-094-8\n68410-98-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-334-00-4\nSolvent naphtha (petroleum), light arom., hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n270-988-8\n68512-78-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-335-00-X\nNaphtha (petroleum), hydrodesulfurized thermal cracked light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]\n285-511-9\n85116-60-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-336-00-5\nNaphtha (petroleum), hydrotreated light, cycloalkane-contg.;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n285-512-4\n85116-61-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-337-00-0\nNaphtha (petroleum), heavy steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha\n295-432-1\n92045-51-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-338-00-6\nNaphtha (petroleum), hydrodesulfurized full-range;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]\n295-433-7\n92045-52-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-339-00-1\nNaphtha (petroleum), hydrotreated light steam-cracked;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n295-438-4\n92045-57-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-340-00-7\nHydrocarbons, C4-12, naphtha-cracking, hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]\n295-443-1\n92045-61-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-341-00-2\nSolvent naphtha (petroleum), hydrotreated light naphthenic;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]\n295-529-9\n92062-15-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-342-00-8\nNaphtha (petroleum), light steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]\n296-942-7\n93165-55-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-343-00-3\nHydrocarbons, C6-11, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-852-0\n93763-33-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-344-00-9\nHydrocarbons, C9-12, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-853-6\n93763-34-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-345-00-4\nStoddard solvent;\nLow boiling point naphtha - unspecified;\n[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]\n232-489-3\n8052-41-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-346-00-X\nNatural gas condensates (petroleum);\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]\n265-047-3\n64741-47-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-347-00-5\nNatural gas (petroleum), raw liq. mix;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]\n265-048-9\n64741-48-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-348-00-0\nNaphtha (petroleum), light hydrocracked;\nLow boiling naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-071-4\n64741-69-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-349-00-6\nNaphtha (petroleum), heavy hydrocracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]\n265-079-8\n64741-78-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-350-00-1\nNaphtha (petroleum), sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]\n265-089-2\n64741-87-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-351-00-7\nNaphtha (petroleum), acid-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-115-2\n64742-15-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-352-00-2\nNaphtha (petroleum), chemically neutralized heavy;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-122-0\n64742-22-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-353-00-8\nNaphtha (petroleum), chemically neutralized light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-123-6\n64742-23-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-354-00-3\nNaphtha (petroleum), catalytic dewaxed;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n265-170-2\n64742-66-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-355-00-9\nNaphtha (petroleum), light steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]\n265-187-5\n64742-83-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-356-00-4\nSolvent naphtha (petroleum), light arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n265-199-0\n64742-95-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-357-00-X\nAromatic hydrocarbons, C6-10, acid-treated, neutralized;\nLow boiling point naphtha - unspecified\n268-618-5\n68131-49-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-358-00-5\nDistillates (petroleum), C3-5, 2-methyl-2-butene-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]\n270-725-7\n68477-34-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-359-00-0\nDistillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-735-1\n68477-50-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-360-00-6\nDistillates (petroleum), steam-cracked, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-736-7\n68477-53-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-361-00-1\nDistillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;\nLow boiling point naphtha - unspecified\n270-738-8\n68477-55-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-362-00-7\nExtracts (petroleum), cold-acid, C4-6;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n270-741-4\n68477-61-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-363-00-2\nDistillates (petroleum), depentanizer overheads;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-771-8\n68477-89-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-364-00-8\nResidues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-791-7\n68478-12-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-365-00-3\nResidual oils (petroleum), deisobutanizer tower;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-795-9\n68478-16-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-366-00-9\nNaphtha (petroleum), full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]\n270-991-4\n68513-02-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-367-00-4\nNaphtha (petroleum), steam-cracked middle arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]\n271-138-9\n68516-20-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-368-00-X\nNaphtha (petroleum), clay-treated full-range straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]\n271-262-3\n68527-21-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-369-00-5\nNaphtha (petroleum), clay-treated light straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]\n271-263-9\n68527-22-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-370-00-0\nNaphtha (petroleum), light steam-cracked arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]\n271-264-4\n68527-23-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-371-00-6\nNaphtha (petroleum), light steam-cracked, debenzenized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]\n271-266-5\n68527-26-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-372-00-1\nNaphtha (petroleum), arom.-contg.;\nLow boiling point naphtha - unspecified\n271-635-0\n68603-08-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-373-00-7\nGasoline, pyrolysis, debutanizer bottoms;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]\n271-726-5\n68606-10-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-374-00-2\nNaphtha (petroleum), light, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]\n272-206-0\n68783-66-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-375-00-8\nNatural gas condensates;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]\n272-896-3\n68919-39-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-376-00-3\nDistillates (petroleum), naphtha unifiner stripper;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n272-932-8\n68921-09-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-377-00-9\nNaphtha (petroleum), catalytic reformed light, arom.-free fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]\n285-510-3\n85116-59-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-378-00-4\nGasoline;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]\n289-220-8\n86290-81-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-379-00-X\nAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;\nLow boiling point naphtha - unspecified\n292-698-0\n90989-42-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-380-00-5\nHydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]\n295-298-4\n91995-38-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-381-00-0\nDistillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n295-302-4\n91995-41-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-382-00-6\nExtracts (petroleum), catalytic reformed light naphtha solvent;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n295-331-2\n91995-68-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-383-00-1\nNaphtha (petroleum), hydrodesulfurized light, dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]\n295-434-2\n92045-53-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-384-00-7\nNaphtha (petroleum), light, C5-rich, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]\n295-442-6\n92045-60-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-385-00-2\nHydrocarbons, C8-11, naphtha-cracking, toluene cut;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]\n295-444-7\n92045-62-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-386-00-8\nHydrocarbons, C4-11, naphtha-cracking, arom.-free;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]\n295-445-2\n92045-63-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-387-00-3\nNaphtha (petroleum), light heat-soaked, steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]\n296-028-8\n92201-97-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-388-00-9\nDistillates (petroleum), C6-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]\n296-903-4\n93165-19-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-389-00-4\nGasoline, pyrolysis, hydrogenated;\nLow boiling point naphtha-unspecified;\n[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]\n302-639-3\n94114-03-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-390-00-X\nDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n305-750-5\n95009-23-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-391-00-5\nExtracts (petroleum) heavy naphtha solvent, clay-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]\n308-261-5\n97926-43-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-392-00-0\nNaphtha (petroleum), light steam-cracked, debenzenized, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]\n308-713-1\n98219-46-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-393-00-6\nNaphtha (petroleum), light steam-cracked, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]\n308-714-7\n98219-47-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-394-00-1\nDistillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]\n309-862-5\n101316-56-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-395-00-7\nHydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]\n309-870-9\n101316-66-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-396-00-2\nNaphtha (petroleum), hydrodesulfurised full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]\n309-879-8\n101316-76-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-397-00-8\nNaphtha (petroleum), sweetened light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]\n309-976-5\n101795-01-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-398-00-3\nHydrocarbons, C3-6, C5-rich, steam-cracked naphtha;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]\n310-012-0\n102110-14-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-399-00-9\nHydrocarbons, C5-rich, dicyclopentadiene-contg.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]\n310-013-6\n102110-15-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-400-00-2\nResidues (petroleum), steam-cracked light, arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]\n310-057-6\n102110-55-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-401-00-8\nHydrocarbons, C≥5, C5-6-rich;\nLow boiling point naphtha - unspecified\n270-690-8\n68476-50-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-402-00-3\nHydrocarbons, C5-rich;\nLow boiling point naphtha - unspecified\n270-695-5\n68476-55-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-403-00-9\nAromatic hydrocarbons, C8-10;\nLow boiling point naphtha - unspecified\n292-695-4\n90989-39-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n\n649-404-00-4\nKerosine (petroleum);\nStraight run kerosine;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]\n232-366-4\n8008-20-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-405-00-X\nSolvent naphtha (petroleum), medium aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]\n265-191-7\n64742-88-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-406-00-5\nSolvent naphtha (petroleum) heavy aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]\n265-200-4\n64742-96-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-407-00-0\nKerosine (petroleum), straight-run wide-cut;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]\n295-418-5\n92045-37-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-408-00-6\nDistillates (petroleum), steam-cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]\n265-194-3\n64742-91-2\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-409-00-1\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]\n270-728-3\n68477-39-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-410-00-7\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]\n270-729-9\n68477-40-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-411-00-2\nDistillates (petroleum), steam-cracked, C8-12 fraction;\nCracked kerosine;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n270-737-2\n68477-54-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-412-00-8\nKerosine (petroleum), hydrodesulfurized thermal cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]\n285-507-7\n85116-55-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-413-00-3\nAromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]\n292-621-0\n90640-98-5\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-414-00-9\nNaphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]\n292-637-8\n90641-13-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-415-00-4\nDistillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]\n309-866-7\n101316-61-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-416-00-X\nDistillates (petroleum), catalytic cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-938-8\n101631-13-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-417-00-5\nSolvent naphtha (petroleum), hydrocracked heavy arom.;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]\n309-881-9\n101316-80-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-418-00-0\nDistillates (petroleum), steam-cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-940-9\n101631-15-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-419-00-6\nDistillates (petroleum), alkylate;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]\n265-074-0\n64741-73-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-420-00-1\nExtracts (petroleum), heavy naphtha solvent;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]\n265-099-7\n64741-98-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-421-00-7\nDistillates (petroleum), chemically neutralized light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-132-5\n64742-31-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-422-00-2\nDistillates (petroleum), hydrotreated light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-149-8\n64742-47-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-423-00-8\nKerosine (petroleum), hydrodesulfurized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-184-9\n64742-81-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-424-00-3\nSolvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]\n265-198-5\n64742-94-5\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-425-00-9\nNaphtha (petroleum), heavy coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]\n269-778-9\n68333-23-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-426-00-4\nNaphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]\n285-508-2\n85116-57-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-427-00-X\nKerosine (petroleum), sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]\n294-799-5\n91770-15-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-428-00-5\nKerosine (petroleum), solvent-refined sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]\n295-416-4\n92045-36-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-429-00-0\nHydrocarbons, C9-16, hydrotreated, dearomatized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-854-1\n93763-35-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-430-00-6\nKerosine (petroleum), solvent-refined hydrodesulfurized;\nKerosine — unspecified\n307-033-2\n97488-94-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-431-00-1\nDistillates (petroleum), hydrodesulfurized full-range middle coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]\n309-864-6\n101316-58-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-432-00-7\nSolvent naphtha (petroleum), hydrodesulfurized heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]\n309-882-4\n101316-81-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-433-00-2\nSolvent naphtha (petroleum), hydrodesulfurized medium;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]\n309-884-5\n101316-82-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-434-00-8\nKerosine (petroleum), hydrotreated;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]\n309-944-0\n101631-19-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-435-00-3\nDistillates (petroleum), light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n265-060-4\n64741-59-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-436-00-9\nDistillates (petroleum), intermediate catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n265-062-5\n64741-60-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-437-00-4\nDistillates (petroleum), light hydrocracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]\n265-078-2\n64741-77-1\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-438-00-X\nDistillates (petroleum), light thermal cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]\n265-084-5\n64741-82-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-439-00-5\nDistillates (petroleum), hydrodesulfurized light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n269-781-5\n68333-25-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-440-00-0\nDistillates (petroleum), light steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]\n270-662-5\n68475-80-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-441-00-6\nDistillates (petroleum), cracked steam-cracked petroleum distillates;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]\n270-727-8\n68477-38-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-442-00-1\nGas oils (petroleum), steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]\n271-260-2\n68527-18-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-443-00-7\nDistillates (petroleum), hydrodesulfurized thermal cracked middle;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n285-505-6\n85116-53-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-444-00-2\nGas oils (petroleum), thermal-cracked, hydrodesulfurized;\nCracked gasoil\n295-411-7\n92045-29-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-445-00-8\nResidues (petroleum), hydrogenated steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]\n295-514-7\n92062-00-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-446-00-3\nResidues (petroleum), steam-cracked naphtha distn.;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]\n295-517-3\n92062-04-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-447-00-9\nDistillates (petroleum), light catalytic cracked, thermally degraded;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]\n295-991-1\n92201-60-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-448-00-4\nResidues (petroleum), steam-cracked heat-soaked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]\n297-905-8\n93763-85-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-449-00-X\nHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]\n307-662-2\n97675-88-2\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-450-00-5\nGas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]\n308-278-8\n97926-59-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-451-00-0\nDistillates (petroleum), hydrodesulfurized middle coker;\nCracked gasoil;\n[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]\n309-865-1\n101316-59-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-452-00-6\nDistillates (petroleum), heavy steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]\n309-939-3\n101631-14-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-453-00-1\nDistillates (petroleum), heavy hydrocracked;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]\n265-077-7\n64741-76-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-454-00-7\nDistillates (petroleum), solvent-refined heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-090-8\n64741-88-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-455-00-2\nDistillates (petroleum), solvent-refined light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-091-3\n64741-89-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-456-00-8\nResidual oils (petroleum), solvent deasphalted;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-096-0\n64741-95-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-457-00-3\nDistillates (petroleum), solvent-refined heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]\n265-097-6\n64741-96-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-458-00-9\nDistillates (petroleum), solvent-refined light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-098-1\n64741-97-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-459-00-4\nResidual oils (petroleum,) solvent-refined;\nBaseoil — unspecified;\n[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-101-6\n64742-01-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-460-00-X\nDistillates (petroleum), clay-treated paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-137-2\n64742-36-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-461-00-5\nDistillates (petroleum), clay-treated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-138-8\n64742-37-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-462-00-0\nResidual oils (petroleum), clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-143-5\n64742-41-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-463-00-6\nDistillates (petroleum), clay-treated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-146-1\n64742-44-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-464-00-1\nDistillates (petroleum), clay-treated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-147-7\n64742-45-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-465-00-7\nDistillates (petroleum), hydrotreated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-155-0\n64742-52-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-466-00-2\nDistillates (petroleum), hydrotreated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-156-6\n64742-53-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-467-00-8\nDistillates (petroleum), hydrotreated heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-157-1\n64742-54-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-468-00-3\nDistillates (petroleum), hydrotreated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-158-7\n64742-55-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-469-00-9\nDistillates (petroleum), solvent-dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-159-2\n64742-56-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-470-00-4\nResidual oils (petroleum), hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-160-8\n64742-57-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-471-00-X\nResidual oils (petroleum), solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-166-0\n64742-62-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-472-00-5\nDistillates (petroleum), solvent-dewaxed heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-167-6\n64742-63-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-473-00-0\nDistillates (petroleum), solvent-dewaxed light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-168-1\n64742-64-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-474-00-6\nDistillates (petroleum), solvent-dewaxed heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-169-7\n64742-65-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-475-00-1\nNaphthenic oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-172-3\n64742-68-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-476-00-7\nNaphthenic oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-173-9\n64742-69-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-477-00-2\nParaffin oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-174-4\n64742-70-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-478-00-8\nParaffin oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-176-5\n64742-71-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-479-00-3\nNaphthenic oils (petroleum), complex dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-179-1\n64742-75-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-480-00-9\nNaphthenic oils (petroleum), complex dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon' numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-180-7\n64742-76-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-481-00-4\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-736-3\n72623-85-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-482-00-X\nLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]\n276-737-9\n72623-86-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-483-00-5\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-738-4\n72623-87-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-484-00-0\nLubricating oils;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]\n278-012-2\n74869-22-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-485-00-6\nDistillates (petroleum), complex dewaxed heavy paraffinci;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-613-7\n90640-91-8\nCarc. Cat. 2; R45\nT\nR: 4\nS: 53-45\n\nH L\n649-486-00-1\nDistillates (petroleum), complex dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-614-2\n90640-92-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-487-00-7\nDistillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-616-3\n90640-94-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-488-00-2\nHydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-617-9\n90640-95-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-489-00-8\nDistillates (petroleum), solvent dewaxed light paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-618-4\n90640-96-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-490-00-3\nDistillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-620-5\n90640-97-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-491-00-9\nResidual oils (petroleum), hydrotreated solvent dewaxed;\nBaseoil — unspecified\n292-656-1\n90669-74-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-492-00-4\nResidual oils (petroleum), catalytic dewaxed;\nBaseoil — unspecified\n294-843-3\n91770-57-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-493-00-X\nDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]\n295-300-3\n91995-39-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-494-00-5\nDistillates (petroleum), dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]\n295-301-9\n91995-40-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-495-00-0\nDistillates (petroleum), hydrocracked solvent-refined, dewaxed;\nBaseoil — unspecified;\n[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]\n295-306-6\n91995-45-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-496-00-6\nDistillates (petroleum), solvent-refined light naphthenic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]\n295-316-0\n91995-54-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-497-00-1\nLubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;\nBaseoil — unspecified\n295-423-2\n92045-42-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-498-00-7\nLubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;\nBaseoil — unspecified\n295-424-8\n92045-43-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-499-00-2\nResidual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]\n295-499-7\n92061-86-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-500-00-6\nParaffin oils (petroleum), solvent-refined dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]\n295-810-6\n92129-09-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-501-00-1\nLubricating oils (petroleum), base oils, paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]\n297-474-6\n93572-43-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-502-00-7\nHydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;\nBaseoil — unspecified\n297-857-8\n93763-38-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-503-00-2\nHydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;\nBaseoil — unspecified\n300-257-1\n93924-61-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-504-00-8\nDistillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;\nBaseoil — unspecified\n305-588-5\n94733-08-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-505-00-3\nDistillates (petroleum), solvent-refined hydrocracked light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]\n305-589-0\n94733-09-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-506-00-9\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-594-8\n94733-15-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-507-00-4\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-595-3\n94733-16-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-508-00-X\nHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-971-7\n95371-04-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-509-00-5\nHydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-972-2\n95371-05-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-510-00-0\nHydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;\nBaseoil — unspecified\n305-974-3\n95371-07-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-511-00-6\nHydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;\nBaseoil — unspecified\n305-975-9\n95371-08-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-512-00-1\nDistillates (petroleum), hydrocracked solvent-refined light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]\n307-010-7\n97488-73-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-513-00-7\nDistillates (petroleum), solvent-refined hydrogenated heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]\n307-011-2\n97488-74-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-514-00-2\nLubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;\nBaseoil — unspecified\n307-034-8\n97488-95-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-515-00-8\nHydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]\n307-661-7\n97675-87-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-516-00-3\nHydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]\n307-755-8\n97722-06-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-517-00-9\nHydrocarbons, C13-27, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.]\n307-758-4\n97722-09-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-518-00-4\nHydrocarbons, C14-29, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]\n307-760-5\n97722-10-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-519-00-X\nHydrocarbons, C27-42, dearomatized;\nBaseoil — unspecified\n308-131-8\n97862-81-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-520-00-5\nHydrocarbons, C17-30, hydrotreated distillates, distn. lights;\nBaseoil — unspecified\n308-132-3\n97862-82-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-521-00-0\nHydrocarbons, C27-45, naphthenic vacuum distn.;\nBaseoil — unspecified\n308-133-9\n97862-83-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-522-00-6\nHydrocarbons, C27-45, dearomatized;\nBaseoil — unspecified\n308-287-7\n97926-68-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-523-00-1\nHydrocarbons, C20-58, hydrotreated;\nBaseoil — unspecified\n308-289-8\n97926-70-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-524-00-7\nHydrocarbons, C27-42, naphthenic;\nBaseoil — unspecified\n308-290-3\n97926-71-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-525-00-2\nResidual oils (petroleum), carbon-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]\n309-710-8\n100684-37-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-526-00-8\nResidual oils (petroleum), clay-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]\n309-711-3\n100684-38-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-527-00-3\nLubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]\n309-874-0\n101316-69-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-528-00-9\nLubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]\n309-875-6\n101316-70-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-529-00-4\nLubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]\n309-876-1\n101316-71-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-530-00-X\nLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]\n309-877-7\n101316-72-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-531-00-5\nExtracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;\nDistillate aromatic extract (treated);\n[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]\n272-175-3\n68783-00-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-532-00-0\nExtracts (petroleum), solvent-refined heavy paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n272-180-0\n68783-04-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-533-00-6\nExtracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]\n272-342-0\n68814-89-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-534-00-1\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]\n292-631-5\n90641-07-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-535-00-7\nExtracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).\n292-632-0\n90641-08-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-536-00-2\nExtracts (petroleum), light paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]\n292-633-6\n90641-09-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-537-00-8\nExtracts (petroleum), hydrotreated light paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n295-335-4\n91995-73-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-538-00-3\nExtracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n295-338-0\n91995-75-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-539-00-9\nExtracts (petroleum), light paraffinic distillate solvent, acid-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n295-339-6\n91995-76-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-540-00-4\nExtracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]\n295-340-1\n91995-77-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-541-00-X\nExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n295-342-2\n91995-79-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-542-00-5\nExtracts (petroleum), heavy paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]\n296-437-1\n92704-08-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-543-00-0\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-827-4\n93763-10-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-544-00-6\nExtracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-829-5\n93763-11-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-545-00-1\nExtracts (petroleum), light paraffinic distillate solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-672-2\n100684-02-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-546-00-7\nExtracts (petroleum), light paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-673-8\n100684-03-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-547-00-2\nExtracts (petroleum), light vacuum, gas oil solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-674-3\n100684-04-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-548-00-8\nExtracts (petroleum), light vacuum gas oil solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-675-9\n100684-05-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-549-00-3\nFoots oil (petroleum);\nFoots oil;\n[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n265-171-8\n64742-67-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-550-00-9\nFoots oil (petroleum), hydrotreated;\nFoots oil\n295-394-6\n92045-12-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n650-002-00-6\nturpentine, oil\n232-350-7\n8006-64-2\nR10\nXn; R20/21/22-65\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 10-20/21/22-36/38-43-51/53-65\nS: (2-)36/37-46-61-62\n\n\n650-003-00-1\nfenson (ISO);\n4-chlorophenyl benzenesulphonate;\n201-274-6\n80-38-6\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53\nS: (2-)24-26-61\n\n\n650-004-00-7\nnorbormide (ISO);\n5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide\n213-589-6\n991-42-4\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n650-005-00-2\n(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone\n201-501-9\n83-79-4\nT; R25\nXi; R36/37/38\nN; R50-53\nT; N\nR: 25-36/37/38-50/53\nS: (1/2-)22-24/25-36-45-60-61\n\n\n650-006-00-8\nbenquinox (ISO);\np-benzoquinone 1-benzoylhydrazone 4-oxime\n207-807-9\n495-73-8\nT; R25\nXn; R21\nT\nR: 21-25\nS: (1/2-)36/37-45\n\n\n650-007-00-3\nchlordimeform (ISO);\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine\n228-200-5\n6164-98-3\nCarc. Cat. 3; R40\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-40-50/53\nS: (2-)22-36/37-60-61\n\n\n650-008-00-9\ndrazoxolon (ISO);\n4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone\n227-197-8\n5707-69-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-24-36/37-45-60-61\n\n\n650-009-00-4\nchlordimeform hydrochloride;\nN'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride\n243-269-1\n19750-95-9\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)22-36/37-60-61\n\n\n650-010-00-X\nbenzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate\n216-901-9\n1694-09-3\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\n\n650-012-00-0\nerionite\n—\n12510-42-8\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\n\n650-013-00-6\nasbestos\n—\n—\n—\n—\n—\n—\n—\n12001-28-4\n132207-32-0\n12172-73-5\n77536-66-4\n77536-68-6\n77536-67-5\n12001-29-5\nCarc. Cat. 1; R45\nT; R48/23\nT\nR: 45-48/23 S: 53-45\n\nE\n650-014-00-1\ndiethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate\n401-770-4\n—\nC; R34\nXn; R22\nC\nR: 22-34\nS: (1/2-)26-36/37/39-45\n\n\n650-015-00-7\nrosin; colophony\n232-475-7\n232-484-6\n277-299-1\n8050-09-7\n8052-10-6\n73138-82-6\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n\n\n650-016-00-2\nMineral wool, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]\n—\n—\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nAQR\n\n650-017-00-8\nRefractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]\n—\n—\nCarc. Cat. 2; R49\nT\nR: 49\nS: 53-45\n\nAR\n\n650-018-00-3\nreaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid\n406-230-1\n—\nR10\nCarc. Cat. 3; R40\nC; R34\nXn; R20\nR43\nN; R50-53\nC; N\nR: 10-20-34-40-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n650-031-00-4\nbis(4-hydroxy-N-methylanilinium) sulphate\n200-237-1\n55-55-0\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)36/37-46-60-61\n\n\n650-032-00-X\ncyproconazole (ISO);\n(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol\n—\n94361-06-5\nRepr. Cat. 3; R63\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53-63\nS: (2-)36/37-60-61\n\n\n\n650-033-00-5\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate\n—\n66230-04-4\nT; R23/25\nR43\nN; R50-53\nT; N\nR: 23/25-43-50/53\nS: (1/2-)24-36/37/39-45-60-61\n\n\n\n650-041-00-9\ntriasulfuron (ISO);\n1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea\n—\n82097-50-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n650-042-00-4\nreaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates\n417-450-2\n—\nXi; R36/38\nR43\nR52-53\nXi\nR: 36/38-43-52/53\nS: (2-)24-26-37-61\n\n\n650-043-00-X\nreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate\n420-310-3\n—\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-56-60-61\n\n\n650-044-00-5\nmixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin\n420-480-9\n158570-99-1\nXi; R38\nR43\nN; R50-53\nXi; N\nR: 38-43-50/53\nS: (2-)24-37-60-61\n\n\n650-045-00-0\nreaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate\n417-110-3\n—\nF; R11\nXi; R38-41\nN; R51-53\nF; Xi; N\nR: 11-38-41-51/53\nS: (2-)9-16-26-37/39-61\n\n\n650-046-00-6\ndi(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates\n416-180-2\n12222-04-7\nXn; R22-48/22\nN; R51-53\nXn; N\nR: 22-48/22-51/53\nS: (2-)22-36-61\n\n\n650-047-00-1\ndibenzylphenylsulfonium hexafluoroantimonate\n417-760-8\n134164-24-2\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R51-53\nT; N\nR: 22-41-43-48/25-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n650-048-00-7\nreaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid\n420-070-1\n—\nO; R7\nXn; R20/21/22\nC; R35\nN; R50\nO; C; N\nR: 7-20/21/22-35-50\nS: (1/2-)3/7-14-26-36/37/39-45-61\n\n\n650-049-00-2\n2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl\n417-960-5\n—\nXi; R38-41\nR43\nN; R50-53\nXi; N\nR: 38-41-43-50/53\nS: (2-)24-26-37/39-60-61\n\n\n650-050-00-8\nreaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;\n1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;\n1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers\n423-600-8\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n650-055-00-5\nsilver sodium zirconium hydrogenphosphate\n422-570-3\n155925-27-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n", "after": "\nANNEX VI\nHarmonised classification and labelling for certain hazardous substances\nPart 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.\nPart 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.\nPart 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.\n\n\n1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED CLASSIFICATIONS AND LABELLING\n\n\n1.1. Information listed for each entry\n\n\n1.1.1. Numbering of entries and identification of a substance\n\n\n1.1.1.1. Index numbers\nEntries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled Index No.\n\n\n1.1.1.2. EC numbers\nThe EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS)\nOJ C 146A, 15.6.1990.. The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of No-longer-polymers (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled EC No.\n\n\n1.1.1.3. CAS number\nThe Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled CAS No.\n\n\n\n1.1.1.4. International Chemical Identification\nWherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of No-longer-polymers are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.\nImpurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.\nSome substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.\nWhere specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.\nWithout prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.\nCertain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: (containing ≥ xx % impurity). The reference in brackets is then to be considered as a part of the name, and must be included on the label.\n\n\n1.1.1.5. Entries for groups of substances\nA number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.\nIn some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase except those specified elsewhere in this Annex.\nIn some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.\nEntries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.\nEC or CAS numbers are not usually included for entries which comprise more than four individual substances.\n\n\n\n1.1.2. Information related to the classification and labelling of each entry in Table 3.1\n\n\n1.1.2.1. Classification codes\n\n\n1.1.2.1.1. Hazard class and category codes\nThe classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.\nThe Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.\n\nTable 1.1\n\nsee Note U in 1.1.3.\n\nHazard Class\nHazard Class and Category Code\nExplosive\nUnst. Expl.\nExpl. 1.1\nExpl. 1.2\nExpl. 1.3\nExpl. 1.4\nExpl. 1.5\nExpl. 1.6\nFlammable gas\nFlam. Gas 1\nFlam. Gas 2\nFlammable aerosol\nFlam. Aerosol 1\nFlam. Aerosol 2\nOxidising gas\nOx. Gas 1\nGases under pressure\nPress. Gas\n\nFlammable liquid\nFlam. Liq. 1\nFlam. Liq. 2\nFlam. Liq. 3\nFlammable solid\nFlam. Sol. 1\nFlam. Sol. 2\nSelf-reactive substance or mixture\nSelf-react. A\nSelf-react. B\nSelf-react. CD\nSelf-react. EF\nSelf-react. G\nPyrophoric liquid\nPyr. Liq. 1\nPyrophoric solid\nPyr. Sol. 1\nSelf-heating substance or mixture\nSelf-heat. 1\nSelf-heat. 2\nSubstance or mixture which in contact with water emits flammable gas\nWater-react. 1\nWater-react. 2\nWater-react. 3\nOxidising liquid\nOx. Liq. 1\nOx. Liq. 2\nOx. Liq. 3\nOxidising solid\nOx. Sol. 1\nOx. Sol. 2\nOx. Sol. 3\nOrganic peroxide\nOrg. Perox. A\nOrg. Perox. B\nOrg. Perox. CD\nOrg. Perox. EF\nOrg. Perox. G\nSubstance or mixture corrosive to metals\nMet. Corr. 1\nAcute toxicity\nAcute Tox. 1\nAcute Tox. 2\nAcute Tox. 3\nAcute Tox. 4\nSkin corrosion/irritation\nSkin Corr. 1A\nSkin Corr. 1B\nSkin Corr. 1C\nSkin Irrit. 2\nSerious eye damage/eye irritation\nEye Dam. 1\nEye Irrit. 2\nRespiratory/skin sensitization\nResp. Sens. 1, 1A, 1B\nSkin. Sens. 1, 1A, 1B\nGerm cell mutagenicity\nMuta. 1A\nMuta. 1B\nMuta. 2\nCarcinogenicity\nCarc. 1A\nCarc. 1B\nCarc. 2\nReproductive toxicity\nRepr. 1A\nRepr. 1B\nRepr. 2\nLact.\nSpecific target organ toxicity — single exposure\nSTOT SE 1\nSTOT SE 2\nSTOT SE 3\nSpecific target organ toxicity — repeated exposure\nSTOT RE 1\nSTOT RE 2\nAspiration hazard\nAsp. Tox. 1\nHazardous to the aquatic environment\nAquatic Acute 1\nAquatic Chronic 1\nAquatic Chronic 2\nAquatic Chronic 3\nAquatic Chronic 4\nHazardous for the ozone layer\nOzone 1\n\n\n1.1.2.1.2. Hazard statement codes\nThe hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:\n\nH350i\nMay cause cancer by inhalation.\nH360F\nMay damage fertility.\nH360D\nMay damage the unborn child.\nH361f\nSuspected of damaging fertility.\nH361d\nSuspected of damaging the unborn child.\nH360FD\nMay damage fertility. May damage the unborn child.\nH361fd\nSuspected of damaging fertility. Suspected of damaging the unborn child.\nH360Fd\nMay damage fertility. Suspected of damaging the unborn child.\nH360Df\nMay damage the unborn child. Suspected of damaging fertility.\n\n\n1.1.2.2. Labelling codes\nIn the labelling column, the following elements are listed:\n\n(i) the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;\n\n(ii) the signal word code Dgr for Dangeror Wng for Warning, in accordance with the precedence rule in Article 20(3);\n\n(iii) the hazard statement codes as specified in Annex III, in accordance with the classification;\n\n(iv) the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.\n\n\n1.1.2.3. Specific concentration limits and M-factors\nSpecific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.\nUnless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.\n\nIn case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in Table 3.1 in the same column as the specific concentration limits. In case an M-factor for Aquatic Acute 1 and an M-factor for Aquatic Chronic 1 have been harmonised, each M-factor shall be listed in the same line as its corresponding differentiation. Where a single M-factor is given in Table 3.1 and the substance is classified as Aquatic Acute 1 and Aquatic Chronic 1, this M-factor shall be used by the manufacturer, importer or downstream user for the classification of a mixture containing this substance for acute and long-term aquatic hazards using the summation method. Where no M-factor is given in Table 3.1, M-factor(s) based on available data for the substance shall be set by the manufacturer, importer or downstream user. For the setting and use of M-factors, see section 4.1.3.5.5.5 of Annex I.\n\n\n\n\n1.1.3. Notes assigned to an entry\nThe note(s) assigned to an entry are listed in the column entitled Notes. The meaning of the notes is as follows:\n\n\n1.1.3.1. Notes relating to the identification, classification and labelling of substances\n\nNote A:\nWithout prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.\nIn Part 3, use is sometimes made of a general description such as ... compounds or ... salts. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.\n\nNote B:\nSome substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.\nIn Part 3 entries with Note B have a general designation of the following type: nitric acid … %.\nIn this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.\n\nNote C:\nSome organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.\nIn this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.\n\nNote D:\nCertain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.\nHowever, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words non-stabilised.\n\nNote E (Table 3.2):\nSubstances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word Also.\n\nNote F:\nThis substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.\n\n\nNote G:\nThis substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.\n\n\nNote H (Table 3.1):\nThe classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.\nThe final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.\n\nNote H (Table 3.2):\nThe classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.\n\n\nNote J:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.\n\nNote K:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote L:\nThe classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote M:\nThe classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.\n\nNote N:\nThe classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.\n\nNote P:\nThe classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).\nWhen the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.\nThis note applies only to certain complex oil-derived substances in Part 3.\n\nNote Q:\nThe classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:\n\n\na short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or\na short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or\nan appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or\nabsence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.\n\nNote R:\nThe classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.\n\nNote S:\nThis substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).\nThis substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).\n\nNote T:\nThis substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.\n\nNote U (Table 3.1):\nWhen put on the market gases have to be classified as Gases under pressure, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.\n\n\n1.1.3.2. Notes relating to the classification and labelling of mixtures\n\nNote 1:\nThe concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.\n\nNote 2:\nThe concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.\n\nNote 3:\nThe concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.\n\nNote 5:\nThe concentration limits for gaseous mixtures are expressed as volume per volume percentage.\n\n\nNote 7:\nAlloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.\n\n\n1.1.4. Information related to the classification and labelling of each entry in Table 3.2\n\n\n1.1.4.1. Classification codes\nThe classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;\nThe abbreviation for each of the categories of danger is shown below:\n\nexplosive: E\noxidising: O\nextremely flammable: F+\nhighly flammable: F\nflammable: R10\nvery toxic: T+\nToxic: T\nharmful: Xn\ncorrosive: C\nirritant: Xi\nsensitising: R42 and/or R43\ncarcinogenic: Carc. Cat. (1, 2 or 3)\nmutagenic: Muta. Cat. (1, 2 or 3)\ntoxic for reproduction: Repr. Cat. (1, 2 or 3)\ndangerous for the environment: N or R52 and/or R53;\n\n\n1.1.4.2. Labelling codes\n\n(i) the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);\n\n(ii) the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;\n\n(iii) the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.\n\nNote that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.\nS1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.\nS2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.\nSafety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.\n\n\n1.1.4.3. Specific Concentration Limits\nThe concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.\nUnless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.\nWhere no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.\n\n\n1.1.4.4. Non-conformity with Table 3.1 for physical hazards\nIt is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.\nUntil these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference in Table 3.2.\n\n\n\n1.2. Classifications and hazard statements in table 3.1 arising from translation of classifications listed in Annex i to directive 67/548/EEC\n\n\n1.2.1. Minimum classification\nFor certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:\n\nthe manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;\nthe minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.\nMinimum classification for a category is indicated by the reference * in the column Classification in Table 3.1.\n\nThe reference * can also be found in the column Specific concentration Limits and M-factors where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be translated into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.\n\n\n1.2.2. Route of exposure cannot be excluded\nFor certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.\nThese hazard statements are indicated by the reference ** in Table 3.1.\n\n\n1.2.3. Hazard statements for reproductive toxicity\nHazard statements H360 and H361 indicate a general concern for effects on both fertility and development: May damage/Suspected of damaging fertility or the unborn child. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.\nIn order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.\nThese hazard statements are indicated by the reference *** in Table 3.1.\n\n\n1.2.4. Correct classification for physical hazards could not be established\nFor some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.\nThe entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.\n\n\n2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION AND LABELLING\nThis Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.\nThe relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.\n\nFor all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.\nA dossier for harmonised classification and labelling shall contain the following:\n\nProposal\nThe proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.\nJustification for the proposed harmonised classification and labelling\nA comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.\nJustification for other effects at Community level\nFor other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.\n\n\n3. PART 3: HARMONISED CLASSIFICATION AND LABELLING TABLES\n\nTable 3.1: List of harmonised classification and labelling of hazardous substances.\nTable 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC.\n\n\n\nTable 3.1\nList of harmonised classification and labelling of hazardous substances\n\nIndex No\nInternational Chemical Identification\nEC No\nCAS No\nClassification\nLabelling\nSpecific Conc. Limits, M-factors\nNotes\nHazard Class and Category Code(s)\nHazard statement Code(s)\nPictogram, Signal Word Code(s)\nHazard statement Code(s)\nSuppl. Hazard statement Code(s)\n\n\n001-001-00-9\nhydrogen\n215-605-7\n1333-74-0\nFlam. Gas 1\nPress. Gas\nH220\nGHS02\nGHS04\nDgr\nH220\n\n\nU\n\n\n001-002-00-4\naluminium lithium hydride\n240-877-9\n16853-85-3\nWater-react. 1\nSkin Corr. 1A\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\n\n\n\n\n001-003-00-X\nsodium hydride\n231-587-3\n7646-69-7\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\n\n001-004-00-5\ncalcium hydride\n232-189-2\n7789-78-8\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\n\n003-001-00-4\nlithium\n231-102-5\n7439-93-2\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n003-002-00-X\nn-hexyllithium\n404-950-0\n21369-64-2\nWater-react. 1\nPyr. Sol. 1\nSkin Corr. 1A\nH260\nH250\nH314\nGHS02\nGHS05\nDgr\nH260\nH250\nH314\nEUH014\n\n\n\n\n003-003-00-5\n(2-methylpropyl)lithium;\nisobutyllithium\n440-620-2\n920-36-5\nWater-react. 1\nPyr. Liq. 1\nSkin Corr. 1A\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH260\nH250\nH314\nH336\nH400\nH410\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH260\nH250\nH314\nH336\nH410\nEUH014\n\n\n\n\n004-001-00-7\nberyllium\n231-150-7\n7440-41-7\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nGHS06\nGHS08\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\n\n\n\n004-002-00-2\nberyllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex\n—\n—\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nH411\n\n\nA\n004-003-00-8\nberyllium oxide\n215-133-1\n1304-56-9\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\nGHS06\nGHS08\nDgr\nH350i\nH330\nH301\nH372 **\nH319\nH335\nH315\nH317\n\n\n\n005-001-00-X\nboron trifluoride\n231-569-5\n7637-07-2\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH314\nEUH014\n\nU\n005-002-00-5\nboron trichloride\n233-658-4\n10294-34-5\nPress. Gas\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1B\nH330\nH300\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH300\nH314\nEUH014\n\nU\n005-003-00-0\nboron tribromide\n233-657-9\n10294-33-4\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH300\nH314\nEUH014\n\n\n005-004-00-6\ntrialkylboranes, solid\n—\n—\nPyr. Sol. 1\nSkin Corr. 1B\nH250\nH314\nGHS02\nGHS05\nDgr\nH250\nH314\n\n\nA\n005-004-01-3\ntrialkylboranes, liquid\n—\n—\nPyr. Liq. 1\nSkin Corr. 1B\nH250\nH314\nGHS02\nGHS05\nDgr\nH250\nH314\n\n\nA\n005-005-00-1\ntrimethyl borate\n204-468-9\n121-43-7\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH312\nGHS02\nGHS07\nWng\nH226\nH312\n\n\n\n\n005-006-00-7\ndibutyltin hydrogen borate\n401-040-5\n75113-37-0\nRepr. 1B\nMuta. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH410\n\n\n\n\n\n\n\n005-007-00-2\nboric acid; [1]\nboric acid; [2]\n233-139-2 [1]\n234-343-4 [2]\n10043-35-3 [1]\n11113-50-1 [2]\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 5,5 %\n\n\n\n005-008-00-8\ndiboron trioxide;\nboric oxide\n215-125-8\n1303-86-2\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 3,1 %\n\n\n005-009-00-3\ntetrabutylammonium butyltriphenylborate\n418-080-4\n120307-06-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n005-010-00-9\nN,N-dimethylanilinium tetrakis(pentafluorophenyl)borate\n422-050-6\n118612-00-3\nCarc. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH351\nH302\nH315\nH318\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH302\nH315\nH318\n\n\n\n\n\n005-011-00-4\ndisodium tetraborate, anhydrous;\nboric acid, disodium salt; [1]\ntetraboron disodium heptaoxide, hydrate; [2]\northoboric acid, sodium salt [3]\n215-540-4 [1]\n235-541-3 [2]\n237-560-2 [3]\n1330-43-4 [1]\n12267-73-1 [2]\n13840-56-7 [3]\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 4,5 %\n\n\n005-011-01-1\ndisodium tetraborate decahydrate;\nborax decahydrate\n215-540-4\n1303-96-4\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 8,5 %\n\n\n005-011-02-9\ndisodium tetraborate pentahydrate;\nborax pentahydrate\n215-540-4\n12179-04-3\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\nRepr. 1B; H360FD: C ≥ 6,5 %\n\n\n\n005-012-00-X\ndiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate\n418-070-1\n141714-54-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n\n005-013-00-5\ndiethylmethoxyborane\n425-380-9\n7397-46-8\nPyr. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 4\nH250\nH332\nH312\nH302\nH373**\nH314\nH317\nH413\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH250\nH332\nH312\nH302\nH373**\nH314\nH317\nH413\n\n\n\n\n005-014-00-0\n4-formylphenylboronic acid\n438-670-5\n87199-17-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n005-015-00-6\n1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n414-380-4\n140681-55-6\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n005-016-00-1\ntetrabutylammonium butyl tris-(4-tert-butylphenyl)borate\n431-370-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n005-017-00-7\nsodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n231-556-4 [2]\n15120-21-5 [1]\n7632-04-4 [2]\nOx. Sol. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH302\nH335\nH318\nGHS03\nGHS05\nGHS08\nGHS07\nDgr\nH272\nH360Df\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n005-017-01-4\nsodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n231-556-4 [2]\n15120-21-5 [1]\n7632-04-4 [2]\nOx. Sol. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH331\nH302\nH335\nH318\nGHS03\nGHS06\nGHS05\nGHS08\nDgr\nH272\nH360Df\nH331\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n005-018-00-2\nperboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\nRepr. 1B\nSTOT SE 3\nEye Dam. 1\nH360Df\nH335\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH360Df\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %\n\n\n\n005-018-01-X\nperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH360Df\nH332\nH335\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH360Df\nH332\nH335\nH318\n\nRepr. 1B; H360 Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %\n\n\n\n005-019-00-8\nperboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]\n11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]\nOx. Sol. 3\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH302\nH335\nH318\nGHS03\nGHS05\nGHS08\nGHS07\nDgr\nH272\nH360Df\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n005-019-01-5\nperboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate [3]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]\n11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]\nOx. Sol. 3\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH272\nH360Df\nH331\nH302\nH335\nH318\nGHS03\nGHS06\nGHS05\nGHS08\nDgr\nH272\nH360Df\nH331\nH302\nH335\nH318\n\nRepr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %\n\n\n\n\n006-001-00-2\ncarbon monoxide\n211-128-3\n630-08-0\nFlam. Gas 1\nPress. Gas\nRepr. 1A\nAcute Tox. 3 *\nSTOT RE 1\nH220\nH360D ***\nH331\nH372 **\nGHS02\nGHS04\nGHS06\nGHS08\nDgr\nH220\nH360D ***\nH331\nH372 **\n\n\nU\n006-002-00-8\nphosgene;\ncarbonyl chloride\n200-870-3\n75-44-5\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nH330\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH330\nH314\n\n\nU\n006-003-00-3\ncarbon disulphide\n200-843-6\n75-15-0\nFlam. Liq. 2\nRepr. 2\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nH225\nH361fd\nH372 **\nH319\nH315\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH361fd\nH372 **\nH319\nH315\n\nRepr. 2; H361fd: C ≥ 1 %\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤C < 1 %\n\n006-004-00-9\ncalcium carbide\n200-848-3\n75-20-7\nWater-react. 1\nH260\nGHS02\nDgr\nH260\n\n\nT\n006-005-00-4\nthiram (ISO);\ntetramethylthiuram disulphide\n205-286-2\n137-26-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH373 **\nH319\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH332\nH302\nH373 **\nH319\nH315\nH317\nH410\n\nM = 10\n\n006-006-00-X\nhydrogen cyanide;\nhydrocyanic acid\n200-821-6\n74-90-8\nFlam. Liq. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH224\nH330\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH224\nH330\nH410\n\n\n\n006-006-01-7\nhydrogen cyanide … %;\nhydrocyanic acid … %\n200-821-6\n74-90-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\n\nB\n\n\n006-007-00-5\nsalts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\nEUH032\n\nA\n\n006-008-00-0\nantu (ISO);\n1-(1-naphthyl)-2-thiourea\n201-706-3\n86-88-4\nAcute Tox. 2 *\nCarc. 2\nH300\nH351\nGHS06\nGHS08\nDgr\nH300\nH351\n\n\n\n006-009-00-6\n1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;\nisolan\n204-318-2\n119-38-0\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n006-010-00-1\n5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;\ndimetan\n204-525-8\n122-15-6\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n\n\n\n006-011-00-7\ncarbaryl (ISO);\n1-naphthyl methylcarbamate\n200-555-0\n63-25-2\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH351\nH332\nH302\nH400\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH302\nH400\n\nM=100\n\n\n006-012-00-2\nziram (ISO);\nzinc bis dimethyldithiocarbamate\n205-288-3\n137-30-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH373 **\nH335\nH318\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH330\nH302\nH373 **\nH335\nH318\nH317\nH410\n\nM = 100\n\n006-013-00-8\nmetam-sodium (ISO);\nsodium methyldithiocarbamate\n205-293-0\n137-42-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\nEUH031\n\n\n006-014-00-3\nnabam (ISO);\ndisodium ethylenebis(N,N'-dithiocarbamate)\n205-547-0\n142-59-6\nAcute Tox. 4 *\nSTOT SE 3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH335\nH317\nH410\nGHS07\nGHS09\nWng\nH302\nH335\nH317\nH410\n\n\n\n\n006-015-00-9\ndiuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea\n206-354-4\n330-54-1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH373**\nH410\n\nM = 10\n\n\n\n006-016-00-4\npropoxur (ISO);\n2-isopropyloxyphenyl N-methylcarbamate;\n2-isopropoxyphenyl methylcarbamate\n204-043-8\n114-26-1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-017-00-X\naldicarb (ISO);\n2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime\n204-123-2\n116-06-3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH410\n\n\n\n006-018-00-5\naminocarb (ISO);\n4-dimethylamino-3-tolyl methylcarbamate\n217-990-7\n2032-59-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n006-019-00-0\ndi-allate (ISO);\nS-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate\n218-961-1\n2303-16-4\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n006-020-00-6\nbarban (ISO);\n4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate\n202-930-4\n101-27-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n006-021-00-1\nlinuron (ISO);\n3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea\n206-356-5\n330-55-2\nRepr. 1B\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH351\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360Df\nH351\nH302\nH373 **\nH410\n\n\n\n006-022-00-7\ndecarbofuran (ISO);\n2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate\n—\n1563-67-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n006-023-00-2\nmercaptodimethur (ISO);\nmethiocarb (ISO);\n3,5-dimethyl-4-methylthiophenyl N-methylcarbamate\n217-991-2\n2032-65-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-024-00-8\nproxan-sodium (ISO);\nsodium O-isopropyldithiocarbonate\n205-443-5\n140-93-2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 2\nH302\nH315\nH411\nGHS07\nGHS09\nWng\nH302\nH315\nH411\n\n\n\n006-025-00-3\nallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;\nbioallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]\nS-bioallethrin;\n(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]\nesbiothrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]\n209-542-4 [1]\n249-013-5 [2]-[3]\n584-79-2 [1]\n28434-00-6 [2]\n84030-86-4 [3]\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\n\nC\n006-026-00-9\ncarbofuran (ISO);\n2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate\n216-353-0\n1563-66-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\n\n006-028-00-X\ndinobuton (ISO);\n2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate\n213-546-1\n973-21-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-029-00-5\ndioxacarb (ISO);\n2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate\n230-253-4\n6988-21-2\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n006-030-00-0\nEPTC (ISO);\nS-ethyl dipropylthiocarbamate\n212-073-8\n759-94-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-031-00-6\nformetanate (ISO);\n3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate\n244-879-0\n22259-30-9\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH317\nH410\n\n\n\n006-032-00-1\nmonolinuron (ISO);\n3-(4-chlorophenyl)-1-methoxy-1-methylurea\n217-129-5\n1746-81-2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH410\n\n\n\n006-033-00-7\nmetoxuron (ISO);\n3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea\n243-433-2\n19937-59-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n006-034-00-2\npebulate (ISO);\nN-butyl-N-ethyl-S-propylthiocarbamate\n214-215-4\n1114-71-2\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-035-00-8\npirimicarb (ISO);\n5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate\n245-430-1\n23103-98-2\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-036-00-3\nbenzthiazuron (ISO);\n1-benzothiazol-2-yl-3-methylurea\n217-685-9\n1929-88-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-037-00-9\npromecarb (ISO);\n3-isopropyl-5-methylphenyl N-methylcarbamate\n220-113-0\n2631-37-0\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n006-038-00-4\nsulfallate (ISO);\n2-chloroallyl N,N-dimethyldithiocarbamate\n202-388-9\n95-06-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n006-039-00-X\ntri-allate (ISO);\nS-2,3,3-trichloroallyl diisopropylthiocarbamate\n218-962-7\n2303-17-5\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n006-040-00-5\n3-methylpyrazol-5-yl-dimethylcarbamate;\nmonometilan\n—\n2532-43-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n006-041-00-0\ndimethylcarbamoyl chloride\n201-208-6\n79-44-7\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH350\nH331\nH302\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH350\nH331\nH302\nH319\nH335\nH315\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n006-042-00-6\nmonuron (ISO);\n3-(4-chlorophenyl)-1,1-dimethylurea\n205-766-1\n150-68-5\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n006-043-00-1\n3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;\nmonuron-TCA\n—\n140-41-0\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH319\nH315\nH410\n\n\n\n006-044-00-7\nisoproturon (ISO);\n3-(4-isopropylphenyl)-1,1-dimethylurea\n251-835-4\n34123-59-6\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\nM = 10\n\n\n\n006-045-00-2\nmethomyl (ISO);\n1-(methylthio)ethylideneamino N-methylcarbamate\n240-815-0\n16752-77-5\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH410\n\nM=100\n\n\n\n006-046-00-8\nbendiocarb (ISO);\n2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate\n245-216-8\n22781-23-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH410\n\n\n\n006-047-00-3\nbufencarb (ISO);\nreaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate\n—\n8065-36-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n006-048-00-9\nethiofencarb (ISO);\n2-(ethylthiomethyl)phenyl N-methylcarbamate\n249-981-9\n29973-13-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-049-00-4\ndixanthogen;\nO,O-diethyl dithiobis(thioformate)\n207-944-4\n502-55-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-050-00-X\n1,1-dimethyl-3-phenyluronium trichloroacetate;\nfenuron-TCA\n—\n4482-55-7\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n006-051-00-5\nferbam (ISO);\niron tris(dimethyldithiocarbamate)\n238-484-2\n14484-64-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\n\n\n006-052-00-0\nformetanate hydrochloride;\n3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate\n245-656-0\n23422-53-9\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH317\nH410\n\n\n\n006-053-00-6\nisoprocarb (ISO);\n2-isopropylphenyl N-methylcarbamate\n220-114-6\n2631-40-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-054-00-1\nmexacarbate (ISO);\n3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate\n206-249-3\n315-18-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n006-055-00-7\nxylylcarb (ISO);\n3,4-dimethylphenyl N-methylcarbamate;\n3,4-xylyl methylcarbamate;\nMPMC\n219-364-9\n2425-10-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-056-00-2\nmetolcarb (ISO);\nm-tolyl methylcarbamate;\nMTMC\n214-446-0\n1129-41-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-057-00-8\nnitrapyrin (ISO);\n2-chloro-6-trichloromethylpyridine\n217-682-2\n1929-82-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-058-00-3\nnoruron (ISO);\n1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea\n—\n2163-79-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-059-00-9\noxamyl (ISO);\nN',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;\n245-445-3\n23135-22-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH330\nH300\nH312\nH411\nGHS06\nGHS09\nDgr\nH330\nH300\nH312\nH411\n\n\n\n006-060-00-4\noxycarboxin (ISO);\n2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide\n226-066-2\n5259-88-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n006-061-00-X\nS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;\nprothiocarb hydrochloride\n243-193-9\n19622-19-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-062-00-5\nmethyl 3,4-dichlorophenylcarbanilate;\nSWEP.\n—\n1918-18-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-063-00-0\nthiobencarb (ISO);\nS-4-chlorobenzyl diethylthiocarbamate\n248-924-5\n28249-77-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-064-00-6\nthiofanox (ISO);\n3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime\n254-346-4\n39196-18-4\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n006-065-00-1\n3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;\ntriamid\n—\n15271-41-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH300\nH311\nH411\nGHS06\nGHS09\nDgr\nH300\nH311\nH411\n\n\n\n006-066-00-7\nvernolate (ISO);\nS-propyl dipropylthiocarbamate\n217-681-7\n1929-77-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n006-067-00-2\nXMC;\n3,5-xylyl methylcarbamate\n—\n2655-14-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n006-068-00-8\ndiazomethane\n206-382-7\n334-88-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n006-069-00-3\nthiophanate-methyl (ISO);\n1,2-di-(3-methoxycarbonyl-2-thioureido)benzene\n245-740-7\n23564-05-8\nMuta. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH332\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH332\nH317\nH410\n\n\n\n006-070-00-9\nfurmecyclox (ISO);\nN-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide\n262-302-0\n60568-05-0\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n006-071-00-4\ncyclooct-4-en-1-yl methyl carbonate\n401-620-8\n87731-18-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n006-072-00-X\nprosulfocarb (ISO);\nS-benzyl N,N-dipropylthiocarbamate\n401-730-6\n52888-80-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n006-073-00-5\n3-(dimethylamino)propylurea\n401-950-2\n31506-43-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n006-074-00-0\n2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate\n402-440-2\n2094-99-7\nAcute Tox. 2 *\nSkin Corr. 1B\nSTOT RE 2 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH314\nH373 **\nH334\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH330\nH314\nH373 **\nH334\nH317\nH410\n\n\n\n\n\n006-076-00-1\nmancozeb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt\n—\n8018-01-7\nRepr. 2\nSkin Sens. 1\nAquatic Acute 1\nH361d***\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH317\nH400\n\nM=10\n\n\n006-077-00-7\nmaneb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric)\n235-654-8\n12427-38-2\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d***\nH332\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH332\nH319\nH317\nH410\n\nM=10\n\n\n006-078-00-2\nzineb (ISO);\nzinc ethylenebis(dithiocarbamate) (polymeric)\n235-180-1\n12122-67-7\nSTOT SE 3\nSkin Sens. 1\nH335\nH317\nGHS07\nWng\nH335\nH317\n\n\n\n006-079-00-8\ndisulfiram;\ntetraethylthiuramdisulfide\n202-607-8\n97-77-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n006-080-00-3\ntetramethylthiuram monosulphide\n202-605-7\n97-74-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n006-081-00-9\nzinc bis(dibutyldithiocarbamate)\n205-232-8\n136-23-2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH410\n\n\n\n006-082-00-4\nzinc bis(diethyldithiocarbamate)\n238-270-9\n14324-55-1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH317\nH410\n\n\n\n006-083-00-X\nbutocarboxim (ISO);\n3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime\n252-139-3\n34681-10-2\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH331\nH311\nH301\nH319\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH226\nH331\nH311\nH301\nH319\nH410\n\n\n\n\n\n\n006-084-00-5\ncarbosulfan (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate\n259-565-9\n55285-14-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH317\nH410\n\n\n\n\n006-085-00-0\nfenobucarb (ISO);\n2-butylphenyl methylcarbamate\n223-188-8\n3766-81-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n006-086-00-6\nethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;\nfenoxycarb\n276-696-7\n72490-01-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n006-087-00-1\nfurathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate\n265-974-3\n65907-30-4\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH373**\nH319\nH315\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH301\nH373**\nH319\nH315\nH317\nH410\n\nM = 100\n\n\n\n006-088-00-7\nbenfuracarb (ISO);\nethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate\n—\n82560-54-1\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH331\nH302\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361f***\nH331\nH302\nH410\n\n\n\n\n\n\n006-089-00-2\nchlorine dioxide\n233-162-8\n10049-04-4\nOx. Gas 1\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1\nH270\nH330\nH314\nH400\nGHS03\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH270\nH330\nH314\nH400\nEUH006\nM = 1000\nU\n006-089-01-X\nchlorine dioxide . . . %\n233-162-8\n10049-04-4\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH314\nH400\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 0,3 % ≤ C < 10 %\nSTOT SE 3; H335: C ≥ 3 %\nM = 10\nB\n\n006-090-00-8\n2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate\n408-010-0\n88558-41-2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH332\nH318\nH412\nGHS05\nGHS07\nDgr\nH332\nH318\nH412\n\n\n\n\n\n006-091-00-3\npropineb (ISO);\npolymeric zinc propylenebis(dithiocarbamate)\n—\n9016-72-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nH332\nH373**\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH332\nH373**\nH317\nH400\n\n\n\n\n006-092-00-9\ntert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate\n425-420-5\n98737-29-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n006-093-00-4\n2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)\n427-180-7\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n006-094-00-X\nO-isobutyl-N-ethoxy carbonylthiocarbamate\n434-350-4\n103122-66-3\nFlam. Liq. 3\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH226\nH350\nH340\nH302\nH373**\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH350\nH340\nH302\nH373**\nH317\nH411\n\n\n\n\n006-095-00-5\nfosetyl-aluminium (ISO);\naluminium triethyl triphosphonate\n254-320-2\n39148-24-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n006-096-00-0\nchlorpropham (ISO);\nisopropyl 3-chlorocarbanilate\n202-925-7\n101-21-3\nCarc. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH351\nH373**\nH411\nGHS08\nGHS09\nWng\nH351\nH373**\nH411\n\n\n\n\n006-097-00-6\n1-phenyl-3-(p-toluenesulfonyl)urea\n424-620-1\n13909-63-2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n006-098-00-1\ntert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate\n429-170-8\n134575-17-0\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\n\n\n\n\n\n006-099-00-7\nN-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;\n3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate\n520-2\n232938-43-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n006-101-00-6\nreaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];\nN-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;\nN,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]\n423-070-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n006-102-00-1\nO-hexyl-N-ethoxycarbonylthiocarbamate\n432-750-3\n—\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH340\nH302\nH373**\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH340\nH302\nH373**\nH317\nH411\n\n\n\n\n006-103-00-7\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea\n445-760-8\n—\nEye Dam. 1\nResp. Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH334\nH400\nH410\nGHS05\nGHS08\nGHS09\nDgr\nH318\nH334\nH410\n\nM=100\n\n\n007-001-00-5\nammonia, anhydrous\n231-635-3\n7664-41-7\nFlam. Gas 2\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH221\nH331\nH314\nH400\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH221\nH331\nH314\nH400\n\n\nU\n007-001-01-2\nammonia ….%\n215-647-6\n1336-21-6\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\nB\n\n\n007-002-00-0\nnitrogen dioxide; [1]\ndinitrogen tetraoxide [2]\n233-272-6 [1]\n234-126-4 [2]\n10102-44-0 [1]\n10544-72-6 [2]\nPress. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1B\nH270\nH330\nH314\nGHS04\nGHS03\nGHS06\nGHS05\nDgr\nH270\nH330\nH314\n\n*\nSTOT SE 3; H335: C ≥ 0,5 %\n5\n\n007-003-00-6\nchlormequat chloride (ISO);\n2-chloroethyltrimethylammonium chloride\n213-666-4\n999-81-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n007-004-00-1\nnitric acid … %\n231-714-2\n7697-37-2\nOx. Liq. 3\nSkin Corr. 1A\nH272\nH314\nGHS03\nGHS05\nDgr\nH272\nH314\n\nSkin Corr. 1A; H314: C ≥ 20 %\nSkin Corr. 1B; H314: 5 % ≤ C < 20 %\nOx. Liq. 3; H272: C ≥ 65 %\nB\n007-006-00-2\nethyl nitrite\n203-722-6\n109-95-5\nFlam. Gas 1\nPress. Gas\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH220\nH332\nH312\nH302\nGHS02\nGHS04\nGHS07\nDgr\nH220\nH332\nH312\nH302\n\n\nU\n\n007-007-00-8\nethyl nitrate\n210-903-3\n625-58-1\nUnst. Expl.\nH200\nGHS01\nDgr\nH200\n\n\n\n\n007-008-00-3\nhydrazine\n206-114-9\n302-01-2\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 3 % ≤ C < 10 %\n\n007-009-00-9\ndicyclohexylammonium nitrite\n221-515-9\n3129-91-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n*\n\n007-010-00-4\nsodium nitrite\n231-555-9\n7632-00-0\nOx. Sol. 3\nAcute Tox. 3 *\nAquatic Acute 1\nH272\nH301\nH400\nGHS03\nGHS06\nGHS09\nDgr\nH272\nH301\nH400\n\n*\n\n007-011-00-X\npotassium nitrite\n231-832-4\n7758-09-0\nOx. Sol. 2\nAcute Tox. 3 *\nAquatic Acute 1\nH272\nH301\nH400\nGHS03\nGHS06\nGHS09\nDgr\nH272\nH301\nH400\n\n*\n\n007-012-00-5\nN,N-dimethylhydrazine\n200-316-0\n57-14-7\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH225\nH350\nH331\nH301\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH331\nH301\nH314\nH411\n\n\n\n007-013-00-0\n1,2-dimethylhydrazine\n—\n540-73-8\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n007-014-00-6\nsalts of hydrazine\n—\n—\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH331\nH311\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH317\nH410\n\n\nA\n007-015-00-1\nO-ethylhydroxylamine\n402-030-3\n624-86-2\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH225\nH331\nH311\nH301\nH372 **\nH319\nH317\nH400\nGHS02\nGHS06\nGHS08\nGHS09\nDgr\nH225\nH331\nH311\nH301\nH372 **\nH319\nH317\nH400\n\n\n\n007-016-00-7\nbutyl nitrite\n208-862-1\n544-16-1\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nH225\nH331\nH301\nGHS02\nGHS06\nDgr\nH225\nH331\nH301\n\n\n\n007-017-00-2\nisobutyl nitrite\n208-819-7\n542-56-3\nFlam. Liq. 2\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH350\nH341\nH332\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH350\nH341\nH332\nH302\n\n\n\n007-018-00-8\nsec-butyl nitrite\n213-104-8\n924-43-6\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-019-00-3\ntert-butyl nitrite\n208-757-0\n540-80-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-020-00-9\npentyl nitrite; [1]\namyl nitrite, mixed isomers [2]\n207-332-7 [1]\n203-770-8 [2]\n463-04-7 [1]\n110-46-3 [2]\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\n\n\n\n007-021-00-4\nhydrazobenzene;\n1,2-diphenylhydrazine\n204-563-5\n122-66-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n007-022-00-X\nhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)\n405-030-1\n—\nCarc. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH302\nH314\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH302\nH314\nH317\nH412\n\n\n\n007-023-00-5\nsodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate\n405-510-0\n—\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n007-024-00-0\n2-(decylthio)ethylammonium chloride\n405-640-8\n36362-09-1\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH315\nH318\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH315\nH318\nH410\n\n\n\n007-025-00-6\n(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride\n406-090-1\n81880-96-8\nMuta. 2\nAcute Tox. 3 *\nSTOT RE 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH301\nH372 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH301\nH372 **\nH317\nH410\n\n\n\n007-026-00-1\noxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide\n413-230-5\n122035-71-6\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n007-027-00-7\n1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane\n420-190-2\n771478-66-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n\n\n007-028-00-2\nhydroxylammonium nitrate\n236-691-2\n13465-08-2\nExpl. 1.1 ****\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH201\nH351\nH311\nH302\nH373**\nH319\nH315\nH317\nH400\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH351\nH311\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\n\n\n007-029-00-8\ndiethyldimethylammonium hydroxide\n419-400-5\n95500-19-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n\n008-001-00-8\noxygen\n231-956-9\n7782-44-7\nOx. Gas 1\nPress. Gas\nH270\nGHS03\nGHS04\nDgr\nH270\n\n\nU\n008-003-00-9\nhydrogen peroxide solution … %\n231-765-0\n7722-84-1\nOx. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH271\nH332\nH302\nH314\nGHS03\nGHS05\nGHS07\nDgr\nH271\nH332\nH302\nH314\n\nOx. Liq. 1; H271: C ≥ 70 %****\nOx. Liq. 2; H272: 50 % ≤ C < 70 % ****\n*\nSkin Corr. 1A; H314: C ≥ 70 %\nSkin Corr. 1B; H314: 50 % ≤ C < 70 %\nSkin Irrit. 2; H315: 35 % ≤ C < 50 %\nEye Dam. 1; H318: 8 % ≤ C < 50 %\nEye Irrit. 2; H319: 5 % ≤ C < 8 %\nSTOT SE 3; H335; C ≥ 35 %\nB\n\n\n009-001-00-0\nfluorine\n231-954-8\n7782-41-4\nPress. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH270\nH330\nH314\nGHS04\nGHS03\nGHS06\nGHS05\nDgr\nH270\nH330\nH314\n\n\n\n\n\n009-002-00-6\nhydrogen fluoride\n231-634-8\n7664-39-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH310\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH310\nH300\nH314\n\n\n\n009-003-00-1\nhydrofluoric acid … %\n231-634-8\n7664-39-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1A\nH330\nH310\nH300\nH314\nGHS06\nGHS05\nDgr\nH330\nH310\nH300\nH314\n\nSkin Corr. 1A; H314: C ≥ 7 %\nSkin Corr. 1B; H314: 1 % ≤ C < 7 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\nB\n009-004-00-7\nsodium fluoride\n231-667-8\n7681-49-4\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH319\nH315\nGHS06\nDgr\nH301\nH319\nH315\nEUH032\n\n\n009-005-00-2\npotassium fluoride\n232-151-5\n7789-23-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n009-006-00-8\nammonium fluoride\n235-185-9\n12125-01-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n009-007-00-3\nsodium bifluoride;\nsodium hydrogen difluoride\n215-608-3\n1333-83-1\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-008-00-9\npotassium bifluoride;\npotassium hydrogen difluoride\n232-156-2\n7789-29-9\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-009-00-4\nammonium bifluoride;\nammonium hydrogen difluoride\n215-676-4\n1341-49-7\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 1 %\nSkin Irrit. 2; H315: 0,1 % ≤ C < 1 %\nEye Irrit. 2; H319: 0,1 % ≤ C < 1 %\n\n009-010-00-X\nfluoroboric acid ... %\n240-898-3\n16872-11-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n009-011-00-5\nfluorosilicic acid ... %\n241-034-8\n16961-83-4\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\nB\n009-012-00-0\nalkali fluorosilicates(Na); [1]\nalkali fluorosilicates(K); [2]\nalkali fluorosilicates(NH4) [3]\n240-934-8 [1]\n240-896-2 [2]\n240-968-3 [3]\n16893-85-9 [1]\n16871-90-2 [2]\n16919-19-0 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n*\nA\n009-013-00-6\nfluorosilicates, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n*\nA\n009-014-00-1\nlead hexafluorosilicate\n247-278-1\n25808-74-6\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n009-015-00-7\nsulphuryl difluoride\n220-281-5\n2699-79-8\nPress. Gas\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH373 **\nH400\nGHS04\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH373 **\nH400\n\n\nU\n\n009-016-00-2\ntrisodium hexafluoroaluminate [1]\n237-410-6 [1]\n13775-53-6 [1]\nSTOT RE 1\nAcute Tox. 4\nAquatic Chronic 2\nH372\nH332\nH411\nGHS07\nGHS08\nGHS09\nDgr\nH372\nH332\nH411\n\n\n\ntrisodium hexafluoroaluminate (cryolite) [2]\n239-148-8 [2]\n15096-52-3 [2]\n\n009-017-00-8\npotassium mu-fluoro-bis(triethylaluminium)\n400-040-2\n12091-08-6\nFlam. Sol. 1\nWater-react. 1\nSkin Corr. 1A\nAcute Tox. 4 *\nH228\nH270\nH314\nH332\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH270\nH314\nH332\nEUH014\n\nT\n009-018-00-3\nmagnesium hexafluorosilicate\n241-022-2\n16949-65-8\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n*\n\n011-001-00-0\nsodium\n231-132-9\n7440-23-5\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n011-002-00-6\nsodium hydroxide;\ncaustic soda\n215-185-5\n1310-73-2\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 5 %\nSkin Corr. 1B; H314: 2 % ≤ C < 5 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 2 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\n\n011-003-00-1\nsodium peroxide\n215-209-4\n1313-60-6\nOx. Sol. 1\nSkin Corr. 1A\nH271\nH314\nGHS03\nGHS05\nDgr\nH271\nH314\n\n\n\n011-004-00-7\nsodium azide\n247-852-1\n26628-22-8\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH400\nH410\nEUH032\n\n\n011-005-00-2\nsodium carbonate\n207-838-8\n497-19-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n011-006-00-8\nsodium cyanate\n213-030-6\n917-61-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n011-007-00-3\npropoxycarbazone-sodium\n—\n181274-15-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 10\n\n012-001-00-3\nmagnesium powder (pyrophoric)\n231-104-6\n7439-95-4\nWater-react. 1\nPyr. Sol. 1\nH260\nH250\nGHS02\nDgr\nH260\nH250\n\n\nT\n012-002-00-9\nmagnesium, powder or turnings\n231-104-6\n—\nFlam. Sol. 1\nWater-react. 2\nSelf-heat. 1\nH228\nH261\nH252\nGHS02\nDgr\nH228\nH261\nH252\n\n\nT\n012-003-00-4\nmagnesium alkyls\n—\n—\nPyr. Liq. 1\nWater-react. 1\nSkin Corr. 1B\nH250\nH260\nH314\nGHS02\nGHS05\nDgr\nH250\nH260\nH314\nEUH014\n\nA\n\n\n012-004-00-X\naluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate\n422-150-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n013-001-00-6\naluminium powder (pyrophoric)\n231-072-3\n7429-90-5\nWater-react. 2\nPyr. Sol. 1\nH261\nH250\nGHS02\nDgr\nH261\nH250\n\n\nT\n\n\n013-002-00-1\naluminium powder (stabilised)\n231-072-3\n7429-90-5\nWater-react. 2\nFlam. Sol. 1\nH261\nH228\nGHS02\nDgr\nH261\nH228\n\n\nT\n\n013-003-00-7\naluminium chloride, anhydrous\n231-208-1\n7446-70-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n013-004-00-2\naluminium alkyls\n—\n—\nPyr. Liq. 1\nWater-react. 1\nSkin Corr. 1B\nH250\nH260\nH314\nGHS02\nGHS05\nDgr\nH250\nH260\nH314\nEUH014\n\nA\n013-005-00-8\ndiethyl(ethyldimethylsilanolato)aluminium\n401-160-8\n55426-95-4\nWater-react. 1\nPyr. Liq. 1\nSkin Corr. 1A\nH260\nH250\nH314\nGHS02\nGHS05\nDgr\nH260\nH250\nH314\nEUH014\n\n\n013-006-00-3\n(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised\n402-370-2\n—\nFlam. Liq. 3\nEye Dam. 1\nH226\nH318\nGHS02\nGHS05\nDgr\nH226\nH318\n\n\n\n013-007-00-9\npoly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)\n403-430-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n013-008-00-4\ndi-n-octylaluminium iodide\n408-190-0\n7585-14-0\nPyr. Liq. 1\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH250\nH314\nH400\nH410\nGHS02\nGHS05\nGHS09\nDgr\nH250\nH314\nH410\nEUH014\n\n\n013-009-00-X\nsodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5\n418-720-2\n—\nFlam. Sol. 1\nWater-react. 1\nPyr. Sol. 1\nAcute Tox. 4 *\nSkin Corr. 1A\nH228\nH260\nH250\nH332\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH260\nH250\nH332\nH314\nEUH014\n\nT\n\n\n013-010-00-5\nhydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)\n430-650-4\n151841-65-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n014-001-00-9\ntrichlorosilane\n233-042-5\n10025-78-2\nFlam. Liq. 1\nPyr. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH224\nH250\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH224\nH250\nH332\nH302\nH314\nEUH014\nEUH029\n*\nSTOT SE 3; H335: C ≥ 1 %\nT\n014-002-00-4\nsilicon tetrachloride\n233-054-0\n10026-04-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\nEUH014\n\n\n014-003-00-X\ndimethyldichlorosilane\n200-901-0\n75-78-5\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\n\n\n\n014-004-00-5\ntrichloro(methyl)silane;\nmethyltrichlorosilane\n200-902-6\n75-79-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\nEUH014\nSkin Irrit. 2; H315: C ≥ 1 %\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n014-005-00-0\ntetraethyl silicate;\nethyl silicate\n201-083-8\n78-10-4\nFlam. Liq. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH226\nH332\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH332\nH319\nH335\n\n\n\n014-006-00-6\nbis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride\n401-380-4\n—\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n014-007-00-1\ntriethoxyisobutylsilane\n402-810-3\n17980-47-1\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n014-008-00-7\n(chloromethyl)bis(4-fluorophenyl)methylsilane\n401-200-4\n85491-26-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-009-00-2\nisobutylisopropyldimethoxysilane\n402-580-4\n111439-76-0\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Irrit. 2\nH226\nH332\nH315\nGHS02\nGHS07\nWng\nH226\nH332\nH315\n\n\n\n014-010-00-8\ndisodium metasilicate\n229-912-9\n6834-92-0\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\n\n\n014-011-00-3\ncyclohexyldimethoxymethylsilane\n402-140-1\n17865-32-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n014-012-00-9\nbis(3-(trimethoxysilyl)propyl)amine\n403-480-3\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n014-013-00-4\nα-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)\n404-920-7\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH312\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH411\n\n\n\n014-014-00-X\netacelasil (ISO);\n6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane\n253-704-7\n37894-46-5\nRepr. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nH360D ***\nH302\nH373 **\nGHS08\nGHS07\nDgr\nH360D ***\nH302\nH373 **\n\n\n\n014-015-00-5\nα-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))\n406-420-4\n69430-40-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n014-016-00-0\nreaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;\n1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane\n406-490-6\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-017-00-6\nflusilazole (ISO);\nbis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane\n—\n85509-19-9\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360D ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D ***\nH302\nH411\n\n\n\n014-018-00-1\noctamethylcyclotetrasiloxane\n209-136-7\n556-67-2\nRepr. 2\nAquatic Chronic 4\nH361f ***\nH413\nGHS08\nWng\nH361f ***\nH413\n\n\n\n014-019-00-7\nreaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;\n1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole\n403-250-2\n—\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360D ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D ***\nH302\nH411\n\n\n\n014-020-00-2\nbis(1,1-dimethyl-2-propynyloxy)dimethylsilane\n414-960-7\n53863-99-3\nAcute Tox. 4 *\nH332\nGHS07\nWng\nH332\n\n\n\n014-021-00-8\ntris(isopropenyloxy)phenyl silane\n411-340-8\n52301-18-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH400\nH410\n\n\n\n014-022-00-3\nreaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)\n401-530-9\n—\nFlam. Sol. 1\nSTOT SE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH228\nH370 **\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH370 **\nH332\nH312\nH302\n\n\nT\n014-023-00-9\nα, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole\n408-160-7\n125613-45-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-024-00-4\n1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene\n412-620-2\n121626-74-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n014-025-00-X\n4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine\n411-400-3\n102089-33-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH302\nH373 **\nH315\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH315\nH318\nH412\n\n\n\n014-026-00-5\ndichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane\n407-180-3\n770722-36-6\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n014-027-00-0\nchloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane\n410-270-5\n770722-46-8\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n014-028-00-6\nα-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)\n415-290-8\n193159-06-7\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n014-029-00-1\nO,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]\n421-870-1\n156145-66-3\nRepr. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nH361f ***\nH302\nH373 **\nGHS08\nGHS07\nWng\nH361f ***\nH302\nH373 **\n\n\n\n014-030-00-7\n[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium\n422-060-0\n137390-08-0\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n014-031-00-2\nbis(1-methylethyl)-dimethoxysilane\n421-540-7\n18230-61-0\nFlam. Liq. 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH315\nH317\nH412\nGHS02\nGHS07\nWng\nH226\nH315\nH317\nH412\n\n\n\n014-032-00-8\ndicyclopentyldimethoxysilane\n404-370-8\n126990-35-0\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n\n\n014-033-00-3\n2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica\n419-030-4\n125804-20-8\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\n\n\n\n\n014-034-00-9\n3-hexylheptamethyltrisiloxane\n428-700-5\n1873-90-1\nAcute Tox. 4 *\nAquatic Chronic 4\nH332\nH413\nGHS07\nWng\nH332\nH413\n\n\n\n\n014-035-00-4\n2-(3,4-epoxycyclohexyl)ethyltriethoxy silane\n425-050-4\n10217-34-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n014-036-00-X\n(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane\n405-020-7\n105024-66-6\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360F***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360F***\nH410\n\nM=1000\n\n\n014-037-00-5\n2-butanone-O,O',O''-(phenylsilylidyne)trioxime\n433-360-6\n34036-80-1\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373**\nH317\nH412\nGHS08\nGHS07\nWng\nH373**\nH317\nH412\n\n\n\n\n014-038-00-0\nS-(3-(triethoxysilyl)propyl) octanethioate\n436-690-9\n220727-26-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n014-039-00-6\n(2,3-dimethylbut-2-yl)-trimethoxysilane\n439-360-2\n142877-45-0\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n014-041-00-7\nN,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane\n445-890-5\n201290-01-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n014-042-00-2\nreaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-010-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n014-043-00-8\nreaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)\n432-200-2\n—\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH335\nH315\nH318\nH412\nGHS05\nGHS07\nDgr\nH335\nH315\nH318\nH412\n\n\n\n\n\n014-044-00-3\n3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane\n433-050-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n014-045-00-9\nmagnesium sodium fluoride silicate\n442-650-1\n—\nSTOT RE 2 *\nH373**\nGHS08\nWng\nH373**\n\n\n\n\n015-001-00-1\nwhite phosphorus\n231-768-7\n12185-10-3\nPyr. Sol. 1\nAcute Tox. 2 *\nAcute Tox. 2 *\nSkin Corr. 1A\nAquatic Acute 1\nH250\nH330\nH300\nH314\nH400\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH250\nH330\nH300\nH314\nH400\n\n\n\n015-002-00-7\nred phosphorus\n231-768-7\n7723-14-0\nFlam. Sol. 1\nAquatic Chronic 3\nH228\nH412\nGHS02\nDgr\nH228\nH412\n\n\n\n\n\n015-003-00-2\ncalcium phosphide;\ntricalcium diphosphide\n215-142-0\n1305-99-3\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nM=100\n\n\n015-004-00-8\naluminium phosphide\n244-088-0\n20859-73-8\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nEUH032\nM=100\n\n\n015-005-00-3\nmagnesium phosphide;\ntrimagnesium diphosphide\n235-023-7\n12057-74-8\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH260\nH300\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH400\nEUH029\nM=100\n\n\n015-006-00-9\ntrizinc diphosphide;\nzinc phosphide\n215-244-5\n1314-84-7\nWater-react. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH260\nH300\nH400\nH410\nGHS02\nGHS06\nGHS09\nDgr\nH260\nH300\nH410\nEUH029\nEUH032\nM=100\nT\n\n015-007-00-4\nphosphorus trichloride\n231-749-3\n7719-12-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nSTOT RE 2 *\nSkin Corr. 1A\nH330\nH300\nH373 **\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH300\nH373 **\nH314\nEUH014\nEUH029\n\n\n015-008-00-X\nphosphorus pentachloride\n233-060-3\n10026-13-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nH330\nH302\nH373 **\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH302\nH373 **\nH314\nEUH014\nEUH029\n\n\n015-009-00-5\nphosphoryl trichloride\n233-046-7\n10025-87-3\nAcute Tox. 2 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1A\nH330\nH372 **\nH302\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH372 **\nH302\nH314\nEUH014\nEUH029\n\n\n015-010-00-0\nphosphorus pentoxide\n215-236-1\n1314-56-3\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n015-011-00-6\nphosphoric acid ... %, orthophosphoric acid ... %\n231-633-2\n7664-38-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n015-012-00-1\ntetraphosphorus trisulphide;\nphosphorus sesquisulphid\n215-245-0\n1314-85-8\nFlam. Sol. 2\nWater-react. 1\nAcute Tox. 4 *\nAquatic Acute 1\nH228\nH260\nH302\nH400\nGHS02\nGHS07\nGHS09\nDgr\nH228\nH260\nH302\nH400\n\n\nT\n015-013-00-7\ntriethyl phosphate\n201-114-5\n78-40-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-014-00-2\ntributyl phosphate\n204-800-2\n126-73-8\nCarc. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nH351\nH302\nH315\nGHS08\nGHS07\nWng\nH351\nH302\nH315\n\n\n\n015-015-00-8\ntricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\ntritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\n201-103-5\n78-30-8\nSTOT SE 1\nAquatic Chronic 2\nH370 **\nH411\nGHS08\nGHS09\nDgr\nH370 **\nH411\n\nSTOT SE 1; H370: C ≥ 1 %\nSTOT SE 2; H371: 0,2 % ≤ C < 1 %\nC\n015-016-00-3\ntricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\ntritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\n201-105-6\n78-32-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH302\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH411\n\n*\nC\n\n\n015-019-00-X\ndichlorvos (ISO);\n2,2-dichlorovinyl dimethyl phosphate\n200-547-7\n62-73-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nH330\nH311\nH301\nH317\nH400\nGHS06\nGHS09\nDgr\nH330\nH311\nH301\nH317\nH400\n\nM=1000\n\n\n015-020-00-5\nmevinphos (ISO);\n2-methoxycarbonyl-1-methylvinyl dimethyl phosphate\n232-095-1\n7786-34-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 10000\n\n015-021-00-0\ntrichlorfon (ISO);\ndimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate\n200-149-3\n52-68-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH400\nH410\n\nM = 1000\n\n015-022-00-6\nphosphamidon (ISO);\n2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate\n236-116-5\n13171-21-6\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH300\nH311\nH410\n\n\n\n015-023-00-1\npyrazoxon;\ndiethyl 3-methylpyrazol-5-yl phosphate\n—\n108-34-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n015-024-00-7\ntriamiphos (ISO);\n5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide\n—\n1031-47-6\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-025-00-2\nTEPP (ISO);\ntetraethyl pyrophosphate\n203-495-3\n107-49-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-026-00-8\nschradan (ISO);\noctamethylpyrophosphoramide\n205-801-0\n152-16-9\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-027-00-3\nsulfotep (ISO);\nO,O,O,O-tetraethyl dithiopyrophosphate\n222-995-2\n3689-24-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n015-028-00-9\ndemeton-O (ISO);\nO,O-diethyl-O-2-ethylthioethyl phosphorothioate\n206-053-8\n298-03-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-029-00-4\ndemeton-S (ISO);\ndiethyl-S-2-ethylthioethyl phosphorothioate\n204-801-8\n126-75-0\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-030-00-X\ndemeton-O-methyl (ISO);\nO-2-ethylthioethyl O,O-dimethyl phosphorothioate\n212-758-1\n867-27-6\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n015-031-00-5\ndemeton-S-methyl (ISO);\nS-2-ethylthioethyl dimethyl phosphorothioate\n213-052-6\n919-86-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH311\nH301\nH411\n\n\n\n015-032-00-0\nprothoate (ISO);\nO,O-diethyl isopropylcarbamoylmethyl phosphorodithioate\n218-893-2\n2275-18-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 3\nH310\nH300\nH412\nGHS06\nDgr\nH310\nH300\nH412\n\n\n\n015-033-00-6\nphorate (ISO);\nO,O-diethyl ethylthiomethyl phosphorodithioate\n206-052-2\n298-02-2\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n015-034-00-1\nparathion (ISO);\nO,O-diethyl O-4-nitrophenyl phosphorothioate\n200-271-7\n56-38-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH300\nH311\nH372 **\nH410\n\nM = 100\n\n015-035-00-7\nparathion — methyl (ISO);\nO,O-dimethyl O-4-nitrophenyl phosphorothioate\n206-050-1\n298-00-0\nFlam. Liq. 3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH330\nH300\nH311\nH373 **\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS09\nDgr\nH226\nH330\nH300\nH311\nH373 **\nH410\n\nM = 100\n\n015-036-00-2\nO-ethyl O-4-nitrophenyl phenylphosphonothioate;\nEPN\n218-276-8\n2104-64-5\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-037-00-8\nphenkapton (ISO);\nS-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate\n218-892-7\n2275-14-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n015-038-00-3\ncoumaphos (ISO);\nO-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate\n200-285-3\n56-72-4\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n015-039-00-9\nazinphos-methyl (ISO);\nO,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n201-676-1\n86-50-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH317\nH410\n\n\n\n015-040-00-4\ndiazinon (ISO);\nO,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate\n206-373-8\n333-41-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH400\nH410\n\n\n\n\n\n\n015-041-00-X\nmalathion (ISO);\n1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;\n[containing ≤ 0,03 % isomalathion]\n204-497-7\n121-75-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=1000\n\n\n015-042-00-5\nchlorthion\nO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate\n207-902-5\n500-28-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\nM = 100\n\n015-043-00-0\nphosnichlor (ISO);\nO-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate\n—\n5826-76-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n015-044-00-6\ncarbophenothion (ISO);\n4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate\n212-324-1\n786-19-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n015-045-00-1\nmecarbam (ISO);\nN-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate\n219-993-9\n2595-54-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH400\nH410\n\n\n\n015-046-00-7\noxydemeton-methyl;\nS-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate\n206-110-7\n301-12-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nH311\nH301\nH400\nGHS06\nGHS09\nDgr\nH311\nH301\nH400\n\n\n\n015-047-00-2\nethion (ISO);\nO,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);\ndiethion\n209-242-3\n563-12-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\nM = 10000\n\n\n\n015-048-00-8\nfenthion (ISO);\nO,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate\n200-231-9\n55-38-9\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH312\nH302\nH372**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH312\nH302\nH372**\nH410\n\nM=100\n\n\n015-049-00-3\nendothion (ISO);\nS-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate\n220-472-3\n2778-04-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n015-050-00-9\nthiometon (ISO);\nS-2-ethylthioethyl O,O-dimethyl phosphorodithioate\n211-362-6\n640-15-3\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n015-051-00-4\ndimethoate (ISO);\nO,O-dimethyl methylcarbamoylmethyl phosphorodithioate\n200-480-3\n60-51-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-052-00-X\nfenchlorphos (ISO);\nO,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate\n206-082-6\n299-84-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-053-00-5\nmenazon (ISO);\nS-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate\n201-123-4\n78-57-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n015-054-00-0\nfenitrothion (ISO);\nO,O-dimethyl O-4-nitro-m-tolyl phosphorothioate\n204-524-2\n122-14-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-055-00-6\nnaled (ISO);\n1,2-dibromo-2,2-dichloroethyl dimethyl phosphate\n206-098-3\n300-76-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nH312\nH302\nH319\nH315\nH400\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH400\n\nM = 1000\n\n\n\n015-056-00-1\nazinphos-ethyl (ISO);\nO,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n220-147-6\n2642-71-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM=100\n\n\n015-057-00-7\nformothion (ISO);\nN-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n219-818-6\n2540-82-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-058-00-2\nmorphothion (ISO);\nO,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate\n205-628-0\n144-41-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n015-059-00-8\nvamidothion (ISO);\nO,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate\n218-894-8\n2275-23-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nH301\nH312\nH400\nGHS06\nGHS09\nDgr\nH301\nH312\nH400\n\n\n\n015-060-00-3\ndisulfoton (ISO);\nO,O-diethyl 2-ethylthioethyl phosphorodithioate\n206-054-3\n298-04-4\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-061-00-9\ndimefox (ISO);\ntetramethylphosphorodiamidic fluoride\n204-076-8\n115-26-4\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-062-00-4\nmipafox (ISO);\nN,N'- di-isopropylphosphorodiamidic fluoride\n206-742-3\n371-86-8\nSTOT SE 1\nH370 **\nGHS08\nDgr\nH370 **\n\n\n\n015-063-00-X\ndioxathion (ISO);\n1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)\n201-107-7\n78-34-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH410\n\nM = 1000\n\n015-064-00-5\nbromophos-ethyl (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate\n225-399-0\n4824-78-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n015-065-00-0\nS-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate\n—\n2703-37-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH411\n\n\n\n015-066-00-6\nomethoate (ISO);\nO,O-dimethyl S-methylcarbamoylmethyl phosphorothioate\n214-197-8\n1113-02-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nH301\nH312\nH400\nGHS06\nGHS09\nDgr\nH301\nH312\nH400\n\n\n\n\n\n015-067-00-1\nphosalone (ISO);\nS-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate\n218-996-2\n2310-17-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH332\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH410\n\nM=1000\n\n\n015-068-00-7\ndichlofenthion (ISO);\nO—2,4-dichlorophenyl O,O-diethyl phosphorothioate\n202-564-5\n97-17-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH400\nH410\n\n\n\n015-069-00-2\nmethidathion (ISO);\n2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate\n213-449-4\n950-37-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH312\nH410\n\n\n\n015-070-00-8\ncyanthoate (ISO);\nS-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate\n223-099-4\n3734-95-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-071-00-3\nchlorfenvinphos (ISO);\n2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate\n207-432-0\n470-90-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-072-00-9\nmonocrotophos (ISO);\ndimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate\n230-042-7\n6923-22-4\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH330\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH330\nH300\nH311\nH410\n\n\n\n015-073-00-4\ndicrotophos (ISO);\n(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate\n205-494-3\n141-66-2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-074-00-X\ncrufomate (ISO);\n4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate\n206-083-1\n299-86-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-075-00-5\nS-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate\n—\n2635-50-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n015-076-00-0\npotasan;\nO,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate\n—\n299-45-6\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\nM = 1000\n\n015-077-00-6\n2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate\n—\n7076-53-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n015-078-00-1\ndemeton-S-methylsulphon (ISO);\nS-2-ethylsulphonylethyl dimethyl phosphorothioate\n241-109-5\n17040-19-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH301\nH312\nH411\nGHS06\nGHS09\nDgr\nH301\nH312\nH411\n\n\n\n015-079-00-7\nacephate (ISO);\nO,S-dimethyl acetylphosphoramidothioate\n250-241-2\n30560-19-1\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-080-00-2\namidithion (ISO);\n2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n—\n919-76-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-081-00-8\nO,O,O',O'-tetrapropyl dithiopyrophosphate\n221-817-0\n3244-90-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-082-00-3\nazothoate (ISO);\nO-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate\n227-419-3\n5834-96-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n015-083-00-9\nbensulide (ISO);\nO,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate\n212-010-4\n741-58-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-084-00-4\nchlorpyrifos (ISO);\nO,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n220-864-4\n2921-88-2\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH400\nH410\n\nM = 10000\n\n015-085-00-X\nchlorphonium chloride (ISO);\ntributyl (2,4-dichlorobenzyl) phosphonium chloride\n204-105-4\n115-78-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH312\nH319\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH315\n\n\n\n015-086-00-5\ncoumithoate (ISO);\nO,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate\n—\n572-48-5\nAcute Tox. 3 *\nH301\nGHS06\nDgr\nH301\n\n\n\n015-087-00-0\ncyanophos (ISO);\nO-4-cyanophenyl O,O-dimethyl phosphorothioate\n220-130-3\n2636-26-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n015-088-00-6\ndialifos (ISO);\n2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate\n233-689-3\n10311-84-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH400\nH410\n\n\n\n015-089-00-1\nethoate-methyl (ISO);\nethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n204-121-1\n116-01-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n015-090-00-7\nfensulfothion (ISO);\nO,O-diethyl O-4-methylsulfinylphenyl phosphorothioate\n204-114-3\n115-90-2\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-091-00-2\nfonofos (ISO);\nO-ethyl phenyl ethylphosphonodithioate\n213-408-0\n944-22-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-092-00-8\nphosacetim (ISO);\nO,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate\n223-874-7\n4104-14-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n015-093-00-3\nleptophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate\n244-472-8\n21609-90-5\nAcute Tox. 3 *\nSTOT SE 1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH370 **\nH312\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH370 **\nH312\nH410\n\n\n\n015-094-00-9\nmephosfolan (ISO);\ndiethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate\n213-447-3\n950-10-7\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH310\nH300\nH411\n\n\n\n015-095-00-4\nmethamidophos (ISO);\nO,S-dimethyl phosphoramidothioate\n233-606-0\n10265-92-6\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nH330\nH300\nH311\nH400\nGHS06\nGHS09\nDgr\nH330\nH300\nH311\nH400\n\n\n\n015-096-00-X\noxydisulfoton (ISO);\nO,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate\n219-679-1\n2497-07-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM = 10\n\n015-097-00-5\nphenthoate (ISO);\nethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate\n219-997-0\n2597-03-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\nM = 100\n\n015-098-00-0\ntrichloronate (ISO);\nO-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate\n206-326-1\n327-98-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\n\n\n015-099-00-6\npirimiphos-ethyl (ISO);\nO,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate\n245-704-0\n23505-41-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n\n\n015-100-00-X\nphoxim (ISO);\nα-(diethoxyphosphinothioylimino) phenylacetonitrile\n238-887-3\n14816-18-3\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f***\nH302\nH317\nH410\n\nM=1000\n\n\n\n015-101-00-5\nphosmet (ISO);\nO,O-dimethyl phthalimidomethyl S-phosphorodithioate\n211-987-4\n732-11-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\nM = 100\n\n\n\n015-102-00-0\ntris(2-chloroethyl)phosphate\n204-118-5\n115-96-8\nCarc. 2\nRepr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH360F***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360F***\nH302\nH411\n\n\n\n\n015-103-00-6\nphosphorus tribromide\n232-178-2\n7789-60-8\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n015-104-00-1\ndiphosphorus pentasulphide;\nphosphorus pentasulphide\n215-242-4\n1314-80-3\nFlam. Sol. 1\nWater-react. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH228\nH260\nH332\nH302\nH400\nGHS02\nGHS07\nGHS09\nDgr\nH228\nH260\nH332\nH302\nH400\nEUH029\n\nT\n015-105-00-7\ntriphenyl phosphite\n202-908-4\n101-02-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Irrit. 2; H319: C ≥ 5 %\n\n015-106-00-2\nhexamethylphosphoric triamide;\nhexamethylphosphoramide\n211-653-8\n680-31-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n015-107-00-8\nethoprophos (ISO);\nethyl-S,S-dipropyl phosphorodithioate\n236-152-1\n13194-48-4\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH301\nH317\nH410\n\n\n\n015-108-00-3\nbromophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate\n218-277-3\n2104-96-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 100\n\n015-109-00-9\ncrotoxyphos (ISO);\n1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate\n231-720-5\n7700-17-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 10\n\n015-110-00-4\ncyanofenphos (ISO);\nO-4-cyanophenyl O-ethyl phenylphosphonothioate\n—\n13067-93-1\nAcute Tox. 3 *\nSTOT SE 1\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH301\nH370 **\nH312\nH319\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH370 **\nH312\nH319\nH411\n\n\n\n015-111-00-X\nphosfolan (ISO);\ndiethyl 1,3-dithiolan-2-ylidenephosphoramidate\n213-423-2\n947-02-4\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-112-00-5\nthionazin (ISO);\nO,O-diethyl O-pyrazin-2-yl phosphorothioate;\n206-049-6\n297-97-2\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n\n\n015-113-00-0\ntolclofos-methyl (ISO);\nO-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate\n260-515-3\n57018-04-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n\n015-114-00-6\nchlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate\n246-538-1\n24934-91-6\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 10\n\n015-115-00-1\nchlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]\n244-663-6\n21923-23-9\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM = 1000\n\n\n015-116-00-7\ndemephion-O (ISO);\nO,O-dimethyl O-2-methylthioethyl phosphorothioate\n211-666-9\n682-80-4\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-117-00-2\ndemephion-S (ISO);\nO,O-dimethyl S-2-methylthioethyl phosphorothioate\n219-971-9\n2587-90-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n015-118-00-8\ndemeton\n—\n8065-48-3\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH310\nH300\nH400\n\n\n\n015-119-00-3\ndimethyl 4-(methylthio)phenyl phosphate\n—\n3254-63-5\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-120-00-9\nditalimfos (ISO);\nO,O-diethyl phthalimidophosphonothioate\n225-875-8\n5131-24-8\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n015-121-00-4\nedifenphos (ISO);\nO-ethyl S,S-diphenyl phosphorodithioate\n241-178-1\n17109-49-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH317\nH410\n\n\n\n015-122-00-X\netrimfos (ISO);\nO-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate\n253-855-9\n38260-54-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 10\n\n015-123-00-5\nfenamiphos (ISO);\nethyl-4-methylthio-m-tolyl isopropyl phosphoramidate\n244-848-1\n22224-92-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH311\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH311\nH410\n\nM = 100\n\n015-124-00-0\nfosthietan (ISO);\ndiethyl 1,3-dithietan-2-ylidenephosphoramidate\n244-437-7\n21548-32-3\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n015-125-00-6\nglyphosine (ISO);\nN,N-bis(phosphonomethyl)glycine\n219-468-4\n2439-99-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n015-126-00-1\nheptenophos (ISO);\n7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate\n245-737-0\n23560-59-0\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\nM = 100\n\n015-127-00-7\niprobenfos(ISO);\nS-benzyl diisopropyl phosphorothioate\n247-449-0\n26087-47-8\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n015-128-00-2\nIPSP;\nS-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate\n—\n5827-05-4\nAcute Tox. 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH301\nH410\n\nM = 100\n\n015-129-00-8\nisofenphos (ISO);\nO-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate\n246-814-1\n25311-71-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 100\n\n015-130-00-3\nisothioate (ISO);\nS-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;\n—\n36614-38-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n015-131-00-9\nisoxathion (ISO);\nO,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate\n242-624-8\n18854-01-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n\n\n015-132-00-4\nS-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;\nmethylcarbophenothione\n—\n953-17-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\nM = 1000\n\n015-133-00-X\npiperophos (ISO);\nS-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate\n—\n24151-93-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 10\n\n015-134-00-5\npirimiphos-methyl (ISO);\nO-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate\n249-528-5\n29232-93-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-135-00-0\nprofenofos (ISO)\nO-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;\n255-255-2\n41198-08-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\nM = 1000\n\n015-136-00-6\ntrans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;\nisopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;\npropetamphos (ISO)\n250-517-2\n31218-83-4\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\nM = 100\n\n015-137-00-1\npyrazophos (ISO);\nO,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate\n236-656-1\n13457-18-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\n\n\n015-138-00-7\nquinalphos (ISO);\nO,O-diethyl-O-quinoxalin-2-yl phosphorothioate\n237-031-6\n13593-03-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\nM = 1000\n\n015-139-00-2\nterbufos (ISO);\nS-tert-butylthiomethyl O,O-diethylphosphorodithioate;\n235-963-8\n13071-79-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\nM = 1000\n\n\n\n015-140-00-8\ntriazophos (ISO);\nO,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate\n245-986-5\n24017-47-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH410\n\nM=100\n\n\n015-141-00-3\nethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers\n400-520-1\n—\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH410\n\n\n\n015-142-00-9\nbutyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate\n401-100-0\n—\nFlam. Liq. 2\nEye Irrit. 2\nAquatic Chronic 2\nH225\nH319\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH319\nH411\n\n\nT\n015-143-00-4\nreaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,\nreaction mass of isomers\n401-740-0\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n015-144-00-X\nreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate\n402-090-0\n87025-52-3\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n015-145-00-5\nreaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate\n401-520-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-146-00-0\nS-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate\n401-850-9\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-147-00-6\nreaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)\n400-930-0\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n015-148-00-1\n2-(diphosphonomethyl)succinic acid\n403-070-4\n51395-42-7\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n015-149-00-7\nreaction mass of: hexyldioctylphosphineoxide;\ndihexyloctylphosphineoxide;\ntrioctylphosphineoxide\n403-470-9\n—\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n015-150-00-2\n(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide\n404-940-6\n86608-70-0\nAcute Tox. 4 *\nEye Dam. 1\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH318\nH373 **\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH318\nH373 **\nH412\n\n\n\n015-151-00-8\ntris(isopropyl/tert-butylphenyl) phosphate\n405-010-2\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n015-152-00-3\ndioxabenzofos (ISO);\n2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide\n223-292-3\n3811-49-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 1\nAquatic Chronic 2\nH311\nH301\nH370 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH311\nH301\nH370 **\nH411\n\n\n\n015-153-00-9\nisazofos (ISO);\nO-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate\n255-863-8\n42509-80-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH311\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH311\nH301\nH373 **\nH317\nH410\n\n\n\n015-154-00-4\n2-chloroethylphosphonic acid;\nethephon\n240-718-3\n16672-87-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH332\nH312\nH314\nH412\nGHS05\nGHS07\nDgr\nH332\nH312\nH314\nH412\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n015-155-00-X\nglufosinate ammonium (ISO);\nammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate\n278-636-5\n77182-82-2\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH360Fd\nH332\nH312\nH302\nH373**\nGHS08\nGHS07\nDgr\nH360Fd\nH332\nH312\nH302\nH373**\n\n\n\n\n015-156-00-5\nmethyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]\nmethacrifos (ISO);\nmethyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]\n250-366-9 [1]-[2]\n30864-28-9 [1]\n62610-77-9 [2]\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n015-157-00-0\nphosphonic acid; [1]\nphosphorous acid [2]\n237-066-7 [1]\n233-663-1\n[2]\n13598-36-2 [1]\n10294-56-1 [2]\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n015-158-00-6\n(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)\n402-340-9\n32760-80-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n015-159-00-1\nhydroxyphosphonoacetic acid\n405-710-8\n23783-26-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH373 **\nH314\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH314\nH317\n\n\n\n015-160-00-7\nvanadyl pyrophosphate\n406-260-5\n58834-75-6\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n015-161-00-2\ndivanadyl pyrophosphate\n407-130-0\n65232-89-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n015-162-00-8\nvanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped\n407-350-7\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH332\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH373 **\nH318\nH411\n\n\n\n015-163-00-3\nbis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide\n412-010-6\n145052-34-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n015-164-00-9\ncalcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate\n400-480-5\n36669-85-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n015-165-00-4\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate\n404-986-7\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n015-166-00-X\n3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n410-290-4\n80693-00-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n015-167-00-5\n3-(hydroxyphenylphosphinyl)propanoic acid\n411-200-6\n14657-64-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n015-168-00-0\nfosthiazate (ISO);\n(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate\n—\n98886-44-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH312\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH312\nH317\nH410\nEUH070\n\n\n015-169-00-6\ntributyltetradecylphosphonium tetrafluoroborate\n413-520-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n015-170-00-1\nreaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;\n1-octane-N,N,N-trimethylammonium di-octylphosphate;\n1-octane-N,N,N-trimethylammonium octylphosphate\n407-490-9\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n015-171-00-7\nO,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate\n406-940-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n015-172-00-2\nreaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;\nisotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate\n406-240-6\n—\nFlam. Liq. 3\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH314\nH411\nGHS02\nGHS05\nGHS09\nDgr\nH226\nH314\nH411\n\n\n\n015-173-00-8\nmethyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate\n414-080-3\n117291-73-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n015-174-00-3\n1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine\n411-370-1\n82857-68-9\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Chronic 2\nH301\nH318\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH411\n\n\n\n015-175-00-9\ntert-butyl (triphenylphosphoranylidene) acetate\n412-880-7\n35000-38-5\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH373 **\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH319\nH317\nH411\n\n\n\n015-176-00-4\nP,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine\n413-430-2\n116163-96-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n015-177-00-X\n((4-phenylbutyl)hydroxyphosphoryl)acetic acid\n412-170-7\n83623-61-4\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH373 **\nH318\nH317\nGHS08\nGHS05\nDgr\nH373 **\nH318\nH317\n\n\n\n015-178-00-5\n(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate\n418-570-8\n25383-07-7\nRepr. 2\nAquatic Chronic 2\nH361f ***\nH411\nGHS08\nGHS09\nWng\nH361f ***\nH411\n\n\n\n015-179-00-0\nUVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine\n422-720-8\n166242-53-1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH351\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n015-180-00-6\n[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt\n415-820-8\n137590-32-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n015-181-00-1\nphosphine\n232-260-8\n7803-51-2\nFlam. Gas 1\nPress. Gas\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1\nH220\nH330\nH314\nH400\nGHS02\nGHS04\nGHS06\nGHS05\nGHS09\nDgr\nH220\nH330\nH314\nH400\n\n\nU\n\n\n015-182-00-7\ntetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)\n430-630-5\n10596-22-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS07\nWng\nH302\nH319\nH317\n\n\n\n\n\n015-183-00-2\n(1-hydroxydodecylidene)diphosphonic acid\n425-230-2\n16610-63-2\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n\n\n015-184-00-8\nSalts of glyphosate, with the exception of those specified elsewhere in this Annex\n—\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\nA\n015-186-00-9\nchlorpyrifos-methyl (ISO)\nO,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n227-011-5\n5598-13-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM = 10000\n\n015-187-00-4\nreaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;\ntrisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide\n417-540-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n\n015-188-00-X\n(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate\n425-220-8\n5945-33-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n015-189-00-5\nphenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide\n423-340-5\n162881-26-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n\n015-190-00-0\nbis(2,4-dicumylphenyl) neopentyl diphosphite;\n3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n421-920-2\n154862-43-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n015-191-00-6\ndodecyldiphenyl phosphate\n431-760-5\n27460-02-2\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n015-192-00-1\ntetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate\n432-770-2\n139189-30-3\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n015-193-00-7\ntriphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)\n442-960-7\n332350-93-3\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH400\nH410\nGHS05\nGHS06\nGHS09\nDgr\nH301\nH318\nH410\n\n\n\n\n015-194-00-2\ntetrabutyl-phosphonium nonafluoro-butane-1-sulfonate\n444-440-5\n220689-12-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n015-195-00-8\nreaction mass of: potassium o-toluenephosphonate;\npotassium m-toluenephosphonate;\npotassium p-toluenephosphonate\n433-860-4\n—\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n\n015-196-00-3\nreaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\ndiethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\nmethyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate\n435-960-3\n—\nCarc. 1B\nMuta. 1B\nSkin Sens. 1\nH350\nH340\nH317\nGHS08\nGHS07\nDgr\nH350\nH340\nH317\n\n\n\n\n015-197-00-9\nbis(2,4,4-trimethylpentyl)dithiophosphonic acid\n420-160-9\n107667-02-7\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH331\nH302\nH314\nH411\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH226\nH331\nH302\nH314\nH411\n\n\n\n\n015-198-00-4\n(4-phenylbutyl)phosphinic acid\n420-450-5\n86552-32-1\nCarc. 2\nEye Dam. 1\nH351\nH318\nGHS05\nGHS08\nDgr\nH351\nH318\n\n\n\n\n\n\n015-199-00-X\ntris[2-chloro-1-chloromethyl)ethyl] phosphate\n237-159-2\n13674-87-8\nCarc. 2\nH351\nGSH08\nWng\nH351\n\n\n\n015-200-00-3\nindium phosphide\n244-959-5\n22398-80-7\nCarc. 1B\nRepr. 2\nSTOT RE 1\nH350\nH361f\nH372 (lungs)\nGHS08\nDgr\nH350\nH361f\nH372 (lungs)\n\nSTOT RE 1;\nH372: C ≥0,1 %\nCarc 1B;\nH350: C ≥0,01 %\nSTOT RE 2;\nH373: 0,01 % ≤ C < 0,1 %\n\n015-201-00-9\ntrixylyl phosphate\n246-677-8\n25155-23-1\nRepr. 1B\nH360F\nGHS08\nDgr\nH360F\n\n\n\n015-202-00-4\ntris(nonylphenyl) phosphite\n247-759-6\n26523-78-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n015-203-00-X\ndiphenyl(2,4,6-trimethylbenzoyl)phosphine oxide\n278-355-8\n75980-60-8\nRepr. 2\nH361f (causing atrophy of the testes)\nGHS08\nWng\nH361f (causing atrophy of the testes)\n\n\n\n\n016-001-00-4\nhydrogen sulphide\n231-977-3\n7783-06-4\nFlam. Gas 1\nPress. Gas\nAcute Tox. 2 *\nAquatic Acute 1\nH220\nH330\nH400\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH330\nH400\n\n\nU\n016-002-00-X\nbarium sulphide\n244-214-4\n21109-95-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH332\nH302\nH400\nGHS07\nGHS09\nWng\nH332\nH302\nH400\nEUH031\n\n\n016-003-00-5\nbarium polysulphides\n256-814-3\n50864-67-0\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-004-00-0\ncalcium sulphide\n243-873-5\n20548-54-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-005-00-6\ncalcium polysulphides\n215-709-2\n1344-81-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\nEUH031\n\n\n016-006-00-1\ndipotassium sulphide;\npotassium sulphide\n215-197-0\n1312-73-8\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\n\n\n016-007-00-7\npotassium polysulphides\n253-390-1\n37199-66-9\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\n\n\n016-008-00-2\nammonium polysulphides\n232-989-1\n9080-17-5\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\nEUH031: C ≥ 1 %\n\n\n\n\n016-009-00-8\ndisodium sulfide;\nsodium sulfide\n215-211-5\n1313-82-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH311\nH302\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH302\nH314\nH400\n\n\n\n\n016-010-00-3\nsodium polysulphides\n215-686-9\n1344-08-7\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH314\nH400\nEUH031\n\n\n016-011-00-9\nsulphur dioxide\n231-195-2\n7446-09-5\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1B\nH331\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH331\nH314\n\n*\nU5\n016-012-00-4\ndisulphur dichloride;\nsulfur monochloride\n233-036-2\n10025-67-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH301\nH332\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH332\nH314\nH400\nEUH014\nEUH029\nSTOT SE 3; H335: C ≥ 1 %\n\n016-013-00-X\nsulphur dichloride\n234-129-0\n10545-99-0\nSkin Corr. 1B\nSTOT SE 3\nAquatic Acute 1\nH314\nH335\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH335\nH400\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n016-014-00-5\nsulphur tetrachloride\n—\n13451-08-6\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n016-015-00-0\nthionyl dichloride;\nthionyl chloride\n231-748-8\n7719-09-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH332\nH302\nH314\nGHS05\nGHS07\nDgr\nH332\nH302\nH314\nEUH014\nEUH029\nSTOT SE 3; H335: C ≥ 1 %\n\n016-016-00-6\nsulphuryl chloride\n232-245-6\n7791-25-5\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n016-017-00-1\nchlorosulphonic acid\n232-234-6\n7790-94-5\nSkin Corr. 1A\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\n\n016-018-00-7\nfluorosulphonic acid\n232-149-4\n7789-21-1\nAcute Tox. 4 *\nSkin Corr. 1A\nH332\nH314\nGHS05\nGHS07\nDgr\nH332\nH314\n\n\n\n016-019-00-2\noleum ... % SO3\n—\n—\nSkin Corr. 1A\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\nEUH014\n\nB\n016-020-00-8\nsulphuric acid ... %\n231-639-5\n7664-93-9\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 15 %\nSkin Irrit. 2; H315: 5 % ≤ C < 15 %\nEye Irrit. 2; H319: 5 % ≤ C < 15 %\nB\n016-021-00-3\nmethanethiol;\nmethyl mercaptan\n200-822-1\n74-93-1\nFlam. Gas. 1\nPress. Gas\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH220\nH331\nH400\nH410\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH331\nH410\n\n\nU\n016-022-00-9\nethanethiol;\nethyl mercaptan\n200-837-3\n75-08-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH225\nH332\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH332\nH410\n\n\n\n016-023-00-4\ndimethyl sulphate\n201-058-1\n77-78-1\nCarc. 1B\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH350\nH341\nH330\nH301\nH314\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH350\nH341\nH330\nH301\nH314\nH317\n\nCarc. 1B; H350: C ≥ 0,01 %\nMuta. 2; H341: C ≥ 0,01 %\nSTOT SE 3; H335: C ≥ 5 %\n\n016-024-00-X\ndimexano(ISO);\nbis(methoxythiocarbonyl) disulphide\n215-993-8\n1468-37-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n016-025-00-5\ndisul (ISO);\n2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;\n2,4-DES\n205-259-5\n149-26-8\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\n\n\n\n016-026-00-0\nsulphamidic acid;\nsulphamic acid;\nsulfamic acid\n226-218-8\n5329-14-6\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n016-027-00-6\ndiethyl sulphate\n200-589-6\n64-67-5\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH350\nH340\nH332\nH312\nH302\nH314\nGHS05\nGHS08\nGHS07\nDgr\nH350\nH340\nH332\nH312\nH302\nH314\n\n\n\n016-028-00-1\nsodium dithionite;\nsodium hydrosulphite\n231-890-0\n7775-14-6\nSelf-heat. 1\nAcute Tox. 4 *\nH251\nH302\nGHS02\nGHS07\nDgr\nH251\nH302\nEUH031\n\n\n016-029-00-7\np-toluenesulphonic acid, containing more than 5 % H2SO4\n—\n—\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\n\n016-030-00-2\np-toluenesulphonic acid (containing a maximum of 5 % H2SO4)\n203-180-0\n104-15-4\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 20 %\n\n016-031-00-8\ntetrahydrothiophene-1,1-dioxide;\nsulpholane\n204-783-1\n126-33-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n016-032-00-3\n1,3-propanesultone;\n1,2-oxathiolane 2,2-dioxide\n214-317-9\n1120-71-4\nCarc. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH350\nH312\nH302\nGHS08\nGHS07\nDgr\nH350\nH312\nH302\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n016-033-00-9\ndimethylsulfamoylchloride\n236-412-4\n13360-57-1\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH350\nH330\nH312\nH302\nH314\nGHS06\nGHS05\nGHS08\nDgr\nH350\nH330\nH312\nH302\nH314\n\n\n\n016-034-00-4\ntetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)\n400-010-9\n81898-60-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-035-00-X\npentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate\n400-120-7\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n016-036-00-5\ntetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate\n400-130-1\n—\nResp. Sens. 1\nAquatic Chronic 2\nH334\nH411\nGHS08\nGHS09\nDgr\nH334\nH411\n\n\n\n016-037-00-0\ndisodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate\n400-350-8\n85153-93-1\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-038-00-6\ndisodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate\n400-380-1\n86393-35-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-039-00-1\ntetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate\n400-430-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-040-00-7\nreaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate\n400-570-4\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n016-041-00-2\ncalcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate\n400-710-4\n—\nAcute Tox. 4 *\nH332\nGHS07\nWng\nH332\n\n\n\n016-042-00-8\ntetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate\n400-790-0\n85665-97-0\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n016-043-00-3\ndilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate\n401-010-1\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-044-00-9\ndisodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate\n401-320-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n016-045-00-4\nlithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate\n401-560-2\n108624-00-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-046-00-X\nsodium hydrogensulphate\n231-665-7\n7681-38-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n016-047-00-5\nhexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate\n401-650-1\n85665-96-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-048-00-0\nsodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate\n401-870-8\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-049-00-6\ncalcium octadecylxylenesulphonate\n402-040-8\n—\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n016-050-00-1\npotassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat\n402-150-6\n—\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n016-051-00-7\ntrisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate\n402-170-5\n106359-91-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-052-00-2\nbenzyltributylammonium 4-hydroxynaphthalene-1-sulphonate\n402-240-5\n102561-46-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH411\nGHS07\nGHS09\nWng\nH332\nH411\n\n\n\n016-053-00-8\n(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate\n402-460-1\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n016-054-00-3\nsodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate\n400-030-8\n—\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Sens. 1\nH331\nH372 **\nH302\nH319\nH335\nH317\nGHS06\nGHS08\nDgr\nH331\nH372 **\nH302\nH319\nH335\nH317\n\n\n\n016-055-00-9\ntetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)\n400-510-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n016-056-00-4\npotassium hydrogensulphate\n231-594-1\n7646-93-7\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\n\n\n016-057-00-X\nstyrene-4-sulfonyl chloride\n404-770-2\n2633-67-2\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n016-058-00-5\nthionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine\n404-820-3\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH317\nH412\nGHS07\nWng\nH315\nH317\nH412\n\n\n\n016-059-00-0\nN,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride\n405-300-9\n17339-60-5\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH317\nH410\n\n\n\n016-060-00-6\ndiammonium peroxodisulphate;\nammonium persulphate\n231-786-5\n7727-54-0\nOx. Sol. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH272\nH302\nH319\nH335\nH315\nH334\nH317\nGHS03\nGHS08\nGHS07\nDgr\nH272\nH302\nH319\nH335\nH315\nH334\nH317\n\n\n\n016-061-00-1\ndipotassium peroxodisulphate;\npotassium persulphate\n231-781-8\n7727-21-1\nOx. Sol. 3\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH272\nH302\nH319\nH335\nH315\nH334\nH317\nGHS03\nGHS08\nGHS07\nDgr\nH272\nH302\nH319\nH335\nH315\nH334\nH317\n\n\n\n016-062-00-7\nbensultap (ISO);\n1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane\n—\n17606-31-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n016-063-00-2\nsodium metabisulphite\n231-673-0\n7681-57-4\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\nEUH031\n\n\n016-064-00-8\nsodium hydrogensulphite . . . %;\nsodium bisulphite . . . %\n231-548-0\n7631-90-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\nEUH031\n\nB\n016-065-00-3\nsodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate\n400-100-8\n84057-97-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n016-066-00-9\ntetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)\n404-070-7\n116912-62-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n016-067-00-4\n(4-methylphenyl)mesitylene sulfonate\n407-530-5\n67811-06-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-068-00-X\nsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate\n407-720-8\n155160-86-4\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-069-00-5\n3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid\n407-990-7\n141915-64-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-070-00-0\n4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone\n408-220-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-071-00-6\ntrisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate\n410-130-3\n136248-03-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n016-072-00-1\n3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide\n411-520-6\n112195-27-4\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n016-073-00-7\ntetrakis(phenylmethyl)thioperoxydi(carbothioamide)\n404-310-0\n10591-85-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n016-074-00-2\n6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene\n405-410-7\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n016-075-00-8\n2,2'-diallyl-4,4'-sulfonyldiphenol\n411-570-9\n41481-66-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n016-076-00-3\n2,3-bis((2-mercaptoethyl)thio)-1-propanethiol\n411-290-7\n131538-00-6\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH410\n\n\n\n016-077-00-9\n2-chloro-p-toluenesulfochloride\n412-890-1\n42413-03-6\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH314\nH317\nH412\n\n\n\n016-078-00-4\n4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide\n413-300-5\n56187-04-3\nAquatic Chronic 4\nH413\n—\n\n\n\n\n016-079-00-X\nN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide\n412-920-3\n16695-22-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n016-080-00-5\nsodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate\n412-320-1\n31361-99-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n016-081-00-0\nhexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide\n418-350-1\n—\nMuta. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH302\nH319\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH319\nH317\nH411\n\n\n\n016-082-00-6\nethoxysulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea\n—\n126801-58-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n016-083-00-1\nacibenzolar-S-methyl;\nbenzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester\n420-050-0\n135158-54-2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH410\n\n\n\n\n\n016-084-00-7\nprosulfuron (ISO);\n1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea\n—\n94125-34-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=100\n\n\n016-085-00-2\nflazasulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea\n—\n104040-78-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n016-086-00-8\ntetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n402-590-9\n109125-56-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n016-087-00-3\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;\npropylene carbonate\n403-490-8\n104558-95-4\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH317\nH410\n\n\n\n016-088-00-9\n4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid\n407-280-7\n71297-11-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n016-089-00-4\nreaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene\n413-840-1\n—\nSelf-react. C ****\nAquatic Chronic 4\nH242\nH413\nGHS02\nDgr\nH242\nH413\n\n\n\n016-090-00-X\n4-methyl-N-(methylsulfonyl)benzenesulfonamide\n415-040-8\n14653-91-9\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH302\nH335\nH318\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\n\n\n\n016-091-00-5\nC12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate\n414-110-5\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n016-092-00-0\nreaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol\n427-050-1\n—\nRepr. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f\nH315\nH317\nH410\n\n\n\n\n\n016-093-00-6\nreaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);\n4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)\n414-770-4\n140698-96-0\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n\n\n016-094-00-1\nsulfur\n231-722-6\n7704-34-9\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n016-095-00-7\nreaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);\nReaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)\n417-980-4\n—\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n016-096-00-2\nthifensulfuron-methyl (ISO);\nmethyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate\n—\n79277-27-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n016-097-00-8\n1-amino-2-methyl-2-propanethiol hydrochloride\n434-480-1\n32047-53-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH412\n\n\n\n\n\n017-001-00-7\nchlorine\n231-959-5\n7782-50-5\nOx. Gas 1\nPress. Gas\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH270\nH331\nH319\nH335\nH315\nH400\nGHS03\nGHS04\nGHS06\nGHS09\nDgr\nH270\nH331\nH319\nH335\nH315\nH400\n\nM = 100\nU\n\n017-002-00-2\nhydrogen chloride\n231-595-7\n7647-01-0\nPress. Gas\nAcute Tox. 3 *\nSkin Corr. 1A\nH331\nH314\nGHS04\nGHS06\nGHS05\nDgr\nH331\nH314\n\n\nU5\n017-002-01-X\nhydrochloric acid ... %\n231-595-7\n—\nSkin Corr. 1B\nSTOT SE 3\nH314\nH335\nGHS05\nGHS07\nDgr\nH314\nH335\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 10 %\nB\n017-003-00-8\nbarium chlorate\n236-760-7\n13477-00-4\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH332\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH332\nH302\nH411\n\n\n\n017-004-00-3\npotassium chlorate\n223-289-7\n3811-04-9\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH332\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH332\nH302\nH411\n\n\n\n017-005-00-9\nsodium chlorate\n231-887-4\n7775-09-9\nOx. Sol. 1\nAcute Tox. 4 *\nAquatic Chronic 2\nH271\nH302\nH411\nGHS03\nGHS07\nGHS09\nDgr\nH271\nH302\nH411\n\n\n\n017-006-00-4\nperchloric acid ... %\n231-512-4\n7601-90-3\nOx. Liq. 1\nSkin Corr. 1A\nH271\nH314\nGHS03\nGHS05\nDgr\nH271\nH314\n\nSkin Corr. 1A; H314: C ≥ 50 %\nSkin Corr. 1B; H314: 10 % ≤ C < 50 %\nSkin Irrit. 2; H315: 1 % ≤ C < 10 %\nEye Irrit. 2; H319: 1 % ≤ C < 10 %\nOx. Liq. 1; H271: C > 50 %:\nOx. Liq. 2; H272: C ≤ 50 %:\nB\n017-007-00-X\nbarium perchlorate\n236-710-4\n13465-95-7\nOx. Sol. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nH271\nH332\nH302\nGHS03\nGHS07\nDgr\nH271\nH332\nH302\n\n\n\n017-008-00-5\npotassium perchlorate\n231-912-9\n7778-74-7\nOx. Sol. 1\nAcute Tox. 4 *\nH271\nH302\nGHS03\nGHS07\nDgr\nH271\nH302\n\n\n\n\n\n\n017-009-00-0\nammonium perchlorate\n232-235-1\n7790-98-9\nExpl. 1.1\nOx. Sol. 1\nH201\nH271\nGHS01\nDgr\nH201\nH271\n\n\nT\n\n017-010-00-6\nsodium perchlorate\n231-511-9\n7601-89-0\nOx. Sol. 1\nAcute Tox. 4 *\nH271\nH302\nGHS03\nGHS07\nDgr\nH271\nH302\n\n\n\n017-011-00-1\nsodium hypochlorite, solution ... % Cl active\n231-668-3\n7681-52-9\nSkin Corr. 1B\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\nEUH031\nEUH031: C ≥ 5 %\nB\n\n017-012-00-7\ncalcium hypochlorite\n231-908-7\n7778-54-3\nOx. Sol. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH272\nH302\nH314\nH400\nGHS03\nGHS05\nGHS07\nGHS09\nDgr\nH272\nH302\nH314\nH400\nEUH031\nSkin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 3 %\nM = 10\nT\n\n017-013-00-2\ncalcium chloride\n233-140-8\n10043-52-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n017-014-00-8\nammonium chloride\n235-186-4\n12125-02-9\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n017-015-00-3\n(2-(aminomethyl)phenyl)acetylchloride hydrochloride\n417-410-4\n61807-67-8\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n017-016-00-9\nmethyltriphenylphosphonium chloride\n418-400-2\n1031-15-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH411\n\n\n\n017-017-00-4\n(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride\n426-210-6\n120086-58-0\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n017-018-00-X\nN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride\n405-660-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n017-019-00-5\n(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride\n415-110-8\n54417-53-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n017-020-00-0\nethyl propoxy aluminium chloride\n421-790-7\n13014-29-4\nWater-react. 1\nSkin Corr. 1A\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n017-021-00-6\nbehenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride\n423-420-1\n136920-10-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n\n017-023-00-7\n[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides\n425-520-9\n197179-61-6\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n\n017-026-00-3\nchlorine dioxide\n233-162-8\n10049-04-4\nPress. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1\nH270\nH330\nH314\nH400\nGHS04\nGHS03\nGHS06\nGHS05\nGHS09\nDgr\nH270\nH330\nH314\nH400\n\nM = 10\n5\n017-026-01-0\nchlorine dioxide … %\n233-162-8\n10049-04-4\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH314\nH400\n\nSkin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,3 % ≤ C < 3 %\nSTOT SE 3; H335: C ≥ 3 %\nM = 10\nB\n\n\n019-001-00-2\npotassium\n231-119-8\n7440-09-7\nWater-react. 1\nSkin Corr. 1B\nH260\nH314\nGHS02\nGHS05\nDgr\nH260\nH314\nEUH014\n\n\n019-002-00-8\npotassium hydroxide;\ncaustic potash\n215-181-3\n1310-58-3\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\nSkin Corr. 1A; H314: C ≥ 5 %\nSkin Corr. 1B; H314: 2 % ≤ C < 5 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 2 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\n\n020-001-00-X\ncalcium\n231-179-5\n7440-70-2\nWater-react. 2\nH261\nGHS02\nDgr\nH261\n\n\n\n020-002-00-5\ncalcium cyanide\n209-740-0\n592-01-8\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH410\nEUH032\n\n\n020-003-00-0\nreaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;\ntri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;\npoly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]\n420-470-4\n—\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n022-001-00-5\ntitanium tetrachloride\n231-441-9\n7550-45-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\nEUH014\n\n\n022-002-00-0\ntitanium(4+) oxalate\n403-260-7\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n022-003-00-6\nbis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium\n412-000-1\n125051-32-3\nFlam. Sol. 1\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH228\nH361f ***\nH373 **\nH411\nGHS02\nGHS08\nGHS09\nDgr\nH228\nH361f ***\nH373 **\nH411\n\n\nT\n\n\n022-004-00-1\npotassium titanium oxide (K2Ti6O13)\n432-240-0\n12056-51-8\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n\n\n022-005-00-7\n[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium\n419-840-8\n169104-71-6\nFlam. Sol. 1****\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 4\nH228\nH314\nH317\nH413\nGHS02\nGHS05\nGHS07\nDgr\nH228\nH314\nH317\nH413\n\n\n\n\n023-001-00-8\ndivanadium pentaoxide;\nvanadium pentoxide\n215-239-8\n1314-62-1\nMuta. 2\nRepr. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nAquatic Chronic 2\nH341\nH361d ***\nH372 **\nH332\nH302\nH335\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH361d ***\nH372 **\nH332\nH302\nH335\nH411\n\n\n\n024-001-00-0\nchromium (VI) trioxide\n215-607-8\n1333-82-0\nOx. Sol. 1\nCarc. 1A\nMuta. 1B\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1A\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350\nH340\nH361f ***\nH330\nH311\nH301\nH372 **\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH271\nH350\nH340\nH361f ***\nH330\nH311\nH301\nH372 **\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 1 %\n\n024-002-00-6\npotassium dichromate\n231-906-6\n7778-50-9\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n3\n024-003-00-1\nammonium dichromate\n232-143-1\n7789-09-5\nOx. Sol. 2 ****\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\nG3\n\n024-004-00-7\nsodium dichromate\n234-190-3\n10588-01-9\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH410\n\nResp. Sens. 1; H334: C ≥ 0,2 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nSTOT SE 3; H335: C ≥ 5 %\n3\n\n\n\n024-004-01-4\nsodium dichromate, dihydrate\n234-190-3\n7789-12-0\nOx. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS03\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH272\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\n3\n\n024-005-00-2\nchromyl dichloride;\nchromic oxychloride\n239-056-8\n14977-61-8\nOx. Liq. 1\nCarc. 1B\nMuta. 1B\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350i\nH340\nH314\nH317\nH400\nH410\nGHS03\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH271\nH350i\nH340\nH314\nH317\nH410\n\nSkin Corr. 1A; H314: C ≥ 10 %\nSkin Corr. 1B; H314: 5 % ≤ C < 10 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 5 %\nSTOT SE 3; H335: 0,5 % ≤ C < 5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\nT3\n024-006-00-8\npotassium chromate\n232-140-5\n7789-00-6\nCarc. 1B\nMuta. 1B\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH340\nH319\nH335\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH340\nH319\nH335\nH315\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,5 %\n3\n024-007-00-3\nzinc chromates including zinc potassium chromate\n—\n—\nCarc. 1A\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH410\n\n\nA\n024-008-00-9\ncalcium chromate\n237-366-8\n13765-19-0\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n024-009-00-4\nstrontium chromate\n232-142-6\n7789-06-2\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH400\nH410\n\n\n\n024-010-00-X\ndichromium tris(chromate);\nchromium III chromate;\nchromic chromate\n246-356-2\n24613-89-6\nOx. Sol. 1\nCarc. 1B\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH271\nH350\nH314\nH317\nH400\nH410\nGHS03\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH271\nH350\nH314\nH317\nH410\n\n\nT\n024-011-00-5\nammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)\n400-110-2\n109125-51-1\nSelf-react. C ****\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH400\nH410\nGHS02\nGHS09\nDgr\nH242\nH410\n\n\n\n024-012-00-0\ntrisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)\n400-810-8\n—\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n024-013-00-6\ntrisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)\n402-500-8\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n024-014-00-1\ntrisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)\n402-870-0\n93952-24-0\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n024-015-00-7\ndisodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)\n404-930-1\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH332\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH318\nH411\n\n\n\n024-016-00-2\ntetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)\n405-110-6\n88377-66-6\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n024-017-00-8\nChromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex\n—\n—\nCarc. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH317\nH410\n\n\nA\n024-018-00-3\nsodium chromate\n231-889-5\n7775-11-3\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH350\nH340\nH360FD\nH330\nH301\nH372 **\nH312\nH314\nH334\nH317\nH410\n\nResp. Sens.; H334: C ≥ 0,2 %\nSkin Sens.; H317: C ≥ 0,2 %\n3\n024-019-00-9\nMain component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);\nby-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);\nby-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-230-1\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n024-020-00-4\ntrisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)\n418-220-4\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n\n024-021-00-X\npotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)\n425-830-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n025-001-00-3\nmanganese dioxide\n215-202-6\n1313-13-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n025-002-00-9\npotassium permanganate\n231-760-3\n7722-64-7\nOx. Sol. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH410\n\n\n\n025-003-00-4\nmanganese sulphate\n232-089-9\n7785-87-7\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n025-004-00-X\nbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate\n411-760-1\n116633-53-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n025-005-00-5\nreaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);\ntetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);\npentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)\n417-660-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n026-001-00-6\n(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate\n407-840-0\n100011-37-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n026-002-00-1\n(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate\n407-880-9\n117549-13-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n026-003-00-7\niron (II) sulfate\n231-753-5\n7720-78-7\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n\n026-003-01-4\niron (II) sulfate (1:1) heptahydrate;\nsulfuric acid, iron(II) salt (1:1), heptahydrate;\nferrous sulfate heptahydrate\n231-753-5\n7782-63-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\nSkin Irrit. 2; H315: C ≥ 25 %\n\n\n026-004-00-2\npotassium ferrite\n430-010-4\n12160-44-0\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n\n027-001-00-9\ncobalt\n231-158-0\n7440-48-4\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 4\nH334\nH317\nH413\nGHS08\nDgr\nH334\nH317\nH413\n\n\n\n\n\n027-002-00-4\ncobalt oxide\n215-154-6\n1307-96-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=10\n\n\n027-003-00-X\ncobalt sulfide\n215-273-3\n1317-42-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n027-004-00-5\ncobalt dichloride\n231-589-4\n7646-79-9\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM=10\n1\n\n027-005-00-0\ncobalt sulfate\n233-334-2\n10124-43-3\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350i\nH341\nH360F***\nH302\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM=10\n1\n\n\n\n027-006-00-6\ncobalt di(acetate)\n200-755-8\n71-48-7\nCarc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350i\nH341\nH360F***\nH334\nH317\nH400\nH410\nGHS08\nGHS09\nDgr\nH350i\nH341\nH360F***\nH334\nH317\nH410\n\nCarc. 1B; H350i: C ≥ 0,01 %\nM = 10\n1\n\n\n027-007-00-1\nzinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex\n425-240-7\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n027-008-00-7\ncomplex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,225 % phlegmatiser]\n211-745-8\n693-21-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 3\nH201\nH330\nH310\nH300\nH373 **\nH412\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH330\nH310\nH300\nH373 **\nH412\n\n\n\n603-034-00-X\nglycerol trinitrate;\nnitroglycerine\n200-240-8\n55-63-0\nUnst. Expl.\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH200\nH330\nH310\nH300\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH200\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n603-034-01-7\nglycerol trinitrate;\nnitroglycerine;\n[>40 % phlegmatiser]\n200-240-8\n55-63-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n603-035-00-5\npentaerythritol tetranitrate; pentaerythrite tetranitrate;\nP.E.T.N.\n201-084-3\n78-11-5\nUnst. Expl.\nH200\nGHS01\nDgr\nH200\n\n\n\n603-035-01-2\npentaerythritol tetranitrate; pentaerythrite tetranitrate;\nP.E.T.N.;\n[>20 % phlegmatiser]\n201-084-3\n78-11-5\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\nT\n603-036-00-0\nmannitol hexanitrate;\nnitromannite\n239-924-6\n15825-70-4\nUnst. Expl.\nH200\nGHS01\nDgr\nH200\n\n\n\n603-036-01-8\nmannitol hexanitrate;\nnitromannite;\n[>40 % phlegmatiser]\n239-924-6\n15825-70-4\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\n\n\n\n603-037-00-6\ncellulose nitrate;\nnitrocellulose\n—\n—\nExpl. 1.1\nH201\nGHS01\nDgr\nH201\n\n\nT\n\n\n603-038-00-1\nallyl glycidyl ether;\nallyl 2,3-epoxypropyl ether;\nprop-2-en-1-yl 2,3-epoxypropyl ether\n203-442-4\n106-92-3\nFlam. Liq. 3\nCarc. 2\nMuta. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH351\nH341\nH361f ***\nH332\nH302\nH335\nH315\nH318\nH317\nH412\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH351\nH341\nH361f ***\nH332\nH302\nH335\nH315\nH318\nH317\nH412\n\n\n\n603-039-00-7\nbutyl glycidyl ether;\nbutyl 2,3-epoxypropyl ether\n219-376-4\n2426-08-6\nFlam. Liq. 3\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH351\nH341\nH332\nH302\nH335\nH317\nH412\nGHS02\nGHS08\nGHS07\nWng\nH226\nH351\nH341\nH332\nH302\nH335\nH317\nH412\n\n\n\n603-040-00-2\nsodium methanolate;\nsodium methoxide; [1]\npotassium methanolate;\npotassium methoxide; [2]\nlithium methanolate;\nlithium methoxide [3]\n204-699-5 [1]\n212-736-1 [2]\n212-737-7 [3]\n124-41-4 [1]\n865-33-8 [2]\n865-34-9 [3]\nSelf-heat 1\nSkin Corr. 1B\nH251\nH314\nGHS02\nGHS05\nDgr\nH251\nH314\nEUH014\n\nT\n603-041-00-8\npotassium ethanolate;\npotassium ethoxide; [1]\nsodium ethanolate;\nsodium ethoxide [2]\n213-029-0 [1]\n205-487-5 [2]\n917-58-8 [1]\n141-52-6 [2]\nSelf-heat 1\nSkin Corr. 1B\nH251\nH314\nGHS02\nGHS05\nDgr\nH251\nH314\nEUH014\n\nT\n603-042-00-3\naluminium-tri-isopropoxide\n209-090-8\n555-31-7\nFlam. Sol. 1\nH228\nGHS02\nDgr\nH228\n\n\nT\n603-043-00-9\ntriarimol (ISO);\n2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol\n—\n26766-27-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-044-00-4\ndicofol (ISO);\n2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol\n204-082-0\n115-32-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH315\nH317\nH410\n\n\n\n603-045-00-X\ndiisopropyl ether; [1]\ndipropyl ether [2]\n203-560-6 [1]\n203-869-6 [2]\n108-20-3 [1]\n111-43-3 [2]\nFlam. Liq. 2\nSTOT SE 3\nH225\nH336\nGHS02\nGHS07\nDgr\nH225\nH336\nEUH019\nEUH066\n\nC\n\n\n603-046-00-5\nbis(chloromethyl) ether;\noxybis(chloromethane)\n208-832-8\n542-88-1\nFlam. Liq. 2\nCarc. 1A\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nH225\nH350\nH330\nH311\nH302\nGHS02\nGHS06\nGHS08\nDgr\nH225\nH350\nH330\nH311\nH302\n\nCarc. 1A; H350: C ≥ 0,001 %\n\n\n603-047-00-0\n2-dimethylaminoethanol;\nN,N-dimethylethanolamine\n203-542-8\n108-01-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-048-00-6\n2-diethylaminoethanol;\nN,N-diethylethanolamine\n202-845-2\n100-37-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07 GHS09\nDgr\nH226\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-049-00-1\nchlorfenethol (ISO);\n1,1-bis (4-chlorophenyl) ethanol\n201-246-3\n80-06-8\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n603-050-00-7\n1-(2-butoxypropoxy)propan-2-ol\n246-011-6\n24083-03-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n603-051-00-2\n2-ethylbutan-1-ol\n202-621-4\n97-95-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n603-052-00-8\n3-butoxypropan-2-ol;\npropylene glycol monobutyl ether\n225-878-4\n5131-66-8\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-053-00-3\n2-methylpentane-2,4-diol\n203-489-0\n107-41-5\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-054-00-9\ndi-n-butyl ether;\ndibutyl ether\n205-575-3\n142-96-1\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH226\nH319\nH335\nH315\nH412\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH412\n\nSTOT SE 3; H335: C ≥ 10 %\n\n603-055-00-4\npropylene oxide;\n1,2-epoxypropane;\nmethyloxirane\n200-879-2\n75-56-9\nFlam. Liq. 1\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH224\nH350\nH340\nH332\nH312\nH302\nH319\nH335\nH315\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH350\nH340\nH332\nH312\nH302\nH319\nH335\nH315\n\n\n\n603-056-00-X\n[(p-tolyloxy)methyl]oxirane; [1]\n[(m-tolyloxy)methyl]oxirane; [2]\n2,3-epoxypropyl o-tolyl ether; [3]\n[(tolyloxy)methyl]oxirane;\ncresyl glycidyl ether [4]\n218-574-8 [1]\n218-575-3 [2]\n218-645-3 [3]\n247-711-4 [4]\n2186-24-5 [1]\n2186-25-6 [2]\n2210-79-9 [3]\n26447-14-3 [4]\nMuta. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH315\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH315\nH317\nH411\n\n\nC\n603-057-00-5\nbenzyl alcohol\n202-859-9\n100-51-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n603-058-00-0\n1,3-propylene oxide\n207-964-3\n503-30-0\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH312\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\n\n\n\n603-059-00-6\nhexan-1-ol\n203-852-3\n111-27-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-060-00-1\n2,2'-bioxirane;\n1,2:3,4-diepoxybutane\n215-979-1\n1464-53-5\nCarc. 1B\nMuta. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH350\nH340\nH330\nH311\nH301\nH314\nGHS06\nGHS08\nGHS05\nDgr\nH350\nH340\nH330\nH311\nH301\nH314\n\n\n\n603-061-00-7\ntetrahydro-2-furylmethanol;\ntetrahydrofurfuryl alcohol\n202-625-6\n97-99-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-062-00-2\ntetrahydrofuran-2,5-diyldimethanol\n203-239-0\n104-80-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n603-063-00-8\n2,3-epoxypropan-1-ol;\nglycidol;\noxiranemethanol\n209-128-3\n556-52-5\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH319\nH335\nH315\n\n\n\n\n\n603-064-00-3\n1-methoxy-2-propanol;\nmonopropylene glycol methyl ether\n203-539-1\n107-98-2\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\n\n\n\n\n603-065-00-9\nresorcinol diglycidyl ether;\n1,3-bis(2,3-epoxypropoxy)benzene\n202-987-5\n101-90-6\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH351\nH341\nH312\nH302\nH319\nH315\nH317\nH412\nGHS08\nGHS07\nWng\nH351\nH341\nH312\nH302\nH319\nH315\nH317\nH412\n\n\n\n\n\n\n603-066-00-4\n1,2-epoxy-4-epoxyethylcyclohexane;\n4-vinylcyclohexene diepoxide\n203-437-7\n106-87-6\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH351\nH331\nH311\nH301\nGHS06\nGHS08\nDgr\nH351\nH331\nH311\nH301\n\n*\n\n\n603-067-00-X\nphenyl glycidyl ether;\n2,3-epoxypropyl phenyl ether;\n1,2-epoxy-3-phenoxypropane\n204-557-2\n122-60-1\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH341\nH332\nH335\nH315\nH317\nH412\nGHS08\nGHS07\nDgr\nH350\nH341\nH332\nH335\nH315\nH317\nH412\n\n\n\n603-068-00-5\n2,3-epoxypropyl-2-ethylcyclohexyl ether;\nethylcyclohexylglycidyl ether\n—\n130014-35-6\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n603-069-00-0\n2,4,6-tris(dimethylaminomethyl)phenol\n202-013-9\n90-72-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n603-070-00-6\n2-amino-2-methylpropanol\n204-709-8\n124-68-5\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n603-071-00-1\n2,2'-iminodiethanol;\ndiethanolamine\n203-868-0\n111-42-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH373 **\nH315\nH318\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH315\nH318\n\n\n\n603-072-00-7\n1,4-bis(2,3 epoxypropoxy)butane;\nbutanedioldiglycidyl ether\n219-371-7\n2425-79-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH312\nH319\nH315\nH317\nGHS07\nWng\nH332\nH312\nH319\nH315\nH317\n\n\n\n603-073-00-2\nbis-[4-(2,3-epoxipropoxi)phenyl]propane\n216-823-5\n1675-54-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n603-074-00-8\nreaction product: bisphenol-A-(epichlorhydrin);\nepoxy resin (number average molecular weight ≤ 700)\n500-033-5\n25068-38-6\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH411\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n603-075-00-3\nchlormethyl methyl ether;\nchlorodimethyl ether\n203-480-1\n107-30-2\nFlam. Liq. 2\nCarc. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH350\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH350\nH332\nH312\nH302\n\n\n\n603-076-00-9\nbut-2-yne-1,4-diol;\n2-butyne-1,4-diol\n203-788-6\n110-65-6\nSkin Corr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nH314\nH331\nH301\nH312\nH373 **\nH317\nGHS06\nGHS05\nGHS08\nDgr\nH314\nH331\nH301\nH312\nH373 **\nH317\n\nSkin Corr. 1B; H314: C ≥ 50 %\nSkin Irrit. 2; H315: 25 % ≤ C < 50 %\nEye Irrit. 2; H319: 25 % ≤ C < 50 %\nD\n603-077-00-4\n1-dimethylaminopropan-2-ol;\ndimepranol (INN)\n203-556-4\n108-16-7\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH302\nH314\n\n\n\n603-078-00-X\nprop-2-yn-1-ol;\npropargyl alcohol\n203-471-2\n107-19-7\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH226\nH331\nH311\nH301\nH314\nH411\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH226\nH331\nH311\nH301\nH314\nH411\n\n\n\n603-079-00-5\n2,2'-(methylimino)diethanol;\nN-methyldiethanolamine\n203-312-7\n105-59-9\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-080-00-0\n2-methylaminoethanol;\nN-methylethanolamine;\nN-methyl-2-ethanolamine;\nN-methyl-2-amino ethanol;\n2-(methylamino)ethanol\n203-710-0\n109-83-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05 GHS07\nDgr\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n603-081-00-6\n2,2'-thiodiethanol;\nthiodiglycol\n203-874-3\n111-48-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-082-00-1\n1-aminopropan-2-ol;\nisopropanolamine\n201-162-7\n78-96-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n603-083-00-7\n1,1'-iminodipropan-2-ol;\ndi-isopropanolamine\n203-820-9\n110-97-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-084-00-2\nstyrene oxide;\n(epoxyethyl)benzene;\nphenyloxirane\n202-476-7\n96-09-3\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nH350\nH312\nH319\nGHS08\nGHS07\nDgr\nH350\nH312\nH319\n\n\n\n\n\n603-085-00-8\nbronopol (INN);\n2-bromo-2-nitropropane-1,3-diol\n200-143-0\n52-51-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH312\nH302\nH335\nH315\nH318\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH335\nH315\nH318\nH400\n\nM=10\n\n\n603-086-00-3\nethirimol (ISO);\n5-butyl-2-ethylamino-6-methylpyrimidin-4-ol\n245-949-3\n23947-60-6\nAcute Tox. 4 *\nH312\nGHS07\nWng\nH312\n\n\n\n603-087-00-9\n2-ethylhexane-1,3-diol;\noctylene glycol;\nethoexadiol\n202-377-9\n94-96-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-088-00-4\n2-(octylthio)ethanol;\n2-hydroxyethyl octyl sulphide\n222-598-4\n3547-33-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-089-00-X\n7,7-dimethyl-3-oxa-6-azaoctan-1-ol\n400-390-6\n—\nSkin Corr. 1A\nAcute Tox. 4 *\nH314\nH302\nGHS05\nGHS07\nDgr\nH314\nH302\n\n\n\n603-090-00-5\n2-(2-bromoethoxy)anisole\n402-010-4\n4463-59-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-091-00-0\nexo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol\n402-470-6\n87172-89-2\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n603-092-00-6\n2-methyl-4-phenylpentanol\n402-770-7\n92585-24-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n603-093-00-1\ncinmethylin (ISO);\nexo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane\n402-410-9\n87818-31-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH411\nGHS07\nGHS09\nDgr\nH332\nH411\n\n\n\n603-094-00-7\n1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane\n241-536-7\n17557-23-2\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n603-095-00-2\n2-(propyloxy)ethanol;\nEGPE\n220-548-6\n2807-30-9\nAcute Tox. 4 *\nEye Irrit. 2\nH312\nH319\nGHS07\nWng\nH312\nH319\n\n\n\n603-096-00-8\n2-(2-butoxyethoxy)ethanol;\ndiethylene glycol monobutyl ether\n203-961-6\n112-34-5\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-097-00-3\n1,1',1''-nitrilotripropan-2-ol;\ntriisopropanolamine\n204-528-4\n122-20-3\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n603-098-00-9\n2-phenoxyethanol\n204-589-7\n122-99-6\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n603-099-00-4\n3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride\n403-440-5\n93633-79-5\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-100-00-8\n1,2-dimethoxypropane\n404-630-0\n7778-85-0\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH019\n\n\n603-101-00-3\ntetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)\n405-040-6\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n603-102-00-9\n1,2-epoxybutane\n203-438-2\n106-88-7\nFlam. Liq. 2\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH225\nH351\nH332\nH312\nH302\nH319\nH335\nH315\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH351\nH332\nH312\nH302\nH319\nH335\nH315\nH412\n\n\n\n603-103-00-4\noxirane, mono[(C12-14-alkyloxy)methyl] derivs.\n271-846-8\n68609-97-2\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n603-104-00-X\nfenarimol (ISO);\n2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol\n262-095-7\n60168-88-9\nRepr. 2\nLact.\nAquatic Chronic 2\nH361fd\nH362\nH411\nGHS08 GHS09\nWng\nH361fd\nH362\nH411\n\n\n\n603-105-00-5\nfuran\n203-727-3\n110-00-9\nFlam. Liq. 1\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Chronic 3\nH224\nH350\nH341\nH332\nH302\nH373 **\nH315\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH350\nH341\nH332\nH302\nH373 **\nH315\nH412\nEUH019\n\n\n603-106-00-0\n2-methoxypropanol\n216-455-5\n1589-47-5\nFlam. Liq. 3\nRepr. 1B\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH226\nH360D ***\nH335\nH315\nH318\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH360D ***\nH335\nH315\nH318\n\n\n\n603-107-00-6\n2-(2-methoxyethoxy)ethanol;\ndiethylene glycol monomethyl ether\n203-906-6\n111-77-3\nRepr. 2\nH361d ***\nGHS08\nWng\nH361d ***\n\n\n\n603-108-00-1\n2-methylpropan-1-ol;\niso-butanol\n201-148-0\n78-83-1\nFlam. Liq. 3\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSTOT SE 3\nH226\nH335\nH315\nH318\nH336\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH335\nH315\nH318\nH336\n\n\n\n\n\n603-109-00-7\nreaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;\n1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane\n425-340-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-110-00-2\nreaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;\ntrans-2-isobutyl-5-methyl 1,3-dioxane\n426-130-1\n166301-21-9\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n603-111-00-8\nreaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;\n1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane\n426-530-6\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n603-112-00-3\ncyclopentyl 2-phenylethyl ether\n428-340-9\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n603-113-00-9\n6-glycidyloxynapht-1-yl oxymethyloxirane\n429-960-2\n27610-48-6\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH341\nH312\nH315\nH317\nH412\nGHS08\nGHS07\nWng\nH341\nH312\nH315\nH317\nH412\n\n\n\n\n603-114-00-4\n9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene\n430-830-2\n26912-64-1\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n603-115-00-X\nreaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-580-0\n—\nSTOT RE 2 *\nAquatic Chronic 4\nH373**\nH413\nGHS08\nWng\nH373**\nH413\n\n\n\n\n603-116-00-5\n(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride\n424-740-2\n138271-16-6\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n603-117-00-0\npropan-2-ol;\nisopropyl alcohol;\nisopropanol\n200-661-7\n67-63-0\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\n\n\n\n603-118-00-6\n6-dimethylaminohexan-1-ol\n404-680-3\n1862-07-3\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH412\n\n\n\n603-119-00-1\n1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)\n405-840-5\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n603-120-00-7\n2-methyl-5-phenylpentanol\n405-890-8\n25634-93-9\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n603-121-00-2\n4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone\n406-057-1\n114565-66-1\nCarc. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH317\nH413\n\n\n\n603-122-00-8\nsodium 2-ethylhexanolate\n406-150-7\n38411-13-1\nFlam. Sol. 1\nSkin Corr. 1B\nAquatic Chronic 3\nH228\nH314\nH412\nGHS02\nGHS05\nDgr\nH228\nH314\nH412\n\n\nT\n603-123-00-3\n4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol\n406-330-5\n122760-84-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n603-124-00-9\n1,4-bis[2-(vinyloxy)ethoxy]benzene\n406-900-3\n84563-49-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-125-00-4\n2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol\n407-850-5\n89544-40-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-126-00-X\n2-((4-methyl-2-nitrophenyl)amino)ethanol\n408-090-7\n100418-33-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n\n603-127-00-5\nbutan-2-ol; [1]\n(S)-butan-2-ol; [2]\n(R)-butan-2-ol; [3]\n(±)-butan-2-ol [4]\n201-158-5 [1]\n224-168-1 [2]\n238-967-8 [3]\n240-029-8 [4]\n78-92-2 [1]\n4221-99-2 [2]\n14898-79-4 [3]\n15892-23-6 [4]\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSTOT SE 3\nH226\nH319\nH335\nH336\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH336\n\n\nC\n\n603-128-00-0\n2-(phenylmethoxy)naphthalene\n405-490-3\n613-62-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-129-00-6\n1-tert-butoxypropan-2-ol\n406-180-0\n57018-52-7\nFlam. Liq. 3\nEye Dam. 1\nH226\nH318\nGHS02\nGHS05\nDgr\nH226\nH318\n\n\n\n603-130-00-1\nreaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)\n406-325-8\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-131-00-7\nreaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;\n1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)\n407-290-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-132-00-2\n2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane\n408-200-3\n63187-91-7\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n603-133-00-8\nreaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;\n3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)\n408-240-1\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-134-00-3\nreaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.\n410-450-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-135-00-9\nbis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium\n410-500-4\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n603-136-00-4\n3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol\n410-910-3\n104226-19-9\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n603-137-00-X\nreaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;\n1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol\n411-130-6\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-138-00-5\n3-(2,2-dimethyl-3-hydroxypropyl)toluene;\n(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol\n403-140-4\n103694-68-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-139-00-0\nbis(2-methoxyethyl) ether\n203-924-4\n111-96-6\nFlam. Liq. 3\nRepr. 1B\nH226\nH360FD\nGHS02\nGHS08\nDgr\nH226\nH360FD\nEUH019\n\n\n603-140-00-6\n2,2' -oxybisethanol;\ndiethylene glycol\n203-872-2\n111-46-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n603-141-00-1\nreaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;\ndodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane\n413-780-6\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-142-00-7\n2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane\n407-360-1\n116230-20-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH373 **\nH315\nH318\nGHS06\nGHS08\nGHS05\nDgr\nH312\nH302\nH373 **\nH315\nH318\n\n\n\n603-143-00-2\nR—2,3-epoxy-1-propanol\n404-660-4\n57044-25-4\nSelf-react. C ****\nCarc. 1B\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH242\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH314\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH242\nH350\nH341\nH360F ***\nH331\nH312\nH302\nH314\n\n\n\n603-144-00-8\nreaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;\n6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol\n413-530-6\n111850-00-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n603-145-00-3\n2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane\n406-970-5\n129228-11-1\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n603-146-00-9\n2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol\n406-080-7\n83016-70-0\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH412\n\n\n\n603-147-00-4\n(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine\n406-030-4\n105812-81-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-148-00-X\n1,4-bis[(vinyloxy)methyl]cyclohexane\n413-370-7\n17351-75-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07 GHS09\nWng\nH317\nH411\n\n\n\n603-149-00-5\nreaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane\n407-640-3\n63767-86-2\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH315\nH411\nGHS07 GHS09\nWng\nH319\nH315\nH411\n\n\n\n603-150-00-0\n(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol\n411-580-3\n107898-54-4\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n603-151-00-6\n(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol\n413-570-4\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-152-00-1\n2-(4-tert-butylphenyl)ethanol\n410-020-5\n5406-86-0\nRepr. 2\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH361f ***\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH361f ***\nH373 **\nH318\nH411\n\n\n\n603-153-00-7\n3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol\n410-010-0\n104333-00-8\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n603-154-00-2\n1-[(2-tert-butyl)cyclohexyloxy]-2-butanol\n412-300-2\n139504-68-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n603-155-00-8\nReaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane\n410-560-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-156-00-3\n2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane\n411-210-0\n89544-48-9\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n603-157-00-9\n6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol\n411-450-6\n143747-72-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-158-00-4\nreaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene\n412-460-3\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07 GHS09\nWng\nH315\nH411\n\n\n\n603-159-00-X\n2-cyclododecylpropan-1-ol\n411-410-8\n118562-73-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-160-00-5\n1,2-diethoxypropane\n412-180-1\n10221-57-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH019\n\n\n603-161-00-0\n1,3-diethoxypropane\n413-140-6\n3459-83-4\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n603-162-00-6\nα[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]\n413-420-8\n144736-29-8\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n603-163-00-1\n2-phenyl-1,3-propanediol\n411-810-2\n1570-95-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n603-164-00-7\n2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole\n412-420-5\n133909-99-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n603-165-00-2\nreaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;\n4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol\n417-470-1\n—\nMuta. 2\nSkin Sens. 1\nH341\nH317\nGHS08\nGHS07\nWng\nH341\nH317\n\n\n\n603-166-00-8\nR-1-chloro-2,3-epoxypropane\n424-280-2\n51594-55-9\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH350\nH331\nH311\nH301\nH314\nH317\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH226\nH350\nH331\nH311\nH301\nH314\nH317\n\n\n\n603-167-00-3\n3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol\n407-920-5\n6390-69-8\nAquatic Chronic 4\nH413\nGHS05\nDgr\nH413\n\n\n\n603-168-00-9\n3-(2-ethylhexyloxy)propane-1,2-diol\n408-080-2\n70445-33-9\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n603-169-00-4\n(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine\n415-550-0\n109887-53-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-170-00-X\nreaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;\n2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;\n2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol\n415-990-3\n67739-11-1\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n603-171-00-5\n5-thiazolylmethanol\n414-780-9\n38585-74-9\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n603-172-00-0\nmono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate\n415-180-1\n773058-82-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n603-173-00-6\n4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane\n421-750-9\n57280-22-5\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n603-174-00-1\n4-cyclohexyl-2-methyl-2-butanol\n420-630-3\n83926-73-2\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n603-175-00-7\n2-(2-hexyloxyethoxy)ethanol;\nDEGHE;\ndiethylene glycol monohexyl ether;\n3,6-dioxa-1-dodecanol;\nhexyl carbitol;\n3,6-dioxadodecan-1-ol\n203-988-3\n112-59-4\nAcute Tox. 4 *\nEye Dam. 1\nH312\nH318\nGHS05\nGHS07\nDgr\nH312\nH318\n\n\n\n603-176-00-2\n1,2-bis(2-methoxyethoxy)ethane;\nTEGDME;\ntriethylene glycol dimethyl ether;\ntriglyme\n203-977-3\n112-49-2\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\nEUH019\n\n\n603-177-00-8\n1-ethoxypropan-2-ol;\n2PG1EE;\n1-ethoxy-2-propanol;\npropylene glycol monoethyl ether; [1]\n2-ethoxy-1-methylethyl acetate;\n2PG1EEA [2]\n216-374-5 [1]\n259-370-9 [2]\n1569-02-4 [1]\n54839-24-6 [2]\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\n\n\n\n603-178-00-3\n2-hexyloxyethanol;\nethylene glycol monohexyl ether;\nn-hexylglycol\n203-951-1\n112-25-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n603-179-00-9\nergocalciferol (ISO);\nVitamin D2\n200-014-9\n50-14-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nH330\nH311\nH301\nH372 **\nGHS06\nGHS08\nDgr\nH330\nH311\nH301\nH372 **\n\n\n\n603-180-00-4\ncolecalciferol;\nVitamin D3\n200-673-2\n67-97-0\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nH330\nH311\nH301\nH372 **\nGHS06\nGHS08\nDgr\nH330\nH311\nH301\nH372 **\n\n\n\n603-181-00-X\ntert-butyl methyl ether;\nMTBE;\n2-methoxy-2-methylpropane\n216-653-1\n1634-04-4\nFlam. Liq. 2\nSkin Irrit. 2\nH225\nH315\nGHS02\nGHS07\nDgr\nH225\nH315\n\n\n\n\n\n603-182-00-5\nreaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide\n428-630-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n603-183-00-0\n2-[2-(2-butoxyethoxy)ethoxy]ethanol;\nTEGBE;\ntriethylene glycol monobutyl ether;\nbutoxytriethylene glycol\n205-592-6\n143-22-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\nEye Dam. 1; H318: C ≥ 30 %\nEye Irrit. 2; H319: 20 % ≤ C < 30 %\n\n603-184-00-6\n2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol\n416-380-1\n146925-83-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n603-185-00-1\n2,4-dichloro-3-ethyl-6-nitrophenol\n420-740-1\n99817-36-4\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n603-186-00-7\ntrans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol\n419-050-3\n79944-37-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n603-187-00-2\n2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride\n419-360-9\n163661-77-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n603-188-00-8\nreaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;\n7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene\n426-970-9\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-189-00-3\nreaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol\n405-250-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n603-190-00-9\n8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane\n424-030-2\n62406-73-9\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n\n603-191-00-4\n2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol\n419-740-4\n137658-79-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n603-192-00-X\n(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol\n423-240-1\n125474-34-2\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n\n603-193-00-5\ndisodium 9,10-anthracenedioxide\n426-030-8\n46492-07-3\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\n\n\n\n603-194-00-0\n2-(2-aminoethylamino)ethanol;\n(AEEA)\n203-867-5\n111-41-1\nRepr. 1B\nSkin Corr. 1B\nSkin Sens. 1\nH360Df\nH314\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH360Df\nH314\nH317\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n603-195-00-6\n2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol\n430-810-3\n154825-62-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n603-196-00-1\n2-(7-ethyl-1H-indol-3-yl)ethanol\n431-020-1\n41340-36-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n603-197-00-7\ntebuconazole (ISO);\n1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol\n403-640-2\n107534-96-3\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH361d ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH411\n\n\n\n603-199-00-8\netoxazol (ISO);\n(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole\n—\n153233-91-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 100\n\n\n\n\n603-200-00-1\n1-pentanol; [1]\n3-pentanol [2]\n200-752-1 [1]\n209-526-7 [2]\n71-41-0 [1]\n584-02-1 [2]\nFlam. Liq. 3\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nH226\nH332\nH335\nH315\nGHS02\nGHS07\nWng\nH226\nH332\nH335\nH315\n\n\n\n\n603-201-00-7\n(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol\n416-120-5\n—\nSkin Irrit. 2\nAquatic Chronic 4\nH315\nH413\nGHS07\nWng\nH315\nH413\n\n\n\n\n603-202-00-2\n4,4,5,5,5-pentafluoropentan-1-ol\n421-360-9\n148043-73-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n603-203-00-8\n(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane\n427-580-1\n—\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n603-204-00-3\nreaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;\n2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane\n428-110-8\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-205-00-9\n(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride\n426-200-1\n172015-79-1\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH372**\nH302\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH372**\nH302\nH318\nH317\nH412\n\n\n\n\n603-206-00-4\n2,2-dichloro-1,3-benzodioxol\n426-850-6\n2032-75-9\nFlam. Liq. 3\nSkin Corr. 1A\nAcute Tox. 4 *\nSkin Sens. 1\nH226\nH314\nH302\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH314\nH302\nH317\nEUH014\n\n\n\n603-207-00-X\n2-isobutyl-2-isopropyl-1,3-dimethoxypropane\n430-800-9\n129228-21-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n603-208-00-5\n1,2-diethoxyethane\n211-076-1\n629-14-1\nFlam. Liq. 2\nRepr. 1A\nEye Irrit. 2\nH225\nH360Df\nH319\nGHS02\nGHS08\nGHS07\nDgr\nH225\nH360Df\nH319\nEUH019\n\n\n\n603-209-00-0\nspinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);\nreaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]\nspinosyn A; [2]\nspinosyn D [3]\n- [1]\n- [2]\n- [3]\n- [1]\n131929-60-7 [2]\n131929-63-0 [3]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n\n603-210-00-6\n2,4-diethyl-1,5-pentanediol\n429-310-8\n57987-55-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n603-211-00-1\n2,3-epoxypropyltrimethylammonium chloride … %;\nglycidyl trimethylammonium chloride … %\n221-221-0\n3033-77-0\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH341\nH361f***\nH312\nH302\nH373**\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH350\nH341\nH361f***\nH312\nH302\nH373**\nH318\nH317\nH412\n\n\nB\n\n603-212-00-7\n1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;\ngalaxolide;\n(HHCB)\n214-946-9\n1222-05-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n603-213-00-2\n2-methoxy-2-methylbutane;\ntert-amyl methyl ether\n213-611-4\n994-05-8\nFlam. Liq. 2\nAcute Tox. 4 *\nSTOT SE 3\nH225\nH302\nH336\nGHS02\nGHS07\nDgr\nH225\nH302\nH336\n\n\n\n\n603-214-00-8\n1,1-diisopropoxycyclohexane\n413-740-8\n1132-95-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n\n603-215-00-3\n1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n418-330-2\n162241-33-0\nExpl. 1.1****\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS01\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n603-216-00-9\ncis-1-amino-2,3-dihydro-1H-inden-2-ol\n422-660-2\n7480-35-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n603-217-00-4\n2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite\n423-560-1\n161717-32-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n603-220-00-0\n1-{]benzyl[}2-(2-methoxyphenoxy)ethyl{]amino[}-3-(9H-carbazol-4-yloxy)propan-2-ol\n432-890-5\n72955-94-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-221-00-6\n1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;\n[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]\n433-580-2\n214353-17-0\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n\n603-221-01-3\n1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;\n[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]\n433-580-2\n214353-17-0\nCarc. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH350\nH302\nH314\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH314\nH411\n\n\n\n\n603-222-00-1\n(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane\n433-820-6\n118058-74-5\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n603-223-00-7\n2-cyclopentylidene cyclopentanol;\n1,1'-bi(cyclopentyliden)-2-ol\n434-270-1\n6261-30-9\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n603-224-00-2\n3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane\n435-790-1\n297730-93-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-225-00-8\nerythromycin A9-oxime (E);\n(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)\n437-070-0\n13127-18-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n603-226-00-3\n4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol\n444-500-0\n1440-00-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-227-00-9\nα-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);\nreaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate\n445-060-2\n203574-04-3\n****\nAquatic Acute 1\nAquatic Chronic 1\n****\nH400\nH410\n****\nGHS09\nWng\n****\nH410\n\n\n\n\n603-228-00-4\n(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;\n6-fluoro-2-(2-oxiranyl)chromane\n419-620-1\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n603-229-00-X\nsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate\n420-800-7\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n\n603-230-00-5\n2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan\n440-030-5\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 4\nH315\nH318\nH413\nGHS05\nDgr\nH315\nH318\nH413\n\n\n\n\n603-231-00-0\n(S)-1,1-diphenyl-1,2-propanediol\n443-220-6\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n603-232-00-6\n3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane\n444-420-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n603-233-00-1\nreaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;\n4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;\n1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;\n1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;\n(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;\n(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol\n444-430-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n603-234-00-7\n(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene\n444-480-3\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n604-001-00-2\nphenol;\ncarbolic acid;\nmonohydroxybenzene;\nphenylalcohol\n203-632-7\n108-95-2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Corr. 1B\nH341\nH331\nH311\nH301\nH373 **\nH314\nGHS06\nGHS08 GHS05\nDgr\nH341\nH331\nH311\nH301\nH373 **\nH314\n\n*\nSkin Corr. 1B; H314: C ≥ 3 %\nSkin Irrit. 2; H315: 1 % ≤ C < 3 %\nEye Irrit. 2; H319: 1 % ≤ C < 3 %\n\n604-002-00-8\npentachlorophenol\n201-778-6\n87-86-5\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH410\n\n\n\n604-003-00-3\nsodium pentachlorophenolate; [1]\npotassium pentachlorophenolate [2]\n205-025-2 [1]\n231-911-3 [2]\n131-52-2 [1]\n7778-73-6 [2]\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH319\nH335\nH315\nH410\n\n\n\n604-004-00-9\nm-cresol; [1]\no-cresol; [2]\np-cresol; [3]\nmix-cresol [4]\n203-577-9 [1]\n202-423-8 [2]\n203-398-6 [3]\n215-293-2 [4]\n108-39-4 [1]\n95-48-7 [2]\n106-44-5 [3]\n1319-77-3 [4]\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH311\nH301\nH314\n\n*\nC\n\n\n604-005-00-4\n1,4-dihydroxybenzene;\nhydroquinone;\nquinol\n204-617-8\n123-31-9\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH302\nH318\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH341\nH302\nH318\nH317\nH400\n\nM=10\n\n\n604-006-00-X\n3,4-xylenol; [1]\n2,5-xylenol; [2]\n2,4-xylenol; [3]\n2,3-xylenol; [4]\n2,6-xylenol; [5]\nxylenol; [6]\n2,4(or 2,5)-xylenol [7]\n202-439-5 [1]\n202-461-5 [2]\n203-321-6 [3]\n208-395-3 [4]\n209-400-1 [5]\n215-089-3 [6]\n276-245-4 [7]\n95-65-8 [1]\n95-87-4 [2]\n105-67-9 [3]\n526-75-0 [4]\n576-26-1 [5]\n1300-71-6 [6]\n71975-58-1 [7]\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Chronic 2\nH311\nH301\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH301\nH314\nH411\n\n\nC\n604-007-00-5\n2-naphthol\n205-182-7\n135-19-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH332\nH302\nH400\nGHS07\nGHS09\nWng\nH332\nH302\nH400\n\n\n\n604-008-00-0\n2-chlorophenol; [1]\n4-chlorophenol; [2]\n3-chlorophenol; [3]\nchlorophenol [4]\n202-433-2 [1]\n203-402-6 [2]\n203-582-6 [3]\n246-691-4 [4]\n95-57-8 [1]\n106-48-9 [2]\n108-43-0 [3]\n25167-80-0 [4]\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH312\nH302\nH411\nGHS07 GHS09\nWng\nH332\nH312\nH302\nH411\n\n\nC\n604-009-00-6\npyrogallol;\n1,2,3-trihydroxybenzene\n201-762-9\n87-66-1\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH341\nH332\nH312\nH302\nH412\nGHS08\nGHS07\nWng\nH341\nH332\nH312\nH302\nH412\n\n*\n\n604-010-00-1\nresorcinol;\n1,3-benzenediol\n203-585-2\n108-46-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nH302\nH319\nH315\nH400\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH400\n\n*\n\n604-011-00-7\n2,4-dichlorophenol\n204-429-6\n120-83-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH311\nH302\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH302\nH314\nH411\n\n\n\n604-012-00-2\n4-chloro-o-cresol;\n4-chloro-2-methyl phenol\n216-381-3\n1570-64-5\nAcute Tox. 3 *\nSkin Corr. 1A\nAquatic Acute 1\nH331\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 1 %\n\n604-013-00-8\n2,3,4,6-tetrachlorophenol\n200-402-8\n58-90-2\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH315\nH410\n\n*\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n604-014-00-3\nchlorocresol;\n4-chloro-m-cresol;\n4-chloro-3-methylphenol\n200-431-6\n59-50-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH312\nH302\nH318\nH317\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH318\nH317\nH400\n\n*\n\n604-015-00-9\n2,2'-methylenebis-(3,4,6-trichlorophenol);\nhexachlorophene\n200-733-8\n70-30-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH301\nH410\n\n*\n\n604-016-00-4\n1,2-dihydroxybenzene;\npyrocatechol\n204-427-5\n120-80-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH312\nH302\nH319\nH315\nGHS07\nWng\nH312\nH302\nH319\nH315\n\n\n\n604-017-00-X\n2,4,5-trichlorophenol\n202-467-8\n95-95-4\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n*\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n604-018-00-5\n2,4,6-trichlorophenol\n201-795-9\n88-06-2\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH315\nH410\n\n\n\n604-019-00-0\ndichlorophen (ISO)\n202-567-1\n97-23-4\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n604-020-00-6\n2-phenylphenol (ISO)\nbiphenyl-2-ol;\n2-hydroxybiphenyl;\n201-993-5\n90-43-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH319\nH335\nH315\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH400\n\n\n\n604-021-00-1\nsodium 2-biphenylate;\n2-phenylphenol, sodium salt\n205-055-6\n132-27-4\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH302\nH335\nH315\nH318\nH400\nGHS05\nGHS07\nGHS09\nWng\nH302\nH335\nH315\nH318\nH400\n\n\n\n604-022-00-7\n2,2-dimethyl-1,3-benzodioxol-4-ol\n400-900-7\n22961-82-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n604-023-00-2\n2,4-dichloro-3-ethylphenol\n401-060-4\n—\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\n\n\n604-024-00-8\n4,4-isobutylethylidenediphenol\n401-720-1\n6807-17-6\nRepr. 1B\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360F ***\nH319\nH400\nH410\nGHS08\nGHS09\nDgr\nH360F ***\nH319\nH410\n\n\n\n604-025-00-3\n2,5-bis(1,1-dimethylbutyl)hydroquinone\n400-220-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-026-00-9\n2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)\n400-270-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-027-00-4\n2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone\n400-530-6\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n604-028-00-X\n4-amino-3-fluorophenol\n402-230-0\n399-95-1\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH411\n\n\n\n604-029-00-5\n1-naphtol\n201-969-4\n90-15-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH335\nH315\nH318\nGHS05\nGHS07\nDgr\nH312\nH302\nH335\nH315\nH318\n\n\n\n\n604-030-00-0\nbisphenol A;\n4,4’-isopropylidenediphenol\n201-245-8\n80-05-7\nRepr. 2\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nH361f***\nH335\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH361f***\nH335\nH318\nH317\n\n\n\n\n604-031-00-6\nguaiacol\n201-964-7\n90-05-1\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n604-032-00-1\nthymol\n201-944-8\n89-83-8\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n604-033-00-7\nisobutyl but-3-enoate\n401-170-2\n24342-03-8\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n604-034-00-2\n4,4'-thiodi-o-cresol\n403-330-7\n24197-34-0\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n604-035-00-8\n4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol\n404-160-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n604-036-00-3\n4,4'-oxybis(ethylenethio)diphenol\n404-590-4\n90884-29-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n604-037-00-9\n3,5-xylenol;\n3,5-dimethylphenol\n203-606-5\n108-68-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH311\nH301\nH314\n\n\n\n604-038-00-4\n4-chloro-3,5-dimethylphenol; [1]\nchloroxylenol [2]\n201-793-8 [1]\n215-316-6 [2]\n88-04-0 [1]\n1321-23-9 [2]\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH302\nH319\nH315\nH317\nGHS07\nWng\nH302\nH319\nH315\nH317\n\n\n\n604-039-00-X\nethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;\nfenoxaprop-ethyl\n266-362-9\n66441-23-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n604-040-00-5\nfomesafen (ISO);\n5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide\n276-439-9\n72178-02-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n604-041-00-0\nacifluorfen (ISO);\n5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]\nsodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;\nacifluorfen-sodium [2]\n256-634-5 [1]\n263-560-7 [2]\n50594-66-6 [1]\n62476-59-9 [2]\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\n\n604-042-00-6\n4-nitrosophenol\n203-251-6\n104-91-6\nMuta. 2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH341\nH302\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH341\nH302\nH318\nH411\n\n\n\n604-043-00-1\nmonobenzone;\n4-hydroxyphenyl benzyl ether;\nhydroquinone monobenzyl ether\n203-083-3\n103-16-2\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n604-044-00-7\nmequinol;\n4-methoxyphenol;\nhydroquinone monomethyl ether\n205-769-8\n150-76-5\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS07\nWng\nH302\nH319\nH317\n\n\n\n604-045-00-2\n2,3,5-trimethylhydroquinone\n211-838-3\n700-13-0\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH335\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH335\nH315\nH318\nH317\nH410\n\n\n\n604-046-00-8\n4-(4-isopropoxyphenylsulfonyl)phenol\n405-520-5\n95235-30-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-047-00-3\n4-(4-tolyloxy)biphenyl\n405-730-7\n51601-57-1\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n604-048-00-9\n4,4',4''-(ethan-1,1,1-triyl)triphenol\n405-800-7\n27955-94-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-049-00-4\n4-4'-methylenebis(oxyethylenethio)diphenol\n407-480-4\n93589-69-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-051-00-5\n3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol\n401-110-5\n87113-78-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n604-052-00-0\n2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)\n403-800-1\n103597-45-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n604-053-00-6\n2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol\n410-760-9\n157661-93-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n604-054-00-1\nreaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;\n4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol\n412-020-0\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n604-055-00-7\n2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane\n413-900-7\n85954-11-6\nCarc. 2\nSkin Sens. 1\nH351\nH317\nGHS08\nGHS07\nWng\nH351\nH317\n\n\n\n\n604-056-00-2\n2-(2-hydroxy-3,5-dinitroanilino)ethanol\n412-520-9\n99610-72-7\nFlam. Sol. 2\nRepr. 2\nAcute Tox. 4 *\nH228\nH361f ***\nH302\nGHS02\nGHS07\nGHS08\nDgr\nH228\nH361f ***\nH302\n\n\n\n604-057-00-8\nreaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;\nisomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;\nisomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6\n401-680-5\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-058-00-3\n1,2-bis(3-methylphenoxy)ethane\n402-730-9\n54914-85-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n604-059-00-9\n2-n-hexadecylhydroquinone\n406-400-5\n—\nSTOT RE 2 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH373 **\nH315\nH317\nH413\nGHS08\nGHS07\nWng\nH373 **\nH315\nH317\nH413\n\n\n\n604-060-00-4\n9,9-bis(4-hydroxyphenyl)fluorene\n406-950-6\n3236-71-3\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n604-061-00-X\nreaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;\n1-ethyldodecyl;\n1-propylundecyl;\n1-butyldecyl;\n1-pentylnonyl;\n1-hexyloctyl\n407-740-7\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH317\nH412\nGHS07\nWng\nH315\nH317\nH412\n\n\n\n604-062-00-5\n2,4-dimethyl-6-(1-methyl-pentadecyl)phenol\n411-220-5\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n604-063-00-0\n5,6-dihydroxyindole\n412-130-9\n3131-52-0\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05 GHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n604-064-00-6\n2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol\n411-380-6\n147315-50-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n604-065-00-1\n4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)\n407-460-5\n111850-25-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n604-066-00-7\nreaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);\n2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;\n2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol\n414-550-8\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n604-067-00-2\nreaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];\nformaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);\nformaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)\n414-520-4\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n604-068-00-8\n(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride\n415-170-5\n90274-24-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nH332\nH302\nH317\nGHS07\nWng\nH332\nH302\nH317\n\n\n\n604-069-00-3\n2-(1-methylpropyl)-4-tert-butylphenol\n421-740-4\n51390-14-8\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n604-070-00-9\ntriclosan;\n2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;\n5-chloro-2-(2,4-dichlorophenoxy)phenol\n222-182-2\n3380-34-5\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\nM = 100\n\n\n\n604-071-00-4\n4,4'-(1-{]4-[}1-(4-hydroxyphenyl)-1-methylethyl{]phenyl[}ethylidene)diphenol\n425-600-3\n110726-28-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-072-00-X\n1,2-bis(phenoxymethyl)benzene\n428-620-0\n10403-74-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-073-00-5\n(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol\n428-010-4\n82413-20-5\nCarc. 2\nRepr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH360F***\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360F***\nH317\nH410\n\n\n\n\n604-074-00-0\ntetrabromobisphenol-A;\n2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol\n201-236-9\n79-94-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-075-00-6\n4-(1,1,3,3-tetramethylbutyl)phenol;\n4-tert-octylphenol\n205-426-2\n140-66-9\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\nM=10\n\n\n604-076-00-1\nphenolphthalein\n201-004-7\n77-09-8\nCarc. 1B\nMuta. 2\nRepr. 2\nH350\nH341\nH361f***\nGHS08\nDgr\nH350\nH341\nH361f***\n\nCarc. 1B; H350: C ≥ 1 %\n\n\n\n604-077-00-7\n2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol\n419-750-9\n98809-58-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-079-00-8\n4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol\n428-970-4\n13595-25-0\nRepr. 2\nSkin Sens. 1\nAquatic Chronic 2\nH361f***\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361f***\nH317\nH411\n\n\n\n\n\n604-080-00-3\n4-fluoro-3-trifluoromethylphenol\n432-560-0\n61721-07-1\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Chronic 2\nH332\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH314\nH317\nH411\n\n\n\n\n604-081-00-9\n1,1-bis(4-hydroxyphenyl)-1-phenylethane\n433-130-5\n1571-75-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n604-082-00-4\n2-chloro-6-fluoro-phenol\n433-890-8\n2040-90-6\nMuta. 1B\nRepr. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH340\nH361f***\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH340\nH361f***\nH302\nH314\nH317\nH411\n\n\n\n\n604-083-00-X\n4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol\n439-270-3\n260408-02-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n604-084-00-5\n1-ethoxy-2,3-difluorobenzene\n441-000-4\n121219-07-6\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n604-087-00-1\nreaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;\n1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;\n1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol\n433-640-8\n—\nPyr. Sol. 1\nAquatic Chronic 4\nH250\nH413\nGHS02\nDgr\nH250\nH413\nEUH044\n\n\n\n604-089-00-2\n2-methyl-5-tert-butylthiophenol\n444-970-7\n—\nFlam. Liq. 3\nRepr. 2\nSTOT RE 2 *\nAsp. Tox. 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH361d***\nH373**\nH304\nH319\nH315\nH317\nH336\nH400\nH410\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH361d***\nH373**\nH304\nH319\nH315\nH317\nH336\nH410\n\n\n\n\n\n605-001-00-5\nformaldehyde ...%\n200-001-8\n50-00-0\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH351\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH351\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Corr. 1B; H314: C ≥25 %\nSkin Irrit. 2; H315: 5 % ≤ C < 25 %\nEye Irrit. 2; H319: 5 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 5 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nB D\n605-002-00-0\n1,3,5-trioxan;\ntrioxymethylene\n203-812-5\n110-88-3\nFlam. Sol. 1\nRepr. 2\nSTOT SE 3\nH228\nH361d ***\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH361d ***\nH335\n\n\nT\n605-003-00-6\nacetaldehyde;\nethanal\n200-836-8\n75-07-0\nFlam. Liq. 1\nCarc. 2\nEye Irrit. 2\nSTOT SE 3\nH224\nH351\nH319\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH224\nH351\nH319\nH335\n\n\n\n\n\n605-004-00-1\n2,4,6-trimethyl-1,3,5-trioxane;\nparaldehyde\n204-639-8\n123-63-7\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n605-005-00-7\n2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;\nmetaldehyde\n203-600-2\n108-62-3\nFlam. Sol. 2\nAcute Tox. 4 *\nH228\nH302\nGHS02\nGHS07\nWng\nH228\nH302\n\n\n\n\n\n\n605-006-00-2\nbutyraldehyde\n204-646-6\n123-72-8\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-007-00-8\n1,1-dimethoxyethane;\ndimethyl acetal\n208-589-8\n534-15-6\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-008-00-3\nacrylaldehyde;\nacrolein;\nprop-2-enal\n203-453-4\n107-02-8\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH225\nH330\nH311\nH301\nH314\nH400\nGHS02\nGHS06\nGHS05\nGHS09\nDgr\nH225\nH330\nH311\nH301\nH314\nH400\n\n\nD\n605-009-00-9\ncrotonaldehyde;\n2-butenal; [1]\n(E)-2-butenal;\n(E)-crotonaldehyde [2]\n224-030-0 [1]\n204-647-1 [2]\n4170-30-3 [1]\n123-73-9 [2]\nFlam. Liq. 2\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nH225\nH341\nH330\nH311\nH301\nH373 **\nH335\nH315\nH318\nH400\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH341\nH330\nH311\nH301\nH373 **\nH335\nH315\nH318\nH400\n\n\n\n\n\n605-010-00-4\n2-furaldehyde\n202-627-7\n98-01-1\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH351\nH331\nH301\nH312\nH319\nH335\nH315\nGHS06\nGHS08\nDgr\nH351\nH331\nH301\nH312\nH319\nH335\nH315\n\n\n\n\n\n605-011-00-X\n2-chlorobenzaldehyde;\no-chlorobenzaldehyde\n201-956-3\n89-98-5\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n605-012-00-5\nbenzaldehyde\n202-860-4\n100-52-7\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n605-013-00-0\nchloralose (INN);\n(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;\nglucochloralose;\nanhydroglucochloral\n240-016-7\n15879-93-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n605-014-00-6\nchloral hydrate;\n2,2,2-trichloroethane-1,1-diol\n206-117-5\n302-17-0\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nH301\nH319\nH315\nGHS06\nDgr\nH301\nH319\nH315\n\n\n\n605-015-00-1\n1,1-diethoxyethane;\nacetal\n203-310-6\n105-57-7\nFlam. Liq. 2\nEye Irrit. 2\nSkin Irrit. 2\nH225\nH319\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH315\n\n\n\n605-016-00-7\nglyoxal...%;\nethandial...%\n203-474-9\n107-22-2\nMuta. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH341\nH332\nH319\nH315\nH317\nGHS07\nGHS08\nWng\nH341\nH332\nH319\nH315\nH317\n\n*\nB\n605-017-00-2\n1,3-dioxolane\n211-463-5\n646-06-0\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n605-018-00-8\npropanal;\npropionaldehyde\n204-623-0\n123-38-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH225\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\n\n\n\n605-019-00-3\ncitral\n226-394-6\n5392-40-5\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n605-020-00-9\nsafrole;\n5-allyl-1,3-benzodioxole\n202-345-4\n94-59-7\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nH350\nH341\nH302\nGHS08\nGHS07\nDgr\nH350\nH341\nH302\n\n\n\n605-021-00-4\nformaldehyde, reaction products with butylphenol\n294-145-9\n91673-30-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n605-022-00-X\nglutaral;\nglutaraldehyde;\n1,5-pentanedial\n203-856-5\n111-30-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nH331\nH301\nH314\nH334\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH301\nH314\nH334\nH317\nH400\n\n*\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 0,5 % ≤ C < 10 %\nEye Dam. ; H318: 2 % ≤ C < 10 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 2 %\nSTOT SE; H335: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n\n\n\n605-023-00-5\n5-chloro-2-(4-chlorophenoxy)phenol\n429-290-0\n3380-30-1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n605-024-00-0\n2-bromo-5-hydroxy-4-methoxybenzaldehyde\n426-540-0\n2973-59-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n605-025-00-6\nchloroacetaldehyde\n203-472-8\n107-20-0\nCarc. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH351\nH330\nH311\nH301\nH314\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH330\nH311\nH301\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\n\n605-026-00-1\n2,5,7,7-tetramethyloctanal\n405-690-0\n114119-97-0\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07 GHS09\nWng\nH315\nH317\nH411\n\n\n\n605-027-00-7\nreaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;\n3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde\n410-480-7\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n605-028-00-2\nβ-methyl-3-(1-methylethyl)-benzenepropanal\n412-050-4\n125109-85-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n605-029-00-8\n2-cyclohexylpropanal\n412-270-0\n2109-22-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n605-030-00-3\n1-(p-methoxyphenyl)acetaldehyde oxime\n411-510-1\n3353-51-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n605-031-00-9\nreaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;\nwater(Including free water and water in hydrated 2,2-dimethoxyethanal)]\n421-890-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n605-032-00-4\n3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal\n425-370-4\n93957-50-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n605-033-00-X\nreaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;\n3,7,11-trimethyl-trans-6,10-dodecadienal\n425-910-9\n32480-08-3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n\n605-034-00-5\nreaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;\n(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;\n(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde\n429-860-9\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n605-035-00-0\n(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal\n426-330-9\n177964-68-0\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH319\nH317\nH413\nGHS07\nWng\nH319\nH317\nH413\n\n\n\n\n605-036-00-6\n2-bromomalonaldehyde\n430-470-6\n2065-75-0\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n605-037-00-1\ntrans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;\n3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde\n421-800-1\n120578-03-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n605-038-00-7\n3-methyl-5-phenylpentan-1-al\n433-900-0\n55066-49-4\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH315\nH317\nH411\n\n\n\n\n605-039-00-2\n3,4-dihydroxy-5-nitrobenzaldehyde\n441-810-8\n116313-85-0\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n606-001-00-8\nacetone;\npropan-2-one;\npropanone\n200-662-2\n67-64-1\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n606-002-00-3\nbutanone;\nethyl methyl ketone\n201-159-0\n78-93-3\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n606-003-00-9\nheptan-3-one;\nbutyl ethyl ketone\n203-388-1\n106-35-4\nFlam. Liq. 3\nAcute Tox. 4 *\nEye Irrit. 2\nH226\nH332\nH319\nGHS02\nGHS07\nWng\nH226\nH332\nH319\n\n\n\n606-004-00-4\n4-methylpentan-2-one;\nisobutyl methyl ketone\n203-550-1\n108-10-1\nFlam. Liq. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH225\nH332\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH332\nH319\nH335\nEUH066\n\n\n606-005-00-X\n2,6-dimethylheptan-4-one;\ndi-isobutyl ketone\n203-620-1\n108-83-8\nFlam. Liq. 3\nSTOT SE 3\nH226\nH335\nGHS02\nGHS07\nWng\nH226\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n606-006-00-5\npentan-3-one;\ndiethyl ketone\n202-490-3\n96-22-0\nFlam. Liq. 2\nSTOT SE 3\nSTOT SE 3\nH225\nH335\nH336\nGHS02\nGHS07\nDgr\nH225\nH335\nH336\nEUH066\n\n\n606-007-00-0\n3-methylbutan-2-one;\nmethyl isopropyl ketone\n209-264-3\n563-80-4\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n606-009-00-1\n4-methylpent-3-en-2-one;\nmesityl oxide\n205-502-5\n141-79-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n*\n\n606-010-00-7\ncyclohexanone\n203-631-1\n108-94-1\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-011-00-2\n2-methylcyclohexanone\n209-513-6\n583-60-8\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-012-00-8\n3,5,5-trimethylcyclohex-2-enone;\nisophorone\n201-126-0\n78-59-1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH351\nH312\nH302\nH319\nH335\nGHS08\nGHS07\nWng\nH351\nH312\nH302\nH319\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n\n606-013-00-3\np-benzoquinone;\nquinone\n203-405-2\n106-51-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nH331\nH301\nH319\nH335\nH315\nH400\nGHS06\nGHS09\nDgr\nH331\nH301\nH319\nH335\nH315\nH400\n\nM=10\n\n\n606-014-00-9\nchlorophacinone (ISO);\n2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione\n223-003-0\n3691-35-8\nAcute Tox. 1\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH331\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH310\nH300\nH331\nH372 **\nH410\n\n\n\n606-016-00-X\npindone (ISO);\n2-pivaloylindan-1,3-dione\n201-462-8\n83-26-1\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH372 **\nH410\n\n\n\n606-017-00-5\ndiketene;\ndiketen\n211-617-1\n674-82-8\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\nD\n606-018-00-0\ndichlone (ISO);\n2,3-dichloro-1,4-naphthoquinone\n204-210-5\n117-80-6\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n\n\n606-019-00-6\nchlordecone (ISO);\nperchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;\ndecachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one\n205-601-3\n143-50-0\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH311\nH301\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH311\nH301\nH410\n\n\n\n606-020-00-1\n5-methylheptan-3-one\n208-793-7\n541-85-5\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH319\nH335\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n\n606-021-00-7\nN-methyl-2-pyrrolidone;\n1-methyl-2-pyrrolidone\n212-828-1\n872-50-4\nRepr. 1B\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH360D***\nH319\nH335\nH315\nGHS08\nGHS07\nDgr\nH360D***\nH319\nH335\nH315\n\nRepr. 1B; H360D: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 10 %\n\n\n606-022-00-2\n1-phenyl-3-pyrazolidone\n202-155-1\n92-43-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-023-00-8\n4-methoxy-4-methylpentan-2-one\n203-512-4\n107-70-0\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-024-00-3\nheptan-2-one;\nmethyl amyl ketone\n203-767-1\n110-43-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH302\n\n\n\n606-025-00-9\ncyclopentanone\n204-435-9\n120-92-3\nFlam. Liq. 3\nEye Irrit. 2\nSkin Irrit. 2\nH226\nH319\nH315\nGHS02\nGHS07\nWng\nH226\nH319\nH315\n\n\n\n606-026-00-4\n5-methylhexan-2-one;\nisoamyl methyl ketone\n203-737-8\n110-12-3\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-027-00-X\nheptan-4-one;\ndi-n-propyl ketone\n204-608-9\n123-19-3\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n606-028-00-5\n2,4-dimethylpentan-3-one;\ndi-isopropyl ketone\n209-294-7\n565-80-0\nFlam. Liq. 2\nAcute Tox. 4 *\nH225\nH332\nGHS02\nGHS07\nDgr\nH225\nH332\n\n\n\n606-029-00-0\npentane-2,4-dione;\nacetylacetone\n204-634-0\n123-54-6\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH302\nGHS02\nGHS07\nWng\nH226\nH302\n\n\n\n606-030-00-6\nhexan-2-one;\nmethyl butyl ketone;\nbutyl methyl ketone;\nmethyl-n-butyl ketone\n209-731-1\n591-78-6\nFlam. Liq. 3\nRepr. 2\nSTOT RE 1\nSTOT SE 3\nH226\nH361f ***\nH372 **\nH336\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH361f ***\nH372 **\nH336\n\n\n\n606-031-00-1\n3-propanolide;\n1,3-propiolactone\n200-340-1\n57-57-8\nCarc. 1B\nAcute Tox. 2 *\nEye Irrit. 2\nSkin Irrit. 2\nH350\nH330\nH319\nH315\nGHS06\nGHS08\nDgr\nH350\nH330\nH319\nH315\n\n\n\n606-032-00-7\nhexachloroacetone\n204-129-5\n116-16-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-033-00-2\n2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;\nmethazole\n243-761-6\n20354-26-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH312\nH302\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH411\n\n\n\n\n\n606-034-00-8\nmetribuzin (ISO);\n4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;\n4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one\n244-209-7\n21087-64-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n606-035-00-3\nchloridazon (ISO);\n5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;\npyrazon\n216-920-2\n1698-60-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n606-036-00-9\nquinomethionate;\nchinomethionat (ISO);\n6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one\n219-455-3\n2439-01-2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH332\nH312\nH302\nH373 **\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH332\nH312\nH302\nH373 **\nH319\nH317\nH410\n\n\n\n606-037-00-4\ntriadimefon (ISO);\n1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone\n256-103-8\n43121-43-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n606-038-00-X\ndiphacinone (ISO);\n2-diphenylacetylindan-1,3-dione\n201-434-5\n82-66-6\nAcute Tox. 2 *\nSTOT RE 1\nH300\nH372 **\nGHS06\nGHS08\nDgr\nH300\nH372 **\n\n\n\n606-039-00-5\n5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one\n400-680-2\n—\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH410\n\n\n\n606-040-00-0\n(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride\n401-840-4\n55845-90-4\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n606-041-00-6\n2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one\n400-600-6\n71868-10-5\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n606-042-00-1\nacetophenone\n202-708-7\n98-86-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n606-043-00-7\n2,4-di-tert-butylcyclohexanone\n405-340-7\n13019-04-0\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n606-044-00-2\n2,4,6-trimethylbenzophenone\n403-150-9\n954-16-5\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n606-045-00-8\noxadiazon (ISO);\n3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one\n243-215-7\n19666-30-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-046-00-3\nreaction mass of cis- and trans-cyclohexadec-8-en-1-one\n401-700-2\n3100-36-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-047-00-9\n2-benzyl-2-dimethylamino-4-morpholinobutyrophenone\n404-360-3\n119313-12-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-048-00-4\n2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one\n406-480-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n606-049-00-X\n4-(trans-4-propylcyclohexyl)acetophenone\n406-700-6\n78531-61-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n606-050-00-5\n6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione\n412-480-2\n72453-58-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-051-00-0\n4-pentylcyclohexanone\n406-670-4\n61203-83-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-052-00-6\n4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone\n410-410-5\n54574-82-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n606-053-00-1\nflurtamone (ISO);\n(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one\n—\n96525-23-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-054-00-7\nisoxaflutole (ISO);\n5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone\n—\n141112-29-0\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH361d ***\nH410\n\n\n\n606-055-00-2\n1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone\n411-180-9\n92836-10-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n606-056-00-8\n4-chloro-3',4'-dimethoxybenzophenone\n404-610-1\n116412-83-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-057-00-3\n4-propylcyclohexanone\n406-810-4\n40649-36-3\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n606-058-00-9\n4'-fluoro-2,2-dimethoxyacetophenone\n407-500-1\n21983-80-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n606-059-00-4\n2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride\n412-390-3\n86386-75-6\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n606-060-00-X\nreaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;\ncis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane\n412-950-7\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-061-00-5\n(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone\n423-290-4\n66938-41-8\nMuta. 2\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH400\nH410\nGHS08\nGHS09\nWng\nH341\nH410\n\n\n\n606-062-00-0\ntetrahydrothiopyran-3-carboxaldehyde\n407-330-8\n61571-06-0\nRepr. 1B\nEye Dam. 1\nAquatic Chronic 3\nH360D ***\nH318\nH412\nGHS08\nGHS05\nDgr\nH360D ***\nH318\nH412\n\n\n\n606-063-00-6\n(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal\n410-980-5\n112704-51-5\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n606-064-00-1\npregn-5-ene-3,20-dione bis(ethylene ketal)\n407-450-0\n7093-55-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n606-065-00-7\n1-(4-morpholinophenyl)butan-1-one\n413-790-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-066-00-2\n(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone\n410-440-9\n164058-20-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-067-00-8\nreaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;\n1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;\n1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;\n1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone\n414-870-8\n96792-67-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-068-00-3\n2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al\n415-770-7\n1638-05-7\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH317\nH412\nGHS08\nGHS07\nWng\nH373 **\nH317\nH412\n\n\n\n606-069-00-9\nspiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]\n415-460-1\n154171-76-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-070-00-4\nbutroxydim (ISO);\n5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one\n414-790-3\n138164-12-2\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361fd\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361fd\nH302\nH315\nH410\n\n\n\n606-071-00-X\n17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one\n421-050-3\n13258-43-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-072-00-5\n3-acetyl-1-phenyl-pyrrolidine-2,4-dione\n421-600-2\n719-86-8\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n606-073-00-0\n4,4'-bis(dimethylamino)benzophenone;\nMichler's ketone\n202-027-5\n90-94-8\nCarc. 1B\nMuta. 2\nEye Dam. 1\nH350\nH341\nH318\nGHS08\nGHS05\nDgr\nH350\nH341\nH318\n\n\n\n\n\n606-074-00-6\nreaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;\n(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene\n425-570-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n606-075-00-1\n1-benzyl-5-ethoxyimidazolidine-2,4-dione\n417-340-4\n65855-02-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n606-076-00-7\n1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione\n418-630-3\n136465-99-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n606-077-00-2\n(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone\n418-650-2\n104872-06-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-078-00-8\n1-octylazepin-2-one\n420-040-6\n59227-88-2\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n606-079-00-3\n2-n-butyl-benzo[d]isothiazol-3-one\n420-590-7\n4299-07-4\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n606-080-00-9\nReaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene\n417-100-9\n—\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n\n606-081-00-4\n(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one\n419-790-7\n4229-69-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n606-082-00-X\nreaction mass of: butan-2-one oxime;\nsyn-O,O'-di(butan-2-one oxime)diethoxysilane\n406-930-7\n\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 3\nH372 **\nH317\nH412\nGHS08\nGHS07\nDgr\nH372 **\nH317\nH412\n\n\n\n606-083-00-5\n2-chloro-5-sec-hexadecylhydroquinone\n407-750-1\n137193-60-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH315\nH317\nH412\nGHS07\nWng\nH319\nH315\nH317\nH412\n\n\n\n606-084-00-0\n1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione\n414-540-3\n484-33-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-085-00-6\n(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one\n418-530-1\n79200-56-9\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n606-086-00-1\n1-(3,3-dimethylcyclohexyl)pent-4-en-1-one\n422-330-8\n56973-87-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n606-087-00-7\n6-ethyl-5-fluoro-4(3H)-pyrimidone\n422-460-5\n137234-87-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n606-088-00-2\n2,4,4,7-tetramethyl-6-octen-3-one\n422-520-0\n74338-72-0\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n606-089-00-8\nreaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;\n1,4-diamino-2,3-bis-phenoxyanthraquinone\n423-220-2\n12223-77-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n606-090-00-3\n1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone\n430-920-1\n73096-98-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n\n606-091-00-9\n6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one\n421-320-0\n118289-55-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n606-092-00-4\nreaction mass of: (E)-oxacyclohexadec-12-en-2-one;\n(E)-oxacyclohexadec-13-en-2-one;\na) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one\n422-320-3\n\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n606-093-00-X\n5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one\n414-470-3\n95885-13-5\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n606-094-00-5\nN-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one\n417-460-7\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-095-00-0\n(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one\n421-830-3\n49805-30-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n606-096-00-6\n3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one\n424-170-4\n130603-71-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n606-097-00-1\n2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone\n424-210-0\n23911-85-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-098-00-7\n1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione\n431-220-9\n158574-65-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-099-00-2\n5-methoxy-4'-(trifluoromethyl)valerophenone\n425-000-1\n61718-80-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-100-00-6\n2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one\n425-150-8\n94723-86-1\nRepr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH360F***\nH302\nH317\nH412\nGHS08\nGHS07\nDgr\nH360F***\nH302\nH317\nH412\n\n\n\n\n606-101-00-1\nreaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;\n1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;\n1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;\n1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;\n1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;\n1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione\n426-050-7\n165038-51-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n606-102-00-7\n4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone\n431-490-8\n79876-59-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-103-00-2\n1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone\n426-460-6\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n606-104-00-8\n1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone\n426-830-7\n78531-59-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-105-00-3\n3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione\n431-500-0\n226065-73-2\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-106-00-9\n1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone\n427-320-7\n83626-30-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-107-00-4\n8-azaspiro[4.5]decane-7,9-dione\n427-770-4\n1075-89-4\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n\n606-108-00-X\n1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone\n436-710-6\n756-13-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n606-109-00-5\n2-(4-methyl-3-pentenyl)anthraquinone\n428-320-1\n71308-16-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 4\nH302\nH317\nH413\nGHS07\nWng\nH302\nH317\nH413\n\n\n\n\n\n606-110-00-0\n5-ethoxy-5H-furan-2-one\n428-330-4\n2833-30-9\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nH314\nH312\nH302\nH373**\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH314\nH312\nH302\nH373**\nH317\n\n\n\n\n606-111-00-6\n5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one\n428-410-9\n67014-36-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n606-112-00-1\n(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one\n428-690-2\n1668-86-6\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH412\nGHS07\nWng\nH302\nH319\nH412\n\n\n\n\n\n606-113-00-7\n1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one\n429-040-0\n272460-97-6\nEye Dam. 1\nAquatic Chronic 4\nH318\nH413\nGHS05\nDgr\nH318\nH413\n\n\n\n\n\n606-114-00-2\n4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone\n429-150-9\n67887-47-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-115-00-8\nprofoxydim (ISO);\n2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{]butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one\n—\n139001-49-3\nCarc. 2\nRepr. 2\nSkin Sens. 1\nH351\nH361d\nH317\nGHS08\nGHS07\nWng\nH351\nH361d\nH317\n\n\n\n\n606-116-00-3\ntepraloxydim (ISO);\n(RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one\n—\n149979-41-9\nCarc. 2\nRepr. 2\nH351\nH361fd\nGHS08\nWng\nH351\nH361fd\n\n\n\n\n606-117-00-9\n2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one\n429-460-4\n7078-98-0\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-118-00-4\nN-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine\n429-640-2\n52870-46-9\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n\n606-119-00-X\n(E)-3-methyl-5-cyclopentadecen-1-one\n429-900-5\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n606-120-00-5\n2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one\n430-170-5\n114625-74-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n606-121-00-0\n(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)\n430-460-1\n133636-82-5\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n606-122-00-6\n3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one\n430-820-8\n114341-88-7\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH302\nH373**\nH315\nH318\nH317\nH410\n\n\n\n\n606-123-00-1\n4-hexadecyl-1-phenylpyrazolidin-3-one\n430-840-7\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n606-124-00-7\n1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione\n421-080-7\n161462-35-7\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n606-125-00-2\n1-benzylimidazolidine-2,4-dione\n421-340-1\n6777-05-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n606-126-00-8\n1,4-bis(2,3-dihydroxypropylamino)anthraquinone\n421-470-7\n99788-75-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n606-128-00-9\n2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione\n422-650-8\n148935-94-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-129-00-4\n5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;\n(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one\n423-090-7\n156732-13-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-130-00-X\n4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone\n423-860-2\n56309-94-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n606-131-00-5\ncyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione\n427-230-8\n5571-36-8\nRepr. 1B\nSTOT RE 2 *\nAquatic Chronic 2\nH360F***\nH373**\nH411\nGHS08\nGHS09\nDgr\nH360F***\nH373**\nH411\n\n\n\n\n606-132-00-0\n(6β)-6,19-epoxyandrost-4-ene-3,17-dione\n433-490-3\n6563-83-3\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n606-134-00-1\nandrosta-1,4,9(11)-triene-3,17-dione\n433-560-3\n15375-21-0\nRepr. 2\nH361f***\nGHS08\nWng\nH361f***\n\n\n\n\n606-135-00-7\ncyclohexadecanone\n438-930-8\n2550-52-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-136-00-2\n(3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone\n444-350-6\n133413-70-4\nEye Irrit. 2\nAquatic Chronic 4\nH319\nH413\nGHS07\nWng\nH319\nH413\n\n\n\n\n606-137-00-8\ntrans-7,7'-dimethyl-(4H, 4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione\n444-750-0\n211387-26-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-138-00-3\n(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone\n444-800-1\n141645-23-0\nFlam. Liq. 3\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH302\nH373**\nH315\nH318\nH317\nH400\nH410\nGHS02\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH302\nH373**\nH315\nH318\nH317\nH410\n\nM=10\n\n\n606-139-00-9\n(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one\n444-830-5\n124379-29-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n606-140-00-4\n2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one\n444-860-9\n474510-57-1\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n606-141-00-X\nsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate\n418-410-7\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n606-142-00-5\nreaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;\n(1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;\n(1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one\n434-290-9\n—\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n\n\n606-143-00-0\nabamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]\n_ [1]\n71751-41-2 [1]\nRepr. 2\nAcute Tox. 2\nAcute Tox. 1\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d\nH300\nH330\nH372 (nervous system)\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d\nH300\nH330\nH372 (nervous system)\nH410\n\nSTOT RE 1;\nH372: C ≥ 5 %\nSTOT RE 2;\nH373: 0,5 % ≤C<5 %\nM = 10000\n\navermectin B1a (purity ≥80 %); [2]\n265-610-3 [2]\n65195-55-3 [2]\n606-144-00-6\nacequinocyl (ISO);\n3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate\n—\n57960-19-7\nSkin Sens. 1\nSTOT SE 1\nSTOT RE 2\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH370 (lung)\n(inhalation)\nH373 (blood system)\nH400\nH410\nGHS07\nGHS08\nGHS09\nDgr\nH317\nH370 (lung)\n(inhalation)\nH373 (blood system)\nH410\n\nM = 1000\n\n\n607-001-00-0\nformic acid ... %\n200-579-1\n64-18-6\nSkin Corr. 1A\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1A; H314: C ≥ 90 %\nSkin Corr. 1B; H314: 10 % ≤ C < 90 %\nSkin Irrit. 2; H315: 2 % ≤ C < 10 %\nEye Irrit. 2; H319: 2 % ≤ C < 10 %\nB\n607-002-00-6\nacetic acid ... %\n200-580-7\n64-19-7\nFlam. Liq. 3\nSkin Corr. 1A\nH226\nH314\nGHS02\nGHS05\nDgr\nH226\nH314\n\nSkin Corr. 1A; H314: C ≥ 90 %\nSkin Corr. 1B; H314: 25 % ≤ C < 90 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nB\n\n\n607-003-00-1\nchloroacetic acid\n201-178-4\n79-11-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1\nH331\nH311\nH301\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n607-004-00-7\nTCA (ISO);\ntrichloroacetic acid\n200-927-2\n76-03-9\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 1 %\n\n607-005-00-2\nTCA-sodium (ISO);\nsodium trichloroacetate\n211-479-2\n650-51-1\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH335\nH410\n\n\n\n607-006-00-8\noxalic acid\n205-634-3\n144-62-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n*\n\n\n\n607-007-00-3\nsalts of oxalic acid with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n*\nA\n\n607-008-00-9\nacetic anhydride\n203-564-8\n108-24-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH302\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 5 % ≤ C < 25 %\nEye Dam. 1; H318: 5 % ≤ C < 25 %\nEye Irrit. 2; H319: 1 % ≤ C < 5 %\nSTOT SE 3; H335: C ≥ 5 %\n\n607-009-00-4\nphthalic anhydride\n201-607-5\n85-44-9\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH302\nH335\nH315\nH318\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH335\nH315\nH318\nH334\nH317\n\n\n\n607-010-00-X\npropionic anhydride\n204-638-2\n123-62-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H315: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\n\n607-011-00-5\nacetyl chloride\n200-865-6\n75-36-5\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\nEUH014\n\n\n\n\n607-012-00-0\nbenzoyl chloride\n202-710-8\n98-88-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH332\nH312\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH332\nH312\nH302\nH314\nH317\n\n\n\n\n607-013-00-6\ndimethyl carbonate\n210-478-4\n616-38-6\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-014-00-1\nmethyl formate\n203-481-7\n107-31-3\nFlam. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH224\nH332\nH302\nH319\nH335\nGHS02\nGHS07\nDgr\nH224\nH332\nH302\nH319\nH335\n\n\n\n607-015-00-7\nethyl formate\n203-721-0\n109-94-4\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH225\nH332\nH302\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH332\nH302\nH319\nH335\n\n\n\n607-016-00-2\npropyl formate; [1]\nisopropyl formate [2]\n203-798-0 [1]\n210-901-2 [2]\n110-74-7 [1]\n625-55-8 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSTOT SE 3\nH225\nH319\nH335\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH336\n\n\nC\n607-017-00-8\nbutyl formate; [1]\ntert-butyl formate; [2]\nisobutyl formate [3]\n209-772-5 [1]\n212-105-0 [2]\n208-818-1 [3]\n592-84-7 [1]\n762-75-4 [2]\n542-55-2 [3]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\n\n\nC\n607-018-00-3\nisopentyl formate; [1]\n2-methylbutyl formate [2]\n203-769-2 [1]\n252-343-2 [2]\n110-45-2 [1]\n35073-27-9 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH335\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\n\n\nC\n607-019-00-9\nmethyl chloroformate\n201-187-3\n79-22-1\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH330\nH312\nH302\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH330\nH312\nH302\nH314\n\n\n\n607-020-00-4\nethyl chloroformate\n208-778-5\n541-41-3\nFlam. Liq. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH330\nH302\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH330\nH302\nH314\n\n\n\n607-021-00-X\nmethyl acetate\n201-185-2\n79-20-9\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n607-022-00-5\nethyl acetate\n205-500-4\n141-78-6\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\n\n607-023-00-0\nvinyl acetate\n203-545-4\n108-05-4\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\nD\n607-024-00-6\npropyl acetate; [1]\nisopropyl acetate [2]\n203-686-1 [1]\n203-561-1 [2]\n109-60-4 [1]\n108-21-4 [2]\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nH225\nH319\nH336\nGHS02\nGHS07\nDgr\nH225\nH319\nH336\nEUH066\n\nC\n607-025-00-1\nn-butyl acetate\n204-658-1\n123-86-4\nFlam. Liq. 3\nSTOT SE 3\nH226\nH336\nGHS02\nGHS07\nWng\nH226\nH336\nEUH066\n\n\n607-026-00-7\nsec-butyl acetate; [1]\nisobutyl acetate; [2]\ntert-butyl acetate [3]\n203-300-1 [1]\n203-745-1 [2]\n208-760-7 [3]\n105-46-4 [1]\n110-19-0 [2]\n540-88-5 [3]\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\nEUH066\n\nC\n607-027-00-2\nmethyl propionate\n209-060-4\n554-12-1\nFlam. Liq. 2\nAcute Tox. 4 *\nH225\nH332\nGHS02\nGHS07\nDgr\nH225\nH332\n\n\n\n607-028-00-8\nethyl propionate\n203-291-4\n105-37-3\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-029-00-3\nn-butyl propionate; [1]\nsec-butyl propionate; [2]\niso-butyl propionate [3]\n209-669-5 [1]\n- [2]\n208-746-0 [3]\n590-01-2 [1]\n591-34-4 [2]\n540-42-1 [3]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-030-00-9\npropyl propionate\n203-389-7\n106-36-5\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH332\nGHS02\nGHS07\nWng\nH226\nH332\n\n\n\n607-031-00-4\nbutyl butyrate\n203-656-8\n109-21-7\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-032-00-X\nethyl acrylate\n205-438-8\n140-88-5\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\n\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Irrit. 2; H319: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 5 %\nD\n607-033-00-5\nn-butyl methacrylate\n202-615-1\n97-88-1\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH317\n\n\nD\n607-034-00-0\nmethyl acrylate;\nmethyl propenoate\n202-500-6\n96-33-3\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH335\nH315\nH317\n\n\nD\n607-035-00-6\nmethyl methacrylate;\nmethyl 2-methylprop-2-enoate;\nmethyl 2-methylpropenoate\n201-297-1\n80-62-6\nFlam. Liq. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH335\nH315\nH317\n\n\nD\n607-036-00-1\n2-methoxyethyl acetate;\nmethylglycol acetate\n203-772-9\n110-49-6\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH360FD\nH332\nH312\nH302\nGHS08\nGHS07\nDgr\nH360FD\nH332\nH312\nH302\n\n\n\n\n\n607-037-00-7\n2-ethoxyethyl acetate;\nethylglycol acetate\n203-839-2\n111-15-9\nFlam. Liq. 3\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH360FD\nH332\nH312\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH360FD\nH332\nH312\nH302\n\n\n\n\n607-038-00-2\n2-butoxyethyl acetate;\nbutylglycol acetate\n203-933-3\n112-07-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nGHS07\nWng\nH332\nH312\n\n\n\n607-039-00-8\n2,4-D (ISO);\n2,4-dichlorophenoxyacetic acid\n202-361-1\n94-75-7\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH335\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\nH317\nH412\n\n\n\n607-040-00-3\nsalts of 2,4-D\n—\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\nA\n607-041-00-9\n2,4,5-T (ISO);\n2,4,5-trichlorophenoxy acetic acid\n202-273-3\n93-76-5\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH410\n\n\n\n607-042-00-4\nsalts and esters of 2,4,5-T;\nsalts and esters of 2,4,5-trichlorophenoxy acetic acid\n—\n—\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH315\nH410\n\n\nA\n607-043-00-X\ndicamba (ISO);\n2,5-dichloro-6-methoxybenzoic acid;\n3,6-dichloro-2-methoxybenzoic acid\n217-635-6\n1918-00-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n607-044-00-5\n3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]\npotassium 3,6-dichloro-o-anisate [2]\n218-951-7 [1]\n233-002-7 [2]\n2300-66-5 [1]\n10007-85-9 [2]\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n607-045-00-0\ndichlorprop (ISO);\n2-(2,4-dichlorophenoxy) propionic acid\n204-390-5\n120-36-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH312\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH312\nH302\nH315\nH318\n\n\n\n607-046-00-6\nsalts of dichlorprop\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\nA\n607-047-00-1\nfenoprop (ISO);\n2-(2,4,5-trichlorophenoxy)propionic acid\n202-271-2\n93-72-1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-048-00-7\nsalts of fenoprop;\nsalts of 2-(2,4,5-trichlorophenoxy)propionic acid\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n607-049-00-2\nmecoprop (ISO);\n2-(4-chloro-o-tolyloxy) propionic acid;\n(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]\n2-(4-chloro-2-methylphenoxy)propionic acid [2]\n230-386-8 [1]\n202-264-4 [2]\n7085-19-0 [1]\n708519-0 [2]\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\nM=100\n\n607-050-00-8\nsalts of mecoprop\n—\n—\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\nA\n\n\n607-051-00-3\nMCPA (ISO);\n4-chloro-o-tolyloxyacetic acid\n202-360-6\n94-74-6\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH410\n\n\n\n\n607-052-00-9\nsalts and esters of MCPA\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n\n\n607-053-00-4\nMCPB (ISO);\n4-(4-chloro-o-tolyloxy) butyric acid\n202-365-3\n94-81-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-054-00-X\nsalts and esters of MCPB\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n607-055-00-5\nendothal-sodium (ISO);\ndisodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate\n204-959-8\n129-67-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH301\nH312\nH319\nH335\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH335\nH315\n\n\n\n607-056-00-0\nwarfarin (ISO); [1]\n(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]\n(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]\n201-377-6 [1]\n226-907-3 [2]\n226-908-9 [3]\n81-81-2 [1]\n5543-57-7 [2]\n5543-58-8 [3]\nRepr. 1A\nSTOT RE 1\nAquatic Chronic 3\nH360D ***\nH372 **\nH412\nGHS08\nDgr\nH360D ***\nH372 **\nH412\n\n\n\n607-057-00-6\ncoumachlor (ISO);\n3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin\n201-378-1\n81-82-3\nSTOT RE 2 *\nAquatic Chronic 3\nH373 **\nH412\nGHS08\nWng\nH373 **\nH412\n\n\n\n607-058-00-1\ncoumafuryl (ISO);\nfumarin;\n(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;\n4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin\n204-195-5\n117-52-2\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 3\nH301\nH372 **\nH412\nGHS06\nGHS08\nDgr\nH301\nH372 **\nH412\n\n\n\n607-059-00-7\ncoumatetralyl;\n4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin\n227-424-0\n5836-29-3\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Chronic 3\nH310\nH300\nH372 **\nH412\nGHS06\nGHS08\nDgr\nH310\nH300\nH372 **\nH412\n\n\n\n607-060-00-2\ndicoumarol;\n4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)\n200-632-9\n66-76-2\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Chronic 2\nH372 **\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH302\nH411\n\n\n\n607-061-00-8\nacrylic acid;\nprop-2-enoic acid\n201-177-9\n79-10-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH226\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH332\nH312\nH302\nH314\nH400\n\nSTOT SE 3; H335: C ≥ 1 %\nD\n607-062-00-3\nn-butyl acrylate\n205-480-7\n141-32-2\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH319\nH335\nH315\nH317\n\n\nD\n607-063-00-9\nisobutyric acid\n201-195-7\n79-31-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n607-064-00-4\nbenzyl chloroformate\n207-925-0\n501-53-1\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH400\nH410\nGHS05\nGHS09\nDgr\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n\n\n\n607-065-00-X\nbromoacetic acid\n201-175-8\n79-08-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nH331\nH311\nH301\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH317\nH400\n\n\n\n\n\n607-066-00-5\ndichloroacetic acid\n201-207-0\n79-43-6\nSkin Corr. 1A\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\n\n\n607-067-00-0\ndichloroacetyl chloride\n201-199-9\n79-36-7\nSkin Corr. 1A\nAquatic Acute 1\nH314\nH400\nGHS05\nGHS09\nDgr\nH314\nH400\n\n\n\n607-068-00-6\niodoacetic acid\n200-590-1\n64-69-7\nAcute Tox. 3 *\nSkin Corr. 1A\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n\n\n607-069-00-1\nethyl bromoacetate\n203-290-9\n105-36-2\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n607-070-00-7\nethyl chloroacetate\n203-294-0\n105-39-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nH331\nH311\nH301\nH400\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH400\n\n\n\n607-071-00-2\nethyl methacrylate\n202-597-5\n97-63-2\nFlam. Liq. 2\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH225\nH319\nH335\nH315\nH317\nGHS02\nGHS07\nDgr\nH225\nH319\nH335\nH315\nH317\n\n\nD\n607-072-00-8\n2-hydroxyethyl acrylate\n212-454-9\n818-61-1\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nH311\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH314\nH317\nH400\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-073-00-3\n4-CPA (ISO);\n4-chlorophenoxyacetic acid\n204-581-3\n122-88-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-074-00-9\nchlorfenac(ISO);\n2,3,6-trichlorophenylacetic acid\n201-599-3\n85-34-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-075-00-4\nchlorfenprop-methyl;\nmethyl 2-chloro-3-(4-chlorophenyl)propionate\n238-413-5\n14437-17-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n607-076-00-X\ndodine(ISO);\ndodecylguanidinium acetate\n219-459-5\n2439-10-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH410\n\n\n\n607-077-00-5\nerbon (ISO);\n2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate\n—\n136-25-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-078-00-0\nfluenetil (ISO);\n2-fluoroethyl biphenyl-4-ylacetate\n—\n4301-50-2\nAcute Tox. 1\nAcute Tox. 2 *\nH310\nH300\nGHS06\nDgr\nH310\nH300\n\n\n\n607-079-00-6\nkelevan (ISO);\nethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;\nethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate\n—\n4234-79-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH311\nH302\nH411\nGHS06\nGHS09\nDgr\nH311\nH302\nH411\n\n\n\n607-080-00-1\nchloroacetyl chloride\n201-171-6\n79-04-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1A\nAquatic Acute 1\nH331\nH311\nH301\nH372 **\nH314\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH372 **\nH314\nH400\nEUH014\nEUH029\n\n\n607-081-00-7\nfluoroacetic acid\n205-631-7\n144-49-0\nAcute Tox. 2 *\nAquatic Acute 1\nH300\nH400\nGHS06\nGHS09\nDgr\nH300\nH400\n\n\n\n607-082-00-2\nfluoroacetates, soluble\n—\n—\nAcute Tox. 2 *\nAquatic Acute 1\nH300\nH400\nGHS06\nGHS09\nDgr\nH300\nH400\n\n\nA\n607-083-00-8\n2,4-DB (ISO);\n4-(2,4-dichlorophenoxy)butyric acid\n202-366-9\n94-82-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-084-00-3\nsalts of 2,4-DB\n—\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\nA\n\n\n607-085-00-9\nbenzyl benzoate\n204-402-9\n120-51-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n607-086-00-4\ndiallyl phthalate\n205-016-3\n131-17-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-088-00-5\nmethacrylic acid;\n2-methylpropenoic acid\n201-204-4\n79-41-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\nD\n607-089-00-0\npropionic acid ... %\n201-176-3\n79-09-4\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\nSkin Corr. 1B; H314: C ≥ 25 %\nSkin Irrit. 2; H319: 10 % ≤ C < 25 %\nEye Irrit. 2; H319: 10 % ≤ C < 25 %\nSTOT SE 3; H335: C ≥ 10 %\nB\n607-090-00-6\nthioglycolic acid\n200-677-4\n68-11-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH331\nH311\nH301\nH314\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\n\n*\n\n607-091-00-1\ntrifluoroacetic acid . . . %\n200-929-3\n76-05-1\nAcute Tox. 4 *\nH332\nGHS05\nH332\n\n*\nB\n\n\n\n\nSkin Corr. 1A\nAquatic Chronic 3\nH314\nH412\nGHS07\nDgr\nH314\nH412\n\n\n\n607-092-00-7\nmethyl lactate; [1]\nmethyl (±)-lactate; [2]\nmethyl (R)-lactate; [3]\nmethyl (S)-(-)-lactate [4]\n208-930-0 [1]\n218-449-8 [2]\n241-420-6 [3]\n248-704-9 [4]\n547-64-8 [1]\n2155-30-8 [2]\n17392-83-5 [3]\n27871-49-4 [4]\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH319\nH335\n\n\nC\n607-093-00-2\npropionyl chloride\n201-170-0\n79-03-8\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\nEUH014\n\nB D\n607-094-00-8\nperacetic acid . . . %\n201-186-8\n79-21-0\nFlam. Liq. 3\nOrg. Perox. D ****\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH226\nH242\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH242\nH332\nH312\nH302\nH314\nH400\n\n*\nSTOT SE 3; H335: C ≥ 1 %\nB D\n\n\n607-095-00-3\nmaleic acid\n203-742-5\n110-16-7\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH302\nH319\nH335\nH315\nH317\nGHS07\nWng\nH302\nH319\nH335\nH315\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n\n607-096-00-9\nmaleic anhydride\n203-571-6\n108-31-6\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH302\nH314\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH314\nH334\nH317\n\n\n\n607-097-00-4\nbenzene-1,2,4-tricarboxylic acid 1,2-anhydride;\ntrimellitic anhydride\n209-008-0\n552-30-7\nSTOT SE 3\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH335\nH318\nH334\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH335\nH318\nH334\nH317\n\n\n\n607-098-00-X\nbenzene-1,2:4,5-tetracarboxylic dianhydride;\nbenzene-1,2:4,5-tetracarboxylic dianhydride;\npyromellitic dianhydride\n201-898-9\n89-32-7\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\n\n607-099-00-5\n1,2,3,6-tetrahydrophthalic anhydride; [1]\ncis-1,2,3,6-tetrahydrophthalic anhydride; [2]\n3,4,5,6-tetrahydrophthalic anhydride; [3]\ntetrahydrophthalic anhydride [4]\n201-605-4 [1]\n213-308-7 [2]\n219-374-3 [3]\n247-570-9 [4]\n85-43-8 [1]\n935-79-5 [2]\n2426-02-0 [3]\n26266-63-7 [4]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH334\nH317\nH412\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\nH412\n\n\nC\n607-100-00-9\nbenzophenone-3,3',4,4'-tetracarboxylic dianhydride;\n4,4'-carbonyldi(phthalic anhydride)\n219-348-1\n2421-28-5\nEye Irrit. 2\nSTOT SE 3\nH319\nH335\nGHS07\nWng\nH319\nH335\n\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-101-00-4\n1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride\n204-077-3\n115-27-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSkin Irrit. 2; H315: C ≥ 1 %\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-102-00-X\ncyclohexane-1,2-dicarboxylic anhydride; [1]\ncis-cyclohexane-1,2-dicarboxylic anhydride; [2]\ntrans-cyclohexane-1,2-dicarboxylic anhydride [3]\n201-604-9 [1]\n236-086-3 [2]\n238-009-9 [3]\n85-42-7 [1]\n13149-00-3 [2]\n14166-21-3 [3]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n\n\n607-103-00-5\nsuccinic anhydride\n203-570-0\n108-30-5\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH302\nH319\nH335\nGHS07\nWng\nH302\nH319\nH335\n\n*\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n\n\n607-104-00-0\ncyclopentane-1,2,3,4-tetracarboxylic dianhydride\n227-964-7\n6053-68-5\nEye Irrit. 2\nSTOT SE 3\nH319\nH335\nGHS07\nWng\nH319\nH335\n\nEye Irrit. 2; H319: C ≥ 1 %\nSTOT SE 3; H335: C ≥ 1 %\n\n607-105-00-6\n8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]\n1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]\n(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]\n204-957-7 [1]\n212-557-9 [2]\n220-384-5 [3]\n129-64-6 [1]\n826-62-0 [2]\n2746-19-2 [3]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-106-00-1\n8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride\n—\n123748-85-6\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH302\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH302\nH319\nH335\nH315\nH334\n\nSTOT SE 3; H335: C ≥ 10 %\nC\n607-107-00-7\n2-ethylhexyl acrylate\n203-080-7\n103-11-7\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH335\nH315\nH317\nGHS07\nWng\nH335\nH315\nH317\n\n\nD\n607-108-00-2\n2-hydroxy-1-methylethylacrylate; [1]\n2-hydroxypropylacrylate; [2]\nacrylic acid, monoester with propane-1,2-diol [3]\n220-852-9 [1]\n213-663-8 [2]\n247-118-0 [3]\n2918-23-2 [1]\n999-61-1 [2]\n25584-83-2 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nC D\n607-109-00-8\nhexamethylene diacrylate;\nhexane-1,6-diol diacrylate\n235-921-9\n13048-33-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-110-00-3\npentaerythritol triacrylate\n222-540-8\n3524-68-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-111-00-9\n2,2-bis(acryloyloxymethyl)butyl acrylate;\ntrimethylolpropane triacrylate\n239-701-3\n15625-89-5\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-112-00-4\n2,2-dimethyltrimethylene diacrylate;\nneopentyl glycol diacrylate\n218-741-5\n2223-82-7\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH311\nH319\nH315\nH317\nGHS06\nDgr\nH311\nH319\nH315\nH317\n\n*\nD\n607-113-00-X\nisobutyl methacrylate\n202-613-0\n97-86-9\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH226\nH319\nH335\nH315\nH317\nH400\nGHS02\nGHS07\nGHS09\nWng\nH226\nH319\nH335\nH315\nH317\nH400\n\n\nD\n607-114-00-5\nethylene dimethacrylate\n202-617-2\n97-90-5\nSTOT SE 3\nSkin Sens. 1\nH335\nH317\nGHS07\nWng\nH335\nH317\n\nSTOT SE 3; H335: C ≥ 10 %\nD\n607-115-00-0\nisobutyl acrylate\n203-417-8\n106-63-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nH226\nH332\nH312\nH315\nH317\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH315\nH317\n\n\nD\n607-116-00-6\ncyclohexyl acrylate\n221-319-3\n3066-71-5\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH335\nH315\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\nD\n607-117-00-1\n2,3-epoxypropyl acrylate;\nglycidyl acrylate\n203-440-3\n106-90-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nH331\nH311\nH301\nH314\nH317\nGHS06\nGHS05\nDgr\nH331\nH311\nH301\nH314\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-118-00-7\n1-methyltrimethylene diacrylate;\n1,3-butylene glycol diacrylate\n243-105-9\n19485-03-1\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\n\n\nD\n607-119-00-2\ntetramethylene diacrylate;\n1,4-butyleneglycol diacrylate\n213-979-6\n1070-70-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\n\n\nD\n607-120-00-8\n2,2'-oxydiethyl diacrylate;\ndiethylene glycol diacrylate\n223-791-6\n4074-88-8\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH311\nH319\nH315\nH317\nGHS06\nDgr\nH311\nH319\nH315\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n607-121-00-3\n8,9,10-trinorborn-2-yl acrylate\n—\n10027-06-2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nH312\nH315\nH317\nGHS07\nWng\nH312\nH315\nH317\n\n\nD\n607-122-00-9\npentaerythritol tetraacrylate\n225-644-1\n4986-89-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-123-00-4\n2,3-epoxypropyl methacrylate;\nglycidyl methacrylate\n203-441-9\n106-91-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH312\nH302\nH319\nH315\nH317\nGHS07\nWng\nH332\nH312\nH302\nH319\nH315\nH317\n\n\nD\n607-124-00-X\n2-hydroxyethyl methacrylate\n212-782-2\n868-77-9\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-125-00-5\n2-hydroxypropyl methacrylate; [1]\n3-hydroxypropyl methacrylate [2]\n213-090-3 [1]\n220-426-2 [2]\n923-26-2 [1]\n2761-09-3 [2]\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\nC D\n607-126-00-0\n2,2'-(ethylenedioxy)diethyl diacrylate;\ntriethylene glycol diacrylate\n216-853-9\n1680-21-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-127-00-6\n2-diethylaminoethyl methacrylate\n203-275-7\n105-16-8\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH332\nH319\nH315\nH317\nGHS07\nWng\nH332\nH319\nH315\nH317\n\n\nD\n607-128-00-1\n2-tert-butylaminoethyl methacrylate\n223-228-4\n3775-90-4\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\nD\n607-129-00-7\nethyl lactate;\nethyl DL-lactate; [1]\nethyl (S)-2-hydroxypropionate;\nethyl L-lactate;\nethyl-(S)-lactate [2]\n202-598-0 [1]\n211-694-1 [2]\n97-64-3 [1]\n687-47-8 [2]\nFlam. Liq. 3\nSTOT SE 3\nEye Dam. 1\nH226\nH335\nH318\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH335\nH318\n\n\nC\n607-130-00-2\npentyl acetate; [1]\nisopentyl acetate; [2]\n1-methylbutyl acetate; [3]\n2-methylbutyl acetat; [4]\n2(or 3)-methylbutyl acetate [5]\n211-047-3 [1]\n204-662-3 [2]\n210-946-8 [3]\n210-843-8 [4]\n282-263-3 [5]\n628-63-7 [1]\n123-92-2 [2]\n626-38-0 [3]\n624-41-9 [4]\n84145-37-9 [5]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\nEUH066\n\nC\n607-131-00-8\nisopentyl propionate; [1]\npentyl propionate; [2]\n2-methylbutyl propionate [3]\n203-322-1 [1]\n210-852-7 [2]\n219-449-0 [3]\n105-68-0 [1]\n624-54-4 [2]\n2438-20-2 [3]\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\nC\n607-132-00-3\n2-dimethylaminoethyl methacrylate\n220-688-8\n2867-47-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH312\nH302\nH319\nH315\nH317\nGHS07\nWng\nH312\nH302\nH319\nH315\nH317\n\n\nD\n607-133-00-9\nmonoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\nA\n607-134-00-4\nmonoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\nA\n607-135-00-X\nbutyric acid\n203-532-3\n107-92-6\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-136-00-5\nbutyryl chloride\n205-498-5\n141-75-3\nFlam. Liq. 2\nSkin Corr. 1B\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\n\n\n\n607-137-00-0\nmethyl acetoacetate\n203-299-8\n105-45-3\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-138-00-6\nbutyl chloroformate;\nchloroformic acid butyl ester\n209-750-5\n592-34-7\nFlam. Liq. 3\nAcute Tox. 3 *\nSkin Corr. 1B\nH226\nH331\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH226\nH331\nH314\n\n\n\n607-139-00-1\n2-chloropropionic acid\n209-952-3\n598-78-7\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n607-140-00-7\nisobutyryl chloride\n201-194-1\n79-30-1\nFlam. Liq. 2\nSkin Corr. 1A\nH225\nH314\nGHS02\nGHS05\nDgr\nH225\nH314\n\n\n\n607-141-00-2\noxydiethylene bis(chloroformate)\n203-430-9\n106-75-2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH411\n\n\n\n\n\n607-142-00-8\npropyl chloroformate;\nchloroformic acid propylester;\nn-propyl chloroformate\n203-687-7\n109-61-5\nFlam. Liq. 2\nAcute Tox. 3 *\nSkin Corr. 1B\nH225\nH331\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH331\nH314\n\n\n\n\n607-143-00-3\nvaleric acid\n203-677-2\n109-52-4\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n607-144-00-9\nadipic acid\n204-673-3\n124-04-9\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-145-00-4\nmethanesulphonic acid\n200-898-6\n75-75-2\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-146-00-X\nfumaric acid\n203-743-0\n110-17-8\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-147-00-5\noxalic acid diethylester;\ndiethyl oxalate\n202-464-1\n95-92-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n607-148-00-0\nguanidinium chloride;\nguanadine hydrochloride\n200-002-3\n50-01-1\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nH302\nH319\nH315\nGHS07\nWng\nH302\nH319\nH315\n\n\n\n607-149-00-6\nurethane (INN);\nethyl carbamate\n200-123-1\n51-79-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n607-150-00-1\nendothal (ISO);\n7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid\n205-660-5\n145-73-3\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH301\nH312\nH319\nH335\nH315\nGHS06\nDgr\nH301\nH312\nH319\nH335\nH315\n\n\n\n607-151-00-7\npropargite (ISO);\n2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite\n219-006-1\n2312-35-8\nCarc. 2\nAcute Tox. 3 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH331\nH315\nH318\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH331\nH315\nH318\nH410\n\nM = 10\n\n607-152-00-2\n2,3,6-TBA (ISO);\n2,3,6-trichlorobenzoic acid\n200-026-4\n50-31-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-153-00-8\nbenazolin (ISO);\n4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid\n223-297-0\n3813-05-6\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH319\nH315\nH412\nGHS07\nWng\nH319\nH315\nH412\n\n\n\n607-154-00-3\nethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;\nbenzoylprop-ethyl (ISO)\n244-845-5\n22212-55-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-155-00-9\n3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;\nblasticidin-s\n—\n2079-00-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n607-156-00-4\nchlorfenson (ISO);\n4-chlorophenyl 4-chlorobenzenesulfonate\n201-270-4\n80-33-1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-157-00-X\n3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;\ndifenacoum\n259-978-4\n56073-07-5\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH300\nH372 **\nH410\n\n\n\n607-158-00-5\nsodium salt of chloroacetic acid;\nsodium chloroacetate\n223-498-3\n3926-62-3\nAcute Tox. 3 *\nSkin Irrit. 2\nAquatic Acute 1\nH301\nH315\nH400\nGHS06\nGHS09\nDgr\nH301\nH315\nH400\n\n\n\n607-159-00-0\nchlorobenzilate (ISO);\nethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;\nethyl 4,4'-dichlorobenzilate\n208-110-2\n510-15-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-160-00-6\nisobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;\nclofop-isobutyl (ISO)\n—\n51337-71-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-161-00-1\ndiethanolamine salt of 4-CPA\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n607-162-00-7\ndalapon;\n2,2-dichloropropionic acid; [1]\ndalapon-sodium;\nsodium 2,2-dichloropropionate [2]\n200-923-0 [1]\n204-828-5 [2]\n75-99-0 [1]\n127-20-8 [2]\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n\n607-163-00-2\n3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;\ndehydracetic acid\n208-293-9\n520-45-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-164-00-8\nsodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;\nsodium dehydracetate\n224-580-1\n4418-26-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-165-00-3\ndiclofop-methyl (ISO)\nmethyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;\nmethyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;\n257-141-8\n51338-27-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-166-00-9\nmedinoterb acetate (ISO);\n6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate\n219-634-6\n2487-01-6\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n607-167-00-4\nsodium 3-chloroacrylate\n—\n4312-97-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n607-168-00-X\ndipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;\npropylisome\n—\n83-59-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH311\nH302\nH410\n\n\n\n607-169-00-5\nsodium fluoroacetate\n200-548-2\n62-74-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nH330\nH310\nH300\nH400\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH400\n\n\n\n607-170-00-0\nbis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;\nthiocyclam-oxalate\n250-859-2\n31895-22-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n607-172-00-1\n4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;\nbrodifacoum\n259-980-5\n56073-10-0\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH310\nH300\nH372 **\nH410\n\n\n\n607-173-00-7\ndimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate\n400-460-6\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-174-00-2\nreaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate\n400-580-9\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-175-00-8\nmethyl 2-(2-nitrobenzylidene)acetoacetate\n400-650-9\n39562-27-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-176-00-3\nreaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)\n400-830-7\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-177-00-9\ntribenuron-methyl (ISO);\nmethyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate\n401-190-1\n101200-48-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM = 100\n\n\n\n607-178-00-4\nmethyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate\n401-340-6\n83055-99-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-179-00-X\n(benzothiazol-2-ylthio)succinic acid\n401-450-4\n95154-01-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-180-00-5\npotassium 2-hydroxycarbazole-1-carboxylate\n401-630-2\n96566-70-0\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Chronic 3\nH302\nH319\nH335\nH412\nGHS07\nWng\nH302\nH319\nH335\nH412\n\n\n\n607-181-00-0\n3,5-dichloro-2,4-difluorobenzoyl fluoride\n401-800-6\n101513-70-6\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH331\nH314\nH302\nH317\nH412\nGHS06\nGHS05\nDgr\nH331\nH314\nH302\nH317\nH412\nEUH029\n\n\n607-182-00-6\nmethyl 3-sulphamoyl-2-thenoate\n402-050-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-183-00-1\nzinc 2-hydroxy-5-C13-18alkylbenzoate\n402-280-3\n—\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH411\n\n\n\n607-184-00-7\nS-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate\n402-290-8\n85702-90-5\nFlam. Liq. 3\nResp. Sens. 1\nSkin Sens. 1\nH226\nH334\nH317\nGHS02\nGHS08\nDgr\nH226\nH334\nH317\n\n\n\n607-185-00-2\nethyl trans-3-dimethylaminoacrylate\n402-650-4\n1117-37-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-186-00-8\nquinclorac (ISO);\n3,7-dichloroquinoline-8-carboxylic acid\n402-780-1\n84087-01-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-187-00-3\nbis(2,2,6,6-tetramethyl-4-piperidyl) succinate\n402-940-0\n62782-03-0\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n607-188-00-9\nhydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate\n402-970-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n607-189-00-4\ntrimethylenediaminetetraacetic acid\n400-400-9\n1939-36-2\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n607-190-00-X\nmethyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)\n401-890-7\n77402-03-0\nCarc. 1B\nMuta. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nH350\nH340\nH302\nH319\nGHS08\nGHS07\nDgr\nH350\nH340\nH302\nH319\n\n\n\n607-191-00-5\nisobutyl 3,4-epoxybutyrate\n401-920-9\n100181-71-3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-192-00-0\ndisodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate\n402-360-8\n92511-22-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-194-00-1\npropylene carbonate\n203-572-1\n108-32-7\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n\n607-195-00-7\n2-methoxy-1-methylethyl acetate\n203-603-9\n108-65-6\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n607-196-00-2\nheptanoic acid\n203-838-7\n111-14-8\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-197-00-8\nnonanoic acid\n203-931-2\n112-05-0\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n607-198-00-3\npropyl 3,4,5-trihydroxybenzoate\n204-498-2\n121-79-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n607-199-00-9\noctyl 3,4,5-trihydroxybenzoate\n213-853-0\n1034-01-1\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n607-200-00-2\ndodecyl 3,4,5-trihydroxybenzoate\n214-620-6\n1166-52-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-201-00-8\nthiocarbonyl chloride\n207-341-6\n463-71-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH331\nH302\nH319\nH335\nH315\nGHS06\nDgr\nH331\nH302\nH319\nH335\nH315\n\n\n\n607-203-00-9\n2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate\n279-452-8\n80387-97-9\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH360D ***\nH317\nH412\nGHS08\nGHS07\nDgr\nH360D ***\nH317\nH412\n\n\n\n607-204-00-4\n(chlorophenyl)(chlorotolyl)methane, mixed isomers\n400-140-6\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-205-00-X\nmethyl chloroacetate\n202-501-1\n96-34-4\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH226\nH331\nH301\nH335\nH315\nH318\nGHS02\nGHS06\nGHS05\nDgr\nH226\nH331\nH301\nH335\nH315\nH318\n\n\n\n607-206-00-5\nisopropyl chloroacetate\n203-301-7\n105-48-6\nFlam. Liq. 3\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH226\nH301\nH319\nH335\nH315\nGHS02\nGHS06\nDgr\nH226\nH301\nH319\nH335\nH315\n\n\n\n607-207-00-0\nhaloxyfop-etotyl (ISO);\n2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;\nhaloxyfop-(2-ethoxyethyl)\n402-560-5\n87237-48-7\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-208-00-6\n4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers\n403-000-2\n91853-67-7\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-209-00-1\nreaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate\n403-030-6\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-210-00-7\nmethyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)\n403-230-3\n77402-05-2\nCarc. 1B\nMuta. 1B\nSkin Corr. 1B\nSkin Sens. 1\nH350\nH340\nH314\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH340\nH314\nH317\n\n\n\n607-211-00-2\nmethyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate\n403-270-1\n6386-39-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-212-00-8\npoly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate\n403-300-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n607-213-00-3\nethyl 3,3-bis(tert-pentylperoxy)butyrate\n403-320-2\n67567-23-1\nOrg. Perox. D****\nFlam. Liq. 3\nAquatic Chronic 2\nH242\nH226\nH411\nGHS02\nGHS09\nDgr\nH242\nH226\nH411\n\n\n\n\n607-214-00-9\nN,N-hydrazinodiacetic acid\n403-510-5\n19247-05-3\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH373 **\nH317\nH412\nGHS06\nGHS08\nDgr\nH301\nH373 **\nH317\nH412\n\n\n\n607-215-00-4\n3-(3-tert-butyl-4-hydroxyphenyl)propionic acid\n403-920-4\n107551-67-7\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n\n607-216-00-X\nglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine\n403-950-8\n—\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH330\nH302\nH314\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH302\nH314\nH400\n\n\n\n\n\n607-217-00-5\n2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate\n403-960-2\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-218-00-0\ndichlorprop-P (ISO);\n(+)-R-2-(2,4-dichlorophenoxy)propionic acid\n403-980-1\n15165-67-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-219-00-6\nbis(2-ethylhexyl) dithiodiacetate\n404-510-8\n62268-47-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n607-221-00-7\n6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid\n404-550-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-222-00-2\n6-(2,3-dimethylmaleimido)hexyl methacrylate\n404-870-6\n63740-41-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-223-00-8\ntransfluthrin (ISO);\n2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate\n405-060-5\n118712-89-3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-224-00-3\nmethyl 2-(3-nitrobenzylidene)acetoacetate\n405-270-7\n39562-17-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-225-00-9\n3-azidosulfonylbenzoic acid\n405-310-3\n15980-11-7\nSelf-React. C ****\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH241\nH373 **\nH318\nH317\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH241\nH373 **\nH318\nH317\n\n\n\n607-226-00-4\nreaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate\n405-360-6\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH315\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\nH412\n\n\n\n607-227-00-X\npotassium 2-amino-2-methylpropionate octahydrate\n405-560-3\n120447-91-8\nAcute Tox. 4 *\nSkin Corr. 1A\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n607-228-00-5\nbis(2-methoxyethyl) phthalate\n204-212-6\n117-82-8\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\n\n\n607-229-00-0\ndiethylcarbamoyl chloride\n201-798-5\n88-10-8\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH351\nH332\nH302\nH319\nH335\nH315\nGHS08\nGHS07\nWng\nH351\nH332\nH302\nH319\nH335\nH315\n\n\n\n607-230-00-6\n2-ethylhexanoic acid\n205-743-6\n149-57-5\nRepr. 2\nH361d ***\nGHS08\nWng\nH361d ***\n\n\n\n\n\n607-231-00-1\nclopyralid (ISO);\n3,6-dichloropyridine-2-carboxylic acid\n216-935-4\n1702-17-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-232-00-7\npyridate (ISO);\nO-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate\n259-686-7\n55512-33-9\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-233-00-2\nhexyl acrylate\n219-698-5\n2499-95-8\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH335\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH411\n\n\n\n607-234-00-8\nflurenol (ISO);\n9-hydroxy-9H-fluorene-9-carboxylic acid\n207-397-1\n467-69-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-235-00-3\nmecrilate;\nmethyl 2-cyanoacrylate\n205-275-2\n137-05-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-236-00-9\nethyl 2-cyanoacrylate\n230-391-5\n7085-85-0\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-237-00-4\nbenzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;\nflurazole\n276-942-3\n72850-64-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-238-00-X\ntau-fluvalinate (ISO);\ncyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate\n—\n102851-06-9\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH315\nH410\n\n\n\n607-239-00-5\nfenpropathrin (ISO);\nα-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate\n254-485-0\n39515-41-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH312\nH410\n\n\n\n607-240-00-0\ncis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]\n1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]\n1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]\ntetrahydromethylphthalic anhydride; [4]\n1,2,3,6-tetrahydromethylphthalic anhydride; [5]\ntetrahydro-4-methylphthalic anhydride; [6]\n2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]\n216-906-6 [1]\n222-323-8 [2]\n226-247-6 [3]\n234-290-7 [4]\n247-830-1 [5]\n251-823-9 [6]\n255-853-3 [7]\n1694-82-2 [1]\n3425-89-6 [2]\n5333-84-6 [3]\n11070-44-3 [4]\n26590-20-5 [5]\n34090-76-1 [6]\n42498-58-8 [7]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-241-00-6\nhexahydro-4-methylphthalic anhydride; [1]\nhexahydromethylphthalic anhydride; [2]\nhexahydro-1-methylphthalic anhydride; [3]\nhexahydro-3-methylphthalic anhydride [4]\n243-072-0 [1]\n247-094-1 [2]\n256-356-4 [3]\n260-566-1 [4]\n19438-60-9 [1]\n25550-51-0 [2]\n48122-14-1 [3]\n57110-29-9 [4]\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH318\nH334\nH317\nGHS08\nGHS05\nDgr\nH318\nH334\nH317\n\n\nC\n607-242-00-1\ntetrachlorophthalic anhydride\n204-171-4\n117-08-8\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH334\nH317\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH318\nH334\nH317\nH410\n\n\n\n607-243-00-7\nsodium 3,6-dichloro-o-anisate; [1]\n3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]\n3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]\n217-846-3 [1]\n246-590-5 [2]\n258-527-9 [3]\n1982-69-0 [1]\n25059-78-3 [2]\n53404-28-7 [3]\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-244-00-2\nisooctyl acrylate\n249-707-8\n29590-42-9\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\nSTOT SE 3; H335: C ≥ 10 %\n\n\n607-245-00-8\ntert-butyl acrylate\n216-768-7\n1663-39-4\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH332\nH312\nH302\nH335\nH315\nH317\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH332\nH312\nH302\nH335\nH315\nH317\nH411\n\n\nD\n\n607-246-00-3\nallyl methacrylate;\n2-methyl-2-propenoic acid 2-propenyl ester\n202-473-0\n96-05-9\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nH226\nH331\nH312\nH302\nH400\nGHS02\nGHS06\nGHS09\nDgr\nH226\nH331\nH312\nH302\nH400\n\n\n\n607-247-00-9\ndodecyl methacrylate\n205-570-6\n142-90-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH335\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH410\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-248-00-4\nnaptalam-sodium (ISO);\nsodium N-naphth-1-ylphthalamate\n205-073-4\n132-67-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-249-00-X\n(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate\n256-032-2\n42978-66-5\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH335\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH411\n\nSTOT SE 3; H335: C ≥ 10 %\n\n607-250-00-5\n4H-3,1-benzoxazine-2,4(1H)-dione\n204-255-0\n118-48-9\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n607-251-00-0\n2-methoxypropyl acetate\n274-724-2\n70657-70-4\nFlam. Liq. 3\nRepr. 1B\nSTOT SE 3\nH226\nH360D ***\nH335\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH360D ***\nH335\n\n\n\n\n\n607-252-00-6\nlambda-cyhalothrin (ISO);\nreaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)\n415-130-7\n91465-08-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH301\nH312\nH410\n\nM=10000\n\n\n607-253-00-1\ncyfluthrin (ISO);\nα-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n269-855-7\n68359-37-5\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH300\nH331\nH400\nH410\nGHS06\nGHS09\nDgr\nH300\nH331\nH410\n\nM=1000\n\n\n607-254-00-7\nα-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;\nbeta-cyfluthrin\n269-855-7\n68359-37-5\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\n\n607-255-00-2\nfluroxypyr (ISO);\n4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid\n—\n69377-81-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-256-00-8\nazoxystrobin (ISO);\nmethyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate\n—\n131860-33-8\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH410\n\n\n\n607-257-00-3\nisopropyl propionate\n211-300-8\n637-78-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\n\n607-258-00-9\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate\n403-990-6\n70950-45-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-259-00-4\nmethyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate\n404-130-2\n105560-93-8\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-260-00-X\nethyl 2-(3-nitrobenzylidene)acetoacetate\n404-490-0\n39562-16-8\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-261-00-5\niso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate\n404-800-4\n118832-72-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-262-00-0\n7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid\n405-050-0\n86393-33-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n607-263-00-6\npotassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate\n405-680-6\n—\nSelf-heat. 2 ****\nAquatic Chronic 2\nH252\nH411\nGHS02\nGHS09\nWng\nH252\nH411\n\n\n\n607-264-00-1\n2-chloro-4-(methylsulfonyl)benzoic acid\n406-520-8\n53250-83-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-265-00-7\nethyl-2-chloro-2,2-diphenylacetate\n406-580-5\n52460-86-3\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n607-266-00-2\nreaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];\n3,5-di-tert-butyl-salicylic acid\n406-890-0\n130296-87-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-267-00-8\ntert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate\n407-620-4\n33610-13-8\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH334\nH317\nH412\nGHS08\nDgr\nH334\nH317\nH412\n\n\n\n607-268-00-3\n2-methylpropyl (R)-2-hydroxypropanoate\n407-770-0\n61597-96-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n607-269-00-9\n(R)-2-(4-hydroxyphenoxy)propanoic acid\n407-960-3\n94050-90-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-270-00-4\n3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane\n410-730-5\n90498-90-1\nAcute Tox. 4 *\nH312\nGHS07\nWng\nH312\n\n\n\n607-271-00-X\n2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane\n417-420-9\n156324-82-2\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n607-272-00-5\nfluroxypyr-meptyl (ISO);\nmethylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]\nfluroxypyr-butometyl (ISO);\n2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]\n279-752-9 [1]\n- [2]\n81406-37-3 [1]\n154486-27-8 [2]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-273-00-0\nammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate\n404-520-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-274-00-6\n2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate\n405-350-1\n54527-73-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-275-00-1\nsodium benzoyloxybenzene-4-sulfonate\n405-450-5\n66531-87-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-276-00-7\nbis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex\n405-635-0\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-277-00-2\nreaction mass of: 2-(hexylthio)ethylamine hydrochloride;\nsodium propionate\n405-720-2\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n607-278-00-8\nreaction mass of isomers of: sodium phenethylnaphthalenesulfonate;\nsodium naphthylethylbenzenesulfonate\n405-760-0\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-279-00-3\nreaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);\nn-octadecylaminodiethyl hydrogen maleate hydrogenphthalate\n405-960-8\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-280-00-9\nsodium 4-chloro-1-hydroxybutane-1-sulfonate\n406-190-5\n54322-20-2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH302\nH319\nH317\nGHS07\nWng\nH302\nH319\nH317\n\n\n\n607-281-00-4\nreaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates\n407-000-3\n127519-17-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-282-00-X\n2-acetoxymethyl-4-benzyloxybut-1-yl acetate\n407-140-5\n131266-10-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-283-00-5\nE-ethyl-4-oxo-4-phenylcrotonate\n408-040-4\n15121-89-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH317\nH410\n\n\n\n607-284-00-0\nreaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);\nlithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)\n410-040-4\n136213-76-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-285-00-6\nreaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;\nsodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;\npotassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate\n410-065-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\n\n\n\n\n607-286-00-1\nreaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate\n410-070-8\n141880-36-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-287-00-7\nO'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate\n410-140-8\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-288-00-2\ntetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively\n410-160-7\n148732-74-5\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n607-289-00-8\n3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid\n410-370-9\n105488-33-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-290-00-3\nreaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;\nammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate\n410-540-2\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n607-291-00-9\ndodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate\n410-630-1\n104051-92-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-292-00-4\nreaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;\n[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid\n410-640-6\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-293-00-X\nreaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;\nN-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate\n410-650-0\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n607-294-00-5\nsodium 2-benzoyloxy-1-hydroxyethane-sulfonate\n410-680-4\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-295-00-0\nreaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;\nhexasodium phosphonobutane-1,2,3,4-tetracarboxylate\n410-800-5\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-296-00-6\nreaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid\n410-830-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-297-00-1\n(E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)\n410-960-6\n92761-26-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-298-00-7\n2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate\n411-010-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-299-00-2\nmethyl 3-(acetylthio)-2-methyl-propanoate\n411-040-7\n97101-46-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n607-300-00-6\ntrisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25\n411-430-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-301-00-1\nreaction mass of: dodecanoic acid;\npoly(1-7)lactate esters of dodecanoic acid\n411-860-5\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-302-00-7\nreaction mass of: tetradecanoic acid;\npoly(1-7)lactate esters of tetradecanoic acid\n411-910-6\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH411\n\n\n\n607-303-00-2\n1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid\n413-760-7\n93107-30-3\nRepr. 2\nAquatic Chronic 3\nH361f ***\nH412\nGHS08\nWng\nH361f ***\nH412\n\n\n\n607-304-00-8\nfluazifop-butyl (ISO);\nbutyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate\n274-125-6\n69806-50-4\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D ***\nH410\n\n\n\n607-305-00-3\nfluazifop-P-butyl (ISO);\nbutyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate\n—\n79241-46-6\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH361d ***\nH410\n\n\n\n607-306-00-9\nchlozolinate (ISO);\nethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate\n282-714-4\n84332-86-5\nCarc. 2\nAquatic Chronic 2\nH351\nH411\nGHS08\nGHS09\nWng\nH351\nH411\n\n\n\n607-307-00-4\nvinclozolin (ISO);\nN-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione\n256-599-6\n50471-44-8\nCarc. 2\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH360FD\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360FD\nH317\nH411\n\n\n\n607-308-00-X\nesters of 2,4-D\n—\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\nA\n607-309-00-5\ncarfentrazone-ethyl (ISO);\nethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate\n—\n128639-02-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-310-00-0\nkresoxim-methyl (ISO);\nmethyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate\n—\n143390-89-0\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n607-311-00-6\nbenazolin-ethyl;\nethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate\n246-591-0\n25059-80-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-312-00-1\nmethoxyacetic acid\n210-894-6\n625-45-6\nRepr. 1B\nAcute Tox. 4 *\nSkin Corr. 1B\nH360FD\nH302\nH314\nGHS08\nGHS05\nGHS07\nDgr\nH360FD\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n607-313-00-7\nneodecanoyl chloride\n254-875-0\n40292-82-8\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH330\nH302\nH314\nGHS06\nGHS06\nDgr\nH330\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n607-314-00-2\nethofumesate (ISO);\n(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate\n247-525-3\n26225-79-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-315-00-8\nglyphosate (ISO);\nN-(phosphonomethyl)glycine\n213-997-4\n1071-83-6\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-316-00-3\nglyphosate-trimesium;\nglyphosate-trimethylsulfonium\n—\n81591-81-3\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07 GHS09\nWng\nH302\nH411\n\n\n\n607-317-00-9\nbis(2-ethylhexyl) phthalate;\ndi-(2-ethylhexyl) phthalate;\nDEHP\n204-211-0\n117-81-7\nRepr. 1B\nH360FD\nGHS08\nDgr\nH360FD\n\n\n\n607-318-00-4\ndibutyl phthalate;\nDBP\n201-557-4\n84-74-2\nRepr. 1B\nAquatic Acute 1\nH360Df\nH400\nGHS08\nGHS09\nDgr\nH360Df\nH400\n\n\n\n\n\n\n607-319-00-X\ndeltamethrin (ISO);\n(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-256-6\n52918-63-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\nM=1000000\n\n\n607-320-00-5\nbis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate\n413-930-0\n130066-57-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-321-00-0\n(S)-methyl-2-chloropropionate\n412-470-8\n73246-45-4\nFlam. Liq. 3\nSTOT RE 2 *\nEye Irrit. 2\nH226\nH373 **\nH319\nGHS02\nGHS08\nWng\nH226\nH373 **\nH319\n\n\n\n607-322-00-6\n4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid\n413-120-7\n107144-30-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-323-00-1\n2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate\n413-850-6\n123968-25-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-324-00-7\nreaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;\ndihydrogenated alkyl (C14-C18)amine\n413-800-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-325-00-2\n(S)-2-chloropropionic acid\n411-150-5\n29617-66-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n607-326-00-8\nreaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;\nisobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate\n410-720-0\n141847-13-4\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-327-00-3\n2-(2-iodoethyl)-1,3-propanediol diacetate\n411-780-0\n127047-77-2\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-328-00-9\nmethyl 4-bromomethyl-3-methoxybenzoate\n410-310-1\n70264-94-7\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-329-00-4\nreaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;\nsodium 2-octadecenyl-amino-1,4-butandioate\n411-250-9\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-330-00-X\n(S)-2,3-dihydro-1H-indole-2-carboxylic acid\n410-860-2\n79815-20-6\nRepr. 2\nSTOT RE 2 *\nSkin Sens. 1\nH361f ***\nH373 **\nH317\nGHS08\nGHS07\nWng\nH361f ***\nH373 **\nH317\n\n\n\n607-331-00-5\nreaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;\n1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane\n406-750-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-332-00-0\ncyclopentyl chloroformate\n411-460-0\n50715-28-1\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH226\nH331\nH302\nH373 **\nH318\nH317\nGHS02\nGHS06\nGHS08\nGHS05\nDgr\nH226\nH331\nH302\nH373 **\nH318\nH317\n\n\n\n607-333-00-6\nreaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;\ntetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate\n405-670-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH410\n\n\n\n607-334-00-1\nethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate\n405-880-3\n100501-62-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-335-00-7\nmethyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate\n406-250-0\n72619-32-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n607-336-00-2\n4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate\n406-560-6\n122760-85-4\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n607-337-00-8\ndi-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate\n406-052-4\n125078-60-6\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH226\nH302\nH315\nH318\nH411\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH226\nH302\nH315\nH318\nH411\n\n\n\n607-338-00-3\n2-methylpropyl 2-hydroxy-2-methylbut-3-enoate\n406-235-9\n72531-53-4\nEye Irrit. 2\nSkin Irrit. 2\nH319\nH315\nGHS07\nWng\nH319\nH315\n\n\n\n607-339-00-9\n2,3,4,5-tetrachlorobenzoylchloride\n406-760-3\n42221-52-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n607-340-00-4\n1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate\n406-990-4\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-341-00-X\n(9S)-9-amino-9-deoxyerythromycin\n406-790-7\n26116-56-3\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n607-342-00-5\n4-chlorobutyl veratrate\n410-950-1\n69788-75-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-343-00-0\n4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)\n407-410-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-344-00-6\nreaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;\nN-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;\n3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate\n407-810-7\n—\nSTOT RE 2 *\nH373 **\nGHS08\nWng\nH373 **\n\n\n\n607-345-00-1\npotassium 2-(2,4-dichlorophenoxy)-(R)-propionate\n413-580-9\n113963-87-4\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-346-00-7\n3-icosyl-4-henicosylidene-2-oxetanone\n401-210-9\n83708-14-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-347-00-2\nsodium (R)-2-(2,4-dichlorophenoxy)propionate\n413-340-3\n119299-10-4\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-348-00-8\nmagnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)\n413-360-2\n—\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-349-00-3\nmono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate\n411-270-8\n—\nAquatic Chronic 3\nH412\n\nH412\n\n\n\n607-350-00-9\nbis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane\n412-060-9\n136210-32-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-351-00-4\nmethyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate\n407-550-4\n69184-17-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-352-00-X\n4,4'-oxydiphthalic anhydride\n412-830-4\n1823-59-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-353-00-5\nreaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;\nethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate\n407-520-0\n80657-64-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-354-00-0\nethyl 2-cyclohexylpropionate\n412-280-5\n2511-00-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-355-00-6\np-tolyl 4-chlorobenzoate\n411-530-0\n15024-10-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-356-00-1\nethyl trans-2,2,6-trimethylcyclohexanecarboxylate\n412-540-8\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n607-357-00-7\nreaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;\ncis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran\n412-450-9\n131766-73-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-358-00-2\n(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate\n412-670-5\n54275-93-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n607-359-00-8\n(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate\n412-800-0\n76109-32-5\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n607-360-00-3\nsodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate\n411-680-7\n133167-77-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-361-00-9\nmethyl (R)-2-(4-hydroxyphenoxy)propionate\n411-950-4\n96562-58-2\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-362-00-4\nreaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;\n(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate\n413-500-2\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH315\nH318\nH411\nGHS05\nGHS09\nDgr\nH315\nH318\nH411\n\n\n\n607-363-00-X\nmethyl-3-methoxyacrylate\n412-900-4\n5788-17-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-364-00-5\n3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione\n413-330-9\n134724-55-3\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n607-365-00-0\n2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride\n410-620-7\n119154-86-8\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n607-366-00-6\n3,5-dimethylbenzoyl chloride\n413-010-9\n6613-44-1\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n607-367-00-1\npotassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate\n411-640-9\n153352-59-1\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-368-00-7\n1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole\n411-650-3\n110895-43-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\n\n\n607-369-00-2\nreaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;\ncis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid\n411-660-8\n147027-04-1\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n607-370-00-8\n2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol\n412-210-3\n41620-33-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-371-00-3\n3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate\n413-410-3\n88150-62-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-372-00-9\nethoxylated bis phenol A di-(norbornene carboxylate)\n412-410-0\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-373-00-4\n(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate\n414-200-4\n119738-06-6\nMuta. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH360Df\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH360Df\nH302\nH373 **\nH410\n\n\n\n607-374-00-X\n5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride\n417-220-1\n37441-29-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-375-00-5\nreaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;\ntrans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin\n421-960-0\n90035-08-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH372 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH372 **\nH410\n\n\n\n607-376-00-0\nbenzyl 2,4-dibromobutanoate\n420-710-8\n23085-60-1\nRepr. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH315\nH317\nH410\n\n\n\n607-377-00-6\ntrans-4-cyclohexyl-L-proline monohydrochloride\n419-160-1\n90657-55-9\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH361f ***\nH302\nH315\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH361f ***\nH302\nH315\nH318\nH317\n\n\n\n607-378-00-1\nammonium (Z)-α-methoxyimino-2-furylacetate\n405-990-1\n97148-39-5\nFlam. Sol. 2\nH228\nGHS02\nDgr\nH228\n\n\nT\n607-379-00-7\nreaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;\nsodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;\nsodium [bis(2-hydroxyethyl)amino]methylsulfonate;\nN,N-bis(2-hydroxyethyl)stearamide\n401-230-8\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-380-00-2\nreaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;\nammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;\nammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate\n407-320-3\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH315\nH318\nH412\nGHS05\nDgr\nH315\nH318\nH412\n\n\n\n607-381-00-8\nreaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid\n413-710-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-382-00-3\n2-((4-amino-2-nitrophenyl)amino)benzoic acid\n411-260-3\n117907-43-4\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n607-383-00-9\nreaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;\n2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate\n415-430-8\n86403-32-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n607-384-00-4\nreaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;\nC15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;\nC13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate\n413-750-2\n171090-93-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-385-00-X\nCopolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate\n414-590-6\n125229-74-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-386-00-5\nreaction mass of: tetradecanoic acid (42,5- 47,5 %);\npoly(1-7)lactate esters of tetradecanoic acid (52,5- 57,5 %)\n412-580-6\n174591-51-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-387-00-0\nreaction mass of: dodecanoic acid (35-40 %);\npoly(1-7)lactate esters of dodecanoic acid (60-65 %)\n412-590-0\n58856-63-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-388-00-6\n4-ethylamino-3-nitrobenzoic acid\n412-090-2\n2788-74-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n607-389-00-1\ntrisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate\n414-130-4\n119710-96-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n607-390-00-7\n1,2,3,4-tetrahydro-6-nitro-quinoxaline\n414-270-6\n41959-35-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n607-391-00-2\ndimethylcyclopropane-1,1-dicarboxylate\n414-240-2\n6914-71-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-392-00-8\n2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate\n414-260-1\n88938-37-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-393-00-3\n3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid\n415-750-8\n106447-44-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-394-00-9\n5-methylpyrazine-2-carboxylic acid\n413-260-9\n5521-55-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-395-00-4\nreaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;\nsodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate\n410-230-7\n—\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n607-396-00-X\nbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate\n414-840-4\n147783-69-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n607-397-00-5\nreaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);\nCa phenates (branched C10-14 and C18-30 alkylated);\nCa sulfurised phenates (branched C10-14 and C18-30 alkylated)\n415-930-6\n—\nRepr. 2\nSkin Sens. 1\nH361f***\nH317\nGHS08\nGHS07\nWng\nH361f***\nH317\n\n\n\n\n607-398-00-0\nethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate\n414-820-5\n125630-94-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-399-00-6\n2,2-dimethyl 3-methyl-3-butenyl propanoate\n415-610-6\n104468-21-5\nSkin Irrit. 2\nAquatic Chronic 3\nH315\nH412\nGHS07\nWng\nH315\nH412\n\n\n\n607-400-00-X\nmethyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate\n414-400-1\n32750-89-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-401-00-5\nethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate\n414-450-4\n88805-65-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n607-402-00-0\nmethyl N-(phenoxycarbonyl)-L-valinate\n414-500-5\n153441-77-1\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-403-00-6\nreaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;\nisopropyl alcohol\n414-810-0\n—\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH318\nH410\n\n\n\n607-404-00-1\nreaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;\ndi-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;\ndi-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;\n(Z)-3,7-dimethyl-2,6-octadienyl butandioate;\n((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid\n415-190-4\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-405-00-7\n2-hexyldecyl-p-hydroxybenzoate\n415-380-7\n148348-12-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-406-00-2\npotassium 2,5-dichlorobenzoate\n415-700-5\n184637-62-5\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n607-407-00-8\nethyl 2-carboxy-3-(2-thienyl)propionate\n415-680-8\n143468-96-6\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH315\nH318\nH317\n\n\n\n607-408-00-3\npotassium N-(4-fluorophenyl)glycinate\n415-710-1\n184637-63-6\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH318\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH373 **\nH318\nH317\nH412\n\n\n\n607-409-00-9\nreaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;\ninert biomass from Aspergillus terreus\n415-840-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-410-00-4\nmono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate\n415-880-5\n779343-34-9\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n607-411-00-X\noxiranemethanol, 4-methylbenzene-sulfonate, (S)-\n417-210-7\n70987-78-9\nCarc. 1B\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH350\nH341\nH318\nH317\nH411\n\n\n\n607-412-00-5\nethyl 2-(1-cyanocyclohexyl)acetate\n415-970-4\n133481-10-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373 **\nH412\nGHS08\nGHS07\nWng\nH302\nH373 **\nH412\n\n\n\n607-413-00-0\ntrans-4-phenyl-L-proline\n416-020-1\n96314-26-0\nRepr. 2\nSkin Sens. 1\nH361f ***\nH317\nGHS08\nGHS07\nWng\nH361f ***\nH317\n\n\n\n607-414-00-6\ntris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate\n402-070-1\n88122-99-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-415-00-1\npoly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride)\n419-590-1\n—\nFlam. Sol. 1\nSkin Sens. 1\nH228\nH317\nGHS02\nGHS07\nDgr\nH228\nH317\n\n\nT\n607-416-00-7\n4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide\n420-730-7\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n607-417-00-2\n3-chloropropyl chloroformiate\n425-770-9\n628-11-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH331\nH302\nH373**\nH315\nH318\nH317\nGHS06\nGHS05\nGHS08\nDgr\nH331\nH302\nH373**\nH315\nH318\nH317\n\n\n\n\n607-418-00-8\n2-ethylhexyl 4-aminobenzoate\n420-170-3\n26218-04-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-419-00-3\n(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid\n422-240-9\n166596-68-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-420-00-9\n2,2-bis(hydroxymethyl)butanoic acid\n424-090-1\n10097-02-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-421-00-4\ncypermethrin cis/trans +/- 40/60;\n(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n52315-07-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH335\nH410\n\n\n\n\n\n607-422-00-X\nα-cypermethrin (ISO);\nracemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;\n(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n67375-30-8\nAcute Tox. 3 *\nSTOT RE 2 *\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373**\nH335\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373**\nH335\nH410\n\nM=1000\n\n\n607-423-00-5\nesters of mecoprop and of mecoprop-P\n—\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\nA\n607-424-00-0\ntrifloxystrobin (ISO);\n(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester\n—\n141517-21-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-425-00-6\nmetalaxyl (ISO);\nmethyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate\n260-979-7\n57837-19-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n607-426-00-1\n1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]\nn-pentyl-isopentylphthalate; [2]\ndi-n-pentyl phthalate; [3]\ndiisopentylphthalate [4]\n284-032-2 [1]\n- [2]\n205-017-9 [3]\n210-088-4 [4]\n84777-06-0 [1]\n- [2]\n131-18-0 [3]\n605-50-5 [4]\nRepr. 1B\nAquatic Acute 1\nH360FD\nH400\nGHS08\nGHS09\nDgr\nH360FD\nH400\n\n\n\n607-427-00-7\nbromoxynil heptanoate (ISO);\n2,6-dibromo-4-cyanophenyl heptanoate\n260-300-4\n56634-95-8\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH332\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH332\nH302\nH317\nH410\n\n\n\n\n\n607-428-00-2\ntetrasodium ethylene diamine tetraacetate\n200-573-9\n64-02-8\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n607-429-00-8\nedetic acid;\n(EDTA)\n200-449-4\n60-00-4\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-430-00-3\nBBP;\nbenzyl butyl phthalate e\n201-622-7\n85-68-7\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH400\nH410\nGHS08\nGHS09\nDgr\nH360Df\nH410\n\n\n\n607-431-00-9\nprallethrin (ISO);\nETOC;\n2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n245-387-9\n23031-36-9\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\n\n\n607-432-00-4\nS-metolachlor;\nreaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]\n- [1]\n- [2]\n87392-12-9 [1]\n178961-20-1 [2]\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n607-433-00-X\ncypermethrin cis/trans +/- 80/20;\n(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n257-842-9\n52315-07-8\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH335\nH315\nH317\nH410\n\n\n\n607-434-00-5\nmecoprop-P [1] and its salts;\n(R)-2-(4-chloro-2-methylphenoxy)propionic acid\n240-539-0\n16484-77-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n607-435-00-0\n2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate\n416-810-6\n111969-64-3\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH373 **\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH373 **\nH318\nH411\n\n\n\n607-436-00-6\n2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate\n417-350-9\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n607-437-00-1\n3-(4-aminophenyl)-2-cyano-2-propenoic acid\n417-480-6\n252977-62-1\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-438-00-7\nmethyl-2-[(aminosulfonyl)methyl]benzoate\n419-010-5\n112941-26-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n607-439-00-2\nmethyl tetrahydro-2-furancarboxylate\n420-670-1\n37443-42-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-440-00-8\nmethyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate\n421-220-7\n144740-59-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n607-441-00-3\n3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid\n421-490-6\n167684-63-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-442-00-9\nbenzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate\n416-050-5\n87460-09-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-443-00-4\nbis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate\n416-140-4\n145650-60-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-444-00-X\nreaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;\ntrans-1,4-dimethylcyclohexyl dibenzoate\n416-230-3\n35541-81-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-445-00-5\nIron (III) tris(4-methylbenzenesulfonate)\n420-960-8\n77214-82-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-446-00-0\nmethyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate\n416-240-8\n155522-12-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-447-00-6\nsodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate\n416-370-5\n156738-27-1\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n607-448-00-1\n2,3,5,6-tetrafluorobenzoic acid\n416-800-1\n652-18-6\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n607-449-00-7\nreaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];\n4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]\n417-080-1\n—\nSelf-react. D ****\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH317\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH317\nH410\n\n\n\n607-450-00-2\n2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate\n419-040-9\n89604-92-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-451-00-8\n4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt\n417-640-5\n161935-19-9\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-453-00-9\n4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)\n418-100-1\n172964-15-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n607-454-00-4\nreaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;\ncis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid\n418-170-3\n116193-72-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n607-455-00-X\n1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt\n419-520-8\n172890-93-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-456-00-5\n3-amino-4-chlorobenzoic acid, hexadecyl ester\n419-700-6\n143269-74-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-457-00-0\ntetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)\n420-350-1\n172277-97-3\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n607-458-00-6\nreaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;\n2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;\n2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]\n420-850-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-459-00-1\nisopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate\n418-930-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-460-00-7\n3-tridecyloxy-propyl-ammonium 9-octadecenoate\n418-990-1\n778577-53-0\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH319\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH319\nH315\nH410\n\n\n\n607-461-00-2\nreaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;\npentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate\n421-160-1\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-462-00-8\nreaction mass of: 1-hexyl acetate;\n2-methyl-1-pentyl acetate;\n3-methyl-1-pentyl acetate;\n4-methyl-1-pentyl acetate;\nother mixed linear and branched C6-alkyl acetates\n421-230-1\n88230-35-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-463-00-3\n3-(phenothiazin-10-yl)propionic acid\n421-260-5\n362-03-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-464-00-9\nreaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;\n5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid\n421-280-4\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-465-00-4\ntris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate\n421-440-3\n778583-04-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-466-00-X\nreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;\nphenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;\nphenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate\n421-480-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-467-00-5\n1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate\n419-430-9\n56533-00-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH314\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH314\nH410\n\n\n\n607-468-00-0\nreaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ndisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ntrisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;\ntetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate\n419-450-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-469-00-6\ndisodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate\n419-460-2\n120029-06-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-470-00-1\npotassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n414-100-0\n154336-20-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n\n607-471-00-7\n1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane\n429-280-6\n151900-44-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n607-472-00-2\nammonium iron(III) trimethylenediaminetetraacetate hemihydrate\n400-660-3\n111687-36-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n\n607-473-00-8\npentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid\n426-590-3\n187412-41-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-474-00-3\n(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid\n410-430-4\n117573-89-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-475-00-9\nreaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;\ntetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)\n412-940-2\n148878-18-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-476-00-4\ntrisodium N,N-bis(carboxymethyl)-β-alanine\n414-070-9\n129050-62-0\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n\n\n607-477-00-X\n(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt\n426-740-8\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-478-00-5\ntetramethylammonium hydrogen phthalate\n416-900-5\n79723-02-7\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH400\n\n\n\n607-479-00-0\nhexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate\n418-550-9\n168689-49-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-480-00-6\n1,2-benzenedicarboxylic acid;\ndi-C7-11-branched and linear alkylesters\n271-084-6\n68515-42-4\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\n\n\n\n\n607-481-00-1\nreaction mass of: trihexyl citrate;\ndihexyloctyl citrate;\ndioctylhexyl citrate;\ndihexyldecyl citrate\n430-290-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-482-00-7\nN-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride\n430-360-8\n84793-24-8\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-483-00-2\n1,2-benzenedicarboxylic acid;\ndi-C6-8-branched alkylesters, C7-rich\n276-158-1\n71888-89-6\nRepr. 1B\nH360D***\nGHS08\nDgr\nH360D***\n\n\n\n\n607-484-00-8\nethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate\n430-480-0\n221452-67-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-485-00-3\n(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate\n430-510-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-486-00-9\npotassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate\n402-110-8\n110081-40-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-487-00-4\nreaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;\ntrisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate\n402-660-9\n—\nRepr. 1B\nAquatic Chronic 3\nH360D ***\nH412\nGHS08\nDgr\nH360D ***\nH412\n\n\n\n607-488-00-X\nethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate\n414-210-9\n147379-38-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-489-00-5\nreaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;\n2-ethylhexyl epoxyoleate;\n2-ethylhexyl diepoxylinoleate;\n2-ethylhexyl triepoxylinolenate\n414-890-7\n71302-79-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-490-00-0\nN-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate\n415-060-7\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n\n\n607-491-00-6\nreaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);\ntriester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)\n427-140-9\n—\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n\n607-492-00-1\n2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate\n415-490-5\n141773-73-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-493-00-7\nmethyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate\n415-670-3\n78850-37-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-494-00-2\nbis(2-ethylhexyl)octylphosphonate\n417-170-0\n52894-02-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-495-00-8\nsodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate\n417-550-6\n168151-92-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n607-496-00-3\n2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite\n418-310-3\n126050-54-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-497-00-9\ncerium oxide isostearate\n419-760-3\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-498-00-4\n(E)-3,7-dimethyl-2,6-octadienylhexadecanoate\n421-370-3\n3681-73-0\nSkin Irrit. 2\nAquatic Chronic 4\nH315\nH413\nGHS07\nWng\nH315\nH413\n\n\n\n607-499-00-X\nbis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)\n421-660-1\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n607-500-00-3\ncalcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate\n421-670-4\n—\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH410\n\n\n\n607-501-00-9\nreaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives\n421-820-9\n192268-65-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n607-502-00-4\n(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate\n422-200-0\n178277-55-9\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH314\nH302\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH411\n\n\n\n607-503-00-X\n2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane\n422-210-5\n68957-94-8\nSkin Corr. 1B\nH314\nGHS05\nDgr\nH314\n\n\n\n\n\n607-504-00-5\ndiammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate\n422-670-7\n—\nRepr. 2\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH361f\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361f\nH301\nH373**\nH410\n\n\n\n\n607-505-00-0\npentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate\n422-930-1\n\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-506-00-6\nreaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;\ndisodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate\n422-970-8\n\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n607-507-00-1\npotassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate\n422-980-2\n187026-95-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n607-508-00-7\ndisodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]\n423-110-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n\n607-509-00-2\n2-phenoxyethyl 4-aminobenzoate\n430-880-5\n88938-23-2\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-510-00-8\n(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide\n427-200-4\n76646-91-8\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH302\nH315\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH317\n\n\n\n\n607-511-00-3\nreaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;\n4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid\n423-750-4\n—\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n\n\n607-512-00-9\ntrisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate\n423-970-0\n182926-43-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n607-513-00-4\nreaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;\n5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;\n5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid\n423-200-3\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n\n607-514-00-X\npotassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate\n427-240-2\n134841-35-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-515-00-5\nreaction mass of: disodium hexyldiphenyl ether disulphonate;\ndisodium dihexyldiphenyl ether disulphonate\n429-650-7\n147732-60-3\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n607-516-00-0\nN,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine\n429-670-6\n105996-54-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n607-517-00-6\n(S)-α-(acetylthio)benzenepropanoic acid\n430-300-0\n76932-17-7\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n\n607-518-00-1\n3-oxoandrost-4-ene-17-β-carboxylic acid\n414-990-0\n302-97-6\nRepr. 2\nAquatic Chronic 4\nH361f\nH413\nGHS08\nWng\nH361f\nH413\n\n\n\n\n\n607-519-00-7\npoly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]\n427-280-0\n176429-27-9\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH335\nH315\nH318\nH410\n\n\n\n\n607-520-00-2\nreaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;\ndisodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate\n427-740-0\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-521-00-8\ntetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate\n429-270-1\n136210-30-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-522-00-3\nsodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate\n429-720-7\n184246-86-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-523-00-9\nreaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6', 13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6', 3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate\n430-200-7\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-524-00-4\ntall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters\n430-310-5\n—\nAquatic Chronic 4\nH413\n\nH413\n\n\n\n\n607-525-00-X\n(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid\n431-520-1\n64485-90-1\nFlam. Sol. 1****\nCarc. 2\nAquatic Chronic 3\nH228\nH351\nH412\nGHS02\nGHS08\nDgr\nH228\nH351\nH412\n\n\n\n\n607-526-00-5\ncartap (ISO);\n1,3-bis(carbamoylthio)-2-(dimethylamino)propane\n—\n15263-53-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n607-527-00-0\nreaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;\n1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate\n423-180-6\n—\nSTOT RE 2 *\nH373 **\nGHS08\nWng\nH373 **\n\n\n\n\n\n607-528-00-6\n(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid\n430-900-2\n192725-50-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-529-00-1\nbenzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate\n426-070-6\n67299-45-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-530-00-7\nreaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate\n406-040-9\n125643-61-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-531-00-2\nmethyl 3-amino-4,6-dibromo-2-methyl-benzoate\n425-190-6\n119916-05-1\nSTOT RE 2 *\nAquatic Chronic 2\nH373**\nH411\nGHS08\nGHS09\nWng\nH373**\nH411\n\n\n\n\n607-532-00-8\n(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt\n425-510-4\n167944-94-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-533-00-3\npentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n414-910-4\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-534-00-9\nethyl 2-(3-benzoylphenyl)propanoate\n414-920-9\n60658-04-0\nAcute Tox. 3 *\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH372**\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH372**\nH317\nH411\n\n\n\n\n607-535-00-4\npotassium 4-iodo-2-sulfonato-benzoic acid\n426-620-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-536-00-X\n(2,6-xylyloxy) acetic acid\n430-910-7\n13335-71-2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n607-537-00-5\nisopropylammonium 2-(3-benzoylphenyl)propionate\n417-970-1\n—\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH372**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH312\nH372**\nH318\nH410\n\n\n\n\n607-539-00-6\npropyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate\n431-000-2\n198705-81-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-540-00-1\n1-(mercaptomethyl)cyclopropylacetic acid\n420-240-3\n162515-68-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH312\nH302\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH312\nH302\nH317\nH411\n\n\n\n\n607-541-00-7\n[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)\n421-940-1\n28698-31-9\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n607-542-00-2\nmethyl 2-(4-butanesulfonamidophenoxy)tetradecanoate\n422-110-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-543-00-8\npoly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]\n427-480-8\n176429-22-4\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH335\nH315\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH335\nH315\nH318\nH410\n\n\n\n\n607-544-00-3\nethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate\n427-490-2\n158585-86-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-545-00-9\n1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate\n424-070-0\n94346-09-5\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-546-00-4\nreaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]methoxycarbonylmethylamino[}acetate;\nmethyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]ethoxycarbonylmethylamino[}acetate\n424-290-7\n188070-47-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-547-00-X\n18-methylnonadecyl 2,2-dimethylpropanoate\n424-370-1\n125496-22-2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n\n\n607-548-00-5\n1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate\n431-010-7\n154486-26-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-549-00-0\nmethyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate\n424-430-7\n125778-19-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n607-550-00-6\n2-amino-4-bromo-5-chlorobenzoic acid\n424-700-4\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n\n607-551-00-1\ntetrabutylammonium 2-amino-6-iodopurinate\n424-710-9\n156126-48-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH373**\nH315\nH318\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH312\nH302\nH373**\nH315\nH318\nH317\nH411\n\n\n\n\n607-552-00-7\nhexadecyl 3-amino-4-isopropoxybenzoate\n424-830-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-553-00-2\n7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt\n424-850-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-554-00-8\n2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid\n424-870-1\n27624-67-5\nExpl. 1.1\nEye Dam. 1\nAquatic Chronic 3\nH201\nH318\nH412\nGHS01\nGHS05\nDgr\nH201\nH318\nH412\n\n\n\n\n607-555-00-3\n1,1,3,3-tetramethylbutylperoxypivalate\n424-980-8\n22288-41-1\nFlam. Liq. 2\nOrg. Perox. D\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH242\nH315\nH317\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH225\nH242\nH315\nH317\nH411\n\n\n\n\n607-556-00-9\n2-acetoxymethylene-4-acetylphenylacetate\n425-160-2\n24085-06-1\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS05 GHS08 GHS07 GHS09 Dgr\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n607-557-00-4\nsalt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid\n425-210-3\n169939-84-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-558-00-X\n2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate\n425-250-1\n147027-10-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-559-00-5\ncoconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid\n425-400-6\n179986-09-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-560-00-0\n(R,S)-2-butyloctanedioic acid\n431-210-4\n50905-10-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-561-00-6\nsodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate\n425-460-3\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-562-00-1\nreaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;\n(2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate\n425-530-3\n98769-75-6\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n607-563-00-7\n5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid\n431-250-2\n171850-30-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-564-00-2\n1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate\n425-730-0\n51178-75-7\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-565-00-8\n3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate\n425-820-1\n88150-42-9\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH373**\nH318\nH410\n\n\n\n\n607-566-00-3\nreaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;\nbis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate\n426-140-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-567-00-9\npotassium 3-iodo-6-methylbenzenesulfonate\n426-300-5\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-568-00-4\npotassium 2-chloro-3-(benzyloxy)propionate\n426-350-8\n138666-92-9\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\n\n\n\n\n607-569-00-X\nreaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;\nsodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate\n426-470-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-570-00-5\nsodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate\n426-520-1\n71420-85-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-571-00-0\n2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate\n431-400-7\n57374-49-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-572-00-6\ndiethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate\n426-790-0\n162208-27-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH312\nH302\nH373**\nH317\nH410\n\n\n\n\n607-573-00-1\nreaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;\ndisodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate\n426-840-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-574-00-7\n[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate\n426-890-4\n77341-67-4\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-575-00-2\n4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt\n426-900-7\n—\nSTOT SE 3\nAquatic Chronic 3\nH335\nH412\nGHS07\nWng\nH335\nH412\n\n\n\n\n607-576-00-8\nbranched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate\n427-030-0\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-577-00-3\n(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate\n427-100-0\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n607-578-00-9\nethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate\n427-110-5\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 4\nH302\nH373**\nH413\nGHS08\nGHS07\nWng\nH302\nH373**\nH413\n\n\n\n\n607-579-00-4\ndiethyl[(p-ethoxyanilino)methylene]malonate\n431-430-0\n103976-28-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n607-580-00-X\nethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate\n422-360-1\n100491-29-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-581-00-5\nethyl 2-ethoxy-4-carboxymethylbenzoate\n427-630-2\n99469-99-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-582-00-0\nreaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;\ntetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate\n427-650-1\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-583-00-6\n4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid\n427-680-5\n188907-52-0\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n607-584-00-1\ntrisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate\n427-710-7\n215612-56-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n607-585-00-7\nstrontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate\n427-930-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-586-00-2\ndodecyl 3-amino-4-chlorobenzoate\n428-020-9\n6195-20-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-587-00-8\nethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate\n428-030-3\n67914-69-6\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n607-588-00-3\nreaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;\nbis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate\n428-050-2\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-589-00-9\ntetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate\n428-070-1\n91788-83-9\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH372**\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH372**\nH302\nH410\n\n\n\n\n607-590-00-4\nhexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate\n428-140-1\n210706-50-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-591-00-X\nreaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ndisodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate\n428-400-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n\n607-592-00-5\ndi(C9-11-alkyl) cyclohexane-1,4-dicarboxylate\n428-870-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-593-00-0\n4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate\n429-000-2\n159235-16-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-594-00-6\nethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate\n429-020-1\n204254-96-6\nSTOT RE 2 *\nSkin Sens. 1\nH373**\nH317\nGHS08\nGHS07\nWng\nH373**\nH317\n\n\n\n\n607-595-00-1\nN-amidino-N-methylglycine-2-oxopropionate\n429-120-5\n208535-04-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-596-00-7\nethyl 2-(4-phenoxyphenyl)lactate\n429-220-9\n132584-17-9\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-597-00-2\ntetrasodium 4,4'-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2'-disulfonate\n429-230-3\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-598-00-8\ntrisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate\n429-240-8\n212652-59-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-599-00-3\n1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate\n431-610-9\n68860-54-8\nOrg. Perox. D\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH317\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH317\nH410\n\n\n\n\n607-600-00-7\n(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate\n431-700-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-601-00-2\n1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate\n429-370-5\n220410-74-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-602-00-8\nethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate\n429-680-0\n122665-86-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-603-00-3\nlithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate\n429-730-1\n193562-37-7\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-604-00-9\nguanidinium benzoate\n429-820-0\n26739-54-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-605-00-4\nmethyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate\n429-890-2\n144550-06-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-606-00-X\n(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid\n430-100-3\n86978-24-7\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-607-00-5\nreaction mass of: calcium bis(C10-14 branched alkyl salicylate);\ncalcium bis(C18-30-alkyl salicylate);\ncalcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;\ncalcium bis (C10-14 branched alkyl phenolate);\ncalcium bis (C18-30-alkyl phenolate);\ncalcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;\nC10-14 branched alkyl phenol;\nC18-30-alkyl phenol\n430-180-1\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-608-00-0\npentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate\n430-210-1\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-609-00-6\nethyl (3R)-4-cyano-3-hydroxybutanoate\n430-220-6\n141942-85-0\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-610-00-1\ntrisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate\n430-280-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-611-00-7\nmethyl 3-amino-2,2,3-trimethylbutyrate\n431-720-7\n90886-53-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 3\nH314\nH302\nH412\nGHS05\nGHS07\nDgr\nH314\nH302\nH412\n\n\n\n\n607-612-00-2\nreaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;\nammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate\n432-190-1\n182176-52-9\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nH302\nH373**\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\n\n\n\n\n607-613-00-8\nreaction mass of: succinic acid;\nmonopersuccinic acid;\ndipersuccinic acid;\nmonomethyl ester of succinic acid;\nmonomethyl ester of persuccinic acid;\ndimethyl succinate;\nglutaric acid;\nmonoperglutaric acid;\ndiperglutaric acid;\nmonomethyl ester of glutaric acid;\nmonomethyl ester of perglutaric acid;\ndimethyl glutarate;\nadipic acid;\nmonoperadipic acid;\ndiperadipic acid;\nmonomethyl ester of adipic acid;\nmonomethyl ester of peradipic acid;\ndimethyl adipate;\nhydrogen peroxide;\nmethanol;\nwater\n432-790-1\n—\nMuta. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH341\nH314\nH332\nH312\nH302\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH314\nH332\nH312\nH302\n\n\n\n\n607-614-00-3\n2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid\n426-480-5\n63562-33-4\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n607-615-00-9\nreaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance\n431-120-5\n—\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH331\nH302\nH319\nH317\nGHS06\nDgr\nH331\nH302\nH319\nH317\n\n\n\n\n607-616-00-4\n2,4-dichloro-5-fluorobenzoylchloride\n428-390-1\n86393-34-2\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH335\nH315\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH335\nH315\nH318\nH317\nH412\n\n\n\n\n607-617-00-X\nbis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate\n430-700-5\n10138-36-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-618-00-5\nmenadione sodium bisulfite;\n2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt\n204-987-0\n130-37-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n\n607-619-00-0\nmenadione nicotinamide bisulfite;\n1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)\n277-543-7\n73581-79-0\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n\n607-620-00-6\ntrisodium nitrilotriacetate\n225-768-6\n5064-31-3\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nH351\nH302\nH319\nGHS08\nGHS07\nWng\nH351\nH302\nH319\n\nCarc. 2; H351: C ≥ 5 %\n\n\n607-621-00-1\nmilbemectin (ISO);\n[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH410\n\nM=100\n\n\n607-622-00-7\n2-ethylhexyl-2-ethylhexanoate\n231-057-1\n7425-14-1\nRepr. 2\nH361d***\nGHS08\nWng\nH361d***\n\n\n\n\n607-623-00-2\ndiisobutyl phthalate\n201-553-2\n84-69-5\nRepr. 1B\nH360Df\nGHS08\nDgr\nH360Df\n\nRepr. 1B; H360Df: C ≥ 25 %\nRepr. 2; H361f: 5 % ≤ C < 25 %\n\n\n607-624-00-8\nperfluorooctane sulfonic acid;\nheptadecafluorooctane-1-sulfonic acid; [1]\npotassium perfluorooctanesulfonate;\npotassium heptadecafluorooctane-1-sulfonate; [2]\ndiethanolamine perfluorooctane sulfonate; [3]\nammonium perfluorooctane sulfonate;\nammonium heptadecafluorooctanesulfonate; [4]\nlithium perfluorooctane sulfonate;\nlithium heptadecafluorooctanesulfonate [5]\n217-179-8 [1]\n220-527-1 [2]\n274-460-8 [3]\n249-415-0 [4]\n249-644-6 [5]\n1763-23-1 [1]\n2795-39-3 [2]\n70225-14-8 [3]\n29081-56-9 [4]\n29457-72-5 [5]\nCarc. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nLact.\nAquatic Chronic 2\nH351\nH360D***\nH372**\nH332\nH302\nH362\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH360D***\nH372**\nH332\nH302\nH362\nH411\n\n\n\n\n607-625-00-3\nclodinafop-propargyl (ISO)\n—\n105512-06-9\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,001 %\nM=1\n\n\n607-626-00-9\nethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate\n401-290-5\n103112-35-2\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n\n607-627-00-4\n[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate\n416-360-0\n162221-28-5\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-628-00-X\n4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine\n419-240-6\n171054-89-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-629-00-5\n[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid\n419-270-1\n123599-82-6\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-630-00-0\nacrylic acid, 3-(trimethoxysilyl)propyl ester\n419-560-6\n4369-14-6\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH332\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH332\nH314\nH317\nH412\n\n\n\n\n607-631-00-6\nreaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;\n(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate\n442-300-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-632-00-1\nN-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide\n420-210-1\n111244-14-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-633-00-7\ntrisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate\n440-480-2\n341026-59-3\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-634-00-2\n(S)-(–)-2-acetoxypropionylchloride;\n(1S)-2-chloro-1-methyl-2-oxoethyl acetate\n420-610-4\n36394-75-9\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\n\n\n\n\n607-635-00-8\ntrisodium N-(3-propionato)-l-aspartate\n422-090-4\n172737-80-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-636-00-3\n1-bromo-2-methylpropyl propionate\n422-900-6\n158894-67-8\nFlam. Liq. 3\nCarc. 2\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH351\nH314\nH317\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH351\nH314\nH317\n\n\n\n\n607-637-00-9\ndisodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[}naphthalene-2-sulfonate\n423-730-5\n250688-43-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-638-00-4\n2-hydroxybenzoic acid 2-butyloctyl ester\n431-090-3\n190085-41-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-639-00-X\n2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate\n431-770-1\n216698-07-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-641-00-0\n2-(formylamino)-3-thiophenecarboxylic acid;\n2-formamido-3-thiophenecarboxylic acid\n431-930-9\n43028-69-9\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n607-642-00-6\n3,6,9-trithiaundecamethylene-1,11-dimethacrylate\n432-210-7\n141631-22-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n607-643-00-1\ndimethyl (2S)-2-hydroxysuccinate\n432-310-0\n617-55-0\nFlam. Liq. 3\nEye Dam. 1\nSkin Sens. 1\nH226\nH318\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH318\nH317\n\n\n\n\n607-644-00-7\nmethyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate\n432-350-9\n81752-87-6\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n\n607-645-00-2\ntetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate\n432-550-6\n243858-01-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-646-00-8\nd-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;\ntert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate\n432-960-5\n124655-09-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-647-00-3\n5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane\n433-530-1\n143446-73-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nH302\nH317\nH400\nGHS07\nGHS09\nWng\nH302\nH317\nH400\n\n\n\n\n607-649-00-4\n[3-(chlorocarbonyl)-2-methylphenyl]acetate\n433-690-0\n167678-46-8\nSkin Corr. 1A\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\n\n\n\n607-650-00-X\n2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate\n433-910-5\n145153-52-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-651-00-5\nsodium 2-(nonanoyloxy)benzenesulfonate\n434-360-9\n91125-43-8\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-652-00-0\nethyl N2-dodecanoyl-l-argininate hydrochloride\n434-630-6\n60372-77-2\nEye Dam. 1\nAquatic Acute 1\nH318\nH400\nGHS05\nGHS09\nDgr\nH318\nH400\n\n\n\n\n607-653-00-6\ntetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate\n434-840-8\n225786-91-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-654-00-1\n(S)-3-hydroxy-γ-butyrolactone\n434-990-4\n7331-52-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-655-00-7\nethyl 6,8-dichlorooctanoate\n435-080-1\n1070-64-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-656-00-2\nsodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid\n435-350-7\n141250-43-3\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-657-00-8\npentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate\n436-920-8\n172399-10-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-658-00-3\n3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt\n440-770-9\n371921-63-0\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-659-00-9\npentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid\n442-030-0\n321912-47-4\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-660-00-4\n2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{]phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt\n442-230-8\n321679-52-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n607-661-00-X\n1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate\n442-850-9\n114772-40-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-662-00-5\nmethyl 2-(acetylamino)-3-chloropropionate\n442-860-3\n87333-22-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n607-663-00-0\nbis(2-ethylhexyl) naphthalene-2,6-dicarboxylate\n442-980-6\n127474-91-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-664-00-6\nmethyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate\n443-120-2\n393509-79-0\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n607-665-00-1\ntrans-methyl-2-ethyl-but-2-enoate\n443-150-6\n101226-85-1\nFlam. Liq. 3\nH226\nGHS02\nWng\nH226\n\n\n\n\n607-666-00-7\n(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid\n443-560-5\n88784-33-2\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n607-667-00-2\nchloro-1-ethylcyclohexyl carbonate\n444-950-8\n99464-83-2\nMuta. 2\nSkin Sens. 1\nH341\nH317\nGHS08\nGHS07\nWng\nH341\nH317\n\n\n\n\n607-668-00-8\ntrans-2-isopropyl-5-carboxy-1,3-dioxane\n445-770-2\n42031-28-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n607-669-00-3\nmethyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate\n445-990-9\n376588-17-9\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n607-670-00-9\ndibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;\n(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate\n448-700-9\n500791-70-8\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH373**\nH318\nH317\nH410\n\nM=10\n\n\n607-671-00-4\ndiethyl 1,4-cyclohexanedicarboxylate\n417-310-0\n72903-27-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n607-672-00-X\nreaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;\n1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;\nx-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate\n419-000-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-673-00-5\n1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate\n419-570-0\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n607-675-00-6\nreaction mass of: cis-9-octadecenedioic acid;\ncis-9-cis-12-octadecadienedioic acid;\nhexadecanedioic acid;\noctadecanedioic acid\n422-260-8\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n607-676-00-1\nreaction mass of: 2-methylnonanedioic acid;\n2,4-dimethyl-4-methoxycarbonylundecanedioic acid;\n2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;\n8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid\n423-670-1\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n607-677-00-7\n2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate\n424-660-8\n—\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH373**\nH318\nH317\n\n\n\n\n607-678-00-2\nreaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;\nethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate\n427-090-8\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-679-00-8\nreaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate);\n3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate);\n3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate)\n431-440-5\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n607-680-00-3\ntert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{]pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate\n432-810-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-681-00-9\nreaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;\n9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;\ndihexadecyl 9-nonyl-10-octylnonadecandioate;\n1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate;\ndioctadecyl 9-nonyl-10-octylnonadecandioate\n432-910-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-682-00-4\ncomplex reaction mass of Chinese gum rosin post reacted with acrylic acid\n434-230-1\n144413-22-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-683-00-X\nreaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\nmethyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)\n435-450-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n607-684-00-5\nalkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts\n435-660-2\n243662-67-1\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n\n607-685-00-0\nammonium 2-cocoyloxyethanesulfonate\n441-050-7\n—\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n\n607-686-00-6\n6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)\n441-550-5\n—\nSelf-react. C ****\nCarc. 2\nH242\nH351\nGHS02\nGHS08\nDgr\nH242\nH351\n\n\n\n\n607-687-00-1\nreaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);\n2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %)\n442-800-6\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n607-688-00-7\n(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride\n444-320-2\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n607-689-00-2\nreaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (para-isomer including cis- and trans- isomers);\nmethyl 1,3-dimethylcyclohexanecarboxylate (meta-isomer including cis- and trans-isomers)\n444-920-4\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n607-690-00-8\ndimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate\n432-860-1\n255387-46-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n607-691-00-3\nmagnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear\n448-690-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-692-00-9\nzinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear\n446-470-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-693-00-4\nhexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate\n443-860-6\n302776-68-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n607-694-00-X\nethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate\n443-870-0\n163520-33-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n607-696-00-0\npentyl formate\n211-340-6\n638-49-3\nFlam. Liq. 3\nEye Irrit. 2\nSTOT SE 3\nH226\nH319\nH335\nGHS02\nGHS07\nDgr\nH226\nH319\nH335\n\n\nC\n607-697-00-6\ntert-butyl propionate\n—\n20487-40-5\nFlam. Liq. 2\nH225\nGHS02\nDgr\nH225\n\n\nC\n\n607-698-00-1\n4-tert-butylbenzoic acid\n202-696-3\n98-73-7\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4\nH360F\nH372\nH302\nGHS07\nGHS08\nDgr\nH360F\nH372\nH302\n\n\n\n\n608-001-00-3\nacetonitrile;\ncyanomethane\n200-835-2\n75-05-8\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH225\nH332\nH312\nH302\nH319\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\n\n\n\n608-002-00-9\ntrichloroacetonitrile\n208-885-7\n545-06-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH331\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH411\n\n\n\n608-003-00-4\nacrylonitrile\n203-466-5\n107-13-1\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH225\nH350\nH331\nH311\nH301\nH335\nH315\nH318\nH317\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH331\nH311\nH301\nH335\nH315\nH318\nH317\nH411\n\n*\nD\n608-004-00-X\n2-hydroxy-2-methylpropionitrile;\n2-cyanopropan-2-ol;\nacetone cyanohydrin\n200-909-4\n75-86-5\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH410\n\n\n\n\n\n608-005-00-5\nn-butyronitrile\n203-700-6\n109-74-0\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH225\nH331\nH311\nH301\nGHS02\nGHS06\nDgr\nH225\nH331\nH311\nH301\n\n\n\n\n608-006-00-0\nbromoxynil (ISO)\n3,5-dibromo-4-hydroxybenzonitrile;\nbromoxynil phenol\n216-882-7\n1689-84-5\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH330\nH301\nH317\nH410\n\nM = 10\n\n608-007-00-6\nioxynil (ISO)\n4-hydroxy-3,5-diiodobenzonitrile\n216-881-1\n1689-83-4\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH410\n\nM = 10\n\n608-008-00-1\nchloroacetonitrile\n203-467-0\n107-14-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH331\nH311\nH301\nH411\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH411\n\n\n\n608-009-00-7\nmalononitrile\n203-703-2\n109-77-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n608-010-00-2\nmethacrylonitrile;\n2-methyl-2-propene nitrile\n204-817-5\n126-98-7\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nH225\nH331\nH311\nH301\nH317\nGHS02\nGHS06\nDgr\nH225\nH331\nH311\nH301\nH317\n\n*\nSkin Sens. 1; H317: C ≥ 0,2 %\nD\n\n608-011-00-8\noxalonitrile;\ncyanogen\n207-306-5\n460-19-5\nPress. Gas\nFlam. Gas 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH220\nH331\nH400\nH410\nGHS02\nGHS04\nGHS06\nGHS09\nDgr\nH220\nH331\nH410\n\n\nU\n\n608-012-00-3\nbenzonitrile\n202-855-7\n100-47-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nH312\nH302\nGHS07\nWng\nH312\nH302\n\n\n\n608-013-00-9\n2-chlorobenzonitrile\n212-836-5\n873-32-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH312\nH302\nH319\nGHS07\nWng\nH312\nH302\nH319\n\n\n\n\n\n608-014-00-4\nchlorothalonil (ISO);\ntetrachloroisophthalonitrile\n217-588-1\n1897-45-6\nCarc. 2\nAcute Tox. 2 *\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH330\nH335\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH351\nH330\nH335\nH318\nH317\nH410\n\nM=10\n\n\n\n608-015-00-X\ndichlobenil (ISO);\n2,6-dichlorobenzonitrile\n214-787-5\n1194-65-6\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH411\nGHS07\nGHS09\nWng\nH312\nH411\n\n\n\n608-016-00-5\n1,4-Dicyano-2,3,5,6-tetra-chloro-benzene\n401-550-8\n1897-41-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n608-017-00-0\nbromoxynil octanoate (ISO);\n2,6-dibromo-4-cyanophenyl octanoate\n216-885-3\n1689-99-2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH302\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH302\nH317\nH410\n\nM = 10\n\n608-018-00-6\nioxynil octanoate (ISO);\n4-cyano-2,6-diiodophenyl octanoate\n223-375-4\n3861-47-0\nRepr. 2\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH301\nH319\nH317\nH410\n\nM = 10\n\n608-019-00-1\n2,2'-dimethyl-2,2'-azodipropiononitrile;\nADZN\n201-132-3\n78-67-1\nSelf-react. C\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH242\nH332\nH302\nH412\nGHS02\nGHS07\nDgr\nH242\nH332\nH302\nH412\n\n\nT\n\n\n608-020-00-7\ndiphenoxymethylenecyanamide\n427-300-8\n79463-77-7\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n608-021-00-2\n3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile\n403-710-2\n76823-93-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n608-022-00-8\n3,7-dimethyloctanenitrile\n403-620-3\n40188-41-8\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH315\nH317\nH411\n\n\n\n608-023-00-3\nfenbuconazole (ISO);\n4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile\n406-140-2\n114369-43-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-024-00-9\n2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile\n407-650-8\n97460-76-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-025-00-4\n2-nitro-4,5-bis(benzyloxy)phenylacetonitrile\n410-970-0\n117568-27-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-026-00-X\n3-cyano-3,5,5-trimethylcyclohexanone\n411-490-4\n7027-11-4\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH373 **\nH317\nH412\nGHS08\nGHS07\nWng\nH302\nH373 **\nH317\nH412\n\n\n\n608-027-00-5\nreaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;\n3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;\n3-(3-ethylphenyl)-2,2-dimethylpropanenitrile\n412-660-0\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n608-028-00-0\n4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate\n413-510-7\n147374-67-2\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n608-029-00-6\n1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile\n411-990-2\n68612-94-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n608-030-00-1\nN-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide\n412-340-0\n147741-93-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-031-00-7\n2-benzyl-2-methyl-3-butenitrile\n407-870-4\n97384-48-0\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n608-032-00-2\nacetamiprid (ISO);\n(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine\n—\n135410-20-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n608-033-00-8\nN-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide\n407-970-8\n75511-91-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n608-034-00-3\nchlorfenapyr (ISO);\n4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile\n—\n122453-73-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\nM=100\n\n\n608-035-00-9\n(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile\n419-290-9\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n608-036-00-4\n3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile\n419-060-8\n79026-02-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n608-037-00-X\nreaction mass of: (E)-2,12-tridecadiennitrile;\n(E)-3,12-tridecadiennitrile;\n(Z)-3,12-tridecadiennitrile\n422-190-8\n\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-038-00-5\n2,2,4-trimethyl-4-phenyl-butane-nitrile\n422-580-8\n75490-39-0\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n608-039-00-0\n2-phenylhexanenitrile\n423-460-8\n3508-98-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n608-040-00-6\n4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)\n423-490-1\n130755-46-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n608-041-00-1\n4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile\n423-500-4\n138401-24-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n608-042-00-7\n(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide\n421-810-4\n194602-27-2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n\n608-043-00-2\n3-(cis-3-hexenyloxy)propanenitril\n415-220-6\n142653-61-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH302\nH410\n\n\n\n\n\n\n608-044-00-8\n2-cyclohexylidene-2-phenylacetonitrile\n423-740-1\n10461-98-0\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n\n608-046-00-9\n5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile\n425-310-7\n77889-90-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n608-047-00-4\n2-piperidin-1-yl-benzonitrile\n427-330-1\n72752-52-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n608-048-00-X\n1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile\n427-450-4\n152630-47-2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373**\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH411\n\n\n\n\n608-049-00-5\n2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile\n429-180-2\n157362-53-3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n608-050-00-0\nreaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;\n5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile\n429-760-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n608-051-00-6\n(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-760-2\n219861-18-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-052-00-1\n(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-770-7\n128173-52-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-053-00-7\n(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile\n430-780-1\n103146-25-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n608-054-00-2\n(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate\n430-790-6\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n\n608-055-00-8\nfipronil (ISO);\n5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile\n—\n120068-37-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH372**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH372**\nH410\n\nM=10\n\n\n608-056-00-3\nN-methyl-N-cyanomethylmorpholiniummethylsulfate\n429-340-1\n—\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n608-057-00-9\n4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate\n431-200-1\n208538-34-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH318\nH317\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\n\n\n\n\n\n\n608-058-00-4\nesfenvalerate (ISO);\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate\n—\n66230-04-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH317\nH410\n\nM = 10000\n\n\n\n608-059-00-X\n5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile\n421-240-6\n120068-79-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n608-060-00-5\n5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile\n421-300-1\n138564-59-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n608-062-00-6\n2-fluoro-4-hydroxybenzonitrile\n422-810-7\n82380-18-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n608-063-00-1\n(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile\n441-070-6\n61826-76-4\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n\n608-064-00-7\ncyanomethyltrimethylammoniummethylsulfate\n433-720-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n608-065-00-2\nsalts of bromoxynil with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH330\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH330\nH301\nH317\nH410\n\nM = 10\nA\n608-066-00-8\nsalts of ioxynil with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH361d ***\nH331\nH301\nH312\nH373 **\nH319\nH410\n\nM = 10\nA\n609-001-00-6\n1-nitropropane\n203-544-9\n108-03-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n*\n\n609-002-00-1\n2-nitropropane\n201-209-1\n79-46-9\nFlam. Liq. 3\nCarc. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH350\nH332\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH226\nH350\nH332\nH302\n\n\n\n609-003-00-7\nnitrobenzene\n202-716-0\n98-95-3\nCarc. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 2\nH351\nH361f ***\nH331\nH311\nH301\nH372 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH361f ***\nH331\nH311\nH301\nH372 **\nH411\n\n\n\n609-004-00-2\ndinitrobenzene; [1]\n1,4-dinitrobenzene; [2]\n1,3-dinitrobenzene; [3]\n1,2-dinitrobenzene [4]\n246-673-6 [1]\n202-833-7 [2]\n202-776-8 [3]\n208-431-8 [4]\n25154-54-5 [1]\n100-25-4 [2]\n99-65-0 [3]\n528-29-0 [4]\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH410\n\n\n\n\n\n609-005-00-8\n1,3,5-trinitrobenzene\n202-752-7\n99-35-4\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH330\nH310\nH300\nH373**\nH400\nH410\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH410\n\n\n\n\n\n609-006-00-3\n4-nitrotoluene\n202-808-0\n99-99-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n\n\n609-007-00-9\n2,4-dinitrotoluene; [1]\ndinitrotoluene [2]\n204-450-0 [1]\n246-836-1 [2]\n121-14-2 [1]\n25321-14-6 [2]\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH361f***\nH331\nH311\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH331\nH311\nH301\nH373**\nH410\n\n\n\n\n609-008-00-4\n2,4,6-trinitrotoluene;\nTNT\n204-289-6\n118-96-7\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH201\nH331\nH311\nH301\nH373 **\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n\n\n609-009-00-X\n2,4,6-trinitrophenol;\npicric acid\n201-865-9\n88-89-1\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH201\nH331\nH311\nH301\nGHS01\nGHS06\nDgr\nH201\nH331\nH311\nH301\n\n\n\n\n\n609-010-00-5\nsalts of picric acid\n—\n—\nUnst. Expl\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH201\nH331\nH311\nH301\nGHS01\nGHS06\nDgr\nH201\nH331\nH311\nH301\n\n\nT\n609-011-00-0\n2,4,6-trinitroanisole\n—\n606-35-9\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH201\nH332\nH312\nH302\nH411\nGHS01\nGHS07\nGHS09\nWng\nH201\nH332\nH312\nH302\nH411\n\n\n\n609-012-00-6\n2,4,6-trinitro-m-cresol\n210-027-1\n602-99-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nWng\nH201\nH332\nH312\nH302\n\n\n\n609-013-00-1\n2,4,6-trinitro-m-xylene\n211-187-5\n632-92-8\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH201\nH332\nH312\nH302\nH373 **\nGHS01\nGHS08\nGHS07\nWng\nH201\nH332\nH312\nH302\nH373 **\n\n\n\n609-015-00-2\n4-nitrophenol;\np-nitrophenol\n202-811-7\n100-02-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nH332\nH312\nH302\nH373 **\nGHS08\nGHS07\nWng\nH332\nH312\nH302\nH373 **\n\n\n\n609-016-00-8\ndinitrophenol (reaction mass of isomers); [1]\n2,4(or 2,6)-dinitrophenol [2]\n247-096-2 [1]\n275-732-9 [2]\n25550-58-7 [1]\n71629-74-8 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n\n\n\n609-018-00-9\n2,4,6-trinitroresorcinol;\nstyphnic acid\n201-436-6\n82-71-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\n\n\n\n\n609-019-00-4\nlead 2,4,6-trinitro-m-phenylene dioxide;\nlead 2,4,6-trinitroresorcinoxide;\nlead styphnate\n239-290-0\n15245-44-0\nUnst. Expl\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH200\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH200\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n609-019-01-1\nlead 2,4,6-trinitro-m-phenylene dioxide;\nlead 2,4,6-trinitroresorcinoxide;\nlead styphnate (≥ 20 % phlegmatiser)\n239-290-0\n15245-44-0\nExpl. 1.1\nRepr. 1A\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH360Df\nH332\nH302\nH373 **\nH400\nH410\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH360Df\nH332\nH302\nH373 **\nH410\n\n\n1\n609-020-00-X\nDNOC (ISO);\n4,6-dinitro-o-cresol\n208-601-1\n534-52-1\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH330\nH310\nH300\nH315\nH318\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH341\nH330\nH310\nH300\nH315\nH318\nH317\nH410\nEUH044\n\n\n609-021-00-5\nsodium salt of DNOC;\nsodium 4,6-dinitro-o-cresolate; [1]\npotassium salt of DNOC;\npotassium 4,6-dinitro-o-cresolate [2]\n219-007-7 [1]\n- [2]\n2312-76-7 [1]\n5787-96-2 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n609-022-00-0\nammonium salt of DNOC;\nammonium 4,6-dinitro-o-tolyl oxide\n221-037-0\n2980-64-5\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH310\nH300\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH410\n\n\n\n\n\n609-023-00-6\ndinocap (ISO);\n(RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which octyl is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups\n254-408-0\n39300-45-3\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH332\nH302\nH373**\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D***\nH332\nH302\nH373**\nH315\nH317\nH410\n\nM=100\n\n\n609-024-00-1\nbinapacryl (ISO);\n2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate\n207-612-9\n485-31-4\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH312\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D ***\nH312\nH302\nH410\n\n\n\n609-025-00-7\ndinoseb(ISO);\n6-sec-butyl-2,4-dinitrophenol\n201-861-7\n88-85-7\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH311\nH301\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360Df\nH311\nH301\nH319\nH410\nEUH044\n\n\n609-026-00-2\nsalts and esters of dinoseb, with the exception of those specified elsewhere in this Annex\n—\n—\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH311\nH301\nH319\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360Df\nH311\nH301\nH319\nH410\nEUH044\n\nA\n609-027-00-8\ndinocton;\nreaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate\n—\n63919-26-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n609-028-00-3\ndinex (ISO);\n2-cyclohexyl-4,6-dinitrophenol\n205-042-5\n131-89-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n609-029-00-9\nsalts and esters of dinex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\nA\n609-030-00-4\ndinoterb (ISO);\n2-tert-butyl-4,6-dinitrophenol\n215-813-8\n1420-07-1\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360D ***\nH300\nH311\nH410\nEUH044\n\n\n609-031-00-X\nsalts and esters of dinoterb\n—\n—\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH300\nH311\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360D ***\nH300\nH311\nH410\n\n\nA\n609-032-00-5\nbromofenoxim (ISO);\n3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime\n236-129-6\n13181-17-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n609-033-00-0\ndinosam (ISO);\n2-(1-methylbutyl)-4,6-dinitrophenol\n—\n4097-36-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\n\n609-034-00-6\nsalts and esters of dinosam\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH410\n\n\nA\n609-035-00-1\nnitroethane\n201-188-9\n79-24-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH302\n\n*\n\n609-036-00-7\nnitromethane\n200-876-6\n75-52-5\nFlam. Liq. 3\nAcute Tox. 4 *\nH226\nH302\nGHS02\nGHS07\nWng\nH226\nH302\n\n*\n\n609-037-00-2\n5-nitroacenaphthene\n210-025-0\n602-87-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n609-038-00-8\n2-nitronaphthalene\n209-474-5\n581-89-5\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n609-039-00-3\n4-nitrobiphenyl\n202-204-7\n92-93-3\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n609-040-00-9\nnitrofen (ISO);\n2,4-dichlorophenyl 4-nitrophenyl ether\n217-406-0\n1836-75-5\nCarc. 1B\nRepr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH360D ***\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH360D ***\nH302\nH410\n\n\n\n609-041-00-4\n2,4-dinitrophenol\n200-087-7\n51-28-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH311\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH400\n\n\n\n609-042-00-X\npendimethalin (ISO);\nN-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine\n254-938-2\n40487-42-1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-043-00-5\nquintozene (ISO);\npentachloronitrobenzene\n201-435-0\n82-68-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-044-00-0\ntecnazene (ISO);\n1,2,4,5-tetrachloro-3-nitrobenzene\n204-178-2\n117-18-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n609-045-00-6\nreaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;\ndinocton-6\n—\n8069-76-9\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n\n609-046-00-1\ntrifluralin (ISO) (containing < 0,5 ppm NPDA);\nα, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA);\n2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA);\nN,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA)\n216-428-8\n1582-09-8\nCarc. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH317\nH410\n\nM=10\n\n\n609-047-00-7\n2-nitroanisole\n202-052-1\n91-23-6\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n609-048-00-2\nsodium 3-nitrobenzenesulphonate\n204-857-3\n127-68-4\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n609-049-00-8\n2,6-dinitrotoluene\n210-106-0\n606-20-2\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\n\n\n\n609-050-00-3\n2,3-dinitrotoluene\n210-013-5\n602-01-7\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n609-051-00-9\n3,4-dinitrotoluene\n210-222-1\n610-39-9\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-052-00-4\n3,5-dinitrotoluene\n210-566-2\n618-85-9\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH412\n\n\n\n609-053-00-X\nhydrazine-trinitromethane\n414-850-9\n—\nExpl. 1.1 ****\nSelf-react. A\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nH201\nH240\nH350\nH331\nH301\nH317\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH240\nH350\nH331\nH301\nH317\n\n\n\n609-054-00-5\n2,3-dinitrophenol; [1]\n2,5-dinitrophenol; [2]\n2,6-dinitrophenol; [3]\n3,4-dinitrophenol; [4]\nsalts of dinitrophenol [5]\n200-628-7 [1]\n206-348-1 [2]\n209-357-9 [3]\n209-415-3 [4]\n- [5]\n66-56-8 [1]\n329-71-5 [2]\n573-56-8 [3]\n577-71-9 [4]\n- [5]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-055-00-0\n2,5-dinitrotoluene\n210-581-4\n619-15-8\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f ***\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n609-056-00-6\n2,2-dibromo-2-nitroethanol\n412-380-9\n69094-18-4\nExpl. 1.1\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH351\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS01\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH201\nH351\nH302\nH373 **\nH314\nH317\nH410\n\n*\nSTOT SE 3; H335: C ≥ 1 %\nT\n609-057-00-1\n3-chloro-2,4-difluoronitrobenzene\n411-980-8\n3847-58-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n609-058-00-7\n2-nitro-2-phenyl-1,3-propanediol\n410-360-4\n5428-02-4\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH312\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH312\nH302\nH317\nH411\nEUH070\n\n\n609-059-00-2\n2-chloro-6-(ethylamino)-4-nitrophenol\n411-440-1\n131657-78-8\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n609-060-00-8\n4-[(3-hydroxypropyl)amino]-3-nitrophenol\n406-305-9\n92952-81-3\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n609-061-00-3\n(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime\n406-100-4\n94097-88-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n609-062-00-9\n2-bromo-2-nitropropanol\n407-030-7\n24403-04-1\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH311\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH311\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n609-063-00-4\n2-[(4-chloro-2-nitrophenyl)amino]ethanol\n413-280-8\n59320-13-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n609-064-00-X\nmesotrione(ISO);\n2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione\n—\n104206-82-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n609-065-00-5\n2-nitrotoluene\n201-853-3\n88-72-2\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH340\nH361f ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH340\nH361f ***\nH302\nH411\n\n\n\n609-066-00-0\nlithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate\n418-870-9\n154212-58-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 2 **\nH332\nH312\nH302\nH371 **\nGHS08\nGHS07\nDgr\nH332\nH312\nH302\nH371 **\n\n\n\n609-067-00-6\nsodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine\n416-280-6\n156769-97-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n609-068-00-1\nmusk xylene;\n5-tert-butyl-2,4,6-trinitro-m-xylene\n201-329-4\n81-15-2\nExpl. 1.1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH351\nH400\nH410\nGHS01\nGHS08\nGHS09\nWng\nH201\nH351\nH410\n\n\nT\n\n\n609-069-00-7\nmusk ketone;\n3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;\n4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone\n201-328-9\n81-14-1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n\n609-070-00-2\n1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene\n415-580-4\n130841-23-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n609-071-00-8\nreaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;\n2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol\n423-520-3\n156137-33-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n609-072-00-3\n4-mesyl-2-nitrotoluene\n430-550-0\n1671-49-4\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH361f***\nH302\nH317\nH412\nGHS08\nGHS07\nWng\nH361f***\nH302\nH317\nH412\n\n\n\n\n\n\n609-073-00-9\nlithium potassium sodium N,N''-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N'-(2-aminoethyl)piperazine\n427-850-9\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n610-001-00-3\ntrichloronitromethane;\nchloropicrin\n200-930-9\n76-06-2\nAcute Tox. 2 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH330\nH302\nH319\nH335\nH315\nGHS06\nDgr\nH330\nH302\nH319\nH335\nH315\n\n\n\n610-002-00-9\n1,1-dichloro-1-nitroethane\n209-854-0\n594-72-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\n\n610-003-00-4\nchlorodinitrobenzene\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\nC\n610-004-00-X\n2-chloro-1,3,5-trinitrobenzene\n201-864-3\n88-88-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH330\nH310\nH300\nH400\nH410\nGHS01\nGHS06\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH410\n\n\n\n610-005-00-5\n1-chloro-4-nitrobenzene\n202-809-6\n100-00-5\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH351\nH341\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n610-006-00-0\nchloronitroanilines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH411\n\n\nA C\n610-007-00-6\n1-chloro-1-nitropropane\n209-990-0\n600-25-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n*\n\n610-008-00-1\n2,6-dichloro-4-nitroanisole\n403-350-6\n17742-69-7\nAcute Tox. 3 *\nAquatic Chronic 2\nH301\nH411\nGHS06\nGHS09\nDgr\nH301\nH411\n\n\n\n610-009-00-7\n2-chloro-4-nitroaniline\n204-502-2\n121-87-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n610-010-00-2\n2-bromo-1-(2-furyl)-2-nitroethylene\n406-110-9\n35950-52-8\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH314\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH314\nH317\nH410\n\n\n\n611-001-00-6\nazobenzene\n203-102-5\n103-33-3\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH332\nH302\nH373 **\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH332\nH302\nH373 **\nH410\n\n\n\n611-002-00-1\nazoxybenzene\n207-802-1\n495-48-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH302\nGHS07\nWng\nH332\nH302\n\n\n\n611-003-00-7\nfenaminosulf (ISO);\nsodium 4-dimethylaminobenzenediazosulphonate\n205-419-4\n140-56-7\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH301\nH312\nH412\nGHS06\nDgr\nH301\nH312\nH412\n\n\n\n611-004-00-2\nmethyl-ONN-azoxymethyl acetate;\nmethyl azoxy methyl acetate\n209-765-7\n592-62-1\nCarc. 1B\nRepr. 1B\nH350\nH360D ***\nGHS08\nDgr\nH350\nH360D ***\n\n\n\n611-005-00-8\ndisodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);\nCI Direct Brown 95\n240-221-1\n16071-86-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-006-00-3\n4-o-tolylazo-o-toluidine;\n4-amino-2',3-dimethylazobenzene;\nfast garnet GBC base;\nAAT;\no-aminoazotoluene\n202-591-2\n97-56-3\nCarc. 1B\nSkin Sens. 1\nH350\nH317\nGHS08\nDgr\nH350\nH317\n\n\n\n611-007-00-9\ntricyclazole (ISO);\n5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;\n255-559-5\n41814-78-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n611-008-00-4\n4-aminoazobenzene;\n4-phenylazoaniline\n200-453-6\n60-09-3\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n611-009-00-X\nsodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)\n401-220-3\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH412\nGHS07\nWng\nH332\nH412\n\n\n\n611-010-00-5\n2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide\n403-010-7\n106359-94-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n611-011-00-0\nN,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate\n403-340-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDg\nH318\nH411\n\n\n\n611-012-00-6\nreaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate\n403-410-1\n114565-65-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-013-00-1\ntrilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate\n403-650-7\n117409-78-6\nExpl. 1.3 ****\nAquatic Chronic 2\nH203\nH411\nGHS01\nGHS09\nDgr\nH203\nH411\n\n\n\n611-014-00-7\n(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide\n404-250-5\n115099-55-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-015-00-2\ntetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate\n404-320-5\n116889-78-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-016-00-8\nreaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride\n404-540-1\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-017-00-3\n2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide\n404-910-2\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-018-00-9\ntetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate\n405-130-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-019-00-4\ntetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate\n405-150-4\n106028-58-4\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-020-00-X\ntetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate\n405-170-3\n116340-05-7\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH317\nH412\nGHS06\nDgr\nH301\nH317\nH412\n\n\n\n611-021-00-5\n2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate\n405-480-9\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Chronic 4\nH302\nH373 **\nH315\nH413\nGHS08\nGHS07\nWng\nH302\nH373 **\nH315\nH413\n\n\n\n611-022-00-0\n4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate\n404-980-4\n—\nSelf-react. C\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH331\nH301\nH312\nH373 **\nH318\nH317\nH400\nH410\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH242\nH331\nH301\nH312\nH373 **\nH318\nH317\nH410\n\n\nT\n611-023-00-6\ndisodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate\n404-600-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-024-00-1\nBenzidine based azo dyes;\n4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA\n611-025-00-7\ndisodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;\nC.I. Direct Black 38\n217-710-3\n1937-37-7\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n611-026-00-2\ntetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];\nC.I. Direct Blue 6\n220-012-1\n2602-46-2\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n611-027-00-8\ndisodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);\nC.I. Direct Red 28\n209-358-4\n573-58-0\nCarc. 1B\nRepr. 2\nH350\nH361d ***\nGHS08\nDgr\nH350\nH361d ***\n\n\n\n\n611-028-00-3\nC,C'-azodi(formamide)\n204-650-8\n123-77-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\nG\n\n\n611-029-00-9\no-dianisidine based azo dyes;\n4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA H\n611-030-00-4\no-tolidine based dyes;\n4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex\n—\n—\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nA H\n611-031-00-X\n4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;\nC.I. Basic Red 9\n209-321-2\n569-61-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-032-00-5\n1,4,5,8-tetraaminoanthraquinone;\nC.I. Disperse Blue 1\n219-603-7\n2475-45-8\nCarc. 1B\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nH350\nH315\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH350\nH315\nH318\nH317\n\n\n\n611-033-00-0\nhexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)\n400-020-3\n82027-60-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-034-00-6\nN-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide\n402-430-8\n105076-77-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n611-035-00-1\ntetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate\n403-660-1\n107246-80-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-036-00-7\n2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate\n405-440-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-037-00-2\n3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate\n406-055-0\n124584-00-5\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n611-038-00-8\ntrisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate\n406-820-9\n—\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n611-039-00-3\n7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid\n407-050-6\n117715-57-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-040-00-9\n3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid\n407-670-7\n115099-58-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-041-00-4\n2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide\n407-680-1\n98809-11-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n611-042-00-X\ntrisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate\n411-770-6\n136213-71-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-043-00-5\nreaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;\ntrisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;\ntrisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)\n402-850-1\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-044-00-0\nreaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);\ntert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);\ntert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);\ntert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)\n403-720-7\n117527-94-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-045-00-6\n2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene\n404-830-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-046-00-1\n4,4'-diamino-2-methylazobenzene\n407-590-2\n43151-99-1\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH410\n\n\n\n611-047-00-7\nreaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;\n2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)\n407-890-3\n111381-11-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-048-00-2\nreaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;\n2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)\n407-900-6\n111381-12-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-049-00-8\nreaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)\n408-000-6\n118658-98-3\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373 **\nH317\nH412\nGHS08\nWng\nH373 **\nH317\nH412\n\n\n\n\n\n\n611-050-00-3\nreaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;\npentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;\npentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;\ntetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;\ntetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate\n415-350-3\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-051-00-9\n2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride\n411-110-7\n136213-74-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-052-00-4\nmonosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex\n400-720-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-053-00-X\n2,2'-azobis[2-methylpropionamidine] dihydrochloride\n221-070-0\n2997-92-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n611-055-00-0\nC.I. Disperse Yellow 3;\nN-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide\n220-600-8\n2832-40-8\nCarc. 2\nSkin Sens. 1\nH351\nH317\nGHS08\nGHS07\nWng\nH351\nH317\n\n\n\n611-056-00-6\nC.I. Solvent Yellow 14;\n1-phenylazo-2-naphthol\n212-668-2\n842-07-9\nCarc. 2\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH341\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH341\nH317\nH413\n\n\n\n611-057-00-1\n6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile\n400-340-3\n85136-74-9\nCarc. 1B\nAquatic Chronic 4\nH350\nH413\nGHS08\nWng\nH350\nH413\n\n\n\n611-058-00-7\n(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate\n402-060-7\n108225-03-2\nCarc. 1B\nEye Dam. 1\nAquatic Chronic 2\nH350\nH318\nH411\nGHS08\nGHS05\nGHS09\nDgr\nH350\nH318\nH411\n\n\n\n611-059-00-2\noctasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate\n412-960-1\n148878-21-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n611-060-00-8\nreaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;\nammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;\n5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid\n413-180-4\n187285-15-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-061-00-3\ndisodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate\n412-530-3\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-062-00-9\noctasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate\n413-550-5\n—\nSkin Irrit. 2\nEye Dam. 1\nH315\nH318\nGHS05\nDgr\nH315\nH318\n\n\n\n611-063-00-4\ntrisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)\n413-590-3\n164058-22-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n611-064-00-X\n4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol\n410-600-8\n124719-26-2\nSTOT RE 2 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH315\nH410\n\n\n\n611-065-00-5\n4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol\n410-610-2\n111850-24-9\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH319\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH319\nH315\nH317\nH410\n\n\n\n611-066-00-0\ntetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate\n411-540-5\n130201-57-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n\n\n611-067-00-6\nreaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;\nbis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate\n406-910-8\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n611-068-00-1\ntetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate\n400-690-7\n85665-98-1\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-069-00-7\nN,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline\n413-380-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-070-00-2\nreaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);\ntrisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)\n405-665-4\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n611-071-00-8\ntris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate\n406-073-9\n131013-81-5\nAcute Tox. 3 *\nAquatic Chronic 3\nH301\nH412\nGHS06\nDgr\nH301\nH412\n\n\n\n611-072-00-3\n2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride\n407-010-8\n118208-02-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n611-073-00-9\ndimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate\n407-310-9\n122630-55-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-074-00-4\nreaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);\nsodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)\n407-100-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-075-00-X\nreaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;\ntris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)\n406-000-0\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-076-00-5\n3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole\n406-280-4\n117584-16-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n611-077-00-0\ndilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)\n407-230-4\n126637-70-5\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n611-078-00-6\n(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate\n407-240-9\n159604-94-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-079-00-1\ndisodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate\n410-390-8\n147703-64-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-080-00-7\nsodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate\n410-150-2\n147703-65-9\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-081-00-2\ntetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)\n411-470-5\n141048-13-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n611-082-00-8\nreaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);\npentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)\n407-570-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-083-00-3\nreaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;\n2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)\n411-560-4\n—\nSTOT RE 1\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH317\nH411\n\n\n\n\n\n611-084-00-9\nreaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;\nN-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide\n412-550-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n611-085-00-4\nreaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;\n3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine\n411-880-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-086-00-X\nmonolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate\n411-360-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-087-00-5\nreaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;\n3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)\n411-710-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-088-00-0\nreaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;\ntrilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate\n411-890-9\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n611-089-00-6\n2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate\n411-100-2\n136213-73-5\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH373 **\nH317\nH410\n\n\n\n611-090-00-1\n2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate\n413-290-2\n93672-52-7\nSelf-react. C\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH242\nH302\nH318\nH317\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH302\nH318\nH317\nH412\n\n\nT\n611-091-00-7\nsodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate\n413-470-0\n134595-59-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-092-00-2\ntert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate\n413-210-6\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-093-00-8\nsodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate\n410-770-3\n146177-84-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-094-00-3\nreaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;\n2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)\n411-600-0\n143145-93-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-095-00-9\nhexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide\n412-240-7\n89797-03-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-096-00-4\nmethyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate\n413-040-2\n149850-30-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-097-00-X\nreaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)\n414-150-3\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-098-00-5\ntetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate\n405-950-3\n131013-83-7\nAcute Tox. 3 *\nAquatic Chronic 3\nH301\nH412\nGHS06\nDgr\nH301\nH412\n\n\n\n611-099-00-0\n(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride\n401-500-5\n118658-99-4\nCarc. 1B\nAquatic Chronic 2\nH350\nH411\nGHS08\nGHS09\nDgr\nH350\nH411\n\n\n\n611-100-00-4\npotassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate\n403-810-6\n140876-13-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-101-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide\n405-200-5\n104366-25-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n611-102-00-5\nreaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[}benzendiazoniumchlorid;\ndisodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{]phenylsulfonylamino[}benzen-diazoniumchlorid\n424-500-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n\n611-103-00-0\ntrisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)\n407-110-1\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n611-104-00-6\nreaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);\ntrisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);\ntrisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);\ntrisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);\ndisodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate\n406-870-1\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-105-00-1\nsodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate\n407-800-2\n136213-75-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-106-00-7\nhexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate\n410-180-6\n157627-99-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-107-00-2\npotassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate\n412-490-7\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-108-00-8\ndisodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate\n413-600-6\n6527-62-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n611-109-00-3\nreaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)\n407-710-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-110-00-9\ntetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene\n408-210-8\n124605-82-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n611-111-00-4\ndisodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)\n414-230-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-112-00-X\ntetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate\n413-070-6\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-113-00-5\nlithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)\n414-280-0\n149626-00-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n611-114-00-0\nlithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)\n414-250-7\n149564-66-9\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n611-115-00-6\ntrilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)\n414-290-5\n149564-65-8\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n611-116-00-1\nreaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;\ntrisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate\n414-620-8\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-117-00-7\n1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt\n415-100-3\n149850-29-3\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-118-00-2\nsodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt\n413-990-8\n\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n611-119-00-8\ntetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate\n415-400-4\n148878-22-2\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-120-00-3\n5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt\n418-340-7\n157707-94-3\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-121-00-9\nmain component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;\nmain component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol\n417-280-9\n30785-74-1\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n611-122-00-4\nhexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel\n417-250-5\n151436-99-6\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-123-00-X\n3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate\n424-310-4\n178452-66-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n611-124-00-5\nreaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;\npentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;\ntetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate\n424-320-9\n\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-125-00-0\nreaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;\nDisodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex\n423-940-7\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-126-00-6\n2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride\n424-120-1\n174514-06-8\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n611-127-00-1\npentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate\n423-790-2\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\nG\n611-128-00-7\nN,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt\n419-500-9\n171599-85-2\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n611-129-00-2\nreaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;\n5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid\n418-230-9\n163879-69-4\nExpl. 1.3 ****\nRepr. 2\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH203\nH361f ***\nH373 **\nH317\nH411\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH203\nH361f ***\nH373 **\nH317\nH411\n\n\n\n\n\n611-130-00-8\ntetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate\n418-520-5\n183130-96-3\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-131-00-3\n2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one\n420-580-2\n151798-26-4\nRepr. 1B\nAquatic Chronic 4\nH360D ***\nH413\nGHS08\nDgr\nH360D ***\nH413\n\n\n\n611-132-00-9\npentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-210-2\n178452-71-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-133-00-4\nProduct by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt\n419-260-5\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-134-00-X\ntrisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex\n423-770-3\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n611-135-00-5\nreaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt\n424-250-9\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n611-136-00-0\n2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate\n424-260-3\n—\nRepr. 2\nEye Dam. 1\nAquatic Chronic 2\nH361f ***\nH318\nH411\nGHS05\nGHS08\nGHS09\nDgr\nH361f ***\nH318\nH411\n\n\n\n611-137-00-6\n6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole\n419-870-1\n159038-16-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n611-138-00-1\n2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole\n415-910-7\n152828-25-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n611-139-00-7\nreaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride\n424-510-1\n—\nEye Dam. 1\nAquatic Chronic 2\nH318\nH411\nGHS05\nGHS09\nDgr\nH318\nH411\n\n\n\n\n611-140-00-2\nazafenidin (ISO);\n2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one\n—\n68049-83-2\nRepr. 1B\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360Df\nH373 **\nH400\nH410\nGHS08\nGHS09\nDgr\nH360Df\nH373 **\nH410\n\nM = 1000\n\n\n\n611-141-00-8\n5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt\n414-410-6\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-142-00-3\nproduct-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;\nsodium chloride\n425-740-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-143-00-9\nreaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);\ntrisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)\n428-260-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-144-00-4\nreaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;\n7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;\n7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;\n7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt\n429-070-4\n214362-06-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-145-00-X\nreaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate;\n3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt\n429-440-5\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-146-00-5\nreaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;\npentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;\npentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;\nhexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate\n430-070-1\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-147-00-0\nsodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate\n430-090-0\n205764-96-1\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-148-00-6\nreaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;\n2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;\n3-(2,6-dichloro-4-nitrophenylazo)carbazol\n429-590-1\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n611-149-00-1\n2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate\n427-570-7\n193486-83-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n611-150-00-7\ntetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate\n440-460-3\n—\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-151-00-2\nchrysoidine;\n4-(phenylazo)benzene-1,3-diamine\n207-803-7\n495-54-5\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH315\nH410\n\n\n\n\n611-152-00-8\nchrysoidine monohydrochloride;\n4-phenylazophenylene-1,3-diamine monohydrochloride; [1]\nchrysoidine monoacetate;\n4-(phenylazo)benzene-1,3-diamine monoacetate; [2]\nchrysoidine acetate;\n4-(phenylazo)benzene-1,3-diamine acetate; [3]\nchrysoidine-p-dodecylbenzenesulfonate;\ndodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]\nchrysoidine dihydrochloride;\n4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]\nchrysoidine sulfate;\nbis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]\n208-545-8 [1]\n278-290-5 [2]\n279-116-0 [3]\n264-409-8 [4]\n281-549-5 [5]\n282-432-1 [6]\n532-82-1 [1]\n75660-25-2 [2]\n79234-33-6 [3]\n63681-54-9 [4]\n83968-67-6 [5]\n84196-22-5 [6]\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH315\nH318\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH341\nH302\nH315\nH318\nH410\n\n\n\n\n611-153-00-3\nchrysoidine C10-14-alkyl derivatives;\nbenzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]\nchrysoidine compound with dibutylnaphthalene sulfonic acid;\ndibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]\n286-946-7 [1]\n304-236-8 [2]\n85407-90-5 [1]\n94247-67-3 [2]\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH341\nH302\nH315\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH302\nH315\nH318\n\n\n\n\n611-154-00-9\ntrisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate\n403-670-6\n92408-46-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-155-00-4\n4,4'-oxybis(benzenesulfonylazide)\n431-850-4\n7456-68-0\nExpl. 1.1****\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH201\nH373**\nH400\nH410\nGHS01\nGHS08\nGHS09\nDgr\nH201\nH373**\nH410\n\n\n\n\n611-156-00-X\ntriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate\n432-270-4\n221354-37-6\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH361f***\nH373**\nH411\nGHS08\nGHS09\nWng\nH361f***\nH373**\nH411\n\n\n\n\n611-157-00-5\nbenzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;\npotassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate\n432-590-4\n243869-48-9\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n\n611-158-00-0\nreaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride\n421-520-8\n—\n****\nAquatic Chronic 4\n****\nH413\n****\n****\nH413\n\n\n\n\n611-159-00-6\ndisodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate\n421-880-6\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-160-00-1\nreaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;\n1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;\nreaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);\nreaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)\n422-760-6\n—\n****\nAquatic Chronic 4\n****\nH413\n****\n****\nH413\n\n\n\n\n611-161-00-7\ntrisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)\n423-100-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-162-00-2\n2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)\n429-600-4\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n611-163-00-8\n2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate\n429-610-9\n—\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 2\nH302\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH411\n\n\n\n\n611-164-00-3\nreaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;\n2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);\n2,2’-dimethyl-2,2’-azoheptanenitrile;\n2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);\n2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)\n429-710-2\n—\nSelf-react. D\nAcute Tox. 4 *\nAquatic Chronic 2\nH242\nH302\nH411\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH302\nH411\n\n\n\n\n\n611-165-00-9\nreaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate\n431-830-5\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-166-00-4\nreaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate\n432-100-9\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-167-00-X\nsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)\n435-240-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-168-00-5\nreaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;\n3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid\n435-440-6\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-169-00-0\nsodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate\n435-800-2\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-170-00-6\nreaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);\ndisodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)\n435-880-9\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n611-171-00-1\nreaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;\ntrisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate\n436-890-6\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-172-00-7\nreaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;\ndiammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate\n438-310-7\n—\nSelf-react. C****\nRepr. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH242\nH361f***\nH302\nH373**\nH412\nGHS02\nGHS08\nGHS07\nDgr\nH242\nH361f***\nH302\nH373**\nH412\n\n\n\n\n611-173-00-2\nreaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;\n3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt\n440-510-4\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-174-00-8\nreaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;\n3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt\n442-290-5\n457624-86-1\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n611-175-00-3\nreaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntrisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ndisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;\ntetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate\n444-050-5\n—\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n611-176-00-9\n2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate\n444-250-2\n—\nSelf-react. C****\nAquatic Chronic 2\nH242\nH411\nGHS02\nGHS09\nDgr\nH242\nH411\n\n\n\n\n611-177-00-4\nreaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);\ntetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);\ntrisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)\n444-290-0\n508202-43-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n611-178-00-X\nreaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;\ntrisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate\n445-280-9\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n611-179-00-5\nreaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;\n2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate\n450-010-8\n—\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n611-180-00-0\niron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts\n417-850-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-001-00-9\nmono-methylamine; [1]\ndi-methylamine; [2]\ntri-methylamine [3]\n200-820-0 [1]\n204-697-4 [2]\n200-875-0 [3]\n74-89-5 [1]\n124-40-3 [2]\n75-50-3 [3]\nFlam. Gas 1\nPress. Gas\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH220\nH332\nH335\nH315\nH318\nGHS02\nGHS04\nGHS05\nGHS07\nDgr\nH220\nH332\nH335\nH315\nH318\n\n*\nSkin Irrit. 2; H315: C ≥ 5 %\nEye Dam. 1; H318: C ≥ 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 5 %\nSTOT SE 3; H335: C ≥ 5 %\nU5\n612-001-01-6\nmono-methylamine ... %; [1]\ndi-methylamine ... %; [2]\ntri-methylamine ... % [3]\n200-820-0 [1]\n204-697-4 [2]\n200-875-0 [3]\n74-89-5 [1]\n124-40-3 [2]\n75-50-3 [3]\nFlam. Liq. 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH224\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH224\nH332\nH302\nH314\n\n*\nSTOT SE 3; H335: C ≥ 5 %\nB\n612-002-00-4\nethylamine\n200-834-7\n75-04-7\nFlam. Gas 1\nPress. Gas\nEye Irrit. 2\nSTOT SE 3\nH220\nH319\nH335\nGHS02\nGHS04\nGHS07\nDgr\nH220\nH319\nH335\n\n\nU\n612-003-00-X\ndiethylamine\n203-716-3\n109-89-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-004-00-5\ntriethylamine\n204-469-4\n121-44-8\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-005-00-0\nbutylamine\n203-699-2\n109-73-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-006-00-6\nethylenediamine;\n1,2-diaminoethane\n203-468-6\n107-15-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH226\nH312\nH302\nH314\nH334\nH317\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\nH334\nH317\n\n\n\n612-007-00-1\n2-aminopropane;\nisopropylamine\n200-860-9\n75-31-0\nFlam. Liq. 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH224\nH319\nH335\nH315\nGHS02\nGHS07\nDgr\nH224\nH319\nH335\nH315\n\n\n\n612-008-00-7\naniline\n200-539-3\n62-53-3\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\n\n*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤ C < 1 %\n\n612-009-00-2\nsalts of aniline\n—\n—\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH351\nH341\nH331\nH311\nH301\nH372 **\nH318\nH317\nH400\n\n*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,2 % ≤ C < 1 %\nA\n612-010-00-8\nchloroanilines (with exception of those specified elsewhere in this Annex)\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\nC\n612-011-00-3\n4-nitrosoaniline\n211-535-6\n659-49-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-012-00-9\no-nitroaniline; [1]\nm-nitroaniline; [2]\np-nitroaniline [3]\n201-855-4 [1]\n202-729-1 [2]\n202-810-1 [3]\n88-74-4 [1]\n99-09-2 [2]\n100-01-6 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n\nC\n612-013-00-4\n3-aminobenzene sulphonic acid;\nmetanilic acid\n204-473-6\n121-47-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-014-00-X\nsulphanilic acid;\n4-aminobenzenesulphonic acid\n204-482-5\n121-57-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH315\nH317\nGHS07\nWng\nH319\nH315\nH317\n\n\n\n612-015-00-5\nN-methylaniline\n202-870-9\n100-61-8\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n612-016-00-0\nN,N-dimethylaniline\n204-493-5\n121-69-7\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH351\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH311\nH301\nH411\n\n\n\n\n\n\n612-017-00-6\nN-methyl-N-2,4,6-tetranitroaniline;\ntetryl\n207-531-9\n479-45-8\nExpl. 1.1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2\nH201\nH331\nH311\nH301\nH373**\nGHS01\nGHS06\nGHS08\nDgr\nH201\nH331\nH311\nH301\nH373**\n\n\n\n\n612-018-00-1\nbis(2,4,6-trinitrophenyl)amine;\nhexyl\n205-037-8\n131-73-7\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373**\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH411\n\n\n\n\n612-019-00-7\ndipicrylamine, ammonium salt\n220-639-0\n2844-92-0\nExpl. 1.1\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2\nAquatic Chronic 2\nH201\nH330\nH310\nH300\nH373**\nH411\nGHS01\nGHS06\nGHS08\nGHS09\nDgr\nH201\nH330\nH310\nH300\nH373**\nH411\n\n\n\n\n612-020-00-2\n1-naphthylamine\n205-138-7\n134-32-7\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n612-022-00-3\n2-naphthylamine\n202-080-4\n91-59-8\nCarc. 1A\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\nCarc. 1A; H350: C ≥ 0,01 %\n\n612-023-00-9\nphenylhydrazine; [1]\nphenylhydrazinium chloride; [2]\nphenylhydrazine hydrochloride; [3]\nphenylhydrazinium sulphate (2:1) [4]\n202-873-5 [1]\n200-444-7 [2]\n248-259-0 [3]\n257-622-2 [4]\n100-63-0 [1]\n59-88-1 [2]\n27140-08-5 [3]\n52033-74-6 [4]\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH350\nH341\nH331\nH311\nH301\nH372 **\nH319\nH315\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH331\nH311\nH301\nH372 **\nH319\nH315\nH317\nH400\n\n\n\n612-024-00-4\nm-toluidine;\n3-aminotoluene\n203-583-1\n108-44-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nH331\nH311\nH301\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH400\n\n\n\n612-025-00-X\nnitrotoluidines, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\nC\n612-026-00-5\ndiphenylamine\n204-539-4\n122-39-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH373 **\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH410\n\n\n\n612-027-00-0\nxylidines with the exception of those specified elsewhere in this Annex;\ndimethyl anilines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\nC\n612-028-00-6\np-phenylenediamine\n203-404-7\n106-50-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-029-00-1\nbenzene-1,4-diamine dihydrochloride;\np-phenylenediamine dihydrochloride\n210-834-9\n624-18-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-030-00-7\n2-methyl-p-phenylenediamine sulphate [1]\n210-431-8 [1]\n228-871-4 [2]\n615-50-9 [1]\n6369-59-1 [2]\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH332\nH312\nH317\nH411\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH411\n\n\n\n612-031-00-2\nN,N-dimethylbenzene-1,3-diamine; [1]\n4-amino-N,N-dimethylaniline;\n3-amino-N,N'-dimethylaniline [2]\n220-623-3 [1]\n202-807-5 [2]\n2836-04-6 [1]\n99-98-9 [2]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH331\nH311\nH301\nGHS06\nDgr\nH331\nH311\nH301\n\n\nC\n612-032-00-8\nN,N,N',N'-tetramethyl-p-phenylenediamine\n202-831-6\n100-22-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n612-033-00-3\n2-aminophenol\n202-431-1\n95-55-6\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nH341\nH332\nH302\nGHS08\nGHS07\nWng\nH341\nH332\nH302\n\n\n\n\n\n612-034-00-9\n2-amino-4,6-dinitrophenol;\npicramic acid\n202-544-6\n96-91-3\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH201\nH332\nH312\nH302\nH412\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\nH412\n\n\n\n\n612-034-01-6\n2-amino-4,6-dinitrophenol;\npicramic acid;\n[≥ 20 % water]\n202-544-6\n96-91-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\n\n\nG\n612-035-00-4\n2-methoxyaniline;\no-anisidine\n201-963-1\n90-04-0\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nH350\nH341\nH331\nH311\nH301\nGHS06\nGHS08\nDgr\nH350\nH341\nH331\nH311\nH301\n\n\n\n612-036-00-X\n3,3'-dimethoxybenzidine;\no-dianisidine\n204-355-4\n119-90-4\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-037-00-5\nsalts of 3,3'-dimethoxybenzidine;\nsalts of o-dianisidine\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\nA\n612-038-00-0\n2-nitro-p-anisidine;\n4-methoxy-2-nitroaniline\n202-547-2\n96-96-8\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 3\nH330\nH310\nH300\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH330\nH310\nH300\nH373 **\nH412\n\n\n\n612-039-00-6\n2-ethoxyaniline;\no-phenetidine\n202-356-4\n94-70-2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH311\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\n\n\n\n612-040-00-1\n2,4-dinitroaniline\n202-553-5\n97-02-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH411\n\n\n\n612-041-00-7\n4,4'-bi-o-toluidine\n204-358-0\n119-93-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\n\n612-042-00-2\nbenzidine;\n1,1'-biphenyl-4,4'-diamine;\n4,4'-diaminobiphenyl;\nbiphenyl-4,4'-ylenediamine\n202-199-1\n92-87-5\nCarc. 1A\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\nCarc. 1A; H350: C ≥ 0,01 %\n\n612-043-00-8\nN,N'-dimethylbenzidine\n—\n2810-74-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH332\nH312\nH302\nGHS07\nWng\nH332\nH312\nH302\n\n\n\n\n\n612-044-00-3\nN,N'-diacetylbenzidine\n210-338-2\n613-35-4\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH350\nH341\nH332\nH312\nH302\nGHS08\nGHS07\nDgr\nH350\nH341\nH332\nH312\nH302\n\n\n\n\n612-046-00-4\nallylamine\n203-463-9\n107-11-9\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH225\nH331\nH311\nH301\nH411\nGHS02\nGHS06\nGHS09\nDgr\nH225\nH331\nH311\nH301\nH411\n\n\n\n612-047-00-X\nbenzylamine\n202-854-1\n100-46-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n612-048-00-5\ndipropylamine\n205-565-9\n142-84-7\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 1 %\n\n612-049-00-0\ndi-n-butylamine; [1]\ndi-sec-butylamine [2]\n203-921-8 [1]\n210-937-9 [2]\n111-92-2 [1]\n626-23-3 [2]\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH226\nH332\nH312\nH302\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\n\n\n\n\n\n\n612-050-00-6\ncyclohexylamine\n203-629-0\n108-91-8\nFlam. Liq. 3\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH361f***\nH312\nH302\nH314\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH361f***\nH312\nH302\nH314\n\n\n\n\n612-051-00-1\n4,4'-diaminodiphenylmethane;\n4,4'-methylenedianiline\n202-974-4\n101-77-9\nCarc. 1B\nMuta. 2\nSTOT SE 1\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH370 **\nH373 **\nH317\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH370 **\nH373 **\nH317\nH411\n\n\n\n612-052-00-7\n(S)-sec-butylamine;\n(S)-2-aminobutane; [1]\n(R)-sec-butylamine;\n(R)-2-aminobutane; [2]\nsec-butylamine;\n2-aminobutane [3]\n208-164-7 [1]\n236-232-6 [2]\n237-732-7 [3]\n513-49-5 [1]\n13250-12-9 [2]\n13952-84-6 [3]\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH225\nH332\nH302\nH314\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH225\nH332\nH302\nH314\nH400\n\n\nC\n612-053-00-2\nN-ethylaniline\n203-135-5\n103-69-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH311\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\n\n\n\n612-054-00-8\nN,N-diethylaniline\n202-088-8\n91-66-7\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n*\n\n612-055-00-3\nN-methyl-o-toluidine; [1]\nN-methyl-m-toluidine; [2]\nN-methyl-p-toluidine [3]\n210-260-9 [1]\n211-795-0 [2]\n210-769-6 [3]\n611-21-2 [1]\n696-44-6 [2]\n623-08-5 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n\nC\n612-056-00-9\nN,N-dimethyl-p-toluidine; [1]\nN,N-dimethyl-m-toluidine; [2]\nN,N-dimethyl-o-toluidine [3]\n202-805-4 [1]\n204-495-6 [2]\n210-199-8 [3]\n99-97-8 [1]\n121-72-2 [2]\n609-72-3 [3]\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 3\nH331\nH311\nH301\nH373 **\nH412\nGHS06\nGHS08\nDgr\nH331\nH311\nH301\nH373 **\nH412\n\n*\nC\n\n\n612-057-00-4\npiperazine;\n[solid]\n203-808-3\n110-85-0\nRepr. 2\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH361fd\nH314\nH334\nH317\nGHS05\nGHS08\nDgr\nH361fd\nH314\nH334\nH317\n\n\n\n\n\n\n612-057-01-1\npiperazine;\n[liquid]\n203-808-3\n110-85-0\nRepr. 2\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nH361fd\nH314\nH334\nH317\nGHS05\nGHS08\nDgr\nH361fd\nH314\nH334\nH317\n\n\n\n\n\n612-058-00-X\n2,2'-iminodiethylamine;\ndiethylenetriamine\n203-865-4\n111-40-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH312\nH302\nH314\nH317\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\n\n\n\n612-059-00-5\n3,6-diazaoctanethylenediamin;\ntriethylenetetramine\n203-950-6\n112-24-3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH314\nH317\nH412\n\n\n\n612-060-00-0\n3,6,9-triazaundecamethylenediamine;\ntetraethylenepentamine\n203-986-2\n112-57-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH411\n\n\n\n612-061-00-6\n3-aminopropyldimethylamine;\nN,N-dimethyl-1,3-diaminopropane\n203-680-9\n109-55-7\nFlam. Liq. 3\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH302\nH314\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH302\nH314\nH317\n\n\n\n612-062-00-1\n3-aminopropyldiethylamine;\nN,N-diethyl-1,3-diaminopropane\n203-236-4\n104-78-9\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH226\nH312\nH302\nH314\nH317\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\nH317\n\n\n\n612-063-00-7\n3,3'-iminodi(propylamine);\ndipropylenetriamine\n200-261-2\n56-18-8\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nSkin Sens. 1\nH330\nH311\nH302\nH314\nH317\nGHS06\nGHS05\nDgr\nH330\nH311\nH302\nH314\nH317\n\n\n\n612-064-00-2\n3,6,9,12-tetra-azatetradecamethylenediamine;\npentacthylenehexamine\n223-775-9\n4067-16-7\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n612-065-00-8\npolyethlyenepolyamines with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n612-066-00-3\ndicyclohexylamine\n202-980-7\n101-83-7\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n612-067-00-9\n3-aminomethyl-3,5,5-trimethylcyclohexylamine\n220-666-8\n2855-13-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\nH412\n\n\n\n612-068-00-4\n3,3'-dichlorobenzidine;\n3,3'-dichlorobiphenyl-4,4'-ylenediamine\n202-109-0\n91-94-1\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH312\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH312\nH317\nH410\n\n\n\n612-069-00-X\nsalts of 3,3'-dichlorobenzidine;\nsalts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH312\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH312\nH317\nH410\n\n\nA\n612-070-00-5\nsalts of benzidine\n208-519-6\n208-520-1\n244-236-4\n252-984-8\n531-85-1\n531-86-2\n21136-70-9\n36341-27-2\nCarc. 1A\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\nA\n612-071-00-0\nsalts of 2-naphthylamine\n209-030-0\n210-313-6\n553-00-4\n612-52-2\nCarc. 1A\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\nA\n612-072-00-6\nbiphenyl-4-ylamine;\nxenylamine;\n4-aminobiphenyl\n202-177-1\n92-67-1\nCarc. 1A\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-073-00-1\nsalts of biphenyl-4-ylamine;\nsalts of xenylamine;\nsalts of 4-aminobiphenyl\n—\n—\nCarc. 1A\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\nA\n612-074-00-7\nbenzyldimethylamine\n203-149-1\n103-83-3\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH226\nH332\nH312\nH302\nH314\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH314\nH412\n\n\n\n612-075-00-2\n2-aminoethyldimethylamine;\n2-dimethylaminoethylamine\n203-541-2\n108-00-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH225\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH312\nH302\nH314\n\n\n\n\n\n612-076-00-8\nethyldimethylamine\n209-940-8\n598-56-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\n\n\n\n\n612-077-00-3\ndimethylnitrosoamine;\nN-nitrosodimethylamine\n200-549-8\n62-75-9\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 1\nAquatic Chronic 2\nH350\nH330\nH301\nH372 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH330\nH301\nH372 **\nH411\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n612-078-00-9\n2,2'-dichloro-4,4'-methylenedianiline;\n4,4'-methylene bis(2-chloroaniline)\n202-918-9\n101-14-4\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\n\n612-079-00-4\nsalts of 2,2'-dichloro-4,4'-methylenedianiline;\nsalts of 4,4'-methylenebis(2-chloroaniline)\n—\n—\nCarc. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH410\n\n\nA\n612-080-00-X\n4-amino-N,N-diethylaniline;\nN,N-diethyl-p-phenylendiamine\n202-214-1\n93-05-0\nAcute Tox. 3 *\nSkin Corr. 1B\nH301\nH314\nGHS06\nGHS05\nDgr\nH301\nH314\n\n\n\n612-081-00-5\nsalts of 4,4'-bi-o-toluidine;\nsalts of 3,3'-dimethylbenzidine;\nsalts of o-tolidine\n210-322-5\n265-294-7\n277-985-0\n612-82-8\n64969-36-4\n74753-18-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\nA\n612-082-00-0\nthiourea;\nthiocarbamide\n200-543-5\n62-56-6\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH351\nH361d ***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361d ***\nH302\nH411\n\n\n\n\n\n\n612-083-00-6\n1-methyl-3-nitro-1-nitrosoguanidine\n200-730-1\n70-25-7\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH350\nH332\nH319\nH315\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH332\nH319\nH315\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n\n612-084-00-1\ndapsone;\n4,4'-diamino diphenyl sulfone\n201-248-4\n80-08-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n612-085-00-7\n4,4'-methylenedi-o-toluidine\n212-658-8\n838-88-0\nCarc. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH317\nH410\n\n\n\n612-086-00-2\namitraz (ISO);\nN,N-bis(2,4-xylyliminomethyl) methylamine\n251-375-4\n33089-61-1\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\nM = 10\n\n612-087-00-8\nguazatine (ISO)\n\n108173-90-6\nAcute Tox. 2 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH312\nH302\nH335\nH315\nH318\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH312\nH302\nH335\nH315\nH318\nH410\n\n\n\n612-088-00-3\nsimazine (ISO);\n6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine\n204-535-2\n122-34-9\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n612-089-00-9\n1,5-naphthylenediamine\n218-817-8\n2243-62-1\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n612-090-00-4\n2,2'-(nitrosoimino)bisethanol\n214-237-4\n1116-54-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\n\n612-091-00-X\no-toluidine;\n2-aminotoluene\n202-429-0\n95-53-4\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nAquatic Acute 1\nH350\nH331\nH301\nH319\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH301\nH319\nH400\n\n\n\n612-092-00-5\nN,N'-(2,2-dimethylpropylidene)hexamethylenediamine\n401-660-6\n1000-78-8\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n612-093-00-0\n3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline\n401-790-3\n104147-32-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n\n612-094-00-6\n4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride\n402-190-4\n113674-95-6\nSTOT RE 1\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH372**\nH302\nH373**\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH372**\nH302\nH373**\nH318\nH317\nH410\n\n\n\n\n\n612-095-00-1\nbenzyl-2-hydroxydodecyldimethylammonium benzoate\n402-610-6\n113694-52-3\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH410\n\n\n\n612-096-00-7\n4,4'-carbonimidoylbis[N,N-dimethylaniline]\n207-762-5\n492-80-8\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH351\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH411\n\n\n\n612-097-00-2\nsalts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]\n—\n—\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH351\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH319\nH411\n\n\nA\n\n\n612-098-00-8\nnitrosodipropylamine\n210-698-0\n621-64-7\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\nCarc. 1B; H350: C ≥ 0,001 %\n\n\n612-099-00-3\n4-methyl-m-phenylenediamine;\n2,4-toluenediamine\n202-453-1\n95-80-7\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH317\nH411\n\n\n\n\n\n612-100-00-7\npropylenediamine\n201-155-9\n78-90-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nH226\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH314\n\n\n\n\n\n612-101-00-2\nmethenamine;\nhexamethylenetetramine\n202-905-8\n100-97-0\nFlam. Sol. 2\nSkin Sens. 1\nH228\nH317\nGHS02\nGHS07\nWng\nH228\nH317\n\n\n\n\n612-102-00-8\nN,N-bis(3-aminopropyl)methylamine\n203-336-8\n105-83-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH331\nH311\nH302\nH314\nGHS06\nGHS05\nDgr\nH331\nH311\nH302\nH314\n\n\n\n612-103-00-3\nN,N,N',N'-tetramethylethylenediamine\n203-744-6\n110-18-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\n\n\n612-104-00-9\nhexamethylenediamine\n204-679-6\n124-09-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Corr. 1B\nH312\nH302\nH335\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH335\nH314\n\n\n\n612-105-00-4\n2-piperazin-1-ylethylamine\n205-411-0\n140-31-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH317\nH412\n\n\n\n612-106-00-X\n2,6-diethylaniline\n209-445-7\n579-66-8\nAcute Tox. 4 *\nH302\n—\nH302\n\n\n\n612-107-00-5\n1-phenylethylamine; [1]\nDL-α-methylbenzylamine [2]\n202-706-6 [1]\n210-545-8 [2]\n98-84-0 [1]\n618-36-0 [2]\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n612-108-00-0\n3-aminopropyltriethoxysilane\n213-048-4\n919-30-2\nAcute Tox. 4 *\nSkin Corr. 1B\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n612-109-00-6\nbis(2-dimethylaminoethyl)(methyl)amine\n221-201-1\n3030-47-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH311\nH302\nH314\nGHS06\nGHS05\nDgr\nH311\nH302\nH314\n\n\n\n612-110-00-1\n2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)\n229-962-1\n6864-37-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Chronic 2\nH331\nH311\nH302\nH314\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH302\nH314\nH411\n\n\n\n612-111-00-7\n2-methyl-m-phenylenediamine;\n2,6-toluenediamine\n212-513-9\n823-40-5\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH312\nH302\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH312\nH302\nH317\nH411\n\n\n\n612-112-00-2\np-anisidine;\n4-methoxyaniline\n203-254-2\n104-94-9\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSTOT RE 2 *\nAquatic Acute 1\nH330\nH310\nH300\nH373 **\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH310\nH300\nH373 **\nH400\n\n\n\n612-113-00-8\n6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine\n403-240-8\n106264-79-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-114-00-3\nR,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate\n404-390-7\n—\nFlam. Sol. 1\nSkin Sens. 1\nAquatic Chronic 3\nH228\nH317\nH412\nGHS02\nGHS07\nWng\nH228\nH317\nH412\n\n\n\n612-115-00-9\ndimethyldioctadecylammonium hydrogen sulfate\n404-050-8\n123312-54-9\nEye Irrit. 2\nAquatic Chronic 4\nH319\nH413\nGHS07\nWng\nH319\nH413\n\n\n\n612-116-00-4\nC8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate\n404-690-8\n68132-19-4\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH314\nH317\nH410\n\n\n\n612-117-00-X\nC12-14-tert-alkylamine, methylphosphonic acid salt\n404-750-3\n119415-07-5\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n612-118-00-5\nA reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;\n(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide\n405-080-4\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-119-00-0\nbenzyldimethyloctadecylammonium 3-nitrobenzenesulfonate\n405-330-2\n—\nSkin Irrit. 2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH315\nH318\nH410\n\n\n\n612-120-00-6\naclonifen (ISO);\n2-chloro-6-nitro-3-phenoxyaniline\n277-704-1\n74070-46-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n612-121-00-1\namines, polyethylenepoly-;\nHEPA\n268-626-9\n68131-73-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n\n\n612-122-00-7\nhydroxylamine … %\n[> 55 % in aqueous solution]\n232-259-2\n7803-49-8\nUnst. Expl.\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH200\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\nGHS01\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH200\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\n\n\nB\n\n\n\n\n612-122-01-4\nhydroxylamine …% [≤ 55 % in aqueous solution]\n232-259-2\n7803-49-8\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH290\nH351\nH312\nH302\nH373**\nH335\nH315\nH318\nH317\nH400\n\n\nB\n\n\n\n612-123-00-2\nhydroxylammonium chloride;\nhydroxylamine hydrochloride; [1]\nbis(hydroxylammonium) sulfate;\nhydroxylamine sulfate (2:1) [2]\n226-798-2 [1]\n233-118-8 [2]\n5470-11-1 [1]\n10039-54-0 [2]\nMet. Corr. 1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH290\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nWng\nH290\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\n\n\n612-124-00-8\nN,N,N-trimethylanilinium chloride\n205-319-0\n138-24-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nH311\nH301\nGHS06\nDgr\nH311\nH301\n\n\n\n612-125-00-3\n2-methyl-p-phenylenediamine;\n2,5-toluenediamine\n202-442-1\n95-70-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH332\nH312\nH317\nH411\nGHS06\nGHS09\nDgr\nH301\nH332\nH312\nH317\nH411\n\n\n\n612-126-00-9\ntoluene-2,4-diammonium sulphate;\n4-methyl-m-phenylenediamine sulfate\n265-697-8\n65321-67-7\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH301\nH312\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH301\nH312\nH319\nH317\nH411\n\n\n\n612-127-00-4\n3-aminophenol\n209-711-2\n591-27-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH302\nH411\nGHS07\nGHS09\nWng\nH332\nH302\nH411\n\n\n\n612-128-00-X\n4-aminophenol\n204-616-2\n123-30-8\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH332\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH332\nH302\nH410\n\n\n\n612-129-00-5\ndiisopropylamine\n203-558-5\n108-18-9\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH225\nH332\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH332\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\n\n612-130-00-0\n2,6-diamino-3,5-diethyltoluene;\n4,6-diethyl-2-methyl-1,3-benzenediamine; [1]\n2,4-diamino-3,5-diethyltoluene;\n2,4-diethyl-6-methyl-1,3-benzenediamine; [2]\ndiethylmethylbenzenediamine [3]\n218-255-3 [1]\n218-256-9 [2]\n270-877-4 [3]\n2095-01-4 [1]\n2095-02-5 [2]\n68479-98-1 [3]\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373 **\nH319\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH312\nH302\nH373 **\nH319\nH410\n\n\nC\n612-131-00-6\ndidecyldimethylammonium chloride\n230-525-2\n7173-51-5\nAcute Tox. 4 *\nSkin Corr. 1B\nH302\nH314\nGHS05\nGHS07\nDgr\nH302\nH314\n\n\n\n612-132-00-1\nN,N'-diphenyl-p-phenylenediamine;\nN,N'-diphenyl-1,4-benzenediamine\n200-806-4\n74-31-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n612-133-00-7\n(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;\n4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate\n247-162-0\n25646-77-9\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH373 **\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH410\n\n\n\n612-134-00-2\nN-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;\n4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate\n247-161-5\n25646-71-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-135-00-8\nN-2-naphthylaniline;\nN-phenyl-2-naphthylamine\n205-223-9\n135-88-6\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH319\nH315\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH319\nH315\nH317\nH411\n\n\n\n612-136-00-3\nN-isopropyl-N'-phenyl-p-phenylenediamine\n202-969-7\n101-72-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n612-137-00-9\n4-chloroaniline\n203-401-0\n106-47-8\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH331\nH311\nH301\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH317\nH410\n\n\n\n612-138-00-4\nfuralaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate\n260-875-1\n57646-30-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n612-139-00-X\nmefenacet (ISO);\n2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide\n277-328-8\n73250-68-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-140-00-5\nquaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides\n264-151-6\n63449-41-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nH312\nH302\nH314\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH400\n\n\n\n612-141-00-0\n4,4'-methylenebis(2-ethylaniline);\n4,4'-methylenebis(2-ethylbenzeneamine)\n243-420-1\n19900-65-3\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n612-142-00-6\nbiphenyl-2-ylamine\n201-990-9\n90-41-5\nCarc. 2\nAcute Tox. 4 *\nAquatic Chronic 3\nH351\nH302\nH412\nGHS08\nGHS07\nWng\nH351\nH302\nH412\n\n\n\n612-143-00-1\nN5,N5-diethyltoluene-2,5-diamine monohydrochloride;\n4-diethylamino-2-methylaniline monohydrochloride\n218-130-3\n2051-79-8\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH317\nH410\n\n\n\n612-144-00-7\nflumetralin (ISO);\nN-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine\n—\n62924-70-3\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH410\n\n\n\n612-145-00-2\no-phenylenediamine\n202-430-6\n95-54-5\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH410\n\n\n\n612-146-00-8\no-phenylenediamine dihydrochloride\n210-418-7\n615-28-1\nCarc. 2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH341\nH301\nH332\nH312\nH319\nH317\nH410\n\n\n\n612-147-00-3\nm-phenylenediamine\n203-584-7\n108-45-2\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-148-00-9\nm-phenylenediamine dihydrochloride\n208-790-0\n541-69-5\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH331\nH311\nH301\nH319\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH331\nH311\nH301\nH319\nH317\nH410\n\n\n\n612-149-00-4\n1,3-diphenylguanidine\n203-002-1\n102-06-7\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH361f ***\nH302\nH319\nH335\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361f ***\nH302\nH319\nH335\nH315\nH411\n\n\n\n612-150-00-X\nspiroxamine (ISO);\n8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine\n—\n118134-30-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH315\nH317\nH410\n\n\n\n\n\n\n612-151-00-5\nmethyl-phenylene diamine;\ndiaminotoluene;\n[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]\n—\n—\nCarc. 1B\nMuta. 2\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH319\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH361f***\nH301\nH312\nH373**\nH319\nH317\nH411\n\n\n\n\n612-152-00-0\nN,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine\n406-610-7\n62478-82-4\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Chronic 3\nH226\nH332\nH302\nH373 **\nH314\nH412\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH332\nH302\nH373 **\nH314\nH412\n\n\n\n612-153-00-6\n4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride\n407-020-2\n132885-85-9\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n612-154-00-1\n6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]\n410-890-6\n95235-29-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-155-00-7\n2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene\n411-730-8\n93071-94-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-156-00-2\nreaction mass of: trihexadecylmethylammonium chloride;\ndihexadecyldimethylammonium chloride\n405-620-9\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-157-00-8\n(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride\n410-780-8\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373 **\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH318\nH317\nH411\n\n\n\n612-158-00-3\nreaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;\n4-dodecylsalicylaldoxime\n410-820-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-159-00-9\nReaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid\n410-880-1\n—\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n612-160-00-4\np-toluidine;\n4-aminotoluene; [1]\ntoluidinium chloride; [2]\ntoluidine sulphate (1:1) [3]\n203-403-1 [1]\n208-740-8 [2]\n208-741-3 [3]\n106-49-0 [1]\n540-23-8 [2]\n540-25-0 [3]\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH351\nH331\nH311\nH301\nH319\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH311\nH301\nH319\nH317\nH400\n\n\n\n612-161-00-X\n2,6-xylidine;\n2,6-dimethylaniline\n201-758-7\n87-62-7\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH351\nH332\nH312\nH302\nH335\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH312\nH302\nH335\nH315\nH411\n\n\n\n612-162-00-5\ndimethyldioctadecylammonium chloride;\nDODMAC\n203-508-2\n107-64-2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-163-00-0\nmetalaxyl-M (ISO);\nmefenoxam;\n(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester\n—\n70630-17-0\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n612-164-00-6\n2-butyl-2-ethyl-1,5-diaminopentane\n412-700-7\n137605-95-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH312\nH302\nH373 **\nH314\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH312\nH302\nH373 **\nH314\nH317\nH412\n\n\n\n612-165-00-1\nN,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine\n413-810-8\n65181-78-4\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-166-00-7\nreaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);\ntrans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)\n411-830-1\n114765-88-7\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n612-167-00-2\n5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride\n410-490-1\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH373 **\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH373 **\nH318\nH317\nH411\n\n\n\n612-168-00-8\n3,5-dichloro-2,6-difluoropyrdine-4-amine\n220-630-1\n2840-00-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH312\nH302\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH411\n\n\n\n\n\n612-169-00-3\nbis(N-methyl-N-phenylhydrazine)sulfate\n423-170-1\n618-26-8\nFlam. Liq. 2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH225\nH372**\nH302\nH318\nH317\nH400\nH410\nGHS02\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH225\nH372**\nH302\nH318\nH317\nH410\n\n\n\n\n612-170-00-9\n4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime\n405-260-2\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-171-00-4\nN,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane\n410-060-3\n130728-76-6\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH317\nH411\nGHS08\nGHS09\nWng\nH341\nH317\nH411\n\n\n\n612-172-00-X\n4,4'-methylenebis(N,N'-dimethylcyclohexanamine\n412-840-9\n13474-64-1\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Chronic 3\nH302\nH373 **\nH314\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH314\nH412\n\n\n\n612-173-00-5\nlithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate\n411-140-0\n125328-86-1\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n612-174-00-0\n4,4-dimethoxybutylamine\n407-690-6\n19060-15-2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH314\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH412\n\n\n\n612-175-00-6\n2-(O-aminooxy)ethylamine dihydrochloride\n412-310-7\n37866-45-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n612-176-00-1\npolymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine\n410-570-6\n143747-73-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n612-177-00-7\n2-naphthylamino-6-sulfomethylamide\n412-120-4\n104295-55-8\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n612-178-00-2\n1,4,7,10-tetraazacyclododecane disulfate\n412-080-8\n112193-77-8\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nAquatic Chronic 3\nH302\nH335\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\nH412\n\n\n\n612-179-00-8\n1-(2-propenyl)pyridinium chloride\n412-740-5\n25965-81-5\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n612-180-00-3\n3-aminobenzylamine\n412-230-2\n4403-70-7\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 2\nH302\nH314\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH411\n\n\n\n612-181-00-9\n2-phenylthioaniline\n413-030-8\n1134-94-7\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n612-182-00-4\n1-ethyl-1-methylmorpholinium bromide\n418-210-1\n65756-41-4\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n612-183-00-X\n1-ethyl-1-methylpyrrolidinium bromide\n418-200-5\n69227-51-6\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n612-184-00-5\n6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one\n403-830-5\n89331-94-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n612-185-00-0\n1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide\n407-400-8\n59493-72-0\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n612-186-00-6\nbis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate\n406-770-8\n149057-64-7\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH373 **\nH318\nH317\nH410\n\n\n\n612-187-00-1\n2,3,4-trifluoroaniline\n407-170-9\n3862-73-5\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH373 **\nH315\nH318\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH315\nH318\nH411\n\n\n\n612-188-00-7\n4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)\n407-560-9\n107934-68-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n612-189-00-2\n4-amino-2-(aminomethyl)phenol dihydrochloride\n412-510-4\n135043-64-0\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n612-190-00-8\n4,4'-methylenebis(2-isopropyl-6-methylaniline)\n415-150-6\n16298-38-7\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n612-191-00-3\npolymer of allylamine hydrochloride\n415-050-2\n71550-12-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n612-192-00-9\n2-isopropyl-4-(N-methyl)aminomethylthiazole\n414-800-6\n154212-60-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH312\nH302\nH315\nH318\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH315\nH318\nH411\n\n\n\n612-193-00-4\n3-methylaminomethylphenylamine\n414-570-7\n18759-96-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH314\nH317\nH410\n\n\n\n612-194-00-X\n2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride\n414-670-0\n141890-30-4\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n612-195-00-5\nbis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate\n415-210-1\n160236-81-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH410\n\n\n\n612-196-00-0\n4-chloro-o-toluidine; [1]\n4-chloro-o-toluidine hydrochloride [2]\n202-441-6 [1]\n221-627-8 [2]\n95-69-2 [1]\n3165-93-3 [2]\nCarc. 1B\nMuta. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH341\nH331\nH311\nH301\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH341\nH331\nH311\nH301\nH410\n\n\n\n612-197-00-6\n2,4,5-trimethylaniline; [1]\n2,4,5-trimethylaniline hydrochloride [2]\n205-282-0 [1] - [2]\n137-17-7 [1]\n21436-97-5 [2]\nCarc. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH331\nH311\nH301\nH411\n\n\n\n612-198-00-1\n4,4'-thiodianiline and its salts\n205-370-9\n139-65-1\nCarc. 1B\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH302\nH411\n\n\n\n612-199-00-7\n4,4'-oxydianiline and its salts;\np-aminophenyl ether\n202-977-0\n101-80-4\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 2\nH350\nH340\nH361f ***\nH331\nH311\nH301\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH350\nH340\nH361f ***\nH331\nH311\nH301\nH411\n\n\n\n612-200-00-0\n2,4-diaminoanisole;\n4-methoxy-m-phenylenediamine; [1]\n2,4-diaminoanisole sulphate [2]\n210-406-1 [1]\n254-323-9 [2]\n615-05-4 [1]\n39156-41-7 [2]\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH350\nH341\nH302\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH302\nH411\n\n\n\n612-201-00-6\nN,N,N',N'-tetramethyl-4,4'-methylendianiline\n202-959-2\n101-61-1\nCarc. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH410\n\n\n\n612-202-00-1\n3,4-dichloroaniline\n202-448-4\n95-76-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH318\nH317\nH410\n\n\n\n\n\n612-203-00-7\nC8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %)\n417-360-3\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nH312\nH302\nH315\nGHS07\nWng\nH312\nH302\nH315\n\n\n\n\n612-204-00-2\nC.I. Basic Violet 3;\n4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride\n208-953-6\n548-62-9\nCarc. 2\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH351\nH302\nH318\nH410\n\n\n\n612-205-00-8\nC.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5)\n208-953-6\n548-62-9\nCarc. 1B\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH302\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH350\nH302\nH318\nH410\n\n\n\n612-206-00-3\nfamoxadone (ISO);\n3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione\n—\n131807-57-3\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n612-207-00-9\n4-ethoxyaniline;\np-phenetidine\n205-855-5\n156-43-4\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH341\nH332\nH312\nH302\nH319\nH317\nGHS08\nGHS07\nWng\nH341\nH332\nH312\nH302\nH319\nH317\n\n\n\n\n\n612-208-00-4\nN-methylbenzene-1,2-diammonium hydrogen phosphate\n424-460-0\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n612-209-00-X\n6-methoxy-m-toluidine;\np-cresidine\n204-419-1\n120-71-8\nCarc. 1B\nAcute Tox. 4 *\nH350\nH302\nGHS08\nGHS07\nDgr\nH350\nH302\n\n\n\n612-210-00-5\n5-nitro-o-toluidine; [1]\n5-nitro-o-toluidine hydrochloride [2]\n202-765-8 [1]\n256-960-8 [2]\n99-55-8 [1]\n51085-52-0 [2]\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Chronic 3\nH351\nH331\nH311\nH301\nH412\nGHS06\nGHS08\nDgr\nH351\nH331\nH311\nH301\nH412\n\n\n\n612-211-00-0\nN-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide\n416-470-9\n170292-97-4\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n612-212-00-6\n2,6-dichloro-4-trifluoromethylaniline\n416-430-0\n24279-39-8\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH315\nH317\nH410\n\n\n\n612-213-00-1\nisobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine\n419-850-2\n148348-13-4\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n612-214-00-7\n4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine\n421-390-2\n89114-90-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n612-215-00-2\n3-chloro-2-(isopropylthio)aniline\n421-700-6\n179104-32-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n\n612-216-00-8\n1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt\n425-870-2\n19450-38-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n612-217-00-3\n1-methoxy-2-propylamine\n422-550-4\n37143-54-7\nFlam. Liq. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nAquatic Chronic 3\nH225\nH314\nH302\nH412\nGHS02\nGHS05\nGHS07\nDgr\nH225\nH314\nH302\nH412\n\n\n\n\n\n612-219-00-4\n(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride\n402-200-7\n—\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-220-00-X\nN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine\n431-060-1\n153719-38-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n612-221-00-5\n2-amino-4-(trifluoromethyl)benzenethiol hydrochloride\n429-560-8\n4274-38-8\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nH314\nH332\nH312\nH302\nH373**\nH317\nH400\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH314\nH332\nH312\nH302\nH373**\nH317\nH400\n\n\n\n\n612-222-00-0\ncis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine\n425-080-8\n104860-26-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH373**\nH318\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH312\nH302\nH373**\nH318\nH410\n\n\n\n\n612-223-00-6\nN-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine\n425-300-2\n186450-73-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n612-224-00-1\nN2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine\n426-150-0\n121246-28-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n612-225-00-7\n1,4,7,10-tetraazacyclododecane\n425-450-9\n294-90-6\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH312\nH302\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH312\nH302\nH410\n\n\n\n\n612-226-00-2\n3-(2'-phenoxyethoxy)propylamine\n427-870-8\n6903-18-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH302\nH315\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\nH412\n\n\n\n\n612-227-00-8\nbenzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride\n428-290-8\n120606-08-8\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n\n612-228-00-3\nreaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine\n414-340-6\n—\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH332\nH312\nH302\nH371\nH318\nH317\nH412\nGHS02\nGHS05\nGHS08\nGHS07\nDgr\nH226\nH332\nH312\nH302\nH371\nH318\nH317\nH412\n\n\n\n\n612-229-00-9\nmepanipyrim;\n4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine\n—\n110235-47-7\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n\n612-230-00-4\nN,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide\n431-530-4\n—\nSkin Corr. 1A\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n\n612-231-00-X\n3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride\n427-370-1\n164288-56-6\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n612-232-00-5\nreaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;\ntriisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid\n430-410-9\n186148-38-9\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-237-00-2\nhydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]\n233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]\n10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]\nExpl. 1.1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\nGHS01\nGHS08\nGHS07\nGHS09\nDgr\nH201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400\n\n\nT\n\n\n612-238-00-8\n(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%\n222-048-3\n3327-22-8\nCarc. 2\nAquatic Chronic 3\nH351\nH412\nGHS08\nWng\nH351\nH412\n\n\nB\n\n612-239-00-3\nbiphenyl-3,3', 4,4'-tetrayltetraamine;\ndiaminobenzidine\n202-110-6\n91-95-2\nCarc. 1B\nMuta. 2\nH350\nH341\nGHS08\nDgr\nH350\nH341\n\n\n\n\n612-240-00-9\npyrimethanil (ISO);\nN-(4,6-dimethylpyrimidin-2-yl)aniline\n—\n53112-28-0\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-241-00-4\npiperazine hydrochloride; [1]\npiperazine dihydrochloride; [2]\npiperazine phosphate [3]\n228-042-7 [1]\n205-551-2 [2]\n217-775-8 [3]\n6094-40-2 [1]\n142-64-3 [2]\n1951-97-9 [3]\nRepr. 2\nEye Irrit. 2\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH361fd\nH319\nH315\nH334\nH317\nH412\nGHS08\nDgr\nH361fd\nH319\nH315\nH334\nH317\nH412\n\n\n\n\n612-242-00-X\ncyprodinil (ISO);\n4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine\n—\n121552-61-2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n612-243-00-5\n(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate\n420-560-3\n79617-97-3\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\nM=10\n\n\n612-244-00-0\n3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride\n421-310-6\n87691-88-1\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f***\nH302\nH319\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH361f***\nH302\nH319\nH317\nH410\n\n\n\n\n612-245-00-6\n2-ethylphenylhydrazine hydrochloride\n421-460-2\n19398-06-2\nCarc. 2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH372**\nH302\nH318\nH317\nH400\nH410\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH372**\nH302\nH318\nH317\nH410\n\nM=10\n\n\n612-246-00-1\n(2-chloroethyl)(3-hydroxypropyl)ammonium chloride\n429-740-6\n40722-80-3\nCarc. 1B\nMuta. 1B\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH340\nH373**\nH317\nH412\nGHS08\nGHS07\nDgr\nH350\nH340\nH373**\nH317\nH412\n\n\n\n\n612-247-00-7\nN-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide\n423-530-8\n152828-23-4\nSTOT RE 1\nAcute Tox. 4 *\nAquatic Chronic 3\nH372**\nH302\nH412\nGHS08\nGHS07\nDgr\nH372**\nH302\nH412\n\n\n\n\n612-248-00-2\nreaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)\n439-540-0\n—\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4\nH315\nH317\nH413\nGHS07\nWng\nH315\nH317\nH413\n\n\n\n\n612-249-00-8\n4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride\n425-030-5\n159939-85-2\nRepr. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH361f***\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH361f***\nH302\nH314\nH317\nH411\n\n\n\n\n612-250-00-3\nchloro-N,N-dimethylformiminium chloride\n425-970-6\n3724-43-4\nRepr. 1B\nAcute Tox. 4 *\nSkin Corr. 1A\nH360D***\nH302\nH314\nGHS05\nGHS08\nGHS07\nDgr\nH360D***\nH302\nH314\nEUH014\n\n\n\n612-251-00-9\ncis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride\n426-020-3\n51229-78-8\nFlam. Sol. 2\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH228\nH361d***\nH302\nH315\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nWng\nH228\nH361d***\nH302\nH315\nH317\nH411\n\n\n\n\n612-252-00-4\nimidacloprid (ISO);\n1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine\n428-040-8\n138261-41-3\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n612-253-00-X\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing < 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-253-01-7\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing ≥ 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nRepr. 1B\nAquatic Chronic 3\nH360D***\nH412\nGHS08\nDgr\nH360D***\nH412\n\n\n\n\n612-254-00-5\nreaction products of diisopropanolamine with formaldehyde (1:4)\n432-440-8\n220444-73-5\nCarc. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH351\nH302\nH314\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH351\nH302\nH314\nH317\nH411\n\n\n\n\n612-255-00-0\n1-(3-methoxypropyl)-4-piperidinamine\n431-950-8\n179474-79-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Chronic 3\nH312\nH302\nH314\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\nH412\n\n\n\n\n612-256-00-6\nbenzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate\n427-470-3\n137864-22-3\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n\n612-257-00-1\ntripropylammonium dihydrogenphosphate\n433-700-3\n35687-90-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n612-259-00-2\nN-ethyl-3-trimethoxysilyl-2-methyl-propanamine\n437-720-3\n227085-51-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n612-261-00-3\n3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline\n441-190-9\n121451-05-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=10\n\n\n612-265-00-5\nbis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate\n444-360-0\n191617-13-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n612-266-00-0\n3-chloro-4-(3-fluorobenzyloxy)aniline\n445-590-4\n202197-26-0\nMuta. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH302\nH373**\nH410\n\n\n\n\n612-267-00-6\nbis(hydrogenated tallow C16-18-alkyl)hydroxylamine\n418-370-0\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n612-269-00-7\nreaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;\n1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;\nreaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;\nN-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline\n420-720-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n612-270-00-2\n(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride\n433-010-2\n—\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH317\nH412\nGHS07\nWng\nH302\nH317\nH412\n\n\n\n\n612-271-00-8\nreaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;\nethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate\n434-970-5\n160987-57-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n612-272-00-3\nammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate\n435-210-5\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n612-273-00-9\nalkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride\n435-650-8\n—\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH410\n\n\n\n\n612-274-00-4\n(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate\n445-750-3\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n612-275-00-X\nfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil\n447-880-6\n206565-89-1\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\nM=10\n\n\n612-276-00-5\n1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts\n451-430-4\n500717-36-2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n612-277-00-0\nreaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;\n4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium\n451-440-9\n586372-44-3\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n612-278-00-6\nethidium bromide;\n3,8-diamino-1-ethyl-6-phenylphenantridinium bromide\n214-984-6\n1239-45-8\nMuta. 2\nAcute Tox. 2 *\nAcute Tox. 4 *\nH341\nH330\nH302\nGHS06\nGHS08\nDgr\nH341\nH330\nH302\n\n\n\n\n612-279-00-1\n(R, S)-2-amino-3,3-dimethylbutane amide\n447-860-7\n144177-62-8\nRepr. 2\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH361f***\nH373**\nH319\nH315\nH317\nGHS08\nGHS07\nWng\nH361f***\nH373**\nH319\nH315\nH317\n\n\n\n\n612-280-00-7\n3-amino-9-ethyl carbazole;\n9-ethylcarbazol-3-ylamine\n205-057-7\n132-32-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n612-281-00-2\nleucomalachite green;\nN,N,N',N'-tetramethyl-4,4'-benzylidenedianiline\n204-961-9\n129-73-7\nCarc. 2\nMuta. 2\nH351\nH341\nGHS08\nWng\nH351\nH341\n\n\n\n\n613-001-00-1\nethyleneimine;\naziridine\n205-793-9\n151-56-4\nFlam. Liq. 2\nCarc. 1B\nMuta. 1B\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Chronic 2\nH225\nH350\nH340\nH330\nH310\nH300\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH340\nH330\nH310\nH300\nH314\nH411\n\n\nD\n613-002-00-7\npyridine\n203-809-9\n110-86-1\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH225\nH332\nH312\nH302\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\n\n*\n\n\n\n613-003-00-2\n1,2,3,4-tetranitrocarbazole\n—\n6202-15-9\nExpl. 1.1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nH201\nH332\nH312\nH302\nGHS01\nGHS07\nDgr\nH201\nH332\nH312\nH302\n\n\n\n\n613-004-00-8\ncrimidine (ISO);\n2-chloro-6-methylpyrimidin-4-yldimethylamine\n208-622-6\n535-89-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n613-007-00-4\ndesmetryne (ISO);\n6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine\n213-800-1\n1014-69-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n613-008-00-X\ndazomet (ISO);\ntetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione\n208-576-7\n533-74-4\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-009-00-5\n2,4,6-trichloro-1,3,5-triazine;\ncyanuric chloride\n203-614-9\n108-77-0\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nH330\nH302\nH314\nH317\nGHS06\nGHS05\nDgr\nH330\nH302\nH314\nH317\nEUH014\nSTOT SE 3; H335: C ≥ 5 %\n\n\n613-010-00-0\nametryn (ISO);\nN-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine\n212-634-7\n834-12-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM = 100\n\n\n613-011-00-6\namitrole (ISO);\n1,2,4-triazol-3-ylamine\n200-521-5\n61-82-5\nRepr. 2\nSTOT RE 2 *\nAquatic Chronic 2\nH361d ***\nH373 **\nH411\nGHS08\nGHS09\nWng\nH361d ***\nH373 **\nH411\n\n\n\n613-012-00-1\nbentazone (ISO);\n3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide\n246-585-8\n25057-89-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH319\nH317\nH412\nGHS07\nWng\nH302\nH319\nH317\nH412\n\n\n\n613-013-00-7\ncyanazine (ISO);\n2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile\n244-544-9\n21725-46-2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-014-00-2\nethoxyquin(ISO);\n6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline\n202-075-7\n91-53-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-015-00-8\nfenazaflor (ISO);\nphenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate\n238-134-9\n14255-88-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n\n613-016-00-3\nfuberidazole (ISO);\n2-(2-furyl)-1H-benzimidazole\n223-404-0\n3878-19-1\nCarc. 2\nAcute Tox. 4\nSTOT RE 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH373 (heart)\nH317\nH400\nH410\nGHS07\nGHS08\nGHS09\nWng\nH351\nH302\nH373 (heart)\nH317\nH410\n\nM = 1\n\n\n613-017-00-9\nbis (8-hydroxyquinolinium) sulphate\n205-137-1\n134-31-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-018-00-4\nmorfamquat (ISO);\n1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion\n—\n7411-47-4\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH335\nH315\nH412\nGHS07\nWng\nH302\nH319\nH335\nH315\nH412\n\n\n\n613-019-00-X\nthioquinox(ISO);\n2-thio-1,3-dithiolo(4,5,b)quinoxaline\n202-272-8\n93-75-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-020-00-5\ntridemorph (ISO);\n2,6-dimethyl-4-tridecylmorpholine\n246-347-3\n24602-86-6\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH360D ***\nH332\nH302\nH315\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH360D ***\nH332\nH302\nH315\nH410\n\n\n\n613-021-00-0\ndithianon (ISO);\n5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile\n222-098-6\n3347-22-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-022-00-6\npyrethrins including cinerins, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n613-023-00-1\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;\npyrethrin I\n204-455-8\n121-21-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\n\n613-024-00-7\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\npyrethrin II\n204-462-6\n121-29-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\n\n613-025-00-2\ncinerin I;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n246-948-0\n25402-06-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-026-00-8\ncinerin II;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate\n204-454-2\n121-20-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-027-00-3\npiperidine\n203-813-0\n110-89-4\nFlam. Liq. 2\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nH225\nH331\nH311\nH314\nGHS02\nGHS06\nGHS05\nDgr\nH225\nH331\nH311\nH314\n\n*\n\n613-028-00-9\nmorpholine\n203-815-1\n110-91-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH226\nH332\nH312\nH302\nH314\nGHS02\nGHS05\nGHS07\nDg\nH226\nH332\nH312\nH302\nH314\n\n\n\n613-029-00-4\ndichloro-1,3,5-triazinetrione;\ndichloroisocyanuric acid\n220-487-5\n2782-57-2\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n\nT\n\n\n613-030-00-X\ntroclosene potassium; [1]\ntroclosene sodium [2]\n218-828-8 [1]\n220-767-7 [2]\n2244-21-5 [1]\n2893-78-9 [2]\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n*\nSTOT SE 3; H335: C ≥ 10 %\nEUH031: C ≥ 10 %\nG\n\n613-030-01-7\ntroclosene sodium, dihydrate\n220-767-7\n51580-86-0\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH335\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH335\nH410\nEUH031\n\n\n613-031-00-5\nsymclosene;\ntrichloroisocyanuric acid;\ntrichloro-1,3,5-triazinetrion\n201-782-8\n87-90-1\nOx. Sol. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nAquatic Acute 1\nAquatic Chronic 1\nH272\nH302\nH319\nH335\nH400\nH410\nGHS03\nGHS07\nGHS09\nDgr\nH272\nH302\nH319\nH335\nH410\nEUH031\n\n\n613-032-00-0\nmethyl-2,3,5,6-tetrachloro-4-pyridylsulphone;\n2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine\n236-035-5\n13108-52-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nH312\nH302\nH319\nH317\nGHS07\nWng\nH312\nH302\nH319\nH317\n\n\n\n613-033-00-6\n2-methylaziridine;\npropyleneimine\n200-878-7\n75-55-8\nFlam. Liq. 2\nCarc. 1B\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nEye Dam. 1\nAquatic Chronic 2\nH225\nH350\nH330\nH310\nH300\nH318\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH225\nH350\nH330\nH310\nH300\nH318\nH411\n\nCarc. 1B; H350: C ≥ 0,01 %\n\n613-034-00-1\n1,2-dimethylimidazole\n217-101-2\n1739-84-0\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nH302\nH315\nH318\nGHS05\nGHS07\nDgr\nH302\nH315\nH318\n\n\n\n613-035-00-7\n1-methylimidazole\n210-484-7\n616-47-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1B\nH312\nH302\nH314\nGHS05\nGHS07\nDgr\nH312\nH302\nH314\n\n\n\n613-036-00-2\n2-methylpyridine;\n2-picoline\n203-643-7\n109-06-8\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nH226\nH332\nH312\nH302\nH319\nH335\nGHS02\nGHS07\nWng\nH226\nH332\nH312\nH302\nH319\nH335\n\n\n\n613-037-00-8\n4-methylpyridine;\n4-picoline\n203-626-4\n108-89-4\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH226\nH311\nH332\nH302\nH319\nH335\nH315\nGHS02\nGHS06\nDgr\nH226\nH311\nH332\nH302\nH319\nH335\nH315\n\n\n\n613-038-00-3\n6-phenyl-1,3,5-triazine-2,4-diyldiamine;\n6-phenyl-1,3,5-triazine-2,4-diamine;\nbenzoguanamine\n202-095-6\n91-76-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-039-00-9\nethylene thiourea;\nimidazolidine-2-thione;\n2-imidazoline-2-thiol\n202-506-9\n96-45-7\nRepr. 1B\nAcute Tox. 4 *\nH360D ***\nH302\nGHS08\nGHS07\nDgr\nH360D ***\nH302\n\n\n\n613-040-00-4\nazaconazole (ISO);\n1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole\n262-102-3\n60207-31-0\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-041-00-X\nmorpholine-4-carbonyl chloride\n239-213-0\n15159-40-7\nCarc. 2\nEye Irrit. 2\nSkin Irrit. 2\nH351\nH319\nH315\nGHS08\nWng\nH351\nH319\nH315\nEUH014\n\n\n613-042-00-5\nimazalil (ISO);\n1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole\n252-615-0\n35554-44-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH410\n\n\n\n613-043-00-0\nimazalil sulphate (ISO) powder;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n613-043-01-8\nimazalil sulphate (ISO), aqueous solution;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nWng\nH302\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 50 %\nSkin Irrit. 2; H315: 30 % ≤ C < 50 %\nEye Dam. 1; H318: 15 % ≤ C < 50 %\nEye Irrit. 2; H319: 5 % ≤ C < 15 %\n\n\n\n613-044-00-6\ncaptan (ISO);\n1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide\n205-087-0\n133-06-2\nCarc. 2\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH351\nH331\nH318\nH317\nH400\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH351\nH331\nH318\nH317\nH400\n\nM=10\n\n\n613-045-00-1\nfolpet (ISO);\nN-(trichloromethylthio)phthalimide\n205-088-6\n133-07-3\nCarc. 2\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH351\nH332\nH319\nH317\nH400\nGHS08\nGHS07\nGHS09\nWng\nH351\nH332\nH319\nH317\nH400\n\nM=10\n\n\n\n613-046-00-7\ncaptafol (ISO);\n1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide\n219-363-3\n2425-06-1\nCarc. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH350\nH317\nH400\nH410\nGHS08\nGHS09\nDgr\nH350\nH317\nH410\n\n\n\n613-047-00-2\n1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;\ndimetilan (ISO)\n211-420-0\n644-64-4\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n613-048-00-8\ncarbendazim (ISO);\nmethyl benzimidazol-2-ylcarbamate\n234-232-0\n10605-21-7\nMuta. 1B\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH340\nH360FD\nH400\nH410\nGHS08\nGHS09\nDgr\nH340\nH360FD\nH410\n\n\n\n613-049-00-3\nbenomyl (ISO);\nmethyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate\n241-775-7\n17804-35-2\nMuta. 1B\nRepr. 1B\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH340\nH360FD\nH335\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH340\nH360FD\nH335\nH315\nH317\nH410\n\nM = 10\n\n613-050-00-9\ncarbadox (INN);\nmethyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;\n2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide\n229-879-0\n6804-07-5\nFlam. Sol. 1\nCarc. 1B\nAcute Tox. 4 *\nH228\nH350\nH302\nGHS02\nGHS08\nGHS07\nDgr\nH228\nH350\nH302\n\n\nT\n613-051-00-4\nmolinate (ISO);\nS-ethyl 1-perhydroazepinecarbothioate;\nS-ethyl perhydroazepine-1-carbothioate\n218-661-0\n2212-67-1\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361f ***\nH332\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361f ***\nH332\nH302\nH373 **\nH317\nH410\n\nM = 100\n\n613-052-00-X\ntrifenmorph (ISO);\n4-tritylmorpholine\n215-812-2\n1420-06-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-053-00-5\nanilazine (ISO);\n2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline\n202-910-5\n101-05-3\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH315\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH315\nH410\n\n\n\n613-054-00-0\nthiabendazol (ISO);\n2-(thiazole-4-yl)benzimidazole\n205-725-8\n148-79-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-056-00-1\n1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;\ndifenzoquat methyl sulfate\n256-152-5\n43222-48-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS09\nWng\nH302\nH410\n\n\n\n613-057-00-7\ndodemorph (ISO);\n4-cyclododecyl-2,6-dimethylmorpholine\n216-474-9\n1593-77-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 2\nH319\nH335\nH315\nH411\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH411\n\n\n\n613-058-00-2\npermethrin (ISO);\nm-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-067-9\n52645-53-1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH302\nH317\nH410\n\nM = 1000\n\n613-059-00-8\nprofluralin (ISO);\nN-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine\n247-656-6\n26399-36-0\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n\n\n613-060-00-3\nresmethrin (ISO);\n5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate\n233-940-7\n10453-86-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=1000\n\n\n613-061-00-9\n6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;\nryania\n239-732-2\n15662-33-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n613-062-00-4\nsabadilla (ISO);\nveratrine\n—\n8051-02-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH319\nH335\nH315\nGHS07\nWng\nH319\nH335\nH315\n\n\n\n613-063-00-X\nsecbumeton (ISO);\n2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n247-554-1\n26259-45-0\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-064-00-5\n5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;\nsesamex\n—\n51-14-9\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-065-00-0\nsimetryn (ISO);\n2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine\n213-801-7\n1014-70-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-066-00-6\nterbumeton (ISO);\n2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n251-637-8\n33693-04-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-067-00-1\npropazine(ISO);\n2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine\n205-359-9\n139-40-2\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n613-068-00-7\natrazine (ISO);\n2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine\n217-617-8\n1912-24-9\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH317\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH317\nH410\n\n\n\n613-069-00-2\nε-caprolactam\n203-313-2\n105-60-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nH332\nH302\nH319\nH335\nH315\nGHS07\nWng\nH332\nH302\nH319\nH335\nH315\n\n\n\n613-070-00-8\npropylenethiourea\n—\n2122-19-2\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 3\nH361d ***\nH302\nH412\nGHS08\nGHS07\nWng\nH361d ***\nH302\nH412\n\n\n\n613-071-00-3\n2-fluoro-5-trifluoromethylpyridine\n400-290-2\n69045-82-5\nFlam. Liq. 3\nSkin Sens. 1\nAquatic Chronic 3\nH226\nH317\nH412\nGHS02\nGHS07\nWng\nH226\nH317\nH412\n\n\n\n613-072-00-9\nN,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine\n401-280-0\n91273-04-0\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH411\n\n\n\n613-073-00-4\nN,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine\n401-410-6\n10357-99-0\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH373 **\nH317\nH411\nGHS08\nGHS09\nWng\nH373 **\nH317\nH411\n\n\n\n613-074-00-X\n3-(3-methylpent-3-yl)isoxazol-5-ylamine\n401-460-9\n82560-06-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nEye Dam. 1\nAquatic Chronic 3\nH331\nH301\nH318\nH412\nGHS06\nGHS05\nDgr\nH331\nH301\nH318\nH412\n\n\n\n613-075-00-5\n1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione\n401-570-7\n89415-87-2\nOx. Sol. 1 ****\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nH271\nH331\nH314\nH302\nH317\nH400\nGHS03\nGHS06\nGHS05\nGHS09\nDgr\nH271\nH331\nH314\nH302\nH317\nH400\n\n\n\n613-076-00-0\n3-chloro-5-trifluoromethyl-2-pyridylamine\n401-670-0\n79456-26-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-077-00-6\nreaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine\n401-940-8\n—\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH302\nH319\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH411\n\n\n\n613-078-00-1\nN,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine\n401-990-0\n106990-43-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-079-00-7\n4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers\n402-520-7\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH315\nH317\nH410\n\n\n\n613-080-00-2\n3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione\n402-540-6\n105254-85-1\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n613-081-00-8\n1-butyl-2-methylpyridinium bromide\n402-680-8\n26576-84-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-082-00-3\n2-methyl-1-pentylpyridinium bromide\n402-690-2\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH312\nH302\nH412\nGHS07\nWng\nH312\nH302\nH412\n\n\n\n613-083-00-9\n2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate\n402-120-2\n—\nSkin Corr. 1B\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH373 **\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH373 **\nH317\nH410\n\n\n\n613-084-00-4\n2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate\n402-490-5\n106359-93-7\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n613-085-00-X\nreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione\n401-970-1\n—\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-086-00-5\ncaffeine\n200-362-1\n58-08-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-087-00-0\ntetrahydrothiophene\n203-728-9\n110-01-0\nFlam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH225\nH332\nH312\nH302\nH319\nH315\nH412\nGHS02\nGHS07\nDgr\nH225\nH332\nH312\nH302\nH319\nH315\nH412\n\n\n\n613-088-00-6\n1,2-benzisothiazol-3(2H)-one;\n1,2-benzisothiazolin-3-one\n220-120-9\n2634-33-5\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH302\nH315\nH318\nH317\nH400\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH315\nH318\nH317\nH400\n\nSkin Sens. 1; H317: C ≥ 0,05 %\n\n613-089-00-1\ndiquat dibromide; [1]\ndiquat dichloride; [2]\n6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]\n201-579-4 [1]\n223-714-6 [2]\n301-467-6 [3]\n85-00-7 [1]\n4032-26-2 [2]\n94021-76-8 [3]\nAcute Tox. 2 *\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH372 **\nH302\nH319\nH335\nH315\nH317\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH372 **\nH302\nH319\nH335\nH315\nH317\nH410\n\n\n\n613-090-00-7\nparaquat dichloride;\n1,1-dimethyl-4,4'-bipyridinium dichloride; [1]\nparaquat dimethylsulfate;\n1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]\n217-615-7 [1]\n218-196-3 [2]\n1910-42-5 [1]\n2074-50-2 [2]\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH311\nH301\nH372 **\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH311\nH301\nH372 **\nH319\nH335\nH315\nH410\n\n\n\n613-091-00-2\nmorfamquat dichloride; [1]\nmorfamquat sulfate [2]\n225-062-8 [1]\n[2]\n4636-83-3 [1]\n29873-36-7 [2]\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH335\nH315\nH412\nGHS07\nWng\nH302\nH319\nH335\nH315\nH412\n\n\n\n613-092-00-8\n1,10-phenanthroline\n200-629-2\n66-71-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n613-093-00-3\nhexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n400-050-7\n85153-92-0\nResp. Sens. 1\nSkin Sens. 1\nH334\nH317\nGHS08\nDgr\nH334\nH317\n\n\n\n613-094-00-9\n4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine\n401-360-5\n5248-39-5\nAcute Tox. 4 *\nSTOT RE 2 *\nH302\nH373 **\nGHS08\nGHS07\nWng\nH302\nH373 **\n\n\n\n613-095-00-4\nsodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate\n403-080-9\n92484-48-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-096-00-X\n2-amino-6-ethoxy-4-methylamino-1,3,5-triazine\n403-580-7\n62096-63-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-097-00-5\n7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid\n403-690-5\n111298-82-9\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH334\nH317\nH412\nGHS08\nDgr\nH334\nH317\nH412\n\n\n\n613-098-00-0\nN-(n-octyl)-2-pyrrolidone\n403-700-8\n2687-94-7\nSkin Corr. 1B\nAquatic Chronic 2\nH314\nH411\nGHS05\nGHS09\nDgr\nH314\nH411\n\n\n\n613-099-00-6\n1-dodecyl-2-pyrrolidone\n403-730-1\n2687-96-9\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH317\nH410\n\n\n\n613-100-00-X\n2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione\n404-230-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n613-101-00-5\nN—tert-pentyl-2-benzothiazolesulfenamide\n404-380-2\n110799-28-5\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-102-00-0\ndimethomorph (ISO);\n4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine\n404-200-2\n110488-70-5\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-103-00-6\nsodium 5-n-butylbenzotriazole\n404-450-2\n118685-34-0\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH411\n\n\n\n613-104-00-1\n5-tert-butyl-3-isoxazolylamine hydrochloride\n404-840-2\n—\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH373 **\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH318\nH412\n\n\n\n613-105-00-7\nhexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)\n405-160-9\n124537-30-0\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Chronic 3\nH301\nH317\nH412\nGHS06\nDgr\nH301\nH317\nH412\n\n\n\n613-106-00-2\ntetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate\n405-240-3\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n613-107-00-8\nhexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate\n405-280-1\n76508-02-6\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n613-108-00-3\nbenzothiazole-2-thiol\n205-736-8\n149-30-4\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-109-00-9\nbis(piperidinothiocarbonyl) disulphide\n202-328-1\n94-37-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nH319\nH335\nH315\nH317\nGHS07\nWng\nH319\nH335\nH315\nH317\n\n\n\n613-110-00-4\ndimepiperate (ISO);\nS-(1-methyl-1-phenylethyl) piperidine-1-carbothioate\n262-784-2\n61432-55-1\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n613-111-00-X\n1,2,4-triazole\n206-022-9\n288-88-0\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nH361d ***\nH302\nH319\nGHS08\nGHS07\nWng\nH361d ***\nH302\nH319\n\n\n\n613-112-00-5\nocthilinone (ISO);\n2-octyl-2H-isothiazol-3-one\n247-761-7\n26530-20-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH302\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH302\nH314\nH317\nH410\n\nSkin Sens. 1; H317: C ≥ 0,05 %\n\n613-113-00-0\n2-(morpholinothio)benzothiazole\n203-052-4\n102-77-2\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH315\nH317\nH411\n\n\n\n613-114-00-6\n2,2',2\"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;\n1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine\n225-208-0\n4719-04-4\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n613-115-00-1\nhymexazol (ISO);\n3-hydroxy-5-methylisoxazole\n233-000-6\n10004-44-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n\n613-116-00-7\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing ≥ 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nAcute Tox. 2 *\nSTOT RE 1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH330\nH372**\nH319\nH335\nH315\nH317\nH400\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH372**\nH319\nH335\nH315\nH317\nH400\n\nM=10\n\n\n\n\n613-116-01-4\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH319\nH335\nH315\nH317\nH400\nGHS07\nGHS09\nWng\nH319\nH335\nH315\nH317\nH400\n\nM=10\n\n\n613-117-00-2\ndiniconazole (ISO);\n(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;\n(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol\n—\n76714-88-0\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-118-00-8\nflubenzimine (ISO);\nN-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline\n253-703-1\n37893-02-0\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH319\nH410\n\n\n\n613-119-00-3\n(benzothiazol-2-ylthio)methyl thiocyanate;\nTCMTB\n244-445-0\n21564-17-0\nAcute Tox. 2 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH319\nH315\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH302\nH319\nH315\nH317\nH410\n\n\n\n\n613-120-00-9\nbioresmethrin (ISO);\n(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate\n249-014-0\n28434-01-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 1000\n\n\n613-121-00-4\nchlorsulfuron (ISO);\n2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide\n265-268-5\n64902-72-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-122-00-X\ndiclobutrazole (ISO);\n(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;\n(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol\n—\n75736-33-3\nEye Irrit. 2\nAquatic Chronic 2\nH319\nH411\nGHS07\nGHS09\nWng\nH319\nH411\n\n\n\n613-123-00-5\n5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;\netem\n251-684-4\n33813-20-6\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-124-00-0\nfenpropimorph (ISO);\ncis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine\n266-719-9\n67564-91-4\nRepr. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 2\nH361d ***\nH302\nH315\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH315\nH411\n\n\n\n613-125-00-6\nhexythiazox(ISO);\ntrans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide\n—\n78587-05-0\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-126-00-1\nimazapyr (ISO);\n2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate\n—\n81334-34-1\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n613-127-00-7\n1,1-dimethylpiperidinium chloride;\nmepiquat chloride\n246-147-6\n24307-26-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-128-00-2\nprochloraz (ISO);\nN-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide\n266-994-5\n67747-09-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-129-00-8\nmetamitron (ISO);\n4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one\n255-349-3\n41394-05-2\nAcute Tox. 4 *\nAquatic Acute 1\nH302\nH400\nGHS07\nGHS09\nWng\nH302\nH400\n\n\n\n613-131-00-9\npyroquilon (ISO);\n1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one\n—\n57369-32-1\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n613-132-00-4\nhexazinone (ISO);\n3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione\n257-074-4\n51235-04-2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH410\n\n\n\n613-133-00-X\netridiazole (ISO);\n5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole\n219-991-8\n2593-15-9\nCarc. 2\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH331\nH312\nH302\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH351\nH331\nH312\nH302\nH410\n\n\n\n613-134-00-5\nmyclobutanil(ISO);\n2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile\n—\n88671-89-0\nRepr. 2\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH361d ***\nH302\nH319\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d ***\nH302\nH319\nH411\n\n\n\n613-135-00-0\ndi(benzothiazol-2-yl) disulphide\n204-424-9\n120-78-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\nEUH031\n\n\n613-136-00-6\nN-cyclohexylbenzothiazole-2-sulphenamide\n202-411-2\n95-33-0\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-137-00-1\nmethabenzthiazuron (ISO);\n1-(1,3-benzothiazol-2-yl)1,3-dimethylurea\n242-505-0\n18691-97-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-138-00-7\nquinoxyfen (ISO);\n5,7-dichloro-4-(4-fluorophenoxy)quinoline\n—\n124495-18-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n613-139-00-2\nmetsulfuron-methyl (ISO);\nmethyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate\n—\n74223-64-6\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM = 1000\n\n\n613-140-00-8\ncycloheximide (ISO);\n4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione\n200-636-0\n66-81-9\nMuta. 2\nRepr. 1B\nAcute Tox. 2 *\nAquatic Chronic 2\nH341\nH360D ***\nH300\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH341\nH360D ***\nH300\nH411\n\n\n\n613-141-00-3\n1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone\n401-470-3\n93686-63-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-142-00-9\ntrans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate\n405-860-4\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-143-00-4\n1-(3-phenylpropyl)-2-methylpyridinium bromide\n405-930-4\n10551-42-5\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH412\nGHS07\nWng\nH302\nH319\nH412\n\n\n\n613-144-00-X\nreaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate\n406-460-2\n125139-08-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-145-00-5\n(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate\n406-960-0\n77497-97-3\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-146-00-0\nN-ethyl-N-methylpiperidinium iodide\n407-780-5\n4186-71-4\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n613-147-00-6\n4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine\n407-940-4\n111681-72-2\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-148-00-1\ntetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane\n411-240-4\n143683-23-2\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-149-00-7\npyridaben (ISO);\n2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one\n405-700-3\n96489-71-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH410\n\n\n\n613-150-00-2\n2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione\n406-295-6\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-151-00-8\n1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine\n406-360-9\n104218-44-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-152-00-3\nphenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate\n406-600-2\n89392-03-0\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-153-00-9\n2,3,5-trichloropyridine\n407-270-2\n16063-70-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-154-00-4\n2-amino-4-chloro-6-methoxypyrimidine\n410-050-9\n5734-64-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-155-00-X\n5-chloro-2,3-difluoropyridine\n410-090-7\n89402-43-7\nFlam. Liq. 3\nAcute Tox. 4 *\nAquatic Chronic 3\nH226\nH302\nH412\nGHS02\nGHS07\nWng\nH226\nH302\nH412\n\n\n\n613-156-00-5\n2-butyl-4-chloro-5-formylimidazole\n410-260-0\n83857-96-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-157-00-0\n2,4-diamino-5-methoxymethylpyrimidine\n410-330-0\n54236-98-5\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nH302\nH373 **\nH319\nGHS08\nGHS07\nWng\nH302\nH373 **\nH319\n\n\n\n613-158-00-6\n2,3-dichloro-5-trifluoromethyl-pyridine\n410-340-5\n69045-84-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH332\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH318\nH317\nH411\n\n\n\n613-159-00-1\nfenazaquin (ISO);\n4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline\n410-580-0\n120928-09-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH332\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH332\nH410\n\n\n\n613-160-00-7\n(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide\n411-000-9\n125224-62-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n613-161-00-2\n(2,4-diaminopteridin-6-yl)methanol hydrobromide\n430-620-0\n76145-91-0\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3\nH373**\nH317\nH412\nGHS08\nGHS07\nWng\nH373**\nH317\nH412\n\n\n\n\n\n613-162-00-8\n(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide\n423-260-0\n100988-63-4\nMuta. 2\nSkin Sens. 1\nAquatic Chronic 2\nH341\nH317\nH411\nGHS08\nGHS07\nGHS09\nWng\nH341\nH317\nH411\n\n\n\n\n\n\n613-163-00-3\nazimsulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea\n—\n120162-55-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n613-164-00-9\nflufenacet (ISO);\nN-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide\n—\n142459-58-3\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\nM=100\n\n\n613-165-00-4\nflupyrsulfuron-methyl-sodium (ISO);\nmethyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt\n—\n144740-54-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=100\n\n\n613-166-00-X\nflumioxazin (ISO);\nN-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide\n—\n103361-09-7\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D***\nH410\n\nM=1000\n\n\n613-167-00-5\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)\n—\n55965-84-9\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH311\nH301\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH311\nH301\nH314\nH317\nH410\n\nSkin Corr. 1B; H314: C ≥ 0,6 %\nSkin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %\nEye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %\nSkin Sens. 1; H317: C ≥ 0,0015 %\n\n613-168-00-0\n1-vinyl-2-pyrrolidone\n201-800-4\n88-12-0\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSTOT SE 3\nEye Dam. 1\nH351\nH332\nH312\nH302\nH373 **\nH335\nH318\nGHS06\nGHS05\nGHS09\nDgr\nH351\nH332\nH312\nH302\nH373 **\nH335\nH318\n\n\nD\n\n\n\n613-169-00-6\n9-vinylcarbazole\n216-055-0\n1484-13-5\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH341\nH312\nH302\nH315\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH341\nH312\nH302\nH315\nH317\nH410\n\nM=100\n\n\n613-170-00-1\n2,2-ethylmethylthiazolidine\n404-500-3\n694-64-4\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-171-00-7\nhexaconazole (ISO);\n(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol\n413-050-7\n79983-71-4\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n613-172-00-2\n5-chloro-1,3-dihydro-2H-indol-2-one\n412-200-9\n17630-75-0\nRepr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3\nH361f ***\nH302\nH317\nH412\nGHS08\nGHS07\nWng\nH361f ***\nH302\nH317\nH412\n\n\n\n613-173-00-8\nfluquinconazole (ISO);\n3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one\n411-960-9\n136426-54-5\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH372 **\nH312\nH315\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH301\nH372 **\nH312\nH315\nH410\n\n\n\n\n\n\n613-174-00-3\ntetraconazole (ISO);\n(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether\n407-760-6\n112281-77-3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2\nH332\nH302\nH411\nGHS07\nGHS09\nWng\nH332\nH302\nH411\n\n\n\n\n613-175-00-9\nepoxiconazole(ISO);\n(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane\n406-850-2\n133855-98-8\nCarc. 2\nRepr. 2\nAquatic Chronic 2\nH351\nH361fd\nH411\nGHS08\nGHS09\nWng\nH351\nH361fd\nH411\n\n\n\n613-176-00-4\n2-methyl-2-azabicyclo[2.2.1]heptane\n404-810-9\n4524-95-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nH226\nH312\nH302\nH373 **\nH314\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH312\nH302\nH373 **\nH314\n\n\n\n613-177-00-X\n8-amino-7-methylquinoline\n412-760-4\n5470-82-6\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH317\nH411\n\n\n\n613-178-00-5\n4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine\n410-470-2\n137796-06-6\nSkin Corr. 1B\nSkin Sens. 1\nH314\nH317\nGHS05\nGHS07\nDgr\nH314\nH317\n\nSTOT SE 3; H335: C ≥ 5 %\n\n613-179-00-0\nlithium 3-oxo-1,2(2H)-benzisothiazol-2-ide\n411-690-1\n111337-53-2\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH314\nH317\nH411\nGHS05\nGHS07\nDgr\nH302\nH314\nH317\nH411\n\n\n\n613-180-00-6\nN-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide\n407-430-1\n3741-80-8\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-181-00-1\n5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone\n405-090-9\n67485-29-4\nSTOT RE 1\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH372 **\nH302\nH319\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH372 **\nH302\nH319\nH410\n\n\n\n613-182-00-7\n1-(1-naphthylmethyl)quinolinium chloride\n406-220-7\n65322-65-8\nCarc. 2\nMuta. 2\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH351\nH341\nH302\nH315\nH318\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH341\nH302\nH315\nH318\nH412\n\n\n\n613-183-00-2\nreaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;\n5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one\n413-640-4\n—\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n613-184-00-8\nnitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate\n413-670-8\n—\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n613-185-00-3\n2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one\n407-630-9\n82633-79-2\nAcute Tox. 3 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH318\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH301\nH318\nH317\nH410\n\n\n\n613-186-00-9\n(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate\n408-050-9\n76855-69-1\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH317\nH411\n\n\n\n\n\n613-187-00-4\n5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene\n410-530-8\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-188-00-X\n1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone\n411-500-7\n116256-11-2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-189-00-5\n1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane\n414-030-0\n52667-88-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n613-190-00-0\ndisodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate\n414-040-5\n149530-93-8\nAcute Tox. 4 *\nSkin Sens. 1\nH302\nH317\nGHS07\nWng\nH302\nH317\n\n\n\n613-191-00-6\n3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine\n421-150-7\n143860-04-2\nRepr. 1B\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360F ***\nH314\nH400\nH410\nGHS08\nGHS05\nGHS09\nDgr\nH360F ***\nH314\nH410\n\n\n\n\n\n\n613-192-00-1\n3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane\n426-750-2\n151860-15-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-193-00-7\npentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate\n414-930-3\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n613-194-00-2\n6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt\n418-000-8\n163062-28-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-195-00-8\n2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)\n418-280-1\n18600-59-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n613-196-00-3\n5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt\n418-380-5\n168113-78-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-197-00-9\nreaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;\n2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;\n[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;\n[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine\n420-390-1\n187547-46-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n613-198-00-4\n2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine\n415-500-8\n145963-84-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n613-199-00-X\nreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;\nreaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione\n421-550-1\n—\nCarc. 1B\nRepr. 1B\nSkin Sens. 1\nAquatic Chronic 3\nH350\nH360D ***\nH317\nH412\nGHS08\nDgr\nH350\nH360D ***\nH317\nH412\n\n\n\n613-200-00-3\nReaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts\n420-980-7\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n613-201-00-9\n(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole\n422-390-5\n143322-57-0\nRepr. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH372 **\nH332\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nDgr\nH361f ***\nH372 **\nH332\nH302\nH317\nH410\nEUH070\n\n\n613-202-00-4\npymetrozine (ISO);\n(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one\n—\n123312-89-0\nCarc. 2\nAquatic Chronic 3\nH351\nH412\nGHS08\nWng\nH351\nH412\n\n\n\n\n\n613-203-00-X\npyraflufen-ethyl (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]\npyraflufen (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]\n- [1]\n- [2]\n129630-19-9 [1]\n129630-17-7 [2]\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=1000\n\n\n\n613-204-00-5\noxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one\n254-637-6\n39807-15-3\nRepr. 2\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH361d***\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH361d***\nH373**\nH410\n\nM = 1000\n\n\n\n613-205-00-0\npropiconazole(ISO);\n(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole\n262-104-4\n60207-90-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n613-206-00-6\nfenamidone (ISO);\n(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one\n—\n161326-34-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-208-00-7\nimazamox (ISO);\n(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid\n—\n114311-32-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-209-00-2\ncis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride\n417-430-3\n63645-17-0\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH373 **\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH301\nH373 **\nH317\nH411\n\n\n\n613-210-00-8\n2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane\n417-650-1\n88128-57-8\nSTOT RE 2 *\nAquatic Chronic 3\nH373 **\nH412\nGHS08\nWng\nH373 **\nH412\n\n\n\n613-211-00-3\nN-methyl-4-(p-formylstyryl)pyridinium methylsulfate\n418-240-3\n74401-04-0\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n613-212-00-9\n4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)\n418-320-8\n133467-41-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n613-213-00-4\ncis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline\n416-040-0\n120807-02-5\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n613-214-00-X\nN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide\n416-260-7\n147613-95-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-215-00-5\n2-chloromethyl-3,4-dimethoxypyridinium chloride\n416-440-5\n72830-09-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH312\nH302\nH373 **\nH315\nH318\nH317\nH411\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH312\nH302\nH373 **\nH315\nH318\nH317\nH411\n\n\n\n613-216-00-0\n6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole\n416-490-8\n162208-01-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n613-217-00-6\n4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine\n416-770-1\n73754-27-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-218-00-1\n6-hydroxyindole\n417-020-4\n2380-86-1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH317\nH411\n\n\n\n613-219-00-7\n7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole\n417-140-7\n79185-77-6\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n613-220-00-2\ntrans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide\n417-290-3\n147086-81-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n613-221-00-8\n2-chloro-5-methyl-pyridine\n418-050-0\n18368-64-4\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nAquatic Chronic 3\nH312\nH302\nH315\nH412\nGHS07\nWng\nH312\nH302\nH315\nH412\n\n\n\n613-222-00-3\n4-(1-oxo-2-propenyl)-morpholine\n418-140-1\n5117-12-4\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373 **\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH302\nH373 **\nH318\nH317\n\n\n\n613-223-00-9\nN-isopropyl-3-(4-fluorophenyl)-1H-indole\n418-790-4\n93957-49-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n613-224-00-4\n2,5-dimercaptomethyl-1,4-dithiane\n419-770-8\n136122-15-1\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n613-225-00-X\nreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;\n2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.\n421-290-9\n—\nSTOT RE 2 *\nAquatic Chronic 4\nH373 **\nH413\nGHS08\nWng\nH373 **\nH413\n\n\n\n613-226-00-5\n1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride\n420-950-3\n163831-67-2\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n613-227-00-0\n(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-600-2\n99199-90-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n613-228-00-6\n(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-630-6\n793669-26-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n\n613-229-00-1\n1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine\n411-930-5\n106917-31-1\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n\n\n613-230-00-7\nflorasulam (ISO);\n2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];\npyrimidine-2-sulfonanilide\n—\n145701-23-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n613-231-00-2\n2,6-diamino-3-((pyridine-3-yl)azo)pyridine\n421-430-9\n28365-08-4\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373**\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH411\n\n\n\n\n613-232-00-8\n3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide\n431-030-6\n163269-30-5\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH373**\nH318\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH331\nH373**\nH318\nH410\n\n\n\n\n613-233-00-3\n4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane\n423-230-7\n56552-15-9\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n\n613-234-00-9\nimidazo[1,2-b]pyridazin hydrochloride\n431-510-5\n18087-70-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n613-235-00-4\n2,3-dihydro-2,2-dimethyl-1H-perimidine\n424-060-6\n6364-17-6\nAcute Tox. 4*\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH317\nH410\n\n\n\n\n613-236-00-X\n2-chloro-3-trifluoromethylpyridine\n424-520-6\n65753-47-1\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Corr. 1B\nAquatic Chronic 3\nH311\nH301\nH372**\nH314\nH412\nGHS06\nGHS05\nGHS08\nDgr\nH311\nH301\nH372**\nH314\nH412\n\n\n\n\n613-237-00-5\n6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine\n424-950-4\n133949-92-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-238-00-0\nsodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate\n430-890-1\n81992-66-7\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n\n613-239-00-6\n2-[3-(methylamino)propyl]-1H-benzimidazole\n425-760-4\n64137-52-6\nEye Dam. 1\nAquatic Chronic 3\nH318\nH412\nGHS05\nDgr\nH318\nH412\n\n\n\n\n613-241-00-7\n3-(2H-tetrazol-5-yl)pyridine\n426-810-8\n3250-74-6\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-242-00-2\nreaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts\n426-860-0\n191877-09-5\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-243-00-8\n4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)\n427-350-0\n182235-14-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-244-00-3\n5,7-dichloro-4-hydroxyquinoline\n427-420-0\n21873-52-9\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-245-00-9\n2-fluoro-6-trifluoromethylpyridine\n428-100-3\n94239-04-0\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH226\nH332\nH302\nH412\nGHS02\nGHS07\nWng\nH226\nH332\nH302\nH412\n\n\n\n\n613-246-00-4\n2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine\n428-200-7\n103577-66-8\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-247-00-X\n3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole\n428-910-7\n107786-36-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-248-00-5\n3,4-dimethyl-1H-pyrazole\n429-130-1\n2820-37-3\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-249-00-0\n1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate\n429-300-3\n155601-30-2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n\n613-250-00-6\nreaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;\nmethyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;\n2-isopropyl-N-hydroxyethyl 1,3-oxazolidine\n429-990-6\n—\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH318\nH317\nH412\n\n\n\n\n613-251-00-1\n(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole\n430-560-5\n180637-89-2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\n\n\n\n\n613-253-00-2\n2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;\nreaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)\n430-580-4\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\nEUH019\n\n\n\n613-254-00-8\nforchlorfenuron (ISO);\n1-(2-chloro-4-pyridyl)-3-phenylurea\n—\n68157-60-8\nCarc. 2\nAquatic Chronic 2\nH351\nH411\nGHS08\nGHS09\nWng\nH351\nH411\n\n\n\n\n613-255-00-3\nreaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)\n424-270-8\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-256-00-9\n3'5'-anhydro thymidine\n425-810-5\n38313-48-3\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-257-00-4\n2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate\n426-400-9\n170222-39-6\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n613-258-00-X\nreaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;\n4-chloro-5-methylbenzotriazole sodium salt;\n5-chloro-4-methylbenzotriazole sodium salt\n427-730-6\n202420-04-0\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n\n613-259-00-5\nreaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;\n[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate\n428-790-6\n72963-72-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n\n613-260-00-0\n(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin\n430-730-9\n—\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH400\nH410\nGHS05\nGHS09\nDgr\nH318\nH410\n\n\n\n\n613-261-00-6\npyrazole-1-carboxamidine monohydrochloride\n429-520-1\n4023-02-3\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH373**\nH318\nH317\nH412\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH317\nH412\n\n\n\n\n613-262-00-1\ndisodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene\n427-310-2\n180850-95-7\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-263-00-7\nmonosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate\n429-570-2\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-266-00-3\n2-chloro-5-chloromethylthiazole\n429-830-5\n105827-91-6\nAcute Tox. 3 *\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH311\nH314\nH302\nH317\nH411\nGHS06\nGHS05\nGHS09\nDgr\nH311\nH314\nH302\nH317\nH411\n\n\n\n\n613-267-00-9\nthiamethoxam (ISO);\n3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine\n428-650-4\n153719-23-4\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n613-268-00-4\n(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine\n425-930-8\n151213-39-7\nSkin Corr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH314\nH332\nH302\nH373**\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH314\nH332\nH302\nH373**\nH411\n\n\n\n\n613-269-00-X\n2-thiazolidinylidenecyanamide\n427-720-1\n26364-65-8\nAcute Tox. 4*\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n613-270-00-5\n5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide\n428-150-6\n113171-13-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-271-00-0\ntritosulfuron (ISO) (containing ≤ 0,02 % AMTT);\n1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)\n—\n142469-14-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n613-272-00-6\npyraclostrobin (ISO);\nmethyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate\n—\n—\nAcute Tox. 3 *\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH315\nH410\n\nM=100\n\n\n613-273-00-1\ntetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine\n427-600-9\n192439-46-6\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-274-00-7\n2,6-dichloro-1-fluoropyridiniumtetrafluoroborate\n427-400-1\n140623-89-8\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH314\nH302\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH314\nH302\nH317\nH410\n\n\n\n\n613-275-00-2\n3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride\n424-530-0\n93076-03-0\nAcute Tox. 3 *\nSTOT SE 2\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH301\nH371**\nH373**\nH318\nH317\nH411\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH301\nH371**\nH373**\nH318\nH317\nH411\n\n\n\n\n\n613-276-00-8\n1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one\n426-110-2\n98377-35-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-277-00-3\n(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one\n427-070-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-278-00-9\n(3-aminophenyl)pyridin-3-ylmethanone\n428-230-0\n79568-06-2\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n613-279-00-4\n2-ethyl-2,3-dihydro-2-methyl-1H-perimidine\n424-380-6\n43057-68-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n613-280-00-X\ntetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;\ndimethyl propyleneurea\n230-625-6\n7226-23-5\nRepr. 2\nAcute Tox. 4 *\nEye Dam. 1\nH361f***\nH302\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH361f***\nH302\nH318\n\n\n\n\n613-281-00-5\nquinoline\n202-051-6\n91-22-5\nCarc. 1B\nMuta. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH350\nH341\nH312\nH302\nH319\nH315\nH411\nGHS08\nGHS07\nGHS09\nDgr\nH350\nH341\nH312\nH302\nH319\nH315\nH411\n\n\n\n\n613-282-00-0\ntriticonazole (ISO);\n(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol\n—\n131983-72-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n613-283-00-6\nketoconazole;\n1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone\n265-667-4\n65277-42-1\nRepr. 1B\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH360F***\nH301\nH373**\nH400\nH410\nGHS06\nGHS08\nGHS09\nDgr\nH360F***\nH301\nH373**\nH410\n\n\n\n\n613-284-00-1\nmetconazole (ISO);\n(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol\n—\n125116-23-6\nRepr. 2\nAcute Tox. 4 *\nAquatic Chronic 2\nH361d***\nH302\nH411\nGHS08\nGHS07\nGHS09\nWng\nH361d***\nH302\nH411\n\n\n\n\n613-285-00-7\n1-hydroxybenzotriazole, anhydrous; [1]\n1-hydroxybenzotriazole, monohydrated [2]\n219-989-7 [1]\n219-989-7 [2]\n2592-95-2 [1]\n123333-53-9 [2]\nExpl. 1.3\nH203\nGHS01\nDgr\nH203\n\n\n\n\n613-286-00-2\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]\n418-260-2\n183196-57-8\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n613-286-01-X\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]\n418-260-2\n183196-57-8\nRepr. 1B\nSkin Sens. 1\nH360D***\nH317\nGHS08\nGHS07\nDgr\nH360D***\nH317\n\n\n\n\n613-287-00-8\n1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole\n419-540-7\n160194-26-3\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n613-288-00-3\n1,3-bis(dimethylcarbamoyl)-imidazolium chloride\n420-930-4\n135756-61-5\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-289-00-9\n3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole\n432-020-4\n142623-48-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-290-00-4\n4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride\n432-470-1\n189012-93-9\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n613-291-00-X\n2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one\n434-820-9\n106461-41-0\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373**\nH400\nH410\nGHS08\nGHS09\nWng\nH373**\nH410\n\n\n\n\n613-292-00-5\nN,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine\n435-010-8\n26157-73-3\nMuta. 2\nAquatic Chronic 3\nH341\nH412\nGHS08\nWng\nH341\nH412\n\n\n\n\n613-293-00-0\n2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester\n448-050-6\n444065-11-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-294-00-6\n2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester\n448-260-8\n379268-96-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-295-00-1\n11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride\n448-720-8\n363138-44-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n613-296-00-7\npentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate\n418-270-7\n—\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n613-297-00-2\n5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole\n420-820-6\n—\nFlam. Liq. 3\nAcute Tox. 4 *\nAquatic Chronic 2\nH226\nH302\nH411\nGHS02\nGHS07\nGHS09\nWng\nH226\nH302\nH411\n\n\n\n\n613-298-00-8\nbis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate\n421-560-6\n—\nSTOT RE 2 *\nEye Dam. 1\nAquatic Chronic 2\nH373**\nH318\nH411\nGHS05\nGHS08\nGHS09\nDgr\nH373**\nH318\nH411\n\n\n\n\n613-299-00-3\nmain component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt\n422-610-1\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-300-00-7\n1-imidazol-1-yl-octadecan-2-ol\n434-120-3\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n613-301-00-2\ndimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate\n443-910-7\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-302-00-8\ndisodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate\n432-980-4\n243858-60-8\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n\n613-303-00-3\n2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine\n429-800-1\n95737-68-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-304-00-9\n5,6-dihydroxy-2,3-dihydro-1H-indolium bromide\n421-170-6\n138937-28-7\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n\n613-305-00-4\n2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole\n448-630-9\n3147-77-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n613-306-00-X\n(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate\n433-520-5\n82911-69-1\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH317\nH411\n\n\n\n\n613-307-00-5\nclothianidin (ISO);\n3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine\n—\n210880-92-5\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\nM=10\n\n\n613-308-00-0\n2-amino-5-methylthiazole\n423-800-5\n7305-71-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373**\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373**\nH410\n\n\n\n\n613-309-00-6\n1-methyl-3-phenyl-1-piperazine\n431-180-2\n5271-27-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3\nH312\nH302\nH315\nH318\nH412\nGHS05\nGHS07\nDgr\nH312\nH302\nH315\nH318\nH412\n\n\n\n\n613-310-00-1\n(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride\n432-360-3\n105813-13-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n\n613-311-00-7\nmethyl-5-nitrophenyl-guanidine\n435-500-1\n152460-07-6\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH319\nH317\nH412\nGHS07\nWng\nH302\nH319\nH317\nH412\n\n\n\n\n613-312-00-2\n2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride\n420-200-5\n—\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n613-313-00-8\n2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione\n442-780-9\n173838-67-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n613-314-00-3\n4-decyloxazolidin-2-one;\n4-decyl-1,3-oxazolidin-2-one\n443-770-7\n7693-82-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n613-315-00-9\ntetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate\n430-390-1\n—\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH412\nGHS07\nWng\nH332\nH412\n\n\n\n\n613-316-00-4\ntrimethylopropane tri(3-aziridinylpropanoate);\n(TAZ)\n257-765-0\n52234-82-9\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nH341\nH318\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH341\nH318\nH317\n\n\nH\n\n614-001-00-4\nnicotine (ISO);\n3-(N-methyl-2-pyrrolidinyl)pyridine\n200-193-3\n54-11-5\nAcute Tox. 1\nAcute Tox. 3 *\nAquatic Chronic 2\nH310\nH301\nH411\nGHS06\nGHS09\nDgr\nH310\nH301\nH411\n\n\n\n614-002-00-X\nsalts of nicotine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Chronic 2\nH330\nH310\nH300\nH411\nGHS06\nGHS09\nDgr\nH330\nH310\nH300\nH411\n\n\nA\n614-003-00-5\nstrychnine\n200-319-7\n57-24-9\nAcute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH310\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH310\nH300\nH410\n\n\n\n614-004-00-0\nsalts of strychnine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH300\nH400\nH410\nGHS06\nGHS09\nDgr\nH330\nH300\nH410\n\n\nA\n\n\n614-005-00-6\ncolchicine\n200-598-5\n64-86-8\nMuta. 1B\nAcute Tox. 2 *\nH340\nH300\nGHS06\nGHS08\nDgr\nH340\nH300\n\n\n\n\n614-006-00-1\nbrucine;\n2,3-dimethoxystrychnine\n206-614-7\n357-57-3\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Chronic 3\nH330\nH300\nH412\nGHS06\nDgr\nH330\nH300\nH412\n\n\n\n614-007-00-7\nbrucine sulphate; [1]\nbrucine nitrate; [2]\nstrychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]\nstrychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]\n225-432-9 [1]\n227-317-9 [2]\n269-439-5 [3]\n269-710-8 [4]\n4845-99-2 [1]\n5786-97-0 [2]\n68239-26-9 [3]\n68310-42-9 [4]\nAcute Tox. 2 *\nAcute Tox. 2 *\nAquatic Chronic 3\nH330\nH300\nH412\nGHS06\nDgr\nH330\nH300\nH412\n\n\nA\n614-008-00-2\naconitine\n206-121-7\n302-27-2\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-009-00-8\nsalts of aconitine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-010-00-3\natropine\n200-104-8\n51-55-8\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-011-00-9\nsalts of atropine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-012-00-4\nhyoscyamine\n202-933-0\n101-31-5\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-013-00-X\nsalts of hyoscyamine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-014-00-5\nhyoscine\n200-090-3\n51-34-3\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\n\n614-015-00-0\nsalts of hyoscine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 1\nAcute Tox. 2 *\nH330\nH310\nH300\nGHS06\nDgr\nH330\nH310\nH300\n\n\nA\n614-016-00-6\npilocarpine\n202-128-4\n92-13-7\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-017-00-1\nsalts of pilocarpine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-018-00-7\npapaverine\n200-397-2\n58-74-2\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n614-019-00-2\nsalts of papaverine\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n614-020-00-8\nphysostigmine\n200-332-8\n57-47-6\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\n\n614-021-00-3\nsalts of physostigmine\n—\n—\nAcute Tox. 2 *\nAcute Tox. 2 *\nH330\nH300\nGHS06\nDgr\nH330\nH300\n\n\nA\n614-022-00-9\ndigitoxin\n200-760-5\n71-63-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-023-00-4\nephedrine\n206-080-5\n299-42-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n614-024-00-X\nsalts of ephedrine\n—\n—\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\nA\n614-025-00-5\nouabain\n211-139-3\n630-60-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-026-00-0\nstrophantin-K\n234-239-9\n11005-63-3\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nH331\nH301\nH373 **\nGHS06\nGHS08\nDgr\nH331\nH301\nH373 **\n\n\n\n614-027-00-6\nbufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;\nred squill;\nscilliroside\n208-077-4\n507-60-8\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n614-028-00-1\nreaction mass of: 2-ethylhexyl mono-D-glucopyranoside;\n2-ethylhexyl di-D-glucopyranoside\n414-420-0\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n614-029-00-7\nconstitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside\n419-640-0\n68784-14-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n615-001-00-7\nmethyl isocyanate\n210-866-3\n624-83-9\nFlam. Liq. 2\nRepr. 2\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nResp. Sens. 1\nSkin Sens. 1\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nH225\nH361d***\nH330\nH311\nH301\nH334\nH317\nH335\nH315\nH318\nGHS02\nGHS06\nGHS05\nGHS08\nDgr\nH225\nH361d***\nH330\nH311\nH301\nH334\nH317\nH335\nH315\nH318\n\n\n\n\n615-002-00-2\nmethyl isothiocyanate\n209-132-5\n556-61-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH314\nH317\nH400\nH410\nGHS06\nGHS05\nGHS09\nDgr\nH331\nH301\nH314\nH317\nH410\n\n\n\n615-003-00-8\nthiocyanic acid\n207-337-4\n463-56-9\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\nEUH032\n\n\n\n\n\n615-004-00-3\nsalts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\nEUH032\n\nA\n\n615-005-00-9\n4,4'-methylenediphenyl diisocyanate;\ndiphenylmethane-4,4'-diisocyanate; [1]\n2,2'-methylenediphenyl diisocyanate;\ndiphenylmethane-2,2'-diisocyanate; [2]\no-(p-isocyanatobenzyl)phenyl isocyanate;\ndiphenylmethane-2,4'-diisocyanate; [3]\nmethylenediphenyl diisocyanate [4]\n202-966-0 [1]\n219-799-4 [2]\n227-534-9 [3]\n247-714-0 [4]\n101-68-8 [1]\n2536-05-2 [2]\n5873-54-1 [3]\n26447-40-5 [4]\nCarc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH351\nH332\nH373**\nH319\nH335\nH315\nH334\nH317\nGHS08\nGHS07\nDgr\nH351\nH332\nH373**\nH319\nH335\nH315\nH334\nH317\n\nEye Irrit. 2; H319: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\nResp. Sens. 1; H334: C ≥ 0,1 %\nSTOT SE 3; H335: C ≥ 5 %\nC2\n\n615-006-00-4\n2-methyl-m-phenylene diisocyanate;\ntoluene-2,4-di-isocyanate; [1]\n4-methyl-m-phenylene diisocyanate;\ntoluene-2,6-di-isocyanate; [2]\nm-tolylidene diisocyanate;\ntoluene-diisocyanate [3]\n202-039-0 [1]\n209-544-5 [2]\n247-722-4 [3]\n91-08-7 [1]\n584-84-9 [2]\n26471-62-5 [3]\nCarc. 2\nAcute Tox. 2 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH351\nH330\nH319\nH335\nH315\nH334\nH317\nH412\nGHS06\nGHS08\nDgr\nH351\nH330\nH319\nH335\nH315\nH334\nH317\nH412\n\nResp. Sens. 1; H334: C ≥ 0,1 %\nC\n615-007-00-X\n1,5-naphthylene diisocyanate\n221-641-4\n3173-72-6\nAcute Tox. 4 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nAquatic Chronic 3\nH332\nH319\nH335\nH315\nH334\nH412\nGHS08\nGHS07\nDgr\nH332\nH319\nH335\nH315\nH334\nH412\n\n\n\n615-008-00-5\n3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;\nisophorone di-isocyanate\n223-861-6\n4098-71-9\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 2\nH331\nH319\nH335\nH315\nH334\nH317\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\nH411\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens.1; H317: C ≥ 0,5 %\n2\n615-009-00-0\n4,4'-methylenedi(cyclohexyl isocyanate);\ndicyclohexylmethane-4,4'-di-isocyanate\n225-863-2\n5124-30-1\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH331\nH319\nH335\nH315\nH334\nH317\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n2\n615-010-00-6\n2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]\n2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]\n241-001-8 [1]\n239-714-4 [2]\n16938-22-0 [1]\n15646-96-5 [2]\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH331\nH319\nH335\nH315\nH334\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\nC2\n615-011-00-1\nhexamethylene-di-isocyanate\n212-485-8\n822-06-0\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nH331\nH319\nH335\nH315\nH334\nH317\nGHS06\nGHS08\nDgr\nH331\nH319\nH335\nH315\nH334\nH317\n\n*\nResp. Sens. 1; H334: C ≥ 0,5 %\nSkin Sens. 1; H317: C ≥ 0,5 %\n2\n615-012-00-7\n4-isocyanatosulphonyltoluene;\ntosyl isocyanate\n223-810-8\n4083-64-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\nEUH014\nEye Irrit.; H319: C ≥ 5 %\nSTOT SE 3; H335: C ≥ 5 %\nSkin Irrit. 2; H315: C ≥ 5 %\n\n615-013-00-2\ncyanamide;\ncarbanonitril\n206-992-3\n420-04-2\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH301\nH312\nH319\nH315\nH317\nGHS06\nDgr\nH301\nH312\nH319\nH315\nH317\n\n\n\n615-014-00-8\ntris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate\n—\n7276-58-6\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n615-015-00-3\n1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;\nisobornyl thiocyanoacetate\n204-081-5\n115-31-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n615-016-00-9\npotassium cyanate\n209-676-3\n590-28-3\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n615-017-00-4\ncalcium cyanamide\n205-861-8\n156-62-7\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1\nH302\nH335\nH318\nGHS05\nGHS07\nDgr\nH302\nH335\nH318\n\n\n\n615-018-00-X\n2-(2-butoxyethoxy)ethyl thiocyanate\n203-985-7\n112-56-1\nFlam. Liq. 3\nAcute Tox. 3 *\nAcute Tox. 3 *\nH226\nH311\nH301\nGHS02\nGHS06\nDgr\nH226\nH311\nH301\n\n\n\n615-019-00-5\ndicyclohexylcarbodiimide\n208-704-1\n538-75-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH311\nH302\nH318\nH317\nGHS06\nGHS05\nDgr\nH311\nH302\nH318\nH317\n\n\n\n615-020-00-0\nmethylene dithiocyanate\n228-652-3\n6317-18-6\nAcute Tox. 2 *\nAcute Tox. 3 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nH330\nH301\nH314\nH317\nH400\nGHS06\nGHS05\nGHS09\nDgr\nH330\nH301\nH314\nH317\nH400\n\n\n\n615-021-00-6\n1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;\nTGIC\n219-514-3\n2451-62-9\nMuta. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH340\nH331\nH301\nH373 **\nH318\nH317\nH412\nGHS06\nGHS08\nGHS05\nDgr\nH340\nH331\nH301\nH373 **\nH318\nH317\nH412\n\n\n\n\n\n615-022-00-1\nmethyl 3-isocyanatosulfonyl-2-thiophene-carboxylate\n410-550-7\n79277-18-2\nSTOT RE 2 *\nResp. Sens. 1\nSkin Sens. 1\nH373**\nH334\nH317\nGHS08\nDgr\nH373**\nH334\nH317\nEUH014\n\n\n\n\n615-023-00-7\n2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;\n(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate\n410-900-9\n83056-32-0\nFlam. Liq. 3\nMuta. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nResp. Sens. 1\nH226\nH341\nH332\nH373 **\nH318\nH334\nGHS02\nGHS08\nGHS05\nGHS07\nDgr\nH226\nH341\nH332\nH373 **\nH318\nH334\nEUH014\n\n\n615-024-00-2\n2-phenylethylisocyanate\n413-080-0\n1943-82-4\nAcute Tox. 3 *\nAcute Tox. 4 *\nSkin Corr. 1A\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 2\nH331\nH302\nH314\nH334\nH317\nH411\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH302\nH314\nH334\nH317\nH411\n\n\n\n615-025-00-8\n4,4'-ethylidenediphenyl dicyanate\n405-740-1\n47073-92-7\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH302\nH373 **\nH318\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH332\nH302\nH373 **\nH318\nH410\n\n\n\n615-026-00-3\n4,4'-methylenebis(2,6-dimethylphenyl cyanate)\n405-790-4\n101657-77-6\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n\n615-028-00-4\nethyl 2-(isocyanatosulfonyl)benzoate\n410-220-2\n77375-79-2\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nH302\nH373**\nH318\nH334\nH317\nGHS05\nGHS08\nGHS07\nDgr\nH302\nH373**\nH318\nH334\nH317\nEUH014\n\n\n\n\n615-029-00-X\n2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane\n411-280-2\n—\nAcute Tox. 2 *\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 3\nH330\nH302\nH314\nH334\nH317\nH412\nGHS06\nGHS08\nGHS05\nDgr\nH330\nH302\nH314\nH334\nH317\nH412\n\n\n\n\n\n615-030-00-5\nalkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 3\nH332\nH312\nH302\nH412\nGHS07\nWng\nH332\nH312\nH302\nH412\n\n\nA\n\n615-031-00-0\nthallium thiocyanate\n222-571-7\n3535-84-0\nAcute Tox. 2 *\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT RE 2\nAquatic Chronic 2\nH330\nH300\nH312\nH373**\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH330\nH300\nH312\nH373**\nH411\n\n\n\n\n615-032-00-6\nmetal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH312\nH302\nH410\n\n\nA\n\n\n\n615-033-00-1\nreaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)\n430-980-9\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-034-00-7\nreaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)\n430-750-8\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-035-00-2\nreaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)\n430-930-6\n122886-55-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-036-00-8\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)\n430-940-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-037-00-3\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)\n430-950-5\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-038-00-9\nreaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)\n430-960-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-039-00-4\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)\n430-970-4\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n615-044-00-1\n4-chlorophenylisocyanate\n203-176-9\n104-12-1\nAcute Tox. 2 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH330\nH302\nH335\nH315\nH318\nH334\nH400\nH410\nGHS06\nGHS05\nGHS08\nGHS09\nDgr\nH330\nH302\nH335\nH315\nH318\nH334\nH410\n\n\n\n\n615-045-00-7\n4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)\n420-530-1\n—\nResp. Sens. 1\nSkin Sens. 1\nAquatic Chronic 4\nH334\nH317\nH413\nGHS08\nDgr\nH334\nH317\nH413\n\n\n\n\n616-001-00-X\nN,N-dimethylformamide;\ndimethyl formamide\n200-679-5\n68-12-2\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nH360D ***\nH332\nH312\nH319\nGHS08\nGHS07\nDgr\nH360D ***\nH332\nH312\nH319\n\n\n\n616-002-00-5\n2-fluoroacetamide\n211-363-1\n640-19-7\nAcute Tox. 2 *\nAcute Tox. 3 *\nH300\nH311\nGHS06\nDgr\nH300\nH311\n\n\n\n616-003-00-0\nacrylamide;\nprop-2-enamide\n201-173-7\n79-06-1\nCarc. 1B\nMuta. 1B\nRepr. 2\nAcute Tox. 3 *\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nH350\nH340\nH361f ***\nH301\nH372 **\nH332\nH312\nH319\nH315\nH317\nGHS06\nGHS08\nDgr\nH350\nH340\nH361f ***\nH301\nH372 **\nH332\nH312\nH319\nH315\nH317\n\n\nD\n616-004-00-6\nallidochlor (ISO);\nN,N-diallylchloroacetamide\n202-270-7\n93-71-0\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH312\nH302\nH319\nH315\nH411\nGHS07\nGHS09\nWng\nH312\nH302\nH319\nH315\nH411\n\n\n\n616-005-00-1\nchlorthiamid (ISO);\n2,6-dichloro (thiobenzamide)\n217-637-7\n1918-13-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n\n616-006-00-7\ndichlofluanid (ISO);\nN-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide\n214-118-7\n1085-98-9\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nH332\nH319\nH317\nH400\nGHS07\nGHS09\nWng\nH332\nH319\nH317\nH400\n\nM=10\n\n\n616-007-00-2\ndiphenamid (ISO);\nN,N-dimethyl-2,2-diphenylacetamide\n213-482-4\n957-51-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-008-00-8\npropachlor (ISO);\n2-chloro-N-isopropylacetanilide;\nα-chloro-N-isopropylacetanilide\n217-638-2\n1918-16-7\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH319\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH319\nH317\nH410\n\n\n\n\n\n616-009-00-3\npropanil (ISO);\n3', 4'-dichloropropionanilide\n211-914-6\n709-98-8\nAcute Tox. 4 *\nAquatic Acute 1\nH302\nH400\nGHS07\nGHS09\nWng\nH302\nH400\n\nM=10\n\n\n616-010-00-9\ntosylchloramide sodium\n204-854-7\n127-65-1\nAcute Tox. 4 *\nSkin Corr. 1B\nResp. Sens. 1\nH302\nH314\nH334\nGHS08\nGHS05\nGHS07\nDg\nH302\nH314\nH334\nEUH031\n\n\n616-011-00-4\nN,N-dimethylacetamide\n204-826-4\n127-19-5\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nH360D ***\nH332\nH312\nGHS08\nGHS07\nDgr\nH360D ***\nH332\nH312\n\nRepr. 1B; H360D: C ≥ 5 %\n\n616-012-00-X\nN-(dichlorofluoromethylthio)phthalimide;\nN-(fluorodichloromethylthio)phthalimide\n211-952-3\n719-96-0\nSkin Irrit. 2\nH315\nGHS07\nWng\nH315\n\n\n\n616-013-00-5\nbutyraldehyde oxime\n203-792-8\n110-69-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nEye Irrit. 2\nH311\nH302\nH319\nGHS06\nDgr\nH311\nH302\nH319\n\n\n\n616-014-00-0\n2-butanone oxime;\nethyl methyl ketoxime;\nethyl methyl ketone oxime\n202-496-6\n96-29-7\nCarc. 2\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nH351\nH312\nH318\nH317\nGHS08\nGHS05\nGHS07\nDgr\nH351\nH312\nH318\nH317\n\n\n\n616-015-00-6\nalachlor (ISO);\n2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide\n240-110-8\n15972-60-8\nCarc. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH317\nH410\n\nM=10\n\n616-016-00-1\n1-(3,4-dichlorophenylimino) thiosemicarbazide\n—\n5836-73-7\nAcute Tox. 2 *\nH300\nGHS06\nDgr\nH300\n\n\n\n616-017-00-7\ncartap hydrochloride\n239-309-2\n15263-52-2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH312\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH312\nH302\nH410\n\n\n\n616-018-00-2\nN,N-diethyl-m-toluamide;\ndeet\n205-149-7\n134-62-3\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH302\nH319\nH315\nH412\nGHS07\nWng\nH302\nH319\nH315\nH412\n\n\n\n616-019-00-8\nperfluidone (ISO);\n1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;\n253-718-3\n37924-13-3\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n616-020-00-3\ntebuthiuron (ISO);\n1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n251-793-7\n34014-18-1\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n616-021-00-9\nthiazafluron (ISO);\n1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea\n246-901-4\n25366-23-8\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n616-022-00-4\nacetamide\n200-473-5\n60-35-5\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n616-023-00-X\nN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide\n401-980-6\n—\nSkin Irrit. 2\nSkin Sens. 1\nH315\nH317\nGHS07\nWng\nH315\nH317\n\n\n\n616-024-00-5\n2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide\n402-260-4\n54942-74-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-025-00-0\nvalinamide\n402-840-7\n20108-78-5\nRepr. 2\nEye Irrit. 2\nSkin Sens. 1\nH361f ***\nH319\nH317\nGHS08\nWng\nH361f ***\nH319\nH317\n\n\n\n616-026-00-6\nthioacetamide\n200-541-4\n62-55-5\nCarc. 1B\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 3\nH350\nH302\nH319\nH315\nH412\nGHS08\nGHS07\nDgr\nH350\nH302\nH319\nH315\nH412\n\n\n\n616-027-00-1\ntris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate\n403-760-5\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-028-00-7\nN-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n403-790-9\n108673-51-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-029-00-2\nN,N'-ethylenebis(vinylsulfonylacetamide)\n404-790-1\n66710-66-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n616-030-00-8\nethidimuron (ISO);\n1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n250-010-6\n30043-49-3\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-031-00-3\ndimethachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;\n256-625-6\n50563-36-5\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-032-00-9\ndiflufenican (ISO);\nN-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide\n—\n83164-33-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-033-00-4\ncyprofuram (ISO);\nN-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide\n274-050-9\n69581-33-5\nAcute Tox. 3 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH312\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH312\nH410\n\n\n\n616-034-00-X\npyracarbolid; (ISO);\n3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide\n246-419-4\n24691-76-7\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-035-00-5\ncymoxanil (ISO);\n2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide\n261-043-0\n57966-95-7\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-036-00-0\n2-chloracetamide\n201-174-2\n79-07-2\nRepr. 2\nAcute Tox. 3 *\nSkin Sens. 1\nH361f ***\nH301\nH317\nGHS06\nGHS08\nDgr\nH361f ***\nH301\nH317\n\nSkin Sens. 1; H317: C ≥ 0,1 %\n\n616-037-00-6\nacetochlor (ISO);\n2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide\n251-899-3\n34256-82-1\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH332\nH335\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH332\nH335\nH315\nH317\nH410\n\n\n\n616-038-00-1\n(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride\n406-010-5\n88918-84-7\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH318\nH317\nH411\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH411\n\n\n\n616-039-00-7\n3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide\n406-200-8\n117827-06-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-040-00-2\npotassium N-(4-toluenesulfonyl)-4-toluenesulfonamide\n406-650-5\n97888-41-0\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n616-041-00-8\n3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide\n406-840-8\n101664-25-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-042-00-3\nN-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide\n407-070-5\n142859-67-4\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-043-00-9\nisoxaben (ISO);\nN-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide\n407-190-8\n82558-50-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-044-00-4\nN-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide\n402-510-2\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-045-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide\n405-190-2\n122371-93-1\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-046-00-5\nN-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n406-390-2\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-047-00-0\nreaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;\n2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide\n406-640-0\n—\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-048-00-6\n3'-trifluoromethylisobutyranilide\n406-740-4\n1939-27-1\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n616-049-00-1\n2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide\n408-150-2\n99141-89-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-050-00-7\nlufenuron (ISO);\nN-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide\n410-690-9\n103055-07-8\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-051-00-2\nreaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;\n2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene\n411-070-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-052-00-8\nformamide\n200-842-0\n75-12-7\nRepr. 1B\nH360D ***\nGHS08\nDgr\nH360D ***\n\n\n\n616-053-00-3\nN-methylacetamide\n201-182-6\n79-16-3\nRepr. 1B\nH360D ***\nGHS08\nDgr\nH360D ***\n\n\n\n616-054-00-9\niprodione (ISO);\n3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide\n253-178-9\n36734-19-7\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n616-055-00-4\npropyzamide (ISO);\n3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide\n245-951-4\n23950-58-5\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH410\n\n\n\n616-056-00-X\nN-methylformamide\n204-624-6\n123-39-7\nRepr. 1B\nAcute Tox. 4 *\nH360D ***\nH312\nGHS08\nGHS07\nDg\nH360D ***\nH312\n\n\n\n616-057-00-5\nreaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nN-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nmethacrylamide;\n2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;\nN-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide\n412-790-8\n—\nCarc. 1B\nMuta. 2\nSTOT RE 2 *\nH350\nH341\nH373 **\nGHS08\nDgr\nH350\nH341\nH373 **\n\n\n\n616-058-00-0\n1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene\n412-570-1\n119462-56-5\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH318\nH317\nH400\nH410\nGHS08\nGHS05\nGHS07\nGHS09\nDgr\nH373 **\nH318\nH317\nH410\n\n\n\n616-059-00-6\n4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide\n412-650-6\n121487-83-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-060-00-1\nCondensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)\n413-770-1\n—\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH314\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH314\nH317\nH410\n\n\n\n616-061-00-7\nN,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide\n413-610-0\n124172-53-8\nEye Irrit. 2\nAquatic Chronic 3\nH319\nH412\nGHS07\nWng\nH319\nH412\n\n\n\n616-062-00-2\nN-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide\n411-590-8\n70693-57-1\nSkin Corr. 1B\nAquatic Chronic 3\nH314\nH412\nGHS05\nDgr\nH314\nH412\n\n\n\n616-063-00-8\n3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione\n411-920-0\n106917-30-0\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1A\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH302\nH373 **\nH314\nH400\nH410\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH331\nH302\nH373 **\nH314\nH410\n\n\n\n616-064-00-3\nN—tert-butyl-3-methylpicolinamide\n406-720-5\n32998-95-1\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-065-00-9\n3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea\n411-970-3\n79881-89-3\nAcute Tox. 4 *\nSTOT RE 2 *\nH302\nH373 **\nGHS08\nGHS07\nWng\nH302\nH373 **\n\n\n\n616-066-00-4\n5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone\n405-100-1\n115662-06-1\nRepr. 2\nH361f ***\nGHS08\nWng\nH361f ***\n\n\n\n616-067-00-X\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate\n407-300-4\n92683-20-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-068-00-5\npotassium 4-(11-methacrylamidoundecanamido)benzenesulfonate\n406-500-9\n174393-75-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-069-00-0\n1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide\n406-210-2\n110560-22-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-070-00-6\nreaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;\n3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-530-2\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-071-00-1\nreaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;\nbis(N-octadecyl-N'-phenyleneureido)methylene;\nbis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)\n406-550-1\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-072-00-7\n1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine\n407-120-6\n55612-11-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-073-00-2\n4'-ethoxy-2-benzimidazoleanilide\n407-600-5\n120187-29-3\nMuta. 2\nAquatic Chronic 4\nH341\nH413\nGHS08\nWng\nH341\nH413\n\n\n\n616-074-00-8\nN-butyl-2-(4-morpholinylcarbonyl)benzamide\n407-730-2\n104958-67-0\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH317\nH412\nGHS07\nWng\nH319\nH317\nH412\n\n\n\n616-075-00-3\nD, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)\n408-120-9\n65197-96-8\nAcute Tox. 4 *\nEye Dam. 1\nH302\nH318\nGHS05\nGHS07\nDgr\nH302\nH318\n\n\n\n616-076-00-9\ntebufenozide (ISO);\nN-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide\n412-850-3\n112410-23-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-077-00-4\nreaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;\npotassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate\n411-310-4\n—\nEye Dam. 1\nH318\nGHS05\nDgr\nH318\n\n\n\n616-078-00-X\n2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide\n411-330-3\n104541-33-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-079-00-5\n1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate\n411-700-4\n140921-24-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-080-00-0\n4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)\n411-850-0\n119018-29-0\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-081-00-6\n5-bromo-8-naphtholactam\n413-480-5\n24856-00-6\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\n\n\n616-082-00-1\nN-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide\n413-200-1\n129604-78-0\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n616-083-00-7\n[2-[(4-nitrophenyl)amino]ethyl]urea\n410-700-1\n27080-42-8\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n616-084-00-2\n2,4-bis[N'-(4-methylphenyl)ureido]toluene\n411-790-5\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-085-00-8\n3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione\n412-190-6\n168900-02-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-086-00-3\n2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene\n412-250-1\n102387-48-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-087-00-9\nreaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;\n7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate\n412-260-6\n52658-19-2\nEye Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH319\nH317\nH411\nGHS07\nGHS09\nWng\nH319\nH317\nH411\n\n\n\n616-088-00-4\n2-aminosulfonyl-N,N-dimethylnicotinamide\n413-440-7\n112006-75-4\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n616-089-00-X\n5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran\n415-360-8\n41107-56-6\nMuta. 2\nH341\nGHS08\nWng\nH341\n\n\n\n616-090-00-5\n1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride\n415-660-9\n70918-74-0\nAcute Tox. 3 *\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Chronic 2\nH331\nH311\nH301\nH373 **\nH411\nGHS06\nGHS08\nGHS09\nDgr\nH331\nH311\nH301\nH373 **\nH411\n\n\n\n616-091-00-0\n1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione\n423-400-0\n59653-74-6\nMuta. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nH340\nH331\nH302\nH373 **\nH318\nH317\nGHS06\nGHS08\nGHS05\nDgr\nH340\nH331\nH302\nH373 **\nH318\nH317\n\n\n\n616-092-00-6\nPolymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide\n404-035-6\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-093-00-1\nReaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride\n406-620-1\n129217-90-9\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-094-00-7\n3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-370-3\n58890-25-8\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n616-095-00-2\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-690-3\n43136-14-7\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-096-00-8\nN-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide\n408-110-4\n110483-07-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-097-00-3\nN,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide\n411-840-6\n83372-55-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-098-00-9\n1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide\n411-750-7\n119126-15-7\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-099-00-4\n2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide\n414-170-2\n135937-20-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-100-00-8\n1,3-dimethyl-1,3-bis(trimethylsilyl)urea\n414-180-7\n10218-17-4\nAcute Tox. 4 *\nSkin Irrit. 2\nH302\nH315\nGHS07\nWng\nH302\nH315\n\n\n\n616-101-00-3\n(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide\n414-600-9\n149182-72-9\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-102-00-9\nreaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);\n1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;\n1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]\n415-870-0\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-103-00-4\n(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide\n415-030-3\n120298-38-6\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\n\n\n616-104-00-X\nbenalaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate\n275-728-7\n71626-11-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-105-00-5\nchlorotoluron (ISO);\n3-(3-chloro-p-tolyl)-1,1-dimethylurea\n239-592-2\n15545-48-9\nCarc. 2\nRepr. 2\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361d ***\nH400\nH410\nGHS08\nGHS09\nWng\nH351\nH361d ***\nH410\n\n\n\n616-106-00-0\nphenmedipham (ISO);\nmethyl 3-(3-methylcarbaniloyloxy)carbanilate\n237-199-0\n13684-63-4\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n616-107-00-6\ncinidon ethyl (ISO);\nethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate\n—\n142891-20-1\nCarc. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH317\nH410\n\n\n\n\n616-108-00-1\niodosulfuron-methyl-sodium;\nsodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide\n—\n144550-36-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-109-00-7\nsulfosulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea\n—\n141776-32-1\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-110-00-2\ncyclanilide (ISO);\n1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid\n419-150-7\n113136-77-9\nAcute Tox. 4 *\nAquatic Chronic 2\nH302\nH411\nGHS07\nGHS09\nWng\nH302\nH411\n\n\n\n616-111-00-8\nfenhexamid (ISO);\nN-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid\n422-530-5\n126833-17-8\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n616-112-00-3\noxasulfuron (ISO);\noxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate\n—\n144651-06-9\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1\nH373 **\nH400\nH410\nGHS08\nGHS09\nWng\nH373 **\nH410\n\n\n\n616-113-00-9\ndesmedipham (ISO);\nethyl 3-phenylcarbamoyloxyphenylcarbamate\n237-198-5\n13684-56-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n616-114-00-4\ndodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-\n418-010-2\n136897-58-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-115-00-X\nN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide\n416-150-9\n136450-06-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-116-00-5\nN-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate\n416-790-9\n143052-96-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-117-00-0\nN-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide\n416-860-9\n777891-21-1\nRepr. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH361f ***\nH317\nH400\nH410\nGHS08\nGHS09\nWng\nH361f ***\nH317\nH410\n\n\n\n616-118-00-6\nN-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride\n417-950-0\n65797-42-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n616-119-00-1\n2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide\n418-060-5\n118020-93-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-120-00-7\nreaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-2-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-3-methyl-phenyl)-benzamide\n420-600-1\n—\nSTOT RE 2 *\nAquatic Chronic 2\nH373 **\nH411\nGHS08\nGHS09\nWng\nH373 **\nH411\n\n\n\n616-121-00-2\n2,4-dihydroxy-N-(2-methoxyphenyl)benzamide\n419-090-1\n129205-19-2\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n\n616-122-00-8\nmethylneodecanamide\n414-460-9\n105726-67-8\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n616-123-00-3\nN-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide\n414-740-0\n96141-86-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\n\n616-124-00-9\nlithium bis(trifluoromethylsulfonyl)imide\n415-300-0\n90076-65-6\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Chronic 3\nH311\nH301\nH373**\nH314\nH412\nGHS06\nGHS05\nGHS08\nDgr\nH311\nH301\nH373**\nH314\nH412\n\n\n\n\n616-125-00-4\n3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide\n415-730-9\n151338-11-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\n410\n\n\n\n\n\n616-126-00-X\n1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide\n423-960-6\n139756-01-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 3\nH302\nH373**\nH412\nGHS08\nGHS07\nWng\nH302\nH373**\nH412\n\n\n\n\n616-127-00-5\nreaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);\n12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;\nN,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n430-050-2\n—\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n616-128-00-0\nN-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide\n417-530-7\n123590-00-1\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n616-129-00-6\nN,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide\n419-710-0\n42774-15-2\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n616-130-00-1\nN-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide\n421-780-2\n150919-56-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n\n616-131-00-7\n1-aminocyclopentanecarboxamide\n422-950-9\n17193-28-1\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nH372**\nH302\nH318\nGHS05\nGHS08\nGHS07\nDgr\nH372**\nH302\nH318\n\n\n\n\n616-132-00-2\nN-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide\n423-250-6\n130016-98-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n616-133-00-8\nN-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide\n423-990-1\n149118-66-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n616-134-00-3\n3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide\n401-820-5\n793710-14-2\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n616-135-00-9\n(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide\n430-230-0\n136522-17-3\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n\n616-136-00-4\nreaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)\n430-380-7\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n\n616-137-00-X\n4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane\n401-130-4\n71526-07-3\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-138-00-5\nbenzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide\n431-600-4\n112226-61-6\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-139-00-0\n(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide\n420-380-5\n136465-81-1\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Chronic 3\nH302\nH318\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH412\n\n\n\n\n616-140-00-6\nN,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]\n429-380-1\n133336-92-2\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-141-00-1\nzoxamide (ISO);\n(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide\n—\n156052-68-5\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH317\nH410\n\nM=10\n\n\n616-142-00-7\n1,3-Bis(vinylsulfonylacetamido)propane\n428-350-3\n93629-90-4\nMuta. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH341\nH318\nH317\nH412\nGHS08\nGHS05\nGHS07\nDgr\nH341\nH318\nH317\nH412\n\n\n\n616-143-00-2\nN,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide\n422-560-9\n149591-38-8\nRepr. 2\nEye Irrit. 2\nAquatic Chronic 4\nH361f ***\nH319\nH413\nGHS08\nWng\nH361f ***\nH319\nH413\n\n\n\n\n\n616-144-00-8\n3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-130-1\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-145-00-3\npethoxamide (ISO);\n2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide\n—\n106700-29-2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH317\nH410\n\nM=100\n\n\n616-146-00-9\nN-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide\n431-330-7\n142776-95-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-147-00-4\n1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide\n424-160-1\n139481-22-4\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n616-148-00-X\nN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide\n424-550-1\n84245-12-5\nCarc. 1B\nMuta. 1B\nRepr. 1B\nH350\nH340\nH360FD\nGHS08\nDgr\nH350\nH340\nH360FD\n\n\n\n\n616-150-00-0\n(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride\n425-260-6\n—\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH373**\nH318\nH317\nH411\nGHS05\nGHS08\nGHS07\nGHS09\nDgr\nH373**\nH318\nH317\nH411\n\n\n\n\n616-151-00-6\nN-(2-amino-4,6-dichloropyrimidin-5-yl)formamide\n425-650-6\n171887-03-9\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 3\nH302\nH318\nH317\nH412\nGHS05\nGHS07\nDgr\nH302\nH318\nH317\nH412\n\n\n\n\n616-152-00-1\n4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide\n425-850-3\n125971-96-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-153-00-7\n4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide\n425-860-8\n125971-57-5\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-154-00-2\n3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-110-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-155-00-8\nN,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide\n431-040-0\n104560-40-9\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-156-00-3\n6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide\n430-500-8\n204277-61-2\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-157-00-9\n3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride\n427-780-9\n114565-70-7\nAcute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH318\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH302\nH318\nH410\n\n\n\n\n\n616-158-00-4\nN-[4-cyano-3-trifluoromethylphenyl]methacrylamide\n427-880-2\n90357-53-2\nSTOT RE 2 *\nAquatic Chronic 2\nH373**\nH411\nGHS08\nGHS09\nWng\nH373**\nH411\n\n\n\n\n616-160-00-5\n2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]\n429-090-3\n61551-69-7\nSkin Sens. 1\nAquatic Chronic 3\nH317\nH412\nGHS07\nWng\nH317\nH412\n\n\n\n\n616-161-00-0\n2,4-dichloro-5-hydroxyacetanilide\n429-110-0\n67669-19-6\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n616-162-00-6\nisostearic acid monoisopropanolamide\n431-540-9\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n\n616-163-00-1\n4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]\n430-350-3\n192463-88-0\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-164-00-7\ndimoxystrobin (ISO);\n(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide\n—\n149961-52-4\nCarc. 2\nRepr. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH361d***\nH332\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH361d***\nH332\nH410\n\nM=10\n\n\n616-165-00-2\nbeflubutamid (ISO);\n(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide\n—\n113614-08-7\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=100\n\n\n616-166-00-8\ncyazofamid (ISO);\n4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide\n—\n120116-88-3\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\nM=10\n\n\n616-167-00-3\nN,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide\n418-290-6\n168612-06-4\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n\n616-168-00-9\n1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium\n418-440-0\n136997-71-2\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n616-169-00-4\n4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one\n420-220-4\n92771-56-7\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-170-00-X\n(2R)-2-amino-2-phenylacetamide\n420-370-0\n6485-67-2\nEye Irrit. 2\nSkin Sens. 1\nH319\nH317\nGHS07\nWng\nH319\nH317\n\n\n\n\n616-171-00-5\n2-(para-chlorophenyl)glycineamide\n420-830-0\n102333-75-5\nEye Dam. 1\nSkin Sens. 1\nH318\nH317\nGHS05\nGHS07\nDgr\nH318\nH317\n\n\n\n\n616-172-00-0\nN-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;\n(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl\n423-840-3\n14691-89-5\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n\n616-174-00-1\n2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride\n424-560-4\n151257-01-1\nAcute Tox. 4 *\nEye Irrit. 2\nH302\nH319\nGHS07\nWng\nH302\nH319\n\n\n\n\n616-175-00-7\n2-(2-hexyldecyloxy)benzamide\n431-230-3\n202483-62-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-176-00-2\n3-N,N-bis(methoxyethyl)aminoacetanilide\n432-530-7\n24294-01-7\nAcute Tox. 4 *\nAquatic Chronic 3\nH302\nH412\nGHS07\nWng\nH302\nH412\n\n\n\n\n616-177-00-8\n(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;\nN-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide\n432-970-1\n217324-98-6\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-178-00-3\nN-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide\n434-500-9\n52583-35-4\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-179-00-9\n2-chloro-N-(4-methylphenyl)acetamide\n435-170-9\n16634-82-5\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH318\nH317\nH400\nH410\nGHS05\nGHS07\nGHS09\nDgr\nH318\nH317\nH410\n\n\n\n\n616-180-00-4\nN,N-(dimethylamino)thioacetamide hydrochloride\n435-470-1\n27366-72-9\nRepr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH360D***\nH400\nH410\nGHS08\nGHS09\nDgr\nH360D***\nH410\n\n\n\n\n616-181-00-X\n4'-methyldodecane-1-sulfonanilide\n435-490-9\n17417-32-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-182-00-5\nN'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide\n435-860-1\n214417-91-1\nSkin Sens. 1\nAquatic Chronic 2\nH317\nH411\nGHS07\nGHS09\nWng\nH317\nH411\n\n\n\n\n616-183-00-0\nN-dodecyl-4-methoxybenzamide\n442-340-6\n1854-15-5\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-184-00-6\n3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide\n442-560-2\n105043-55-8\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-186-00-7\nN,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)\n443-010-4\n53641-10-4\nAquatic Chronic 3\nH412\n—\nH412\n\n\n\n\n616-188-00-8\n2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide\n443-980-9\n221215-20-9\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-189-00-3\nN-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide\n444-780-4\n452962-97-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-190-00-9\nN-decyl-4-nitrobenzamide\n445-880-0\n64026-19-3\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-191-00-4\n2-ethyl-N-methyl-N-(3-methylphenyl)butanamide\n446-190-2\n406488-30-0\nAcute Tox. 4 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH302\nH319\nH315\nH317\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH315\nH317\nH411\n\n\n\n\n616-192-00-X\n2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide\n448-060-0\n727678-39-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-193-00-5\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide\n449-940-7\n368450-39-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-194-00-0\n2,2-diethoxy-N,N-dimethylacetamide\n449-950-1\n34640-92-1\nEye Irrit. 2\nH319\nGHS07\nWng\nH319\n\n\n\n\n616-196-00-1\ndisodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide\n419-990-4\n—\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n616-197-00-7\nreaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;\nN-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide\n422-500-1\n—\nSTOT RE 2 *\nH373**\nGHS08\nWng\nH373**\n\n\n\n\n616-198-00-2\n1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene\n423-300-7\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-200-00-1\nreaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);\n12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;\nN,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n432-430-3\n—\nSkin Sens. 1\nAquatic Chronic 4\nH317\nH413\nGHS07\nWng\nH317\nH413\n\n\n\n\n616-201-00-7\n12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine\n432-840-2\n220926-97-6\nAcute Tox. 4 *\nAquatic Chronic 4\nH332\nH413\nGHS07\nWng\nH332\nH413\n\n\n\n\n616-202-00-2\nreaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide\n434-330-5\n—\nCarc. 2\nSkin Sens. 1\nAquatic Chronic 4\nH351\nH317\nH413\nGHS08\nGHS07\nWng\nH351\nH317\nH413\n\n\n\n\n616-203-00-8\nreaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide\n442-280-0\n—\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n616-204-00-3\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]\n451-060-3\n122886-55-9\nAquatic Chronic 4\nH413\n—\nH413\n\n\n\n\n\n616-205-00-9\nMetazachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide\n266-583-0\n67129-08-2\nSkin Sens. 1B\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1\nH317\nH351\nH400\nH410\nGHS07\nGHS08\nGHS09\nWng\nH317\nH351\nH410\n\nM = 100\nM = 100\n\n\n\n617-001-00-2\ndi-tert-butyl peroxide\n203-733-6\n110-05-4\nOrg. Perox. E\nFlam. Liq. 2\nMuta. 2\nH242\nH225\nH341\nGHS02\nGHS08\nDgr\nH242\nH225\nH341\n\n\n\n\n617-002-00-8\nα, α-dimethylbenzyl hydroperoxide;\ncumene hydroperoxide\n201-254-7\n80-15-9\nOrg. Perox. E\nAcute Tox. 3 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Corr. 1B\nAquatic Chronic 2\nH242\nH331\nH312\nH302\nH373 **\nH314\nH411\nGHS02\nGHS06\nGHS08\nGHS05\nGHS09\nDgr\nH242\nH331\nH312\nH302\nH373 **\nH314\nH411\n\nSkin Corr. 1B; H314: C ≥ 10 %\nSkin Irrit. 2; H315: 3 % ≤ C < 10 %\nEye Dam. 1; H318: 3 % ≤ C < 10 %\nEye Irrit. 2; H319: 1 % ≤ C < 3 %\nSTOT SE 3; H335: C < 10 %\n\n617-003-00-3\ndilauroyl peroxide\n203-326-3\n105-74-8\nOrg. Perox. D\nH242\nGHS02\nDgr\nH242\n\n\n\n617-004-00-9\n1,2,3,4-tetrahydro-1-naphthyl hydroperoxide\n212-230-0\n771-29-9\nOrg. Perox. D\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH302\nH314\nH400\nH410\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH302\nH314\nH410\n\nSTOT SE 3; H335: C ≥ 5 %\n\n617-006-00-X\nbis(α, α-dimethylbenzyl) peroxide\n201-279-3\n80-43-3\nOrg. Perox. F\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Chronic 2\nH242\nH319\nH315\nH411\nGHS02\nGHS07\nGHS09\nWng\nH242\nH319\nH315\nH411\n\n\n\n617-007-00-5\ntert-butyl α, α-dimethylbenzyl peroxide\n222-389-8\n3457-61-2\nOrg. Perox. E Skin Irrit. 2\nAquatic Chronic 2\nH242\nH315\nH411\nGHS02\nGHS07\nGHS09\nWng\nH242\nH315\nH411\n\n\n\n\n617-008-00-0\ndibenzoyl peroxide;\nbenzoyl peroxide\n202-327-6\n94-36-0\nOrg. Perox. B\nEye Irrit. 2\nSkin Sens. 1\nH241\nH319\nH317\nGHS01\nGHS02\nGHS07\nDgr\nH241\nH319\nH317\n\n\n\n617-010-00-1\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1’-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nOrg. Perox. A\nSkin Corr. 1B\nAcute Tox. 4 *\nH240\nH314\nH302\nGHS01\nGHS05\nGHS07\nDgr\nH240\nH314\nH302\n\nSTOT SE 3; H335: C ≥ 5 %\nC\n\n\n617-010-01-9\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n[≤ 91 % solution]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nOrg. Perox. C\nAcute Tox. 4 *\nSkin Corr. 1B\nH242\nH302\nH314\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH302\nH314\n\nSTOT SE 3; H335: C ≥ 5 %\nC T\n617-012-00-2\n8-p-menthyl hydroperoxide;\np-menthane hydroperoxide\n201-281-4\n80-47-7\nOrg. Perox. D\nSkin Corr. 1B\nAcute Tox. 4 *\nH242\nH314\nH332\nGHS02\nGHS05\nGHS07\nDgr\nH242\nH314\nH332\n\nSTOT SE 3; H335: C ≥ 5 %\n\n617-013-00-8\nO,O-tert-butyl O-docosyl monoperoxyoxalate\n404-300-6\n116753-76-5\nOrg. Perox. C ****\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH400\nH410\nGHS02\nGHS09\nDgr\nH242\nH410\n\n\n\n617-014-00-3\n6-(nonylamino)-6-oxo-peroxyhexanoic acid\n406-680-9\n104788-63-8\nOrg. Perox. C ****\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nH242\nH318\nH317\nH400\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH318\nH317\nH400\n\n\n\n617-015-00-9\nbis(4-methylbenzoyl)peroxide\n407-950-9\n895-85-2\nOrg. Perox. B ****\nAquatic Acute 1\nAquatic Chronic 1\nH241\nH400\nH410\nGHS01\nGHS02\nGHS09\nDgr\nH241\nH410\n\n\n\n617-016-00-4\n3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate\n413-910-1\n—\nOrg. Perox. C ****\nFlam. Liq. 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH242\nH226\nH315\nH400\nH410\nGHS02\nGHS07\nGHS09\nDgr\nH242\nH226\nH315\nH410\n\n\n\n\n\n\n617-017-00-X\nreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;\n2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene\n412-140-3\n32144-25-5\nOrg. Perox. D\nAquatic Chronic 4\nH242\nH413\nGHS02\nDgr\nH242\nH413\n\n\nT\n\n617-018-00-5\nreaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;\n1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight\n410-840-3\n71566-50-2\nOrg. Perox. C ****\nAquatic Chronic 2\nH242\nH411\nGHS02\nGHS09\nDgr\nH242\nH411\n\n\nT\n617-019-00-0\n6-(phthalimido)peroxyhexanoic acid\n410-850-8\n128275-31-0\nOrg. Perox. D\nEye Dam. 1\nAquatic Acute 1\nH242\nH318\nH400\nGHS02\nGHS05\nGHS09\nDgDgr\nH242\nH318\nH400\n\n\nT\n617-020-00-6\n1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)\n420-060-5\n117663-11-3\nFlam. Liq. 3\nOrg. Perox. D ****\nAquatic Chronic 2\nH226\nH242\nH411\nGHS02\nGHS09\nDgr\nH226\nH242\nH411\n\n\n\n\n\n617-021-00-1\nmethylethylketone peroxide trimer\n429-320-2\n—\nOrg. Perox. B****\nAsp. Tox. 1\nSkin Irrit. 2\nSkin Sens. 1\nH241\nH304\nH315\nH317\nGHS01\nGHS02\nGHS08\nGHS07\nDgr\nH241\nH304\nH315\nH317\n\n\n\n\n617-022-00-7\nreaction mass of: 1,2-dimethylpropylidene dihydroperoxide;\ndimethyl 1,2-benzenedicarboxylate\n442-480-8\n—\nOrg. Perox. C\nAcute Tox. 4 *\nSkin Corr. 1B\nSkin Sens. 1\nAquatic Chronic 2\nH242\nH302\nH314\nH317\nH411\nGHS02\nGHS05\nGHS07\nGHS09\nDgr\nH242\nH302\nH314\nH317\nH411\n\n\n\n\n647-001-00-8\nglucosidase, β-\n232-589-7\n9001-22-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-002-00-3\ncellulase\n232-734-4\n9012-54-8\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-003-00-9\ncellobiohydrolase, exo-\n253-465-9\n37329-65-0\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-004-00-4\ncellulases with the exception of those specified elsewhere in this Annex\n—\n—\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\nA\n647-005-00-X\nbromelain, juice\n232-572-4\n9001-00-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-006-00-5\nficin\n232-599-1\n9001-33-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-007-00-0\npapain\n232-627-2\n9001-73-4\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-008-00-6\npepsin A\n232-629-3\n9001-75-6\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-009-00-1\nrennin\n232-645-0\n9001-98-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-010-00-7\ntrypsin\n232-650-8\n9002-07-7\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-011-00-2\nchymotrypsin\n232-671-2\n9004-07-3\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-012-00-8\nsubtilisin\n232-752-2\n9014-01-1\nSTOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nH335\nH315\nH318\nH334\nGHS08\nGHS05 GHS07\nDgr\nH335\nH315\nH318\nH334\n\n\n\n647-013-00-3\nproteinase, microbial neutral\n232-966-6\n9068-59-1\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-014-00-9\nproteases with the exception of those specified elsewhere in this Annex\n—\n—\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nResp. Sens. 1\nH319\nH335\nH315\nH334\nGHS08\nGHS07\nDgr\nH319\nH335\nH315\nH334\n\n\n\n647-015-00-4\namylase, α-\n232-565-6\n9000-90-2\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n647-016-00-X\namylases with the exception of those specified elsewhere in this Annex\n—\n—\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n\n\n647-017-00-5\nlaccase\n420-150-4\n80498-15-3\nResp. Sens. 1\nH334\nGHS08\nDgr\nH334\n\n\n\n\n648-001-00-0\nDistillates (coal tar), benzole fraction;\nLight Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]\n283-482-7\n84650-02-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-002-00-6\nTar oils, brown-coal;\nLight Oil;\n[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]\n302-674-4\n94114-40-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-003-00-1\nBenzol forerunnings (coal);\nLight Oil Redistillate, low boiling;\n[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]\n266-023-5\n65996-88-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-004-00-7\nDistillates (coal tar), benzole fraction, BTX-rich;\nLight Oil Redistillate, low boiling;\n[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]\n309-984-9\n101896-26-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-005-00-2\nAromatic hydrocarbons, C6-10, C8-rich;\nLight Oil Redistillate, low boiling\n292-697-5\n90989-41-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-006-00-8\nSolvent naphtha (coal), light;\nLight Oil Redistillate, low boiling\n287-498-5\n85536-17-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-007-00-3\nSolvent naphtha (coal), xylene-styrene cut;\nLight Oil Redistillate, intermediate boiling\n287-502-5\n85536-20-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-008-00-9\nSolvent naphtha (coal), coumarone-styrene contg.;\nLight Oil Redistillate, intermediate boiling\n287-500-4\n85536-19-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-009-00-4\nNaphtha (coal), distn. residues;\nLight Oil Redistillate, high boiling;\n[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]\n292-636-2\n90641-12-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-010-00-X\nAromatic hydrocarbons, C8;\nLight Oil Redistillate, high boiling\n292-694-9\n90989-38-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-012-00-0\nAromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;\nLight Oil Redistillate, high boiling;\n[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]\n295-281-1\n91995-20-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-013-00-6\nAromatic hydrocarbons, C9-12, benzene distn.;\nLight Oil Redistillate, high boiling\n295-551-9\n92062-36-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-014-00-1\nExtract residues (coal), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]\n295-323-9\n91995-61-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-015-00-7\nExtract residues (coal tar), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]\n309-868-8\n101316-63-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-016-00-2\nExtract residues (coal), benzole fraction acid;\nLight Oil Extract Residues, low boiling;\n[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]\n298-725-2\n93821-38-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-017-00-8\nExtract residues (coal), light oil alk., distn. overheads;\nLight Oil Extract Residues, low boiling;\n[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]\n292-625-2\n90641-02-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-018-00-3\nExtract residues (coal), light oil alk., acid ext., indene fraction;\nLight Oil Extract Residues, intermediate boiling\n309-867-2\n101316-62-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-019-00-9\nExtract residues (coal), light oil alk., indene naphtha fraction;\nLight Oil Extract Residues, high boiling;\n[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]\n292-626-8\n90641-03-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-020-00-4\nSolvent naphtha (coal);\nLight Oil Extract Residues, high boiling;\n[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]\n266-013-0\n65996-79-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-021-00-X\nDistillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]\n309-971-8\n101794-90-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-022-00-5\nDistillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;\n[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]\n292-609-5\n90640-87-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-023-00-0\nDistillates (coal tar), light oils; Carbolic Oil;\n[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]\n283-483-2\n84650-03-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-024-00-6\nTar oils, coal;\nCarbolic Oil;\n[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]\n266-016-7\n65996-82-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-026-00-7\nExtract residues (coal), light oil alk., acid ext.;\nCarbolic Oil Extract Residue;\n[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]\n292-624-7\n90641-01-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-027-00-2\nExtract residues (coal), tar oil alk.;\nCarbolic Oil Extract Residue;\n[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]\n266-021-4\n65996-87-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-028-00-8\nExtract oils (coal), light oil;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-622-6\n90640-99-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-029-00-3\nPyridine, alkyl derivs.;\nCrude Tar Bases;\n[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]\n269-929-9\n68391-11-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-030-00-9\nTar bases, coal, picoline fraction;\nDistillate Bases;\n[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]\n295-548-2\n92062-33-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-031-00-4\nTar bases, coal, lutidine fraction;\nDistillate Bases\n293-766-2\n91082-52-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-032-00-X\nExtract oils (coal), tar base, collidine fraction;\nDistillate Bases;\n[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]\n273-077-3\n68937-63-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-033-00-5\nTar bases, coal, collidine fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]\n295-543-5\n92062-28-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-034-00-0\nTar bases, coal, aniline fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]\n295-541-4\n92062-27-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-035-00-6\nTar bases, coal, toluidine fraction;\nDistillate Bases\n293-767-8\n91082-53-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-036-00-1\nDistillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;\nRedistillates;\n[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]\n295-292-1\n91995-31-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-037-00-7\nDistillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]\n295-295-8\n91995-35-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-038-00-2\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;\nRedistillates;\n[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]\n295-329-1\n91995-66-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-039-00-8\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]\n310-170-0\n122070-79-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-040-00-3\nExtract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;\nRedistillates;\n[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]\n310-171-6\n122070-80-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n\n648-041-00-9\nAbsorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]\n309-851-5\n101316-45-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-042-00-4\nDistillates (coal tar), upper, fluorene-rich;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]\n284-900-0\n84989-11-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-043-00-X\nCreosote oil, acenaphthene fraction, acenaphthene-free;\nWash Oil Redistillate;\n[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]\n292-606-9\n90640-85-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-044-00-5\nDistillates (coal tar), heavy oils;\nHeavy Anthracene Oil;\n[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]\n292-607-4\n90640-86-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-045-00-0\nDistillates (coal tar), upper;\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]\n266-026-1\n65996-91-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-046-00-6\nAnthracene oil, acid ext.;\nAnthracene Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]\n295-274-3\n91995-14-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-047-00-1\nDistillates (coal tar);\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]\n266-027-7\n65996-92-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-048-00-7\nDistillates (coal tar), pitch, heavy oils;\nHeavy Anthracene Oil;\n[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]\n295-312-9\n91995-51-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-049-00-2\nDistillates (coal tar), pitch;\nHeavy Anthracene Oil;\n[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]\n309-855-7\n101316-49-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-050-00-8\nDistillates (coal tar), heavy oils, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]\n295-304-5\n91995-42-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-051-00-3\nDistillates (coal tar), pitch, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]\n295-313-4\n91995-52-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-052-00-9\nParaffin waxes (coal), brown-coal high-temp. tar, carbon-treated;\nCoal Tar Extract;\n[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-296-6\n97926-76-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-053-00-4\nParaffin waxes (coal), brown-coal high-temp tar, clay-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-297-1\n97926-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-054-00-X\nPitch;\nPitch\n263-072-4\n61789-60-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-055-00-5\nPitch, coal tar, high-temp.;\nPitch;\n[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n266-028-2\n65996-93-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-056-00-0\nPitch, coal tar, high-temp., heat-treated;\nPitch;\n[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n310-162-7\n121575-60-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-057-00-6\nPitch, coal tar, high-temp., secondary;\nPitch Redistillate;\n[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]\n302-650-3\n94114-13-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-058-00-1\nResidues (coal tar), pitch distn.;\nPitch Redistillate;\n[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]\n295-507-9\n92061-94-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-059-00-7\nTar, coal, high-temp., distn. and storage residues;\nCoal Tar Solids Residue;\n[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]\n295-535-1\n92062-20-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-060-00-2\nTar, coal, storage residues;\nCoal Tar Solids Residue;\n[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]\n293-764-1\n91082-50-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-061-00-8\nTar, coal, high-temp., residues;\nCoal Tar Solids Residue;\n[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]\n309-726-5\n100684-51-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-062-00-3\nTar, coal, high-temp., high-solids;\nCoal Tar Solids Residue;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]\n273-615-7\n68990-61-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-063-00-9\nWaste solids, coal-tar pitch coking;\nCoal Tar Solids Residue;\n[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]\n295-549-8\n92062-34-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-064-00-4\nExtract residues (coal), brown;\nCoal Tar Extract;\n[The residue from extraction of dried coal.]\n294-285-0\n91697-23-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-065-00-X\nParaffin waxes (coal), brown-coal-high-temp. tar;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-454-1\n92045-71-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-066-00-5\nParaffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-455-7\n92045-72-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-067-00-0\nParaffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-298-7\n97926-78-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-068-00-6\nTar, coal, low-temp., distn. residues;\nTar Oil, intermediate boiling;\n[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]\n309-887-1\n101316-85-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-069-00-1\nPitch, coal tar, low-temp;\nPitch Residue;\n[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-651-4\n90669-57-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-070-00-7\nPitch, coal tar, low-temp., oxidized;\nPitch Residue, oxidised;\n[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-654-0\n90669-59-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-071-00-2\nPitch, coal tar, low-temp., heat-treated;\nPitch Residue, oxidised;\nPitch Residue, heat-treated;\n[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]\n292-653-5\n90669-58-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-072-00-8\nDistillates (coal-petroleum), condensed-ring arom;\nDistillates;\n[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]\n269-159-3\n68188-48-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-073-00-3\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-956-6\n101794-74-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-074-00-9\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-957-1\n101794-75-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-075-00-4\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-958-7\n101794-76-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-076-00-X\nPitch, coal tar-petroleum;\nPitch Residues;\n[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]\n269-109-0\n68187-57-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-077-00-5\nPhenanthrene, distn. residues;\nHeavy Anthracene Oil Redistillate;\n[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]\n310-169-5\n122070-78-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-078-00-0\nDistillates (coal tar), upper, fluorene-free;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]\n284-899-7\n84989-10-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-079-00-6\nAnthracene oil;\nAnthracene oil;\n[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]\n292-602-7\n90640-80-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n\n648-080-00-1\nResidues (coal tar), creosote oil distn.;\nWash Oil Redistillate;\n[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]\n295-506-3\n92061-93-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-081-00-7\nTar, coal;\nCoal tar;\n[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]\n232-361-7\n8007-45-2\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-082-00-2\nTar, coal, high-temp.;\nCoal tar;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]\n266-024-0\n65996-89-6\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-083-00-8\nTar, coal, low-temp.;\nCoal oil;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]\n266-025-6\n65996-90-9\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-084-00-3\nDistillates (coal), coke-oven light oil, naphthalene cut;\nNaphthalene Oil;\n[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]\n285-076-5\n85029-51-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-085-00-9\nDistillates (coal tar), naphthalene oils;\nNaphthalene Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]\n283-484-8\n84650-04-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-086-00-4\nDistillates (coal tar), naphthalene oils, naphthalene-low;\nNaphthalene Oil Redistillate;\n[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]\n284-898-1\n84989-09-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-087-00-X\nDistillates (coal tar), naphthalene oil crystn. mother liquor;\nNaphthalene Oil Redistillate;\n[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]\n295-310-8\n91995-49-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-088-00-5\nExtract residues (coal), naphthalene oil, alk.;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]\n310-166-9\n121620-47-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-089-00-0\nExtract residues (coal), naphthalene oil, alk., naphthalene-low;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-167-4\n121620-48-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-090-00-6\nDistillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;\nNaphthalene Oil Extract Residue;\n[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]\n292-612-1\n90640-90-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-091-00-1\nExtract residues (coal), naphthalene oil alk., distn. overheads;\nNaphthalene Oil Extract Residue;\n[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]\n292-627-3\n90641-04-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-092-00-7\nDistillates (coal tar), naphthalene oils, methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]\n309-985-4\n101896-27-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-093-00-2\nDistillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]\n309-972-3\n101794-91-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-094-00-8\nDistillates (coal tar), naphthalene oils, acid exts.;\nMethylnaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]\n295-309-2\n91995-48-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-095-00-3\nExtract residues (coal), naphthalene oil alk., distn. residues;\nMethylnaphthalene Oil Extract Residue;\n[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]\n292-628-9\n90641-05-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-096-00-9\nExtract oils (coal), acidic, tar-base free;\nMethylnaphthalene Oil Extract Residue;\n[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]\n284-901-6\n84989-12-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-097-00-4\nDistillates (coal tar), benzole fraction, distn. residues;\nWash Oil;\n[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-165-3\n121620-46-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-098-00-X\nCreosote oil, acenaphthene fraction;\nWash Oil;\n[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]\n292-605-3\n90640-84-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-099-00-5\nCreosote oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]\n263-047-8\n61789-28-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-100-00-9\nCreosote oil, high-boiling distillate;\nWash Oil;\n[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]\n274-565-9\n70321-79-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n\n648-101-00-4\nCreosote;\n[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]\n232-287-5\n8001-58-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-102-00-X\nExtract residues (coal), creosote oil acid;\nWash Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]\n310-189-4\n122384-77-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-103-00-5\nAnthracene oil, anthracene paste;\nAnthracene Oil Fraction;\n[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]\n292-603-2\n90640-81-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-104-00-0\nAnthracene oil, anthracene-low;\nAnthracene Oil Fraction;\n[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]\n292-604-8\n90640-82-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-105-00-6\nResidues (coal tar), anthracene oil distn.;\nAnthracene Oil Fraction;\n[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]\n295-505-8\n92061-92-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-106-00-1\nAnthracene oil, anthracene paste, anthracene fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-275-9\n91995-15-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-107-00-7\nAnthracene oil, anthracene paste, carbazole fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-276-4\n91995-16-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-108-00-2\nAnthracene oil, anthracene paste, distn. lights;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]\n295-278-5\n91995-17-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-109-00-8\nTar oils, coal, low-temp.;\nTar Oil, high boiling;\n[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]\n309-889-2\n101316-87-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-110-00-3\nExtract residues (coal), low temp. coal atar alk.;\n[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]\n310-191-5\n122384-78-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-111-00-9\nPhenols, ammonia liquor ext.;\nAlkaline Extract;\n[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]\n284-881-9\n84988-93-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-112-00-4\nDistillates (coal tar), light oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-610-0\n90640-88-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-113-00-X\nExtracts, coal tar oil alk.;\nAlkaline Extract;\n[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n266-017-2\n65996-83-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-114-00-5\nDistillates (coal tar), naphthalene oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-611-6\n90640-89-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-115-00-0\nExtract residues (coal), tar oil alk., carbonated, limed;\nCrude Phenols;\n[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]\n292-629-4\n90641-06-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-116-00-6\nTar acids, coal, crude;\nCrude Phenols;\n[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]\n266-019-3\n65996-85-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-117-00-1\nTar acids, brown-coal, crude;\nCrude Phenols;\n[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]\n309-888-7\n101316-86-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-118-00-7\nTar acids, brown-coal gasification;\nCrude Phenols;\n[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]\n295-536-7\n92062-22-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-119-00-2\nTar acids, distn. residues;\nDistillate Phenols;\n[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]\n306-251-5\n96690-55-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-120-00-8\nTar acids, methylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-892-9\n84989-04-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-121-00-3\nTar acids, polyalkylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]\n284-893-4\n84989-05-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-122-00-9\nTar acids, xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-895-5\n84989-06-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-123-00-4\nTar acids, ethylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-891-3\n84989-03-7\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-124-00-X\nTar acids, 3,5-xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]\n284-896-0\n84989-07-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-125-00-5\nTar acids, residues, distillates, first-cut;\nDistillate Phenols;\n[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]\n270-713-1\n68477-23-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-126-00-0\nTar acids, cresylic, residues;\nDistillate Phenols;\n[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]\n271-418-0\n68555-24-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-127-00-6\nPhenols, C9-11;\nDistillate Phenols\n293-435-2\n91079-47-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-128-00-1\nTar acids, cresylic;\nDistillate Phenols;\n[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]\n295-540-9\n92062-26-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-129-00-7\nTar acids, brown-coal, C2-alkylphenol fraction;\nDistillate Phenols;\n[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]\n302-662-9\n94114-29-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-130-00-2\nExtract oils (coal), naphthalene oils;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-623-1\n90641-00-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-131-00-8\nTar bases, quinoline derivs.;\nDistillate Bases\n271-020-7\n68513-87-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-132-00-3\nTar bases, coal, quinoline derivs. fraction;\nDistillate Bases\n274-560-1\n70321-67-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-133-00-9\nTar bases, coal, distn. residues;\nDistillate Bases;\n[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]\n295-544-0\n92062-29-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-134-00-4\nHydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]\n309-745-9\n100801-63-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-135-00-X\nHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]\n309-748-5\n100801-65-8\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-136-00-5\nHydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]\n309-749-0\n100801-66-9\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-137-00-0\nExtract residues (coal), tar oil alk., naphthalene distn. residues;\nNaphthalene Oil Extract Residue;\n[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]\n277-567-8\n73665-18-6\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-138-00-6\nCreosote oil, low-boiling distillate;\nWash Oil;\n[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]\n274-566-4\n70321-80-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n\n648-139-00-1\nTar acids, cresylic, sodium salts, caustic solns.;\nAlkaline Extract\n272-361-4\n68815-21-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-140-00-7\nExtract oils (coal), tar base;\nAcid Extract;\n[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]\n266-020-9\n65996-86-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-141-00-2\nTar bases, coal, crude;\nCrude Tar Bases;\n[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]\n266-018-8\n65996-84-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nHJM\n\n648-142-00-8\nResidues (coal), liq. solvent extn.;\n[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]\n302-681-2\n94114-46-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-143-00-3\nCoal liquids, liq. solvent extn. soln.;\n[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]\n302-682-8\n94114-47-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-144-00-9\nCoal liquids, liq. solvent extn.;\n[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]\n302-683-3\n94114-48-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH M\n648-145-00-4\nTar brown-coal;\n[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]\n309-885-0\n101316-83-0\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n648-146-00-X\nTar, brown-coal, low-temp.;\n[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]\n309-886-6\n101316-84-1\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-147-00-5\nLight oil (coal), coke-oven;\nCrude benzole;\n[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]\n266-012-5\n65996-78-3\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-148-00-0\nDistillates (coal), liq. solvent extn., primary;\n[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]\n302-688-0\n94114-52-0\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-149-00-6\nDistillates (coal), solvent extn., hydrocracked;\n[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-689-6\n94114-53-1\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-150-00-1\nNaphtha (coal), solvent extn., hydrocracked;\n[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-690-1\n94114-54-2\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-151-00-7\nGasoline, coal solvent extn., hydrocracked naphtha;\n[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]\n302-691-7\n94114-55-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n\n648-152-00-2\nDistillates (coal), solvent extn., hydrocracked middle;\n[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]\n302-692-2\n94114-56-4\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-153-00-8\nDistillates (coal), solvent extn., hydrocracked hydrogenated middle;\n[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]\n302-693-8\n94114-57-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n648-154-00-3\nFuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;\n[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]\n302-694-3\n94114-58-6\nCarc. 2\nH351\nGHS08\nWng\nH350\n\n\nH\n648-155-00-9\nFuels, diesel, coal solvent extn., hydrocracked hydrogenated;\n[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]\n302-695-9\n94114-59-7\nCarc. 2\nH351\nGHS08\nWng\nH350\n\n\nH\n\n\n648-156-00-4\nLight oil (coal), semi-coking process;\nFresh oil;\n[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]\n292-635-7\n90641-11-5\nCarc. 1B\nMuta. 1B\nH350\nH340\nGHS08\nDgr\nH350\nH340\n\n\nH J\n\n\n649-001-00-3\nExtracts (petroleum), light naphthenic distillate solvent\n265-102-1\n64742-03-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-002-00-9\nExtracts (petroleum), heavy paraffinic distillate solvent\n265-103-7\n64742-04-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-003-00-4\nExtracts (petroleum), light paraffinic distillate solvent\n265-104-2\n64742-05-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-004-00-X\nExtracts (petroleum), heavy naphthenic distillate solvent\n265-111-0\n64742-11-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-005-00-5\nExtracts (petroleum), light vacuum gas oil solvent\n295-341-7\n91995-78-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-006-00-0\nhydrocarbons C26-55, arom-rich\n307-753-7\n97722-04-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-007-00-6\nfatty acids, tall-oil, reaction products with iminodiethanol and boric acid\n400-160-5\n—\nSkin Irrit. 2\nAquatic Chronic 2\nH315\nH411\nGHS07\nGHS09\nWng\nH315\nH411\n\n\n\n649-008-00-1\nResidues (petroleum), atm. tower;\nHeavy Fuel oil;\n[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-045-2\n64741-45-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-009-00-7\nGas oils (petroleum), heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n265-058-3\n64741-57-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-010-00-2\nDistillates (petroleum), heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-063-0\n64741-61-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-011-00-8\nClarified oils (petroleum), catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-064-6\n64741-62-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-012-00-3\nResidues (petroleum), hydrocracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]\n265-076-1\n64741-75-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-013-00-9\nResidues (petroleum), thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-081-9\n64741-80-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-014-00-4\nDistillates (petroleum), heavy thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-082-4\n64741-81-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-015-00-X\nGas oils (petroleum), hydrotreated vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-162-9\n64742-59-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-016-00-5\nResidues (petroleum), hydrodesulfurized atmospheric tower;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-181-2\n64742-78-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-017-00-0\nGas oils (petroleum), hydrodesulfurized heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-189-6\n64742-86-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-018-00-6\nResidues (petroleum), steam-cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-193-8\n64742-90-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-019-00-1\nResidues (petroleum), atmospheric;\nHeavy Fuel oil;\n[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-777-3\n68333-22-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-020-00-7\nClarified oils (petroleum), hydrodesulfurized catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-782-0\n68333-26-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-021-00-2\nDistillates (petroleum), hydrodesulfurized intermediate catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n269-783-6\n68333-27-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-022-00-8\nDistillates (petroleum), hydrodesulfurized heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n269-784-1\n68333-28-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-023-00-3\nFuel oil, residues-straight-run gas oils, high-sulfur;\nHeavy Fuel oil\n270-674-0\n68476-32-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-024-00-9\nFuel oil, residual;\nHeavy Fuel oil;\n[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]\n270-675-6\n68476-33-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-025-00-4\nResidues (petroleum), catalytic reformer fractionator residue distn.;\nHeavy Fuel oil;\n[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]\n270-792-2\n68478-13-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-026-00-X\nResidues (petroleum), heavy coker gas oil and vacuum gas oil;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-796-4\n68478-17-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-027-00-5\nResidues (petroleum), heavy coker and light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-983-0\n68512-61-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-028-00-0\nResidues (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-984-6\n68512-62-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-029-00-6\nResidues (petroleum), steam-cracked light;\nHeavy Fuel oil;\n[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]\n271-013-9\n68513-69-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-030-00-1\nFuel oil, No 6;\nHeavy Fuel oil;\n[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]\n271-384-7\n68553-00-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-031-00-7\nResidues (petroleum), topping plant, low-sulfur;\nHeavy Fuel oil;\n[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]\n271-763-7\n68607-30-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-032-00-2\nGas oils (petroleum), heavy atmospheric;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]\n272-184-2\n68783-08-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-033-00-8\nResidues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;\nHeavy Fuel oil;\n[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]\n272-187-9\n68783-13-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-034-00-3\nDistillates (petroleum), petroleum residues vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]\n273-263-4\n68955-27-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-035-00-9\nResidues (petroleum), steam-cracked, resinous;\nHeavy Fuel oil;\n[A complex residuum from the distillation of steam-cracked petroleum residues.]\n273-272-3\n68955-36-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-036-00-4\nDistillates (petroleum), intermediate vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-683-0\n70592-76-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-037-00-X\nDistillates (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]\n274-684-6\n70592-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-038-00-5\nDistillates (petroleum), vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-685-1\n70592-78-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-039-00-0\nGas oils (petroleum), hydrodesulfurized coker heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n285-555-9\n85117-03-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-040-00-6\nResidues (petroleum), steam-cracked, distillates;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]\n292-657-7\n90669-75-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-041-00-1\nResidues (petroleum), vacuum, light;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]\n292-658-2\n90669-76-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-042-00-7\nFuel oil, heavy, high-sulfur;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n295-396-7\n92045-14-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-043-00-2\nResidues (petroleum), catalytic cracking;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]\n295-511-0\n92061-97-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-044-00-8\nDistillates (petroleum), intermediate catalytic cracked, thermally degraded;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]\n295-990-6\n92201-59-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-045-00-3\nResidual oils (petroleum);\nHeavy Fuel oil;\n[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]\n298-754-0\n93821-66-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-046-00-9\nResidues, steam cracked, thermally treated;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]\n308-733-0\n98219-64-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-047-00-4\nDistillates (petroleum), hydrodesulfurized full-range middle;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]\n309-863-0\n101316-57-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-048-00-X\nResidues (petroleum), catalytic reformer fractionator;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]\n265-069-3\n64741-67-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-049-00-5\nPetroleum;\nCrude oil;\n[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]\n232-298-5\n8002-05-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-050-00-0\nDistillates (petroleum), light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]\n265-051-5\n64741-50-0\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-051-00-6\nDistillates (petroleum), heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]\n265-052-0\n64741-51-1\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-052-00-1\nDistillates (petroleum), light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-053-6\n64741-52-2\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-053-00-7\nDistillates (petroleum), heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-054-1\n64741-53-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-054-00-2\nDistillates (petroleum), acid-treated heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-117-3\n64742-18-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-055-00-8\nDistillates (petroleum), acid-treated light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-118-9\n64742-19-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-056-00-3\nDistillates (petroleum), acid-treated heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-119-4\n64742-20-7\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-057-00-9\nDistillates (petroleum), acid-treated light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-121-5\n64742-21-8\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-058-00-4\nDistillates (petroleum), chemically neutralized heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]\n265-127-8\n64742-27-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-059-00-X\nDistillates (petroleum), chemically neutralized light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-128-3\n64742-28-5\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-060-00-5\nDistillates (petroleum), chemically neutralized heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-135-1\n64742-34-3\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-061-00-0\nDistillates (petroleum), chemically neutralized light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-136-7\n64742-35-4\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\nH\n\n649-062-00-6\nGases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]\n270-755-0\n68477-73-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-063-00-1\nGases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-756-6\n68477-74-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-064-00-7\nGases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]\n270-757-1\n68477-75-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-065-00-2\nGases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]\n270-758-7\n68477-76-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-066-00-8\nGases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]\n270-760-8\n68477-79-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-067-00-3\nGases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]\n270-765-5\n68477-83-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-068-00-9\nGases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-767-6\n68477-85-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-069-00-4\nGases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]\n270-768-1\n68477-86-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-070-00-X\nGases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-769-7\n68477-87-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-071-00-5\nGases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]\n270-772-3\n68477-90-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-072-00-0\nGases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-773-9\n68477-91-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-073-00-6\nGases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]\n270-777-0\n68477-94-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-074-00-1\nGases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-778-6\n68477-95-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-075-00-7\nGases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas\n270-782-8\n68477-99-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-076-00-2\nTail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-802-5\n68478-21-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-077-00-8\nTail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-803-0\n68478-22-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-078-00-3\nTail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]\n270-804-6\n68478-24-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-079-00-9\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-806-7\n68478-26-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-080-00-4\nTail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]\n270-813-5\n68478-32-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-081-00-X\nTail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]\n270-814-0\n68478-33-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-082-00-5\nTail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-815-6\n68478-34-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-083-00-0\nHydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]\n270-990-9\n68512-91-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-084-00-6\nGases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-000-8\n68513-15-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-085-00-1\nGases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]\n271-001-3\n68513-16-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-086-00-7\nGases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-002-9\n68513-17-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-087-00-2\nResidues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11.7 °C to 27.8 °C (11 °F to 82 °F).]\n271-010-2\n68513-66-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-088-00-8\nHydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0.5 °C (– 263 °F to 31 °F).]\n271-032-2\n68514-31-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-089-00-3\nHydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0.5 °C (– 263 °F to 31 °F).]\n271-038-5\n68514-36-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-090-00-9\nHydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]\n271-259-7\n68527-16-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-091-00-4\nHydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas\n271-261-8\n68527-19-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-092-00-X\nGases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n271-624-0\n68602-83-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-093-00-5\nHydrocarbons, C2-4;\nPetroleum gas\n271-734-9\n68606-25-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-094-00-0\nHydrocarbons, C3;\nPetroleum gas\n271-735-4\n68606-26-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-095-00-6\nGases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n271-737-5\n68606-27-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-096-00-1\nGases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]\n271-742-2\n68606-34-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-097-00-7\nGases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-183-7\n68783-07-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-098-00-2\nGases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n272-203-4\n68783-64-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-099-00-8\nGases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]\n272-205-5\n68783-65-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-100-00-1\nGases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-871-7\n68918-99-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-101-00-7\nGases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-872-2\n68919-00-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-102-00-2\nGases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-878-5\n68919-05-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-103-00-8\nGases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-879-0\n68919-06-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-104-00-3\nGases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]\n272-882-7\n68919-09-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-105-00-9\nGases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.]\n272-893-7\n68919-20-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-106-00-4\nGases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-883-2\n68919-10-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-107-00-X\nGases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-169-3\n68952-76-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-108-00-5\nTail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-170-9\n68952-77-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-109-00-0\nTail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-175-6\n68952-81-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-110-00-6\nTail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-176-1\n68952-82-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-111-00-1\nGases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]\n273-265-5\n68955-28-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-112-00-7\nGases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n273-270-2\n68955-34-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-113-00-2\nHydrocarbons, C4;\nPetroleum gas\n289-339-5\n87741-01-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-114-00-8\nAlkanes, C1-4, C3-rich;\nPetroleum gas\n292-456-4\n90622-55-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-115-00-3\nGases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]\n295-404-9\n92045-22-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-116-00-9\nHydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).]\n295-405-4\n92045-23-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-117-00-4\nPetroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]\n295-463-0\n92045-80-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK S U\n649-118-00-X\nHydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas\n306-004-1\n95465-89-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-119-00-5\nRaffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas\n307-769-4\n97722-19-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-120-00-0\nGases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]\n270-746-1\n68477-65-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-121-00-6\nGases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]\n270-747-7\n68477-66-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-122-00-1\nGases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]\n270-748-2\n68477-67-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-123-00-7\nGases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-749-8\n68477-68-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-124-00-2\nGases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-759-2\n68477-77-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-125-00-8\nGases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-761-3\n68477-80-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-126-00-3\nGases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]\n270-762-9\n68477-81-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-127-00-9\nGases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas\n270-763-4\n68477-82-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-128-00-4\nGases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]\n270-766-0\n68477-84-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-129-00-X\nGases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-774-4\n68477-92-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-130-00-5\nGases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]\n270-776-5\n68477-93-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-131-00-0\nGases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]\n270-779-1\n68477-96-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-132-00-6\nGases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]\n270-780-7\n68477-97-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-133-00-1\nGases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-781-2\n68477-98-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-134-00-7\nGases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n270-783-3\n68478-00-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-135-00-2\nGases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-784-9\n68478-01-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-136-00-8\nGases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-785-4\n68478-02-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-137-00-3\nGases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n270-787-5\n68478-03-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-138-00-9\nGases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-788-0\n68478-04-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-139-00-4\nGases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-789-6\n68478-05-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-140-00-X\nTail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-805-1\n68478-25-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-141-00-5\nTail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-807-2\n68478-27-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-142-00-0\nTail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-808-8\n68478-28-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-143-00-6\nTail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-809-3\n68478-29-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-144-00-1\nTail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-810-9\n68478-30-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-145-00-7\nGases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]\n270-999-8\n68513-14-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-146-00-2\nGases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-003-4\n68513-18-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-147-00-8\nGases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-005-5\n68513-19-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-148-00-3\nGases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]\n271-258-1\n68527-15-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-149-00-9\nGases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]\n271-623-5\n68602-82-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-150-00-4\nGases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n271-625-6\n68602-84-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-151-00-X\nPetroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-750-6\n68607-11-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-152-00-5\nGases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-182-1\n68783-06-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-153-00-0\nGases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-338-9\n68814-67-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-154-00-6\nGases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n272-343-6\n68814-90-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-155-00-1\nGases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]\n272-775-5\n68911-58-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-156-00-7\nGases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n272-776-0\n68911-59-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-157-00-2\nGases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]\n272-873-8\n68919-01-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-158-00-8\nGases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-874-3\n68919-02-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-159-00-3\nGases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]\n272-875-9\n68919-03-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-160-00-9\nGases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-876-4\n68919-04-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-161-00-4\nGases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]\n272-880-6\n68919-07-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-162-00-X\nGases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-881-1\n68919-08-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-163-00-5\nGases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-884-8\n68919-11-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-164-00-0\nGases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]\n272-885-3\n68919-12-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-165-00-6\nTail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]\n273-173-5\n68952-79-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-166-00-1\nTail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n273-174-0\n68952-80-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-167-00-7\nGases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-269-7\n68955-33-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-168-00-2\nGases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-563-5\n68989-88-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-169-00-8\nGases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n295-397-2\n92045-15-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-170-00-3\nGases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n295-398-8\n92045-16-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-171-00-9\nGases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n295-399-3\n92045-17-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-172-00-4\nGases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n295-400-7\n92045-18-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-173-00-X\nGases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]\n295-401-2\n92045-19-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-174-00-5\nGases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n295-402-8\n92045-20-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n\n\n649-175-00-0\nFoots oil (petroleum), acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-225-7\n93924-31-3\nFlam. Gas 1\nPress. Gas\nCarc. 1B\nH220\nH350\nH340\nGHS02\nGHS04\nGHS08\nDgr\nH220\nH350\nH340\n\n\nH K U\n649-176-00-6\nFoots oil (petroleum), clay-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-226-2\n93924-32-4\nFlam. Gas 1\nPress. Gas\nCarc. 1B\nH220\nH350\nH340\nGHS02\nGHS04\nGHS08\nDgr\nH220\nH350\nH340\n\n\nH K U\n\n\n649-177-00-1\nGases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]\n268-629-5\n68131-75-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-178-00-7\nTail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-617-2\n68307-98-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-179-00-2\nTail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-618-8\n68307-99-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-180-00-8\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-619-3\n68308-00-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-181-00-3\nTail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-620-9\n68308-01-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-182-00-9\nTail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-630-3\n68308-10-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-183-00-4\nTail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-623-5\n68308-03-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-184-00-X\nTail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-624-0\n68308-04-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-185-00-5\nTail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-625-6\n68308-05-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-186-00-0\nTail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-626-1\n68308-06-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-187-00-6\nTail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-627-7\n68308-07-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-188-00-1\nTail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-629-8\n68308-09-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-189-00-7\nTail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-631-9\n68308-11-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-190-00-2\nTail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-632-4\n68308-12-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-191-00-8\nGases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]\n270-071-2\n68409-99-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-193-00-9\nAlkanes, C1-2;\nPetroleum gas\n270-651-5\n68475-57-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-194-00-4\nAlkanes, C2-3;\nPetroleum gas\n270-652-0\n68475-58-1\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-195-00-X\nAlkanes, C3-4;\npetroleum gas\n270-653-6\n68475-59-2\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-196-00-5\nAlkanes, C4-5;\nPetroleum gas\n270-654-1\n68475-60-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-197-00-0\nFuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]\n270-667-2\n68476-26-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-198-00-6\nFuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]\n270-670-9\n68476-29-9\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-199-00-1\nHydrocarbons, C3-4;\nPetroleum gas\n270-681-9\n68476-40-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-200-00-5\nHydrocarbons, C4-5;\nPetroleum gas\n270-682-4\n68476-42-6\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-201-00-0\nHydrocarbons, C2-4, C3-rich;\nPetroleum gas\n270-689-2\n68476-49-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-202-00-6\nPetroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-704-2\n68476-85-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK S U\n649-203-00-1\nPetroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-705-8\n68476-86-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK S U\n649-204-00-7\ngases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]\n270-724-1\n68477-33-8\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-205-00-2\nDistillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]\n270-726-2\n68477-35-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-206-00-8\nGases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-750-3\n68477-69-0\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-207-00-3\nGases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]\n270-751-9\n68477-70-3\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-208-00-9\nGases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-752-4\n68477-71-4\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-209-00-4\nGases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-754-5\n68477-72-5\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n649-210-00-X\nTail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-628-2\n68308-08-7\nPress. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B\nH220\nH350\nH340\nGHS04\nGHS02\nGHS08\nDgr\nH220\nH350\nH340\n\n\nK U\n\n\n649-211-00-5\nFoots oil (petroleum), carbon-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-126-0\n97862-76-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-212-00-0\nDistillates (petroleum), sweetened middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-088-7\n64741-86-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-213-00-6\nGas oils (petroleum), solvent-refined;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-092-9\n64741-90-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-214-00-1\nDistillates (petroleum), solvent-refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-093-4\n64741-91-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-215-00-7\nGas oils (petroleum), acid-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-112-6\n64742-12-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-216-00-2\nDistillates (petroleum), acid-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-113-1\n64742-13-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-217-00-8\nDistillates (petroleum), acid-treated light;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-114-7\n64742-14-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-218-00-3\nGas oils (petroleum), chemically neutralized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-129-9\n64742-29-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-219-00-9\nDistillates (petroleum), chemically neutralized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-130-4\n64742-30-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-220-00-4\nDistillates (petroleum), clay-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-139-3\n64742-38-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-221-00-X\nDistillates (petroleum), hydrotreated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-148-2\n64742-46-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-222-00-5\nGas oils (petroleum), hydrodesulfurized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-182-8\n64742-79-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-223-00-0\nDistillates (petroleum), hydrodesulfurized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-183-3\n64742-80-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-224-00-6\nFuels, diesel;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]\n269-822-7\n68334-30-5\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH N\n649-225-00-1\nFuel oil, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]\n270-671-4\n68476-30-2\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-226-00-7\nFuel oil, No 4;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]\n270-673-5\n68476-31-3\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-227-00-2\nFuels, diesel, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]\n270-676-1\n68476-34-6\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-228-00-8\nDistillates (petroleum), catalytic reformer fractionator residue, high-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]\n270-719-4\n68477-29-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-229-00-3\nDistillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]\n270-721-5\n68477-30-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-230-00-9\nDistillates (petroleum), catalytic reformer fractionator residue, low-boiling;\nGasoil — unspecified;\n[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]\n270-722-0\n68477-31-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-231-00-4\nDistillates (petroleum), highly refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]\n292-615-8\n90640-93-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-232-00-X\nDistillates (petroleum) catalytic reformer, heavy arom. conc.;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n295-294-2\n91995-34-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-233-00-5\nGas oils, paraffinic;\nGasoil — unspecified;\n[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]\n300-227-8\n93924-33-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-234-00-0\nNaphtha (petroleum), solvent-refined hydrodesulfurized heavy;\nGasoil — unspecified\n307-035-3\n97488-96-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-235-00-6\nHydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-659-6\n97675-85-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-236-00-1\nHydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-660-1\n97675-86-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-237-00-7\nHydrocarbons, C11-17, solvent-extd. light naphthenic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n307-757-9\n97722-08-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-238-00-2\nGas oils, hydrotreated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]\n308-128-1\n97862-78-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-239-00-8\nDistillates (petroleum), carbon-treated light paraffinic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]\n309-667-5\n100683-97-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-240-00-3\nDistillates (petroleum), intermediate paraffinic, carbon-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-668-0\n100683-98-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-241-00-9\nDistillates (petroleum), intermediate paraffinic, clay-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-669-6\n100683-99-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-242-00-4\nAlkanes, C12-26-branched and linear\n292-454-3\n90622-53-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-243-00-X\nLubricating greases;\nGrease;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]\n278-011-7\n74869-21-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-244-00-5\nSlack wax (petroleum);\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n265-165-5\n64742-61-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-245-00-0\nSlack wax (petroleum), acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n292-659-8\n90669-77-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-246-00-6\nSlack wax (petroleum), clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]\n292-660-3\n90669-78-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-247-00-1\nSlack wax (petroleum), hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n295-523-6\n92062-09-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-248-00-7\nSlack wax (petroleum), low-melting;\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-524-1\n92062-10-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-249-00-2\nSlack wax (petroleum), low-melting, hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-525-7\n92062-11-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-250-00-8\nSlack wax (petroleum), low-melting, carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-155-9\n97863-04-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-251-00-3\nSlack wax (petroleum), low-melting, clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-156-4\n97863-05-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-252-00-9\nSlack wax (petroleum), low-melting, silicic acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-158-5\n97863-06-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-253-00-4\nSlack wax (petroleum), carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]\n309-723-9\n100684-49-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-254-00-X\nPetrolatum;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n232-373-2\n8009-03-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-255-00-5\nPetrolatum (petroleum), oxidized;\nPetrolatum;\n[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]\n265-206-7\n64743-01-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-256-00-0\nPetrolatum (petroleum), alumina-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n285-098-5\n85029-74-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-257-00-6\nPetrolatum (petroleum), hydrotreated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]\n295-459-9\n92045-77-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-258-00-1\nPetrolatum (petroleum), carbon-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-149-6\n97862-97-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-259-00-7\nPetrolatum (petroleum), silicic acid-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-150-1\n97862-98-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n649-260-00-2\nPetrolatum (petroleum), clay-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]\n309-706-6\n100684-33-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH N\n\n\n649-261-00-8\nGasoline, natural;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]\n232-349-1\n8006-61-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-262-00-3\nNaphtha;\nLow boiling point naphtha;\n[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n232-443-2\n8030-30-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-263-00-9\nLigroine;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]\n232-453-7\n8032-32-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-264-00-4\nNaphtha (petroleum), heavy straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-041-0\n64741-41-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-265-00-X\nNaphtha (petroleum), full-range straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]\n265-042-6\n64741-42-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-266-00-5\nNaphtha (petroleum), light straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-046-8\n64741-46-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-267-00-0\nSolvent naphtha (petroleum), light aliph.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]\n265-192-2\n64742-89-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-268-00-6\nDistillates (petroleum), straight-run light;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]\n270-077-5\n68410-05-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-269-00-1\nGasoline, vapor-recovery;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C (– 4 °F to 384 °F).]\n271-025-4\n68514-15-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-270-00-7\nGasoline, straight-run, topping-plant;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]\n271-727-0\n68606-11-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-271-00-2\nNaphtha (petroleum), unsweetened;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]\n272-186-3\n68783-12-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-272-00-8\nDistillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]\n272-931-2\n68921-08-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-273-00-3\nNaphtha (petroleum), heavy straight run, arom.-contg.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n309-945-6\n101631-20-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-274-00-9\nNaphtha (petroleum), full-range alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]\n265-066-7\n64741-64-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-275-00-4\nNaphtha (petroleum), heavy alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]\n265-067-2\n64741-65-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-276-00-X\nNaphtha (petroleum), light alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]\n265-068-8\n64741-66-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-277-00-5\nNaphtha (petroleum), isomerization;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]\n265-073-5\n64741-70-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-278-00-0\nNaphtha (petroleum), solvent-refined light;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n265-086-6\n64741-84-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-279-00-6\nNaphtha (petroleum), solvent-refined heavy;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-095-5\n64741-92-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-280-00-1\nRaffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]\n270-088-5\n68410-71-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-281-00-7\nRaffinates (petroleum), reformer, Lurgi unit-sepd.;\nLow boiling point modified naphtha;\n[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]\n270-349-3\n68425-35-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-282-00-2\nNaphtha (petroleum), full-range alkylate, butane-contg.;\nLow boiling point modified naphta;\n[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]\n271-267-0\n68527-27-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-283-00-8\nDistillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]\n295-315-5\n91995-53-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-284-00-3\nNaphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-430-0\n92045-49-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-285-00-9\nHydrocarbons, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]\n295-436-3\n92045-55-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-286-00-4\nNaphtha (petroleum), isomerization, C6-fraction;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]\n295-440-5\n92045-58-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-287-00-X\nHydrocarbons, C6-7, naphtha-cracking, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]\n295-446-8\n92045-64-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-288-00-5\nHydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]\n309-871-4\n101316-67-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-289-00-0\nNaphtha (petroleum), heavy catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-055-7\n64741-54-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-290-00-6\nNaphtha (petroleum), light catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-056-2\n64741-55-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-291-00-1\nHydrocarbons, C3-11, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]\n270-686-6\n68476-46-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-292-00-7\nNaphtha (petroleum), catalytic cracked light distd.;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-185-8\n68783-09-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-293-00-2\nDistillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;\nLow boiling point cat-cracked naphtha.;\n[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]\n295-311-3\n91995-50-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-294-00-8\nNaphtha (petroleum), heavy catalytic cracked, sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]\n295-431-6\n92045-50-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-295-00-3\nNaphtha (petroleum), light catalytic cracked sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-441-0\n92045-59-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-296-00-9\nHydrocarbons, C8-12, catalytic-cracking, chem. neutralized;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n295-794-0\n92128-94-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-297-00-4\nHydrocarbons, C8-12, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]\n309-974-4\n101794-97-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-298-00-X\nHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;\nLow boiling point cat-cracked naphtha\n309-987-5\n101896-28-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-299-00-5\nNaphtha (petroleum), light catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n265-065-1\n64741-63-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-300-00-9\nNaphtha (petroleum), heavy catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-070-9\n64741-68-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-301-00-4\nDistillates (petroleum), catalytic reformed depentanizer;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]\n270-660-4\n68475-79-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-302-00-X\nHydrocarbons, C2-6, C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha\n270-687-1\n68476-47-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-303-00-5\nResidues (petroleum), C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha;\n[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n270-794-3\n68478-15-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-304-00-0\nNaphtha (petroleum), light catalytic reformed, arom.-free;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]\n270-993-5\n68513-03-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-305-00-6\nDistillates (petroleum), catalytic reformed straight-run naphtha overheads;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-008-1\n68513-63-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-306-00-1\nPetroleum products, hydrofiner-powerformer reformates;\nLow boiling point cat-reformed naphtha;\n[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]\n271-058-4\n68514-79-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-307-00-7\nNaphtha (petroleum), full-range reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n272-895-8\n68919-37-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-308-00-2\nNaphtha (petroleum), catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n273-271-8\n68955-35-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-309-00-8\nDistillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]\n285-509-8\n85116-58-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-310-00-3\nAromatic hydrocarbons, C8, catalytic reforming-derived;\nLow boiling point cat-reformed naphtha\n295-279-0\n91995-18-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-311-00-9\nAromatic hydrocarbons, C7-12, C8-rich;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]\n297-401-8\n93571-75-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-312-00-4\nGasoline, C5-11, high-octane stabilised reformed;\nLow boiling point cat-reformed naphtha;\n[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]\n297-458-9\n93572-29-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-313-00-X\nHydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]\n297-465-7\n93572-35-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-314-00-5\nHydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]\n297-466-2\n93572-36-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n\n649-315-00-0\nFoots oil (petroleum), silicic acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-127-6\n97862-77-6\nCarc. 1B\nH350\nH304\nGHS08\nDgr\nH350\nH304\n\n\nH L\n\n\n649-316-00-6\nNaphtha (petroleum), light thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]\n265-075-6\n64741-74-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-317-00-1\nNaphtha (petroleum), heavy thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]\n265-085-0\n64741-83-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-318-00-7\nDistillates (petroleum), heavy arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]\n267-563-4\n67891-79-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-319-00-2\nDistillates (petroleum), light arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]\n267-565-5\n67891-80-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-320-00-8\nDistillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]\n270-344-6\n68425-29-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-321-00-3\nAromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]\n270-658-3\n68475-70-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-322-00-9\nDistillates (petroleum), thermal cracked naphtha and gas oil;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]\n271-631-9\n68603-00-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-323-00-4\nDistillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]\n271-632-4\n68603-01-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-324-00-X\nDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]\n271-634-5\n68603-03-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-325-00-5\nDistillates (petroleum), light thermal cracked, debutanized arom.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]\n273-266-0\n68955-29-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-326-00-0\nNaphtha (petroleum), light thermal cracked, sweetened;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]\n295-447-3\n92045-65-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-327-00-6\nNaphtha (petroleum), hydrotreated heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-150-3\n64742-48-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-328-00-1\nNaphtha (petroleum), hydrotreated light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-151-9\n64742-49-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-329-00-7\nNaphtha (petroleum), hydrodesulfurized light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-178-6\n64742-73-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-330-00-2\nNaphtha (petroleum), hydrodesulfurized heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-185-4\n64742-82-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-331-00-8\nDistillates (petroleum), hydrotreated middle, intermediate boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]\n270-092-7\n68410-96-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-332-00-3\nDistillates (petroleum), light distillate hydrotreating process, low-boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]\n270-093-2\n68410-97-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-333-00-9\nDistillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]\n270-094-8\n68410-98-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-334-00-4\nSolvent naphtha (petroleum), light arom., hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n270-988-8\n68512-78-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-335-00-X\nNaphtha (petroleum), hydrodesulfurized thermal cracked light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]\n285-511-9\n85116-60-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-336-00-5\nNaphtha (petroleum), hydrotreated light, cycloalkane-contg.;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n285-512-4\n85116-61-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-337-00-0\nNaphtha (petroleum), heavy steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha\n295-432-1\n92045-51-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-338-00-6\nNaphtha (petroleum), hydrodesulfurized full-range;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]\n295-433-7\n92045-52-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-339-00-1\nNaphtha (petroleum), hydrotreated light steam-cracked;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n295-438-4\n92045-57-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-340-00-7\nHydrocarbons, C4-12, naphtha-cracking, hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]\n295-443-1\n92045-61-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-341-00-2\nSolvent naphtha (petroleum), hydrotreated light naphthenic;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]\n295-529-9\n92062-15-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-342-00-8\nNaphtha (petroleum), light steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]\n296-942-7\n93165-55-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-343-00-3\nHydrocarbons, C6-11, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-852-0\n93763-33-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-344-00-9\nHydrocarbons, C9-12, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-853-6\n93763-34-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-345-00-4\nStoddard solvent;\nLow boiling point naphtha - unspecified;\n[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]\n232-489-3\n8052-41-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-346-00-X\nNatural gas condensates (petroleum);\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]\n265-047-3\n64741-47-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-347-00-5\nNatural gas (petroleum), raw liq. mix;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]\n265-048-9\n64741-48-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-348-00-0\nNaphtha (petroleum), light hydrocracked;\nLow boiling naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-071-4\n64741-69-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-349-00-6\nNaphtha (petroleum), heavy hydrocracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]\n265-079-8\n64741-78-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-350-00-1\nNaphtha (petroleum), sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]\n265-089-2\n64741-87-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-351-00-7\nNaphtha (petroleum), acid-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-115-2\n64742-15-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-352-00-2\nNaphtha (petroleum), chemically neutralized heavy;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-122-0\n64742-22-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-353-00-8\nNaphtha (petroleum), chemically neutralized light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-123-6\n64742-23-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-354-00-3\nNaphtha (petroleum), catalytic dewaxed;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n265-170-2\n64742-66-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-355-00-9\nNaphtha (petroleum), light steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]\n265-187-5\n64742-83-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-356-00-4\nSolvent naphtha (petroleum), light arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n265-199-0\n64742-95-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-357-00-X\nAromatic hydrocarbons, C6-10, acid-treated, neutralized;\nLow boiling point naphtha - unspecified\n268-618-5\n68131-49-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-358-00-5\nDistillates (petroleum), C3-5, 2-methyl-2-butene-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]\n270-725-7\n68477-34-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-359-00-0\nDistillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-735-1\n68477-50-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-360-00-6\nDistillates (petroleum), steam-cracked, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-736-7\n68477-53-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-361-00-1\nDistillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;\nLow boiling point naphtha - unspecified\n270-738-8\n68477-55-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-362-00-7\nExtracts (petroleum), cold-acid, C4-6;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n270-741-4\n68477-61-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-363-00-2\nDistillates (petroleum), depentanizer overheads;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-771-8\n68477-89-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-364-00-8\nResidues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-791-7\n68478-12-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nP\n\n\n649-365-00-3\nResidual oils (petroleum), deisobutanizer tower;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-795-9\n68478-16-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-366-00-9\nNaphtha (petroleum), full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]\n270-991-4\n68513-02-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-367-00-4\nNaphtha (petroleum), steam-cracked middle arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]\n271-138-9\n68516-20-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-368-00-X\nNaphtha (petroleum), clay-treated full-range straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]\n271-262-3\n68527-21-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-369-00-5\nNaphtha (petroleum), clay-treated light straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]\n271-263-9\n68527-22-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-370-00-0\nNaphtha (petroleum), light steam-cracked arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]\n271-264-4\n68527-23-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-371-00-6\nNaphtha (petroleum), light steam-cracked, debenzenized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]\n271-266-5\n68527-26-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-372-00-1\nNaphtha (petroleum), arom.-contg.;\nLow boiling point naphtha - unspecified\n271-635-0\n68603-08-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-373-00-7\nGasoline, pyrolysis, debutanizer bottoms;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]\n271-726-5\n68606-10-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-374-00-2\nNaphtha (petroleum), light, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]\n272-206-0\n68783-66-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-375-00-8\nNatural gas condensates;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]\n272-896-3\n68919-39-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-376-00-3\nDistillates (petroleum), naphtha unifiner stripper;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n272-932-8\n68921-09-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-377-00-9\nNaphtha (petroleum), catalytic reformed light, arom.-free fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]\n285-510-3\n85116-59-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-378-00-4\nGasoline;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]\n289-220-8\n86290-81-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-379-00-X\nAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;\nLow boiling point naphtha - unspecified\n292-698-0\n90989-42-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-380-00-5\nHydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]\n295-298-4\n91995-38-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-381-00-0\nDistillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n295-302-4\n91995-41-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-382-00-6\nExtracts (petroleum), catalytic reformed light naphtha solvent;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n295-331-2\n91995-68-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-383-00-1\nNaphtha (petroleum), hydrodesulfurized light, dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]\n295-434-2\n92045-53-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-384-00-7\nNaphtha (petroleum), light, C5-rich, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]\n295-442-6\n92045-60-8\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-385-00-2\nHydrocarbons, C8-11, naphtha-cracking, toluene cut;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]\n295-444-7\n92045-62-0\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-386-00-8\nHydrocarbons, C4-11, naphtha-cracking, arom.-free;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]\n295-445-2\n92045-63-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-387-00-3\nNaphtha (petroleum), light heat-soaked, steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]\n296-028-8\n92201-97-3\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-388-00-9\nDistillates (petroleum), C6-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]\n296-903-4\n93165-19-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-389-00-4\nGasoline, pyrolysis, hydrogenated;\nLow boiling point naphtha-unspecified;\n[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]\n302-639-3\n94114-03-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-390-00-X\nDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n305-750-5\n95009-23-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-391-00-5\nExtracts (petroleum) heavy naphtha solvent, clay-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]\n308-261-5\n97926-43-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-392-00-0\nNaphtha (petroleum), light steam-cracked, debenzenized, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]\n308-713-1\n98219-46-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-393-00-6\nNaphtha (petroleum), light steam-cracked, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]\n308-714-7\n98219-47-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-394-00-1\nDistillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]\n309-862-5\n101316-56-7\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-395-00-7\nHydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]\n309-870-9\n101316-66-9\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-396-00-2\nNaphtha (petroleum), hydrodesulfurised full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]\n309-879-8\n101316-76-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-397-00-8\nNaphtha (petroleum), sweetened light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]\n309-976-5\n101795-01-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-398-00-3\nHydrocarbons, C3-6, C5-rich, steam-cracked naphtha;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]\n310-012-0\n102110-14-5\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-399-00-9\nHydrocarbons, C5-rich, dicyclopentadiene-contg.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]\n310-013-6\n102110-15-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-400-00-2\nResidues (petroleum), steam-cracked light, arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]\n310-057-6\n102110-55-4\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-401-00-8\nHydrocarbons, C≥5, C5-6-rich;\nLow boiling point naphtha - unspecified\n270-690-8\n68476-50-6\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-402-00-3\nHydrocarbons, C5-rich;\nLow boiling point naphtha - unspecified\n270-695-5\n68476-55-1\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-403-00-9\nAromatic hydrocarbons, C8-10;\nLow boiling point naphtha - unspecified\n292-695-4\n90989-39-2\nCarc. 1B\nMuta. 1B\nAsp. Tox. 1\nH350\nH340\nH304\nGHS08\nDgr\nH350\nH340\nH304\n\n\nH P\n\n649-404-00-4\nKerosine (petroleum);\nStraight run kerosine;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]\n232-366-4\n8008-20-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-405-00-X\nSolvent naphtha (petroleum), medium aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]\n265-191-7\n64742-88-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-406-00-5\nSolvent naphtha (petroleum) heavy aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]\n265-200-4\n64742-96-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-407-00-0\nKerosine (petroleum), straight-run wide-cut;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]\n295-418-5\n92045-37-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-408-00-6\nDistillates (petroleum), steam-cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]\n265-194-3\n64742-91-2\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-409-00-1\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]\n270-728-3\n68477-39-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-410-00-7\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]\n270-729-9\n68477-40-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-411-00-2\nDistillates (petroleum), steam-cracked, C8-12 fraction;\nCracked kerosine;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n270-737-2\n68477-54-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-412-00-8\nKerosine (petroleum), hydrodesulfurized thermal cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]\n285-507-7\n85116-55-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-413-00-3\nAromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]\n292-621-0\n90640-98-5\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-414-00-9\nNaphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]\n292-637-8\n90641-13-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-415-00-4\nDistillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]\n309-866-7\n101316-61-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-416-00-X\nDistillates (petroleum), catalytic cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-938-8\n101631-13-4\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-417-00-5\nSolvent naphtha (petroleum), hydrocracked heavy arom.;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]\n309-881-9\n101316-80-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-418-00-0\nDistillates (petroleum), steam-cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-940-9\n101631-15-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-419-00-6\nDistillates (petroleum), alkylate;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]\n265-074-0\n64741-73-7\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-420-00-1\nExtracts (petroleum), heavy naphtha solvent;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]\n265-099-7\n64741-98-6\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-421-00-7\nDistillates (petroleum), chemically neutralized light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-132-5\n64742-31-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-422-00-2\nDistillates (petroleum), hydrotreated light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-149-8\n64742-47-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-423-00-8\nKerosine (petroleum), hydrodesulfurized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-184-9\n64742-81-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-424-00-3\nSolvent naphtha (petroleum), heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]\n265-198-5\n64742-94-5\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-425-00-9\nNaphtha (petroleum), heavy coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]\n269-778-9\n68333-23-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-426-00-4\nNaphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]\n285-508-2\n85116-57-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-427-00-X\nKerosine (petroleum), sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]\n294-799-5\n91770-15-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-428-00-5\nKerosine (petroleum), solvent-refined sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]\n295-416-4\n92045-36-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-429-00-0\nHydrocarbons, C9-16, hydrotreated, dearomatized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-854-1\n93763-35-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-430-00-6\nKerosine (petroleum), solvent-refined hydrodesulfurized;\nKerosine — unspecified\n307-033-2\n97488-94-3\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-431-00-1\nDistillates (petroleum), hydrodesulfurized full-range middle coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]\n309-864-6\n101316-58-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-432-00-7\nSolvent naphtha (petroleum), hydrodesulfurized heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]\n309-882-4\n101316-81-8\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-433-00-2\nSolvent naphtha (petroleum), hydrodesulfurized medium;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]\n309-884-5\n101316-82-9\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-434-00-8\nKerosine (petroleum), hydrotreated;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]\n309-944-0\n101631-19-0\nAsp. Tox. 1\nH304\nGHS08\nDgr\nH304\n\n\nH\n649-435-00-3\nDistillates (petroleum), light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n265-060-4\n64741-59-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-436-00-9\nDistillates (petroleum), intermediate catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n265-062-5\n64741-60-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-437-00-4\nDistillates (petroleum), light hydrocracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]\n265-078-2\n64741-77-1\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-438-00-X\nDistillates (petroleum), light thermal cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]\n265-084-5\n64741-82-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-439-00-5\nDistillates (petroleum), hydrodesulfurized light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n269-781-5\n68333-25-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-440-00-0\nDistillates (petroleum), light steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]\n270-662-5\n68475-80-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-441-00-6\nDistillates (petroleum), cracked steam-cracked petroleum distillates;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]\n270-727-8\n68477-38-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-442-00-1\nGas oils (petroleum), steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]\n271-260-2\n68527-18-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-443-00-7\nDistillates (petroleum), hydrodesulfurized thermal cracked middle;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n285-505-6\n85116-53-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-444-00-2\nGas oils (petroleum), thermal-cracked, hydrodesulfurized;\nCracked gasoil\n295-411-7\n92045-29-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-445-00-8\nResidues (petroleum), hydrogenated steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]\n295-514-7\n92062-00-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-446-00-3\nResidues (petroleum), steam-cracked naphtha distn.;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]\n295-517-3\n92062-04-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-447-00-9\nDistillates (petroleum), light catalytic cracked, thermally degraded;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]\n295-991-1\n92201-60-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-448-00-4\nResidues (petroleum), steam-cracked heat-soaked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]\n297-905-8\n93763-85-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-449-00-X\nHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]\n307-662-2\n97675-88-2\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nH\n649-450-00-5\nGas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]\n308-278-8\n97926-59-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-451-00-0\nDistillates (petroleum), hydrodesulfurized middle coker;\nCracked gasoil;\n[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]\n309-865-1\n101316-59-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-452-00-6\nDistillates (petroleum), heavy steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]\n309-939-3\n101631-14-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH\n649-453-00-1\nDistillates (petroleum), heavy hydrocracked;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]\n265-077-7\n64741-76-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-454-00-7\nDistillates (petroleum), solvent-refined heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-090-8\n64741-88-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-455-00-2\nDistillates (petroleum), solvent-refined light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-091-3\n64741-89-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-456-00-8\nResidual oils (petroleum), solvent deasphalted;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-096-0\n64741-95-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-457-00-3\nDistillates (petroleum), solvent-refined heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]\n265-097-6\n64741-96-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-458-00-9\nDistillates (petroleum), solvent-refined light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-098-1\n64741-97-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-459-00-4\nResidual oils (petroleum,) solvent-refined;\nBaseoil — unspecified;\n[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-101-6\n64742-01-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-460-00-X\nDistillates (petroleum), clay-treated paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-137-2\n64742-36-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-461-00-5\nDistillates (petroleum), clay-treated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-138-8\n64742-37-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-462-00-0\nResidual oils (petroleum), clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-143-5\n64742-41-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-463-00-6\nDistillates (petroleum), clay-treated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-146-1\n64742-44-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-464-00-1\nDistillates (petroleum), clay-treated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-147-7\n64742-45-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-465-00-7\nDistillates (petroleum), hydrotreated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-155-0\n64742-52-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-466-00-2\nDistillates (petroleum), hydrotreated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-156-6\n64742-53-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-467-00-8\nDistillates (petroleum), hydrotreated heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-157-1\n64742-54-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-468-00-3\nDistillates (petroleum), hydrotreated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-158-7\n64742-55-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-469-00-9\nDistillates (petroleum), solvent-dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-159-2\n64742-56-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-470-00-4\nResidual oils (petroleum), hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-160-8\n64742-57-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-471-00-X\nResidual oils (petroleum), solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-166-0\n64742-62-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-472-00-5\nDistillates (petroleum), solvent-dewaxed heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-167-6\n64742-63-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-473-00-0\nDistillates (petroleum), solvent-dewaxed light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-168-1\n64742-64-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-474-00-6\nDistillates (petroleum), solvent-dewaxed heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-169-7\n64742-65-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-475-00-1\nNaphthenic oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-172-3\n64742-68-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-476-00-7\nNaphthenic oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-173-9\n64742-69-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-477-00-2\nParaffin oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-174-4\n64742-70-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-478-00-8\nParaffin oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-176-5\n64742-71-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-479-00-3\nNaphthenic oils (petroleum), complex dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-179-1\n64742-75-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-480-00-9\nNaphthenic oils (petroleum), complex dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-180-7\n64742-76-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-481-00-4\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-736-3\n72623-85-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-482-00-X\nLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]\n276-737-9\n72623-86-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-483-00-5\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-738-4\n72623-87-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-484-00-0\nLubricating oils;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]\n278-012-2\n74869-22-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-485-00-6\nDistillates (petroleum), complex dewaxed heavy paraffinci;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-613-7\n90640-91-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-486-00-1\nDistillates (petroleum), complex dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-614-2\n90640-92-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-487-00-7\nDistillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-616-3\n90640-94-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-488-00-2\nHydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-617-9\n90640-95-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-489-00-8\nDistillates (petroleum), solvent dewaxed light paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-618-4\n90640-96-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-490-00-3\nDistillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-620-5\n90640-97-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-491-00-9\nResidual oils (petroleum), hydrotreated solvent dewaxed;\nBaseoil — unspecified\n292-656-1\n90669-74-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-492-00-4\nResidual oils (petroleum), catalytic dewaxed;\nBaseoil — unspecified\n294-843-3\n91770-57-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-493-00-X\nDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]\n295-300-3\n91995-39-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-494-00-5\nDistillates (petroleum), dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]\n295-301-9\n91995-40-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-495-00-0\nDistillates (petroleum), hydrocracked solvent-refined, dewaxed;\nBaseoil — unspecified;\n[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]\n295-306-6\n91995-45-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-496-00-6\nDistillates (petroleum), solvent-refined light naphthenic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]\n295-316-0\n91995-54-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-497-00-1\nLubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;\nBaseoil — unspecified\n295-423-2\n92045-42-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-498-00-7\nLubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;\nBaseoil — unspecified\n295-424-8\n92045-43-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-499-00-2\nResidual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]\n295-499-7\n92061-86-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-500-00-6\nParaffin oils (petroleum), solvent-refined dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]\n295-810-6\n92129-09-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-501-00-1\nLubricating oils (petroleum), base oils, paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]\n297-474-6\n93572-43-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-502-00-7\nHydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;\nBaseoil — unspecified\n297-857-8\n93763-38-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-503-00-2\nHydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;\nBaseoil — unspecified\n300-257-1\n93924-61-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-504-00-8\nDistillates (petroleum), solvent-refined hydrotreated heavy;\nhydrogenated;\nBaseoil — unspecified\n305-588-5\n94733-08-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-505-00-3\nDistillates (petroleum), solvent-refined hydrocracked light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]\n305-589-0\n94733-09-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-506-00-9\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-594-8\n94733-15-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-507-00-4\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-595-3\n94733-16-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-508-00-X\nHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-971-7\n95371-04-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-509-00-5\nHydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-972-2\n95371-05-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-510-00-0\nHydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;\nBaseoil — unspecified\n305-974-3\n95371-07-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-511-00-6\nHydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;\nBaseoil — unspecified\n305-975-9\n95371-08-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-512-00-1\nDistillates (petroleum), hydrocracked solvent-refined light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]\n307-010-7\n97488-73-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-513-00-7\nDistillates (petroleum), solvent-refined hydrogenated heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]\n307-011-2\n97488-74-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-514-00-2\nLubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;\nBaseoil — unspecified\n307-034-8\n97488-95-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-515-00-8\nHydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]\n307-661-7\n97675-87-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-516-00-3\nHydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]\n307-755-8\n97722-06-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-517-00-9\nHydrocarbons, C13-27, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).]\n307-758-4\n97722-09-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-518-00-4\nHydrocarbons, C14-29, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]\n307-760-5\n97722-10-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-519-00-X\nHydrocarbons, C27-42, dearomatized;\nBaseoil — unspecified\n308-131-8\n97862-81-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-520-00-5\nHydrocarbons, C17-30, hydrotreated distillates, distn. lights;\nBaseoil — unspecified\n308-132-3\n97862-82-3\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-521-00-0\nHydrocarbons, C27-45, naphthenic vacuum distn.;\nBaseoil — unspecified\n308-133-9\n97862-83-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-522-00-6\nHydrocarbons, C27-45, dearomatized;\nBaseoil — unspecified\n308-287-7\n97926-68-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-523-00-1\nHydrocarbons, C20-58, hydrotreated;\nBaseoil — unspecified\n308-289-8\n97926-70-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-524-00-7\nHydrocarbons, C27-42, naphthenic;\nBaseoil — unspecified\n308-290-3\n97926-71-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-525-00-2\nResidual oils (petroleum), carbon-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]\n309-710-8\n100684-37-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-526-00-8\nResidual oils (petroleum), clay-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]\n309-711-3\n100684-38-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-527-00-3\nLubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]\n309-874-0\n101316-69-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-528-00-9\nLubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]\n309-875-6\n101316-70-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-529-00-4\nLubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]\n309-876-1\n101316-71-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-530-00-X\nLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]\n309-877-7\n101316-72-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-531-00-5\nExtracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;\nDistillate aromatic extract (treated);\n[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]\n272-175-3\n68783-00-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-532-00-0\nExtracts (petroleum), solvent-refined heavy paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n272-180-0\n68783-04-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-533-00-6\nExtracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]\n272-342-0\n68814-89-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-534-00-1\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]\n292-631-5\n90641-07-9\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-535-00-7\nExtracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).\n292-632-0\n90641-08-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-536-00-2\nExtracts (petroleum), light paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]\n292-633-6\n90641-09-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-537-00-8\nExtracts (petroleum), hydrotreated light paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n295-335-4\n91995-73-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-538-00-3\nExtracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n295-338-0\n91995-75-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-539-00-9\nExtracts (petroleum), light paraffinic distillate solvent, acid-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n295-339-6\n91995-76-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-540-00-4\nExtracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]\n295-340-1\n91995-77-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-541-00-X\nExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n295-342-2\n91995-79-8\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-542-00-5\nExtracts (petroleum), heavy paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]\n296-437-1\n92704-08-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-543-00-0\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-827-4\n93763-10-1\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-544-00-6\nExtracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-829-5\n93763-11-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-545-00-1\nExtracts (petroleum), light paraffinic distillate solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-672-2\n100684-02-4\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-546-00-7\nExtracts (petroleum), light paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-673-8\n100684-03-5\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-547-00-2\nExtracts (petroleum), light vacuum, gas oil solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-674-3\n100684-04-6\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-548-00-8\nExtracts (petroleum), light vacuum gas oil solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-675-9\n100684-05-7\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-549-00-3\nFoots oil (petroleum);\nFoots oil;\n[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n265-171-8\n64742-67-2\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n649-550-00-9\nFoots oil (petroleum), hydrotreated;\nFoots oil\n295-394-6\n92045-12-0\nCarc. 1B\nH350\nGHS08\nDgr\nH350\n\n\nH L\n650-002-00-6\nturpentine, oil\n232-350-7\n8006-64-2\nFlam. Liq. 3\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nAsp. Tox. 1\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2\nH226\nH332\nH312\nH302\nH304\nH319\nH315\nH317\nH411\nGHS02\nGHS08\nGHS07\nGHS09\nDgr\nH226\nH332\nH312\nH302\nH304\nH319\nH315\nH317\nH411\n\n\n\n650-003-00-1\nfenson (ISO);\n4-chlorophenyl benzenesulphonate;\n201-274-6\n80-38-6\nAcute Tox. 4 *\nEye Irrit. 2\nAquatic Chronic 2\nH302\nH319\nH411\nGHS07\nGHS09\nWng\nH302\nH319\nH411\n\n\n\n650-004-00-7\nnorbormide (ISO);\n5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide\n213-589-6\n991-42-4\nAcute Tox. 4 *\nH302\nGHS07\nWng\nH302\n\n\n\n650-005-00-2\n(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone\n201-501-9\n83-79-4\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH319\nH335\nH315\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH319\nH335\nH315\nH410\n\n\n\n650-006-00-8\nbenquinox (ISO);\np-benzoquinone 1-benzoylhydrazone 4-oxime\n207-807-9\n495-73-8\nAcute Tox. 3 *\nAcute Tox. 4 *\nH301\nH312\nGHS06\nDgr\nH301\nH312\n\n\n\n650-007-00-3\nchlordimeform (ISO);\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine\n228-200-5\n6164-98-3\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH312\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH312\nH302\nH410\n\n\n\n650-008-00-9\ndrazoxolon (ISO);\n4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone\n227-197-8\n5707-69-7\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1\nH301\nH400\nH410\nGHS06\nGHS09\nDgr\nH301\nH410\n\n\n\n650-009-00-4\nchlordimeform hydrochloride;\nN'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride\n243-269-1\n19750-95-9\nCarc. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH351\nH302\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH351\nH302\nH410\n\n\n\n650-010-00-X\nbenzyl violet 4B;\nα-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate\n216-901-9\n1694-09-3\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\n\n650-012-00-0\nerionite\n—\n12510-42-8\nCarc. 1A\nH350\nGHS08\nDgr\nH350\n\n\n\n650-013-00-6\nasbestos\n—\n—\n—\n—\n—\n—\n—\n12001-28-4\n132207-32-0\n12172-73-5\n77536-66-4\n77536-68-6\n77536-67-5\n12001-29-5\nCarc. 1A\nSTOT RE 1\nH350\nH372 **\nGHS08\nDgr\nH350\nH372 **\n\n\n\n650-014-00-1\ndiethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate\n401-770-4\n—\nSkin Corr. 1B\nAcute Tox. 4 *\nH314\nH302\nGHS05\nGHS07\nDgr\nH314\nH302\n\n\n\n650-015-00-7\nrosin;\ncolophony\n232-475-7\n232-484-6\n277-299-1\n8050-09-7\n8052-10-6\n73138-82-6\nSkin Sens. 1\nH317\nGHS07\nWng\nH317\n\n\n\n\n\n650-016-00-2\nMineral wool, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]\n—\n—\nCarc. 2\nH351\nGHS08\nWng\nH351\n\n\nAQR\n\n650-017-00-8\nRefractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]\n—\n—\nCarc. 1B\nH350i\nGHS08\nDgr\nH350i\n\n\nAR\n\n650-018-00-3\nReaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid\n406-230-1\n—\nFlam. Liq. 3\nCarc. 2\nSkin Corr. 1B\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH226\nH351\nH314\nH332\nH317\nH400\nH410\nGHS02\nGHS08\nGHS05 GHS07\nGHS09\nDgr\nH226\nH351\nH314\nH332\nH317\nH410\n\n\n\n650-031-00-4\nbis(4-hydroxy-N-methylanilinium) sulphate\n200-237-1\n55-55-0\nAcute Tox. 4 *\nSTOT RE 2 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH373 **\nH317\nH400\nH410\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH317\nH410\n\n\n\n650-032-00-X\ncyproconazole (ISO);\n(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol\n—\n94361-06-5\nRepr. 2\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH361d ***\nH302\nH400\nH410\nGHS08\nGHS07 GHS09\nWng\nH361d ***\nH302\nH410\n\n\n\n\n\n650-033-00-5\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;\nesfenvalerate\n—\n66230-04-4\nAcute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH331\nH301\nH317\nH400\nH410\nGHS06\nGHS09\nDgr\nH331\nH301\nH317\nH410\n\n\n\n\n650-041-00-9\ntriasulfuron (ISO);\n1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea\n—\n82097-50-5\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n650-042-00-4\nreaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates\n417-450-2\n—\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 3\nH319\nH315\nH317\nH412\nGHS07\nWng\nH319\nH315\nH317\nH412\n\n\n\n650-043-00-X\nreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate\n420-310-3\n—\nAcute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1\nH302\nH400\nH410\nGHS07\nGHS09\nWng\nH302\nH410\n\n\n\n650-044-00-5\nmixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin\n420-480-9\n158570-99-1\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH317\nH400\nH410\nGHS07\nGHS09\nWng\nH315\nH317\nH410\n\n\n\n650-045-00-0\nreaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate\n417-110-3\n—\nFlam. Liq. 2\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 2\nH225\nH315\nH318\nH411\nGHS02\nGHS05\nGHS09\nDgr\nH225\nH315\nH318\nH411\n\n\n\n650-046-00-6\ndi(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates\n416-180-2\n12222-04-7\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Chronic 2\nH302\nH373 **\nH411\nGHS08\nGHS07\nGHS09\nWng\nH302\nH373 **\nH411\n\n\n\n650-047-00-1\ndibenzylphenylsulfonium hexafluoroantimonate\n417-760-8\n134164-24-2\nSTOT RE 1\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2\nH372 **\nH302\nH318\nH317\nH411\nGHS08\nGHS05 GHS07\nGHS09\nDgr\nH372 **\nH302\nH318\nH317\nH411\n\n\n\n650-048-00-7\nreaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid\n420-070-1\n—\nOrg. Perox. D ****\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Corr. 1A\nAquatic Acute 1\nH242\nH332\nH312\nH302\nH314\nH400\nGHS02\nGHS05 GHS07\nGHS09\nDgr\nH242\nH332\nH312\nH302\nH314\nH400\n\n\n\n650-049-00-2\n2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl\n417-960-5\n—\nSkin Irrit. 2\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1\nH315\nH318\nH317\nH400\nH410\nGHS05 GHS07\nGHS09\nDgr\nH315\nH318\nH317\nH410\n\n\n\n650-050-00-8\nreaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;\n1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;\n1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers\n423-600-8\n—\nAquatic Chronic 2\nH411\nGHS09\nH411\n\n\n\n650-055-00-5\nsilver sodium zirconium hydrogenphosphate\n422-570-3\n155925-27-2\nAquatic Acute 1\nAquatic Chronic 1\nH400\nH410\nGHS09\nWng\nH410\n\n\n\n\n\nTable 3.2\nThe list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC\n\nIndex No\nInternational Chemical Identification\nEC No\nCAS No\nClassification\nLabelling\nConcentration Limits\nNotes\n001-001-00-9\nhydrogen\n215-605-7\n1333-74-0\nF+; R12\nF+\nR: 12\nS: (2-)9-16-33\n\n\n\n\n001-002-00-4\naluminium lithium hydride\n240-877-9\n16853-85-3\nF; R15\nC; R35\nF; C\nR: 15-35\nS: (1/2-)7/8-26-36/37/39-43-45\n\n\n\n001-003-00-X\nsodium hydride\n231-587-3\n7646-69-7\nF; R15\nF\nR: 15\nS: (2-)7/8-24/25-43\n\n\n001-004-00-5\ncalcium hydride\n232-189-2\n7789-78-8\nF; R15\nF\nR: 15\nS: (2-)7/8-24/25-43\n\n\n003-001-00-4\nlithium\n231-102-5\n7439-93-2\nF; R15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)8-43-45\n\n\n003-002-00-X\nn-hexyllithium\n404-950-0\n21369-64-2\nF; R15-17\nR14\nC; R35\nF; C\nR: 14/15-17-35\nS: (1/2-)6-16-26-30-36/37/39-43-45\n\n\n\n\n003-003-00-5\n(2-methylpropyl)lithium;\nisobutyllithium\n440-620-2\n920-36-5\nF; R15-17\nR14\nC; R35\nR67\nN; R50-53\nF; C; N\nR: 14/15-17-35-67-50/53\nS: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61\n\n\n\n\n004-001-00-7\nberyllium\n231-150-7\n7440-41-7\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nT+\nR: 49-25-26-36/37/38-43-48/23\nS: 53-45\n\nE\n004-002-00-2\nberyllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex\n—\n—\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nN; R51-53\nT+; N\nR: 49-25-26-36/37/38-43-48/23-51/53\nS: 53-45-61\n\nAE\n004-003-00-8\nberyllium oxide\n215-133-1\n1304-56-9\nCarc. Cat. 2; R49\nT+; R26\nT; R25-48/23\nXi; R36/37/38\nR43\nT+\nR: 49-25-26-36/37/38-43-48/23\nS: 53-45\n\nE\n005-001-00-X\nboron trifluoride\n231-569-5\n7637-07-2\nR14\nT+; R26\nC; R35\nT+; C\nR: 14-26-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-002-00-5\nboron trichloride\n233-658-4\n10294-34-5\nR14\nT+; R26/28\nC; R34\nT+\nR: 14-26/28-34\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-003-00-0\nboron tribromide\n233-657-9\n10294-33-4\nR14\nT+; R26/28\nC; R35\nT+; C\nR: 14-26/28-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n005-004-00-6\ntrialkylboranes\n—\n—\nF; R17\nC; R34\nF; C\nR: 17-34\nS: (1/2-)7-23-26-36/37/39-43-45\n\nA\n005-005-00-1\ntrimethyl borate\n204-468-9\n121-43-7\nR10\nXn; R21\nXn\nR: 10-21\nS: (2-)23-25\n\n\n\n\n\n005-006-00-7\ndibutyltin hydrogen borate\n401-040-5\n75113-37-0\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60-61\nT; R48/25\nXn; R21/22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 60-61-21/22-41-43-48/25-68-50/53\nS: 53-45-60-61\n\nE\n\n\n\n005-007-00-2\nboric acid; [1]\nboric acid [2]\n233-139-2 [1]\n234-343-4 [2]\n10043-35-3 [1]\n11113-50-1 [2]\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 5,5 %\n\n\n\n005-008-00-8\ndiboron trioxide;\nboric oxide\n215-125-8\n1303-86-2\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 3,1 %\n\n\n005-009-00-3\ntetrabutylammonium butyltriphenylborate\n418-080-4\n120307-06-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-56-61\n\n\n005-010-00-9\nN,N-dimethylanilinium tetrakis(pentafluorophenyl)borate\n422-050-6\n118612-00-3\nCarc. Cat. 3; R40\nXn; R22\nXi; R38-41\nXn\nR: 22-38-40-41\nS: (2-)22-26-36/37/39\n\n\n\n\n005-011-00-4\ndisodium tetraborate, anhydrous;\nboric acid, disodium salt; [1]\ntetraboron disodium heptaoxide, hydrate; [2]\northoboric acid, sodium salt [3]\n215-540-4 [1]\n235-541-3 [2]\n237-560-2 [3]\n1330-43-4 [1]\n12267-73-1 [2]\n13840-56-7 [3]\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 4,5 %\n\n\n005-011-01-1\ndisodium tetraborate decahydrate;\nborax decahydrate\n215-540-4\n1303-96-4\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 8,5 %\n\n\n005-011-02-9\ndisodium tetraborate pentahydrate;\nborax pentahydrate\n215-540-4\n12179-04-3\nRepr. Cat. 2; R60-61\nT\nR: 60-61\nS: 53-45\nRepr. Cat. 2; R60-61: C ≥ 6,5 %\n\n\n005-012-00-X\ndiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate\n418-070-1\n141714-54-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n005-013-00-5\ndiethylmethoxyborane\n425-380-9\n7397-46-8\nF; R17\nXn; R20/21/22-48/22\nC; R34\nR43\nR53\nF; C\nR: 17-20/21/22-34-43-48/22-53\nS: (1/2-)6-26-36/37/39-43-45-61\n\n\n\n005-014-00-0\n4-formylphenylboronic acid\n438-670-5\n87199-17-5\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n005-015-00-6\n1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)\n414-380-4\n140681-55-6\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)21-26-36/37/39-61\n\n\n\n005-016-00-1\ntetrabutylammonium butyl tris-(4-tert-butylphenyl)borate\n431-370-5\n-\nR53\nR: 53\nS: 61\n\n\n\n005-017-00-7\nsodium perborate; [1]\nperboric acid, sodium salt; [2]\nperboric acid, sodium salt, monohydrate; [3]\nsodium peroxometaborate; [4]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [5]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n234-390-0 [3]\n231-556-4 [4]\n231-556-4 [5]\n15120-21-5 [1]\n11138-47-9 [2]\n12040-72-1 [3]\n7632-04-4 [4]\n10332-33-9 [5]\nO; R8\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXn; R22\nXi; R37-41\nO; T\nR: 61-8-22-37-41-62\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 6,5 %\nRepr. Cat. 3; R62: C ≥ 9 %\nXi; R41: C ≥ 22 %\nXi; R36: 14 % ≤ C < 22 %\nE\n\n005-017-01-4\nsodium perborate; [1]\nperboric acid, sodium salt; [2]\nperboric acid, sodium salt, monohydrate; [3]\nsodium peroxometaborate; [4]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [5]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n234-390-0 [3]\n231-556-4 [4]\n231-556-4 [5]\n15120-21-5 [1]\n11138-47-9 [2]\n12040-72-1 [3]\n7632-04-4 [4]\n10332-33-9 [5]\n-\nO; R8\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nT; R23\nXn; R22\nXi; R37-41\nO; T\nR: 61-8-22-23-37-41-62\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 6,5 %\nRepr. Cat. 3; R62: C ≥ 9 %\nXi; R41: C ≥ 22 %\nXi; R36: 14 % ≤ C < 22 %\nE\n\n005-018-00-2\nperboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\n-\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXi; R37-41\nT\nR: 61-37-41-62\nS: 53-45-47\nRepr. Cat. 2; R61: C ≥ 10 %\nRepr. Cat. 3; R62: C ≥ 14 %\nXi; R41: C ≥ 36 %\nXi; R36: 22 % ≤ C < 36 %\n\n\n005-018-01-X\nperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n239-172-9 [1]\n234-390-0 [2]\n231556-4 [3]\n13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]\n-\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nXn; R20\nXi; R37-41\nT\nR: 61-20-37-41-62\nS: 53-45-47\nRepr. Cat. 2; R61: C ≥ 10 %\nRepr. Cat. 3; R62: C ≥ 14 %\nXi; R41: C ≥ 36 %\nXi; R36: 22 % ≤ C < 36 %\nE\n\n006-001-00-2\ncarbon monoxide\n211-128-3\n630-08-0\nF+; R12\nRepr. Cat. 1; R61\nT; R23-48/23\nF+; T\nR: 61-12-23-48/23\nS: 53-45\n\nE\n006-002-00-8\nphosgene;\ncarbonyl chloride\n200-870-3\n75-44-5\nT+; R26\nC; R34\nT+\nR: 26-34\nS: (1/2-)9-26-36/37/39-45\n\n\n006-003-00-3\ncarbon disulphide\n200-843-6\n75-15-0\nF; R11\nRepr. Cat. 3; R62-63\nT; R48/23\nXi; R36/38\nF; T\nR: 11-36/38-48/23-62-63\nS: (1/2-)16-33-36/37-45\nRepr. Cat. 3; R62-63: C ≥ 1 %\nT; R48/23: C ≥ 1 %\nXn; R48/20: 0,2 % ≤ C < 1 %\n\n006-004-00-9\ncalcium carbide\n200-848-3\n75-20-7\nF; R15\nF\nR: 15\nS: (2-)8-43\n\n\n006-005-00-4\nthiram (ISO);\ntetramethylthiuram disulphide\n205-286-2\n137-26-8\nXn; R20/22-48/22\nXi; R36/38\nR43\nN; R50-53\nXn; N\nR: 20/22-36/38-43-48/22-50/53\nS: (2-)26-36/37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n006-006-00-X\nhydrogen cyanide;\nhydrocyanic acid\n200-821-6\n74-90-8\nF+; R12\nT+; R26\nN; R50-53\nF+; T+; N\nR: 12-26-50/53\nS: (1/2-)7/9-16-36/37-38-45-60-61\n\n\n006-006-01-7\nhydrogen cyanide ...%;\nhydrocyanic acid ...%\n200-821-6\n74-90-8\nT+; R26/27/28\nN; R50-53\nT+; N\nR: 26/27/28-50/53\nS: (1/2-)7/9-36/37-38-45-60-61\n\nB\n\n\n006-007-00-5\nsalts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex\n—\n—\nT+; R26/27/28\nR32\nN; R50-53\nT+; N\nR: 26/27/28-32-50/53\nS: (1/2-)7-28-29-45-60-61\n\nA\n\n\n006-008-00-0\nantu (ISO);\n1-(1-naphthyl)-2-thiourea\n201-706-3\n86-88-4\nT+; R28\nCarc. Cat. 3; R40\nT+\nR: 28-40\nS: (1/2-)25-36/37-45\n\n\n006-009-00-6\n1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;\nisolan\n204-318-2\n119-38-0\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37/39-45\n\n\n006-010-00-1\n5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;\ndimetan\n204-525-8\n122-15-6\nT; R25\nT\nR: 25\nS: (1/2-)36/37-45\n\n\n\n\n006-011-00-7\ncarbaryl (ISO);\n1-naphthyl methylcarbamate\n200-555-0\n63-25-2\nCarc. Cat. 3; R40\nXn; R20/22\nN; R50\nXn; N\nR: 20/22-40-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 0,25 %\n\n\n006-012-00-2\nziram (ISO);\nzinc bis dimethyldithiocarbamate\n205-288-3\n137-30-4\nT+; R26\nXn; R22-48/22\nXi; R37-41\nR43\nN; R50-53\nT+; N\nR: 22-26-37-41-43-48/22-50/53\nS: (1/2-)22-26-28-36/37/39-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n006-013-00-8\nmetam-sodium (ISO);\nsodium methyldithiocarbamate\n205-293-0\n137-42-8\nXn; R22\nR31\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-31-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n006-014-00-3\nnabam (ISO);\ndisodium ethylenebis(N,N'-dithiocarbamate)\n205-547-0\n142-59-6\nXn; R22\nXi; R37\nR43\nN; R50-53\nXn; N\nR: 22-37-43-50/53\nS: (2-)8-24/25-46-60-61\n\n\n\n\n\n006-015-00-9\ndiuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea\n206-354-4\n330-54-1\nCarc. Cat. 3; R40\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-40-48/22-50/53\nS: (2-)13-36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n006-016-00-4\npropoxur (ISO);\n2-isopropyloxyphenyl N-methylcarbamate;\n2-isopropoxyphenyl methylcarbamate\n204-043-8\n114-26-1\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\n\n\n006-017-00-X\naldicarb (ISO);\n2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime\n204-123-2\n116-06-3\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n006-018-00-5\naminocarb (ISO);\n4-dimethylamino-3-tolyl methylcarbamate\n217-990-7\n2032-59-9\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n006-019-00-0\ndi-allate (ISO);\nS-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate\n218-961-1\n2303-16-4\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)25-36/37-60-61\n\n\n006-020-00-6\nbarban (ISO);\n4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate\n202-930-4\n101-27-9\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-36/37-60-61\n\n\n006-021-00-1\nlinuron (ISO);\n3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea\n206-356-5\n330-55-2\nRepr. Cat. 2; R61\nRepr. Cat. 3; R62\nCarc. Cat. 3; R40\nXn; R22-48/22\nN; R50-53\nT; N\nR: 61-22-40-48/22-62-50/53\nS: 53-45-60-61\n\nE\n006-022-00-7\ndecarbofuran (ISO);\n2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate\n—\n1563-67-3\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-36/37-45\n\n\n006-023-00-2\nmercaptodimethur (ISO);\nmethiocarb (ISO);\n3,5-dimethyl-4-methylthiophenyl N-methylcarbamate\n217-991-2\n2032-65-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-37-45-60-61\n\n\n006-024-00-8\nproxan-sodium (ISO);\nsodium O-isopropyldithiocarbonate\n205-443-5\n140-93-2\nXn; R22\nXi; R38\nN; R51-53\nXn; N\nR: 22-38-51/53\nS: (2-)13-61\n\n\n006-025-00-3\nallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;\nbioallethrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]\nS-bioallethrin;\n(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]\nesbiothrin;\n(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]\n209-542-4 [1]\n249-013-5 [2]\n- [3]\n584-79-2 [1]\n28434-00-6 [2]\n84030-86-4 [3]\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53\nS: (2-)36-60-61\n\nC\n006-026-00-9\ncarbofuran (ISO);\n2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate\n216-353-0\n1563-66-2\nT+; R26/28\nN; R50-53\nT+; N\nR: 26/28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n006-028-00-X\ndinobuton (ISO);\n2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate\n213-546-1\n973-21-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\n\n\n006-029-00-5\ndioxacarb (ISO);\n2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate\n230-253-4\n6988-21-2\nT; R25\nN; R51-53\nT; N\nR: 25-51/53\nS: (1/2-)37-45-61\n\n\n006-030-00-0\nEPTC (ISO);\nS-ethyl dipropylthiocarbamate\n212-073-8\n759-94-4\nXn; R22\nXn\nR: 22\nS: (2-)23\n\n\n006-031-00-6\nformetanate (ISO);\n3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate\n244-879-0\n22259-30-9\nT+; R26/28\nR43\nN; R50-53\nT+; N\nR: 26/28-43-50/53\nS: (1/2-)24-28-37/39-45-60-61\n\n\n006-032-00-1\nmonolinuron (ISO);\n3-(4-chlorophenyl)-1-methoxy-1-methylurea\n217-129-5\n1746-81-2\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)22-60-61\n\n\n006-033-00-7\nmetoxuron (ISO);\n3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea\n243-433-2\n19937-59-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n006-034-00-2\npebulate (ISO);\nN-butyl-N-ethyl-S-propylthiocarbamate\n214-215-4\n1114-71-2\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)23-61\n\n\n006-035-00-8\npirimicarb (ISO);\n5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate\n245-430-1\n23103-98-2\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-37-45-60-61\n\n\n006-036-00-3\nbenzthiazuron (ISO);\n1-benzothiazol-2-yl-3-methylurea\n217-685-9\n1929-88-0\nXn; R22\nXn\nR: 22\nS: (2-)24/25\n\n\n006-037-00-9\npromecarb (ISO);\n3-isopropyl-5-methylphenyl N-methylcarbamate\n220-113-0\n2631-37-0\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)24-37-45-60-61\n\n\n006-038-00-4\nsulfallate (ISO);\n2-chloroallyl N,N-dimethyldithiocarbamate\n202-388-9\n95-06-7\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n006-039-00-X\ntri-allate (ISO);\nS-2,3,3-trichloroallyl diisopropylthiocarbamate\n218-962-7\n2303-17-5\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)24-37-60-61\n\n\n006-040-00-5\n3-methylpyrazol-5-yl-dimethylcarbamate;\nmonometilan\n—\n2532-43-6\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n006-041-00-0\ndimethylcarbamoyl chloride\n201-208-6\n79-44-7\nCarc. Cat. 2; R45\nT; R23\nXn; R22\nXi; R36/37/38\nT\nR: 45-22-23-36/37/38\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,001 %\nE\n006-042-00-6\nmonuron (ISO);\n3-(4-chlorophenyl)-1,1-dimethylurea\n205-766-1\n150-68-5\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)36/37-60-61\n\n\n006-043-00-1\n3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;\nmonuron-TCA\n—\n140-41-0\nXi; R36/38\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 36/38-40-50/53\nS: (2-)36/37-60-61\n\n\n006-044-00-7\nisoproturon (ISO);\n3-(4-isopropylphenyl)-1,1-dimethylurea\n251-835-4\n34123-59-6\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n\n006-045-00-2\nmethomyl (ISO);\n1-(methylthio)ethylideneamino N-methylcarbamate\n240-815-0\n16752-77-5\nT+; R28\nN; R50-53\nT+; N\nR: 28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n006-046-00-8\nbendiocarb (ISO);\n2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate\n245-216-8\n22781-23-3\nT; R23/25\nXn; R21\nN; R50-53\nT; N\nR: 21-23/25-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n006-047-00-3\nbufencarb (ISO);\nreaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate\n—\n8065-36-9\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n006-048-00-9\nethiofencarb (ISO);\n2-(ethylthiomethyl)phenyl N-methylcarbamate\n249-981-9\n29973-13-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-049-00-4\ndixanthogen;\nO,O-diethyl dithiobis(thioformate)\n207-944-4\n502-55-6\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n006-050-00-X\n1,1-dimethyl-3-phenyluronium trichloroacetate;\nfenuron-TCA\n—\n4482-55-7\nXi; R38\nN; R50-53\nXi; N\nR: 38-50/53\nS: (2-)60-61\n\n\n006-051-00-5\nferbam (ISO);\niron tris(dimethyldithiocarbamate)\n238-484-2\n14484-64-1\nXi; R36/37/38\nN; R50-53\nXi; N\nR: 36/37/38-50/53\nS: (2-)60-61\n\n\n006-052-00-0\nformetanate hydrochloride;\n3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate\n245-656-0\n23422-53-9\nT+; R26/28\nR43\nN; R50-53\nT+; N\nR: 26/28-43-50/53\nS: (1/2-)24-28-37/39-45-60-61\n\n\n006-053-00-6\nisoprocarb (ISO);\n2-isopropylphenyl N-methylcarbamate\n220-114-6\n2631-40-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-054-00-1\nmexacarbate (ISO);\n3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate\n206-249-3\n315-18-4\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n006-055-00-7\nxylylcarb (ISO);\n3,4-dimethylphenyl N-methylcarbamate;\n3,4-xylyl methylcarbamate;\nMPMC\n219-364-9\n2425-10-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-056-00-2\nmetolcarb (ISO);\nm-tolyl methylcarbamate;\nMTMC\n214-446-0\n1129-41-5\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-057-00-8\nnitrapyrin (ISO);\n2-chloro-6-trichloromethylpyridine\n217-682-2\n1929-82-4\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)24-61\n\n\n006-058-00-3\nnoruron (ISO);\n1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea\n—\n2163-79-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-059-00-9\noxamyl (ISO);\nN',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;\n245-445-3\n23135-22-0\nT+; R26/28\nXn; R21\nN; R51-53\nT+; N\nR: 21-26/28-51/53\nS: (1/2-)36/37-45-61\n\n\n006-060-00-4\noxycarboxin (ISO);\n2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide\n226-066-2\n5259-88-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n006-061-00-X\nS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;\nprothiocarb hydrochloride\n243-193-9\n19622-19-6\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-062-00-5\nmethyl 3,4-dichlorophenylcarbanilate;\nSWEP.\n—\n1918-18-9\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-063-00-0\nthiobencarb (ISO);\nS-4-chlorobenzyl diethylthiocarbamate;\n248-924-5\n28249-77-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-064-00-6\nthiofanox (ISO);\n3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime;\n254-346-4\n39196-18-4\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)27-36/37-45-60-61\n\n\n006-065-00-1\n3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;\ntriamid\n—\n15271-41-7\nT+; R28\nT; R24\nN; R51-53\nT+; N\nR: 24-28-51/53\nS: (1/2-)28-36/37-45-61\n\n\n006-066-00-7\nvernolate (ISO);\nS-propyl dipropylthiocarbamate;\n217-681-7\n1929-77-7\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n006-067-00-2\nXMC;\n3,5-xylyl methylcarbamate\n—\n2655-14-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n006-068-00-8\ndiazomethane\n206-382-7\n334-88-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\n\n006-069-00-3\nthiophanate-methyl (ISO);\n1,2-di-(3-methoxycarbonyl-2-thioureido)benzene\n245-740-7\n23564-05-8\nMuta. Cat. 3; R68\nXn; R20\nR43\nN; R50-53\nXn; N\nR: 20-43-50/53-68\nS: (2-)36/37-46-60-61\n\n\n006-070-00-9\nfurmecyclox (ISO);\nN-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide;\n262-302-0\n60568-05-0\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n006-071-00-4\ncyclooct-4-en-1-yl methyl carbonate\n401-620-8\n87731-18-8\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n006-072-00-X\nprosulfocarb(ISO);\nS-benzyl N,N-dipropylthiocarbamate;\n401-730-6\n52888-80-9\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n006-073-00-5\n3-(dimethylamino)propylurea\n401-950-2\n31506-43-1\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n006-074-00-0\n2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate\n402-440-2\n2094-99-7\nT+; R26\nC; R34\nXn; R48/20\nR42/43\nN; R50-53\nT+; N\nR: 26-34-42/43-48/20-50/53\nS: (1/2-)7-15-28-36/37/39-38-45-60-61\n\n\n\n\n006-076-00-1\nmancozeb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt\n—\n8018-01-7\nRepr. Cat. 3; R63\nR43\nN; R50\nXn; N\nR: 43-63-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n006-077-00-7\nmaneb (ISO);\nmanganese ethylenebis(dithiocarbamate) (polymeric)\n235-654-8\n12427-38-2\nRepr. Cat. 3; R63\nXn; R20\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 20-36-43-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n006-078-00-2\nzineb (ISO);\nzinc ethylenebis(dithiocarbamate) (polymeric)\n235-180-1\n12122-67-7\nXi; R37\nR43\nXi\nR: 37-43\nS: (2-)8-24/25-46\n\n\n006-079-00-8\ndisulfiram;\ntetraethylthiuramdisulfide\n202-607-8\n97-77-8\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)24-37-60-61\n\n\n006-080-00-3\ntetramethylthiuram monosulphide\n202-605-7\n97-74-5\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-26-37-61\n\n\n006-081-00-9\nzinc bis(dibutyldithiocarbamate)\n205-232-8\n136-23-2\nXi; R36/37/38\nR43\nN; R50-53\nXi; N\nR: 36/37/38-43-50/53\nS: (2-)24-37-60-61\n\n\n006-082-00-4\nzinc bis(diethyldithiocarbamate)\n238-270-9\n14324-55-1\nXn; R22\nXi; R36/37/38\nR43\nN; R50-53\nXn; N\nR: 22-36/37/38-43-50/53\nS: (2-)24-37-60-61\n\n\n006-083-00-X\nbutocarboxim (ISO);\n3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime\n252-139-3\n34681-10-2\nR10\nT; R23/24/25\nXi; R36\nN; R50-53\nT; N\nR: 10-23/24/25-36-50/53\nS: (1/2-)36/37-45-60-61\n\n\n\n\n006-084-00-5\ncarbosulfan (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate\n259-565-9\n55285-14-8\nT+; R26\nT; R25\nR43\nN; R50-53\nT+; N\nR: 25-26-43-50/53\nS: (1/2-)28-36/37-38-45-63-60-61\n\n\n\n\n006-085-00-0\nfenobucarb (ISO);\n2-butylphenyl methylcarbamate;\n223-188-8\n3766-81-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n006-086-00-6\nethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;\nfenoxycarb\n276-696-7\n72490-01-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n006-087-00-1\nfurathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate\n265-974-3\n65907-30-4\nT+; R26\nT; R25\nXn; R48/22\nXi; R36/38\nR43\nN; R50-53\nT+; N\nR: 25-26-36/38-43-48/22-50/53\nS: (1/2-)28-36/37-38-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n006-088-00-7\nbenfuracarb (ISO);\nethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate\n—\n82560-54-1\nRepr. Cat. 3; R62\nT; R23\nXn; R22\nN; R50-53\nT; N\nR: 22-23-62-50/53\nS: (1/2-)36/37-45-60-61\n\n\n\n\n006-089-00-2\nchlorine dioxide\n233-162-8\n10049-04-4\nO; R8\nR6\nT+; R26\nC; R34\nN; R50\nO; T+; N\nR: 6-8-26-34-50\nS: (1/2-)23-26-28-36/37/39-38-45-61\nN; R50: C ≥ 0,02 %\n5\n006-089-01-X\nchlorine dioxide … %\n233-162-8\n10049-04-4\nT; R25\nC; R34\nN; R50\nT; N\nR: 25-34-50\nS: (1/2-)23-26-28-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 3 % ≤ C < 10 %\nXi; R36: 0,3 % ≤ C < 3 %\nN; R50: C ≥ 3 %\nB\n\n006-090-00-8\n2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate\n408-010-0\n88558-41-2\nXn; R20\nXi; R41\nR52-53\nXn\nR: 20-41-52/53\nS: (2-)22-26-39-61\n\n\n\n\n006-091-00-3\npropineb (ISO);\npolymeric zinc propylenebis(dithiocarbamate)\n-\n9016-72-2\nXn; R20-48/20/22\nR43\nN; R50\nXn; N\nR: 20-43-48/20/22-50\nS: (1/2-)24-37-46-61\n\n\n\n006-092-00-9\ntert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate\n425-420-5\n98737-29-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n006-093-00-4\n2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)\n427-180-7\n-\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)15-22-29-36/37-60-61\n\n\n\n006-094-00-X\nO-isobutyl-N-ethoxy carbonylthiocarbamate\n434-350-4\n103122-66-3\nR10\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R22-48/22\nR43\nN; R51-53\nT; N\nR: 45-46-10-22-43-48/22-51/53\nS: 53-45-61\n\nE\n\n006-095-00-5\nfosetyl-aluminium (ISO);\naluminium triethyl triphosphonate\n254-320-2\n39148-24-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39-46\n\n\n\n006-096-00-0\nchlorpropham (ISO);\nisopropyl 3-chlorocarbanilate\n202-925-7\n101-21-3\nCarc. Cat. 3; R40\nXn; R48/22\nN; R51-53\nXn; N\nR: 40-48/22-51/53\nS: (2-)36/37-61\n\n\n\n006-097-00-6\n1-phenyl-3-(p-toluenesulfonyl)urea\n424-620-1\n13909-63-2\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n006-098-00-1\ntert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate\n429-170-8\n134575-17-0\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)22-26-36/37/39\n\n\n\n006-099-00-7\nN-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;\n3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate\n432-520-2\n232938-43-1\nN; R51-53\nN\nR: 51/53\nS: 22-61\n\n\n\n006-101-00-6\nreaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];\nN-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;\nN,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]\n423-070-8\n-\nR53\nR: 53\nS: 61\n\n\n\n006-102-00-1\nO-hexyl-N-ethoxycarbonylthiocarbamate\n432-750-3\n-\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R22-48/22\nR43\nN; R51-53\nT; N\nR: 45-46-22-43-48/22-51/53\nS: 53-45-61\n\nE\n\n006-103-00-7\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea\n445-760-8\n-\nXi; R41\nR42\nN; R50-53\nXn; N\nR: 41-42-50/53\nS: (2-)22-26-39-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n007-001-00-5\nammonia, anhydrous\n231-635-3\n7664-41-7\nR10\nT; R23\nC; R34\nN; R50\nT; N\nR: 10-23-34-50\nS: (1/2-)9-16-26-36/37/39-45-61\n\n\n007-001-01-2\nammonia ....%\n215-647-6\n1336-21-6\nC; R34\nN; R50\nC; N\nR: 34-50\nS: (1/2-)26-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nB\n\n\n007-002-00-0\nnitrogen dioxide; [1]\ndinitrogen tetraoxide [2]\n233-272-6 [1]\n234-126-4 [2]\n10102-44-0 [1]\n10544-72-6 [2]\nO; R8\nT+; R26\nC; R34\nO; T+\nR: 8-26-34\nS: (1/2-)9-26-28-36/37/39-45\nT+; R26: C ≥ 10 %\nT; R23: 1 % ≤ C < 10 %\nXn; R20: 0,1 % ≤ C < 1 %\n5\n\n\n007-003-00-6\nchlormequat chloride (ISO);\n2-chloroethyltrimethylammonium chloride\n213-666-4\n999-81-5\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n007-004-00-1\nnitric acid ... %\n231-714-2\n7697-37-2\nO; R8\nC; R35\nO; C\nR: 8-35\nS: (1/2-)23-26-36-45\nC; R35: C ≥ 20 %\nC; R34: 5 % ≤ C < 20 %\nFootnote:\nO; R8: C ≥ 70 %\nB\n007-006-00-2\nethyl nitrite\n203-722-6\n109-95-5\nE; R2\nXn; R20/21/22\nE; Xn\nR: 2-20/21/22\nS: (2-)\n\n\n\n\n007-007-00-8\nethyl nitrate\n210-903-3\n625-58-1\nE; R3\nE\nR: 3\nS: (2-)23-24/25\n\n\n\n007-008-00-3\nhydrazine\n206-114-9\n302-01-2\nR10\nCarc. Cat. 2; R45\nT; R23/24/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 45-10-23/24/25-34-43-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/38: 3 % ≤ C < 10 %\nE\n007-009-00-9\ndicyclohexylammonium nitrite\n221-515-9\n3129-91-7\nXn; R20/22\nXn\nR: 20/22\nS: (2-)15-41\nXn; R20/22: C ≥ 10 %\n\n007-010-00-4\nsodium nitrite\n231-555-9\n7632-00-0\nO; R8\nT; R25\nN; R50\nO; T; N\nR: 8-25-50\nS: (1/2-)45-61\nT; R25: C ≥ 5 %\nXn; R22: 1 % ≤ C < 5 %\n\n007-011-00-X\npotassium nitrite\n231-832-4\n7758-09-0\nO; R8\nT; R25\nN; R50\nO; T; N\nR: 8-25-50\nS: (1/2-)45-61\nT; R25: C ≥ 5 %\nXn; R22: 1 % ≤ C < 5 %\n\n007-012-00-5\nN,N-dimethylhydrazine\n200-316-0\n57-14-7\nF; R11\nCarc. Cat. 2; R45\nT; R23/25\nC; R34\nN; R51-53\nF; T; N\nR: 45-11-23/25-34-51/53\nS: 53-45-61\n\nE\n007-013-00-0\n1,2-dimethylhydrazine\n—\n540-73-8\nCarc. Cat. 2; R45\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-23/24/25-51/53\nS: 53-45-61\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n007-014-00-6\nsalts of hydrazine\n—\n—\nCarc. Cat. 2; R45\nT; R23/24/25\nR43\nN; R50-53\nT; N\nR: 45-23/24/25-43-50/53\nS: 53-45-60-61\n\nAE\n007-015-00-1\nO-ethylhydroxylamine\n402-030-3\n624-86-2\nF; R11\nT; R23/24/25-48/23\nXi; R36\nR43\nN; R50\nF; T; N\nR: 11-23/24/25-36-43-48/23-50\nS: (1/2-)16-26-36/37/39-45-60-61\n\n\n007-016-00-7\nbutyl nitrite\n208-862-1\n544-16-1\nF; R11\nT; R23/25\nF; T\nR: 11-23/25\nS: (1/2-)16-24-45\n\n\n007-017-00-2\nisobutyl nitrite\n208-819-7\n542-56-3\nF; R11\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R20/22\nF; T\nR: 11-20/22-45-68\nS: 53-45\n\nE\n007-018-00-8\nsec-butyl nitrite\n213-104-8\n924-43-6\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-019-00-3\ntert-butyl nitrite\n208-757-0\n540-80-7\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-020-00-9\npentyl nitrite; [1]\namyl nitrite, mixed isomers [2]\n207-332-7 [1]\n203-770-8 [2]\n463-04-7 [1]\n110-46-3 [2]\nF; R11\nXn; R20/22\nF; Xn\nR: 11-20/22\nS: (2-)16-24-46\n\n\n007-021-00-4\nhydrazobenzene;\n1,2-diphenylhydrazine\n204-563-5\n122-66-7\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n007-022-00-X\nhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)\n405-030-1\n—\nCarc. Cat. 2; R45\nXn; R22\nC; R34\nR43\nR52-53\nT\nR: 45-22-34-43-52/53\nS: 53-45-61\n\nE\n007-023-00-5\nsodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate\n405-510-0\n—\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)24-37\n\n\n007-024-00-0\n2-(decylthio)ethylammonium chloride\n405-640-8\n36362-09-1\nXn; R48/22\nXi; R38-41\nN; R50-53\nXn; N\nR: 38-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n007-025-00-6\n(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride\n406-090-1\n81880-96-8\nMuta. Cat. 3; R68\nT; R25-48/25\nR43\nN; R50-53\nT; N\nR: 25-43-48/25-68-50/53\nS: (1/2-)22-36/37/39-45-60-61\n\n\n007-026-00-1\noxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide\n413-230-5\n122035-71-6\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)8-22-24-26-30-37/39\n\n\n007-027-00-7\n1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane\n420-190-2\n771478-66-1\nC; R34\nXn; R21/22-48/21\nR43\nN; R50-53\nC; N\nR: 21/22-34-43-48/21-50/53\nS: (1/2-)7-26-36/37/39-45-60-61\n\n\n\n\n\n007-028-00-2\nhydroxylammonium nitrate\n236-691-2\n13465-08-2\nE; R2\nCarc. Cat. 3; R40\nT; R24\nXn; R22-48/22\nXi; R36/38\nR43\nN; R50\nE; T; N\nR: 2-22-24-36/38-40-43-48/22-50\nS: (1/2-)26-36/37-45-61\n\n\n\n007-029-00-8\ndiethyldimethylammonium hydroxide\n419-400-5\n95500-19-9\nXn; R21/22\nC; R35\nC\nR: 21/22-35\nS: (1/2-)26-36/37/39-45\n\n\n\n008-001-00-8\noxygen\n231-956-9\n7782-44-7\nO; R8\nO\nR: 8\nS: (2-)17\n\n\n008-003-00-9\nhydrogen peroxide solution ... %\n231-765-0\n7722-84-1\nR5\nO; R8\nC; R35\nXn; R20/22\nO; C\nR: 5-8-20/22-35\nS: (1/2-)17-26-28-36/37/39-45\nXn; R20: C ≥ 50 %\nXn; R22: C ≥ 8 %\nC; R35: C ≥ 70 %\nC; R34: 50 % ≤ C < 70 %\nXi; R37/38: 35 % ≤ C < 50 %\nXi; R41: 8 % ≤ C < 50 %\nXi; R36: 5 % ≤ C < 8 %\nFootnote:\nO; R8: C ≥ 50 %\nR5: C ≥ 70 %\nB\n\n\n009-001-00-0\nfluorine\n231-954-8\n7782-41-4\nO; R8\nT+; R26\nC; R35\nO; T+; C\nR: 8-26-35\nS: (1/2-)9-26-28-36/37/39-45\n\n\n\n\n009-002-00-6\nhydrogen fluoride\n231-634-8\n7664-39-3\nT+; R26/27/28\nC; R35\nT+; C\nR: 26/27/28-35\nS: (1/2-)7/9-26-36/37/39-45\n\n\n009-003-00-1\nhydrofluoric acid ... %\n231-634-8\n7664-39-3\nT+; R26/27/28\nC; R35\nT+; C\nR: 26/27/28-35\nS: (1/2-)7/9-26-36/37-45\nC; R35: C ≥ 7 %\nC; R34: 1 % ≤ C < 7 %\nXi; R36: 0,1 % ≤ C < 1 %\nB\n009-004-00-7\nsodium fluoride\n231-667-8\n7681-49-4\nT; R25\nXi; R36/38\nR32\nT\nR: 25-32-36/38\nS: (1/2-)22-36-45\n\n\n009-005-00-2\npotassium fluoride\n232-151-5\n7789-23-3\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\n\n\n009-006-00-8\nammonium fluoride\n235-185-9\n12125-01-8\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\n\n\n009-007-00-3\nsodium bifluoride;\nsodium hydrogen difluoride\n215-608-3\n1333-83-1\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-008-00-9\npotassium bifluoride;\npotassium hydrogen difluoride\n232-156-2\n7789-29-9\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-009-00-4\nammonium bifluoride;\nammonium hydrogen difluoride\n215-676-4\n1341-49-7\nT; R25\nC; R34\nT; C\nR: 25-34\nS: (1/2-)22-26-37-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\nC; R34: C ≥ 1 %\nXi; R36/38: 0,1 % ≤ C < 1 %\n\n009-010-00-X\nfluoroboric acid ... %\n240-898-3\n16872-11-0\nC; R34\nC\nR: 34\nS: (1/2-)26-27-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\nB\n009-011-00-5\nfluorosilicic acid ... %\n241-034-8\n16961-83-4\nC; R34\nC\nR: 34\nS: (1/2-)26-27-45\n\nB\n009-012-00-0\nalkali fluorosilicates(Na); [1]\nalkali fluorosilicates(K); [2]\nalkali fluorosilicates(NH4) [3]\n240-934-8 [1]\n240-896-2 [2]\n240-968-3 [3]\n16893-85-9 [1]\n16871-90-2 [2]\n16919-19-0 [3]\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)26-45\nT; R23/24/25: C ≥ 10 %\nXn; R20/21/22: 1 % ≤ C < 10 %\nA\n009-013-00-6\nfluorosilicates, with the exception of those specified elsewhere in this annex\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)13-24/25\nXn; R22: C ≥ 10 %\nA\n009-014-00-1\nlead hexafluorosilicate\n247-278-1\n25808-74-6\nRepr. Cat. 1; R61\nRepr. Cat. 3; R62\nXn; R20/22\nR33\nN; R50-53\nT; N\nR: 61-62-20/22-33-50/53\nS: 53-45-60-61\n\nE1\n009-015-00-7\nsulphuryl difluoride\n220-281-5\n2699-79-8\nT; R23\nXn; R48/20\nN; R50\nT; N\nR: 23-48/20-50\nS: (1/2-)45-63-60-61\n\n\n\n009-016-00-2\ntrisodium hexafluoroaluminate [1]\n237-410-6 [1]\n13775-53-6 [1]\nXn; R20\nT; R48/23/25\nN; R51-53\nT; N\nR: 20-48/23/25-51/53\nS: (1/2-)22-37-45-61\n\n\ntrisodium hexafluoroaluminate (cryolite) [2]\n239-148-8 [2]\n15096-52-3 [2]\n\n\n009-017-00-8\npotassium mu-fluoro-bis(triethylaluminium)\n400-040-2\n12091-08-6\nF; R11-14/15\nC; R35\nXn; R20\nF; C\nR: 11-14/15-20-35\nS: (1/2-)16-30-36/39-43-45\n\n\n009-018-00-3\nmagnesium hexafluorosilicate\n241-022-2\n16949-65-8\nT; R25\nT\nR: 25\nS: (1/2-)24/25-45\nT; R25: C ≥ 10 %\nXn; R22: 1 % ≤ C < 10 %\n\n011-001-00-0\nsodium\n231-132-9\n7440-23-5\nF; 15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)5-8-43-45\n\n\n011-002-00-6\nsodium hydroxide;\ncaustic soda\n215-185-5\n1310-73-2\nC; R35\nC\nR: 35\nS: (1/2-)26-37/39-45\nC; R35: C ≥ 5 %\nC; R34: 2 % ≤ C < 5 %\nXi; R36/38: 0,5 % ≤ C < 2 %\n\n011-003-00-1\nsodium peroxide\n215-209-4\n1313-60-6\nO; R8\nC; R35\nO; C\nR: 8-35\nS: (1/2-)8-27-39-45\n\n\n011-004-00-7\nsodium azide\n247-852-1\n26628-22-8\nT+; R28\nR32\nN; R50-53\nT+; N\nR: 28-32-50/53\nS: (1/2-)28-45-60-61\n\n\n011-005-00-2\nsodium carbonate\n207-838-8\n497-19-8\nXi; R36\nXi\nR: 36\nS: (2-)22-26\n\n\n011-006-00-8\nsodium cyanate\n213-030-6\n917-61-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)24/25-61\n\n\n011-007-00-3\npropoxycarbazone-sodium\n—\n181274-15-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n012-001-00-3\nmagnesium powder (pyrophoric)\n231-104-6\n7439-95-4\nF; R15-17\nF\nR: 15-17\nS: (2-)7/8-43\n\n\n012-002-00-9\nmagnesium, powder or turnings\n231-104-6\n—\nF; R11-15\nF\nR: 11-15\nS: (2-)7/8-43\n\n\n012-003-00-4\nmagnesium alkyls\n—\n—\nR14\nF; R17\nC; R34\nF; C\nR: 14-17-34\nS: (1/2-)16-43-45\n\nA\n\n\n012-004-00-X\naluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate\n422-150-1\n-\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n013-001-00-6\naluminium powder (pyrophoric)\n231-072-3\n7429-90-5\nF; R15-17\nF\nR: 15-17\nS: (2-)7/8-43\n\n\n\n\n013-002-00-1\naluminium powder (stabilised)\n231-072-3\n7429-90-5\nF; R11-15\nF\nR: 11-15\nS: (2-)7/8-43\n\nT\n\n013-003-00-7\naluminium chloride, anhydrous\n231-208-1\n7446-70-0\nC; R34\nC\nR: 34\nS: (1/2-)7/8-28-45\n\n\n013-004-00-2\naluminium alkyls\n—\n—\nR14\nF; R17\nC; R34\nF; C\nR: 14-17-34\nS: (1/2-)16-43-45\n\nA\n013-005-00-8\ndiethyl(ethyldimethylsilanolato)aluminium\n401-160-8\n55426-95-4\nF; R 15-17\nR14\nC; R35\nF; C\nR: 14/15-17-35\nS: (1/2-)6-16-30-36/39-43-45\n\n\n013-006-00-3\n(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised\n402-370-2\n—\nR10\nXi; R41\nXi\nR: 10-41\nS: (2-)26-39\n\n\n013-007-00-9\npoly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)\n403-430-0\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n013-008-00-4\ndi-n-octylaluminium iodide\n408-190-0\n7585-14-0\nR14\nF; R17\nC; R34\nN; R50-53\nF; C; N\nR: 14-17-34-50/53\nS: (1/2-)6-16-26-36/37/39-43-45-60-61\n\n\n013-009-00-X\nsodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5\n418-720-2\n—\nF; R11-15-17\nR14\nXn; R20\nC; R35\nF; C\nR: 11-14/15-17-20-35\nS: (1/2-)6-16-26-30-36/37/39-43-45\n\n\n\n\n013-010-00-5\nhydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide)\n430-650-4\n151841-65-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n014-001-00-9\ntrichlorosilane\n233-042-5\n10025-78-2\nF+; R12\nR14\nF; R17\nXn; R20/22\nR29\nC; R35\nF+; C\nR: 12-14-17-20/22-29-35\nS: (2-)7/9-16-26-36/37/39-43-45\nXn; R20/22: C ≥ 10 %\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n014-002-00-4\nsilicon tetrachloride\n233-054-0\n10026-04-7\nR14\nXi; R36/37/38\nXi\nR: 14-36/37/38\nS: (2-)7/8-26\n\n\n014-003-00-X\ndimethyldichlorosilane\n200-901-0\n75-78-5\nF; R11\nXi; R36/37/38\nF; Xi\nR: 11-36/37/38\nS: (2-)\n\n\n014-004-00-5\ntrichloro(methyl)silane;\nmethyltrichlorosilane\n200-902-6\n75-79-6\nR14\nF; R11\nXi; R36/37/38\nF; Xi\nR: 11-14-36/37/38\nS: (2-)26-39\nXi; R36/37/38: C ≥ 1 %\n\n014-005-00-0\ntetraethyl silicate;\nethyl silicate\n201-083-8\n78-10-4\nR10\nXn; R20\nXi; R36/37\nXn\nR: 10-20-36/37\nS: (2-)\n\n\n014-006-00-6\nbis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride\n401-380-4\n—\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n014-007-00-1\ntriethoxyisobutylsilane\n402-810-3\n17980-47-1\nXi; R38\nXi\nR: 38\nS: (2-)24\n\n\n014-008-00-7\n(chloromethyl)bis(4-fluorophenyl)methylsilane\n401-200-4\n85491-26-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-009-00-2\nisobutylisopropyldimethoxysilane\n402-580-4\n111439-76-0\nR10\nXn; R20\nXi; R38\nXn\nR: 10-20-38\nS: (2-)25-26-36/37\n\n\n014-010-00-8\ndisodium metasilicate\n229-912-9\n6834-92-0\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)13-24/25-36/37/39-45\n\n\n014-011-00-3\ncyclohexyldimethoxymethylsilane\n402-140-1\n17865-32-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)24-61\n\n\n014-012-00-9\nbis(3-(trimethoxysilyl)propyl)amine\n403-480-3\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)24-26-39-61\n\n\n014-013-00-4\nα-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)\n404-920-7\n—\nXn; R21/22\nC; R34\nN; R51-53\nC; N\nR: 21/22-34-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n014-014-00-X\netacelasil (ISO);\n6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane;\n253-704-7\n37894-46-5\nRepr. Cat. 2; R61\nXn; R22-48/22\nT\nR: 61-22-48/22\nS: 53-45\n\nE\n014-015-00-5\nα-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))\n406-420-4\n69430-40-6\nR53\nR: 53\nS: 61\n\n\n014-016-00-0\nreaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;\n1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane\n406-490-6\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-017-00-6\nflusilazole (ISO);\nbis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane\n—\n85509-19-9\nCarc. Cat. 3; R40\nRepr. Cat. 2; R61\nXn; R22\nN; R51-53\nT; N\nR: 61-22-40-51/53\nS: 53-45-61\n\nE\n014-018-00-1\noctamethylcyclotetrasiloxane\n209-136-7\n556-67-2\nRepr. Cat. 3; R62\nR53\nXn\nR: 53-62\nS: (2-)36/37-46-51-61\n\n\n014-019-00-7\nreaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;\n1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole\n403-250-2\n—\nCarc. Cat. 3; R40\nRepr. Cat. 2; R61\nXn; R22\nN; R51-53\nT; N\nR: 61-22-40-51/53\nS: 53-45-61\n\nE\n014-020-00-2\nbis(1,1-dimethyl-2-propynyloxy)dimethylsilane\n414-960-7\n53863-99-3\nXn; R20\nXn\nR: 20\nS: (2)\n\n\n014-021-00-8\ntris(isopropenyloxy)phenyl silane\n411-340-8\n52301-18-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n014-022-00-3\nreaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)\n401-530-9\n—\nF; R11\nT; R39/23/24/25\nXn; R20/21/22\nF; T\nR: 11-20/21/22-39/23/24/25\nS: (1/2-)16-29-36/37-45\n\n\n014-023-00-9\nα, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole\n408-160-7\n125613-45-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-024-00-4\n1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene\n412-620-2\n121626-74-2\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n014-025-00-X\n4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine\n411-400-3\n102089-33-8\nXn; R22-48/21\nXi; R38-41\nR52-53\nXn\nR: 22-38-41-48/21-52/53\nS: (2-)26-36/37/39-61\n\n\n014-026-00-5\ndichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane\n407-180-3\n770722-36-6\nC; R35\nC\nR: 35\nS: (1/2-)26-36/37/39-45\n\n\n014-027-00-0\nchloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane\n410-270-5\n770722-46-8\nC; R35\nC\nR: 35\nS: (1/2-)8-26-28-36/37/39-45\n\n\n014-028-00-6\nα-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)\n415-290-8\n193159-06-7\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n014-029-00-1\nO,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]\n421-870-1\n156145-66-3\nRepr. Cat. 3; R62\nXn; R22-48/22\nXn\nR: 22-48/22-62\nS: (2-)36/37\n\n\n014-030-00-7\n[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium\n422-060-0\n137390-08-0\nT+; R28\nT+\nR: 28\nS: (1/2-)6-22-28-36/37-45\n\n\n014-031-00-2\nbis(1-methylethyl)-dimethoxysilane\n421-540-7\n18230-61-0\nR10\nXi; R38\nR43\nR52-53\nXi\nR: 10-38-43-52/53\nS: (2-)24-37-61\n\n\n014-032-00-8\ndicyclopentyldimethoxysilane\n404-370-8\n126990-35-0\nXi; R38-41\nN; R50-53\nXi; N\nR: 38-41-50/53\nS: (2-)26-37/39-60-61\n\n\n\n\n014-033-00-3\n2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica\n419-030-4\n125804-20-8\nF; R11\nXi; R36\nR67\nF; Xi\nR: 11-36-67\nS: (2-)16-26\n\n\n\n014-034-00-9\n3-hexylheptamethyltrisiloxane\n428-700-5\n1873-90-1\nXn; R20\nR53\nXn\nR: 20-53\nS: (2-)61\n\n\n\n014-035-00-4\n2-(3,4-epoxycyclohexyl)ethyltriethoxy silane\n425-050-4\n10217-34-2\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n014-036-00-X\n(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane\n405-020-7\n105024-66-6\nRepr. Cat.2; R60\nN; R50-53\nT; N\nR: 60-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n014-037-00-5\n2-butanone-O, O', O''-(phenylsilylidyne)trioxime\n433-360-6\n34036-80-1\nXn; R48/22\nR43\nR52-53\nXn\nR: 43-48/22-52/53\nS: (2-)36/37-61\n\n\n\n014-038-00-0\nS-(3-(triethoxysilyl)propyl) octanethioate\n436-690-9\n220727-26-4\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n014-039-00-6\n(2,3-dimethylbut-2-yl)-trimethoxysilane\n439-360-2\n142877-45-0\nXi; R38-41\nR52-53\nXi\nR: 38-41-52/53\nS: (2-)26-37/39-61\n\n\n\n014-041-00-7\nN,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane\n445-890-5\n201290-01-9\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\n\n\n\n014-042-00-2\nreaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)\n423-010-0\n-\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n014-043-00-8\nreaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)\n432-200-2\n-\nF; R11\nXi; R37/38-41\nR52-53\nF; Xi\nR: 11-37/38-41-52/53\nS: (2-)6-26-36/39-61\n\n\n\n014-044-00-3\n3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane\n433-050-0\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n014-045-00-9\nmagnesium sodium fluoride silicate\n442-650-1\n-\nXn; R48/20\nXn\nR: 48/20\nS: (2-)22-36\n\n\n\n015-001-00-1\nwhite phosphorus\n231-768-7\n12185-10-3\nF; R17\nT+; R26/28\nC; R35\nN; R50\nF; T+; C; N\nR: 17-26/28-35-50\nS: (1/2-)5-26-38-45-61\n\n\n015-002-00-7\nred phosphorus\n231-768-7\n7723-14-0\nF; R11\nR16\nR52-53\nF\nR: 11-16-52/53\nS: (2-)7-43-61\n\n\n\n\n015-003-00-2\ncalcium phosphide;\ntricalcium diphosphide\n215-142-0\n1305-99-3\nF; R15\nT+; R28\nR29\nN; R50\nF; T+; N\nR: 15/29-28-50\nS: (1/2-)22-28-36/37-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-004-00-8\naluminium phosphide\n244-088-0\n20859-73-8\nF; R15\nT+; R28\nR29\nR32\nN; R50\nF; T+; N\nR: 15/29-28-32-50\nS: (1/2-)3/9/14-28-30-36/37-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-005-00-3\nmagnesium phosphide;\ntrimagnesium diphosphide\n235-023-7\n12057-74-8\nF; R15\nT+; R28\nR29\nN; R50\nF; T+; N\nR: 15/29-28-50\nS: (1/2-)22-28-43-45-61\nN; R50: C ≥ 0,25 %\n\n\n015-006-00-9\ntrizinc diphosphide;\nzinc phosphide\n215-244-5\n1314-84-7\nF; R15\nT+; R28\nR29\nR32\nN; R50-53\nF; T+; N\nR: 15/29-28-32-50/53\nS: (1/2-)28-30-36/37-43-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\nT\n\n015-007-00-4\nphosphorus trichloride\n231-749-3\n7719-12-2\nR14\nT+; R26/28\nXn; R48/20\nC; R35\nR29\nT+; C\nR: 14-26/28-35-48/20\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-008-00-X\nphosphorus pentachloride\n233-060-3\n10026-13-8\nR14\nT+; R26\nXn; R22-48/20\nC; R34\nR29\nT+\nR: 14-22-26-34-48/20\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-009-00-5\nphosphoryl trichloride\n233-046-7\n10025-87-3\nR14\nT+; R26\nT; R48/23\nXn; R22\nC; R35\nR29\nT+; C\nR: 14-22-26-35-48/23\nS: (1/2-)7/8-26-36/37/39-45\n\n\n015-010-00-0\nphosphorus pentoxide\n215-236-1\n1314-56-3\nC; R35\nC\nR: 35\nS: (1/2-)22-26-45\n\n\n015-011-00-6\nphosphoric acid ... %, orthophosphoric acid ... %\n231-633-2\n7664-38-2\nC; R34\nC\nR: 34\nS: (1/2-)26-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\nB\n015-012-00-1\ntetraphosphorus trisulphide;\nphosphorus sesquisulphid\n215-245-0\n1314-85-8\nF; R11\nXn; R22\nN; R50\nF; Xn; N\nR: 11-22-50\nS: (2-)7-16-24/25-61\n\n\n015-013-00-7\ntriethyl phosphate\n201-114-5\n78-40-0\nXn; R22\nXn\nR: 22\nS: (2-)25\n\n\n015-014-00-2\ntributyl phosphate\n204-800-2\n126-73-8\nCarc. Cat. 3; R40\nXn; R22\nXi; R38\nXn\nR: 22-38-40\nS: (2-)36/37-46\n\n\n015-015-00-8\ntricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\ntritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);\n201-103-5\n78-30-8\nT; R39/23/24/25\nN; R51-53\nT; N\nR: 39/23/24/25-51/53\nS: (1/2-)20/21-28-45-61\nT; R39/23/24/25: C ≥ 1 %\nXn; R68/20/21/22: 0,2 % ≤ C < 1 %\nC\n015-016-00-3\ntricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\ntritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);\n201-105-6\n78-32-0\nXn; R21/22\nN; R51-53\nXn; N\nR: 21/22-51/53\nS: (2-)28-61\nXn; R21/22: C ≥ 5 %\nC\n\n\n015-019-00-X\ndichlorvos (ISO);\n2,2-dichlorovinyl dimethyl phosphate\n200-547-7\n62-73-7\nT+; R26\nT; R24/25\nR43\nN; R50\nT+; N\nR: 24/25-26-43-50\nS: (1/2-)28-36/37-45-61\nN; R50: C ≥ 0,025 %\n\n\n015-020-00-5\nmevinphos (ISO);\n2-methoxycarbonyl-1-methylvinyl dimethyl phosphate\n232-095-1\n7786-34-7\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-021-00-0\ntrichlorfon (ISO);\ndimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate\n200-149-3\n52-68-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-022-00-6\nphosphamidon (ISO);\n2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate\n236-116-5\n13171-21-6\nT+; R28\nT; R24\nMuta. Cat. 3; R68\nN; R50-53\nT+; N\nR: 24-28-50/53-68\nS: (1/2-)23-36/37-45-60-61\n\n\n015-023-00-1\npyrazoxon;\ndiethyl 3-methylpyrazol-5-yl phosphate\n—\n108-34-9\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)13-28-45\n\n\n015-024-00-7\ntriamiphos (ISO);\n5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide\n—\n1031-47-6\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)22-28-36/37-45\n\n\n015-025-00-2\nTEPP (ISO);\ntetraethyl pyrophosphate\n203-495-3\n107-49-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)36/37/39-38-45-61\n\n\n015-026-00-8\nschradan (ISO);\noctamethylpyrophosphoramide\n205-801-0\n152-16-9\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37-38-45\n\n\n015-027-00-3\nsulfotep (ISO);\nO,O,O,O-tetraethyl dithiopyrophosphate\n222-995-2\n3689-24-5\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-028-00-9\ndemeton-O (ISO);\nO,O-diethyl-O-2-ethylthioethyl phosphorothioate\n206-053-8\n298-03-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-029-00-4\ndemeton-S (ISO);\ndiethyl-S-2-ethylthioethyl phosphorothioate\n204-801-8\n126-75-0\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-030-00-X\ndemeton-O-methyl (ISO);\nO-2-ethylthioethyl O,O-dimethyl phosphorothioate\n212-758-1\n867-27-6\nT; R25\nT\nR: 25\nS: (1/2-)24-36/37-45\n\n\n015-031-00-5\ndemeton-S-methyl (ISO);\nS-2-ethylthioethyl dimethyl phosphorothioate\n213-052-6\n919-86-8\nT; R24/25\nN; R51-53\nT; N\nR: 24/25-51/53\nS: (1/2-)28-36/37-45-61\n\n\n015-032-00-0\nprothoate (ISO);\nO,O-diethyl isopropylcarbamoylmethyl phosphorodithioate\n218-893-2\n2275-18-5\nT+; R27/28\nR52-53\nT+\nR: 27/28-52/53\nS: (1/2-)28-36/37-45-61\n\n\n015-033-00-6\nphorate (ISO);\nO,O-diethyl ethylthiomethyl phosphorodithioate\n206-052-2\n298-02-2\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-034-00-1\nparathion (ISO);\nO,O-diethyl O-4-nitrophenyl phosphorothioate\n200-271-7\n56-38-2\nT+; R26/28\nT; R24-48/25\nN; R50-53\nT+; N\nR: 24-26/28-48/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-035-00-7\nparathion — methyl (ISO);\nO,O-dimethyl O-4-nitrophenyl phosphorothioate\n206-050-1\n298-00-0\nR5\nR10\nT+; R26/28\nT; R24\nXn; R48/22\nN; R50-53\nT+; N\nR: 5-10-24-26/28-48/22-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-036-00-2\nO-ethyl O-4-nitrophenyl phenylphosphonothioate;\nEPN\n218-276-8\n2104-64-5\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)22-36/37-45-60-61\n\n\n015-037-00-8\nphenkapton (ISO);\nS-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate\n218-892-7\n2275-14-1\nT; R23/24/25\nN; R50-53\nT; N\nR: 23/24/25-50/53\nS: (1/2-)13-45-60-61\n\n\n015-038-00-3\ncoumaphos (ISO);\nO-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate\n200-285-3\n56-72-4\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-039-00-9\nazinphos-methyl (ISO);\nO,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n201-676-1\n86-50-0\nT+; R26/28\nT; R24\nR43\nN; R50-53\nT+; N\nR: 24-26/28-43-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-040-00-4\ndiazinon (ISO);\nO,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate\n206-373-8\n333-41-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24/25-60-61\n\n\n\n\n015-041-00-X\nmalathion (ISO);\n1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;\n[containing ≤ 0,03 % isomalathion]\n204-497-7\n121-75-5\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-042-00-5\nchlorthion\nO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate\n207-902-5\n500-28-7\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-043-00-0\nphosnichlor (ISO);\nO-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate\n—\n5826-76-6\nXn; R20/21/22\nXn\nR: 20/21/22\nS: (2-)13\n\n\n015-044-00-6\ncarbophenothion (ISO);\n4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate\n212-324-1\n786-19-6\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-045-00-1\nmecarbam (ISO);\nN-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate\n219-993-9\n2595-54-2\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n015-046-00-7\noxydemeton-methyl;\nS-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate\n206-110-7\n301-12-2\nT; R24/25\nN; R50\nT; N\nR: 24/25-50\nS: (1/2-)23-36/37-45-61\n\n\n015-047-00-2\nethion (ISO);\nO,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);\ndiethion\n209-242-3\n563-12-2\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)25-36/37-45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n\n\n015-048-00-8\nfenthion (ISO);\nO,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate\n200-231-9\n55-38-9\nMuta. Cat. 3; R68\nT; R23-48/25\nXn; R21/22\nN; R50-53\nT; N\nR: 21/22-23-48/25-68-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-049-00-3\nendothion (ISO);\nS-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate\n220-472-3\n2778-04-3\nT; R24/25\nT\nR: 24/25\nS: (1/2-)36/37-45\n\n\n015-050-00-9\nthiometon (ISO);\nS-2-ethylthioethyl O,O-dimethyl phosphorodithioate\n211-362-6\n640-15-3\nT; R25\nXn; R21\nT\nR: 21-25\nS: (1/2-)36/37-45\n\n\n015-051-00-4\ndimethoate (ISO);\nO,O-dimethyl methylcarbamoylmethyl phosphorodithioate\n200-480-3\n60-51-5\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-052-00-X\nfenchlorphos (ISO);\nO,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate\n206-082-6\n299-84-3\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)25-36/37-60-61\n\n\n015-053-00-5\nmenazon (ISO);\nS-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate\n201-123-4\n78-57-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n015-054-00-0\nfenitrothion (ISO);\nO,O-dimethyl O-4-nitro-m-tolyl phosphorothioate\n204-524-2\n122-14-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-055-00-6\nnaled (ISO);\n1,2-dibromo-2,2-dichloroethyl dimethyl phosphate\n206-098-3\n300-76-5\nXn; R21/22\nXi; R36/38\nN; R50\nXn; N\nR: 21/22-36/38-50\nS: (2-)36/37-61\nN; R50: C ≥ 0,025 %\n\n\n\n015-056-00-1\nazinphos-ethyl (ISO);\nO,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate\n220-147-6\n2642-71-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-057-00-7\nformothion (ISO);\nN-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n219-818-6\n2540-82-1\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-058-00-2\nmorphothion (ISO);\nO,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate\n205-628-0\n144-41-2\nT; R23/24/25\nN; R50-53\nT; N\nR: 23/24/25-50/53\nS: (1/2-)13-45-60-61\n\n\n015-059-00-8\nvamidothion (ISO);\nO,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate\n218-894-8\n2275-23-2\nT; R25\nXn; R21\nN; R50\nT; N\nR: 21-25-50\nS: (1/2-)36/37-45-61\n\n\n015-060-00-3\ndisulfoton (ISO);\nO,O-diethyl 2-ethylthioethyl phosphorodithioate\n206-054-3\n298-04-4\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-061-00-9\ndimefox (ISO);\ntetramethylphosphorodiamidic fluoride\n204-076-8\n115-26-4\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)23-28-36/37-38-45\n\n\n015-062-00-4\nmipafox (ISO);\nN,N'- di-isopropylphosphorodiamidic fluoride\n206-742-3\n371-86-8\nT+; R39/26/27/28\nT+\nR: 39/26/27/28\nS: (1/2-)13-45\n\n\n015-063-00-X\ndioxathion (ISO);\n1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)\n201-107-7\n78-34-2\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-064-00-5\nbromophos-ethyl (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate\n225-399-0\n4824-78-6\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-065-00-0\nS-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate\n—\n2703-37-9\nT+; R26/27/28\nN; R51-53\nT+; N\nR: 26/27/28-51/53\nS: (1/2-)13-28-45-61\n\n\n015-066-00-6\nomethoate (ISO);\nO,O-dimethyl S-methylcarbamoylmethyl phosphorothioate\n214-197-8\n1113-02-6\nT; R25\nXn; R21\nN; R50\nT; N\nR: 21-25-50\nS: (1/2-)23-36/37-45-61\n\n\n\n\n015-067-00-1\nphosalone (ISO);\nS-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate\n218-996-2\n2310-17-0\nT; R25\nXn; R20/21\nR43\nN; R50-53\nT; N\nR: 20/21-25-43-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-068-00-7\ndichlofenthion (ISO);\nO-,4-dichlorophenyl O,O-diethyl phosphorothioate\n202-564-5\n97-17-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-069-00-2\nmethidathion (ISO);\n2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate\n213-449-4\n950-37-8\nT+; R28\nXn; R21\nN; R50-53\nT+; N\nR: 21-28-50/53\nS: (1/2-)22-28-36/37-45-60-61\n\n\n015-070-00-8\ncyanthoate (ISO);\nS-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate\n223-099-4\n3734-95-0\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)36/37-45\n\n\n015-071-00-3\nchlorfenvinphos (ISO);\n2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate\n207-432-0\n470-90-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-072-00-9\nmonocrotophos (ISO);\ndimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate\n230-042-7\n6923-22-4\nMuta. Cat. 3; R68\nT+; R26/28\nT; R24\nN; R50-53\nT+; N\nR: 24-26/28-50/53-68\nS: (1/2-)36/37-45-60-61\n\n\n015-073-00-4\ndicrotophos (ISO);\n(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate\n205-494-3\n141-66-2\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-074-00-X\ncrufomate (ISO);\n4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate\n206-083-1\n299-86-5\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-075-00-5\nS-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate\n—\n2635-50-9\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n015-076-00-0\npotasan;\nO,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate\n—\n299-45-6\nT+; R26/27/28\nN; R50-53\nT+; N\nR: 26/27/28-50/53\nS: (1/2-)13-28-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-077-00-6\n2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate\n—\n7076-53-1\nT; R23/24/25\nT\nR: 23/24/25\nS: (1/2-)13-45\n\n\n015-078-00-1\ndemeton-S-methylsulphon (ISO);\nS-2-ethylsulphonylethyl dimethyl phosphorothioate\n241-109-5\n17040-19-6\nT; R25\nXn; R21\nN; R51-53\nT; N\nR: 21-25-51/53\nS: (1/2-)22-28-36/37-45-61\n\n\n015-079-00-7\nacephate (ISO);\nO,S-dimethyl acetylphosphoramidothioate\n250-241-2\n30560-19-1\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n015-080-00-2\namidithion (ISO);\n2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n—\n919-76-6\nXn; R22\nXn\nR: 22\nS: (2-)24-36\n\n\n015-081-00-8\nO,O,O',O'-tetrapropyl dithiopyrophosphate\n221-817-0\n3244-90-4\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-082-00-3\nazothoate (ISO);\nO-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate\n227-419-3\n5834-96-8\nXn; R20/22\nXn\nR: 20/22\nS: (2-)13\n\n\n015-083-00-9\nbensulide (ISO);\nO,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate\n212-010-4\n741-58-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24-36-60-61\n\n\n015-084-00-4\nchlorpyrifos (ISO);\nO,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n220-864-4\n2921-88-2\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)45-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-085-00-X\nchlorphonium chloride (ISO);\ntributyl (2,4-dichlorobenzyl) phosphonium chloride\n204-105-4\n115-78-6\nT; R25\nXn; R21\nXi; R36/38\nT\nR: 21-25-36/38\nS: (1/2-)36/37/39-45\n\n\n015-086-00-5\ncoumithoate (ISO);\nO,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate\n—\n572-48-5\nT; R25\nT\nR: 25\nS: (1/2-)28-36/37-45\n\n\n015-087-00-0\ncyanophos (ISO);\nO-4-cyanophenyl O,O-dimethyl phosphorothioate\n220-130-3\n2636-26-2\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n015-088-00-6\ndialifos (ISO);\n2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate\n233-689-3\n10311-84-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-089-00-1\nethoate-methyl (ISO);\nethylcarbamoylmethyl O,O-dimethyl phosphorodithioate\n204-121-1\n116-01-8\nXn; R21/22\nXn\nR: 21/22\nS: (2-)36/37\n\n\n015-090-00-7\nfensulfothion (ISO);\nO,O-diethyl O-4-methylsulfinylphenyl phosphorothioate\n204-114-3\n115-90-2\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)23-28-36/37-45-60-61\n\n\n015-091-00-2\nfonofos (ISO);\nO-ethyl phenyl ethylphosphonodithioate\n213-408-0\n944-22-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-092-00-8\nphosacetim (ISO);\nO,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate\n223-874-7\n4104-14-7\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-093-00-3\nleptophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate\n244-472-8\n21609-90-5\nT; R25-39/25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-39/25-50/53\nS: (1/2-)25-36/37/39-45-60-61\n\n\n015-094-00-9\nmephosfolan (ISO);\ndiethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate\n213-447-3\n950-10-7\nT+; R27/28\nN; R51-53\nT+; N\nR: 27/28-51/53\nS: (1/2-)36/37/39-45-61\n\n\n015-095-00-4\nmethamidophos (ISO);\nO,S-dimethyl phosphoramidothioate\n233-606-0\n10265-92-6\nT+; R26/28\nT; R24\nN; R50\nT+; N\nR: 24-26/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-096-00-X\noxydisulfoton (ISO);\nO, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate\n219-679-1\n2497-07-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-097-00-5\nphenthoate (ISO);\nethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate\n219-997-0\n2597-03-7\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)22-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-098-00-0\ntrichloronate (ISO);\nO-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate\n206-326-1\n327-98-0\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)23-28-36/37-45-60-61\n\n\n015-099-00-6\npirimiphos-ethyl (ISO);\nO,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate\n245-704-0\n23505-41-1\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)23-36/37-45-60-61\n\n\n\n\n015-100-00-X\nphoxim (ISO);\nα-(diethoxyphosphinothioylimino) phenylacetonitrile\n238-887-3\n14816-18-3\nRepr. Cat. 3; R62\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-62-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-101-00-5\nphosmet (ISO);\nO,O-dimethyl phthalimidomethyl S-phosphorodithioate\n211-987-4\n732-11-6\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)22-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n\n\n015-102-00-0\ntris(2-chloroethyl)phosphate\n204-118-5\n115-96-8\nCarc. Cat. 3; R40\nRepr. Cat. 2; R60\nXn; R22\nN; R51-53\nT; N\nR: 60-22-40-51/53\nS: 53-45-61\n\nE\n\n015-103-00-6\nphosphorus tribromide\n232-178-2\n7789-60-8\nR14\nC; R34\nXi; R37\nC\nR: 14-34-37\nS: (1/2-)26-45\n\n\n015-104-00-1\ndiphosphorus pentasulphide;\nphosphorus pentasulphide\n215-242-4\n1314-80-3\nF; R11\nR29\nXn; R20/22\nN; R50\nF; Xn; N\nR: 11-20/22-29-50\nS: (2-)61\n\n\n015-105-00-7\ntriphenyl phosphite\n202-908-4\n101-02-0\nXi; R36/38\nN; R50-53\nXi; N\nR: 36/38-50/53\nS: (2-)28-60-61\nXi; R36/38: C ≥ 5 %\n\n015-106-00-2\nhexamethylphosphoric triamide;\nhexamethylphosphoramide\n211-653-8\n680-31-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,01 %\n\n015-107-00-8\nethoprophos (ISO);\nethyl-S,S-dipropyl phosphorodithioate\n236-152-1\n13194-48-4\nT+; R26/27\nT; R25\nR43\nN; R50-53\nT+; N\nR: 25-26/27-43-50/53\nS: (1/2-)27/28-36/37/39-45-60-61\n\n\n015-108-00-3\nbromophos (ISO);\nO-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate\n218-277-3\n2104-96-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-) 46-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-109-00-9\ncrotoxyphos (ISO);\n1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate\n231-720-5\n7700-17-6\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-110-00-4\ncyanofenphos (ISO);\nO-4-cyanophenyl O-ethyl phenylphosphonothioate\n—\n13067-93-1\nT; R25-39/25\nXn; R21\nXi; R36\nN; R51-53\nT; N\nR: 21-25-36-39/25-51/53\nS: (1/2-)36/37-45-61\n\n\n015-111-00-X\nphosfolan (ISO);\ndiethyl 1,3-dithiolan-2-ylidenephosphoramidate\n213-423-2\n947-02-4\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-112-00-5\nthionazin (ISO);\nO,O-diethyl O-pyrazin-2-yl phosphorothioate;\n206-049-6\n297-97-2\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37/39-38-45\n\n\n\n\n015-113-00-0\ntolclofos-methyl (ISO);\nO-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate\n260-515-3\n57018-04-9\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n\n015-114-00-6\nchlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate\n246-538-1\n24934-91-6\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)27-28-36/37-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n015-115-00-1\nchlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]\n244-663-6\n21923-23-9\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n015-116-00-7\ndemephion-O (ISO);\nO,O-dimethyl O-2-methylthioethyl phosphorothioate\n211-666-9\n682-80-4\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)28-36/37-45\n\n\n015-117-00-2\ndemephion-S (ISO);\nO,O-dimethyl S-2-methylthioethyl phosphorothioate\n219-971-9\n2587-90-8\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)28-36/37-45\n\n\n015-118-00-8\ndemeton\n—\n8065-48-3\nT+; R27/28\nN; R50\nT+; N\nR: 27/28-50\nS: (1/2-)28-36/37-45-61\n\n\n015-119-00-3\ndimethyl 4-(methylthio)phenyl phosphate\n—\n3254-63-5\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)28-36/37-45\n\n\n015-120-00-9\nditalimfos (ISO);\nO,O-diethyl phthalimidophosphonothioate;\n225-875-8\n5131-24-8\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)36/37\n\n\n015-121-00-4\nedifenphos (ISO);\nO-ethyl S,S-diphenyl phosphorodithioate\n241-178-1\n17109-49-8\nT; R23/25\nXn; R21\nR43\nN; R50-53\nT; N\nR: 21-23/25-43-50/53\nS: (1/2-)36/37-45-60-61\n\n\n015-122-00-X\netrimfos (ISO);\nO-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate;\n253-855-9\n38260-54-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-123-00-5\nfenamiphos (ISO);\nethyl-4-methylthio-m-tolyl isopropyl phosphoramidate\n244-848-1\n22224-92-6\nT+; R28\nT; R24\nN; R50-53\nT+; N\nR: 24-28-50/53\nS: (1/2-)23-28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-124-00-0\nfosthietan (ISO);\ndiethyl 1,3-dithietan-2-ylidenephosphoramidate;\n244-437-7\n21548-32-3\nT+; R27/28\nT+\nR: 27/28\nS: (1/2-)36/37-45\n\n\n015-125-00-6\nglyphosine (ISO);\nN,N-bis(phosphonomethyl)glycine\n219-468-4\n2439-99-8\nXi; R41\nXi\nR: 41\nS: (2-)26\n\n\n015-126-00-1\nheptenophos (ISO);\n7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate\n245-737-0\n23560-59-0\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)23-28-37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-127-00-7\niprobenfos (ISO);\nS-benzyl diisopropyl phosphorothioate\n247-449-0\n26087-47-8\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n015-128-00-2\nIPSP;\nS-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate\n—\n5827-05-4\nT+; R27\nT; R25\nN; R50-53\nT+; N\nR: 25-27-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-129-00-8\nisofenphos (ISO);\nO-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate\n246-814-1\n25311-71-1\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-130-00-3\nisothioate (ISO)\nS-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;\n—\n36614-38-7\nT; R24/25\nT\nR: 24/25\nS: (1/2-)28-36/37-45\n\n\n015-131-00-9\nisoxathion (ISO);\nO,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate\n242-624-8\n18854-01-8\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\n\n\n015-132-00-4\nS-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;\nmethylcarbophenothione\n—\n953-17-3\nT; R24/25\nN; R50-53\nT; N\nR: 24/25-50/53\nS: (1/2-)28-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-133-00-X\npiperophos (ISO);\nS-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate\n—\n24151-93-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n015-134-00-5\npirimiphos-methyl (ISO);\nO-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate\n249-528-5\n29232-93-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n015-135-00-0\nprofenofos (ISO);\nO-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate\n255-255-2\n41198-08-7\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-136-00-6\ntrans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;\nisopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;\npropetamphos (ISO)\n250-517-2\n31218-83-4\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n015-137-00-1\npyrazophos (ISO);\nO,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate\n236-656-1\n13457-18-6\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53\nS: (2-)36/37-46-60-61\n\n\n015-138-00-7\nquinalphos (ISO);\nO,O-diethyl-O-quinoxalin-2-yl phosphorothioate\n237-031-6\n13593-03-8\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)22-36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n015-139-00-2\nterbufos (ISO)\nS-tert-butylthiomethyl O,O-diethylphosphorodithioate;\n235-963-8\n13071-79-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n\n015-140-00-8\ntriazophos (ISO);\nO,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate\n245-986-5\n24017-47-8\nT; R23/25\nXn; R21\nN; R50-53\nT; N\nR: 21-23/25-50/53\nS: (1/2-)36/37-45-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n015-141-00-3\nethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers\n400-520-1\n—\nC; R34\nXn; R22\nN; R50-53\nC; N\nR: 22-34-50/53\nS: (1/2-)24/25-26-28-39-45-60-61\n\n\n015-142-00-9\nbutyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate\n401-100-0\n—\nF; R11\nXi; R36\nN; R51-53\nF; Xi; N\nR: 11-36-51/53\nS: (2-)7/9-16-26-43-61\n\n\n015-143-00-4\nreaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers\n401-740-0\n—\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n015-144-00-X\nreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate\n402-090-0\n87025-52-3\nC; R34\nC\nR: 34\nS: (1/2-)26-36/37/39-45\n\n\n015-145-00-5\nreaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate\n401-520-4\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-146-00-0\nS-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate\n401-850-9\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-147-00-6\nreaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)\n400-930-0\n—\nXi; R38-41\nN; R51-53\nR43\nXi; N\nR: 38-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n015-148-00-1\n2-(diphosphonomethyl)succinic acid\n403-070-4\n51395-42-7\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)26-36/37/39-45\n\n\n015-149-00-7\nreaction mass of: hexyldioctylphosphineoxide;\ndihexyloctylphosphineoxide;\ntrioctylphosphineoxide\n403-470-9\n—\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n015-150-00-2\n(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide\n404-940-6\n86608-70-0\nXn; R22\nXi; R41\nR33\nR52-53\nXn\nR: 22-33-41-52/53\nS: (2-)22-26-39-61\n\n\n015-151-00-8\ntris(isopropyl/tert-butylphenyl) phosphate\n405-010-2\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n015-152-00-3\ndioxabenzofos (ISO);\n2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide;\n223-292-3\n3811-49-2\nT; R24/25-39/25\nN; R51-53\nT; N\nR: 24/25-39/25-51/53\nS: (1/2-)36/37-38-45-61\n\n\n015-153-00-9\nisazofos (ISO);\nO-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate;\n255-863-8\n42509-80-8\nT+; R26\nT; R24/25\nXn; R48/20\nR43\nN; R50-53\nT+; N\nR: 24/25-26-43-48/20-50/53\nS: (1/2-)28-36/37-38-45-59-61\n\n\n015-154-00-4\n2-chloroethylphosphonic acid;\nethephon\n240-718-3\n16672-87-0\nXn; R20/21\nC; R34\nR52-53\nC\nR: 20/21-34-52/53\nS: (1/2-)26-28-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n\n\n015-155-00-X\nglufosinate ammonium (ISO);\nammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate\n278-636-5\n77182-82-2\nRepr. Cat. 2; R60\nRepr. Cat. 3; R63\nXn; R20/21/22-48/20/22\nT\nR: 60-20/21/22-48/20/22-63\nS: 53-45\n\nE\n\n015-156-00-5\nmethyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]\nmethacrifos (ISO);\nmethyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]\n250-366-9 [1]\n- [2]\n30864-28-9 [1]\n62610-77-9 [2]\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-60-61\n\n\n015-157-00-0\nphosphonic acid; [1]\nphosphorous acid [2]\n237-066-7 [1]\n233-663-1 [2]\n13598-36-2 [1]\n10294-56-1 [2]\nXn; R22\nC; R35\nC\nR: 22-35\nS: (1/2-)26-36/37/39-45\n\n\n015-158-00-6\n(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)\n402-340-9\n32760-80-8\nR52-53\nR: 52/53\nS: 61\n\n\n015-159-00-1\nhydroxyphosphonoacetic acid\n405-710-8\n23783-26-8\nXn; R22-48/22\nC; R34\nR43\nC\nR: 22-34-43-48/22\nS: (1/2-)22-26-36/37/39-45\n\n\n015-160-00-7\nvanadyl pyrophosphate\n406-260-5\n58834-75-6\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n015-161-00-2\ndivanadyl pyrophosphate\n407-130-0\n65232-89-5\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n015-162-00-8\nvanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped\n407-350-7\n—\nXn; R20-48/22\nXi; R41\nN; R51-53\nXn; N\nR: 20-41-48/22-51/53\nS: (2-)22-26-36/39-61\n\n\n015-163-00-3\nbis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide\n412-010-6\n145052-34-2\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n015-164-00-9\ncalcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate\n400-480-5\n36669-85-9\nR52-53\nR: 52/53\nS: 61\n\n\n015-165-00-4\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate\n404-986-7\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)15-26-39-60-61\n\n\n015-166-00-X\n3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n410-290-4\n80693-00-1\nR53\nR: 53\nS: 61\n\n\n015-167-00-5\n3-(hydroxyphenylphosphinyl)propanoic acid\n411-200-6\n14657-64-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n015-168-00-0\nfosthiazate (ISO);\n(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate\n—\n98886-44-3\nT; R23/25-39\nXn; R21\nXi; R41\nR43\nN; R50-53\nT; N\nR: 21-23/25-39-41-43-50/53\nS: (1/2-)53-45-25-26-39-60-61\n\n\n015-169-00-6\ntributyltetradecylphosphonium tetrafluoroborate\n413-520-1\n—\nXn; R22-48/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-48/22-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n015-170-00-1\nreaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;\n1-octane-N,N,N-trimethylammonium di-octylphosphate;\n1-octane-N,N,N-trimethylammonium octylphosphate\n407-490-9\n—\nXn; R21/22\nC; R34\nC\nR: 21/22-34\nS: (1/2-)26-36/37/39-45\n\n\n015-171-00-7\nO,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate\n406-940-1\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n015-172-00-2\nreaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;\nisotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate\n406-240-6\n—\nR10\nC; R34\nN; R51-53\nC; N\nR: 10-34-51/53\nS: (1/2-)23-26-28-36/37/39-45-61\n\n\n015-173-00-8\nmethyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate\n414-080-3\n117291-73-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)23-36-60-61\n\n\n015-174-00-3\n1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine\n411-370-1\n82857-68-9\nT; R25\nXi; R41\nN; R51-53\nT; N\nR: 25-41-51/53\nS: (1/2-)26-37/39-41-45-61\n\n\n015-175-00-9\ntert-butyl (triphenylphosphoranylidene) acetate\n412-880-7\n35000-38-5\nT; R25\nXn; R48/22\nXi; R36\nR43\nN; R51-53\nT; N\nR: 25-36-43-48/22-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n015-176-00-4\nP,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine\n413-430-2\n116163-96-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n015-177-00-X\n((4-phenylbutyl)hydroxyphosphoryl)acetic acid\n412-170-7\n83623-61-4\nXn; R48/22\nXi; R41\nR43\nXn\nR: 41-43-48/22\nS: (2-)22-26-36/37/39\n\n\n015-178-00-5\n(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate\n418-570-8\n25383-07-7\nRepr. Cat. 3; R62\nN; R51-53\nXn; N\nR: 62-51/53\nS: (2-)22-36/37-61\n\n\n015-179-00-0\nUVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine\n422-720-8\n166242-53-1\nCarc. Cat. 3; R40\nXn; R22-48/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-40-43-48/22-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n015-180-00-6\n[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt\n415-820-8\n137590-32-0\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n015-181-00-1\nphosphine\n232-260-8\n7803-51-2\nF+; R12\nR17\nT+; R26\nC; R34\nN; R50\nF+; T+; N\nR: 12-17-26-34-50\nS: (1/2-)28-36/37-45-61-63\n\n\n\n\n015-182-00-7\ntetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)\n430-630-5\n10596-22-2\nXn; R22\nXi; R36\nR43\nXn\nR: 22-36-43\nS: (2-)24-26-37\n\n\n\n\n015-183-00-2\n(1-hydroxydodecylidene)diphosphonic acid\n425-230-2\n16610-63-2\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n\n015-184-00-8\nSalts of glyphosate, with the exception of those specified elsewhere in this Annex\n—\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\nA\n015-186-00-9\nchlorpyrifos-methyl (ISO),\nO, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate\n227-011-5\n5598-13-0\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)36/37-60-61\nN; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %\n\n015-187-00-4\nreaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;\ntrisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide\n417-540-1\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)26-39-61\n\n\n\n\n015-188-00-X\n(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate\n425-220-8\n5945-33-5\nR53\nR: 53\nS: 61\n\n\n\n015-189-00-5\nphenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide\n423-340-5\n162881-26-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n\n\n015-190-00-0\nbis(2,4-dicumylphenyl) neopentyl diphosphite;\n3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane\n421-920-2\n154862-43-8\nR53\nR: 53\nS: 61\n\n\n\n015-191-00-6\ndodecyldiphenyl phosphate\n431-760-5\n27460-02-2\nXi; R38\nR52-53\nXi\nR: 38-52/53\nS: (2-)37-61\n\n\n\n015-192-00-1\ntetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate\n432-770-2\n139189-30-3\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n015-193-00-7\ntriphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)\n442-960-7\n332350-93-3\nT; R25\nXi; R41\nN; R50-53\nT; N\nR: 25-41-50/53\nS: (1/2-)26-39-45-60-61\n\n\n\n015-194-00-2\ntetrabutyl-phosphonium nonafluoro-butane-1-sulfonate\n444-440-5\n220689-12-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n\n015-195-00-8\nreaction mass of: potassium o-toluenephosphonate;\npotassium m-toluenephosphonate;\npotassium p-toluenephosphonate\n433-860-4\n-\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n\n015-196-00-3\nreaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\ndiethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;\nmethyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate\n435-960-3\n-\nCarc. Cat.2; R45\nMuta. Cat.2; R46\nR43\nT\nR: 45-46-43\nS: 53-45\n\n\n\n015-197-00-9\nbis(2,4,4-trimethylpentyl)dithiophosphonic acid\n420-160-9\n107667-02-7\nR10\nT; R23\nXn; R22\nC; R34\nN; R51-53\nT; N\nR: 10-22-23-34-51/53\nS: (1/2-)9-26-36/37/39-45-61\n\n\n\n015-198-00-4\n(4-phenylbutyl)phosphinic acid\n420-450-5\n86552-32-1\nCarc. Cat.3; R40\nXi; R41\nXn\nR: 40-41\nS: (2-)23-26-36/37/39\n\n\n\n\n\n015-199-00-X\ntris[2-chloro-1-chloromethyl)ethyl] phosphate\n237-159-2\n13674-87-8\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\n\n015-200-00-3\nindium phosphide\n244-959-5\n22398-80-7\nCarc. Cat. 2; R45\nRepr. Cat. 3; R62\nT; R48/23\nT\nR: 45–48/23–62\nS: 45- 53\nT; R48/23: C ≥0,1%\nCarc Cat 2; R45: C ≥0,01%\nXn; R48/20: 0,01%≤ C < 0,1%\nE\n015-201-00-9\ntrixylyl phosphate\n246-677-8\n25155-23-1\nRepr. Cat. 2; R60\nT\nR: 60\nS: 53-45\n\n\n015-202-00-4\ntris(nonylphenyl) phosphite\n247-759-6\n26523-78-4\nXi; R43\nN; R50-53\nXi; N\nR: 43-50/53\nS: 24-37-60-61\n\n\n015-203-00-X\ndiphenyl(2,4,6-trimethylbenzoyl)phosphine oxide\n278-355-8\n75980-60-8\nRepr. Cat. 3; R62\nXn\nR: 62\nS: (2)-22-36/37.\n\n\n\n016-001-00-4\nhydrogen sulphide\n231-977-3\n7783-06-4\nF+; R12\nT+; R26\nN; R50\nF+; T+; N\nR: 12-26-50\nS: (1/2-)9-16-36-38-45-61\n\n\n016-002-00-X\nbarium sulphide\n244-214-4\n21109-95-5\nR31\nXn; R20/22\nN; R50\nXn; N\nR: 20/22-31-50\nS: (2-)28-61\n\n\n016-003-00-5\nbarium polysulphides\n256-814-3\n50864-67-0\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-004-00-0\ncalcium sulphide\n243-873-5\n20548-54-3\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-005-00-6\ncalcium polysulphides\n215-709-2\n1344-81-6\nR31\nXi; R36/37/38\nN; R50\nXi; N\nR: 31-36/37/38-50\nS: (2-)28-61\n\n\n016-006-00-1\ndipotassium sulphide;\npotassium sulphide\n215-197-0\n1312-73-8\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\n\n\n016-007-00-7\npotassium polysulphides\n253-390-1\n37199-66-9\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\n\n\n016-008-00-2\nammonium polysulphides\n232-989-1\n9080-17-5\nR31\nC; R34\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)26-45-61\nC; R34: C ≥ 5 %\nXi; R36/38: 1 % ≤ C < 5 %\nR31: C ≥ 1 %\n\n\n\n016-009-00-8\ndisodium sulfide;\nsodium sulfide\n215-211-5\n1313-82-2\nT; R24\nXn; R22\nC; R34\nR31\nN; R50\nT; C; N\nR: 22-24-31-34-50\nS: (1/2-)26-36/37/39-45-61\n\n\n\n\n016-010-00-3\nsodium polysulphides\n215-686-9\n1344-08-7\nT; R25\nR31\nC; R34\nN; R50\nT; N\nR: 25-31-34-50\nS: (1/2-)26-36/37/39-45-61\n\n\n016-011-00-9\nsulphur dioxide\n231-195-2\n7446-09-5\nT; R23\nC; R34\nT\nR: 23-34\nS: (1/2-)9-26-36/37/39-45\nT; R23: C ≥ 20 %\nXn; R20: 5 % ≤ C < 20 %\n5\n016-012-00-4\ndisulphur dichloride;\nsulfur monochloride\n233-036-2\n10025-67-9\nR14\nT; R25\nXn; R20\nR29\nC; R35\nN; R50\nT; C; N\nR: 14-20-25-29-35-50\nS: (1/2-)26-36/37/39-45-61\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n016-013-00-X\nsulphur dichloride\n234-129-0\n10545-99-0\nR14\nC; R34\nXi; R37\nN; R50\nC; N\nR: 14-34-37-50\nS: (1/2-)26-45-61\n\n\n016-014-00-5\nsulphur tetrachloride\n—\n13451-08-6\nR14\nC; R34\nN; R50\nC; N\nR: 14-34-50\nS: (1/2-)26-45-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n016-015-00-0\nthionyl dichloride;\nthionyl chloride\n231-748-8\n7719-09-7\nR14\nXn; R20/22\nR29\nC; R35\nC\nR: 14-20/22-29-35\nS: (1/2-)26-36/37/39-45\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\n\n016-016-00-6\nsulphuryl chloride\n232-245-6\n7791-25-5\nR14\nC; R34\nXi; R37\nC\nR: 14-34-37\nS: (1/2-)26-45\n\n\n016-017-00-1\nchlorosulphonic acid\n232-234-6\n7790-94-5\nR14\nC; R35\nXi; R37\nC\nR: 14-35-37\nS: (1/2-)26-45\n\n\n016-018-00-7\nfluorosulphonic acid\n232-149-4\n7789-21-1\nXn; R20\nC; R35\nC\nR: 20-35\nS: (1/2-)26-45\n\n\n016-019-00-2\noleum ... % SO3\n—\n—\nR14\nC; R35\nXi; R37\nC\nR: 14-35-37\nS: (1/2-)26-30-45\n\nB\n016-020-00-8\nsulphuric acid ... %\n231-639-5\n7664-93-9\nC; R35\nC\nR: 35\nS: (1/2-)26-30-45\nC; R35: C ≥ 15 %\nXi; R36/38: 5 % ≤ C < 15 %\nB\n016-021-00-3\nmethanethiol;\nmethyl mercaptan\n200-822-1\n74-93-1\nF+; R12\nT; R23\nN; R50-53\nF+; T; N\nR: 12-23-50/53\nS: (2-)16-25-60-61\n\n\n016-022-00-9\nethanethiol;\nethyl mercaptan\n200-837-3\n75-08-1\nF; R11\nXn; R20\nN; R50-53\nF; Xn; N\nR: 11-20-50/53\nS: (2-)16-25-60-61\n\n\n016-023-00-4\ndimethyl sulphate\n201-058-1\n77-78-1\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT+; R26\nT; R25\nC; R34\nR43\nT+\nR: 45-25-26-34-43-68\nS: 53-45\nCar. Cat. 2; R45: C ≥ 0,01 %\nMuta. Cat. 3, R68: C ≥ 0,01 %\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nE\n016-024-00-X\ndimexano (ISO);\nbis(methoxythiocarbonyl) disulphide\n215-993-8\n1468-37-7\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n016-025-00-5\ndisul (ISO);\n2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;\n2,4-DES\n205-259-5\n149-26-8\nXn; R22\nXi; R38-41\nXn\nR: 22-38-41\nS: (2-)26\n\n\n016-026-00-0\nsulphamidic acid;\nsulphamic acid;\nsulfamic acid\n226-218-8\n5329-14-6\nXi; R36/38\nR52-53\nXi\nR: 36/38-52/53\nS: (2-)26-28-61\n\n\n016-027-00-6\ndiethyl sulphate\n200-589-6\n64-67-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R20/21/22\nC; R34\nT\nR: 45-46-20/21/22-34\nS: 53-45\n\nE\n016-028-00-1\nsodium dithionite;\nsodium hydrosulphite\n231-890-0\n7775-14-6\nR7\nR31\nXn; R22\nXn\nR: 7-22-31\nS: (2-)7/8-26-28-43\n\n\n016-029-00-7\np-toluenesulphonic acid, containing more than 5 % H2SO4\n—\n—\nC; R34\nC\nR: 34\nS: (1/2-)26-37/39-45\nC; R34: C ≥ 25 %\nXi; R36/38: 10 % ≤ C < 25 %\n\n016-030-00-2\np-toluenesulphonic acid (containing a maximum of 5 % H2SO4)\n203-180-0\n104-15-4\nXi; R36/37/38\nXi\nR: 36/37/38\nS: (2-)26-37\n\n\n016-031-00-8\ntetrahydrothiophene-1,1-dioxide;\nsulpholane\n204-783-1\n126-33-0\nXn; R22\nXn\nR: 22\nS: (2-)25\n\n\n016-032-00-3\n1,3-propanesultone;\n1,2-oxathiolane 2,2-dioxide\n214-317-9\n1120-71-4\nCarc. Cat. 2; R45\nXn; R21/22\nT\nR: 45-21/22\nS: 53-45\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n016-033-00-9\ndimethylsulfamoylchloride\n236-412-4\n13360-57-1\nCarc. Cat. 2; R45\nT+; R26\nXn; R21/22\nC; R34\nT+\nR: 45-21/22-26-34\nS: 53-45\n\nE\n016-034-00-4\ntetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)\n400-010-9\n81898-60-4\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-035-00-X\npentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate\n400-120-7\n—\nXi; R36\nXi\nR: 36\nS: (2-)22-26\n\n\n016-036-00-5\ntetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate\n400-130-1\n—\nR42\nN; R51-53\nXn; N\nR: 42-51/53\nS: (2-)22-61\n\n\n016-037-00-0\ndisodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate\n400-350-8\n85153-93-1\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n016-038-00-6\ndisodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate\n400-380-1\n86393-35-3\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-039-00-1\ntetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate\n400-430-2\n—\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-040-00-7\nreaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate\n400-570-4\n—\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n016-041-00-2\ncalcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate\n400-710-4\n—\nXn; R20\nXn\nR: 20\nS: (2-)\n\n\n016-042-00-8\ntetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate\n400-790-0\n85665-97-0\nXi; R36/38\nR43\nXi\nR: 36/38-43\nS: (2-)22-24/25-37\n\n\n016-043-00-3\ndilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate\n401-010-1\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n016-044-00-9\ndisodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate\n401-320-7\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n016-045-00-4\nlithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate\n401-560-2\n108624-00-6\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-046-00-X\nsodium hydrogensulphate\n231-665-7\n7681-38-1\nXi; R41\nXi\nR: 41\nS: (2-)24-26\n\n\n016-047-00-5\nhexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate\n401-650-1\n85665-96-9\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-048-00-0\nsodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate\n401-870-8\n—\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-61\n\n\n016-049-00-6\ncalcium octadecylxylenesulphonate\n402-040-8\n—\nC; R34\nN; R51-53\nC; N\nR: 34-51/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n016-050-00-1\npotassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat\n402-150-6\n—\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)22-24-26-37\n\n\n016-051-00-7\ntrisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate\n402-170-5\n106359-91-5\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n016-052-00-2\nbenzyltributylammonium 4-hydroxynaphthalene-1-sulphonate\n402-240-5\n102561-46-6\nXn; R20\nN; R51-53\nXn; N\nR: 20-51/53\nS: (2-)22-61\n\n\n016-053-00-8\n(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate\n402-460-1\n—\nXi; R38\nR43\nR53\nXi\nR: 38-43-53\nS: (2-)24-37-61\n\n\n016-054-00-3\nsodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate\n400-030-8\n—\nT; R23-48/23\nXn; R22\nXi; R36/37\nR43\nT\nR: 22-23-36/37-43-48/23\nS: (1/2-)22-24-36-45\n\n\n016-055-00-9\ntetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)\n400-510-7\n—\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)22-24-26-37/39\n\n\n016-056-00-4\npotassium hydrogensulphate\n231-594-1\n7646-93-7\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)26-36/37/39-45\n\n\n016-057-00-X\nstyrene-4-sulfonyl chloride\n404-770-2\n2633-67-2\nXi; R38-41\nR43\nXi\nR: 38-41-43\nS: (2-)24-26-37/39\n\n\n016-058-00-5\nthionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine\n404-820-3\n—\nXi; R38\nR43\nR52-53\nXi\nR: 38-43-52/53\nS: (2-)36/37-61\n\n\n016-059-00-0\nN,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride\n405-300-9\n17339-60-5\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-50/53\nS: (2-)26-36/37-60-61\n\n\n016-060-00-6\ndiammonium peroxodisulphate;\nammonium persulphate\n231-786-5\n7727-54-0\nO; R8\nXn; R22\nXi; R36/37/38\nR42/43\nO; Xn\nR: 8-22-36/37/38-42/43\nS: (2-)22-24-26-37\n\n\n016-061-00-1\ndipotassium peroxodisulphate;\npotassium persulphate\n231-781-8\n7727-21-1\nO; R8\nXn; R22\nXi; R36/37/38\nR42/43\nO; Xn\nR: 8-22-36/37/38-42/43\nS: (2-)22-24-26-37\n\n\n016-062-00-7\nbensultap (ISO);\n1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane\n—\n17606-31-4\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n016-063-00-2\nsodium metabisulphite\n231-673-0\n7681-57-4\nXn; R22\nXi; R41\nR31\nXn\nR: 22-31-41\nS: (2-)26-39-46\n\n\n016-064-00-8\nsodium hydrogensulphite … %;\nsodium bisulphite … %\n231-548-0\n7631-90-5\nXn; R22\nR31\nXn\nR: 22-31\nS: (2-)25-46\n\nB\n016-065-00-3\nsodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate\n400-100-8\n84057-97-6\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n016-066-00-9\ntetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)\n404-070-7\n116912-62-0\nR52-53\nR: 52/53\nS: 61\n\n\n016-067-00-4\n(4-methylphenyl)mesitylene sulfonate\n407-530-5\n67811-06-7\nR53\nR: 53\nS: 61\n\n\n016-068-00-X\nsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate\n407-720-8\n155160-86-4\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-069-00-5\n3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid\n407-990-7\n141915-64-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-070-00-0\n4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone\n408-220-2\n—\nR53\nR: 53\nS: 61\n\n\n016-071-00-6\ntrisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate\n410-130-3\n136248-03-8\nR43\nXi\nR: - 43\nS: (2-)22-24-37\n\n\n016-072-00-1\n3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide\n411-520-6\n112195-27-4\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n016-073-00-7\ntetrakis(phenylmethyl)thioperoxydi(carbothioamide)\n404-310-0\n10591-85-2\nR53\nR: 53\nS: 61\n\n\n016-074-00-2\n6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene\n405-410-7\n—\nXi; R38-41\nR43\nN; R51-53\nXi; N\nR: 38-41-43-51/53\nS: (2-)26-36/37/39-61\n\n\n016-075-00-8\n2,2'-diallyl-4,4'-sulfonyldiphenol\n411-570-9\n41481-66-7\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n016-076-00-3\n2,3-bis((2-mercaptoethyl)thio)-1-propanethiol\n411-290-7\n131538-00-6\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)23-24/25-36-60-61\n\n\n016-077-00-9\n2-chloro-p-toluenesulfochloride\n412-890-1\n42413-03-6\nC; R34\nR43\nR52-53\nC\nR: 34-43-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n016-078-00-4\n4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide\n413-300-5\n56187-04-3\nR53\nR: 53\nS: 61\n\n\n016-079-00-X\nN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide\n412-920-3\n16695-22-0\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n016-080-00-5\nsodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate\n412-320-1\n31361-99-6\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n016-081-00-0\nhexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide\n418-350-1\n—\nMuta. Cat. 3; R68\nXn; R22\nXi; R36\nR43\nN; R51-53\nXn; N\nR: 22-36-43-68-51/53\nS: (2-)26-36/37-61\n\n\n016-082-00-6\nethoxysulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea\n—\n126801-58-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n016-083-00-1\nacibenzolar-S-methyl;\nbenzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester\n420-050-0\n135158-54-2\nXi; R36/37/38\nR43\nN; R50-53\nXi; N\nR: 36/37/38-43-50/53\nS: (2-)24/25-37-46-59-60-61\n\n\n\n\n016-084-00-7\nprosulfuron (ISO);\n1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea\n—\n94125-34-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n016-085-00-2\nflazasulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea\n—\n104040-78-0\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n016-086-00-8\ntetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n402-590-9\n109125-56-6\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n016-087-00-3\nreaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;\ndiphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;\npropylene carbonate\n403-490-8\n104558-95-4\nXi; R36\nR43\nN; R50-53\nXi; N\nR: 36-43-50/53\nS: (2-)24-26-37-60-61\n\n\n016-088-00-9\n4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid\n407-280-7\n71297-11-5\nR52-53\nR: 52/53\nS: 61\n\n\n016-089-00-4\nreaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene\n413-840-1\n—\nE; R2\nF; R11\nR53\nE\nR: 2-11-53\nS: (2-)33-35-40-61\n\n\n016-090-00-X\n4-methyl-N-(methylsulfonyl)benzenesulfonamide\n415-040-8\n14653-91-9\nXn; R22\nXi; R37-41\nXn\nR: 22-37-41\nS: (2-)26-39\n\n\n016-091-00-5\nC12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate\n414-110-5\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n\n016-092-00-0\nreaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol\n427-050-1\n-\nRepr. Cat. 3; R62\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 38-43-62-50/53\nS: (2-)36/37-60-61\n\n\n\n016-093-00-6\nreaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);\n4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)\n414-770-4\n140698-96-0\nF; R11\nCarc. Cat. 3; R40\nF; Xn\nR: 11-40\nS: (2-)7-36/37\n\n\n\n\n016-094-00-1\nsulfur\n231-722-6\n7704-34-9\nXi; R38\nXi\nR: 38\nS: (2-)46\n\n\n\n016-095-00-7\nreaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);\nReaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)\n417-980-4\n—\nF; R11\nCarc. Cat. 3; R40\nF; Xn\nR: 11-40\nS: (2-)7-36/37\n\n\n016-096-00-2\nthifensulfuron-methyl (ISO);\nmethyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate\n—\n79277-27-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n016-097-00-8\n1-amino-2-methyl-2-propanethiol hydrochloride\n434-480-1\n32047-53-3\nXn; R22\nC; R34\nR43\nR52-53\nC\nR: 22-34-43-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n\n017-001-00-7\nchlorine\n231-959-5\n7782-50-5\nO; R8\nT; R23\nXi; R36/37/38\nN; R50\nO; T; N\nR: 8-23-36/37/38-50\nS: (1/2-)9-45-61\nN; R50: C ≥ 0,25 %\n\n\n017-002-00-2\nhydrogen chloride\n231-595-7\n7647-01-0\nT; R23\nC; R35\nT; C\nR: 23-35\nS: (1/2-)9-26-36/37/39-45\n\n5\n017-002-01-X\nhydrochloric acid ... %\n231-595-7\n—\nC; R34\nXi; R37\nC\nR: 34-37\nS: (1/2-)26-45\nC; R34-37: C ≥ 25 %\nXi; R36/37/38: 10 % ≤ C < 25 %\nB\n017-003-00-8\nbarium chlorate\n236-760-7\n13477-00-4\nO; R9\nXn; R20/22\nN; R51-53\nO; Xn; N\nR: 9-20/22-51/53\nS: (2-)13-27-61\n\n\n017-004-00-3\npotassium chlorate\n223-289-7\n3811-04-9\nO; R9\nXn; R20/22\nN; R51-53\nO; Xn; N\nR: 9-20/22-51/53\nS: (2-)13-16-27-61\n\n\n017-005-00-9\nsodium chlorate\n231-887-4\n7775-09-9\nO; R9\nXn; R22\nN; R51-53\nO; Xn; N\nR: 9-22-51/53\nS: (2-)13-17-46-61\n\n\n017-006-00-4\nperchloric acid ... %\n231-512-4\n7601-90-3\nR5\nO; R8\nC; R35\nO; C\nR: 5-8-35\nS: (1/2-)23-26-36-45\nC; R35: C ≥ 50 %\nC; R34: 10 % ≤ C < 50 %\nXi; R36/38: 1 % ≤ C < 10 %\nFootnote\nO; R5-8: C > 50 %\nB\n017-007-00-X\nbarium perchlorate\n236-710-4\n13465-95-7\nO; R9\nXn; R20/22\nO; Xn\nR: 9-20/22\nS: (2-)27\n\n\n017-008-00-5\npotassium perchlorate\n231-912-9\n7778-74-7\nO; R9\nXn; R22\nO; Xn\nR: 9-22\nS: (2-)13-22-27\n\n\n\n\n017-009-00-0\nammonium perchlorate;\n[containing ≥ 80 % of 0-30 μm particles]\n232-235-1\n7790-98-9\nE; R3\nO; R9\nE\nR: 3-9\nS: (2-)14-16-36/37\n\nT\n\n\n\n017-009-01-8\nammonium perchlorate;\n[containing < 80 % of 0-30 μm particles]\n232-235-1\n7790-98-9\nE; R2\nO; R9\nE\nR: 2-9\nS: (2-)14-16-36/37\n\nT\n\n017-010-00-6\nsodium perchlorate\n231-511-9\n7601-89-0\nO; R9\nXn; R22\nO; Xn\nR: 9-22\nS: (2-)13-22-27\n\n\n017-011-00-1\nsodium hypochlorite, solution ... % Cl active\n231-668-3\n7681-52-9\nC; R34\nR31\nN; R50\nC; N\nR: 31-34-50\nS: (1/2-)28-45-50-61\nR31: C ≥ 5 %\nB\n\n\n\n017-012-00-7\ncalcium hypochlorite\n231-908-7\n7778-54-3\nO; R8\nC; R34\nXn; R22\nR31\nN; R50\nO; C; N\nR: 8-22-31-34-50\nS: (1/2-)26-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R37/38-41: 3 % ≤ C < 10 %\nXi; R36: 0,5 % ≤ C < 3 %\nN; R50: C ≥ 2,5 %\n\n\n017-013-00-2\ncalcium chloride\n233-140-8\n10043-52-4\nXi; R36\nXi\nR: 36\nS: (2-)22-24\n\n\n017-014-00-8\nammonium chloride\n235-186-4\n12125-02-9\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22\n\n\n017-015-00-3\n(2-(aminomethyl)phenyl)acetylchloride hydrochloride\n417-410-4\n61807-67-8\nXn; R22\nC; R35\nR43\nC\nR: 22-35-43\nS: (1/2-)26-36/37/39-45\n\n\n017-016-00-9\nmethyltriphenylphosphonium chloride\n418-400-2\n1031-15-8\nXn; R21/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-51/53\nS: (2-)22-26-36/37/39-61\n\n\n017-017-00-4\n(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride\n426-210-6\n120086-58-0\nC; R34\nN; R50-53\nC; N\nR: 34-50/53\nS: (2-)26-36/37/39-45-60-61\n\n\n017-018-00-X\nN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride\n405-660-7\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n017-019-00-5\n(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride\n415-110-8\n54417-53-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n017-020-00-0\nethyl propoxy aluminium chloride\n421-790-7\n13014-29-4\nF; R15\nR 14\nC; R35\nF; C\nR: 14/15-35\nS: (1/2-)16-23-26-30-36/37/39-43-45\n\n\n017-021-00-6\nbehenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride\n423-420-1\n136920-10-0\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)26-36/37/39-60-61\n\n\n\n\n017-023-00-7\n[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides\n425-520-9\n197179-61-6\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n\n017-026-00-3\nchlorine dioxide\n233-162-8\n10049-04-4\nO; R8\nR6\nT+; R26\nC; R34\nN; R50\nO; T+; N\nR: 6-8-26-34-50\nS: (1/2-)23-26-28-36/37/39-38-45-61\nN; R50: C ≥ 2,5 %\n5\n017-026-01-0\nchlorine dioxide … %\n233-162-8\n10049-04-4\nT; R25\nC; R34\nN; R50\nT; N\nR: 25-34-50\nS: (1/2-)23-26-28-36/37/39-45-61\nC; R34: C ≥ 10 %\nXi; R37/38: 3 % ≤ C < 10 %\nXi; R36: 0,3 % ≤ C < 10 %\nN; R50: C ≥ 2,5 %\nB\n\n\n019-001-00-2\npotassium\n231-119-8\n7440-09-7\nF; R15\nR14\nC; R34\nF; C\nR: 14/15-34\nS: (1/2-)5-8-45\n\n\n019-002-00-8\npotassium hydroxide;\ncaustic potash\n215-181-3\n1310-58-3\nXn; R22\nC; R35\nC\nR: 22-35\nS: (1/2-)26-36/37/39-45\nC; R35: C ≥ 5 %\nC; R34: 2 % ≤ C < 5 %\nXi; R36/38: 0.5 % ≤ C < 2 %\n\n020-001-00-X\ncalcium\n231-179-5\n7440-70-2\nF; R15\nF\nR: 15\nS: (2-)8-24/25-43\n\n\n020-002-00-5\ncalcium cyanide\n209-740-0\n592-01-8\nT+; R28\nR32\nN; R50-53\nT+; N\nR: 28-32-50/53\nS: (1/2-)7/8-23-36/37-45-60-61\n\n\n020-003-00-0\nreaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;\ntri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;\npoly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]\n420-470-4\n—\nXi; R36/38\nR43\nXi\nR: 36/38-43\nS: (2-)24-26-37\n\n\n022-001-00-5\ntitanium tetrachloride\n231-441-9\n7550-45-0\nR14\nC; R34\nC\nR: 14-34\nS: (1/2-)7/8-26-36/37/39-45\n\n\n022-002-00-0\ntitanium(4+) oxalate\n403-260-7\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n022-003-00-6\nbis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium\n412-000-1\n125051-32-3\nF; R11\nRepr. Cat. 3; R62\nXn; R48/22\nN; R51-53\nF; Xn; N\nR: 11-48/22-62-51/53\nS: (2-)7-22-33-36/37-61\n\n\n\n\n022-004-00-1\npotassium titanium oxide (K2Ti6O13)\n432-240-0\n12056-51-8\nCarc. Cat.3; R40\nXn\nR: 40\nS: (2-)22-36/37\n\n\n\n022-005-00-7\n[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium\n419-840-8\n169104-71-6\nF; R11\nC; R34\nR43\nR53\nF; C\nR: 11-34-43-53\nS: (1/2-)6-9-16-26-36/37/39-45-61\n\n\n\n023-001-00-8\ndivanadium pentaoxide;\nvanadium pentoxide\n215-239-8\n1314-62-1\nMuta. Cat. 3; R68\nRepr. Cat. 3; R63\nT; R48/23\nXn; R20/22\nXi; R37\nN; R51-53\nT; N\nR: 20/22-37-48/23-51/53-63-68\nS: (1/2-)36/37-38-45-61\n\n\n024-001-00-0\nchromium (VI) trioxide\n215-607-8\n1333-82-0\nO; R9\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT+; R26\nT; R24/25-48/23\nC; R35\nR42/43\nN; R50-53\nO; T+; N\nR: 45-46-9-24/25-26-35-42/43-48/23-62-50/53\nS: 53-45-60-61\nC: R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 1 % ≤ C < 5 %\nE\n024-002-00-6\npotassium dichromate\n231-906-6\n7778-50-9\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N; O\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %:\nXi; R36/37/38: 5 % ≤ C < 10 %\nE3\n024-003-00-1\nammonium dichromate\n232-143-1\n7789-09-5\nE; R2\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nE; T+; N\nR: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE3\n\n024-004-00-7\nsodium dichromate\n234-190-3\n10588-01-9\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nO; T+; N\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE\n3\n\n\n\n024-004-01-4\nsodium dichromate, dihydrate\n234-190-3\n7789-12-0\nO; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N; O\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %\nE3\n\n024-005-00-2\nchromyl dichloride;\nchromic oxychloride\n239-056-8\n14977-61-8\nO; R8\nCarc. Cat. 2; R49\nMuta. Cat. 2; R46\nC; R35\nR43\nN; R50-53\nO; T; C; N\nR: 49-46-8-35-43-50/53\nS: 53-45-60-61\nC; R35: C ≥ 10 %\nC; R34: 5 % ≤ C < 10 %\nXi; R36/37/38: 0,5 % ≤ C < 5 %\nR43: C ≥ 0,5 %\n3\n024-006-00-8\npotassium chromate\n232-140-5\n7789-00-6\nCarc. Cat. 2; R49\nMuta. Cat. 2; R46\nXi; R36/37/38\nR43\nN; R50-53\nT; N\nR: 49-46-36/37/38-43-50/53\nS: 53-45-60-61\nR43: C ≥ 0,5 %\n3\n024-007-00-3\nzinc chromates including zinc potassium chromate\n—\n—\nCarc. Cat. 1; R45\nXn; R22\nR43\nN; R50-53\nT; N\nR: 45-22-43-50/53\nS: 53-45-60-61\n\nAE\n024-008-00-9\ncalcium chromate\n237-366-8\n13765-19-0\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n024-009-00-4\nstrontium chromate\n232-142-6\n7789-06-2\nCarc. Cat. 2; R45\nXn; R22\nN; R50-53\nT; N\nR: 45-22-50/53\nS: 53-45-60-61\n\nE\n024-010-00-X\ndichromium tris(chromate);\nchromium III chromate;\nchromic chromate\n246-356-2\n24613-89-6\nO; R8\nCarc. Cat. 2; R45\nC; R35\nR43\nN; R50-53\nO; T; C; N\nR: 45-8-35-43-50/53\nS: 53-45-60-61\n\n\n024-011-00-5\nammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)\n400-110-2\n109125-51-1\nF; R11\nN; R50-53\nF; N\nR: 11-50/53\nS: (2-)33-60-61\n\n\n024-012-00-0\ntrisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)\n400-810-8\n—\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)22-36/37\n\n\n024-013-00-6\ntrisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)\n402-500-8\n—\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)26-39-61\n\n\n024-014-00-1\ntrisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)\n402-870-0\n93952-24-0\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n024-015-00-7\ndisodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)\n404-930-1\n—\nXn; R20\nXi; R41\nN; R51-53\nXn; N\nR: 20-41-51/53\nS: (2-)26-39-61\n\n\n024-016-00-2\ntetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)\n405-110-6\n88377-66-6\nXn; R48/22\nR53\nXn\nR: 48/22-53\nS: (2-)22-36-61\n\n\n024-017-00-8\nChromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex\n—\n—\nCarc. Cat. 2; R49\nR43\nN; R50-53\nT; N\nR: 49-43-50/53\nS: 53-45-60-61\n\nA\n024-018-00-3\nsodium chromate\n231-889-5\n7775-11-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53\nT+; N\nR: 45-46-60-61-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61\nR42/43: C ≥ 0,2 %\nE3\n024-019-00-9\nMain component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);\nby-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);\nby-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)\n419-230-1\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n024-020-00-4\ntrisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)\n418-220-4\n—\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n\n\n024-021-00-X\npotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)\n425-830-4\n-\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n025-001-00-3\nmanganese dioxide\n215-202-6\n1313-13-9\nXn; R20/22\nXn\nR: 20/22\nS: (2-)25\n\n\n025-002-00-9\npotassium permanganate\n231-760-3\n7722-64-7\nO; R8\nXn; R22\nN; R50-53\nO; Xn; N\nR: 8-22-50/53\nS: (2-)60-61\n\n\n025-003-00-4\nmanganese sulphate\n232-089-9\n7785-87-7\nXn; R48/20/22\nN; R51-53\nXn; N\nR: 48/20/22-51/53\nS: (2-)22-61\n\n\n025-004-00-X\nbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate\n411-760-1\n116633-53-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n025-005-00-5\nreaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);\ntetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);\npentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)\n417-660-4\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n026-001-00-6\n(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate\n407-840-0\n100011-37-8\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n026-002-00-1\n(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate\n407-880-9\n117549-13-0\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)26-61\n\n\n\n\n026-003-00-7\niron (II) sulfate\n231-753-5\n7720-78-7\nXn; R22\nXi; R36/38\nXn\nR: 22-36/38\nS: (2-)46\n\n\n\n026-003-01-4\niron (II) sulfate (1:1) heptahydrate;\nsulfuric acid, iron(II) salt (1:1), heptahydrate;\nferrous sulfate heptahydrate\n231-753-5\n7782-63-0\nXn; R22\nXi; R36/38\nXn\nR: 22-36/38\nS: (2-)46\nXi; R38: C ≥ 25 %\n\n\n026-004-00-2\npotassium ferrite\n430-010-4\n12160-44-0\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)22-26-36/37/39-40-45\n\n\n\n\n027-001-00-9\ncobalt\n231-158-0\n7440-48-4\nR42/43\nR53\nXn\nR: 42/43-53\nS: (2-)22-24-37-61\n\n\n\n\n027-002-00-4\ncobalt oxide\n215-154-6\n1307-96-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n027-003-00-X\ncobalt sulfide\n215-273-3\n1317-42-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n027-004-00-5\ncobalt dichloride\n231-589-4\n7646-79-9\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nXn; R22\nR42/43\nN; R50-53\nT; N\nR: 49-60-22-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\nE1\n\n027-005-00-0\ncobalt sulfate\n233-334-2\n10124-43-3\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nXn; R22\nR42/43\nN; R50-53\nT; N\nR: 49-60-22-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\nE1\n\n\n\n\n027-006-00-6\ncobalt di(acetate)\n200-755-8\n71-48-7\nCarc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53\nT; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61\nCarc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n1\n\n\n027-007-00-1\nzinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex\n425-240-7\n-\nXi; R41\nN; R51-53\nXi; N\nR: 41-51/53\nS: (2-)22-26-39-61\n\n\n\n027-008-00-7\ncomplex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2 55 % in aqueous solution]\n232-259-2\n7803-49-8\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R37/38-41\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-37/38-40-41-43-48/22-50\nS: (2-)26-36/37/39-61\n\nB\n\n\n\n612-122-01-4\nhydroxylamine …% [≤ 55 % in aqueous solution]\n232-259-2\n7803-49-8\nR5\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R37/38-41\nR43\nN; R50\nXn; N\nR: 5-21/22-37/38-40-41-43-48/22-50\nS: (2-)26-36/37/39-46-61\n\nB\n\n\n\n612-123-00-2\nhydroxylammonium chloride;\nhydroxylamine hydrochloride; [1]\nbis(hydroxylammonium) sulfate;\nhydroxylamine sulfate (2:1) [2]\n226-798-2 [1]\n233-118-8 [2]\n5470-11-1 [1]\n10039-54-0 [2]\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R36/38\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-36/38-40-43-48/22-50\nS: (2-)36/37-61\n\n\n\n612-124-00-8\nN,N,N-trimethylanilinium chloride\n205-319-0\n138-24-9\nT; R24/25\nT\nR: 24/25\nS: (1/2-)25-39-45-53\n\n\n612-125-00-3\n2-methyl-p-phenylenediamine;\n2,5-toluenediamine\n202-442-1\n95-70-5\nT; R25\nXn; R20/21\nR43\nN; R51-53\nT; N\nR: 20/21-25-43-51/53\nS: (1/2-)24-37-45-61\n\n\n612-126-00-9\ntoluene-2,4-diammonium sulphate;\n4-methyl-m-phenylenediamine sulfate\n265-697-8\n65321-67-7\nCarc. Cat. 2; R45\nT; R25\nXn; R21\nXi; R36\nR43\nN; R51-53\nT; N\nR: 45-21-25-36-43-51/53\nS: 53-45-61\n\nE\n612-127-00-4\n3-aminophenol\n209-711-2\n591-27-5\nXn; R20/22\nN; R51-53\nXn; N\nR: 20/22-51/53\nS: (2-)28-61\n\n\n612-128-00-X\n4-aminophenol\n204-616-2\n123-30-8\nMuta. Cat. 3; R68\nXn; R20/22\nN; R50-53\nXn; N\nR: 20/22-50/53-68\nS: (2-)28-36/37-60-61\n\n\n612-129-00-5\ndiisopropylamine\n203-558-5\n108-18-9\nF; R11\nXn; R20/22\nC; R34\nF; C\nR: 11-20/22-34\nS: (1/2-)16-26-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n612-130-00-0\n2,6-diamino-3,5-diethyltoluene;\n4,6-diethyl-2-methyl-1,3-benzenediamine; [1]\n2,4-diamino-3,5-diethyltoluene;\n2,4-diethyl-6-methyl-1,3-benzenediamine; [2]\ndiethylmethylbenzenediamine [3]\n218-255-3 [1]\n218-256-9 [2]\n270-877-4 [3]\n2095-01-4 [1]\n2095-02-5 [2]\n68479-98-1 [3]\nXn; R21/22-48/22\nXi; R36\nN; R50-53\nXn; N\nR: 21/22-36-48/22-50/53\nS: (2-)26-28-36/37/39-60-61\n\nC\n612-131-00-6\ndidecyldimethylammonium chloride\n230-525-2\n7173-51-5\nXn; R22\nC; R34\nC\nR: 22-34\nS: (2-)26-36/37/39-45\n\n\n612-132-00-1\nN,N'-diphenyl-p-phenylenediamine;\nN,N'-diphenyl-1,4-benzenediamine\n200-806-4\n74-31-7\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n612-133-00-7\n(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;\n4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate\n247-162-0\n25646-77-9\nT; R25\nXn; R48/22\nR43\nN; R50-53\nT; N\nR: 25-43-48/22-50/53\nS: (1/2-)24-37-45-60-61\n\n\n612-134-00-2\nN-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;\n4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate\n247-161-5\n25646-71-3\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n612-135-00-8\nN-2-naphthylaniline;\nN-phenyl-2-naphthylamine\n205-223-9\n135-88-6\nCarc. Cat. 3; R40\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 36/38-40-43-51/53\nS: (2-)26-36/37-61\n\n\n612-136-00-3\nN-isopropyl-N'-phenyl-p-phenylenediamine\n202-969-7\n101-72-4\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nR43: C ≥ 0,1 %\n\n612-137-00-9\n4-chloroaniline\n203-401-0\n106-47-8\nCarc. Cat. 2; R45\nT; R23/24/25\nR43\nN; R50-53\nT; N\nR: 45-23/24/25-43-50/53\nS: 53-45-60-61\n\nE\n612-138-00-4\nfuralaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate\n260-875-1\n57646-30-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)36/37/39-61\n\n\n612-139-00-X\nmefenacet (ISO);\n2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide\n277-328-8\n73250-68-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-140-00-5\nquaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides\n264-151-6\n63449-41-2\nXn; R21/22\nC; R34\nN; R50\nC; N\nR: 21/22-34-50\nS: (2-)36/37/39-45-61\n\n\n612-141-00-0\n4,4'-methylenebis(2-ethylaniline);\n4,4'-methylenebis(2-ethylbenzeneamine)\n243-420-1\n19900-65-3\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)36/37-60-61\n\n\n612-142-00-6\nbiphenyl-2-ylamine\n201-990-9\n90-41-5\nCarc. Cat. 3; R40\nXn; R22\nR52-53\nXn\nR: 22-40-52/53\nS: (2-)36/37-61\n\n\n612-143-00-1\nN5,N5-diethyltoluene-2,5-diamine monohydrochloride;\n4-diethylamino-2-methylaniline monohydrochloride\n218-130-3\n2051-79-8\nT; R25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 25-36-43-50/53\nS: (1/2-)24-26-37-45-60-61\n\n\n612-144-00-7\nflumetralin (ISO);\nN-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine\n—\n62924-70-3\nXi; R36/38\nR43\nN; R50-53\nXi; N\nR: 36/38-43-50/53\nS: (2-)36/37-60-61\n\n\n612-145-00-2\no-phenylenediamine\n202-430-6\n95-54-5\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nT; R25\nXn; R20/21\nXi; R36\nR43\nN; R50-53\nT; N\nR: 20/21-25-36-40-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-146-00-8\no-phenylenediamine dihydrochloride\n210-418-7\n615-28-1\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nT; R25\nXn; R20/21\nXi; R36\nR43\nN; R50-53\nT; N\nR: 20/21-25-36-40-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-147-00-3\nm-phenylenediamine\n203-584-7\n108-45-2\nMuta. Cat. 3; R68\nT; R23/24/25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 23/24/25-36-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-148-00-9\nm-phenylenediamine dihydrochloride\n208-790-0\n541-69-5\nMuta. Cat. 3; R68\nT; R23/24/25\nXi; R36\nR43\nN; R50-53\nT; N\nR: 23/24/25-36-43-50/53-68\nS: (1/2-)28-36/37-45-60-61\n\n\n612-149-00-4\n1,3-diphenylguanidine\n203-002-1\n102-06-7\nRepr. Cat. 3; R62\nXn; R22\nXi; R36/37/38\nN; R51-53\nXn; N\nR: 22-36/37/38-51/53-62\nS: (2-)26-36/37/39-61\n\n\n612-150-00-X\nspiroxamine (ISO);\n8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine\n—\n118134-30-8\nXn; R20/21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 20/21/22-38-43-50/53\nS: (2-)36/37/39-46-60-61\n\n\n\n\n612-151-00-5\nmethyl-phenylene diamine;\ndiaminotoluene;\n[technical product – reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]\n—\n—\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nRepr. Cat. 3; R62\nT; R25\nXn; R21-48/22\nXi; R36\nR43\nN; R51-53\nT; N\nR: 45-21-25-36-43-48/22-62-68-51/53\nS: 53-45-61\n\nE\n\n612-152-00-0\nN,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine\n406-610-7\n62478-82-4\nR10\nXn; R20/22-48/20\nC; R35\nR52-53\nC\nR: 10-20/22-35-48/20-52/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n612-153-00-6\n4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride\n407-020-2\n132885-85-9\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-24-37-61\n\n\n612-154-00-1\n6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]\n410-890-6\n95235-29-3\nR53\nR: 53\nS: 61\n\n\n612-155-00-7\n2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene\n411-730-8\n93071-94-4\nR53\nR: 53\nS: 61\n\n\n612-156-00-2\nreaction mass of: trihexadecylmethylammonium chloride;\ndihexadecyldimethylammonium chloride\n405-620-9\n—\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n612-157-00-8\n(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride\n410-780-8\n—\nXn; R22-48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-158-00-3\nreaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;\n4-dodecylsalicylaldoxime\n410-820-4\n—\nR53\nR: 53\nS: 61\n\n\n612-159-00-9\nReaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid\n410-880-1\n—\nXn; R22\nC; R34\nN; R50-53\nC; N\nR: 22-34-50/53\nS: (1/2-)23-26-36/37/39-45-60-61\n\n\n612-160-00-4\np-toluidine;\n4-aminotoluene; [1]\ntoluidinium chloride; [2]\ntoluidine sulphate (1:1) [3]\n203-403-1 [1]\n208-740-8 [2]\n208-741-3 [3]\n106-49-0 [1]\n540-23-8 [2]\n540-25-0 [3]\nCarc. Cat. 3; R40\nT; R23/24/25\nXi; R36\nR43\nN; R50\nT; N\nR: 23/24/25-36-40-43-50\nS: (1/2-)28-36/37-45-61\n\n\n612-161-00-X\n2,6-xylidine;\n2,6-dimethylaniline\n201-758-7\n87-62-7\nCarc. Cat. 3; R40\nXn; R20/21/22\nXi; R37/38\nN; R51-53\nXn; N\nR: 20/21/22-37/38-40-51/53\nS: (2-)23-25-36/37-61\n\n\n612-162-00-5\ndimethyldioctadecylammonium chloride;\nDODMAC\n203-508-2\n107-64-2\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)24-26-39-46-60-61\n\n\n612-163-00-0\nmetalaxyl-M (ISO);\nmefenoxam;\n(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester\n—\n70630-17-0\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)26-39-46\n\n\n612-164-00-6\n2-butyl-2-ethyl-1,5-diaminopentane\n412-700-7\n137605-95-9\nXn; R21/22-48/22\nC; R34\nR43\nR52-53\nC\nR: 21/22-34-43-48/22-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-165-00-1\nN,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine\n413-810-8\n65181-78-4\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-166-00-7\nreaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);\ntrans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)\n411-830-1\n114765-88-7\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n612-167-00-2\n5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride\n410-490-1\n—\nXn; R22-48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-168-00-8\n3,5-dichloro-2,6-difluoropyrdine-4-amine\n220-630-1\n2840-00-8\nXn; R21/22\nN; R51-53\nXn; N\nR: 21/22-51/53\nS: (2-)36/37-61\n\n\n\n\n612-169-00-3\nbis(N-methyl-N-phenylhydrazine)sulfate\n423-170-1\n618-26-8\nF; R11\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R50-53\nF; T; N\nR: 11-22-41-43-48/25-50/53\nS: (1/2-)22-26-33-36/37/39-45-60-61\n\n\n\n\n612-170-00-9\n4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime\n405-260-2\n—\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n612-171-00-4\nN,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane\n410-060-3\n130728-76-6\nMuta. Cat. 3; R68\nR43\nN; R51-53\nXn; N\nR: 43-68-51/53\nS: (2-)36/37-61\n\n\n612-172-00-X\n4,4'-methylenebis(N,N'-dimethylcyclohexanamine\n412-840-9\n13474-64-1\nXn; R22-48/22\nC; R35\nR52-53\nC\nR: 22-35-48/22-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-173-00-5\nlithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate\n411-140-0\n125328-86-1\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)22-26-36/37/39-61\n\n\n612-174-00-0\n4,4-dimethoxybutylamine\n407-690-6\n19060-15-2\nXn; R22\nC; R34\nR43\nR52-53\nC\nR: 22-34-43-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n612-175-00-6\n2-(O-aminooxy)ethylamine dihydrochloride\n412-310-7\n37866-45-8\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n612-176-00-1\nPolymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine\n410-570-6\n143747-73-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n612-177-00-7\n2-naphthylamino-6-sulfomethylamide\n412-120-4\n104295-55-8\nXn; R48/22\nR43\nN; R51-53\nXn; N\nR: 43-48/22-51/53\nS: (2-)22-36/37-61\n\n\n612-178-00-2\n1,4,7,10-tetraazacyclododecane disulfate\n412-080-8\n112193-77-8\nXn; R22\nXi; R37-41\nR52-53\nXn\nR: 22-37-41-52/53\nS: (2-)26-36/37/39-61\n\n\n612-179-00-8\n1-(2-propenyl)pyridinium chloride\n412-740-5\n25965-81-5\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\n\n\n612-180-00-3\n3-aminobenzylamine\n412-230-2\n4403-70-7\nXn; R22\nC; R34\nN; R51-53\nC; N\nR: 22-34-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n612-181-00-9\n2-phenylthioaniline\n413-030-8\n1134-94-7\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n612-182-00-4\n1-ethyl-1-methylmorpholinium bromide\n418-210-1\n65756-41-4\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)36/37\n\n\n612-183-00-X\n1-ethyl-1-methylpyrrolidinium bromide\n418-200-5\n69227-51-6\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)36/37\n\n\n612-184-00-5\n6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one\n403-830-5\n89331-94-2\nR52-53\nR: 52/53\nS: 61\n\n\n612-185-00-0\n1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide\n407-400-8\n59493-72-0\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n612-186-00-6\nbis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate\n406-770-8\n149057-64-7\nXn; R48/22\nXi; R41\nR43\nN; R50-53\nXn; N\nR: 41-43-48/22-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n612-187-00-1\n2,3,4-trifluoroaniline\n407-170-9\n3862-73-5\nXn; R21/22-48/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-48/22-51/53\nS: (2-)23-26-36/37/39-61\n\n\n612-188-00-7\n4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)\n407-560-9\n107934-68-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n612-189-00-2\n4-amino-2-(aminomethyl)phenol dihydrochloride\n412-510-4\n135043-64-0\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n612-190-00-8\n4,4'-methylenebis(2-isopropyl-6-methylaniline)\n415-150-6\n16298-38-7\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36-61\n\n\n612-191-00-3\nPolymer of allylamine hydrochloride\n415-050-2\n71550-12-4\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)36/37\n\n\n612-192-00-9\n2-isopropyl-4-(N-methyl)aminomethylthiazole\n414-800-6\n154212-60-9\nXn; R21/22\nXi; R38-41\nN; R51-53\nXn; N\nR: 21/22-38-41-51/53\nS: (2-)26-36/37/39-61\n\n\n612-193-00-4\n3-methylaminomethylphenylamine\n414-570-7\n18759-96-1\nXn; R21/22\nC; R34\nR43\nN; R50-53\nC; N\nR: 21/22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n612-194-00-X\n2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride\n414-670-0\n141890-30-4\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)26-39-60-61\n\n\n612-195-00-5\nbis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate\n415-210-1\n160236-81-7\nXn; R20/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-50/53\nS: (2-)26-36/39-60-61\n\n\n612-196-00-0\n4-chloro-o-toluidine; [1]\n4-chloro-o-toluidine hydrochloride [2]\n202-441-6 [1]\n221-627-8 [2]\n95-69-2 [1]\n3165-93-3 [2]\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT; R23/24/25\nN; R50-53\nT; N\nR: 45-23/24/25-68-50/53\nS: 53-45-60-61\n\nE\n612-197-00-6\n2,4,5-trimethylaniline; [1]\n2,4,5-trimethylaniline hydrochloride [2]\n205-282-0 [1]\n[2]\n137-17-7 [1]\n21436-97-5 [2]\nCarc. Cat. 2; R45\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-23/24/25-51/53\nS: 53-45-61\n\nE\n612-198-00-1\n4,4'-thiodianiline and its salts\n205-370-9\n139-65-1\nCarc. Cat. 2; R45\nXn; R22\nN; R51-53\nT; N\nR: 45-22-51/53\nS: 53-45-61\n\nE\n612-199-00-7\n4,4'-oxydianiline and its salts;\np-aminophenyl ether\n202-977-0\n101-80-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT; R23/24/25\nN; R51-53\nT; N\nR: 45-46-23/24/25-62-51/53\nS: 53-45-61\n\nE\n612-200-00-0\n2,4-diaminoanisole;\n4-methoxy-m-phenylenediamine; [1]\n2,4-diaminoanisole sulphate [2]\n210-406-1 [1]\n254-323-9 [2]\n615-05-4 [1]\n39156-41-7 [2]\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R22\nN; R51-53\nT; N\nR: 45-22-68-51/53\nS: 53-45-61\n\nE\n612-201-00-6\nN,N,N',N'-tetramethyl-4,4'-methylendianiline\n202-959-2\n101-61-1\nCarc. Cat. 2; R45\nN; R50-53\nT; N\nR: 45-50/53\nS: 53-45-60-61\n\n\n612-202-00-1\n3,4-dichloroaniline\n202-448-4\n95-76-1\nT; R23/24/25\nXi; R41\nR43\nN; R50-53\nT; N\nR: 23/24/25-41-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n\n612-203-00-7\nC8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %-85 %, chain > C10: <3 %)\n417-360-3\n-\nXn; R21/22\nXi; R38\nXn\nR: 21/22-38\nS: (2-)25-36/37\n\n\n\n612-204-00-2\nC.I. Basic Violet 3;\n4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride\n208-953-6\n548-62-9\nCarc. Cat. 3; R40\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-40-41-50/53\nS: (2-)26-36/37/39-46-60-61\n\n\n612-205-00-8\nC.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5)\n208-953-6\n548-62-9\nCarc. Cat. 2; R45\nXn; R22\nXi; R41\nN; R50-53\nT; N\nR: 45-22-41-50/53\nS: 53-45-60-61\n\nE\n612-206-00-3\nfamoxadone (ISO);\n3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione\n—\n131807-57-3\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)46-60-61\n\n\n612-207-00-9\n4-ethoxyaniline;\np-phenetidine\n205-855-5\n156-43-4\nMuta. Cat. 3; R68\nXn; R20/21/22\nXi; R36\nR43\nXn\nR: 20/21/22-36-43-68\nS: (2-)36/37-46\n\n\n\n\n612-208-00-4\nN-methylbenzene-1,2-diammonium hydrogen phosphate\n424-460-0\n-\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)22-25-36/37-61\n\n\n\n612-209-00-X\n6-methoxy-m-toluidine;\np-cresidine\n204-419-1\n120-71-8\nCarc. Cat. 2; R45\nXn; R22\nT\nR: 45-22\nS: 53-45\n\nE\n612-210-00-5\n5-nitro-o-toluidine; [1]\n5-nitro-o-toluidine hydrochloride [2]\n202-765-8 [1]\n256-960-8 [2]\n99-55-8 [1]\n51085-52-0 [2]\nCarc. Cat. 3; R40\nT; R23/24/25\nR52-53\nT\nR: 23/24/25-40-52/53\nS: (1/2-)36/37-45-61\n\n\n612-211-00-0\nN-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide\n416-470-9\n170292-97-4\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n612-212-00-6\n2,6-dichloro-4-trifluoromethylaniline\n416-430-0\n24279-39-8\nXn; R20/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 20/22-38-43-50/53\nS: (2-)24-37-60-61\n\n\n612-213-00-1\nisobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine\n419-850-2\n148348-13-4\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n612-214-00-7\n4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine\n421-390-2\n89114-90-9\nR53\nR: 53\nS: 61\n\n\n612-215-00-2\n3-chloro-2-(isopropylthio)aniline\n421-700-6\n179104-32-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n\n\n612-216-00-8\n1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt\n425-870-2\n19450-38-5\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n612-217-00-3\n1-methoxy-2-propylamine\n422-550-4\n37143-54-7\nF; R11\nC; R34\nXn; R22\nR52-53\nF; C\nR: 11-22-34-52/53\nS: (1/2-)9-26-36/37/39-45-61\n\n\n\n\n612-219-00-4\n(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride\n402-200-7\n-\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-220-00-X\nN-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine\n431-060-1\n153719-38-1\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-24-37-61\n\n\n\n612-221-00-5\n2-amino-4-(trifluoromethyl)benzenethiol hydrochloride\n429-560-8\n4274-38-8\nC; R34\nXn; R20/21/22-48/22\nR43\nN; R50\nC; N\nR: 20/21/22-34-43-48/22-50\nS: (1/2-)26-36/37/39-45-61\n\n\n\n612-222-00-0\ncis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine\n425-080-8\n104860-26-6\nXn; R21/22-48/22\nXi; R41\nN; R50-53\nXn; N\nR: 21/22-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n\n612-223-00-6\nN-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine\n425-300-2\n186450-73-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n\n612-224-00-1\nN2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine\n426-150-0\n121246-28-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n\n612-225-00-7\n1,4,7,10-tetraazacyclododecane\n425-450-9\n294-90-6\nC; R34\nXn; R21/22\nN; R50-53\nC; N\nR: 21/22-34-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\n\n\n\n612-226-00-2\n3-(2'-phenoxyethoxy)propylamine\n427-870-8\n6903-18-0\nXn; R22\nXi; R38-41\nR52-53\nXn\nR: 22-38-41-52/53\nS: (2-)23-26-37/39-61\n\n\n\n612-227-00-8\nbenzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride\n428-290-8\n120606-08-8\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)22-26-39-60-61\n\n\n\n612-228-00-3\nreaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;\nN-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;\nN,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine\n414-340-6\n-\nR10\nXn; R20/21/22-68/20/21/22\nXi; R41\nR43\nR52-53\nXn\nR: 10-20/21/22-41-43-68/20/21/22-52/53\nS: (2-)26-36/37/39-61\n\n\n\n612-229-00-9\nmepanipyrim;\n4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine\n-\n110235-47-7\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-46-60-61\n\n\n\n612-230-00-4\nN,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide\n431-530-4\n-\nC; R35\nR43\nN; R50-53\nC; N\nR: 35-43-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n\n612-231-00-X\n3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride\n427-370-1\n164288-56-6\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n\n612-232-00-5\nreaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;\ntriisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid\n430-410-9\n186148-38-9\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-237-00-2\nhydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]\n233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]\n10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]\nE; R2\nCarc. Cat. 3; R40\nXn; R21/22-48/22\nXi; R36/38\nR43\nN; R50\nE; Xn; N\nR: 2-21/22-36/38-40-43-48/22-50\nS: (2-)36/37-61\n\nT\n\n612-238-00-8\n(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%\n222-048-3\n3327-22-8\nCarc. Cat. 3, R40\nR52-53\nXn\nR: 40-52/53\nS: 36/37-61\n\nB\n\n612-239-00-3\nbiphenyl-3,3', 4,4'-tetrayltetraamine;\ndiaminobenzidine\n202-110-6\n91-95-2\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nT\nR: 45-68\nS: 53-45\n\n\n\n612-240-00-9\npyrimethanil (ISO);\nN-(4,6-dimethylpyrimidin-2-yl)aniline\n-\n53112-28-0\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n612-241-00-4\npiperazine hydrochloride; [1]\npiperazine dihydrochloride; [2]\npiperazine phosphate [3]\n228-042-7 [1]\n205-551-2 [2]\n217-775-8 [3]\n6094-40-2 [1]\n142-64-3 [2]\n1951-97-9 [3]\nRepr. Cat. 3; R62-63\nXi; R36/38\nR42/43\nR52-53\nXn\nR: 36/38-42/43-62-63-52/53\nS: (1/2-)22-36/37-45-63-61\n\n\n\n612-242-00-X\ncyprodinil (ISO);\n4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine\n-\n121552-61-2\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-243-00-5\n(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate\n420-560-3\n79617-97-3\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-244-00-0\n3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride\n421-310-6\n87691-88-1\nRepr. Cat. 3; R62\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-62-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n\n612-245-00-6\n2-ethylphenylhydrazine hydrochloride\n421-460-2\n19398-06-2\nCarc. Cat. 3; R40\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 22-40-41-43-48/25-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-246-00-1\n(2-chloroethyl)(3-hydroxypropyl)ammonium chloride\n429-740-6\n40722-80-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R48/22\nR43\nR52-53\nT\nR: 45-46-43-48/22-52/53\nS: 53-45-61\n\nE\n\n612-247-00-7\nN-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide\n423-530-8\n152828-23-4\nT; R48/25\nXn; R22\nR52-53\nT\nR: 22-48/25-52/53\nS: (1/2-)22-36-45-61\n\n\n\n612-248-00-2\nreaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)\n439-540-0\n-\nXi; R38\nR43\nR53\nXi\nR: 38-43-53\nS: (2-)24-37-61\n\n\n\n612-249-00-8\n4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride\n425-030-5\n159939-85-2\nRepr. Cat. 3; R62\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-62-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n612-250-00-3\nchloro-N,N-dimethylformiminium chloride\n425-970-6\n3724-43-4\nR14\nRepr. Cat. 2; R61\nXn; R22\nC; R35\nT; C\nR: 61-14-22-35\nS: 53-45\n\nE\n\n612-251-00-9\ncis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride\n426-020-3\n51229-78-8\nF; R11\nRepr. Cat. 3; R63\nXn; R22\nXi; R38\nR43\nN; R51-53\nF; Xn; N\nR: 11-22-38-43-63-51/53\nS: (2-)7-22-33-36/37-61\n\n\n\n612-252-00-4\nimidacloprid (ISO);\n1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine\n428-040-8\n138261-41-3\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-57-60-61\n\n\n\n612-253-00-X\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing < 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nR52-53\nR: R52/53\nS: 61\n\n\n\n612-253-01-7\n7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;\n[containing ≥ 0,5 % formamide (EC No 200-842-0)]\n429-400-7\n199327-61-2\nRepr. Cat. 2; R61\nR52-53\nT\nR: 61-52/53\nS: 53-45-61\n\n\n\n612-254-00-5\nreaction products of diisopropanolamine with formaldehyde (1:4)\n432-440-8\n220444-73-5\nCarc. Cat. 3; R40\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-40-43-51/53\nS: (1/2-)13-25-26-36/37/39-45-61\n\n\n\n612-255-00-0\n1-(3-methoxypropyl)-4-piperidinamine\n431-950-8\n179474-79-4\nXn; R21/22\nC; R34\nR52-53\nC\nR: 21/22-34-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n612-256-00-6\nbenzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate\n427-470-3\n137864-22-3\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)36/37\n\n\n\n612-257-00-1\ntripropylammonium dihydrogenphosphate\n433-700-3\n35687-90-2\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n\n612-259-00-2\nN-ethyl-3-trimethoxysilyl-2-methyl-propanamine\n437-720-3\n227085-51-0\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n612-261-00-3\n3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline\n441-190-9\n121451-05-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-265-00-5\nbis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate\n444-360-0\n191617-13-7\nR52-53\nR: 52/53\nS: 61\n\n\n\n612-266-00-0\n3-chloro-4-(3-fluorobenzyloxy)aniline\n445-590-4\n202197-26-0\nMuta. Cat. 3; R68\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-68-50/53\nS: (2-)22-36/37-60-61\n\n\n\n612-267-00-6\nbis(hydrogenated tallow C16-18-alkyl)hydroxylamine\n418-370-0\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)36/37-61\n\n\n\n612-269-00-7\nreaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;\n1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;\nreaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;\nN-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline\n420-720-2\n-\nR53\nR: 53\nS: 22-61\n\n\n\n612-270-00-2\n(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride\n433-010-2\n-\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-52/53\nS: (2-)22-36/37-61\n\n\n\n612-271-00-8\nreaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;\nethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate\n434-970-5\n160987-57-5\nR53\nR: 53\nS: 61\n\n\n\n612-272-00-3\nammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate\n435-210-5\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n612-273-00-9\nalkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride\n435-650-8\n-\nXn; R22\nC; R35\nN; R50-53\nC; N\nR: 22-35-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n612-274-00-4\n(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate\n445-750-3\n-\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)22-24-26-37/39-61\n\n\n\n612-275-00-X\nfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil\n447-880-6\n206565-89-1\nXi; R38-41\nR43\nN; R50-53\nXi; N\nR: 38-41-43-50/53\nS: (2-)23-26-36/37/39-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n612-276-00-5\n1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts\n451-430-4\n500717-36-2\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)22-24-26-36/37/39-61\n\n\n\n612-277-00-0\nreaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;\n4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium\n451-440-9\n586372-44-3\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n612-278-00-6\nethidium bromide;\n3,8-diamino-1-ethyl-6-phenylphenantridinium bromide\n214-984-6\n1239-45-8\nMuta. Cat. 3; R68\nT+; R26\nXn; R22\nT+\nR: 22-26-68\nS: (1/2-)28-36/37-45-63\n\n\n\n612-279-00-1\n(R, S)-2-amino-3,3-dimethylbutane amide\n447-860-7\n144177-62-8\nRepr. Cat. 3; R62\nXn; R48/22\nXi; R36/38\nR43\nXn\nR: 36/38-43-48/22-62\nS: (2-)22-26-36/37\n\n\n\n612-280-00-7\n3-amino-9-ethyl carbazole;\n9-ethylcarbazol-3-ylamine\n205-057-7\n132-32-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n612-281-00-2\nleucomalachite green\nN,N,N',N'-tetramethyl-4,4'-benzylidenedianiline\n204-961-9\n129-73-7\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nXn\nR: 40-68\nS: (2-)36/37\n\n\n\n613-001-00-1\nethyleneimine;\naziridine\n205-793-9\n151-56-4\nF; R11\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT+; R26/27/28\nC; R34\nN; R51-53\nF; T+; N\nR: 45-46-11-26/27/28-34-51/53\nS: 53-45-61\n\nD E\n613-002-00-7\npyridine\n203-809-9\n110-86-1\nF; R11\nXn; R20/21/22\nF; Xn\nR: 11-20/21/22\nS: (2-)26-28\nXn; R20/21/22: C ≥ 5 %\n\n\n\n613-003-00-2\n1,2,3,4-tetranitrocarbazole\n—\n6202-15-9\nE; R2\nXn; R20/21/22\nE; Xn\nR: 2-20/21/22\nS: (2-)35-36/37\n\n\n\n613-004-00-8\ncrimidine (ISO);\n2-chloro-6-methylpyrimidin-4-yldimethylamine\n208-622-6\n535-89-7\nT+; R28\nT+\nR: 28\nS: (1/2-)36/37-45\n\n\n613-007-00-4\ndesmetryne (ISO);\n6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine\n213-800-1\n1014-69-3\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n613-008-00-X\ndazomet (ISO);\ntetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione\n208-576-7\n533-74-4\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)15-22-24-60-61\n\n\n613-009-00-5\n2,4,6-trichloro-1,3,5-triazine;\ncyanuric chloride\n203-614-9\n108-77-0\nR14\nT+; R26\nXn; R22\nC; R34\nR43\nT+;\nR: 14-22-26-34-43\nS: (1/2-)26-28-36/37/39-45-46-63\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n\n613-010-00-0\nametryn (ISO);\nN-ethyl-N′-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine\n212-634-7\n834-12-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)36-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n\n613-011-00-6\namitrole (ISO);\n1,2,4-triazol-3-ylamine\n200-521-5\n61-82-5\nRepr. Cat. 3; R63\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-63-51/53\nS: (2-)13-36/37-61\n\n\n613-012-00-1\nbentazone (ISO);\n3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide\n246-585-8\n25057-89-0\nXn; R22\nXi; R36\nR43\nR52-53\nXn\nR: 22-36-43-52/53\nS: (2-)24-37-61\n\n\n613-013-00-7\ncyanazine (ISO);\n2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile\n244-544-9\n21725-46-2\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)37-60-61\n\n\n613-014-00-2\nethoxyquin (ISO);\n6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline\n202-075-7\n91-53-2\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n613-015-00-8\nfenazaflor (ISO);\nphenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate\n238-134-9\n14255-88-0\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n\n613-016-00-3\nfuberidazole (ISO);\n2-(2-furyl)-1H-benzimidazole\n223-404-0\n3878-19-1\nCarc. Cat. 3; R40\nXn; R48/22\nXn; R22\nXi; R43\nN; R50-53\nXn; N\nR: 40-48/22-22-43-50/53\nS: (2)-22-36/37-60-61\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %\n\n\n613-017-00-9\nbis (8-hydroxyquinolinium) sulphate\n205-137-1\n134-31-6\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n613-018-00-4\nmorfamquat (ISO);\n1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion\n—\n7411-47-4\nXn; R22\nXi; R36/37/38\nR52-53\nXn\nR: 22-36/37/38-52/53\nS: (2-)22-36-61\n\n\n613-019-00-X\nthioquinox (ISO);\n2-thio-1,3-dithiolo(4,5,b)quinoxaline\n202-272-8\n93-75-4\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n613-020-00-5\ntridemorph (ISO);\n2,6-dimethyl-4-tridecylmorpholine\n246-347-3\n24602-86-6\nRepr. Cat. 2; R61\nXn; R20/22\nXi; R38\nN; R50-53\nT; N\nR: 61-20/22-38-50/53\nS: 53-45-60-61\n\nE\n613-021-00-0\ndithianon (ISO);\n5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile\n222-098-6\n3347-22-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24-60-61\n\n\n613-022-00-6\npyrethrins including cinerins, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\nA\n613-023-00-1\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;\npyrethrin I\n204-455-8\n121-21-1\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\n\n613-024-00-7\n2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;\npyrethrin II\n204-462-6\n121-29-9\nXn; R20/21/22\nN; R50-53\nXn; N\nR: 20/21/22-50/53\nS: (2-)13-60-61\n\n\n613-025-00-2\ncinerin I;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate\n246-948-0\n25402-06-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-026-00-8\ncinerin II;\n3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate\n204-454-2\n121-20-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-027-00-3\npiperidine\n203-813-0\n110-89-4\nF; R11\nT; R23/24\nC; R34\nF; T\nR: 11-23/24-34\nS: (1/2-)16-26-27-45\nT; R23/24: C ≥ 5 %\nXn; R20/21: 1 % ≤ C < 5 %\nC; R34: C ≥ 5 %\nXi: R36/38: 1 % ≤ C < 5 %\n\n613-028-00-9\nmorpholine\n203-815-1\n110-91-8\nR10\nXn; R20/21/22\nC; R34\nC\nR: 10-20/21/22-34\nS: (1/2-)23-36-45\nC; R34: C ≥ 10 %\nXi; R36/38: 1 % ≤ C < 10 %\n\n613-029-00-4\ndichloro-1,3,5-triazinetrione;\ndichloroisocyanuric acid\n220-487-5\n2782-57-2\nO; R8\nXn; R22\nR31\nXi; R36/37\nN; R50-53\nO; Xn; N\nR: 8-22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n\n\n613-030-00-X\ntroclosene potassium; [1]\ntroclosene sodium [2]\n218-828-8 [1]\n220-767-7 [2]\n2244-21-5 [1]\n2893-78-9 [2]\nE; R2\nO; R8\nXn; R22\nXi; R36/37\nR31\nN; R50-53\nE; Xn; N\nR: 2-8-22-31-36/37-50/53\nS: (2-)8-26-41-45-60-61\nXn; R22: C ≥ 10 %\nXi; R36/37: C ≥ 10 %\nR31: C ≥ 10 %\nT\n\n613-030-01-7\ntroclosene sodium, dihydrate\n220-767-7\n51580-86-0\nXn; R22\nR31\nXi; R36/37\nN; R50-53\nXn; N\nR: 22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n613-031-00-5\nsymclosene;\ntrichloroisocyanuric acid;\ntrichloro-1,3,5-triazinetrion\n201-782-8\n87-90-1\nO; R8\nXn; R22\nXi; R36/37\nR31\nN; R50-53\nO; Xn; N\nR: 8-22-31-36/37-50/53\nS: (2-)8-26-41-60-61\n\n\n613-032-00-0\nmethyl-2,3,5,6-tetrachloro-4-pyridylsulphone;\n2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine\n236-035-5\n13108-52-6\nXn; R21/22\nXi; R36\nR43\nXn\nR: 21/22-36-43\nS: (2-)26-28\n\n\n613-033-00-6\n2-methylaziridine;\npropyleneimine\n200-878-7\n75-55-8\nF; R11\nCarc. Cat. 2; R45\nT+; R26/27/28\nXi; R41\nN; R51-53\nF; T+; N\nR: 45-11-26/27/28-41-51/53\nS: 53-45-61\nCarc. Cat. 2; R45: C ≥ 0,01 %\nE\n613-034-00-1\n1,2-dimethylimidazole\n217-101-2\n1739-84-0\nXn; R22\nXi; R38-41\nXn\nR: 22-38-41\nS: (2-)24-26\n\n\n613-035-00-7\n1-methylimidazole\n210-484-7\n616-47-7\nXn; R21/22\nC; R34\nC\nR: 21/22-34\nS: (1/2-)26-36-45\n\n\n613-036-00-2\n2-methylpyridine;\n2-picoline\n203-643-7\n109-06-8\nR10\nXn; R20/21/22\nXi; R36/37\nXn\nR: 10-20/21/22-36/37\nS: (2-)26-36\n\n\n613-037-00-8\n4-methylpyridine;\n4-picoline\n203-626-4\n108-89-4\nR10\nT; R24\nXn; R20/22\nXi; R36/37/38\nT\nR: 10-20/22-24-36/37/38\nS: (1/2-)26-36-45\n\n\n613-038-00-3\n6-phenyl-1,3,5-triazine-2,4-diyldiamine;\n6-phenyl-1,3,5-triazine-2,4-diamine;\nbenzoguanamine\n202-095-6\n91-76-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-039-00-9\nethylene thiourea;\nimidazolidine-2-thione;\n2-imidazoline-2-thiol\n202-506-9\n96-45-7\nRepr. Cat. 2; R61\nXn; R22\nT\nR: 61-22\nS: 53-45\n\nE\n613-040-00-4\nazaconazole (ISO);\n1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole\n262-102-3\n60207-31-0\nXn; R22\nXn\nR: 22\nS: (2-)46\n\n\n613-041-00-X\nmorpholine-4-carbonyl chloride\n239-213-0\n15159-40-7\nR14\nCarc. Cat. 3; R40\nXi; R36/38\nXn\nR: 14-36/38-40\nS: (2-)26-30-36-38\n\n\n613-042-00-5\nimazalil (ISO);\n1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole\n252-615-0\n35554-44-0\nXn; R20/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-50/53\nS: (2-)26-39-60-61\n\n\n613-043-00-0\nimazalil sulphate (ISO) powder;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24/25-37-46-60-61\n\n\n613-043-01-8\nimazalil sulphate (ISO), aqueous solution;\n1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]\n(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]\n261-351-5 [1]\n281-291-3 [2]\n58594-72-2 [1]\n83918-57-4 [2]\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (2-)26-36/37/39-45-60-61\nC; R34: C ≥ 50 %\nXi; R38: 30 % ≤ C < 50 %\nXi; R41: 15 % ≤ C < 50 %\nXi; R36: 5 % ≤ C < 15 %\n\n\n\n613-044-00-6\ncaptan (ISO);\n1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide\n205-087-0\n133-06-2\nCarc. Cat. 3; R40\nT; R23\nXi; R41\nR43\nN; R50\nT; N\nR: 23-40-41-43-50\nS: (1/2-)26-29-36/37/39-45-61\nN; R50: C ≥ 2,5 %\n\n\n613-045-00-1\nfolpet (ISO);\nN-(trichloromethylthio)phthalimide\n205-088-6\n133-07-3\nCarc. Cat. 3; R40\nXn; R20\nXi; R36\nR43\nN; R50\nXn; N\nR: 20-36-40-43-50\nS: (2-)36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n613-046-00-7\ncaptafol (ISO);\n1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide\n219-363-3\n2425-06-1\nCarc. Cat. 2; R45\nR43\nN; R50-53\nT; N\nR: 45-43-50/53\nS: 53-45-60-61\n\n\n613-047-00-2\n1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;\ndimetilan (ISO)\n211-420-0\n644-64-4\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n613-048-00-8\ncarbendazim (ISO);\nmethyl benzimidazol-2-ylcarbamate\n234-232-0\n10605-21-7\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nN; R50-53\nT; N\nR: 46-60-61-50/53\nS: 53-45-60-61\n\n\n613-049-00-3\nbenomyl (ISO);\nmethyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate\n241-775-7\n17804-35-2\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nXi; R37/38\nR43\nN; R50-53\nT; N\nR: 46-60-61-37/38-43-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n613-050-00-9\ncarbadox (INN);\nmethyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;\n2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide\n229-879-0\n6804-07-5\nF; R11\nCarc. Cat. 2; R45\nXn; R22\nF; T\nR: 45-11-22\nS: 53-45\n\nE\n613-051-00-4\nmolinate (ISO);\nS-ethyl 1-perhydroazepinecarbothioate;\nS-ethyl perhydroazepine-1-carbothioate\n218-661-0\n2212-67-1\nCarc. Cat. 3; R40\nRepr. Cat. 3; R62\nXn; R20/2248/22\nR43\nN; R50-53\nXn; N\nR: 20/22-40-43-48/22-62-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n613-052-00-X\ntrifenmorph (ISO);\n4-tritylmorpholine\n215-812-2\n1420-06-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-053-00-5\nanilazine (ISO);\n2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline\n202-910-5\n101-05-3\nXi; R36/38\nN; R50-53\nXi; N\nR: 36/38-50/53\nS: (2-)22-60-61\n\n\n613-054-00-0\nthiabendazol (ISO);\n2-(thiazole-4-yl)benzimidazole\n205-725-8\n148-79-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-056-00-1\n1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;\ndifenzoquat methyl sulfate\n256-152-5\n43222-48-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-057-00-7\ndodemorph (ISO);\n4-cyclododecyl-2,6-dimethylmorpholine\n216-474-9\n1593-77-7\nXi; R36/37/38\nN; R51-53\nXi; N\nR: 36/37/38-51/53\nS: (2-)26-61\n\n\n613-058-00-2\npermethrin (ISO);\nm-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate\n258-067-9\n52645-53-1\nXn; R20/22\nR43\nN; R50-53\nXn; N\nR: 20/22-43-50/53\nS: (2-)13-24-36/37/39-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n613-059-00-8\nprofluralin (ISO);\nN-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine\n247-656-6\n26399-36-0\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)60-61\n\n\n\n\n613-060-00-3\nresmethrin (ISO);\n5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate\n233-940-7\n10453-86-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-061-00-9\n6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;\nryania\n239-732-2\n15662-33-6\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n613-062-00-4\nsabadilla (ISO);\nveratrine\n—\n8051-02-3\nXi; R36/37/38\nXi\nR: 36/37/38\nS: (2-)36/37/39\n\n\n613-063-00-X\nsecbumeton (ISO);\n2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n247-554-1\n26259-45-0\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)60-61\n\n\n613-064-00-5\n5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;\nsesamex\n—\n51-14-9\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-065-00-0\nsimetryn (ISO);\n2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine\n213-801-7\n1014-70-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-066-00-6\nterbumeton (ISO);\n2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine\n251-637-8\n33693-04-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-067-00-1\npropazine (ISO);\n2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine\n205-359-9\n139-40-2\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n613-068-00-7\natrazine (ISO);\n2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine\n217-617-8\n1912-24-9\nXn; R48/22\nR43\nN; R50-53\nXn; N\nR: 43-48/22-50/53\nS: (2-)36/37-60-61\n\n\n613-069-00-2\nε-caprolactam\n203-313-2\n105-60-2\nXn; R20/22\nXi; R36/37/38\nXn\nR: 20/22-36/37/38\nS: (2-)\n\n\n613-070-00-8\npropylenethiourea\n—\n2122-19-2\nRepr. Cat. 3; R63\nXn; R22\nR52-53\nXn\nR: 22-52/53-63\nS: (2-)36/37-46-61\n\n\n613-071-00-3\n2-fluoro-5-trifluoromethylpyridine\n400-290-2\n69045-82-5\nR10\nR43\nR52-53\nXi\nR: 10-43-52/53\nS: (2-)24-37-61\n\n\n613-072-00-9\nN,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine\n401-280-0\n91273-04-0\nC; R34\nR43\nN; R51-53\nC; N\nR: 34-43-51/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n613-073-00-4\nN,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine\n401-410-6\n10357-99-0\nXn; R48/22\nR43\nN; R51-53\nXn; N\nR: 43-48/22-51/53\nS: (2-)24-37-61\n\n\n613-074-00-X\n3-(3-methylpent-3-yl)isoxazol-5-ylamine\n401-460-9\n82560-06-3\nT; R23/25\nXi; R41\nR52-53\nT\nR: 23/25-41-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n613-075-00-5\n1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione\n401-570-7\n89415-87-2\nO; R8\nT; R23\nC; R34\nXn; R22\nR43\nN; R50\nO; T; N\nR: 8-22-23-34-43-50\nS: (1/2-)8-26-36/37/39-45-61\n\n\n613-076-00-0\n3-chloro-5-trifluoromethyl-2-pyridylamine\n401-670-0\n79456-26-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-077-00-6\nreaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine\n401-940-8\n—\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53\nS: (2-)22-26-61\n\n\n613-078-00-1\nN,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine\n401-990-0\n106990-43-6\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n613-079-00-7\n4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers\n402-520-7\n—\nXn; R21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 21/22-38-43-50/53\nS: (2-)36/37-60-61\n\n\n613-080-00-2\n3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione\n402-540-6\n105254-85-1\nC; R34\nR43\nN; R50-53\nC; N\nR: 34-43-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n613-081-00-8\n1-butyl-2-methylpyridinium bromide\n402-680-8\n26576-84-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-082-00-3\n2-methyl-1-pentylpyridinium bromide\n402-690-2\n—\nXn; R21/22\nR52-53\nXn\nR: 21/22-52/53\nS: (2-)36/37-61\n\n\n613-083-00-9\n2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate\n402-120-2\n—\nC; R34\nXn; R48/22\nR43\nN; R50-53\nC; N\nR: 34-43-48/22-50/53\nS: (1/2-)24-26-28-37/39-45-60-61\n\n\n613-084-00-4\n2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate\n402-490-5\n106359-93-7\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)26-60-61\n\n\n613-085-00-X\nreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione\n401-970-1\n—\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-086-00-5\ncaffeine\n200-362-1\n58-08-2\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-087-00-0\ntetrahydrothiophene\n203-728-9\n110-01-0\nF; R11\nXn; R20/21/22\nXi; R36/38\nR52-53\nF; Xn\nR: 11-20/21/22-36/38-52/53\nS: (2-)16-23-36/37-61\n\n\n613-088-00-6\n1,2-benzisothiazol-3(2H)-one;\n1,2-benzisothiazolin-3-one\n220-120-9\n2634-33-5\nXn; R22\nXi; R38-41\nR43\nN; R50\nXn; N\nR: 22-38-41-43-50\nS: (2-)24-26-37/39-61\nR43: C ≥ 0,05 %\n\n613-089-00-1\ndiquat dibromide; [1]\ndiquat dichloride; [2]\n6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]\n201-579-4 [1]\n223-714-6 [2]\n301-467-6 [3]\n85-00-7 [1]\n4032-26-2 [2]\n94021-76-8 [3]\nT+; R26\nT; R48/25\nXn; R22\nXi; R36/37/38\nR43\nN; R50-53\nT+; N\nR: 22-26-36/37/38-43-48/25-50/53\nS: (1/2-)28-36/37/39-45-60-61\n\n\n613-090-00-7\nparaquat dichloride;\n1,1-dimethyl-4,4'-bipyridinium dichloride; [1]\nparaquat dimethylsulfate;\n1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]\n217-615-7 [1]\n218-196-3 [2]\n1910-42-5 [1]\n2074-50-2 [2]\nT+; R26\nT; R24/25-48/25\nXi; R36/37/38\nN; R50-53\nT+; N\nR: 24/25-26-36/37/38-48/25-50/53\nS: (1/2-)22-28-36/37/39-45-60-61\n\n\n613-091-00-2\nmorfamquat dichloride; [1]\nmorfamquat sulfate [2]\n225-062-8 [1]\n[2]\n4636-83-3 [1]\n29873-36-7 [2]\nXn; R22\nXi; R36/37/38\nR52-53\nXn\nR: 22-36/37/38-52/53\nS: (2-)22-36-61\n\n\n613-092-00-8\n1,10-phenanthroline\n200-629-2\n66-71-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)45-60-61\n\n\n613-093-00-3\nhexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate\n400-050-7\n85153-92-0\nR42/43\nXn\nR: 42/43\nS: (2-)22-24-37\n\n\n613-094-00-9\n4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine\n401-360-5\n5248-39-5\nXn; R22-48/22\nXn\nR: 22-48/22\nS: (2-)22-36\n\n\n613-095-00-4\nsodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate\n403-080-9\n92484-48-5\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-096-00-X\n2-amino-6-ethoxy-4-methylamino-1,3,5-triazine\n403-580-7\n62096-63-3\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n613-097-00-5\n7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid\n403-690-5\n111298-82-9\nR42/43\nR52-53\nXn\nR: 42/43-52/53\nS: (2-)22-24-37-61\n\n\n613-098-00-0\nN-(n-octyl)-2-pyrrolidone\n403-700-8\n2687-94-7\nC; R34\nN; R51-53\nC; N\nR: 34-51/53\nS: (1/2-)23-26-36/37/39-45\n\n\n613-099-00-6\n1-dodecyl-2-pyrrolidone\n403-730-1\n2687-96-9\nC; R34\nR43\nN; R50-53\nC; N\nR: 34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n613-100-00-X\n2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione\n404-230-6\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n613-101-00-5\nN-tert-pentyl-2-benzothiazolesulfenamide\n404-380-2\n110799-28-5\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)36/37-61\n\n\n613-102-00-0\ndimethomorph (ISO);\n4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine\n404-200-2\n110488-70-5\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-103-00-6\nsodium 5-n-butylbenzotriazole\n404-450-2\n118685-34-0\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n613-104-00-1\n5-tert-butyl-3-isoxazolylamine hydrochloride\n404-840-2\n—\nXn; R22-48/22\nXi; R41\nR52-53\nXn\nR: 22-41-48/22-52/53\nS: (2-)26-36/39-61\n\n\n613-105-00-7\nhexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)\n405-160-9\n124537-30-0\nT; R25\nR43\nR52-53\nT\nR: 25-43-52/53\nS: (1/2-)24-37-45-61\n\n\n613-106-00-2\ntetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate\n405-240-3\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n613-107-00-8\nhexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate\n405-280-1\n76508-02-6\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n613-108-00-3\nbenzothiazole-2-thiol\n205-736-8\n149-30-4\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-109-00-9\nbis(piperidinothiocarbonyl) disulphide\n202-328-1\n94-37-1\nXi; R36/37/38\nR43\nXi\nR: 36/37/38-43\nS: (2-)24-26-37\n\n\n613-110-00-4\ndimepiperate (ISO);\nS-(1-methyl-1-phenylethyl) piperidine-1-carbothioate\n262-784-2\n61432-55-1\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n613-111-00-X\n1,2,4-triazole\n206-022-9\n288-88-0\nRepr. Cat. 3; R63\nXn; R22\nXi; R36\nXn\nR: 22-36-63\nS: (2-)36/37\n\n\n613-112-00-5\nocthilinone (ISO);\n2-octyl-2H-isothiazol-3-one\n247-761-7\n26530-20-1\nT; R23/24\nXn; R22\nC; R34\nR43\nN; R50-53\nT; N\nR: 22-23/24-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\nR43: C ≥ 0,05 %\n\n613-113-00-0\n2-(morpholinothio)benzothiazole\n203-052-4\n102-77-2\nXi; R36/38\nR43\nN; R51-53\nXi; N\nR: 36/38-43-51/53\nS: (2-)24-26-37-61\n\n\n613-114-00-6\n2,2',2\"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;\n1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine\n225-208-0\n4719-04-4\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)24-37\nR43: C ≥ 0,1 %\n\n613-115-00-1\nhymexazol (ISO);\n3-hydroxy-5-methylisoxazole\n233-000-6\n10004-44-1\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)26-39-61\n\n\n\n\n613-116-00-7\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nT+; R26\nT; R48/23\nXi; R36/37/38\nR43\nN; R50\nT+; N\nR: 26-36/37/38-43-48/23-50\nS: (1/2-)28-36/37/39-45-63-61\nN; R50: C ≥ 2,5 %\n\n\n\n\n613-116-01-4\ntolylfluanid (ISO);\ndichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]\n211-986-9\n731-27-1\nXi; R36/37/38\nR43\nN; R50\nXi; N\nR: 36/37/38-43-50\nS: (2-)25-36/37-46-61\nN; R50: C ≥ 2,5 %\n\n\n\n613-117-00-2\ndiniconazole (ISO);\n(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;\n(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol\n—\n76714-88-0\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-118-00-8\nflubenzimine (ISO);\nN-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline;\n253-703-1\n37893-02-0\nXi; R36\nN; R50-53\nXi; N\nR: 36-50/53\nS: (2-)26-60-61\n\n\n613-119-00-3\n(benzothiazol-2-ylthio)methyl thiocyanate;\nTCMTB\n244-445-0\n21564-17-0\nT+; R26\nXn; R22\nXi; R36/38\nR43\nN; R50-53\nT+; N\nR: 22-26-36/38-43-50/53\nS: (1/2-)28-36/37-38-45-60-61\n\n\n\n613-120-00-9\nbioresmethrin (ISO);\n(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate\n249-014-0\n28434-01-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-121-00-4\nchlorsulfuron (ISO);\n2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide;\n265-268-5\n64902-72-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-122-00-X\ndiclobutrazole (ISO);\n(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;\n(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol\n—\n75736-33-3\nXi; R36\nN; R51-53\nXi; N\nR: 36-51/53\nS: (2-)26-61\n\n\n613-123-00-5\n5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;\netem\n251-684-4\n33813-20-6\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-124-00-0\nfenpropimorph (ISO);\ncis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine\n266-719-9\n67564-91-4\nRepr. Cat. 3; R63\nXn; R22\nXi; R38\nN; R51-53\nXn; N\nR: 22-38-63-51/53\nS: (2-)36/37-46-61\n\n\n613-125-00-6\nhexythiazox (ISO);\ntrans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide\n—\n78587-05-0\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-126-00-1\nimazapyr (ISO);\n2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate\n—\n81334-34-1\nXi; R36\nR52-53\nXi\nR: 36-52/53\nS: (2-)26-61\n\n\n613-127-00-7\n1,1-dimethylpiperidinium chloride;\nmepiquat chloride\n246-147-6\n24307-26-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-128-00-2\nprochloraz (ISO);\nN-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide;\n266-994-5\n67747-09-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n613-129-00-8\nmetamitron (ISO);\n4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one\n255-349-3\n41394-05-2\nXn; R22\nN; R50\nXn; N\nR: 22-50\nS: (2-)61\n\n\n613-131-00-9\npyroquilon (ISO);\n1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one\n—\n57369-32-1\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n613-132-00-4\nhexazinone (ISO);\n3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione;\n257-074-4\n51235-04-2\nXn; R22\nXi; R36\nN; R50-53\nXn; N\nR: 22-36-50/53\nS: (2-)60-61\n\n\n613-133-00-X\netridiazole (ISO);\n5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole\n219-991-8\n2593-15-9\nCarc. Cat. 3; R40\nT; R23\nXn; R21/22\nN; R50-53\nT; N\nR: 21/22-23-40-50/53\nS: (1/2-)36/37-38-45-60-61\n\n\n613-134-00-5\nmyclobutanil (ISO);\n2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile\n—\n88671-89-0\nRepr. Cat. 3; R63\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53-63\nS: (2-)36/37-46-61\n\n\n613-135-00-0\ndi(benzothiazol-2-yl) disulphide\n204-424-9\n120-78-5\nR31\nR43\nN; R50-53\nXi; N\nR: 31-43-50/53\nS: (2-)36/37-60-61\n\n\n613-136-00-6\nN-cyclohexylbenzothiazole-2-sulphenamide\n202-411-2\n95-33-0\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-137-00-1\nmethabenzthiazuron (ISO);\n1-(1,3-benzothiazol-2-yl)1,3-dimethylurea\n242-505-0\n18691-97-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-138-00-7\nquinoxyfen (ISO);\n5,7-dichloro-4-(4-fluorophenoxy)quinoline\n—\n124495-18-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\n\n\n\n613-139-00-2\nmetsulfuron-methyl (ISO);\nmethyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate\n—\n74223-64-6\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-140-00-8\ncycloheximide (ISO);\n4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione\n200-636-0\n66-81-9\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT+; R28\nN; R51-53\nT+; N\nR: 61-28-51/53-68\nS: 53-45-61\n\nE\n613-141-00-3\n1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone\n401-470-3\n93686-63-6\nR53\nR: 53\nS: 61\n\n\n613-142-00-9\ntrans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate\n405-860-4\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n613-143-00-4\n1-(3-phenylpropyl)-2-methylpyridinium bromide\n405-930-4\n10551-42-5\nXn; R22\nXi; R36\nR52-53\nXn\nR: 22-36-52/53\nS: (2-)26-36/37-61\n\n\n613-144-00-X\nReaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate\n406-460-2\n125139-08-4\nR52-53\nR: 52/53\nS: 61\n\n\n613-145-00-5\n(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate\n406-960-0\n77497-97-3\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-146-00-0\nN-ethyl-N-methylpiperidinium iodide\n407-780-5\n4186-71-4\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)22-61\n\n\n613-147-00-6\n4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine\n407-940-4\n111681-72-2\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-148-00-1\ntetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane\n411-240-4\n143683-23-2\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24/25-37-61\n\n\n613-149-00-7\npyridaben (ISO);\n2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one\n405-700-3\n96489-71-3\nT; R23/25\nN; R50-53\nT; N\nR: 23/25-50/53\nS: (1/2-)36/37-45-60-61\n\n\n613-150-00-2\n2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione\n406-295-6\n—\nR53\nR: 53\nS: 61\n\n\n613-151-00-8\n1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine\n406-360-9\n104218-44-2\nR53\nR: 53\nS: 61\n\n\n613-152-00-3\nphenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate\n406-600-2\n89392-03-0\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n613-153-00-9\n2,3,5-trichloropyridine\n407-270-2\n16063-70-0\nR52-53\nR: 52/53\nS: 61\n\n\n613-154-00-4\n2-amino-4-chloro-6-methoxypyrimidine\n410-050-9\n5734-64-5\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n613-155-00-X\n5-chloro-2,3-difluoropyridine\n410-090-7\n89402-43-7\nR10\nXn; R22\nR52-53\nXn\nR: 10-22-52/53\nS: (2-)23-36-61\n\n\n613-156-00-5\n2-butyl-4-chloro-5-formylimidazole\n410-260-0\n83857-96-9\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n613-157-00-0\n2,4-diamino-5-methoxymethylpyrimidine\n410-330-0\n54236-98-5\nXn; R22-48/22\nXi; R36\nXn\nR: 22-36-48/22\nS: (2-)22-26-36\n\n\n613-158-00-6\n2,3-dichloro-5-trifluoromethyl-pyridine\n410-340-5\n69045-84-7\nXn; R20/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 20/22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-159-00-1\nfenazaquin (ISO);\n4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline\n410-580-0\n120928-09-8\nT; R25\nXn; R20\nN; R50-53\nT; N\nR: 20-25-50/53\nS: (1/2-)37-45-60-61\n\n\n613-160-00-7\n(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide\n411-000-9\n125224-62-6\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n\n\n613-161-00-2\n(2,4-diaminopteridin-6-yl)methanol hydrobromide\n430-620-0\n76145-91-0\nXn; R48/22\nR43\nR52-53\nXn\nR: 43-48/22-52/53\nS: (2-)22-36/37-61\n\n\n\n\n613-162-00-8\n(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide\n423-260-0\n100988-63-4\nMuta. Cat. 3; R68\nR43\nN; R51-53\nXn; N\nR: 43-68-51/53\nS: (2-)36/37-61\n\n\n\n\n\n613-163-00-3\nazimsulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea\n—\n120162-55-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-164-00-9\nflufenacet (ISO);\nN-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide\n—\n142459-58-3\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)13-24-37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-165-00-4\nflupyrsulfuron-methyl-sodium (ISO);\nmethyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt\n—\n144740-54-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-166-00-X\nflumioxazin (ISO);\nN-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide\n—\n103361-09-7\nRepr. Cat. 2; R61\nN; R50-53\nT; N\nR: 61-50/53\nS: 53-45-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n\n613-167-00-5\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);\nreaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]\nand 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)\n—\n55965-84-9\nT; R23/24/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 23/24/25-34-43-50/53\nS: (2-)26-28-36/37/39-45-60-61\nC; R34: C ≥ 0,6 %\nXi; R36/38: 0,06 % ≤ C < 0,6 %\nR43: C ≥ 0,0015 %\n\n613-168-00-0\n1-vinyl-2-pyrrolidone\n201-800-4\n88-12-0\nCarc. Cat. 3; R40\nXn; R20/21/22-48/20\nXi; R37-41\nXn\nR: 20/21/22-37-40-41-48/20\nS: (2-)26-36/37/39\n\nD\n\n\n613-169-00-6\n9-vinylcarbazole\n216-055-0\n1484-13-5\nMuta. Cat. 3; R68\nXn; R21/22\nXi; R38\nR43\nN; R50-53\nXn; N\nR: 21/22-38-43-68-50/53\nS: (2-)22-23-36/37-60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-170-00-1\n2,2-ethylmethylthiazolidine\n404-500-3\n694-64-4\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-171-00-7\nhexaconazole (ISO);\n(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol\n413-050-7\n79983-71-4\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n613-172-00-2\n5-chloro-1,3-dihydro-2H-indol-2-one\n412-200-9\n17630-75-0\nRepr. Cat. 3; R62\nXn; R22\nR43\nR52-53\nXn\nR: 22-43-62-52/53\nS: (2-)22-36/37-61\n\n\n613-173-00-8\nfluquinconazole (ISO);\n3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one\n411-960-9\n136426-54-5\nT; R23/25-48/25\nXn; R21\nXi; R38\nN; R50-53\nT; N\nR: 21-23/25-38-48/25-50/53\nS: (1/2-)36/37/39-38-45-60-61\n\n\n\n\n\n613-174-00-3\ntetraconazole (ISO);\n(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether\n407-760-6\n112281-77-3\nXn; R20/22\nN; R51-53\nXn; N\nR: 20/22-51/53\nS: (2-)36-61\n\n\n\n613-175-00-9\nepoxiconazole (ISO);\n(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane\n406-850-2\n133855-98-8\nCarc. Cat. 3; R40\nRepr. Cat. 3; R62\nRepr. Cat. 3; R63\nN; R51-53\nXn; N\nR: 40-62-63-51/53\nS: (2-)36/37-46-61\n\n\n613-176-00-4\n2-methyl-2-azabicyclo[2.2.1]heptane\n404-810-9\n4524-95-2\nR10\nXn; R21/22-48/20\nC; R34\nC\nR: 10-21/22-34-48/20\nS: (1/2-)16-26-36/37/39-45\n\n\n613-177-00-X\n8-amino-7-methylquinoline\n412-760-4\n5470-82-6\nXn; R21/22\nR43\nN; R51-53\nXn; N\nR: 21/22-43-51/53\nS: (2-)36/37-61\n\n\n613-178-00-5\n4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine\n410-470-2\n137796-06-6\nC; R34\nR43\nC\nR: 34-43\nS: (1/2-)7/8-26-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n613-179-00-0\nlithium 3-oxo-1,2(2H)-benzisothiazol-2-ide\n411-690-1\n111337-53-2\nXn; R22\nC; R34\nR43\nN; R51-53\nC; N\nR: 22-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n613-180-00-6\nN-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide\n407-430-1\n3741-80-8\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-181-00-1\n5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone\n405-090-9\n67485-29-4\nT; R48/25\nXn; R22\nXi; R36\nN; R50-53\nT; N\nR: 22-36-48/25-50/53\nS: (1/2-)22-26-36/37-45-60-61\n\n\n613-182-00-7\n1-(1-naphthylmethyl)quinolinium chloride\n406-220-7\n65322-65-8\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nXn; R22\nXi; R38-41\nR52-53\nXn\nR: 22-38-40-41-52/53-68\nS: (2-)22-26-36/37/39-61\n\n\n613-183-00-2\nreaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;\n5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one\n413-640-4\n—\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)36-60-61\n\n\n613-184-00-8\nnitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate\n413-670-8\n—\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)24-26-37\n\n\n613-185-00-3\n2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one\n407-630-9\n82633-79-2\nT; R25\nXi; R41\nR43\nN; R50-53\nT; N\nR: 25-41-43-50/53\nS: (1/2-)22-26-36/37/39-45-60-61\n\n\n613-186-00-9\n(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate\n408-050-9\n76855-69-1\nXi; R36\nR43\nN; R51-53\nXi; N\nR: 36-43-51/53\nS: (2-)24-26-37-61\n\n\n\n\n613-187-00-4\n5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene\n410-530-8\n-\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-188-00-X\n1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone\n411-500-7\n116256-11-2\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)22-24-26-37/39-61\n\n\n613-189-00-5\n1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane\n414-030-0\n52667-88-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n613-190-00-0\ndisodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate\n414-040-5\n149530-93-8\nXn; R22\nR43\nXn\nR: 22-43\nS: (2-)22-24-37\n\n\n613-191-00-6\n3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine\n421-150-7\n143860-04-2\nRepr. Cat. 2; R60\nC; R34\nN; R50-53\nT; N\nR: 60-34-50/53\nS: 53-45-60-61\n\n\n\n\n613-192-00-1\n3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane\n426-750-2\n151860-15-0\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n\n613-193-00-7\npentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate\n414-930-3\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n613-194-00-2\n6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt\n418-000-8\n163062-28-0\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n613-195-00-8\n2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)\n418-280-1\n18600-59-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n613-196-00-3\n5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt\n418-380-5\n168113-78-8\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n613-197-00-9\nreaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;\n2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;\n[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;\n[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine\n420-390-1\n187547-46-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n\n613-198-00-4\n2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine\n415-500-8\n145963-84-4\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n613-199-00-X\nreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;\nreaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione\n421-550-1\n—\nCarc. Cat. 2; R45\nRepr. Cat. 2; R61\nR43\nR52-53\nT\nR: 45-61-43-52/53\nS: 53-45-61\n\n\n613-200-00-3\nReaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts\n420-980-7\n—\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n613-201-00-9\n(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole\n422-390-5\n143322-57-0\nRepr. Cat. 3; R62\nT; R39-48/25\nXn; R20/22\nXi; R41\nR43\nN; R50-53\nT; N\nR: 20/22-39-41-43-48/25-62-50/53\nS: (1/2-)53-45-60-61\n\n\n613-202-00-4\npymetrozine (ISO);\n(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one\n—\n123312-89-0\nCarc. Cat. 3; R40\nR52-53\nXn\nR: 40-52/53\nS: (2-)36/37-61\n\n\n\n\n\n613-203-00-X\npyraflufen-ethyl (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1]\npyraflufen (ISO);\n2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2]\n- [1]\n- [2]\n129630-19-9 [1]\n129630-17-7 [2]\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n613-204-00-5\noxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;\n254-637-6\n39807-15-3\nRepr. Cat. 3; R63\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %\n\n\n\n613-205-00-0\npropiconazole (ISO);\n(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole\n262-104-4\n60207-90-1\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-46-60-61\n\n\n613-206-00-6\nfenamidone (ISO);\n(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one\n—\n161326-34-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-208-00-7\nimazamox (ISO);\n(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid\n—\n114311-32-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-209-00-2\ncis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride\n417-430-3\n63645-17-0\nT; R25\nXn; R48/22\nR43\nN; R51-53\nT; N\nR: 25-43-48/22-51/53\nS: (1/2-)22-36/37-45-61\n\n\n613-210-00-8\n2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane\n417-650-1\n88128-57-8\nXn; R48/22\nR52-53\nXn\nR: 48/22-52/53\nS: (2-)23-25-36-61\n\n\n613-211-00-3\nN-methyl-4-(p-formylstyryl)pyridinium methylsulfate\n418-240-3\n74401-04-0\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n613-212-00-9\n4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)\n418-320-8\n133467-41-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-60-61\n\n\n613-213-00-4\ncis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline\n416-040-0\n120807-02-5\nR52-53\nR: 52/53\nS: 61\n\n\n613-214-00-X\nN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide\n416-260-7\n147613-95-4\nR53\nR: 53\nS: 61\n\n\n613-215-00-5\n2-chloromethyl-3,4-dimethoxypyridinium chloride\n416-440-5\n72830-09-2\nXn; R21/22-48/22\nXi; R38-41\nR43\nN; R51-53\nXn; N\nR: 21/22-38-41-43-48/22-51/53\nS: (2-)26-36/37/39-61\n\n\n613-216-00-0\n6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole\n416-490-8\n162208-01-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n613-217-00-6\n4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine\n416-770-1\n73754-27-5\nR53\nR: 53\nS: 61\n\n\n613-218-00-1\n6-hydroxyindole\n417-020-4\n2380-86-1\nXn; R22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 22-41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n613-219-00-7\n7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole\n417-140-7\n79185-77-6\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n613-220-00-2\ntrans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide\n417-290-3\n147086-81-5\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n613-221-00-8\n2-chloro-5-methyl-pyridine\n418-050-0\n18368-64-4\nXn; R21/22\nXi; R38\nR52-53\nXn\nR: 21/22-38-52/53\nS: (2-)23-25-36/37-61\n\n\n613-222-00-3\n4-(1-oxo-2-propenyl)-morpholine\n418-140-1\n5117-12-4\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)23-26-36/37/39\n\n\n613-223-00-9\nN-isopropyl-3-(4-fluorophenyl)-1H-indole\n418-790-4\n93957-49-4\nR53\nR: 53\nS: 61\n\n\n613-224-00-4\n2,5-dimercaptomethyl-1,4-dithiane\n419-770-8\n136122-15-1\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n613-225-00-X\nreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;\n2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.\n421-290-9\n—\nXn; R48/22\nR53\nXn\nR: 48/22-53\nS: (2-)22-36-61\n\n\n613-226-00-5\n1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride\n420-950-3\n163831-67-2\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)26-39-60-61\n\n\n613-227-00-0\n(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-600-2\n99199-90-3\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-28-36/37-61\n\n\n613-228-00-6\n(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran\n419-630-6\n793669-26-8\nN; R51-53\nN\nR: 51/53\nS: 24-61\n\n\n\n\n613-229-00-1\n1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine\n411-930-5\n106917-31-1\nXi; R38\nR43\nN; R50-53\nXi; N\nR: 38-43-50/53\nS: (2-)24-37-60-61\n\n\n\n613-230-00-7\nflorasulam (ISO);\n2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];\npyrimidine-2-sulfonanilide\n—\n145701-23-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n613-231-00-2\n2,6-diamino-3-((pyridine-3-yl)azo)pyridine\n421-430-9\n28365-08-4\nXn; R22-48/22\nN; R51-53\nXn; N\nR: 22-48/22-51/53\nS: (2-)22-36-61\n\n\n\n613-232-00-8\n3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide\n431-030-6\n163269-30-5\nT; R23\nXn; R48/22\nXi; R41\nN; R50-53\nT; N\nR: 23-41-48/22-50/53\nS: (1/2-)26-36/39-45-57-60-61\n\n\n\n613-233-00-3\n4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane\n423-230-7\n56552-15-9\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n\n613-234-00-9\nimidazo[1,2-b]pyridazin hydrochloride\n431-510-5\n18087-70-2\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)26\n\n\n\n613-235-00-4\n2,3-dihydro-2,2-dimethyl-1H-perimidine\n424-060-6\n6364-17-6\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)28-36/37-60-61\n\n\n\n613-236-00-X\n2-chloro-3-trifluoromethylpyridine\n424-520-6\n65753-47-1\nT; R24/25-48/25\nC; R34\nR52-53\nT\nR: 24/25-34-48/25-52/53\nS: (1/2-)23-26-36/37/39-45-61\n\n\n\n613-237-00-5\n6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine\n424-950-4\n133949-92-5\nR53\nR: 53\nS: 61\n\n\n\n613-238-00-0\nsodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate\n430-890-1\n81992-66-7\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)22-24-37-60-61\n\n\n\n613-239-00-6\n2-[3-(methylamino)propyl]-1H-benzimidazole\n425-760-4\n64137-52-6\nXi; R41\nR52-53\nXi\nR: 41-52/53\nS: (2-)26-39-61\n\n\n\n613-241-00-7\n3-(2H-tetrazol-5-yl)pyridine\n426-810-8\n3250-74-6\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-242-00-2\nreaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts\n426-860-0\n191877-09-5\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-243-00-8\n4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)\n427-350-0\n182235-14-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-244-00-3\n5,7-dichloro-4-hydroxyquinoline\n427-420-0\n21873-52-9\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-245-00-9\n2-fluoro-6-trifluoromethylpyridine\n428-100-3\n94239-04-0\nR10\nXn; R20/22\nR52-53\nXn\nR: 10-20/22-52/53\nS: (2-)16-61\n\n\n\n613-246-00-4\n2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine\n428-200-7\n103577-66-8\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-247-00-X\n3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole\n428-910-7\n107786-36-7\nR53\nR: 53\nS: 61\n\n\n\n613-248-00-5\n3,4-dimethyl-1H-pyrazole\n429-130-1\n2820-37-3\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)26-39-61\n\n\n\n613-249-00-0\n1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate\n429-300-3\n155601-30-2\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n\n613-250-00-6\nreaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;\nmethyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;\n2-isopropyl-N-hydroxyethyl 1,3-oxazolidine\n429-990-6\n-\nXi; R41\nR43\nR52-53\nXi\nR: 41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n\n613-251-00-1\n(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole\n430-560-5\n180637-89-2\nXn; R22-48/22\nXi; R41\nR43\nXn\nR: 22-41-43-48/22\nS: (2-)26-36/37/39\n\n\n\n613-253-00-2\n2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;\nreaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)\n430-580-4\n-\nR19\nXi; R38\nN; R51-53\nXi; N\nR: 19-38-51/53\nS: (2-)37-61\n\n\n\n613-254-00-8\nforchlorfenuron (ISO);\n1-(2-chloro-4-pyridyl)-3-phenylurea\n-\n68157-60-8\nCarc. Cat. 3; R40\nN; R51-53\nXn; N\nR: 40-51/53\nS: (2-)36/37-46-61\n\n\n\n613-255-00-3\nreaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)\n424-270-8\n-\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n613-256-00-9\n3'5'-anhydro thymidine\n425-810-5\n38313-48-3\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-257-00-4\n2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate\n426-400-9\n170222-39-6\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n613-258-00-X\nreaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;\n4-chloro-5-methylbenzotriazole sodium salt;\n5-chloro-4-methylbenzotriazole sodium salt\n427-730-6\n202420-04-0\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)26-28-36/37/39-45-61\n\n\n\n613-259-00-5\nreaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;\n[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate\n428-790-6\n72963-72-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n\n613-260-00-0\n(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin\n430-730-9\n-\nXi; R41\nN; R50-53\nXi; N\nR: 41-50/53\nS: (2-)22-26-39-60-61\n\n\n\n613-261-00-6\npyrazole-1-carboxamidine monohydrochloride\n429-520-1\n4023-02-3\nXn; R22-48/22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-48/22-52/53\nS: (2-)22-26-36/37/39-61\n\n\n\n613-262-00-1\ndisodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene\n427-310-2\n180850-95-7\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n\n613-263-00-7\nmonosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate\n429-570-2\n-\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-266-00-3\n2-chloro-5-chloromethylthiazole\n429-830-5\n105827-91-6\nT; R24\nC; R34\nXn; R22\nR43\nN; R51-53\nT; N\nR: 22-24-34-43-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n613-267-00-9\nthiamethoxam (ISO);\n3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine\n428-650-4\n153719-23-4\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-268-00-4\n(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine\n425-930-8\n151213-39-7\nC; R34\nXn; R20/22-48/22\nN; R51-53\nC; N\nR: 20/22-34-48/22-51/53\nS: (1/2-)26-36/37/39-45-61\n\n\n\n613-269-00-X\n2-thiazolidinylidenecyanamide\n427-720-1\n26364-65-8\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36-61\n\n\n\n613-270-00-5\n5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide\n428-150-6\n113171-13-4\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-271-00-0\ntritosulfuron (ISO) (containing ≤ 0,02 % AMTT);\n1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)\n-\n142469-14-5\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-272-00-6\npyraclostrobin (ISO);\nmethyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate\n-\n-\nT; R23\nXi; R38\nN; R50-53\nT; N\nR: 23-38-50/53\nS: (1/2-)45-60-61-63\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n613-273-00-1\ntetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine\n427-600-9\n192439-46-6\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-274-00-7\n2,6-dichloro-1-fluoropyridiniumtetrafluoroborate\n427-400-1\n140623-89-8\nC; R34\nXn; R22\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n\n613-275-00-2\n3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride\n424-530-0\n93076-03-0\nT; R25\nXn; R68/21-48/22\nXi; R41\nR43\nN; R51-53\nT; N\nR: 25-41-43-48/22-68/21-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n613-276-00-8\n1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one\n426-110-2\n98377-35-6\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24/25-37-61\n\n\n\n613-277-00-3\n(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one\n427-070-9\n-\nR53\nR: 53\nS: 61\n\n\n\n613-278-00-9\n(3-aminophenyl)pyridin-3-ylmethanone\n428-230-0\n79568-06-2\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-279-00-4\n2-ethyl-2,3-dihydro-2-methyl-1H-perimidine\n424-380-6\n43057-68-7\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)36/37-60-61\n\n\n\n613-280-00-X\ntetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;\ndimethyl propyleneurea\n230-625-6\n7226-23-5\nRepr. Cat. 3; R62\nXn; R22\nXi; R41\nXn\nR: 22-41-62\nS: 26-36/37/39\n\n\n\n613-281-00-5\nquinoline\n202-051-6\n91-22-5\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R21/22\nXi; R36/38\nN; R51-53\nT; N\nR: 45-21/22-36/38-68-51/53\nS: 53-45-61\n\nE\n\n613-282-00-0\ntriticonazole (ISO);\n(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol\n-\n131983-72-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n613-283-00-6\nketoconazole;\n1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone\n265-667-4\n65277-42-1\nRepr. Cat. 2; R60\nT; R25\nXn; R48/22\nN; R50-53\nT; N\nR: 60-25-48/22-50/53\nS: 53-45-60-61\n\nE\n\n613-284-00-1\nmetconazole (ISO);\n(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol\n-\n125116-23-6\nRepr. Cat. 3; R63\nXn; R22\nN; R51-53\nXn; N\nR: 22-63-51/53\nS: (2-)36/37-46-61\n\n\n\n613-285-00-7\n1-hydroxybenzotriazole, anhydrous; [1]\n1-hydroxybenzotriazole, monohydrated [2]\n219-989-7 [1]\n219-989-7 [2]\n2592-95-2 [1]\n123333-53-9 [2]\nE; R2\nE\nR: 2\nS: 16-35\n\n\n\n613-286-00-2\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]\n418-260-2\n183196-57-8\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n613-286-01-X\npotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;\n[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]\n418-260-2\n183196-57-8\nRepr. Cat. 2; R61\nR43\nT\nR: 61-43\nS: 53-45\n\n\n\n613-287-00-8\n1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole\n419-540-7\n160194-26-3\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n\n613-288-00-3\n1,3-bis(dimethylcarbamoyl)-imidazolium chloride\n420-930-4\n135756-61-5\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-37/39-61\n\n\n\n613-289-00-9\n3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole\n432-020-4\n142623-48-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n613-290-00-4\n4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride\n432-470-1\n189012-93-9\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)24-26-37/39-60-61\n\n\n\n613-291-00-X\n2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one\n434-820-9\n106461-41-0\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-292-00-5\nN,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine\n435-010-8\n26157-73-3\nMuta. Cat. 3; R68\nR52-53\nXn\nR: 68-52/53\nS: (2-)36/37-61\n\n\n\n613-293-00-0\n2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester\n448-050-6\n444065-11-6\nR53\nR: 53\nS: 61\n\n\n\n613-294-00-6\n2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester\n448-260-8\n379268-96-9\nR53\nR: 53\nS: 61\n\n\n\n613-295-00-1\n11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride\n448-720-8\n363138-44-7\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n\n613-296-00-7\npentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate\n418-270-7\n-\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-47-61\n\n\n\n613-297-00-2\n5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole\n420-820-6\n-\nR10\nXn; R22\nN; R51-53\nXn; N\nR: 10-22-51/53\nS: (2-)16-61\n\n\n\n613-298-00-8\nbis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate\n421-560-6\n-\nXn; R48/22\nXi; R41\nN; R51-53\nXn; N\nR: 41-48/22-51/53\nS: (2-)22-26-36/39-61\n\n\n\n613-299-00-3\nmain component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;\nmain component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt\n422-610-1\n-\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-300-00-7\n1-imidazol-1-yl-octadecan-2-ol\n434-120-3\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n613-301-00-2\ndimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate\n443-910-7\n-\nR53\nR: 53\nS: 61\n\n\n\n613-302-00-8\ndisodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate\n432-980-4\n243858-60-8\nXi; R41\nXi\nR: 41\nS: (2-)22-26-39\n\n\n\n613-303-00-3\n2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine\n429-800-1\n95737-68-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n613-304-00-9\n5,6-dihydroxy-2,3-dihydro-1H-indolium bromide\n421-170-6\n138937-28-7\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)22-26-39\n\n\n\n613-305-00-4\n2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole\n448-630-9\n3147-77-1\nR53\nR: 53\nS: 61\n\n\n\n613-306-00-X\n(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate\n433-520-5\n82911-69-1\nXn; R22\nR43\nN; R51-53\nXn; N\nR: 22-43-51/53\nS: (2-)24-37-61\n\n\n\n613-307-00-5\nclothianidin (ISO);\n3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine\n-\n210880-92-5\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n613-308-00-0\n2-amino-5-methylthiazole\n423-800-5\n7305-71-7\nXn; R22-48/22\nN; R50-53\nXn; N\nR: 22-48/22-50/53\nS: (2-)22-36-60-61\n\n\n\n613-309-00-6\n1-methyl-3-phenyl-1-piperazine\n431-180-2\n5271-27-2\nXn; R21/22\nXi; R38-41\nR52-53\nXn\nR: 21/22-38-41-52/53\nS: (2-)26-36/37/39-61\n\n\n\n613-310-00-1\n(–)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride\n432-360-3\n105813-13-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n\n613-311-00-7\nmethyl-5-nitrophenyl-guanidine\n435-500-1\n152460-07-6\nXn; R22\nXi; R36\nR43\nR52-53\nXn\nR: 22-36-43-52/53\nS: (2-)22-24-26-37-61\n\n\n\n613-312-00-2\n2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride\n420-200-5\n-\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)22-26-36/37/39-61\n\n\n\n613-313-00-8\n2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione\n442-780-9\n173838-67-0\nR52-53\nR: 52/53\nS: 61\n\n\n\n613-314-00-3\n4-decyloxazolidin-2-one;\n4-decyl-1,3-oxazolidin-2-one\n443-770-7\n7693-82-5\nN; R50-53\nN\nR: 50/53\nS: 22-24-60-61\n\n\n\n613-315-00-9\ntetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate\n430-390-1\n-\nXn; R20\nR52-53\nXn\nR: 20-52/53\nS: (2-)25-61\n\n\n\n613-316-00-4\ntrimethylopropane tri(3-aziridinylpropanoate);\n(TAZ)\n257-765-0\n52234-82-9\nMuta. Cat. 3; R68\nXi; R41\nR43\nXn\nR: 41-43-68\nS: 26-36/37/39-42\n\nH\n\n\n614-001-00-4\nnicotine (ISO);\n3-(N-methyl-2-pyrrolidinyl)pyridine\n200-193-3\n54-11-5\nT+; R27\nT; R25\nN; R51-53\nT+; N\nR: 25-27-51/53\nS: (1/2-)36/37-45-61\n\n\n614-002-00-X\nsalts of nicotine\n—\n—\nT+; R26/27/28\nN; R51-53\nT+; N\nR: 26/27/28-51/53\nS: (1/2-)13-28-45-61\n\nA\n614-003-00-5\nstrychnine\n200-319-7\n57-24-9\nT+; R27/28\nN; R50-53\nT+; N\nR: 27/28-50/53\nS: (1/2-)36/37-45-60-61\n\n\n614-004-00-0\nsalts of strychnine\n—\n—\nT+; R26/28\nN; R50-53\nT+; N\nR: 26/28-50/53\nS: (1/2-)13-28-45-60-61\n\nA\n\n\n614-005-00-6\ncolchicine\n200-598-5\n64-86-8\nMuta. Cat. 2; R46\nT+; R28\nT+\nR: 46-28\nS: 53-45\n\nE\n\n614-006-00-1\nbrucine;\n2,3-dimethoxystrychnine\n206-614-7\n357-57-3\nT+; R26/28\nR52-53\nT+\nR: 26/28-52/53\nS: (1/2-)13-45-61\n\n\n614-007-00-7\nbrucine sulphate; [1]\nbrucine nitrate; [2]\nStrychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]\nStrychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]\n225-432-9 [1]\n227-317-9 [2]\n269-439-5 [3]\n269-710-8 [4]\n4845-99-2 [1]\n5786-97-0 [2]\n68239-26-9 [3]\n68310-42-9 [4]\nT+; R26/28\nR52-53\nT+\nR: 26/28-52/53\nS: (1/2-)13-45-61\n\nA\n614-008-00-2\naconitine\n206-121-7\n302-27-2\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\n\n614-009-00-8\nsalts of aconitine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\nA\n614-010-00-3\natropine\n200-104-8\n51-55-8\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-011-00-9\nsalts of atropine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-012-00-4\nhyoscyamine\n202-933-0\n101-31-5\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\n\n614-013-00-X\nsalts of hyoscyamine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)24-45\n\nA\n614-014-00-5\nhyoscine\n200-090-3\n51-34-3\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)25-45\n\n\n614-015-00-0\nsalts of hyoscine\n—\n—\nT+; R26/27/28\nT+\nR: 26/27/28\nS: (1/2-)25-45\n\nA\n614-016-00-6\npilocarpine\n202-128-4\n92-13-7\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-017-00-1\nsalts of pilocarpine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-018-00-7\npapaverine\n200-397-2\n58-74-2\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n614-019-00-2\nsalts of papaverine\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)22\n\nA\n614-020-00-8\nphysostigmine\n200-332-8\n57-47-6\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\n\n614-021-00-3\nsalts of physostigmine\n—\n—\nT+; R26/28\nT+\nR: 26/28\nS: (1/2-)25-45\n\nA\n614-022-00-9\ndigitoxin\n200-760-5\n71-63-6\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-023-00-4\nephedrine\n206-080-5\n299-42-3\nXn; R22\nXn\nR: 22\nS: (2-)22-25\n\n\n614-024-00-X\nsalts of ephedrine\n—\n—\nXn; R22\nXn\nR: 22\nS: (2-)22-25\n\nA\n614-025-00-5\nouabain\n211-139-3\n630-60-4\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-026-00-0\nstrophantin-K\n234-239-9\n11005-63-3\nT; R23/25\nR33\nT\nR: 23/25-33\nS: (1/2-)45\n\n\n614-027-00-6\nbufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;\nred squill;\nscilliroside\n208-077-4\n507-60-8\nT+; R28\nT+\nR: 28\nS: (1/2-)36/37-45\n\n\n614-028-00-1\nreaction mass of: 2-ethylhexyl mono-D-glucopyranoside;\n2-ethylhexyl di-D-glucopyranoside\n414-420-0\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n614-029-00-7\nconstitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;\nconstitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside\n419-640-0\n68784-14-5\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n\n\n615-001-00-7\nmethyl isocyanate\n210-866-3\n624-83-9\nF; R11\nRepr. Cat. 3; R63\nT+; R26\nT; R24/25\nR42/43\nXi; R37/38-41\nF; T+\nR: 11-24/25-26-37/38-41-42/43-63\nS: (1/2-)16-26-27/28-36/37/39-45-63\n\n\n\n615-002-00-2\nmethyl isothiocyanate\n209-132-5\n556-61-6\nT; R23/25\nC; R34\nR43\nN; R50-53\nT; N\nR: 23/25-34-43-50/53\nS: (1/2-)36/37-38-45-60-61\n\n\n615-003-00-8\nthiocyanic acid\n207-337-4\n463-56-9\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-61\n\n\n\n\n615-004-00-3\nsalts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-36/37-46-61\n\nA\n\n615-005-00-9\n4,4'-methylenediphenyl diisocyanate;\ndiphenylmethane-4,4'-diisocyanate; [1]\n2,2'-methylenediphenyl diisocyanate;\ndiphenylmethane-2,2'-diisocyanate; [2]\no-(p-isocyanatobenzyl)phenyl isocyanate;\ndiphenylmethane-2,4'-diisocyanate; [3]\nmethylenediphenyl diisocyanate [4]\n202-966-0 [1]\n219-799-4 [2]\n227-534-9 [3]\n247-714-0 [4]\n101-68-8 [1]\n2536-05-2 [2]\n5873-54-1 [3]\n26447-40-5 [4]\nCarc. Cat. 3; R40\nXn; R20-48/20\nXi; R36/37/38\nR42/43\nXn\nR: 20-36/37/38-40-42/43-48/20\nS: (1/2-)23-36/37-45\nXi; R36/37/38: C ≥ 5 %\nR42: C ≥ 0,1 %\nC2\n\n\n615-006-00-4\n2-methyl-m-phenylene diisocyanate;\ntoluene-2,4-di-isocyanate; [1]\n4-methyl-m-phenylene diisocyanate;\ntoluene-2,6-di-isocyanate; [2]\nm-tolylidene diisocyanate;\ntoluene-diisocyanate [3]\n202-039-0 [1]\n209-544-5 [2]\n247-722-4 [3]\n91-08-7 [1]\n584-84-9 [2]\n26471-62-5 [3]\nCarc. Cat. 3; R40\nT+; R26\nXi; R36/37/38\nR42/43\nR52-53\nT+\nR: 26-36/37/38-40-42/43-52/53\nS: (1/2-)23-36/37-45-61\nR42: C ≥ 0,1 %\nC2\n615-007-00-X\n1,5-naphthylene diisocyanate\n221-641-4\n3173-72-6\nXn; R20\nXi; R36/37/38\nR42\nR52-53\nXn\nR: 20-36/37/38-42-52/53\nS: (2-)26-28-38-45-61\n\n\n615-008-00-5\n3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;\nisophorone di-isocyanate\n223-861-6\n4098-71-9\nT; R23\nXi; R36/37/38\nR42/43\nN; R51-53\nT; N\nR: 23-36/37/38-42/43-51/53\nS: (1/2-)26-28-38-45-61\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-009-00-0\n4,4'-methylenedi(cyclohexyl isocyanate);\ndicyclohexylmethane-4,4'-di-isocyanate\n225-863-2\n5124-30-1\nT; R23\nXi; R36/37/38\nR42/43\nT\nR: 23-36/37/38-42/43\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-010-00-6\n2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]\n2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]\n241-001-8 [1]\n239-714-4 [2]\n16938-22-0 [1]\n15646-96-5 [2]\nT; R23\nXi; R36/37/38\nR42\nT\nR: 23-36/37/38-42\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42: C ≥ 0,5 %\nC2\n615-011-00-1\nhexamethylene-di-isocyanate\n212-485-8\n822-06-0\nT; R23\nXi; R36/37/38\nR42/43\nT\nR: 23-36/37/38-42/43\nS: (1/2-)26-28-38-45\nT; R23: C ≥ 2 %\nXn; R20: 0,5 % ≤ C < 2 %\nR42/43: C ≥ 0,5 %\n2\n615-012-00-7\n4-isocyanatosulphonyltoluene;\ntosyl isocyanate\n223-810-8\n4083-64-1\nR14\nXi; R36/37/38\nR42\nXn\nR: 14-36/37/38-42\nS: (2-)26-28-30\nXi; R36/37/38: C ≥ 5 %\n\n615-013-00-2\ncyanamide;\ncarbanonitril\n206-992-3\n420-04-2\nT; R25\nXn; R21\nXi; R36/38\nR43\nT\nR: 21-25-36/38-43\nS: (1/2-)3-22-36/37-45\n\n\n615-014-00-8\ntris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate\n—\n7276-58-6\nXn; R22\nXn\nR: 22\nS: (2-)24\n\n\n615-015-00-3\n1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;\nisobornyl thiocyanoacetate\n204-081-5\n115-31-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)24/25-60-61\n\n\n615-016-00-9\npotassium cyanate\n209-676-3\n590-28-3\nXn; R22\nXn\nR: 22\nS: (2-)24/25\n\n\n615-017-00-4\ncalcium cyanamide\n205-861-8\n156-62-7\nXn; R22\nXi; R37-41\nXn\nR: 22-37-41\nS: (2-)22-26-36/37/39\n\n\n615-018-00-X\n2-(2-butoxyethoxy)ethyl thiocyanate\n203-985-7\n112-56-1\nR10\nT; R24/25\nT\nR: 10-24/25\nS: (1/2-)13-36/37-45\n\n\n615-019-00-5\ndicyclohexylcarbodiimide\n208-704-1\n538-75-0\nT; R24\nXn; R22\nXi; R41\nR43\nT\nR: 22-24-41-43\nS: (1/2-)24-26-37/39-45\n\n\n615-020-00-0\nmethylene dithiocyanate\n228-652-3\n6317-18-6\nT+; R26\nT; R25\nC; R34\nR43\nN; R50\nT+; N\nR: 25-26-34-43-50\nS: (1/2-)26-28-36/37/39-45-61\n\n\n615-021-00-6\n1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;\nTGIC\n219-514-3\n2451-62-9\nMuta. Cat. 2; R46\nT; R23/25\nXn; R48/22\nXi; R41\nR43\nR52-53\nT\nR: 46-23/25-41-43-48/22-52/53\nS: 53-45-61\n\nE\n\n\n615-022-00-1\nmethyl 3-isocyanatosulfonyl-2-thiophene-carboxylate\n410-550-7\n79277-18-2\nR14\nXn; R48/22\nR42/43\nXn\nR: 14-42/43-48/22\nS: (2-)22-30-35-36/37-45\n\n\n\n615-023-00-7\n2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;\n(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate\n410-900-9\n83056-32-0\nR10\nR14\nMuta. Cat. 3; R68\nXn; R20-48/22\nXi; R41\nR42\nXn\nR: 10-14-20-41-42-48/22-68\nS: (2-)23-26-36/37/39\n\n\n615-024-00-2\n2-phenylethylisocyanate\n413-080-0\n1943-82-4\nT; R23\nXn; R22\nC; R35\nR42/43\nN; R51-53\nT; C; N\nR: 22-23-35-42/43-51/53\nS: (1/2-)23-26-36/37/39-43-45-61\n\n\n615-025-00-8\n4,4'-ethylidenediphenyl dicyanate\n405-740-1\n47073-92-7\nXn; R20/22-48/22\nXi; R41\nN; R50-53\nXn; N\nR: 20/22-41-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n615-026-00-3\n4,4'-methylenebis(2,6-dimethylphenyl cyanate)\n405-790-4\n101657-77-6\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)22-24-37-61\n\n\n\n\n\n615-028-00-4\nethyl 2-(isocyanatosulfonyl)benzoate\n410-220-2\n77375-79-2\nR14\nXn; R22-48/22\nXi; R41\nR42/43\nXn\nR: 14-22-41-42/43-48/22\nS: (2-)8-23-26-30-35-36/37/39\n\n\n\n615-029-00-X\n2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane\n411-280-2\n—\nT+; R26\nXn; R22\nC; R34\nR42/43\nR52-53\nT+\nR: 22-26-34-42/43-52/53\nS: (1/2-)23-26-28-36/37/39-45-61\n\n\n\n\n615-030-00-5\nalkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nR52-53\nXn\nR: 20/21/22-32-52/53\nS: (2-)13-36/37-46-61\n\nA\n\n615-031-00-0\nthallium thiocyanate\n222-571-7\n3535-84-0\nT+; R26/28\nXn; R21\nR32\nR33\nN; R51-53\nT+; N\nR: 21-26/28-32-33-51/53\nS: (1/2-)13-28-36/37-45-61\n\n\n\n615-032-00-6\nmetal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex\n—\n—\nXn; R20/21/22\nR32\nN; R50-53\nXn; N\nR: 20/21/22-32-50/53\nS: (2-)13-36/37-46-60-61\n\nA\n\n\n\n615-033-00-1\nreaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)\n430-980-9\n-\nR53\nR: 53\nS: 61\n\n\n\n615-034-00-7\nreaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)\n430-750-8\n-\nR53\nR: 53\nS: 61\n\n\n\n615-035-00-2\nreaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)\n430-930-6\n122886-55-9\nR53\nR: 53\nS: 61\n\n\n\n615-036-00-8\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)\n430-940-0\n-\nR53\nR: 53\nS: 61\n\n\n\n615-037-00-3\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)\n430-950-5\n-\nR53\nR: 53\nS: 61\n\n\n\n615-038-00-9\nreaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)\n430-960-1\n-\nR53\nR: 53\nS: 61\n\n\n\n615-039-00-4\nreaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)\n430-970-4\n-\nR53\nR: 53\nS: 61\n\n\n\n615-044-00-1\n4-chlorophenylisocyanate\n203-176-9\n104-12-1\nT+; R26\nXn; R22\nXi; R37/38-41\nR42\nN; R50-53\nT+; N\nR: 22-26-37/38-41-42-50/53\nS: (1/2-)26-28-36/37/39-45-63-60-61\n\n\n\n615-045-00-7\n4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)\n420-530-1\n-\nR42/43\nR53\nXn\nR: 42/43-53\nS: (2-)23-24-37-45-61\n\n\n\n616-001-00-X\nN,N-dimethylformamide;\ndimethyl formamide\n200-679-5\n68-12-2\nRepr. Cat. 2; R61\nXn; R20/21\nXi; R36\nT\nR: 61-20/21-36\nS: 53-45\n\nE\n616-002-00-5\n2-fluoroacetamide\n211-363-1\n640-19-7\nT+; R28\nT; R24\nT+\nR: 24-28\nS: (1/2-)36/37-45\n\n\n616-003-00-0\nacrylamide;\nprop-2-enamide\n201-173-7\n79-06-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 3; R62\nT; R25-48/23/24/25\nXn; R20/21\nXi; R36/38\nR43\nT\nR: 45-46-20/21-25-36/38-43-48/23/24/25-62\nS: 53-45\n\nDE\n616-004-00-6\nallidochlor (ISO);\nN,N-diallylchloroacetamide\n202-270-7\n93-71-0\nXn; R21/22\nXi; R36/38\nN; R51-53\nXn; N\nR: 21/22-36/38-51/53\nS: (2-)26-28-36/37/39-61\n\n\n616-005-00-1\nchlorthiamid (ISO);\n2,6-dichloro (thiobenzamide)\n217-637-7\n1918-13-4\nXn; R22\nXn\nR: 22\nS: (2-)36\n\n\n\n\n616-006-00-7\ndichlofluanid (ISO);\nN-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide\n214-118-7\n1085-98-9\nXn; R20\nXi; R36\nR43\nN; R50\nXn; N\nR: 20-36-43-50\nS: (2-)24-37-61\nN; R50: C ≥ 2,5 %\n\n\n616-007-00-2\ndiphenamid (ISO);\nN,N-dimethyl-2,2-diphenylacetamide\n213-482-4\n957-51-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n616-008-00-8\npropachlor (ISO);\n2-chloro-N-isopropylacetanilide;\nα-chloro-N-isopropylacetanilide\n217-638-2\n1918-16-7\nXn; R22\nXi; R36\nR43\nN; R50-53\nXn; N\nR: 22-36-43-50/53\nS: (2-)24-37-60-61\n\n\n\n\n616-009-00-3\npropanil (ISO);\n3', 4'-dichloropropionanilide\n211-914-6\n709-98-8\nXn; R22\nN; R50\nXn; N\nR: 22-50\nS: (2-)22-61\nN; R50: C ≥ 2,5 %\n\n\n\n616-010-00-9\ntosylchloramide sodium\n204-854-7\n127-65-1\nXn; R22\nR31\nC; R34\nR42\nC\nR: 22-31-34-42\nS: (1/2-)7-22-26-36/37/39-45\n\n\n616-011-00-4\nN,N-dimethylacetamide\n204-826-4\n127-19-5\nRepr. Cat. 2; R61\nXn; R20/21\nT\nR: 61-20/21\nS: 53-45\nRepr. Cat. 2; R61: C ≥ 5 %\nE\n616-012-00-X\nN-(dichlorofluoromethylthio)phthalimide;\nN-(fluorodichloromethylthio)phthalimide\n211-952-3\n719-96-0\nXi; R38\nXi\nR: 38\nS: (2-)28\n\n\n616-013-00-5\nbutyraldehyde oxime\n203-792-8\n110-69-0\nT; R24\nXn; R22\nXi; R36\nT\nR: 22-24-36\nS: (1/2-)23-36-45\n\n\n616-014-00-0\n2-butanone oxime;\nethyl methyl ketoxime;\nethyl methyl ketone oxime\n202-496-6\n96-29-7\nCarc. Cat. 3; R40\nXn; R21\nXi; R41\nR43\nXn\nR: 21-40-41-43\nS: (2-)13-23-26-36/37/39\n\n\n616-015-00-6\nalachlor (ISO);\n2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide\n240-110-8\n15972-60-8\nCarc. Cat. 3; R40\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-40-43-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 0,2,5 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n616-016-00-1\n1-(3,4-dichlorophenylimino) thiosemicarbazide\n—\n5836-73-7\nT+; R28\nT+\nR: 28\nS: (1/2-)22-36/37-45\n\n\n616-017-00-7\ncartap hydrochloride\n239-309-2\n15263-52-2\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-50/53\nS: (2-)36/37-60-61\n\n\n616-018-00-2\nN,N-diethyl-m-toluamide;\ndeet\n205-149-7\n134-62-3\nXn; R22\nXi; R36/38\nR52-53\nXn\nR: 22-36/38-52/53\nS: (2-)61\n\n\n616-019-00-8\nperfluidone (ISO);\n1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide\n253-718-3\n37924-13-3\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)\n\n\n616-020-00-3\ntebuthiuron (ISO);\n1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n251-793-7\n34014-18-1\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)37-60-61\n\n\n616-021-00-9\nthiazafluron (ISO);\n1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea\n246-901-4\n25366-23-8\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)60-61\n\n\n616-022-00-4\nacetamide\n200-473-5\n60-35-5\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\n\n616-023-00-X\nN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide\n401-980-6\n—\nXi; R38\nR43\nXi\nR: 38-43\nS: (2-)24-37\n\n\n616-024-00-5\n2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide\n402-260-4\n54942-74-4\nR53\nR: 53\nS: 61\n\n\n616-025-00-0\nvalinamide\n402-840-7\n20108-78-5\nRepr. Cat. 3; R62\nXi; R36\nR43\nXn\nR: 36-43-62\nS: (2-)26-36/37\n\n\n616-026-00-6\nthioacetamide\n200-541-4\n62-55-5\nCarc. Cat. 2; R45\nXn; R22\nXi; R36/38\nR52-53\nT\nR: 45-22-36/38-52/53\nS: 53-45-61\n\nE\n616-027-00-1\ntris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate\n403-760-5\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-028-00-7\nN-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n403-790-9\n108673-51-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-029-00-2\nN,N'-ethylenebis(vinylsulfonylacetamide)\n404-790-1\n66710-66-5\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)24-26-37/39\n\n\n616-030-00-8\nethidimuron (ISO);\n1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea\n250-010-6\n30043-49-3\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-031-00-3\ndimethachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide\n256-625-6\n50563-36-5\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-60-61\n\n\n616-032-00-9\ndiflufenican (ISO);\nN-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide\n—\n83164-33-4\nR52-53\nR: 52/53\nS: 61\n\n\n616-033-00-4\ncyprofuram (ISO);\nN-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide\n274-050-9\n69581-33-5\nT; R25\nXn; R21\nN; R50-53\nT; N\nR: 21-25-50/53\nS: (1/2-)36/37-60-61\n\n\n616-034-00-X\npyracarbolid (ISO);\n3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide\n246-419-4\n24691-76-7\nR52-53\nR: 52/53\nS: 61\n\n\n616-035-00-5\ncymoxanil (ISO);\n2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide\n261-043-0\n57966-95-7\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)36/37-60-61\n\n\n616-036-00-0\n2-chloracetamide\n201-174-2\n79-07-2\nRepr. Cat. 3; R62\nT; R25\nR43\nT\nR: 25-43-62\nS: (1/2-)22-36/37-45\nR43: C ≥ 0,1 %\n\n616-037-00-6\nacetochlor (ISO);\n2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide\n251-899-3\n34256-82-1\nXn; R20\nXi; R37/38\nR43\nN; R50-53\nXn; N\nR: 20-37/38-43-50/53\nS: (2-)36/37-60-61\n\n\n616-038-00-1\n(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride\n406-010-5\n88918-84-7\nXi; R41\nR43\nN; R51-53\nXi; N\nR: 41-43-51/53\nS: (2-)24-26-37/39-61\n\n\n616-039-00-7\n3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide\n406-200-8\n117827-06-2\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-040-00-2\npotassium N-(4-toluenesulfonyl)-4-toluenesulfonamide\n406-650-5\n97888-41-0\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n616-041-00-8\n3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide\n406-840-8\n101664-25-9\nR53\nR: 53\nS: 61\n\n\n616-042-00-3\nN-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide\n407-070-5\n142859-67-4\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n616-043-00-9\nisoxaben (ISO);\nN-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide\n407-190-8\n82558-50-7\nR53\nR: 53\nS: 61\n\n\n616-044-00-4\nN-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide\n402-510-2\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-045-00-X\n2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide\n405-190-2\n122371-93-1\nR43\nR53\nXi\nR: 43-53\nS: 2-22-24-37-61\n\n\n616-046-00-5\nN-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide\n406-390-2\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-047-00-0\nreaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;\n2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide\n406-640-0\n—\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-048-00-6\n3'-trifluoromethylisobutyranilide\n406-740-4\n1939-27-1\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)22-36-61\n\n\n616-049-00-1\n2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide\n408-150-2\n99141-89-6\nR53\nR: 53\nS: 61\n\n\n616-050-00-7\nlufenuron (ISO);\nN-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide\n410-690-9\n103055-07-8\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-051-00-2\nreaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;\n2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene\n411-070-0\n—\nR53\nR: 53\nS: 61\n\n\n616-052-00-8\nformamide\n200-842-0\n75-12-7\nRepr. Cat. 2; R61\nT\nR: 61\nS: 53-45\n\n\n616-053-00-3\nN-methylacetamide\n201-182-6\n79-16-3\nRepr. Cat. 2; R61\nT\nR: 61\nS: 53-45\n\n\n616-054-00-9\niprodione (ISO);\n3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide\n253-178-9\n36734-19-7\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n616-055-00-4\npropyzamide (ISO);\n3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide\n245-951-4\n23950-58-5\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-50/53\nS: (2-)36/37-60-61\n\n\n616-056-00-X\nN-methylformamide\n204-624-6\n123-39-7\nRepr. Cat. 2; R61\nXn; R21\nT\nR: 61-21\nS: 53-45\n\nE\n616-057-00-5\nreaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nN-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;\nmethacrylamide;\n2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;\nN-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide\n412-790-8\n—\nCarc. Cat. 2; R45\nMuta. Cat. 3; R68\nXn; R48/22\nT\nR: 45-48/22\nS: 53-45\n\nE\n616-058-00-0\n1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene\n412-570-1\n119462-56-5\nXn; R48/22\nXi; R41\nR43\nN; R50-53\nXn; N\nR: 41-43-48/22-50/53\nS: (2-)26-36/37/39-60-61\n\n\n616-059-00-6\n4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide\n412-650-6\n121487-83-0\nR53\nR: 53\nS: 61\n\n\n616-060-00-1\nCondensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)\n413-770-1\n—\nXn; R22\nC; R34\nR43\nN; R50-53\nC; N\nR: 22-34-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n616-061-00-7\nN,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide\n413-610-0\n124172-53-8\nXi; R36\nR52-53\nXi\nR: 36-52/53\nS: (2-)26-61\n\n\n616-062-00-2\nN-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide\n411-590-8\n70693-57-1\nC; R34\nR52-53\nC\nR: 34-52/53\nS: (1/2-)26-36/37/39-45-61\n\n\n616-063-00-8\n3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione\n411-920-0\n106917-30-0\nT; R23\nXn; R22-48/22\nC; R35\nN; R50-53\nT; C; N\nR: 22-23-35-48/22-50/53\nS: (1/2-)26-28-36/37/39-45-60-61\n\n\n616-064-00-3\nN-tert-butyl-3-methylpicolinamide\n406-720-5\n32998-95-1\nR52-53\nR: 52/53\nS: 61\n\n\n616-065-00-9\n3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea\n411-970-3\n79881-89-3\nXn; R22-48/22\nXn\nR: 22-48/22\nS: (2-)22-36\n\n\n616-066-00-4\n5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone\n405-100-1\n115662-06-1\nRepr. Cat. 3; R62\nXn\nR: 62\nS: (2-)22-36/37\n\n\n616-067-00-X\ndodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate\n407-300-4\n92683-20-0\nR53\nR: 53\nS: 61\n\n\n616-068-00-5\npotassium 4-(11-methacrylamidoundecanamido)benzenesulfonate\n406-500-9\n174393-75-0\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n616-069-00-0\n1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide\n406-210-2\n110560-22-0\nR53\nR: 53\nS: 61\n\n\n616-070-00-6\nreaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;\n3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-530-2\n—\nR53\nR: 53\nS: 22-61\n\n\n616-071-00-1\nreaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;\nbis(N-octadecyl-N'-phenyleneureido)methylene;\nbis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)\n406-550-1\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)22-24-37-61\n\n\n616-072-00-7\n1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine\n407-120-6\n55612-11-8\nR53\nR: 53\nS: 61\n\n\n616-073-00-2\n4'-ethoxy-2-benzimidazoleanilide\n407-600-5\n120187-29-3\nMuta. Cat. 3; R68\nR53\nXn\nR: 68-53\nS: (2-)22-36/37-61\n\n\n616-074-00-8\nN-butyl-2-(4-morpholinylcarbonyl)benzamide\n407-730-2\n104958-67-0\nXi; R36\nR43\nR52-53\nXi\nR: 36-43-52/53\nS: (2-)24-26-37-61\n\n\n616-075-00-3\nD,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)\n408-120-9\n65197-96-8\nXn; R22\nXi; R41\nXn\nR: 22-41\nS: (2-)26-39-46\n\n\n616-076-00-9\ntebufenozide (ISO);\nN-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide\n412-850-3\n112410-23-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-077-00-4\nreaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;\npotassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate\n411-310-4\n—\nXi; R41\nXi\nR: 41\nS: (2-)26-39\n\n\n616-078-00-X\n2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide\n411-330-3\n104541-33-5\nR53\nR: 53\nS: 61\n\n\n616-079-00-5\n1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate\n411-700-4\n140921-24-0\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-080-00-0\n4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)\n411-850-0\n119018-29-0\nR52-53\nR: 52/53\nS: 61\n\n\n616-081-00-6\n5-bromo-8-naphtholactam\n413-480-5\n24856-00-6\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)22-24-37-60-61\n\n\n616-082-00-1\nN-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide\n413-200-1\n129604-78-0\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n616-083-00-7\n[2-[(4-nitrophenyl)amino]ethyl]urea\n410-700-1\n27080-42-8\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n616-084-00-2\n2,4-bis[N'-(4-methylphenyl)ureido]toluene\n411-790-5\n—\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-085-00-8\n3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione\n412-190-6\n168900-02-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-086-00-3\n2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene\n412-250-1\n102387-48-4\nR53\nR: 53\nS: 61\n\n\n616-087-00-9\nreaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;\n7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate\n412-260-6\n52658-19-2\nXi; R36\nR43\nN; R51-53\nXi; N\nR: 36-43-51/53\nS: (2-)26-36/37-61\n\n\n616-088-00-4\n2-aminosulfonyl-N,N-dimethylnicotinamide\n413-440-7\n112006-75-4\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)24-37-61\n\n\n616-089-00-X\n5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran\n415-360-8\n41107-56-6\nMuta. Cat. 3; R68\nXn\nR: 68\nS: (2-)22-36/37\n\n\n616-090-00-5\n1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride\n415-660-9\n70918-74-0\nT; R23/24/25\nXn; R48/22\nN; R51-53\nT; N\nR: 23/24/25-48/22-51/53\nS: 53-45-61\n\n\n616-091-00-0\n1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione\n423-400-0\n59653-74-6\nMuta. Cat. 2; R46\nT; R23\nXn; R22-48/22\nXi; R41\nR43\nT\nR: 46-22-23-41-43-48/22\nS: 53-45\n\nE\n616-092-00-6\nPolymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide\n404-035-6\n—\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-093-00-1\nReaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride\n406-620-1\n129217-90-9\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n616-094-00-7\n3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-370-3\n58890-25-8\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n616-095-00-2\n3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea\n406-690-3\n43136-14-7\nR53\nR: 53\nS: 61\n\n\n616-096-00-8\nN-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide\n408-110-4\n110483-07-3\nR53\nR: 53\nS: 61\n\n\n616-097-00-3\nN,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide\n411-840-6\n83372-55-8\nR53\nR: 53\nS: 61\n\n\n616-098-00-9\n1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide\n411-750-7\n119126-15-7\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-099-00-4\n2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide\n414-170-2\n135937-20-1\nR53\nR: 53\nS: 61\n\n\n616-100-00-8\n1,3-dimethyl-1,3-bis(trimethylsilyl)urea\n414-180-7\n10218-17-4\nXn; R22\nXi; R38\nXn\nR: 22-38\nS: (2-)36/37\n\n\n616-101-00-3\n(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide\n414-600-9\n149182-72-9\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n616-102-00-9\nreaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);\n1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;\n1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]\n415-870-0\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)36/37-61\n\n\n616-103-00-4\n(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide\n415-030-3\n120298-38-6\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-60-61\n\n\n616-104-00-X\nbenalaxyl (ISO);\nmethyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate\n275-728-7\n71626-11-4\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-105-00-5\nchlorotoluron (ISO);\n3-(3-chloro-p-tolyl)-1,1-dimethylurea\n239-592-2\n15545-48-9\nCarc. Cat. 3; R40\nRepr. Cat. 3; R63\nN; R50-53\nXn; N\nR: 40-63-50/53\nS: (2-)26-36/37-46-60-61\n\n\n616-106-00-0\nphenmedipham (ISO);\nmethyl 3-(3-methylcarbaniloyloxy)carbanilate\n237-199-0\n13684-63-4\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n616-107-00-6\ncinidon ethyl (ISO);\nethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate\n-\n142891-20-1\nCarc. Cat. 3; R40\nR43\nN; R50-53\nXn; N\nR: 40-43-50/53\nS: (2-)24-37-46-60-61\n\n\n\n\n616-108-00-1\niodosulfuron-methyl-sodium;\nsodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide\n—\n144550-36-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-109-00-7\nsulfosulfuron (ISO);\n1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea\n—\n141776-32-1\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-110-00-2\ncyclanilide (ISO);\n1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid\n419-150-7\n113136-77-9\nXn; R22\nN; R51-53\nXn; N\nR: 22-51/53\nS: (2-)61\n\n\n616-111-00-8\nfenhexamid (ISO);\nN-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid\n422-530-5\n126833-17-8\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n616-112-00-3\noxasulfuron (ISO);\noxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate\n—\n144651-06-9\nXn; R48/22\nN; R50-53\nXn; N\nR: 48/22-50/53\nS: (2-)46-60-61\n\n\n616-113-00-9\ndesmedipham (ISO);\nethyl 3-phenylcarbamoyloxyphenylcarbamate\n237-198-5\n13684-56-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n616-114-00-4\ndodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-\n418-010-2\n136897-58-0\nR53\nR: 53\nS: 22-61\n\n\n616-115-00-X\nN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide\n416-150-9\n136450-06-1\nR53\nR: 53\nS: 61\n\n\n616-116-00-5\nN-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate\n416-790-9\n143052-96-4\nR53\nR: 53\nS: 61\n\n\n616-117-00-0\nN-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide\n416-860-9\n777891-21-1\nRepr. Cat. 3; R62\nR43\nN; R50-53\nXn; N\nR: 43-62-50/53\nS: (2-)22-36/37-60-61\n\n\n616-118-00-6\nN-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride\n417-950-0\n65797-42-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n616-119-00-1\n2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide\n418-060-5\n118020-93-2\nR53\nR: 53\nS: 61\n\n\n616-120-00-7\nreaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-2-methyl-phenyl)-benzamide;\nN-(3-dimethylamino-3-methyl-phenyl)-benzamide\n420-600-1\n—\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36/37-61\n\n\n616-121-00-2\n2,4-dihydroxy-N-(2-methoxyphenyl)benzamide\n419-090-1\n129205-19-2\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n\n616-122-00-8\nmethylneodecanamide\n414-460-9\n105726-67-8\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n\n616-123-00-3\nN-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide\n414-740-0\n96141-86-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n\n616-124-00-9\nlithium bis(trifluoromethylsulfonyl)imide\n415-300-0\n90076-65-6\nT; R24/25\nXn; R48/22\nC; R34\nR52-53\nT\nR: 24/25-34-48/22-52/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n\n616-125-00-4\n3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide\n415-730-9\n151338-11-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n\n616-126-00-X\n1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide\n423-960-6\n139756-01-7\nXn; R22-48/22\nR52-53\nXn\nR: 22-48/22-52/53\nS: (2-)22-36/37-61\n\n\n\n616-127-00-5\nreaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);\n12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;\nN,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n430-050-2\n—\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n616-128-00-0\nN-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide\n417-530-7\n123590-00-1\nR53\nR: 53\nS: 61\n\n\n616-129-00-6\nN,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide\n419-710-0\n42774-15-2\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22-25-26\n\n\n616-130-00-1\nN-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide\n421-780-2\n150919-56-5\nR53\nR: 53\nS: 61\n\n\n\n\n616-131-00-7\n1-aminocyclopentanecarboxamide\n422-950-9\n17193-28-1\nT; R48/25\nXn; R22\nXi; R41\nT\nR: 22-41-48/25\nS: (1/2-)22-26-36/39-45\n\n\n\n\n616-132-00-2\nN-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide\n423-250-6\n130016-98-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n616-133-00-8\nN-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide\n423-990-1\n149118-66-1\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)22-26-39-60-61\n\n\n616-134-00-3\n3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide\n401-820-5\n793710-14-2\nR52-53\nR: 52/53\nS: 61\n\n\n616-135-00-9\n(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide\n430-230-0\n136522-17-3\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-61\n\n\n\n\n616-136-00-4\nreaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)\n430-380-7\n-\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n\n616-137-00-X\n4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane\n401-130-4\n71526-07-3\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-138-00-5\nbenzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide\n431-600-4\n112226-61-6\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-139-00-0\n(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide\n420-380-5\n136465-81-1\nXn; R22\nXi; R41\nR52-53\nXn\nR: 22-41-52/53\nS: (2-)22-26-39-61\n\n\n\n616-140-00-6\nN,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]\n429-380-1\n133336-92-2\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-141-00-1\nzoxamide (ISO);\n(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide\n-\n156052-68-5\nR43\nN; R50-53\nXi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-142-00-7\n1,3-Bis(vinylsulfonylacetamido)propane\n428-350-3\n93629-90-4\nMuta. Cat. 3; R68\nXi; R41\nR43\nR52-53\nXn\nR: 41-43-68-52/53\nS: (2-)22-26-36/37/39-61\n\n\n616-143-00-2\nN,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide\n422-560-9\n149591-38-8\nRepr. Cat. 3; R62\nXi; R36\nR53\nXn\nR: 36-62-53\nS: (2-)26-36/37-61\n\n\n\n\n616-144-00-8\n3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-130-1\n-\nR53\nR: 53\nS: 61\n\n\n\n616-145-00-3\npethoxamide (ISO);\n2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide\n-\n106700-29-2\nXn; R22\nR43\nN; R50-53\nXn; N\nR: 22-43-50/53\nS: (2-)24-37-46-60-61\nN; R50-53: C ≥ 0, 25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n616-146-00-9\nN-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide\n431-330-7\n142776-95-2\nR53\nR: 53\nS: 22-61\n\n\n\n616-147-00-4\n1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide\n424-160-1\n139481-22-4\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)61\n\n\n\n616-148-00-X\nN-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide\n424-550-1\n84245-12-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT\nR: 45-46-60-61\nS: 53-45\n\n\n\n616-150-00-0\n(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride\n425-260-6\n-\nXn; R48/22\nXi; R41\nR43\nN; R51-53\nXn; N\nR: 41-43-48/22-51/53\nS: (2-)22-26-36/37/39-61\n\n\n\n616-151-00-6\nN-(2-amino-4,6-dichloropyrimidin-5-yl)formamide\n425-650-6\n171887-03-9\nXn; R22\nXi; R41\nR43\nR52-53\nXn\nR: 22-41-43-52/53\nS: (2-)24-26-37/39-61\n\n\n\n616-152-00-1\n4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide\n425-850-3\n125971-96-2\nR53\nR: 53\nS: 61\n\n\n\n616-153-00-7\n4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide\n425-860-8\n125971-57-5\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)22-24-37-61\n\n\n\n616-154-00-2\n3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide\n431-110-0\n-\nR53\nR: 53\nS: 61\n\n\n\n616-155-00-8\nN,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide\n431-040-0\n104560-40-9\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-156-00-3\n6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide\n430-500-8\n204277-61-2\nR53\nR: 53\nS: 61\n\n\n\n616-157-00-9\n3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride\n427-780-9\n114565-70-7\nXn; R22\nXi; R41\nN; R50-53\nXn; N\nR: 22-41-50/53\nS: (2-)26-39-60-61\n\n\n\n616-158-00-4\nN-[4-cyano-3-trifluoromethylphenyl]methacrylamide\n427-880-2\n90357-53-2\nXn; R48/22\nN; R51-53\nXn; N\nR: 48/22-51/53\nS: (2-)36-61\n\n\n\n616-160-00-5\n2,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]\n429-090-3\n61551-69-7\nR43\nR52-53\nXi\nR: 43-52/53\nS: (2-)12-15-24-37-61\n\n\n\n616-161-00-0\n2,4-dichloro-5-hydroxyacetanilide\n429-110-0\n67669-19-6\nR52-53\nR: 52/53\nS: 61\n\n\n\n616-162-00-6\nisostearic acid monoisopropanolamide\n431-540-9\n-\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)37-61\n\n\n\n616-163-00-1\n4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]\n430-350-3\n192463-88-0\nR53\nR: 53\nS: 61\n\n\n\n616-164-00-7\ndimoxystrobin (ISO);\n(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide\n-\n149961-52-4\nCarc. Cat. 3; R40\nRepr. Cat. 3; R63\nXn; R20\nN; R50-53\nXn; N\nR: 20-40-63-50/53\nS: (2-)36/37-46-60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-165-00-2\nbeflubutamid (ISO);\n(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide\n-\n113614-08-7\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %\n\n\n616-166-00-8\ncyazofamid (ISO);\n4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide\n-\n120116-88-3\nN; R50-53\nN\nR: 50/53\nS: 60-61\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %\n\n\n616-167-00-3\nN,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide\n418-290-6\n168612-06-4\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)24-26-37\n\n\n\n616-168-00-9\n1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium\n418-440-0\n136997-71-2\nR43\nXi\nR: 43\nS: (2-)22-24-37\n\n\n\n616-169-00-4\n4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one\n420-220-4\n92771-56-7\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-170-00-X\n(2R)-2-amino-2-phenylacetamide\n420-370-0\n6485-67-2\nXi; R36\nR43\nXi\nR: 36-43\nS: (2-)22-26-36/37\n\n\n\n616-171-00-5\n2-(para-chlorophenyl)glycineamide\n420-830-0\n102333-75-5\nXi; R41\nR43\nXi\nR: 41-43\nS: (2-)24-26-37/39\n\n\n\n616-172-00-0\nN-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;\n(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl\n423-840-3\n14691-89-5\nXn; R22\nXn\nR: 22\nS: (2-)22\n\n\n\n616-174-00-1\n2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride\n424-560-4\n151257-01-1\nXn; R22\nXi; R36\nXn\nR: 22-36\nS: (2-)22-26\n\n\n\n616-175-00-7\n2-(2-hexyldecyloxy)benzamide\n431-230-3\n202483-62-3\nR53\nR: 53\nS: 61\n\n\n\n616-176-00-2\n3-N,N-bis(methoxyethyl)aminoacetanilide\n432-530-7\n24294-01-7\nXn; R22\nR52-53\nXn\nR: 22-52/53\nS: (2-)22-24-61\n\n\n\n616-177-00-8\n(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;\nN-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide\n432-970-1\n217324-98-6\nR53\nR: 53\nS: 61\n\n\n\n616-178-00-3\nN-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide\n434-500-9\n52583-35-4\nR53\nR: 53\nS: 22-61\n\n\n\n616-179-00-9\n2-chloro-N-(4-methylphenyl)acetamide\n435-170-9\n16634-82-5\nXi; R41\nR43\nN; R50-53\nXi; N\nR: 41-43-50/53\nS: (2-)22-26-36/37/39-60-61\n\n\n\n616-180-00-4\nN,N-(dimethylamino)thioacetamide hydrochloride\n435-470-1\n27366-72-9\nRepr. Cat. 2; R61\nN; R50-53\nT; N\nR: 61-50/53\nS: 53-45-60-61\n\n\n\n616-181-00-X\n4'-methyldodecane-1-sulfonanilide\n435-490-9\n17417-32-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-182-00-5\nN'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide\n435-860-1\n214417-91-1\nR43\nN; R51-53\nXi; N\nR: 43-51/53\nS: (2-)24-37-61\n\n\n\n616-183-00-0\nN-dodecyl-4-methoxybenzamide\n442-340-6\n1854-15-5\nR53\nR: 53\nS: 61\n\n\n\n616-184-00-6\n3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide\n442-560-2\n105043-55-8\nR53\nR: 53\nS: 61\n\n\n\n616-186-00-7\nN,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)\n443-010-4\n53641-10-4\nR52-53\nR: 52/53\nS: 61\n\n\n\n616-188-00-8\n2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide\n443-980-9\n221215-20-9\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-189-00-3\nN-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide\n444-780-4\n452962-97-9\nR53\nR: 53\nS: 61\n\n\n\n616-190-00-9\nN-decyl-4-nitrobenzamide\n445-880-0\n64026-19-3\nR53\nR: 53\nS: 61\n\n\n\n616-191-00-4\n2-ethyl-N-methyl-N-(3-methylphenyl)butanamide\n446-190-2\n406488-30-0\nXn; R22\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 22-36/38-43-51/53\nS: (2-)24-26-37-61\n\n\n\n616-192-00-X\n2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide\n448-060-0\n727678-39-9\nR53\nR: 53\nS: 61\n\n\n\n616-193-00-5\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide\n449-940-7\n368450-39-9\nR53\nR: 53\nS: 61\n\n\n\n616-194-00-0\n2,2-diethoxy-N,N-dimethylacetamide\n449-950-1\n34640-92-1\nXi; R36\nXi\nR: 36\nS: (2-)26\n\n\n\n616-196-00-1\ndisodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide\n419-990-4\n-\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n\n616-197-00-7\nreaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;\nN-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide\n422-500-1\n-\nXn; R48/22\nXn\nR: 48/22\nS: (2-)22-36\n\n\n\n616-198-00-2\n1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene\n423-300-7\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-200-00-1\nreaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);\n12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;\nN,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)\n432-430-3\n-\nR43\nR53\nXi\nR: 43-53\nS: (2-)24-37-61\n\n\n\n616-201-00-7\n12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine\n432-840-2\n220926-97-6\nXn; R20\nR53\nXn\nR: 20-53\nS: (2-)22-61\n\n\n\n616-202-00-2\nreaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;\n2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide\n434-330-5\n-\nCarc. Cat. 3; R40\nR43\nR53\nXn\nR: 40-43-53\nS: (2-)36/37-61\n\n\n\n616-203-00-8\nreaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;\nN-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide\n442-280-0\n-\nR53\nR: 53\nS: 61\n\n\n\n616-204-00-3\nN,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]\n451-060-3\n122886-55-9\nR53\nR: 53\nS: 61\n\n\n\n\n616-205-00-9\nMetazachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide\n266-583-0\n67129-08-2\nR43\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-43-50/53\nS: (2-)36-37-60-61\nN; R50-53: C ≥ 0,25%\nN; R51-53: 0,025% ≤ C < 0,25%\nR52-53: 0,0025% ≤ C < 0,025%\n\n\n\n617-001-00-2\ndi-tert-butyl peroxide\n203-733-6\n110-05-4\nO; R7\nF; R11\nMuta. Cat. 3, R68\nO; F; Xn\nR: 7-11-68\nS: (2-)3/7-14-16-23-36/37/39\n\n\n\n617-002-00-8\nα,α-dimethylbenzyl hydroperoxide;\ncumene hydroperoxide\n201-254-7\n80-15-9\nO; R7\nT; R23\nXn; R21/22-48/20/22\nC; R34\nN; R51-53\nO; T; N\nR: 7-21/22-23-34-48/20/22-51/53\nS: (1/2-)3/7-14-36/37/39-45-50-61\nC; R34: C ≥ 10 %\nXi; R37/38-41: 3 % ≤ C < 10 %\nXi; R36/37: 1 % ≤ C < 3 %\n\n617-003-00-3\ndilauroyl peroxide\n203-326-3\n105-74-8\nO; R7\nO\nR: 7\nS: (2-)3/7-14-36/37/39\n\n\n617-004-00-9\n1,2,3,4-tetrahydro-1-naphthyl hydroperoxide\n212-230-0\n771-29-9\nO; R7\nXn; R22\nC; R34\nN; R50-53\nO; C; N\nR: 7-22-34-50/53\nS: (1/2-)3/7-14-26-36/37/39-45-60-61\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n617-006-00-X\nbis(α,α-dimethylbenzyl) peroxide\n201-279-3\n80-43-3\nO; R7\nXi; R36/38\nN; R51-53\nO; Xi; N\nR: 7-36/38-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n617-007-00-5\ntert-butyl α,α-dimethylbenzyl peroxide\n222-389-8\n3457-61-2\nO; R7\nXi; R38\nN; R51-53\nO; Xi; N\nR: 7-38-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n\n\n617-008-00-0\ndibenzoyl peroxide;\nbenzoyl peroxide\n202-327-6\n94-36-0\nE; R3\nO; R7\nXi; R36\nR43\nE; Xi\nR: 3-7-36-43\nS: (2-)3/7-14-36/37/39\n\n\n\n617-010-00-1\n1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]\n201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]\n78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]\nE; R3\nO; R7\nC; R34\nXn; R22\nE; C\nR: 3-7-22-34\nS: (1/2-)3/7-14-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nC\n\n617-012-00-2\n8-p-menthyl hydroperoxide;\np-menthane hydroperoxide\n201-281-4\n80-47-7\nO; R7\nC; R34\nXn; R20\nO; C\nR: 7-20-34\nS: (1/2-)3/7-14-36/37/39-45\nC; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\n\n617-013-00-8\nO,O-tert-butyl O-docosyl monoperoxyoxalate\n404-300-6\n116753-76-5\nO; R7\nN; R50-53\nO; N\nR: 7-50/53\nS: (2-)7-14-36/37/39-47-60-61\n\n\n617-014-00-3\n6-(nonylamino)-6-oxo-peroxyhexanoic acid\n406-680-9\n104788-63-8\nO; R7\nXi; R41\nR43\nN; R50\nO; Xi; N\nR: 7-41-43-50\nS: (2-)3/7-14-26-36/37/39-61\n\n\n617-015-00-9\nbis(4-methylbenzoyl)peroxide\n407-950-9\n895-85-2\nE; R2\nO; R7\nN; R50-53\nE; N\nR: 2-7-50/53\nS: (2-)7-14-36/37/39-47-60-61\n\n\n617-016-00-4\n3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate\n413-910-1\n—\nO; R7\nR10\nXi; R38\nN; R50-53\nO; Xi; N\nR: 7-10-38-50/53\nS: (2-)7/47-14-36/37/39-60-61\n\n\n\n\n617-017-00-X\nreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;\n2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene\n412-140-3\n32144-25-5\nE; R2\nO; R7\nR53\nE\nR: 2-7-53\nS: (2-)3/7-14-36/37/39-61\n\nT\n\n617-018-00-5\nreaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;\n1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight\n410-840-3\n71566-50-2\nO; R7\nN; R51-53\nO; N\nR: 7-51/53\nS: (2-)3/7-14-36/37/39-61\n\n\n617-019-00-0\n6-(phthalimido)peroxyhexanoic acid\n410-850-8\n128275-31-0\nO; R7\nXi; R41\nN; R50\nO; Xi; N\nR: 7-41-50\nS: (2-)3/7-14-26-36/37/39-61\n\n\n617-020-00-6\n1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)\n420-060-5\n117663-11-3\nR10\nO; R7\nN; R51-53\nO; N\nR: 7-10-51/53\nS: (2-)7-14-36/37/39-47-61\n\n\n\n\n617-021-00-1\nmethylethylketone peroxide trimer\n429-320-2\n-\nE; R2\nO; R7\nXn; R65\nXi; R38\nR43\nE; Xn\nR: 2-7-38-43-65\nS: (2-)3/7-14-23-36/37/39-62\n\n\n\n617-022-00-7\nreaction mass of: 1,2-dimethylpropylidene dihydroperoxide;\ndimethyl 1,2-benzenedicarboxylate\n442-480-8\n-\nO; R7\nXn; R22\nC; R34\nR43\nN; R51-53\nO; C; N\nR: 7-22-34-43-51/53\nS: (1/2-)3/7-14-26-36/37/39-45-50-61\n\n\n\n647-001-00-8\nglucosidase, β-\n232-589-7\n9001-22-3\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-002-00-3\ncellulase\n232-734-4\n9012-54-8\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-003-00-9\ncellobiohydrolase, exo-\n253-465-9\n37329-65-0\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-004-00-4\ncellulases with the exception of those specified elsewhere in this Annex\n—\n—\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\nA\n647-005-00-X\nbromelain, juice\n232-572-4\n9001-00-7\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-006-00-5\nficin\n232-599-1\n9001-33-6\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-007-00-0\npapain\n232-627-2\n9001-73-4\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-008-00-6\npepsin A\n232-629-3\n9001-75-6\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-009-00-1\nrennin\n232-645-0\n9001-98-3\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-010-00-7\ntrypsin\n232-650-8\n9002-07-7\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-011-00-2\nchymotrypsin\n232-671-2\n9004-07-3\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-012-00-8\nsubtilisin\n232-752-2\n9014-01-1\nXi; R37/38-41\nR42\nXn\nR: 37/38-41-42\nS: (2-)22-24-26-36/37/39\n\n\n647-013-00-3\nproteinase, microbial neutral\n232-966-6\n9068-59-1\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-014-00-9\nproteases with the exception of those specified elsewhere in this Annex\n—\n—\nXi; R36/37/38\nR42\nXn\nR: 36/37/38-42\nS: (2-)22-24-26-36/37\n\n\n647-015-00-4\namylase, α-\n232-565-6\n9000-90-2\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n647-016-00-X\namylases with the exception of those specified elsewhere in this Annex\n—\n—\nR42\nXn\nR: 42\nS: (2-)22-24-36/37\n\n\n\n\n647-017-00-5\nlaccase\n420-150-4\n80498-15-3\nR42\nXn\nR: 42\nS: (2-)23-45\n\n\n\n\n648-001-00-0\nDistillates (coal tar), benzole fraction;\nLight Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]\n283-482-7\n84650-02-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-002-00-6\nTar oils, brown-coal;\nLight Oil;\n[The distillate from lignite tar boiling in the range of approximately 80 °C to 250 °C (176 °F to 482 °F). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]\n302-674-4\n94114-40-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-003-00-1\nBenzol forerunnings (coal);\nLight Oil Redistillate, low boiling;\n[The distillate from coke oven light oil having an approximate distillation range below 100 °C (212 °F). Composed primarily of C4 to C6 aliphatic hydrocarbons.]\n266-023-5\n65996-88-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-004-00-7\nDistillates (coal tar), benzole fraction, BTX-rich;\nLight Oil Redistillate, low boiling;\n[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 °C to 200 °C (167 °F to 392 °F).]\n309-984-9\n101896-26-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-005-00-2\nAromatic hydrocarbons, C6-10, C8-rich;\nLight Oil Redistillate, low boiling\n292-697-5\n90989-41-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-006-00-8\nSolvent naphtha (coal), light;\nLight Oil Redistillate, low boiling\n287-498-5\n85536-17-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-007-00-3\nSolvent naphtha (coal), xylene-styrene cut;\nLight Oil Redistillate, intermediate boiling\n287-502-5\n85536-20-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-008-00-9\nSolvent naphtha (coal), coumarone-styrene contg.;\nLight Oil Redistillate, intermediate boiling\n287-500-4\n85536-19-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-009-00-4\nNaphtha (coal), distn. residues;\nLight Oil Redistillate, high boiling;\n[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]\n292-636-2\n90641-12-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-010-00-X\nAromatic hydrocarbons, C8;\nLight Oil Redistillate, high boiling\n292-694-9\n90989-38-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-012-00-0\nAromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;\nLight Oil Redistillate, high boiling;\n[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 °C to 215 °C (248 °F to 419 °F).]\n295-281-1\n91995-20-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-013-00-6\nAromatic hydrocarbons, C9-12, benzene distn.;\nLight Oil Redistillate, high boiling\n295-551-9\n92062-36-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-014-00-1\nExtract residues (coal), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 °C to 160 °C (194 °F to 320 °F). It consists predominantly of benzene, toluene and xylenes.]\n295-323-9\n91995-61-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-015-00-7\nExtract residues (coal tar), benzole fraction alk., acid ext.;\nLight Oil Extract Residues, low boiling;\n[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 °C to 195 °C (185 °F to 383 °F).]\n309-868-8\n101316-63-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-016-00-2\nExtract residues (coal), benzole fraction acid;\nLight Oil Extract Residues, low boiling;\n[An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]\n298-725-2\n93821-38-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-017-00-8\nExtract residues (coal), light oil alk., distn. overheads;\nLight Oil Extract Residues, low boiling;\n[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145 °C (293 °F). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]\n292-625-2\n90641-02-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-018-00-3\nExtract residues (coal), light oil alk., acid ext., indene fraction;\nLight Oil Extract Residues, intermediate boiling\n309-867-2\n101316-62-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-019-00-9\nExtract residues (coal), light oil alk., indene naphtha fraction;\nLight Oil Extract Residues, high boiling;\n[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 °C to 180 °C (311 °F to 356 °F). Composed primarily of indene, indan and trimethylbenzenes.]\n292-626-8\n90641-03-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-020-00-4\nSolvent naphtha (coal);\nLight Oil Extract Residues, high boiling;\n[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 °C to 210 °C (266 °F to 410 °F). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]\n266-013-0\n65996-79-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-021-00-X\nDistillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F). May also include unsaturated hydrocarbons such as indene and coumarone.]\n309-971-8\n101794-90-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-022-00-5\nDistillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling;\n[This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 °C to 215 °C (284 °F to 419 °F).]\n292-609-5\n90640-87-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-023-00-0\nDistillates (coal tar), light oils; Carbolic Oil;\n[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 °C to 210 °C (302 °F to 410 °F).]\n283-483-2\n84650-03-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-024-00-6\nTar oils, coal;\nCarbolic Oil;\n[The distillate from high temperature coal tar having an approximate distillation range of 130 °C to 250 °C (266 °F to 410 °F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]\n266-016-7\n65996-82-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-026-00-7\nExtract residues (coal), light oil alk., acid ext.;\nCarbolic Oil Extract Residue;\n[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]\n292-624-7\n90641-01-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-027-00-2\nExtract residues (coal), tar oil alk.;\nCarbolic Oil Extract Residue;\n[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]\n266-021-4\n65996-87-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-028-00-8\nExtract oils (coal), light oil;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-622-6\n90640-99-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-029-00-3\nPyridine, alkyl derivs.;\nCrude Tar Bases;\n[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 °C (302 °F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]\n269-929-9\n68391-11-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-030-00-9\nTar bases, coal, picoline fraction;\nDistillate Bases;\n[Pyridine bases boiling in the range of approximately 125 °C to 160 °C (257 °F 320 °F) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]\n295-548-2\n92062-33-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-031-00-4\nTar bases, coal, lutidine fraction;\nDistillate Bases\n293-766-2\n91082-52-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-032-00-X\nExtract oils (coal), tar base, collidine fraction;\nDistillate Bases;\n[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]\n273-077-3\n68937-63-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-033-00-5\nTar bases, coal, collidine fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 181 °C to 186 °C (356 °F to 367 °F) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]\n295-543-5\n92062-28-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-034-00-0\nTar bases, coal, aniline fraction;\nDistillate Bases;\n[The distillation fraction boiling in the range of approximately 180 °C to 200 °C (356 °F to 392 °F) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]\n295-541-4\n92062-27-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-035-00-6\nTar bases, coal, toluidine fraction;\nDistillate Bases\n293-767-8\n91082-53-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-036-00-1\nDistillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;\nRedistillates;\n[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 °C to 190 °C (320 °F to 374 °F).]\n295-292-1\n91995-31-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-037-00-7\nDistillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 °C to 270 °C (374 °F to 518 °F). Composed primarily of substituted dinuclear aromatics.]\n295-295-8\n91995-35-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-038-00-2\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;\nRedistillates;\n[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 °C to 230 °C (428 °F to 446 °F). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]\n295-329-1\n91995-66-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-039-00-8\nExtract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;\nRedistillates;\n[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225 °C to 255 °C (437 °F to 491 °F). Composed primarily of substituted dinuclear aromatic hydrocarbons.]\n310-170-0\n122070-79-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-040-00-3\nExtract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;\nRedistillates;\n[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 °C to 260 °C (464 °F to 500 °F). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]\n310-171-6\n122070-80-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-041-00-9\nAbsorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]\n309-851-5\n101316-45-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-042-00-4\nDistillates (coal tar), upper, fluorene-rich;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]\n284-900-0\n84989-11-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-043-00-X\nCreosote oil, acenaphthene fraction, acenaphthene-free;\nWash Oil Redistillate;\n[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]\n292-606-9\n90640-85-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-044-00-5\nDistillates (coal tar), heavy oils;\nHeavy Anthracene Oil;\n[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]\n292-607-4\n90640-86-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n648-045-00-0\nDistillates (coal tar), upper;\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]\n266-026-1\n65996-91-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-046-00-6\nAnthracene oil, acid ext.;\nAnthracene Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]\n295-274-3\n91995-14-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-047-00-1\nDistillates (coal tar);\nHeavy Anthracene Oil;\n[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]\n266-027-7\n65996-92-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-048-00-7\nDistillates (coal tar), pitch, heavy oils;\nHeavy Anthracene Oil;\n[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]\n295-312-9\n91995-51-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-049-00-2\nDistillates (coal tar), pitch;\nHeavy Anthracene Oil;\n[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]\n309-855-7\n101316-49-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-050-00-8\nDistillates (coal tar), heavy oils, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]\n295-304-5\n91995-42-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-051-00-3\nDistillates (coal tar), pitch, pyrene fraction;\nHeavy Anthracene Oil Redistillate;\n[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]\n295-313-4\n91995-52-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-052-00-9\nParaffin waxes (coal), brown-coal high-temp. tar, carbon-treated;\nCoal Tar Extract;\n[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-296-6\n97926-76-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-053-00-4\nParaffin waxes (coal), brown-coal high-temp tar, clay-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-297-1\n97926-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-054-00-X\nPitch;\nPitch\n263-072-4\n61789-60-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-055-00-5\nPitch, coal tar, high-temp.;\nPitch;\n[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n266-028-2\n65996-93-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n648-056-00-0\nPitch, coal tar, high-temp., heat-treated;\nPitch;\n[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]\n310-162-7\n121575-60-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-057-00-6\nPitch, coal tar, high-temp., secondary;\nPitch Redistillate;\n[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]\n302-650-3\n94114-13-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-058-00-1\nResidues (coal tar), pitch distn.;\nPitch Redistillate;\n[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]\n295-507-9\n92061-94-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-059-00-7\nTar, coal, high-temp., distn. and storage residues;\nCoal Tar Solids Residue;\n[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]\n295-535-1\n92062-20-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-060-00-2\nTar, coal, storage residues;\nCoal Tar Solids Residue;\n[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]\n293-764-1\n91082-50-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-061-00-8\nTar, coal, high-temp., residues;\nCoal Tar Solids Residue;\n[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]\n309-726-5\n100684-51-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-062-00-3\nTar, coal, high-temp., high-solids;\nCoal Tar Solids Residue;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]\n273-615-7\n68990-61-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-063-00-9\nWaste solids, coal-tar pitch coking;\nCoal Tar Solids Residue;\n[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]\n295-549-8\n92062-34-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-064-00-4\nExtract residues (coal), brown;\nCoal Tar Extract;\n[The residue from extraction of dried coal.]\n294-285-0\n91697-23-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-065-00-X\nParaffin waxes (coal), brown-coal-high-temp. tar;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-454-1\n92045-71-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-066-00-5\nParaffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]\n295-455-7\n92045-72-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-067-00-0\nParaffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;\nCoal Tar Extract;\n[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-298-7\n97926-78-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-068-00-6\nTar, coal, low-temp., distn. residues;\nTar Oil, intermediate boiling;\n[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]\n309-887-1\n101316-85-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-069-00-1\nPitch, coal tar, low-temp;\nPitch Residue;\n[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-651-4\n90669-57-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-070-00-7\nPitch, coal tar, low-temp., oxidized;\nPitch Residue, oxidised;\n[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]\n292-654-0\n90669-59-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-071-00-2\nPitch, coal tar, low-temp., heat-treated;\nPitch Residue, oxidised;\nPitch Residue, heat-treated;\n[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]\n292-653-5\n90669-58-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-072-00-8\nDistillates (coal-petroleum), condensed-ring arom;\nDistillates;\n[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]\n269-159-3\n68188-48-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-073-00-3\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-956-6\n101794-74-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-074-00-9\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-957-1\n101794-75-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-075-00-4\nAromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;\nPyrolysis Products;\n[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]\n309-958-7\n101794-76-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-076-00-X\nPitch, coal tar-petroleum;\nPitch Residues;\n[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]\n269-109-0\n68187-57-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-077-00-5\nPhenanthrene, distn. residues;\nHeavy Anthracene Oil Redistillate;\n[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]\n310-169-5\n122070-78-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-078-00-0\nDistillates (coal tar), upper, fluorene-free;\nWash Oil Redistillate;\n[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]\n284-899-7\n84989-10-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-079-00-6\nAnthracene oil;\nAnthracene oil;\n[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]\n292-602-7\n90640-80-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-080-00-1\nResidues (coal tar), creosote oil distn.;\nWash Oil Redistillate;\n[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 °C to 330 °C (518 °F to 626 °F). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]\n295-506-3\n92061-93-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n\n648-081-00-7\nTar, coal;\nCoal tar;\n[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]\n232-361-7\n8007-45-2\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-082-00-2\nTar, coal, high-temp.;\nCoal tar;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]\n266-024-0\n65996-89-6\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-083-00-8\nTar, coal, low-temp.;\nCoal oil;\n[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]\n266-025-6\n65996-90-9\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n\n648-084-00-3\nDistillates (coal), coke-oven light oil, naphthalene cut;\nNaphthalene Oil;\n[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 °C (298 °F).]\n285-076-5\n85029-51-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-085-00-9\nDistillates (coal tar), naphthalene oils;\nNaphthalene Oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 °C to 250 °C (392 °F to 482 °F).]\n283-484-8\n84650-04-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-086-00-4\nDistillates (coal tar), naphthalene oils, naphthalene-low;\nNaphthalene Oil Redistillate;\n[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]\n284-898-1\n84989-09-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-087-00-X\nDistillates (coal tar), naphthalene oil crystn. mother liquor;\nNaphthalene Oil Redistillate;\n[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]\n295-310-8\n91995-49-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-088-00-5\nExtract residues (coal), naphthalene oil, alk.;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]\n310-166-9\n121620-47-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-089-00-0\nExtract residues (coal), naphthalene oil, alk., naphthalene-low;\nNaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-167-4\n121620-48-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-090-00-6\nDistillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;\nNaphthalene Oil Extract Residue;\n[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]\n292-612-1\n90640-90-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-091-00-1\nExtract residues (coal), naphthalene oil alk., distn. overheads;\nNaphthalene Oil Extract Residue;\n[The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 °C to 220 °C (356 °F to 428 °F). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]\n292-627-3\n90641-04-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-092-00-7\nDistillates (coal tar), naphthalene oils, methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 °C to 255 °C (437 °F to 491 °F).]\n309-985-4\n101896-27-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-093-00-2\nDistillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;\nMethylnaphthalene Oil;\n[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 °C to 255 °C (455 °F to 491 °F).]\n309-972-3\n101794-91-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-094-00-8\nDistillates (coal tar), naphthalene oils, acid exts.;\nMethylnaphthalene Oil Extract Residue;\n[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 °C to 255 °C (446 °F to 491 °F). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]\n295-309-2\n91995-48-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-095-00-3\nExtract residues (coal), naphthalene oil alk., distn. residues;\nMethylnaphthalene Oil Extract Residue;\n[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 °C to 300 °C (428 °F to 572 °F). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]\n292-628-9\n90641-05-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-096-00-9\nExtract oils (coal), acidic, tar-base free;\nMethylnaphthalene Oil Extract Residue;\n[The extract oil boiling in the range of approximately 220 °C to 265 °C (428 °F to 509 °F) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]\n284-901-6\n84989-12-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-097-00-4\nDistillates (coal tar), benzole fraction, distn. residues;\nWash Oil;\n[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 °C to 300 °C (302 °F to 572 °F) or a semi-solid or solid with a melting point up to 70 °C (158 °F). It is composed primarily of naphthalene and alkyl naphthalenes.]\n310-165-3\n121620-46-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-098-00-X\nCreosote oil, acenaphthene fraction;\nWash Oil;\n[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 °C to 280 °C (464 °F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]\n292-605-3\n90640-84-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-099-00-5\nCreosote oil;\n[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392 °F to 617 °F).]\n263-047-8\n61789-28-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-100-00-9\nCreosote oil, high-boiling distillate;\nWash Oil;\n[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41 °F).]\n274-565-9\n70321-79-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-101-00-4\nCreosote;\n[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]\n232-287-5\n8001-58-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-102-00-X\nExtract residues (coal), creosote oil acid;\nWash Oil Extract Residue;\n[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 °C to 280 °C (482 °F to 536 °F). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]\n310-189-4\n122384-77-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-103-00-5\nAnthracene oil, anthracene paste;\nAnthracene Oil Fraction;\n[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]\n292-603-2\n90640-81-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-104-00-0\nAnthracene oil, anthracene-low;\nAnthracene Oil Fraction;\n[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]\n292-604-8\n90640-82-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-105-00-6\nResidues (coal tar), anthracene oil distn.;\nAnthracene Oil Fraction;\n[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 °C to 400 °C (644 °F to 752 °F). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]\n295-505-8\n92061-92-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-106-00-1\nAnthracene oil, anthracene paste, anthracene fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 °C to 350 °C (626 °F to 662 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-275-9\n91995-15-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-107-00-7\nAnthracene oil, anthracene paste, carbazole fraction;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 °C to 360 °C (662 °F to 680 °F). It contains chiefly anthracene, carbazole and phenanthrene.]\n295-276-4\n91995-16-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-108-00-2\nAnthracene oil, anthracene paste, distn. lights;\nAnthracene Oil Fraction;\n[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 °C to 340 °C (554 °F to 644 °F). It contains chiefly trinuclear aromatics and their dihydro derivatives.]\n295-278-5\n91995-17-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-109-00-8\nTar oils, coal, low-temp.;\nTar Oil, high boiling;\n[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 °C to 340 °C (320 °F to 644 °F).]\n309-889-2\n101316-87-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-110-00-3\nExtract residues (coal), low temp. coal atar alk.;\n[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]\n310-191-5\n122384-78-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-111-00-9\nPhenols, ammonia liquor ext.;\nAlkaline Extract;\n[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.]\n284-881-9\n84988-93-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-112-00-4\nDistillates (coal tar), light oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-610-0\n90640-88-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-113-00-X\nExtracts, coal tar oil alk.;\nAlkaline Extract;\n[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n266-017-2\n65996-83-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-114-00-5\nDistillates (coal tar), naphthalene oils, alk. exts.;\nAlkaline Extract;\n[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]\n292-611-6\n90640-89-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-115-00-0\nExtract residues (coal), tar oil alk., carbonated, limed;\nCrude Phenols;\n[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]\n292-629-4\n90641-06-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-116-00-6\nTar acids, coal, crude;\nCrude Phenols;\n[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]\n266-019-3\n65996-85-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-117-00-1\nTar acids, brown-coal, crude;\nCrude Phenols;\n[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]\n309-888-7\n101316-86-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-118-00-7\nTar acids, brown-coal gasification;\nCrude Phenols;\n[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]\n295-536-7\n92062-22-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-119-00-2\nTar acids, distn. residues;\nDistillate Phenols;\n[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 °C to 80 °C (140 °F to 176 °F).]\n306-251-5\n96690-55-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-120-00-8\nTar acids, methylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-892-9\n84989-04-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-121-00-3\nTar acids, polyalkylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 °C to 320 °C (437 °F to 608 °F). Composed primarily of polyalkylphenols.]\n284-893-4\n84989-05-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-122-00-9\nTar acids, xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-895-5\n84989-06-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-123-00-4\nTar acids, ethylphenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]\n284-891-3\n84989-03-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-124-00-X\nTar acids, 3,5-xylenol fraction;\nDistillate Phenols;\n[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]\n284-896-0\n84989-07-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-125-00-5\nTar acids, residues, distillates, first-cut;\nDistillate Phenols;\n[The residue from the distillation in the range of 235 °C to 355 °C (481 °F to 697 °F) of light carbolic oil.]\n270-713-1\n68477-23-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-126-00-0\nTar acids, cresylic, residues;\nDistillate Phenols;\n[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 °C (176 °F). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.]\n271-418-0\n68555-24-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-127-00-6\nPhenols, C9-11;\nDistillate Phenols\n293-435-2\n91079-47-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-128-00-1\nTar acids, cresylic;\nDistillate Phenols;\n[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). It contains chiefly phenols and pyridine bases.]\n295-540-9\n92062-26-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-129-00-7\nTar acids, brown-coal, C2-alkylphenol fraction;\nDistillate Phenols;\n[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 °C to 230 °C (392 °F to 446 °F). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]\n302-662-9\n94114-29-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-130-00-2\nExtract oils (coal), naphthalene oils;\nAcid Extract;\n[The aqueous extract produced by an acidic wash of alkali-washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]\n292-623-1\n90641-00-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-131-00-8\nTar bases, quinoline derivs.;\nDistillate Bases\n271-020-7\n68513-87-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-132-00-3\nTar bases, coal, quinoline derivs. fraction;\nDistillate Bases\n274-560-1\n70321-67-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-133-00-9\nTar bases, coal, distn. residues;\nDistillate Bases;\n[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]\n295-544-0\n92062-29-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-134-00-4\nHydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of a polyethylene/polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 120 °C (158 °F to 248 °F).]\n309-745-9\n100801-63-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-135-00-X\nHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 °C to 120 °C (158 °F to 248 °F).]\n309-748-5\n100801-65-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-136-00-5\nHydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;\nHeat Treatment Products;\n[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 °C to 210 °C (158 °F to 410 °F).]\n309-749-0\n100801-66-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-137-00-0\nExtract residues (coal), tar oil alk., naphthalene distn. residues;\nNaphthalene Oil Extract Residue;\n[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]\n277-567-8\n73665-18-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-138-00-6\nCreosote oil, low-boiling distillate;\nWash Oil;\n[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 °C (100 °F).]\n274-566-4\n70321-80-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n\n648-139-00-1\nTar acids, cresylic, sodium salts, caustic solns.;\nAlkaline Extract\n272-361-4\n68815-21-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-140-00-7\nExtract oils (coal), tar base;\nAcid Extract;\n[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]\n266-020-9\n65996-86-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-141-00-2\nTar bases, coal, crude;\nCrude Tar Bases;\n[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]\n266-018-8\n65996-84-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nHJM\n\n648-142-00-8\nResidues (coal), liq. solvent extn.;\n[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]\n302-681-2\n94114-46-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-143-00-3\nCoal liquids, liq. solvent extn. soln.;\n[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]\n302-682-8\n94114-47-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-144-00-9\nCoal liquids, liq. solvent extn.;\n[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]\n302-683-3\n94114-48-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH M\n648-145-00-4\nTar brown-coal;\n[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]\n309-885-0\n101316-83-0\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n648-146-00-X\nTar, brown-coal, low-temp.;\n[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]\n309-886-6\n101316-84-1\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-147-00-5\nLight oil (coal), coke-oven;\nCrude benzole;\n[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]\n266-012-5\n65996-78-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-148-00-0\nDistillates (coal), liq. solvent extn., primary;\n[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]\n302-688-0\n94114-52-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-149-00-6\nDistillates (coal), solvent extn., hydrocracked;\n[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 300 °C (86 °F to 572 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-689-6\n94114-53-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-150-00-1\nNaphtha (coal), solvent extn., hydrocracked;\n[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86 °F to 356 °F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]\n302-690-1\n94114-54-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-151-00-7\nGasoline, coal solvent extn., hydrocracked naphtha;\n[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]\n302-691-7\n94114-55-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n648-152-00-2\nDistillates (coal), solvent extn., hydrocracked middle;\n[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 300 °C (356 °F to 572 °F. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]\n302-692-2\n94114-56-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n648-153-00-8\nDistillates (coal), solvent extn., hydrocracked hydrogenated middle;\n[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 °C to 280 °C (356 °F to 536 °F). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]\n302-693-8\n94114-57-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n\n648-154-00-3\nFuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;\n[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]\n302-694-3\n94114-58-6\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n648-155-00-9\nFuels, diesel, coal solvent extn., hydrocracked hydrogenated;\n[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]\n302-695-9\n94114-59-7\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n\n\n648-156-00-4\nLight oil (coal), semi-coking process;\nFresh oil;\n[The volatile organic liquid condensed from the gas evolved in the low-temperature (less than 700 °C (1292 °F)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]\n292-635-7\n90641-11-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nT\nR: 45-46\nS: 53-45\n\nH J\n\n\n649-001-00-3\nExtracts (petroleum), light naphthenic distillate solvent\n265-102-1\n64742-03-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-002-00-9\nExtracts (petroleum), heavy paraffinic distillate solvent\n265-103-7\n64742-04-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-003-00-4\nExtracts (petroleum), light paraffinic distillate solvent\n265-104-2\n64742-05-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-004-00-X\nExtracts (petroleum), heavy naphthenic distillate solvent\n265-111-0\n64742-11-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-005-00-5\nExtracts (petroleum), light vacuum gas oil solvent\n295-341-7\n91995-78-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-006-00-0\nhydrocarbons C26-55, arom-rich\n307-753-7\n97722-04-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-007-00-6\nfatty acids, tall-oil, reaction products with iminodiethanol and boric acid\n400-160-5\n—\nXi; R38\nN; R51-53\nXi; N\nR: 38-51/53\nS: (2-)28-37-61\n\n\n649-008-00-1\nResidues (petroleum), atm. tower;\nHeavy Fuel oil;\n[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-045-2\n64741-45-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-009-00-7\nGas oils (petroleum), heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n265-058-3\n64741-57-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-010-00-2\nDistillates (petroleum), heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-063-0\n64741-61-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-011-00-8\nClarified oils (petroleum), catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-064-6\n64741-62-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-012-00-3\nResidues (petroleum), hydrocracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]\n265-076-1\n64741-75-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-013-00-9\nResidues (petroleum), thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-081-9\n64741-80-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-014-00-4\nDistillates (petroleum), heavy thermal cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-082-4\n64741-81-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-015-00-X\nGas oils (petroleum), hydrotreated vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-162-9\n64742-59-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-016-00-5\nResidues (petroleum), hydrodesulfurized atmospheric tower;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-181-2\n64742-78-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-017-00-0\nGas oils (petroleum), hydrodesulfurized heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-189-6\n64742-86-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-018-00-6\nResidues (petroleum), steam-cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n265-193-8\n64742-90-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-019-00-1\nResidues (petroleum), atmospheric;\nHeavy Fuel oil;\n[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-777-3\n68333-22-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-020-00-7\nClarified oils (petroleum), hydrodesulfurized catalytic cracked;\nHeavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]\n269-782-0\n68333-26-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-021-00-2\nDistillates (petroleum), hydrodesulfurized intermediate catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n269-783-6\n68333-27-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-022-00-8\nDistillates (petroleum), hydrodesulfurized heavy catalytic cracked;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n269-784-1\n68333-28-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-023-00-3\nFuel oil, residues-straight-run gas oils, high-sulfur;\nHeavy Fuel oil\n270-674-0\n68476-32-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-024-00-9\nFuel oil, residual;\nHeavy Fuel oil;\n[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]\n270-675-6\n68476-33-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-025-00-4\nResidues (petroleum), catalytic reformer fractionator residue distn.;\nHeavy Fuel oil;\n[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]\n270-792-2\n68478-13-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-026-00-X\nResidues (petroleum), heavy coker gas oil and vacuum gas oil;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-796-4\n68478-17-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-027-00-5\nResidues (petroleum), heavy coker and light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-983-0\n68512-61-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-028-00-0\nResidues (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]\n270-984-6\n68512-62-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-029-00-6\nResidues (petroleum), steam-cracked light;\nHeavy Fuel oil;\n[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]\n271-013-9\n68513-69-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-030-00-1\nFuel oil, No 6;\nHeavy Fuel oil;\n[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]\n271-384-7\n68553-00-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-031-00-7\nResidues (petroleum), topping plant, low-sulfur;\nHeavy Fuel oil;\n[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]\n271-763-7\n68607-30-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-032-00-2\nGas oils (petroleum), heavy atmospheric;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]\n272-184-2\n68783-08-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-033-00-8\nResidues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;\nHeavy Fuel oil;\n[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]\n272-187-9\n68783-13-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-034-00-3\nDistillates (petroleum), petroleum residues vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]\n273-263-4\n68955-27-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-035-00-9\nResidues (petroleum), steam-cracked, resinous;\nHeavy Fuel oil;\n[A complex residuum from the distillation of steam-cracked petroleum residues.]\n273-272-3\n68955-36-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-036-00-4\nDistillates (petroleum), intermediate vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-683-0\n70592-76-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-037-00-X\nDistillates (petroleum), light vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]\n274-684-6\n70592-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-038-00-5\nDistillates (petroleum), vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n274-685-1\n70592-78-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-039-00-0\nGas oils (petroleum), hydrodesulfurized coker heavy vacuum;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n285-555-9\n85117-03-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-040-00-6\nResidues (petroleum), steam-cracked, distillates;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]\n292-657-7\n90669-75-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-041-00-1\nResidues (petroleum), vacuum, light;\nHeavy Fuel oil;\n[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]\n292-658-2\n90669-76-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-042-00-7\nFuel oil, heavy, high-sulfur;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n295-396-7\n92045-14-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-043-00-2\nResidues (petroleum), catalytic cracking;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]\n295-511-0\n92061-97-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-044-00-8\nDistillates (petroleum), intermediate catalytic cracked, thermally degraded;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]\n295-990-6\n92201-59-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-045-00-3\nResidual oils (petroleum);\nHeavy Fuel oil;\n[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]\n298-754-0\n93821-66-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-046-00-9\nResidues, steam cracked, thermally treated;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]\n308-733-0\n98219-64-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-047-00-4\nDistillates (petroleum), hydrodesulfurized full-range middle;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]\n309-863-0\n101316-57-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-048-00-X\nResidues (petroleum), catalytic reformer fractionator;\nHeavy Fuel oil;\n[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]\n265-069-3\n64741-67-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-049-00-5\nPetroleum;\nCrude oil;\n[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]\n232-298-5\n8002-05-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-050-00-0\nDistillates (petroleum), light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]\n265-051-5\n64741-50-0\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-051-00-6\nDistillates (petroleum), heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]\n265-052-0\n64741-51-1\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-052-00-1\nDistillates (petroleum), light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-053-6\n64741-52-2\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-053-00-7\nDistillates (petroleum), heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-054-1\n64741-53-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-054-00-2\nDistillates (petroleum), acid-treated heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-117-3\n64742-18-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-055-00-8\nDistillates (petroleum), acid-treated light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-118-9\n64742-19-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-056-00-3\nDistillates (petroleum), acid-treated heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-119-4\n64742-20-7\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-057-00-9\nDistillates (petroleum), acid-treated light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-121-5\n64742-21-8\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-058-00-4\nDistillates (petroleum), chemically neutralized heavy paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]\n265-127-8\n64742-27-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-059-00-X\nDistillates (petroleum), chemically neutralized light paraffinic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-128-3\n64742-28-5\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-060-00-5\nDistillates (petroleum), chemically neutralized heavy naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-135-1\n64742-34-3\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n649-061-00-0\nDistillates (petroleum), chemically neutralized light naphthenic;\nUnrefined or mildly refined baseoil;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-136-7\n64742-35-4\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\nH\n\n\n649-062-00-6\nGases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]\n270-755-0\n68477-73-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-063-00-1\nGases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-756-6\n68477-74-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-064-00-7\nGases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]\n270-757-1\n68477-75-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-065-00-2\nGases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]\n270-758-7\n68477-76-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-066-00-8\nGases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]\n270-760-8\n68477-79-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-067-00-3\nGases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]\n270-765-5\n68477-83-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-068-00-9\nGases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-767-6\n68477-85-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-069-00-4\nGases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]\n270-768-1\n68477-86-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-070-00-X\nGases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-769-7\n68477-87-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-071-00-5\nGases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]\n270-772-3\n68477-90-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-072-00-0\nGases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-773-9\n68477-91-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-073-00-6\nGases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]\n270-777-0\n68477-94-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-074-00-1\nGases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n270-778-6\n68477-95-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-075-00-7\nGases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas\n270-782-8\n68477-99-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-076-00-2\nTail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-802-5\n68478-21-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-077-00-8\nTail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-803-0\n68478-22-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-078-00-3\nTail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]\n270-804-6\n68478-24-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-079-00-9\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-806-7\n68478-26-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-080-00-4\nTail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]\n270-813-5\n68478-32-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-081-00-X\nTail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]\n270-814-0\n68478-33-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-082-00-5\nTail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-815-6\n68478-34-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-083-00-0\nHydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]\n270-990-9\n68512-91-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-084-00-6\nGases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-000-8\n68513-15-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-085-00-1\nGases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]\n271-001-3\n68513-16-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-086-00-7\nGases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-002-9\n68513-17-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-087-00-2\nResidues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27.8 °C (11 °F to 82 °F).]\n271-010-2\n68513-66-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-088-00-8\nHydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]\n271-032-2\n68514-31-8\nF+; R12\nCarc. Cat 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-089-00-3\nHydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]\n271-038-5\n68514-36-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-090-00-9\nHydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]\n271-259-7\n68527-16-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-091-00-4\nHydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas\n271-261-8\n68527-19-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-092-00-X\nGases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n271-624-0\n68602-83-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-093-00-5\nHydrocarbons, C2-4;\nPetroleum gas\n271-734-9\n68606-25-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-094-00-0\nHydrocarbons, C3;\nPetroleum gas\n271-735-4\n68606-26-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-095-00-6\nGases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n271-737-5\n68606-27-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-096-00-1\nGases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]\n271-742-2\n68606-34-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-097-00-7\nGases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-183-7\n68783-07-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-098-00-2\nGases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n272-203-4\n68783-64-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-099-00-8\nGases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]\n272-205-5\n68783-65-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-100-00-1\nGases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-871-7\n68918-99-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-101-00-7\nGases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-872-2\n68919-00-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-102-00-2\nGases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-878-5\n68919-05-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-103-00-8\nGases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-879-0\n68919-06-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-104-00-3\nGases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]\n272-882-7\n68919-09-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-105-00-9\nGases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]\n272-893-7\n68919-20-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-106-00-4\nGases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-883-2\n68919-10-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-107-00-X\nGases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-169-3\n68952-76-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-108-00-5\nTail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-170-9\n68952-77-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-109-00-0\nTail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-175-6\n68952-81-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-110-00-6\nTail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-176-1\n68952-82-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-111-00-1\nGases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]\n273-265-5\n68955-28-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-112-00-7\nGases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n273-270-2\n68955-34-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-113-00-2\nHydrocarbons, C4;\nPetroleum gas\n289-339-5\n87741-01-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-114-00-8\nAlkanes, C1-4, C3-rich;\nPetroleum gas\n292-456-4\n90622-55-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-115-00-3\nGases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]\n295-404-9\n92045-22-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-116-00-9\nHydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]\n295-405-4\n92045-23-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-117-00-4\nPetroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]\n295-463-0\n92045-80-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-118-00-X\nHydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas\n306-004-1\n95465-89-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-119-00-5\nRaffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas\n307-769-4\n97722-19-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-120-00-0\nGases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]\n270-746-1\n68477-65-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-121-00-6\nGases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]\n270-747-7\n68477-66-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-122-00-1\nGases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]\n270-748-2\n68477-67-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-123-00-7\nGases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-749-8\n68477-68-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-124-00-2\nGases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n270-759-2\n68477-77-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-125-00-8\nGases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-761-3\n68477-80-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-126-00-3\nGases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]\n270-762-9\n68477-81-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-127-00-9\nGases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas\n270-763-4\n68477-82-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-128-00-4\nGases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]\n270-766-0\n68477-84-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-129-00-X\nGases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-774-4\n68477-92-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-130-00-5\nGases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]\n270-776-5\n68477-93-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-131-00-0\nGases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]\n270-779-1\n68477-96-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-132-00-6\nGases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]\n270-780-7\n68477-97-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-133-00-1\nGases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-781-2\n68477-98-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-134-00-7\nGases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n270-783-3\n68478-00-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-135-00-2\nGases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-784-9\n68478-01-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-136-00-8\nGases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-785-4\n68478-02-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-137-00-3\nGases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n270-787-5\n68478-03-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-138-00-9\nGases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-788-0\n68478-04-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-139-00-4\nGases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-789-6\n68478-05-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-140-00-X\nTail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n270-805-1\n68478-25-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-141-00-5\nTail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-807-2\n68478-27-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-142-00-0\nTail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-808-8\n68478-28-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-143-00-6\nTail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n270-809-3\n68478-29-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-144-00-1\nTail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n270-810-9\n68478-30-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-145-00-7\nGases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]\n270-999-8\n68513-14-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-146-00-2\nGases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-003-4\n68513-18-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-147-00-8\nGases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-005-5\n68513-19-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-148-00-3\nGases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]\n271-258-1\n68527-15-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-149-00-9\nGases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]\n271-623-5\n68602-82-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-150-00-4\nGases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n271-625-6\n68602-84-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-151-00-X\nPetroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]\n271-750-6\n68607-11-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-152-00-5\nGases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-182-1\n68783-06-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-153-00-0\nGases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n272-338-9\n68814-67-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-154-00-6\nGases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]\n272-343-6\n68814-90-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-155-00-1\nGases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]\n272-775-5\n68911-58-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-156-00-7\nGases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]\n272-776-0\n68911-59-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-157-00-2\nGases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]\n272-873-8\n68919-01-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-158-00-8\nGases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-874-3\n68919-02-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-159-00-3\nGases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]\n272-875-9\n68919-03-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-160-00-9\nGases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-876-4\n68919-04-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-161-00-4\nGases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]\n272-880-6\n68919-07-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-162-00-X\nGases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-881-1\n68919-08-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-163-00-5\nGases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n272-884-8\n68919-11-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-164-00-0\nGases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]\n272-885-3\n68919-12-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-165-00-6\nTail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]\n273-173-5\n68952-79-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-166-00-1\nTail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n273-174-0\n68952-80-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-167-00-7\nGases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n273-269-7\n68955-33-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-168-00-2\nGases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n273-563-5\n68989-88-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-169-00-8\nGases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]\n295-397-2\n92045-15-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-170-00-3\nGases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]\n295-398-8\n92045-16-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-171-00-9\nGases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n295-399-3\n92045-17-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-172-00-4\nGases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n295-400-7\n92045-18-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-173-00-X\nGases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]\n295-401-2\n92045-19-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-174-00-5\nGases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n295-402-8\n92045-20-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-175-00-0\nFoots oil (petroleum), acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-225-7\n93924-31-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-176-00-6\nFoots oil (petroleum), clay-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]\n300-226-2\n93924-32-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n\n\n649-177-00-1\nGases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]\n268-629-5\n68131-75-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-178-00-7\nTail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-617-2\n68307-98-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-179-00-2\nTail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]\n269-618-8\n68307-99-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-180-00-8\nTail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-619-3\n68308-00-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-181-00-3\nTail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-620-9\n68308-01-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-182-00-9\nTail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-630-3\n68308-10-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-183-00-4\nTail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-623-5\n68308-03-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-184-00-X\nTail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-624-0\n68308-04-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-185-00-5\nTail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-625-6\n68308-05-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-186-00-0\nTail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-626-1\n68308-06-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-187-00-6\nTail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-627-7\n68308-07-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-188-00-1\nTail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n269-629-8\n68308-09-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-189-00-7\nTail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-631-9\n68308-11-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-190-00-2\nTail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]\n269-632-4\n68308-12-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-191-00-8\nGases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]\n270-071-2\n68409-99-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-193-00-9\nAlkanes, C1-2;\nPetroleum gas\n270-651-5\n68475-57-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-194-00-4\nAlkanes, C2-3;\nPetroleum gas\n270-652-0\n68475-58-1\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-195-00-X\nAlkanes, C3-4;\npetroleum gas\n270-653-6\n68475-59-2\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-196-00-5\nAlkanes, C4-5;\nPetroleum gas\n270-654-1\n68475-60-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-197-00-0\nFuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]\n270-667-2\n68476-26-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-198-00-6\nFuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]\n270-670-9\n68476-29-9\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-199-00-1\nHydrocarbons, C3-4;\nPetroleum gas\n270-681-9\n68476-40-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-200-00-5\nHydrocarbons, C4-5;\nPetroleum gas\n270-682-4\n68476-42-6\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-201-00-0\nHydrocarbons, C2-4, C3-rich;\nPetroleum gas\n270-689-2\n68476-49-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-202-00-6\nPetroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-704-2\n68476-85-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-203-00-1\nPetroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]\n270-705-8\n68476-86-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nHKS\n\n649-204-00-7\ngases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]\n270-724-1\n68477-33-8\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-205-00-2\nDistillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]\n270-726-2\n68477-35-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-206-00-8\nGases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]\n270-750-3\n68477-69-0\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-207-00-3\nGases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]\n270-751-9\n68477-70-3\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-208-00-9\nGases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]\n270-752-4\n68477-71-4\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-209-00-4\nGases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]\n270-754-5\n68477-72-5\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-210-00-X\nTail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]\n269-628-2\n68308-08-7\nF+; R12\nCarc. Cat. 1; R45\nMuta. Cat. 2; R46\nF+; T\nR: 45-46-12\nS: 53-45\n\nH K\n\n649-211-00-5\nFoots oil (petroleum), carbon-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-126-0\n97862-76-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-212-00-0\nDistillates (petroleum), sweetened middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-088-7\n64741-86-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-213-00-6\nGas oils (petroleum), solvent-refined;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-092-9\n64741-90-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-214-00-1\nDistillates (petroleum), solvent-refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-093-4\n64741-91-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-215-00-7\nGas oils (petroleum), acid-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-112-6\n64742-12-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-216-00-2\nDistillates (petroleum), acid-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-113-1\n64742-13-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-217-00-8\nDistillates (petroleum), acid-treated light;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-114-7\n64742-14-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-218-00-3\nGas oils (petroleum), chemically neutralized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-129-9\n64742-29-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-219-00-9\nDistillates (petroleum), chemically neutralized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]\n265-130-4\n64742-30-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-220-00-4\nDistillates (petroleum), clay-treated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]\n265-139-3\n64742-38-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-221-00-X\nDistillates (petroleum), hydrotreated middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-148-2\n64742-46-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-222-00-5\nGas oils (petroleum), hydrodesulfurized;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]\n265-182-8\n64742-79-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-223-00-0\nDistillates (petroleum), hydrodesulfurized middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n265-183-3\n64742-80-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-224-00-6\nFuels, diesel;\nGasoil — unspecified;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]\n269-822-7\n68334-30-5\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH N\n649-225-00-1\nFuel oil, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]\n270-671-4\n68476-30-2\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-226-00-7\nFuel oil, No 4;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]\n270-673-5\n68476-31-3\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-227-00-2\nFuels, diesel, No 2;\nGasoil — unspecified;\n[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]\n270-676-1\n68476-34-6\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-228-00-8\nDistillates (petroleum), catalytic reformer fractionator residue, high-boiling;\nGasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]\n270-719-4\n68477-29-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-229-00-3\nDistillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;\nGasoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]\n270-721-5\n68477-30-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-230-00-9\nDistillates (petroleum), catalytic reformer fractionator residue, low-boiling;\nGasoil — unspecified;\n[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]\n270-722-0\n68477-31-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-231-00-4\nDistillates (petroleum), highly refined middle;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]\n292-615-8\n90640-93-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-232-00-X\nDistillates (petroleum) catalytic reformer, heavy arom. conc.;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n295-294-2\n91995-34-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-233-00-5\nGas oils, paraffinic;\nGasoil — unspecified;\n[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]\n300-227-8\n93924-33-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-234-00-0\nNaphtha (petroleum), solvent-refined hydrodesulfurized heavy;\nGasoil — unspecified\n307-035-3\n97488-96-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-235-00-6\nHydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-659-6\n97675-85-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-236-00-1\nHydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]\n307-660-1\n97675-86-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-237-00-7\nHydrocarbons, C11-17, solvent-extd. light naphthenic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]\n307-757-9\n97722-08-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-238-00-2\nGas oils, hydrotreated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]\n308-128-1\n97862-78-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-239-00-8\nDistillates (petroleum), carbon-treated light paraffinic;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]\n309-667-5\n100683-97-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-240-00-3\nDistillates (petroleum), intermediate paraffinic, carbon-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-668-0\n100683-98-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-241-00-9\nDistillates (petroleum), intermediate paraffinic, clay-treated;\nGasoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n309-669-6\n100683-99-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-242-00-4\nAlkanes, C12-26-branched and linear\n292-454-3\n90622-53-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-243-00-X\nLubricating greases;\nGrease;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]\n278-011-7\n74869-21-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-244-00-5\nSlack wax (petroleum);\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n265-165-5\n64742-61-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-245-00-0\nSlack wax (petroleum), acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n292-659-8\n90669-77-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-246-00-6\nSlack wax (petroleum), clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]\n292-660-3\n90669-78-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-247-00-1\nSlack wax (petroleum), hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]\n295-523-6\n92062-09-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-248-00-7\nSlack wax (petroleum), low-melting;\nSlack wax;\n[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-524-1\n92062-10-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-249-00-2\nSlack wax (petroleum), low-melting, hydrotreated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n295-525-7\n92062-11-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-250-00-8\nSlack wax (petroleum), low-melting, carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-155-9\n97863-04-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-251-00-3\nSlack wax (petroleum), low-melting, clay-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-156-4\n97863-05-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-252-00-9\nSlack wax (petroleum), low-melting, silicic acid-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-158-5\n97863-06-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-253-00-4\nSlack wax (petroleum), carbon-treated;\nSlack wax;\n[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]\n309-723-9\n100684-49-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-254-00-X\nPetrolatum;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n232-373-2\n8009-03-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-255-00-5\nPetrolatum (petroleum), oxidized;\nPetrolatum;\n[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]\n265-206-7\n64743-01-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-256-00-0\nPetrolatum (petroleum), alumina-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]\n285-098-5\n85029-74-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-257-00-6\nPetrolatum (petroleum), hydrotreated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]\n295-459-9\n92045-77-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-258-00-1\nPetrolatum (petroleum), carbon-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-149-6\n97862-97-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-259-00-7\nPetrolatum (petroleum), silicic acid-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]\n308-150-1\n97862-98-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n649-260-00-2\nPetrolatum (petroleum), clay-treated;\nPetrolatum;\n[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]\n309-706-6\n100684-33-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH N\n\n\n649-261-00-8\nGasoline, natural;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 °C to 120 °C (– 4 °F to 248 °F).]\n232-349-1\n8006-61-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-262-00-3\nNaphtha;\nLow boiling point naphtha;\n[Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n232-443-2\n8030-30-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-263-00-9\nLigroine;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 °C to 135 °C (58 °F to 275 °F).]\n232-453-7\n8032-32-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-264-00-4\nNaphtha (petroleum), heavy straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-041-0\n64741-41-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-265-00-X\nNaphtha (petroleum), full-range straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 428 °F).]\n265-042-6\n64741-42-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-266-00-5\nNaphtha (petroleum), light straight-run;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-046-8\n64741-46-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-267-00-0\nSolvent naphtha (petroleum), light aliph.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 °C to 160 °C (95 °F to 320 °F).]\n265-192-2\n64742-89-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-268-00-6\nDistillates (petroleum), straight-run light;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately – 88 °C to 99 °C (– 127 °F to 210 °F).]\n270-077-5\n68410-05-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-269-00-1\nGasoline, vapor-recovery;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 196 °C(-4 °F to 384 °F).]\n271-025-4\n68514-15-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-270-00-7\nGasoline, straight-run, topping-plant;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 °C to 193,3 °C (97 °F to 380 °F).]\n271-727-0\n68606-11-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-271-00-2\nNaphtha (petroleum), unsweetened;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 °C to 230 °C (25 °F to 446 °F).]\n272-186-3\n68783-12-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-272-00-8\nDistillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6.]\n272-931-2\n68921-08-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-273-00-3\nNaphtha (petroleum), heavy straight run, arom.-contg.;\nLow boiling point naphtha;\n[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n309-945-6\n101631-20-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-274-00-9\nNaphtha (petroleum), full-range alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 220 °C (194 °F to 428 °F).]\n265-066-7\n64741-64-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-275-00-4\nNaphtha (petroleum), heavy alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 °C to 220 °C (302 °F to 428 °F).]\n265-067-2\n64741-65-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-276-00-X\nNaphtha (petroleum), light alkylate;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 °C to 160 °C (194 °F to 320 °F).]\n265-068-8\n64741-66-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-277-00-5\nNaphtha (petroleum), isomerization;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]\n265-073-5\n64741-70-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-278-00-0\nNaphtha (petroleum), solvent-refined light;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n265-086-6\n64741-84-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-279-00-6\nNaphtha (petroleum), solvent-refined heavy;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-095-5\n64741-92-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-280-00-1\nRaffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]\n270-088-5\n68410-71-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-281-00-7\nRaffinates (petroleum), reformer, Lurgi unit-sepd.;\nLow boiling point modified naphtha;\n[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]\n270-349-3\n68425-35-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-282-00-2\nNaphtha (petroleum), full-range alkylate, butane-contg.;\nLow boiling point modified naphta;\n[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 °C to 200 °C (95 °F to 428 °F).]\n271-267-0\n68527-27-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-283-00-8\nDistillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]\n295-315-5\n91995-53-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-284-00-3\nNaphtha (petroleum), C4-12, butane-alkylate, isooctane-rich;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-430-0\n92045-49-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-285-00-9\nHydrocarbons, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 °C to 99 °C (201 °F to 210 °F).]\n295-436-3\n92045-55-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-286-00-4\nNaphtha (petroleum), isomerization, C6-fraction;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 °C to 66 °C (140 °F to 151 °F).]\n295-440-5\n92045-58-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-287-00-X\nHydrocarbons, C6-7, naphtha-cracking, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 °C to 100 °C (158 °F to 212 °F).]\n295-446-8\n92045-64-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-288-00-5\nHydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;\nLow boiling point modified naphtha;\n[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 °C to 70 °C (149 °F to 158 °F).]\n309-871-4\n101316-67-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-289-00-0\nNaphtha (petroleum), heavy catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-055-7\n64741-54-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-290-00-6\nNaphtha (petroleum), light catalytic cracked;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F). It contains a relatively large proportion of unsaturated hydrocarbons.]\n265-056-2\n64741-55-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-291-00-1\nHydrocarbons, C3-11, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 °C (400 °F).]\n270-686-6\n68476-46-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-292-00-7\nNaphtha (petroleum), catalytic cracked light distd.;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]\n272-185-8\n68783-09-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-293-00-2\nDistillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;\nLow boiling point cat-cracked naphtha.;\n[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.]\n295-311-3\n91995-50-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-294-00-8\nNaphtha (petroleum), heavy catalytic cracked, sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 °C to 200 °C (140 °F to 392 °F).]\n295-431-6\n92045-50-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-295-00-3\nNaphtha (petroleum), light catalytic cracked sweetened;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 °C to 210 °C (95 °F to 410 °F).]\n295-441-0\n92045-59-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-296-00-9\nHydrocarbons, C8-12, catalytic-cracking, chem. neutralized;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 °C to 210 °C (266 °F to 410 °F).]\n295-794-0\n92128-94-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-297-00-4\nHydrocarbons, C8-12, catalytic cracker distillates;\nLow boiling point cat-cracked naphtha;\n[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 °C to 210 °C (284 °F to 410 °F).]\n309-974-4\n101794-97-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-298-00-X\nHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;\nLow boiling point cat-cracked naphtha\n309-987-5\n101896-28-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-299-00-5\nNaphtha (petroleum), light catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n265-065-1\n64741-63-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-300-00-9\nNaphtha (petroleum), heavy catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-070-9\n64741-68-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-301-00-4\nDistillates (petroleum), catalytic reformed depentanizer;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 63 °C (– 57 °F to 145 °F).]\n270-660-4\n68475-79-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-302-00-X\nHydrocarbons, C2-6, C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha\n270-687-1\n68476-47-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-303-00-5\nResidues (petroleum), C6-8 catalytic reformer;\nLow boiling point cat-reformed naphtha;\n[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n270-794-3\n68478-15-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-304-00-0\nNaphtha (petroleum), light catalytic reformed, arom.-free;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 °C to 120 °C (95 °F to 248 °F). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]\n270-993-5\n68513-03-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-305-00-6\nDistillates (petroleum), catalytic reformed straight-run naphtha overheads;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n271-008-1\n68513-63-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-306-00-1\nPetroleum products, hydrofiner-powerformer reformates;\nLow boiling point cat-reformed naphtha;\n[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 °C to 210 °C (80 °F to 410 °F).]\n271-058-4\n68514-79-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-307-00-7\nNaphtha (petroleum), full-range reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n272-895-8\n68919-37-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-308-00-2\nNaphtha (petroleum), catalytic reformed;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 220 °C (90 °F to 430 °F). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]\n273-271-8\n68955-35-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-309-00-8\nDistillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 °C to 180 °C (320 °F to 356 °F).]\n285-509-8\n85116-58-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-310-00-3\nAromatic hydrocarbons, C8, catalytic reforming-derived;\nLow boiling point cat-reformed naphtha\n295-279-0\n91995-18-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-311-00-9\nAromatic hydrocarbons, C7-12, C8-rich;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 °C to 200 °C (266 °F to 392 °F).]\n297-401-8\n93571-75-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-312-00-4\nGasoline, C5-11, high-octane stabilised reformed;\nLow boiling point cat-reformed naphtha;\n[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 °C to 185 °C (113 °F to 365 °F).]\n297-458-9\n93572-29-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-313-00-X\nHydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 °C to 210 °C (248 °F to 380 °F) and C9 and higher aromatic hydrocarbons.]\n297-465-7\n93572-35-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-314-00-5\nHydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;\nLow boiling point cat-reformed naphtha;\n[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 125 °C (94 °F to 257 °F), benzene and toluene.]\n297-466-2\n93572-36-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-315-00-0\nFoots oil (petroleum), silicic acid-treated;\nFoots oil;\n[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]\n308-127-6\n97862-77-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n\n\n649-316-00-6\nNaphtha (petroleum), light thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately – 10 °C to 130 °C (14 °F to 266 °F).]\n265-075-6\n64741-74-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-317-00-1\nNaphtha (petroleum), heavy thermal cracked;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 220 °C (148 °F to 428 °F).]\n265-085-0\n64741-83-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-318-00-7\nDistillates (petroleum), heavy arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]\n267-563-4\n67891-79-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-319-00-2\nDistillates (petroleum), light arom.;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]\n267-565-5\n67891-80-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-320-00-8\nDistillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;\nLow boiling point thermally cracked naphtha;\n[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 °C (400 °F).]\n270-344-6\n68425-29-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-321-00-3\nAromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 °C (1500 °F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]\n270-658-3\n68475-70-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-322-00-9\nDistillates (petroleum), thermal cracked naphtha and gas oil;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 °C to 60 °C (91 °F to 140 °F).]\n271-631-9\n68603-00-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-323-00-4\nDistillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 °C to 184 °C (91 °F to 363 °F).]\n271-632-4\n68603-01-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-324-00-X\nDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 °C to 40 °C (88 °F to 104 °F).]\n271-634-5\n68603-03-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-325-00-5\nDistillates (petroleum), light thermal cracked, debutanized arom.;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]\n273-266-0\n68955-29-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-326-00-0\nNaphtha (petroleum), light thermal cracked, sweetened;\nLow boiling point thermally cracked naphtha;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 °C to 100 °C (68 °F to 212 °F).]\n295-447-3\n92045-65-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-327-00-6\nNaphtha (petroleum), hydrotreated heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-150-3\n64742-48-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-328-00-1\nNaphtha (petroleum), hydrotreated light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-151-9\n64742-49-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-329-00-7\nNaphtha (petroleum), hydrodesulfurized light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-178-6\n64742-73-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-330-00-2\nNaphtha (petroleum), hydrodesulfurized heavy;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-185-4\n64742-82-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-331-00-8\nDistillates (petroleum), hydrotreated middle, intermediate boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 °C to 188 °C (262 °F to 370 °F).]\n270-092-7\n68410-96-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-332-00-3\nDistillates (petroleum), light distillate hydrotreating process, low-boiling;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 °C to 194 °C (37 °F to 382 °F).]\n270-093-2\n68410-97-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-333-00-9\nDistillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 49 °C to 68 °C (– 57 °F to 155 °F).]\n270-094-8\n68410-98-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-334-00-4\nSolvent naphtha (petroleum), light arom., hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n270-988-8\n68512-78-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-335-00-X\nNaphtha (petroleum), hydrodesulfurized thermal cracked light;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 195 °C (73 °F to 383 °F).]\n285-511-9\n85116-60-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-336-00-5\nNaphtha (petroleum), hydrotreated light, cycloalkane-contg.;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n285-512-4\n85116-61-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-337-00-0\nNaphtha (petroleum), heavy steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha\n295-432-1\n92045-51-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-338-00-6\nNaphtha (petroleum), hydrodesulfurized full-range;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 250 °C (86 °F to 482 °F).]\n295-433-7\n92045-52-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-339-00-1\nNaphtha (petroleum), hydrotreated light steam-cracked;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 °C to 190 °C (95 °F to 374 °F).]\n295-438-4\n92045-57-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-340-00-7\nHydrocarbons, C4-12, naphtha-cracking, hydrotreated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 °C to 230 °C (86 °F to 446 °F).]\n295-443-1\n92045-61-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-341-00-2\nSolvent naphtha (petroleum), hydrotreated light naphthenic;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 °C to 85 °C (163 °F to 185 °F).]\n295-529-9\n92062-15-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-342-00-8\nNaphtha (petroleum), light steam-cracked, hydrogenated;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 °C to 200 °C (122 °F to 392 °F). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulfur and oxygenated compounds.]\n296-942-7\n93165-55-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-343-00-3\nHydrocarbons, C6-11, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-852-0\n93763-33-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-344-00-9\nHydrocarbons, C9-12, hydrotreated, dearomatized;\nLow boiling point hydrogen treated naphtha;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-853-6\n93763-34-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-345-00-4\nStoddard solvent;\nLow boiling point naphtha - unspecified;\n[A colorless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 148,8 °C to 204,4 °C. (300 °F to 400 °F).]\n232-489-3\n8052-41-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-346-00-X\nNatural gas condensates (petroleum);\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]\n265-047-3\n64741-47-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-347-00-5\nNatural gas (petroleum), raw liq. mix;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]\n265-048-9\n64741-48-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-348-00-0\nNaphtha (petroleum), light hydrocracked;\nLow boiling naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately – 20 °C to 180 °C (– 4 °F to 356 °F).]\n265-071-4\n64741-69-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-349-00-6\nNaphtha (petroleum), heavy hydrocracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 °C to 230 °C (148 °F to 446 °F).]\n265-079-8\n64741-78-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-350-00-1\nNaphtha (petroleum), sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately – 10 °C to 230 °C (14 °F to 446 °F).]\n265-089-2\n64741-87-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-351-00-7\nNaphtha (petroleum), acid-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 °C to 230 °C (194 °F to 446 °F).]\n265-115-2\n64742-15-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-352-00-2\nNaphtha (petroleum), chemically neutralized heavy;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 °C to 230 °C (149 °F to 446 °F).]\n265-122-0\n64742-22-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-353-00-8\nNaphtha (petroleum), chemically neutralized light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 190 °C (– 4 °F to 374 °F).]\n265-123-6\n64742-23-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-354-00-3\nNaphtha (petroleum), catalytic dewaxed;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 °C to 230 °C (95 °F to 446 °F).]\n265-170-2\n64742-66-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-355-00-9\nNaphtha (petroleum), light steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 °C to 190 °C (– 4 °F to 374 °F). This stream is likely to contain 10 vol. % or more benzene.]\n265-187-5\n64742-83-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-356-00-4\nSolvent naphtha (petroleum), light arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 °C to 210 °C (275 °F to 410 °F).]\n265-199-0\n64742-95-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-357-00-X\nAromatic hydrocarbons, C6-10, acid-treated, neutralized;\nLow boiling point naphtha - unspecified\n268-618-5\n68131-49-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-358-00-5\nDistillates (petroleum), C3-5, 2-methyl-2-butene-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]\n270-725-7\n68477-34-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-359-00-0\nDistillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-735-1\n68477-50-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-360-00-6\nDistillates (petroleum), steam-cracked, C5-12 fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]\n270-736-7\n68477-53-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-361-00-1\nDistillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;\nLow boiling point naphtha - unspecified\n270-738-8\n68477-55-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-362-00-7\nExtracts (petroleum), cold-acid, C4-6;\nLow boiling point naphtha - unspecified;\n[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n270-741-4\n68477-61-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-363-00-2\nDistillates (petroleum), depentanizer overheads;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-771-8\n68477-89-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-364-00-8\nResidues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-791-7\n68478-12-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-365-00-3\nResidual oils (petroleum), deisobutanizer tower;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]\n270-795-9\n68478-16-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-366-00-9\nNaphtha (petroleum), full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 °C to 250 °C (110 °F-500 °F).]\n270-991-4\n68513-02-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-367-00-4\nNaphtha (petroleum), steam-cracked middle arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 °C to 220 °C (266 °F to 428 °F).]\n271-138-9\n68516-20-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-368-00-X\nNaphtha (petroleum), clay-treated full-range straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately – 20 °C to 220 °C (– 4 °F to 429 °F).]\n271-262-3\n68527-21-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-369-00-5\nNaphtha (petroleum), clay-treated light straight-run;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 °C to 180 °C (200 °F to 356 °F).]\n271-263-9\n68527-22-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-370-00-0\nNaphtha (petroleum), light steam-cracked arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 °C to 165 °C (230 °F to 329 °F).]\n271-264-4\n68527-23-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-371-00-6\nNaphtha (petroleum), light steam-cracked, debenzenized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 °C to 218 °C (176 °F to 424 °F).]\n271-266-5\n68527-26-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-372-00-1\nNaphtha (petroleum), arom.-contg.;\nLow boiling point naphtha - unspecified\n271-635-0\n68603-08-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-373-00-7\nGasoline, pyrolysis, debutanizer bottoms;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]\n271-726-5\n68606-10-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-374-00-2\nNaphtha (petroleum), light, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately – 20 °C to 100 °C (– 4 °F to 212 °F).]\n272-206-0\n68783-66-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-375-00-8\nNatural gas condensates;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]\n272-896-3\n68919-39-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-376-00-3\nDistillates (petroleum), naphtha unifiner stripper;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]\n272-932-8\n68921-09-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-377-00-9\nNaphtha (petroleum), catalytic reformed light, arom.-free fraction;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 °C to 121 °C (151 °F to 250 °F).]\n285-510-3\n85116-59-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-378-00-4\nGasoline;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 °C to 260 °C (86 °F to 500 °F).]\n289-220-8\n86290-81-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-379-00-X\nAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;\nLow boiling point naphtha - unspecified\n292-698-0\n90989-42-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-380-00-5\nHydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 °C to 40 °C (77 °F to 104 °F).]\n295-298-4\n91995-38-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-381-00-0\nDistillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]\n295-302-4\n91995-41-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-382-00-6\nExtracts (petroleum), catalytic reformed light naphtha solvent;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 °C to 200 °C (212 °F to 392 °F).]\n295-331-2\n91995-68-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-383-00-1\nNaphtha (petroleum), hydrodesulfurized light, dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 °C to 100 °C (194 °F to 212 °F).]\n295-434-2\n92045-53-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-384-00-7\nNaphtha (petroleum), light, C5-rich, sweetened;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 °C to 35 °C (14 °F to 95 °F).]\n295-442-6\n92045-60-8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-385-00-2\nHydrocarbons, C8-11, naphtha-cracking, toluene cut;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 °C to 205 °C (266 °F to 401 °F).]\n295-444-7\n92045-62-0\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-386-00-8\nHydrocarbons, C4-11, naphtha-cracking, arom.-free;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 °C to 205 °C (86 °F to 401 °F).]\n295-445-2\n92045-63-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-387-00-3\nNaphtha (petroleum), light heat-soaked, steam-cracked;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approximately 0 °C to 80 °C (32 °F to 176 °F).]\n296-028-8\n92201-97-3\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-388-00-9\nDistillates (petroleum), C6-rich;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 °C to 70 °C (140 °F to 158 °F).]\n296-903-4\n93165-19-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-389-00-4\nGasoline, pyrolysis, hydrogenated;\nLow boiling point naphtha-unspecified;\n[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 °C to 200 °C (68 °F to 392 °F).]\n302-639-3\n94114-03-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-390-00-X\nDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n305-750-5\n95009-23-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-391-00-5\nExtracts (petroleum) heavy naphtha solvent, clay-treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 °C to 180 °C (175 °F to 356 °F).]\n308-261-5\n97926-43-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-392-00-0\nNaphtha (petroleum), light steam-cracked, debenzenized, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 °C to 200 °C (203 °F to 392 °F).]\n308-713-1\n98219-46-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-393-00-6\nNaphtha (petroleum), light steam-cracked, thermally treated;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 °C to 80 °C (95 °F to 176 °F).]\n308-714-7\n98219-47-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-394-00-1\nDistillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 °C to 130 °C (248 °F to 266 °F).]\n309-862-5\n101316-56-7\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-395-00-7\nHydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 °C to 135 °C (176 °F to 275 °F).]\n309-870-9\n101316-66-9\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-396-00-2\nNaphtha (petroleum), hydrodesulfurised full-range coker;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 °C to 196 °C (73 °F to 385 °F).]\n309-879-8\n101316-76-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-397-00-8\nNaphtha (petroleum), sweetened light;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 °C to 130 °C (68 °F to 266 °F).]\n309-976-5\n101795-01-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-398-00-3\nHydrocarbons, C3-6, C5-rich, steam-cracked naphtha;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]\n310-012-0\n102110-14-5\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-399-00-9\nHydrocarbons, C5-rich, dicyclopentadiene-contg.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 °C to 170 °C (86 °F to 338 °F).]\n310-013-6\n102110-15-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-400-00-2\nResidues (petroleum), steam-cracked light, arom.;\nLow boiling point naphtha - unspecified;\n[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 °C (104 °F).]\n310-057-6\n102110-55-4\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-401-00-8\nHydrocarbons, C≥5, C5-6-rich;\nLow boiling point naphtha - unspecified\n270-690-8\n68476-50-6\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-402-00-3\nHydrocarbons, C5-rich;\nLow boiling point naphtha - unspecified\n270-695-5\n68476-55-1\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n649-403-00-9\nAromatic hydrocarbons, C8-10;\nLow boiling point naphtha - unspecified\n292-695-4\n90989-39-2\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nXn; R65\nT\nR: 45-46-65\nS: 53-45\n\nH P\n\n\n649-404-00-4\nKerosine (petroleum);\nStraight run kerosine;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]\n232-366-4\n8008-20-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-405-00-X\nSolvent naphtha (petroleum), medium aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]\n265-191-7\n64742-88-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-406-00-5\nSolvent naphtha (petroleum) heavy aliph.;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]\n265-200-4\n64742-96-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-407-00-0\nKerosine (petroleum), straight-run wide-cut;\nStraight run kerosine;\n[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]\n295-418-5\n92045-37-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-408-00-6\nDistillates (petroleum), steam-cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]\n265-194-3\n64742-91-2\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-409-00-1\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]\n270-728-3\n68477-39-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-410-00-7\nDistillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]\n270-729-9\n68477-40-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-411-00-2\nDistillates (petroleum), steam-cracked, C8-12 fraction;\nCracked kerosine;\n[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]\n270-737-2\n68477-54-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-412-00-8\nKerosine (petroleum), hydrodesulfurized thermal cracked;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]\n285-507-7\n85116-55-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-413-00-3\nAromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]\n292-621-0\n90640-98-5\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-414-00-9\nNaphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]\n292-637-8\n90641-13-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-415-00-4\nDistillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]\n309-866-7\n101316-61-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-416-00-X\nDistillates (petroleum), catalytic cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-938-8\n101631-13-4\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-417-00-5\nSolvent naphtha (petroleum), hydrocracked heavy arom.;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]\n309-881-9\n101316-80-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-418-00-0\nDistillates (petroleum), steam-cracked heavy tar light;\nCracked kerosine;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]\n309-940-9\n101631-15-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-419-00-6\nDistillates (petroleum), alkylate;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]\n265-074-0\n64741-73-7\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-420-00-1\nExtracts (petroleum), heavy naphtha solvent;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]\n265-099-7\n64741-98-6\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-421-00-7\nDistillates (petroleum), chemically neutralized light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-132-5\n64742-31-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-422-00-2\nDistillates (petroleum), hydrotreated light;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-149-8\n64742-47-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-423-00-8\nKerosine (petroleum), hydrodesulfurized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]\n265-184-9\n64742-81-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-424-00-3\nSolvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;\n[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]\n265-198-5\n64742-94-5\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-425-00-9\nNaphtha (petroleum), heavy coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]\n269-778-9\n68333-23-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-426-00-4\nNaphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;\nKerosine — unspecified;\n[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]\n285-508-2\n85116-57-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-427-00-X\nKerosine (petroleum), sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]\n294-799-5\n91770-15-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-428-00-5\nKerosine (petroleum), solvent-refined sweetened;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]\n295-416-4\n92045-36-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-429-00-0\nHydrocarbons, C9-16, hydrotreated, dearomatized;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]\n297-854-1\n93763-35-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-430-00-6\nKerosine (petroleum), solvent-refined hydrodesulfurized;\nKerosine — unspecified\n307-033-2\n97488-94-3\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-431-00-1\nDistillates (petroleum), hydrodesulfurized full-range middle coker;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]\n309-864-6\n101316-58-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-432-00-7\nSolvent naphtha (petroleum), hydrodesulfurized heavy arom.;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]\n309-882-4\n101316-81-8\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-433-00-2\nSolvent naphtha (petroleum), hydrodesulfurized medium;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]\n309-884-5\n101316-82-9\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-434-00-8\nKerosine (petroleum), hydrotreated;\nKerosine — unspecified;\n[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]\n309-944-0\n101631-19-0\nXn; R65\nXn\nR: 65\nS: (2-)23-24-62\n\nH\n649-435-00-3\nDistillates (petroleum), light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n265-060-4\n64741-59-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-436-00-9\nDistillates (petroleum), intermediate catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]\n265-062-5\n64741-60-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-437-00-4\nDistillates (petroleum), light hydrocracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]\n265-078-2\n64741-77-1\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-438-00-X\nDistillates (petroleum), light thermal cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]\n265-084-5\n64741-82-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-439-00-5\nDistillates (petroleum), hydrodesulfurized light catalytic cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]\n269-781-5\n68333-25-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-440-00-0\nDistillates (petroleum), light steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]\n270-662-5\n68475-80-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-441-00-6\nDistillates (petroleum), cracked steam-cracked petroleum distillates;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]\n270-727-8\n68477-38-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-442-00-1\nGas oils (petroleum), steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]\n271-260-2\n68527-18-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-443-00-7\nDistillates (petroleum), hydrodesulfurized thermal cracked middle;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]\n285-505-6\n85116-53-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-444-00-2\nGas oils (petroleum), thermal-cracked, hydrodesulfurized;\nCracked gasoil\n295-411-7\n92045-29-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-445-00-8\nResidues (petroleum), hydrogenated steam-cracked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]\n295-514-7\n92062-00-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-446-00-3\nResidues (petroleum), steam-cracked naphtha distn.;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]\n295-517-3\n92062-04-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-447-00-9\nDistillates (petroleum), light catalytic cracked, thermally degraded;\nCracked gasoil;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]\n295-991-1\n92201-60-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-448-00-4\nResidues (petroleum), steam-cracked heat-soaked naphtha;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]\n297-905-8\n93763-85-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-449-00-X\nHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]\n307-662-2\n97675-88-2\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nH\n649-450-00-5\nGas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]\n308-278-8\n97926-59-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-451-00-0\nDistillates (petroleum), hydrodesulfurized middle coker;\nCracked gasoil;\n[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]\n309-865-1\n101316-59-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-452-00-6\nDistillates (petroleum), heavy steam-cracked;\nCracked gasoil;\n[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]\n309-939-3\n101631-14-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH\n649-453-00-1\nDistillates (petroleum), heavy hydrocracked;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]\n265-077-7\n64741-76-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-454-00-7\nDistillates (petroleum), solvent-refined heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-090-8\n64741-88-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-455-00-2\nDistillates (petroleum), solvent-refined light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-091-3\n64741-89-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-456-00-8\nResidual oils (petroleum), solvent deasphalted;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-096-0\n64741-95-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-457-00-3\nDistillates (petroleum), solvent-refined heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]\n265-097-6\n64741-96-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-458-00-9\nDistillates (petroleum), solvent-refined light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-098-1\n64741-97-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-459-00-4\nResidual oils (petroleum,) solvent-refined;\nBaseoil — unspecified;\n[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-101-6\n64742-01-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-460-00-X\nDistillates (petroleum), clay-treated paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-137-2\n64742-36-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-461-00-5\nDistillates (petroleum), clay-treated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-138-8\n64742-37-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-462-00-0\nResidual oils (petroleum), clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]\n265-143-5\n64742-41-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-463-00-6\nDistillates (petroleum), clay-treated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-146-1\n64742-44-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-464-00-1\nDistillates (petroleum), clay-treated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-147-7\n64742-45-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-465-00-7\nDistillates (petroleum), hydrotreated heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-155-0\n64742-52-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-466-00-2\nDistillates (petroleum), hydrotreated light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-156-6\n64742-53-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-467-00-8\nDistillates (petroleum), hydrotreated heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-157-1\n64742-54-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-468-00-3\nDistillates (petroleum), hydrotreated light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]\n265-158-7\n64742-55-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-469-00-9\nDistillates (petroleum), solvent-dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-159-2\n64742-56-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-470-00-4\nResidual oils (petroleum), hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-160-8\n64742-57-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-471-00-X\nResidual oils (petroleum), solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]\n265-166-0\n64742-62-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-472-00-5\nDistillates (petroleum), solvent-dewaxed heavy naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-167-6\n64742-63-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-473-00-0\nDistillates (petroleum), solvent-dewaxed light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-168-1\n64742-64-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-474-00-6\nDistillates (petroleum), solvent-dewaxed heavy paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-169-7\n64742-65-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-475-00-1\nNaphthenic oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-172-3\n64742-68-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-476-00-7\nNaphthenic oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-173-9\n64742-69-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-477-00-2\nParaffin oils (petroleum), catalytic dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]\n265-174-4\n64742-70-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-478-00-8\nParaffin oils (petroleum), catalytic dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]\n265-176-5\n64742-71-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-479-00-3\nNaphthenic oils (petroleum), complex dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-179-1\n64742-75-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-480-00-9\nNaphthenic oils (petroleum), complex dewaxed light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon' numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n265-180-7\n64742-76-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-481-00-4\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-736-3\n72623-85-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-482-00-X\nLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]\n276-737-9\n72623-86-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-483-00-5\nLubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]\n276-738-4\n72623-87-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-484-00-0\nLubricating oils;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]\n278-012-2\n74869-22-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-485-00-6\nDistillates (petroleum), complex dewaxed heavy paraffinci;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-613-7\n90640-91-8\nCarc. Cat. 2; R45\nT\nR: 4\nS: 53-45\n\nH L\n649-486-00-1\nDistillates (petroleum), complex dewaxed light paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]\n292-614-2\n90640-92-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-487-00-7\nDistillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-616-3\n90640-94-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-488-00-2\nHydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n292-617-9\n90640-95-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-489-00-8\nDistillates (petroleum), solvent dewaxed light paraffinic, clay-treated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-618-4\n90640-96-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-490-00-3\nDistillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]\n292-620-5\n90640-97-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-491-00-9\nResidual oils (petroleum), hydrotreated solvent dewaxed;\nBaseoil — unspecified\n292-656-1\n90669-74-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-492-00-4\nResidual oils (petroleum), catalytic dewaxed;\nBaseoil — unspecified\n294-843-3\n91770-57-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-493-00-X\nDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]\n295-300-3\n91995-39-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-494-00-5\nDistillates (petroleum), dewaxed light paraffinic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]\n295-301-9\n91995-40-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-495-00-0\nDistillates (petroleum), hydrocracked solvent-refined, dewaxed;\nBaseoil — unspecified;\n[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]\n295-306-6\n91995-45-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-496-00-6\nDistillates (petroleum), solvent-refined light naphthenic, hydrotreated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]\n295-316-0\n91995-54-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-497-00-1\nLubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;\nBaseoil — unspecified\n295-423-2\n92045-42-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-498-00-7\nLubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;\nBaseoil — unspecified\n295-424-8\n92045-43-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-499-00-2\nResidual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]\n295-499-7\n92061-86-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-500-00-6\nParaffin oils (petroleum), solvent-refined dewaxed heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]\n295-810-6\n92129-09-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-501-00-1\nLubricating oils (petroleum), base oils, paraffinic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]\n297-474-6\n93572-43-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-502-00-7\nHydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;\nBaseoil — unspecified\n297-857-8\n93763-38-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-503-00-2\nHydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;\nBaseoil — unspecified\n300-257-1\n93924-61-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-504-00-8\nDistillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;\nBaseoil — unspecified\n305-588-5\n94733-08-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-505-00-3\nDistillates (petroleum), solvent-refined hydrocracked light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]\n305-589-0\n94733-09-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-506-00-9\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-594-8\n94733-15-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-507-00-4\nLubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]\n305-595-3\n94733-16-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-508-00-X\nHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-971-7\n95371-04-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-509-00-5\nHydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;\nBaseoil — unspecified\n305-972-2\n95371-05-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-510-00-0\nHydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;\nBaseoil — unspecified\n305-974-3\n95371-07-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-511-00-6\nHydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;\nBaseoil — unspecified\n305-975-9\n95371-08-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-512-00-1\nDistillates (petroleum), hydrocracked solvent-refined light;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]\n307-010-7\n97488-73-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-513-00-7\nDistillates (petroleum), solvent-refined hydrogenated heavy;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]\n307-011-2\n97488-74-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-514-00-2\nLubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;\nBaseoil — unspecified\n307-034-8\n97488-95-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-515-00-8\nHydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]\n307-661-7\n97675-87-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-516-00-3\nHydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]\n307-755-8\n97722-06-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-517-00-9\nHydrocarbons, C13-27, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.]\n307-758-4\n97722-09-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-518-00-4\nHydrocarbons, C14-29, solvent-extd. light naphthenic;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]\n307-760-5\n97722-10-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-519-00-X\nHydrocarbons, C27-42, dearomatized;\nBaseoil — unspecified\n308-131-8\n97862-81-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-520-00-5\nHydrocarbons, C17-30, hydrotreated distillates, distn. lights;\nBaseoil — unspecified\n308-132-3\n97862-82-3\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-521-00-0\nHydrocarbons, C27-45, naphthenic vacuum distn.;\nBaseoil — unspecified\n308-133-9\n97862-83-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-522-00-6\nHydrocarbons, C27-45, dearomatized;\nBaseoil — unspecified\n308-287-7\n97926-68-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-523-00-1\nHydrocarbons, C20-58, hydrotreated;\nBaseoil — unspecified\n308-289-8\n97926-70-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-524-00-7\nHydrocarbons, C27-42, naphthenic;\nBaseoil — unspecified\n308-290-3\n97926-71-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-525-00-2\nResidual oils (petroleum), carbon-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]\n309-710-8\n100684-37-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-526-00-8\nResidual oils (petroleum), clay-treated solvent-dewaxed;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]\n309-711-3\n100684-38-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-527-00-3\nLubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]\n309-874-0\n101316-69-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-528-00-9\nLubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]\n309-875-6\n101316-70-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-529-00-4\nLubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]\n309-876-1\n101316-71-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-530-00-X\nLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;\nBaseoil — unspecified;\n[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]\n309-877-7\n101316-72-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-531-00-5\nExtracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;\nDistillate aromatic extract (treated);\n[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]\n272-175-3\n68783-00-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-532-00-0\nExtracts (petroleum), solvent-refined heavy paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n272-180-0\n68783-04-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-533-00-6\nExtracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]\n272-342-0\n68814-89-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-534-00-1\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]\n292-631-5\n90641-07-9\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-535-00-7\nExtracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).\n292-632-0\n90641-08-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-536-00-2\nExtracts (petroleum), light paraffinic distillate solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]\n292-633-6\n90641-09-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-537-00-8\nExtracts (petroleum), hydrotreated light paraffinic distillate solvent;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]\n295-335-4\n91995-73-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-538-00-3\nExtracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]\n295-338-0\n91995-75-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-539-00-9\nExtracts (petroleum), light paraffinic distillate solvent, acid-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n295-339-6\n91995-76-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-540-00-4\nExtracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]\n295-340-1\n91995-77-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-541-00-X\nExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n295-342-2\n91995-79-8\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-542-00-5\nExtracts (petroleum), heavy paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]\n296-437-1\n92704-08-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-543-00-0\nExtracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-827-4\n93763-10-1\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-544-00-6\nExtracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]\n297-829-5\n93763-11-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-545-00-1\nExtracts (petroleum), light paraffinic distillate solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-672-2\n100684-02-4\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-546-00-7\nExtracts (petroleum), light paraffinic distillate solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]\n309-673-8\n100684-03-5\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-547-00-2\nExtracts (petroleum), light vacuum, gas oil solvent, carbon-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-674-3\n100684-04-6\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-548-00-8\nExtracts (petroleum), light vacuum gas oil solvent, clay-treated;\nDistillate aromatic extract (treated);\n[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]\n309-675-9\n100684-05-7\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-549-00-3\nFoots oil (petroleum);\nFoots oil;\n[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]\n265-171-8\n64742-67-2\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n649-550-00-9\nFoots oil (petroleum), hydrotreated;\nFoots oil\n295-394-6\n92045-12-0\nCarc. Cat. 2; R45\nT\nR: 45\nS: 53-45\n\nH L\n650-002-00-6\nturpentine, oil\n232-350-7\n8006-64-2\nR10\nXn; R20/21/22-65\nXi; R36/38\nR43\nN; R51-53\nXn; N\nR: 10-20/21/22-36/38-43-51/53-65\nS: (2-)36/37-46-61-62\n\n\n650-003-00-1\nfenson (ISO);\n4-chlorophenyl benzenesulphonate;\n201-274-6\n80-38-6\nXn; R22\nXi; R36\nN; R51-53\nXn; N\nR: 22-36-51/53\nS: (2-)24-26-61\n\n\n650-004-00-7\nnorbormide (ISO);\n5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide\n213-589-6\n991-42-4\nXn; R22\nXn\nR: 22\nS: (2-)\n\n\n650-005-00-2\n(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone\n201-501-9\n83-79-4\nT; R25\nXi; R36/37/38\nN; R50-53\nT; N\nR: 25-36/37/38-50/53\nS: (1/2-)22-24/25-36-45-60-61\n\n\n650-006-00-8\nbenquinox (ISO);\np-benzoquinone 1-benzoylhydrazone 4-oxime\n207-807-9\n495-73-8\nT; R25\nXn; R21\nT\nR: 21-25\nS: (1/2-)36/37-45\n\n\n650-007-00-3\nchlordimeform (ISO);\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine\n228-200-5\n6164-98-3\nCarc. Cat. 3; R40\nXn; R21/22\nN; R50-53\nXn; N\nR: 21/22-40-50/53\nS: (2-)22-36/37-60-61\n\n\n650-008-00-9\ndrazoxolon (ISO);\n4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone\n227-197-8\n5707-69-7\nT; R25\nN; R50-53\nT; N\nR: 25-50/53\nS: (1/2-)22-24-36/37-45-60-61\n\n\n650-009-00-4\nchlordimeform hydrochloride;\nN'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;\nN2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride\n243-269-1\n19750-95-9\nCarc. Cat. 3; R40\nXn; R22\nN; R50-53\nXn; N\nR: 22-40-50/53\nS: (2-)22-36/37-60-61\n\n\n650-010-00-X\nbenzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate\n216-901-9\n1694-09-3\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\n\n650-012-00-0\nerionite\n—\n12510-42-8\nCarc. Cat. 1; R45\nT\nR: 45\nS: 53-45\n\n\n650-013-00-6\nasbestos\n—\n—\n—\n—\n—\n—\n—\n12001-28-4\n132207-32-0\n12172-73-5\n77536-66-4\n77536-68-6\n77536-67-5\n12001-29-5\nCarc. Cat. 1; R45\nT; R48/23\nT\nR: 45-48/23 S: 53-45\n\nE\n650-014-00-1\ndiethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate\n401-770-4\n—\nC; R34\nXn; R22\nC\nR: 22-34\nS: (1/2-)26-36/37/39-45\n\n\n650-015-00-7\nrosin; colophony\n232-475-7\n232-484-6\n277-299-1\n8050-09-7\n8052-10-6\n73138-82-6\nR43\nXi\nR: 43\nS: (2-)24-37\n\n\n\n\n\n650-016-00-2\nMineral wool, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]\n—\n—\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n\nAQR\n\n650-017-00-8\nRefractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;\n[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]\n—\n—\nCarc. Cat. 2; R49\nT\nR: 49\nS: 53-45\n\nAR\n\n650-018-00-3\nreaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid\n406-230-1\n—\nR10\nCarc. Cat. 3; R40\nC; R34\nXn; R20\nR43\nN; R50-53\nC; N\nR: 10-20-34-40-43-50/53\nS: (1/2-)26-36/37/39-45-60-61\n\n\n650-031-00-4\nbis(4-hydroxy-N-methylanilinium) sulphate\n200-237-1\n55-55-0\nXn; R22-48/22\nR43\nN; R50-53\nXn; N\nR: 22-43-48/22-50/53\nS: (2-)36/37-46-60-61\n\n\n650-032-00-X\ncyproconazole (ISO);\n(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol\n—\n94361-06-5\nRepr. Cat. 3; R63\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53-63\nS: (2-)36/37-60-61\n\n\n\n650-033-00-5\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate\n—\n66230-04-4\nT; R23/25\nR43\nN; R50-53\nT; N\nR: 23/25-43-50/53\nS: (1/2-)24-36/37/39-45-60-61\n\n\n\n650-041-00-9\ntriasulfuron (ISO);\n1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea\n—\n82097-50-5\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n\n650-042-00-4\nreaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates\n417-450-2\n—\nXi; R36/38\nR43\nR52-53\nXi\nR: 36/38-43-52/53\nS: (2-)24-26-37-61\n\n\n650-043-00-X\nreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate\n420-310-3\n—\nXn; R22\nN; R50-53\nXn; N\nR: 22-50/53\nS: (2-)22-56-60-61\n\n\n650-044-00-5\nmixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin\n420-480-9\n158570-99-1\nXi; R38\nR43\nN; R50-53\nXi; N\nR: 38-43-50/53\nS: (2-)24-37-60-61\n\n\n650-045-00-0\nreaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate\n417-110-3\n—\nF; R11\nXi; R38-41\nN; R51-53\nF; Xi; N\nR: 11-38-41-51/53\nS: (2-)9-16-26-37/39-61\n\n\n650-046-00-6\ndi(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates\n416-180-2\n12222-04-7\nXn; R22-48/22\nN; R51-53\nXn; N\nR: 22-48/22-51/53\nS: (2-)22-36-61\n\n\n650-047-00-1\ndibenzylphenylsulfonium hexafluoroantimonate\n417-760-8\n134164-24-2\nT; R48/25\nXn; R22\nXi; R41\nR43\nN; R51-53\nT; N\nR: 22-41-43-48/25-51/53\nS: (1/2-)22-26-36/37/39-45-61\n\n\n650-048-00-7\nreaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid\n420-070-1\n—\nO; R7\nXn; R20/21/22\nC; R35\nN; R50\nO; C; N\nR: 7-20/21/22-35-50\nS: (1/2-)3/7-14-26-36/37/39-45-61\n\n\n650-049-00-2\n2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl\n417-960-5\n—\nXi; R38-41\nR43\nN; R50-53\nXi; N\nR: 38-41-43-50/53\nS: (2-)24-26-37/39-60-61\n\n\n650-050-00-8\nreaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;\n1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;\n1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers\n423-600-8\n—\nN; R51-53\nN\nR: 51/53\nS: 61\n\n\n650-055-00-5\nsilver sodium zirconium hydrogenphosphate\n422-570-3\n155925-27-2\nN; R50-53\nN\nR: 50/53\nS: 60-61\n\n", "previous_location": null, "changed_within": [ "AN VI SCT 3" ], "table_entries": { "tables": [ { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key_label": "Index No", "header": [ [ "Index No", "International Chemical Identification", "EC No", "CAS No", "Classification", null, "Labelling", null, null, "Specific Conc. Limits, M-factors", "Notes" ], [ null, null, null, null, "Hazard Class and Category Code(s)", "Hazard statement Code(s)", "Pictogram, Signal Word Code(s)", "Hazard statement Code(s)", "Suppl. Hazard statement Code(s)", "", "" ] ] }, { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key_label": "Index No", "header": [ [ "Index No", "International Chemical Identification", "EC No", "CAS No", "Classification", "Labelling", "Concentration Limits", "Notes" ] ] } ], "changes": [ { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-006-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-006-00-7", "occurrence": 1, "group": null, "rows": [ [ "005-006-00-7", "dibutyltin hydrogen borate", "401-040-5", "75113-37-0", "Repr. 1B\nMuta. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH400\nH410", "GHS05\nGHS08\nGHS07\nGHS09\nDgr", "H360FD\nH341\nH372\nH312\nH302\nH318\nH317\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "75113-37-0" }, { "scheme": "ec", "value": "401-040-5" }, { "scheme": "index", "value": "005-006-00-7" } ], "failed_check_digits": 0, "name": "dibutyltin hydrogen borate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-006-00-7", "occurrence": 1, "group": null, "rows": [ [ "005-006-00-7", "dibutyltin hydrogen borate", "401-040-5", "75113-37-0", "Repr. 1B\nMuta. 2\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH400\nH410", "GHS05\nGHS08\nGHS07\nGHS09\nDgr", "H360FD\nH341\nH372**\nH312\nH302\nH318\nH317\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "75113-37-0" }, { "scheme": "ec", "value": "401-040-5" }, { "scheme": "index", "value": "005-006-00-7" } ], "failed_check_digits": 0, "name": "dibutyltin hydrogen borate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-007-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-007-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-007-00-2", "boric acid; [1]\nboric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]", "233-139-2 [1]\n234-343-4 [2]", "10043-35-3 [1]\n11113-50-1 [2]", "Repr. 1B", "H360FD", "GHS08\nDgr", "H360FD", "", "Repr. 1B; H360FD: C ≥ 5,5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10043-35-3" }, { "scheme": "cas", "value": "11113-50-1" }, { "scheme": "ec", "value": "233-139-2" }, { "scheme": "ec", "value": "234-343-4" }, { "scheme": "index", "value": "005-007-00-2" } ], "failed_check_digits": 0, "name": "boric acid; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-007-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-007-00-2", "boric acid; [1]\nboric acid; [2]", "233-139-2 [1]\n234-343-4 [2]", "10043-35-3 [1]\n11113-50-1 [2]", "Repr. 1B", "H360FD", "GHS08\nDgr", "H360FD", "", "Repr. 1B; H360FD: C ≥ 5,5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10043-35-3" }, { "scheme": "cas", "value": "11113-50-1" }, { "scheme": "ec", "value": "233-139-2" }, { "scheme": "ec", "value": "234-343-4" }, { "scheme": "index", "value": "005-007-00-2" } ], "failed_check_digits": 0, "name": "boric acid; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-017-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-017-00-7", "occurrence": 1, "group": null, "rows": [ [ "005-017-00-7", "sodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n231-556-4 [2]", "15120-21-5 [1]\n7632-04-4 [2]", "Oxid. Sol. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH302\nH335\nH318", "GHS03\nGHS05\nGHS08\nGHS07\nDgr", "H272\nH360Df\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "15120-21-5" }, { "scheme": "cas", "value": "7632-04-4" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-017-00-7" } ], "failed_check_digits": 0, "name": "sodium perborate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-017-00-7", "occurrence": 1, "group": null, "rows": [ [ "005-017-00-7", "sodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n231-556-4 [2]", "15120-21-5 [1]\n7632-04-4 [2]", "Ox. Sol. 2\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH302\nH335\nH318", "GHS03\nGHS05\nGHS08\nGHS07\nDgr", "H272\nH360Df\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "15120-21-5" }, { "scheme": "cas", "value": "7632-04-4" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-017-00-7" } ], "failed_check_digits": 0, "name": "sodium perborate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-017-01-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-017-01-4", "occurrence": 1, "group": null, "rows": [ [ "005-017-01-4", "sodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n231-556-4 [2]", "15120-21-5 [1]\n7632-04-4 [2]", "Oxid. Sol. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH331\nH302\nH335\nH318", "GHS03\nGHS06\nGHS05\nGHS08\nDgr", "H272\nH360Df\nH331\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "15120-21-5" }, { "scheme": "cas", "value": "7632-04-4" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-017-01-4" } ], "failed_check_digits": 0, "name": "sodium perborate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-017-01-4", "occurrence": 1, "group": null, "rows": [ [ "005-017-01-4", "sodium perborate; [1]\nsodium peroxometaborate; [2]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n231-556-4 [2]", "15120-21-5 [1]\n7632-04-4 [2]", "Ox. Sol. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH331\nH302\nH335\nH318", "GHS03\nGHS06\nGHS05\nGHS08\nDgr", "H272\nH360Df\nH331\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "15120-21-5" }, { "scheme": "cas", "value": "7632-04-4" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-017-01-4" } ], "failed_check_digits": 0, "name": "sodium perborate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-018-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-018-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-018-00-2", "perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]", "13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]", "Repr. 1B\nSTOT SE 3\nEye Dam. 1", "H360Df\nH335\nH318", "GHS05\nGHS08\nGHS07\nDgr", "H360Df\nH335\nH318", "", "Repr. 1B; H360 Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10486-00-7" }, { "scheme": "cas", "value": "13517-20-9" }, { "scheme": "cas", "value": "37244-98-7" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-018-00-2" } ], "failed_check_digits": 0, "name": "perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-018-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-018-00-2", "perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]\nperboric acid, sodium salt, tetrahydrate; [2]\nperboric acid (HBO(O2)), sodium salt, tetrahydrate [3]\nsodium peroxoborate hexahydrate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "239-172-9 [1]\n234-390-0 [2]\n231-556-4 [3]", "13517-20-9 [1]\n37244-98-7 [2]\n10486-00-7 [3]", "Repr. 1B\nSTOT SE 3\nEye Dam. 1", "H360Df\nH335\nH318", "GHS05\nGHS08\nGHS07\nDgr", "H360Df\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 14 %\nRepr. 1B; H360D: 10 % ≤ C < 14 %\nEye Dam. 1; H318: C ≥ 36 %\nEye Irrit. 2; H319: 22 % ≤ C < 36 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10486-00-7" }, { "scheme": "cas", "value": "13517-20-9" }, { "scheme": "cas", "value": "37244-98-7" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "ec", "value": "239-172-9" }, { "scheme": "index", "value": "005-018-00-2" } ], "failed_check_digits": 0, "name": "perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-019-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-019-00-8", "occurrence": 1, "group": null, "rows": [ [ "005-019-00-8", "perboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]", "11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]", "Oxid. Sol. 3\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH302\nH335\nH318", "GHS03\nGHS05\nGHS08\nGHS07\nDgr", "H272\nH360Df\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10332-33-9" }, { "scheme": "cas", "value": "11138-47-9" }, { "scheme": "cas", "value": "12040-72-1" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "index", "value": "005-019-00-8" } ], "failed_check_digits": 0, "name": "perboric acid, sodium salt; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-019-00-8", "occurrence": 1, "group": null, "rows": [ [ "005-019-00-8", "perboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]", "11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]", "Ox. Sol. 3\nRepr. 1B\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH302\nH335\nH318", "GHS03\nGHS05\nGHS08\nGHS07\nDgr", "H272\nH360Df\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10332-33-9" }, { "scheme": "cas", "value": "11138-47-9" }, { "scheme": "cas", "value": "12040-72-1" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "index", "value": "005-019-00-8" } ], "failed_check_digits": 0, "name": "perboric acid, sodium salt; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "005-019-01-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-019-01-5", "occurrence": 1, "group": null, "rows": [ [ "005-019-01-5", "perboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate; [3]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]", "11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]", "Oxid. Sol. 3\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH331\nH302\nH335\nH318", "GHS03\nGHS06\nGHS05\nGHS08\nDgr", "H272\nH360Df\nH331\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10332-33-9" }, { "scheme": "cas", "value": "11138-47-9" }, { "scheme": "cas", "value": "12040-72-1" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "index", "value": "005-019-01-5" } ], "failed_check_digits": 0, "name": "perboric acid, sodium salt; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "005-019-01-5", "occurrence": 1, "group": null, "rows": [ [ "005-019-01-5", "perboric acid, sodium salt; [1]\nperboric acid, sodium salt, monohydrate; [2]\nperboric acid (HBO(O2)), sodium salt, monohydrate [3]\nsodium peroxoborate;\n[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]", "234-390-0 [1]\n234-390-0 [2]\n231-556-4 [3]", "11138-47-9 [1]\n12040-72-1 [2]\n10332-33-9 [3]", "Ox. Sol. 3\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT SE 3\nEye Dam. 1", "H272\nH360Df\nH331\nH302\nH335\nH318", "GHS03\nGHS06\nGHS05\nGHS08\nDgr", "H272\nH360Df\nH331\nH302\nH335\nH318", "", "Repr. 1B; H360Df: C ≥ 9 %\nRepr. 1B; H360D: 6,5 % ≤ C < 9 %\nEye Dam. 1; H318: C ≥ 22 %\nEye Irrit. 2; H319: 14 % ≤ C < 22 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10332-33-9" }, { "scheme": "cas", "value": "11138-47-9" }, { "scheme": "cas", "value": "12040-72-1" }, { "scheme": "ec", "value": "231-556-4" }, { "scheme": "ec", "value": "234-390-0" }, { "scheme": "index", "value": "005-019-01-5" } ], "failed_check_digits": 0, "name": "perboric acid, sodium salt; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "006-015-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-015-00-9", "occurrence": 1, "group": null, "rows": [ [ "006-015-00-9", "diuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea", "206-354-4", "330-54-1", "Carc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H351\nH302\nH373**\nH400\nH410", "GHS08\nGHS07\nGHS09\nWng", "H351\nH302\nH373\nH410", "", "M=10", "" ] ], "identifiers": [ { "scheme": "cas", "value": "330-54-1" }, { "scheme": "ec", "value": "206-354-4" }, { "scheme": "index", "value": "006-015-00-9" } ], "failed_check_digits": 0, "name": "diuron (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-015-00-9", "occurrence": 1, "group": null, "rows": [ [ "006-015-00-9", "diuron (ISO);\n3-(3,4-dichlorophenyl)-1,1-dimethylurea", "206-354-4", "330-54-1", "Carc. 2\nAcute Tox. 4 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H351\nH302\nH373**\nH400\nH410", "GHS08\nGHS07\nGHS09\nWng", "H351\nH302\nH373**\nH410", "", "M = 10", "" ] ], "identifiers": [ { "scheme": "cas", "value": "330-54-1" }, { "scheme": "ec", "value": "206-354-4" }, { "scheme": "index", "value": "006-015-00-9" } ], "failed_check_digits": 0, "name": "diuron (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "006-087-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-087-00-1", "occurrence": 1, "group": null, "rows": [ [ "006-087-00-1", "furathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate", "265-974-3", "65907-30-4", "Acute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H330\nH301\nH373**\nH319\nH315\nH317\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H330\nH301\nH373\nH319\nH315\nH317\nH410", "", "M=100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "65907-30-4" }, { "scheme": "ec", "value": "265-974-3" }, { "scheme": "index", "value": "006-087-00-1" } ], "failed_check_digits": 0, "name": "furathiocarb (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-087-00-1", "occurrence": 1, "group": null, "rows": [ [ "006-087-00-1", "furathiocarb (ISO);\n2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate", "265-974-3", "65907-30-4", "Acute Tox. 2 *\nAcute Tox. 3 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H330\nH301\nH373**\nH319\nH315\nH317\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H330\nH301\nH373**\nH319\nH315\nH317\nH410", "", "M = 100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "65907-30-4" }, { "scheme": "ec", "value": "265-974-3" }, { "scheme": "index", "value": "006-087-00-1" } ], "failed_check_digits": 0, "name": "furathiocarb (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "006-098-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-098-00-1", "occurrence": 1, "group": null, "rows": [ [ "006-098-00-1", "tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate", "429-170-8", "134575-17-0", "Acute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1", "H302\nH373**\nH318\nH317", "GHS05\nGHS08\nGHS07\nDgrg", "H302\nH373**\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "134575-17-0" }, { "scheme": "ec", "value": "429-170-8" }, { "scheme": "index", "value": "006-098-00-1" } ], "failed_check_digits": 0, "name": "tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "006-098-00-1", "occurrence": 1, "group": null, "rows": [ [ "006-098-00-1", "tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate", "429-170-8", "134575-17-0", "Acute Tox. 4 *\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1", "H302\nH373**\nH318\nH317", "GHS05\nGHS08\nGHS07\nDgr", "H302\nH373**\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "134575-17-0" }, { "scheme": "ec", "value": "429-170-8" }, { "scheme": "index", "value": "006-098-00-1" } ], "failed_check_digits": 0, "name": "tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "007-007-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "007-007-00-8", "occurrence": 1, "group": null, "rows": [ [ "007-007-00-8", "ethyl nitrate", "210-903-3", "625-58-1", "Unst. Expl", "H200", "GHS01\nDgr", "H200", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "625-58-1" }, { "scheme": "ec", "value": "210-903-3" }, { "scheme": "index", "value": "007-007-00-8" } ], "failed_check_digits": 0, "name": "ethyl nitrate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "007-007-00-8", "occurrence": 1, "group": null, "rows": [ [ "007-007-00-8", "ethyl nitrate", "210-903-3", "625-58-1", "Unst. Expl.", "H200", "GHS01\nDgr", "H200", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "625-58-1" }, { "scheme": "ec", "value": "210-903-3" }, { "scheme": "index", "value": "007-007-00-8" } ], "failed_check_digits": 0, "name": "ethyl nitrate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "009-016-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "009-016-00-2", "occurrence": 1, "group": null, "rows": [ [ "009-016-00-2", "trisodium hexafluoroaluminate;\ncryolite", "237-410-6\n239-148-8", "13775-53-6\n15096-52-3", "STOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nAquatic Chronic 2", "H372 **\nH332\nH302\nH411", "GHS08\nGHS07\nGHS09\nDgr", "H372 **\nH332\nH302\nH411", "", "", "C" ] ], "identifiers": [ { "scheme": "cas", "value": "13775-53-6" }, { "scheme": "cas", "value": "15096-52-3" }, { "scheme": "ec", "value": "237-410-6" }, { "scheme": "ec", "value": "239-148-8" }, { "scheme": "index", "value": "009-016-00-2" } ], "failed_check_digits": 0, "name": "trisodium hexafluoroaluminate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "009-016-00-2", "occurrence": 1, "group": null, "rows": [ [ "009-016-00-2", "trisodium hexafluoroaluminate [1]", "237-410-6 [1]", "13775-53-6 [1]", "STOT RE 1\nAcute Tox. 4\nAquatic Chronic 2", "H372\nH332\nH411", "GHS07\nGHS08\nGHS09\nDgr", "H372\nH332\nH411", "", "", "" ], [ null, "trisodium hexafluoroaluminate (cryolite) [2]", "239-148-8 [2]", "15096-52-3 [2]", null, null, null, null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "13775-53-6" }, { "scheme": "cas", "value": "15096-52-3" }, { "scheme": "ec", "value": "237-410-6" }, { "scheme": "ec", "value": "239-148-8" }, { "scheme": "index", "value": "009-016-00-2" } ], "failed_check_digits": 0, "name": "trisodium hexafluoroaluminate [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "014-043-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "014-043-00-8", "occurrence": 1, "group": null, "rows": [ [ "014-043-00-8", "reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)", "432-200-2", "—", "Aquatic Chronic 2", "H411", "GHS09", "H411", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "432-200-2" }, { "scheme": "index", "value": "014-043-00-8" } ], "failed_check_digits": 0, "name": "reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "014-043-00-8", "occurrence": 1, "group": null, "rows": [ [ "014-043-00-8", "reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)", "432-200-2", "—", "STOT SE 3\nSkin Irrit. 2\nEye Dam. 1\nAquatic Chronic 3", "H335\nH315\nH318\nH412", "GHS05\nGHS07\nDgr", "H335\nH315\nH318\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "432-200-2" }, { "scheme": "index", "value": "014-043-00-8" } ], "failed_check_digits": 0, "name": "reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "015-114-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-114-00-6", "occurrence": 1, "group": null, "rows": [ [ "015-114-00-6", "chlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate", "246-538-1", "24934-91-6", "Acute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH400\nH410", "GHS06\nGHS09\nDgr", "H317\nH410", "", "M=10", "" ] ], "identifiers": [ { "scheme": "cas", "value": "24934-91-6" }, { "scheme": "ec", "value": "246-538-1" }, { "scheme": "index", "value": "015-114-00-6" } ], "failed_check_digits": 0, "name": "chlormephos (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-114-00-6", "occurrence": 1, "group": null, "rows": [ [ "015-114-00-6", "chlormephos (ISO);\nS-chloromethyl O,O-diethyl phosphorodithioate", "246-538-1", "24934-91-6", "Acute Tox. 1\nAcute Tox. 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H310\nH300\nH400\nH410", "GHS06\nGHS09\nDgr", "H310\nH300\nH410", "", "M = 10", "" ] ], "identifiers": [ { "scheme": "cas", "value": "24934-91-6" }, { "scheme": "ec", "value": "246-538-1" }, { "scheme": "index", "value": "015-114-00-6" } ], "failed_check_digits": 0, "name": "chlormephos (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "015-115-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-115-00-1", "occurrence": 1, "group": null, "rows": [ [ "015-115-00-1", "chlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]", "244-663-6", "21923-23-9", "Acute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1", "H310\nH300\nH400\nH410", "GHS06\nGHS09\nDgr", "H310\nH300\nH410", "", "M=1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "21923-23-9" }, { "scheme": "ec", "value": "244-663-6" }, { "scheme": "index", "value": "015-115-00-1" } ], "failed_check_digits": 0, "name": "chlorthiophos (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-115-00-1", "occurrence": 1, "group": null, "rows": [ [ "015-115-00-1", "chlorthiophos (ISO);\n[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]", "244-663-6", "21923-23-9", "Acute Tox. 2 *\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1", "H300\nH311\nH400\nH410", "GHS06\nGHS09\nDgr", "H300\nH311\nH410", "", "M = 1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "21923-23-9" }, { "scheme": "ec", "value": "244-663-6" }, { "scheme": "index", "value": "015-115-00-1" } ], "failed_check_digits": 0, "name": "chlorthiophos (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "015-182-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-182-00-7", "occurrence": 1, "group": null, "rows": [ [ "015-182-00-7", "tetraisopropyldichloromethylenebisphosphonate", "430-630-5", "10596-22-2", "Acute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1", "H302\nH319\nH317", "GHS06\nWng", "H302\nH319\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10596-22-2" }, { "scheme": "ec", "value": "430-630-5" }, { "scheme": "index", "value": "015-182-00-7" } ], "failed_check_digits": 0, "name": "tetraisopropyldichloromethylenebisphosphonate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-182-00-7", "occurrence": 1, "group": null, "rows": [ [ "015-182-00-7", "tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)", "430-630-5", "10596-22-2", "Acute Tox. 4 *\nEye Irrit. 2\nSkin Sens. 1", "H302\nH319\nH317", "GHS07\nWng", "H302\nH319\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10596-22-2" }, { "scheme": "ec", "value": "430-630-5" }, { "scheme": "index", "value": "015-182-00-7" } ], "failed_check_digits": 0, "name": "tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "015-199-00-X", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-199-00-X", "occurrence": 1, "group": null, "rows": [ [ "015-199-00-X", "tris[2-chloro-1-chloromethyl)ethyl] phosphate", "237-159-2", "13674-87-8", "Carc. 2", "H351", "GSH08\nWng", "H351", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13674-87-8" }, { "scheme": "ec", "value": "237-159-2" }, { "scheme": "index", "value": "015-199-00-X" } ], "failed_check_digits": 0, "name": "tris[2-chloro-1-chloromethyl)ethyl] phosphate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "015-200-00-3", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-200-00-3", "occurrence": 1, "group": null, "rows": [ [ "015-200-00-3", "indium phosphide", "244-959-5", "22398-80-7", "Carc. 1B\nRepr. 2\nSTOT RE 1", "H350\nH361f\nH372 (lungs)", "GHS08\nDgr", "H350\nH361f\nH372 (lungs)", "", "STOT RE 1;\nH372: C ≥0,1 %\nCarc 1B;\nH350: C ≥0,01 %\nSTOT RE 2;\nH373: 0,01 % ≤ C < 0,1 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "22398-80-7" }, { "scheme": "ec", "value": "244-959-5" }, { "scheme": "index", "value": "015-200-00-3" } ], "failed_check_digits": 0, "name": "indium phosphide" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "015-201-00-9", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-201-00-9", "occurrence": 1, "group": null, "rows": [ [ "015-201-00-9", "trixylyl phosphate", "246-677-8", "25155-23-1", "Repr. 1B", "H360F", "GHS08\nDgr", "H360F", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "25155-23-1" }, { "scheme": "ec", "value": "246-677-8" }, { "scheme": "index", "value": "015-201-00-9" } ], "failed_check_digits": 0, "name": "trixylyl phosphate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "015-202-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-202-00-4", "occurrence": 1, "group": null, "rows": [ [ "015-202-00-4", "tris(nonylphenyl) phosphite", "247-759-6", "26523-78-4", "Skin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH400\nH410", "GHS07\nGHS09\nWng", "H317\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "26523-78-4" }, { "scheme": "ec", "value": "247-759-6" }, { "scheme": "index", "value": "015-202-00-4" } ], "failed_check_digits": 0, "name": "tris(nonylphenyl) phosphite" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "015-203-00-X", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "015-203-00-X", "occurrence": 1, "group": null, "rows": [ [ "015-203-00-X", "diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide", "278-355-8", "75980-60-8", "Repr. 2", "H361f (causing atrophy of the testes)", "GHS08\nWng", "H361f (causing atrophy of the testes)", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "75980-60-8" }, { "scheme": "ec", "value": "278-355-8" }, { "scheme": "index", "value": "015-203-00-X" } ], "failed_check_digits": 0, "name": "diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "016-092-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "016-092-00-0", "occurrence": 1, "group": null, "rows": [ [ "016-092-00-0", "reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol", "427-050-1", "—", "Repr. 1A\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H361f\nH315\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nDgr", "H361f\nH315\nH317\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "427-050-1" }, { "scheme": "index", "value": "016-092-00-0" } ], "failed_check_digits": 0, "name": "reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "016-092-00-0", "occurrence": 1, "group": null, "rows": [ [ "016-092-00-0", "reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;\n5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol", "427-050-1", "—", "Repr. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H361f\nH315\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nWng", "H361f\nH315\nH317\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "427-050-1" }, { "scheme": "index", "value": "016-092-00-0" } ], "failed_check_digits": 0, "name": "reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "017-001-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-001-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-001-00-7", "chlorine", "231-959-5", "7782-50-5", "Acute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1", "H331\nH319\nH335\nH315\nH400", "GHS06\nGHS09\nDgr", "H331\nH319\nH335\nH315\nH400", "", "M=100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7782-50-5" }, { "scheme": "ec", "value": "231-959-5" }, { "scheme": "index", "value": "017-001-00-7" } ], "failed_check_digits": 0, "name": "chlorine" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-001-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-001-00-7", "chlorine", "231-959-5", "7782-50-5", "Ox. Gas 1\nPress. Gas\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2\nAquatic Acute 1", "H270\nH331\nH319\nH335\nH315\nH400", "GHS03\nGHS04\nGHS06\nGHS09\nDgr", "H270\nH331\nH319\nH335\nH315\nH400", "", "M = 100", "U" ] ], "identifiers": [ { "scheme": "cas", "value": "7782-50-5" }, { "scheme": "ec", "value": "231-959-5" }, { "scheme": "index", "value": "017-001-00-7" } ], "failed_check_digits": 0, "name": "chlorine" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "017-012-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-012-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-012-00-7", "calcium hypochlorite", "231-908-7", "7778-54-3", "Ox. Sol. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1", "H272\nH302\nH314\nH400", "GHS03\nGHS05\nGHS07\nGHS09\nDgr", "H272\nH302\nH314\nH400", "EUH031", "Skin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H; 315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 3 %\nSTOT SE 3; H335: C ≥ 3 %\nM=10", "T" ] ], "identifiers": [ { "scheme": "cas", "value": "7778-54-3" }, { "scheme": "ec", "value": "231-908-7" }, { "scheme": "index", "value": "017-012-00-7" } ], "failed_check_digits": 0, "name": "calcium hypochlorite" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-012-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-012-00-7", "calcium hypochlorite", "231-908-7", "7778-54-3", "Ox. Sol. 2\nAcute Tox. 4 *\nSkin Corr. 1B\nAquatic Acute 1", "H272\nH302\nH314\nH400", "GHS03\nGHS05\nGHS07\nGHS09\nDgr", "H272\nH302\nH314\nH400", "EUH031", "Skin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,5 % ≤ C < 3 %\nM = 10", "T" ] ], "identifiers": [ { "scheme": "cas", "value": "7778-54-3" }, { "scheme": "ec", "value": "231-908-7" }, { "scheme": "index", "value": "017-012-00-7" } ], "failed_check_digits": 0, "name": "calcium hypochlorite" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "017-026-00-3", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-026-00-3", "occurrence": 1, "group": null, "rows": [ [ "017-026-00-3", "chlorine dioxide", "233-162-8", "10049-04-4", "Press. Gas\nOx. Gas 1\nAcute Tox. 2 *\nSkin Corr. 1B\nAquatic Acute 1", "H270\nH330\nH314\nH400", "GHS04\nGHS03\nGHS06\nGHS05\nGHS09\nDgr", "H270\nH330\nH314\nH400", "", "M = 10", "5" ] ], "identifiers": [ { "scheme": "cas", "value": "10049-04-4" }, { "scheme": "ec", "value": "233-162-8" }, { "scheme": "index", "value": "017-026-00-3" } ], "failed_check_digits": 0, "name": "chlorine dioxide" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "017-026-01-0", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "017-026-01-0", "occurrence": 1, "group": null, "rows": [ [ "017-026-01-0", "chlorine dioxide … %", "233-162-8", "10049-04-4", "Acute Tox. 3 *\nSkin Corr. 1B\nAquatic Acute 1", "H301\nH314\nH400", "GHS06\nGHS05\nGHS09\nDgr", "H301\nH314\nH400", "", "Skin Corr. 1B; H314: C ≥ 5 %\nSkin Irrit. 2; H315: 1 % ≤ C < 5 %\nEye Dam. 1; H318: 3 % ≤ C < 5 %\nEye Irrit. 2; H319: 0,3 % ≤ C < 3 %\nSTOT SE 3; H335: C ≥ 3 %\nM = 10", "B" ] ], "identifiers": [ { "scheme": "cas", "value": "10049-04-4" }, { "scheme": "ec", "value": "233-162-8" }, { "scheme": "index", "value": "017-026-01-0" } ], "failed_check_digits": 0, "name": "chlorine dioxide … %" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "022-004-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "022-004-00-1", "occurrence": 1, "group": null, "rows": [ [ "022-004-00-1", "potassium titanium oxide (K2Ti6O13)", "432-240-0", "12056-51-8", "Carc. 2", "H351", "GHS08\nDgr", "H351", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "12056-51-8" }, { "scheme": "ec", "value": "432-240-0" }, { "scheme": "index", "value": "022-004-00-1" } ], "failed_check_digits": 0, "name": "potassium titanium oxide (K2Ti6O13)" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "022-004-00-1", "occurrence": 1, "group": null, "rows": [ [ "022-004-00-1", "potassium titanium oxide (K2Ti6O13)", "432-240-0", "12056-51-8", "Carc. 2", "H351", "GHS08\nWng", "H351", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "12056-51-8" }, { "scheme": "ec", "value": "432-240-0" }, { "scheme": "index", "value": "022-004-00-1" } ], "failed_check_digits": 0, "name": "potassium titanium oxide (K2Ti6O13)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "024-004-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "024-004-00-7", "occurrence": 1, "group": null, "rows": [ [ "024-004-00-7", "sodium dichromate", "234-190-3", "10588-01-9", "Ox. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH400\nH410", "GHS03\nGHS06\nGHS05\nGHS08\nGHS09\nDgr", "H272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH410", "", "Resp. Sens. 1; H334: C ≥ 0,2 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nSTOT SE 3; H335: C ≥ 5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10588-01-9" }, { "scheme": "ec", "value": "234-190-3" }, { "scheme": "index", "value": "024-004-00-7" } ], "failed_check_digits": 0, "name": "sodium dichromate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "024-004-00-7", "occurrence": 1, "group": null, "rows": [ [ "024-004-00-7", "sodium dichromate", "234-190-3", "10588-01-9", "Ox. Sol. 2\nCarc. 1B\nMuta. 1B\nRepr. 1B\nAcute Tox. 2 *\nAcute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nSkin Corr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH400\nH410", "GHS03\nGHS06\nGHS05\nGHS08\nGHS09\nDgr", "H272\nH350\nH340\nH360FD\nH330\nH301\nH312\nH372**\nH314\nH334\nH317\nH410", "", "Resp. Sens. 1; H334: C ≥ 0,2 %\nSkin Sens. 1; H317: C ≥ 0,2 %\nSTOT SE 3; H335: C ≥ 5 %", "3" ] ], "identifiers": [ { "scheme": "cas", "value": "10588-01-9" }, { "scheme": "ec", "value": "234-190-3" }, { "scheme": "index", "value": "024-004-00-7" } ], "failed_check_digits": 0, "name": "sodium dichromate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "027-006-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "027-006-00-6", "occurrence": 1, "group": null, "rows": [ [ "027-006-00-6", "cobalt acetate", "200-755-8", "71-48-7", "Carc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360F***\nH334\nH317\nH400\nH410", "GHS08\nGHS09\nDgr", "H350i\nH341\nH360F***\nH334\nH317\nH410", "", "Carc. 1B; H350i: C ≥ 0,01 %\nM=10", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "71-48-7" }, { "scheme": "ec", "value": "200-755-8" }, { "scheme": "index", "value": "027-006-00-6" } ], "failed_check_digits": 0, "name": "cobalt acetate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "027-006-00-6", "occurrence": 1, "group": null, "rows": [ [ "027-006-00-6", "cobalt di(acetate)", "200-755-8", "71-48-7", "Carc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360F***\nH334\nH317\nH400\nH410", "GHS08\nGHS09\nDgr", "H350i\nH341\nH360F***\nH334\nH317\nH410", "", "Carc. 1B; H350i: C ≥ 0,01 %\nM = 10", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "71-48-7" }, { "scheme": "ec", "value": "200-755-8" }, { "scheme": "index", "value": "027-006-00-6" } ], "failed_check_digits": 0, "name": "cobalt di(acetate)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "027-009-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "027-009-00-2", "occurrence": 1, "group": null, "rows": [ [ "027-009-00-2", "cobalt nitrate", "233-402-1", "10141-05-6", "Carc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360F***\nH334\nH317\nH400\nH410", "GHS08\nGHS09\nDgr", "H350i\nH341\nH360F***\nH334\nH317\nH410", "", "Carc. 1B; H350i: C ≥ 0,01 %\nM=10", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "10141-05-6" }, { "scheme": "ec", "value": "233-402-1" }, { "scheme": "index", "value": "027-009-00-2" } ], "failed_check_digits": 0, "name": "cobalt nitrate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "027-009-00-2", "occurrence": 1, "group": null, "rows": [ [ "027-009-00-2", "cobalt dinitrate", "233-402-1", "10141-05-6", "Carc. 1B\nMuta. 2\nRepr. 1B\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360F***\nH334\nH317\nH400\nH410", "GHS08\nGHS09\nDgr", "H350i\nH341\nH360F***\nH334\nH317\nH410", "", "Carc. 1B; H350i: C ≥ 0,01 %\nM = 10", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "10141-05-6" }, { "scheme": "ec", "value": "233-402-1" }, { "scheme": "index", "value": "027-009-00-2" } ], "failed_check_digits": 0, "name": "cobalt dinitrate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "028-009-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-009-00-5", "occurrence": 1, "group": null, "rows": [ [ "028-009-00-5", "nickel sulfate", "232-104-9", "7786-81-4", "Carc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH334\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nDgr", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH334\nH317\nH410", "", "STOT RE 1; H373: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % ≤ C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM=1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7786-81-4" }, { "scheme": "ec", "value": "232-104-9" }, { "scheme": "index", "value": "028-009-00-5" } ], "failed_check_digits": 0, "name": "nickel sulfate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-009-00-5", "occurrence": 1, "group": null, "rows": [ [ "028-009-00-5", "nickel sulfate", "232-104-9", "7786-81-4", "Carc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH334\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nDgr", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH334\nH317\nH410", "", "STOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % ≤ C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM = 1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7786-81-4" }, { "scheme": "ec", "value": "232-104-9" }, { "scheme": "index", "value": "028-009-00-5" } ], "failed_check_digits": 0, "name": "nickel sulfate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "028-011-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-011-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-011-00-6", "nickel dichloride", "231-743-0", "7718-54-9", "Carc. 1A\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH331\nH301\nH372**\nH315\nH334\nH317\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H350i\nH341\nH360D***\nH331\nH301\nH372**\nH315\nH334\nH317\nH410", "", "STOT RE. 1; H373: C ≥ 1 %\nSTOT RE. 2; H373: 0,1 % < C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM=1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7718-54-9" }, { "scheme": "ec", "value": "231-743-0" }, { "scheme": "index", "value": "028-011-00-6" } ], "failed_check_digits": 0, "name": "nickel dichloride" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-011-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-011-00-6", "nickel dichloride", "231-743-0", "7718-54-9", "Carc. 1A\nMuta. 2\nRepr. 1B\nAcute Tox. 3 *\nAcute Tox. 3 *\nSTOT RE 1\nSkin Irrit. 2\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH331\nH301\nH372**\nH315\nH334\nH317\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H350i\nH341\nH360D***\nH331\nH301\nH372**\nH315\nH334\nH317\nH410", "", "STOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % < C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM = 1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7718-54-9" }, { "scheme": "ec", "value": "231-743-0" }, { "scheme": "index", "value": "028-011-00-6" } ], "failed_check_digits": 0, "name": "nickel dichloride" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "028-012-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-012-00-1", "occurrence": 1, "group": null, "rows": [ [ "028-012-00-1", "nickel dinitrate; [1]\nnitric acid, nickel salt [2]", "236-068-5 [1]\n238-076-4 [2]", "13138-45-9 [1]\n14216-75-2 [2]", "Ox. Sol. 2\nCarc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H272\nH350i\nH341\nH360D***\nH372**\nH332\nH302\nH318\nH315\nH317\nH400\nH410", "GHS03\nGHS05\nGHS08\nGHS07\nGHS09\nDgr", "H272\nH350i\nH341\nH360D***\nH372**\nH332\nH302\nH318\nH315\nH317\nH410", "", "STOT RE. 1; H373: C ≥ 1 %\nSTOT RE. 2; H373: 0,1 % < C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM=1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13138-45-9" }, { "scheme": "cas", "value": "14216-75-2" }, { "scheme": "ec", "value": "236-068-5" }, { "scheme": "ec", "value": "238-076-4" }, { "scheme": "index", "value": "028-012-00-1" } ], "failed_check_digits": 0, "name": "nickel dinitrate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-012-00-1", "occurrence": 1, "group": null, "rows": [ [ "028-012-00-1", "nickel dinitrate; [1]\nnitric acid, nickel salt [2]", "236-068-5 [1]\n238-076-4 [2]", "13138-45-9 [1]\n14216-75-2 [2]", "Ox. Sol. 2\nCarc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nSkin Irrit. 2\nEye Dam. 1\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H272\nH350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH318\nH334\nH317\nH400\nH410", "GHS03\nGHS05\nGHS08\nGHS07\nGHS09\nDgr", "H272\nH350i\nH341\nH360D***\nH372**\nH332\nH302\nH315\nH318\nH334\nH317\nH410", "", "STOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % < C < 1 %\nSkin Irrit. 2; H315: C ≥ 20 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM = 1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13138-45-9" }, { "scheme": "cas", "value": "14216-75-2" }, { "scheme": "ec", "value": "236-068-5" }, { "scheme": "ec", "value": "238-076-4" }, { "scheme": "index", "value": "028-012-00-1" } ], "failed_check_digits": 0, "name": "nickel dinitrate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "028-022-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-022-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-022-00-6", "nickel di(acetate); [1]\nnickel acetate [2]", "206-761-7 [1]\n239-086-1 [2]", "373-02-4 [1]\n14998-37-9 [2]", "Carc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH334\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nDgr", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH334\nH317\nH410", "", "STOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % ≤ C < 1 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM=1", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "14998-37-9" }, { "scheme": "cas", "value": "373-02-4" }, { "scheme": "ec", "value": "206-761-7" }, { "scheme": "ec", "value": "239-086-1" }, { "scheme": "index", "value": "028-022-00-6" } ], "failed_check_digits": 0, "name": "nickel di(acetate); [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-022-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-022-00-6", "nickel di(acetate); [1]\nnickel acetate [2]", "206-761-7 [1]\n239-086-1 [2]", "373-02-4 [1]\n14998-37-9 [2]", "Carc. 1A\nMuta. 2\nRepr. 1B\nSTOT RE 1\nAcute Tox. 4 *\nAcute Tox. 4 *\nResp. Sens. 1\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH334\nH317\nH400\nH410", "GHS08\nGHS07\nGHS09\nDgr", "H350i\nH341\nH360D***\nH372**\nH332\nH302\nH334\nH317\nH410", "", "STOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,1 % ≤ C < 1 %\nSkin Sens. 1; H317: C ≥ 0,01 %\nM = 1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "14998-37-9" }, { "scheme": "cas", "value": "373-02-4" }, { "scheme": "ec", "value": "206-761-7" }, { "scheme": "ec", "value": "239-086-1" }, { "scheme": "index", "value": "028-022-00-6" } ], "failed_check_digits": 0, "name": "nickel di(acetate); [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "028-052-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-052-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-052-00-X", "nickel barium titanium primrose priderite;\nC.I. Pigment Yellow 157;\nC.I. 77900", "271-853-6", "68610-24-2", "Carc. 1A\nSTOT RE 1\nSkin Sens. 1", "H350i\nH372**\nH317", "GHS08\nGHS07\nGHS09\nDgr", "H350i\nH372**\nH317", "", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "68610-24-2" }, { "scheme": "ec", "value": "271-853-6" }, { "scheme": "index", "value": "028-052-00-X" } ], "failed_check_digits": 0, "name": "nickel barium titanium primrose priderite;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "028-052-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-052-00-X", "nickel barium titanium primrose priderite;\nC.I. Pigment Yellow 157;\nC.I. 77900", "271-853-6", "68610-24-2", "Carc. 1A\nSTOT RE 1\nSkin Sens. 1", "H350i\nH372**\nH317", "GHS08\nGHS07\nDgr", "H350i\nH372**\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "68610-24-2" }, { "scheme": "ec", "value": "271-853-6" }, { "scheme": "index", "value": "028-052-00-X" } ], "failed_check_digits": 0, "name": "nickel barium titanium primrose priderite;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "050-008-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "050-008-00-3", "occurrence": 1, "group": null, "rows": [ [ "050-008-00-3", "tributyltin compounds, with the exception of those specified elsewhere in this Annex", "—", "—", "Acute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1", "H301\nH312\nH372**\nH319\nH315\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H301\nH312\nH372**\nH319\nH315\nH410", "", "*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,25 % ≤ C < 1 %\nSkin Irrit. 2; C ≥ 1 %\nEye Irrit. 2; C ≥ 1 %\nM=10", "A1" ] ], "identifiers": [ { "scheme": "index", "value": "050-008-00-3" } ], "failed_check_digits": 0, "name": "tributyltin compounds, with the exception of those specified elsewhere in this Annex" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "050-008-00-3", "occurrence": 1, "group": null, "rows": [ [ "050-008-00-3", "tributyltin compounds, with the exception of those specified elsewhere in this Annex", "—", "—", "Acute Tox. 3 *\nAcute Tox. 4 *\nSTOT RE 1\nEye Irrit. 2\nSkin Irrit. 2\nAquatic Acute 1\nAquatic Chronic 1", "H301\nH312\nH372**\nH319\nH315\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H301\nH312\nH372**\nH319\nH315\nH410", "", "*\nSTOT RE 1; H372: C ≥ 1 %\nSTOT RE 2; H373: 0,25 % ≤ C < 1 %\nSkin Irrit. 2; H315: C ≥ 1 %\nEye Irrit. 2; H319: C ≥ 1 %\nM = 10", "A\n1" ] ], "identifiers": [ { "scheme": "index", "value": "050-008-00-3" } ], "failed_check_digits": 0, "name": "tributyltin compounds, with the exception of those specified elsewhere in this Annex" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "053-003-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "053-003-00-4", "occurrence": 1, "group": null, "rows": [ [ "053-003-00-4", "iodoxybenzene", "—", "696-33-3", "Expl. ****", "****", "****", "****", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "696-33-3" }, { "scheme": "index", "value": "053-003-00-4" } ], "failed_check_digits": 0, "name": "iodoxybenzene" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "053-004-00-X", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "053-004-00-X", "occurrence": 1, "group": null, "rows": [ [ "053-004-00-X", "calcium iodoxybenzoate", "—", "—", "Expl. ****", "****", "****", "****", "", "", "C" ] ], "identifiers": [ { "scheme": "index", "value": "053-004-00-X" } ], "failed_check_digits": 0, "name": "calcium iodoxybenzoate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "602-084-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "602-084-00-X", "occurrence": 1, "group": null, "rows": [ [ "602-084-00-X", "1,1-dichloro-1-fluoroethane", "404-080-1", "1717-00-6", "Aquatic\nChronic 3\nOzone 1", "H412\nH420", "GHS07 Wng—", "H412\nH420", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "1717-00-6" }, { "scheme": "ec", "value": "404-080-1" }, { "scheme": "index", "value": "602-084-00-X" } ], "failed_check_digits": 0, "name": "1,1-dichloro-1-fluoroethane" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "602-084-00-X", "occurrence": 1, "group": null, "rows": [ [ "602-084-00-X", "1,1-dichloro-1-fluoroethane", "404-080-1", "1717-00-6", "Aquatic\nChronic 3\nOzone 1", "H412\nH420", "GHS07\nWng", "H412\nH420", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "1717-00-6" }, { "scheme": "ec", "value": "404-080-1" }, { "scheme": "index", "value": "602-084-00-X" } ], "failed_check_digits": 0, "name": "1,1-dichloro-1-fluoroethane" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "602-109-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "602-109-00-4", "occurrence": 1, "group": null, "rows": [ [ "602-109-00-4", "Hexabromocyclododecane [1]", "247-148-4 [1]", "25637-99-4[1]", "Repr. 2\nLact.", "H361\nH362", "GHS08\nWng", "H361\nH362", "", "", "" ], [ null, "1,2,5,6,9,10-hexabromocyclododecane [2]", "221-695-9[2]", "3194-55-6[2]", null, null, null, null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "25637-99-4" }, { "scheme": "cas", "value": "3194-55-6" }, { "scheme": "ec", "value": "221-695-9" }, { "scheme": "ec", "value": "247-148-4" }, { "scheme": "index", "value": "602-109-00-4" } ], "failed_check_digits": 0, "name": "Hexabromocyclododecane [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "603-012-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-012-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-012-00-X", "2-ethoxyethanol;\nethylene glycol monoethyl ether", "203-804-1", "110-80-5", "Flam. Liq. 3\nRepr. 1B\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *", "H226\nH360FD\nH332\nH312\nH302", "GHS02\nGHS08\nGHS07\nDgr", "H226\nH360FD\nH332\nH312\nH302", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-80-5" }, { "scheme": "ec", "value": "203-804-1" }, { "scheme": "index", "value": "603-012-00-X" } ], "failed_check_digits": 0, "name": "2-ethoxyethanol;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-012-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-012-00-X", "2-ethoxyethanol;\nethylene glycol monoethyl ether", "203-804-1", "110-80-5", "Flam. Liq. 3\nRepr. 1B\nAcute Tox. 3\nAcute Tox. 4", "H226\nH360FD\nH331\nH302", "GHS02\nGHS08\nGHS06\nDgr", "H226\nH360FD\nH331\nH302", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-80-5" }, { "scheme": "ec", "value": "203-804-1" }, { "scheme": "index", "value": "603-012-00-X" } ], "failed_check_digits": 0, "name": "2-ethoxyethanol;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "603-023-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-023-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-023-00-X", "ethylene oxide;\noxirane", "200-849-9", "75-21-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2", "H220\nH350\nH340\nH331\nH319\nH335\nH315", "GHS02\nGHS04\nGHS06\nGHS08\nDgr", "H220\nH350\nH340\nH331\nH319\nH335\nH315", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "75-21-8" }, { "scheme": "ec", "value": "200-849-9" }, { "scheme": "index", "value": "603-023-00-X" } ], "failed_check_digits": 0, "name": "ethylene oxide;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-023-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-023-00-X", "ethylene oxide;\noxirane", "200-849-9", "75-21-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B\nAcute Tox. 3 *\nEye Irrit. 2\nSTOT SE 3\nSkin Irrit. 2", "H220\nH350\nH340\nH331\nH319\nH335\nH315", "GHS02\nGHS04\nGHS06\nGHS08\nDgr", "H220\nH350\nH340\nH331\nH319\nH335\nH315", "", "", "U" ] ], "identifiers": [ { "scheme": "cas", "value": "75-21-8" }, { "scheme": "ec", "value": "200-849-9" }, { "scheme": "index", "value": "603-023-00-X" } ], "failed_check_digits": 0, "name": "ethylene oxide;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "603-025-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-025-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-025-00-0", "tetrahydrofuran", "203-726-8", "109-99-9", "Flam. Liq. 2\nEye Irrit. 2\nSTOT SE 3", "H225\nH319\nH335", "GHS02\nGHS07\nDgr", "H225\nH319\nH335", "EUH019", "Eye Irrit. 2; H319: C ≥ 25 %\nSTOT SE 3; H335: C ≥ 25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "109-99-9" }, { "scheme": "ec", "value": "203-726-8" }, { "scheme": "index", "value": "603-025-00-0" } ], "failed_check_digits": 0, "name": "tetrahydrofuran" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-025-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-025-00-0", "tetrahydrofuran", "203-726-8", "109-99-9", "Flam. Liq. 2\nCarc. 2\nEye Irrit. 2\nSTOT SE 3", "H225\nH351\nH319\nH335", "GHS02\nGHS07\nGHS08\nDgr", "H225\nH351\nH319\nH335", "EUH019", "STOT SE 3;\nH335: C ≥ 25 %\nEye Irrit.2;\nH319: C ≥ 25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "109-99-9" }, { "scheme": "ec", "value": "203-726-8" }, { "scheme": "index", "value": "603-025-00-0" } ], "failed_check_digits": 0, "name": "tetrahydrofuran" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "603-194-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-194-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-194-00-0", "2-(2-aminoethylamino)ethanol;\n(AEEA)", "203-867-5", "111-41-1", "Repr. 1B\nSkin Corr. 1B\nSkin Sens. 1", "H360Fd\nH361\nH314\nH317", "GHS05\nGHS08\nGHS07\nDgr", "H360Fd\nH361\nH314\nH317", "", "STOT SE 3; H335: C ≥ 5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "111-41-1" }, { "scheme": "ec", "value": "203-867-5" }, { "scheme": "index", "value": "603-194-00-0" } ], "failed_check_digits": 0, "name": "2-(2-aminoethylamino)ethanol;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "603-194-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-194-00-0", "2-(2-aminoethylamino)ethanol;\n(AEEA)", "203-867-5", "111-41-1", "Repr. 1B\nSkin Corr. 1B\nSkin Sens. 1", "H360Df\nH314\nH317", "GHS05\nGHS08\nGHS07\nDgr", "H360Df\nH314\nH317", "", "STOT SE 3; H335: C ≥ 5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "111-41-1" }, { "scheme": "ec", "value": "203-867-5" }, { "scheme": "index", "value": "603-194-00-0" } ], "failed_check_digits": 0, "name": "2-(2-aminoethylamino)ethanol;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "604-030-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-030-00-0", "occurrence": 1, "group": null, "rows": [ [ "604-030-00-0", "bisphenol A;\n4,4'-isopropylidenediphenol", "201-245-8", "80-05-7", "Repr. 2\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1", "H361f***\nH335\nH318\nH317", "GHS05\nGHS08\nGHS07\nDgr", "H361f\nH335\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "80-05-7" }, { "scheme": "ec", "value": "201-245-8" }, { "scheme": "index", "value": "604-030-00-0" } ], "failed_check_digits": 0, "name": "bisphenol A;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-030-00-0", "occurrence": 1, "group": null, "rows": [ [ "604-030-00-0", "bisphenol A;\n4,4’-isopropylidenediphenol", "201-245-8", "80-05-7", "Repr. 2\nSTOT SE 3\nEye Dam. 1\nSkin Sens. 1", "H361f***\nH335\nH318\nH317", "GHS05\nGHS08\nGHS07\nDgr", "H361f***\nH335\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "80-05-7" }, { "scheme": "ec", "value": "201-245-8" }, { "scheme": "index", "value": "604-030-00-0" } ], "failed_check_digits": 0, "name": "bisphenol A;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "604-076-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-076-00-1", "occurrence": 1, "group": null, "rows": [ [ "604-076-00-1", "phenolphthalein", "201-004-7", "77-09-8", "Carc. 1B\nMuta. 2\nRepr. 2", "H350\nH341\nH361f***", "GHS08\nDgr", "H350\nH341\nH361f***", "", "Carc. 1A; H350: C ≥ 1 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "77-09-8" }, { "scheme": "ec", "value": "201-004-7" }, { "scheme": "index", "value": "604-076-00-1" } ], "failed_check_digits": 0, "name": "phenolphthalein" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-076-00-1", "occurrence": 1, "group": null, "rows": [ [ "604-076-00-1", "phenolphthalein", "201-004-7", "77-09-8", "Carc. 1B\nMuta. 2\nRepr. 2", "H350\nH341\nH361f***", "GHS08\nDgr", "H350\nH341\nH361f***", "", "Carc. 1B; H350: C ≥ 1 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "77-09-8" }, { "scheme": "ec", "value": "201-004-7" }, { "scheme": "index", "value": "604-076-00-1" } ], "failed_check_digits": 0, "name": "phenolphthalein" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "604-079-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-079-00-8", "occurrence": 1, "group": null, "rows": [ [ "604-079-00-8", "4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol", "428-970-4", "13595-25-0", "Repr. 2\nSkin Sens. 1\nAquatic Chronic 2", "H361f***\nH317\nH411", "GHS08\nGHS09\nWng", "H361f***\nH317\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13595-25-0" }, { "scheme": "ec", "value": "428-970-4" }, { "scheme": "index", "value": "604-079-00-8" } ], "failed_check_digits": 0, "name": "4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "604-079-00-8", "occurrence": 1, "group": null, "rows": [ [ "604-079-00-8", "4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol", "428-970-4", "13595-25-0", "Repr. 2\nSkin Sens. 1\nAquatic Chronic 2", "H361f***\nH317\nH411", "GHS08\nGHS07\nGHS09\nWng", "H361f***\nH317\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13595-25-0" }, { "scheme": "ec", "value": "428-970-4" }, { "scheme": "index", "value": "604-079-00-8" } ], "failed_check_digits": 0, "name": "4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "605-005-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "605-005-00-7", "occurrence": 1, "group": null, "rows": [ [ "605-005-00-7", "2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;\nmetaldehyde", "203-600-2", "108-62-3", "Flam. Sol. 2\nAcute Tox. 4 *", "H228\nH302", "GHS02\nGHS07\nDgr", "H228\nH302", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "108-62-3" }, { "scheme": "ec", "value": "203-600-2" }, { "scheme": "index", "value": "605-005-00-7" } ], "failed_check_digits": 0, "name": "2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "605-005-00-7", "occurrence": 1, "group": null, "rows": [ [ "605-005-00-7", "2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;\nmetaldehyde", "203-600-2", "108-62-3", "Flam. Sol. 2\nAcute Tox. 4 *", "H228\nH302", "GHS02\nGHS07\nWng", "H228\nH302", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "108-62-3" }, { "scheme": "ec", "value": "203-600-2" }, { "scheme": "index", "value": "605-005-00-7" } ], "failed_check_digits": 0, "name": "2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "606-109-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-109-00-5", "occurrence": 1, "group": null, "rows": [ [ "606-109-00-5", "2-(4-methyl-3-pentenyl)anthraquinone", "428-320-1", "71308-16-2", "Acute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 4", "H302\nH317\nH314", "GHS07\nWng", "H302\nH317\nH314", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "71308-16-2" }, { "scheme": "ec", "value": "428-320-1" }, { "scheme": "index", "value": "606-109-00-5" } ], "failed_check_digits": 0, "name": "2-(4-methyl-3-pentenyl)anthraquinone" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-109-00-5", "occurrence": 1, "group": null, "rows": [ [ "606-109-00-5", "2-(4-methyl-3-pentenyl)anthraquinone", "428-320-1", "71308-16-2", "Acute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 4", "H302\nH317\nH413", "GHS07\nWng", "H302\nH317\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "71308-16-2" }, { "scheme": "ec", "value": "428-320-1" }, { "scheme": "index", "value": "606-109-00-5" } ], "failed_check_digits": 0, "name": "2-(4-methyl-3-pentenyl)anthraquinone" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "606-113-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-113-00-7", "occurrence": 1, "group": null, "rows": [ [ "606-113-00-7", "1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one", "429-040-0", "272460-97-6", "Eye Dam. 1\nAquatic Chronic 4", "H318\nH314", "GHS05\nDgr", "H318\nH314", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "272460-97-6" }, { "scheme": "ec", "value": "429-040-0" }, { "scheme": "index", "value": "606-113-00-7" } ], "failed_check_digits": 0, "name": "1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-113-00-7", "occurrence": 1, "group": null, "rows": [ [ "606-113-00-7", "1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one", "429-040-0", "272460-97-6", "Eye Dam. 1\nAquatic Chronic 4", "H318\nH413", "GHS05\nDgr", "H318\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "272460-97-6" }, { "scheme": "ec", "value": "429-040-0" }, { "scheme": "index", "value": "606-113-00-7" } ], "failed_check_digits": 0, "name": "1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "606-143-00-0", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-143-00-0", "occurrence": 1, "group": null, "rows": [ [ "606-143-00-0", "abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]", "_ [1]", "71751-41-2 [1]", "Repr. 2\nAcute Tox. 2\nAcute Tox. 1\nSTOT RE 1\nAquatic Acute 1\nAquatic Chronic 1", "H361d\nH300\nH330\nH372 (nervous system)\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H361d\nH300\nH330\nH372 (nervous system)\nH410", "", "STOT RE 1;\nH372: C ≥ 5 %\nSTOT RE 2;\nH373: 0,5 % ≤C<5 %\nM = 10000", "" ], [ null, "avermectin B1a (purity ≥80 %); [2]", "265-610-3 [2]", "65195-55-3 [2]", null, null, null, null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "65195-55-3" }, { "scheme": "cas", "value": "71751-41-2" }, { "scheme": "ec", "value": "265-610-3" }, { "scheme": "index", "value": "606-143-00-0" } ], "failed_check_digits": 0, "name": "abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "606-144-00-6", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "606-144-00-6", "occurrence": 1, "group": null, "rows": [ [ "606-144-00-6", "acequinocyl (ISO);\n3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate", "—", "57960-19-7", "Skin Sens. 1\nSTOT SE 1\nSTOT RE 2\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH370 (lung)\n(inhalation)\nH373 (blood system)\nH400\nH410", "GHS07\nGHS08\nGHS09\nDgr", "H317\nH370 (lung)\n(inhalation)\nH373 (blood system)\nH410", "", "M = 1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "57960-19-7" }, { "scheme": "index", "value": "606-144-00-6" } ], "failed_check_digits": 0, "name": "acequinocyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-177-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-177-00-9", "occurrence": 1, "group": null, "rows": [ [ "607-177-00-9", "tribenuron-methyl (ISO);\n2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester;\nmethyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate", "401-190-1", "101200-48-0", "Skin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH400\nH410", "GHS07\nGHS09\nWng", "H317\nH410", "", "M=100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "101200-48-0" }, { "scheme": "ec", "value": "401-190-1" }, { "scheme": "index", "value": "607-177-00-9" } ], "failed_check_digits": 0, "name": "tribenuron-methyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-177-00-9", "occurrence": 1, "group": null, "rows": [ [ "607-177-00-9", "tribenuron-methyl (ISO);\nmethyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate", "401-190-1", "101200-48-0", "Skin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH400\nH410", "GHS07\nGHS09\nWng", "H317\nH410", "", "M = 100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "101200-48-0" }, { "scheme": "ec", "value": "401-190-1" }, { "scheme": "index", "value": "607-177-00-9" } ], "failed_check_digits": 0, "name": "tribenuron-methyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-245-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-245-00-8", "occurrence": 1, "group": null, "rows": [ [ "607-245-00-8", "tert-butyl acrylate", "216-768-7", "1663-39-4", "Flam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2", "H225\nH332\nH312\nH302\nH335\nH315\nH317\nH411", "GHS02\nGHS07\nGHS09\nWng", "H225\nH332\nH312\nH302\nH335\nH315\nH317\nH411", "", "", "D" ] ], "identifiers": [ { "scheme": "cas", "value": "1663-39-4" }, { "scheme": "ec", "value": "216-768-7" }, { "scheme": "index", "value": "607-245-00-8" } ], "failed_check_digits": 0, "name": "tert-butyl acrylate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-245-00-8", "occurrence": 1, "group": null, "rows": [ [ "607-245-00-8", "tert-butyl acrylate", "216-768-7", "1663-39-4", "Flam. Liq. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT SE 3\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 2", "H225\nH332\nH312\nH302\nH335\nH315\nH317\nH411", "GHS02\nGHS07\nGHS09\nDgr", "H225\nH332\nH312\nH302\nH335\nH315\nH317\nH411", "", "", "D" ] ], "identifiers": [ { "scheme": "cas", "value": "1663-39-4" }, { "scheme": "ec", "value": "216-768-7" }, { "scheme": "index", "value": "607-245-00-8" } ], "failed_check_digits": 0, "name": "tert-butyl acrylate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-504-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-504-00-5", "occurrence": 1, "group": null, "rows": [ [ "607-504-00-5", "diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate", "422-670-7", "—", "Repr. 1A\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H361f\nH301\nH373**\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H361f\nH301\nH373**\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "422-670-7" }, { "scheme": "index", "value": "607-504-00-5" } ], "failed_check_digits": 0, "name": "diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-504-00-5", "occurrence": 1, "group": null, "rows": [ [ "607-504-00-5", "diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate", "422-670-7", "—", "Repr. 2\nAcute Tox. 3 *\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H361f\nH301\nH373**\nH400\nH410", "GHS06\nGHS08\nGHS09\nDgr", "H361f\nH301\nH373**\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "422-670-7" }, { "scheme": "index", "value": "607-504-00-5" } ], "failed_check_digits": 0, "name": "diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-518-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-518-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-518-00-1", "3-oxoandrost-4-ene-17-β-carboxylic acid", "414-990-0", "302-97-6", "Repr. 1A\nAquatic Chronic 4", "H361f\nH413", "GHS08\nDgr", "H361f\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "302-97-6" }, { "scheme": "ec", "value": "414-990-0" }, { "scheme": "index", "value": "607-518-00-1" } ], "failed_check_digits": 0, "name": "3-oxoandrost-4-ene-17-β-carboxylic acid" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-518-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-518-00-1", "3-oxoandrost-4-ene-17-β-carboxylic acid", "414-990-0", "302-97-6", "Repr. 2\nAquatic Chronic 4", "H361f\nH413", "GHS08\nWng", "H361f\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "302-97-6" }, { "scheme": "ec", "value": "414-990-0" }, { "scheme": "index", "value": "607-518-00-1" } ], "failed_check_digits": 0, "name": "3-oxoandrost-4-ene-17-β-carboxylic acid" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-547-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-547-00-X", "occurrence": 1, "group": null, "rows": [ [ "607-547-00-X", "18-methylnonadecyl 2,2 -dimethylpropanoate", "424-370-1", "125496-22-2", "Skin Irrit. 2\nSkin Sens. 1\nAquatic Chronic", "H315\nH317\nH413", "GHS07\nWng", "H315\nH317\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "125496-22-2" }, { "scheme": "ec", "value": "424-370-1" }, { "scheme": "index", "value": "607-547-00-X" } ], "failed_check_digits": 0, "name": "18-methylnonadecyl 2,2 -dimethylpropanoate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-547-00-X", "occurrence": 1, "group": null, "rows": [ [ "607-547-00-X", "18-methylnonadecyl 2,2-dimethylpropanoate", "424-370-1", "125496-22-2", "Skin Irrit. 2\nSkin Sens. 1\nAquatic Chronic 4", "H315\nH317\nH413", "GHS07\nWng", "H315\nH317\nH413", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "125496-22-2" }, { "scheme": "ec", "value": "424-370-1" }, { "scheme": "index", "value": "607-547-00-X" } ], "failed_check_digits": 0, "name": "18-methylnonadecyl 2,2-dimethylpropanoate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-550-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-550-00-6", "occurrence": 1, "group": null, "rows": [ [ "607-550-00-6", "2-amino-4-bromo-5-chlorobenzoic acid", "424-700-4", "—", "Eye Dam. 1\nAquatic Chronic 3", "H318\nH410", "GHS05\nDgr", "H318\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "424-700-4" }, { "scheme": "index", "value": "607-550-00-6" } ], "failed_check_digits": 0, "name": "2-amino-4-bromo-5-chlorobenzoic acid" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-550-00-6", "occurrence": 1, "group": null, "rows": [ [ "607-550-00-6", "2-amino-4-bromo-5-chlorobenzoic acid", "424-700-4", "—", "Eye Dam. 1\nAquatic Chronic 3", "H318\nH412", "GHS05\nDgr", "H318\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "424-700-4" }, { "scheme": "index", "value": "607-550-00-6" } ], "failed_check_digits": 0, "name": "2-amino-4-bromo-5-chlorobenzoic acid" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "607-591-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-591-00-X", "occurrence": 1, "group": null, "rows": [ [ "607-591-00-X", "reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ndisodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate", "428-400-4", "—", "Eye Dam.", "H318", "GHS05\nDgr", "H318", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "428-400-4" }, { "scheme": "index", "value": "607-591-00-X" } ], "failed_check_digits": 0, "name": "reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-591-00-X", "occurrence": 1, "group": null, "rows": [ [ "607-591-00-X", "reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;\ndisodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate", "428-400-4", "—", "Eye Dam. 1", "H318", "GHS05\nDgr", "H318", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "428-400-4" }, { "scheme": "index", "value": "607-591-00-X" } ], "failed_check_digits": 0, "name": "reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "607-698-00-1", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "607-698-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-698-00-1", "4-tert-butylbenzoic acid", "202-696-3", "98-73-7", "Repr. 1B\nSTOT RE 1\nAcute Tox. 4", "H360F\nH372\nH302", "GHS07\nGHS08\nDgr", "H360F\nH372\nH302", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "98-73-7" }, { "scheme": "ec", "value": "202-696-3" }, { "scheme": "index", "value": "607-698-00-1" } ], "failed_check_digits": 0, "name": "4-tert-butylbenzoic acid" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "608-011-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "608-011-00-8", "occurrence": 1, "group": null, "rows": [ [ "608-011-00-8", "oxalonitrile;\ncyanogen", "207-306-5", "460-19-5", "Press. Gas\nFlam. Gas 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1", "H220\nH331\nH400\nH410", "GHS02\nGHS04\nGHS06\nGHS09\nDgr", "H220\nH331\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "460-19-5" }, { "scheme": "ec", "value": "207-306-5" }, { "scheme": "index", "value": "608-011-00-8" } ], "failed_check_digits": 0, "name": "oxalonitrile;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "608-011-00-8", "occurrence": 1, "group": null, "rows": [ [ "608-011-00-8", "oxalonitrile;\ncyanogen", "207-306-5", "460-19-5", "Press. Gas\nFlam. Gas 1\nAcute Tox. 3 *\nAquatic Acute 1\nAquatic Chronic 1", "H220\nH331\nH400\nH410", "GHS02\nGHS04\nGHS06\nGHS09\nDgr", "H220\nH331\nH410", "", "", "U" ] ], "identifiers": [ { "scheme": "cas", "value": "460-19-5" }, { "scheme": "ec", "value": "207-306-5" }, { "scheme": "index", "value": "608-011-00-8" } ], "failed_check_digits": 0, "name": "oxalonitrile;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "608-057-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "608-057-00-9", "occurrence": 1, "group": null, "rows": [ [ "608-057-00-9", "4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate", "431-200-1", "208538-34-5", "Acute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1", "H302\nH318\nH317", "GHS05\nGHS07\nDgr", "H302\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "208538-34-5" }, { "scheme": "ec", "value": "431-200-1" }, { "scheme": "index", "value": "608-057-00-9" } ], "failed_check_digits": 0, "name": "4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "608-057-00-9", "occurrence": 1, "group": null, "rows": [ [ "608-057-00-9", "4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate", "431-200-1", "208538-34-5", "Acute Tox. 4 *\nEye Dam. 1\nSkin Sens. 1", "H302\nH318\nH317", "GHS05\nGHS07\nDgr", "H302\nH318\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "208538-34-5" }, { "scheme": "ec", "value": "431-200-1" }, { "scheme": "index", "value": "608-057-00-9" } ], "failed_check_digits": 0, "name": "4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "608-058-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "608-058-00-4", "occurrence": 1, "group": null, "rows": [ [ "608-058-00-4", "esfenvalerate (ISO);\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate", "—", "66230-04-4", "Acute Tox. 3 *\nAcute Tox. 3 *\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H331\nH301\nH317\nH400\nH410", "GHS06\nGHS09\nDgr", "H331\nH301\nH317\nH410", "", "M = 10000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "66230-04-4" }, { "scheme": "index", "value": "608-058-00-4" } ], "failed_check_digits": 0, "name": "esfenvalerate (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "609-072-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "609-072-00-3", "occurrence": 1, "group": null, "rows": [ [ "609-072-00-3", "4-mesyl-2-nitrotoluene", "430-550-0", "1671-49-4", "Repr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3", "H361f***\nH302\nH317\nH412", "GHS08\nGHS07\nDgr", "H361f***\nH302\nH317\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "1671-49-4" }, { "scheme": "ec", "value": "430-550-0" }, { "scheme": "index", "value": "609-072-00-3" } ], "failed_check_digits": 0, "name": "4-mesyl-2-nitrotoluene" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "609-072-00-3", "occurrence": 1, "group": null, "rows": [ [ "609-072-00-3", "4-mesyl-2-nitrotoluene", "430-550-0", "1671-49-4", "Repr. 2\nAcute Tox. 4 *\nSkin Sens. 1\nAquatic Chronic 3", "H361f***\nH302\nH317\nH412", "GHS08\nGHS07\nWng", "H361f***\nH302\nH317\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "1671-49-4" }, { "scheme": "ec", "value": "430-550-0" }, { "scheme": "index", "value": "609-072-00-3" } ], "failed_check_digits": 0, "name": "4-mesyl-2-nitrotoluene" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "611-028-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "611-028-00-3", "occurrence": 1, "group": null, "rows": [ [ "611-028-00-3", "C,C'-azodi(formamide)", "204-650-8", "123-77-3", "Resp. Sens. 1", "H334", "GHS08\nDgr", "H334", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "123-77-3" }, { "scheme": "ec", "value": "204-650-8" }, { "scheme": "index", "value": "611-028-00-3" } ], "failed_check_digits": 0, "name": "C,C'-azodi(formamide)" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "611-028-00-3", "occurrence": 1, "group": null, "rows": [ [ "611-028-00-3", "C,C'-azodi(formamide)", "204-650-8", "123-77-3", "Resp. Sens. 1", "H334", "GHS08\nDgr", "H334", "", "", "G" ] ], "identifiers": [ { "scheme": "cas", "value": "123-77-3" }, { "scheme": "ec", "value": "204-650-8" }, { "scheme": "index", "value": "611-028-00-3" } ], "failed_check_digits": 0, "name": "C,C'-azodi(formamide)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "611-164-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "611-164-00-3", "occurrence": 1, "group": null, "rows": [ [ "611-164-00-3", "reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;\n2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);\n2,2'-dimethyl-2,2'-azoheptanenitrile;\n2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);\n2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)", "429-710-2", "—", "Self React D\nAcute Tox. 4 *\nAquatic Chronic 2", "H242\nH302\nH411", "GHS02\nGHS07\nGHS09\nDgr", "H242\nH302\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "429-710-2" }, { "scheme": "index", "value": "611-164-00-3" } ], "failed_check_digits": 0, "name": "reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "611-164-00-3", "occurrence": 1, "group": null, "rows": [ [ "611-164-00-3", "reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;\n2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile);\n2,2’-dimethyl-2,2’-azoheptanenitrile;\n2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile);\n2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile)", "429-710-2", "—", "Self-react. D\nAcute Tox. 4 *\nAquatic Chronic 2", "H242\nH302\nH411", "GHS02\nGHS07\nGHS09\nDgr", "H242\nH302\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "ec", "value": "429-710-2" }, { "scheme": "index", "value": "611-164-00-3" } ], "failed_check_digits": 0, "name": "reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "612-237-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "612-237-00-2", "occurrence": 1, "group": null, "rows": [ [ "612-237-00-2", "hydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]", "233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]", "10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]", "Expl. 1.1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1", "H201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400", "HS01\nGHS08\nGHS07\nGHS09\nDgr", "H201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400", "", "", "T" ] ], "identifiers": [ { "scheme": "cas", "value": "10046-00-1" }, { "scheme": "cas", "value": "19098-16-9" }, { "scheme": "cas", "value": "20845-01-6" }, { "scheme": "cas", "value": "53933-48-5" }, { "scheme": "ec", "value": "233-154-4" }, { "scheme": "ec", "value": "242-818-2" }, { "scheme": "ec", "value": "244-077-0" }, { "scheme": "ec", "value": "258-872-5" }, { "scheme": "index", "value": "612-237-00-2" } ], "failed_check_digits": 0, "name": "hydroxylammonium hydrogensulfate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "612-237-00-2", "occurrence": 1, "group": null, "rows": [ [ "612-237-00-2", "hydroxylammonium hydrogensulfate;\nhydroxylamine sulfate(1:1); [1]\nhydroxylamine phosphate; [2]\nhydroxylamine dihydrogenphosphate; [3]\nhydroxylamine 4-methylbenzenesulfonate [4]", "233-154-4 [1]\n244-077-0 [2]\n242-818-2 [3]\n258-872-5 [4]", "10046-00-1 [1]\n20845-01-6 [2]\n19098-16-9 [3]\n53933-48-5 [4]", "Expl. 1.1\nCarc. 2\nAcute Tox. 4 *\nAcute Tox. 4 *\nSTOT RE 2 *\nEye Irrit. 2\nSkin Irrit. 2\nSkin Sens. 1\nAquatic Acute 1", "H201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400", "GHS01\nGHS08\nGHS07\nGHS09\nDgr", "H201\nH351\nH312\nH302\nH373**\nH319\nH315\nH317\nH400", "", "", "T" ] ], "identifiers": [ { "scheme": "cas", "value": "10046-00-1" }, { "scheme": "cas", "value": "19098-16-9" }, { "scheme": "cas", "value": "20845-01-6" }, { "scheme": "cas", "value": "53933-48-5" }, { "scheme": "ec", "value": "233-154-4" }, { "scheme": "ec", "value": "242-818-2" }, { "scheme": "ec", "value": "244-077-0" }, { "scheme": "ec", "value": "258-872-5" }, { "scheme": "index", "value": "612-237-00-2" } ], "failed_check_digits": 0, "name": "hydroxylammonium hydrogensulfate;" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "612-281-00-2", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "612-281-00-2", "occurrence": 1, "group": null, "rows": [ [ "612-281-00-2", "leucomalachite green;\nN,N,N',N'-tetramethyl-4,4'-benzylidenedianiline", "204-961-9", "129-73-7", "Carc. 2\nMuta. 2", "H351\nH341", "GHS08\nWng", "H351\nH341", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "129-73-7" }, { "scheme": "ec", "value": "204-961-9" }, { "scheme": "index", "value": "612-281-00-2" } ], "failed_check_digits": 0, "name": "leucomalachite green;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-010-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-010-00-0", "occurrence": 1, "group": null, "rows": [ [ "613-010-00-0", "ametryn (ISO);\n2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine", "212-634-7", "834-12-8", "Acute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1", "H302\nH400\nH410", "GHS07\nGHS09\nWng", "H302\nH410", "", "M=100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "834-12-8" }, { "scheme": "ec", "value": "212-634-7" }, { "scheme": "index", "value": "613-010-00-0" } ], "failed_check_digits": 0, "name": "ametryn (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-010-00-0", "occurrence": 1, "group": null, "rows": [ [ "613-010-00-0", "ametryn (ISO);\nN-ethyl-N'-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine", "212-634-7", "834-12-8", "Acute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1", "H302\nH400\nH410", "GHS07\nGHS09\nWng", "H302\nH410", "", "M = 100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "834-12-8" }, { "scheme": "ec", "value": "212-634-7" }, { "scheme": "index", "value": "613-010-00-0" } ], "failed_check_digits": 0, "name": "ametryn (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-016-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "613-016-00-3", "fuberidazole(ISO);\n2-(2-furyl)benzimidazole", "223-404-0", "3878-19-1", "Acute Tox. 4 *\nAquatic Acute 1\nAquatic Chronic 1", "H302\nH400\nH410", "GHS07\nGHS09\nWng", "H302\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "3878-19-1" }, { "scheme": "ec", "value": "223-404-0" }, { "scheme": "index", "value": "613-016-00-3" } ], "failed_check_digits": 0, "name": "fuberidazole(ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "613-016-00-3", "fuberidazole (ISO);\n2-(2-furyl)-1H-benzimidazole", "223-404-0", "3878-19-1", "Carc. 2\nAcute Tox. 4\nSTOT RE 2\nSkin Sens. 1\nAquatic Acute 1\nAquatic Chronic 1", "H351\nH302\nH373 (heart)\nH317\nH400\nH410", "GHS07\nGHS08\nGHS09\nWng", "H351\nH302\nH373 (heart)\nH317\nH410", "", "M = 1", "" ] ], "identifiers": [ { "scheme": "cas", "value": "3878-19-1" }, { "scheme": "ec", "value": "223-404-0" }, { "scheme": "index", "value": "613-016-00-3" } ], "failed_check_digits": 0, "name": "fuberidazole (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-120-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-120-00-9", "occurrence": 1, "group": null, "rows": [ [ "613-120-00-9", "bioresmethrin (ISO);\n(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate", "249-014-0", "28434-01-7", "Aquatic Acute 1\nAquatic Chronic 1", "H400\nH410", "GHS09\nWng", "H410", "", "M=1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "28434-01-7" }, { "scheme": "ec", "value": "249-014-0" }, { "scheme": "index", "value": "613-120-00-9" } ], "failed_check_digits": 0, "name": "bioresmethrin (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-120-00-9", "occurrence": 1, "group": null, "rows": [ [ "613-120-00-9", "bioresmethrin (ISO);\n(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate", "249-014-0", "28434-01-7", "Aquatic Acute 1\nAquatic Chronic 1", "H400\nH410", "GHS09\nWng", "H410", "", "M = 1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "28434-01-7" }, { "scheme": "ec", "value": "249-014-0" }, { "scheme": "index", "value": "613-120-00-9" } ], "failed_check_digits": 0, "name": "bioresmethrin (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-139-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-139-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-139-00-2", "metsulfuron-methyl (ISO);\n2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid", "—", "74223-64-6", "Aquatic Acute 1\nAquatic Chronic 1", "H400\nH410", "GHS09\nWng", "H410", "", "M=1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "74223-64-6" }, { "scheme": "index", "value": "613-139-00-2" } ], "failed_check_digits": 0, "name": "metsulfuron-methyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-139-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-139-00-2", "metsulfuron-methyl (ISO);\nmethyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate", "—", "74223-64-6", "Aquatic Acute 1\nAquatic Chronic 1", "H400\nH410", "GHS09\nWng", "H410", "", "M = 1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "74223-64-6" }, { "scheme": "index", "value": "613-139-00-2" } ], "failed_check_digits": 0, "name": "metsulfuron-methyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-161-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-161-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-161-00-2", "2,4-diamino-6-hydroxymethylpteridinehydrobromide", "430-620-0", "76145-91-0", "STOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3", "H373**\nH317\nH412", "GHS08\nGHS07\nWng", "H373**\nH317\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "76145-91-0" }, { "scheme": "ec", "value": "430-620-0" }, { "scheme": "index", "value": "613-161-00-2" } ], "failed_check_digits": 0, "name": "2,4-diamino-6-hydroxymethylpteridinehydrobromide" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-161-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-161-00-2", "(2,4-diaminopteridin-6-yl)methanol hydrobromide", "430-620-0", "76145-91-0", "STOT RE 2 *\nSkin Sens. 1\nAquatic Chronic 3", "H373**\nH317\nH412", "GHS08\nGHS07\nWng", "H373**\nH317\nH412", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "76145-91-0" }, { "scheme": "ec", "value": "430-620-0" }, { "scheme": "index", "value": "613-161-00-2" } ], "failed_check_digits": 0, "name": "(2,4-diaminopteridin-6-yl)methanol hydrobromide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-204-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-204-00-5", "occurrence": 1, "group": null, "rows": [ [ "613-204-00-5", "oxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;\n5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one", "254-637-6", "39807-15-3", "Repr. 1A\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H360Fd\nH373**\nH400\nH410", "GHS08\nGHS09\nDgr", "H360Fd\nH373**\nH410", "", "M=1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "39807-15-3" }, { "scheme": "ec", "value": "254-637-6" }, { "scheme": "index", "value": "613-204-00-5" } ], "failed_check_digits": 0, "name": "oxadiargyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-204-00-5", "occurrence": 1, "group": null, "rows": [ [ "613-204-00-5", "oxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one", "254-637-6", "39807-15-3", "Repr. 2\nSTOT RE 2 *\nAquatic Acute 1\nAquatic Chronic 1", "H361d***\nH373**\nH400\nH410", "GHS08\nGHS09\nWng", "H361d***\nH373**\nH410", "", "M = 1000", "" ] ], "identifiers": [ { "scheme": "cas", "value": "39807-15-3" }, { "scheme": "ec", "value": "254-637-6" }, { "scheme": "index", "value": "613-204-00-5" } ], "failed_check_digits": 0, "name": "oxadiargyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "613-275-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-275-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-275-00-2", "3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride", "424-530-0", "93076-03-0", "Acute Tox. 3 *\nSTOT SE 2\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2", "H301\nH371**\nH373**\nH318\nH317\nH411", "GHS06\nGHS05\nGHS08\nGHS09\nDgr", "H301\nH371\nH373**\nH318\nH317\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "93076-03-0" }, { "scheme": "ec", "value": "424-530-0" }, { "scheme": "index", "value": "613-275-00-2" } ], "failed_check_digits": 0, "name": "3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "613-275-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-275-00-2", "3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride", "424-530-0", "93076-03-0", "Acute Tox. 3 *\nSTOT SE 2\nSTOT RE 2 *\nEye Dam. 1\nSkin Sens. 1\nAquatic Chronic 2", "H301\nH371**\nH373**\nH318\nH317\nH411", "GHS06\nGHS05\nGHS08\nGHS09\nDgr", "H301\nH371**\nH373**\nH318\nH317\nH411", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "93076-03-0" }, { "scheme": "ec", "value": "424-530-0" }, { "scheme": "index", "value": "613-275-00-2" } ], "failed_check_digits": 0, "name": "3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "616-157-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "616-157-00-9", "occurrence": 1, "group": null, "rows": [ [ "616-157-00-9", "3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride", "427-780-9", "114565-70-7", "Acute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic", "H302\nH318\nH400\nH410", "GHS05\nGHS07\nGHS09\nDgr", "H302\nH318\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "114565-70-7" }, { "scheme": "ec", "value": "427-780-9" }, { "scheme": "index", "value": "616-157-00-9" } ], "failed_check_digits": 0, "name": "3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "616-157-00-9", "occurrence": 1, "group": null, "rows": [ [ "616-157-00-9", "3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride", "427-780-9", "114565-70-7", "Acute Tox. 4 *\nEye Dam. 1\nAquatic Acute 1\nAquatic Chronic 1", "H302\nH318\nH400\nH410", "GHS05\nGHS07\nGHS09\nDgr", "H302\nH318\nH410", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "114565-70-7" }, { "scheme": "ec", "value": "427-780-9" }, { "scheme": "index", "value": "616-157-00-9" } ], "failed_check_digits": 0, "name": "3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 1, "key": "616-205-00-9", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "616-205-00-9", "occurrence": 1, "group": null, "rows": [ [ "616-205-00-9", "Metazachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide", "266-583-0", "67129-08-2", "Skin Sens. 1B\nCarc. 2\nAquatic Acute 1\nAquatic Chronic 1", "H317\nH351\nH400\nH410", "GHS07\nGHS08\nGHS09\nWng", "H317\nH351\nH410", "", "M = 100\nM = 100", "" ] ], "identifiers": [ { "scheme": "cas", "value": "67129-08-2" }, { "scheme": "ec", "value": "266-583-0" }, { "scheme": "index", "value": "616-205-00-9" } ], "failed_check_digits": 0, "name": "Metazachlor (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "617-001-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-001-00-2", "occurrence": 1, "group": null, "rows": [ [ "617-001-00-2", "di-tert-butyl peroxide", "203-733-6", "110-05-4", "Org. Perox. E\nFlam. Liq. 2", "H242\nH225", "GHS02\nDgr", "H242\nH225", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-05-4" }, { "scheme": "ec", "value": "203-733-6" }, { "scheme": "index", "value": "617-001-00-2" } ], "failed_check_digits": 0, "name": "di-tert-butyl peroxide" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-001-00-2", "occurrence": 1, "group": null, "rows": [ [ "617-001-00-2", "di-tert-butyl peroxide", "203-733-6", "110-05-4", "Org. Perox. E\nFlam. Liq. 2\nMuta. 2", "H242\nH225\nH341", "GHS02\nGHS08\nDgr", "H242\nH225\nH341", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-05-4" }, { "scheme": "ec", "value": "203-733-6" }, { "scheme": "index", "value": "617-001-00-2" } ], "failed_check_digits": 0, "name": "di-tert-butyl peroxide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "617-008-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-008-00-0", "occurrence": 1, "group": null, "rows": [ [ "617-008-00-0", "dibenzoyl peroxide;\nbenzoyl peroxide", "202-327-6", "94-36-0", "Org. Perox. B\nEye Irrit. 2\nSkin Sens. 1", "H214\nH319\nH317", "GHS01\nGHS02\nGHS07\nDgr", "H214\nH319\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "94-36-0" }, { "scheme": "ec", "value": "202-327-6" }, { "scheme": "index", "value": "617-008-00-0" } ], "failed_check_digits": 0, "name": "dibenzoyl peroxide;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-008-00-0", "occurrence": 1, "group": null, "rows": [ [ "617-008-00-0", "dibenzoyl peroxide;\nbenzoyl peroxide", "202-327-6", "94-36-0", "Org. Perox. B\nEye Irrit. 2\nSkin Sens. 1", "H241\nH319\nH317", "GHS01\nGHS02\nGHS07\nDgr", "H241\nH319\nH317", "", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "94-36-0" }, { "scheme": "ec", "value": "202-327-6" }, { "scheme": "index", "value": "617-008-00-0" } ], "failed_check_digits": 0, "name": "dibenzoyl peroxide;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "617-010-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-010-00-1", "occurrence": 1, "group": null, "rows": [ [ "617-010-00-1", "1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1'-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]", "201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]", "78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]", "Org. Perox. A\nSkin Corr. 1B\nAcute Tox. 4 *", "H242\nH314\nH302", "GHS01\nGHS05\nGHS07\nDgr", "H242\nH314\nH302", "", "STOT SE 3; H335: C ≥ 5 %", "C" ] ], "identifiers": [ { "scheme": "cas", "value": "12262-58-7" }, { "scheme": "cas", "value": "2407-94-5" }, { "scheme": "cas", "value": "2699-11-8" }, { "scheme": "cas", "value": "78-18-2" }, { "scheme": "ec", "value": "201-091-1" }, { "scheme": "ec", "value": "219-306-2" }, { "scheme": "ec", "value": "220-279-4" }, { "scheme": "ec", "value": "235-527-7" }, { "scheme": "index", "value": "617-010-00-1" } ], "failed_check_digits": 0, "name": "1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "617-010-00-1", "occurrence": 1, "group": null, "rows": [ [ "617-010-00-1", "1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]\n1,1’-dioxybiscyclohexan-1-ol; [2]\ncyclohexylidene hydroperoxide; [3]\ncyclohexanone, peroxide [4]", "201-091-1 [1]\n219-306-2 [2]\n220-279-4 [3]\n235-527-7 [4]", "78-18-2 [1]\n2407-94-5 [2]\n2699-11-8 [3]\n12262-58-7 [4]", "Org. Perox. A\nSkin Corr. 1B\nAcute Tox. 4 *", "H240\nH314\nH302", "GHS01\nGHS05\nGHS07\nDgr", "H240\nH314\nH302", "", "STOT SE 3; H335: C ≥ 5 %", "C" ] ], "identifiers": [ { "scheme": "cas", "value": "12262-58-7" }, { "scheme": "cas", "value": "2407-94-5" }, { "scheme": "cas", "value": "2699-11-8" }, { "scheme": "cas", "value": "78-18-2" }, { "scheme": "ec", "value": "201-091-1" }, { "scheme": "ec", "value": "219-306-2" }, { "scheme": "ec", "value": "220-279-4" }, { "scheme": "ec", "value": "235-527-7" }, { "scheme": "index", "value": "617-010-00-1" } ], "failed_check_digits": 0, "name": "1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-062-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-062-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-062-00-6", "Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]", "270-755-0", "68477-73-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-73-6" }, { "scheme": "ec", "value": "270-755-0" }, { "scheme": "index", "value": "649-062-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-062-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-062-00-6", "Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]", "270-755-0", "68477-73-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-73-6" }, { "scheme": "ec", "value": "270-755-0" }, { "scheme": "index", "value": "649-062-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-063-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-063-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-063-00-1", "Gases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-756-6", "68477-74-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-74-7" }, { "scheme": "ec", "value": "270-756-6" }, { "scheme": "index", "value": "649-063-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracker;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-063-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-063-00-1", "Gases (petroleum), catalytic cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-756-6", "68477-74-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-74-7" }, { "scheme": "ec", "value": "270-756-6" }, { "scheme": "index", "value": "649-063-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracker;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-064-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-064-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-064-00-7", "Gases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]", "270-757-1", "68477-75-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-75-8" }, { "scheme": "ec", "value": "270-757-1" }, { "scheme": "index", "value": "649-064-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracker, C1-5-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-064-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-064-00-7", "Gases (petroleum), catalytic cracker, C1-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]", "270-757-1", "68477-75-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-75-8" }, { "scheme": "ec", "value": "270-757-1" }, { "scheme": "index", "value": "649-064-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracker, C1-5-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-065-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-065-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-065-00-2", "Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]", "270-758-7", "68477-76-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-76-9" }, { "scheme": "ec", "value": "270-758-7" }, { "scheme": "index", "value": "649-065-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-065-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-065-00-2", "Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]", "270-758-7", "68477-76-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-76-9" }, { "scheme": "ec", "value": "270-758-7" }, { "scheme": "index", "value": "649-065-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-066-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-066-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-066-00-8", "Gases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]", "270-760-8", "68477-79-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-79-2" }, { "scheme": "ec", "value": "270-760-8" }, { "scheme": "index", "value": "649-066-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformer, C1-4-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-066-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-066-00-8", "Gases (petroleum), catalytic reformer, C1-4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]", "270-760-8", "68477-79-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-79-2" }, { "scheme": "ec", "value": "270-760-8" }, { "scheme": "index", "value": "649-066-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformer, C1-4-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-067-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-067-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-067-00-3", "Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]", "270-765-5", "68477-83-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-83-8" }, { "scheme": "ec", "value": "270-765-5" }, { "scheme": "index", "value": "649-067-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-067-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-067-00-3", "Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;\nPetroleum gas;\n[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]", "270-765-5", "68477-83-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-83-8" }, { "scheme": "ec", "value": "270-765-5" }, { "scheme": "index", "value": "649-067-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-068-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-068-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-068-00-9", "Gases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]", "270-767-6", "68477-85-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-85-0" }, { "scheme": "ec", "value": "270-767-6" }, { "scheme": "index", "value": "649-068-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C4-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-068-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-068-00-9", "Gases (petroleum), C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]", "270-767-6", "68477-85-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-85-0" }, { "scheme": "ec", "value": "270-767-6" }, { "scheme": "index", "value": "649-068-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C4-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-069-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-069-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-069-00-4", "Gases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]", "270-768-1", "68477-86-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-86-1" }, { "scheme": "ec", "value": "270-768-1" }, { "scheme": "index", "value": "649-069-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), deethanizer overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-069-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-069-00-4", "Gases (petroleum), deethanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]", "270-768-1", "68477-86-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-86-1" }, { "scheme": "ec", "value": "270-768-1" }, { "scheme": "index", "value": "649-069-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), deethanizer overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-070-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-070-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-070-00-X", "Gases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "270-769-7", "68477-87-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-87-2" }, { "scheme": "ec", "value": "270-769-7" }, { "scheme": "index", "value": "649-070-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), deisobutanizer tower overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-070-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-070-00-X", "Gases (petroleum), deisobutanizer tower overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "270-769-7", "68477-87-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-87-2" }, { "scheme": "ec", "value": "270-769-7" }, { "scheme": "index", "value": "649-070-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), deisobutanizer tower overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-071-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-071-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-071-00-5", "Gases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]", "270-772-3", "68477-90-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-90-7" }, { "scheme": "ec", "value": "270-772-3" }, { "scheme": "index", "value": "649-071-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer dry, propene-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-071-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-071-00-5", "Gases (petroleum), depropanizer dry, propene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]", "270-772-3", "68477-90-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-90-7" }, { "scheme": "ec", "value": "270-772-3" }, { "scheme": "index", "value": "649-071-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer dry, propene-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-072-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-072-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-072-00-0", "Gases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "270-773-9", "68477-91-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-91-8" }, { "scheme": "ec", "value": "270-773-9" }, { "scheme": "index", "value": "649-072-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-072-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-072-00-0", "Gases (petroleum), depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "270-773-9", "68477-91-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-91-8" }, { "scheme": "ec", "value": "270-773-9" }, { "scheme": "index", "value": "649-072-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-073-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-073-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-073-00-6", "Gases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]", "270-777-0", "68477-94-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-94-1" }, { "scheme": "ec", "value": "270-777-0" }, { "scheme": "index", "value": "649-073-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas recovery plant depropanizer overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-073-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-073-00-6", "Gases (petroleum), gas recovery plant depropanizer overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]", "270-777-0", "68477-94-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-94-1" }, { "scheme": "ec", "value": "270-777-0" }, { "scheme": "index", "value": "649-073-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas recovery plant depropanizer overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-074-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-074-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-074-00-1", "Gases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "270-778-6", "68477-95-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-95-2" }, { "scheme": "ec", "value": "270-778-6" }, { "scheme": "index", "value": "649-074-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), Girbotol unit feed;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-074-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-074-00-1", "Gases (petroleum), Girbotol unit feed;\nPetroleum gas;\n[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "270-778-6", "68477-95-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-95-2" }, { "scheme": "ec", "value": "270-778-6" }, { "scheme": "index", "value": "649-074-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), Girbotol unit feed;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-075-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-075-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-075-00-7", "Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas", "270-782-8", "68477-99-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-99-6" }, { "scheme": "ec", "value": "270-782-8" }, { "scheme": "index", "value": "649-075-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-075-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-075-00-7", "Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;\nPetroleum gas", "270-782-8", "68477-99-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-99-6" }, { "scheme": "ec", "value": "270-782-8" }, { "scheme": "index", "value": "649-075-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-076-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-076-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-076-00-2", "Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-802-5", "68478-21-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-21-7" }, { "scheme": "ec", "value": "270-802-5" }, { "scheme": "index", "value": "649-076-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-076-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-076-00-2", "Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-802-5", "68478-21-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-21-7" }, { "scheme": "ec", "value": "270-802-5" }, { "scheme": "index", "value": "649-076-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-077-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-077-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-077-00-8", "Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-803-0", "68478-22-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-22-8" }, { "scheme": "ec", "value": "270-803-0" }, { "scheme": "index", "value": "649-077-00-8" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-077-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-077-00-8", "Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-803-0", "68478-22-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-22-8" }, { "scheme": "ec", "value": "270-803-0" }, { "scheme": "index", "value": "649-077-00-8" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-078-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-078-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-078-00-3", "Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]", "270-804-6", "68478-24-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-24-0" }, { "scheme": "ec", "value": "270-804-6" }, { "scheme": "index", "value": "649-078-00-3" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-078-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-078-00-3", "Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]", "270-804-6", "68478-24-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-24-0" }, { "scheme": "ec", "value": "270-804-6" }, { "scheme": "index", "value": "649-078-00-3" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-079-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-079-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-079-00-9", "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "270-806-7", "68478-26-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-26-2" }, { "scheme": "ec", "value": "270-806-7" }, { "scheme": "index", "value": "649-079-00-9" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-079-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-079-00-9", "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "270-806-7", "68478-26-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-26-2" }, { "scheme": "ec", "value": "270-806-7" }, { "scheme": "index", "value": "649-079-00-9" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-080-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-080-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-080-00-4", "Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]", "270-813-5", "68478-32-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-32-0" }, { "scheme": "ec", "value": "270-813-5" }, { "scheme": "index", "value": "649-080-00-4" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-080-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-080-00-4", "Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]", "270-813-5", "68478-32-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-32-0" }, { "scheme": "ec", "value": "270-813-5" }, { "scheme": "index", "value": "649-080-00-4" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-081-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-081-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-081-00-X", "Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]", "270-814-0", "68478-33-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-33-1" }, { "scheme": "ec", "value": "270-814-0" }, { "scheme": "index", "value": "649-081-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-081-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-081-00-X", "Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]", "270-814-0", "68478-33-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-33-1" }, { "scheme": "ec", "value": "270-814-0" }, { "scheme": "index", "value": "649-081-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-082-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-082-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-082-00-5", "Tail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-815-6", "68478-34-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-34-2" }, { "scheme": "ec", "value": "270-815-6" }, { "scheme": "index", "value": "649-082-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), vacuum residues thermal cracker;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-082-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-082-00-5", "Tail gas (petroleum), vacuum residues thermal cracker;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-815-6", "68478-34-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-34-2" }, { "scheme": "ec", "value": "270-815-6" }, { "scheme": "index", "value": "649-082-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), vacuum residues thermal cracker;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-083-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-083-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-083-00-0", "Hydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]", "270-990-9", "68512-91-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68512-91-4" }, { "scheme": "ec", "value": "270-990-9" }, { "scheme": "index", "value": "649-083-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3-4-rich, petroleum distillate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-083-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-083-00-0", "Hydrocarbons, C3-4-rich, petroleum distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]", "270-990-9", "68512-91-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68512-91-4" }, { "scheme": "ec", "value": "270-990-9" }, { "scheme": "index", "value": "649-083-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3-4-rich, petroleum distillate;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-084-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-084-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-084-00-6", "Gases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]", "271-000-8", "68513-15-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-15-5" }, { "scheme": "ec", "value": "271-000-8" }, { "scheme": "index", "value": "649-084-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), full-range straight-run naphtha dehexanizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-084-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-084-00-6", "Gases (petroleum), full-range straight-run naphtha dehexanizer off;\npetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]", "271-000-8", "68513-15-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-15-5" }, { "scheme": "ec", "value": "271-000-8" }, { "scheme": "index", "value": "649-084-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), full-range straight-run naphtha dehexanizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-085-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-085-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-085-00-1", "Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]", "271-001-3", "68513-16-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-16-6" }, { "scheme": "ec", "value": "271-001-3" }, { "scheme": "index", "value": "649-085-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-085-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-085-00-1", "Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;\nPetroleum gas;\n[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]", "271-001-3", "68513-16-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-16-6" }, { "scheme": "ec", "value": "271-001-3" }, { "scheme": "index", "value": "649-085-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-086-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-086-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-086-00-7", "Gases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]", "271-002-9", "68513-17-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-17-7" }, { "scheme": "ec", "value": "271-002-9" }, { "scheme": "index", "value": "649-086-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), light straight-run naphtha stabilizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-086-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-086-00-7", "Gases (petroleum), light straight-run naphtha stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]", "271-002-9", "68513-17-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-17-7" }, { "scheme": "ec", "value": "271-002-9" }, { "scheme": "index", "value": "649-086-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), light straight-run naphtha stabilizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-087-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-087-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-087-00-2", "Residues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11,7 °C to 27,8 °C (11 °F to 82 °F).]", "271-010-2", "68513-66-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-66-6" }, { "scheme": "ec", "value": "271-010-2" }, { "scheme": "index", "value": "649-087-00-2" } ], "failed_check_digits": 0, "name": "Residues (petroleum), alkylation splitter, C4-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-087-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-087-00-2", "Residues (petroleum), alkylation splitter, C4-rich;\nPetroleum gas;\n[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately – 11.7 °C to 27.8 °C (11 °F to 82 °F).]", "271-010-2", "68513-66-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-66-6" }, { "scheme": "ec", "value": "271-010-2" }, { "scheme": "index", "value": "649-087-00-2" } ], "failed_check_digits": 0, "name": "Residues (petroleum), alkylation splitter, C4-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-088-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-088-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-088-00-8", "Hydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0,5 °C (– 263 °F to 31 °F).]", "271-032-2", "68514-31-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68514-31-8" }, { "scheme": "ec", "value": "271-032-2" }, { "scheme": "index", "value": "649-088-00-8" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-088-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-088-00-8", "Hydrocarbons, C1-4;\nPetroleum gas;\n[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 °C to minus 0.5 °C (– 263 °F to 31 °F).]", "271-032-2", "68514-31-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68514-31-8" }, { "scheme": "ec", "value": "271-032-2" }, { "scheme": "index", "value": "649-088-00-8" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-089-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-089-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-089-00-3", "Hydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0,5 °C (– 263 °F to 31 °F).]", "271-038-5", "68514-36-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68514-36-3" }, { "scheme": "ec", "value": "271-038-5" }, { "scheme": "index", "value": "649-089-00-3" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4, sweetened;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-089-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-089-00-3", "Hydrocarbons, C1-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 164 °C to – 0.5 °C (– 263 °F to 31 °F).]", "271-038-5", "68514-36-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68514-36-3" }, { "scheme": "ec", "value": "271-038-5" }, { "scheme": "index", "value": "649-089-00-3" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4, sweetened;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-090-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-090-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-090-00-9", "Hydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]", "271-259-7", "68527-16-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-16-2" }, { "scheme": "ec", "value": "271-259-7" }, { "scheme": "index", "value": "649-090-00-9" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-3;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-090-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-090-00-9", "Hydrocarbons, C1-3;\nPetroleum gas;\n[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 °C to minus 42 °C (– 263 °F to – 44 °F).]", "271-259-7", "68527-16-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-16-2" }, { "scheme": "ec", "value": "271-259-7" }, { "scheme": "index", "value": "649-090-00-9" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-3;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-091-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-091-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-091-00-4", "Hydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas", "271-261-8", "68527-19-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-19-5" }, { "scheme": "ec", "value": "271-261-8" }, { "scheme": "index", "value": "649-091-00-4" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4, debutanizer fraction;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-091-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-091-00-4", "Hydrocarbons, C1-4, debutanizer fraction;\nPetroleum gas", "271-261-8", "68527-19-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-19-5" }, { "scheme": "ec", "value": "271-261-8" }, { "scheme": "index", "value": "649-091-00-4" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C1-4, debutanizer fraction;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-092-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-092-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-092-00-X", "Gases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "271-624-0", "68602-83-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-83-5" }, { "scheme": "ec", "value": "271-624-0" }, { "scheme": "index", "value": "649-092-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C1-5, wet;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-092-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-092-00-X", "Gases (petroleum), C1-5, wet;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "271-624-0", "68602-83-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-83-5" }, { "scheme": "ec", "value": "271-624-0" }, { "scheme": "index", "value": "649-092-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C1-5, wet;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-093-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-093-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-093-00-5", "Hydrocarbons, C2-4;\nPetroleum gas", "271-734-9", "68606-25-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-25-7" }, { "scheme": "ec", "value": "271-734-9" }, { "scheme": "index", "value": "649-093-00-5" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C2-4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-093-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-093-00-5", "Hydrocarbons, C2-4;\nPetroleum gas", "271-734-9", "68606-25-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-25-7" }, { "scheme": "ec", "value": "271-734-9" }, { "scheme": "index", "value": "649-093-00-5" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C2-4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-094-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-094-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-094-00-0", "Hydrocarbons, C3;\nPetroleum gas", "271-735-4", "68606-26-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-26-8" }, { "scheme": "ec", "value": "271-735-4" }, { "scheme": "index", "value": "649-094-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-094-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-094-00-0", "Hydrocarbons, C3;\nPetroleum gas", "271-735-4", "68606-26-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-26-8" }, { "scheme": "ec", "value": "271-735-4" }, { "scheme": "index", "value": "649-094-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-095-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-095-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-095-00-6", "Gases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "271-737-5", "68606-27-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-27-9" }, { "scheme": "ec", "value": "271-737-5" }, { "scheme": "index", "value": "649-095-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), alkylation feed;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-095-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-095-00-6", "Gases (petroleum), alkylation feed;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "271-737-5", "68606-27-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-27-9" }, { "scheme": "ec", "value": "271-737-5" }, { "scheme": "index", "value": "649-095-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), alkylation feed;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-096-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-096-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-096-00-1", "Gases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]", "271-742-2", "68606-34-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-34-8" }, { "scheme": "ec", "value": "271-742-2" }, { "scheme": "index", "value": "649-096-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer bottoms fractionation off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-096-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-096-00-1", "Gases (petroleum), depropanizer bottoms fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]", "271-742-2", "68606-34-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68606-34-8" }, { "scheme": "ec", "value": "271-742-2" }, { "scheme": "index", "value": "649-096-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), depropanizer bottoms fractionation off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-097-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-097-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-097-00-7", "Gases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-183-7", "68783-07-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-07-3" }, { "scheme": "ec", "value": "272-183-7" }, { "scheme": "index", "value": "649-097-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), refinery blend;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-097-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-097-00-7", "Gases (petroleum), refinery blend;\nPetroleum gas;\n[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-183-7", "68783-07-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-07-3" }, { "scheme": "ec", "value": "272-183-7" }, { "scheme": "index", "value": "649-097-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), refinery blend;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-098-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-098-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-098-00-2", "Gases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "272-203-4", "68783-64-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-64-2" }, { "scheme": "ec", "value": "272-203-4" }, { "scheme": "index", "value": "649-098-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracking;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-098-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-098-00-2", "Gases (petroleum), catalytic cracking;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "272-203-4", "68783-64-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-64-2" }, { "scheme": "ec", "value": "272-203-4" }, { "scheme": "index", "value": "649-098-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracking;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-099-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-099-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-099-00-8", "Gases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]", "272-205-5", "68783-65-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-65-3" }, { "scheme": "ec", "value": "272-205-5" }, { "scheme": "index", "value": "649-099-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-4, sweetened;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-099-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-099-00-8", "Gases (petroleum), C2-4, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately – 51 °C to – 34 °C (– 60 °F to – 30 °F).]", "272-205-5", "68783-65-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-65-3" }, { "scheme": "ec", "value": "272-205-5" }, { "scheme": "index", "value": "649-099-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-4, sweetened;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-100-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-100-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-100-00-1", "Gases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-871-7", "68918-99-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68918-99-0" }, { "scheme": "ec", "value": "272-871-7" }, { "scheme": "index", "value": "649-100-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), crude oil fractionation off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-100-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-100-00-1", "Gases (petroleum), crude oil fractionation off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-871-7", "68918-99-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68918-99-0" }, { "scheme": "ec", "value": "272-871-7" }, { "scheme": "index", "value": "649-100-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), crude oil fractionation off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-101-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-101-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-101-00-7", "Gases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-872-2", "68919-00-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-00-6" }, { "scheme": "ec", "value": "272-872-2" }, { "scheme": "index", "value": "649-101-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), dehexanizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-101-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-101-00-7", "Gases (petroleum), dehexanizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-872-2", "68919-00-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-00-6" }, { "scheme": "ec", "value": "272-872-2" }, { "scheme": "index", "value": "649-101-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), dehexanizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-102-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-102-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-102-00-2", "Gases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-878-5", "68919-05-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-05-1" }, { "scheme": "ec", "value": "272-878-5" }, { "scheme": "index", "value": "649-102-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), light straight run gasoline fractionation stabilizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-102-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-102-00-2", "Gases (petroleum), light straight run gasoline fractionation stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-878-5", "68919-05-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-05-1" }, { "scheme": "ec", "value": "272-878-5" }, { "scheme": "index", "value": "649-102-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), light straight run gasoline fractionation stabilizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-103-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-103-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-103-00-8", "Gases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-879-0", "68919-06-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-06-2" }, { "scheme": "ec", "value": "272-879-0" }, { "scheme": "index", "value": "649-103-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), naphtha unifiner desulfurization stripper off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-103-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-103-00-8", "Gases (petroleum), naphtha unifiner desulfurization stripper off;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-879-0", "68919-06-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-06-2" }, { "scheme": "ec", "value": "272-879-0" }, { "scheme": "index", "value": "649-103-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), naphtha unifiner desulfurization stripper off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-104-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-104-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-104-00-3", "Gases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]", "272-882-7", "68919-09-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-09-5" }, { "scheme": "ec", "value": "272-882-7" }, { "scheme": "index", "value": "649-104-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run naphtha catalytic reforming off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-104-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-104-00-3", "Gases (petroleum), straight-run naphtha catalytic reforming off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]", "272-882-7", "68919-09-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-09-5" }, { "scheme": "ec", "value": "272-882-7" }, { "scheme": "index", "value": "649-104-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run naphtha catalytic reforming off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-105-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-105-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-105-00-9", "Gases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]", "272-893-7", "68919-20-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-20-0" }, { "scheme": "ec", "value": "272-893-7" }, { "scheme": "index", "value": "649-105-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker splitter overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-105-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-105-00-9", "Gases (petroleum), fluidized catalytic cracker splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.]", "272-893-7", "68919-20-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-20-0" }, { "scheme": "ec", "value": "272-893-7" }, { "scheme": "index", "value": "649-105-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker splitter overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-106-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-106-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-106-00-4", "Gases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-883-2", "68919-10-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-10-8" }, { "scheme": "ec", "value": "272-883-2" }, { "scheme": "index", "value": "649-106-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run stabilizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-106-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-106-00-4", "Gases (petroleum), straight-run stabilizer off;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-883-2", "68919-10-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-10-8" }, { "scheme": "ec", "value": "272-883-2" }, { "scheme": "index", "value": "649-106-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run stabilizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-107-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-107-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-107-00-X", "Gases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-169-3", "68952-76-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-76-1" }, { "scheme": "ec", "value": "273-169-3" }, { "scheme": "index", "value": "649-107-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked naphtha debutanizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-107-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-107-00-X", "Gases (petroleum), catalytic cracked naphtha debutanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-169-3", "68952-76-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-76-1" }, { "scheme": "ec", "value": "273-169-3" }, { "scheme": "index", "value": "649-107-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked naphtha debutanizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-108-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-108-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-108-00-5", "Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-170-9", "68952-77-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-77-2" }, { "scheme": "ec", "value": "273-170-9" }, { "scheme": "index", "value": "649-108-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-108-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-108-00-5", "Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-170-9", "68952-77-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-77-2" }, { "scheme": "ec", "value": "273-170-9" }, { "scheme": "index", "value": "649-108-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-109-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-109-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-109-00-0", "Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-175-6", "68952-81-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-81-8" }, { "scheme": "ec", "value": "273-175-6" }, { "scheme": "index", "value": "649-109-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-109-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-109-00-0", "Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;\npetroleum gas;\n[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-175-6", "68952-81-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-81-8" }, { "scheme": "ec", "value": "273-175-6" }, { "scheme": "index", "value": "649-109-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-110-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-110-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-110-00-6", "Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-176-1", "68952-82-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-82-9" }, { "scheme": "ec", "value": "273-176-1" }, { "scheme": "index", "value": "649-110-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-110-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-110-00-6", "Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-176-1", "68952-82-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-82-9" }, { "scheme": "ec", "value": "273-176-1" }, { "scheme": "index", "value": "649-110-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-111-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-111-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-111-00-1", "Gases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]", "273-265-5", "68955-28-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-28-2" }, { "scheme": "ec", "value": "273-265-5" }, { "scheme": "index", "value": "649-111-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum, light steam-cracked, butadiene conc.;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-111-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-111-00-1", "Gases (petroleum, light steam-cracked, butadiene conc.;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.]", "273-265-5", "68955-28-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-28-2" }, { "scheme": "ec", "value": "273-265-5" }, { "scheme": "index", "value": "649-111-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum, light steam-cracked, butadiene conc.;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-112-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-112-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-112-00-7", "Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "273-270-2", "68955-34-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-34-0" }, { "scheme": "ec", "value": "273-270-2" }, { "scheme": "index", "value": "649-112-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-112-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-112-00-7", "Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "273-270-2", "68955-34-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-34-0" }, { "scheme": "ec", "value": "273-270-2" }, { "scheme": "index", "value": "649-112-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-113-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-113-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-113-00-2", "Hydrocarbons, C4;\nPetroleum gas", "289-339-5", "87741-01-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "87741-01-3" }, { "scheme": "ec", "value": "289-339-5" }, { "scheme": "index", "value": "649-113-00-2" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-113-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-113-00-2", "Hydrocarbons, C4;\nPetroleum gas", "289-339-5", "87741-01-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "87741-01-3" }, { "scheme": "ec", "value": "289-339-5" }, { "scheme": "index", "value": "649-113-00-2" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-114-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-114-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-114-00-8", "Alkanes, C1-4, C3-rich;\nPetroleum gas", "292-456-4", "90622-55-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "90622-55-2" }, { "scheme": "ec", "value": "292-456-4" }, { "scheme": "index", "value": "649-114-00-8" } ], "failed_check_digits": 0, "name": "Alkanes, C1-4, C3-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-114-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-114-00-8", "Alkanes, C1-4, C3-rich;\nPetroleum gas", "292-456-4", "90622-55-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "90622-55-2" }, { "scheme": "ec", "value": "292-456-4" }, { "scheme": "index", "value": "649-114-00-8" } ], "failed_check_digits": 0, "name": "Alkanes, C1-4, C3-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-115-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-115-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-115-00-3", "Gases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]", "295-404-9", "92045-22-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-22-2" }, { "scheme": "ec", "value": "295-404-9" }, { "scheme": "index", "value": "649-115-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), steam-cracker C3-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-115-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-115-00-3", "Gases (petroleum), steam-cracker C3-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately – 70 °C to 0 °C (– 94 °F to 32 °F).]", "295-404-9", "92045-22-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-22-2" }, { "scheme": "ec", "value": "295-404-9" }, { "scheme": "index", "value": "649-115-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), steam-cracker C3-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-116-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-116-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-116-00-9", "Hydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10,4 °F to 41 °F).]", "295-405-4", "92045-23-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-23-3" }, { "scheme": "ec", "value": "295-405-4" }, { "scheme": "index", "value": "649-116-00-9" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4, steam-cracker distillate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-116-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-116-00-9", "Hydrocarbons, C4, steam-cracker distillate;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 °C to 5 °C (10.4 °F to 41 °F).]", "295-405-4", "92045-23-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-23-3" }, { "scheme": "ec", "value": "295-405-4" }, { "scheme": "index", "value": "649-116-00-9" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4, steam-cracker distillate;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-117-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-117-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-117-00-4", "Petroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]", "295-463-0", "92045-80-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKSU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-80-2" }, { "scheme": "ec", "value": "295-463-0" }, { "scheme": "index", "value": "649-117-00-4" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied, sweetened, C4 fraction;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-117-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-117-00-4", "Petroleum gases, liquefied, sweetened, C4 fraction;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]", "295-463-0", "92045-80-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K S U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-80-2" }, { "scheme": "ec", "value": "295-463-0" }, { "scheme": "index", "value": "649-117-00-4" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied, sweetened, C4 fraction;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-118-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-118-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-118-00-X", "Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas", "306-004-1", "95465-89-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "95465-89-7" }, { "scheme": "ec", "value": "306-004-1" }, { "scheme": "index", "value": "649-118-00-X" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-118-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-118-00-X", "Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;\nPetroleum gas", "306-004-1", "95465-89-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "95465-89-7" }, { "scheme": "ec", "value": "306-004-1" }, { "scheme": "index", "value": "649-118-00-X" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-119-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-119-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-119-00-5", "Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas", "307-769-4", "97722-19-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "97722-19-5" }, { "scheme": "ec", "value": "307-769-4" }, { "scheme": "index", "value": "649-119-00-5" } ], "failed_check_digits": 0, "name": "Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-119-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-119-00-5", "Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;\nPetroleum gas", "307-769-4", "97722-19-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "97722-19-5" }, { "scheme": "ec", "value": "307-769-4" }, { "scheme": "index", "value": "649-119-00-5" } ], "failed_check_digits": 0, "name": "Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-120-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-120-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-120-00-0", "Gases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]", "270-746-1", "68477-65-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-65-6" }, { "scheme": "ec", "value": "270-746-1" }, { "scheme": "index", "value": "649-120-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), amine system feed;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-120-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-120-00-0", "Gases (petroleum), amine system feed;\nRefinery gas;\n[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]", "270-746-1", "68477-65-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-65-6" }, { "scheme": "ec", "value": "270-746-1" }, { "scheme": "index", "value": "649-120-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), amine system feed;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-121-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-121-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-121-00-6", "Gases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]", "270-747-7", "68477-66-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-66-7" }, { "scheme": "ec", "value": "270-747-7" }, { "scheme": "index", "value": "649-121-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit hydrodesulfurizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-121-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-121-00-6", "Gases (petroleum), benzene unit hydrodesulfurizer off;\nRefinery gas;\n[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]", "270-747-7", "68477-66-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-66-7" }, { "scheme": "ec", "value": "270-747-7" }, { "scheme": "index", "value": "649-121-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit hydrodesulfurizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-122-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-122-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-122-00-1", "Gases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]", "270-748-2", "68477-67-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-67-8" }, { "scheme": "ec", "value": "270-748-2" }, { "scheme": "index", "value": "649-122-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit recycle, hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-122-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-122-00-1", "Gases (petroleum), benzene unit recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]", "270-748-2", "68477-67-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-67-8" }, { "scheme": "ec", "value": "270-748-2" }, { "scheme": "index", "value": "649-122-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit recycle, hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-123-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-123-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-123-00-7", "Gases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-749-8", "68477-68-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-68-9" }, { "scheme": "ec", "value": "270-749-8" }, { "scheme": "index", "value": "649-123-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), blend oil, hydrogen-nitrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-123-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-123-00-7", "Gases (petroleum), blend oil, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-749-8", "68477-68-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-68-9" }, { "scheme": "ec", "value": "270-749-8" }, { "scheme": "index", "value": "649-123-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), blend oil, hydrogen-nitrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-124-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-124-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-124-00-2", "Gases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "270-759-2", "68477-77-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-77-0" }, { "scheme": "ec", "value": "270-759-2" }, { "scheme": "index", "value": "649-124-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformed naphtha stripper overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-124-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-124-00-2", "Gases (petroleum), catalytic reformed naphtha stripper overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "270-759-2", "68477-77-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-77-0" }, { "scheme": "ec", "value": "270-759-2" }, { "scheme": "index", "value": "649-124-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformed naphtha stripper overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-125-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-125-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-125-00-8", "Gases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-761-3", "68477-80-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-80-5" }, { "scheme": "ec", "value": "270-761-3" }, { "scheme": "index", "value": "649-125-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer recycle;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-125-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-125-00-8", "Gases (petroleum), C6-8 catalytic reformer recycle;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-761-3", "68477-80-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-80-5" }, { "scheme": "ec", "value": "270-761-3" }, { "scheme": "index", "value": "649-125-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer recycle;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-126-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-126-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-126-00-3", "Gases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]", "270-762-9", "68477-81-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-81-6" }, { "scheme": "ec", "value": "270-762-9" }, { "scheme": "index", "value": "649-126-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-126-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-126-00-3", "Gases (petroleum), C6-8 catalytic reformer;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]", "270-762-9", "68477-81-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-81-6" }, { "scheme": "ec", "value": "270-762-9" }, { "scheme": "index", "value": "649-126-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-127-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-127-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-127-00-9", "Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas", "270-763-4", "68477-82-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-82-7" }, { "scheme": "ec", "value": "270-763-4" }, { "scheme": "index", "value": "649-127-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-127-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-127-00-9", "Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;\nRefinery gas", "270-763-4", "68477-82-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-82-7" }, { "scheme": "ec", "value": "270-763-4" }, { "scheme": "index", "value": "649-127-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-128-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-128-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-128-00-4", "Gases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]", "270-766-0", "68477-84-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-84-9" }, { "scheme": "ec", "value": "270-766-0" }, { "scheme": "index", "value": "649-128-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-return stream;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-128-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-128-00-4", "Gases (petroleum), C2-return stream;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]", "270-766-0", "68477-84-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-84-9" }, { "scheme": "ec", "value": "270-766-0" }, { "scheme": "index", "value": "649-128-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-return stream;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-129-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-129-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-129-00-X", "Gases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "270-774-4", "68477-92-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-92-9" }, { "scheme": "ec", "value": "270-774-4" }, { "scheme": "index", "value": "649-129-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), dry sour, gas-concn.-unit-off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-129-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-129-00-X", "Gases (petroleum), dry sour, gas-concn.-unit-off;\nRefinery gas;\n[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "270-774-4", "68477-92-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-92-9" }, { "scheme": "ec", "value": "270-774-4" }, { "scheme": "index", "value": "649-129-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), dry sour, gas-concn.-unit-off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-130-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-130-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-130-00-5", "Gases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]", "270-776-5", "68477-93-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-93-0" }, { "scheme": "ec", "value": "270-776-5" }, { "scheme": "index", "value": "649-130-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas concn. reabsorber distn.;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-130-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-130-00-5", "Gases (petroleum), gas concn. reabsorber distn.;\nRefinery gas;\n[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]", "270-776-5", "68477-93-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-93-0" }, { "scheme": "ec", "value": "270-776-5" }, { "scheme": "index", "value": "649-130-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas concn. reabsorber distn.;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-131-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-131-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-131-00-0", "Gases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]", "270-779-1", "68477-96-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-96-3" }, { "scheme": "ec", "value": "270-779-1" }, { "scheme": "index", "value": "649-131-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogen absorber off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-131-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-131-00-0", "Gases (petroleum), hydrogen absorber off;\nRefinery gas;\n[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]", "270-779-1", "68477-96-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-96-3" }, { "scheme": "ec", "value": "270-779-1" }, { "scheme": "index", "value": "649-131-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogen absorber off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-132-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-132-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-132-00-6", "Gases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]", "270-780-7", "68477-97-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-97-4" }, { "scheme": "ec", "value": "270-780-7" }, { "scheme": "index", "value": "649-132-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-132-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-132-00-6", "Gases (petroleum), hydrogen-rich;\nRefinery gas;\n[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]", "270-780-7", "68477-97-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-97-4" }, { "scheme": "ec", "value": "270-780-7" }, { "scheme": "index", "value": "649-132-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-133-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-133-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-133-00-1", "Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-781-2", "68477-98-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-98-5" }, { "scheme": "ec", "value": "270-781-2" }, { "scheme": "index", "value": "649-133-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-133-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-133-00-1", "Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-781-2", "68477-98-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-98-5" }, { "scheme": "ec", "value": "270-781-2" }, { "scheme": "index", "value": "649-133-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-134-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-134-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-134-00-7", "Gases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]", "270-783-3", "68478-00-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-00-2" }, { "scheme": "ec", "value": "270-783-3" }, { "scheme": "index", "value": "649-134-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), recycle, hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-134-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-134-00-7", "Gases (petroleum), recycle, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]", "270-783-3", "68478-00-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-00-2" }, { "scheme": "ec", "value": "270-783-3" }, { "scheme": "index", "value": "649-134-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), recycle, hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-135-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-135-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-135-00-2", "Gases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-784-9", "68478-01-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-01-3" }, { "scheme": "ec", "value": "270-784-9" }, { "scheme": "index", "value": "649-135-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer make-up, hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-135-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-135-00-2", "Gases (petroleum), reformer make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-784-9", "68478-01-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-01-3" }, { "scheme": "ec", "value": "270-784-9" }, { "scheme": "index", "value": "649-135-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer make-up, hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-136-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-136-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-136-00-8", "Gases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "270-785-4", "68478-02-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-02-4" }, { "scheme": "ec", "value": "270-785-4" }, { "scheme": "index", "value": "649-136-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-136-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-136-00-8", "Gases (petroleum), reforming hydrotreater;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "270-785-4", "68478-02-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-02-4" }, { "scheme": "ec", "value": "270-785-4" }, { "scheme": "index", "value": "649-136-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-137-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-137-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-137-00-3", "Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]", "270-787-5", "68478-03-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-03-5" }, { "scheme": "ec", "value": "270-787-5" }, { "scheme": "index", "value": "649-137-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-137-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-137-00-3", "Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]", "270-787-5", "68478-03-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-03-5" }, { "scheme": "ec", "value": "270-787-5" }, { "scheme": "index", "value": "649-137-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-138-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-138-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-138-00-9", "Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-788-0", "68478-04-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-04-6" }, { "scheme": "ec", "value": "270-788-0" }, { "scheme": "index", "value": "649-138-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-138-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-138-00-9", "Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;\nRefinery gas;\n[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-788-0", "68478-04-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-04-6" }, { "scheme": "ec", "value": "270-788-0" }, { "scheme": "index", "value": "649-138-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-139-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-139-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-139-00-4", "Gases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-789-6", "68478-05-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-05-7" }, { "scheme": "ec", "value": "270-789-6" }, { "scheme": "index", "value": "649-139-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), thermal cracking distn.;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-139-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-139-00-4", "Gases (petroleum), thermal cracking distn.;\nRefinery gas;\n[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-789-6", "68478-05-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-05-7" }, { "scheme": "ec", "value": "270-789-6" }, { "scheme": "index", "value": "649-139-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), thermal cracking distn.;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-140-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-140-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-140-00-X", "Tail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "270-805-1", "68478-25-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-25-1" }, { "scheme": "ec", "value": "270-805-1" }, { "scheme": "index", "value": "649-140-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracker refractionation absorber;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-140-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-140-00-X", "Tail gas (petroleum), catalytic cracker refractionation absorber;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "270-805-1", "68478-25-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-25-1" }, { "scheme": "ec", "value": "270-805-1" }, { "scheme": "index", "value": "649-140-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracker refractionation absorber;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-141-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-141-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-141-00-5", "Tail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-807-2", "68478-27-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-27-3" }, { "scheme": "ec", "value": "270-807-2" }, { "scheme": "index", "value": "649-141-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha separator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-141-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-141-00-5", "Tail gas (petroleum), catalytic reformed naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-807-2", "68478-27-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-27-3" }, { "scheme": "ec", "value": "270-807-2" }, { "scheme": "index", "value": "649-141-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha separator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-142-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-142-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-142-00-0", "Tail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-808-8", "68478-28-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-28-4" }, { "scheme": "ec", "value": "270-808-8" }, { "scheme": "index", "value": "649-142-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha stabilizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-142-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-142-00-0", "Tail gas (petroleum), catalytic reformed naphtha stabilizer;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-808-8", "68478-28-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-28-4" }, { "scheme": "ec", "value": "270-808-8" }, { "scheme": "index", "value": "649-142-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha stabilizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-143-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-143-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-143-00-6", "Tail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-809-3", "68478-29-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-29-5" }, { "scheme": "ec", "value": "270-809-3" }, { "scheme": "index", "value": "649-143-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), cracked distillate hydrotreater separator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-143-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-143-00-6", "Tail gas (petroleum), cracked distillate hydrotreater separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "270-809-3", "68478-29-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-29-5" }, { "scheme": "ec", "value": "270-809-3" }, { "scheme": "index", "value": "649-143-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), cracked distillate hydrotreater separator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-144-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-144-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-144-00-1", "Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-810-9", "68478-30-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-30-8" }, { "scheme": "ec", "value": "270-810-9" }, { "scheme": "index", "value": "649-144-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-144-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-144-00-1", "Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "270-810-9", "68478-30-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-30-8" }, { "scheme": "ec", "value": "270-810-9" }, { "scheme": "index", "value": "649-144-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-145-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-145-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-145-00-7", "Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]", "270-999-8", "68513-14-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-14-4" }, { "scheme": "ec", "value": "270-999-8" }, { "scheme": "index", "value": "649-145-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-145-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-145-00-7", "Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]", "270-999-8", "68513-14-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-14-4" }, { "scheme": "ec", "value": "270-999-8" }, { "scheme": "index", "value": "649-145-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-146-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-146-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-146-00-2", "Gases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-003-4", "68513-18-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-18-8" }, { "scheme": "ec", "value": "271-003-4" }, { "scheme": "index", "value": "649-146-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer effluent high-pressure flash drum off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-146-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-146-00-2", "Gases (petroleum), reformer effluent high-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-003-4", "68513-18-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-18-8" }, { "scheme": "ec", "value": "271-003-4" }, { "scheme": "index", "value": "649-146-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer effluent high-pressure flash drum off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-147-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-147-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-147-00-8", "Gases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-005-5", "68513-19-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-19-9" }, { "scheme": "ec", "value": "271-005-5" }, { "scheme": "index", "value": "649-147-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer effluent low-pressure flash drum off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-147-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-147-00-8", "Gases (petroleum), reformer effluent low-pressure flash drum off;\nRefinery gas;\n[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-005-5", "68513-19-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68513-19-9" }, { "scheme": "ec", "value": "271-005-5" }, { "scheme": "index", "value": "649-147-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), reformer effluent low-pressure flash drum off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-148-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-148-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-148-00-3", "Gases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]", "271-258-1", "68527-15-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-15-1" }, { "scheme": "ec", "value": "271-258-1" }, { "scheme": "index", "value": "649-148-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), oil refinery gas distn. off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-148-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-148-00-3", "Gases (petroleum), oil refinery gas distn. off;\nRefinery gas;\n[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]", "271-258-1", "68527-15-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68527-15-1" }, { "scheme": "ec", "value": "271-258-1" }, { "scheme": "index", "value": "649-148-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), oil refinery gas distn. off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-149-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-149-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-149-00-9", "Gases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]", "271-623-5", "68602-82-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-82-4" }, { "scheme": "ec", "value": "271-623-5" }, { "scheme": "index", "value": "649-149-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit hydrotreater depentanizer overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-149-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-149-00-9", "Gases (petroleum), benzene unit hydrotreater depentanizer overheads;\nRefinery gas;\n[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]", "271-623-5", "68602-82-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-82-4" }, { "scheme": "ec", "value": "271-623-5" }, { "scheme": "index", "value": "649-149-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), benzene unit hydrotreater depentanizer overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-150-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-150-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-150-00-4", "Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "271-625-6", "68602-84-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-84-6" }, { "scheme": "ec", "value": "271-625-6" }, { "scheme": "index", "value": "649-150-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-150-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-150-00-4", "Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "271-625-6", "68602-84-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68602-84-6" }, { "scheme": "ec", "value": "271-625-6" }, { "scheme": "index", "value": "649-150-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-151-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-151-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-151-00-X", "Petroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-750-6", "68607-11-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68607-11-4" }, { "scheme": "ec", "value": "271-750-6" }, { "scheme": "index", "value": "649-151-00-X" } ], "failed_check_digits": 0, "name": "Petroleum products, refinery gases;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-151-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-151-00-X", "Petroleum products, refinery gases;\nRefinery gas;\n[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]", "271-750-6", "68607-11-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68607-11-4" }, { "scheme": "ec", "value": "271-750-6" }, { "scheme": "index", "value": "649-151-00-X" } ], "failed_check_digits": 0, "name": "Petroleum products, refinery gases;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-152-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-152-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-152-00-5", "Gases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "272-182-1", "68783-06-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-06-2" }, { "scheme": "ec", "value": "272-182-1" }, { "scheme": "index", "value": "649-152-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrocracking low-pressure separator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-152-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-152-00-5", "Gases (petroleum), hydrocracking low-pressure separator;\nRefinery gas;\n[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "272-182-1", "68783-06-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68783-06-2" }, { "scheme": "ec", "value": "272-182-1" }, { "scheme": "index", "value": "649-152-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrocracking low-pressure separator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-153-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-153-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-153-00-0", "Gases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "272-338-9", "68814-67-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68814-67-5" }, { "scheme": "ec", "value": "272-338-9" }, { "scheme": "index", "value": "649-153-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), refinery;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-153-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-153-00-0", "Gases (petroleum), refinery;\nRefinery gas;\n[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "272-338-9", "68814-67-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68814-67-5" }, { "scheme": "ec", "value": "272-338-9" }, { "scheme": "index", "value": "649-153-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), refinery;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-154-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-154-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-154-00-6", "Gases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "272-343-6", "68814-90-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68814-90-4" }, { "scheme": "ec", "value": "272-343-6" }, { "scheme": "index", "value": "649-154-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), platformer products separator off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-154-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-154-00-6", "Gases (petroleum), platformer products separator off;\nRefinery gas;\n[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]", "272-343-6", "68814-90-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68814-90-4" }, { "scheme": "ec", "value": "272-343-6" }, { "scheme": "index", "value": "649-154-00-6" } ], "failed_check_digits": 0, "name": "Gases (petroleum), platformer products separator off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-155-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-155-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-155-00-1", "Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]", "272-775-5", "68911-58-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68911-58-0" }, { "scheme": "ec", "value": "272-775-5" }, { "scheme": "index", "value": "649-155-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-155-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-155-00-1", "Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;\nRefinery gas;\n[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]", "272-775-5", "68911-58-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68911-58-0" }, { "scheme": "ec", "value": "272-775-5" }, { "scheme": "index", "value": "649-155-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-156-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-156-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-156-00-7", "Gases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]", "272-776-0", "68911-59-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68911-59-1" }, { "scheme": "ec", "value": "272-776-0" }, { "scheme": "index", "value": "649-156-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreated sour kerosine flash drum;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-156-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-156-00-7", "Gases (petroleum), hydrotreated sour kerosine flash drum;\nRefinery gas;\n[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]", "272-776-0", "68911-59-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68911-59-1" }, { "scheme": "ec", "value": "272-776-0" }, { "scheme": "index", "value": "649-156-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrotreated sour kerosine flash drum;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-157-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-157-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-157-00-2", "Gases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]", "272-873-8", "68919-01-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-01-7" }, { "scheme": "ec", "value": "272-873-8" }, { "scheme": "index", "value": "649-157-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), distillate unifiner desulfurization stripper off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-157-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-157-00-2", "Gases (petroleum), distillate unifiner desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]", "272-873-8", "68919-01-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-01-7" }, { "scheme": "ec", "value": "272-873-8" }, { "scheme": "index", "value": "649-157-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), distillate unifiner desulfurization stripper off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-158-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-158-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-158-00-8", "Gases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-874-3", "68919-02-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-02-8" }, { "scheme": "ec", "value": "272-874-3" }, { "scheme": "index", "value": "649-158-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker fractionation off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-158-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-158-00-8", "Gases (petroleum), fluidized catalytic cracker fractionation off;\nRefinery gas;\n[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-874-3", "68919-02-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-02-8" }, { "scheme": "ec", "value": "272-874-3" }, { "scheme": "index", "value": "649-158-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker fractionation off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-159-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-159-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-159-00-3", "Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]", "272-875-9", "68919-03-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-03-9" }, { "scheme": "ec", "value": "272-875-9" }, { "scheme": "index", "value": "649-159-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-159-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-159-00-3", "Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;\nRefinery gas;\n[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]", "272-875-9", "68919-03-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-03-9" }, { "scheme": "ec", "value": "272-875-9" }, { "scheme": "index", "value": "649-159-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-160-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-160-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-160-00-9", "Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-876-4", "68919-04-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-04-0" }, { "scheme": "ec", "value": "272-876-4" }, { "scheme": "index", "value": "649-160-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-160-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-160-00-9", "Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;\nRefinery gas;\n[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-876-4", "68919-04-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-04-0" }, { "scheme": "ec", "value": "272-876-4" }, { "scheme": "index", "value": "649-160-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-161-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-161-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-161-00-4", "Gases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]", "272-880-6", "68919-07-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-07-3" }, { "scheme": "ec", "value": "272-880-6" }, { "scheme": "index", "value": "649-161-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), platformer stabilizer off, light ends fractionation;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-161-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-161-00-4", "Gases (petroleum), platformer stabilizer off, light ends fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.]", "272-880-6", "68919-07-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-07-3" }, { "scheme": "ec", "value": "272-880-6" }, { "scheme": "index", "value": "649-161-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), platformer stabilizer off, light ends fractionation;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-162-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-162-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-162-00-X", "Gases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-881-1", "68919-08-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-08-4" }, { "scheme": "ec", "value": "272-881-1" }, { "scheme": "index", "value": "649-162-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), preflash tower off, crude distn.;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-162-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-162-00-X", "Gases (petroleum), preflash tower off, crude distn.;\nRefinery gas;\n[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "272-881-1", "68919-08-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-08-4" }, { "scheme": "ec", "value": "272-881-1" }, { "scheme": "index", "value": "649-162-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), preflash tower off, crude distn.;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-163-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-163-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-163-00-5", "Gases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-884-8", "68919-11-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-11-9" }, { "scheme": "ec", "value": "272-884-8" }, { "scheme": "index", "value": "649-163-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), tar stripper off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-163-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-163-00-5", "Gases (petroleum), tar stripper off;\nRefinery gas;\n[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "272-884-8", "68919-11-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-11-9" }, { "scheme": "ec", "value": "272-884-8" }, { "scheme": "index", "value": "649-163-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), tar stripper off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-164-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-164-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-164-00-0", "Gases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]", "272-885-3", "68919-12-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-12-0" }, { "scheme": "ec", "value": "272-885-3" }, { "scheme": "index", "value": "649-164-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), unifiner stripper off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-164-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-164-00-0", "Gases (petroleum), unifiner stripper off;\nRefinery gas;\n[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]", "272-885-3", "68919-12-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68919-12-0" }, { "scheme": "ec", "value": "272-885-3" }, { "scheme": "index", "value": "649-164-00-0" } ], "failed_check_digits": 0, "name": "Gases (petroleum), unifiner stripper off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-165-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-165-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-165-00-6", "Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]", "273-173-5", "68952-79-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-79-4" }, { "scheme": "ec", "value": "273-173-5" }, { "scheme": "index", "value": "649-165-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-165-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-165-00-6", "Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;\nRefinery gas;\n[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]", "273-173-5", "68952-79-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-79-4" }, { "scheme": "ec", "value": "273-173-5" }, { "scheme": "index", "value": "649-165-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-166-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-166-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-166-00-1", "Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "273-174-0", "68952-80-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-80-7" }, { "scheme": "ec", "value": "273-174-0" }, { "scheme": "index", "value": "649-166-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-166-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-166-00-1", "Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;\nRefinery gas;\n[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "273-174-0", "68952-80-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68952-80-7" }, { "scheme": "ec", "value": "273-174-0" }, { "scheme": "index", "value": "649-166-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-167-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-167-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-167-00-7", "Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-269-7", "68955-33-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-33-9" }, { "scheme": "ec", "value": "273-269-7" }, { "scheme": "index", "value": "649-167-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-167-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-167-00-7", "Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;\nRefinery gas;\n[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "273-269-7", "68955-33-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68955-33-9" }, { "scheme": "ec", "value": "273-269-7" }, { "scheme": "index", "value": "649-167-00-7" } ], "failed_check_digits": 0, "name": "Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-168-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-168-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-168-00-2", "Gases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-563-5", "68989-88-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68989-88-8" }, { "scheme": "ec", "value": "273-563-5" }, { "scheme": "index", "value": "649-168-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), crude distn. and catalytic cracking;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-168-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-168-00-2", "Gases (petroleum), crude distn. and catalytic cracking;\nRefinery gas;\n[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "273-563-5", "68989-88-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68989-88-8" }, { "scheme": "ec", "value": "273-563-5" }, { "scheme": "index", "value": "649-168-00-2" } ], "failed_check_digits": 0, "name": "Gases (petroleum), crude distn. and catalytic cracking;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-169-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-169-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-169-00-8", "Gases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]", "295-397-2", "92045-15-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-15-3" }, { "scheme": "ec", "value": "295-397-2" }, { "scheme": "index", "value": "649-169-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil diethanolamine scrubber off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-169-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-169-00-8", "Gases (petroleum), gas oil diethanolamine scrubber off;\nRefinery gas;\n[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]", "295-397-2", "92045-15-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-15-3" }, { "scheme": "ec", "value": "295-397-2" }, { "scheme": "index", "value": "649-169-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil diethanolamine scrubber off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-170-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-170-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-170-00-3", "Gases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "295-398-8", "92045-16-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-16-4" }, { "scheme": "ec", "value": "295-398-8" }, { "scheme": "index", "value": "649-170-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil hydrodesulfurization effluent;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-170-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-170-00-3", "Gases (petroleum), gas oil hydrodesulfurization effluent;\nRefinery gas;\n[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]", "295-398-8", "92045-16-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-16-4" }, { "scheme": "ec", "value": "295-398-8" }, { "scheme": "index", "value": "649-170-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil hydrodesulfurization effluent;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-171-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-171-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-171-00-9", "Gases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "295-399-3", "92045-17-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-17-5" }, { "scheme": "ec", "value": "295-399-3" }, { "scheme": "index", "value": "649-171-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil hydrodesulfurization purge;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-171-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-171-00-9", "Gases (petroleum), gas oil hydrodesulfurization purge;\nRefinery gas;\n[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "295-399-3", "92045-17-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-17-5" }, { "scheme": "ec", "value": "295-399-3" }, { "scheme": "index", "value": "649-171-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), gas oil hydrodesulfurization purge;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-172-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-172-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-172-00-4", "Gases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "295-400-7", "92045-18-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-18-6" }, { "scheme": "ec", "value": "295-400-7" }, { "scheme": "index", "value": "649-172-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogenator effluent flash drum off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-172-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-172-00-4", "Gases (petroleum), hydrogenator effluent flash drum off;\nRefinery gas;\n[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "295-400-7", "92045-18-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-18-6" }, { "scheme": "ec", "value": "295-400-7" }, { "scheme": "index", "value": "649-172-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), hydrogenator effluent flash drum off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-173-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-173-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-173-00-X", "Gases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]", "295-401-2", "92045-19-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-19-7" }, { "scheme": "ec", "value": "295-401-2" }, { "scheme": "index", "value": "649-173-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), naphtha steam cracking high-pressure residual;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-173-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-173-00-X", "Gases (petroleum), naphtha steam cracking high-pressure residual;\nRefinery gas;\n[A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]", "295-401-2", "92045-19-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-19-7" }, { "scheme": "ec", "value": "295-401-2" }, { "scheme": "index", "value": "649-173-00-X" } ], "failed_check_digits": 0, "name": "Gases (petroleum), naphtha steam cracking high-pressure residual;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-174-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-174-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-174-00-5", "Gases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "295-402-8", "92045-20-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-20-0" }, { "scheme": "ec", "value": "295-402-8" }, { "scheme": "index", "value": "649-174-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), residue visbaking off;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-174-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-174-00-5", "Gases (petroleum), residue visbaking off;\nRefinery gas;\n[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "295-402-8", "92045-20-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "92045-20-0" }, { "scheme": "ec", "value": "295-402-8" }, { "scheme": "index", "value": "649-174-00-5" } ], "failed_check_digits": 0, "name": "Gases (petroleum), residue visbaking off;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-177-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-177-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-177-00-1", "Gases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]", "268-629-5", "68131-75-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68131-75-9" }, { "scheme": "ec", "value": "268-629-5" }, { "scheme": "index", "value": "649-177-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C3-4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-177-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-177-00-1", "Gases (petroleum), C3-4;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]", "268-629-5", "68131-75-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68131-75-9" }, { "scheme": "ec", "value": "268-629-5" }, { "scheme": "index", "value": "649-177-00-1" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C3-4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-178-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-178-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-178-00-7", "Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]", "269-617-2", "68307-98-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68307-98-2" }, { "scheme": "ec", "value": "269-617-2" }, { "scheme": "index", "value": "649-178-00-7" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-178-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-178-00-7", "Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;\nPetroleum gas;\n[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]", "269-617-2", "68307-98-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68307-98-2" }, { "scheme": "ec", "value": "269-617-2" }, { "scheme": "index", "value": "649-178-00-7" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-179-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-179-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-179-00-2", "Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]", "269-618-8", "68307-99-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68307-99-3" }, { "scheme": "ec", "value": "269-618-8" }, { "scheme": "index", "value": "649-179-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-179-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-179-00-2", "Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]", "269-618-8", "68307-99-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68307-99-3" }, { "scheme": "ec", "value": "269-618-8" }, { "scheme": "index", "value": "649-179-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-180-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-180-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-180-00-8", "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-619-3", "68308-00-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-00-9" }, { "scheme": "ec", "value": "269-619-3" }, { "scheme": "index", "value": "649-180-00-8" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-180-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-180-00-8", "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-619-3", "68308-00-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-00-9" }, { "scheme": "ec", "value": "269-619-3" }, { "scheme": "index", "value": "649-180-00-8" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-181-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-181-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-181-00-3", "Tail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-620-9", "68308-01-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-01-0" }, { "scheme": "ec", "value": "269-620-9" }, { "scheme": "index", "value": "649-181-00-3" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), cracked distillate hydrotreater stripper;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-181-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-181-00-3", "Tail gas (petroleum), cracked distillate hydrotreater stripper;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-620-9", "68308-01-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-01-0" }, { "scheme": "ec", "value": "269-620-9" }, { "scheme": "index", "value": "649-181-00-3" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), cracked distillate hydrotreater stripper;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-182-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-182-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-182-00-9", "Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-630-3", "68308-10-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-10-1" }, { "scheme": "ec", "value": "269-630-3" }, { "scheme": "index", "value": "649-182-00-9" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-182-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-182-00-9", "Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-630-3", "68308-10-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-10-1" }, { "scheme": "ec", "value": "269-630-3" }, { "scheme": "index", "value": "649-182-00-9" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-183-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-183-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-183-00-4", "Tail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-623-5", "68308-03-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-03-2" }, { "scheme": "ec", "value": "269-623-5" }, { "scheme": "index", "value": "649-183-00-4" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas oil catalytic cracking absorber;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-183-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-183-00-4", "Tail gas (petroleum), gas oil catalytic cracking absorber;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-623-5", "68308-03-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-03-2" }, { "scheme": "ec", "value": "269-623-5" }, { "scheme": "index", "value": "649-183-00-4" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas oil catalytic cracking absorber;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-184-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-184-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-184-00-X", "Tail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-624-0", "68308-04-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-04-3" }, { "scheme": "ec", "value": "269-624-0" }, { "scheme": "index", "value": "649-184-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas recovery plant;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-184-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-184-00-X", "Tail gas (petroleum), gas recovery plant;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-624-0", "68308-04-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-04-3" }, { "scheme": "ec", "value": "269-624-0" }, { "scheme": "index", "value": "649-184-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas recovery plant;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-185-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-185-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-185-00-5", "Tail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-625-6", "68308-05-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-05-4" }, { "scheme": "ec", "value": "269-625-6" }, { "scheme": "index", "value": "649-185-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas recovery plant deethanizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-185-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-185-00-5", "Tail gas (petroleum), gas recovery plant deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-625-6", "68308-05-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-05-4" }, { "scheme": "ec", "value": "269-625-6" }, { "scheme": "index", "value": "649-185-00-5" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), gas recovery plant deethanizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-186-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-186-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-186-00-0", "Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-626-1", "68308-06-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-06-5" }, { "scheme": "ec", "value": "269-626-1" }, { "scheme": "index", "value": "649-186-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-186-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-186-00-0", "Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-626-1", "68308-06-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-06-5" }, { "scheme": "ec", "value": "269-626-1" }, { "scheme": "index", "value": "649-186-00-0" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-187-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-187-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-187-00-6", "Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-627-7", "68308-07-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-07-6" }, { "scheme": "ec", "value": "269-627-7" }, { "scheme": "index", "value": "649-187-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-187-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-187-00-6", "Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-627-7", "68308-07-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-07-6" }, { "scheme": "ec", "value": "269-627-7" }, { "scheme": "index", "value": "649-187-00-6" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-188-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-188-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-188-00-1", "Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-629-8", "68308-09-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-09-8" }, { "scheme": "ec", "value": "269-629-8" }, { "scheme": "index", "value": "649-188-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-188-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-188-00-1", "Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]", "269-629-8", "68308-09-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-09-8" }, { "scheme": "ec", "value": "269-629-8" }, { "scheme": "index", "value": "649-188-00-1" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-189-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-189-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-189-00-7", "Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-631-9", "68308-11-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-11-2" }, { "scheme": "ec", "value": "269-631-9" }, { "scheme": "index", "value": "649-189-00-7" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-189-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-189-00-7", "Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-631-9", "68308-11-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-11-2" }, { "scheme": "ec", "value": "269-631-9" }, { "scheme": "index", "value": "649-189-00-7" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-190-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-190-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-190-00-2", "Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-632-4", "68308-12-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-12-3" }, { "scheme": "ec", "value": "269-632-4" }, { "scheme": "index", "value": "649-190-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-190-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-190-00-2", "Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]", "269-632-4", "68308-12-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-12-3" }, { "scheme": "ec", "value": "269-632-4" }, { "scheme": "index", "value": "649-190-00-2" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-191-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-191-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-191-00-8", "Gases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]", "270-071-2", "68409-99-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68409-99-4" }, { "scheme": "ec", "value": "270-071-2" }, { "scheme": "index", "value": "649-191-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-191-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-191-00-8", "Gases (petroleum), catalytic cracked overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately – 48 °C to 32 °C (– 54 °F to 90 °F).]", "270-071-2", "68409-99-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68409-99-4" }, { "scheme": "ec", "value": "270-071-2" }, { "scheme": "index", "value": "649-191-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic cracked overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-193-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-193-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-193-00-9", "Alkanes, C1-2;\nPetroleum gas", "270-651-5", "68475-57-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-57-0" }, { "scheme": "ec", "value": "270-651-5" }, { "scheme": "index", "value": "649-193-00-9" } ], "failed_check_digits": 0, "name": "Alkanes, C1-2;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-193-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-193-00-9", "Alkanes, C1-2;\nPetroleum gas", "270-651-5", "68475-57-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-57-0" }, { "scheme": "ec", "value": "270-651-5" }, { "scheme": "index", "value": "649-193-00-9" } ], "failed_check_digits": 0, "name": "Alkanes, C1-2;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-194-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-194-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-194-00-4", "Alkanes, C2-3;\nPetroleum gas", "270-652-0", "68475-58-1", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-58-1" }, { "scheme": "ec", "value": "270-652-0" }, { "scheme": "index", "value": "649-194-00-4" } ], "failed_check_digits": 0, "name": "Alkanes, C2-3;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-194-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-194-00-4", "Alkanes, C2-3;\nPetroleum gas", "270-652-0", "68475-58-1", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-58-1" }, { "scheme": "ec", "value": "270-652-0" }, { "scheme": "index", "value": "649-194-00-4" } ], "failed_check_digits": 0, "name": "Alkanes, C2-3;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-195-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-195-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-195-00-X", "Alkanes, C3-4;\npetroleum gas", "270-653-6", "68475-59-2", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-59-2" }, { "scheme": "ec", "value": "270-653-6" }, { "scheme": "index", "value": "649-195-00-X" } ], "failed_check_digits": 0, "name": "Alkanes, C3-4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-195-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-195-00-X", "Alkanes, C3-4;\npetroleum gas", "270-653-6", "68475-59-2", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-59-2" }, { "scheme": "ec", "value": "270-653-6" }, { "scheme": "index", "value": "649-195-00-X" } ], "failed_check_digits": 0, "name": "Alkanes, C3-4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-196-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-196-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-196-00-5", "Alkanes, C4-5;\nPetroleum gas", "270-654-1", "68475-60-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-60-5" }, { "scheme": "ec", "value": "270-654-1" }, { "scheme": "index", "value": "649-196-00-5" } ], "failed_check_digits": 0, "name": "Alkanes, C4-5;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-196-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-196-00-5", "Alkanes, C4-5;\nPetroleum gas", "270-654-1", "68475-60-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68475-60-5" }, { "scheme": "ec", "value": "270-654-1" }, { "scheme": "index", "value": "649-196-00-5" } ], "failed_check_digits": 0, "name": "Alkanes, C4-5;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-197-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-197-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-197-00-0", "Fuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]", "270-667-2", "68476-26-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-26-6" }, { "scheme": "ec", "value": "270-667-2" }, { "scheme": "index", "value": "649-197-00-0" } ], "failed_check_digits": 0, "name": "Fuel gases;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-197-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-197-00-0", "Fuel gases;\nPetroleum gas;\n[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]", "270-667-2", "68476-26-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-26-6" }, { "scheme": "ec", "value": "270-667-2" }, { "scheme": "index", "value": "649-197-00-0" } ], "failed_check_digits": 0, "name": "Fuel gases;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-198-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-198-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-198-00-6", "Fuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]", "270-670-9", "68476-29-9", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-29-9" }, { "scheme": "ec", "value": "270-670-9" }, { "scheme": "index", "value": "649-198-00-6" } ], "failed_check_digits": 0, "name": "Fuel gases, crude oil of distillates;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-198-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-198-00-6", "Fuel gases, crude oil of distillates;\nPetroleum gas;\n[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – 217 °C to – 12 °C (– 423 °F to 10 °F).]", "270-670-9", "68476-29-9", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-29-9" }, { "scheme": "ec", "value": "270-670-9" }, { "scheme": "index", "value": "649-198-00-6" } ], "failed_check_digits": 0, "name": "Fuel gases, crude oil of distillates;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-199-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-199-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-199-00-1", "Hydrocarbons, C3-4;\nPetroleum gas", "270-681-9", "68476-40-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-40-4" }, { "scheme": "ec", "value": "270-681-9" }, { "scheme": "index", "value": "649-199-00-1" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3-4;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-199-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-199-00-1", "Hydrocarbons, C3-4;\nPetroleum gas", "270-681-9", "68476-40-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-40-4" }, { "scheme": "ec", "value": "270-681-9" }, { "scheme": "index", "value": "649-199-00-1" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C3-4;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-200-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-200-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-200-00-5", "Hydrocarbons, C4-5;\nPetroleum gas", "270-682-4", "68476-42-6", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-42-6" }, { "scheme": "ec", "value": "270-682-4" }, { "scheme": "index", "value": "649-200-00-5" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4-5;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-200-00-5", "occurrence": 1, "group": null, "rows": [ [ "649-200-00-5", "Hydrocarbons, C4-5;\nPetroleum gas", "270-682-4", "68476-42-6", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-42-6" }, { "scheme": "ec", "value": "270-682-4" }, { "scheme": "index", "value": "649-200-00-5" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C4-5;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-201-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-201-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-201-00-0", "Hydrocarbons, C2-4, C3-rich;\nPetroleum gas", "270-689-2", "68476-49-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-49-3" }, { "scheme": "ec", "value": "270-689-2" }, { "scheme": "index", "value": "649-201-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C2-4, C3-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-201-00-0", "occurrence": 1, "group": null, "rows": [ [ "649-201-00-0", "Hydrocarbons, C2-4, C3-rich;\nPetroleum gas", "270-689-2", "68476-49-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-49-3" }, { "scheme": "ec", "value": "270-689-2" }, { "scheme": "index", "value": "649-201-00-0" } ], "failed_check_digits": 0, "name": "Hydrocarbons, C2-4, C3-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-202-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-202-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-202-00-6", "Petroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]", "270-704-2", "68476-85-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKSU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-85-7" }, { "scheme": "ec", "value": "270-704-2" }, { "scheme": "index", "value": "649-202-00-6" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-202-00-6", "occurrence": 1, "group": null, "rows": [ [ "649-202-00-6", "Petroleum gases, liquefied;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]", "270-704-2", "68476-85-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K S U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-85-7" }, { "scheme": "ec", "value": "270-704-2" }, { "scheme": "index", "value": "649-202-00-6" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-203-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-203-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-203-00-1", "Petroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]", "270-705-8", "68476-86-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKSU" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-86-8" }, { "scheme": "ec", "value": "270-705-8" }, { "scheme": "index", "value": "649-203-00-1" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied, sweetened;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-203-00-1", "occurrence": 1, "group": null, "rows": [ [ "649-203-00-1", "Petroleum gases, liquefied, sweetened;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – 40 °C to 80 °C (– 40 °F to 176 °F).]", "270-705-8", "68476-86-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K S U" ] ], "identifiers": [ { "scheme": "cas", "value": "68476-86-8" }, { "scheme": "ec", "value": "270-705-8" }, { "scheme": "index", "value": "649-203-00-1" } ], "failed_check_digits": 0, "name": "Petroleum gases, liquefied, sweetened;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-204-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-204-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-204-00-7", "gases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]", "270-724-1", "68477-33-8", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-33-8" }, { "scheme": "ec", "value": "270-724-1" }, { "scheme": "index", "value": "649-204-00-7" } ], "failed_check_digits": 0, "name": "gases (petroleum), C3-4, isobutane-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-204-00-7", "occurrence": 1, "group": null, "rows": [ [ "649-204-00-7", "gases (petroleum), C3-4, isobutane-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]", "270-724-1", "68477-33-8", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-33-8" }, { "scheme": "ec", "value": "270-724-1" }, { "scheme": "index", "value": "649-204-00-7" } ], "failed_check_digits": 0, "name": "gases (petroleum), C3-4, isobutane-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-205-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-205-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-205-00-2", "Distillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]", "270-726-2", "68477-35-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-35-0" }, { "scheme": "ec", "value": "270-726-2" }, { "scheme": "index", "value": "649-205-00-2" } ], "failed_check_digits": 0, "name": "Distillates (petroleum), C3-6, piperylene-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-205-00-2", "occurrence": 1, "group": null, "rows": [ [ "649-205-00-2", "Distillates (petroleum), C3-6, piperylene-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]", "270-726-2", "68477-35-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-35-0" }, { "scheme": "ec", "value": "270-726-2" }, { "scheme": "index", "value": "649-205-00-2" } ], "failed_check_digits": 0, "name": "Distillates (petroleum), C3-6, piperylene-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-206-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-206-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-206-00-8", "Gases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "270-750-3", "68477-69-0", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-69-0" }, { "scheme": "ec", "value": "270-750-3" }, { "scheme": "index", "value": "649-206-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), butane splitter overheads;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-206-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-206-00-8", "Gases (petroleum), butane splitter overheads;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]", "270-750-3", "68477-69-0", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-69-0" }, { "scheme": "ec", "value": "270-750-3" }, { "scheme": "index", "value": "649-206-00-8" } ], "failed_check_digits": 0, "name": "Gases (petroleum), butane splitter overheads;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-207-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-207-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-207-00-3", "Gases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]", "270-751-9", "68477-70-3", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-70-3" }, { "scheme": "ec", "value": "270-751-9" }, { "scheme": "index", "value": "649-207-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-3-;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-207-00-3", "occurrence": 1, "group": null, "rows": [ [ "649-207-00-3", "Gases (petroleum), C2-3-;\nPetroleum gas;\n[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]", "270-751-9", "68477-70-3", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-70-3" }, { "scheme": "ec", "value": "270-751-9" }, { "scheme": "index", "value": "649-207-00-3" } ], "failed_check_digits": 0, "name": "Gases (petroleum), C2-3-;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-208-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-208-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-208-00-9", "Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]", "270-752-4", "68477-71-4", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-71-4" }, { "scheme": "ec", "value": "270-752-4" }, { "scheme": "index", "value": "649-208-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-208-00-9", "occurrence": 1, "group": null, "rows": [ [ "649-208-00-9", "Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]", "270-752-4", "68477-71-4", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-71-4" }, { "scheme": "ec", "value": "270-752-4" }, { "scheme": "index", "value": "649-208-00-9" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-209-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-209-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-209-00-4", "Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "270-754-5", "68477-72-5", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-72-5" }, { "scheme": "ec", "value": "270-754-5" }, { "scheme": "index", "value": "649-209-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-209-00-4", "occurrence": 1, "group": null, "rows": [ [ "649-209-00-4", "Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]", "270-754-5", "68477-72-5", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68477-72-5" }, { "scheme": "ec", "value": "270-754-5" }, { "scheme": "index", "value": "649-209-00-4" } ], "failed_check_digits": 0, "name": "Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-210-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-210-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-210-00-X", "Tail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-628-2", "68308-08-7", "Press. Gas\nFlam. Gas 1\nCarc. 1B\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "HKU" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-08-7" }, { "scheme": "ec", "value": "269-628-2" }, { "scheme": "index", "value": "649-210-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), isomerized naphtha fractionation stabilizer;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-210-00-X", "occurrence": 1, "group": null, "rows": [ [ "649-210-00-X", "Tail gas (petroleum), isomerized naphtha fractionation stabilizer;\nPetroleum gas;\n[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]", "269-628-2", "68308-08-7", "Press. Gas\nFlam. Gas 1\nCarc. 1A\nMuta. 1B", "H220\nH350\nH340", "GHS04\nGHS02\nGHS08\nDgr", "H220\nH350\nH340", "", "", "K U" ] ], "identifiers": [ { "scheme": "cas", "value": "68308-08-7" }, { "scheme": "ec", "value": "269-628-2" }, { "scheme": "index", "value": "649-210-00-X" } ], "failed_check_digits": 0, "name": "Tail gas (petroleum), isomerized naphtha fractionation stabilizer;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 1, "key": "649-364-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-364-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-364-00-8", "Residues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]", "270-791-7", "68478-12-6", "Carc. 1B\nMuta. 1B\nAsp. Tox. 1", "H350\nH340\nH304", "GHS08\nDgr", "", "", "", "H P" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-12-6" }, { "scheme": "ec", "value": "270-791-7" }, { "scheme": "index", "value": "649-364-00-8" } ], "failed_check_digits": 0, "name": "Residues (petroleum), butane splitter bottoms;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 1, "key": "649-364-00-8", "occurrence": 1, "group": null, "rows": [ [ "649-364-00-8", "Residues (petroleum), butane splitter bottoms;\nLow boiling point naphtha - unspecified;\n[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]", "270-791-7", "68478-12-6", "Carc. 1B\nMuta. 1B\nAsp. Tox. 1", "H350\nH340\nH304", "GHS08\nDgr", "H350\nH340\nH304", "", "", "P" ] ], "identifiers": [ { "scheme": "cas", "value": "68478-12-6" }, { "scheme": "ec", "value": "270-791-7" }, { "scheme": "index", "value": "649-364-00-8" } ], "failed_check_digits": 0, "name": "Residues (petroleum), butane splitter bottoms;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "005-007-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "005-007-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-007-00-2", "boric acid; [1]\nboric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]", "233-139-2 [1]\n234-343-4 [2]", "10043-35-3 [1]\n11113-50-1 [2]", "Repr. Cat. 2; R60-61", "T\nR: 60-61\nS: 53-45", "Repr. Cat. 2; R60-61: C ≥ 5,5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10043-35-3" }, { "scheme": "cas", "value": "11113-50-1" }, { "scheme": "ec", "value": "233-139-2" }, { "scheme": "ec", "value": "234-343-4" }, { "scheme": "index", "value": "005-007-00-2" } ], "failed_check_digits": 0, "name": "boric acid; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "005-007-00-2", "occurrence": 1, "group": null, "rows": [ [ "005-007-00-2", "boric acid; [1]\nboric acid [2]", "233-139-2 [1]\n234-343-4 [2]", "10043-35-3 [1]\n11113-50-1 [2]", "Repr. Cat. 2; R60-61", "T\nR: 60-61\nS: 53-45", "Repr. Cat. 2; R60-61: C ≥ 5,5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10043-35-3" }, { "scheme": "cas", "value": "11113-50-1" }, { "scheme": "ec", "value": "233-139-2" }, { "scheme": "ec", "value": "234-343-4" }, { "scheme": "index", "value": "005-007-00-2" } ], "failed_check_digits": 0, "name": "boric acid; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "009-016-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "009-016-00-2", "occurrence": 1, "group": null, "rows": [ [ "009-016-00-2", "trisodium hexafluoroaluminate;\ncryolite", "237-410-6\n239-148-8", "13775-53-6\n15096-52-3", "T; R48/23/25\nXn; R20/22\nN; R51-53", "T; N\nR: 20/22-48/23/25-51/53\nS: (1/2-)22-37-45-61", "", "C" ] ], "identifiers": [ { "scheme": "cas", "value": "13775-53-6" }, { "scheme": "cas", "value": "15096-52-3" }, { "scheme": "ec", "value": "237-410-6" }, { "scheme": "ec", "value": "239-148-8" }, { "scheme": "index", "value": "009-016-00-2" } ], "failed_check_digits": 0, "name": "trisodium hexafluoroaluminate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "009-016-00-2", "occurrence": 1, "group": null, "rows": [ [ "009-016-00-2", "trisodium hexafluoroaluminate [1]", "237-410-6 [1]", "13775-53-6 [1]", "Xn; R20\nT; R48/23/25\nN; R51-53", "T; N\nR: 20-48/23/25-51/53\nS: (1/2-)22-37-45-61", "", "" ], [ null, "trisodium hexafluoroaluminate (cryolite) [2]", "239-148-8 [2]", "15096-52-3 [2]", null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "13775-53-6" }, { "scheme": "cas", "value": "15096-52-3" }, { "scheme": "ec", "value": "237-410-6" }, { "scheme": "ec", "value": "239-148-8" }, { "scheme": "index", "value": "009-016-00-2" } ], "failed_check_digits": 0, "name": "trisodium hexafluoroaluminate [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "015-182-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-182-00-7", "occurrence": 1, "group": null, "rows": [ [ "015-182-00-7", "tetraisopropyldichloromethylenebisphosphonate", "430-630-5", "10596-22-2", "Xn; R22\nXi; R36\nR43", "Xn\nR: 22-36-43\nS: (2-)24-26-37", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10596-22-2" }, { "scheme": "ec", "value": "430-630-5" }, { "scheme": "index", "value": "015-182-00-7" } ], "failed_check_digits": 0, "name": "tetraisopropyldichloromethylenebisphosphonate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-182-00-7", "occurrence": 1, "group": null, "rows": [ [ "015-182-00-7", "tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)", "430-630-5", "10596-22-2", "Xn; R22\nXi; R36\nR43", "Xn\nR: 22-36-43\nS: (2-)24-26-37", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "10596-22-2" }, { "scheme": "ec", "value": "430-630-5" }, { "scheme": "index", "value": "015-182-00-7" } ], "failed_check_digits": 0, "name": "tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "015-199-00-X", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-199-00-X", "occurrence": 1, "group": null, "rows": [ [ "015-199-00-X", "tris[2-chloro-1-chloromethyl)ethyl] phosphate", "237-159-2", "13674-87-8", "Carc. Cat. 3; R40", "Xn\nR: 40\nS: (2-)36/37", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "13674-87-8" }, { "scheme": "ec", "value": "237-159-2" }, { "scheme": "index", "value": "015-199-00-X" } ], "failed_check_digits": 0, "name": "tris[2-chloro-1-chloromethyl)ethyl] phosphate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "015-200-00-3", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-200-00-3", "occurrence": 1, "group": null, "rows": [ [ "015-200-00-3", "indium phosphide", "244-959-5", "22398-80-7", "Carc. Cat. 2; R45\nRepr. Cat. 3; R62\nT; R48/23", "T\nR: 45–48/23–62\nS: 45- 53", "T; R48/23: C ≥0,1%\nCarc Cat 2; R45: C ≥0,01%\nXn; R48/20: 0,01%≤ C < 0,1%", "E" ] ], "identifiers": [ { "scheme": "cas", "value": "22398-80-7" }, { "scheme": "ec", "value": "244-959-5" }, { "scheme": "index", "value": "015-200-00-3" } ], "failed_check_digits": 0, "name": "indium phosphide" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "015-201-00-9", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-201-00-9", "occurrence": 1, "group": null, "rows": [ [ "015-201-00-9", "trixylyl phosphate", "246-677-8", "25155-23-1", "Repr. Cat. 2; R60", "T\nR: 60\nS: 53-45", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "25155-23-1" }, { "scheme": "ec", "value": "246-677-8" }, { "scheme": "index", "value": "015-201-00-9" } ], "failed_check_digits": 0, "name": "trixylyl phosphate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "015-202-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-202-00-4", "occurrence": 1, "group": null, "rows": [ [ "015-202-00-4", "tris(nonylphenyl) phosphite", "247-759-6", "26523-78-4", "Xi; R43\nN; R50-53", "Xi; N\nR: 43-50/53\nS: 24-37-60-61", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "26523-78-4" }, { "scheme": "ec", "value": "247-759-6" }, { "scheme": "index", "value": "015-202-00-4" } ], "failed_check_digits": 0, "name": "tris(nonylphenyl) phosphite" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "015-203-00-X", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "015-203-00-X", "occurrence": 1, "group": null, "rows": [ [ "015-203-00-X", "diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide", "278-355-8", "75980-60-8", "Repr. Cat. 3; R62", "Xn\nR: 62\nS: (2)-22-36/37.", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "75980-60-8" }, { "scheme": "ec", "value": "278-355-8" }, { "scheme": "index", "value": "015-203-00-X" } ], "failed_check_digits": 0, "name": "diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "017-001-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "017-001-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-001-00-7", "chlorine", "231-959-5", "7782-50-5", "T; R23\nXi; R36/37/38\nN; R50", "T; N\nR: 23-36/37/38-50\nS: (1/2-)9-45-61", "N; R50: C ≥ 0,25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7782-50-5" }, { "scheme": "ec", "value": "231-959-5" }, { "scheme": "index", "value": "017-001-00-7" } ], "failed_check_digits": 0, "name": "chlorine" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "017-001-00-7", "occurrence": 1, "group": null, "rows": [ [ "017-001-00-7", "chlorine", "231-959-5", "7782-50-5", "O; R8\nT; R23\nXi; R36/37/38\nN; R50", "O; T; N\nR: 8-23-36/37/38-50\nS: (1/2-)9-45-61", "N; R50: C ≥ 0,25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "7782-50-5" }, { "scheme": "ec", "value": "231-959-5" }, { "scheme": "index", "value": "017-001-00-7" } ], "failed_check_digits": 0, "name": "chlorine" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "017-026-00-3", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "017-026-00-3", "occurrence": 1, "group": null, "rows": [ [ "017-026-00-3", "chlorine dioxide", "233-162-8", "10049-04-4", "O; R8\nR6\nT+; R26\nC; R34\nN; R50", "O; T+; N\nR: 6-8-26-34-50\nS: (1/2-)23-26-28-36/37/39-38-45-61", "N; R50: C ≥ 2,5 %", "5" ] ], "identifiers": [ { "scheme": "cas", "value": "10049-04-4" }, { "scheme": "ec", "value": "233-162-8" }, { "scheme": "index", "value": "017-026-00-3" } ], "failed_check_digits": 0, "name": "chlorine dioxide" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "017-026-01-0", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "017-026-01-0", "occurrence": 1, "group": null, "rows": [ [ "017-026-01-0", "chlorine dioxide … %", "233-162-8", "10049-04-4", "T; R25\nC; R34\nN; R50", "T; N\nR: 25-34-50\nS: (1/2-)23-26-28-36/37/39-45-61", "C; R34: C ≥ 10 %\nXi; R37/38: 3 % ≤ C < 10 %\nXi; R36: 0,3 % ≤ C < 10 %\nN; R50: C ≥ 2,5 %", "B" ] ], "identifiers": [ { "scheme": "cas", "value": "10049-04-4" }, { "scheme": "ec", "value": "233-162-8" }, { "scheme": "index", "value": "017-026-01-0" } ], "failed_check_digits": 0, "name": "chlorine dioxide … %" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "024-004-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "024-004-00-7", "occurrence": 1, "group": null, "rows": [ [ "024-004-00-7", "sodium dichromate", "234-190-3", "10588-01-9", "O; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53", "O; T+; N\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61", "C; R34: C ≥ 25 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %", "E" ] ], "identifiers": [ { "scheme": "cas", "value": "10588-01-9" }, { "scheme": "ec", "value": "234-190-3" }, { "scheme": "index", "value": "024-004-00-7" } ], "failed_check_digits": 0, "name": "sodium dichromate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "024-004-00-7", "occurrence": 1, "group": null, "rows": [ [ "024-004-00-7", "sodium dichromate", "234-190-3", "10588-01-9", "O; R8\nCarc. Cat. 2; R45\nMuta. Cat. 2; R46\nRepr. Cat. 2; R60-61\nT+; R26\nT; R25-48/23\nXn; R21\nC; R34\nR42/43\nN; R50-53", "O; T+; N\nR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53\nS: 53-45-60-61", "C; R34: C ≥ 10 %\nXi; R36/37/38: 5 % ≤ C < 10 %\nR42/43: C ≥ 0,2 %", "E\n3" ] ], "identifiers": [ { "scheme": "cas", "value": "10588-01-9" }, { "scheme": "ec", "value": "234-190-3" }, { "scheme": "index", "value": "024-004-00-7" } ], "failed_check_digits": 0, "name": "sodium dichromate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "027-006-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "027-006-00-6", "occurrence": 1, "group": null, "rows": [ [ "027-006-00-6", "cobalt acetate", "200-755-8", "71-48-7", "Carc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53", "T; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61", "Carc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "71-48-7" }, { "scheme": "ec", "value": "200-755-8" }, { "scheme": "index", "value": "027-006-00-6" } ], "failed_check_digits": 0, "name": "cobalt acetate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "027-006-00-6", "occurrence": 1, "group": null, "rows": [ [ "027-006-00-6", "cobalt di(acetate)", "200-755-8", "71-48-7", "Carc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53", "T; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61", "Carc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "71-48-7" }, { "scheme": "ec", "value": "200-755-8" }, { "scheme": "index", "value": "027-006-00-6" } ], "failed_check_digits": 0, "name": "cobalt di(acetate)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "027-009-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "027-009-00-2", "occurrence": 1, "group": null, "rows": [ [ "027-009-00-2", "cobalt nitrate", "233-402-1", "10141-05-6", "Carc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53", "T; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61", "Carc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "10141-05-6" }, { "scheme": "ec", "value": "233-402-1" }, { "scheme": "index", "value": "027-009-00-2" } ], "failed_check_digits": 0, "name": "cobalt nitrate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "027-009-00-2", "occurrence": 1, "group": null, "rows": [ [ "027-009-00-2", "cobalt dinitrate", "233-402-1", "10141-05-6", "Carc. Cat. 2; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R60\nR42/43\nN; R50-53", "T; N\nR: 49-60-42/43-68-50/53\nS: 53-45-60-61", "Carc. Cat. 2; R49: C ≥ 0,01 %\nN; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %", "1" ] ], "identifiers": [ { "scheme": "cas", "value": "10141-05-6" }, { "scheme": "ec", "value": "233-402-1" }, { "scheme": "index", "value": "027-009-00-2" } ], "failed_check_digits": 0, "name": "cobalt dinitrate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-013-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-013-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-013-00-7", "nickel matte", "273-749-6", "69012-50-6", "Carc. Cat. 1; R49\nT; R48/23\nR43\nN; R50-53", "T; N\nR: 49-43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "69012-50-6" }, { "scheme": "ec", "value": "273-749-6" }, { "scheme": "index", "value": "028-013-00-7" } ], "failed_check_digits": 0, "name": "nickel matte" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-013-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-013-00-7", "nickel matte", "273-749-6", "69012-50-6", "Carc. Cat. 1; R49\nT; R48/23\nR43\nN; R50-53", "T; N\nR: 49-43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "69012-50-6" }, { "scheme": "ec", "value": "273-749-6" }, { "scheme": "index", "value": "028-013-00-7" } ], "failed_check_digits": 0, "name": "nickel matte" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-015-00-8", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-015-00-8", "occurrence": 1, "group": null, "rows": [ [ "028-015-00-8", "slimes and sludges, copper electrolyte refining, decopperised", "305-433-1", "94551-87-8", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 1; R61\nRepr. Cat. 3; R62\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-62-68-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "94551-87-8" }, { "scheme": "ec", "value": "305-433-1" }, { "scheme": "index", "value": "028-015-00-8" } ], "failed_check_digits": 0, "name": "slimes and sludges, copper electrolyte refining, decopperised" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-015-00-8", "occurrence": 1, "group": null, "rows": [ [ "028-015-00-8", "slimes and sludges, copper electrolyte refining, decopperised", "305-433-1", "94551-87-8", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 1; R61\nRepr. Cat. 3; R62\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-62-68-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "94551-87-8" }, { "scheme": "ec", "value": "305-433-1" }, { "scheme": "index", "value": "028-015-00-8" } ], "failed_check_digits": 0, "name": "slimes and sludges, copper electrolyte refining, decopperised" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-016-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "028-016-00-3", "nickel diperchlorate;\nperchloric acid, nickel(II) salt", "237-124-1", "13637-71-3", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nC; R34\nR42/43\nN; R50-53", "T; N\nR: 49-61-34-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %\nXn; R48/20: 0,1 % ≤ C < 1 %\nC; R34: C ≥ 5 %:\nXi; R36/38: 1 % ≤ C < 5 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "13637-71-3" }, { "scheme": "ec", "value": "237-124-1" }, { "scheme": "index", "value": "028-016-00-3" } ], "failed_check_digits": 0, "name": "nickel diperchlorate;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "028-016-00-3", "nickel diperchlorate;\nperchloric acid, nickel(II) salt", "237-124-1", "13637-71-3", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nC; R34\nR42/43\nN; R50-53", "T; N\nR: 49-61-34-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %\nXn; R48/20: 0,1 % ≤ C < 1 %\nC; R34: C ≥ 5 %:\nXi; R36/38: 1 % ≤ C < 5 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "13637-71-3" }, { "scheme": "ec", "value": "237-124-1" }, { "scheme": "index", "value": "028-016-00-3" } ], "failed_check_digits": 0, "name": "nickel diperchlorate;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-017-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-017-00-9", "occurrence": 1, "group": null, "rows": [ [ "028-017-00-9", "nickel dipotassium bis(sulfate); [1]\ndiammonium nickel bis(sulfate) [2]", "237-563-9 [1]\n239-793-2 [2]", "13842-46-1 [1]\n15699-18-0 [2]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nXn; R20/22\nR42/43\nN; R50-53", "T; N\nR: 49-61-20/22-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53:2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "13842-46-1" }, { "scheme": "cas", "value": "15699-18-0" }, { "scheme": "ec", "value": "237-563-9" }, { "scheme": "index", "value": "028-017-00-9" } ], "failed_check_digits": 1, "name": "nickel dipotassium bis(sulfate); [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-017-00-9", "occurrence": 1, "group": null, "rows": [ [ "028-017-00-9", "nickel dipotassium bis(sulfate); [1]\ndiammonium nickel bis(sulfate) [2]", "237-563-9 [1]\n239-793-2 [2]", "13842-46-1 [1]\n15699-18-0 [2]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nXn; R20/22\nR42/43\nN; R50-53", "T; N\nR: 49-61-20/22-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53:2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "13842-46-1" }, { "scheme": "cas", "value": "15699-18-0" }, { "scheme": "ec", "value": "237-563-9" }, { "scheme": "index", "value": "028-017-00-9" } ], "failed_check_digits": 1, "name": "nickel dipotassium bis(sulfate); [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-018-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-018-00-4", "occurrence": 1, "group": null, "rows": [ [ "028-018-00-4", "nickel bis(sulfamidate);\nnickel sulfamate", "237-396-1", "13770-89-3", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "13770-89-3" }, { "scheme": "ec", "value": "237-396-1" }, { "scheme": "index", "value": "028-018-00-4" } ], "failed_check_digits": 0, "name": "nickel bis(sulfamidate);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-018-00-4", "occurrence": 1, "group": null, "rows": [ [ "028-018-00-4", "nickel bis(sulfamidate);\nnickel sulfamate", "237-396-1", "13770-89-3", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "13770-89-3" }, { "scheme": "ec", "value": "237-396-1" }, { "scheme": "index", "value": "028-018-00-4" } ], "failed_check_digits": 0, "name": "nickel bis(sulfamidate);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-019-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-019-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-019-00-X", "nickel bis(tetrafluoroborate)", "238-753-4", "14708-14-6", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "14708-14-6" }, { "scheme": "ec", "value": "238-753-4" }, { "scheme": "index", "value": "028-019-00-X" } ], "failed_check_digits": 0, "name": "nickel bis(tetrafluoroborate)" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-019-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-019-00-X", "nickel bis(tetrafluoroborate)", "238-753-4", "14708-14-6", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "14708-14-6" }, { "scheme": "ec", "value": "238-753-4" }, { "scheme": "index", "value": "028-019-00-X" } ], "failed_check_digits": 0, "name": "nickel bis(tetrafluoroborate)" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-021-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-021-00-0", "occurrence": 1, "group": null, "rows": [ [ "028-021-00-0", "nickel diformate; [1]\nformic acid, nickel salt; [2]\nformic acid, copper nickel salt [3]", "222-101-0 [1]\n239-946-6 [2]\n268-755-0 [3]", "3349-06-2 [1]\n15843-02-4 [2]\n68134-59-8 [3]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "15843-02-4" }, { "scheme": "cas", "value": "3349-06-2" }, { "scheme": "cas", "value": "68134-59-8" }, { "scheme": "ec", "value": "222-101-0" }, { "scheme": "ec", "value": "239-946-6" }, { "scheme": "ec", "value": "268-755-0" }, { "scheme": "index", "value": "028-021-00-0" } ], "failed_check_digits": 0, "name": "nickel diformate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-021-00-0", "occurrence": 1, "group": null, "rows": [ [ "028-021-00-0", "nickel diformate; [1]\nformic acid, nickel salt; [2]\nformic acid, copper nickel salt [3]", "222-101-0 [1]\n239-946-6 [2]\n268-755-0 [3]", "3349-06-2 [1]\n15843-02-4 [2]\n68134-59-8 [3]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "15843-02-4" }, { "scheme": "cas", "value": "3349-06-2" }, { "scheme": "cas", "value": "68134-59-8" }, { "scheme": "ec", "value": "222-101-0" }, { "scheme": "ec", "value": "239-946-6" }, { "scheme": "ec", "value": "268-755-0" }, { "scheme": "index", "value": "028-021-00-0" } ], "failed_check_digits": 0, "name": "nickel diformate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-022-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-022-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-022-00-6", "nickel di(acetate); [1]\nnickel acetate [2]", "206-761-7 [1]\n239-086-1 [2]", "373-02-4 [1]\n14998-37-9 [2]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nXn; R20/22\nR42/43\nN; R50-53", "T; N\nR: 49-61-20/22-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "14998-37-9" }, { "scheme": "cas", "value": "373-02-4" }, { "scheme": "ec", "value": "206-761-7" }, { "scheme": "ec", "value": "239-086-1" }, { "scheme": "index", "value": "028-022-00-6" } ], "failed_check_digits": 0, "name": "nickel di(acetate); [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-022-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-022-00-6", "nickel di(acetate); [1]\nnickel acetate [2]", "206-761-7 [1]\n239-086-1 [2]", "373-02-4 [1]\n14998-37-9 [2]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nXn; R20/22\nR42/43\nN; R50-53", "T; N\nR: 49-61-20/22-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "14998-37-9" }, { "scheme": "cas", "value": "373-02-4" }, { "scheme": "ec", "value": "206-761-7" }, { "scheme": "ec", "value": "239-086-1" }, { "scheme": "index", "value": "028-022-00-6" } ], "failed_check_digits": 0, "name": "nickel di(acetate); [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-024-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-024-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-024-00-7", "nickel dibenzoate", "209-046-8", "553-71-9", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "553-71-9" }, { "scheme": "ec", "value": "209-046-8" }, { "scheme": "index", "value": "028-024-00-7" } ], "failed_check_digits": 0, "name": "nickel dibenzoate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-024-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-024-00-7", "nickel dibenzoate", "209-046-8", "553-71-9", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "553-71-9" }, { "scheme": "ec", "value": "209-046-8" }, { "scheme": "index", "value": "028-024-00-7" } ], "failed_check_digits": 0, "name": "nickel dibenzoate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-027-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-027-00-3", "occurrence": 1, "group": null, "rows": [ [ "028-027-00-3", "nickel dilactate", "-", "16039-61-5", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "16039-61-5" }, { "scheme": "index", "value": "028-027-00-3" } ], "failed_check_digits": 0, "name": "nickel dilactate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-027-00-3", "occurrence": 1, "group": null, "rows": [ [ "028-027-00-3", "nickel dilactate", "-", "16039-61-5", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "16039-61-5" }, { "scheme": "index", "value": "028-027-00-3" } ], "failed_check_digits": 0, "name": "nickel dilactate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-028-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-028-00-9", "occurrence": 1, "group": null, "rows": [ [ "028-028-00-9", "nickel(II) octanoate", "225-656-7", "4995-91-9", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat 2; R61\nT; R48/23\nC; R35\nR42/43\nN; R50-53", "T; C; N\nR: 49-61-35-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "4995-91-9" }, { "scheme": "ec", "value": "225-656-7" }, { "scheme": "index", "value": "028-028-00-9" } ], "failed_check_digits": 0, "name": "nickel(II) octanoate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-028-00-9", "occurrence": 1, "group": null, "rows": [ [ "028-028-00-9", "nickel(II) octanoate", "225-656-7", "4995-91-9", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat 2; R61\nT; R48/23\nC; R35\nR42/43\nN; R50-53", "T; C; N\nR: 49-61-35-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "4995-91-9" }, { "scheme": "ec", "value": "225-656-7" }, { "scheme": "index", "value": "028-028-00-9" } ], "failed_check_digits": 0, "name": "nickel(II) octanoate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-029-00-4", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-029-00-4", "occurrence": 1, "group": null, "rows": [ [ "028-029-00-4", "nickel difluoride; [1]\nnickel dibromide; [2]\nnickel diiodide; [3]\nnickel potassium fluoride [4]", "233-071-3 [1]\n236-665-0 [2]\n236-666-6 [3]\n- [4]", "10028-18-9 [1]\n13462-88-9 [2]\n13462-90-3 [3]\n11132-10-8 [4]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "10028-18-9" }, { "scheme": "cas", "value": "11132-10-8" }, { "scheme": "cas", "value": "13462-88-9" }, { "scheme": "cas", "value": "13462-90-3" }, { "scheme": "ec", "value": "233-071-3" }, { "scheme": "ec", "value": "236-665-0" }, { "scheme": "ec", "value": "236-666-6" }, { "scheme": "index", "value": "028-029-00-4" } ], "failed_check_digits": 0, "name": "nickel difluoride; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-029-00-4", "occurrence": 1, "group": null, "rows": [ [ "028-029-00-4", "nickel difluoride; [1]\nnickel dibromide; [2]\nnickel diiodide; [3]\nnickel potassium fluoride [4]", "233-071-3 [1]\n236-665-0 [2]\n236-666-6 [3]\n- [4]", "10028-18-9 [1]\n13462-88-9 [2]\n13462-90-3 [3]\n11132-10-8 [4]", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "10028-18-9" }, { "scheme": "cas", "value": "11132-10-8" }, { "scheme": "cas", "value": "13462-88-9" }, { "scheme": "cas", "value": "13462-90-3" }, { "scheme": "ec", "value": "233-071-3" }, { "scheme": "ec", "value": "236-665-0" }, { "scheme": "ec", "value": "236-666-6" }, { "scheme": "index", "value": "028-029-00-4" } ], "failed_check_digits": 0, "name": "nickel difluoride; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-030-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-030-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-030-00-X", "nickel hexafluorosilicate", "247-430-7", "26043-11-8", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "26043-11-8" }, { "scheme": "ec", "value": "247-430-7" }, { "scheme": "index", "value": "028-030-00-X" } ], "failed_check_digits": 0, "name": "nickel hexafluorosilicate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-030-00-X", "occurrence": 1, "group": null, "rows": [ [ "028-030-00-X", "nickel hexafluorosilicate", "247-430-7", "26043-11-8", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "26043-11-8" }, { "scheme": "ec", "value": "247-430-7" }, { "scheme": "index", "value": "028-030-00-X" } ], "failed_check_digits": 0, "name": "nickel hexafluorosilicate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-031-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-031-00-5", "occurrence": 1, "group": null, "rows": [ [ "028-031-00-5", "nickel selenate", "239-125-2", "15060-62-5", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "15060-62-5" }, { "scheme": "ec", "value": "239-125-2" }, { "scheme": "index", "value": "028-031-00-5" } ], "failed_check_digits": 0, "name": "nickel selenate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-031-00-5", "occurrence": 1, "group": null, "rows": [ [ "028-031-00-5", "nickel selenate", "239-125-2", "15060-62-5", "Carc. Cat. 1; R49\nMuta. Cat. 3; R68\nRepr. Cat. 2; R61\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-61-42/43-48/23-68-50/53\nS: 53-45-60-61", "T R48/23: C ≥ 1 %:\nXn; R48/20: 0,1 % ≤ C < 1 %\nR43: C ≥ 0,01 %\nN; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "15060-62-5" }, { "scheme": "ec", "value": "239-125-2" }, { "scheme": "index", "value": "028-031-00-5" } ], "failed_check_digits": 0, "name": "nickel selenate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-032-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-032-00-0", "occurrence": 1, "group": null, "rows": [ [ "028-032-00-0", "nickel hydrogen phosphate; [1]\nnickel bis(dihydrogen phosphate); [2]\ntrinickel bis(orthophosphate); [3]\ndinickel diphosphate; [4]\nnickel bis(phosphinate); [5]\nnickel phosphinate; [6]\nphosphoric acid, calcium nickel salt; [7]\ndiphosphoric acid, nickel(II) salt [8]", "238-278-2 [1]\n242-522-3 [2]\n233-844-5 [3]\n238-426-6 [4]\n238-511-8 [5]\n252-840-4 [6]\n- [7]\n- [8]", "14332-34-4 [1]\n18718-11-1 [2]\n10381-36-9 [3]\n14448-18-1 [4]\n14507-36-9 [5]\n36026-88-7 [6]\n17169-61-8 [7]\n19372-20-4 [8]", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "10381-36-9" }, { "scheme": "cas", "value": "14332-34-4" }, { "scheme": "cas", "value": "14448-18-1" }, { "scheme": "cas", "value": "14507-36-9" }, { "scheme": "cas", "value": "17169-61-8" }, { "scheme": "cas", "value": "18718-11-1" }, { "scheme": "cas", "value": "19372-20-4" }, { "scheme": "cas", "value": "36026-88-7" }, { "scheme": "ec", "value": "233-844-5" }, { "scheme": "ec", "value": "238-278-2" }, { "scheme": "ec", "value": "238-426-6" }, { "scheme": "ec", "value": "238-511-8" }, { "scheme": "ec", "value": "242-522-3" }, { "scheme": "ec", "value": "252-840-4" }, { "scheme": "index", "value": "028-032-00-0" } ], "failed_check_digits": 0, "name": "nickel hydrogen phosphate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-032-00-0", "occurrence": 1, "group": null, "rows": [ [ "028-032-00-0", "nickel hydrogen phosphate; [1]\nnickel bis(dihydrogen phosphate); [2]\ntrinickel bis(orthophosphate); [3]\ndinickel diphosphate; [4]\nnickel bis(phosphinate); [5]\nnickel phosphinate; [6]\nphosphoric acid, calcium nickel salt; [7]\ndiphosphoric acid, nickel(II) salt [8]", "238-278-2 [1]\n242-522-3 [2]\n233-844-5 [3]\n238-426-6 [4]\n238-511-8 [5]\n252-840-4 [6]\n- [7]\n- [8]", "14332-34-4 [1]\n18718-11-1 [2]\n10381-36-9 [3]\n14448-18-1 [4]\n14507-36-9 [5]\n36026-88-7 [6]\n17169-61-8 [7]\n19372-20-4 [8]", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "10381-36-9" }, { "scheme": "cas", "value": "14332-34-4" }, { "scheme": "cas", "value": "14448-18-1" }, { "scheme": "cas", "value": "14507-36-9" }, { "scheme": "cas", "value": "17169-61-8" }, { "scheme": "cas", "value": "18718-11-1" }, { "scheme": "cas", "value": "19372-20-4" }, { "scheme": "cas", "value": "36026-88-7" }, { "scheme": "ec", "value": "233-844-5" }, { "scheme": "ec", "value": "238-278-2" }, { "scheme": "ec", "value": "238-426-6" }, { "scheme": "ec", "value": "238-511-8" }, { "scheme": "ec", "value": "242-522-3" }, { "scheme": "ec", "value": "252-840-4" }, { "scheme": "index", "value": "028-032-00-0" } ], "failed_check_digits": 0, "name": "nickel hydrogen phosphate; [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-033-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-033-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-033-00-6", "diammonium nickel hexacyanoferrate", "-", "74195-78-1", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "74195-78-1" }, { "scheme": "index", "value": "028-033-00-6" } ], "failed_check_digits": 0, "name": "diammonium nickel hexacyanoferrate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-033-00-6", "occurrence": 1, "group": null, "rows": [ [ "028-033-00-6", "diammonium nickel hexacyanoferrate", "-", "74195-78-1", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "74195-78-1" }, { "scheme": "index", "value": "028-033-00-6" } ], "failed_check_digits": 0, "name": "diammonium nickel hexacyanoferrate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-034-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-034-00-1", "occurrence": 1, "group": null, "rows": [ [ "028-034-00-1", "nickel dicyanide", "209-160-8", "557-19-7", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nR32\nN; R50-53", "T; N\nR: 49-32-42/43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "557-19-7" }, { "scheme": "ec", "value": "209-160-8" }, { "scheme": "index", "value": "028-034-00-1" } ], "failed_check_digits": 0, "name": "nickel dicyanide" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-034-00-1", "occurrence": 1, "group": null, "rows": [ [ "028-034-00-1", "nickel dicyanide", "209-160-8", "557-19-7", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nR32\nN; R50-53", "T; N\nR: 49-32-42/43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "557-19-7" }, { "scheme": "ec", "value": "209-160-8" }, { "scheme": "index", "value": "028-034-00-1" } ], "failed_check_digits": 0, "name": "nickel dicyanide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-035-00-7", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-035-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-035-00-7", "nickel chromate", "238-766-5", "14721-18-7", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "14721-18-7" }, { "scheme": "ec", "value": "238-766-5" }, { "scheme": "index", "value": "028-035-00-7" } ], "failed_check_digits": 0, "name": "nickel chromate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-035-00-7", "occurrence": 1, "group": null, "rows": [ [ "028-035-00-7", "nickel chromate", "238-766-5", "14721-18-7", "Carc. Cat. 1; R49\nT; R48/23\nR42/43\nN; R50-53", "T; N\nR: 49-42/43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "14721-18-7" }, { "scheme": "ec", "value": "238-766-5" }, { "scheme": "index", "value": "028-035-00-7" } ], "failed_check_digits": 0, "name": "nickel chromate" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "028-036-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-036-00-2", "occurrence": 1, "group": null, "rows": [ [ "028-036-00-2", "nickel(II) silicate; [1]\ndinickel orthosilicate; [2]\nnickel silicate (3:4); [3]\nsilicic acid, nickel salt; [4]\ntrihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]", "244-578-4 [1]\n237-411-1 [2]\n250-788-7 [3]\n253-461-7 [4]\n235-688-3 [5]", "21784-78-1 [1]\n13775-54-7 [2]\n31748-25-1 [3]\n37321-15-6 [4]\n12519-85-6 [5]", "Carc. Cat. 1; R49\nT; R48/23\nR43\nN; R50-53", "T; N\nR: 49-43-48/23-50/53\nS: 53-45-60-61", "", "H" ] ], "identifiers": [ { "scheme": "cas", "value": "12519-85-6" }, { "scheme": "cas", "value": "13775-54-7" }, { "scheme": "cas", "value": "21784-78-1" }, { "scheme": "cas", "value": "31748-25-1" }, { "scheme": "cas", "value": "37321-15-6" }, { "scheme": "ec", "value": "235-688-3" }, { "scheme": "ec", "value": "237-411-1" }, { "scheme": "ec", "value": "244-578-4" }, { "scheme": "ec", "value": "250-788-7" }, { "scheme": "ec", "value": "253-461-7" }, { "scheme": "index", "value": "028-036-00-2" } ], "failed_check_digits": 0, "name": "nickel(II) silicate; [1]" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "028-036-00-2", "occurrence": 1, "group": null, "rows": [ [ "028-036-00-2", "nickel(II) silicate; [1]\ndinickel orthosilicate; [2]\nnickel silicate (3:4); [3]\nsilicic acid, nickel salt; [4]\ntrihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]", "244-578-4 [1]\n237-411-1 [2]\n250-788-7 [3]\n253-461-7 [4]\n235-688-3 [5]", "21784-78-1 [1]\n13775-54-7 [2]\n31748-25-1 [3]\n37321-15-6 [4]\n12519-85-6 [5]", "Carc. Cat. 1; R49\nT; R48/23\nR43\nN; R50-53", "T; N\nR: 49-43-48/23-50/53\nS: 53-45-60-61", "", "E H" ] ], "identifiers": [ { "scheme": "cas", "value": "12519-85-6" }, { "scheme": "cas", "value": "13775-54-7" }, { "scheme": "cas", "value": "21784-78-1" }, { "scheme": "cas", "value": "31748-25-1" }, { "scheme": "cas", "value": "37321-15-6" }, { "scheme": "ec", "value": "235-688-3" }, { "scheme": "ec", "value": "237-411-1" }, { "scheme": "ec", "value": "244-578-4" }, { "scheme": "ec", "value": "250-788-7" }, { "scheme": "ec", "value": "253-461-7" }, { "scheme": "index", "value": "028-036-00-2" } ], "failed_check_digits": 0, "name": "nickel(II) silicate; [1]" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "602-109-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "602-109-00-4", "occurrence": 1, "group": null, "rows": [ [ "602-109-00-4", "Hexabromocyclododecane [1]", "247-148-4 [1]", "25637-99-4[1]", "Repr. Cat. 3; R63 R64", "Xn\nR: 63-64\nS: 36/37-53", "", "" ], [ null, "1,2,5,6,9,10-hexabromocyclododecane [2]", "221-695-9[2]", "3194-55-6[2]", null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "25637-99-4" }, { "scheme": "cas", "value": "3194-55-6" }, { "scheme": "ec", "value": "221-695-9" }, { "scheme": "ec", "value": "247-148-4" }, { "scheme": "index", "value": "602-109-00-4" } ], "failed_check_digits": 0, "name": "Hexabromocyclododecane [1]" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "603-012-00-X", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "603-012-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-012-00-X", "2-ethoxyethanol;\nethylene glycol monoethyl ether", "203-804-1", "110-80-5", "R10\nRepr. Cat. 2; R60-61\nXn; R20/21/22", "T\nR: 60-61-10-20/21/22\nS: 53-45", "", "E" ] ], "identifiers": [ { "scheme": "cas", "value": "110-80-5" }, { "scheme": "ec", "value": "203-804-1" }, { "scheme": "index", "value": "603-012-00-X" } ], "failed_check_digits": 0, "name": "2-ethoxyethanol;" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "603-012-00-X", "occurrence": 1, "group": null, "rows": [ [ "603-012-00-X", "2-ethoxyethanol;\nethylene glycol monoethyl ether", "203-804-1", "110-80-5", "R10\nRepr. Cat. 2; R60-61\nXn; R20/22", "T\nR: 60-61-10-20/22\nS: 53-45", "", "E" ] ], "identifiers": [ { "scheme": "cas", "value": "110-80-5" }, { "scheme": "ec", "value": "203-804-1" }, { "scheme": "index", "value": "603-012-00-X" } ], "failed_check_digits": 0, "name": "2-ethoxyethanol;" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "603-025-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "603-025-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-025-00-0", "tetrahydrofuran", "203-726-8", "109-99-9", "F; R11-19\nXi; R36/37", "F; Xi\nR: 11-19-36/37\nS: (2-)16-29-33", "Xi; R36/37: C ≥ 25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "109-99-9" }, { "scheme": "ec", "value": "203-726-8" }, { "scheme": "index", "value": "603-025-00-0" } ], "failed_check_digits": 0, "name": "tetrahydrofuran" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "603-025-00-0", "occurrence": 1, "group": null, "rows": [ [ "603-025-00-0", "tetrahydrofuran", "203-726-8", "109-99-9", "F; R11-19\nCarc. Cat. 3; R40\nXi; R36/37", "F; Xn;\nR: 11-19-40-36/37\nS: (2-)(13-)16-29-33-36-37(-46)", "Xi; R36/37: C ≥ 25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "109-99-9" }, { "scheme": "ec", "value": "203-726-8" }, { "scheme": "index", "value": "603-025-00-0" } ], "failed_check_digits": 0, "name": "tetrahydrofuran" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "606-138-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "606-138-00-3", "occurrence": 1, "group": null, "rows": [ [ "606-138-00-3", "(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone", "444-800-1", "141645-23-0", "R10\nXn; R22-48/22\nXi; R38-41\nR43\nN; R50-53", "Xn; N\nR: 10-22-38-41-43-48/22-50/53\nS: (2-)23-26-36/37/39-60-61", "N; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %3", "" ] ], "identifiers": [ { "scheme": "cas", "value": "141645-23-0" }, { "scheme": "ec", "value": "444-800-1" }, { "scheme": "index", "value": "606-138-00-3" } ], "failed_check_digits": 0, "name": "(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "606-138-00-3", "occurrence": 1, "group": null, "rows": [ [ "606-138-00-3", "(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone", "444-800-1", "141645-23-0", "R10\nXn; R22-48/22\nXi; R38-41\nR43\nN; R50-53", "Xn; N\nR: 10-22-38-41-43-48/22-50/53\nS: (2-)23-26-36/37/39-60-61", "N; R50-53: C ≥ 2,5 %\nN; R51-53: 0,25 % ≤ C < 2,5 %\nR52-53: 0,025 % ≤ C < 0,25 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "141645-23-0" }, { "scheme": "ec", "value": "444-800-1" }, { "scheme": "index", "value": "606-138-00-3" } ], "failed_check_digits": 0, "name": "(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "606-143-00-0", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "606-143-00-0", "occurrence": 1, "group": null, "rows": [ [ "606-143-00-0", "abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]", "_ [1]", "71751-41-2 [1]", "Repr. Cat. 3; R63\nT+; R26/28\nT; R48/23/25\nN; R50-53", "T+; N\nR: 63-26/28-48/23/25-50/53\nS: 28-36/37-45-60-61", "T; R48/23: C ≥ 5%\nXn; R48/20: 0,5% ≤ C <5%\nN; R50-53: C ≥ 0,0025%\nN; R51-53: 0,00025% ≤ C<0,0025%\nR52-53: 0,000025% ≤ C<0,00025%", "" ], [ null, "avermectin B1a (purity ≥80%); [2]", "265-610-3 [2]", "65195-55-3 [2]", null, null, null, null ] ], "identifiers": [ { "scheme": "cas", "value": "65195-55-3" }, { "scheme": "cas", "value": "71751-41-2" }, { "scheme": "ec", "value": "265-610-3" }, { "scheme": "index", "value": "606-143-00-0" } ], "failed_check_digits": 0, "name": "abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "606-144-00-6", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "606-144-00-6", "occurrence": 1, "group": null, "rows": [ [ "606-144-00-6", "acequinocyl (ISO);\n3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate", "—", "57960-19-7", "T; R39/23\nXi; R43\nN; R50-53", "T; N\nR: 39/23-43-50/53,\nS: (2-)24-37-38-60-61", "N; R50-53: C ≥ 0,025%\nN; R51-53: 0,0025% ≤ C < 0,025%\nR52-53: 0,00025% ≤ C < 0,0025%", "" ] ], "identifiers": [ { "scheme": "cas", "value": "57960-19-7" }, { "scheme": "index", "value": "606-144-00-6" } ], "failed_check_digits": 0, "name": "acequinocyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "607-003-00-1", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "607-003-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-003-00-1", "chloroacetic acid", "201-178-4", "79-11-8", "T; R23/24/25\nC; R34\nN; R50", "T; N\nR: 23/24/25-34-50\nS: (1/2-)26-36/37/39-45-61-63", "C; R34: C ≥ 10 %\nXn; 36/37/38: 5 % ≤ C < 10 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "79-11-8" }, { "scheme": "ec", "value": "201-178-4" }, { "scheme": "index", "value": "607-003-00-1" } ], "failed_check_digits": 0, "name": "chloroacetic acid" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "607-003-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-003-00-1", "chloroacetic acid", "201-178-4", "79-11-8", "T; R23/24/25\nC; R34\nN; R50", "T; N\nR: 23/24/25-34-50\nS: (1/2-)26-36/37/39-45-61-63", "C; R34: C ≥ 10 %\nXn; R36/37/38: 5 % ≤ C < 10 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "79-11-8" }, { "scheme": "ec", "value": "201-178-4" }, { "scheme": "index", "value": "607-003-00-1" } ], "failed_check_digits": 0, "name": "chloroacetic acid" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "607-177-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "607-177-00-9", "occurrence": 1, "group": null, "rows": [ [ "607-177-00-9", "tribenuron-methyl (ISO);\n2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester;\nmethyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-methylureidosulfonyl)benzoate", "401-190-1", "101200-48-0", "R43\nN; R50-53", "Xi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61", "N; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "101200-48-0" }, { "scheme": "ec", "value": "401-190-1" }, { "scheme": "index", "value": "607-177-00-9" } ], "failed_check_digits": 0, "name": "tribenuron-methyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "607-177-00-9", "occurrence": 1, "group": null, "rows": [ [ "607-177-00-9", "tribenuron-methyl (ISO)\nmethyl 2-[N-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-N-methylcarbamoylsulfamoyl]benzoate", "401-190-1", "101200-48-0", "R43\nN; R50-53", "Xi; N\nR: 43-50/53\nS: (2-)24-37-46-60-61", "N; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "101200-48-0" }, { "scheme": "ec", "value": "401-190-1" }, { "scheme": "index", "value": "607-177-00-9" } ], "failed_check_digits": 0, "name": "tribenuron-methyl (ISO)" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "607-698-00-1", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "607-698-00-1", "occurrence": 1, "group": null, "rows": [ [ "607-698-00-1", "4-tert-butylbenzoic acid", "202-696-3", "98-73-7", "Repr. Cat. 2; R60\nT; R48/23/24/25\nXn; R22", "T\nR: 60-22-48/23/24/25\nS: 53-45", "", "E" ] ], "identifiers": [ { "scheme": "cas", "value": "98-73-7" }, { "scheme": "ec", "value": "202-696-3" }, { "scheme": "index", "value": "607-698-00-1" } ], "failed_check_digits": 0, "name": "4-tert-butylbenzoic acid" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "608-057-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "608-057-00-9", "occurrence": 1, "group": null, "rows": [ [ "608-057-00-9", "4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate", "431-200-1", "208538-34-5", "Xn; R22\nXi; R41\nR43", "Xn\nR: 22-41-43\nS: (2-)22-24-26-37/39", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "208538-34-5" }, { "scheme": "ec", "value": "431-200-1" }, { "scheme": "index", "value": "608-057-00-9" } ], "failed_check_digits": 0, "name": "4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "608-057-00-9", "occurrence": 1, "group": null, "rows": [ [ "608-057-00-9", "4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate", "431-200-1", "208538-34-5", "Xn; R22\nXi; R41\nR43", "Xn\nR: 22-41-43\nS: (2-)22-24-26-37/39", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "208538-34-5" }, { "scheme": "ec", "value": "431-200-1" }, { "scheme": "index", "value": "608-057-00-9" } ], "failed_check_digits": 0, "name": "4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "608-058-00-4", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "608-058-00-4", "occurrence": 1, "group": null, "rows": [ [ "608-058-00-4", "esfenvalerate (ISO);\n(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate", "—", "66230-04-4", "T; R23/25\nR43\nN; R50-53", "T; N\nR: 23/25-43-50/53\nS: (1/2-)24-36/37/39-45-60-61", "N; R50-53: C ≥ 0,0025 %\nN; R51-53: 0,00025 % ≤ C < 0,0025 %\nR52-53: 0,000025 % ≤ C < 0,00025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "66230-04-4" }, { "scheme": "index", "value": "608-058-00-4" } ], "failed_check_digits": 0, "name": "esfenvalerate (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "612-050-00-6", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "612-050-00-6", "occurrence": 1, "group": null, "rows": [ [ "612-050-00-6", "cyclohexylamine", "203-629-0", "108-91-8", "R10\nRepr. Cat. 3; R62\nXn; R21/22\nC; R34", "C\nR: 10-21/22-34-62\nS: (1/2-)26-36/37/39-45", "C; 34: C ≥ 10 %\nXi; R36/38: 2 % ≤ C < 10 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "108-91-8" }, { "scheme": "ec", "value": "203-629-0" }, { "scheme": "index", "value": "612-050-00-6" } ], "failed_check_digits": 0, "name": "cyclohexylamine" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "612-050-00-6", "occurrence": 1, "group": null, "rows": [ [ "612-050-00-6", "cyclohexylamine", "203-629-0", "108-91-8", "R10\nRepr. Cat. 3; R62\nXn; R21/22\nC; R34", "C\nR: 10-21/22-34-62\nS: (1/2-)26-36/37/39-45", "C; R34: C ≥ 10 %\nXi; R36/38: 2 % ≤ C < 10 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "108-91-8" }, { "scheme": "ec", "value": "203-629-0" }, { "scheme": "index", "value": "612-050-00-6" } ], "failed_check_digits": 0, "name": "cyclohexylamine" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "612-281-00-2", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "612-281-00-2", "occurrence": 1, "group": null, "rows": [ [ "612-281-00-2", "leucomalachite green\nN,N,N',N'-tetramethyl-4,4'-benzylidenedianiline", "204-961-9", "129-73-7", "Carc. Cat. 3; R40\nMuta. Cat. 3; R68", "Xn\nR: 40-68\nS: (2-)36/37", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "129-73-7" }, { "scheme": "ec", "value": "204-961-9" }, { "scheme": "index", "value": "612-281-00-2" } ], "failed_check_digits": 0, "name": "leucomalachite green" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-010-00-0", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-010-00-0", "occurrence": 1, "group": null, "rows": [ [ "613-010-00-0", "ametryn (ISO);\n2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine", "212-634-7", "834-12-8", "Xn; R22\nN; R50-53", "Xn; N\nR: 22-50/53\nS: (2-)36-60-61", "N; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "834-12-8" }, { "scheme": "ec", "value": "212-634-7" }, { "scheme": "index", "value": "613-010-00-0" } ], "failed_check_digits": 0, "name": "ametryn (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-010-00-0", "occurrence": 1, "group": null, "rows": [ [ "613-010-00-0", "ametryn (ISO);\nN-ethyl-N′-isopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine", "212-634-7", "834-12-8", "Xn; R22\nN; R50-53", "Xn; N\nR: 22-50/53\nS: (2-)36-60-61", "N; R50-53: C ≥ 0,25 %\nN; R51-53: 0,025 % ≤ C < 0,25 %\nR52-53: 0,0025 % ≤ C < 0,025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "834-12-8" }, { "scheme": "ec", "value": "212-634-7" }, { "scheme": "index", "value": "613-010-00-0" } ], "failed_check_digits": 0, "name": "ametryn (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-016-00-3", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "613-016-00-3", "fuberidazole (ISO);\n2-(2-furyl)benzimidazole", "223-404-0", "3878-19-1", "Xn; R22\nN; R50-53", "Xn; N\nR: 22-50/53\nS: (2-)22-60-61", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "3878-19-1" }, { "scheme": "ec", "value": "223-404-0" }, { "scheme": "index", "value": "613-016-00-3" } ], "failed_check_digits": 0, "name": "fuberidazole (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-016-00-3", "occurrence": 1, "group": null, "rows": [ [ "613-016-00-3", "fuberidazole (ISO);\n2-(2-furyl)-1H-benzimidazole", "223-404-0", "3878-19-1", "Carc. Cat. 3; R40\nXn; R48/22\nXn; R22\nXi; R43\nN; R50-53", "Xn; N\nR: 40-48/22-22-43-50/53\nS: (2)-22-36/37-60-61", "N; R50-53: C ≥ 25 %\nN; R51-53: 2,5 % ≤ C < 25 %\nR52-53: 0,25 % ≤ C < 2,5 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "3878-19-1" }, { "scheme": "ec", "value": "223-404-0" }, { "scheme": "index", "value": "613-016-00-3" } ], "failed_check_digits": 0, "name": "fuberidazole (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-120-00-9", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-120-00-9", "occurrence": 1, "group": null, "rows": [ [ "613-120-00-9", "bioresmethrin (ISO);\n(5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate", "249-014-0", "28434-01-7", "N; R50-53", "N\nR: 50/53\nS: 60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "28434-01-7" }, { "scheme": "ec", "value": "249-014-0" }, { "scheme": "index", "value": "613-120-00-9" } ], "failed_check_digits": 0, "name": "bioresmethrin (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-120-00-9", "occurrence": 1, "group": null, "rows": [ [ "613-120-00-9", "bioresmethrin (ISO);\n(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate", "249-014-0", "28434-01-7", "N; R50-53", "N\nR: 50/53\nS: 60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "28434-01-7" }, { "scheme": "ec", "value": "249-014-0" }, { "scheme": "index", "value": "613-120-00-9" } ], "failed_check_digits": 0, "name": "bioresmethrin (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-139-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-139-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-139-00-2", "metsulfuron-methyl (ISO);\n2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid", "—", "74223-64-6", "N; R50-53", "N\nR: 50/53\nS: 60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "74223-64-6" }, { "scheme": "index", "value": "613-139-00-2" } ], "failed_check_digits": 0, "name": "metsulfuron-methyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-139-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-139-00-2", "metsulfuron-methyl (ISO);\nmethyl 2-{[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate", "—", "74223-64-6", "N; R50-53", "N\nR: 50/53\nS: 60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "74223-64-6" }, { "scheme": "index", "value": "613-139-00-2" } ], "failed_check_digits": 0, "name": "metsulfuron-methyl (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-161-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-161-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-161-00-2", "2,4-diamino-6-hydroxymethylpteridinehydrobromide", "430-620-0", "76145-91-0", "Xn; R48/22\nR43\nR52-53", "Xn\nR: 43-48/22-52/53\nS: (2-)22-36/37-61", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "76145-91-0" }, { "scheme": "ec", "value": "430-620-0" }, { "scheme": "index", "value": "613-161-00-2" } ], "failed_check_digits": 0, "name": "2,4-diamino-6-hydroxymethylpteridinehydrobromide" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-161-00-2", "occurrence": 1, "group": null, "rows": [ [ "613-161-00-2", "(2,4-diaminopteridin-6-yl)methanol hydrobromide", "430-620-0", "76145-91-0", "Xn; R48/22\nR43\nR52-53", "Xn\nR: 43-48/22-52/53\nS: (2-)22-36/37-61", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "76145-91-0" }, { "scheme": "ec", "value": "430-620-0" }, { "scheme": "index", "value": "613-161-00-2" } ], "failed_check_digits": 0, "name": "(2,4-diaminopteridin-6-yl)methanol hydrobromide" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "613-204-00-5", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-204-00-5", "occurrence": 1, "group": null, "rows": [ [ "613-204-00-5", "oxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;\n5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one", "254-637-6", "39807-15-3", "Repr. Cat. 3; R63\nXn; R48/22\nN; R50-53", "Xn; N\nR: 48/22-63-50/53\nS: (2-)36/37-46-60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "39807-15-3" }, { "scheme": "ec", "value": "254-637-6" }, { "scheme": "index", "value": "613-204-00-5" } ], "failed_check_digits": 0, "name": "oxadiargyl (ISO);" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "613-204-00-5", "occurrence": 1, "group": null, "rows": [ [ "613-204-00-5", "oxadiargyl (ISO);\n3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;", "254-637-6", "39807-15-3", "Repr. Cat. 3; R63\nXn; R48/22\nN; R50-53", "Xn; N\nR: 48/22-63-50/53\nS: (2-)36/37-46-60-61", "N; R50-53: C ≥ 0,025 %\nN; R51-53: 0,0025 % ≤ C < 0,025 %\nR52-53: 0,00025 % ≤ C < 0,0025 %", "" ] ], "identifiers": [ { "scheme": "cas", "value": "39807-15-3" }, { "scheme": "ec", "value": "254-637-6" }, { "scheme": "index", "value": "613-204-00-5" } ], "failed_check_digits": 0, "name": "oxadiargyl (ISO);" } }, { "kind": "added", "container": "AN VI SCT 3", "table": 2, "key": "616-205-00-9", "occurrence": 1, "typography_only": false, "before": null, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "616-205-00-9", "occurrence": 1, "group": null, "rows": [ [ "616-205-00-9", "Metazachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide", "266-583-0", "67129-08-2", "R43\nCarc. Cat. 3; R40\nN; R50-53", "Xn; N\nR: 40-43-50/53\nS: (2-)36-37-60-61", "N; R50-53: C ≥ 0,25%\nN; R51-53: 0,025% ≤ C < 0,25%\nR52-53: 0,0025% ≤ C < 0,025%", "" ] ], "identifiers": [ { "scheme": "cas", "value": "67129-08-2" }, { "scheme": "ec", "value": "266-583-0" }, { "scheme": "index", "value": "616-205-00-9" } ], "failed_check_digits": 0, "name": "Metazachlor (ISO);" } }, { "kind": "amended", "container": "AN VI SCT 3", "table": 2, "key": "617-001-00-2", "occurrence": 1, "typography_only": false, "before": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "617-001-00-2", "occurrence": 1, "group": null, "rows": [ [ "617-001-00-2", "di-tert-butyl peroxide", "203-733-6", "110-05-4", "O; R7\nF; R11", "O; F\nR: 7-11\nS: (2-)3/7-14-16-36/37/39", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-05-4" }, { "scheme": "ec", "value": "203-733-6" }, { "scheme": "index", "value": "617-001-00-2" } ], "failed_check_digits": 0, "name": "di-tert-butyl peroxide" }, "after": { "unit": "AN VI", "container": "AN VI SCT 3", "table": 2, "key": "617-001-00-2", "occurrence": 1, "group": null, "rows": [ [ "617-001-00-2", "di-tert-butyl peroxide", "203-733-6", "110-05-4", "O; R7\nF; R11\nMuta. Cat. 3, R68", "O; F; Xn\nR: 7-11-68\nS: (2-)3/7-14-16-23-36/37/39", "", "" ] ], "identifiers": [ { "scheme": "cas", "value": "110-05-4" }, { "scheme": "ec", "value": "203-733-6" }, { "scheme": "index", "value": "617-001-00-2" } ], "failed_check_digits": 0, "name": "di-tert-butyl peroxide" } } ], "unchanged": 8016, "whitespace_only": 0, "unpaired": [], "gaps_before": { "unrecognised_tables": 0, "unkeyed_rows": 1, "failed_check_digits": 4, "repeated_keys": [] }, "gaps_after": { "unrecognised_tables": 0, "unkeyed_rows": 1, "failed_check_digits": 4, "repeated_keys": [] } }, "amending_acts": [ { "corpus": "eu", "key": "32012R0618", "display_name": null }, { "corpus": "eu", "key": "32013R0487", "display_name": null }, { "corpus": "eu", "key": "32013R0758", "display_name": null }, { "corpus": "eu", "key": "32013R0944", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2012-07-31", "applies_from": { "kind": "unchanged" }, "signals": { "structural_diff": { "status": "observed", "detail": "structural_diff", "change_types": [ "MODIFIED" ] }, "corpus_metadata": { "status": "observed", "detail": "32012R0618 TXT; 32013R0487 M; 32013R0758 M; 32013R0944 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": false, "dispute_reason": null }, "outcome": "passed", "sentences": [ { "text": "In the entry for boric acid (005-007-00-2), the description of the second listed substance was simplified from a longer technical description of crude natural boric acid with a purity qualifier to simply 'boric acid'.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20110419", "location": "AN VI" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20110419#anx_VI", "label": "Annex VI, 02008R1272-20110419" }, { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN VI" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_VI", "label": "Annex VI, 02008R1272-20131201" } ] }, { "text": "Several entries had their hazard class code for oxidising solids changed from the abbreviation 'Oxid. Sol.' to 'Ox. Sol.' in entries such as 005-017-00-7, 005-017-01-4, 005-019-00-8 and 005-019-01-5.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20110419", "location": "AN VI" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20110419#anx_VI", "label": "Annex VI, 02008R1272-20110419" }, { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN VI" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_VI", "label": "Annex VI, 02008R1272-20131201" } ] }, { "text": "The text shown is truncated at the same point in both versions, so further differences beyond entry 006-003-00-3 cannot be described.", "fallback": false, "citations": [ { "ref": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN VI" }, "url": "https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:02008R1272-20131201#anx_VI", "label": "Annex VI, 02008R1272-20131201" } ] } ], "applicability_note": null, "unexplained": "", "unexplained_kind": "" }, { "change": { "change_type": "MODIFIED", "provision": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "version": "02008R1272-20131201", "location": "AN VII" }, "heading": null, "before": null, "after": null, "previous_location": null, "changed_within": [], "table_entries": null, "amending_acts": [ { "corpus": "eu", "key": "32013R0487", "display_name": null } ], "dates_removed": [], "dates_added": [], "in_force": "2013-06-21", "applies_from": { "kind": "unknown", "reason": null }, "signals": { "structural_diff": { "status": "absent", "detail": "structural_diff", "change_types": [] }, "corpus_metadata": { "status": "observed", "detail": "32013R0487 M", "change_types": [ "MODIFIED" ] }, "instruction_parse": { "status": "unavailable", "detail": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "change_types": [] } }, "disputed": true, "dispute_reason": "textless_metadata_only" }, "outcome": "unexplained", "sentences": [], "applicability_note": null, "unexplained": "the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships marked disputed", "unexplained_kind": "nothing_to_explain" } ], "corroboration": { "act": { "corpus": "eu", "key": "32008R1272", "display_name": "Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance)" }, "from_version": "02008R1272-20110419", "to_version": "02008R1272-20131201", "signals": [ { "signal": "structural_diff", "available": true, "units": [ "AN I", "AN III", "AN IV", "AN VI" ], "note": null, "claims": [] }, { "signal": "corpus_metadata", "available": true, "units": [ "AR 14", "AR 23", "AN I", "AN II", "AN III", "AN IV", "AN V", "AN VI", "AN VII" ], "note": "18 annotations in (2011-04-19, 2013-12-01]", "claims": [ { "location": "AN VI 3.1", "change_type": null, "in_force": "2012-07-31", "source": "32012R0618 TXT", "amending_act": { "corpus": "eu", "key": "32012R0618", "display_name": null } }, { "location": "AN VI 3.2", "change_type": null, "in_force": "2012-07-31", "source": "32012R0618 TXT", "amending_act": { "corpus": "eu", "key": "32012R0618", "display_name": null } }, { "location": "AN II", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN III", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN VI", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AR 23 PO F)", "change_type": "INSERTED", "in_force": "2013-06-21", "source": "32013R0487 J", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN V", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN I", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN IV", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN VII", "change_type": "MODIFIED", "in_force": "2013-06-21", "source": "32013R0487 M", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AR 14 PO C)", "change_type": null, "in_force": "2013-06-21", "source": "32013R0487 SU", "amending_act": { "corpus": "eu", "key": "32013R0487", "display_name": null } }, { "location": "AN III", "change_type": "MODIFIED", "in_force": "2013-07-01", "source": "32013R0517 C", "amending_act": { "corpus": "eu", "key": "32013R0517", "display_name": null } }, { "location": "AN III P.1", "change_type": "MODIFIED", "in_force": "2013-07-01", "source": "32013R0517 C", "amending_act": { "corpus": "eu", "key": "32013R0517", "display_name": null } }, { "location": "AN IV P.2", "change_type": "MODIFIED", "in_force": "2013-07-01", "source": "32013R0517 C", "amending_act": { "corpus": "eu", "key": "32013R0517", "display_name": null } }, { "location": "AN III P.2", "change_type": "MODIFIED", "in_force": "2013-07-01", "source": "32013R0517 C", "amending_act": { "corpus": "eu", "key": "32013R0517", "display_name": null } }, { "location": "AN VI P. 3", "change_type": "MODIFIED", "in_force": "2013-08-13", "source": "32013R0758 M", "amending_act": { "corpus": "eu", "key": "32013R0758", "display_name": null } }, { "location": "AN VI P.3", "change_type": "MODIFIED", "in_force": "2013-10-23", "source": "32013R0944 M", "amending_act": { "corpus": "eu", "key": "32013R0944", "display_name": null } }, { "location": "AN IV", "change_type": "MODIFIED", "in_force": "2013-10-23", "source": "32013R0944 M", "amending_act": { "corpus": "eu", "key": "32013R0944", "display_name": null } } ] }, { "signal": "instruction_parse", "available": false, "units": [], "note": "the window folds in 5 amending acts: 32012R0618, 32013R0487, 32013R0517, 32013R0758, 32013R0944", "claims": [] } ], "agreements": [ { "left": "structural_diff", "right": "corpus_metadata", "left_units": 4, "right_units": 9, "shared": 4, "precision": 1.0, "recall": 0.4444444444444444, "f1": 0.6153846153846153, "kind_mismatches": 0 } ], "disagreements": [ { "unit": "AR 14", "reason": "seen by corpus_metadata, not by structural_diff", "observed_by": [ "corpus_metadata" ], "absent_from": [ "structural_diff" ], "kinds": [] }, { "unit": "AR 23", "reason": "seen by corpus_metadata, not by structural_diff", "observed_by": [ "corpus_metadata" ], "absent_from": [ "structural_diff" ], "kinds": [ [ "corpus_metadata", [ "MODIFIED" ] ] ] }, { "unit": "AN II", "reason": "seen by corpus_metadata, not by structural_diff", "observed_by": [ "corpus_metadata" ], "absent_from": [ "structural_diff" ], "kinds": [ [ "corpus_metadata", [ "MODIFIED" ] ] ] }, { "unit": "AN V", "reason": "seen by corpus_metadata, not by structural_diff", "observed_by": [ "corpus_metadata" ], "absent_from": [ "structural_diff" ], "kinds": [ [ "corpus_metadata", [ "MODIFIED" ] ] ] }, { "unit": "AN VII", "reason": "seen by corpus_metadata, not by structural_diff", "observed_by": [ "corpus_metadata" ], "absent_from": [ "structural_diff" ], "kinds": [ [ "corpus_metadata", [ "MODIFIED" ] ] ] } ], "metadata_only_units": [ "AR 14", "AR 23", "AN II", "AN V", "AN VII" ], "instruction_only_units": [] }, "explain": { "model_id": "openrouter:anthropic/claude-sonnet-5", "changes": 9, "explained": 2, "unavailable": 7, "replayed": 0, "synthetic": 0, "truncated": 4, "no_evidence": 1, "model_failed": 0, "nothing_to_explain": 0, "provider_unavailable": 0, "usage": { "input_tokens": 75794, "output_tokens": 605, "requests": 2, "schema_repairs": 0 } }, "gate": { "changes": 9, "passed_first": 2, "passed_on_retry": 0, "fallback": 0, "unexplained": 7, "retries": 0, "sentences": 5, "citations": 8, "citations_rejected": 0, "notes_dropped": 0, "coordinates_unsupported": 0 }, "repairs": [ { "kind": "unexplained", "repaired_on": "2026-09-04", "addressed": 1, "repaired": 1, "remaining": 0, "usage": { "input_tokens": 0, "output_tokens": 0, "requests": 0, "schema_repairs": 0 }, "coordinates_checked": false }, { "kind": "explanations", "repaired_on": "2026-09-04", "addressed": 1, "repaired": 1, "remaining": 0, "usage": { "input_tokens": 45691, "output_tokens": 229, "requests": 1, "schema_repairs": 0 }, "coordinates_checked": false }, { "kind": "evidence", "repaired_on": "2026-09-05", "addressed": 3, "repaired": 2, "remaining": 1, "usage": { "input_tokens": 118249, "output_tokens": 1012, "requests": 3, "schema_repairs": 1 }, "coordinates_checked": true }, { "kind": "signals", "repaired_on": "2026-10-08", "addressed": 9, "repaired": 2, "remaining": 0, "usage": { "input_tokens": 0, "output_tokens": 0, "requests": 0, "schema_repairs": 0 }, "coordinates_checked": false }, { "kind": "tables", "repaired_on": "2026-10-17", "addressed": 1, "repaired": 1, "remaining": 0, "usage": { "input_tokens": 0, "output_tokens": 0, "requests": 0, "schema_repairs": 0 }, "coordinates_checked": false } ], "evidence": [ { "location": "AN III", "occurrence": 0, "digest": "sha256:58f97699dd2143fc4a18e9b9c45ca6efc5ea6c49e965605fa1cb35901c2c5f06" }, { "location": "AN VI", "occurrence": 0, "digest": "sha256:fe5af1ba8680cad1e27ca80949403394889a10861a2a42ff1d6d3df35606504a" } ] }